PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tittarelli, A; Janji, B; Van Moer, K; Noman, MZ; Chouaib, S				Tittarelli, Andres; Janji, Bassam; Van Moer, Kris; Noman, Muhammad Zaeem; Chouaib, Salem			The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; MELANOMA; SUSCEPTIBILITY; APOPTOSIS; CX43	Although natural killer (NK) cells play an important role in the control of melanoma, hypoxic stress in the tumor microenvironment may impair NK-mediated tumor cell killing by mechanisms that are not fully understood. In this study, we investigated the effect of hypoxia on the expression and channel activity of connexin 43 (Cx43) in melanoma cells and its impact on their susceptibility to NK cell-mediated lysis. Our results demonstrated that hypoxic stress increases Cx43 expression in melanoma cells via hypoxia-inducible factor-1 alpha (HIF-1 alpha) transcriptional activity. Hypoxic cells displaying increased Cx43 expression were less susceptible to NK cell-mediated lysis compared with normoxic cells expressing a moderate level of Cx43. Conversely, when overexpressed in normoxic tumor cells, Cx43 improves their susceptibility to N cell-mediated killing. We show that the NK cell immune synapse formed with normoxic melanoma cells is more stable and contains a high level of gap-junctional Cx43 whereas that formed with hypoxic cells is less stable and contains a significant lower level of gap-junctional Cx43. We provide evidence that the activation of autophagy in hypoxic melanoma cells selectively degrades gap-junctional Cx43, leading to the destabilization of the immune synapse and the impairment of NK cell-mediated killing. Inhibition of autophagy by genetic or pharmacological approaches as well as expression of the non-degradable form of Cx43 significantly restore its accumulation at the immune synapse and improves N cell-mediated lysis of hypoxic melanoma cells. This study provides the first evidence that the hypoxic microenvironment negatively affects the immune surveillance of tumors by NK cells through the modulation of Cx43-mediated intercellular communications.	[Tittarelli, Andres; Noman, Muhammad Zaeem; Chouaib, Salem] INSERM U753, F-94805 Villejuif, France; [Janji, Bassam; Van Moer, Kris] Luxembourg Inst Hlth, Lab Expt Canc Res, Dept Oncol, L-1526 Luxembourg, Luxembourg	Institut National de la Sante et de la Recherche Medicale (Inserm); Luxembourg Institute of Health	Chouaib, S (corresponding author), INSERM U753, Gustave Roussy Canc Campus, F-94805 Villejuif, France.	salem.chouaib@gustaveroussy.fr	Chouaib, Salem/F-7939-2016; Tittarelli, Andrés/AAH-6601-2020; NOMAN, Muhammmad Zaeem/AAJ-1466-2021; NOMAN, Muhammmad Zaeem/AAJ-1465-2021; Tittarelli, Andres/AAO-9851-2020; Noman, Muhammad zaeem/AAF-8483-2020	NOMAN, Muhammmad Zaeem/0000-0002-1837-3097; NOMAN, Muhammmad Zaeem/0000-0002-1837-3097; JANJI, Bassam/0000-0002-9763-0943	"Equipe labellisee Ligue Contre le Cancer", European Union Seventh Framework Program (European Project RBUCE-UP) [246556]; INSERM; Universite Paris-Sud; Luxembourg Institute for Health Grant [LHCE-2013-1105]; Fondation Cancer Luxembourg Grant [FC/2012/02]	"Equipe labellisee Ligue Contre le Cancer", European Union Seventh Framework Program (European Project RBUCE-UP); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Sud; Luxembourg Institute for Health Grant; Fondation Cancer Luxembourg Grant	This project was supported by a grant "Equipe labellisee Ligue Contre le Cancer," European Union Seventh Framework Program Grant FP7/2007-2013 under grant agreement 246556 (European Project RBUCE-UP) and by grants from INSERM and the Universite Paris-Sud, by Luxembourg Institute for Health Grant LHCE-2013-1105, and by Fondation Cancer Luxembourg Grant FC/2012/02. The authors declare that they have no conflicts of interest with the contents of this article.	Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Benlalam H, 2013, J MOL MED, V91, P1207, DOI 10.1007/s00109-013-1058-5; Bhaskaracharya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093058; Burke S, 2010, TRENDS IMMUNOL, V31, P339, DOI 10.1016/j.it.2010.06.003; CALLEWAERT DM, 1991, CYTOMETRY, V12, P666, DOI 10.1002/cyto.990120711; Carette D, 2014, BIOCHIMIE, V101, P1, DOI 10.1016/j.biochi.2013.11.015; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Chen J, 2002, J APPL PHYSIOL, V92, P1480, DOI 10.1152/japplphysiol.00077.2001; Chouaib S, 2014, CRIT REV IMMUNOL, V34, P91, DOI 10.1615/CritRevImmunol.2014010183; Conklin CMJ, 2007, CARCINOGENESIS, V28, P93, DOI 10.1093/carcin/bgl106; Dufour E, 1997, J IMMUNOL, V158, P3787; Elgueta R, 2009, J IMMUNOL, V183, P277, DOI 10.4049/jimmunol.0801854; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Haass NK, 2004, J MOL HISTOL, V35, P309; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Le HT, 2014, J BIOL CHEM, V289, P1345, DOI 10.1074/jbc.M113.508390; Liu H, 2013, SEMIN CANCER BIOL, V23, P352, DOI 10.1016/j.semcancer.2013.06.008; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Mace EM, 2014, IMMUNOL CELL BIOL, V92, P245, DOI 10.1038/icb.2013.96; Machtaler S, 2011, J CELL SCI, V124, P2611, DOI 10.1242/jcs.089532; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Mendoza-Naranjo A, 2011, J IMMUNOL, V187, P3121, DOI 10.4049/jimmunol.1100378; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Noman MZ, 2011, CANCER RES, V71, P5976, DOI 10.1158/0008-5472.CAN-11-1094; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PUIG S, 1995, AM J HUM GENET, V57, P395; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Saccheri F, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000739; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Siemens DR, 2008, CANCER RES, V68, P4746, DOI 10.1158/0008-5472.CAN-08-0054; Sirnes S, 2012, INT J CANCER, V131, P570, DOI 10.1002/ijc.26392; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tittarelli A, 2014, J IMMUNOL, V192, P1313, DOI 10.4049/jimmunol.1301297; Tran K, 2013, J IMMUNOL, V190; Waza AA, 2014, CELL SIGNAL, V26, P1909, DOI 10.1016/j.cellsig.2014.05.002	44	68	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23670	23679		10.1074/jbc.M115.651547	http://dx.doi.org/10.1074/jbc.M115.651547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26221040	Green Published, hybrid			2022-12-28	WOS:000361816500017
J	Deng, G; Zheng, XD; Zhou, J; Wei, HM; Tian, ZG; Sun, R				Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui			Generation and Preclinical Characterization of an NKp80-Fc Fusion Protein for Redirected Cytolysis of Natural Killer (NK) Cells against Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; ACTIVATION; RECEPTORS; CYTOTOXICITY; INDUCTION; ANTIBODY	The capacity of natural killer (NK) cells to mediate Fc receptor-dependent effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), largely contributes to their clinical application. Given that activation-induced C-type lectin (AICL), an identified ligand for the NK-activating receptor NKp80, is frequently highly expressed on leukemia cells, the lack of therapeutic AICL-specific antibodies limits clinical application. Here we explore a strategy to reinforce NK anti-leukemia reactivity by combining targeting AICL-expressing leukemia cells with the induction of NK cell ADCC using NKp80-Fc fusion proteins. The NKp80-Fc fusion protein we generated bound specifically to leukemia cells in an AICL-specific manner. Cell binding assays between NK and leukemia cells showed that NKp80-Fc significantly increased NK target cell conjugation. In functional analyses, treatment with NKp80-Fc clearly induced the ADCC effect of NK cells. NKp80-Fc not only promoted NK-mediated leukemia cell apoptosis in the early stage of cell conjugation but also enhanced NK cell degranulation and cytotoxicity activity in the late stage. The bifunctional NKp80-Fc could redirect NK cells toward leukemia cells and triggered NK cell killing in vitro. Moreover, NKp80-Fc enhanced the lysis of NK cells against tumors in leukemia xenograft non-obese diabetic/severe combined immunodeficiency mice. Taken together, our results demonstrate that NKp80-Fc potently amplifies NK cell anti-leukemia effects in vitro and in vivo through induction of the NK cell ADCC effect. This method could potentially be useful for molecular targeted therapy, and the fusion proteins may be a promising drug for immunotherapy of leukemia.	[Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Inst Immunol, Hefei 230027, Anhui, Peoples R China; [Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Sun, Rui] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Wei, Haiming; Tian, Zhigang; Sun, Rui] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xiamen University	Zheng, XD (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei 230027, Anhui, Peoples R China.	zhxdd@ustc.edu.cn; sunr@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013		Ministry of Science and Technology of China [2013CB530506]; Natural Science Foundation of China [91029303]; National Science and Technology Major Project [2012ZX10002014, 2012ZX10002006]; National High Technology Research and Development Program [2012AA020901]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by Ministry of Science and Technology of China Grant 2013CB530506, Natural Science Foundation of China Grant 91029303, National Science and Technology Major Project Grants 2012ZX10002014 and 2012ZX10002006, and National High Technology Research and Development Program Grant 2012AA020901. The authors declare that they have no conflicts of interest with the contents of this article.	Akatsuka A, 2010, INT IMMUNOL, V22, P783, DOI 10.1093/intimm/dxq430; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Cremer I, 2012, ONCOIMMUNOLOGY, V1, P244, DOI 10.4161/onci.1.2.18309; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Feldman EJ, 2005, J CLIN ONCOL, V23, P4110, DOI 10.1200/JCO.2005.09.133; Keating GM, 2010, DRUGS, V70, P1445, DOI 10.2165/11201110-000000000-00000; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Marras F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/152430; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Owen C, 2012, EXPERT OPIN BIOL TH, V12, P343, DOI 10.1517/14712598.2012.657622; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Steinbacher J, 2015, INT J CANCER, V136, P1073, DOI 10.1002/ijc.29083; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	20	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22474	22484		10.1074/jbc.M115.678912	http://dx.doi.org/10.1074/jbc.M115.678912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198633	hybrid, Green Published			2022-12-28	WOS:000361171500015
J	Normant, V; Beaudoin, J; Labbe, S				Normant, Vincent; Beaudoin, Jude; Labbe, Simon			An Antisense RNA-mediated Mechanism Eliminates a Meiosis-specific Copper-regulated Transcript in Mitotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER GENE-EXPRESSION; BINDING FACTOR PHP4; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SELECTIVE ELIMINATION; SPORULATING CELLS; CONVERGENT GENES; IRON-DEFICIENCY; S. POMBE; POLYMERASE	Sense and antisense transcripts produced from convergent gene pairs could interfere with the expression of either partner gene. In Schizosaccharomyces pombe, we found that the iss1(+) gene produces two transcript isoforms, including a long antisense mRNA that is complementary to the meiotic cum1(+) sense transcript, inhibiting cum1(+) expression in vegetative cells. Inhibition of cum1(+) transcription was not at the level of its initiation because fusion of the cum1(+) promoter to the lacZ gene showed that activation of the reporter gene occurs in response to low copper conditions. Further analysis showed that the transcription factor Cuf1 and conserved copper-signaling elements (CuSEs) are required for induction of cum1(+)-lacZ transcription under copper deficiency. Insertion of a multipartite polyadenylation signal immediately downstream of iss1(+) led to the exclusive production of a shorter iss1(+) mRNA isoform, thereby allowing accumulation of cum1(+) sense mRNA in copper-limited vegetative cells. This finding suggested that the long iss1(+) antisense mRNA could pair with cum1(+) sense mRNA, thereby producing double-stranded RNA molecules that could induce RNAi. We consistently found that mutant strains for RNAi (dcr1 Delta, ago1 Delta, rdp1 Delta, and clr4 Delta) are defective in selectively eliminating cum1(+) sense transcript in the G(1) phase of the cell cycle. Taken together, these results describe the first example of a copper-regulated meiotic gene repressed by an antisense transcription mechanism in vegetative cells.	[Normant, Vincent; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci Sante, 3201,Pavillon Z-8,Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	Canadian Institutes of Health Research Grant [MOP-114986]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-114986 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Aranda A, 1999, MOL CELL BIOL, V19, P1251; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Beaudoin J, 2013, EUKARYOT CELL, V12, P575, DOI 10.1128/EC.00019-13; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Chen HM, 2011, CURR OPIN MICROBIOL, V14, P655, DOI 10.1016/j.mib.2011.09.010; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Gullerova M, 2011, GENE DEV, V25, P556, DOI 10.1101/gad.618611; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ioannoni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036338; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Moldon A, 2009, NAT STRUCT MOL BIOL, V16, P350, DOI 10.1038/nsmb0409-350; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Plante S, 2014, J BIOL CHEM, V289, P10168, DOI 10.1074/jbc.M113.543678; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Singleton TL, 2002, EUKARYOT CELL, V1, P44, DOI 10.1128/EC.01.1.44-55.2002; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Suzuki S, 2013, FUNGAL GENET BIOL, V56, P42, DOI 10.1016/j.fgb.2013.04.008; Wang LW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004021; Werner A, 2009, CURR OPIN NEPHROL HY, V18, P343, DOI 10.1097/MNH.0b013e32832cb982; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 2013, NUCLEIC ACIDS RES, V41, P9680, DOI 10.1093/nar/gkt763; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014	50	2	2	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22622	22637		10.1074/jbc.M115.674556	http://dx.doi.org/10.1074/jbc.M115.674556			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26229103	hybrid, Green Published			2022-12-28	WOS:000361171500028
J	Pathak, D; Shields, LY; Mendelsohn, BA; Haddad, D; Lin, W; Gerencser, AA; Kim, H; Brand, MD; Edwards, RH; Nakamura, K				Pathak, Divya; Shields, Lauren Y.; Mendelsohn, Bryce A.; Haddad, Dominik; Lin, Wei; Gerencser, Akos A.; Kim, Hwajin; Brand, Martin D.; Edwards, Robert H.; Nakamura, Ken			The Role of Mitochondrially Derived ATP in Synaptic Vesicle Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL MITOCHONDRIA; PARKINSON DISEASE; POOL VESICLES; ENERGY; GLUCOSE; DYSFUNCTION; NEURONS; EXOCYTOSIS; CONTRIBUTE; INCREASES	Synaptic mitochondria are thought to be critical in supporting neuronal energy requirements at the synapse, and bioenergetic failure at the synapse may impair neural transmission and contribute to neurodegeneration. However, little is known about the energy requirements of synaptic vesicle release or whether these energy requirements go unmet in disease, primarily due to a lack of appropriate tools and sensitive assays. To determine the dependence of synaptic vesicle cycling on mitochondrially derived ATP levels, we developed two complementary assays sensitive to mitochondrially derived ATP in individual, living hippocampal boutons. The first is a functional assay for mitochondrially derived ATP that uses the extent of synaptic vesicle cycling as a surrogate for ATP level. The second uses ATP FRET sensors to directly measure ATP at the synapse. Using these assays, we show that endocytosis has high ATP requirements and that vesicle reacidification and exocytosis require comparatively little energy. We then show that to meet these energy needs, mitochondrially derived ATP is rapidly dispersed in axons, thereby maintaining near normal levels of ATP even in boutons lacking mitochondria. As a result, the capacity for synaptic vesicle cycling is similar in boutons without mitochondria as in those with mitochondria. Finally, we show that loss of a key respiratory subunit implicated in Leigh disease markedly decreases mitochondrially derived ATP levels in axons, thus inhibiting synaptic vesicle cycling. This proves that mitochondria-based energy failure can occur and be detected in individual neurons that have a genetic mitochondrial defect.	[Pathak, Divya; Shields, Lauren Y.; Mendelsohn, Bryce A.; Haddad, Dominik; Lin, Wei; Kim, Hwajin; Nakamura, Ken] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Shields, Lauren Y.; Edwards, Robert H.; Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Shields, Lauren Y.; Edwards, Robert H.; Nakamura, Ken] Univ Calif San Francisco, Grad Programs Neurosci & Biomed Sci, San Francisco, CA 94158 USA; [Mendelsohn, Bryce A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gerencser, Akos A.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Buck Institute for Research on Aging	Nakamura, K (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	ken.nakamura@gladstone.ucsf.edu	Brand, Martin D/A-9423-2012; Regan, Clinton/E-6250-2012	Brand, Martin D/0000-0003-4418-6153; Nakamura, Ken/0000-0002-9192-182X	National Institutes of Health [RR018928]; Betty Brown's Family; Joan and David Traitel Family Trust; Burroughs-Wellcome Medical Scientist Fund; National Institutes of Health from NINDS [1KO8NS062954-01A1, 1RO1NS091902-01, P30NS069496]; National Science Foundation; Pediatric Scientist Development Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091902, P30NS069496, K08NS062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Betty Brown's Family; Joan and David Traitel Family Trust; Burroughs-Wellcome Medical Scientist Fund; National Institutes of Health from NINDS; National Science Foundation(National Science Foundation (NSF)); Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RR018928 (to the Gladstone Institutes). This work was also supported by Betty Brown's Family and the Joan and David Traitel Family Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Burroughs-Wellcome Medical Scientist Fund Career Award and National Institutes of Health Grants 1KO8NS062954-01A1, 1RO1NS091902-01, and P30NS069496 from the NINDS.; Supported by a National Science Foundation graduate research fellowship.; Supported by the Pediatric Scientist Development Program.	BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Berthet A, 2014, J NEUROSCI, V34, P14304, DOI 10.1523/JNEUROSCI.0930-14.2014; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Budzinski KL, 2011, BIOPHYS J, V101, P1580, DOI 10.1016/j.bpj.2011.08.032; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Choi SW, 2012, J NEUROSCI, V32, P16775, DOI 10.1523/JNEUROSCI.2414-12.2012; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Egashira Y, 2015, J NEUROSCI, V35, P3701, DOI 10.1523/JNEUROSCI.4160-14.2015; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Foss SM, 2013, J NEUROSCI, V33, P10647, DOI 10.1523/JNEUROSCI.5662-12.2013; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Imamura Hiromi, 2009, Tanpakushitsu Kakusan Koso, V54, P1937; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kuiper JWP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-73; Kuner T, 2008, P NATL ACAD SCI USA, V105, P347, DOI 10.1073/pnas.0707197105; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nagase M, 2014, J NEUROSCI, V34, P2605, DOI 10.1523/JNEUROSCI.4687-12.2014; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Pathak D, 2013, ANN NEUROL, V74, P506, DOI 10.1002/ana.24014; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rex A, 2009, PHYSIOL BEHAV, V98, P467, DOI 10.1016/j.physbeh.2009.07.015; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SMYTHE E, 1989, J CELL BIOL, V108, P843, DOI 10.1083/jcb.108.3.843; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Tanaka T, 2014, J BIOL CHEM, V289, P2205, DOI 10.1074/jbc.M113.499111; Tsuyama T, 2013, ANAL CHEM, V85, P7889, DOI 10.1021/ac4015325; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Waters J, 2003, PFLUG ARCH EUR J PHY, V447, P363, DOI 10.1007/s00424-003-1182-0; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Yasuda T, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-16; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029	62	140	143	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22325	22336		10.1074/jbc.M115.656405	http://dx.doi.org/10.1074/jbc.M115.656405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26126824	Green Published, hybrid			2022-12-28	WOS:000361171500002
J	Meyer, NH; Mayerhofer, H; Tripsianes, K; Blindow, S; Barths, D; Mewes, A; Weimar, T; Kohli, T; Bade, S; Madl, T; Frey, A; Haas, H; Mueller-Dieckmann, J; Sattler, M; Schramm, G				Meyer, N. Helge; Mayerhofer, Hubert; Tripsianes, Konstantinos; Blindow, Silke; Barths, Daniela; Mewes, Astrid; Weimar, Thomas; Koehli, Thies; Bade, Steffen; Madl, Tobias; Frey, Andreas; Haas, Helmut; Mueller-Dieckmann, Jochen; Sattler, Michael; Schramm, Gabriele			A Crystallin Fold in the Interleukin-4-inducing Principle of Schistosoma mansoni Eggs (IPSE/alpha-1) Mediates IgE Binding for Antigen-independent Basophil Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STRUCTURES; IL-4 PRODUCTION; CUTTING EDGE; IN-VIVO; RECEPTOR; NMR; CELLS; PURIFICATION; GLYCOPROTEIN; AGGREGATION	The IL-4-inducing principle from Schistosoma mansoni eggs (IPSE/alpha-1), the major secretory product of eggs from the parasitic worm S. mansoni, efficiently triggers basophils to release the immunomodulatory key cytokine interleukin-4. Activation by IPSE/alpha-1 requires the presence of IgE on the basophils, but the detailed molecular mechanism underlying activation is unknown. NMR and crystallographic analysis of IPSE Delta NLS, a monomeric IPSE/alpha-1 mutant, revealed that IPSE/alpha-1 is a new member of the beta gamma-crystallin superfamily. We demonstrate that this molecule is a general immunoglobulin-binding factor with highest affinity for IgE. NMR binding studies of IPSE Delta NLS with the 180-kDa molecule IgE identified a large positively charged binding surface that includes a flexible loop, which is unique to the IPSE/alpha-1 crystallin fold. Mutational analysis of amino acids in the binding interface showed that residues contributing to IgE binding are important for IgE-dependent activation of basophils. As IPSE/alpha-1 is unable to cross-link IgE, we propose that this molecule, by taking advantage of its unique IgE-binding crystallin fold, activates basophils by a novel, cross-linking-independent mechanism.	[Meyer, N. Helge; Tripsianes, Konstantinos; Madl, Tobias; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Meyer, N. Helge; Tripsianes, Konstantinos; Madl, Tobias; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci & Biomol NMR, D-85747 Garching, Germany; [Mayerhofer, Hubert; Mueller-Dieckmann, Jochen] DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany; [Blindow, Silke; Barths, Daniela; Mewes, Astrid; Haas, Helmut; Schramm, Gabriele] Res Ctr Borstel, Cellular Allergol, D-23845 Borstel, Germany; [Bade, Steffen; Frey, Andreas] Res Ctr Borstel, Mucosal Immunol & Diagnost Sect, D-23845 Borstel, Germany; [Weimar, Thomas; Koehli, Thies] Univ Lubeck, Inst Chem, D-23562 Lubeck, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Forschungszentrum Borstel; Forschungszentrum Borstel; University of Lubeck	Mueller-Dieckmann, J (corresponding author), DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany.	jochen.mueller-dieckmann@uni-hamburg.de; Sattler@helmholtz-muenchen.de; gschramm@fz-borstel.de	Madl, Tobias/B-1682-2012; Sattler, Michael/A-2407-2012; Tripsianes, Konstantinos/I-8382-2014	Madl, Tobias/0000-0002-9725-5231; Sattler, Michael/0000-0002-1594-0527; Tripsianes, Konstantinos/0000-0003-0948-813X; Meyer, Niels Helge/0000-0003-1018-4942; Mayerhofer, Hubert/0000-0002-3291-2376	Deutsche Forschungsgemeinschaft [EXC114, SFB 594]; Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network; Alexander von Humboldt Foundation; EMBO Long Term Fellowship; Schrodinger Fellowship by the Austrian Science Fund; APART Fellowship from the Austrian Academy of Sciences	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Schrodinger Fellowship by the Austrian Science Fund(Austrian Science Fund (FWF)); APART Fellowship from the Austrian Academy of Sciences	This work was supported in part by Deutsche Forschungsgemeinschaft Grants EXC114 and SFB 594 (to M. S) and the Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Alexander von Humboldt Foundation. Present address: Central European Institute of Technology, Masaryk University, 601 77Brno, Czech Republic.; Supported by an EMBO Long Term Fellowship, a Schrodinger Fellowship by the Austrian Science Fund, and an APART Fellowship from the Austrian Academy of Sciences. Present address: Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, 8010 Graz, Austria.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunet LR, 1997, J IMMUNOL, V159, P777; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUNNE DW, 1991, PARASITOLOGY, V103, P225, DOI 10.1017/S0031182000059503; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcone FH, 1996, EUR J IMMUNOL, V26, P1147, DOI 10.1002/eji.1830260528; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Haisch K, 1999, J IMMUNOL METHODS, V226, P129, DOI 10.1016/S0022-1759(99)00059-9; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Herbert DR, 2008, J IMMUNOL, V180, P4948, DOI 10.4049/jimmunol.180.7.4948; Holowka D, 2007, IMMUNOL REV, V217, P269, DOI 10.1111/j.1600-065X.2007.00517.x; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Kaur I, 2011, INFECT IMMUN, V79, P1779, DOI 10.1128/IAI.01048-10; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Mayerhofer H, 2009, ACTA CRYSTALLOGR F, V65, P594, DOI 10.1107/S1744309109015899; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer NH, 2011, BIOMOL NMR ASSIGN, V5, P225, DOI 10.1007/s12104-011-9305-6; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patella V, 2000, J IMMUNOL, V164, P589, DOI 10.4049/jimmunol.164.2.589; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; Rockendorf N, 2007, BIOCONJUGATE CHEM, V18, P573, DOI 10.1021/bc0602376; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2010, MICROBES INFECT, V12, P881, DOI 10.1016/j.micinf.2010.06.001; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Schweitzer-Stenner R, 2005, J IMMUNOL, V174, P4461, DOI 10.4049/jimmunol.174.8.4461; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Watanabe T, 1999, EUR J IMMUNOL, V29, P413, DOI 10.1002/(SICI)1521-4141(199902)29:02<413::AID-IMMU413>3.3.CO;2-P; Wuhrer M, 2006, FEBS J, V273, P2276, DOI 10.1111/j.1742-4658.2006.05242.x; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065	48	23	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22111	22126		10.1074/jbc.M115.675066	http://dx.doi.org/10.1074/jbc.M115.675066			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26163514	Green Published, hybrid			2022-12-28	WOS:000360968500029
J	Cejka, P				Cejka, Petr			DNA End Resection: Nucleases Team Up with the Right Partners to Initiate Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; RECBCD ENZYME; CHECKPOINT ACTIVATION; GENOME STABILITY; DAMAGE RESPONSE; MRE11 NUCLEASE; FUNCTIONAL MRX; BUDDING YEAST; EXONUCLEASE 1	The repair of DNA double-strand breaks by homologous recombination commences by nucleolytic degradation of the 5'-terminated strand of the DNA break. This leads to the formation of 3'-tailed DNA, which serves as a substrate for the strand exchange protein Rad51. The nucleoprotein filament then invades homologous DNA to drive template-directed repair. In this review, I discuss mainly the mechanisms of DNA end resection in Saccharomyces cerevisiae, which includes short-range resection by Mre11-Rad50-Xrs2 and Sae2, as well as processive long-range resection by Sgs1-Dna2 or Exo1 pathways. Resection mechanisms are highly conserved between yeast and humans, and analogous machineries are found in prokaryotes as well.	Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	University of Zurich	Cejka, P (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	cejka@imcr.uzh.ch		Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation [PP00P3 133636]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant (PP00P3 133636). The author declares that he has no conflicts of interest with the contents of this article.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Andres SN, 2015, NAT STRUCT MOL BIOL, V22, P158, DOI 10.1038/nsmb.2945; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bonetti D, 2015, EMBO REP, V16, P351, DOI 10.15252/embr.201439764; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Chen H, 2015, P NATL ACAD SCI USA, V112, pE1880, DOI 10.1073/pnas.1503331112; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chen L, 2005, J BIOL CHEM, V280, P2620, DOI 10.1074/jbc.M410192200; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Davies OR, 2015, NAT STRUCT MOL BIOL, V22, P150, DOI 10.1038/nsmb.2937; Deshpande RA, 2014, EMBO J, V33, P482, DOI 10.1002/embj.201386100; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Ferretti Lorenza P., 2013, Frontiers in Genetics, V4, P99, DOI 10.3389/fgene.2013.00099; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fu Q, 2014, MOL CELL BIOL, V34, P778, DOI 10.1128/MCB.00963-13; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2002, CURR OPIN STRUC BIOL, V12, P115, DOI 10.1016/S0959-440X(02)00297-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Levikova M, 2013, P NATL ACAD SCI USA, V110, pE1992, DOI 10.1073/pnas.1300390110; Liang J, 2015, J BIOL CHEM, V290, P10751, DOI 10.1074/jbc.M114.625293; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moreau S, 1999, MOL CELL BIOL, V19, P556; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Ngo GHP, 2015, NUCLEIC ACIDS RES, V43, P5017, DOI 10.1093/nar/gkv409; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; PETRINI JHJ, 1995, GENOMICS, V29, P80, DOI 10.1006/geno.1995.1217; Prinz S, 1997, GENETICS, V146, P781; Puddu F, 2015, EMBO J, V34, P1509, DOI 10.15252/embj.201590973; Rattray AJ, 2001, GENETICS, V158, P109; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Sturzenegger A, 2014, J BIOL CHEM, V289, P27314, DOI 10.1074/jbc.M114.578823; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsai FL, 2014, CELL CYCLE, V13, P3460, DOI 10.4161/15384101.2014.958386; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	95	129	130	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22931	22938		10.1074/jbc.R115.675942	http://dx.doi.org/10.1074/jbc.R115.675942			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26231213	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000361685500006
J	Foda, BM; Singh, U				Foda, Bardees M.; Singh, Upinder			Dimethylated H3K27 Is a Repressive Epigenetic Histone Mark in the Protist Entamoeba histolytica and Is Significantly Enriched in Genes Silenced via the RNAi Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II INITIATION; ANTISENSE SMALL RNAS; DNA ELIMINATION; JMJC DOMAIN; HETEROCHROMATIN; METHYLATION; TRANSCRIPTION; CHROMATIN; H3; INTERFERENCE	RNA interference (RNAi) is a fundamental biological process that plays a crucial role in regulation of gene expression in many organisms. Transcriptional gene silencing (TGS) is one of the important nuclear roles of RNAi. Our previous data show that Entamoeba histolytica has a robust RNAi pathway that links to TGS via Argonaute 2-2 (Ago2-2) associated 27-nucleotide small RNAs with 5'-polyphosphate termini. Here, we report the first repressive histone mark to be identified in E. histolytica, dimethylation of H3K27 (H3K27Me2), and demonstrate that it is enriched at genes that are silenced by RNAi-mediated TGS. An RNAi-silencing trigger can induce H3K27Me2 deposits at both episomal and chromosomal loci, mediating gene silencing. Our data support two phases of RNAi-mediated TGS: an active silencing phase where the RNAi trigger is present and both H3K27Me2 and Ago2-2 concurrently enrich at chromosomal loci; and an established silencing phase in which the RNAi trigger is removed, but gene silencing with H3K27Me2 enrichment persist independently of Ago2-2 deposition. Importantly, some genes display resistance to chromosomal silencing despite induction of functional small RNAs. In those situations, the RNAi-triggering plasmid that is maintained episomally gets partially silenced and has H3K27Me2 enrichment, but the chromosomal copy displays no repressive histone enrichment. Our data are consistent with a model in which H3K27Me2 is a repressive histone modification, which is strongly associated with transcriptional repression. This is the first example of an epigenetic histone modification that functions to mediate RNAi-mediated TGS in the deep-branching eukaryote E. histolytica.	[Foda, Bardees M.; Singh, Upinder] Stanford Univ, Dept Internal Med, Div Infect Dis, Sch Med, Stanford, CA 94305 USA; [Singh, Upinder] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Foda, Bardees M.] Natl Res Ctr, Dept Mol Genet & Enzymol, Dokki, Egypt	Stanford University; Stanford University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Singh, U (corresponding author), Stanford Univ, Dept Internal Med, Div Infect Dis, Sch Med, Stanford, CA 94305 USA.	usingh@stanford.edu	Regan, Clinton/E-6250-2012; Foda, Bardees/B-2182-2019	Foda, Bardees/0000-0001-8869-3697; Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [R01AI053724, R21 AI102277]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102277, R01AI053724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI053724 and R21 AI102277 (to U.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Batista TM, 2011, J PROTEOMICS, V74, P1504, DOI 10.1016/j.jprot.2011.02.032; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan FL, 2012, NUCLEIC ACIDS RES, V40, P11178, DOI 10.1093/nar/gks921; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chujo T, 2014, MOL MICROBIOL, V92, P413, DOI 10.1111/mmi.12567; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Eichten SR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003127; Ellison TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111502; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FODINGER M, 1993, MOL BIOCHEM PARASIT, V59, P315, DOI 10.1016/0166-6851(93)90229-Q; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Furuhashi H, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-15; Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huguenin M, 2010, PARASITOLOGY, V137, P619, DOI 10.1017/S0031182009991363; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jhingan GD, 2009, MOL BIOCHEM PARASIT, V167, P72, DOI 10.1016/j.molbiopara.2009.04.011; Johnson A, 2013, J BIOL CHEM, V288, P28771, DOI 10.1074/jbc.M113.460071; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Lyko F, 2006, CURR TOP MICROBIOL, V310, P23; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2006, COLD SPRING HARB SYM, V71, P461, DOI 10.1101/sqb.2006.71.044; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Neumann P, 2007, GENETICS, V176, P749, DOI 10.1534/genetics.107.071902; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Papazyan R, 2014, ELIFE, V3, DOI 10.7554/eLife.02996; Pearson RJ, 2013, J BIOL CHEM, V288, P4462, DOI 10.1074/jbc.M112.423467; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Pompey JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106477; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tovy A, 2010, FUTURE MICROBIOL, V5, P1875, DOI 10.2217/FMB.10.140; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06179; Wang JY, 2014, CELL MOL LIFE SCI, V71, P4841, DOI 10.1007/s00018-014-1725-x; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	71	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21114	21130		10.1074/jbc.M115.647263	http://dx.doi.org/10.1074/jbc.M115.647263			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26149683	hybrid, Green Published			2022-12-28	WOS:000360011800043
J	Huang, SP; Liu, SF; Fu, JJ; Wang, TT; Yao, XL; Kumar, A; Liu, G; Fu, MG				Huang, Shengping; Liu, Shufeng; Fu, Jia J.; Wang, T. Tony; Yao, Xiaolan; Kumar, Anil; Liu, Gang; Fu, Mingui			Monocyte Chemotactic Protein-induced Protein 1 and 4 Form a Complex but Act Independently in Regulation of Interleukin-6 mRNA Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; KAPPA-B ACTIVATION; T-CELLS; MCPIP1; GW182; INFLAMMATION; INHIBITION; EXPRESSION; INFECTION; REGNASE-1	It was recently demonstrated that MCPIP1 is a critical factor that controls inflammation and immune homeostasis; however, the relationship between MCPIP1 and other members of this protein family is largely unknown. Here, we report that MCPIP1 interacts with MCPIP4 to form a protein complex, but acts independently in the regulation of IL-6 mRNA degradation. In an effort to identify MCPIP1-interacting proteins by co-immunoprecipitation (Co-IP) and mass-spec analysis, MCPIP4 was identified as a MCPIP1-interacting protein, which was further confirmed by Co-IP and mammalian two-hybrid assay. Immunofluorescence staining showed that MCPIP4 was co-localized with MCPIP1 in the GW-body, which features GW182 and Argonaute 2. Further studies showed that MCPIP1 and MCPIP4 act independently in regulation of IL-6 mRNA degradation. These results suggest that MCPIP1 and MCPIP4 may additively contribute to control IL-6 production in vivo.	[Huang, Shengping; Fu, Jia J.; Fu, Mingui] Univ Missouri, Shock Trauma Res Ctr, Sch Med, Kansas City, MO 64108 USA; [Huang, Shengping; Fu, Jia J.; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64108 USA; [Liu, Shufeng; Wang, T. Tony] SRI Int, Biosci Div, Harrisonburg, VA 22802 USA; [Yao, Xiaolan] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Liu, Gang] Univ Alabama Birmingham, Sch Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; SRI International; University of Missouri System; University of Missouri Kansas City; University of Alabama System; University of Alabama Birmingham	Fu, MG (corresponding author), Univ Missouri, Shock Trauma Res Ctr, Sch Med, Kansas City, MO 64108 USA.	fum@umkc.edu	Regan, Clinton/E-6250-2012	Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	National Institutes of Health [AI103618, HL105473, HL076206, DA025528, DA025011, AA020806, DK088787]; UMKC SOM Dean's Support Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105473, R01HL076206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK088787, R01DK088787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMKC SOM Dean's Support Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant AI103618 (to M. F.) and a UMKC SOM Dean's Support Fund (to M. F.). This work was also supported by National Institutes of Health Grants HL105473 and HL076206 (to G. L.), National Institutes of Health Grants DA025528, DA025011, and AA020806 (to A. K.), and National Institutes of Health Grant DK088787 (to T. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2013, COLD SH Q B, V78, P51, DOI 10.1101/sqb.2013.78.019877; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chan EKL, 2013, ADV EXP MED BIOL, V768, P261, DOI 10.1007/978-1-4614-5107-5_15; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Huang SP, 2013, CELL SIGNAL, V25, P1228, DOI 10.1016/j.cellsig.2013.02.009; Huang SP, 2012, CELL SIGNAL, V24, P569, DOI 10.1016/j.cellsig.2011.10.011; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lin RJ, 2014, J IMMUNOL, V193, P4159, DOI 10.4049/jimmunol.1400337; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Liu L, 2013, BIOCHEM J, V451, P55, DOI 10.1042/BJ20130019; Liu SF, 2013, P NATL ACAD SCI USA, V110, P19083, DOI 10.1073/pnas.1316208110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Miao RD, 2013, IMMUNOL CELL BIOL, V91, P368, DOI 10.1038/icb.2013.11; Minagawa K, 2007, BRIT J HAEMATOL, V139, P161, DOI 10.1111/j.1365-2141.2007.06752.x; Minagawa K, 2014, J IMMUNOL, V192, P1512, DOI 10.4049/jimmunol.1301619; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Owerbach D, 2004, DIABETES, V53, P1890, DOI 10.2337/diabetes.53.7.1890; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Qi YF, 2010, FEBS LETT, V584, P3065, DOI 10.1016/j.febslet.2010.05.040; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tan DZ, 2014, NAT STRUCT MOL BIOL, V21, P679, DOI 10.1038/nsmb.2857; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Wang M, 2007, CANCER RES, V67, P93, DOI 10.1158/0008-5472.CAN-06-2723; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	38	20	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20782	20792		10.1074/jbc.M114.635870	http://dx.doi.org/10.1074/jbc.M114.635870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134560	Green Published, hybrid			2022-12-28	WOS:000360011800016
J	Panneton, V; Nath, A; Sader, F; Delaunay, N; Pelletier, A; Maier, D; Oh, K; Hipfner, DR				Panneton, Vincent; Nath, Apurba; Sader, Fadi; Delaunay, Nathalie; Pelletier, Ariane; Maier, Dominic; Oh, Karen; Hipfner, David R.			Regulation of Catalytic and Non-catalytic Functions of the Drosophila Ste20 Kinase Slik by Activation Segment Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES CELLULAR GROWTH; PROTEIN-KINASES; STE20-RELATED KINASE; EPITHELIAL-CELLS; HIPPO PATHWAY; SLK; APOPTOSIS; PROLIFERATION; MOESIN; MERLIN	Protein kinases carry out important functions in cells both by phosphorylating substrates and by means of regulated non-catalytic activities. Such non-catalytic functions have been ascribed to many kinases, including some members of the Ste20 family. The Drosophila Ste20 kinase Slik phosphorylates and activates Moesin in developing epithelial tissues to promote epithelial tissue integrity. It also functions non-catalytically to promote epithelial cell proliferation and tissue growth. We carried out a structure-function analysis to determine how these two distinct activities of Slik are controlled. We find that the conserved C-terminal coiled-coil domain of Slik, which is necessary and sufficient for apical localization of the kinase in epithelial cells, is not required for Moesin phosphorylation but is critical for the growth-promoting function of Slik. Slik is auto-and trans-phosphorylated in vivo. Phosphorylation of at least two of three conserved sites in the activation segment is required for both efficient catalytic activity and non-catalytic signaling. Slik function is thus dependent upon proper localization of the kinase via the C-terminal coiled-coil domain and activation via activation segment phosphorylation, which enhances both phosphorylation of substrates like Moesin and engagement of effectors of its non-catalytic growth-promoting activity.	[Panneton, Vincent; Nath, Apurba; Sader, Fadi; Delaunay, Nathalie; Pelletier, Ariane; Maier, Dominic; Oh, Karen; Hipfner, David R.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Panneton, Vincent; Nath, Apurba; Hipfner, David R.] Univ Montreal, Program Mol Biol, Montreal, PQ H3T 3J7, Canada; [Maier, Dominic; Hipfner, David R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Hipfner, David R.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal	Hipfner, DR (corresponding author), Inst Rech Clin Montreal, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	david.hipfner@ircm.qc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant (to D. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chaar Z, 2006, J BIOL CHEM, V281, P28193, DOI 10.1074/jbc.M605665200; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Du W, 1996, EMBO J, V15, P3684, DOI 10.1002/j.1460-2075.1996.tb00738.x; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hipfner DR, 2003, PLOS BIOL, V1, P244, DOI 10.1371/journal.pbio.0000035; Hipfner DR, 2002, GENETICS, V161, P1527; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lim J, 2003, BIOCHEM BIOPH RES CO, V300, P694, DOI 10.1016/S0006-291X(02)02909-1; Luhovy AY, 2012, J BIOL CHEM, V287, P5446, DOI 10.1074/jbc.M111.302018; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	64	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20960	20971		10.1074/jbc.M115.645952	http://dx.doi.org/10.1074/jbc.M115.645952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26170449	Green Published, hybrid			2022-12-28	WOS:000360011800030
J	Ji, CJ; Kim, JH; Won, YB; Lee, YE; Choi, TW; Ju, SY; Youn, H; Helmann, JD; Lee, JW				Ji, Chang-Jun; Kim, Jung-Hoon; Won, Young-Bin; Lee, Yeh-Eun; Choi, Tae-Woo; Ju, Shin-Yeong; Youn, Hwan; Helmann, John D.; Lee, Jin-Won			Staphylococcus aureus PerR Is a Hypersensitive Hydrogen Peroxide Sensor using Iron-mediated Histidine Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS RESISTANCE; TRANSCRIPTION FACTOR; MODEL HOST; FUR; REGULATOR; PROTEIN; IDENTIFICATION; SUPEROXIDE; MECHANISMS; EXPRESSION	In many Gram-positive bacteria PerR is a major peroxide sensor whose repressor activity is dependent on a bound metal cofactor. The prototype for PerR sensors, the Bacillus subtilis PerRBS protein, represses target genes when bound to either Mn2+ or Fe2+ as corepressor, but only the Fe2+-bound form responds to H2O2. The orthologous protein in the human pathogen Staphylococcus aureus, PerR(SA), plays important roles in H2O2 resistance and virulence. However, PerR(SA) is reported to only respond to Mn2+ as corepressor, which suggests that it might rely on a distinct, iron-independent mechanism for H2O2 sensing. Here we demonstrate that PerR(SA) uses either Fe2+ or Mn2+ as corepressor, and that, like PerRBS, the Fe2+-bound form of PerR(SA) senses physiological levels of H2O2 by iron-mediated histidine oxidation. Moreover, we show that PerR(SA) is poised to sense very low levels of endogenous H2O2, which normally cannot be sensed by B. subtilis PerRBS. This hypersensitivity of PerR(SA) accounts for the apparent lack of Fe2+-dependent repressor activity and consequent Mn2+-specific repressor activity under aerobic conditions. We also provide evidence that the activity of PerR(SA) is directly correlated with virulence, whereas it is inversely correlated with H2O2 resistance, suggesting that PerR(SA) may be an attractive target for the control of S. aureus pathogenesis.	[Ji, Chang-Jun; Kim, Jung-Hoon; Won, Young-Bin; Lee, Yeh-Eun; Choi, Tae-Woo; Ju, Shin-Yeong; Lee, Jin-Won] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Ji, Chang-Jun; Kim, Jung-Hoon; Won, Young-Bin; Lee, Yeh-Eun; Choi, Tae-Woo; Ju, Shin-Yeong; Lee, Jin-Won] Hanyang Univ, Res Ctr Nat Sci, Seoul 133791, South Korea; [Youn, Hwan] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Hanyang University; Hanyang University; California State University System; California State University Fresno; Cornell University	Helmann, JD (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	jdh9@cornell.edu; jwl@hanyang.ac.kr	Kim, Jung-Hoon/A-6409-2017; LEE, JIN-WON/L-1116-2016; Regan, Clinton/E-6250-2012	Kim, Jung-Hoon/0000-0003-2775-4518; LEE, JIN-WON/0000-0002-1201-8254; Ju, Shinyeong/0000-0001-5483-4690	National Institutes of Health [GM059323]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2011-0017199, NRF-2009-0068133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF) - Korea government (MSIP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059323 (to J. D. H.) and National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) Grants NRF-2011-0017199 and NRF-2009-0068133 (to J.-W. L.). The authors declare that they have no conflict of interest.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Duarte V, 2013, FUTURE MED CHEM, V5, P1177, DOI 10.4155/fmc.13.92; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Faulkner MJ, 2012, J BACTERIOL, V194, P1226, DOI 10.1128/JB.06566-11; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P5036, DOI 10.1093/nar/gkr095; Morrissey JA, 2004, INFECT IMMUN, V72, P972, DOI 10.1128/IAI.72.2.972-979.2004; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wen YT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007013; Won YB, 2010, B KOREAN CHEM SOC, V31, P1573, DOI 10.5012/bkcs.2010.31.6.1573; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	41	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20374	20386		10.1074/jbc.M115.664961	http://dx.doi.org/10.1074/jbc.M115.664961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134568	Green Published, hybrid			2022-12-28	WOS:000359608900035
J	Li, J; Newhall, J; Ishiyama, N; Gottardi, C; Ikura, M; Leckband, DE; Tajkhorshid, E				Li, Jing; Newhall, Jillian; Ishiyama, Noboru; Gottardi, Cara; Ikura, Mitsuhiko; Leckband, Deborah E.; Tajkhorshid, Emad			Structural Determinants of the Mechanical Stability of alpha-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; MOLECULAR-DYNAMICS; VINCULIN ACTIVATION; ADHERENS JUNCTIONS; CRYSTAL-STRUCTURE; BINDING-SITES; CADHERIN; ADHESION; FORCE; MECHANOTRANSDUCTION	alpha-Catenin plays a crucial role in cadherin-mediated adhesion by binding to beta-catenin, F-actin, and vinculin, and its dysfunction is linked to a variety of cancers and developmental disorders. As a mechanotransducer in the cadherin complex at intercellular adhesions, mechanical and force-sensing properties of alpha-catenin are critical to its proper function. Biochemical data suggest that alpha-catenin adopts an autoinhibitory conformation, in the absence of junctional tension, and biophysical studies have shown that alpha-catenin is activated in a tension-dependent manner that in turn results in the recruitment of vinculin to strengthen the cadherin complex/F-actin linkage. However, the molecular switch mechanism from autoinhibited to the activated state remains unknown for alpha-catenin. Here, based on the results of an aggregate of 3 mu s of molecular dynamics simulations, we have identified a dynamic salt-bridge network within the core M region of alpha-catenin that may be the structural determinant of the stability of the autoinhibitory conformation. According to our constant-force steered molecular dynamics simulations, the reorientation of the MII/MIII subdomains under force may constitute an initial step along the transition pathway. The simulations also suggest that the vinculin-binding domain (subdomain MI) is intrinsically much less stable than the other two subdomains in the M region (MII and MIII). Our findings reveal several key insights toward a complete understanding of the multistaged, force-induced conformational transition of alpha-catenin to the activated conformation.	[Li, Jing; Leckband, Deborah E.; Tajkhorshid, Emad] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Li, Jing; Leckband, Deborah E.; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Li, Jing; Leckband, Deborah E.; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Newhall, Jillian; Leckband, Deborah E.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Ishiyama, Noboru; Ikura, Mitsuhiko] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Gottardi, Cara] Northwestern Univ, Feinberg Coll Med, Dept Acute Pulm Care, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Northwestern University; Feinberg School of Medicine	Leckband, DE (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	leckband@illinois.edu; emad@life.illinois.edu	Tajkhorshid, Emad/AAN-8323-2021; Gottardi, Cara J./AAU-4691-2021; Regan, Clinton/E-6250-2012	Gottardi, Cara J./0000-0003-0912-7617; Ikura, Mitsuhiko/0000-0002-9524-1303; Tajkhorshid, Emad/0000-0001-8434-1010; LI, Jing/0000-0003-3277-6818	National Institutes of Health [P41-GM104601]; National Science Foundation [1029871]; Canadian Institutes of Health Research [MOP-130297]; Xsede [MCA06N060]; Illinois Campus Cluster Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, R01GM076561] Funding Source: NIH RePORTER; Division Of Chemistry [1213755] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Xsede; Illinois Campus Cluster Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grant P41-GM104601, National Science Foundation Grant 1029871, and the Canadian Institutes of Health Research grant (MOP-130297). This work was also supported by a supercomputing allocation through Xsede Grant MCA06N060 and the Illinois Campus Cluster Program. The authors declare that they have no conflicts of interest with the contents of this article.	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZM, 2009, ARTERIOSCL THROM VAS, V29, P1067, DOI 10.1161/ATVBAHA.109.186692; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Collins C, 2012, CURR BIOL, V22, P2087, DOI 10.1016/j.cub.2012.08.051; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grubmuller H., 1996, SOLVATE VERSION 1 0; GUMBINER BM, 1993, J CELL SCI, P155; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Kuttel M, 2002, J COMPUT CHEM, V23, P1236, DOI 10.1002/jcc.10119; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schreiner E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-190; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Seong J, 2013, P NATL ACAD SCI USA, V110, P19372, DOI 10.1073/pnas.1307405110; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Vermeulen SJ, 1997, ANN NY ACAD SCI, V833, P186, DOI 10.1111/j.1749-6632.1997.tb48607.x; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	68	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18890	18903		10.1074/jbc.M115.647941	http://dx.doi.org/10.1074/jbc.M115.647941			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070562	Green Published, hybrid			2022-12-28	WOS:000358781100002
J	Roux, D; Cywes-Bentley, C; Zhang, YF; Pons, S; Konkol, M; Kearns, DB; Little, DJ; Howell, PL; Skurnik, D; Pier, GB				Roux, Damien; Cywes-Bentley, Colette; Zhang, Yi-Fan; Pons, Stephanie; Konkol, Melissa; Kearns, Daniel B.; Little, Dustin J.; Howell, P. Lynne; Skurnik, David; Pier, Gerald B.			Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; SURFACE POLYSACCHARIDE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; EXOPOLYSACCHARIDE PRODUCTION; CAPSULAR POLYSACCHARIDES; INTERCELLULAR-ADHESION; ANTIBIOTIC-RESISTANCE	Bacillus subtilis is intensively studied as a model organism for the development of bacterial biofilms or pellicles. A key component is currently undefined exopolysaccharides produced from proteins encoded by genes within the eps locus. Within this locus are four genes, epsHIJK, known to be essential for pellicle formation. We show they encode proteins synthesizing the broadly expressed microbial carbohydrate poly-N-acetylglucosamine (PNAG). PNAG was present in both pellicle and planktonic wild-type B. subtilis cells and in strains with deletions in the epsA-G and -L-O genes but not in strains deleted for epsH-K. Cloning of the B. subtilis epsH-K genes into Escherichia coli with in-frame deletions in the PNAG biosynthetic genes pgaA-D, respectively, restored PNAG production in E. coli. Cloning the entire B. subtilis epsHIJK locus into pga-deleted E. coli, Klebsiella pneumoniae, or alginate-negative Pseudomonas aeruginosa restored or conferred PNAG production. Bioinformatic and structural predictions of the EpsHIJK proteins suggest EpsH and EpsJ are glycosyltransferases (GT) with a GT-A fold; EpsI is a GT with a GT-B fold, and EpsK is an alpha-helical membrane transporter. B. subtilis, E. coli, and pga-deleted E. coli carrying the epsHIJK genes on a plasmid were all susceptible to opsonic killing by antibodies to PNAG. The immunochemical and genetic data identify the genes and proteins used by B. subtilis to produce PNAG as a significant carbohydrate factor essential for pellicle formation.	[Roux, Damien; Cywes-Bentley, Colette; Zhang, Yi-Fan; Pons, Stephanie; Skurnik, David; Pier, Gerald B.] Harvard Univ, Sch Med, Div Infect Dis,Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Zhang, Yi-Fan] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Konkol, Melissa; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Little, Dustin J.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Little, Dustin J.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Skurnik, D (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 181 Longwood Ave, Boston, MA 02115 USA.	dskurnik@rics.bwh.harvard.edu; gpier@rics.bwh.harvard.edu	Roux, Damien/C-5618-2014; Pier, Gerald/AAO-2692-2021; Regan, Clinton/E-6250-2012; Roux, Damien/L-3671-2014	Roux, Damien/0000-0002-6103-6416; Pier, Gerald/0000-0002-9112-2331; Roux, Damien/0000-0002-6103-6416; Cywes Bentley, Colette/0000-0002-6301-0930; Skurnik, David/0000-0002-4205-9639; Zhang, Yifan/0000-0002-2414-2703; Pons, Stephanie/0000-0002-7372-3563	National Institutes of Health [EY016104, AI057159, U54A1057159, GM093030]; AXA Research Fund; Fondation pour la Recherche Medicale; William Randolph Hearst Fund; Hood Foundation; Seedlings Foundation; Canadian Institutes of Health Research [43998]; Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Brigham and Women's Hospital from Alopexx Vaccine, LLC; University of Toronto; Ontario Graduate Scholarship Program; Canadian Institutes of Health Research; NATIONAL EYE INSTITUTE [R01EY016144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AXA Research Fund(AXA Research Fund); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); William Randolph Hearst Fund; Hood Foundation; Seedlings Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Brigham and Women's Hospital from Alopexx Vaccine, LLC; University of Toronto(University of Toronto); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016104 and AI057159 (a component of Award U54A1057159) (to G. B. P.) and Grant GM093030 (to D. B. K.). This work was also supported by the AXA Research Fund and the Fondation pour la Recherche Medicale (to D. R.), awards from the William Randolph Hearst Fund (to D. R.) and the Hood Foundation (to D. S.) and the Seedlings Foundation (to D. S. and C. C.-B.), and Grant 43998 from the Canadian Institutes of Health Research (to P. L. H.). G. B. P. is an inventor of intellectual properties (human monoclonal antibody to PNAG and PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC, entities in which G. B. P. also holds equity. As an inventor of intellectual properties, G. B. P. also has the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC. G. B. P.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners Healthcare in accordance with their conflict of interest policies. C. C.-B. and D. S. are inventors of intellectual properties (use of human monoclonal antibody to PNAG and use of PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC. As inventors of intellectual properties, C. C.-B. and D. S. also have the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC.; Supported in part by graduate scholarships from the University of Toronto, the Ontario Graduate Scholarship Program, and Canadian Institutes of Health Research.	Alibert-Franco S, 2009, CURR MED CHEM, V16, P301, DOI 10.2174/092986709787002619; Bakaletz LO, 2012, PAEDIATR RESPIR REV, V13, P154, DOI 10.1016/j.prrv.2012.03.001; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Chuang CH, 2014, GUT, V63, P736, DOI 10.1136/gutjnl-2013-304786; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; Elsholz AKW, 2014, GENE DEV, V28, P1710, DOI 10.1101/gad.246397.114; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konkol MA, 2013, J BACTERIOL, V195, P4085, DOI 10.1128/JB.00696-13; Little DJ, 2014, J BIOL CHEM, V289, P35907, DOI 10.1074/jbc.M114.611400; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Lu X, 2014, MBIO, V5, DOI 10.1128/mBio.00974-14; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mack D, 2009, TOP CURR CHEM, V288, P157, DOI 10.1007/128_2008_19; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Martinez A, 1997, APPL MICROBIOL BIOT, V47, P40, DOI 10.1007/s002530050885; Marvasi M, 2010, FEMS MICROBIOL LETT, V313, P1, DOI 10.1111/j.1574-6968.2010.02085.x; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nagorska K, 2010, J APPL GENET, V51, P369, DOI 10.1007/BF03208867; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pozsgai ER, 2012, APPL ENVIRON MICROB, V78, P778, DOI 10.1128/AEM.07098-11; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Romero D, 2013, RES MICROBIOL, V164, P788, DOI 10.1016/j.resmic.2013.06.004; Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; SIMON R, 1986, METHOD ENZYMOL, V118, P640; Skurnik D, 2012, J INFECT DIS, V205, P1709, DOI 10.1093/infdis/jis254; SMITH RL, 1979, ANAL BIOCHEM, V98, P478, DOI 10.1016/0003-2697(79)90170-2; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Valvano MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P729, DOI 10.1134/S0006297911070029; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Ye LB, 2014, GLYCOBIOLOGY, V24, P351, DOI 10.1093/glycob/cwu001	64	67	68	5	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19261	19272		10.1074/jbc.M115.648709	http://dx.doi.org/10.1074/jbc.M115.648709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26078454	hybrid, Green Published			2022-12-28	WOS:000358781100039
J	Hazra, S; Henderson, JN; Liles, K; Hilton, MT; Wachter, RM				Hazra, Suratna; Henderson, J. Nathan; Liles, Kevin; Hilton, Matthew T.; Wachter, Rebekka M.			Regulation of Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (Rubisco) Activase PRODUCT INHIBITION, COOPERATIVITY, AND MAGNESIUM ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE FTSH; METALLOPROTEASE FTSH; SUBUNIT INTERACTIONS; CRYSTAL-STRUCTURE; HEXAMERIC RING; ATP HYDROLYSIS; AAA+ PROTEINS; ATPASES; COMPLEX; DOMAIN	In many photosynthetic organisms, tight-binding Rubisco inhibitors are released by the motor protein Rubisco activase (Rca). In higher plants, Rca plays a pivotal role in regulating CO2 fixation. Here, the ATPase activity of 0.005 mM tobacco Rca was monitored under steady-state conditions, and global curve fitting was utilized to extract kinetic constants. The k(cat) was best fit by 22.3 +/- 4.9 min(-1), the Km for ATP by 0.104 +/- 0.024 mM, and the K-i for ADP by 0.037 +/- 0.007 mM. Without ADP, the Hill coefficient for ATP hydrolysis was extracted to be 1.0 +/- 0.1, indicating noncooperative behavior of homo-oligomeric Rca assemblies. However, the addition of ADP was shown to introduce positive cooperativity between two or more subunits (Hill coefficient 1.9 +/- 0.2), allowing for regulation via the prevailing ATP/ADP ratio. ADP-mediated activation was not observed, although larger amounts led to competitive product inhibition of hydrolytic activity. The catalytic efficiency increased 8.4-fold upon cooperative binding of a second magnesium ion (Hill coefficient 2.5 +/- 0.5), suggesting at least three conformational states (ATP-bound, ADP-bound, and empty) within assemblies containing an average of about six subunits. The addition of excess Rubisco (24:1, L8S8/Rca6) and crowding agents did not modify catalytic rates. However, high magnesium provided for thermal Rca stabilization. We propose that magnesium mediates the formation of closed hexameric toroids capable of high turnover rates and amenable to allosteric regulation. We suggest that in vivo, the Rca hydrolytic activity is tuned by fluctuating [Mg2+] in response to changes in available light.	[Wachter, Rebekka M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wachter, RM (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	rwachter@asu.edu			United States Department of Energy, Office of Basic Energy Sciences, Photosynthetic Systems Grant [DE-FG02-09-ER16123]	United States Department of Energy, Office of Basic Energy Sciences, Photosynthetic Systems Grant(United States Department of Energy (DOE))	This work was supported by United States Department of Energy, Office of Basic Energy Sciences, Photosynthetic Systems Grant DE-FG02-09-ER16123 (to R. M. W). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Andralojc PJ, 2012, BIOCHEM J, V442, P733, DOI 10.1042/BJ20111443; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barta C, 2010, ARCH BIOCHEM BIOPHYS, V499, P17, DOI 10.1016/j.abb.2010.04.022; Barthelme D, 2014, P NATL ACAD SCI USA, V111, pE1687, DOI 10.1073/pnas.1404823111; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Blayney MJ, 2011, J AM SOC MASS SPECTR, V22, P1588, DOI 10.1007/s13361-011-0187-8; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bracher A, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.2, 10.1038/nplants.2014.2]; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; CraftsBrandner SJ, 1997, PLANT PHYSIOL, V114, P439, DOI 10.1104/pp.114.2.439; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Frasch WD, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P257; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hasse D, 2015, ACTA CRYSTALLOGR D, V71, P800, DOI 10.1107/S1399004715001182; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Henderson JN, 2011, J BIOL CHEM, V286, P35683, DOI 10.1074/jbc.C111.289595; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kallis RP, 2000, PLANT PHYSIOL, V123, P1077, DOI 10.1104/pp.123.3.1077; Keown JR, 2014, BIOCHEM J, V464, P413, DOI 10.1042/BJ20140676; Keown JR, 2013, J BIOL CHEM, V288, P20607, DOI 10.1074/jbc.M113.466383; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Kuriata AM, 2014, BIOCHEMISTRY-US, V53, P7232, DOI 10.1021/bi500968h; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lilley RM, 1997, PLANT PHYSIOL, V114, P605, DOI 10.1104/pp.114.2.605; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; MORRISON JF, 1961, BIOCHIM BIOPHYS ACTA, V52, P82, DOI 10.1016/0006-3002(61)90906-4; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Neuwald AF, 1999, GENOME RES, V9, P27; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Page AN, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.210187; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Pulido NO, 2010, BIOCHEMISTRY-US, V49, P5258, DOI 10.1021/bi1006767; SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B; Salvucci ME, 2003, PLANTA, V216, P736, DOI 10.1007/s00425-002-0923-1; Scales JC, 2014, PHOTOSYNTH RES, V119, P355, DOI 10.1007/s11120-013-9964-5; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Stinson BM, 2015, NAT STRUCT MOL BIOL, V22, P411, DOI 10.1038/nsmb.3012; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Wachter RM, 2013, PHOTOSYNTH RES, V117, P557, DOI 10.1007/s11120-013-9827-0; Wang DF, 2006, PHOTOSYNTH RES, V88, P185, DOI 10.1007/s11120-006-9051-2; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; WANG ZY, 1991, BIOCHIM BIOPHYS ACTA, V1079, P263, DOI 10.1016/0167-4838(91)90067-A; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	66	40	41	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24222	24236		10.1074/jbc.M115.651745	http://dx.doi.org/10.1074/jbc.M115.651745			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283786	hybrid, Green Published			2022-12-28	WOS:000362218900015
J	Meng, M; Cheng, DJ; Peng, J; Qian, WL; Li, JR; Dai, DD; Zhang, TL; Xia, QY				Meng, Meng; Cheng, Dao-jun; Peng, Jian; Qian, Wen-liang; Li, Jia-rui; Dai, Dan-dan; Zhang, Tian-lei; Xia, Qing-you			The Homeodomain Transcription Factors Antennapedia and POU-M2 Regulate the Transcription of the Steroidogenic Enzyme Gene Phantom in the Silkworm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBYX-MORI; PROTHORACICOTROPIC HORMONE; DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; ECDYSTEROID BIOSYNTHESIS; MIDGUT MORPHOGENESIS; PROTEIN INTERACTIONS; INSECT DEVELOPMENT; MOLTING HORMONE; MOLECULAR-BASIS	The steroid hormone ecdysone, which controls insect molting and metamorphosis, is synthesized in the prothoracic gland (PG), and several steroidogenic enzymes that are expressed specifically in the PG are involved in ecdysteroidogenesis. In this study, we identified new regulators that are involved in the transcriptional control of the silkworm steroidogenic enzyme genes. In silico analysis predicted several potential cis-regulatory elements ((REs) for the homedomain transcription factors Antennapedia (Antp) and POU-M2 in the proximal promoters of steroidogenic enzyme genes. Antp and POLI-M2 are expressed dynamically in the PG during larval development, and their overexpression in silkworm embryo-derived (BmE) cells induced the expression of steroidogenic enzyme genes. Importantly, luciferase reporter analyses, electrophoretic mobility shift assays, and chromatin immunoprecipitation assays revealed that Antp and POU-M2 promote the transcription of the silkworm steroidogenic enzyme gene Phantom (Phm) by binding directly to specific motifs within overlapping CREs in the Phm promoter. Mutations of these CREs in the Phm promoter suppressed the transcriptional activities of both Antp and POU-M2 in BmE cells and decreased the activities of mutated Phm promoters in the silkworm PG. In addition, pulldown and co-immunoprecipitation assays demonstrated that Antp can interact with POU-M2. Moreover, RNA interferencemediated down-regulation of either Antp or POU-M2 during silkworm wandering not only decreased the ecdysone titer but also led to the failure of metamorphosis. In summary, our results suggest that Antp and POU-M2 coordinate the transcription of the silkworm Phm gene directly, indicating new roles for homeodomain proteins in regulating insect ecdysteroidogenesis.	[Meng, Meng; Cheng, Dao-jun; Peng, Jian; Qian, Wen-liang; Li, Jia-rui; Dai, Dan-dan; Zhang, Tian-lei; Xia, Qing-you] Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Meng, Meng; Cheng, Dao-jun; Peng, Jian; Qian, Wen-liang; Li, Jia-rui; Dai, Dan-dan; Zhang, Tian-lei; Xia, Qing-you] Southwest Univ, Coll Biotechnol, Minist Agr, Key Sericultural Lab, Chongqing 400715, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Cheng, DJ (corresponding author), Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	chengdj@swu.edu.cn; xiagy@swu.edu.cn			National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31172267, 31272503]; National Hi-Tech Research and Development Program of China [2011AA100306]; Municipal Natural Science Foundation of Chongqing [cstc2012jjA80023]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Municipal Natural Science Foundation of Chongqing	This work was supported by National Basic Research Program of China Grant 2012CB114600, National Natural Science Foundation of China Grants 31172267 and 31272503, National Hi-Tech Research and Development Program of China Grant 2011AA100306, and Municipal Natural Science Foundation of Chongqing Grant cstc2012jjA80023. The authors declare that they have no conflicts of interest with the contents of this article.	Akin ZN, 2005, CELL MOL NEUROBIOL, V25, P697, DOI 10.1007/s10571-005-3971-9; Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cai XY, 2014, GENE, V542, P232, DOI 10.1016/j.gene.2014.03.012; Chen P, 2013, HEREDITY, V111, P182, DOI 10.1038/hdy.2013.36; Cheng CC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004425; Cheng DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109111; Cohen LE, 1996, ENDOCRIN METAB CLIN, V25, P523, DOI 10.1016/S0889-8529(05)70339-X; Danielsen ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004343; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Gilbert Lawrence I., 1997, Invertebrate Neuroscience, V3, P205, DOI 10.1007/BF02480376; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu SH, 1997, MOL CELL ENDOCRINOL, V127, P109, DOI 10.1016/S0303-7207(96)03995-0; Gu SH, 2015, J INSECT PHYSIOL, V72, P61, DOI 10.1016/j.jinsphys.2014.11.007; Heffer A, 2013, ANNU REV ENTOMOL, V58, P161, DOI 10.1146/annurev-ento-120811-153601; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HEUER JG, 1995, DEVELOPMENT, V121, P3861; Hua YJ, 1999, J BIOL CHEM, V274, P31169, DOI 10.1074/jbc.274.44.31169; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002; Lelli KM, 2011, P NATL ACAD SCI USA, V108, P21122, DOI 10.1073/pnas.1114118109; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu QX, 2000, DEV BIOL, V225, P437, DOI 10.1006/dbio.2000.9836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; MATHIES LD, 1994, DEVELOPMENT, V120, P2799; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Nagata T, 1996, GENES CELLS, V1, P555, DOI 10.1046/j.1365-2443.1996.d01-260.x; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Papadopoulos DK, 2012, DEV BIOL, V367, P78, DOI 10.1016/j.ydbio.2012.04.021; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028; Rewitz KF, 2013, CURR TOP DEV BIOL, V103, P1, DOI 10.1016/B978-0-12-385979-2.00001-0; Rezsohazy R, 2014, DEV DYNAM, V243, P117, DOI 10.1002/dvdy.24060; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Smith WA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00019; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009; Truman JW, 2006, P NATL ACAD SCI USA, V103, P8909, DOI 10.1073/pnas.0603252103; Vershon AK, 1996, CURR OPIN BIOTECH, V7, P392, DOI 10.1016/S0958-1669(96)80113-3; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Wierman ME, 1997, MOL CELL BIOL, V17, P1652, DOI 10.1128/MCB.17.3.1652; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yao LC, 1999, DEV BIOL, V211, P268, DOI 10.1006/dbio.1999.9309; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0; Zhang TY, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-25; Zhang TY, 2004, BIOCHEM J, V380, P255, DOI 10.1042/BJ20031482; Zhao GD, 2014, GENE, V551, P152, DOI 10.1016/j.gene.2014.08.050	73	20	20	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24438	24452		10.1074/jbc.M115.651810	http://dx.doi.org/10.1074/jbc.M115.651810			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26253172	hybrid, Green Published			2022-12-28	WOS:000362218900031
J	Montermini, L; Meehan, B; Gamier, D; Lee, WJ; Lee, TH; Guha, A; Al-Nedawi, K; Rake, J				Montermini, Laura; Meehan, Brian; Gamier, Delphine; Lee, Wan Jin; Lee, Tae Hoon; Guha, Abhijit; Al-Nedawi, Khalid; Rake, Janusz			Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; EMERGING ROLE; CANCER-CELLS; MICROVESICLES; TISSUE; EXPRESSION; SECRETION; HETEROGENEITY; RESISTANCE; BIOMARKERS	Cancer cells emit extracellular vesicles (EVs) containing unique molecular signatures. Here, we report that the oncogenic EGF receptor (EGER) and its inhibitors reprogram phosphoproteomes and cargo of tumor cell-derived EVs. Thus, phosphorylated EGER (P-EGFR) and several other receptor tyrosine kinases can be detected in 1/Vs purified from plasma of tumorbearing mice and from conditioned media of cultured cancer cells. Treatment of EGER-driven tumor cells with second generation EGER kinase inhibitors (EKIs), including CI-1033 and PE-00299804 but not with anti-EGER antibody (Cetuximab) or etoposide, triggers a burst in emission of exosome-like Ells contaming EGER, P-EGER, and genomic DNA (exo-gDNA). The EV release can be attenuated by treatment with inhibitors of exosome biogenesis (GW4869) and caspase pathways (ZVAD). The content of P-EGFR isoforms (Tyr-845, Tyr-1068, and Tyr1173), ERK, and AKT varies between cells and their corresponding EVs and as a function of EKI treatment, Immunocapture experiments reveal the presence of EC-FR and exo-gDNA within the same EV population following EKI treatment. These findings suggest that targeted agents may induce cancer cells to change the EV emission profiles reflective of drug-related therapeutic stress. We suggest that EV-based assays may serve as companion diagnostics for targeted anticancer agents.	[Montermini, Laura; Meehan, Brian; Gamier, Delphine; Lee, Wan Jin; Lee, Tae Hoon; Guha, Abhijit; Rake, Janusz] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada; [Guha, Abhijit] Univ Toronto Hlth Network, Hamilton, ON MSG 1L7, Canada; [Al-Nedawi, Khalid] McMaster Univ, Hamilton, ON L8S 4K1, Canada	McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University	Rake, J (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Glen Site,1001 Decarie Blvd,Rm EMl 2244, Montreal, PQ H4A 3J1, Canada.	janusz.rak@mcgill.ca		Garnier, Delphine/0000-0002-5744-5612; Rak, Janusz/0000-0002-2912-5566; , Khalid/0000-0001-5140-3799	Canadian Institutes of Health Research; Foundation of Stars; Montreal Children's Hospital Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars; Montreal Children's Hospital Foundation	This work was supported by operating grants from the Canadian Institutes of Health Research (to J. R.), and infrastructure support was provided by Fonds de Recherche en Sante du Quebec. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Thelma Adams Award Program from the Foundation of Stars.r Supported by Award Program from the Montreal Children's Hospital Foundation.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Amorim M, 2014, PROTEOMICS, V14, P1472, DOI 10.1002/pmic.201300485; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bobrie A, 2013, BIOCHEM SOC T, V41, P263, DOI 10.1042/BST20120245; Brzezniak C, 2013, EXPERT OPIN PHARMACO, V14, P247, DOI 10.1517/14656566.2013.758714; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; D'Asti E, 2014, J THROMB HAEMOST, V12, P1838, DOI 10.1111/jth.12715; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garnier D, 2013, EXP CELL RES, V319, P2747, DOI 10.1016/j.yexcr.2013.08.003; Garnier D, 2012, J BIOL CHEM, V287, P43565, DOI 10.1074/jbc.M112.401760; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang PH, 2010, MOL BIOSYST, V6, P1227, DOI 10.1039/c001196g; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Moreno-Gonzalo O, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00383; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Myers MV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015222; Nawaz M, 2014, NAT REV UROL, V11, P688, DOI 10.1038/nrurol.2014.301; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petit AMV, 1997, AM J PATHOL, V151, P1523; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Rak J, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00021; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P2148, DOI 10.1074/mcp.M112.027086; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van Dommelen S. M., 2015, J EXTRACELL VESICLES, V4, pP; Verweij Frederik J, 2012, Commun Integr Biol, V5, P88; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	59	77	78	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24534	24546		10.1074/jbc.M115.679217	http://dx.doi.org/10.1074/jbc.M115.679217			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26272609	Green Published, hybrid			2022-12-28	WOS:000362218900038
J	Karki, P; Kim, C; Smith, K; Son, DS; Aschner, M; Lee, E				Karki, Pratap; Kim, Clifford; Smith, Keisha; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook			Transcriptional Regulation of the Astrocytic Excitatory Amino Acid Transporter 1 (EAAT1) via NF-kappa B and Yin Yang 1 (YY1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; INDUCED UP-REGULATION; EPIDERMAL-GROWTH-FACTOR; GLUTAMATE TRANSPORTER; VALPROIC ACID; DIFFERENTIAL EXPRESSION; FACTOR YIN-YANG-1; EPISODIC ATAXIA; MAJOR ROLE; RAT	Astrocytic glutamate transporter excitatory amino acid transporter (EAAT) 1, also known as glutamate aspartate transporter (GLAST) in rodents, is one of two glial glutamate transporters that are responsible for removing excess glutamate from synaptic clefts to prevent excitotoxic neuronal death. Despite its important role in neurophysiological functions, the molecular mechanisms of EAAT1 regulation at the transcriptional level remain to be established. Here, we report that NF-kappa B is a main positive transcription factor for EAAT1, supported by the following: 1) EAAT1 contains two consensus sites for NF-kappa B, 2) mutation of NF-kappa B binding sites decreased EAAT1 promoter activity, and 3) activation of NF-kappa B increased, whereas inhibition of NF-kappa B decreased EAAT1 promoter activity and mRNA/protein levels. EGF increased EAAT1 mRNA/protein levels and glutamate uptake via NF-kappa B. The transcription factor yin yang 1 (YY1) plays a role as a critical negative regulator of EAAT1, supported by the following: 1) the EAAT1 promoter contains multiple consensus sites for YY1, 2) overexpression of YY1 decreased EAAT1 promoter activity and mRNA/protein levels, and 3) knockdown of YY1 increased EAAT1 promoter activity and mRNA/protein levels. Manganese decreased EAAT1 expression via YY1. Epigenetic modifiers histone deacetylases (HDACs) served as co-repressors of YY1 to further decrease EAAT1 promoter activity, whereas inhibition of HDACs reversed manganese-induced decrease of EAAT1 expression. Taken together, our findings suggest that NF-kappa B is a critical positive regulator of EAAT1, mediating the stimulatory effects of EGF, whereas YY1 is a negative regulator of EAAT1 with HDACs as co-repressors, mediating the inhibitory effects of manganese on EAAT1 regulation.	[Karki, Pratap; Smith, Keisha; Son, Deok-Soo; Lee, Eunsook] Meharry Med Coll, Sch Med, Dept Physiol, Nashville, TN 37208 USA; [Kim, Clifford] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Meharry Medical College; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Lee, E (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	elee@mmc.edu	Regan, Clinton/E-6250-2012	Smith, Keisha/0000-0001-7655-7997	National Institutes of Health [SC1 089630, R01 ES024756, UL1 TR000445, R01 ES10563, R01 ES07331, SC1 I089073, MD007593]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI089073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563, R01ES007331, R01ES024756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, SC1GM089630] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1 089630 (to E.L.), R01 ES024756 (to E.L.), UL1 TR000445 (to E.L.), R01 ES10563 (to M.A.), R01 ES07331 (to M.A.), SC1 I089073 (to D.-S.S.), and MD007593. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Aguirre G, 2008, NEUROCHEM INT, V52, P1322, DOI 10.1016/j.neuint.2008.01.015; Allritz C, 2009, NEUROCHEM INT, V55, P22, DOI 10.1016/j.neuint.2008.12.020; ASCHNER M, 1992, J NEUROCHEM, V58, P730, DOI 10.1111/j.1471-4159.1992.tb09778.x; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Vries B, 2009, ARCH NEUROL-CHICAGO, V66, P97, DOI 10.1001/archneurol.2008.535; Deng ZY, 2010, TRANSCR-AUSTIN, V1, P81, DOI 10.4161/trns.1.2.12375; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Erikson K, 2002, NEUROTOXICOLOGY, V23, P595, DOI 10.1016/S0161-813X(02)00012-8; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Furuta A, 1997, J NEUROSCI, V17, P8363; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Ji YF, 2013, GLIA, V61, P1959, DOI 10.1002/glia.22566; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Karki P, 2015, NEUROCHEM INT, V88, P53, DOI 10.1016/j.neuint.2014.08.002; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; Karki P, 2013, J BIOL CHEM, V288, P28975, DOI 10.1074/jbc.M113.483826; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Liang Z, 2002, J NEUROCHEM, V80, P807, DOI 10.1046/j.0022-3042.2002.00779.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miller HP, 1997, J NEUROCHEM, V68, P1564; Moreno JA, 2011, TOXICOL SCI, V122, P121, DOI 10.1093/toxsci/kfr091; Mutkus L, 2005, BIOL TRACE ELEM RES, V107, P221, DOI 10.1385/BTER:107:3:221; Naskar R, 2000, INVEST OPHTH VIS SCI, V41, P1940; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Rauen T, 1998, CELL TISSUE RES, V291, P19; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rosas S, 2007, J NEUROCHEM, V101, P1134, DOI 10.1111/j.1471-4159.2007.04517.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Sery O, 2015, NEUROCHEM RES, V40, P2461, DOI 10.1007/s11064-015-1605-2; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Suzuki K, 2001, J CELL SCI, V114, P3717; Swanson RA, 1997, J NEUROSCI, V17, P932; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Unger T, 2012, CELL MOL NEUROBIOL, V32, P539, DOI 10.1007/s10571-011-9790-2; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Yanagisawa M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.45; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001	69	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23725	23737		10.1074/jbc.M115.649327	http://dx.doi.org/10.1074/jbc.M115.649327			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269591	hybrid, Green Published			2022-12-28	WOS:000361816500021
J	Ouyang, J; Yu, W; Liu, J; Zhang, N; Florens, L; Chen, JK; Liu, H; Washburn, M; Pei, DQ; Xie, T				Ouyang, Juan; Yu, Wei; Liu, Jing; Zhang, Nian; Florens, Laurence; Chen, Jiekai; Liu, He; Washburn, Michael; Pei, Duanqing; Xie, Ting			Cyclin-dependent Kinase-mediated Sox2 Phosphorylation Enhances the Ability of Sox2 to Establish the Pluripotent State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; SELF-RENEWAL; DNA-BINDING; CDK2; INHIBITION; PEPTIDES; INK4/ARF; CANCER; G1	Sox2 is a key factor in maintaining self-renewal of embryonic stem cells (ESCs) and adult stem cells as well as in reprogramming differentiated cells back into pluripotent or multipotent stem cells. Although previous studies have shown that Sox2 is phosphorylated in human ESCs, the biological significance of Sox2 phosphorylation in ESC maintenance and reprogramming has not been well understood. In this study we have identified new phosphorylation sites on Sox2 and have further demonstrated that Cdk2-mediated Sox2 phosphorylation at Ser-39 and Ser-253 is required for establishing the pluripotent state during reprogramming but is dispensable for ESC maintenance. Mass spectrometry analysis of purified Sox2 protein has identified new phosphorylation sites on two tyrosine and six serine/Threonine residues. Cdk2 physically interacts with Sox2 and phosphorylates Sox2 at Ser-39 and Ser-253 in vitro. Surprisingly, Sox2 phosphorylation at Ser-39 and Ser-253 is dispensable for ESC self-renewal and cell cycle progression. In addition, Sox2 phosphorylation enhances its ability to establish the pluripotent state during reprogramming by working with Oct4 and Klf4. Finally, Cdk2 can also modulate the ability of Oct4, Sox2, and Klf4 in reprogramming fibroblasts back into pluripotent stem cells. Therefore, this study has for the first time demonstrated that Sox2 phosphorylation by Cdk2 promotes the establishment but not the maintenance of the pluripotent state. It might also help explain why the inactivation of CDK inhibitors such as p53, p21, and Arf/Ink4 promotes the induction of pluripotent stem cells.	[Ouyang, Juan] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Wei; Zhang, Nian; Florens, Laurence; Washburn, Michael; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Ouyang, Juan; Liu, Jing; Chen, Jiekai; Liu, He; Pei, Duanqing] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomedicine & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Washburn, Michael] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Xie, Ting] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Tsinghua University; Stowers Institute for Medical Research; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Pei, DQ (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomedicine & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn; tgx@stowers.org		Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	Tsinghua-Peking Joint Center for Life Sciences; National Basic Research Program of China [2012CB966802]; Stowers Institute for Medical Research	Tsinghua-Peking Joint Center for Life Sciences; National Basic Research Program of China(National Basic Research Program of China); Stowers Institute for Medical Research	This work was supported by the Tsinghua-Peking Joint Center for Life Sciences (to J.O.), the National Basic Research Program of China 2012CB966802 (to D.P.), and the Stowers Institute for Medical Research (to T.X). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi K, 2012, CURR OPIN GENET DEV, V22, P416, DOI 10.1016/j.gde.2012.07.001; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Florens Laurence, 2006, V328, P159; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Koledova Z, 2010, STEM CELLS DEV, V19, P181, DOI 10.1089/scd.2009.0065; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Spelat R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386755; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039606; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WW, 2011, J CELL BIOCHEM, V112, P942, DOI 10.1002/jcb.23010; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	49	28	30	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22782	22794		10.1074/jbc.M115.658195	http://dx.doi.org/10.1074/jbc.M115.658195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26139602	Green Published, hybrid			2022-12-28	WOS:000361171500041
J	Vaughn, LS; Bragg, DC; Sharma, N; Camargos, S; Cardoso, F; Patel, RC				Vaughn, Lauren S.; Bragg, D. Cristopher; Sharma, Nutan; Camargos, Sarah; Cardoso, Francisco; Patel, Rekha C.			Altered Activation of Protein Kinase PKR and Enhanced Apoptosis in Dystonia Cells Carrying a Mutation in PKR Activator Protein PACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING DOMAIN; 16 ACUTE ONSET; CELLULAR ACTIVATOR; STRESS; DYT16; IDENTIFICATION; TRBP; RAX; PHOSPHORYLATION; ASSOCIATION	PACT is a stress-modulated activator of the interferon-induced double-stranded RNA-activated protein kinase (PKR). Stress-induced phosphorylation of PACT is essential for PACT's association with PKR leading to PKR activation. PKR activation leads to phosphorylation of translation initiation factor eIF2 alpha inhibition of protein synthesis and apoptosis. A recessively inherited form of early-onset dystonia DYT16 has been recently identified to arise due to a homozygous missense mutation P222L in PACT. To examine if the mutant P222L protein alters the stress-response pathway, we examined the ability of mutant P222L to interact with and activate PKR. Our results indicate that the substitution mutant P222L activates PKR more robustly and for longer duration albeit with slower kinetics in response to the endoplasmic reticulum stress. In addition, the affinity of PACT-PACT and PACT-PKR interactions is enhanced in dystonia patient lymphoblasts, thereby leading to intensified PKR activation and enhanced cellular death. P222L mutation also changes the affinity of PACT-TRBP interaction after cellular stress, thereby offering a mechanism for the delayed PKR activation in response to stress. Our results demonstrate the impact of a dystonia-causing substitution mutation on stress-induced cellular apoptosis.	[Vaughn, Lauren S.; Patel, Rekha C.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Bragg, D. Cristopher; Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Camargos, Sarah; Cardoso, Francisco] Univ Fed Minas Gerais, Dept Internal Med, BR-31270901 Belo Horizonte, MG, Brazil	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Harvard University; Massachusetts General Hospital; Universidade Federal de Minas Gerais	Patel, RC (corresponding author), Univ S Carolina, Dept Biol Sci, 700 Sumter St, Columbia, SC 29208 USA.	patelr@biol.sc.edu	Bragg, D. Cristopher/AGT-6759-2022; CAMARGOS, SARAH/Y-4071-2019; CAMARGOS, SARAH T/O-4670-2014; Patel, Rekha/M-7123-2015	CAMARGOS, SARAH/0000-0001-9829-6783; CAMARGOS, SARAH T/0000-0001-9829-6783; Patel, Rekha/0000-0001-9434-4880; Vaughn, Lauren/0000-0003-2282-6738	Dystonia Medical Research Foundation; National Institutes of Health (NINDS) [P50NS037409]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409] Funding Source: NIH RePORTER	Dystonia Medical Research Foundation; National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Dystonia Medical Research Foundation grant (to R. P.). The work was also supported by National Institutes of Health Grant P50NS037409 (NINDS; to N. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguiar PD, 2015, MOVEMENT DISORD, V30, P877, DOI 10.1002/mds.26175; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Brashear A, 2013, MOVEMENT DISORD, V28, P1939, DOI 10.1002/mds.25774; Bressman SB, 2007, PARKINSONISM RELAT D, V13, pS347, DOI 10.1016/S1353-8020(08)70029-4; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Camargos S, 2012, J NEUROL NEUROSUR PS, V83, P1012, DOI 10.1136/jnnp-2012-302841; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Geyer HL, 2006, LANCET NEUROL, V5, P780, DOI 10.1016/S1474-4422(06)70547-6; Gordon KL, 2011, NEUROCHEM RES, V36, P452, DOI 10.1007/s11064-010-0363-4; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Heyam A, 2015, WIRES RNA, V6, P271, DOI 10.1002/wrna.1272; Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/BJ20020204; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Klein C, 2008, LANCET NEUROL, V7, P192, DOI 10.1016/S1474-4422(08)70023-1; Lemmon ME, 2013, MOVEMENT DISORD, V28, P1937, DOI 10.1002/mds.25703; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Paquet C, 2012, BRAIN PATHOL, V22, P219, DOI 10.1111/j.1750-3639.2011.00520.x; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; PATEL RC, 1992, J BIOL CHEM, V267, P7671; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Peters GA, 2006, J BIOL CHEM, V281, P35129, DOI 10.1074/jbc.M607714200; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Seibler P, 2008, LANCET NEUROL, V7, P380, DOI 10.1016/S1474-4422(08)70075-9; Singh M, 2012, J CELL BIOCHEM, V113, P2754, DOI 10.1002/jcb.24152; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Singh M, 2009, J MOL BIOL, V385, P457, DOI 10.1016/j.jmb.2008.10.068; Stoessl AJ, 2014, LANCET, V384, P532, DOI 10.1016/S0140-6736(14)60041-6; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; Thompson ML, 2014, DIS MODEL MECH, V7, P233, DOI 10.1242/dmm.013615; Vaughn LS, 2014, GENE, V536, P90, DOI 10.1016/j.gene.2013.11.074; Xiao JF, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0462-8; Yong Yue, 2014, Front Biol (Beijing), V9, P382; Zech M, 2014, MOVEMENT DISORD, V29, P1504, DOI 10.1002/mds.25981	50	36	38	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22543	22557		10.1074/jbc.M115.669408	http://dx.doi.org/10.1074/jbc.M115.669408			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26231208	hybrid, Green Published			2022-12-28	WOS:000361171500021
J	Yao, JW; Dodson, VJ; Frank, MW; Rock, CO				Yao, Jiangwei; Dodson, V. Joshua; Frank, Matthew W.; Rock, Charles O.			Chlamydia trachomatis Scavenges Host Fatty Acids for Phospholipid Synthesis via an Acyl-Acyl Carrier Protein Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE PATHOGENS; ESCHERICHIA-COLI; ENZYMATIC-SYNTHESIS; BINDING PROTEIN; ACYLTRANSFERASE; PURIFICATION; LIPOPROTEIN; PROLIPOPROTEIN; CHROMATOGRAPHY; QUANTITATION	The obligate intracellular parasite Chlamydia trachomatis has a reduced genome but relies on de novo fatty acid and phospholipid biosynthesis to produce its membrane phospholipids. Lipidomic analyses showed that 8% of the phospholipid molecular species synthesized by C. trachomatis contained oleic acid, an abundant host fatty acid that cannot be made by the bacterium. Mass tracing experiments showed that isotopically labeled palmitic, myristic, and lauric acids added to the medium were incorporated into C. trachomatis-derived phospholipid molecular species. HeLa cells did not elongate lauric acid, but infected HeLa cell cultures elongated laurate to myristate and palmitate. The elongated fatty acids were incorporated exclusively into C. trachomatis-produced phospholipid molecular species. C. trachomatis has adjacent genes encoding the separate domains of the bifunctional acyl-acyl carrier protein (ACP) synthetase/2-acylglycerolphosphoethanolamine acyltransferase gene (aas) of Escherichia coli. The CT775 gene encodes an acyltransferase (LpaT) that selectively transfers fatty acids from acyl-ACP to the 1-position of 2-acyl-glycerophospholipids. The CT776 gene encodes an acyl-ACP synthetase (AasC) with a substrate preference for palmitic compared with oleic acid in vitro. Exogenous fatty acids were elongated and incorporated into phospholipids by Escherichia coli-expressing AasC, illustrating its function as an acyl-ACP synthetase in vivo. These data point to an AasC-dependent pathway in C. trachomatis that selectively scavenges host saturated fatty acids to be used for the de novo synthesis of its membrane constituents.	[Yao, Jiangwei; Dodson, V. Joshua; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Regan, Clinton/E-6250-2012	Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034496 (to C. O. R.). This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article.	Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; BIDAWID S, 1989, A VAN LEEUW J MICROB, V55, P123, DOI 10.1007/BF00404752; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COOPER CL, 1989, J BIOL CHEM, V264, P7384; Dumoux M, 2015, CURR OPIN MICROBIOL, V23, P1, DOI 10.1016/j.mib.2014.09.019; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; EVERETT KDE, 1994, J BACTERIOL, V176, P6082, DOI 10.1128/jb.176.19.6082-6087.1994; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; Hillmann F, 2011, J BIOL CHEM, V286, P27936, DOI 10.1074/jbc.M111.243519; HSU L, 1991, J BIOL CHEM, V266, P13783; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; KAMEDA K, 1981, J BIOL CHEM, V256, P5702; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; MUNOA FJ, 1991, J BIOL CHEM, V266, P17667; Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06; Parsons JB, 2015, ANTIMICROB AGENTS CH, V59, P849, DOI 10.1128/AAC.04179-14; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; RAY TK, 1976, P NATL ACAD SCI USA, V73, P4374, DOI 10.1073/pnas.73.12.4374; Rock C O, 1981, Methods Enzymol, V72, P397; ROCK CO, 1979, J BIOL CHEM, V254, P7123; ROCK CO, 1979, J BIOL CHEM, V254, P7116; Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234; SPENCER AK, 1979, FEBS LETT, V101, P253, DOI 10.1016/0014-5793(79)81019-4; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Wang GQ, 2007, MICROBIOL-SGM, V153, P1935, DOI 10.1099/mic.0.2006/003491-0; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao JW, 2015, J BIOL CHEM, V290, P18874, DOI 10.1074/jbc.M115.657148; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185	41	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22163	22173		10.1074/jbc.M115.671008	http://dx.doi.org/10.1074/jbc.M115.671008			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195634	hybrid, Green Published			2022-12-28	WOS:000360968500033
J	Mauceri, D; Hagenston, AM; Schramm, K; Weiss, U; Bading, H				Mauceri, Daniela; Hagenston, Anna M.; Schramm, Kathrin; Weiss, Ursula; Bading, Hilmar			Nuclear Calcium Buffering Capacity Shapes Neuronal Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; SYNAPTIC ACTIVITY; HISTONE DEACETYLASES; NMDA RECEPTORS; CELL-DEATH; PHOSPHORYLATION; BRAIN; ACTIVATION; REPRESSION; EXPRESSION	Calcium-binding proteins (CaBPs) such as parvalbumin are part of the cellular calcium buffering system that determines intracellular calcium diffusion and influences the spatiotemporal dynamics of calcium signals. In neurons, CaBPs are primarily localized to the cytosol and function, for example, in nerve terminals in short-term synaptic plasticity. However, CaBPs are also expressed in the cell nucleus, suggesting that they modulate nuclear calcium signals, which are key regulators of neuronal gene expression. Here we show that the calcium buffering capacity of the cell nucleus in mouse hippocampal neurons regulates neuronal architecture by modulating the expression levels of VEGFD and the complement factor C1q-c, two nuclear calcium-regulated genes that control dendrite geometry and spine density, respectively. Increasing the levels of nuclear calcium buffers by means of expression of a nuclearly targeted form of parvalbumin fused to mCherry (PV. NLS-mC) led to a reduction in VEGFD expression and, as a result, to a decrease in total dendritic length and complexity. In contrast, mRNA levels of the synapse pruning factor C1q-c were increased in neurons expressing PV. NLS-mC, causing a reduction in the density and size of dendritic spines. Our results establish a close link between nuclear calcium buffering capacity and the transcription of genes that determine neuronal structure. They suggest that the development of cognitive deficits observed in neurological conditions associated with CaBP deregulation may reflect the loss of necessary structural features of dendrites and spines.	[Mauceri, Daniela; Hagenston, Anna M.; Schramm, Kathrin; Weiss, Ursula; Bading, Hilmar] Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de	Mauceri, Daniela/C-4969-2014	Mauceri, Daniela/0000-0003-1225-4633	ERC; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 636]; Excellence Cluster CellNetworks at Heidelberg University; German Ministry of Education and Research [01GQ1003A]	ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster CellNetworks at Heidelberg University; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by an ERC Advanced Grant (to H. B.), by Sonderforschungsbereich 636 of the Deutsche Forschungsgemeinschaft, by the Excellence Cluster CellNetworks at Heidelberg University, and by German Ministry of Education and Research Grant 01GQ1003A. The authors declare that they have no conflicts of interest with the contents of this article.	ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Dickstein DL, 2013, NEUROSCIENCE, V251, P21, DOI 10.1016/j.neuroscience.2012.09.077; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; Kasischke K, 2001, ACTA NEUROPATHOL, V101, P483; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; Mellstrom B, 2001, SEMIN CELL DEV BIOL, V12, P59, DOI 10.1006/scdb.2000.0218; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Pegoraro S, 2010, J CELL PHYSIOL, V222, P713, DOI 10.1002/jcp.21998; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Riascos D, 2011, ACTA NEUROPATHOL, V122, P565, DOI 10.1007/s00401-011-0865-4; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; SHOLL DA, 1953, J ANAT, V87, P387; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wittmann M, 2009, J NEUROSCI, V29, P14687, DOI 10.1523/JNEUROSCI.1160-09.2009; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	51	19	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23039	23049		10.1074/jbc.M115.654962	http://dx.doi.org/10.1074/jbc.M115.654962			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26231212	Green Published, hybrid			2022-12-28	WOS:000361685500018
J	Murakawa, T; Hamaguchi, A; Nakanishi, S; Kataoka, M; Nakai, T; Kawano, Y; Yamaguchi, H; Hayashi, H; Tanizawa, K; Okajima, T				Murakawa, Takeshi; Hamaguchi, Akio; Nakanishi, Shota; Kataoka, Misumi; Nakai, Tadashi; Kawano, Yoshiaki; Yamaguchi, Hiroshi; Hayashi, Hideyuki; Tanizawa, Katsuyuki; Okajima, Toshihide			Probing the Catalytic Mechanism of Copper Amine Oxidase from Arthrobacter globiformis with Halide Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; VASCULAR ADHESION PROTEIN-1; OXIDATIVE HALF-REACTION; ACTIVE-SITE COPPER; CRYSTAL-STRUCTURE; TOPA QUINONE; SUBSTRATE-SPECIFICITY; HANSENULA-POLYMORPHA; METHYLAMINE OXIDASE; DIRECTED INHIBITOR	The catalytic reaction of copper amine oxidase proceeds through a ping-pong mechanism comprising two half-reactions. In the initial half-reaction, the substrate amine reduces the Tyr-derived cofactor, topa quinone (TPQ), to an aminoresorcinol form (TPQ(amr)) that is in equilibrium with a semiquinone radical (TPQ(sq)) via an intramolecular electron transfer to the active-site copper. Wehave analyzed this reductive half-reaction in crystals of the copper amine oxidase from Arthrobacter globiformis. Anerobic soaking of the crystals with an amine substrate shifted the equilibrium toward TPQsq in an "on-copper" conformation, in which the 4-OH group ligated axially to the copper center, which was probably reduced to Cu(I). When the crystals were soaked with substrate in the presence of halide ions, which act as uncompetitive and noncompetitive inhibitors with respect to the amine substrate and dioxygen, respectively, the equilibrium in the crystals shifted toward the "off-copper" conformation of TPQ(amr). The halide ion was bound to the axial position of the copper center, thereby preventing TPQ(amr) from adopting the on-copper conformation. Furthermore, transient kinetic analyses in the presence of viscogen (glycerol) revealed that only the rate constant in the step of TPQ(amr)/TPQ(sq) interconversion is markedly affected by the viscogen, which probably perturbs the conformational change. These findings unequivocally demonstrate that TPQ undergoes large conformational changes during the reductive half-reaction.	[Murakawa, Takeshi] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan; [Hamaguchi, Akio; Nakanishi, Shota; Nakai, Tadashi; Tanizawa, Katsuyuki; Okajima, Toshihide] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Kataoka, Misumi; Yamaguchi, Hiroshi] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan; [Kawano, Yoshiaki; Yamaguchi, Hiroshi] RIKEN, SPring Ctr 8, Adv Photon Technol Div, Mikazuki, Hyogo 6795148, Japan; [Hayashi, Hideyuki; Okajima, Toshihide] Osaka Med Coll, Dept Chem, Takatsuki, Osaka 5698686, Japan; [Tanizawa, Katsuyuki] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic	Osaka Medical College; Osaka University; Kwansei Gakuin University; RIKEN; Osaka Medical College; Palacky University Olomouc	Okajima, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	tokajima@sanken.osaka-u.ac.jp	Nakai, Tadashi/F-8047-2010; Kawano, Yoshiaki/C-7585-2017	Nakai, Tadashi/0000-0001-9770-8168; Okajima, Toshihide/0000-0003-1733-9580	Japan Society for the Promotion of Science [23770127, 26440037, 18350085, 15K07391]; Operational Program Education for Competitiveness-European Social Fund Project [CZ.1.07/2.3.00/20.0165]; Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research [26440037] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Operational Program Education for Competitiveness-European Social Fund Project; Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 23770127 and 26440037 (to T. M.) and 18350085 and 15K07391 (to T. O.); Operational Program Education for Competitiveness-European Social Fund Project CZ.1.07/2.3.00/20.0165) (to K. T.); and by funding from the Network Joint Research Center for Materials and Devices. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisby RH, 1999, LASER CHEM, V19, P201, DOI 10.1155/1999/62680; Chang CM, 2010, BIOCHEMISTRY-US, V49, P2540, DOI 10.1021/bi901933d; Chiu YC, 2006, BIOCHEMISTRY-US, V45, P4105, DOI 10.1021/bi052464l; CHOI YH, 1995, J BIOL CHEM, V270, P4712, DOI 10.1074/jbc.270.9.4712; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Dooley DM, 1996, J BIOL INORG CHEM, V1, P205, DOI 10.1007/s007750050044; Dooley DM, 1998, J AM CHEM SOC, V120, P2599, DOI 10.1021/ja970312a; DOOLEY DM, 1985, INORG CHEM, V24, P3996, DOI 10.1021/ic00218a007; DOOLEY DM, 1991, NATURE, V349, P262, DOI 10.1038/349262a0; DOOLEY DM, 1990, J AM CHEM SOC, V112, P2782, DOI 10.1021/ja00163a047; Duff AP, 2003, BIOCHEMISTRY-US, V42, P15148, DOI 10.1021/bi035338v; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fersht A, 1998, STRUCTURE MECH PROTE, P103; Floris G., 2009, COPPER AMINE OXIDASE; HARDY LW, 1984, BIOCHEMISTRY-US, V23, P1275, DOI 10.1021/bi00301a040; Hernandez M, 2006, BBA-MOL CELL RES, V1763, P164, DOI 10.1016/j.bbamcr.2005.11.017; Inoue T, 2013, BIOORGAN MED CHEM, V21, P3873, DOI 10.1016/j.bmc.2013.04.011; Jakobsson E, 2005, ACTA CRYSTALLOGR D, V61, P1550, DOI 10.1107/S0907444905028805; Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674; Johnson BJ, 2013, J BIOL CHEM, V288, P28409, DOI 10.1074/jbc.M113.501791; Kishishita S, 2003, J AM CHEM SOC, V125, P1041, DOI 10.1021/ja017899k; Klema VJ, 2012, INT J MOL SCI, V13, P5375, DOI 10.3390/ijms13055375; KLINMAN JP, 1994, ANNU REV BIOCHEM, V63, P299, DOI 10.1146/annurev.bi.63.070194.001503; Kumar V, 1996, STRUCTURE, V4, P943, DOI 10.1016/S0969-2126(96)00101-3; Kyte J., 1995, MECH PROTEIN CHEM, P350; Leslie A. G. W, 1992, JOINT CCP4 EESF EACM; Li RB, 1998, STRUCTURE, V6, P293, DOI 10.1016/S0969-2126(98)00033-1; Jesus AJL, 2011, J PHYS CHEM A, V115, P14069, DOI 10.1021/jp206193a; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lunelli M, 2005, J MOL BIOL, V346, P991, DOI 10.1016/j.jmb.2004.12.038; MacIntire W. S., 1993, PRINCIPLES APPL QUIN, P97; Maintz L, 2007, AM J CLIN NUTR, V85, P1185, DOI 10.1093/ajcn/85.5.1185; Masson P, 2013, BIOCHEM J, V454, P387, DOI 10.1042/BJ20130389; MATSUZAKI R, 1994, FEBS LETT, V351, P360, DOI 10.1016/0014-5793(94)00884-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath AP, 2009, BIOCHEMISTRY-US, V48, P9810, DOI 10.1021/bi9014192; McGuirl MA, 1997, J BIOL INORG CHEM, V2, P336, DOI 10.1007/s007750050140; Meszaros Z, 1999, EUR J DRUG METAB PH, V24, P299, DOI 10.1007/BF03190036; Mukherjee A, 2008, J AM CHEM SOC, V130, P9459, DOI 10.1021/ja801378f; Murakawa T, 2006, BIOCHEM BIOPH RES CO, V342, P414, DOI 10.1016/j.bbrc.2006.01.150; Murakawa T, 2013, ACTA CRYSTALLOGR D, V69, P2483, DOI 10.1107/S0907444913023196; Murakawa T, 2012, J BIOCHEM, V151, P167, DOI 10.1093/jb/mvr125; MURE M, 1993, J AM CHEM SOC, V115, P7117, DOI 10.1021/ja00069a008; Murray JM, 1999, BIOCHEMISTRY-US, V38, P8217, DOI 10.1021/bi9900469; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKATANI H, 1979, J PHYS CHEM-US, V83, P2662, DOI 10.1021/j100483a023; Okajima T., 2009, COPPER AMINE OXIDASE, P103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Plastino J, 1999, BIOCHEMISTRY-US, V38, P8204, DOI 10.1021/bi9826660; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwartz B, 2001, BIOCHEMISTRY-US, V40, P2954, DOI 10.1021/bi0021378; Shepard EM, 2004, J BIOL INORG CHEM, V9, P256, DOI 10.1007/s00775-004-0522-7; Shepard EM, 2006, J BIOL INORG CHEM, V11, P1039, DOI 10.1007/s00775-006-0153-2; Shepard EM, 2008, BIOCHEMISTRY-US, V47, P13907, DOI 10.1021/bi8011516; Shimizu E, 1997, BIOSCI BIOTECH BIOCH, V61, P501, DOI 10.1271/bbb.61.501; Su QJ, 1998, BIOCHEMISTRY-US, V37, P12513, DOI 10.1021/bi981103l; Taki M, 2008, BIOCHEMISTRY-US, V47, P7726, DOI 10.1021/bi800623f; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; TUROWSKI PN, 1993, J BIOL CHEM, V268, P17680; Welford RWD, 2007, BIOCHEMISTRY-US, V46, P10817, DOI 10.1021/bi700943r; Wilce MCJ, 1997, BIOCHEMISTRY-US, V36, P16116, DOI 10.1021/bi971797i; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu PH, 2001, BIOCHEM PHARMACOL, V61, P741, DOI 10.1016/S0006-2952(01)00524-X	68	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23094	23109		10.1074/jbc.M115.662726	http://dx.doi.org/10.1074/jbc.M115.662726			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26269595	hybrid, Green Published			2022-12-28	WOS:000361685500022
J	Agarwal, S; Tiwari, SK; Seth, B; Yadav, A; Singh, A; Mudawal, A; Chauhan, LKS; Gupta, SK; Choubey, V; Tripathi, A; Kumar, A; Ray, RS; Shukla, S; Parmar, D; Chaturvedi, RK				Agarwal, Swati; Tiwari, Shashi Kant; Seth, Brashket; Yadav, Anuradha; Singh, Anshuman; Mudawal, Anubha; Chauhan, Lalit Kumar Singh; Gupta, Shailendra Kumar; Choubey, Vinay; Tripathi, Anurag; Kumar, Amit; Ray, Ratan Singh; Shukla, Shubha; Parmar, Devendra; Chaturvedi, Rajnish Kumar			RETRACTED: Activation of Autophagic Flux against Xenoestrogen Bisphenol-A-induced Hippocampal Neurodegeneration via AMP kinase (AMPK)/Mammalian Target of Rapamycin (mTOR) Pathways (Retracted article. See vol. 295, pg. 2889, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							OXIDATIVE STRESS; PROTEIN-KINASE; CELL-DEATH; UBIQUITIN-PROTEASOME; INDUCED APOPTOSIS; EXPOSURE; PHOSPHORYLATION; DYSFUNCTION; BRAIN; NEUROGENESIS	The human health hazards related to persisting use of bisphenol-A (BPA) are well documented. BPA-induced neurotoxicity occurs with the generation of oxidative stress, neurodegeneration, and cognitive dysfunctions. However, the cellular and molecular mechanism(s) of the effects of BPA on autophagy and association with oxidative stress and apoptosis are still elusive. We observed that BPA exposure during the early postnatal period enhanced the expression and the levels of autophagy genes/proteins. BPA treatment in the presence of bafilomycin A(1) increased the levels of LC3-II and SQSTM1 and also potentiated GFP-LC3 puncta index in GFP-LC3-transfected hippocampal neural stem cell-derived neurons. BPA-induced generation of reactive oxygen species and apoptosis were mitigated by a pharmacological activator of autophagy (rapamycin). Pharmacological (wortmannin and bafilomycin A1) and genetic (beclin siRNA) inhibition of autophagy aggravated BPA neuro-toxicity. Activation of autophagy against BPA resulted in intracellular energy sensor AMP kinase (AMPK) activation, increased phosphorylation of raptor and acetyl-CoA carboxylase, and decreased phosphorylation of ULK1 (Ser-757), and silencing of AMPK exacerbated BPA neurotoxicity. Conversely, BPA exposure down-regulated the mammalian target of rapamycin (mTOR) pathway by phosphorylation of raptor as a transient cell's compensatory mechanism to preserve cellular energy pool. Moreover, silencing of mTOR enhanced autophagy, which further alleviated BPA-induced reactive oxygen species generation and apoptosis. BPA-mediated neurotoxicity also resulted in mitochondrial loss, bioenergetic deficits, and increased PARKIN mitochondrial translocation, suggesting enhanced mitophagy. These results suggest implication of autophagy against BPA-mediated neurodegeneration through involvement of AMPK and mTOR pathways. Hence, autophagy, which arbitrates cell survival and demise during stress conditions, requires further assessment to be established as a biomarker of xenoestrogen exposure.	[Agarwal, Swati; Tiwari, Shashi Kant; Seth, Brashket; Yadav, Anuradha; Singh, Anshuman; Mudawal, Anubha; Kumar, Amit; Parmar, Devendra; Chaturvedi, Rajnish Kumar] CSIR, IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Lucknow 226001, Uttar Pradesh, India; [Agarwal, Swati; Tiwari, Shashi Kant; Seth, Brashket; Yadav, Anuradha; Mudawal, Anubha; Gupta, Shailendra Kumar; Tripathi, Anurag; Kumar, Amit; Ray, Ratan Singh; Parmar, Devendra; Chaturvedi, Rajnish Kumar] CSIR, IITR, Acad Sci & Innovat Res, Lucknow 226001, Uttar Pradesh, India; [Chauhan, Lalit Kumar Singh] CSIR, IITR, Cent Instrumentat Facil, Lucknow 226001, Uttar Pradesh, India; [Choubey, Vinay] Univ Tartu, Ctr Excellence Translat Med, Dept Pharmacol, EE-50050 Tartu, Estonia; [Tripathi, Anurag] CSIR, IITR, Food Drug & Chem Toxicol Grp, Lucknow 226001, Uttar Pradesh, India; [Gupta, Shailendra Kumar; Ray, Ratan Singh] CSIR, IITR, Syst Toxicol & Hlth Risk Assessment Grp, Lucknow 226001, Uttar Pradesh, India; [Shukla, Shubha] CSIR, Cent Drug Res Inst, Dept Pharmacol, Sect 10, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); University of Tartu; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Chaturvedi, RK (corresponding author), CSIR, IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 80 MG Marg, Lucknow 226001, Uttar Pradesh, India.	rajnish@iitr.res.in	Choubey, Vinay/H-3170-2015; Chaturvedi, Rajnish/AAZ-9955-2020; Tiwari, Shashi Kant/R-8533-2018	Choubey, Vinay/0000-0002-1953-5692; Tiwari, Shashi Kant/0000-0002-6121-6249; Chaturvedi, Rajnish Kumar/0000-0001-9591-7636; Gupta, Shailendra/0000-0002-3470-3260	Council of Scientific and Industrial Research (CSIR) Network [BSC0111]; Lady Tata Memorial Young Scientist grant; Senior Research Fellowship from CSIR, New Delhi; Senior Research Fellowship from the University Grants Commission, New Delhi; Junior Research Fellowship from CSIR, New Delhi; Junior Research Fellowship from the University Grants Commission, New Delhi	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Memorial Young Scientist grant; Senior Research Fellowship from CSIR, New Delhi; Senior Research Fellowship from the University Grants Commission, New Delhi; Junior Research Fellowship from CSIR, New Delhi; Junior Research Fellowship from the University Grants Commission, New Delhi	This work was supported by Council of Scientific and Industrial Research (CSIR) Network Grant InDEPTH (BSC0111) and a Lady Tata Memorial Young Scientist grant (to R. K. C.). This is CSIR-IITR manuscript communication 3303.; Recipient of a Senior Research Fellowship from CSIR, New Delhi.; Recipient of a Senior Research Fellowship from the University Grants Commission, New Delhi.; Recipient of a Junior Research Fellowship from CSIR, New Delhi.; Recipient of a Junior Research Fellowship from the University Grants Commission, New Delhi.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Babu S, 2013, TOXICOL MECH METHOD, V23, P273, DOI 10.3109/15376516.2012.753969; Balmer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074162; Campanella M, 2013, AUTOPHAGY, V9, P1647, DOI 10.4161/auto.26915; Chaturvedi RK, 2012, HUM MOL GENET, V21, P3474, DOI 10.1093/hmg/dds178; Chen G, 2012, AUTOPHAGY, V8, P1577, DOI 10.4161/auto.21376; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044754; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chitra KC, 2003, TOXICOLOGY, V185, P119, DOI 10.1016/S0300-483X(02)00597-8; Choubey V, 2014, AUTOPHAGY, V10, P1105, DOI 10.4161/auto.28615; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Di Gioacchino M, 2008, SCI TOTAL ENVIRON, V392, P50, DOI 10.1016/j.scitotenv.2007.11.009; Ding SB, 2014, J ENDOCRINOL, V221, P167, DOI 10.1530/JOE-13-0386; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Duarte FV, 2012, TOXICOL LETT, V209, P35, DOI 10.1016/j.toxlet.2011.11.029; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; El-Missiry MA, 2014, J NEUROL SCI, V347, P251, DOI 10.1016/j.jns.2014.10.009; Erden ES, 2014, EUR REV MED PHARMACO, V18, P3477; Gabryel B, 2014, CELL BIOL INT, V38, P1086, DOI 10.1002/cbin.10299; Garcia-Garcia A, 2013, TOXICOL SCI, V136, P166, DOI 10.1093/toxsci/kft188; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hassan ZK, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/194829; Huebener P, 2014, CELL METAB, V19, P539, DOI 10.1016/j.cmet.2014.01.014; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Ishido M, 2011, TOXICOL LETT, V206, P300, DOI 10.1016/j.toxlet.2011.08.011; Itoh K, 2012, NEUROPATHOLOGY, V32, P447, DOI 10.1111/j.1440-1789.2011.01287.x; Jain S, 2011, FOOD CHEM TOXICOL, V49, P1404, DOI 10.1016/j.fct.2011.03.032; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Jurewicz J, 2013, INT J OCCUP MED ENV, V26, P185, DOI 10.2478/s13382-013-0099-x; Kabuto H, 2003, ENVIRON RES, V93, P31, DOI 10.1016/S0013-9351(03)00062-8; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim ME, 2011, FOOD CHEM TOXICOL, V49, P3383, DOI 10.1016/j.fct.2011.09.017; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Lee S, 2008, J NEUROSCI RES, V86, P2932, DOI 10.1002/jnr.21739; Lee S, 2013, NEUROTOX RES, V23, P249, DOI 10.1007/s12640-012-9353-4; Ma J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.64; MacLusky NJ, 2005, ENVIRON HEALTH PERSP, V113, P675, DOI 10.1289/ehp.7633; Masuo Y, 2011, J TOXICOL ENV HEAL B, V14, P346, DOI 10.1080/10937404.2011.578557; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Minamiyama Y, 2010, FREE RADICAL RES, V44, P1398, DOI 10.3109/10715762.2010.510523; Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009; Mishra D, 2012, TOXICOL SCI, V127, P84, DOI 10.1093/toxsci/kfs004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nanjappa MK, 2014, TOXICOL LETT, V225, P479, DOI 10.1016/j.toxlet.2014.01.024; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pahuja R, 2015, ACS NANO, V9, P4850, DOI 10.1021/nn506408v; Parganlija D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095288; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pla A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.46; Poels J, 2012, AUTOPHAGY, V8, P1401, DOI 10.4161/auto.21052; Qi YL, 2014, EXP TOXICOL PATHOL, V66, P163, DOI 10.1016/j.etp.2014.01.004; Rahman MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09169; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Rothaug M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0182-y; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Ryter Stefan W, 2014, Int J Cell Biol, V2014, P502676, DOI 10.1155/2014/502676; Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Suthar H, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/259763; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tiwari MN, 2013, FREE RADICAL BIO MED, V65, P704, DOI 10.1016/j.freeradbiomed.2013.07.042; Tiwari SK, 2016, MOL NEUROBIOL, V53, P3010, DOI 10.1007/s12035-015-9197-z; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Tiwari SK, 2015, MOL NEUROBIOL, V51, P1395, DOI 10.1007/s12035-014-8817-3; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Viberg H, 2011, TOXICOLOGY, V290, P187, DOI 10.1016/j.tox.2011.09.006; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Williams T, 2011, P NATL ACAD SCI USA, V108, P5849, DOI 10.1073/pnas.1013660108; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Xu XH, 2010, TOXICOL APPL PHARM, V249, P188, DOI 10.1016/j.taap.2010.09.007; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009	91	60	63	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21163	21184		10.1074/jbc.M115.648998	http://dx.doi.org/10.1074/jbc.M115.648998			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139607	Green Published, hybrid			2022-12-28	WOS:000360011800047
J	Chakrabarti, R; Sanyal, S; Ghosh, A; Bhar, K; Das, C; Siddhanta, A				Chakrabarti, Rajarshi; Sanyal, Sulagna; Ghosh, Amit; Bhar, Kaushik; Das, Chandrima; Siddhanta, Anirban			Phosphatidylinositol-4-phosphate 5-Kinase 1 alpha Modulates Ribosomal RNA Gene Silencing through Its Interaction with Histone H3 Lysine 9 Trimethylation and Heterochromatin Protein HP1-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; NUCLEOLAR CAPS; 4,5-BISPHOSPHATE; PHOSPHOINOSITIDES; EXPRESSION; KINASE; TRANSCRIPTION; INHIBITION; REVERSES; BINDING	Phosphoinositide signaling has been implicated in the regulation of numerous cellular processes including cytoskeletal dynamics, cellular motility, vesicle trafficking, and gene transcription. Studies have also shown that nuclear phosphoinositide(s) regulates processes such as mRNA export, cell cycle progression, gene transcription, and DNA repair. We have shown previously that the nuclear form of phosphatidylinositol-4-phosphate 5-kinase 1 alpha (PIP5K), the enzyme responsible for phosphatidylinositol 4,5-bisphosphate synthesis, is modified by small ubiquitin-like modifier (SUMO)-1. In this study, we have shown that due to the site-specific Lys to Ala mutations of PIP5K at Lys-244 and Lys-490, it is unable to localize in the nucleus and nucleolus, respectively. Furthermore, by using chromatin immunoprecipitation assays, we have observed that PIP5K associates with the chromatin silencing complex constituted of H3K9me3 and heterochromatin protein 1 alpha at multiple ribosomal DNA (rDNA) loci. These interactions followed a definite cyclical pattern of occupancy (mostly G(1)) and release from the rDNA loci (G(1)/S) throughout the cell cycle. Moreover, the immunoprecipitation results clearly demonstrate that PIP5K SUMOylated at Lys-490 interacts with components of the chromatin silencing machinery, H3K9me3 and heterochromatin protein 1 alpha. However, PIP5K does not interact with the gene activation signature protein H3K4me3. This study, for the first time, demonstrates that PIP5K, an enzyme actively associated with lipid modification pathway, has additional roles in rDNA silencing.	[Chakrabarti, Rajarshi; Ghosh, Amit; Bhar, Kaushik; Siddhanta, Anirban] Univ Calcutta, Dept Biochem, Kolkata 700019, India; [Sanyal, Sulagna; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India	University of Calcutta; Saha Institute of Nuclear Physics	Siddhanta, A (corresponding author), Univ Calcutta, Dept Biochem, Kolkata 700019, India.	chandrima.das@saha.ac.in; asiddhanto@yahoo.com	Das, Chandrima/AAI-7398-2021; Chakrabarti, Rajarshi/J-3240-2019	Chakrabarti, Rajarshi/0000-0002-4184-8492; Das, Chandrima/0000-0002-8117-2810	Department of Biotechnology Grant (DBT) [BT/PR11415/BRB/10/656/2008]; Department of Science and Technology Grant, Government of India [SR/SO/HS-51/2008]; Center for Advanced Studies in Biochemistry (University Potential for Excellence) (University Grants Commission); Center for Modern Biology (University Potential for Excellence) (University Grants Commission); Calcutta University (CU)-DBT-Interdisciplinary Program in Life Sciences (IPLS); Council of Scientific and Industrial Research, Government of India; Biomolecular Assembly, Recognition and Dynamics Project Grant from the Department of Atomic Energy, Government of India [12-RD-SIN-5.040103]; Department of Biotechnology, Government of India	Department of Biotechnology Grant (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology Grant, Government of India(Department of Science & Technology (India)); Center for Advanced Studies in Biochemistry (University Potential for Excellence) (University Grants Commission); Center for Modern Biology (University Potential for Excellence) (University Grants Commission); Calcutta University (CU)-DBT-Interdisciplinary Program in Life Sciences (IPLS); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Biomolecular Assembly, Recognition and Dynamics Project Grant from the Department of Atomic Energy, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by Department of Biotechnology Grant (DBT) BT/PR11415/BRB/10/656/2008 and Department of Science and Technology Grant SR/SO/HS-51/2008, Government of India; the Center for Advanced Studies in Biochemistry and Center for Modern Biology (University Potential for Excellence) (University Grants Commission); and Calcutta University (CU)-DBT-Interdisciplinary Program in Life Sciences (IPLS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Council of Scientific and Industrial Research, Government of India.; Supported by Biomolecular Assembly, Recognition and Dynamics Project Grant 12-R&D-SIN-5.040103 from the Department of Atomic Energy, Government of India and the Ramalingaswami Fellowship from the Department of Biotechnology, Government of India.	Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Chakrabarti R, 2013, BIOCHEM BIOPH RES CO, V439, P209, DOI 10.1016/j.bbrc.2013.08.058; Christensen MO, 2004, J BIOL CHEM, V279, P21873, DOI 10.1074/jbc.M400498200; Cong R, 2014, NUCLEIC ACIDS RES, V42, P181, DOI 10.1093/nar/gkt863; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Cui YP, 2010, J BIOL CHEM, V285, P32988, DOI 10.1074/jbc.M110.140905; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Divecha N, 2002, CURR BIOL, V12, P582, DOI 10.1016/S0960-9822(02)00769-8; Doughman RL, 2003, J BIOL CHEM, V278, P23036, DOI 10.1074/jbc.M211397200; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Ferrero GO, 2014, BIOCHEM J, V461, P521, DOI 10.1042/BJ20131376; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Ghosh S, 2001, PROTEIN EXPRES PURIF, V21, P40, DOI 10.1006/prep.2000.1319; Grant PA, 2001, GENOME BIOL, V2; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Kalt I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030825; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Logan MR, 2006, BIOL CELL, V98, P377, DOI 10.1042/BC20050081; Malik MQ, 2014, J BIOL CHEM, V289, P35468, DOI 10.1074/jbc.M114.609123; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; REYNOLDS RC, 1964, CANCER RES, V24, P1269; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Semenas J, 2014, P NATL ACAD SCI USA, V111, pE3689, DOI 10.1073/pnas.1405801111; Shah ZH, 2013, FEBS J, V280, P6295, DOI 10.1111/febs.12543; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Sobol M, 2013, NUCLEUS-PHILA, V4, P478, DOI 10.4161/nucl.27154; Thapa N, 2013, J BIOL CHEM, V288, P34707, DOI 10.1074/jbc.M113.512848; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Yildirim S, 2013, J CELL SCI, V126, P2730, DOI 10.1242/jcs.123661; YORK JD, 1994, J BIOL CHEM, V269, P7847; Yu HY, 1998, EUR J BIOCHEM, V251, P281, DOI 10.1046/j.1432-1327.1998.2510281.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	37	17	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20893	20903		10.1074/jbc.M114.633727	http://dx.doi.org/10.1074/jbc.M114.633727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157143	Green Published, hybrid			2022-12-28	WOS:000360011800025
J	Fan, LL; Peng, GH; Hussain, A; Fazli, L; Guns, E; Gleave, M; Qi, JF				Fan, Lingling; Peng, Guihong; Hussain, Arif; Fazli, Ladan; Guns, Emma; Gleave, Martin; Qi, Jianfei			The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSENTIA HOMOLOG 2; ANDROGEN RECEPTOR; IN-VITRO; EXPRESSION; INHIBITORS; TUMORIGENESIS; ABIRATERONE; RESISTANCE; HYPOXIA; TARGET	Re-activation of androgen receptor (AR) activity is the main driver for development of castration-resistant prostate cancer. We previously reported that the ubiquitin ligase Siah2 enhanced AR transcriptional activity and prostate cancer cell growth. Among the genes we found to be regulated by Siah2 was AKR1C3, which encodes a key androgen biosynthetic enzyme implicated in castration-resistant prostate cancer development. Here, we found that Siah2 inhibition in CWR22Rv1 prostate cancer cells decreased AKR1C3 expression as well as intracellular androgen levels, concomitant with inhibition of cell growth in vitro and in orthotopic prostate tumors. Re-expression of either wild-type or catalytically inactive forms of AKR1C3 partially rescued AR activity and growth defects in Siah2 knockdown cells, suggesting a nonenzymatic role for AKR1C3 in these outcomes. Unexpectedly, AKR1C3 re-expression in Siah2 knockdown cells elevated Siah2 protein levels, whereas AKR1C3 knockdown had the opposite effect. We further found that AKR1C3 can bind Siah2 and inhibit its self-ubiquitination and degradation, thereby increasing Siah2 protein levels. We observed parallel expression of Siah2 and AKR1C3 in human prostate cancer tissues. Collectively, our findings identify a new role for AKR1C3 in regulating Siah2 stability and thus enhancing Siah2-dependent regulation of AR activity in prostate cancer cells.	[Fan, Lingling; Peng, Guihong; Hussain, Arif; Qi, Jianfei] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Fan, Lingling; Peng, Guihong; Hussain, Arif; Qi, Jianfei] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hussain, Arif] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Fazli, Ladan; Guns, Emma; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University of British Columbia	Qi, JF (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, 655 W Baltimore St, Baltimore, MD 21201 USA.	JQI@som.umaryland.edu		qi, jianfei/0000-0001-7884-7656; Gleave, Martin/0000-0003-4235-0167	National Institutes of Health from NCI [CA154888]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [K99CA154888, R00CA154888] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA154888 from NCI (to J. Q.). This work was also supported by a Merit Review Award from the Department of Veterans Affairs (to A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adeniji AO, 2013, J STEROID BIOCHEM, V137, P136, DOI 10.1016/j.jsbmb.2013.05.012; Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Chan P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2828; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Depaux A, 2006, BIOCHEM BIOPH RES CO, V348, P857, DOI 10.1016/j.bbrc.2006.07.092; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Hofland J, 2010, CANCER RES, V70, P1256, DOI 10.1158/0008-5472.CAN-09-2092; Hu G, 1999, MOL CELL BIOL, V19, P724; Kang N, 2014, MOL CELLS, V37, P389, DOI 10.14348/molcells.2014.0032; Kikuchi A, 2014, INVEST NEW DRUG, V32, P860, DOI 10.1007/s10637-014-0130-5; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Liedtke AJ, 2013, J MED CHEM, V56, P2429, DOI 10.1021/jm3017656; Liu CF, 2015, CANCER RES, V75, P1413, DOI 10.1158/0008-5472.CAN-14-3080; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Ming DS, 2014, J STEROID BIOCHEM, V143, P19, DOI 10.1016/j.jsbmb.2014.02.006; Mitsiades N, 2012, CANCER RES, V72, P6142, DOI 10.1158/0008-5472.CAN-12-1335; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Muller S, 2014, ONCOTARGET, V5, P3184; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; PAWLOWSKI JE, 1994, J BIOL CHEM, V269, P13502; Pham S, 2014, J STEROID BIOCHEM, V144, P436, DOI 10.1016/j.jsbmb.2014.09.004; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rizzardi AE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-244; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stein MN, 2014, ASIAN J ANDROL, V16, P387, DOI 10.4103/1008-682X.129133; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tian YT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-42; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yepuru M, 2013, CLIN CANCER RES, V19, P5613, DOI 10.1158/1078-0432.CCR-13-1151; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zang TZ, 2015, CHEM-BIOL INTERACT, V234, P339, DOI 10.1016/j.cbi.2014.12.015; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127	52	21	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20865	20879		10.1074/jbc.M115.662155	http://dx.doi.org/10.1074/jbc.M115.662155			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160177	Green Published, hybrid			2022-12-28	WOS:000360011800023
J	Sriwimol, W; Aroonkesorn, A; Sakdee, S; Kanchanawarin, C; Uchihashi, T; Ando, T; Angsuthanasombat, C				Sriwimol, Wilaiwan; Aroonkesorn, Aratee; Sakdee, Somsri; Kanchanawarin, Chalermpol; Uchihashi, Takayuki; Ando, Toshio; Angsuthanasombat, Chanan			Potential Prepore Trimer Formation by the Bacillus thuringiensis Mosquito-specific Toxin MOLECULAR INSIGHTS INTO A CRITICAL PREREQUISITE OF MEMBRANE-BOUND MONOMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING DOMAIN; ATOMIC-FORCE MICROSCOPY; CRY4BA DELTA-ENDOTOXIN; AEDES-AEGYPTI LARVAE; CRYSTAL-STRUCTURE; TOXICITY; BINDING; PROTEINS; OLIGOMERIZATION; RESOLUTION	The insecticidal feature of the three-domain Cry delta-endotoxins from Bacillus thuringiensis is generally attributed to their capability to form oligomeric pores, causing lysis of target larval midgut cells. However, the molecular description of their oligomerization process has not been clearly defined. Here a stable prepore of the 65-kDa trypsin-activated Cry4Ba mosquito-specific toxin was established through membrane-mimetic environments by forming an similar to 200-kDa octyl-beta-D-glucoside micelle-induced trimer. The SDS-resistant trimer caused cytolysis to Sf9 insect cells expressing Aedes-mALP (a Cry4Ba receptor) and was more effective than a toxin monomer in membrane perturbation of calcein-loaded liposomes. A three-dimensional model of toxin trimer obtained by negative-stain EM in combination with single-particle reconstruction at similar to 5 nm resolution showed a propeller-shaped structure with 3-fold symmetry. Fitting the three-dimensional reconstructed EM map with a 100-ns molecular dynamics-simulated Cry4Ba structure interacting with an octyl-beta-D-glucoside micelle showed relative positioning of individual domains in the context of the trimeric complex with a major protrusion from the pore-forming domain. Moreover, high-speed atomic force microscopy imaging at nanometer resolution and a subsecond frame rate demonstrated conformational transitions from a propeller-like to a globularly shaped trimer upon lipid membrane interactions, implying prepore-to-pore conversion. Real-time trimeric arrangement of monomers associated with L-alpha-dimyristoylphosphatidylcholine/3-[(3-cholamidopropyl) dimethylammonio]-2-hydroxy1-propanesulfonic acid bicelle membranes was also envisaged by successive high-speed atomic force microscopy imaging, depicting interactions among three individual subunits toward trimer formation. Together, our data provide the first pivotal insights into the structural requirement of membrane-induced conformational changes of Cry4Ba toxin monomers for the molecular assembly of a prepore trimer capable of inserting into target membranes to generate a lytic pore.	[Sriwimol, Wilaiwan] Mahidol Univ, Fac Med Technol, Dept Clin Chem, Nakhon Pathom 73170, Thailand; [Sriwimol, Wilaiwan; Aroonkesorn, Aratee; Sakdee, Somsri; Angsuthanasombat, Chanan] Mahidol Univ, Inst Mol Biosci, Bacterial Prot Toxin Res Cluster, Nakhon Pathom 73170, Thailand; [Kanchanawarin, Chalermpol] Kasetsart Univ, Fac Sci, Dept Phys, Lab Theoret & Computat Biophys, Bangkok 10900, Thailand; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Bio AFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Angsuthanasombat, Chanan] Biophys Inst Res & Dev, Lab Mol Biophys & Struct Biochem, Bangkok 10160, Thailand	Mahidol University; Mahidol University; Kasetsart University; Kanazawa University; Kanazawa University	Angsuthanasombat, C (corresponding author), Mahidol Univ, Inst Mol Biosci, Bacterial Prot Toxin Res Cluster, Nakhon Pathom 73170, Thailand.	ang@mahidol.ac.th	Aroonkesorn, Aratee/AAX-2660-2020; ANDO, Toshio/E-7054-2015; Uchihashi, Takayuki/D-5209-2011; Kanchanawarin, Chalermpol/HHS-3620-2022; Sriwimol, Wilaiwan/AAS-4281-2021	ANDO, Toshio/0000-0001-8819-154X; Uchihashi, Takayuki/0000-0002-0263-5312; Aroonkesorn, Aratee/0000-0003-2845-8155; Angsuthanasombat, Chanan/0000-0001-7891-9007; Sriwimol, Wilaiwan/0000-0002-0911-0607	Thailand Research Fund Grants [IRG 57-8-0009, BRG-58-8-0002]; Commission of Higher Education, Ministry of Education (Thailand); Grants-in-Aid for Scientific Research [26600052] Funding Source: KAKEN	Thailand Research Fund Grants; Commission of Higher Education, Ministry of Education (Thailand); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research work was supported in part by Thailand Research Fund Grants IRG 57-8-0009 and BRG-58-8-0002) in cooperation with the Commission of Higher Education, Ministry of Education (Thailand). This work was also supported by a scholarship from the Commission of Higher Education, Ministry of Education (Thailand) (to W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2013, MICROSCOPY-JPN, V62, P81, DOI 10.1093/jmicro/dfs093; Angsuthanasombat C., 2010, OPEN TOXINOL J, V3, P119; Aroonkesorn A, 2015, BIOCHEM BIOPH RES CO, V461, P300, DOI 10.1016/j.bbrc.2015.04.026; Becker Norbert, 1993, P147; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Dechklar M, 2011, INSECT BIOCHEM MOLEC, V41, P159, DOI 10.1016/j.ibmb.2010.11.006; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; Guo SY, 2009, BIOTECHNOL LETT, V31, P1769, DOI 10.1007/s10529-009-0078-2; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imtong C, 2014, BBA-PROTEINS PROTEOM, V1844, P1111, DOI 10.1016/j.bbapap.2014.03.003; Juntadech T, 2014, BBA-BIOMEMBRANES, V1838, P319, DOI 10.1016/j.bbamem.2013.10.002; Leetachewa S, 2006, J BIOCHEM MOL BIOL, V39, P270; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Likitvivatanavong S, 2006, ARCH BIOCHEM BIOPHYS, V445, P46, DOI 10.1016/j.abb.2005.11.007; Lin X, 2014, BBA-BIOMEMBRANES, V1838, P1777, DOI 10.1016/j.bbamem.2014.03.006; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; MRSNY RJ, 1986, CHEM PHYS LIPIDS, V39, P185, DOI 10.1016/0009-3084(86)90111-8; Munoz-Garay C, 2009, BBA-BIOMEMBRANES, V1788, P2229, DOI 10.1016/j.bbamem.2009.06.014; Ounjai P, 2007, BIOCHEM BIOPH RES CO, V361, P890, DOI 10.1016/j.bbrc.2007.07.086; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Puntheeranurak T, 2005, ULTRAMICROSCOPY, V105, P115, DOI 10.1016/j.ultramic.2005.06.026; Rodriguez-Almazan C, 2012, BIOCHEM J, V443, P711, DOI 10.1042/BJ20111579; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Spenneberg R, 1998, BBA-MOL CELL RES, V1448, P311, DOI 10.1016/S0167-4889(98)00131-1; Taveecharoenkool Taveechai, 2010, PMC Biophys, V3, P10, DOI 10.1186/1757-5036-3-10; Thammasittirong A, 2011, APPL ENVIRON MICROB, V77, P6836, DOI 10.1128/AEM.05775-11; Thamwiriyasati N, 2010, ACTA CRYSTALLOGR F, V66, P721, DOI 10.1107/S1744309110015344; Tiewsiri K, 2009, ARCH BIOCHEM BIOPHYS, V482, P17, DOI 10.1016/j.abb.2008.11.025; Tiewsiri K, 2007, J BIOCHEM MOL BIOL, V40, P163; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070	46	22	22	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20793	20803		10.1074/jbc.M114.627554	http://dx.doi.org/10.1074/jbc.M114.627554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26112409	Green Published, hybrid			2022-12-28	WOS:000360011800017
J	Chen, Y; Zhang, HS; Fong, GH; Xi, QL; Wu, GH; Bai, CG; Ling, ZQ; Fan, L; Xu, YM; Qin, YQ; Yuan, TL; Sun, H; Fang, J				Chen, Ying; Zhang, Hai-Sheng; Fong, Guo-Hua; Xi, Qiu-Lei; Wu, Guo-Hao; Bai, Chen-Guang; Ling, Zhi-Qiang; Fan, Li; Xu, Yi-Ming; Qin, Yan-Qing; Yuan, Tang-Long; Sun, Heng; Fang, Jing			PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROLYL; DOMAIN; COLITIS; EGLN3; HIF; INHIBITION; DIFFERENTIATION; HYDROXYLATION; PERMEABILITY	Prolyl hydroxylase domain proteins (PHDs) control cellular adaptation to hypoxia. PHDs are found involved in inflammatory bowel disease (IBD); however, the exact role of PHD3, a member of the PHD family, in IBD remains unknown. We show here that PHD3 plays a critical role in maintaining intestinal epithelial barrier function. We found that genetic ablation of Phd3 in intestinal epithelial cells led to spontaneous colitis in mice. Deletion of PHD3 decreases the level of tight junction protein occludin, leading to a failure of intestinal epithelial barrier function. Further studies indicate that PHD3 stabilizes occludin by preventing the interaction between the E3 ligase Itch and occludin, in a hydroxylase-independent manner. Examination of biopsy of human ulcerative colitis patients indicates that PHD3 is decreased with disease severity, indicating that PHD3 down-regulation is associated with progression of this disease. We show that PHD3 protects intestinal epithelial barrier function and reveal a hydroxylase-independent function of PHD3 in stabilizing occludin. These findings may help open avenues for developing a therapeutic strategy for IBD.	[Chen, Ying; Zhang, Hai-Sheng; Fan, Li; Xu, Yi-Ming; Qin, Yan-Qing; Yuan, Tang-Long; Sun, Heng; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Lab Food Safety Res, Shanghai 200031, Peoples R China; [Fong, Guo-Hua] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Xi, Qiu-Lei; Wu, Guo-Hao] Fudan Univ, Zhongshan Hosp, Dept Surg, Sch Med, Shanghai 200030, Peoples R China; [Bai, Chen-Guang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Dept Pathol, Hangzhou 310022, Zhejiang, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Ctr, Hangzhou 310022, Zhejiang, Peoples R China; [Fang, Jing] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Connecticut; Fudan University; Naval Medical University; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Lab Food Safety Res, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn		Wu, Guohao/0000-0001-9490-4200	National Natural Science Foundation of China [31270829]; Science and Technology Commission of Shanghai Municipality [13JC1406200]; Shanghai Institutes for Biochemistry and Cell Biology [2012CSP003]; CAS/SAFEA International Partnership Program for Creative Research Teams; NATIONAL EYE INSTITUTE [R01EY019721] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Institutes for Biochemistry and Cell Biology; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Natural Science Foundation of China Grants 31270829 and 31270829, Science and Technology Commission of Shanghai Municipality Grant 13JC1406200, Shanghai Institutes for Biochemistry and Cell Biology Grant 2012CSP003, and the CAS/SAFEA International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Braus NA, 2009, CLIN IMMUNOL, V132, P1, DOI 10.1016/j.clim.2009.02.006; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; JONES SC, 1995, GUT, V36, P724, DOI 10.1136/gut.36.5.724; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Sheridan B. S., 2012, CURR PROTOC IMMUNOL, V99; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taniguchi CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008523; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	50	38	40	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20580	20589		10.1074/jbc.M115.653584	http://dx.doi.org/10.1074/jbc.M115.653584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124271	Green Published, hybrid			2022-12-28	WOS:000359608900053
J	Daher, JPL; Abdelmotilib, HA; Hu, XZ; Volpicelli-Daley, LA; Moehle, MS; Fraser, KB; Needle, E; Chen, Y; Steyn, SJ; Galatsis, P; Hirst, WD; West, AB				Daher, Joao P. L.; Abdelmotilib, Hisham A.; Hu, Xianzhen; Volpicelli-Daley, Laura A.; Moehle, Mark S.; Fraser, Kyle B.; Needle, Elie; Chen, Yi; Steyn, Stefanus J.; Galatsis, Paul; Hirst, Warren D.; West, Andrew B.			Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates alpha-Synuclein Gene-induced Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSON-LIKE NEURODEGENERATION; VECTOR-MEDIATED OVEREXPRESSION; SUBSTANTIA-NIGRA; RAT MODEL; DISEASE	Therapeutic approaches to slow or block the progression of Parkinson disease (PD) do not exist. Genetic and biochemical studies implicate alpha-synuclein and leucine-rich repeat kinase 2 (LRRK2) in late-onset PD. LRRK2 kinase activity has been linked to neurodegenerative pathways. However, the therapeutic potential of LRRK2 kinase inhibitors is not clear because significant toxicities have been associated with one class of LRRK2 kinase inhibitors. Furthermore, LRRK2 kinase inhibitors have not been tested previously for efficacy in models of alpha-synuclein-induced neurodegeneration. To better understand the therapeutic potential of LRRK2 kinase inhibition in PD, we evaluated the tolerability and efficacy of a LRRK2 kinase inhibitor, PF-06447475, in preventing alpha-synuclein-induced neurodegeneration in rats. Both wild-type rats as well as transgenic G2019S-LRRK2 rats were injected intracranially with adeno-associated viral vectors expressing human alpha-synuclein in the substantia nigra. Rats were treated with PF-06447475 or a control compound for 4 weeks post-viral transduction. We found that rats expressing G2019S-LRRK2 have exacerbated dopaminergic neurodegeneration and inflammation in response to the overexpression of alpha-synuclein. Both neurodegeneration and neuro-inflammation associated with G2019S-LRRK2 expression were mitigated by LRRK2 kinase inhibition. Furthermore, PF-06447475 provided neuroprotection in wild-type rats. We could not detect adverse pathological indications in the lung, kidney, or liver of rats treated with PF-06447475. These results demonstrate that pharmacological inhibition of LRRK2 is well tolerated for a 4-week period of time in rats and can counteract dopaminergic neurodegeneration caused by acute alpha-synuclein overexpression.	[Daher, Joao P. L.; Abdelmotilib, Hisham A.; Hu, Xianzhen; Volpicelli-Daley, Laura A.; Moehle, Mark S.; Fraser, Kyle B.; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Needle, Elie; Chen, Yi; Hirst, Warren D.] Pfizer Neurosci Res Unit, Cambridge, MA USA; [Steyn, Stefanus J.] Pfizer Pharmacokinet Dynam & Metab Cambridge, Cambridge, MA 02139 USA; [Galatsis, Paul] Pfizer Worldwide Med Chem, Cambridge, MA 02139 USA	University of Alabama System; University of Alabama Birmingham; Pfizer; Pfizer; Pfizer	West, AB (corresponding author), 1719 6th Ave S, Birmingham, AL 35294 USA.	abwest@uab.edu	Abdelmotilib, Hisham/AAT-1452-2020; Moehle, Mark/GNH-1825-2022	Moehle, Mark/0000-0002-8023-1313; West, Andrew/0000-0002-3034-4061; Hirst, Warren/0000-0003-0389-8891	NINDS/National Institutes of Health [F31 NS081963, T32 GM00811127, R01 NS064934]; Michael J. Fox Foundation for Parkinson's Disease Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081963, R01NS064934] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation for Parkinson's Disease Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grants F31 NS081963 (to M. S. M.), T32 GM00811127 (to K. B. F.), and R01 NS064934 (to A. B. W.). This work was also supported by the Michael J. Fox Foundation for Parkinson's Disease Research (to A. B. W. and W. D. H.) and the American Parkinson's Disease Association (to J. P. L. D. and L. A. V.). E. N., Y. C., S. J. S., P. G., and W. D. H. are employees of Pfizer Inc., which holds patent rights to PF-06447475.	Baptista MAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080705; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Fuji RN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3634; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Harms AS, 2011, MOL THER, V19, P46, DOI 10.1038/mt.2010.217; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Henderson JL, 2015, J MED CHEM, V58, P419, DOI 10.1021/jm5014055; Herzig MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036581; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lee JW, 2015, NEUROBIOL AGING, V36, P505, DOI 10.1016/j.neurobiolaging.2014.07.011; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Moehle MS, 2015, HUM MOL GENET, V24, P4250, DOI 10.1093/hmg/ddv157; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ness D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066164; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Puccini JM, 2015, J NEUROSCI, V35, P5271, DOI 10.1523/JNEUROSCI.0650-14.2015; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Van der Perren A, 2015, NEUROBIOL AGING, V36, P1543, DOI 10.1016/j.neurobiolaging.2014.11.015; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2015, MOVEMENT DISORD, V30, P180, DOI 10.1002/mds.26075; West AB, 2014, J COMP NEUROL, V522, P2465, DOI 10.1002/cne.23583	40	128	133	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19433	19444		10.1074/jbc.M115.660001	http://dx.doi.org/10.1074/jbc.M115.660001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26078453	Green Published, hybrid			2022-12-28	WOS:000359364600004
J	Mohan, R; Mao, YP; Zhang, SG; Zhang, YW; Xu, CR; Gradwohl, G; Tang, XQ				Mohan, Ramkumar; Mao, Yiping; Zhang, Shungang; Zhang, Yu-Wei; Xu, Cheng-Ran; Gradwohl, Gerard; Tang, Xiaoqing			Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic beta- and alpha-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; GLUCAGON-SECRETION; CYTOKINE SIGNALING-3; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; DIABETES-MELLITUS; APOPTOSIS; PROLIFERATION; SUPPRESSOR; SOCS-3	Insulin secreted from pancreatic beta-cells and glucagon secreted from pancreatic alpha-cells are the two major hormones working in the pancreas in an opposing manner to regulate and maintain a normal glucose homeostasis. How microRNAs (miRNAs), a population of non-coding RNAs so far demonstrated to be differentially expressed in various types of cells, regulate gene expression in pancreatic beta-cells and its closely associated alpha-cells is not completely clear. In this study, miRNA profiling was performed and compared between pancreatic beta-cells and their partner alpha-cells. One novel miRNA, miR-483, was identified for its highly differential expression in pancreatic beta-cells when compared to its expression in alpha-cells. Overexpression of miR-483 in beta-cells increased insulin transcription and secretion by targeting SOCS3, a member of suppressor of cytokine signaling family. In contrast, overexpression of miR-483 decreased glucagon transcription and secretion in alpha-cells. Moreover, overexpressed miR-483 protected against proinflammatory cytokine-induced apoptosis in beta-cells. This correlates with a higher expression level of miR-483 and the expanded beta-cell mass observed in the islets of prediabetic db/db mice. Together, our data suggest that miR-483 has opposite effects in alpha- and beta-cells by targeting SOCS3, and the imbalance of miR-483 and its targets may play a crucial role in diabetes pathogenesis.	[Mohan, Ramkumar; Mao, Yiping; Zhang, Shungang; Tang, Xiaoqing] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Zhang, Yu-Wei; Xu, Cheng-Ran] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Gradwohl, Gerard] Univ Strasbourg, Inst Genet & Mol & Cellular Biol, Dept Dev & Stem cells, F-67404 Illkirch Graffenstaden, France	Michigan Technological University; Peking University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tang, XQ (corresponding author), Michigan Technol Univ, Dept Biol Sci, 1400 Townsend Dr, Houghton, MI 49931 USA.	xtang2@mtu.edu	Gradwohl, Gérard/AFM-9024-2022; Mohan, Ramkumar/J-9037-2019; Regan, Clinton/E-6250-2012; Gradwohl, Gérard/H-8543-2014	Gradwohl, Gérard/0000-0002-6730-2615; Mohan, Ramkumar/0000-0002-1308-1642; Gradwohl, Gérard/0000-0002-6730-2615; Zhang, Shungang/0000-0002-6668-7453	National Institutes of Health [DK084166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK103197, R03DK084166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK084166 (to X. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Barbagallo D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-62; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Breckenridge SM, 2007, DIABETES, V56, P2442, DOI 10.2337/db07-0751; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cooperberg BA, 2010, DIABETES, V59, P2936, DOI 10.2337/db10-0728; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; Emanuelli B, 2004, DIABETES, V53, pS97, DOI 10.2337/diabetes.53.suppl_3.S97; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hill DJ, 2000, ENDOCRINOLOGY, V141, P1151, DOI 10.1210/en.141.3.1151; Hope KM, 2004, DIABETES, V53, P1488, DOI 10.2337/diabetes.53.6.1488; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Laubner K, 2005, DIABETES, V54, P3410, DOI 10.2337/diabetes.54.12.3410; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Liu MZ, 2013, GENE DEV, V27, P2543, DOI 10.1101/gad.224170.113; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mao YP, 2013, PHARMACOL RES, V75, P37, DOI 10.1016/j.phrs.2013.06.005; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Montanya E, 2009, METHODS MOL BIOL, V560, P137, DOI 10.1007/978-1-59745-448-3_11; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Piccand J, 2014, DIABETES, V63, P203, DOI 10.2337/db13-0384; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ronn SG, 2002, MOL ENDOCRINOL, V16, P2124, DOI 10.1210/me.2002-0082; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Xu CR, 2014, EMBO J, V33, P2157, DOI 10.15252/embj.201488671; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zhou HR, 2004, DIABETES, V53, P1482, DOI 10.2337/diabetes.53.6.1482	67	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19955	19966		10.1074/jbc.M115.650705	http://dx.doi.org/10.1074/jbc.M115.650705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109062	Green Published, hybrid			2022-12-28	WOS:000359364600050
J	Zhang, JF; Ranheim, EA; Du, J; Liu, YG; Wang, JY; Kong, GY; Zhang, J				Zhang, Jingfang; Ranheim, Erik A.; Du, Juan; Liu, Yangang; Wang, Jinyong; Kong, Guangyao; Zhang, Jing			Deficiency of beta Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in Nras(G12D/+) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; JUVENILE MYELOMONOCYTIC LEUKEMIA; FACTOR GM-CSF; HEMATOPOIETIC STEM; ONCOGENIC NRAS; SIGNALING PATHWAY; MURINE MODEL; CELLS; NF1; ACTIVATION	Activating Ras signaling is a major driver in juvenile and the myeloproliferative variant of chronic myelomonocytic leukemia (JMML/MP-CMML). Numerous studies suggest that GM-CSF signaling plays a central role in establishing and maintaining JMML/MP-CMML phenotypes in human and mouse. However, it remains elusive how GM-CSF signaling impacts on JMML/MP-CMML initiation and progression. Here, we investigate this issue in a well characterized MP-CMML model induced by endogenous Nras(G12D/+) mutation. In this model, Nras(G12D/+) hematopoietic stem cells (HSCs) are required to initiate and maintain CMML phenotypes and serve as CMML-initiating cells. We show that the common beta chain of the GM-CSF receptor (beta c) is dispensable for Nras(G12D/+) HSC function; loss of beta c does not affect the expansion, increased self-renewal, or myeloid differentiation bias in Nras(G12D/+) HSCs. Therefore, beta c(-/-) does not abrogate CMML in Nras(G12D/+) mice. However, beta c deficiency indeed significantly reduces Nras(G12D/+)-induced splenomegaly and spontaneous colony formation and prolongs the survival of CMML-bearing mice, suggesting that GM-CSF signaling plays an important role in promoting CMML progression. Together, our results suggest that inhibiting GM-CSF signaling in JMML/MP-CMML patients might alleviate disease symptoms but would not eradicate the disease.	[Zhang, Jingfang; Du, Juan; Liu, Yangang; Wang, Jinyong; Kong, Guangyao; Zhang, Jing] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53705 USA; [Ranheim, Erik A.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, J (corresponding author), Univ Wisconsin, McArdle Lab, Room 7453,1111 Highland Ave, Madison, WI 53705 USA.	zhang@oncology.wisc.edu	Regan, Clinton/E-6250-2012; Kong, Guangyao/L-2162-2013; Ranheim, Erik/AAY-6505-2021		National Institutes of Health [R01 CA152108, HL113066]; Leukemia & Lymphoma Society; National Institutes of Health NCI through the University of Wisconsin Comprehensive Cancer Center [P30 CA014520]; NATIONAL CANCER INSTITUTE [R01CA152108, P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health NCI through the University of Wisconsin Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 CA152108 and HL113066 and a Scholar Award from the Leukemia & Lymphoma Society (to J. Z.). This work was also supported in part by National Institutes of Health NCI Grant P30 CA014520 through the University of Wisconsin Comprehensive Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Bowen DT, 2005, HEMATOL ONCOL, V23, P26, DOI 10.1002/hon.745; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Cambier N, 1997, HEMATOL CELL THER, V39, P41, DOI 10.1007/s00282-997-0041-4; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Du J, 2013, LEUKEMIA, V27, P754, DOI 10.1038/leu.2012.251; Elliot MA, 2006, BEST PRACT RES CL HA, V19, P571, DOI 10.1016/j.beha.2005.07.012; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; EMANUEL PD, 1991, BLOOD, V77, P925; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Iversen PO, 1997, BLOOD, V90, P4910, DOI 10.1182/blood.V90.12.4910.4910_4910_4917; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim A, 2007, BLOOD, V109, P1687, DOI 10.1182/blood-2006-05-025395; Kong GY, 2014, J CLIN INVEST, V124, P2762, DOI 10.1172/JCI74182; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Li Q, 2013, NATURE, V504, P143, DOI 10.1038/nature12830; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Matsuura S, 2012, BLOOD, V119, P3155, DOI 10.1182/blood-2011-04-350694; Nicola NA, 1997, CIBA F SYMP, V204, P19; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Okuda K, 1999, ANN NY ACAD SCI, V872, P305, DOI 10.1111/j.1749-6632.1999.tb08474.x; Onida Francesco, 2004, Curr Hematol Rep, V3, P218; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wang JY, 2013, BLOOD, V121, P5203, DOI 10.1182/blood-2012-12-475863; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Woodcock JM, 1997, BLOOD, V90, P3005, DOI 10.1182/blood.V90.8.3005; Yoshida N, 2009, PEDIATR RES, V65, P334, DOI 10.1203/PDR.0b013e3181961d2a; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262	35	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19093	19103		10.1074/jbc.M115.653154	http://dx.doi.org/10.1074/jbc.M115.653154			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082490	Green Published, hybrid			2022-12-28	WOS:000358781100026
J	Chandrahas, V; Glinton, K; Liang, Z; Donahue, DL; Ploplis, VA; Castellino, FJ				Chandrahas, Vishwanatha; Glinton, Kristofor; Liang, Zhong; Donahue, Deborah L.; Ploplis, Victoria A.; Castellino, Francis J.			Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; CLUSTER 2B STREPTOKINASE; FUNCTIONAL DIFFERENCES; INTERNAL SEQUENCE; VIRULENCE FACTOR; TISSUE TROPISM; PATHOGENESIS; FIBRINOGEN; DOMAIN; PAM	Streptokinase (SK), secreted by Group A Streptococcus (GAS), is a single-chain similar to 47-kDa protein containing three consecutive primary sequence regions that comprise its alpha, beta, and gamma modules. Phylogenetic analyses of the variable beta-domain sequences from different GAS strains suggest that SKs can be arranged into two clusters, SK1 and SK2, with a subdivision of SK2 into SK2a and SK2b. SK2b is secreted by skin-tropic Pattern D M-protein strains that also express plasminogen (human Pg (hPg)) binding Group A streptococcal M-protein (PAM) as its major cell surface M-protein. SK2a-expressing strains are associated with nasopharynx tropicity, and many of these strains express human fibrinogen (hFg) binding Pattern A-C M-proteins, e.g. M1. PAM interacts with hPg directly, whereas M1 binds to hPg indirectly via M1-bound hFg. Subsequently, SK is secreted by GAS and activates hPg to plasmin (hPm), thus generating a proteolytic surface on GAS that enhances its dissemination. Due to these different modes of hPg/hPm recognition by GAS, full characterizations of the mechanisms of activation of hPg by SK2a and SK2b and their roles in GAS virulence are important topics. To more fully examine these subjects, isogenic chimeric SK- and M-protein-containing GAS strains were generated, and the virulence of these chimeric strains were analyzed in mice. We show that SK and M-protein alterations influenced the virulence of GAS and were associated with the different natures of hPg activation and hPm binding. These studies demonstrate that GAS virulence can be explained by disparate hPg activation by SK2a and SK2b coupled with the coinherited M-proteins of these strains.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Chandrahas, Vishwanatha K./I-8256-2019; Regan, Clinton/E-6250-2012	Chandrahas, Vishwanatha K./0000-0001-8227-5021; Glinton, Kristofor/0000-0001-9301-7132	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013423, R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423. The authors declare that they have no conflicts of interest with the contents of this article.	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; ANONICK PK, 1991, BIOCHEM J, V275, P53, DOI 10.1042/bj2750053; BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Bhattacharya S, 2014, J BIOL CHEM, V289, P21684, DOI 10.1074/jbc.M114.570218; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Conejero-Lara F, 1998, PROTEIN SCI, V7, P2190, DOI 10.1002/pro.5560071017; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fu QH, 2008, J BIOL CHEM, V283, P1580, DOI 10.1074/jbc.M705063200; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; HOLLINGSHEAD SK, 1994, MOL BIOL EVOL, V11, P208; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Iwaki T, 2005, CURR DRUG TARGETS, V6, P535, DOI 10.2174/1389450054546006; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; MALKE H, 1993, ZBL BAKT-INT J MED M, V278, P246; Mayfield JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100698; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380; NOVOKHATNY VV, 1984, J MOL BIOL, V179, P215, DOI 10.1016/0022-2836(84)90466-2; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Ringdahl U, 2000, METHODS, V21, P143, DOI 10.1006/meth.2000.0985; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; SCHICK LA, 1973, BIOCHEMISTRY-US, V12, P4315, DOI 10.1021/bi00746a003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHANKAR H, 1987, J BIOMED MATER RES, V21, P897, DOI 10.1002/jbm.820210706; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; WHITNACK E, 1985, J BACTERIOL, V164, P350, DOI 10.1128/JB.164.1.350-358.1985; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V444, P595, DOI 10.1016/j.bbrc.2014.01.109; Zhang YL, 2013, FEBS LETT, V587, P1304, DOI 10.1016/j.febslet.2013.02.033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	54	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18833	18842		10.1074/jbc.M115.655365	http://dx.doi.org/10.1074/jbc.M115.655365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070561	hybrid, Green Published			2022-12-28	WOS:000358512100049
J	Hu, HQ; Zhou, Q; Li, ZY				Hu, Huiqing; Zhou, Qing; Li, Ziyin			A Novel Basal Body Protein That Is a Polo-like Kinase Substrate Is Required for Basal Body Segregation and Flagellum Adhesion in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHMENT ZONE FILAMENT; CELL-CYCLE; LOCALIZATION; CYTOKINESIS; IDENTIFICATION; CYTOSKELETON; DUPLICATION; INHERITANCE; EXPRESSION; ANTIBODIES	The Polo-like kinase (PLK) in Trypanosoma brucei plays multiple roles in basal body segregation, flagellum attachment, and cytokinesis. However, the mechanistic role of TbPLK remains elusive, mainly because most of its substrates are not known. Here, we report a new substrate of TbPLK, SPBB1, and its essential roles in T. brucei. SPBB1 was identified through yeast twohybrid screening with the kinase-dead TbPLK as the bait. It interacts with TbPLK in vitro and in vivo, and is phosphorylated by TbPLK in vitro. SPBB1 localizes to both the mature basal body and the probasal body throughout the cell cycle, and co-localizes with TbPLK at the basal body during early cell cycle stages. RNAi against SPBB1 in procyclic trypanosomes inhibited basal body segregation, disrupted the new flagellum attachment zone filament, detached the new flagellum, and caused defective cytokinesis. Moreover, RNAi of SPBB1 confined TbPLK at the basal body and the bilobe structure, resulting in constitutive phosphorylation of TbCentrin2 at the bilobe. Altogether, these results identified a basal body protein as a TbPLK substrate and its essential role in promoting basal body segregation and flagellum attachment zone filament assembly for flagellum adhesion and cytokinesis initiation.	[Hu, Huiqing; Zhou, Qing; Li, Ziyin] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019; Regan, Clinton/E-6250-2012	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI101437, AI108657]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R56AI108657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants AI101437 and AI108657 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; de Graffenried CL, 2013, MOL BIOL CELL, V24, P1947, DOI 10.1091/mbc.E12-12-0911; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Paoletti A, 1996, J CELL SCI, V109, P3089; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Vaughan S, 2003, J CELL SCI, V116, P757, DOI 10.1242/jcs.00287; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Yu ZL, 2012, J CELL SCI, V125, P1519, DOI 10.1242/jcs.094243; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	43	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25012	25022		10.1074/jbc.M115.674796	http://dx.doi.org/10.1074/jbc.M115.674796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26272611	hybrid, Green Published			2022-12-28	WOS:000362598300030
J	Nakatsu, Y; Iwashita, M; Sakoda, H; Ono, H; Nagata, K; Matsunaga, Y; Fukushima, T; Fujishiro, M; Kushiyama, A; Kamata, H; Takahashi, SI; Katagiri, H; Honda, H; Kiyonari, H; Uchida, T; Asano, T				Nakatsu, Yusuke; Iwashita, Misaki; Sakoda, Hideyuki; Ono, Hiraku; Nagata, Kengo; Matsunaga, Yasuka; Fukushima, Toshiaki; Fujishiro, Midori; Kushiyama, Akifumi; Kamata, Hideaki; Takahashi, Shin-Ichiro; Katagiri, Hideki; Honda, Hiroaki; Kiyonari, Hiroshi; Uchida, Takafumi; Asano, Tomichiro			Prolyl Isomerase Pin1 Negatively Regulates AMP-activated Protein Kinase (AMPK) by Associating with the CBS Domain in the gamma Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; UPSTREAM KINASE; PHOSPHORYLATION; LKB1; METABOLISM; SIRT1; CELL; PGC-1-ALPHA	AMP-activated protein kinase (AMPK) plays a critical role in metabolic regulation. In this study, first, it was revealed that Pin1 associates with any isoform of gamma, but not with either the alpha or the beta subunit, of AMPK. The association between Pin1 and the AMPK gamma 1 subunit is mediated by the WW domain of Pin1 and the Thr211Pro-containing motif located in the CBS domain of the gamma 1 subunit. Importantly, overexpression of Pin1 suppressed AMPK phosphorylation in response to either 2-deoxyglucose or biguanide stimulation, whereas Pin1 knockdown by siRNAs or treatment with Pin1 inhibitors enhanced it. The experiments using recombinant Pin1, AMPK, LKB1, and PP2C proteins revealed that the protective effect of AMP against PP2C-induced AMPK alpha subunit dephosphorylation was markedly suppressed by the addition of Pin1. In good agreement with the in vitro data, the level of AMPK phosphorylation as well as the expressions of mitochondria-related genes, such as PGC-1 alpha, which are known to be positively regulated by AMPK, were markedly higher with reduced triglyceride accumulation in the muscles of Pin1 KO mice as compared with controls. These findings suggest that Pin1 plays an important role in the pathogenic mechanisms underlying impaired glucose and lipid metabolism, functioning as a negative regulator of AMPK.	[Nakatsu, Yusuke; Nagata, Kengo; Matsunaga, Yasuka; Fukushima, Toshiaki; Kamata, Hideaki; Asano, Tomichiro] Hiroshima Univ, Dept Med Sci, Grad Sch Med, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348553, Japan; [Iwashita, Misaki] Hiroshima Univ, Dept Dent Sci Hlth Promot, Grad Sch Biomed Sci, Minami Ku, Hiroshima, Hiroshima 7348553, Japan; [Honda, Hiroaki] Hiroshima Univ, Dept Dis Model, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Fujishiro, Midori] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ono, Hiraku] Saitama Med Univ, Sch Med, Dept Endocrinol & Diabet, Moroyama, Saitama 3500495, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo 1030002, Japan; [Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Anim Resource Dev Unit, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Genet Engn Team, Div Biofunct Dynam Imaging,Chuou Ku, Kobe, Hyogo 6500047, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; Hiroshima University; Hiroshima University; University of Tokyo; Saitama Medical University; Asahi Life Foundation; University of Tokyo; Tohoku University; RIKEN; RIKEN; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Dept Med Sci, Grad Sch Med, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348553, Japan.	tasano@hiroshima-u.ac.jp	Kushiyama, Akifumi/W-5988-2019; Kushiyama, Akifumi/A-6386-2011; Kiyonari, Hiroshi/N-7936-2015; 祐介, 中津/AAP-8396-2020; Kamata, Hideaki/N-3907-2017	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Uchida, Takafumi/0000-0003-3665-4906; Nakatsu, Yusuke/0000-0003-3279-1276; Iwashita, Misaki/0000-0002-8557-346X	Ministry of Education, Science, Sports, and Culture, Japan; Ono Medical Research Foundation; Tsuchiya Medical Foundation; Hiroshima University Fujii Research Promotion Fund; Grants-in-Aid for Scientific Research [15H01382, 26252064] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Tsuchiya Medical Foundation; Hiroshima University Fujii Research Promotion Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research (C) (to N. Y.) and a Grant-in-Aid for Scientific Research (B) (to T. A.) from the Ministry of Education, Science, Sports, and Culture, Japan, and grants from the Ono Medical Research Foundation, the Tsuchiya Medical Foundation, and the 2012 Hiroshima University Fujii Research Promotion Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Fila C, 2008, J BIOL CHEM, V283, P21714, DOI 10.1074/jbc.M710264200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khanal P, 2013, MOL CARCINOGEN, V52, P813, DOI 10.1002/mc.21920; Lessard SJ, 2009, ENDOCRINOLOGY, V150, P4883, DOI 10.1210/en.2009-0158; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Liu Y, 2006, BIOCHEM BIOPH RES CO, V339, P701, DOI 10.1016/j.bbrc.2005.11.068; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nakatsu Y, 2012, J BIOL CHEM, V287, P44526, DOI 10.1074/jbc.M112.397133; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Potter A, 2010, BIOORG MED CHEM LETT, V20, P6483, DOI 10.1016/j.bmcl.2010.09.063; Potter AJ, 2010, BIOORG MED CHEM LETT, V20, P586, DOI 10.1016/j.bmcl.2009.11.090; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	51	25	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24255	24266		10.1074/jbc.M115.658559	http://dx.doi.org/10.1074/jbc.M115.658559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276391	hybrid, Green Published			2022-12-28	WOS:000362218900017
J	Rudack, T; Jenrich, S; Brucker, S; Vetter, IR; Gerwert, K; Kotting, C				Rudack, Till; Jenrich, Sarah; Brucker, Sven; Vetter, Ingrid R.; Gerwert, Klaus; Koetting, Carsten			Catalysis of GTP Hydrolysis by Small GTPases at Atomic Detail by Integration of X-ray Crystallography, Experimental, and Theoretical IR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FTIR; ACTIVATING PROTEINS; MECHANISM; STATE; TRANSPORT; EFFECTOR; COMPLEX; P21; SIMULATIONS; CHROMOPHORE	Small GTPases regulate key processes in cells. Malfunction of their GTPase reaction by mutations is involved in severe diseases. Here, we compare the GTPase reaction of the slower hydrolyzing GTPase Ran with Ras. By combination of time-resolved FTIR difference spectroscopy and QM/MM simulations we elucidate that the Mg(2+)coordination by the phosphate groups, which varies largely among the x-ray structures, is the same for Ran and Ras. A new x-ray structure of a Ran.RanBD1 complex with improved resolution confirmed this finding and revealed a general problem with the refinement of Mg2+ in GTPases. The Mg2+ coordination is not responsible for the much slower GTPase reaction of Ran. Instead, the location of the Tyr-39 side chain of Ran between the gamma-phosphate and Gln-69 prevents the optimal positioning of the attacking water molecule by the Gln-69 relative to the gamma-phosphate. This is confirmed in the RanY39A.RanBD1 crystal structure. The QM/MM simulations provide IR spectra of the catalytic center, which agree very nicely with the experimental ones. The combination of both methods can correlate spectra with structure at atomic detail. For example the FTIR difference spectra of RasA18T and RanT25A mutants show that spectral differences are mainly due to the hydrogen bond of Thr-25 to the gamma-phosphate in Ran. By integration of x-ray structure analysis, experimental, and theoretical IR spectroscopy the catalytic center of the x-ray structural models are further refined to sub-angstrom resolution, allowing an improved understanding of catalysis.	[Rudack, Till; Jenrich, Sarah; Brucker, Sven; Gerwert, Klaus; Koetting, Carsten] Univ Bochum, Dept Biophys, Univ Str 750, D-44780 Bochum, Germany; [Vetter, Ingrid R.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Gerwert, Klaus] Chinese Acad Sci, Max Planck Partner Inst, Shanghai 200031, Peoples R China; [Gerwert, Klaus] Shanghai Inst Biol Sci, Key Lab Computat Biol, Shanghai 200031, Peoples R China	Ruhr University Bochum; Max Planck Society; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gerwert, K (corresponding author), Univ Bochum, Dept Biophys, Univ Str 750, D-44780 Bochum, Germany.	klaus.gerwert@bph.rub.de; carsten.koetting@rub.de	Kötting, Carsten/A-8266-2008; Gerwert, Klaus/G-7311-2015	Kötting, Carsten/0000-0002-3599-9657; 	Deutsche Forschungsgemeinschaft [SFB 642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 642. The authors declare no conflict of interest.	Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; Brucker S, 2010, J MOL BIOL, V401, P1, DOI 10.1016/j.jmb.2010.05.068; Cepus V, 1998, BIOCHEMISTRY-US, V37, P10263, DOI 10.1021/bi973183j; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cox Adrienne D, 2010, Small GTPases, V1, P2; Demunter A, 2001, CANCER RES, V61, P4916; Fidyk NJ, 2002, BIOCHEMISTRY-US, V41, P15644, DOI 10.1021/bi026413p; Fischer N, 2011, PROTEINS, V79, P2871, DOI 10.1002/prot.23122; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Groenhof G, 2004, J AM CHEM SOC, V126, P4228, DOI 10.1021/ja039557f; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Howeler U., 2007, MAXIMOBY 9 07 MOBY 3; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Kotting C, 2007, CHEMBIOCHEM, V8, P781, DOI 10.1002/cbic.200600552; Kotting C, 2004, CHEM PHYS, V307, P227, DOI 10.1016/j.chemphys.2004.06.051; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Kubelka J, 2001, J PHYS CHEM A, V105, P10922, DOI 10.1021/jp013203y; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Ligeti E, 2012, PHYSIOL REV, V92, P237, DOI 10.1152/physrev.00045.2010; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Park CH, 1997, J AM CHEM SOC, V119, P2453, DOI 10.1021/ja9635589; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rohrer M, 2001, BIOCHEMISTRY-US, V40, P1884, DOI 10.1021/bi002164y; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Rudack T, 2012, BIOPHYS J, V103, P293, DOI 10.1016/j.bpj.2012.06.015; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Steinbrecher Thomas, 2013, Methods Mol Biol, V924, P91, DOI 10.1007/978-1-62703-017-5_5; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; WARSHEL A, 1972, J AM CHEM SOC, V94, P5612, DOI 10.1021/ja00771a014; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Xia F, 2011, PHYS CHEM CHEM PHYS, V13, P21451, DOI 10.1039/c1cp22741f; Yoo HY, 2001, J PHYS CHEM B, V105, P2850, DOI 10.1021/jp003683d	47	15	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24079	24090		10.1074/jbc.M115.648071	http://dx.doi.org/10.1074/jbc.M115.648071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26272610	hybrid, Green Published			2022-12-28	WOS:000362218900004
J	Valentin-Hansen, L; Frimurer, TM; Mokrosinski, J; Holliday, ND; Schwartz, TW				Valentin-Hansen, Louise; Frimurer, Thomas M.; Mokrosinski, Jacek; Holliday, Nicholas D.; Schwartz, Thue W.			Biased G(s) Versus G(q) Proteins and beta-Arrestin Signaling in the NK1 Receptor Determined by Interactions in the Water Hydrogen Bond Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; COUPLED RECEPTORS; OPIOID RECEPTOR; FUNCTIONAL SELECTIVITY; ALLOSTERIC MODULATION; STRUCTURAL BASIS; ACTIVATION; COMPLEX; SODIUM; SWITCH	X-ray structures, molecular dynamics simulations, and mutational analysis have previously indicated that an extended water hydrogen bond network between trans-membranes I III, VI, and VII constitutes an allosteric interface essential for stabilizing different active and inactive helical constellations during the seven-trans-membrane receptor activation. The neurokinin-1 receptor signals efficiently through Gq, Gs, and p-arrestin when stimulated by substance P, but it lacks any sign of constitutive activity. In the water hydrogen bond network the neurokinin-1 has a unique Glu residue instead of the highly conserved Asp11:10 (2.50). Here, we find that this Glu11:10 occupies the space of a putative allosteric modulating Na ion and makes direct inter-helical interactions in particular with SerIII:15 (3.39) and AsnVII:16 (7.49) of the NPXXY motif. Mutational changes in the interface between (=dull: 10 and AsnVII:16 created receptors that selectively signaled through the following: 1) Gq only; 2) p-arrestin only; and 3) Gq and p-arrestin but not through Gs. Interestingly, increased constitutive Gs but not G signaling was observed by Ala substitution of four out of the six core polar residues of the network, in particular SerIII:15. Three residues were essential for all three signaling pathways, i.e. the water-gating micro-switch residues TrpVI:13 (6.48) of the CWXP motif and TyrVII:20 (7.53) of the NPXXY motif plus the totally conserved AsnI:18 (1.50) stabilizing the kink in trans-membrane VII. It is concluded that the interface between position II:10 (2.50), 111:15 (3.39), and VII:16 (7.49) in the center of the water hydrogen bond network constitutes a focal point for fine-tuning seven trans- membrane receptor conformations activating different signal transduction pathways.	[Valentin-Hansen, Louise; Mokrosinski, Jacek; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Mokrosinski, Jacek; Schwartz, Thue W.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Holliday, Nicholas D.] Univ Nottingham, Queens Med Ctr, Cell Signaling Res Grp, Sch Life Sci, Nottingham NG7 2UH, England	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Nottingham	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk	Mokrosinski, Jacek/M-1963-2019	Mokrosinski, Jacek/0000-0001-5008-0457; Schwartz, Thue W./0000-0002-0261-6904; Frimruer, Thomas/0000-0002-9682-8245; Holliday, Nicholas/0000-0002-2900-828X	Novo Nordisk Foundation; MRC [G0700049] Funding Source: UKRI; Medical Research Council [G0700049] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Schwartz Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF14CC0001] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	The Novo Nom disk Foundation Center for Basic Metabolic Research is based on an unconditional grant from the Novo Nordisk Foundation to the Faculty of Health Sciences at University of Copenhagen.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COSTA T, 1990, MOL PHARMACOL, V37, P383; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gales C, 2000, J BIOL CHEM, V275, P17321, DOI 10.1074/jbc.M909801199; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; GETHER U, 1993, P NATL ACAD SCI USA, V90, P6194, DOI 10.1073/pnas.90.13.6194; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Gutierrez-de-Teran H, 2013, STRUCTURE, V21, P2175, DOI 10.1016/j.str.2013.09.020; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jin LQ, 2001, J NEUROCHEM, V78, P981, DOI 10.1046/j.1471-4159.2001.00470.x; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kilts JD, 2000, CIRC RES, V87, P705, DOI 10.1161/01.RES.87.8.705; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Luttrell LM, 2014, MOL ENDOCRINOL, V28, P281, DOI 10.1210/me.2013-1314; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Martini L, 2002, MOL PHARMACOL, V62, P30, DOI 10.1124/mol.62.1.30; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nielsen SM, 1998, EUR J BIOCHEM, V251, P217, DOI 10.1046/j.1432-1327.1998.2510217.x; Nikiforovich GV, 2006, CHEM BIOL DRUG DES, V68, P239, DOI 10.1111/j.1747-0285.2006.00444.x; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sivertsen B, 2011, J BIOL CHEM, V286, P20845, DOI 10.1074/jbc.M110.173237; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Webb DR, 2013, BIOCHEM PHARMACOL, V85, P147, DOI 10.1016/j.bcp.2012.08.021; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilson MH, 2001, MOL PHARMACOL, V59, P929, DOI 10.1124/mol.59.4.929; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083; ZHOU W, 1994, MOL PHARMACOL, V45, P165	70	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24495	24508		10.1074/jbc.M115.641944	http://dx.doi.org/10.1074/jbc.M115.641944			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269596	Green Published, hybrid			2022-12-28	WOS:000362218900035
J	Ebbers, L; Satheesh, SV; Janz, K; Ruttiger, L; Blosa, M; Hofmann, F; Morawski, M; Griesemer, D; Knipper, M; Friauf, E; Nothwang, HG				Ebbers, Lena; Satheesh, Somisetty V.; Janz, Katrin; Ruettiger, Lukas; Blosa, Maren; Hofmann, Franz; Morawski, Markus; Griesemer, Desiree; Knipper, Marlies; Friauf, Eckhard; Nothwang, Hans Gerd			L-type Calcium Channel Ca(v)1.2 Is Required for Maintenance of Auditory Brainstem Nuclei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT REGULATION; LONG-TERM ADAPTATION; CA2+ CHANNELS; EXTRACELLULAR-MATRIX; SPIRAL GANGLION; CREB PHOSPHORYLATION; SYNAPTIC PLASTICITY; GLUA1 TRAFFICKING; PROTEIN-KINASES; GENE-EXPRESSION	Ca(v)1.2andCa(v)1.3are the major L-type voltage-gated Ca2+ channels in the CNS. Yet, their individual in vivo functions are largely unknown. Both channel subunits are expressed in the auditory brainstem, where Ca(v)1.3 is essential for proper maturation. Here, we investigated the role of Ca(v)1.2 by targeted deletion in the mouse embryonic auditory brainstem. Similar to Ca(v)1.3, loss of Ca(v)1.2 resulted in a significant decrease in the volume and cell number of auditory nuclei. Contrary to the deletion of Ca(v)1.3, the action potentials of lateral superior olive (LSO) neurons were narrower compared with controls, whereas the firing behavior and neurotransmission appeared unchanged. Furthermore, auditory brainstem responses were nearly normal in mice lacking Ca(v)1.2. Perineuronal nets were also unaffected. The medial nucleus of the trapezoid body underwent a rapid cell loss between postnatal days P0 and P4, shortly after circuit formation. Phosphorylated cAMP response element-binding protein (CREB), nuclear NFATc4, and the expression levels of p75NTR, Fas, and FasL did not correlate with cell death. These data demonstrate for the first time that both Ca(v)1.2 and Ca(v)1.3 are necessary for neuronal survival but are differentially required for the biophysical properties of neurons. Thus, they perform common as well as distinct functions in the same tissue.	[Ebbers, Lena; Satheesh, Somisetty V.; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany; [Janz, Katrin; Griesemer, Desiree; Friauf, Eckhard] Univ Kaiserlautern, Dept Biol, Anim Physiol Grp, D-67663 Kaiserslautern, Germany; [Ruettiger, Lukas; Knipper, Marlies] Univ Tubingen, Dept Otolaryngol, Hearing Res Ctr Tubingen THRC, Mol Physiol Hearing, D-72076 Tubingen, Germany; [Blosa, Maren; Morawski, Markus] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, D-04103 Leipzig, Germany; [Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Eberhard Karls University of Tubingen; Leipzig University; Technical University of Munich; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de	Morawski, Markus/X-2977-2019; Morawski, Markus/D-4877-2011; Griesemer, Désirée/A-9152-2018; Friauf, Eckhard/D-7529-2012	Morawski, Markus/0000-0002-3817-5186; Griesemer, Désirée/0000-0002-0551-038X; Friauf, Eckhard/0000-0002-1833-1698; Nothwang, Hans Gerd/0000-0001-7695-6437; Blosa, Maren/0000-0001-7680-5217	Deutsche Forschungsgemeinschaft (DFG), priority program, "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing" [428/10-1, Fri1784/15-1, Mo2249/2-1, 1608]; CAVNET from European Union [MRTN-CT-2006-035367]; Cluster of Excellence Hearing4All	Deutsche Forschungsgemeinschaft (DFG), priority program, "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"(German Research Foundation (DFG)); CAVNET from European Union; Cluster of Excellence Hearing4All	This work was supported by Grants 428/10-1, Fri1784/15-1, and Mo2249/2-1 from the Deutsche Forschungsgemeinschaft (DFG), priority program 1608, "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"; CAVNET Grant MRTN-CT-2006-035367 (to H. G. N.) from the European Union; and a grant from the Cluster of Excellence Hearing4All (to H. G. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berger S, 2014, CELL TISSUE RES, V357, P463, DOI 10.1007/s00441-014-1936-3; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blosa M, 2013, NEUROSCIENCE, V228, P215, DOI 10.1016/j.neuroscience.2012.10.003; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Bruckner G, 2001, EXP BRAIN RES, V137, P83; Caicedo A, 1997, J COMP NEUROL, V378, P1, DOI 10.1002/(SICI)1096-9861(19970203)378:1<1::AID-CNE1>3.0.CO;2-8; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; Chonko KT, 2013, DEV BIOL, V381, P401, DOI 10.1016/j.ydbio.2013.06.022; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Ehmann H, 2013, J BIOL CHEM, V288, P25865, DOI 10.1074/jbc.M113.490508; Ehmann H, 2008, HEARING RES, V245, P65, DOI 10.1016/j.heares.2008.08.008; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; Fulton D, 2010, GLIA, V58, P1292, DOI 10.1002/glia.21008; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; GALLI C, 1995, J NEUROSCI, V15, P1172; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hafidi A, 1996, J COMP NEUROL, V367, P454; Hafidi A, 1999, INT J DEV NEUROSCI, V17, P285, DOI 10.1016/S0736-5748(99)00043-X; Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Hirtz JJ, 2012, J NEUROSCI, V32, P14602, DOI 10.1523/JNEUROSCI.0765-12.2012; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Hoffpauir BK, 2009, BRAIN RES, V1277, P115, DOI 10.1016/j.brainres.2009.02.050; Hrabetova S, 2009, J PHYSIOL-LONDON, V587, P4029, DOI 10.1113/jphysiol.2009.170092; Jager C, 2013, NEUROSCIENCE, V238, P168, DOI 10.1016/j.neuroscience.2013.02.014; Jurkovicova-Tarabova B, 2012, J NEUROPHYSIOL, V108, P365, DOI 10.1152/jn.00948.2011; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; LACHICA EA, 1995, J NEUROSCI, V15, P1724, DOI 10.1523/JNEUROSCI.15-03-01724.1995; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; Lohrke S, 2005, EUR J NEUROSCI, V22, P2708, DOI 10.1111/j.1460-9568.2005.04465.x; Lv P, 2014, J NEUROSCI, V34, P7383, DOI 10.1523/JNEUROSCI.5416-13.2014; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Maroto M, 2013, J NEUROCHEM, V125, P205, DOI 10.1111/jnc.12159; Marrs GS, 2012, J PHYSIOL-LONDON, V590, P2391, DOI 10.1113/jphysiol.2011.226886; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Mostafapour SP, 2000, J COMP NEUROL, V426, P561, DOI 10.1002/1096-9861(20001030)426:4<561::AID-CNE5>3.0.CO;2-G; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce E T, 1973, Prog Brain Res, V40, P53; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rosengauer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049503; Rubel EW, 2004, PLASTICITY AUDITORY, P9; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Satheesh SV, 2012, HUM MOL GENET, V21, P3896, DOI 10.1093/hmg/dds217; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Schierberl K, 2012, CHANNELS, V6, P11, DOI 10.4161/chan.19324; Schierberl K, 2011, J NEUROSCI, V31, P13562, DOI 10.1523/JNEUROSCI.2315-11.2011; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Schweigreiter R, 2006, BIOESSAYS, V28, P583, DOI 10.1002/bies.20419; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sterenborg JC, 2010, HEARING RES, V270, P119, DOI 10.1016/j.heares.2010.08.013; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tierney TS, 1997, J COMP NEUROL, V378, P295, DOI 10.1002/(SICI)1096-9861(19970210)378:2<295::AID-CNE11>3.0.CO;2-R; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Vigetti D, 2008, CELL PHYSIOL BIOCHEM, V22, P137, DOI 10.1159/000149791; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Willaredt MA, 2014, HEARING RES, V312, P9, DOI 10.1016/j.heares.2014.02.004; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; YAN Q, 1988, J NEUROSCI, V8, P3481; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P283, DOI 10.1038/mp.2014.181; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zirpel L, 1998, J NEUROPHYSIOL, V79, P2288, DOI 10.1152/jn.1998.79.5.2288; Zirpel L, 2000, J NEUROSCI, V20, P6267, DOI 10.1523/JNEUROSCI.20-16-06267.2000; Zucca S, 2010, J NEUROSCI, V30, P6776, DOI 10.1523/JNEUROSCI.5405-09.2010; Zuccotti A, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00020; Zuccotti A, 2011, TRENDS PHARMACOL SCI, V32, P366, DOI 10.1016/j.tips.2011.02.012	102	14	15	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23692	23710		10.1074/jbc.M115.672675	http://dx.doi.org/10.1074/jbc.M115.672675			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242732	Green Published, hybrid			2022-12-28	WOS:000361816500019
J	Stout, RF; Snapp, EL; Spray, DC				Stout, Randy F., Jr.; Snapp, Erik Lee; Spray, David C.			Connexin Type and Fluorescent Protein Fusion Tag Determine Structural Stability of Gap Junction Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LIVING CELLS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; MULTIPLE-SCLEROSIS; IMAGE-ANALYSIS; WHITE-MATTER; MOUSE MODEL; HELA-CELLS; CHANNELS	Gap junctions (GJs) are made up of plaques of laterally clustered intercellular channels and the membranes in which the channels are embedded. Arrangement of channels within a plaque determines subcellular distribution of connexin binding partners and sites of intercellular signaling. Here, we report the discovery that some connexin types form plaque structures with strikingly different degrees of fluidity in the arrangement of the GJ channel subcomponents of the GJ plaque. We uncovered this property of GJs by applying fluorescence recovery after photobleaching to GJs formed from connexins fused with fluorescent protein tags. We found that connexin 26 (Cx26) and Cx30 GJs readily diffuse within the plaque structures, whereas Cx43 GJs remain persistently immobile for more than 2 min after bleaching. The cytoplasmic C terminus of Cx43 was required for stability of Cx43 plaque arrangement. We provide evidence that these qualitative differences in GJ arrangement stability reflect endogenous characteristics, with the caveat that the sizes of the GJs examined were necessarily large for these measurements. We also uncovered an unrecognized effect of non-monomerized fluorescent protein on the dynamically arranged GJs and the organization of plaques composed of multiple connexin types. Together, these findings redefine our understanding of the GJ plaque structure and should be considered in future studies using fluorescent protein tags to probe dynamics of highly ordered protein complexes.	[Stout, Randy F., Jr.; Spray, David C.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Snapp, Erik Lee] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Spray, DC (corresponding author), Albert Einstein Coll Med, Dept Neurosci, 1410Pelham Pkwy S, Bronx, NY 10461 USA.	david.spray@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Stout, Randy/0000-0003-2725-306X; Spray, David/0000-0001-8368-5073	National Institutes of Health (NIH), NINDS [R01NS092466]; NIH, NIAMS [R01AR057139]; NIH, NICHD Program Grant Pilot Subgrant [P30HD07193]; NIH, NINDS, Institutional Training Grant [T32NS07439]; NIH, NIGMS [GM10599]; NIH, NCI, Cancer Center Support [P30DK041296]; NIH, NIDDK [P30DK041296]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD007193] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM010599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092466, T32NS007439] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH, NICHD Program Grant Pilot Subgrant; NIH, NINDS, Institutional Training Grant; NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCI, Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NINDS, Grant R01NS092466; NIH, NIAMS, Grant R01AR057139; NIH, NICHD Program Grant Pilot Subgrant P30HD07193; NIH, NINDS, Institutional Training Grant T32NS07439; NIH, NIGMS, Grant GM10599; and NIH, NCI, Cancer Center Support Grant P30CA013330. The Marion Bessin Liver Center Imaging and Cell Structure Core is supported by NIH, NIDDK, Grant P30DK041296. A provisional patent application has been filed covering part of the results described in this paper (E. L. S). Albert Einstein College Medicine and E. L. S. have licensed technology described in this manuscript to Lucigen Corp.	Abrams CK, 2012, BBA-BIOMEMBRANES, V1818, P2030, DOI 10.1016/j.bbamem.2011.08.015; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Baker SM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-15; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bejarano E, 2014, NAT CELL BIOL, V16, P401, DOI 10.1038/ncb2934; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Beyer EC, 2001, CELL COMMUN ADHES, V8, P199, DOI 10.3109/15419060109080723; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Clarner T, 2014, J MOL NEUROSCI, V53, P22, DOI 10.1007/s12031-013-0184-4; Cone AC, 2014, J BIOL CHEM, V289, P8781, DOI 10.1074/jbc.M113.533265; Costantini LM, 2013, DNA CELL BIOL, V32, P622, DOI 10.1089/dna.2013.2172; Cotrina ML, 2012, BRAIN RES, V1487, P61, DOI 10.1016/j.brainres.2012.07.003; Cui YW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-42; Das A, 2012, NEUROSCIENCE, V220, P237, DOI 10.1016/j.neuroscience.2012.06.002; Das Sarma J, 2005, CELL COMMUN ADHES, V12, P237, DOI 10.1080/15419060500511875; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; ECKERT R, 1993, PFLUG ARCH EUR J PHY, V424, P335, DOI 10.1007/BF00384361; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343; Falk MM, 2000, J CELL SCI, V113, P4109; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Fort AG, 2011, J BIOL CHEM, V286, P22875, DOI 10.1074/jbc.M111.219709; Gemel J, 2004, J CELL SCI, V117, P2469, DOI 10.1242/jcs.01084; Genoud C, 2015, NEUROSCIENCE, V291, P241, DOI 10.1016/j.neuroscience.2015.01.051; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Gong XQ, 2007, J BIOL CHEM, V282, P19190, DOI 10.1074/jbc.M609653200; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Koulakoff A, 2012, BBA-BIOMEMBRANES, V1818, P2048, DOI 10.1016/j.bbamem.2011.10.001; Koval M, 2014, FEBS LETT, V588, P1193, DOI 10.1016/j.febslet.2014.02.025; Kyle JW, 2008, J CELL SCI, V121, P2744, DOI 10.1242/jcs.032482; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Laird DW, 2001, MICROSC RES TECHNIQ, V52, P263, DOI 10.1002/1097-0029(20010201)52:3<263::AID-JEMT1012>3.0.CO;2-Q; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa C, 2012, BIOSCI BIOTECH BIOCH, V76, P388, DOI 10.1271/bbb.110677; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rash JE, 1997, J COMP NEUROL, V388, P265, DOI 10.1002/(SICI)1096-9861(19971117)388:2<265::AID-CNE6>3.0.CO;2-#; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schirmer L, 2014, ANN NEUROL, V75, P810, DOI 10.1002/ana.24168; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Snapp Erik Lee, 2011, Cold Spring Harb Protoc, V2011, P1366, DOI 10.1101/pdb.prot066563; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; TRAUB O, 1987, EUR J CELL BIOL, V43, P48; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Windoffer R, 2000, CELL TISSUE RES, V299, P347, DOI 10.1007/s004419900162; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	70	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23497	23514		10.1074/jbc.M115.659979	http://dx.doi.org/10.1074/jbc.M115.659979			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26265468	Green Published, hybrid			2022-12-28	WOS:000361816500003
J	Aizawa, M; Fukuda, M				Aizawa, Megumi; Fukuda, Mitsunori			Small GTPase Rab2B and Its Specific Binding Protein Golgi-associated Rab2B Interactor-like 4 (GARI-L4) Regulate Golgi Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTEROGRADE MELANOSOME TRANSPORT; COILED-COIL PROTEINS; ACTIVATING PROTEINS; MEMBRANE IDENTITY; DISTINCT; CELLS; COMPLEX; DOMAIN; SECRETION; FAMILY	Rab small GTPases are crucial regulators of the membrane traffic that maintains organelle identity and morphology. Several Rab isoforms are present in the Golgi, and it has been suggested that they regulate the compacted morphology of the Golgi in mammalian cells. However, the functional relationships among the Golgi-resident Rabs, e.g. whether they are functionally redundant or different, are poorly understood. In this study, we used specific siRNAs to perform genome-wide screening for human Rabs that are involved in Golgi morphology in HeLa-S3 cells. The results showed that knockdown of any one of the six Rab isoforms (Rab1A/1B/2A/2B/6B/8A) induced fragmentation of the Golgi in HeLa-S3 cells and that its phenotype was rescued by re-expression of their respective siRNA-resistant construct. We then performed systematic knockdown-rescue experiments in relation to each of the six Rabs. Interestingly, with the exception of the Rab8A knockdown, the Golgi fragmentation phenotype induced by knockdown of a single Rab isoform, e.g. Rab2B, was efficiently rescued by re-expression of its siRNA-resistant Rab alone, not by any of the other five Rabs, e.g. Rab2A, which is highly homologous to Rab2B, indicating that these Rab isoforms non-redundantly regulate Golgi morphology possibly through interaction with isoform-specific effector molecules. In addition, we identified Golgi-associated Rab2B interactor-like 4 (GARI-L4) as a novel Golgi-resident Rab2B-specific binding protein whose knockdown also induced fragmentation of the Golgi. Our findings suggest that the compacted Golgi morphology of mammalian cells is finely tuned by multiple sets of Rab (or Rab-effector complexes) that for the most part function independently.	[Aizawa, Megumi; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology of Japan [26111501, 15H04367, 15H01198]; Grants-in-Aid for Scientific Research [26111501] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 26111501, 15H04367, and 15H01198 from the Ministry of Education, Culture, Sports, and Technology of Japan (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Galea G, 2015, J CELL SCI, V128, P2339, DOI 10.1242/jcs.167973; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Ishibashi K, 2012, MOL BIOL CELL, V23, P3193, DOI 10.1091/mbc.E12-01-0010; Ishida M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08238; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; James P, 1996, GENETICS, V144, P1425; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Lapierre LA, 2003, EXP CELL RES, V290, P322, DOI 10.1016/S0014-4827(03)00340-9; Liu SJ, 2015, INT REV CEL MOL BIO, V315, P1, DOI 10.1016/bs.ircmb.2014.12.002; Majeed W, 2014, TRAFFIC, V15, P630, DOI 10.1111/tra.12167; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Papanikou E, 2014, CURR OPIN CELL BIOL, V29, P74, DOI 10.1016/j.ceb.2014.04.010; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Pfeffer SR, 2012, BIOCHEM SOC T, V40, P1373, DOI 10.1042/BST20120168; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rendon WO, 2013, HISTOCHEM CELL BIOL, V139, P671, DOI 10.1007/s00418-012-1059-4; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Wang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096242; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Zenner HL, 2011, J VIROL, V85, P8012, DOI 10.1128/JVI.00500-11; Zheng JY, 1998, J CELL SCI, V111, P1061	51	35	36	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22250	22261		10.1074/jbc.M115.669242	http://dx.doi.org/10.1074/jbc.M115.669242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26209634	Green Published, hybrid			2022-12-28	WOS:000360968500041
J	de Montellano, PRO				de Montellano, Paul R. Ortiz			Heme and I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE IRON LIGAND; H BOND ACTIVATION; MYCOBACTERIUM-TUBERCULOSIS; PROSTHETIC HEME; EPOXIDE HYDROLASE; CRYSTAL-STRUCTURE; DRUG ETHIONAMIDE; CYTOCHROME-P-450; OXIDATION; MECHANISM		Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 91158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 91158 USA.	ortiz@cgl.ucsf.edu						ATOR MA, 1987, J BIOL CHEM, V262, P1542; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; BORHAN B, 1995, J BIOL CHEM, V270, P26923, DOI 10.1074/jbc.270.45.26923; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Colas C, 2004, J BIOL CHEM, V279, P24131, DOI 10.1074/jbc.M401687200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COREY EJ, 1966, J AM CHEM SOC, V88, P4750, DOI 10.1021/ja00972a056; COREY EJ, 1967, J AM CHEM SOC, V89, P3362, DOI 10.1021/ja00989a055; de Montellano PRO, 2014, HANDB PORPHYR SCI, V30, P1; DEAN PDG, 1967, J BIOL CHEM, V242, P3014; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; DEMONTELLANO PRO, 1986, J AM CHEM SOC, V108, P5584; DEMONTELLANO PRO, 1987, J AM CHEM SOC, V109, P3415; DEMONTELLANO PRO, 1981, P NATL ACAD SCI-BIOL, V78, P1490; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P3330; DEMONTELLANO PRO, 1981, BIOCHEM J, V195, P761, DOI 10.1042/bj1950761; DEMONTELLANO PRO, 1981, J BIOL CHEM, V256, P4395; DEMONTELLANO PRO, 1981, BIOCHEM PHARMACOL, V30, P1138, DOI 10.1016/0006-2952(81)90455-X; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DESJARLAIS RL, 1990, P NATL ACAD SCI USA, V87, P6644, DOI 10.1073/pnas.87.17.6644; Evans JP, 2008, J BIOL CHEM, V283, P19530, DOI 10.1074/jbc.M709685200; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Garcia-Fernandez E, 2013, ENVIRON MICROBIOL, V15, P2342, DOI 10.1111/1462-2920.12108; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; He X, 2004, J BIOL CHEM, V279, P39479, DOI 10.1074/jbc.M406838200; Hoch U, 2001, J BIOL CHEM, V276, P11339, DOI 10.1074/jbc.M009969200; Huang LS, 2005, J AM CHEM SOC, V127, P5345, DOI 10.1021/ja050278x; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Jiang YY, 2009, J INORG BIOCHEM, V103, P316, DOI 10.1016/j.jinorgbio.2008.11.002; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; KOMIVES EA, 1987, J BIOL CHEM, V262, P9793; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; KUNZE KL, 1983, J AM CHEM SOC, V105, P1380, DOI 10.1021/ja00343a057; LACOURCIERE GM, 1993, J AM CHEM SOC, V115, P10466, DOI 10.1021/ja00075a115; LeBrun LA, 2002, J BIOL CHEM, V277, P12755, DOI 10.1074/jbc.M112155200; LEE JS, 1988, BIOCHEMISTRY-US, V27, P7703, DOI 10.1021/bi00420a020; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Liu Y, 1997, J BIOL CHEM, V272, P6909, DOI 10.1074/jbc.272.11.6909; LOEWEN PC, 1993, BIOCHEMISTRY-US, V32, P10159, DOI 10.1021/bi00089a035; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Newcomb M, 2005, BIOCHEM BIOPH RES CO, V338, P394, DOI 10.1016/j.bbrc.2005.08.208; Nishida CR, 2011, CHEM-BIOL INTERACT, V192, P21, DOI 10.1016/j.cbi.2010.09.015; Ortiz de Montellano P. R., 1997, ACCOUNTS CHEM RES, V20, P289; ORTIZDEMONTELLANO PR, 1978, BIOCHIM BIOPHYS ACTA, V544, P504, DOI 10.1016/0304-4165(78)90325-2; ORTIZDEMONTELLANO PR, 1980, MOL PHARMACOL, V18, P128; ORTIZDEMONTELLANO PR, 1979, P NATL ACAD SCI USA, V76, P746; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Peng DG, 2009, BIOCHEMISTRY-US, V48, P11231, DOI 10.1021/bi901216s; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; RAAG R, 1990, BIOCHEMISTRY-US, V29, P8119, DOI 10.1021/bi00487a019; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Sivaramakrishnan S, 2013, BIOSENSORS-BASEL, V3, P259, DOI 10.3390/bios3030259; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; STEARNS RA, 1985, J AM CHEM SOC, V107, P4081, DOI 10.1021/ja00299a056; STEARNS RA, 1985, J AM CHEM SOC, V107, P234, DOI 10.1021/ja00287a042; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; SWANSON BA, 1991, J BIOL CHEM, V266, P19258; Vannelli TA, 2002, J BIOL CHEM, V277, P12824, DOI 10.1074/jbc.M110751200; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; WILKS A, 1995, J AM CHEM SOC, V117, P2925, DOI 10.1021/ja00115a027; WILKS A, 1994, J BIOL CHEM, V269, P29553; WILKS A, 1993, J BIOL CHEM, V268, P22357; Wojciechowski G, 2005, J AM CHEM SOC, V127, P15871, DOI 10.1021/ja054084t; Wong FT, 2015, J AM CHEM SOC, V137, P86, DOI 10.1021/ja511374k; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w	78	2	3	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21833	21844		10.1074/jbc.X115.680066	http://dx.doi.org/10.1074/jbc.X115.680066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195628	Green Published, hybrid			2022-12-28	WOS:000360968500006
J	Wu, XZ; Gowda, NM; Gowda, DC				Wu, Xianzhu; Gowda, Nagaraj M.; Gowda, D. Channe			Phagosomal Acidification Prevents Macrophage Inflammatory Cytokine Production to Malaria, and Dendritic Cells Are the Major Source at the Early Stages of Infection IMPLICATION FOR MALARIA PROTECTIVE IMMUNITY DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM; PARASITES; ALPHA; DNA; ERYTHROCYTES; PHAGOCYTOSIS; GENERATION; EXPRESSION; HEMOZOIN; VACCINE	Inflammatory cytokines produced at the early stages of malaria infection contribute to shaping protective immunity and pathophysiology. To gain mechanistic insight into these processes, it is important to understand the cellular origin of cytokines because both cytokine input and cytokine-producing cells play key roles. Here, we determined cytokine responses by monocytes, macrophages, and dendritic cells (DCs) to purified Plasmodium falciparum and Plasmodium berghei ANKA, and by spleen macrophages and DCs from Plasmodium yoelii 17NXL-infected and P. berghei ANKA-infected mice. The results demonstrate that monocytes and macrophages do not produce inflammatory cytokines to malaria parasites and that DCs are the primary source early in infection, and DC subsets differentially produce cytokines. Importantly, blocking of phagosomal acidification by inhibiting vacuolar-type H+-ATPase enabled macrophages to elicit cytokine responses. Because cytokine responses to malaria parasites are mediated primarily through endosomal Toll-like receptors, our data indicate that the inability of macrophages to produce cytokines is due to the phagosomal acidification that disrupts endosomal ligand-receptor engagement. Macrophages efficiently produced cytokines to LPS upon simultaneously internalizing parasites and to heat-killed Escherichia coli, demonstrating that phagosomal acidification affects endosomal receptor-mediated, but not cell surface receptor-mediated, recognition of Toll-like receptor agonists. Enabling monocytes/macrophages to elicit immune responses to parasites by blocking endosomal acidification can be a novel strategy for the effective development of protective immunity to malaria. The results have important implications for enhancing the efficacy of a whole parasite-based malaria vaccine and for designing strategies for the development of protective immunity to pathogens that induce immune responses primarily through endosomal receptors.	[Wu, Xianzhu; Gowda, Nagaraj M.; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Hershey Med Ctr, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu		Gowda, Channe/0000-0002-6860-5108	National Institutes of Health from NIAID [R01 AI41139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139, R01AI104844] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI41139 from NIAID. The authors declare that they have no conflicts of interest with the contents of this article.	Antonelli LRV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004393; Baccarella A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-354; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; DENT G, 1994, AM J RESP CELL MOL, V10, P565, DOI 10.1165/ajrcmb.10.5.8179921; Doxsee CL, 2003, J IMMUNOL, V171, P1156, DOI 10.4049/jimmunol.171.3.1156; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Egan TJ, 2006, FEBS LETT, V580, P5105, DOI 10.1016/j.febslet.2006.08.043; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Good MF, 2011, TRENDS PARASITOL, V27, P335, DOI 10.1016/j.pt.2011.03.003; Gowda NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077604; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Haque A, 2014, J CLIN INVEST, V124, P2483, DOI 10.1172/JCI70698; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Marwick JA, 2008, BIOCHEM BIOPH RES CO, V377, P797, DOI 10.1016/j.bbrc.2008.10.065; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Seixas E, 2001, EUR J IMMUNOL, V31, P2970, DOI 10.1002/1521-4141(2001010)31:10&lt;2970::AID-IMMU2970&gt;3.0.CO;2-S; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stout-Delgado HW, 2007, J IMMUNOL, V179, P6561, DOI 10.4049/jimmunol.179.10.6561; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Targett GAT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-362; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Urban BC, 2005, CURR TOP MICROBIOL, V297, P25; Wu J, 2014, P NATL ACAD SCI USA, V111, pE511, DOI 10.1073/pnas.1316467111; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	53	17	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23135	23147		10.1074/jbc.M115.671065	http://dx.doi.org/10.1074/jbc.M115.671065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240140	Green Published, hybrid			2022-12-28	WOS:000361685500025
J	Arredouani, A; Ruas, M; Collins, SC; Parkesh, R; Clough, F; Pillinger, T; Coltart, G; Rietdorf, K; Royle, A; Johnson, P; Braun, M; Zhang, Q; Sones, W; Shimomura, K; Morgan, AJ; Lewis, AM; Chuang, KT; Tunn, R; Gadea, J; Teboul, L; Heister, PM; Tynan, PW; Bellomo, EA; Rutter, GA; Rorsman, P; Churchill, GC; Parrington, J; Galione, A				Arredouani, Abdelilah; Ruas, Margarida; Collins, Stephan C.; Parkesh, Raman; Clough, Frederick; Pillinger, Toby; Coltart, George; Rietdorf, Katja; Royle, Andrew; Johnson, Paul; Braun, Matthias; Zhang, Quan; Sones, William; Shimomura, Kenju; Morgan, Anthony J.; Lewis, Alexander M.; Chuang, Kai-Ting; Tunn, Ruth; Gadea, Joaquin; Teboul, Lydia; Heister, Paula M.; Tynan, Patricia W.; Bellomo, Elisa A.; Rutter, Guy A.; Rorsman, Patrik; Churchill, Grant C.; Parrington, John; Galione, Antony			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Endolysosomal Two-pore Channels Modulate Membrane Excitability and Stimulus-Secretion Coupling in Mouse Pancreatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; endosome; insulin; lysosome; nicotinic acid adenine dinucleotide phosphate (NAADP); TPC1; TPC2	CYCLIC ADP-RIBOSE; INDUCED INSULIN-SECRETION; CYTOSOLIC CA2+ CONCENTRATION; GLUCAGON-LIKE PEPTIDE-1; ENDOPLASMIC-RETICULUM; BETA-CELL; MOBILIZES CA2+; INTRACELLULAR MESSENGER; INOSITOL TRISPHOSPHATE; ELECTRICAL-ACTIVITY	Background: TPCs are regulated by NAADP and other factors. Results: NAADP-induced Ca2+ release from acidic stores evokes depolarizing currents in pancreatic cells. Inhibition of NAADP signaling or TPC knock out attenuates Ca2+ signaling and insulin secretion. Conclusion: NAADP-evoked Ca2+ release enhances cell excitability and insulin secretion in response to glucose or sulfonylureas. Significance: NAADP signaling pathways offer novel therapeutic targets for diabetes treatment. Pancreatic cells are electrically excitable and respond to elevated glucose concentrations with bursts of Ca2+ action potentials due to the activation of voltage-dependent Ca2+ channels (VDCCs), which leads to the exocytosis of insulin granules. We have examined the possible role of nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated Ca2+ release from intracellular stores during stimulus-secretion coupling in primary mouse pancreatic cells. NAADP-regulated Ca2+ release channels, likely two-pore channels (TPCs), have recently been shown to be a major mechanism for mobilizing Ca2+ from the endolysosomal system, resulting in localized Ca2+ signals. We show here that NAADP-mediated Ca2+ release from endolysosomal Ca2+ stores activates inward membrane currents and depolarizes the cell to the threshold for VDCC activation and thereby contributes to glucose-evoked depolarization of the membrane potential during stimulus-response coupling. Selective pharmacological inhibition of NAADP-evoked Ca2+ release or genetic ablation of endolysosomal TPC1 or TPC2 channels attenuates glucose- and sulfonylurea-induced membrane currents, depolarization, cytoplasmic Ca2+ signals, and insulin secretion. Our findings implicate NAADP-evoked Ca2+ release from acidic Ca2+ storage organelles in stimulus-secretion coupling in cells.	[Arredouani, Abdelilah; Ruas, Margarida; Parkesh, Raman; Clough, Frederick; Pillinger, Toby; Coltart, George; Rietdorf, Katja; Royle, Andrew; Morgan, Anthony J.; Lewis, Alexander M.; Chuang, Kai-Ting; Tunn, Ruth; Gadea, Joaquin; Heister, Paula M.; Tynan, Patricia W.; Churchill, Grant C.; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Teboul, Lydia] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England; [Johnson, Paul] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Shimomura, Kenju] Univ Oxford, Henry Wellcome Ctr Gene Funct, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Collins, Stephan C.; Bellomo, Elisa A.] Ctr Sci Gout & Alimentat, Equipe 5, F-21000 Dijon, France; [Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Diabet Endocrinol & Med, Sect Cell Biol & Funct Genom, London W12 0NN, England; [Braun, Matthias; Zhang, Quan; Sones, William; Rorsman, Patrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; MRC Harwell; University of Oxford; University of Oxford; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Imperial College London; University of Oxford	Arredouani, A (corresponding author), Qatar Fdn, Qatar Biomed Res Inst, POB 5825, Doha, Qatar.	aarredouani@qf.org.qa; john.parrington@pharm.ox.ac.uk; antony.galione@pharm.ox.ac.uk	arredouani, abdelilah/Q-9650-2019; collins, stephan c/P-4409-2016; Gadea, Joaquin/C-9731-2009; Rorsman, Patrik/A-4331-2016; Zhang, Quan/AAZ-1154-2021; Teboul, Lydia/P-2428-2019	collins, stephan c/0000-0002-1533-3380; Gadea, Joaquin/0000-0002-3474-7626; Rorsman, Patrik/0000-0001-7578-0767; Teboul, Lydia/0000-0002-2789-8637; Rutter, Guy/0000-0001-6360-0343; Pillinger, Toby/0000-0002-6074-2626; Coltart, George/0000-0001-7648-8741; Zhang, Quan/0000-0002-3626-4855; Heister, Paula/0000-0001-7207-869X; Ruas, Margarida/0000-0002-4872-7618; arredouani, abdelilah/0000-0002-5060-916X; Galione, Antony/0000-0002-4132-7646; Bellomo, Elisa/0000-0003-4823-2209	Wellcome Trust; Medical Research Council; Royal Society; BBSRC [BB/G008523/1] Funding Source: UKRI; MRC [MC_UP_1502/1, MR/K001981/1, G0901521] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; Medical Research Council [G0901521, MR/K001981/1, MC_UP_1502/1] Funding Source: researchfish; Wellcome Trust [102828/Z/13/Z, 095531/Z/11/Z] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from The Wellcome Trust, the Medical Research Council, and The Royal Society. The authors declare that they have no conflicts of interest with the contents of this article.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; AMMALA C, 1991, NATURE, V353, P849, DOI 10.1038/353849a0; Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; Arredouani A, 2002, AM J PHYSIOL-ENDOC M, V282, pE982, DOI 10.1152/ajpendo.00347.2001; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Ashcroft SJH, 2000, J MEMBRANE BIOL, V176, P187, DOI 10.1007/s002320001095; Best L, 2005, J PHYSIOL-LONDON, V568, P137, DOI 10.1113/jphysiol.2005.093740; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brixel LR, 2010, PFLUG ARCH EUR J PHY, V460, P69, DOI 10.1007/s00424-010-0835-z; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Cross SE, 2008, TRANSPLANTATION, V86, P907, DOI 10.1097/TP.0b013e318186df87; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; Davis LC, 2012, CURR BIOL, V22, P2331, DOI 10.1016/j.cub.2012.10.035; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dufer M, 2004, DIABETOLOGIA, V47, P488, DOI 10.1007/s00125-004-1348-0; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 1998, ENDOCRINOLOGY, V139, P993, DOI 10.1210/en.139.3.993; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hockey LN, 2015, J CELL SCI, V128, P232, DOI 10.1242/jcs.164152; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Ikehata F, 1998, J CLIN INVEST, V102, P395, DOI 10.1172/JCI1656; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Krishnan K, 2014, PANCREAS, V43, P597, DOI 10.1097/MPA.0000000000000027; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Leech CA, 1997, J BIOL CHEM, V272, P17987, DOI 10.1074/jbc.272.29.17987; Lin-Moshier Y, 2014, P NATL ACAD SCI USA, V111, P13087, DOI 10.1073/pnas.1407004111; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Marchant Jonathan S, 2013, Messenger (Los Angel), V2, P113; Marchant Jonathan S, 2012, Messenger (Los Angel), V1, P63; Marigo V, 2009, MOL CELL ENDOCRINOL, V299, P194, DOI 10.1016/j.mce.2008.11.011; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan AJ, 2014, BIOESSAYS, V36, P173, DOI 10.1002/bies.201300118; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Ogunbayo OA, 2015, J BIOL CHEM, V290, P1086, DOI 10.1074/jbc.M114.610493; Palade P, 2007, AM J PHYSIOL-CELL PH, V292, pC4, DOI 10.1152/ajpcell.00390.2006; Park DR, 2015, DIABETES, V64, P1224, DOI 10.2337/db14-0939; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pupilli C, 1999, DIABETES, V48, P2309, DOI 10.2337/diabetes.48.12.2309; Ronco V, 2015, CELL CALCIUM, V57, P89, DOI 10.1016/j.ceca.2015.01.001; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Ruas M, 2014, MOL CELL BIOL, V34, P3981, DOI 10.1128/MCB.00113-14; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Rutter GA, 2006, BIOCHEM SOC T, V34, P675, DOI 10.1042/BST0340675; Rybalchenko V, 2012, J BIOL CHEM, V287, P20407, DOI 10.1074/jbc.M112.359612; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Shawl AI, 2012, ISLETS, V4, P145, DOI 10.4161/isl.19490; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tsaih SW, 2014, GENETICS, V198, P17, DOI 10.1534/genetics.114.162982; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014; Zhao YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P719, DOI 10.1093/abbs/gms044; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	96	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21376	21392		10.1074/jbc.M115.671248	http://dx.doi.org/10.1074/jbc.M115.671248			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152717	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000360637600015
J	Chen, X; Hnida, K; Graewert, MA; Andersen, JT; Iversen, R; Tuukkanen, A; Svergun, D; Sollid, LM				Chen, Xi; Hnida, Kathrin; Graewert, Melissa Ann; Andersen, Jan Terje; Iversen, Rasmus; Tuukkanen, Anne; Svergun, Dmitri; Sollid, Ludvig M.			Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; epitope mapping; mutagenesis; small-angle x-ray scattering (SAXS); surface plasmon resonance (SPR); transglutaminase; celiac disease	TISSUE TRANSGLUTAMINASE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CELLS; RESOLUTION; DYNAMICS; EPITOPES; BINDING; SURFACE; SYSTEM	Background: Knowledge of how celiac disease autoantibodies recognize transglutaminase 2 (TG2) is limited. Results: The interaction between TG2 and a celiac disease epitope 1 anti-TG2 antibody was studied by small angle x-ray scattering and mutational analysis. Conclusion: TG2 residues Arg-116 and His-134 are part of epitope 1. Significance: The study gives insights into key aspects of celiac disease. Antibodies to the autoantigen transglutaminase 2 (TG2) are a hallmark of celiac disease. We have studied the interaction between TG2 and an anti-TG2 antibody (679-14-E06) derived from a single gut IgA plasma cell of a celiac disease patient. The antibody recognizes one of four identified epitopes targeted by antibodies of plasma cells of the disease lesion. The binding interface was identified by small angle x-ray scattering, ab initio and rigid body modeling using the known crystal structure of TG2 and the crystal structure of the antibody Fab fragment, which was solved at 2.4 angstrom resolution. The result was confirmed by testing binding of the antibody to TG2 mutants by ELISA and surface plasmon resonance. TG2 residues Arg-116 and His-134 were identified to be critical for binding of 679-14-E06 as well as other epitope 1 antibodies. In contrast, antibodies directed toward the two other main epitopes (epitopes 2 and 3) were not affected by these mutations. Molecular dynamics simulations suggest interactions of 679-14-E06 with the N-terminal domain of TG2 via the CDR2 and CDR3 loops of the heavy chain and the CDR2 loop of the light chain. In addition there were contacts of the framework 3 region of the heavy chain with the catalytic domain of TG2. The results provide an explanation for the biased usage of certain heavy and light chain gene segments by epitope 1-specific antibodies in celiac disease.	[Chen, Xi; Hnida, Kathrin; Andersen, Jan Terje; Iversen, Rasmus; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Chen, Xi; Hnida, Kathrin; Andersen, Jan Terje; Iversen, Rasmus; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Chen, Xi; Hnida, Kathrin; Andersen, Jan Terje; Iversen, Rasmus; Sollid, Ludvig M.] Oslo Univ Hosp, N-0372 Oslo, Norway; [Graewert, Melissa Ann; Tuukkanen, Anne; Svergun, Dmitri] European Mol Biol Lab, Hamburg Outstn, D-22607 Hamburg, Germany	University of Oslo; University of Oslo; University of Oslo; European Molecular Biology Laboratory (EMBL)	Sollid, LM (corresponding author), Oslo Univ Hosp, Rikshosp, Ctr Immune Regulat, N-0372 Oslo, Norway.	l.m.sollid@medisin.uio.no	Andersen, Jan Terje/AAB-6209-2020; Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Andersen, Jan Terje/0000-0003-1710-1628; Iversen, Rasmus/0000-0002-3292-1766	Regional Core Facility for Structural Biology and Bioinformatics at the South-Eastern Norway Regional Health Authority [2012085, 2015095]	Regional Core Facility for Structural Biology and Bioinformatics at the South-Eastern Norway Regional Health Authority	We thank Bjorg Simonsen for help with antibody production, Dr Bjorn Dalhus for access to crystallization screening at the Regional Core Facility for Structural Biology and Bioinformatics at the South-Eastern Norway Regional Health Authority (Grants 2012085 and 2015095) and Dr. Hyun Ho Park for providing the structure of TG2 with GTP (PDB code 4PYG) before public release. We also acknowledge the European Synchrotron Radiation Facility (ESRF) for providing beam time (MX-1587), and we thank the staff of ESRF for assistance and support in using beamline BM30.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mariani P, 2000, BIOPHYS J, V78, P3240, DOI 10.1016/S0006-3495(00)76860-3; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Raposo B, 2014, J EXP MED, V211, P405, DOI 10.1084/jem.20130968; Sarang Z, 2005, HEPATOLOGY, V42, P578, DOI 10.1002/hep.20812; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	48	23	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21365	21375		10.1074/jbc.M115.669895	http://dx.doi.org/10.1074/jbc.M115.669895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160175	Green Published, hybrid			2022-12-28	WOS:000360637600014
J	Solomou, A; Meur, G; Bellomo, E; Hodson, DJ; Tomas, A; Li, SM; Philippe, E; Herrera, PL; Magnan, C; Rutter, GA				Solomou, Antonia; Meur, Gargi; Bellomo, Elisa; Hodson, David J.; Tomas, Alejandra; Li, Stephanie Migrenne; Philippe, Erwann; Herrera, Pedro L.; Magnan, Christophe; Rutter, Guy A.			The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic alpha-Cells for Hypoglycemia-induced Glucagon Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; diabetes; glucagon; secretion; zinc	GENOME-WIDE ASSOCIATION; FREE CYTOSOLIC ZN2+; GLUCOSE-HOMEOSTASIS; INSULIN-RELEASE; RISK LOCI; ISLETS; EXPRESSION; MOUSE; MUTATIONS; RESPONSES	Background: The role of the type 2 diabetes risk gene SLC30A8, encoding ZnT8, in the control of glucagon secretion is not clearly established. Results: Inactivation of ZnT8 in a subset of -cells leads to increased glucagon secretion in vivo and in vitro. Conclusion: ZnT8 is involved in normal glucagon release. Significance:SLC30A8 diabetes risk alleles may influence glucagon secretion. SLC30A8 encodes a zinc transporter ZnT8 largely restricted to pancreatic islet - and -cells, and responsible for zinc accumulation into secretory granules. Although common SLC30A8 variants, believed to reduce ZnT8 activity, increase type 2 diabetes risk in humans, rare inactivating mutations are protective. To investigate the role of Slc30a8 in the control of glucagon secretion, Slc30a8 was inactivated selectively in -cells by crossing mice with alleles floxed at exon 1 to animals expressing Cre recombinase under the pre-proglucagon promoter. Further crossing to Rosa26:tdRFP mice, and sorting of RFP+: glucagon(+) cells from KO mice, revealed recombination in approximate to 30% of -cells, of which approximate to 50% were ZnT8-negative (14 +/- 1.8% of all -cells). Although glucose and insulin tolerance were normal, female ZnT8KO mice required lower glucose infusion rates during hypoglycemic clamps and displayed enhanced glucagon release (p < 0.001) versus WT mice. Correspondingly, islets isolated from ZnT8KO mice secreted more glucagon at 1 mm glucose, but not 17 mm glucose, than WT controls (n = 5; p = 0.008). Although the expression of other ZnT family members was unchanged, cytoplasmic (n = 4 mice per genotype; p < 0.0001) and granular (n = 3, p < 0.01) free Zn2+ levels were significantly lower in KO -cells versus control cells. In response to low glucose, the amplitude and frequency of intracellular Ca2+ increases were unchanged in -cells of ZnT8KO KO mice. ZnT8 is thus important in a subset of -cells for normal responses to hypoglycemia and acts via Ca2+-independent mechanisms.	[Solomou, Antonia; Meur, Gargi; Bellomo, Elisa; Hodson, David J.; Tomas, Alejandra; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, London W12 0NN, England; [Tomas, Alejandra] Univ Coll London, Inst Ophthalmol, Dept Cell Biol, Greater London EC1V 9EL, England; [Li, Stephanie Migrenne; Philippe, Erwann; Magnan, Christophe] Univ Paris 07, Unit Funct & Adapt Biol BFA EAC CNRS 7059, F-75013 Paris, France; [Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	Imperial College London; University of London; University College London; UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Hammersmith Hosp,Sect Cell Biol & Funct Genom, Dept Med,Div Diabet Endocrinol & Metab, Du Cane Rd, London W12 0NN, England.	g.rutter@imperial.ac.uk	magnan, christophe/AAJ-7622-2021	magnan, christophe/0000-0002-7044-2571; Rutter, Guy/0000-0001-6360-0343; Meur, Gargi/0000-0002-8466-2997; Bellomo, Elisa/0000-0003-4823-2209; Herrera Merino, Pedro Luis/0000-0003-0771-9504; Tomas, Alejandra/0000-0002-2290-8453; Hodson, David/0000-0002-8641-8568	Diabetes UK [BDA 11/0004409, BDA 11/0004210]; Wellcome Trust [081958/Z/07/Z, WT098424AIA]; Medical Research Council (MRC) [GO401641, MR/J0003042/1]; Innovative Medicines Initiative Joint Undertaking [155005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; MRC [MR/K001981/1] Funding Source: UKRI; Diabetes UK [11/0004409] Funding Source: researchfish; Medical Research Council [MR/K001981/1] Funding Source: researchfish	Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Diabetes UK (Ph.D. studentship BDA 11/0004409 and Project BDA 11/0004210), the Wellcome Trust (Programme 081958/Z/07/Z; Senior Investigator Award WT098424AIA), and the Medical Research Council (MRC) (Project GO401641; Programme MR/J0003042/1) (to G. A. R.). This work was also supported by the Innovative Medicines Initiative Joint Undertaking under Grant Agreement 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies. The authors declare that they have no conflicts of interest with the contents of this article.	Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Cox RD, 2011, DIS MODEL MECH, V4, P155, DOI 10.1242/dmm.000414; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; ELAYAT AA, 1995, J ANAT, V186, P629; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; GEELEN MJH, 1978, FEBS LETT, V90, P57, DOI 10.1016/0014-5793(78)80297-X; Gerber PA, 2014, DIABETOLOGIA, V57, P1635, DOI 10.1007/s00125-014-3266-0; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kim I, 2011, PHARMACOGENOMICS J, V11, P191, DOI 10.1038/tpj.2010.22; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Martinez-Sanchez A, 2015, MOL ENDOCRINOL, V29, P1067, DOI 10.1210/me.2015; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rutter GA, 2006, BIOCHEM SOC T, V34, P675, DOI 10.1042/BST0340675; Rutter GA, 2014, DIABETIC MED, V31, P1480, DOI 10.1111/dme.12579; Rutter GA, 2004, NEUROREPORT, V15, P79, DOI 10.1097/00001756-200401190-00016; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scully Tony, 2012, Nature, V485, pS2; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stalmans W., 1983, GLUCAGON 1, V66/1, P291; Sun G, 2015, MOL METAB, V4, P277, DOI 10.1016/j.molmet.2015.01.006; Taborsky GJ, 1998, DIABETES, V47, P995, DOI 10.2337/diabetes.47.7.995; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wideman RD, 2006, P NATL ACAD SCI USA, V103, P13468, DOI 10.1073/pnas.0600655103; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; WITTERS LA, 1979, AM J PHYSIOL, V237, pE23, DOI 10.1152/ajpendo.1979.237.1.E23; Woodroofe CC, 2004, CHEM BIOL, V11, P1659, DOI 10.1016/j.chembiol.2004.09.013; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	49	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21432	21442		10.1074/jbc.M115.645291	http://dx.doi.org/10.1074/jbc.M115.645291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178371	Green Published, hybrid			2022-12-28	WOS:000360637600020
J	Vanheule, V; Janssens, R; Boff, D; Kitic, N; Berghmans, N; Ronsse, I; Kungl, AJ; Amaral, FA; Teixeira, MM; Van Damme, J; Proost, P; Mortier, A				Vanheule, Vincent; Janssens, Rik; Boff, Daiane; Kitic, Nikola; Berghmans, Nele; Ronsse, Isabelle; Kungl, Andreas J.; Amaral, Flavio Almeida; Teixeira, Mauro Martins; Van Damme, Jo; Proost, Paul; Mortier, Anneleen			The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; glycosaminoglycan; inflammation; migration; neutrophil	IN-VIVO ACTIVITY; HEPARAN-SULFATE; POSTTRANSLATIONAL MODIFICATION; BIOLOGICAL-ACTIVITY; CHEMOKINE ACTIVITY; CXCR3 LIGANDS; ENDOTHELIAL-CELLS; C-TERMINUS; CYTOKINES; IDENTIFICATION	Background: Chemokines, such as CXCL8 and CXCL9, drive leukocyte migration to an inflammation site. Results: CXCL9(74-103), derived from CXCL9, lacks leukocyte-attracting activity but competes with CXCL8 for GAG binding and inhibits neutrophil migration in two murine acute inflammation models. Conclusion: Through inhibition of chemokine-GAG interaction, CXCL9(74-103) blocks neutrophil migration. Significance: CXCL9(74-103) may be a lead molecule for development of anti-inflammatory agents. The ELR-CXC chemokine CXCL9 is characterized by a long, highly positively charged COOH-terminal region, absent in most other chemokines. Several natural leukocyte- and fibroblast-derived COOH-terminally truncated CXCL9 forms missing up to 30 amino acids were identified. To investigate the role of the COOH-terminal region of CXCL9, several COOH-terminal peptides were chemically synthesized. These peptides display high affinity for glycosaminoglycans (GAGs) and compete with functional intact chemokines for GAG binding, the longest peptide (CXCL9(74-103)) being the most potent. The COOH-terminal peptide CXCL9(74-103) does not signal through or act as an antagonist for CXCR3, the G protein-coupled CXCL9 receptor, and does not influence neutrophil chemotactic activity of CXCL8 in vitro. Based on the GAG binding data, an anti-inflammatory role for CXCL9(74-103) was further evidenced in vivo. Simultaneous intravenous injection of CXCL9(74-103) with CXCL8 injection in the joint diminished CXCL8-induced neutrophil extravasation. Analogously, monosodium urate crystal-induced neutrophil migration to the tibiofemural articulation, a murine model of gout, is highly reduced by intravenous injection of CXCL9(74-103). These data show that chemokine-derived peptides with high affinity for GAGs may be used as anti-inflammatory peptides; by competing with active chemokines for binding and immobilization on GAGs, these peptides may lower chemokine presentation on the endothelium and disrupt the generation of a chemokine gradient, thereby preventing a chemokine from properly performing its chemotactic function. The CXCL9 peptide may serve as a lead molecule for further development of inhibitors of inflammation based on interference with chemokine-GAG interactions.	[Vanheule, Vincent; Janssens, Rik; Berghmans, Nele; Ronsse, Isabelle; Van Damme, Jo; Proost, Paul; Mortier, Anneleen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Mol Immunol, B-3000 Louvain, Belgium; [Boff, Daiane; Amaral, Flavio Almeida; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil; [Kitic, Nikola; Kungl, Andreas J.] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Chem, A-8010 Graz, Austria	KU Leuven; Universidade Federal de Minas Gerais; University of Graz	Proost, P (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Mol Immunol, Minderbroedersstr 10, B-3000 Louvain, Belgium.	paul.proost@rega.kuleuven.be	Amaral, Flávio Almeida/C-3768-2018; Boff, Daiane/AAU-2149-2021; Proost, Paul/V-3052-2017; Janssens, Rik/S-7744-2017; Teixeira, Mauro M/A-4587-2008	Amaral, Flávio Almeida/0000-0002-1695-0612; Proost, Paul/0000-0002-0133-5545; Janssens, Rik/0000-0003-1428-3921; Teixeira, Mauro M/0000-0002-6944-3008; Boff, Daiane/0000-0001-8127-916X; Mortier, Anneleen/0000-0002-9662-674X; Kungl, Andreas/0000-0003-3362-797X; Van Damme, Jo/0000-0002-6707-1167	Interuniversity Attraction Poles Programme (I.A.P. Project) [7/40]; Fund for Scientific Research of Flanders (FWO-Vlaanderen Projects) [G.0764.14, G.0773.13, G.0D66.13]; Brazilian National Council for Scientific and Technological Development (CNPq); Concerted Research Actions of the Regional Government of Flanders [GOA/12/017]; Hercules foundation of the Flemish government [AKUL/11/31]	Interuniversity Attraction Poles Programme (I.A.P. Project); Fund for Scientific Research of Flanders (FWO-Vlaanderen Projects)(FWO); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Concerted Research Actions of the Regional Government of Flanders; Hercules foundation of the Flemish government	This research was supported by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (I.A.P. Project 7/40), the Fund for Scientific Research of Flanders (FWO-Vlaanderen Projects G.0764.14, G.0773.13, and G.0D66.13), the Brazilian National Council for Scientific and Technological Development (CNPq), and the Concerted Research Actions of the Regional Government of Flanders (GOA/12/017). The Hercules foundation of the Flemish government provided funding to purchase LC-MS/MS equipment (Contract AKUL/11/31). The authors declare that they have no conflicts of interest with the contents of this article.	Adage T, 2012, BRIT J PHARMACOL, V167, P1195, DOI 10.1111/j.1476-5381.2012.02089.x; Alcami A, 2010, CURR OPIN IMMUNOL, V22, P482, DOI 10.1016/j.coi.2010.06.004; Ali S, 2000, J BIOL CHEM, V275, P11721, DOI 10.1074/jbc.275.16.11721; Allegretti M, 2012, IMMUNOL LETT, V145, P68, DOI 10.1016/j.imlet.2012.04.003; Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; BRANDT E, 1993, MOL IMMUNOL, V30, P979, DOI 10.1016/0161-5890(93)90123-S; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Denis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034199; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; EHLERT JE, 1995, J BIOL CHEM, V270, P6338, DOI 10.1074/jbc.270.11.6338; Ehlert JE, 1998, J IMMUNOL, V161, P4975; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Falsone A., 2013, BIOSCIENCE REP, P33; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Gerlza T, 2014, MOLECULES, V19, P10618, DOI 10.3390/molecules190710618; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hensbergen PJ, 2004, J BIOL CHEM, V279, P13402, DOI 10.1074/jbc.M312814200; Hensbergen PJ, 2001, EUR J BIOCHEM, V268, P4992, DOI 10.1046/j.0014-2956.2001.02433.x; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Keeley EC, 2011, EXP CELL RES, V317, P685, DOI 10.1016/j.yexcr.2010.10.020; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Kumar A.V., 2015, CURR PROTEIN PEPT SC, V16, P77; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Liehn EA, 2010, J AM COLL CARDIOL, V56, P1847, DOI 10.1016/j.jacc.2010.04.066; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Moelants EAV, 2014, INFECT IMMUN, V82, P2511, DOI 10.1128/IAI.01624-14; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P402, DOI 10.1038/icb.2013.16; Mortier A, 2012, IMMUNOL LETT, V145, P2, DOI 10.1016/j.imlet.2012.04.015; Mortier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023913; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nesmelova IV, 2005, J BIOL CHEM, V280, P4948, DOI 10.1074/jbc.M405364200; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Piccinini AM, 2010, J BIOL CHEM, V285, P8782, DOI 10.1074/jbc.M109.043299; Proost P, 2004, J LEUKOCYTE BIOL, V75, P777, DOI 10.1189/jlb.1003524; Proost P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1997; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schuh JM, 2003, CYTOKINE GROWTH F R, V14, P503, DOI 10.1016/S1359-6101(03)00057-1; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Szekanecz Zoltan, 2010, Front Biosci (Schol Ed), V2, P153; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Van Raemdonck K, 2014, ONCOTARGET, V5, P10916; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456	72	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21292	21304		10.1074/jbc.M115.649855	http://dx.doi.org/10.1074/jbc.M115.649855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26183778	Green Published, hybrid			2022-12-28	WOS:000360637600009
J	Latge, C; Cabral, KMS; de Oliveira, GAP; Raymundo, DP; Freitas, JA; Johanson, L; Romao, LF; Palhano, FL; Herrmann, T; Almeida, MS; Foguel, D				Latge, Cristiane; Cabral, Katia M. S.; de Oliveira, Guilherme A. P.; Raymundo, Diana P.; Freitas, Julia A.; Johanson, Laizes; Romao, Luciana F.; Palhano, Fernando L.; Herrmann, Torsten; Almeida, Marcius S.; Foguel, Debora			The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against alpha-Synuclein Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; PRACTICAL ASPECTS; CDNF PROTECTS; FACTOR MANF; RAT MODEL; RELAXATION; AUTOPHAGY; NEURONS; AGGREGATION; BINDING	Cerebral dopamine neurotrophic factor (CDNF) is a promising therapeutic agent for Parkinson disease. As such, there has been great interest in studying its mode of action, which remains unknown. The three-dimensional crystal structure of the N terminus (residues 9-107) of CDNF has been determined, but there have been no published structural studies on the full-length protein due to proteolysis of its C-terminal domain, which is considered intrinsically disordered. An improved purification protocol enabled us to obtain active full-length CDNF and to determine its three-dimensional structure in solution. CDNF contains two well folded domains (residues 10-100 and 111-157) that are linked by a loop of intermediate flexibility. We identified two surface patches on the N-terminal domain that were characterized by increased conformational dynamics that should allow them to embrace active sites. One of these patches is formed by residues Ser-33, Leu-34, Ala-66, Lys-68, Ile-69, Leu-70, Ser-71, and Glu-72. The other includes a flexibly disordered N-terminal tail (residues 1-9), followed by the N-terminal portion of alpha-helix 1 (residues Cys-11, Glu-12, Val-13, Lys-15, and Glu-16) and residue Glu-88. The surface of the C-terminal domain contains two conserved active sites, which have previously been identified in mesencephalic astrocyte-derived neurotrophic factor, a CDNF paralog, which corresponds to its intracellular mode of action. We also showed that CDNF was able to protect dopaminergic neurons against injury caused by alpha-synuclein oligomers. This advises its use against physiological damages caused by alpha-synuclein oligomers, as observed in Parkinson disease and several other neurodegenerative diseases.	[Latge, Cristiane; Cabral, Katia M. S.; de Oliveira, Guilherme A. P.; Raymundo, Diana P.; Freitas, Julia A.; Johanson, Laizes; Palhano, Fernando L.; Almeida, Marcius S.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Romao, Luciana F.] Univ Fed Rio de Janeiro, UFRJ Polo Xerem, BR-25245390 Rio De Janeiro, Brazil; [Herrmann, Torsten] UMR 5280 CNRS, Inst Sci Analyt, F-69100 Villeurbanne, France; [Almeida, Marcius S.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem CENABIO, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universidade Federal do Rio de Janeiro	Almeida, MS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.	msalmeida@bioqmed.ufrj.br; foguel@bioqmed.ufrj.br	de Oliveira, Guilherme A. P./O-1192-2013; Palhano, Fernando/AAB-3144-2021; Herrmann, Torsten/B-9978-2008	de Oliveira, Guilherme A. P./0000-0002-0063-5888; Palhano, Fernando/0000-0001-5336-632X; almeida, marcius/0000-0003-4921-8185; Herrmann, Torsten/0000-0003-2115-4781; Foguel, Debora/0000-0001-7312-7115	European Union FP7 IRSES Grant [247546]	European Union FP7 IRSES Grant	The 1 GHz NMR spectra were collected at the RALF-NMR large scale facility for high-field NMR in Lyon was supported by proposal European Union FP7 IRSES Grant 247546 (WW-NMR). SAXS data were collected at the Brazilian Synchrotron Light Laboratory (LNLS) under proposal SAXS1-14200. We thank Dr. Luciana Ferreira Romao for the primary cultures of dopaminergic neurons. The Centro Nacional de Ressonancia Magnetica Nuclear Jiri Jonas (CNRMN) is gratefully acknowledged for providing access to NMR instrumentation.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Baba M, 1998, AM J PATHOL, V152, P879; Back S, 2013, BRAIN BEHAV, V3, P75, DOI 10.1002/brb3.117; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Bordner AJ, 2005, PROTEINS, V60, P353, DOI 10.1002/prot.20433; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chambraud B, 2010, P NATL ACAD SCI USA, V107, P2658, DOI 10.1073/pnas.0914957107; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cordero-Llana O, 2015, MOL THER, V23, P244, DOI 10.1038/mt.2014.206; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Guerry P, 2012, METHODS MOL BIOL, V831, P429, DOI 10.1007/978-1-61779-480-3_22; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Latge C, 2013, BIOMOL NMR ASSIGN, V7, P101, DOI 10.1007/s12104-012-9388-8; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lin DW, 2000, ACTA CRYSTALLOGR D, V56, P828, DOI 10.1107/S0907444900005655; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; LINDSAY RM, 1993, EXP NEUROL, V124, P103, DOI 10.1006/exnr.1993.1181; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; Mei JM, 2014, NEUROL SCI, V35, P1275, DOI 10.1007/s10072-014-1700-1; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nadella R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0209-0; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; PENG JW, 1994, METHOD ENZYMOL, V239, P563; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ren XM, 2013, EXP NEUROL, V248, P148, DOI 10.1016/j.expneurol.2013.06.002; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Serrano P, 2012, J BIOMOL NMR, V53, P341, DOI 10.1007/s10858-012-9645-2; Shaltiel-Karyo R, 2013, J BIOL CHEM, V288, P17579, DOI 10.1074/jbc.M112.434787; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Sun ZP, 2011, J NEUROCHEM, V117, P121, DOI 10.1111/j.1471-4159.2011.07179.x; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; VOLD RL, 1968, J CHEM PHYS, V48, P3831, DOI 10.1063/1.1669699; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voutilainen MH, 2011, EXP NEUROL, V228, P99, DOI 10.1016/j.expneurol.2010.12.013; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	70	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20527	20540		10.1074/jbc.M115.662254	http://dx.doi.org/10.1074/jbc.M115.662254			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149686	hybrid, Green Published			2022-12-28	WOS:000359608900049
J	Bittner, LM; Westphal, K; Narberhaus, F				Bittner, Lisa-Marie; Westphal, Kai; Narberhaus, Franz			Conditional Proteolysis of the Membrane Protein YfgM by the FtsH Protease Depends on a Novel N-terminal Degron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; TRANSCRIPTION FACTOR SIGMA(32); AMINO-ACID STARVATION; ESCHERICHIA-COLI FTSH; INORGANIC POLYPHOSPHATE; TURNOVER ELEMENT; REGULATED DEGRADATION; LENGTH RECOGNITION; STRINGENT RESPONSE; RCS PHOSPHORELAY	Regulated proteolysis efficiently and rapidly adapts the bacterial proteome to changing environmental conditions. Many protease substrates contain recognition motifs, so-called degrons, that direct them to the appropriate protease. Here we describe an entirely new degron identified in the cytoplasmic N-terminal end of the membrane-anchored protein YfgM of Escherichia coli. YfgM is stable during exponential growth and degraded in stationary phase by the essential FtsH protease. The alarmone (p) ppGpp, but not the previously described YfgM interactors RcsB and PpiD, influence YfgM degradation. By scanning mutagenesis, we define individual amino acids responsible for turnover of YfgM and find that the degron does not at all comply with the known N-end rule pathway. The YfgM degron is a distinct module that facilitates FtsH-mediated degradation when fused to the N terminus of another monotopic membrane protein but not to that of a cytoplasmic protein. Several lines of evidence suggest that stress-induced degradation of YfgM relieves the response regulator RcsB and thereby permits cellular protection by the Rcs phosphorelay system. On the basis of these and other results in the literature, we propose a model for how the membrane-spanning YfgM protein serves as connector between the stress responses in the periplasm and cytoplasm.	[Bittner, Lisa-Marie; Westphal, Kai; Narberhaus, Franz] Ruhr Univ Bochum, Microbial Biol, D-44801 Bochum, Germany	Ruhr University Bochum	Narberhaus, F (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, Fak Biol & Biotechnol, Univ Str 150, D-44801 Bochum, Germany.	franz.narberhaus@rub.de		Narberhaus, Franz/0000-0002-8552-5310	German Research Foundation grant in the Collaborative Research Center [SFB642]	German Research Foundation grant in the Collaborative Research Center	This work was supported by German Research Foundation grant in the Collaborative Research Center SFB642 "GTP- and ATP-dependent membrane processes" (to F. N.). The authors declare that they have no conflicts of interest with the contents of this article.	AIBA H, 1981, J BIOL CHEM, V256, P1905; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Carballes F, 1999, MOL MICROBIOL, V34, P442, DOI 10.1046/j.1365-2958.1999.01605.x; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; Chiba S, 2000, EMBO REP, V1, P47, DOI 10.1093/embo-reports/kvd005; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Davalos-Garcia M, 2001, J BACTERIOL, V183, P5870, DOI 10.1128/JB.183.20.5870-5876.2001; Dougan DA, 2010, MOL MICROBIOL, V76, P545, DOI 10.1111/j.1365-2958.2010.07120.x; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gotzke H, 2015, MOL CELL PROTEOMICS, V14, P216, DOI 10.1074/mcp.M114.043216; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Gur Eyal, 2013, Subcell Biochem, V66, P3, DOI 10.1007/978-94-007-5940-4_1; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; HENGGEARONIS R, 1993, J BACTERIOL, V175, P259, DOI 10.1128/JB.175.1.259-265.1993; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Horikoshi M, 2004, J BACTERIOL, V186, P7474, DOI 10.1128/JB.186.22.7474-7480.2004; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Jain V, 2006, J MICROBIOL, V44, P1; Johnson MD, 2011, J BACTERIOL, V193, P3653, DOI 10.1128/JB.05040-11; Karimova G, 2012, J BACTERIOL, V194, P5576, DOI 10.1128/JB.00774-12; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kuroda A, 2006, BIOSCI BIOTECH BIOCH, V70, P325, DOI 10.1271/bbb.70.325; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Langklotz S, 2011, MOL MICROBIOL, V80, P1313, DOI 10.1111/j.1365-2958.2011.07646.x; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Obrist M, 2009, FEMS MICROBIOL LETT, V290, P199, DOI 10.1111/j.1574-6968.2008.01423.x; Obrist M, 2007, MICROBIOL-SGM, V153, P2560, DOI 10.1099/mic.0.2007/007047-0; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Peterson CN, 2006, J BACTERIOL, V188, P3175, DOI 10.1128/JB.188.9.3175-3181.2006; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Sachelaru I, 2014, J BIOL CHEM, V289, P21706, DOI 10.1074/jbc.M114.577916; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schakermann M, 2013, J BACTERIOL, V195, P1912, DOI 10.1128/JB.02134-12; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Shotland Y, 2000, J MOL BIOL, V299, P953, DOI 10.1006/jmbi.2000.3767; Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Slominska M, 1999, VIROLOGY, V262, P431, DOI 10.1006/viro.1999.9907; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Westphal K, 2012, J BIOL CHEM, V287, P42962, DOI 10.1074/jbc.M112.388470; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; Wu J, 2009, J CELL PHYSIOL, V220, P297, DOI 10.1002/jcp.21797; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	83	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19367	19378		10.1074/jbc.M115.648550	http://dx.doi.org/10.1074/jbc.M115.648550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26092727	Green Published, hybrid			2022-12-28	WOS:000358781100047
J	Chumjan, W; Winterhalter, M; Schulte, A; Benz, R; Suginta, W				Chumjan, Watcharin; Winterhalter, Mathias; Schulte, Albert; Benz, Roland; Suginta, Wipa			Chitoporin from the Marine Bacterium Vibrio harveyi PROBING THE ESSENTIAL ROLES OF TRP136 AT THE SURFACE OF THE CONSTRICTION ZONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BASS LATES-CALCARIFER; ESCHERICHIA-COLI; OUTER-MEMBRANE; ION-TRANSPORT; CURRENT NOISE; PSEUDOMONAS-AERUGINOSA; MALTOPORIN CHANNELS; KLEBSIELLA-OXYTOCA; CHITIN UTILIZATION	VhChiP is a sugar-specific porin present in the outer membrane of the marine bacterium Vibrio harveyi. VhChiP is responsible for the uptake of chitin oligosaccharides, with particular selectivity for chitohexaose. In this study, we employed electrophysiological and biochemical approaches to demonstrate that Trp(136), located at the mouth of the VhChiP pore, plays an essential role in controlling the channel's ion conductivity, chitin affinity, and permeability. Kinetic analysis of sugar translocation obtained from single channel recordings indicated that the Trp(136) mutations W136A, W136D, W136R, and W136F considerably reduce the binding affinity of the protein channel for its best substrate, chitohexaose. Liposome swelling assays confirmed that the Trp(136) mutations decreased the rate of bulk chitohexaose permeation through the VhChiP channel. Notably, all of the mutants show increases in the off-rate for chitohexaose of up to 20-fold compared with that of the native channel. Furthermore, the cation/anion permeability ratio P-c/P-a is decreased in the W136R mutant and increased in the W136D mutant. This demonstrates that the negatively charged surface at the interior of the protein lumen preferentially attracts cationic species, leading to the cation selectivity of this trimeric channel.	[Chumjan, Watcharin; Schulte, Albert; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Chumjan, Watcharin; Suginta, Wipa] Suranaree Univ Technol, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Schulte, Albert] Suranaree Univ Technol, Sch Chem, Nakhon Ratchasima 30000, Thailand; [Winterhalter, Mathias; Benz, Roland] Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology; Jacobs University	Winterhalter, M (corresponding author), Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany.	m.winterhalter@jacobs-university.de		Winterhalter, Mathias/0000-0002-1604-3318	CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand) [60/2550]; Thailand Research Fund Basic Research Grant [BRG578001]; Suranaree University of Technology [SUT1-102-57-36-18, SUT1-102-56-12-30]	CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand); Thailand Research Fund Basic Research Grant(Thailand Research Fund (TRF)); Suranaree University of Technology	Supported by CHE-PhD-SW Scholarship Contract 60/2550 from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand). This author's 15-month research visit in Germany was supported through the Deutscher Akademischer Austausch Dienst.; Supported by Thailand Research Fund Basic Research Grant BRG578001 and Suranaree University of Technology Grants SUT1-102-57-36-18 and SUT1-102-56-12-30.	Abraham TJ, 2004, AQUACULTURE, V232, P81, DOI 10.1016/S0044-8486(03)00485-X; Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Aunkham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095918; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BENZ R, 1987, J GEN PHYSIOL, V89, P275, DOI 10.1085/jgp.89.2.275; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; Haldar S, 2010, MICROBIOL RES, V165, P639, DOI 10.1016/j.micres.2009.12.001; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Jung B. O., 2008, VIBRIOS MACROMOL RES, DOI [10.1007/BF03218953, DOI 10.1007/BF03218953]; Kim BH, 2002, J MEMBRANE BIOL, V187, P239, DOI 10.1007/s00232-001-0167-1; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Mahendran KR, 2009, EUR BIOPHYS J BIOPHY, V38, P1141, DOI 10.1007/s00249-009-0495-0; Neves P, 2005, BIOPHYS CHEM, V113, P123, DOI 10.1016/j.bpc.2004.08.004; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Orlik F, 2003, BIOPHYS J, V85, P876, DOI 10.1016/S0006-3495(03)74527-5; Orlik F, 2002, BIOPHYS J, V82, P2466, DOI 10.1016/S0006-3495(02)75589-6; Pajatsch M, 1999, J BIOL CHEM, V274, P25159, DOI 10.1074/jbc.274.35.25159; Pezeshki S, 2009, BIOPHYS J, V97, P1898, DOI 10.1016/j.bpj.2009.07.018; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Ransangan J, 2009, J AQUAT ANIM HEALTH, V21, P150, DOI 10.1577/H09-002.1; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schulte A, 2009, J MEMBRANE BIOL, V230, P101, DOI 10.1007/s00232-009-9194-0; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Srivastava DB, 2006, J STRUCT BIOL, V156, P505, DOI 10.1016/j.jsb.2006.05.008; Suginta W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.238102; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Tendencia EA, 2002, AQUAC RES, V33, P455, DOI 10.1046/j.1365-2109.2002.00688.x; Ulmke C, 1999, J BACTERIOL, V181, P1920, DOI 10.1128/JB.181.6.1920-1923.1999; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; World Health Organization, 1995, CDRGPV951 WHO; WYLIE JL, 1993, J BIOENERG BIOMEMBR, V25, P547, DOI 10.1007/BF01108411; Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1	43	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19184	19196		10.1074/jbc.M115.660530	http://dx.doi.org/10.1074/jbc.M115.660530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082491	Green Published, hybrid			2022-12-28	WOS:000358781100033
J	Ibeawuchi, SRC; Agbor, LN; Quelle, FW; Sigmund, CD				Ibeawuchi, Stella-Rita C.; Agbor, Larry N.; Quelle, Frederick W.; Sigmund, Curt D.			Hypertension-causing Mutations in Cullin3 Protein Impair RhoA Protein Ubiquitination and Augment the Association with Substrate Adaptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-CAUSING MUTATIONS; VASCULAR SMOOTH-MUSCLE; KELCH-LIKE 3; LIGASE COMPLEX; DEGRADATION; KINASE; NEDD8; WNK4; MECHANISM; SUBUNIT	Cullin/Ring ubiquitin ligases regulate protein turnover by promoting the ubiquitination of substrate proteins, targeting them for proteasomal degradation. It has been shown previously that mutations in Cullin3 (Cul3) causing deletion of 57 amino acids encoded by exon 9 (Cul3 Delta 9) cause hypertension. Moreover, RhoA activity contributes to vascular constriction and hypertension. We show that ubiquitination and degradation of RhoA is dependent on Cul3 in HEK293T cells in which Cul3 expression is ablated by either siRNA or by CRISPR-Cas9 genome editing. The latter was used to generate a Cul3-null cell line (HEK293T(Cul3KO)). When expressed in these cells, Cul3 Delta 9 supported reduced ubiquitin ligase activity toward RhoA compared with equivalent levels of wild-type Cul3 (Cul3WT). Consistent with its reduced activity, binding of Cul3 Delta 9 to the E3 ubiquitin ligase Rbx1 and neddylation of Cul3 Delta 9 were impaired significantly compared with Cul3WT. Conversely, Cul3 Delta 9 bound to substrate adaptor proteins more efficiently than Cul3WT. Cul3 Delta 9 also forms unstable dimers with Cul3WT, disrupting dimers of Cul3WT complexes that are required for efficient ubiquitination of some substrates. Indeed, coexpression of Cul3WT and Cul3 Delta 9 in HEK293T(Cul3KO) cells resulted in a decrease in the active form of Cul3WT. We conclude that Cul3 Delta 9-associated ubiquitin ligase activity toward RhoA is impaired and suggest that Cul3 Delta 9 mutations may act dominantly by sequestering substrate adaptors and disrupting Cul3WT complexes.	[Ibeawuchi, Stella-Rita C.; Agbor, Larry N.; Quelle, Frederick W.; Sigmund, Curt D.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.	curt-sigmund@uiowa.edu	Regan, Clinton/E-6250-2012; Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921; Quelle, Frederick/0000-0002-1184-6170	National Institutes of Health [HL048058, HL062984, HL084207]; American Heart Association [14PRE18420033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048058, P01HL084207, P01HL062984, R01HL125603, R37HL048058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL048058, HL062984, and HL084207 (to C. D. S.). This work was also supported by American Heart Association Grant 14PRE18420033 (to S. R. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Choo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041350; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Friedman AD, 2003, J BIOL CHEM, V278, P26851, DOI 10.1074/jbc.M210039200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; McCormick JA, 2014, J CLIN INVEST, V124, P4723, DOI 10.1172/JCI76126; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Oberg EA, 2012, J BIOL CHEM, V287, P43378, DOI 10.1074/jbc.M112.420281; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wu GJ, 2013, FEBS LETT, V587, P1717, DOI 10.1016/j.febslet.2013.04.032; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	42	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19208	19217		10.1074/jbc.M115.645358	http://dx.doi.org/10.1074/jbc.M115.645358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26100637	Green Published, hybrid			2022-12-28	WOS:000358781100035
J	Lei, LL; West, J; Yan, ZJ; Gao, XL; Fang, P; Dennis, JH; Gnatovskiy, L; Wang, WD; Kingston, RE; Wang, Z				Lei, Lenglam; West, Jason; Yan, Zhijiang; Gao, Xiaolin; Fang, Peng; Dennis, Jonathan H.; Gnatovskiy, Leonid; Wang, Weidong; Kingston, Robert E.; Wang, Zhong			BAF250a Protein Regulates Nucleosome Occupancy and Histone Modifications in Priming Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTIONAL NETWORK; SELF-RENEWAL; PLURIPOTENCY; GENOME; ESBAF; PROMOTERS; COMPONENT; CLUSTERS; REGIONS	The unique chromatin signature of ES cells is fundamental to the pluripotency and differentiation of ES cells. One key feature is the poised chromatin state of master developmental genes that are transcriptionally repressed in ES cells but ready to be activated in response to differentiation signals. Poised chromatin in ES cells contains both H3 Lys-4 trimethylation (H3K4me3) and H3 Lys-27 trimethylation (H3K27me3) methylation, indicating activating and repressing potential. However, the contribution of non-covalent chromatin structure to the poised state is not well understood. To address whether remodeling of nucleosomes is important to the poised state, we characterized the function of BAF250a, a key regulatory subunit of the ES cell ATP-dependent Brahma-associated factor (BAF) chromatin remodeling complex (esBAF). Acute deletion of BAF250a disrupted the differentiation potential of ES cells by altering the expression timing of key developmental genes and pluripotent genes. Our genome-wide nucleosome and histone modification analyses indicated that the disruption of gene expression timing was largely due to changes of chromatin structures at poised genes, particularly those key developmental genes mediated by BAF250a. Specifically, BAF250a deletion caused a nucleosome occupancy increase at H3K4me3- and/or H3K27me3-associated promoters. Moreover, H3K27me3 levels and the number of bivalent promoter genes were reduced in BAF250aKOES cells. We revealed that BAF250a ablation led to elevated Brg1 but reduced Suz12 recruitment at nucleosome occupancy-increased regions, indicating an unexpected and complicated role of BAF250a in regulating esBAF and Polycomb repressive complex (PRC) activities. Together, our studies identified that BAF250a mediates esBAF and PRC functions to establish the poised chromatin configuration in ES cells, which is essential for the proper differentiation of ES cells.	[Lei, Lenglam; Gnatovskiy, Leonid; Wang, Zhong] Univ Michigan, Dept Cardiac Surg, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA; [West, Jason; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; [Gao, Xiaolin; Fang, Peng] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Yan, Zhijiang; Wang, Weidong] NIA, Genome Instabil & Chromatin Remodeling Sect, NIH, Baltimore, MD 21224 USA; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; Florida State University	Wang, Z (corresponding author), Univ Michigan, Dept Cardiac Surg, Cardiovasc Res Ctr, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	zhongw@med.umich.edu	Regan, Clinton/E-6250-2012; Wang, Weidong/AAV-2446-2021; Lei, IENG LAM/AAT-8216-2020; West, Jason/I-4445-2014	Lei, IENG LAM/0000-0002-0248-6871; Wang, Weidong/0000-0002-0658-7928; West, Jason/0000-0002-7252-8651	National Institutes of Health [HL109054]; Intramural Research Program of the NIA/National Institutes of Health [AG000650-10]; Samuel and Jean Frankel Cardiovascular Center, University of Michigan (Inaugural Fund); NATIONAL INSTITUTE ON AGING [ZIAAG000661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Samuel and Jean Frankel Cardiovascular Center, University of Michigan (Inaugural Fund); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant HL109054 (to W. Z.) and Intramural Research Program of the NIA/National Institutes of Health Grant AG000650-10 (to W. W.). This work was also supported by the Samuel and Jean Frankel Cardiovascular Center, University of Michigan (Inaugural Fund) (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chen KF, 2013, GENOME RES, V23, P312, DOI 10.1101/gr.141952.112; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Deng T, 2013, MOL CELL BIOL, V33, P3377, DOI 10.1128/MCB.00435-13; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy A., 2003, MANIPULATING MOUSE E; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Woo CJ, 2013, MOL CELL BIOL, V33, P3274, DOI 10.1128/MCB.00275-13; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	35	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19343	19352		10.1074/jbc.M115.637389	http://dx.doi.org/10.1074/jbc.M115.637389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070559	Green Published, hybrid			2022-12-28	WOS:000358781100045
J	Dai, FF; Bhattacharjee, A; Liu, Y; Batchuluun, B; Zhang, M; Wang, XS; Huang, XY; Luu, L; Zhu, D; Gaisano, H; Wheeler, MB				Dai, Feihan F.; Bhattacharjee, Alpana; Liu, Ying; Batchuluun, Battsetseg; Zhang, Ming; Wang, Xinye Serena; Huang, Xinyi; Luu, Lemieux; Zhu, Dan; Gaisano, Herbert; Wheeler, Michael B.			A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; PRORENIN RECEPTOR; H+-ATPASE; FUNCTIONAL EXPRESSION; PROINSULIN; INCRETIN; IDENTIFICATION; PHYSIOLOGY; CLEAVAGE; GLUCOSE	GLP1 activates its receptor, GLP1R, to enhance insulin secretion. The activation and transduction of GLP1R requires complex interactions with a host of accessory proteins, most of which remain largely unknown. In this study, we used membrane-based split ubiquitin yeast two-hybrid assays to identify novel GLP1R interactors in both mouse and human islets. Among these, ATP6ap2 (ATPase H+-transporting lysosomal accessory protein 2) was identified in both mouse and human islet screens. ATP6ap2 was shown to be abundant in islets including both alpha and beta cells. When GLP1R and ATP6ap2 were co-expressed in beta cells, GLP1R was shown to directly interact with ATP6ap2, as assessed by co-immunoprecipitation. In INS-1 cells, overexpression of ATP6ap2 did not affect insulin secretion; however, siRNA knock-down decreased both glucose-stimulated and GLP1-induced insulin secretion. Decreases in GLP1-induced insulin secretion were accompanied by attenuated GLP1 stimulated cAMP accumulation. Because ATP6ap2 is a subunit required for V-ATPase assembly of insulin granules, it has been reported to be involved in granule acidification. In accordance with this, we observed impaired insulin granule acidification upon ATP6ap2 knockdown but paradoxically increased proinsulin secretion. Importantly, as a GLP1R interactor, ATP6ap2 was required for GLP1-induced Ca2+ influx, in part explaining decreased insulin secretion in ATP6ap2 knockdown cells. Taken together, our findings identify a group of proteins that interact with the GLP1R. Wefurther show that one interactor, ATP6ap2, plays a novel dual role in beta cells, modulating both GLP1R signaling and insulin processing to affect insulin secretion.	[Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Cir,Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Liu, Ying/H-6045-2018	Liu, Ying/0000-0001-7710-0809; Wheeler, Michael B./0000-0002-7480-7267	Novo Nordisk Innovation Award; Canadian Institutes of Health Research [MOP-102588]; Banting and Best Diabetes Center (BBDC); BBDC graduate student award; BBDC summer student award	Novo Nordisk Innovation Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Center (BBDC); BBDC graduate student award; BBDC summer student award	This work was supported by a grant from a Novo Nordisk Innovation Award and Canadian Institutes of Health Research MOP-102588 (to M. B. W.), Banting and Best Diabetes Center (BBDC) postdoctoral fellowships (to Y. L and M. Z.), a BBDC graduate student award (to X. H.), and a BBDC summer student award (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Boutant M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030847; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DILLON JS, 1993, ENDOCRINOLOGY, V133, P1907, DOI 10.1210/en.133.4.1907; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dunnwald M, 1999, MOL BIOL CELL, V10, P329, DOI 10.1091/mbc.10.2.329; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Edwards CMB, 1999, DIABETES, V48, P86, DOI 10.2337/diabetes.48.1.86; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gromada J, 1998, DIABETES, V47, P57, DOI 10.2337/diabetes.47.1.57; Gromada J, 1998, PFLUG ARCH EUR J PHY, V435, P583, DOI 10.1007/s004240050558; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565; Heller C, 2011, AM J PHYSIOL-ENDOC M, V301, pE864, DOI 10.1152/ajpendo.00144.2011; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Jansen EJR, 2012, CURR PROTEIN PEPT SC, V13, P124; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Jun LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093746; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; KREYMANN B, 1987, LANCET, V2, P1300; Krisai P, 2015, HYPERTENSION, V65, P306, DOI 10.1161/HYPERTENSIONAHA.114.04718; Liu Y, 2015, J BIOL CHEM, V290, P18757, DOI 10.1074/jbc.M115.640524; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; ORCI L, 1994, J CELL BIOL, V126, P1149, DOI 10.1083/jcb.126.5.1149; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Salehi M, 2008, J CLIN ENDOCR METAB, V93, P4909, DOI 10.1210/jc.2008-0605; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Sihn G, 2010, KIDNEY INT, V78, P246, DOI 10.1038/ki.2010.151; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Talbot J, 2012, MOL CELL ENDOCRINOL, V364, P65, DOI 10.1016/j.mce.2012.08.010; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; von Scholten BJ, 2015, DIABETIC MED, V32, P343, DOI 10.1111/dme.12594; WHEELER MB, 1993, ENDOCRINOLOGY, V133, P57, DOI 10.1210/en.133.1.57; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wittke S, 1999, MOL BIOL CELL, V10, P2519, DOI 10.1091/mbc.10.8.2519; Woerle HJ, 2012, DIABETES, V61, P2349, DOI 10.2337/db11-1701; Wolff NA, 2014, FASEB J, V28, P2134, DOI 10.1096/fj.13-240564; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Ye YM, 2010, AM J PHYSIOL-HEART C, V298, pH1454, DOI 10.1152/ajpheart.00867.2009; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Zhang M, 2014, MOL CELL PROTEOMICS, V13, P3049, DOI 10.1074/mcp.M114.040196; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799	67	17	17	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25045	25061		10.1074/jbc.M115.648592	http://dx.doi.org/10.1074/jbc.M115.648592			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26272612	Green Published, hybrid			2022-12-28	WOS:000362598300033
J	Jarantow, SW; Bushey, BS; Pardinas, JR; Boakye, K; Lacy, ER; Sanders, R; Sepulveda, MA; Moores, SL; Chiu, ML				Jarantow, Stephen W.; Bushey, Barbara S.; Pardinas, Jose R.; Boakye, Ken; Lacy, Eilyn R.; Sanders, Renouard; Sepulveda, Manuel A.; Moores, Sheri L.; Chiu, Mark L.			Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor x c-MET Bispecific Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTITATIVE FLOW-CYTOMETRY; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED-RESISTANCE; DENSITY; AFFINITY; HETEROGENEITY; CYTOTOXICITY; QUANTIFICATION; PERFORMANCE; PRECURSORS	The efficacy of engaging multiple drug targets using bispecific antibodies (BsAbs) is affected by the relative cell-surface protein levels of the respective targets. In this work, the receptor density values were correlated to the in vitro activity of a BsAb (JNJ-61186372) targeting epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-MET). Simultaneous binding of the BsAb to both receptors was confirmed in vitro. By using controlled Fab-arm exchange, a set of BsAbs targeting EGFR and c-MET was generated to establish an accurate receptor quantitation of a panel of lung and gastric cancer cell lines expressing heterogeneous levels of EGFR and c-MET. EGFR and c-MET receptor density levels were correlated to the respective gene expression levels as well as to the respective receptor phosphorylation inhibition values. We observed a bias in BsAb binding toward the more highly expressed of the two receptors, EGFR or c-MET, which resulted in the enhanced in vitro potency of JNJ-61186372 against the less highly expressed target. On the basis of these observations, we propose an avidity model of how JNJ-61186372 engages EGFR and c-MET with potentially broad implications for bispecific drug efficacy and design.	[Jarantow, Stephen W.; Bushey, Barbara S.; Pardinas, Jose R.; Boakye, Ken; Lacy, Eilyn R.; Sepulveda, Manuel A.; Moores, Sheri L.; Chiu, Mark L.] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Sanders, Renouard] Janssen Res & Dev, Janssen Diagnost, Huntingdon Valley, PA 19104 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Chiu, ML (corresponding author), Janssen R&D LLC, Dept Biol Res, 1400 McKean Rd,POB 776, Spring House, PA 19477 USA.	MChiu@its.jnj.com	chiu, mark/AAK-2756-2021	Chiu, Mark/0000-0001-6300-404X				Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054170; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; BENE MC, 1995, LEUKEMIA, V9, P1783; Bikoue A, 1996, CYTOMETRY, V26, P137, DOI 10.1002/(SICI)1097-0320(19960615)26:2<137::AID-CYTO7>3.3.CO;2-E; Castoldi R, 2013, ONCOGENE, V32, P5593, DOI 10.1038/onc.2013.245; Davis KA, 1998, CYTOMETRY, V33, P197, DOI 10.1002/(SICI)1097-0320(19981001)33:2<197::AID-CYTO14>3.0.CO;2-P; Derer S, 2012, J IMMUNOL, V189, P5230, DOI 10.4049/jimmunol.1202037; DRACH J, 1992, CYTOMETRY, V13, P893, DOI 10.1002/cyto.990130813; Engelberts PJ, 2013, J IMMUNOL METHODS, V388, P8, DOI 10.1016/j.jim.2012.11.007; Ferrand VL, 1996, CYTOMETRY, V23, P120, DOI 10.1002/(SICI)1097-0320(19960201)23:2<120::AID-CYTO5>3.0.CO;2-O; Ginaldi L, 1998, J CLIN PATHOL, V51, P364, DOI 10.1136/jcp.51.5.364; Gratama JW, 1998, CYTOMETRY, V33, P166, DOI 10.1002/(SICI)1097-0320(19981001)33:2<166::AID-CYTO11>3.0.CO;2-S; Hsi ED, 2003, BRIT J HAEMATOL, V120, P1017, DOI 10.1046/j.1365-2141.2003.04213.x; Iyer SB, 1998, CYTOMETRY, V33, P206, DOI 10.1002/(SICI)1097-0320(19981001)33:2<206::AID-CYTO15>3.0.CO;2-Y; Janku F, 2014, THER ADV MED ONCOL, V6, P43, DOI 10.1177/1758834013517414; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; KORNILOVA ES, 1992, ONCOGENE, V7, P511; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; LANGLEY KE, 1975, P NATL ACAD SCI USA, V72, P1254, DOI 10.1073/pnas.72.4.1254; Laurent S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-108; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Maher K. J., 2005, CLIN APPL IMMUNOL RE, V5, P353, DOI DOI 10.1016/j.cair.2005.10.001; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Panke C, 2013, PROTEIN ENG DES SEL, V26, P645, DOI 10.1093/protein/gzt035; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; PONCELET P, 1991, RES IMMUNOL, V142, P291, DOI 10.1016/0923-2494(91)90078-W; Puri Neelu, 2008, J Carcinog, V7, P9; Rego EM, 2001, BRAZ J MED BIOL RES, V34, P183, DOI 10.1590/S0100-879X2001000200005; Rossmann ED, 2007, CYTOM PART B-CLIN CY, V72B, P450, DOI 10.1002/cyto.b.20359; Rudnick SI, 2009, CANCER BIOTHER RADIO, V24, P155, DOI 10.1089/cbr.2009.0627; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Velders MP, 1998, BRIT J CANCER, V78, P478, DOI 10.1038/bjc.1998.518; Wang L, 2007, CYTOM PART B-CLIN CY, V72B, P442, DOI 10.1002/cyto.b.20354; Wang LL, 2012, CYTOM PART A, V81A, P567, DOI 10.1002/cyto.a.22060; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Zenger VE, 1998, CYTOMETRY, V33, P138, DOI 10.1002/(SICI)1097-0320(19981001)33:2<138::AID-CYTO8>3.0.CO;2-F; Zuckier LS, 2000, CANCER RES, V60, P7008	43	30	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24689	24704		10.1074/jbc.M115.651653	http://dx.doi.org/10.1074/jbc.M115.651653			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26260789	Green Published, hybrid			2022-12-28	WOS:000362598300006
J	Huang, L; Han, JJ; Ben-Hail, D; He, LW; Li, BW; Chen, ZH; Wang, YY; Yang, YL; Liu, L; Zhu, YS; Shoshan-Barmatz, V; Liu, HW; Chen, Q				Huang, Li; Han, Junjie; Ben-Hail, Danya; He, Luwei; Li, Baowei; Chen, Ziheng; Wang, Yueying; Yang, Yanlei; Liu, Lei; Zhu, Yushan; Shoshan-Barmatz, Varda; Liu, Hongwei; Chen, Quan			A New Fungal Diterpene Induces VDAC1-dependent Apoptosis in Bax/Bak-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; OUTER MITOCHONDRIAL-MEMBRANE; CYTOCHROME-C RELEASE; VDAC1 N-TERMINUS; BCL-2 FAMILY; MUTATIONAL INACTIVATION; MELANOMA-CELLS; BAX; PROTEIN	The pro-apoptotic Bax and Bak proteins are considered central to apoptosis, yet apoptosis occurs in their absence. Here, we asked whether the mitochondrial protein VDAC1 mediates apoptosis independently of Bax/Bak. Upon screening a fungal secondary metabolite library for compounds inducing apoptosis in Bax/Bak-deficient mouse embryonic fibroblasts, we identified cyathin-R, a new cyathane diterpenoid compound able to activate apoptosis in the absence of Bax/Bak via promotion of the VDAC1 oligomerization that mediates cytochrome c release. Diphenylamine-2-carboxilic acid, an inhibitor of VDAC1 conductance and oligomerization, inhibited cyathin-R-induced VDAC1 oligomerization and apoptosis. Similarly, Bcl-2 overexpression conferred resistance to cyathin-R-induced apoptosis and VDAC1 oligomerization. Silencing of VDAC1 expression prevented cyathin-R-induced apoptosis. Finally, cyathin-R effectively attenuated tumor growth and induced apoptosis in Bax/Bak-deficient cells implanted into a xenograft mouse model. Hence, this study identified a new compound promoting VDAC1-dependent apoptosis as a potential therapeutic option for cancerous cells lacking or presenting inactivated Bax/Bak.	[Huang, Li; Li, Baowei; Chen, Ziheng; Wang, Yueying; Yang, Yanlei; Liu, Lei; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Huang, Li; Li, Baowei; Chen, Ziheng; Wang, Yueying; Yang, Yanlei; Liu, Lei; Chen, Quan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Han, Junjie; He, Luwei; Liu, Hongwei] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100101, Peoples R China; [Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Zhu, Yushan] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 30071, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Ben Gurion University; Ben Gurion University; Nankai University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il; liuhw@im.ac.cn; chenq@ioz.ac.cn	yang, yanlei/GQH-5514-2022	Ben-Hail, Danya/0000-0002-8210-3446; Chen, Quan/0000-0001-7539-8728	Natural Science Foundation of China [91213304, 8113004]; Ministry of Science and Technology of China [2014CB138304]; Israel Science Foundation [307/13]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Israel Science Foundation(Israel Science Foundation)	This work was supported by key projects of the Natural Science Foundation of China (Grants 91213304 and 8113004) and the Ministry of Science and Technology of China (Grant 2014CB138304) and by Israel Science Foundation Grant 307/13 (to V.S.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Brustovetsky T, 2010, BBA-BIOENERGETICS, V1797, P1795, DOI 10.1016/j.bbabio.2010.07.006; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Chacko AD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-380; Cheng SL, 2007, J BIOMED SCI, V14, P87, DOI 10.1007/s11373-006-9130-6; Claveria C, 2004, J BIOL CHEM, V279, P1368, DOI 10.1074/jbc.M309819200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; el Dein OS, 2012, BIOCHEM PHARMACOL, V83, P1172, DOI 10.1016/j.bcp.2012.01.017; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Han JJ, 2013, FITOTERAPIA, V84, P22, DOI 10.1016/j.fitote.2012.10.001; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; Jiang N, 2011, J PROTEOMICS, V74, P843, DOI 10.1016/j.jprot.2011.02.034; Jung JY, 2007, NEUROSCI LETT, V411, P222, DOI 10.1016/j.neulet.2006.09.089; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lai JC, 2006, P NATL ACAD SCI USA, V103, P7494, DOI 10.1073/pnas.0602217103; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu JH, 2013, FREE RADICAL BIO MED, V63, P485, DOI 10.1016/j.freeradbiomed.2013.05.038; Lu AJ, 2007, FISH SHELLFISH IMMUN, V23, P601, DOI 10.1016/j.fsi.2007.01.007; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Martel C, 2014, MITOCHONDRION, V19, P69, DOI 10.1016/j.mito.2014.07.009; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Mizuta T, 2007, J BIOL CHEM, V282, P16623, DOI 10.1074/jbc.M611060200; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; ShoshanBarmatz V, 1996, FEBS LETT, V386, P205, DOI 10.1016/0014-5793(96)00442-5; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Voehringer DW, 2000, P NATL ACAD SCI USA, V97, P2680, DOI 10.1073/pnas.97.6.2680; Wan KF, 2008, J BIOL CHEM, V283, P8423, DOI 10.1074/jbc.M707687200; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Weisthal S, 2014, BBA-MOL CELL RES, V1843, P2270, DOI 10.1016/j.bbamcr.2014.03.021; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhao LX, 2012, J BIOL CHEM, V287, P1054, DOI 10.1074/jbc.M111.264481; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	66	37	41	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23563	23578		10.1074/jbc.M115.648774	http://dx.doi.org/10.1074/jbc.M115.648774			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26253170	Green Published, hybrid			2022-12-28	WOS:000361816500009
J	Li, J; Inoue, J; Choi, JM; Nakamura, S; Yan, Z; Fushinobu, S; Kamada, H; Kato, H; Hashidume, T; Shimizu, M; Sato, R				Li, Juan; Inoue, Jun; Choi, Jung-Min; Nakamura, Shugo; Yan, Zhen; Fushinobu, Shinya; Kamada, Haruhiko; Kato, Hisanori; Hashidume, Tsutomu; Shimizu, Makoto; Sato, Ryuichiro			Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; ACTIVATED RECEPTOR-GAMMA; DIET-INDUCED OBESITY; GENE-EXPRESSION; INSULIN-RESISTANCE; HEPG2 CELLS; INTESTINAL-ABSORPTION; APOLIPOPROTEIN B100; MODY1 GENE; APO-B	Hepatocyte nuclear factor 4 alpha(HNF4 alpha) is a nuclear receptor that regulates the expression of genes involved in the secretion of apolipoprotein B (apoB)-containing lipoproteins and in glucose metabolism. In the present study, we identified a naturally occurring flavonoid, luteolin, as a repressor of HNF4 alpha by screening for effectors of the human microsomal triglyceride transfer protein (MTP) promoter. Luciferase reporter gene assays revealed that the activity of the MTP gene promoter was suppressed by luteolin and that the mutation of HNF4 alpha-binding element abolished luteolin responsiveness. Luteolin treatment caused a significant decrease in the mRNA levels of HNF4 alpha target genes in HepG2 cells and inhibited apoB-containing lipoprotein secretion in HepG2 and differentiated Caco2 cells. The interaction between luteolin and HNF4 alpha was demonstrated using absorption spectrum analysis and luteolin-immobilized beads. Luteolin did not affect the DNA binding of HNF4 alpha to the promoter region of its target genes but suppressed the acetylation level of histone H3 in the promoter region of certain HNF4 alpha target genes. Short term treatment of mice with luteolin significantly suppressed the expression of HNF4 alpha target genes in the liver. In addition, long term treatment of mice with luteolin significantly suppressed their diet-induced obesity and improved their serum glucose and lipid parameters. Importantly, long term luteolin treatment lowered serum VLDL and LDL cholesterol and serum apoB protein levels, which was not accompanied by fat accumulation in the liver. These results suggest that the flavonoid luteolin ameliorates an atherogenic lipid profile in vivo that is likely to be mediated through the inactivation of HNF4 alpha.	[Li, Juan; Inoue, Jun; Choi, Jung-Min; Kato, Hisanori; Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Nakamura, Shugo; Yan, Zhen; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Kamada, Haruhiko] Natl Inst Biomed Innovat, Lab Biopharmaceut Res, Osaka 5670085, Japan; [Kato, Hisanori] Univ Tokyo, Corp Sponsored Res Program Food Life, Org Interdisciplinary Res Projects, Tokyo 1138657, Japan; [Hashidume, Tsutomu] Univ Tokyo, Inst Gerontol, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo; National Institute of Health Sciences - Japan; University of Tokyo; University of Tokyo	Inoue, J (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ajinoue@mail.ecc.u-tokyo.ac.jp; aroysato@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; INOUE, Jun/O-7352-2016	Fushinobu, Shinya/0000-0003-1346-6435; INOUE, Jun/0000-0003-4145-3754	Japan Science and Technology Agency (Research for Promoting Technological Seeds); Tojuro Iijima Foundation for Food Science and Technology; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japanese Council for Science, Technology and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP) [14533567]	Japan Science and Technology Agency (Research for Promoting Technological Seeds)(Japan Science & Technology Agency (JST)); Tojuro Iijima Foundation for Food Science and Technology; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japanese Council for Science, Technology and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP)	This work was supported by research grants from the Japan Science and Technology Agency (Research for Promoting Technological Seeds) (to J. I.); the Tojuro Iijima Foundation for Food Science and Technology (to J. I.); the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to S. N.); the Japanese Council for Science, Technology and Innovation; and the Cross-ministerial Strategic Innovation Promotion Program (SIP Project 14533567). The authors declare that they have no conflicts of interest with the contents of this article.	Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Bailly A, 2001, NUCLEIC ACIDS RES, V29, P3495, DOI 10.1093/nar/29.17.3495; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; Borradaile NM, 2002, BIOCHEM J, V366, P531, DOI 10.1042/BJ20020046; Burnett JR, 2007, EXPERT OPIN THER TAR, V11, P181, DOI 10.1517/14728222.11.2.181; Dang ZC, 2004, J BONE MINER RES, V19, P853, DOI 10.1359/JBMR.040120; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ding L, 2010, J NUTR BIOCHEM, V21, P941, DOI 10.1016/j.jnutbio.2009.07.009; Drewes T, 1996, MOL CELL BIOL, V16, P925; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; Fisher E, 2014, J BIOMED RES, V28, P178, DOI 10.7555/JBR.28.20140019; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hata T, 2011, DIABETES OBES METAB, V13, P446, DOI 10.1111/j.1463-1326.2011.01368.x; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hirokane H, 2004, J BIOL CHEM, V279, P45685, DOI 10.1074/jbc.M404255200; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Huang HC, 2010, J AGR FOOD CHEM, V58, P8699, DOI 10.1021/jf101003v; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Inoue J, 2011, FEBS J, V278, P2739, DOI 10.1111/j.1742-4658.2011.08204.x; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jurasekova Z, 2009, BIOPOLYMERS, V91, P917, DOI 10.1002/bip.21278; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kiselyuk A, 2012, CHEM BIOL, V19, P806, DOI 10.1016/j.chembiol.2012.05.014; Kritas SK, 2013, J BIOL REG HOMEOS AG, V27, P955; Kwon EY, 2015, DIABETES, V64, P1658, DOI 10.2337/db14-0631; Lee SH, 2013, STEM CELLS, V31, P2396, DOI 10.1002/stem.1496; Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6; Liu JF, 2011, PHYTOTHER RES, V25, P588, DOI 10.1002/ptr.3305; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lubura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037026; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Park SH, 2013, FOOD CHEM TOXICOL, V56, P100, DOI 10.1016/j.fct.2013.02.022; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Rha GB, 2009, J BIOL CHEM, V284, P35165, DOI 10.1074/jbc.M109.052506; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Wilcox LJ, 2001, J LIPID RES, V42, P725; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zhou P, 2008, J AGR FOOD CHEM, V56, P296, DOI 10.1021/jf072612+	46	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					24021	24035		10.1074/jbc.M115.645200	http://dx.doi.org/10.1074/jbc.M115.645200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26272613	Green Published, hybrid			2022-12-28	WOS:000361816500045
J	Kitazawa, M; Kubo, Y; Nakajo, K				Kitazawa, Masahiro; Kubo, Yoshihiro; Nakajo, Koichi			Kv4.2 and Accessory Dipeptidyl Peptidase-like Protein 10 (DPP10) Subunit Preferentially Form a 4:2 (Kv4.2:DPP10) Channel Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT OUTWARD CURRENT; ALPHA-SUBUNITS; K+ CHANNEL; MOLECULAR PHYSIOLOGY; VENTRICULAR-MUSCLE; BETA-SUBUNIT; EXPRESSION; STOICHIOMETRY; INACTIVATION; MODULATION	Kv4 is a member of the voltage-gated K+ channel family and forms a complex with various accessory subunits. Dipeptidyl aminopeptidase-like protein (DPP) is one of the auxiliary subunits for the Kv4 channel. Although DPP has been well characterized and is known to increase the current amplitude and accelerate the inactivation and recovery from inactivation of Kv4 current, it remains to be determined how many DPPs bind to one Kv4 channel. To examine whether the expression level of DPP changes the biophysical properties of Kv4, we expressed Kv4.2 and DPP10 in different ratios in Xenopus oocytes and analyzed the currents under two-electrode voltage clamp. The current amplitude and the speed of recovery from inactivation of Kv4.2 changed depending on the co-expression level of DPP10. This raised the possibility that the stoichiometry of the Kv4.2-DPP10 complex is variable and affects the biophysical properties of Kv4.2. We next determined the stoichiometry of DPP10 alone by subunit counting using single-molecule imaging. Approximately 70% of the DPP10 formed dimers in the plasma membrane, and the rest existed as monomers in the absence of Kv4.2. We next determined the stoichiometry of the Kv4.2-DPP10 complex; Kv4.2-mCherry and mEGFP-DPP10 were co-expressed in different ratios and the stoichiometries of Kv4.2-DPP10 complexes were evaluated by the subunit counting method. The stoichiometry of the Kv4.2-DPP10 complex was variable depending on the relative expression level of each subunit, with a preference for 4: 2 stoichiometry. This preference may come from the bulky dimeric structure of the extracellular domain of DPP10.	[Kubo, Yoshihiro] Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400155, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Kubo, Y (corresponding author), Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan.	ykubo@nips.ac.jp	Nakajo, Koichi/J-2601-2019	Nakajo, Koichi/0000-0003-0766-7281; Kubo, Yoshihiro/0000-0001-6707-0837	(KAKENHI) from the Japan Society for the Promotion of Science	(KAKENHI) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for scientific research (KAKENHI) from the Japan Society for the Promotion of Science (to K.N. and Y.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; Arant RJ, 2014, CHEMPHYSCHEM, V15, P600, DOI 10.1002/cphc.201301092; Bezerra GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08769; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brahmajothi MV, 1999, J GEN PHYSIOL, V113, P581, DOI 10.1085/jgp.113.4.581; Chen T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/209398; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chien CH, 2004, J BIOL CHEM, V279, P52338, DOI 10.1074/jbc.M406185200; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; DIXON JE, 1994, CIRC RES, V75, P252, DOI 10.1161/01.RES.75.2.252; Dougherty K, 2009, CHANNELS, V3, P122, DOI 10.4161/chan.3.2.8333; Foeger NC, 2012, J BIOL CHEM, V287, P9640, DOI 10.1074/jbc.M111.324574; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00082; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Liao C, 2013, EUR J MED GENET, V56, P484, DOI 10.1016/j.ejmg.2013.06.008; Lin L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3270; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2011, SEMIN CELL DEV BIOL, V22, P145, DOI 10.1016/j.semcdb.2010.10.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsuyoshi H, 2012, LIFE SCI, V91, P258, DOI 10.1016/j.lfs.2012.07.007; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Sanguinetti MC, 2002, CIRC RES, V90, P497, DOI 10.1161/01.RES.0000014284.39141.8C; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; Soh H, 2008, J BIOL CHEM, V283, P15072, DOI 10.1074/jbc.M706964200; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; Takimoto K, 2006, BIOCHEM BIOPH RES CO, V348, P1094, DOI 10.1016/j.bbrc.2006.07.157; Ulbrich MH, 2008, P NATL ACAD SCI USA, V105, P14163, DOI 10.1073/pnas.0802075105; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wang WC, 2015, J COMP NEUROL, V523, P608, DOI 10.1002/cne.23698; Xu HD, 1999, J PHYSIOL-LONDON, V519, P11, DOI 10.1111/j.1469-7793.1999.0011o.x; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhou JH, 2015, BIOPHYS J, V108, P2658, DOI 10.1016/j.bpj.2015.04.024	61	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22724	22733		10.1074/jbc.M115.646794	http://dx.doi.org/10.1074/jbc.M115.646794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209633	hybrid, Green Published			2022-12-28	WOS:000361171500036
J	Hamacher-Brady, A; Brady, NR				Hamacher-Brady, Anne; Brady, Nathan Ryan			Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH PROTEASES; BCL-2; CLEAVAGE; FAMILY; SMAC; IAP; BAX; DOMAIN; CHEMOTHERAPY	Efficient apoptosis requires Bax/Bak-mediated mitochondrial outer membrane permeabilization (MOMP), which releases death-promoting proteins cytochrome c and Smac to the cytosol, which activate apoptosis and inhibit X-linked inhibitor of apoptosis protein (XIAP) suppression of executioner caspases, respectively. We recently identified that in response to Bcl-2 homology domain 3 (BH3)-only proteins and mitochondrial depolarization, XIAP can permeabilize and enter mitochondria. Consequently, XIAP E3 ligase activity recruits endolysosomes into mitochondria, resulting in Smac degradation. Here, we explored mitochondrial XIAP action within the intrinsic apoptosis signaling pathway. Mechanistically, we demonstrate that mitochondrial XIAP entry requires Bax or Bak and is antagonized by pro-survival Bcl-2 proteins. Moreover, intramitochondrial Smac degradation by XIAP occurs independently of Drp1-regulated cytochrome c release. Importantly, mitochondrial XIAP actions are activated cell-intrinsically by typical apoptosis inducers TNF and staurosporine, and XIAP overexpression reduces the lag time between the administration of an apoptotic stimuli and the onset of mitochondrial permeabilization. To elucidate the role of mitochondrial XIAP action during apoptosis, we integrated our findings within a mathematical model of intrinsic apoptosis signaling. Simulations suggest that moderate increases of XIAP, combined with mitochondrial XIAP preconditioning, would reduce MOMP signaling. To test this scenario, we pre-activated XIAP at mitochondria via mitochondrial depolarization or by artificially targeting XIAP to the intermembrane space. Both approaches resulted in suppression of TNF-mediated caspase activation. Taken together, we propose that XIAP enters mitochondria through a novel mode of mitochondrial permeabilization and through Smac degradation can compete with canonical MOMP to act as an anti-apoptotic tuning mechanism, reducing the mitochondrial contribution to the cellular apoptosis capacity.	[Hamacher-Brady, Anne] German Canc Res Ctr, Lysosomal Syst Biol, D-69120 Heidelberg, Germany; [Brady, Nathan Ryan] German Canc Res Ctr, Syst Biol Cell Death Mech, D-69120 Heidelberg, Germany; [Brady, Nathan Ryan] Univ Heidelberg Hosp, Dept Surg, D-69120 Heidelberg, Germany; [Hamacher-Brady, Anne; Brady, Nathan Ryan] Heidelberg Univ, Bioquant, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hamacher-Brady, A (corresponding author), INF 267,BQ0045, D-69120 Heidelberg, Germany.	a.brady@dkfz.de; n.brady@dkfz.de	Hamacher-Brady, Anne/G-4268-2013	Brady, Nathan/0000-0002-1901-5996; Hamacher-Brady, Anne/0000-0001-5042-1338	German Cancer Research Center through SBCancer within the Helmholtz Alliance on Systems Biology - Initiative and Networking Fund of the Helmholtz Association; e:Bio Grant from the Federal Ministry of Education and Research, Germany [0316191]	German Cancer Research Center through SBCancer within the Helmholtz Alliance on Systems Biology - Initiative and Networking Fund of the Helmholtz Association; e:Bio Grant from the Federal Ministry of Education and Research, Germany	This work was supported by the German Cancer Research Center through SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association (to N. R. B.) and by e:Bio Grant 0316191 (LysoSys) from the Federal Ministry of Education and Research, Germany (to A. H.-B.). The authors declare that they have no conflicts of interest with the contents of this article.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bhola PD, 2009, BIOPHYS J, V97, P2222, DOI 10.1016/j.bpj.2009.07.056; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Ferreira CG, 2001, ANN ONCOL, V12, P799, DOI 10.1023/A:1011167113067; Flanagan L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.26; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamacher-Brady A, 2014, CELL DEATH DIFFER, V21, P1862, DOI 10.1038/cdd.2014.101; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kawatani M, 2003, J BIOL CHEM, V278, P19732, DOI 10.1074/jbc.M213038200; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kushnareva Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001394; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Owens TW, 2010, J BIOL CHEM, V285, P1081, DOI 10.1074/jbc.M109.072322; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3157	43	31	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22005	22018		10.1074/jbc.M115.643064	http://dx.doi.org/10.1074/jbc.M115.643064			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26134559	Green Published, hybrid			2022-12-28	WOS:000360968500021
J	Clark, AL; Naya, FJ				Clark, Amanda L.; Naya, Francisco J.			MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; MYOCARDIAL-INFARCTION; HEART DEVELOPMENT; TFAP2B MUTATIONS; CELL-CYCLE; GENE; IDENTIFICATION; EXPRESSION; DEFECTS; PROTEIN	Understanding cell cycle regulation in postmitotic cardiomyocytes may lead to new therapeutic approaches to regenerate damaged cardiac tissue. We have demonstrated previously that microRNAs encoded by the Gtl2-Dio3 noncoding RNA locus function downstream of the MEF2A transcription factor in skeletal muscle regeneration. We have also reported expression of these miRNAs in the heart. Here we investigated the role of two Gtl2-Dio3 miRNAs, miR-410 and miR-495, in cardiac muscle. Overexpression of miR-410 and miR-495 robustly stimulated cardiomyocyte DNA synthesis and proliferation. Interestingly, unlike our findings in skeletal muscle, these miRNAs did not modulate the activity of the WNT signaling pathway. Instead, these miRNAs targeted Cited2, a coactivator required for proper cardiac development. Consistent with miR-410 and miR-495 overexpression, siRNA knockdown of Cited2 in neonatal cardiomyocytes resulted in robust proliferation. This phenotype was associated with reduced expression of Cdkn1c/p57/ Kip2, a cell cycle inhibitor, and increased expression of VEGFA, a growth factor with proliferation-promoting effects. Therefore, miR-410 and miR-495 are among a growing number of miRNAs that have the ability to potently stimulate neonatal cardiomyocyte proliferation.	[Clark, Amanda L.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			NHLBI, National Institutes of Health [HL73304]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL73304 (to F. J. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Chu HY, 2014, TUMOR BIOL, V35, P3487, DOI 10.1007/s13277-013-1460-1; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; EDELHOFF S, 1993, GENOMICS, V17, P93, DOI 10.1006/geno.1993.1288; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Feng T, 2015, CLIN SCI, V128, P761, DOI 10.1042/CS20140606; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Janssen R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00171; Janssen R, 2013, ENDOCRINOLOGY, V154, P1973, DOI 10.1210/en.2012-2017; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Kobayashi Y, 2005, HYPERTENS RES, V28, P229, DOI 10.1291/hypres.28.229; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu D, 2015, THROMB RES, V135, P146, DOI 10.1016/j.thromres.2014.10.027; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; MacDonald ST, 2013, EUR HEART J, V34, P2557, DOI 10.1093/eurheartj/ehs056; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Mani A, 2005, P NATL ACAD SCI USA, V102, P2975, DOI 10.1073/pnas.0409852102; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Otte C, 2010, J CLIN ENDOCR METAB, V95, P2885, DOI 10.1210/jc.2009-2251; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Takakura S, 2001, INT J ONCOL, V18, P817; Tang HL, 2011, BRAIN RES, V1390, P21, DOI 10.1016/j.brainres.2011.03.034; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Tian Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010841; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xu M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-7; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Zacchigna S, 2014, CARDIOVASC RES, V102, P312, DOI 10.1093/cvr/cvu057; Zhao D, 2015, MOL CELL BIOCHEM, V400, P87, DOI 10.1007/s11010-014-2265-2; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	58	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23162	23172		10.1074/jbc.M115.672659	http://dx.doi.org/10.1074/jbc.M115.672659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240138	Green Published, hybrid			2022-12-28	WOS:000361685500027
J	Alloy, AP; Kayode, O; Wang, RY; Hockla, A; Soares, AS; Radisky, ES				Alloy, Alexandre P.; Kayode, Olumide; Wang, Ruiying; Hockla, Alexandra; Soares, Alexei S.; Radisky, Evette S.			Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; protease inhibitor; protein evolution; protein structure; proteolysis; serine protease; site-directed mutagenesis; substrate specificity; trypsin	HEPATOCYTE GROWTH-FACTOR; PROTEIN INHIBITORS; SERINE PROTEASES; TUMOR-GROWTH; ACTIVE-SITE; KUNITZ; METASTASIS; EXPRESSION; MECHANISM; AFFINITY	Background: Canonical serine protease inhibitors normally behave as uncleavable substrates; mesotrypsin targets these inhibitors as substrates. Results: Four spatially separated amino acid residues cooperate to facilitate inhibitor cleavage by mesotrypsin. Conclusion: Inhibitor cleavage is a complex evolutionary adaptation. Significance: Mesotrypsin may regulate a network of serine proteases through its ability to cleave and inactivate multiple protease inhibitors. Human mesotrypsin is highly homologous to other mammalian trypsins, and yet it is functionally unique in possessing resistance to inhibition by canonical serine protease inhibitors and in cleaving these inhibitors as preferred substrates. Arg-193 and Ser-39 have been identified as contributors to the inhibitor resistance and cleavage capability of mesotrypsin, but it is not known whether these residues fully account for the unusual properties of mesotrypsin. Here, we use human cationic trypsin as a template for engineering a gain of catalytic function, assessing mutants containing mesotrypsin-like mutations for resistance to inhibition by bovine pancreatic trypsin inhibitor (BPTI) and amyloid precursor protein Kunitz protease inhibitor (APPI), and for the ability to hydrolyze these inhibitors as substrates. We find that Arg-193 and Ser-39 are sufficient to confer mesotrypsin-like resistance to inhibition; however, compared with mesotrypsin, the trypsin-Y39S/G193R double mutant remains 10-fold slower at hydrolyzing BPTI and 2.5-fold slower at hydrolyzing APPI. We identify two additional residues in mesotrypsin, Lys-74 and Asp-97, which in concert with Arg-193 and Ser-39 confer the full catalytic capability of mesotrypsin for proteolysis of BPTI and APPI. Novel crystal structures of trypsin mutants in complex with BPTI suggest that these four residues function cooperatively to favor conformational dynamics that assist in dissociation of cleaved inhibitors. Our results reveal that efficient inhibitor cleavage is a complex capability to which at least four spatially separated residues of mesotrypsin contribute. These findings suggest that inhibitor cleavage represents a functional adaptation of mesotrypsin that may have evolved in response to positive selection pressure.	[Alloy, Alexandre P.; Kayode, Olumide; Wang, Ruiying; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Regan, Clinton/E-6250-2012; Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X	National Institutes of Health [R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA154387 (to E. S. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Cattaruzza F, 2014, BRIT J PHARMACOL, V171, P3814, DOI 10.1111/bph.12738; Ceppa EP, 2011, AM J PHYSIOL-GASTR L, V300, pG1033, DOI 10.1152/ajpgi.00305.2010; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P124, DOI 10.1021/bi00542a019; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Fukuoka S, 2002, BBA-MOL BASIS DIS, V1588, P106, DOI 10.1016/S0925-4439(02)00153-9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076667; Hayashi H, 2011, P NATL ACAD SCI USA, V108, P18766, DOI 10.1073/pnas.1116273108; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; KOBAYASHI H, 1994, CANCER RES, V54, P844; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Laskowski Jr M., 1974, PROTEINASE INHIBITOR, P597; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; Rowen L, 2005, MOL BIOL EVOL, V22, P1712, DOI 10.1093/molbev/msi166; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; WAGNER SL, 1992, BIOCHEM BIOPH RES CO, V186, P1138, DOI 10.1016/0006-291X(92)90865-I; Yagyu T, 2006, INT J CANCER, V118, P2322, DOI 10.1002/ijc.21293; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	60	20	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21523	21535		10.1074/jbc.M115.662429	http://dx.doi.org/10.1074/jbc.M115.662429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175157	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000360637600027
J	Vogan, JM; Collins, K				Vogan, Jacob M.; Collins, Kathleen			Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; mitosis; telomerase; telomerase reverse transcriptase (TERT); telomere; Cajal bodies; RNP assembly; RNP trafficking	CAJAL BODY LOCALIZATION; HUMAN CANCER-CELLS; DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; CHROMOSOME ENDS; PCR DATA; RNA; RECRUITMENT; BODIES; TRAFFICKING	Background: Telomerase elongation of chromosome ends is restricted within the cell cycle. Results: A human telomerase holoenzyme subunit mediating Cajal body and telomere localization disassembles reversibly from the RNP catalytic core in each cell cycle. Conclusion: Telomerase holoenzyme assembly and disassembly are favored at distinct stages of the cell cycle. Significance: Human telomerase is relicensed for telomere synthesis in G(1). Human telomerase acts on telomeres during the genome synthesis phase of the cell cycle, accompanied by its concentration in Cajal bodies and transient colocalization with telomeres. Whether the regulation of human telomerase holoenzyme assembly contributes to the cell cycle restriction of telomerase function is unknown. We investigated the steady-state levels, assembly, and exchange dynamics of human telomerase subunits with quantitative in vivo cross-linking and other methods. We determined the physical association of telomerase subunits in cells blocked or progressing through the cell cycle as synchronized by multiple protocols. The total level of human telomerase RNA (hTR) was invariant across the cell cycle. In vivo snapshots of telomerase holoenzyme composition established that hTR remains bound to human telomerase reverse transcriptase (hTERT) throughout all phases of the cell cycle, and subunit competition assays suggested that hTERT-hTR interaction is not readily exchangeable. In contrast, the telomerase holoenzyme Cajal body-associated protein, TCAB1, was released from hTR in mitotic cells coincident with TCAB1 delocalization from Cajal bodies. This telomerase holoenzyme disassembly was reversible with cell cycle progression without any change in total TCAB1 protein level. Consistent with differential cell cycle regulation of hTERT-hTR and TCAB1-hTR protein-RNA interactions, overexpression of hTERT or TCAB1 had limited if any influence on hTR assembly of the other subunit. Overall, these findings revealed a cell cycle regulation that disables human telomerase association with telomeres while preserving the co-folded hTERT-hTR ribonucleoprotein catalytic core. Studies here, integrated with previous work, led to a unifying model for telomerase subunit assembly and trafficking in human cells.	[Vogan, Jacob M.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 HL079585, T32 GM007232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL079585 (to K.C.) and T32 GM007232 (to J.M.V.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blackburn Elizabeth H, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a003558; Cesare AJ, 2012, CURR OPIN CELL BIOL, V24, P731, DOI 10.1016/j.ceb.2012.08.007; Chen YL, 2015, NUCLEIC ACIDS RES, V43, P385, DOI 10.1093/nar/gku1277; Chow TT, 2012, GENE DEV, V26, P1167, DOI 10.1101/gad.187211.112; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; Dionne I, 2013, RNA, V19, P992, DOI 10.1261/rna.037663.112; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Fu D, 2006, GENE DEV, V20, P531, DOI 10.1101/gad.1390306; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gallardo F, 2012, RNA BIOL, V9, P1139, DOI 10.4161/rna.21498; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Lee JH, 2014, HISTOCHEM CELL BIOL, V141, P137, DOI 10.1007/s00418-013-1166-x; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moser BA, 2009, BIOCHEM CELL BIOL, V87, P747, DOI 10.1139/O09-037; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ribeyre C, 2013, CHROMOSOMA, V122, P159, DOI 10.1007/s00412-013-0404-2; Richard P, 2006, MOL CELL BIOL, V26, P2540, DOI 10.1128/MCB.26.7.2540-2549.2006; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Theimer CA, 2007, MOL CELL, V27, P869, DOI 10.1016/j.molcel.2007.07.017; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tomlinson RL, 2010, EXP CELL RES, V316, P2797, DOI 10.1016/j.yexcr.2010.07.001; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Tucey TM, 2014, GENE DEV, V28, P2077, DOI 10.1101/gad.246256.114; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Upton HE, 2014, MOL CELL BIOL, V34, P4200, DOI 10.1128/MCB.01030-14; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wu RA, 2014, EMBO J, V33, P921, DOI 10.1002/embj.201387205; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zhu X, 1996, P NATL ACAD SCI USA, V93, P5091	62	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21320	21335		10.1074/jbc.M115.659359	http://dx.doi.org/10.1074/jbc.M115.659359			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170453	Green Published, hybrid			2022-12-28	WOS:000360637600011
J	Dou, WF; Xu, YM; Pagadala, V; Pedersen, LC; Liu, J				Dou, Wenfang; Xu, Yongmei; Pagadala, Vijayakanth; Pedersen, Lars C.; Liu, Jian			Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; SUBSTRATE-SPECIFICITY; CHEMOENZYMATIC SYNTHESIS; BIOSYNTHESIS; NDST-1; CELLS; MOUSE; MICE; 2-O-SULFOTRANSFERASE; GLYCOSAMINOGLYCANS	Heparan sulfate (HS) is a highly sulfated polysaccharide that plays important physiological roles. The biosynthesis of HS involves a series of enzymes, including glycosyltransferases (or HS polymerase), epimerase, and sulfotransferases. N-Deacetylase/N-Sulfotransferase isoform 1 (NDST-1) is a critical enzyme in this pathway. NDST-1, a bifunctional enzyme, displays N-deacetylase and N-sulfotransferase activities to convert an N-acetylated glucosamine residue to an N-sulfo glucosamine residue. Here, we report the cooperative effects between N-deacetylase and N-sulfotransferase activities. Using baculovirus expression in insect cells, we obtained three recombinant proteins: full-length NDST-1 and the individual N-deacetylase and N-sulfotransferase domains. Structurally defined oligosaccharide substrates were synthesized to test the substrate specificities of the enzymes. We discovered that N-deacetylation is the limiting step and that interplay between the N-sulfotransferase and N-deacetylase accelerates the reaction. Furthermore, combining the individually expressed N-deacetylase and N-sulfotransferase domains produced different sulfation patterns when compared with that made by the NDST-1 enzyme. Our data demonstrate the essential role of domain cooperation within NDST-1 in producing HS with specific domain structures.	[Dou, Wenfang; Xu, Yongmei; Pagadala, Vijayakanth; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Dou, Wenfang] Jiangnan Univ, Sch Pharmaceut Sci, Lab Pharmaceut Engn, Wuxi 214122, Peoples R China; [Pedersen, Lars C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; Jiangnan University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liu, J (corresponding author), Univ N Carolina, Rm 1044,Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Regan, Clinton/E-6250-2012; Pagadala, Vijayakanth/ABI-8446-2020; Pedersen, Lars/C-6173-2019	Pedersen, Lars/0000-0002-4488-4077; Pagadala, Vijayakanth/0000-0001-7349-4230	National Institutes of Health [GM102137, HL094463]; Division of Intramural Research of the NIEHS, National Institutes of Health Research [ZIA ES102645]; China Scholarship Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the NIEHS, National Institutes of Health Research; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants GM102137 and HL094463 and by the Division of Intramural Research of the NIEHS, National Institutes of Health Research Project number ZIA ES102645 (to L. C. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Partially supported by a fellowship from the China Scholarship Council.	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Jemth P, 2003, J BIOL CHEM, V278, P24371, DOI 10.1074/jbc.M212155200; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Liu CH, 2014, J BIOL CHEM, V289, P13407, DOI 10.1074/jbc.M113.530535; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e; Liu RP, 2011, BIOCHEMISTRY-US, V50, P4382, DOI 10.1021/bi200072t; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Peterson S, 2012, J BIOL CHEM, V287, P34836, DOI 10.1074/jbc.M112.390161; Reuter MS, 2014, AM J MED GENET A, V164, P2753, DOI 10.1002/ajmg.a.36723; RIESENFELD J, 1982, J BIOL CHEM, V257, P7050; RIESENFELD J, 1980, J BIOL CHEM, V255, P922; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Saribas AS, 2004, GLYCOBIOLOGY, V14, P1217, DOI 10.1093/glycob/cwh129; Sasaki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008262; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Shively J. E., 1976, BIOCHEMISTRY-US, V15, P3932; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478	46	18	19	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20427	20437		10.1074/jbc.M115.664409	http://dx.doi.org/10.1074/jbc.M115.664409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26109066	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000359608900040
J	Noguchi, Y; Sakiyama, Y; Kawakami, H; Katayama, T				Noguchi, Yasunori; Sakiyama, Yukari; Kawakami, Hironori; Katayama, Tsutomu			The Arg Fingers of Key DnaA Protomers Are Oriented Inward within the Replication Origin oriC and Stimulate DnaA Subcomplexes in the Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; IN-VITRO; E. COLI; HOMOLOGOUS RECOMBINATION; SEQUENTIAL BINDING; NEGATIVE CONTROL; STRUCTURAL BASIS; GENE-EXPRESSION; ATP HYDROLYSIS	ATP-DnaA binds to multiple DnaA boxes in the Escherichia coli replication origin (oriC) and forms left-half and right-half subcomplexes that promote DNA unwinding and DnaB helicase loading. DnaA forms homo-oligomers in a head-to-tail manner via interactions between the bound ATP and Arg-285 of the adjacent protomer. DnaA boxes R1 and R4 reside at the outer edges of the DnaA-binding region and have opposite orientations. In this study, roles for the protomers bound at R1 and R4 were elucidated using chimeric DnaA molecules that had alternative DNA binding sequence specificity and chimeric oriC molecules bearing the alternative DnaA binding sequence at R1 or R4. In vitro, protomers at R1 and R4 promoted initiation regardless of whether the bound nucleotide was ADP or ATP. Arg-285 was shown to play an important role in the formation of subcomplexes that were active in oriC unwinding and DnaB loading. The results of in vivo analysis using the chimeric molecules were consistent with the in vitro data. Taken together, the data suggest a model in which DnaA subcomplexes form in symmetrically opposed orientations and in which the Arg-285 fingers face inward to mediate interactions with adjacent protomers. This mode is consistent with initiation regulation by ATP-DnaA and bidirectional loading of DnaB helicases.	[Noguchi, Yasunori; Sakiyama, Yukari; Kawakami, Hironori; Katayama, Tsutomu] Kyushu Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp	Kawakami, Hironori/H-6792-2017	Kawakami, Hironori/0000-0001-8971-1914; Katayama, Tsutomu/0000-0001-9994-1684	Japan Society of Promotion of Sciences [22370064, 26291004]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [26291004] Funding Source: KAKEN	Japan Society of Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (KAKENHI Grants 22370064 and 26291004) from the Japan Society of Promotion of Sciences and the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Asklund M, 2005, J MOL BIOL, V345, P717, DOI 10.1016/j.jmb.2004.10.092; BATES DB, 1995, NUCLEIC ACIDS RES, V23, P3119, DOI 10.1093/nar/23.16.3119; Bocchetta M, 2000, J MOL EVOL, V50, P366, DOI 10.1007/s002399910040; Chodavarapu S, 2013, NUCLEIC ACIDS RES, V41, P10254, DOI 10.1093/nar/gkt774; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Donczew R, 2014, J MOL BIOL, V426, P2769, DOI 10.1016/j.jmb.2014.05.018; Donczew R, 2012, NUCLEIC ACIDS RES, V40, P9647, DOI 10.1093/nar/gks742; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kasho K, 2014, NUCLEIC ACIDS RES, V42, P13134, DOI 10.1093/nar/gku1051; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; KATAYAMA T, 1994, J BIOL CHEM, V269, P12698; KATAYAMA T, 1994, J BIOL CHEM, V269, P22075; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kaur G, 2014, MOL MICROBIOL, V91, P1148, DOI 10.1111/mmi.12525; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Obita T, 2002, BIOCHEM BIOPH RES CO, V299, P42, DOI 10.1016/S0006-291X(02)02590-1; Ozaki S, 2006, GENES CELLS, V11, P425, DOI 10.1111/j.1365-2443.2006.00950.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, J BIOL CHEM, V287, P37458, DOI 10.1074/jbc.M112.372052; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Ozaki S, 2009, PLASMID, V62, P71, DOI 10.1016/j.plasmid.2009.06.003; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; Saxena R, 2013, INT J MOL SCI, V14, P8517, DOI 10.3390/ijms14048517; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Skarstad K, 1995, METHOD ENZYMOL, V262, P604; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Taylor JA, 2011, MOL MICROBIOL, V82, P312, DOI 10.1111/j.1365-2958.2011.07785.x; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; YUNG BYM, 1990, J BIOL CHEM, V265, P1282; Zorman S, 2012, NUCLEIC ACIDS RES, V40, P7375, DOI 10.1093/nar/gks371	65	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20295	20312		10.1074/jbc.M115.662601	http://dx.doi.org/10.1074/jbc.M115.662601			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26126826	hybrid, Green Published			2022-12-28	WOS:000359608900029
J	Tao, WW; Wu, J; Xie, BX; Zhao, YY; Shen, N; Jiang, S; Wang, XX; Xu, N; Jiang, C; Chen, S; Gao, X; Xue, B; Li, CJ				Tao, Weiwei; Wu, Jing; Xie, Bing-Xian; Zhao, Yuan-Yuan; Shen, Ning; Jiang, Shan; Wang, Xiu-Xing; Xu, Na; Jiang, Chen; Chen, Shuai; Gao, Xiang; Xue, Bin; Li, Chao-Jun			Lipid-induced Muscle Insulin Resistance Is Mediated by GGPPS via Modulation of the RhoA/Rho Kinase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PRENYLATION; RECEPTOR SUBSTRATE-1; GLUCOSE-METABOLISM; MEVALONATE PATHWAY; ROK-ALPHA; SENSITIVITY; CELLS; MICE; DIFFERENTIATION; ADIPOGENESIS	Elevated circulating free fatty acid levels are important contributors to insulin resistance in the muscle and liver, but the underlying mechanisms require further elucidation. Here, we show that geranylgeranyl diphosphate synthase 1 (GGPPS), which is a branch point enzyme in the mevalonic acid pathway, promotes lipid-induced muscle insulin resistance through activation of the RhoA/Rho kinase signaling pathway. We have found that metabolic perturbation would increase GGPPS expression in the skeletal muscles of db/db mice and high fat diet-fed mice. To address the metabolic effects of GGPPS activity in skeletal muscle, we generated mice with specific GGPPS deletions in their skeletal muscle tissue. Heterozygous knockout of GGPPS in the skeletal muscle improved systemic insulin sensitivity and glucose homeostasis in mice fed both normal chow and high fat diets. These metabolic alterations were accompanied by activated PI3K/Akt signaling and enhanced glucose uptake in the skeletal muscle. Further investigation showed that the free fatty acid-stimulated GGPPS expression in the skeletal muscle was able to enhance the geranylgeranylation of RhoA, which further induced the inhibitory phosphorylation of IRS-1 (Ser-307) by increasing Rho kinase activity. These results implicate a crucial role of the GGPPS/RhoA/Rho kinase/IRS-1 pathway in skeletal muscle, in which it mediates lipid-induced systemic insulin resistance in obese mice. Therefore, skeletal muscle GGPPS may represent a potential pharmacological target for the prevention and treatment of obesity-related type 2 diabetes.	Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; Nanjing Univ, Sch Med, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Xue, B (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China.	xuebin@nju.edu.cn; licj@nju.edu.cn	Wang, Xiuxing/ABF-8681-2020; Xu, Na/AAA-3531-2021; wang, xiuxing/AAY-4068-2021; Wang, Xiuxing/HGU-0583-2022; tao, wei/GXN-4445-2022; Wang, Xiuxing/N-6759-2019; Xie, Bingxian/Y-6487-2019; Xu, Na/AAO-8259-2021	Wang, Xiuxing/0000-0001-7115-729X; Wang, Xiuxing/0000-0002-5993-9368; Xu, Na/0000-0001-5387-7760; Li, Chaojun/0000-0001-9474-7321; Jiang, Chen/0000-0002-0010-0402; Tao, Weiwei/0000-0003-2933-9262; Jiang, Shan/0000-0003-2020-6447	Chinese National Program on Key Basic Research Project 973 Grant [2012CB524900]; National Natural Science Foundation of China [31171306]; Nature Science Foundation of Jiangsu Province [BK2011568]	Chinese National Program on Key Basic Research Project 973 Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Chinese National Program on Key Basic Research Project 973 Grant 2012CB524900 (to C.-J. L.), by National Natural Science Foundation of China Grant 31171306, and by Nature Science Foundation of Jiangsu Province Grant BK2011568 (to B. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Bankar G., 2013, THESIS U BRIT COLUMB; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Blonder J, 2006, NAT PROTOC, V1, P2784, DOI 10.1038/nprot.2006.359; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; Gee RH, 2015, TOXICOLOGY, V329, P40, DOI 10.1016/j.tox.2015.01.005; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huptas S, 2006, AM J CARDIOL, V98, P66, DOI 10.1016/j.amjcard.2006.01.055; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kikuchi Y, 2007, J ENDOCRINOL, V192, P595, DOI 10.1677/JOE-06-0045; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lalli CA, 2008, METABOLISM, V57, P57, DOI 10.1016/j.metabol.2007.07.021; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lim MJ, 2007, MOL ENDOCRINOL, V21, P2282, DOI 10.1210/me.2007-0114; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Okada K, 2005, J ATHEROSCLER THROMB, V12, P322, DOI 10.5551/jat.12.322; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Senn JJ, 2006, J BIOL CHEM, V281, P26865, DOI 10.1074/jbc.M513304200; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Shen N, 2011, AM J PATHOL, V178, P110, DOI 10.1016/j.ajpath.2010.11.016; Suzuki M, 2005, J ATHEROSCLER THROMB, V12, P77, DOI 10.5551/jat.12.77; Taghibiglou C, 2009, NEUROPHARMACOLOGY, V57, P268, DOI 10.1016/j.neuropharm.2009.05.013; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Thrush AB, 2008, AM J PHYSIOL-REG I, V294, pR1205, DOI 10.1152/ajpregu.00909.2007; Vicent D, 2000, MOL CELL BIOL, V20, P2158, DOI 10.1128/MCB.20.6.2158-2166.2000; Wang XX, 2013, J EXP MED, V210, P1559, DOI 10.1084/jem.20121806; Weivoda MM, 2012, BONE, V50, P467, DOI 10.1016/j.bone.2011.09.056; Xu N, 2015, J PATHOL, V235, P672, DOI 10.1002/path.4480; Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	41	25	27	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20086	20097		10.1074/jbc.M115.657742	http://dx.doi.org/10.1074/jbc.M115.657742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26112408	hybrid, Green Published			2022-12-28	WOS:000359608900007
J	Toda, A; Tsurumura, T; Yoshida, T; Tsumori, Y; Tsuge, H				Toda, Akiyuki; Tsurumura, Toshiharu; Yoshida, Toru; Tsumori, Yayoi; Tsuge, Hideaki			Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATING EXOENZYME; ACTIN STRESS FIBERS; CRYSTAL-STRUCTURE; CLOSTRIDIUM-BOTULINUM; STAPHYLOCOCCUS-AUREUS; BACILLUS-CEREUS; PROTEIN; RIBOSYLTRANSFERASE; BINDING; TOXIN	C3 exoenzyme is a mono-ADP-ribosyltransferase (ART) that catalyzes transfer of an ADP-ribose moiety from NAD(+) to Rho GTPases. C3 has long been used to study the diverse regulatory functions of Rho GTPases. How C3 recognizes its substrate and how ADP-ribosylation proceeds are still poorly understood. Crystal structures of C3-RhoA complex reveal that C3 recognizes RhoA via the switch I, switch II, and interswitch regions. In C3-RhoA(GTP) and C3-RhoA(GDP), switch I and II adopt the GDP and GTP conformations, respectively, which explains why C3 can ADP-ribosylate both nucleotide forms. Based on structural information, we successfully changed Cdc42 to an active substrate with combined mutations in the C3-Rho GTPase interface. Moreover, the structure reflects the close relationship among Gln-183 in the QXE motif (C3), a modified Asn-41 residue (RhoA) and NC1 of NAD(H), which suggests that C3 is the prototype ART. These structures show directly for the first time that the ARTT loop is the key to target protein recognition, and they also serve to bridge the gaps among independent studies of Rho GTPases and C3.	[Toda, Akiyuki; Tsurumura, Toshiharu; Yoshida, Toru; Tsumori, Yayoi; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kamigamo Motoyama, Kyoto 6038555, Japan; [Tsurumura, Toshiharu; Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Struct Biol Res Ctr, Kamigamo Motoyama, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto Sangyo University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kamigamo Motoyama, Kyoto 6038555, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan [15K08289, 25121733]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work supported in part by a Strategic Research Foundation Grant-aided project for private universities from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and by Grants-in-aid for Scientific Research 15K08289 and 25121733 from MEXT of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans HR, 2003, J BIOL CHEM, V278, P45924, DOI 10.1074/jbc.M307719200; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holbourn KP, 2005, P NATL ACAD SCI USA, V102, P5357, DOI 10.1073/pnas.0501525102; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; INOUE S, 1991, BIOCHEM BIOPH RES CO, V174, P459, DOI 10.1016/0006-291X(91)91438-I; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; JUST I, 1992, J BIOL CHEM, V267, P10274; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; OHASHI Y, 1987, J BIOL CHEM, V262, P1430; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; POPOFF M, 1990, NUCLEIC ACIDS RES, V18, P1291, DOI 10.1093/nar/18.5.1291; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Sundriyal A, 2009, J BIOL CHEM, V284, P28713, DOI 10.1074/jbc.M109.043018; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Vogelsgesang M, 2008, FEBS LETT, V582, P1032, DOI 10.1016/j.febslet.2008.02.051; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wilde C, 2003, BIOCHEMISTRY-US, V42, P9694, DOI 10.1021/bi034583b; Wilde C, 2002, J BIOL CHEM, V277, P14771, DOI 10.1074/jbc.M201072200; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; Wilde C, 2002, TRENDS MICROBIOL, V10, P5, DOI 10.1016/S0966-842X(01)02281-8; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yamaguchi T, 2001, INFECT IMMUN, V69, P7760, DOI 10.1128/IAI.69.12.7760-7771.2001	53	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19423	19432		10.1074/jbc.M115.653220	http://dx.doi.org/10.1074/jbc.M115.653220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26067270	Green Published, hybrid			2022-12-28	WOS:000359364600003
J	Lizarraga-Mollinedo, E; Fernandez-Millan, E; Garcia-San Frutos, M; de Toro-Martin, J; Fernandez-Agullo, T; Ros, M; Alvarez, C; Escriva, F				Lizarraga-Mollinedo, Esther; Fernandez-Millan, Elisa; Garcia-San Frutos, Miriam; de Toro-Martin, Juan; Fernandez-Agullo, Teresa; Ros, Manuel; Alvarez, Carmen; Escriva, Fernando			Early and Long-term Undernutrition in Female Rats Exacerbates the Metabolic Risk Associated with Nutritional Rehabilitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTNATAL LEPTIN SURGE; HIGH-FAT; GLUCOSE-UPTAKE; ADULT-RATS; OBESITY; INSULIN; RESTRICTION; NEURONS; MALNUTRITION; RESISTANCE	Human studies have suggested that early undernutrition increases the risk of obesity, thereby explaining the increase in overweight among individuals from developing countries who have been undernourished as children. However, this conclusion is controversial, given that other studies do not concur. This study sought to determine whether rehabilitation after undernutrition increases the risk of obesity and metabolic disorders. Weemployed a published experimental food-restriction model. Wistar female rats subjected to severe food restriction since fetal stage and controls were transferred to a moderately high-fat diet (cafeteria) provided at 70 days of life to 6.5 months. Another group of undernourished rats were rehabilitated with chow. The energy intake of undernourished animals transferred to cafeteria formula exceeded that of the controls under this regime and was probably driven by hypothalamic disorders in insulin and leptin signal transduction. The cafeteria diet resulted in greater relative increases in both fat and lean body mass in the undernourished rats when compared with controls, enabling the former group to completely catch up in length and body mass index. White adipose tissues of undernourished rats transferred to the high-lipid regime developed a browning which, probably, contributed to avoid the obesigenic effect observed in controls. Nevertheless, the restricted group rehabilitated with cafeteria formula had greater accretion of visceral than subcutaneous fat, showed increased signs of macrophage infiltration and inflammation in visceral pad, dyslipidemia, and ectopic fat accumulation. The data indicate that early long-term undernutrition is associated with increased susceptibility to the harmful effects of nutritional rehabilitation, without causing obesity.	[Lizarraga-Mollinedo, Esther; de Toro-Martin, Juan; Alvarez, Carmen; Escriva, Fernando] Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Lizarraga-Mollinedo, Esther; Fernandez-Millan, Elisa; Alvarez, Carmen; Escriva, Fernando] Ctr Invest Red Diabet & Enfermedades Metab Asocia, ISCIII, Madrid 28029, Spain; [Garcia-San Frutos, Miriam; Fernandez-Agullo, Teresa; Ros, Manuel] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Bioquim Fisiol & Genet Mol, Madrid 28922, Spain	Complutense University of Madrid; Instituto de Salud Carlos III; Universidad Rey Juan Carlos	Escriva, F (corresponding author), Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, Ciudad Univ S-N, E-28040 Madrid, Spain.	fescriva@farm.ucm.es	Lizárraga-Mollinedo, Esther/B-3867-2015; FERNÁNDEZ MILLÁN, ELISA/B-2674-2015; Frutos, Miriam García-San/C-1592-2015; Alvarez, Carmen/B-2582-2015	Lizárraga-Mollinedo, Esther/0000-0002-1059-8654; FERNÁNDEZ MILLÁN, ELISA/0000-0002-2807-3776; Frutos, Miriam García-San/0000-0001-7097-3498; Alvarez, Carmen/0000-0003-1874-1045; , Teresa/0000-0002-7812-747X	Ministerio de Economia y Competitividad (MINECO) [BFU 2011-25420]; Comunidad de Madrid, CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM, ISCIII) [MOIR S2010/BMD-2423]; UCM-Comunidad de Madrid [CCG97-UCM/SAL-30041]	Ministerio de Economia y Competitividad (MINECO); Comunidad de Madrid, CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM, ISCIII); UCM-Comunidad de Madrid(Comunidad de Madrid)	This work was supported Grant BFU 2011-25420 from the Ministerio de Economia y Competitividad (MINECO), Grant MOIR S2010/BMD-2423 from Comunidad de Madrid, CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM, ISCIII), and Grant CCG97-UCM/SAL-30041 from UCM-Comunidad de Madrid. The authors declare that they have no conflicts of interest with the contents of this article.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bergeron G, 2012, ADV NUTR, V3, P242, DOI 10.3945/an.111.001263; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Couturier A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-48; de Rooij SR, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0536-7; De Toro-Martin J, 2014, ENDOCRINOLOGY, V155, P3769, DOI 10.1210/en.2013-2043; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49; ESCRIVA F, 1992, AM J PHYSIOL, V263, pE1, DOI 10.1152/ajpendo.1992.263.1.E1; Fernandez E, 2006, AM J PHYSIOL-ENDOC M, V291, pE913, DOI 10.1152/ajpendo.00638.2005; Fernandez-Galaz C, 2002, DIABETOLOGIA, V45, P997, DOI 10.1007/s00125-002-0851-4; FORBES GB, 1987, NUTR REV, V45, P225; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Gavete ML, 2002, ENDOCRINOLOGY, V143, P4295, DOI 10.1210/en.2002-220258; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Koletzko B, 2014, ANN NUTR METAB, V65, P101, DOI 10.1159/000365873; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Lai M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.30; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Liu XM, 2013, J CLIN BIOCHEM NUTR, V52, P43, DOI 10.3164/jcbn.12-28; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizarraga-Mollinedo E, 2012, AM J PHYSIOL-ENDOC M, V302, pE1070, DOI 10.1152/ajpendo.00495.2011; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Nomura K, 2010, J AM GERIATR SOC, V58, P1658, DOI 10.1111/j.1532-5415.2010.03018.x; Plagemann A, 2012, BEST PRACT RES CL EN, V26, P641, DOI 10.1016/j.beem.2012.03.008; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Sanchez-Lozada LG, 2010, EUR J NUTR, V49, P1, DOI 10.1007/s00394-009-0042-x; Sardinha FLC, 2006, NUTRITION, V22, P1152, DOI 10.1016/j.nut.2006.07.002; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Storlien LH, 1997, ANN NY ACAD SCI, V827, P287, DOI 10.1111/j.1749-6632.1997.tb51842.x; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Thomas EL, 2003, INT J OBESITY, V27, P211, DOI 10.1038/sj.ijo.802229; Vickers MH, 2010, NUTR DIET SUPPL, V2, P137, DOI 10.2147/NDS.S8555; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wattez JS, 2013, HORM METAB RES, V45, P980, DOI 10.1055/s-0033-1357182; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	50	8	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19353	19366		10.1074/jbc.M114.549204	http://dx.doi.org/10.1074/jbc.M114.549204			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26105051	Green Published, hybrid			2022-12-28	WOS:000358781100046
J	Satoh, K; Abe-Dohmae, S; Yokoyama, S; St George-Hyslop, P; Fraser, PE				Satoh, Kanayo; Abe-Dohmae, Sumiko; Yokoyama, Shinji; St George-Hyslop, Peter; Fraser, Paul E.			ATP-binding Cassette Transporter A7 (ABCA7) Loss of Function Alters Alzheimer Amyloid Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HIGH-DENSITY-LIPOPROTEIN; HOST-DEFENSE SYSTEM; PRECURSOR PROTEIN; MOUSE MODEL; CELLULAR CHOLESTEROL; APOLIPOPROTEIN-E; ENHANCE PHAGOCYTOSIS; BETA ACCUMULATION; COMMON VARIANTS	The ATP-binding cassette transporter A7 (ABCA7) has been identified as a susceptibility factor of late onset Alzheimer disease in genome-wide association studies. ABCA7 has been shown to mediate phagocytosis and affect membrane trafficking. The current study examined the impact of ABCA7 loss of function on amyloid precursor protein (APP) processing and generation of amyloid-beta (A beta). Suppression of endogenous ABCA7 in several different cell lines resulted in increased beta-secretase cleavage and elevated A beta. ABCA7 knock-out mice displayed an increased production of endogenous murine amyloid A beta 42 species. Crossing ABCA7-deficient animals to an APP transgenic model resulted in significant increases in the soluble A beta as compared with mice expressing normal levels of ABCA7. Only modest changes in the amount of insoluble A beta and amyloid plaque densities were observed once the amyloid pathology was well developed, whereas A beta deposition was enhanced in younger animals. In vitro studies indicated a more rapid endocytosis of APP in ABCA7 knock-out cells that is mechanistically consistent with the increased A beta production. These in vitro and in vivo findings indicate a direct role of ABCA7 in amyloid processing that may be associated with its primary biological function to regulate endocytic pathways. Several potential loss-of-function ABCA7 mutations and deletions linked to Alzheimer disease that in some instances have a greater impact than apoE allelic variants have recently been identified. A reduction in ABCA7 expression or loss of function would be predicted to increase amyloid production and that may be a contributing factor in the associated Alzheimer disease susceptibility.	[Satoh, Kanayo; St George-Hyslop, Peter; Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Abe-Dohmae, Sumiko] Nagoya City Univ, Grad Sch Med Sci, Biochem, Nagoya, Aichi 1678601, Japan; [Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [St George-Hyslop, Peter; Fraser, Paul E.] Univ Toronto, Dept Med Neurol, Toronto, ON M5G 1L7, Canada; [St George-Hyslop, Peter; Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Toronto; Nagoya City University; Chubu University; University of Toronto; University of Toronto; University of Cambridge	Satoh, K (corresponding author), Univ Toronto, Tanz CRND, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	kanayo.sato@utoronto.ca		St George-Hyslop, Peter/0000-0003-0796-7209; Satoh, Kanayo/0000-0001-9684-239X	Canadian Institute of Health Research [MOP-115056]; Ontario Alzheimer's Society; Ontario Research Fund; Japan Society for the Promotion of Science KAKENHI [21591164, 25461375]; Japan Health Sciences Foundation; Ministry of Education, Culture, Sports, Science and Technology; MRC [MC_G1000734] Funding Source: UKRI	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Alzheimer's Society; Ontario Research Fund; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Health Sciences Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Canadian Institute of Health Research Grant MOP-115056 (to P. E. F.), the Ontario Alzheimer's Society, the Ontario Research Fund, Japan Society for the Promotion of Science KAKENHI Grants 21591164 and 25461375, the Japan Health Sciences Foundation, and the Ministry of Education, Culture, Sports, Science and Technology-supported program for the Strategic Research Foundation at Private Universities (Japan). The authors declare no competing financial interests.	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Abe-Dohmae S, 2012, CLIN LIPIDOL, V7, P677, DOI 10.2217/CLP.12.67; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bali J, 2012, P NATL ACAD SCI USA, V109, P15307, DOI 10.1073/pnas.1201632109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cole R, 2001, PROTOCOLS NEURAL CEL, P117, DOI [10.1385/1-59259-207-4:117, DOI 10.1385/1-59259-207-4:117]; Cuyvers E, 2015, LANCET NEUROL, V14, P814, DOI 10.1016/S1474-4422(15)00133-7; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Durk MR, 2014, J NEUROSCI, V34, P7091, DOI 10.1523/JNEUROSCI.2711-13.2014; Ghani M, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.07.038; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; Hertz L, 1982, NEUROSCIENCE APPROAC, V1, P175; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kim WS, 2013, J NEUROSCI, V33, P4387, DOI 10.1523/JNEUROSCI.4165-12.2013; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; Logge W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045959; Michaki V, 2012, J BIOL CHEM, V287, P1100, DOI 10.1074/jbc.M111.288258; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Soscia SJ, 2013, CLIN LIPIDOL, V8, P97, DOI 10.2217/CLP.12.91; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka N, 2011, ATHEROSCLEROSIS, V217, P407, DOI 10.1016/j.atherosclerosis.2011.06.031; Tanaka N, 2011, J ATHEROSCLER THROMB, V18, P274, DOI 10.5551/jat.6726; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tremblay P, 2007, BRAIN RES, V1139, P60, DOI 10.1016/j.brainres.2006.12.055; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Walter J, 2012, CURR ALZHEIMER RES, V9, P189, DOI 10.2174/156720512799361583; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wu FB, 2009, BIOCHEM BIOPH RES CO, V385, P247, DOI 10.1016/j.bbrc.2009.05.050; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zhou Y, 2010, NEUROCHEM RES, V35, P2124, DOI 10.1007/s11064-010-0325-x	64	72	74	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24152	24165		10.1074/jbc.M115.655076	http://dx.doi.org/10.1074/jbc.M115.655076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26260791	Green Published, hybrid			2022-12-28	WOS:000362218900009
J	Ye, Q; Wang, M; Fang, ZP; Ruan, ZR; Ji, QQ; Zhou, XL; Wang, ED				Ye, Qing; Wang, Meng; Fang, Zhi-Peng; Ruan, Zhi-Rong; Ji, Quan-Quan; Zhou, Xiao-Long; Wang, En-Duo			Degenerate Connective Polypeptide 1 (CP1) Domain from Human Mitochondria! Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL QUALITY-CONTROL; ESCHERICHIA-COLI; EDITING-DOMAIN; AMINO-ACIDS; AMINOACYLATION IDENTITY; PROTEIN-BIOSYNTHESIS; CRYSTAL-STRUCTURE; NORVALINE; YEAST; SITE	The connective polypeptide 1 (CP1) editing domain of leucyltRNA synthetase (LeuRS) from various species either harbors a conserved active site to exclude tRNA mis-charging with noncognate amino acids or is evolutionarily truncated or lost because there is no requirement for high translational fidelity. However, human mitochondrial LeuRS (hmtI.euRS) contains a full-length but degenerate CP1 domain that has mutations in some residues important for post-transfer editing. The significance of such an inactive CP1 domain and a translational accuracy mechanism with different noncognate amino acids are not completely understood. Here, we identified the essential role of the evolutionarily divergent CP1 domain in facilitating hmtLeuRS's catalytic efficiency and endowing enzyme with resistance to AN2690, a broad-spectrum drug acting on LeuRSs. In addition, the canonical core of hmtLeuRS is not stringent for noncognate norvaline (Nva) and valine (Val). hmtLeuRS has a very weak tRNA-independent pre-transfer editing activity for Nva, which is insufficient to remove mis-activated Nva. Moreover, hmtLeuRS chimeras fused with a functional CP1 domain from LeuRSs of other species, regardless of origin, showed restored post-transfer editing activity and acquired fidelity during aminoacylation. This work offers a novel perspective on the role of the CP1 domain in optimizing aminoacylation efficiency.	[Ye, Qing; Wang, Meng; Fang, Zhi-Peng; Ruan, Zhi-Rong; Ji, Quan-Quan; Zhou, Xiao-Long; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhou, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Ruan, Zhi-Rong/0000-0002-1806-2942; Fang, Zhipeng/0000-0001-5720-1709	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee)	This work was supported by National Key Basic Research Foundation of China Grant 2012CB911000, Natural Science Foundation of China Grants 31130064 and 91440204, and Committee of Science and Technology in Shanghai Grants 12JC1409700 and 15ZR1446500.The authors declare that they have no conflicts of interest with the contents of this article.	Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fang ZP, 2014, NUCLEIC ACIDS RES, V42, P5109, DOI 10.1093/nar/gku108; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Fender A, 2012, BIOCHIMIE, V94, P1090, DOI 10.1016/j.biochi.2012.02.030; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677; Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; KISUMI M, 1976, J BIOCHEM-TOKYO, V80, P333, DOI 10.1093/oxfordjournals.jbchem.a131281; Lee KW, 2004, PROTEINS, V54, P693, DOI 10.1002/prot.10300; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lue SW, 2007, BIOCHEMISTRY-US, V46, P4466, DOI 10.1021/bi0618215; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Sarkar J, 2012, J BIOL CHEM, V287, P14772, DOI 10.1074/jbc.M111.322412; Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5; Soini J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-30; SternJohn J, 2007, P NATL ACAD SCI USA, V104, P2127, DOI 10.1073/pnas.0611110104; Tan M, 2013, BIOCHEM J, V449, P123, DOI 10.1042/BJ20121258; Tan M, 2012, BIOCHEM J, V443, P477, DOI 10.1042/BJ20111925; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Yao YN, 2003, PROTEIN EXPRES PURIF, V30, P112, DOI 10.1016/S1046-5928(03)00097-4; Yao YN, 2003, FEBS LETT, V534, P139, DOI 10.1016/S0014-5793(02)03833-4; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P9825, DOI 10.1093/nar/gkt741; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2010, BIOCHEM J, V430, P325, DOI 10.1042/BJ20100474; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	49	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24391	24402		10.1074/jbc.M115.672824	http://dx.doi.org/10.1074/jbc.M115.672824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26272616	hybrid, Green Published			2022-12-28	WOS:000362218900027
J	Cho, Y; Park, D; Cavalli, V				Cho, Yongcheol; Park, Dongeun; Cavalli, Valeria			Filamin A Is Required in Injured Axons for HDAC5 Activity and Axon Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; KINASE-C; HISTONE DEACETYLASE-5; NUCLEAR EXPORT; CELL-ADHESION; GROWTH; NEURONS; MICROTUBULES; TRANSPORT; VIMENTIN	Microtubule dynamics are important for axon growth during development as well as axon regeneration after injury. We have previously identified HDAC5 as an injury-regulated tubulin deacetylase that functions at the injury site to promote axon regeneration. However, the mechanisms involved in the spatial control of HDAC5 activity remain poorly understood. Here we reveal that HDAC5 interacts with the actin binding protein filamin A via its C-terminal domain. Filamin A plays critical roles in HDAC5-dependent tubulin deacetylation because, in cells lacking filamin A, the levels of acetylated tubulin are elevated markedly. We found that nerve injury increases filamin A axonal expression in a protein synthesis-dependent manner. Reducing filamin A levels or interfering with the interaction between HDAC5 and filamin A prevents injury-induced tubulin deacetylation as well as HDAC5 localization at the injured axon tips. In addition, neurons lacking filamin A display reduced axon regeneration. Our findings suggest a model in which filamin A local translation following axon injury controls localized HDAC5 activity to promote axon regeneration.	[Cho, Yongcheol; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Park, Dongeun] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Washington University (WUSTL); Seoul National University (SNU)	Park, D (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	depark@snu.ac.kr; cavalli@pcg.wustl.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [NS082446]; National Research Foundation of Korea [NRF-2012R1A6A3A03039290, M103KV010013-04K2201-01310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS082446 (to V.C.). This work was also supported by National Research Foundation of Korea Grants NRF-2012R1A6A3A03039290 (to Y.C.) and M103KV010013-04K2201-01310 (to D.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cho Y, 2014, J BIOL CHEM, V289, P15820, DOI 10.1074/jbc.M113.536607; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; HARTWIG JH, 1980, J CELL BIOL, V87, P841, DOI 10.1083/jcb.87.3.841; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kim C, 2005, EMBO REP, V6, P1045, DOI 10.1038/sj.embor.7400534; Kim C, 2011, BLOOD, V117, P1415, DOI 10.1182/blood-2010-03-275289; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Liz MA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-47; Lynch CD, 2011, MOL BIOL CELL, V22, P1263, DOI 10.1091/mbc.E10-08-0661; Merianda TT, 2013, J CELL SCI, V126, P90, DOI 10.1242/jcs.107268; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Saijilafu, 2013, NEUROSCI BULL, V29, P411, DOI 10.1007/s12264-013-1357-4; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang JP, 2013, J NEUROSCI, V33, P15735, DOI 10.1523/JNEUROSCI.1939-13.2013; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	51	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22759	22770		10.1074/jbc.M115.638445	http://dx.doi.org/10.1074/jbc.M115.638445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26157139	Green Published, hybrid			2022-12-28	WOS:000361171500039
J	Granner, DK				Granner, Daryl K.			In Pursuit of Genes of Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; ACID RESPONSE ELEMENT; AMINOTRANSFERASE MESSENGER-RNA; HEXOKINASE-II GENE; DIBUTYRYL-CYCLIC-AMP; TYROSINE-AMINOTRANSFERASE; RETINOIC ACID; GLUCOCORTICOID RESPONSE; HYPOPHYSECTOMIZED RATS; GLUCOKINASE GENE		[Granner, Daryl K.] Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA	University of Iowa	Granner, DK (corresponding author), Univ Iowa, Mol Physiol & Biophys, Iowa City, IA 52242 USA.	daryl-granner@uiowa.edu						ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ANDREONE TL, 1982, J BIOL CHEM, V257, P35; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; BALHORN R, 1975, BIOCHEMISTRY-US, V14, P2504, DOI 10.1021/bi00682a033; BARNETT CA, 1971, J BIOL CHEM, V246, P7201; BEALE EG, 1982, J BIOL CHEM, V257, P2022; BEALE EG, 1985, J BIOL CHEM, V260, P748; BEALE EG, 1981, BIOCHEMISTRY-US, V20, P4878, DOI 10.1021/bi00520a012; CHAN L, 1973, P NATL ACAD SCI USA, V70, P1870, DOI 10.1073/pnas.70.6.1870; DIESTERHAFT M, 1980, EUR J BIOCHEM, V108, P357, DOI 10.1111/j.1432-1033.1980.tb04730.x; DIESTERHAFT M, 1977, BIOCHEM BIOPH RES CO, V79, P1015, DOI 10.1016/0006-291X(77)91106-8; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; FOREST CD, 1990, MOL ENDOCRINOL, V4, P1302, DOI 10.1210/mend-4-9-1302; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; GRANNER D, 1990, J BIOL CHEM, V265, P10173; Granner DK, 2015, ADV EXP MED BIOL, V872, P3, DOI 10.1007/978-1-4939-2895-8_1; GRANNER DK, 1968, J MOL BIOL, V35, P291, DOI 10.1016/S0022-2836(68)80025-7; GRANNER DK, 1970, J BIOL CHEM, V245, P1472; GRANNER DK, 1962, ENDOCRINOLOGY, V71, P816, DOI 10.1210/endo-71-5-816; GRANNER DK, 1963, ENDOCRINOLOGY, V72, P503, DOI 10.1210/endo-72-3-503; GRANNER DK, 1963, ENDOCRINOLOGY, V72, P100, DOI 10.1210/endo-72-1-100; GUNN JM, 1975, BIOCHEMISTRY-US, V14, P2350, DOI 10.1021/bi00682a012; HALL RK, 1992, MOL CELL BIOL, V12, P5527, DOI 10.1128/MCB.12.12.5527; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hall RK, 2007, MOL ENDOCRINOL, V21, P550, DOI 10.1210/me.2006-0307; Hanson RW, 2005, J BIOL CHEM, V280, P1705, DOI 10.1074/jbc.X400009200; Hargrove J. L., 1983, TRANSAMINASES, P511; HAYASHI SI, 1967, J BIOL CHEM, V242, P3998; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1977, J BIOL CHEM, V252, P655; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Larner J, 2013, J BIOL CHEM, V288, P12313, DOI 10.1074/jbc.X113.471177; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; LUCAS PC, 1991, MOL CELL BIOL, V11, P5164, DOI 10.1128/MCB.11.10.5164; MAGNUSON MA, 1987, J BIOL CHEM, V262, P14917; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MARTIN D, 1969, P NATL ACAD SCI USA, V62, P248, DOI 10.1073/pnas.62.1.248; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; NICKOL JM, 1976, BIOCHEM BIOPH RES CO, V72, P687, DOI 10.1016/S0006-291X(76)80094-0; NOGUCHI T, 1978, J BIOL CHEM, V253, P1332; OBrien RM, 1995, BBA-GENE STRUCT EXPR, V1264, P284, DOI 10.1016/0167-4781(95)00194-8; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; ODoherty RM, 1996, J APPL PHYSIOL, V81, P789, DOI 10.1152/jappl.1996.81.2.789; ODOHERTY RM, 1994, AM J PHYSIOL, V266, pE171; OLSON PS, 1980, BIOCHEMISTRY-US, V19, P1705, DOI 10.1021/bi00549a029; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Osawa H, 1996, J BIOL CHEM, V271, P16690, DOI 10.1074/jbc.271.28.16690; OSAWA H, 1995, DIABETES, V44, P1426, DOI 10.2337/diabetes.44.12.1426; Osawa H, 1996, J BIOL CHEM, V271, P17296, DOI 10.1074/jbc.271.29.17296; PARSLOW TG, 1983, NUCLEIC ACIDS RES, V11, P4775, DOI 10.1093/nar/11.14.4775; PARSLOW TG, 1982, NATURE, V299, P449, DOI 10.1038/299449a0; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PETERKOFSKY B, 1968, P NATL ACAD SCI USA, V60, P222, DOI 10.1073/pnas.60.1.222; PLESKO MM, 1983, J BIOL CHEM, V258, P3738; PRINTZ RL, 1995, DIABETES, V44, P290, DOI 10.2337/diabetes.44.3.290; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; RINGOLD GM, 1975, CELL, V6, P299, DOI 10.1016/0092-8674(75)90181-6; ROEWEKAMP WG, 1976, EUR J BIOCHEM, V70, P259, DOI 10.1111/j.1432-1033.1976.tb10977.x; SAMUELS HH, 1970, J MOL BIOL, V52, P57, DOI 10.1016/0022-2836(70)90177-4; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SASAKI K, 1988, P NATL ACAD SCI USA, V85, P2954, DOI 10.1073/pnas.85.9.2954; SCHIMKE RT, 1965, J BIOL CHEM, V240, P322; Scott DK, 1998, MOL ENDOCRINOL, V12, P482, DOI 10.1210/me.12.4.482; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SHRAGO E, 1963, J BIOL CHEM, V238, P3188; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; SUTHERLAND C, 1995, J BIOL CHEM, V270, P15501, DOI 10.1074/jbc.270.26.15501; Thompson E. B., 1979, HORMONES CELL CULTUR, P339; THOMPSON EB, 1966, P NATL ACAD SCI USA, V56, P296, DOI 10.1073/pnas.56.1.296; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; Wang XHL, 2004, J BIOL CHEM, V279, P34191, DOI 10.1074/jbc.M403455200; WOLF G, 1957, J BIOL CHEM, V225, P995; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	82	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22312	22324		10.1074/jbc.X115.681353	http://dx.doi.org/10.1074/jbc.X115.681353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209640	hybrid, Green Published			2022-12-28	WOS:000361171500001
J	Pan, PY; Marrs, J; Ryan, TA				Pan, Ping-Yue; Marrs, Julia; Ryan, Timothy A.			Vesicular Glutamate Transporter 1 Orchestrates Recruitment of Other Synaptic Vesicle Cargo Proteins during Synaptic Vesicle Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTOSIS; RETRIEVAL; SYNAPTOPHYSIN; EXOCYTOSIS	A long standing question in synaptic physiology is how neurotransmitter-filled vesicles are rebuilt after exocytosis. Among the first steps in this process is the endocytic retrieval of the transmembrane proteins that are enriched in synaptic vesicles (SVs). At least six types of transmembrane proteins must be recovered, but the rules for how this multiple cargo selection is accomplished are poorly understood. Among these SV cargos is the vesicular glutamate transporter (vGlut). We show here that vGlut1 has a strong influence on the kinetics of retrieval of half of the known SV cargos and that specifically impairing the endocytosis of vGlut1 in turn slows down other SV cargos, demonstrating that cargo retrieval is a collective cargo-driven process. Finally, we demonstrate that different cargos can be retrieved in the same synapse with different kinetics, suggesting that additional post-endocytic sorting steps likely occur in the nerve terminal.	[Pan, Ping-Yue; Marrs, Julia; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Pan, Pingyue/0000-0002-2805-6810; Ryan, Timothy/0000-0003-2533-9548	NINDS, National Institutes of Health [NS036942]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942, R37NS036942] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant NS036942 (to T. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Armbruster M, 2011, NAT NEUROSCI, V14, P824, DOI 10.1038/nn.2828; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Koch M, 2012, BBA-MOL CELL BIOL L, V1821, P1114, DOI 10.1016/j.bbalip.2012.02.008; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Willox AK, 2012, CURR BIOL, V22, P1435, DOI 10.1016/j.cub.2012.05.048; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	27	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22593	22601		10.1074/jbc.M115.651711	http://dx.doi.org/10.1074/jbc.M115.651711			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224632	Green Published, hybrid			2022-12-28	WOS:000361171500025
J	Hong, W; Lang, YG; Li, T; Zeng, ZY; Song, Y; Wu, YL; Li, WX; Cao, ZJ				Hong, Wei; Lang, Yange; Li, Tian; Zeng, Zhengyang; Song, Yu; Wu, Yingliang; Li, Wenxin; Cao, Zhijian			A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLUS RIBAVIRIN; PROTEIN; ARCHITECTURE; MECHANISM; VIROPORIN; DESIGN; ENTRY; NS5A	Viral infection is an early stage of its life cycle and represents a promising target for antiviral drug development. Here we designed and characterized three peptide inhibitors of hepatitis C virus (HCV) infection based on the structural features of the membrane-associated p7 polypeptide of HCV. The three peptides exhibited low toxicity and high stability while potently inhibiting initial HCV infection and suppressed established HCV infection at non-cytotoxic concentrations in vitro. The most efficient peptide (designated H2-3), which is derived from the H2 helical region of HCV p7 ion channel, inhibited HCV infection by inactivating both intracellular and extracellular viral particles. The H2-3 peptide inactivated free HCV with an EC50 (50% effective concentration) of 82.11 nM, which is >1000-fold lower than the CC50 (50% cytotoxic concentration) of Huh7.5.1 cells. H2-3 peptide also bound to cell membrane and protected host cells from viral infection. The peptide H2-3 did not alter the normal electrophysiological profile of the p7 ion channel or block viral release from Huh7.5.1 cells. Our work highlights a new anti-viral peptide design strategy based on ion channel, giving the possibility that ion channels are potential resources to generate antiviral peptides.	[Hong, Wei; Lang, Yange; Li, Tian; Zeng, Zhengyang; Song, Yu; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn	Hong, Wei/AAJ-6912-2020	Hong, Wei/0000-0001-7410-4679	National Science Fund for Excellent Young Scholars [31422049]; Hubei Science Fund for Excellent Scholars [2015CFA042]; Fundamental Research Fund for the Central Universities in China [2042014kf0205]; China Scholarship Council [201308420306]	National Science Fund for Excellent Young Scholars; Hubei Science Fund for Excellent Scholars; Fundamental Research Fund for the Central Universities in China; China Scholarship Council(China Scholarship Council)	This work was supported by the grants from National Science Fund for Excellent Young Scholars (31422049), Hubei Science Fund for Excellent Scholars (2015CFA042), Fundamental Research Fund for the Central Universities in China (2042014kf0205), and the China Scholarship Council (201308420306).	Alter HJ, 2005, J HEPATOL, V43, P550, DOI 10.1016/j.jhep.2005.07.002; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Bultmann H, 2002, J BIOL CHEM, V277, P36018, DOI 10.1074/jbc.M204849200; Chamoun AM, 2012, ANTIMICROB AGENTS CH, V56, P672, DOI 10.1128/AAC.05722-11; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Chevaliez S, 2006, HEPATITIS C VIRUSES; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P1448, DOI 10.1016/j.bbamem.2010.08.010; de Witte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018917; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013; Hong W, 2013, BIOMATERIALS, V34, P3511, DOI 10.1016/j.biomaterials.2013.01.075; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Leone N, 2005, Minerva Gastroenterol Dietol, V51, P31; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Liu XY, 2013, J VIROL, V87, P1649, DOI 10.1128/JVI.02201-12; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Qin Z, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13053-8; Steinmann E, 2010, VIRUSES-BASEL, V2, P2078, DOI 10.3390/v2092078; Vieyres G, 2013, J VIROL, V87, P1664, DOI 10.1128/JVI.02782-12; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoon J, 2011, ANTIVIR RES, V92, P470, DOI 10.1016/j.antiviral.2011.10.009; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	30	3	4	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23254	23263		10.1074/jbc.M115.662452	http://dx.doi.org/10.1074/jbc.M115.662452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26251517	hybrid, Green Published			2022-12-28	WOS:000361685500034
J	Igoucheva, O; Alexeev, V; Halabi, CM; Adams, SM; Stoilov, I; Sasaki, T; Arita, M; Donahue, A; Mecham, RP; Birk, DE; Chu, ML				Igoucheva, Olga; Alexeev, Vitali; Halabi, Carmen M.; Adams, Sheila M.; Stoilov, Ivan; Sasaki, Takako; Arita, Machiko; Donahue, Adele; Mecham, Robert P.; Birk, David E.; Chu, Mon-Li			Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; connective tissue; elastin; extracellular matrix; lysyl oxidase; skin; tendon; aneurysm; aorta; forelimb	OF-THE-LITERATURE; LATENT TGF-BETA; LYSYL OXIDASE; OSTEOGENESIS IMPERFECTA; ARTERIAL TORTUOSITY; TISSUE LOCALIZATION; GENDER-DIFFERENCES; MATRIX PROTEINS; AORTIC-ANEURYSM; ELASTOGENESIS	Background: Mutations in fibulin-4 cause autosomal recessive cutis laxa 1B, characterized by loose skin with vascular, lung, and skeletal abnormalities. Results: A mouse strain carrying a recurrent fibulin-4 missense mutation was generated and characterized. Conclusion: Mutant mice recapitulate the complete clinical features of the disease. Significance: The study provides the first evidence that fibulin-4 regulates collagen fibrillogenesis. Fibulin-4 is an extracellular matrix protein essential for elastic fiber formation. Frameshift and missense mutations in the fibulin-4 gene (EFEMP2/FBLN4) cause autosomal recessive cutis laxa (ARCL) 1B, characterized by loose skin, aortic aneurysm, arterial tortuosity, lung emphysema, and skeletal abnormalities. Homozygous missense mutations in FBLN4 are a prevalent cause of ARCL 1B. Here we generated a knock-in mouse strain bearing a recurrent fibulin-4 E57K homozygous missense mutation. The mutant mice survived into adulthood and displayed abnormalities in multiple organ systems, including loose skin, bent forelimb, aortic aneurysm, tortuous artery, and pulmonary emphysema. Biochemical studies of dermal fibroblasts showed that fibulin-4 E57K mutant protein was produced but was prone to dimer formation and inefficiently secreted, thereby triggering an endoplasmic reticulum stress response. Immunohistochemistry detected a low level of fibulin-4 E57K protein in the knock-in skin along with altered expression of selected elastic fiber components. Processing of a precursor to mature lysyl oxidase, an enzyme involved in cross-linking of elastin and collagen, was compromised. The knock-in skin had a reduced level of desmosine, an elastin-specific cross-link compound, and ultrastructurally abnormal elastic fibers. Surprisingly, structurally aberrant collagen fibrils and altered organization into fibers were characteristics of the knock-in dermis and forelimb tendons. Type I collagen extracted from the knock-in skin had decreased amounts of covalent intermolecular cross-links, which could contribute to the collagen fibril abnormalities. Our studies provide the first evidence that fibulin-4 plays a role in regulating collagen fibril assembly and offer a preclinical platform for developing treatments for ARCL 1B.	[Igoucheva, Olga; Alexeev, Vitali; Arita, Machiko; Donahue, Adele; Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Halabi, Carmen M.; Stoilov, Ivan; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Adams, Sheila M.; Birk, David E.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33612 USA; [Sasaki, Takako] Oita Univ, Dept Biochem, Fac Med, Yufu, Oita 8795593, Japan	Jefferson University; Washington University (WUSTL); State University System of Florida; University of South Florida; Oita University	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 South 10th St, Philadelphia, PA 19107 USA.	mon-li.chu@jefferson.edu	Halabi, Carmen/V-5978-2019; Birk, David/I-4072-2012; Regan, Clinton/E-6250-2012	Halabi, Carmen/0000-0003-4889-8131; Birk, David/0000-0002-4865-9088; 	National Institutes of Health [AR056523, HL53325, HL105314, AR044745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053325, R37HL053325, R01HL105314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044745, R21AR056523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056523 (M.-L.C.),HL53325 (R.P.M.), HL105314 (R.P.M.), and AR044745 (D.E.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acharya M, 2012, MOL VIS, V18, P2182; Al-Hassnan ZN, 2012, AM J CARDIOL, V109, P1677, DOI 10.1016/j.amjcard.2012.01.394; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cheng JK, 2013, BIOMECH MODEL MECHAN, V12, P497, DOI 10.1007/s10237-012-0420-9; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Dao H, 2007, GENDER MED, V4, P308; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Erickson LK, 2012, PEDIATR DEVEL PATHOL, V15, P137, DOI 10.2350/11-03-1010-CR.1; Gallagher WM, 2001, FEBS LETT, V489, P59, DOI 10.1016/S0014-5793(00)02389-9; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hebson C, 2014, EUR J PEDIATR, V173, P671, DOI 10.1007/s00431-013-2217-y; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Holmberg J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-25; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Hoyer J, 2009, CLIN GENET, V76, P276, DOI 10.1111/j.1399-0004.2009.01204.x; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Iascone M, 2012, CIRCULATION, V126, P2764, DOI 10.1161/CIRCULATIONAHA.112.119883; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Kappanayil M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-61; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Papke CL, 2014, MATRIX BIOL, V37, P142, DOI 10.1016/j.matbio.2014.02.004; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ramnath NWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106054; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Sawyer SL, 2013, AM J MED GENET A, V161A, P1148, DOI 10.1002/ajmg.a.35827; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Uitto J, 2013, EXP DERMATOL, V22, P88, DOI 10.1111/exd.12025; Urban Z, 2014, MATRIX BIOL, V33, P16, DOI 10.1016/j.matbio.2013.07.006; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Xiang Y, 2006, J IMMUNOL, V176, P3196, DOI 10.4049/jimmunol.176.5.3196; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009	49	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21443	21459		10.1074/jbc.M115.640425	http://dx.doi.org/10.1074/jbc.M115.640425			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178373	Green Published, hybrid			2022-12-28	WOS:000360637600021
J	Sarkar, A; Dai, Y; Haque, MM; Seeger, F; Ghosh, A; Garcin, ED; Montfort, WR; Hazen, SL; Misra, S; Stuehr, DJ				Sarkar, Anindya; Dai, Yue; Haque, Mohammad Mahfuzul; Seeger, Franziska; Ghosh, Arnab; Garcin, Elsa D.; Montfort, William R.; Hazen, Stanley L.; Misra, Saurav; Stuehr, Dennis J.			Heat Shock Protein 90 Associates with the Per-Arnt-Sim Domain of Heme-free Soluble Guanylate Cyclase IMPLICATIONS FOR ENZYME MATURATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); fluorescence anisotropy; heat shock protein 90 (hsp90); hydrogen exchange mass spectrometry; protein-protein interaction; signal transduction; H-NOX domain; PAS domain; heme insertion; structural modeling	ARYL-HYDROCARBON RECEPTOR; MOLECULAR CHAPERONE HSP90; NITRIC-OXIDE SYNTHASE; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; INDUCED ACTIVATION; ESCHERICHIA-COLI; KINASE-ACTIVITY; CLIENT PROTEIN; ALPHA-SUBUNIT	Background: hsp90 binds to heme-free sGC1 subunit to enable heme insertion during maturation, but the mechanism is unclear. Results: Their interaction involves the hsp90 M domain and the Per-Arnt-Sim (PAS) domain of apo-sGC1. Conclusion: hsp90 may modulate the apo-sGC1 through its PAS domain, suggesting a means to aid heme insertion. Significance: This work expands our knowledge of how hsp90 regulates PAS-containing client proteins like sGC. Heat shock protein 90 (hsp90) drives heme insertion into the 1 subunit of soluble guanylate cyclase (sGC) 1, which enables it to associate with a partner sGC1 subunit and mature into a nitric oxide (NO)-responsive active form. We utilized fluorescence polarization measurements and hydrogen-deuterium exchange mass spectrometry to define molecular interactions between the specific human isoforms hsp90 and apo-sGC1. hsp90 and its isolated M domain, but not its isolated N and C domains, bind with low micromolar affinity to a heme-free, truncated version of sGC1 (sGC1(1-359)-H105F). Surprisingly, hsp90 and its M domain bound to the Per-Arnt-Sim (PAS) domain of apo-sGC-1(1-359), which lies adjacent to its heme-binding (H-NOX) domain. The interaction specifically involved solvent-exposed regions in the hsp90 M domain that are largely distinct from sites utilized by other hsp90 clients. The interaction strongly protected two regions of the sGC1 PAS domain and caused local structural relaxation in other regions, including a PAS dimerization interface and a segment in the H-NOX domain. Our results suggest a means by which the hsp90 interaction could prevent apo-sGC1 from associating with its partner sGC1 subunit while enabling structural changes to assist heme insertion into the H-NOX domain. This mechanism would parallel that in other clients like the aryl hydrocarbon receptor and HIF1, which also interact with hsp90 through their PAS domains to control protein partner and small ligand binding interactions.	[Sarkar, Anindya; Dai, Yue; Haque, Mohammad Mahfuzul; Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Misra, Saurav] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Seeger, Franziska; Garcin, Elsa D.] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Montfort, William R.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; University of Arizona	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Dai, Yue/AAD-9906-2019; Garcin, Elsa D/C-1556-2013; Regan, Clinton/E-6250-2012; Hazen, Stanley L/ABD-5845-2021	Dai, Yue/0000-0001-9368-7769; Garcin, Elsa D/0000-0003-0501-8421; GHOSH, ARNAB/0000-0002-7498-1994; Misra, Saurav/0000-0002-1385-8554; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM097041, GM051491, HL076491]; American Heart Association [10SDG2600345, 13PRE17000045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097041, R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097041 and GM051491 (to D. J. S.) and HL076491 (to S. L. H.). This work was also supported by American Heart Association Awards 10SDG2600345 (to E. D. G.) and 13PRE17000045 (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Blacklock K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086547; Campbell MG, 2014, P NATL ACAD SCI USA, V111, P2960, DOI 10.1073/pnas.1400711111; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; da Silva VCH, 2012, J PROTEOMICS, V75, P2790, DOI 10.1016/j.jprot.2011.12.028; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Heid SE, 2000, MOL PHARMACOL, V57, P82; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee HC, 2009, PROTEIN PEPTIDE LETT, V16, P642, DOI 10.2174/092986609788490113; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Mukai K, 2011, PROTEIN PEPTIDE LETT, V18, P1251, DOI 10.2174/092986611797642733; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Purohit R, 2014, BIOCHEMISTRY-US, V53, P101, DOI 10.1021/bi4015133; Purohit R, 2013, PROTEIN SCI, V22, P1439, DOI 10.1002/pro.2331; Ratzke C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5192; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schneider S, 2007, NAT PROD REP, V24, P621, DOI 10.1039/b604186h; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Stankiewicz Marta, 2012, Biomol Concepts, V3, P79, DOI 10.1515/bmc.2011.054; Street TO, 2012, J MOL BIOL, V415, P3, DOI 10.1016/j.jmb.2011.10.038; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Tsuji N, 2014, FEBS OPEN BIO, V4, P796, DOI 10.1016/j.fob.2014.09.003; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Whitesell L, 2014, P NATL ACAD SCI USA, V111, P18297, DOI 10.1073/pnas.1421323111; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022	68	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21615	21628		10.1074/jbc.M115.645515	http://dx.doi.org/10.1074/jbc.M115.645515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26134567	Green Published, hybrid			2022-12-28	WOS:000360637600034
J	Antonopoulos, C; Russo, HM; El Sanadi, C; Martin, BN; Li, XX; Kaiser, WJ; Mocarski, ES; Dubyak, GR				Antonopoulos, Christina; Russo, Hana M.; El Sanadi, Caroline; Martin, Bradley N.; Li, Xiaoxia; Kaiser, William J.; Mocarski, Edward S.; Dubyak, George R.			Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; P2X7 RECEPTOR; ATP RELEASE; INTERLEUKIN-1-BETA MATURATION; CASPASE-8-DEPENDENT APOPTOSIS; IL-1-BETA PRODUCTION; CONVERTING-ENZYME; MOLECULAR-CLONING; MATURE IL-1-BETA	We recently described the induction of noncanonical IL-1 beta processing via caspase-8 recruited to ripoptosome signaling platforms in myeloid leukocytes. Here, we demonstrate that activated NLRP3.ASC inflammasomes recruit caspase-8 to drive IL-1 beta processing in murine bone marrow-derived dendritic cells (BMDC) independent of caspase-1 and -11. Sustained stimulation (> 2 h) of LPS-primed caspase-1-deficient (Casp1/11(-/-)) BMDC with the canonical NLRP3 inflammasome agonist nigericin results in release of bioactive IL-1 beta in conjunction with robust caspase-8 activation. This IL-1 beta processing and caspase-8 activation do not proceed in Nlrp3(-/-) or Asc(-/-) BMDC and are suppressed by pharmacological inhibition of caspase-8, indicating that caspase-8 can act as a direct IL-1 beta-converting enzyme during NLRP3 inflammasome activation. In contrast to the rapid caspase-1-mediated death of wild type (WT) BMDC via NLRP3-dependent pyroptosis, nigericinstimulated Casp1/11(-/-) BMDC exhibit markedly delayed cell death via NLRP3-dependent apoptosis. Biochemical analyses of WTand Casp1/11(-/-) BMDCindicated that caspase-8 is proteolytically processed within detergent-insoluble ASC-enriched protein complexes prior to extracellular export during nigericin treatment. Although nigericin-stimulated caspase-1 activation and activity are only modestly attenuated in caspase-8-deficient (Casp8(-/-) Rip3(-/-)) BMDC, these cells do not exhibit the rapid loss of viability ofWTcells. These results support a contribution of caspase-8 to both IL-1 beta production and regulated death signaling via NLRP3 inflammasomes. In the absence of caspase-1, NLRP3 inflammasomes directly utilize caspase-8 as both a proapoptotic initiator and major IL-1 beta-converting protease. In the presence of caspase-1, caspase-8 acts as a positive modulator of the NLRP3-dependent caspase-1 signaling cascades that drive both IL-1 beta production and pyroptotic death.	[El Sanadi, Caroline; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Antonopoulos, Christina; Russo, Hana M.; Martin, Bradley N.; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Martin, Bradley N.; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Kaiser, William J.; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Emory University	Dubyak, GR (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	george.dubyak@case.edu	Regan, Clinton/E-6250-2012; Martin, Bradley/AAM-5041-2020; Mocarski, Edward/ABC-2893-2020	Martin, Bradley/0000-0002-8902-8805; Dubyak, George/0000-0001-9720-4226	National Institutes of Health [R01-GM36387, R01-AI118853, OD012198, T32-AI089474, T32-GM007250]; National Multiple Sclerosis Society [RG 5130A2/1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474, R01AI118853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036387, T32GM007250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM36387 (to G. R. D.), R01-AI118853 (to E. S. M.), and OD012198 (to W. J. K.). This work was also supported by National Multiple Sclerosis Society Grant RG 5130A2/1 (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by National Institutes of Health Training Grants T32-AI089474 and T32-GM007250.	Ainscough JS, 2014, J BIOL CHEM, V289, P35582, DOI 10.1074/jbc.M114.595686; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cuda CM, 2014, J IMMUNOL, V192, P5548, DOI 10.4049/jimmunol.1400122; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Estacion M, 2003, AM J PHYSIOL-CELL PH, V284, pC1006, DOI 10.1152/ajpcell.00258.2002; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Ganesan S, 2014, J IMMUNOL, V193, P2519, DOI 10.4049/jimmunol.1400276; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mocarski ES, 2014, J IMMUNOL, V192, P2019, DOI 10.4049/jimmunol.1302426; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; NETT MA, 1992, J IMMUNOL, V149, P3254; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Schilling WP, 2006, AM J PHYSIOL-CELL PH, V291, pC657, DOI 10.1152/ajpcell.00063.2006; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Stehlik C, 2009, ARTHRITIS RHEUM-US, V60, P3524, DOI 10.1002/art.24961; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Uchiyama R, 2013, J IMMUNOL, V190, P4245, DOI 10.4049/jimmunol.1203059; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Verhoef PA, 2004, MOL PHARMACOL, V66, P909, DOI 10.1124/mol.66.4.909; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wu YH, 2014, CELL DEATH DIFFER, V21, P451, DOI 10.1038/cdd.2013.165; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653	78	128	130	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20167	20184		10.1074/jbc.M115.652321	http://dx.doi.org/10.1074/jbc.M115.652321			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26100631	hybrid, Green Published			2022-12-28	WOS:000359608900019
J	Dohlman, HG				Dohlman, Henrik G.			Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Over the past half-century, The Journal of Biological Chemistry has been the venue for many landmark publications on the topic of G protein-coupled receptors (GPCRs, also known as seven-transmembrane receptors). The GPCR superfamily in humans is composed of about 800 members, and is the target of about one-third of all pharmaceuticals. Most of these drugs target a very small subset of GPCRs, and do so by mimicking or competing with endogenous hormones and neurotransmitters. This thematic minireview series examines some emerging trends in GPCR drug discovery. The first article describes efforts to systematically interrogate the human "GPCR-ome," including more than 150 uncharacterized "orphan" receptors. The second article describes recent efforts to target alternative receptor binding sites with drugs that act as allosteric modulators of orthosteric ligands. The third article describes how the recent expansion of GPCR structures is providing new opportunities for computer-guided drug discovery. Collectively, these three articles provide a roadmap for the most important emerging trends in GPCR pharmacology.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729				Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Isom DG, 2015, P NATL ACAD SCI USA, V112, P5702, DOI 10.1073/pnas.1417888112; Jazayeri A, 2015, J BIOL CHEM, V290, P19489, DOI 10.1074/jbc.R115.668251; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764	7	23	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19469	19470		10.1074/jbc.R115.675728	http://dx.doi.org/10.1074/jbc.R115.675728			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26126823	Green Published, hybrid			2022-12-28	WOS:000359364600007
J	Lange, C; Kiesel, S; Peters, S; Virus, S; Scheer, H; Jahn, D; Moser, J				Lange, Christiane; Kiesel, Svenja; Peters, Sabine; Virus, Simone; Scheer, Hugo; Jahn, Dieter; Moser, Juergen			Broadened Substrate Specificity of 3-Hydroxyethyl Bacteriochlorophyllide a Dehydrogenase (BchC) Indicates a New Route for the Biosynthesis of Bacteriochlorophyll a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; PHOTOSYNTHETIC GENE-CLUSTER; L-THREONINE DEHYDROGENASE; COMPLETE GENOME SEQUENCE; GREEN-SULFUR BACTERIUM; RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS SPHEROIDES; CHLOROBIUM-TEPIDUM; ROSEOBACTER-DENITRIFICANS; MDR SUPERFAMILY	Bacteriochlorophyll a biosynthesis requires formation of a 3-hydroxyethyl group on pyrrole ring A that gets subsequently converted into a 3-acetyl group by 3-vinyl bacteriochlorophyllide a hydratase (BchF) followed by 3-hydroxyethyl bacteriochlorophyllide a dehydrogenase (BchC). Heterologous overproduction of Chlorobaculum tepidum BchF revealed an integral transmembrane protein that was efficiently isolated by detergent solubilization. Recombinant C. tepidum BchC was purified as a soluble protein-NAD(+) complex. Substrate recognition of BchC was investigated using six artificial substrate molecules. Modification of the isocyclic E ring, omission of the central magnesium ion, zinc as an alternative metal ion, and a non-reduced B ring system were tolerated by BchC. According to this broadened in vitro activity, the chlorin 3-hydroxyethyl chlorophyllide a was newly identified as a natural substrate of BchC in a reconstituted pathway consisting of dark-operative protochlorophyllide oxidoreductase, BchF, and BchC. The established reaction sequence would allow for an additional new branching point for the synthesis of bacteriochlorophyll a. Biochemical and site-directed mutagenesis analyses revealed, in contrast to theoretical predictions, a zinc-independent BchC catalysis that requires NAD(+) as a cofactor. Based on these results, we are designating a new medium-chain dehydrogenase/reductase family (MDR057 BchC) as theoretically proposed from a recent bioinformatics analysis.	[Lange, Christiane; Kiesel, Svenja; Peters, Sabine; Virus, Simone; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Scheer, Hugo] Univ Munich, Dept Biol 1, Bot, D-80638 Munich, Germany	Braunschweig University of Technology; University of Munich	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [JA 470/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant JA 470/9-2. The authors declare that they have no conflicts of interest with the contents of this article.	Addlesee HA, 2000, J BACTERIOL, V182, P3175, DOI 10.1128/JB.182.11.3175-3182.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; BOLLIVAR DW, 1994, BIOCHEMISTRY-US, V33, P12763, DOI 10.1021/bi00209a006; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Brocker MJ, 2012, HANDB PORPHYR SCI, V20, P1; BROUERS M, 1983, PHOTOSYNTH RES, V4, P265, DOI [10.1007/BF00052130, 10.1007/BF00041822]; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Ganapathy S, 2012, BIOCHEMISTRY-US, V51, P4488, DOI 10.1021/bi201817x; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; Gough SP, 2007, PLANT PHYSIOL BIOCH, V45, P932, DOI 10.1016/j.plaphy.2007.09.001; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Harada J, 2014, J BIOL CHEM, V289, P12716, DOI 10.1074/jbc.M113.546739; Hartwich G, 1998, J AM CHEM SOC, V120, P3675, DOI 10.1021/ja970874u; Hebecker S, 2011, MOL MICROBIOL, V80, P935, DOI 10.1111/j.1365-2958.2011.07621.x; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Helfrich M, 1996, J AM CHEM SOC, V118, P2606, DOI 10.1021/ja953440c; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; JONES OTG, 1964, BIOCHEM J, V91, P572, DOI 10.1042/bj0910572; Kiesel S, 2015, J BIOL CHEM, V290, P1141, DOI 10.1074/jbc.M114.617761; Kim EJ, 2008, J BIOL CHEM, V283, P3718, DOI 10.1074/jbc.M707774200; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; LASCELLES J, 1966, BIOCHEM J, V100, P175, DOI 10.1042/bj1000175; Liu Z., 2012, HDB PORPHYRIN SCI CH, P107; Liu ZF, 2011, J BIOL CHEM, V286, P22393, DOI 10.1074/jbc.M111.249433; Machielsen R, 2006, FEBS J, V273, P2722, DOI 10.1111/j.1742-4658.2006.05290.x; MAGONET E, 1992, BIOCHEM J, V287, P361, DOI 10.1042/bj2870361; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MCGLYNN P, 1993, MOL GEN GENET, V236, P227, DOI 10.1007/BF00277117; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Muller AH, 2011, ANAL BIOCHEM, V419, P271, DOI 10.1016/j.ab.2011.08.028; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Oster U, 1997, J BIOL CHEM, V272, P9671; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; PUDEK MR, 1975, BIOCHEMISTRY-US, V14, P3132, DOI 10.1021/bi00685a015; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; RICHARDS WR, 1969, BIOCHEMISTRY-US, V8, P3473, DOI 10.1021/bi00836a051; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Scheer Hugo, 2006, V25, P1; Schiefner A, 2013, J BIOL CHEM, V288, P16815, DOI 10.1074/jbc.M113.453852; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH JRL, 1966, J AM CHEM SOC, V88, P4500, DOI 10.1021/ja00971a036; STRUCK A, 1992, BIOCHIM BIOPHYS ACTA, V1101, P321, DOI 10.1016/0167-4838(92)90559-V; TAYLOR DP, 1983, J BACTERIOL, V154, P580, DOI 10.1128/JB.154.2.580-590.1983; Tsukatani Y, 2013, BBA-BIOENERGETICS, V1827, P1200, DOI 10.1016/j.bbabio.2013.06.007; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; WELLINGTON CL, 1989, GENE, V83, P251, DOI 10.1016/0378-1119(89)90111-X; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990; YOUNG DA, 1989, MOL GEN GENET, V218, P1, DOI 10.1007/BF00330558; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; ZSEBO KM, 1984, CELL, V37, P937, DOI 10.1016/0092-8674(84)90428-8	68	9	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19697	19709		10.1074/jbc.M115.660555	http://dx.doi.org/10.1074/jbc.M115.660555			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088139	hybrid, Green Published			2022-12-28	WOS:000359364600029
J	Franco, MC; Ricart, KC; Gonzalez, AS; Dennys, CN; Nelson, PA; Janes, MS; Mehl, RA; Landar, A; Estevez, AG				Franco, Maria C.; Ricart, Karina C.; Gonzalez, Analia S.; Dennys, Cassandra N.; Nelson, Pascal A.; Janes, Michael S.; Mehl, Ryan A.; Landar, Aimee; Estevez, Alvaro G.			Nitration of Hsp90 on Tyrosine 33 Regulates Mitochondrial Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXYNITRITE-INDUCED APOPTOSIS; CYTOCHROME-C-OXIDASE; NITRIC-OXIDE; CHAPERONE MACHINERY; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ATP HYDROLYSIS; GROWTH-FACTOR; PC12 CELLS; PHOSPHORYLATION	Peroxynitrite production and tyrosine nitration are present in several pathological conditions, including neurodegeneration, stroke, aging, and cancer. Nitration of the pro-survival chaperone heat shock protein 90 (Hsp90) in position 33 and 56 induces motor neuron death through a toxic gain-of-function. Here we show that nitrated Hsp90 regulates mitochondrial metabolism independently of the induction of cell death. In PC12 cells, a small fraction of nitrated Hsp90 was located on the mitochondrial outer membrane and down-regulated mitochondrial membrane potential, oxygen consumption, and ATP production. Neither endogenous Hsp90 present in the homogenate nor unmodified and fully active recombinant Hsp90 was able to compete with the nitrated protein for the binding to mitochondria. Moreover, endogenous or recombinant Hsp90 did not prevent the decrease in mitochondrial activity but supported nitrated Hsp90 mitochondrial gain-of-function. Nitrotyrosine in position 33, but not in any of the other four tyrosine residues prone to nitration in Hsp90, was sufficient to down-regulate mitochondrial activity. Thus, in addition to induction of cell death, nitrated Hsp90 can also regulate mitochondrial metabolism, suggesting that depending on the cell type, distinct Hsp90 nitration states regulate different aspects of cellular metabolism. This regulation of mitochondrial homeostasis by nitrated Hsp90 could be of particular relevance in cancer cells.	[Franco, Maria C.; Dennys, Cassandra N.; Nelson, Pascal A.; Estevez, Alvaro G.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Ricart, Karina C.; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Gonzalez, Analia S.] Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Janes, Michael S.] ThermoFisher Sci, Eugene, OR 97402 USA; [Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	State University System of Florida; University of Central Florida; University of Alabama System; University of Alabama Birmingham; University of Buenos Aires; Oregon State University	Franco, MC (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA.	mariaclara.franco@ucf.edu	Franco, Maria/O-7862-2015		 [P30 ES00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sarah B. Gitto and Jonathan Virgilio for technical assistance and Victor Darley-Usmar and Paul S. Brookes for constructive criticism on the manuscript. The Oregon State University Cell Imaging and Analysis Facilities of the Environmental Health Sciences Center is supported by Grant P30 ES00210 (to R. A. M.).	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Borutaite V, 1999, BBA-MOL BASIS DIS, V1453, P41, DOI 10.1016/S0925-4439(98)00082-9; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brookes PS, 1998, J NEUROCHEM, V70, P2195; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Cobbs CS, 2001, ARCH BIOCHEM BIOPHYS, V394, P167, DOI 10.1006/abbi.2001.2540; Cooley RB, 2014, BIOCHEMISTRY-US, V53, P1916, DOI 10.1021/bi5001239; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Flynn JM, 2015, J MOL BIOL, V427, P2904, DOI 10.1016/j.jmb.2015.03.017; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200; Gadelha FR, 1997, ARCH BIOCHEM BIOPHYS, V345, P243, DOI 10.1006/abbi.1997.0259; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kawasaki H, 2011, FREE RADICAL BIO MED, V50, P419, DOI 10.1016/j.freeradbiomed.2010.10.688; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Nakamura Y, 2006, CLIN CANCER RES, V12, P1201, DOI 10.1158/1078-0432.CCR-05-1269; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Reardon DA, 2012, J NEURO-ONCOL, V107, P213, DOI 10.1007/s11060-011-0740-0; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Robinson KM, 2005, METHOD ENZYMOL, V396, P207, DOI 10.1016/S0076-6879(05)96019-9; Sahawneh MA, 2010, J BIOL CHEM, V285, P33885, DOI 10.1074/jbc.M110.118901; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Sreedhar AS, 2004, FEBS LETT, V562, P11; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Viera L, 2013, FREE RADICAL BIO MED, V55, P101, DOI 10.1016/j.freeradbiomed.2012.10.535; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	54	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19055	19066		10.1074/jbc.M115.663278	http://dx.doi.org/10.1074/jbc.M115.663278			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085096	Green Published, hybrid			2022-12-28	WOS:000358781100023
J	Tian, HP; Lun, SM; Huang, HJ; He, R; Kong, PZ; Wang, QS; Li, XQ; Feng, YM				Tian, Hong-Pan; Lun, Shu-Min; Huang, Huan-Jing; He, Rui; Kong, Peng-Zhou; Wang, Qing-Shan; Li, Xiao-Qing; Feng, Yu-Mei			DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; HUMAN PROSTATE; FACTOR SP1; TGF-BETA; METASTASIS; METHYLTRANSFERASES; PROLIFERATION; PROGRESSION; MECHANISMS	FOXF2 (forkhead box F2) is a mesenchyme-specific transcription factor that plays a critical role in tissue homeostasis through the maintenance of epithelial polarity. In a previous study, we demonstrated that FOXF2 is specifically expressed in basal-like breast cancer (BLBC) cells and functions as an epithelial-mesenchymal transition suppressor. FOXF2 deficiency enhances the metastatic ability of BLBC cells through activation of the epithelial-mesenchymal transition program, but reduces cell proliferation. In this study, we demonstrate that CpG island methylation of the FOXF2 proximal promoter region is involved in the regulatory mechanism of the subtype-specific expression of FOXF2 in breast cancer cells. DNMT1, DNMT3A, and DNMT3B commonly or individually contributed to this DNA methylation in different breast cancer cells. SP1 regulated the transcriptional activity of FOXF2 through direct binding to the proximal promoter region, whereas this binding was abrogated through DNA methylation. FOXF2 mediated the SP1-regulated suppression of progression and promotion of proliferation of non-methylated BLBC cells. Thus, we conclude that the subtype-specific expression and function of FOXF2 in breast cancer cells are regulated through the combined effects of DNA methylation and SP1 transcriptional regulation.	[Tian, Hong-Pan; Lun, Shu-Min; Huang, Huan-Jing; He, Rui; Kong, Peng-Zhou; Wang, Qing-Shan; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Wang, Qing-Shan; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Minist Educ, Key Lab Breast Canc Prevent & Treatment, Tianjin 300060, Peoples R China	Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	ymfeng@tijmu.edu.cn			National Natural Science Foundation of China [81272357, 81472680]; Major Program of Applied Basic Research Projects of Tianjin Grant [13JCZDJC30100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Applied Basic Research Projects of Tianjin Grant	This work was supported by National Natural Science Foundation of China Grants 81272357 and 81472680 and Major Program of Applied Basic Research Projects of Tianjin Grant 13JCZDJC30100. The authors declare that they have no conflicts of interest with the contents of this article.	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dunwell T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-44; Guo D, 2012, BIOCHEM BIOPH RES CO, V428, P80, DOI 10.1016/j.bbrc.2012.10.010; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kolesnikoff N, 2014, J BIOL CHEM, V289, P11194, DOI 10.1074/jbc.M113.529172; Kong PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061591; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang QS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0531-1; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Yue L, 2013, CARCINOGENESIS, V34, P927, DOI 10.1093/carcin/bgs399	33	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19173	19183		10.1074/jbc.M114.636126	http://dx.doi.org/10.1074/jbc.M114.636126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070560	Green Published, hybrid			2022-12-28	WOS:000358781100032
J	Wen, GM; Zhang, C; Chen, QS; Luong, LA; Mustafa, A; Ye, S; Xiao, QZ				Wen, Guanmei; Zhang, Cheng; Chen, Qishan; Luong, Le Anh; Mustafa, Arif; Ye, Shu; Xiao, Qingzhong			A Novel Role of Matrix Metalloproteinase-8 in Macrophage Differentiation and Polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; IN-VIVO; ACTIVATION; MICE; FIBROMODULIN; SUBSETS; ATHEROSCLEROSIS; HETEROGENEITY; INFLAMMATION	Matrix metalloproteinase-8 (MMP8) has been shown to influence various cellular functions. As monocytes and macrophages (M phi) express MMP8, we investigated if MMP8 played a role in macrophage differentiation and polarization. MMP8 expression was significantly increased during monocyte differentiation into M phi. Monocyte-derived M phi from MMP8-deficient mice expressed higher levels of M1-M phi markers but lower levels of M2-M phi markers than monocyte-derived M phi from wild-type mice. Although M phi from either MMP8-deficient or wild-type mice were inducible by interferon-gamma into M1-M phi, only wildtype M phi but not MMP8-deficient M phi could be induced into M2-M phi by interleukin-4. However, MMP8-deficient M phi exposed to conditioned culture media of wild-type M phi developed a M2-M phi phenotype. Compared with conditioned culture media of wild-type M phi, conditioned culture media of MMP8-deficient M phi contained a lower concentration of active transforming growth factor-beta (TGF-beta), an M2-M phi inducer. Moreover, evidence also showed that the degradation of the TGF-beta sequester, fibromodulin, was modulated by MMP8. The data indicate a previously unknown role of MMP8 in M2-M phi polarization by cleaving fibromodulin and therefore increasing the bioavailability of the M2-M phi inducer TGF-beta.	[Wen, Guanmei; Zhang, Cheng; Chen, Qishan; Luong, Le Anh; Ye, Shu; Xiao, Qingzhong] Queen Mary Univ London, Ctr Clin Pharmacol, London EC1M 6BQ, England; [Mustafa, Arif] Queen Mary Univ London, Biol Serv Unit, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Wen, Guanmei] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou 510182, Guangdong, Peoples R China; [Zhang, Cheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Thorac Surg & Cardio Thorac Surg, Chongqing 400016, Peoples R China	University of London; Queen Mary University London; University of London; Queen Mary University London; Guangzhou Medical University; Chongqing Medical University	Xiao, QZ (corresponding author), Queen Mary Univ London, Ctr Clin Pharmacol, London EC1M 6BQ, England.	sy127@le.ac.uk; q.xiao@qmul.ac.uk	Ye, Shu/R-6384-2017; wen, guanmei/E-4969-2013	Ye, Shu/0000-0002-4126-4278; 	National Institute of Health Research; British Heart Foundation [PG/13/45/30326, FS/09/044/28007, PG/11/40/28891, PG/15/11/31279] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Butcher MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00044; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Krakowiak MS, 2015, ONCOGENE, V34, P1865, DOI 10.1038/onc.2014.135; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Roch T, 2014, CLIN HEMORHEOL MICRO, V58, P147, DOI 10.3233/CH-141885; Shimada K, 2009, CIRC J, V73, P994, DOI 10.1253/circj.CJ-09-0277; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Soria-Valles C, 2014, ONCOGENE, V33, P3054, DOI 10.1038/onc.2013.267; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Williams HJ, 2012, J INNATE IMMUN, V4, P498, DOI 10.1159/000336618; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2014, ARTERIOSCL THROM VAS, V34, P90, DOI 10.1161/ATVBAHA.113.301418; Xiao QZ, 2013, CIRC RES, V112, P35, DOI 10.1161/CIRCRESAHA.112.274019; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Zheng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096011, 10.1371/journal.pone.0090817]	41	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19158	19172		10.1074/jbc.M114.634022	http://dx.doi.org/10.1074/jbc.M114.634022			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26092731	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000358781100031
J	Patterson, MA; Bandyopadhyay, A; Devaraneni, PK; Woodward, J; Rooney, L; Yang, ZY; Skach, WR				Patterson, Melissa A.; Bandyopadhyay, Anannya; Devaraneni, Prasanna K.; Woodward, Josha; Rooney, LeeAnn; Yang, Zhongying; Skach, William R.			The Ribosome-Sec61 Translocon Complex Forms a Cytosolically Restricted Environment for Early Polytopic Membrane Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; endoplasmic reticulum (ER); membrane protein; protein folding; protein translocation; ribosome function; polytopic membrane protein; ribosome translocon complex; sec61 translocon	ENDOPLASMIC-RETICULUM MEMBRANE; TRANSMEMBRANE CONDUCTANCE REGULATOR; ER MEMBRANE; SEC61 TRANSLOCON; SIGNAL SEQUENCE; WATER CHANNELS; INTEGRATION; SEGMENTS; BIOGENESIS; INSERTION	Transmembrane topology of polytopic membrane proteins (PMPs) is established in the endoplasmic reticulum (ER) by the ribosome Sec61-translocon complex (RTC) through iterative cycles of translocation initiation and termination. It remains unknown, however, whether tertiary folding of transmembrane domains begins after the nascent polypeptide integrates into the lipid bilayer or within a proteinaceous environment proximal to translocon components. To address this question, we used cysteine scanning mutagenesis to monitor aqueous accessibility of stalled translation intermediates to determine when, during biogenesis, hydrophilic peptide loops of the aquaporin-4 (AQP4) water channel are delivered to cytosolic and lumenal compartments. Results showed that following ribosome docking on the ER membrane, the nascent polypeptide was shielded from the cytosol as it emerged from the ribosome exit tunnel. Extracellular loops followed a well defined path through the ribosome, the ribosome translocon junction, the Sec61-translocon pore, and into the ER lumen coincident with chain elongation. In contrast, intracellular loops (ICLs) and C-terminalresidues exited the ribosome into a cytosolically shielded environment and remained inaccessible to both cytosolic and lumenal compartments until translation was terminated. Shielding of ICL1 and ICL2, but not the C terminus, became resistant to maneuvers that disrupt electrostatic ribosome interactions. Thus, the early folding landscape of polytopic proteins is shaped by a spatially restricted environment localized within the assembled ribosome translocon complex.	[Patterson, Melissa A.; Bandyopadhyay, Anannya; Devaraneni, Prasanna K.; Woodward, Josha; Rooney, LeeAnn; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem Mol Biol, Portland, OR 97239 USA; [Skach, William R.] Cyst Fibrosis Fdn, CFFT, Bethesda, MD 20814 USA	Oregon Health & Science University; Cystic Fibrosis Foundation	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	skachw@ohsu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK51818, GM53457, T32 HL083808]; Cystic Fibrosis Foundation Therapeutics Inc. [SKACH05X0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51818 (to W. R. S.), GM53457 (to W. R. S.), and T32 HL083808 (to M. A. P.), and Cystic Fibrosis Foundation Therapeutics Inc. Grant SKACH05X0 (to W. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Carveth K, 2002, J BIOL CHEM, V277, P39507, DOI 10.1074/jbc.M205759200; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Conti BJ, 2014, NAT STRUCT MOL BIOL, V21, P228, DOI 10.1038/nsmb.2779; Cross BCS, 2009, J CELL SCI, V122, P1768, DOI 10.1242/jcs.046094; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; HIGH S, 1992, Current Opinion in Cell Biology, V4, P581, DOI 10.1016/0955-0674(92)90075-N; HIGH S, 1993, J BIOL CHEM, V268, P26745; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Johnson AE, 2005, FEBS LETT, V579, P916, DOI 10.1016/j.febslet.2004.11.046; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kida Y, 2010, MOL BIOL CELL, V21, P418, DOI 10.1091/mbc.E09-08-0738; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; LIN JL, 1995, J BIOL CHEM, V270, P6935, DOI 10.1074/jbc.270.12.6935; Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matsumura Y, 2011, METHODS MOL BIOL, V741, P233, DOI 10.1007/978-1-61779-117-8_16; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacock SL, 2002, MOL BIOL CELL, V13, P4114, DOI 10.1091/mbc.E02-04-0198; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Oberdorf J, 2005, J BIOL CHEM, V280, P38193, DOI 10.1074/jbc.M504200200; Ojemalm K, 2013, J CELL SCI, V126, P464, DOI 10.1242/jcs.111773; Ojemalm K, 2012, MOL CELL, V45, P529, DOI 10.1016/j.molcel.2011.12.024; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Sauri A, 2005, J BIOL CHEM, V280, P25907, DOI 10.1074/jbc.M412476200; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; SHI LB, 1995, BIOCHEMISTRY-US, V34, P8250, DOI 10.1021/bi00026a006; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; SKACH WR, 1993, J BIOL CHEM, V268, P6903; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VERKMAN AS, 1995, KIDNEY INT, V48, P1069, DOI 10.1038/ki.1995.390; Virkki M, 2014, J MOL BIOL, V426, P2529, DOI 10.1016/j.jmb.2014.04.020; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; White SH, 2004, CURR OPIN STRUC BIOL, V14, P397, DOI 10.1016/j.sbi.2004.07.003; YOST CS, 1983, CELL, V34, P759	83	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28944	28952		10.1074/jbc.M115.672261	http://dx.doi.org/10.1074/jbc.M115.672261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26254469	hybrid, Green Published			2022-12-28	WOS:000365762300033
J	Ozeir, M; Pelosi, L; Ismail, A; Mellot-Draznieks, C; Fontecave, M; Pierrel, F				Ozeir, Mohammad; Pelosi, Ludovic; Ismail, Alexandre; Mellot-Draznieks, Caroline; Fontecave, Marc; Pierrel, Fabien			Coq6 Is Responsible for the C4-deamination Reaction in Coenzyme Q Biosynthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-AMINOBENZOIC ACID; FLAVIN-DEPENDENT MONOOXYGENASES; ESCHERICHIA-COLI; ANGUCYCLINE BIOSYNTHESIS; OXIDATIVE STRESS; NULL MUTANTS; PROTEIN; YEAST; UBIQUINONE; FLAVOPROTEIN	The yeast Saccharomyces cerevisiae is able to use para-aminobenzoic acid (pABA) in addition to 4-hydroxybenzoic acid as a precursor of coenzyme Q, a redox lipid essential to the function of the mitochondrial respiratory chain. The biosynthesis of coenzyme Q from pABA requires a deamination reaction at position C4 of the benzene ring to substitute the amino group with an hydroxyl group. We show here that the FAD-dependent monooxygenase Coq6, which is known to hydroxylate position C5, also deaminates position C4 in a reaction implicating molecular oxygen, as demonstrated with labeling experiments. We identify mutations in Coq6 that abrogate the C4-deamination activity, whereas preserving the C5-hydroxylation activity. Several results support that the deletion of Coq9 impacts Coq6, thus explaining the C4-deamination defect observed in Delta coq9 cells. The vast majority of flavin monooxygenases catalyze hydroxylation reactions on a single position of their substrate. Coq6 is thus a rare example of a flavin monooxygenase that is able to act on two different carbon atoms of its C4-aminated substrate, allowing its deamination and ultimately its conversion into coenzyme Q by the other proteins constituting the coenzyme Q biosynthetic pathway.	[Ozeir, Mohammad] Univ Grenoble Alpes, LCBM, UMR5249, F-38000 Grenoble, France; [Pelosi, Ludovic; Pierrel, Fabien] Univ Grenoble Alpes, LAPM, F-38000 Grenoble, France; [Pelosi, Ludovic; Pierrel, Fabien] CNRS, LAPM, F-38000 Grenoble, France; [Ismail, Alexandre; Mellot-Draznieks, Caroline; Fontecave, Marc] UPMC, Coll France, Lab Chim Processus Biol, UMR CNRS 8229, F-75231 Paris 05, France; [Ismail, Alexandre] Sup Biotech, IONIS Educ Grp, F-94800 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Pierrel, F (corresponding author), Univ Grenoble Alpes, Inst Jean Roget, Lab Adaptat Pathogenie Microorganismes, UMR UJF CNRS 5163, Domaine De La Merci, F-38700 La Tronche, France.	fabien.pierrel@ujf-grenoble.fr	Pelosi, Ludovic/AAB-9832-2020; PIERREL, Fabien/M-6016-2014	Pelosi, Ludovic/0000-0002-4198-5681; PIERREL, Fabien/0000-0003-2083-3002	Fondation de l'Orangerie; Region Rhone-Alpes program CIBLE; ANR pABACoQ; French State Program "Investissements d'Avenir" Grants LABEX DYNAMO;  [ANR-11-LABX-0011]	Fondation de l'Orangerie; Region Rhone-Alpes program CIBLE(Region Auvergne-Rhone-Alpes); ANR pABACoQ(French National Research Agency (ANR)); French State Program "Investissements d'Avenir" Grants LABEX DYNAMO(French National Research Agency (ANR)); 	Supported by the Fondation de l'Orangerie.r This work was supported in part by the Region Rhone-Alpes program CIBLE 2009 and ANR pABACoQ (to F. P.) and French State Program "Investissements d'Avenir" Grants LABEX DYNAMO and ANR-11-LABX-0011 (to M. F. and C. M. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4745, DOI 10.1021/bi00615a023; Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; Anusevicius Z, 2005, ARCH BIOCHEM BIOPHYS, V437, P144, DOI 10.1016/j.abb.2005.03.015; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Behan RK, 2010, BIOCHEMISTRY-US, V49, P9679, DOI 10.1021/bi101475z; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Block A, 2014, PLANT CELL, V26, P1938, DOI 10.1105/tpc.114.125807; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Burke D., 2000, METHODS YEAST GENETI; Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Clarke CF, 2000, PROTOPLASMA, V213, P134, DOI 10.1007/BF01282151; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; Cochrane RVK, 2014, ACCOUNTS CHEM RES, V47, P3148, DOI 10.1021/ar500242c; Crozier-Reabe KR, 2008, BIOCHEMISTRY-US, V47, P12420, DOI 10.1021/bi8010434; DAUM G, 1982, J BIOL CHEM, V257, P3028; Doimo M, 2014, BBA-MOL BASIS DIS, V1842, P1, DOI 10.1016/j.bbadis.2013.10.007; Duberley KEC, 2013, J INHERIT METAB DIS, V36, P63, DOI 10.1007/s10545-012-9511-0; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Garcia-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Gonzalez-Aragon D, 2005, BIOFACTORS, V25, P31, DOI 10.1002/biof.5520250105; Gonzalez-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243; He CWH, 2015, BBA-MOL CELL BIOL L, V1851, P1227, DOI 10.1016/j.bbalip.2015.05.003; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kallio P, 2011, BIOCHEMISTRY-US, V50, P5535, DOI 10.1021/bi200600k; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lohman DC, 2014, P NATL ACAD SCI USA, V111, pE4697, DOI 10.1073/pnas.1413128111; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; POWLOWSKI JB, 1987, J BIOL CHEM, V262, P69; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sevin DC, 2014, NAT CHEM BIOL, V10, P266, DOI 10.1038/nchembio.1437; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Swanson MA, 2008, BIOCHEMISTRY-US, V47, P8894, DOI 10.1021/bi800507p; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Xie LTX, 2015, J LIPID RES, V56, P909, DOI 10.1194/jlr.M057919; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354	50	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24140	24151		10.1074/jbc.M115.675744	http://dx.doi.org/10.1074/jbc.M115.675744			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26260787	Green Published, hybrid			2022-12-28	WOS:000362218900008
J	Hargrove, TY; Wawrzak, Z; Lamb, DC; Guengerich, FP; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Lamb, David C.; Guengerich, F. Peter; Lepesheva, Galina I.			Structure-Functional Characterization of Cytochrome P450 Sterol 14 alpha-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-CRUZI; CONFORMATIONAL DYNAMICS; SUBSTRATE PREFERENCES; FUNGAL-INFECTIONS; RESISTANCE; BINDING; IDENTIFICATION; CONSERVATION; RECOGNITION; INHIBITION	Aspergillus fumigatus is the opportunistic fungal pathogen that predominantly affects the immunocompromised population and causes 600,000 deaths/year. The cytochrome P450 51 (CYP51) inhibitor voriconazole is currently the drug of choice, yet the treatment efficiency remains low, calling for rational development of more efficient agents. A. fumigatus has two CYP51 genes, CYP51A and CYP51B, which share 59% amino acid sequence identity. CYP51B is expressed constitutively, whereas gene CYP51A is reported to be inducible. We expressed, purified, and characterized A. fumigatus CYP51B, including determination of its substrate preferences, catalytic parameters, inhibition, and x-ray structure in complexes with voriconazole and the experimental inhibitor (R)-N-(1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl) benzamide (VNI). The enzyme demethylated its natural substrate eburicol and the plant CYP51 substrate obtusifoliol at steady-state rates of 17 and 16 min(-1), respectively, but did not metabolize lanosterol, and the topical antifungal drug miconazole was the strongest inhibitor that we identified. The x-ray crystal structures displayed high overall similarity of A. fumigatus CYP51B to CYP51 orthologs from other biological kingdoms but revealed phylum-specific differences relevant to enzyme catalysis and inhibition. The complex with voriconazole provides an explanation for the potency of this relatively small molecule, whereas the complex with VNI outlines a direction for further enhancement of the efficiency of this new inhibitory scaffold to treat humans afflicted with filamentous fungal infections.	[Hargrove, Tatiana Y.; Guengerich, F. Peter; Lepesheva, Galina I.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Lamb, David C.] Swansea Univ, Swansea SA2 8PP, W Glam, Wales; [Lepesheva, Galina I.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Northwestern University; Swansea University; Vanderbilt University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM067871]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM067871 (to G. I. L.). Vanderbilt University is a member institution of the Life Science Collaborative Team at Sector 21 of the Advanced Photon Source (APS) (Argonne, IL). Use of the APS at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andriani G, 2013, J MED CHEM, V56, P2556, DOI 10.1021/jm400012e; Angarone M, 2014, CANCER TREAT RES, V161, P129, DOI 10.1007/978-3-319-04220-6_4; Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen SCA, 2010, CURR OPIN PHARMACOL, V10, P522, DOI 10.1016/j.coph.2010.06.002; Cherkesova TS, 2014, FEBS LETT, V588, P3878, DOI 10.1016/j.febslet.2014.08.030; Correia MA., 2005, CYTOCHROME P450 STRU, P246; Soeiro MDC, 2013, ANTIMICROB AGENTS CH, V57, P4151, DOI 10.1128/AAC.00070-13; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364, DOI 10.1128/AAC.41.6.1364; Efimov I, 2014, FEBS LETT, V588, P701, DOI 10.1016/j.febslet.2013.12.030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JR, 2013, NEW PHYTOL, V198, P821, DOI 10.1111/nph.12193; Friggeri L, 2014, J MED CHEM, V57, P6704, DOI 10.1021/jm500739f; GOTOH O, 1992, J BIOL CHEM, V267, P83; Gullo A, 2009, DRUGS, V69, P65, DOI 10.2165/11315530-000000000-00000; Hargrove TY, 2013, J BIOL CHEM, V288, P31602, DOI 10.1074/jbc.M113.497990; Hargrove TY, 2012, INT J PARASITOL-DRUG, V2, P178, DOI 10.1016/j.ijpddr.2012.06.001; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Hawkins NJ, 2014, MOL BIOL EVOL, V31, P1793, DOI 10.1093/molbev/msu134; Heeres J, 2010, MOLECULES, V15, P4129, DOI 10.3390/molecules15064129; Hope WW, 2005, MED MYCOL, V43, pS207, DOI 10.1080/13693780400025179; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, ARCH BIOCHEM BIOPHYS, V464, P221, DOI 10.1016/j.abb.2007.05.017; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2015, J INFECT DIS, V212, P1439, DOI 10.1093/infdis/jiv228; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; OMURA T, 1964, J BIOL CHEM, V239, P2370; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Van den Bossche H, 1988, MODE ACTION PYRIDINE, P79; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; VANDENBOSSCHE H, 1980, ANTIMICROB AGENTS CH, V17, P922, DOI 10.1128/AAC.17.6.922; Villalta F, 2013, J INFECT DIS, V208, P504, DOI 10.1093/infdis/jit042; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4225, DOI 10.1128/AAC.00316-10; Xie JL, 2014, FUTURE MICROBIOL, V9, P523, DOI 10.2217/fmb.14.18	61	90	92	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23916	23934		10.1074/jbc.M115.677310	http://dx.doi.org/10.1074/jbc.M115.677310			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269599	Green Published, hybrid			2022-12-28	WOS:000361816500037
J	Demmer, JK; Huang, H; Wang, SN; Demmer, U; Thauer, RK; Ermler, U				Demmer, Julius K.; Huang, Haiyan; Wang, Shuning; Demmer, Ulrike; Thauer, Rudolf K.; Ermler, Ulrich			Insights into Flavin-based Electron Bifurcation via the NADH-dependent Reduced Ferredoxin:NADP Oxidoreductase Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE-B; CRYSTAL-STRUCTURE; DIHYDROPYRIMIDINE DEHYDROGENASE; FERREDOXIN-NADP(+) REDUCTASE; HETERODISULFIDE REDUCTASE; TRANSFERRING FLAVOPROTEIN; COMPLEX; PROTEIN; FORMATE; CLUSTER	NADH-dependent reduced ferredoxin: NADP oxidoreductase (NfnAB) is found in the cytoplasm of various anaerobic bacteria and archaea. The enzyme reversibly catalyzes the endergonic reduction of ferredoxin with NADPH driven by the exergonic transhydrogenation from NADPH onto NAD(+). Coupling is most probably accomplished via the mechanism of flavin-based electron bifurcation. To understand this process on a structural basis, we heterologously produced the NfnAB complex of Thermotoga maritima in Escherichia coli, provided kinetic evidence for its bifurcating behavior, and determined its x-ray structure in the absence and presence of NADH. The structure of NfnAB reveals an electron transfer route including the FAD (a-FAD), the [2Fe-2S] cluster of NfnA and the FAD (b-FAD), and the two [4Fe-4S] clusters of NfnB. Ferredoxin is presumably docked onto NfnB close to the [4Fe-4S] cluster distal to b-FAD. NAD(H) binds to a-FAD and NADP(H) consequently to b-FAD, which is positioned in the center of the NfnAB complex and the site of electron bifurcation. Arg(187) is hydrogen-bonded to N-5 and O-4 of the bifurcating b-FAD and might play a key role in adjusting a low redox potential of the FADH(center dot)/FAD pair required for ferredoxin reduction. A mechanism of FAD-coupled electron bifurcation by NfnAB is proposed.	[Demmer, Julius K.; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Demmer, Julius K.; Huang, Haiyan; Wang, Shuning; Thauer, Rudolf K.] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society	Thauer, RK (corresponding author), Max Planck Inst Terr Mikrobiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	thauer@mpi-marburg.mpg.de; ulrich.ermler@biophys.mpg.de		Wang, Shuning/0000-0002-1166-078X; Demmer, Julius K./0000-0002-5232-3069	Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was supported by the Max-Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Aliverti A, 1999, METH MOL B, V131, P9; ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bertsch J, 2013, J BIOL CHEM, V288, P11304, DOI 10.1074/jbc.M112.444919; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; CHEN JS, 1974, BIOCHIM BIOPHYS ACTA, V371, P283, DOI 10.1016/0005-2795(74)90025-7; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; Costa KC, 2013, J BACTERIOL, V195, P5160, DOI 10.1128/JB.00895-13; Costa KC, 2010, P NATL ACAD SCI USA, V107, P11050, DOI 10.1073/pnas.1003653107; Cottevieille M, 2008, J BIOL CHEM, V283, P8237, DOI 10.1074/jbc.M708529200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; Dickert S, 2000, EUR J BIOCHEM, V267, P3874, DOI 10.1046/j.1432-1327.2000.01427.x; Dobritzsch D, 2002, J BIOL CHEM, V277, P13155, DOI 10.1074/jbc.M111877200; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hagen WR, 2000, EUR J BIOCHEM, V267, P3640, DOI 10.1046/j.1432-1327.2000.01393.x; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Kaster AK, 2011, ARCHAEA, V2011, DOI 10.1155/2011/973848; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lebedev AA, 2006, ACTA CRYSTALLOGR D, V62, P83, DOI 10.1107/S0907444905036759; Lee M, 2010, J MOL BIOL, V404, P600, DOI 10.1016/j.jmb.2010.09.050; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Lie TJ, 2012, P NATL ACAD SCI USA, V109, P15473, DOI 10.1073/pnas.1208779109; MacedoRibeiro S, 1996, STRUCTURE, V4, P1291, DOI 10.1016/S0969-2126(96)00137-2; Mohsen AWA, 2004, BIOCHEMISTRY-US, V43, P6498, DOI 10.1021/bi036179i; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PIERIK AJ, 1992, EUR J BIOCHEM, V206, P697, DOI 10.1111/j.1432-1033.1992.tb16976.x; Ravasio S, 2001, BIOCHEMISTRY-US, V40, P5533, DOI 10.1021/bi0100889; Rowland P, 2000, STRUCTURE, V8, P1227, DOI 10.1016/S0969-2126(00)00530-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; SMITH ET, 1995, BIOCHEMISTRY-US, V34, P7161, DOI 10.1021/bi00021a030; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; WAHL RC, 1987, J BIOL CHEM, V262, P10489; Wang SN, 2013, J BACTERIOL, V195, P4373, DOI 10.1128/JB.00678-13; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Weghoff MC, 2015, ENVIRON MICROBIOL, V17, P670, DOI 10.1111/1462-2920.12493	52	59	59	1	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21985	21995		10.1074/jbc.M115.656520	http://dx.doi.org/10.1074/jbc.M115.656520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26139605	Green Published, hybrid			2022-12-28	WOS:000360968500019
J	Wilderman, A; Guo, YR; Divakaruni, AS; Perkins, G; Zhang, LZ; Murphy, AN; Taylor, SS; Insel, PA				Wilderman, Andrea; Guo, Yurong; Divakaruni, Ajit S.; Perkins, Guy; Zhang, Lingzhi; Murphy, Anne N.; Taylor, Susan S.; Insel, Paul A.			Proteomic and Metabolic Analyses of S49 Lymphoma Cells Reveal Novel Regulation of Mitochondria by cAMP and Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CAMP/PROTEIN-KINASE; GENE-EXPRESSION; WILD-TYPE; SPECIFICITY; APOPTOSIS; SUBUNIT; DEATH	Cyclic AMP (cAMP), acting via protein kinase A (PKA), regulates many cellular responses, but the role of mitochondria in such responses is poorly understood. To define such roles, we used quantitative proteomic analysis of mitochondria-enriched fractions and performed functional and morphologic studies of wildtype (WT) and kin(-) (PKA-null) murine S49 lymphoma cells. Basally, 75 proteins significantly differed in abundance between WTand kin(-) S49 cells. WT, but not kin(-) S49 cells incubated with the cAMP analog 8-(4-chlorophenylthio)adenosine cAMP (CPT-cAMP) for 16 h have (a) increased expression of mitochondria-related genes and proteins, including ones in pathways of branched-chain amino acid and fatty acid metabolism and (b) increased maximal capacity of respiration on branched-chain keto acids and fatty acids. CPT-cAMP also regulates the cellular rate of ATP-utilization, as the rates of both ATP-linked respiration and proton efflux are decreased in WT but not kin(-) cells. CPT-cAMP protected WT S49 cells from glucose or glutamine deprivation, In contrast, CPT-cAMP did not protect kin(-) cells or WT cells treated with the PKA inhibitor H89 from glutamine deprivation. Under basal conditions, the mitochondrial structure of WT and kin(-) S49 cells is similar. Treatment with CPT-cAMP produced apoptotic changes (i.e. decreased mitochondrial density and size and loss of cristae) in WT, but not kin(-) cells. Together, these findings show that cAMP acts via PKA to regulate multiple aspects of mitochondrial function and structure. Mitochondrial perturbation thus likely contributes to cAMP/PKA-mediated cellular responses.	[Wilderman, Andrea; Divakaruni, Ajit S.; Zhang, Lingzhi; Murphy, Anne N.; Taylor, Susan S.; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guo, Yurong; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Perkins, Guy] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,BSB 3073,0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	Regan, Clinton/E-6250-2012; Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902; Perkins, Guy/0000-0002-1834-6646; Wilderman, Andrea/0000-0002-4832-9476	National Institutes of Health [DK54441, GM066232, HL107200, CA189477]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R21CA189477] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM066232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54441 (to S. S. T.) and GM066232, HL107200, and CA189477 (to P. A. I.). This work was also supported by the Howard Hughes Medical Institute (to S. S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; Dekkers BGJ, 2013, PHARMACOL THERAPEUT, V137, P248, DOI 10.1016/j.pharmthera.2012.10.006; Dent P, 1997, CELL SIGNAL, V9, P539, DOI 10.1016/S0898-6568(97)00048-X; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Field MS, 2015, P NATL ACAD SCI USA, V112, P400, DOI 10.1073/pnas.1414555112; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Giansanti P, 2013, MOL CELL PROTEOMICS, V12, P3350, DOI 10.1074/mcp.O113.028456; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Guo YR, 2012, BIOCHEMISTRY-US, V51, P9323, DOI 10.1021/bi301282k; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Herrmann PC, 2012, METHODS MOL BIOL, V823, P265, DOI 10.1007/978-1-60327-216-2_17; HOCHMAN J, 1975, P NATL ACAD SCI USA, V72, P5051, DOI 10.1073/pnas.72.12.5051; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Insel PA, 2014, HORM METAB RES, V46, P854, DOI 10.1055/s-0034-1384519; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; INSEL PA, 1975, SCIENCE, V190, P896, DOI 10.1126/science.171770; Keshwani MM, 2012, P NATL ACAD SCI USA, V109, pE1221, DOI 10.1073/pnas.1202741109; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Lamb D, 2002, J CELL PHYSIOL, V192, P216, DOI 10.1002/jcp.10131; Lemire BD, 2015, BBA-BIOENERGETICS, V1847, P451, DOI 10.1016/j.bbabio.2015.01.014; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Marchitti SA, 2010, FREE RADICAL BIO MED, V49, P1432, DOI 10.1016/j.freeradbiomed.2010.08.004; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Palorini R, 2013, ONCOGENE, V32, P352, DOI 10.1038/onc.2012.50; Pichler P, 2010, ANAL CHEM, V82, P6549, DOI 10.1021/ac100890k; RICHARDSON MD, 1994, LIFE SCI, V54, P863, DOI 10.1016/0024-3205(94)00623-7; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Valsecchi F, 2013, PHYSIOLOGY, V28, P199, DOI 10.1152/physiol.00004.2013; van Daalen Wetters T, 1987, Methods Enzymol, V151, P9; Wang B, 2014, BIOCHEM BIOPH RES CO, V447, P441, DOI 10.1016/j.bbrc.2014.04.028; Warda M, 2013, EXPERT REV PROTEOMIC, V10, P97, DOI [10.1586/EPR.12.69, 10.1586/epr.12.69]; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang LZ, 2008, J BIOL CHEM, V283, P4304, DOI 10.1074/jbc.M708673200; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	51	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22274	22286		10.1074/jbc.M115.658153	http://dx.doi.org/10.1074/jbc.M115.658153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203188	hybrid, Green Published			2022-12-28	WOS:000360968500043
J	Ali, M; Daze, KD; Strongin, DE; Rothbart, SB; Rincon-Arano, H; Allen, HF; Li, J; Strahl, BD; Hof, F; Kutateladze, TG				Ali, Muzaffar; Daze, Kevin D.; Strongin, Daniel E.; Rothbart, Scott B.; Rincon-Arano, Hector; Allen, Hillary F.; Li, Janessa; Strahl, Brian D.; Hof, Fraser; Kutateladze, Tatiana G.			Molecular Insights into Inhibition of the Methylated Histone-Plant Homeodomain Complexes by Calixarenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; LYSINE BINDING; CHROMATIN-BINDING; EPIGENETIC MARKS; GENE REPRESSION; DNA METHYLATION; DRUG DISCOVERY; H3; RECOGNITION; DOMAIN	Plant homeodomain (PHD) finger-containing proteins are implicated in fundamental biological processes, including transcriptional activation and repression, DNA damage repair, cell differentiation, and survival. The PHD finger functions as an epigenetic reader that binds to posttranslationally modified or unmodified histone H3 tails, recruiting catalytic writers and erasers and other components of the epigenetic machinery to chromatin. Despite the critical role of the histone-PHD interaction in normal and pathological processes, selective inhibitors of this association have not been well developed. Here we demonstrate that macrocyclic calixarenes can disrupt binding of PHD fingers to methylated lysine 4 of histone H3 in vitro and in vivo. The inhibitory activity relies on differences in binding affinities of the PHD fingers for H3K4me and the methylation state of the histone ligand, whereas the composition of the aromatic H3K4me-binding site of the PHD fingers appears to have no effect. Our approach provides a novel tool for studying the biological roles of methyllysine readers in epigenetic signaling.	[Ali, Muzaffar; Allen, Hillary F.; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Daze, Kevin D.; Li, Janessa; Hof, Fraser] Univ Victoria, Dept Chem, Victoria, BC V8W 3V6, Canada; [Strongin, Daniel E.; Rincon-Arano, Hector] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Strahl, Brian D.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Victoria; Fred Hutchinson Cancer Center; Van Andel Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kutateladze, TG (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	fhof@uvic.ca; tatiana.kutateladze@ucdenver.edu	Regan, Clinton/E-6250-2012; Strahl, Brian D/C-7601-2012	Kutateladze, Tatiana/0000-0001-7375-6990; Hof, Fraser/0000-0003-4658-9132; Strahl, Brian D/0000-0002-4947-6259	National Institutes of Health [GM101664, GM100907, CA181343]; W. M. Keck Foundation; Prostate Cancer Canada; WestCoast Ride to Live; Prostate Cancer Foundation of British Columbia; NATIONAL CANCER INSTITUTE [K99CA181343, R00CA181343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100907, R01GM101664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Prostate Cancer Canada; WestCoast Ride to Live; Prostate Cancer Foundation of British Columbia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grants GM101664 and GM100907 (to T. G. K.) and CA181343 (to S. B. R.). This work was also supported by grants from the W. M. Keck Foundation (to B. D. S.) and from Prostate Cancer Canada (to F. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by WestCoast Ride to Live and the Prostate Cancer Foundation of British Columbia.	Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Allen HF, 2014, BIOCHEM J, V459, P505, DOI 10.1042/BJ20140145; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Beaver JE, 2015, ORG BIOMOL CHEM, V13, P3220, DOI 10.1039/c4ob02231a; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Chang PY, 2010, J MOL BIOL, V400, P137, DOI 10.1016/j.jmb.2010.05.005; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Daze KD, 2012, ORG LETT, V14, P1512, DOI 10.1021/ol300243b; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Florea M, 2012, CHEM-EUR J, V18, P3521, DOI 10.1002/chem.201103397; Gamal-Eldin MA, 2013, ORG BIOMOL CHEM, V11, P488, DOI 10.1039/c2ob27007b; Gao C, 2011, J AM CHEM SOC, V133, P5357, DOI 10.1021/ja110432e; Ghale G, 2014, ANGEW CHEM INT EDIT, V53, P2762, DOI 10.1002/anie.201309583; He FH, 2010, STRUCTURE, V18, P1127, DOI 10.1016/j.str.2010.06.012; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; James LI, 2013, J AM CHEM SOC, V135, P6450, DOI 10.1021/ja307907p; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu YL, 2014, PHARMACOL THERAPEUT, V143, P275, DOI 10.1016/j.pharmthera.2014.03.007; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Martos V, 2009, P NATL ACAD SCI USA, V106, P10482, DOI 10.1073/pnas.0813396106; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McGovern RE, 2015, CHEM SCI, V6, P442, DOI 10.1039/c4sc02383h; McGovern RE, 2012, NAT CHEM, V4, P527, DOI [10.1038/nchem.1342, 10.1038/NCHEM.1342]; Miller TCR, 2014, ACS CHEM BIOL, V9, P2864, DOI 10.1021/cb500585s; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pinkin NK, 2014, ORG BIOMOL CHEM, V12, P7059, DOI 10.1039/c4ob01249f; Ren CY, 2015, CHEM BIOL, V22, P161, DOI 10.1016/j.chembiol.2014.11.021; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Wagner EK, 2012, BIOCHEMISTRY-US, V51, P8293, DOI 10.1021/bi3009278; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	46	22	22	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22919	22930		10.1074/jbc.M115.669333	http://dx.doi.org/10.1074/jbc.M115.669333			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229108	Green Published, hybrid			2022-12-28	WOS:000361685500005
J	Awad, W; Adamczyk, B; Ornros, J; Karlsson, NG; Mani, K; Logan, DT				Awad, Wael; Adamczyk, Barbara; Ornros, Jessica; Karlsson, Niclas G.; Mani, Katrin; Logan, Derek T.			Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; SECONDARY STRUCTURE PREDICTION; HEPARAN-SULFATE; BIOLOGICAL MACROMOLECULES; CRYSTAL-STRUCTURE; CORE PROTEIN; WEB SERVER; DALLY-LIKE; GLYCANS; CELLS	Glypicans are multifunctional cell surface proteoglycans involved in several important cellular signaling pathways. Glypican-1 (Gpc1) is the predominant heparan sulfate proteoglycan in the developing and adult human brain. The two N-linked glycans and the C-terminal domain that attach the core protein to the cell membrane are not resolved in the Gpc1 crystal structure. Therefore, we have studied Gpc1 using crystallography, small angle x-ray scattering, and chromatographic approaches to elucidate the composition, structure, and function of the N-glycans and the Cterminus and also the topology of Gpc1 with respect to the membrane. The Cterminus is shown to be highly flexible in solution, but it orients the core protein transverse to the membrane, directing a surface evolutionarily conserved in Gpc1 orthologs toward the membrane, where it may interact with signaling molecules and/or membrane receptors on the cell surface, or even the enzymes involved in heparan sulfate substitution in the Golgi apparatus. Furthermore, the N-glycans are shown to extend the protein stability and lifetime by protection against proteolysis and aggregation.	[Awad, Wael; Logan, Derek T.] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Adamczyk, Barbara; Ornros, Jessica; Karlsson, Niclas G.] Univ Gothenburg, Dept Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; [Mani, Katrin] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University; University of Gothenburg; Lund University	Logan, DT (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Box 124, SE-22100 Lund, Sweden.	derek.logan@biochemistry.lu.se	Adamczyk, Barbara/G-9660-2013; Logan, Derek/O-2497-2019; Logan, Derek T/A-1114-2011; Karlsson, Niclas/G-5235-2013	Adamczyk, Barbara/0000-0001-9111-1301; Logan, Derek/0000-0002-0098-8560; Logan, Derek T/0000-0002-0098-8560; Karlsson, Niclas/0000-0002-3045-2628; Awad, Wael/0000-0002-7597-2133; Mani, Katrin/0000-0002-1821-0634	Swedish Research Council; European Union FP7 GastricGlycoExplorer ITN [316929]; Swedish Cancer Society; Ahlen and Olle Engkvist Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union FP7 GastricGlycoExplorer ITN; Swedish Cancer Society(Swedish Cancer Society); Ahlen and Olle Engkvist Foundation	This work was supported by the Swedish Research Council, European Union FP7 GastricGlycoExplorer ITN Grant 316929, the Swedish Cancer Society, Alfred Osterlund, and the Ahlen and Olle Engkvist Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Awad W., 2014, ATLAS GENET CYTOGENE, V18, P461; Awad W, 2013, ACTA CRYSTALLOGR D, V69, P2524, DOI 10.1107/S0907444913025250; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bowler MW, 2015, CRYST GROWTH DES, V15, P1043, DOI 10.1021/cg500890r; Brewer AK, 2011, ANALYST, V136, P515, DOI 10.1039/c0an00738b; BROWN D, 1992, J AM SOC NEPHROL, V3, P895; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng W, 2008, CARCINOGENESIS, V29, P1319, DOI 10.1093/carcin/bgn091; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Guttman M, 2013, STRUCTURE, V21, P321, DOI 10.1016/j.str.2013.02.004; Hamouda H, 2014, J PROTEOME RES, V13, P6144, DOI 10.1021/pr5003005; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Hooper NM, 2011, J NEUROCHEM, V116, P721, DOI 10.1111/j.1471-4159.2010.06936.x; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Khan S, 2013, J BIOL CHEM, V288, P27737, DOI 10.1074/jbc.M113.492223; Kim HI, 2013, J PROTEOME RES, V12, P3547, DOI 10.1021/pr400276r; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Matsuda K, 2001, CANCER RES, V61, P5562; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pei JM, 2012, PROTEIN SCI, V21, P1172, DOI 10.1002/pro.2105; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Royle Louise, 2006, V347, P125; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Su G, 2006, AM J PATHOL, V168, P2014, DOI 10.2353/ajpath.2006.050800; Svensson G, 2012, J BIOL CHEM, V287, P14040, DOI 10.1074/jbc.M111.322487; Svensson G, 2011, BIOCHEMISTRY-US, V50, P9377, DOI 10.1021/bi200218s; Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zuegg J, 2000, GLYCOBIOLOGY, V10, P959, DOI 10.1093/glycob/10.10.959	63	16	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22991	23008		10.1074/jbc.M115.660878	http://dx.doi.org/10.1074/jbc.M115.660878			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26203194	hybrid, Green Published			2022-12-28	WOS:000361685500012
J	Pozhidaeva, AK; Mohni, KN; Dhe-Paganon, S; Arrowsmith, CH; Weller, SK; Korzhnev, DM; Bezsonova, I				Pozhidaeva, Alexandra K.; Mohni, Kareem N.; Dhe-Paganon, Sirano; Arrowsmith, Cheryl H.; Weller, Sandra K.; Korzhnev, Dmitry M.; Bezsonova, Irina			Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; REGULATORY PROTEIN; P53 STABILIZATION; P53-MDM2 PATHWAY; CHEMICAL-SHIFTS; E3 LIGASE; USP7; HAUSP; USP7/HAUSP; DOMAIN	Human ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme that prevents protein degradation by removing polyubiquitin chains from its substrates. It regulates the stability of a number of human transcription factors and tumor suppressors and plays a critical role in the development of several types of cancer, including prostate and small cell lung cancer. In addition, human USP7 is targeted by several viruses of the Herpesviridae family and is required for effective herpesvirus infection. The USP7 C-terminal region (C-USP7) contains five ubiquitin-like domains (UBL1-5) that interact with several USP7 substrates. Although structures of the USP7 C terminus bound to its substrates could provide vital information for understanding USP7 substrate specificity, no such data has been available to date. In this work we have demonstrated that the USP7 ubiquitin-like domains can be studied in isolation by solution NMR spectroscopy, and we have determined the structure of the UBL1 domain. Furthermore, we have employed NMR and viral plaque assays to probe the interaction between the C-USP7 and HSV-1 immediate-early protein ICP0 (infected cell protein 0), which is essential for efficient lytic infection and virus reactivation from latency. We have shown that depletion of the USP7 in HFF-1 cells negatively affects the efficiency of HSV-1 lytic infection. We have also found that USP7 directly binds ICP0 via its C-terminal UBL1-2 domains and mapped the USP7-binding site for ICP0. Therefore, this study represents a first step toward understanding the molecular mechanism of C-USP7 specificity toward its substrates and may provide the basis for future development of novel antiviral and anticancer therapies.	[Pozhidaeva, Alexandra K.; Weller, Sandra K.; Korzhnev, Dmitry M.; Bezsonova, Irina] Univ Connecticut Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Mohni, Kareem N.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Connecticut; Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; University of Toronto; Structural Genomics Consortium	Bezsonova, I (corresponding author), Univ Connecticut Hlth, Dept Mol Biol & Biophys, 263 Farmington Ave, Farmington, CT 06030 USA.	bezsonova@uchc.edu	; Weller, Sandra/N-3979-2013	Pozhidaeva, Alexandra/0000-0001-8602-1790; Arrowsmith, Cheryl/0000-0002-4971-3250; Weller, Sandra/0000-0002-4519-6276	Charles H. Hood Foundation; State of Connecticut Department of Public Health Biomedical Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021747] Funding Source: NIH RePORTER	Charles H. Hood Foundation; State of Connecticut Department of Public Health Biomedical Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Charles H. Hood Foundation child health research award and a State of Connecticut Department of Public Health Biomedical Research Grant (to I. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2013, J GEN VIROL, V94, P465, DOI 10.1099/vir.0.048900-0; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cheng CY, 2013, J VIROL, V87, P6232, DOI 10.1128/JVI.00384-13; Ching W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003273; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EVERETT RD, 1993, J MOL BIOL, V234, P1038, DOI 10.1006/jmbi.1993.1657; Everett RD, 1999, J VIROL, V73, P417, DOI 10.1128/JVI.73.1.417-426.1999; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Goddard D., 2008, SPARKY 3; Grishaev A, 2005, PROTEINS, V61, P36, DOI 10.1002/prot.20457; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Jager W, 2012, J VIROL, V86, P6745, DOI 10.1128/JVI.06840-11; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Keller R, 2004, THESIS ETH ZURICH; Kessler BM, 2007, J PROTEOME RES, V6, P4163, DOI 10.1021/pr0702161; Korzhnev DM, 2002, J AM CHEM SOC, V124, P10743, DOI 10.1021/ja0204776; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Ma JH, 2010, ARCH BIOCHEM BIOPHYS, V503, P207, DOI 10.1016/j.abb.2010.08.020; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Mohni KN, 2010, J VIROL, V84, P12152, DOI 10.1128/JVI.01643-10; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wrigley JD, 2011, CELL BIOCHEM BIOPHYS, V60, P99, DOI 10.1007/s12013-011-9186-4; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546	58	25	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22907	22918		10.1074/jbc.M115.664805	http://dx.doi.org/10.1074/jbc.M115.664805			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26224631	Green Published, hybrid			2022-12-28	WOS:000361685500004
J	Qi, YF; Wang, W; Chen, JB; Dai, L; Kaczorowski, D; Gao, X; Xia, P				Qi, Yanfei; Wang, Wei; Chen, Jinbiao; Dai, Lan; Kaczorowski, Dominik; Gao, Xin; Xia, Pu			Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1 alpha Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; ER STRESS; INHIBITS APOPTOSIS; ENDOTHELIAL-CELLS; UP-REGULATION; CANCER CELLS; 1-PHOSPHATE; PATHWAY; DISEASE	Aberrant deposition of fat including free fatty acids in the liver often causes damage to hepatocytes, namely lipotoxicity, which is a key pathogenic event in the development and progression of fatty liver diseases. This study demonstrates a pivotal role of sphingosine kinase 1 (SphK1) in protecting hepatocytes from lipotoxicity. Exposure of primary murine hepatocytes to palmitate resulted in dose-dependent cell death, which was enhanced significantly in Sphk1-deficient cells. In keeping with this, expression of dominant-negative mutant SphK1 also markedly promoted palmitate-induced cell death. In contrast, overexpression of wild-type SphK1 profoundly protected hepatocytes from lipotoxicity. Mechanistically, the protective effect of SphK1 is attributable to suppression of ER stress-mediated proapoptotic pathways, as reflected in the inhibition of IRE1 alpha activation, XBP1 splicing, JNK phosphorylation, and CHOP induction. Of note, SphK1 inhibited the IRE1 alpha pathway by reducing IRE1 alpha expression at the transcriptional level. Moreover, S1P mimicked the effect of SphK1, suppressing IRE1 alpha expression in a receptor-dependent manner. Furthermore, enforced overexpression of IRE1 alpha significantly blocked the protective effect of SphK1 against lipotoxicity. Therefore, this study provides new insights into the role of SphK1 in hepatocyte survival and uncovers a novel mechanism for protection against ER stress-mediated cell death.	[Qi, Yanfei; Chen, Jinbiao; Dai, Lan; Kaczorowski, Dominik; Xia, Pu] Univ Sydney, Centenary Inst, Signal Transduct Program, Sydney, NSW 2042, Australia; [Wang, Wei; Gao, Xin; Xia, Pu] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China	University of Sydney; Centenary Institute; Fudan University	Xia, P (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China.	xiapu_fudan@163.com	Xia, Pu/G-3090-2010; Chen, Jinbiao/N-9905-2019; Qi, Yanfei/ABC-1242-2021; Chen, Jinbiao/J-5868-2013	Xia, Pu/0000-0003-4705-8878; Chen, Jinbiao/0000-0003-0339-5880; Qi, Yanfei/0000-0003-1391-4111; Chen, Jinbiao/0000-0003-0339-5880; Gao, Xin/0000-0003-1864-7796	Australian National Health and Medical Research Council [571408]; National Natural Science Foundation of China [81370937]; Fudan University	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University	This work was supported by grants from the Australian National Health and Medical Research Council (Program 571408), National Natural Science Foundation of China Grant 81370937, and a Fudan University distinguished professorship (to P. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Chatzakos V, 2012, BIOCHEM PHARMACOL, V84, P712, DOI 10.1016/j.bcp.2012.06.009; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Fayyaz S, 2014, DIABETOLOGIA, V57, P373, DOI 10.1007/s00125-013-3123-6; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; Fuchs M, 2012, J HEPATOL, V56, P291, DOI 10.1016/j.jhep.2011.05.019; Gandy KAO, 2013, BBA-MOL CELL BIOL L, V1831, P157, DOI 10.1016/j.bbalip.2012.07.002; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Guo FJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.194; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Karimian G, 2013, BBA-MOL BASIS DIS, V1832, P1922, DOI 10.1016/j.bbadis.2013.06.011; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; RICHIERI GV, 1995, J LIPID RES, V36, P229; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xia P, 2011, CYTOKINE GROWTH F R, V22, P45, DOI 10.1016/j.cytogfr.2010.09.004; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614	42	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23282	23290		10.1074/jbc.M115.677542	http://dx.doi.org/10.1074/jbc.M115.677542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240153	Green Published, hybrid			2022-12-28	WOS:000361685500036
J	Rushworth, D; Mathews, A; Alpert, A; Cooper, LJN				Rushworth, David; Mathews, Amber; Alpert, Amir; Cooper, Laurence J. N.			Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CODING REGION; MESSENGER-RNA; GENE-TRANSFER; FUSION GENE; CELLS; INTERLEUKIN-12; IDENTIFICATION; IMMUNOTHERAPY; TRANSLATION; EXPRESSION	Methotrexate (MTX) is an anti-folate that inhibits de novo purine and thymidine nucleotide synthesis. MTX induces death in rapidly replicating cells and is used in the treatment of multiple cancers. MTX inhibits thymidine synthesis by targeting dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS). The use of MTX to treat cancer also causes bone marrow suppression and inhibits the immune system. This has led to the development of an MTX-resistant DHFR, DHFR L22F, F31S (DHFRFS), to rescue healthy cells. 5-Fluorouracil-resistant TYMS T51S, G52S (TYMSSS) is resistant to MTX and improves MTX resistance of DHFRFS in primary T cells. Here we find that a known mechanism of MTX-induced increase in DHFR expression persists with DHFRFS and cis-expressed transgenes. We also find that TYMSSS expression of cis-expressed transgenes is similarly decreased in an MTX-inducible manner. MTX-inducible changes in DHFRFS and TYMSSS expression changes are lost when both genes are expressed together. In fact, expression of the DHFRFS and TYMSSS cis-expressed transgenes becomes correlated. These findings provide the basis for an unrecognized post-transcriptional mechanism that functionally links expression of DHFR and TYMS. These findings were made in genetically modified primary human T cells and have a clear potential for use in clinical applications where gene expression needs to be regulated by drug or maintained at a specific expression level. We demonstrate a potential application of this system in the controlled expression of systemically toxic cytokine IL-12.	[Rushworth, David; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr MDACC, Div Pediat, Childrens Canc Hosp, Houston, TX 77030 USA; [Rushworth, David; Mathews, Amber; Alpert, Amir; Cooper, Laurence J. N.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Cooper, LJN (corresponding author), Univ Texas MD Anderson Canc Ctr MDACC, Div Pediat, Childrens Canc Hosp, Houston, TX 77030 USA.	ljncooper@mdanderson.org		alpert, amir/0000-0002-1274-1813	NCI Cancer Center through the National Institutes of Health [P30CA16672]; Cancer Center Core Grant [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA120956, R01CA141303, P01CA148600, R01CA124782] Funding Source: NIH RePORTER	NCI Cancer Center through the National Institutes of Health; Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We extend gratitude to the dedicated work of Helen Huls, Tiejuan Mi, and Drs. Kumar, Belousova, and Singh for laboratory support. We thank Drs. Dat Tran, Dean Lee, and George McNamara for assistance in manuscript preparation, and Dr. David Spencer for assistance in developing and utilizing iC9. We thank the MDACC South Campus Flow Cytometry Facility, supported by the NCI Cancer Center Support Grant P30CA16672 through the National Institutes of Health and Cancer Center Core Grant (CA16672), for use of their facilities.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; Anderson DD, 2012, J BIOL CHEM, V287, P7051, DOI 10.1074/jbc.M111.333120; Capiaux GM, 2004, CANCER GENE THER, V11, P767, DOI 10.1038/sj.cgt.7700683; Capiaux GM, 2003, HUM GENE THER, V14, P435, DOI 10.1089/104303403321467207; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Corrigan-Curay J, 2014, MOL THER, V22, P1564, DOI 10.1038/mt.2014.148; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; ErcikanAbali EA, 1997, BIOCHEMISTRY-US, V36, P12317, DOI 10.1021/bi971026e; ErcikanAbali EA, 1996, CANCER RES, V56, P4142; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Jonnalagadda M, 2013, GENE THER, V20, P853, DOI 10.1038/gt.2012.97; Jonnalagadda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065519; Kacherovsky N, 2015, BIOTECHNOL BIOENG, V112, P1429, DOI 10.1002/bit.25538; Kerkar SP, 2010, CANCER RES, V70, P6725, DOI 10.1158/0008-5472.CAN-10-0735; Landis DM, 2001, CANCER RES, V61, P666; Leonard JP, 1997, BLOOD, V90, P2541; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Mayer-Kuckuk P, 2002, P NATL ACAD SCI USA, V99, P3400, DOI 10.1073/pnas.062036899; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Rushworth D, 2016, GENE THER, V23, P119, DOI 10.1038/gt.2015.88; Rushworth D, 2014, J IMMUNOTHER, V37, P204, DOI 10.1097/CJI.0000000000000032; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Skacel N, 2005, J BIOL CHEM, V280, P22721, DOI 10.1074/jbc.M500277200; Sorrentino BR, 2002, NAT REV CANCER, V2, P431, DOI 10.1038/nrc823; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tai NW, 2004, BIOCHEM J, V378, P999, DOI 10.1042/BJ20031396; Tai NW, 2002, NUCLEIC ACIDS RES, V30, P4481, DOI 10.1093/nar/gkf562; Walling J, 2006, INVEST NEW DRUG, V24, P37, DOI 10.1007/s10637-005-4541-1; Zhang L, 2015, CLIN CANCER RES, V21, P2278, DOI 10.1158/1078-0432.CCR-14-2085	30	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22970	22976		10.1074/jbc.C115.671123	http://dx.doi.org/10.1074/jbc.C115.671123			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26242737	Green Published, hybrid			2022-12-28	WOS:000361685500010
J	Shioda, N; Sawai, M; Ishizuka, Y; Shirao, T; Fukunaga, K				Shioda, Norifumi; Sawai, Masahiro; Ishizuka, Yuta; Shirao, Tomoaki; Fukunaga, Kohji			Nuclear Translocation of Calcium/Calmodulin-dependent Protein Kinase II delta 3 Promoted by Protein Phosphatase-1 Enhances Brain-derived Neurotrophic Factor Expression in Dopaminergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BDNF; Ca2+; calmodulin-dependent protein kinase II (CaMKII); dopamine receptor; nuclear translocation; protein phosphatase 1 (PP1)	BINDING PROTEIN; CAM KINASE; LOCALIZATION SIGNAL; GENE-EXPRESSION; II ACTIVITY; ISOFORMS; ACTIVATION; PHOSPHORYLATION; RECEPTOR; RAT	Background: The physiological function of CaMKII3 phosphorylation at Ser(332) remains unclear. Results: CaMKII3 dephosphorylation at Ser(332) promotes its nuclear localization and stimulates BDNF expression. Conclusion: Dopamine D-2 receptor stimulation triggers CaMKII3 dephosphorylation at Ser(332) by PP1. Significance: CaMKII3 (Ser(332)) dephosphorylation is critical for neurite extension and survival of dopaminergic neurons. We have reported previously that dopamine D-2 receptor stimulation activates calcium/calmodulin-dependent protein kinase II (CaMKII) 3, a CaMKII nuclear isoform, increasing BDNF gene expression. However, the mechanisms underlying that activity remained unclear. Here we report that CaMKII3 is dephosphorylated at Ser(332) by protein phosphatase 1 (PP1), promoting CaMKII3 nuclear translocation. Neuro-2a cells transfected with CaMKII3 showed cytoplasmic and nuclear staining, but the staining was predominantly nuclear when CaMKII3 was coexpressed with PP1. Indeed, PP1 and CaMKII3 coexpression significantly increased nuclear CaMKII activity and enhanced BDNF expression. In support of this idea, chronic administration of the dopamine D-2 receptor partial agonist aripiprazole increased PP1 activity and promoted nuclear CaMKII3 translocation and BDNF expression in the rat brain substantia nigra. Moreover, aripiprazole treatment enhanced neurite extension and inhibited cell death in cultured dopaminergic neurons, effects blocked by PP1 knockdown. Taken together, nuclear translocation of CaMKII3 following dephosphorylation at Ser(332) by PP1 likely accounts for BDNF expression and subsequent neurite extension and survival of dopaminergic neurons.	[Shioda, Norifumi; Sawai, Masahiro; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 9808578, Japan; [Ishizuka, Yuta; Shirao, Tomoaki] Gunma Univ, Dept Neurobiol & Behav, Grad Sch Med, Maebashi, Gunma 3718511, Japan	Tohoku University; Gunma University	Shioda, N (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	shioda@m.tohoku.ac.jp; kfukunaga@m.tohoku.ac.jp	Ishizuka, Yuta/ACN-8245-2022; Ishizuka, Yuta/AAB-9170-2019; Fukunaga, Kohji/AAI-8811-2021; Shirao, Tomoaki/I-9257-2016	Ishizuka, Yuta/0000-0002-2036-902X; Shirao, Tomoaki/0000-0003-4323-028X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25110705, 25460090, 24102505, 25293124]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids 25110705 and 25460090 (to N. S.) and 24102505 and 25293124 (to K. F.) for Scientific Research in the Innovative Area "Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; BARKER HM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P228, DOI 10.1016/0167-4889(93)90014-G; BARKER HM, 1994, BBA-MOL CELL RES, V1220, P212, DOI 10.1016/0167-4889(94)90138-4; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Bordelon JR, 2005, CEREB CORTEX, V15, P1928, DOI 10.1093/cercor/bhi070; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; BROCKE L, 1995, J NEUROSCI, V15, P6797; COHEN PTW, 1988, FEBS LETT, V232, P17, DOI 10.1016/0014-5793(88)80378-8; Cohen PTW, 2002, J CELL SCI, V115, P241; Colbran R J, 1990, Curr Top Cell Regul, V31, P181; DOMBRADI V, 1990, EUR J BIOCHEM, V194, P739, DOI 10.1111/j.1432-1033.1990.tb19464.x; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Fan W, 2007, INVEST OPHTH VIS SCI, V48, P3854, DOI 10.1167/iovs.06-1382; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; FUKUNAGA K, 1982, J NEUROCHEM, V39, P1607, DOI 10.1111/j.1471-4159.1982.tb07994.x; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; Fukunaga K, 2000, NEUROSCI RES, V38, P3, DOI 10.1016/S0168-0102(00)00139-5; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Kamata A, 2006, J NEUROCHEM, V96, P195, DOI 10.1111/j.1471-4159.2005.03531.x; Kim SY, 2008, EXP NEUROL, V214, P69, DOI 10.1016/j.expneurol.2008.07.014; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luoni A, 2014, PHARMACOL RES, V80, P1, DOI 10.1016/j.phrs.2013.11.008; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MAYER P, 1993, FEBS LETT, V333, P315, DOI 10.1016/0014-5793(93)80678-N; Miglio G, 2004, EUR J PHARMACOL, V489, P157, DOI 10.1016/j.ejphar.2004.03.006; MISRA RP, 1994, J BIOL CHEM, V269, P25483; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; Sawada H, 1998, ANN NEUROL, V44, P110, DOI 10.1002/ana.410440117; SCHULMAN H, 1993, NEUROCHEM RES, V18, P65, DOI 10.1007/BF00966924; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shimomura A, 1996, J BIOL CHEM, V271, P17957, DOI 10.1074/jbc.271.30.17957; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack Stefan, 2008, P459, DOI 10.1007/978-0-387-77232-5_16; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Takahashi H, 2009, J CELL SCI, V122, P1211, DOI 10.1242/jcs.043729; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Takeuchi Y, 2002, J NEUROCHEM, V82, P316, DOI 10.1046/j.1471-4159.2002.00967.x; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Yano S, 1996, J BIOL CHEM, V271, P23520, DOI 10.1074/jbc.271.38.23520; Yoshimura R, 2012, HUM PSYCHOPHARM CLIN, V27, P33, DOI 10.1002/hup.1257; Yoshioka M, 2002, NEUROSCI RES, V43, P259, DOI 10.1016/S0168-0102(02)00040-8; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	67	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21663	21675		10.1074/jbc.M115.664920	http://dx.doi.org/10.1074/jbc.M115.664920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26163515	Green Published, hybrid			2022-12-28	WOS:000360637600038
J	Kern, G; Palmer, T; Ehmann, DE; Shapiro, AB; Andrews, B; Basarab, GS; Doig, P; Fan, J; Gao, N; Mills, SD; Mueller, J; Sriram, S; Thresher, J; Walkup, GK				Kern, Gunther; Palmer, Tiffany; Ehmann, David E.; Shapiro, Adam B.; Andrews, Beth; Basarab, Gregory S.; Doig, Peter; Fan, Jun; Gao, Ning; Mills, Scott D.; Mueller, John; Sriram, Shubha; Thresher, Jason; Walkup, Grant K.			Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERCOILED DNA RELAXATION; ANISOTROPY-BASED ASSAY; METAL ION BRIDGE; ESCHERICHIA-COLI; QUINOLONE RESISTANCE; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; GYRASE INHIBITOR; 2-GATE MECHANISM; POLYMERASE-V	We characterized the inhibition of Neisseria gonorrhoeae type II topoisomerases gyrase and topoisomerase IV by AZD0914 (AZD0914 will be henceforth known as ETX0914 (Entasis Therapeutics)), a novel spiropyrimidinetrione antibacterial compound that is currently in clinical trials for treatment of drug-resistant gonorrhea. AZD0914 has potent bactericidal activity against N. gonorrhoeae, including multidrug-resistant strains and key Gram-positive, fastidious Gram-negative, atypical, and anaerobic bacterial species (Huband, M. D., Bradford, P. A., Otterson, L. G., Basrab, G. S., Giacobe, R. A., Patey, S. A., Kutschke, A. C., Johnstone, M. R., Potter, M. E., Miller, P. F., and Mueller, J. P. (2014) In Vitro Antibacterial Activity of AZD0914: A New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-positive, Fastidious Gram-negative, and Atypical Bacteria. Antimicrob. Agents Chemother. 59, 467-474). AZD0914 inhibited DNA biosynthesis preferentially to other macromolecules in Escherichia coli and induced the SOS response to DNA damage in E. coli. AZD0914 stabilized the enzyme-DNA cleaved complex for N. gonorrhoeae gyrase and topoisomerase IV. The potency of AZD0914 for inhibition of supercoiling and the stabilization of cleaved complex by N. gonorrhoeae gyrase increased in a fluoroquinolone-resistant mutant enzyme. When a mutation, conferring mild resistance to AZD0914, was present in the fluoroquinolone-resistant mutant, the potency of ciprofloxacin for inhibition of supercoiling and stabilization of cleaved complex was increased greater than 20-fold. In contrast to ciprofloxacin, religation of the cleaved DNA did not occur in the presence of AZD0914 upon removal of magnesium from the DNA-gyrase-inhibitor complex. AZD0914 had relatively low potency for inhibition of human type II topoisomerases alpha and beta.	[Kern, Gunther; Palmer, Tiffany; Ehmann, David E.; Shapiro, Adam B.; Andrews, Beth; Fan, Jun; Mills, Scott D.; Mueller, John; Sriram, Shubha; Walkup, Grant K.] AstraZeneca R&D Boston, Dept Biosci, Waltham, MA 02451 USA; [Basarab, Gregory S.] AstraZeneca R&D Boston, Dept Chem, Infect Innovat Med Unit, Waltham, MA 02451 USA; [Doig, Peter; Gao, Ning; Thresher, Jason] AstraZeneca R&D Boston, Dept Struct & Biophys, Discovery Sci, Waltham, MA 02451 USA	AstraZeneca; AstraZeneca; AstraZeneca	Kern, G (corresponding author), AstraZeneca R&D Boston, Dept Biosci, Infect Innovat Med Unit, 35 Gatehouse Dr, Waltham, MA 02451 USA.	gunther.kern@gmail.com	Fan, Jianqing/B-2115-2008	Basarab, Greg/0000-0001-5684-6046; Gao, Ning/0000-0003-1605-4137; Shapiro, Adam/0000-0002-2662-6146				Aedo S, 2012, ANTIMICROB AGENTS CH, V56, P5458, DOI 10.1128/AAC.01182-12; Aldred KJ, 2014, ANTIMICROB AGENTS CH, V58, P7182, DOI 10.1128/AAC.03734-14; Aldred KJ, 2014, BIOCHEMISTRY-US, V53, P1565, DOI 10.1021/bi5000564; Aldred KJ, 2013, ACS CHEM BIOL, V8, P2660, DOI 10.1021/cb400592n; Aldred KJ, 2013, NUCLEIC ACIDS RES, V41, P4628, DOI 10.1093/nar/gkt124; Aldred KJ, 2012, BIOCHEMISTRY-US, V51, P370, DOI 10.1021/bi2013905; Alm RA, 2015, ANTIMICROB AGENTS CH, V59, P1478, DOI 10.1128/AAC.04456-14; Anderson VE, 1999, J BIOL CHEM, V274, P35927, DOI 10.1074/jbc.274.50.35927; Basarab GS, 2014, J MED CHEM, V57, P9078, DOI 10.1021/jm501174m; BELLAND RJ, 1994, MOL MICROBIOL, V14, P371, DOI 10.1111/j.1365-2958.1994.tb01297.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambau E, 2009, J ANTIMICROB CHEMOTH, V63, P443, DOI 10.1093/jac/dkn528; Centers for Disease Control and Prevention, 2013, NEISS GON INF FREQ U; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; CHU DTW, 1992, DRUG EXP CLIN RES, V18, P275; Deguchi T, 1997, CHEMOTHERAPY, V43, P239, DOI 10.1159/000239573; Ehmann DE, 2014, CURR OPIN PHARMACOL, V18, P76, DOI 10.1016/j.coph.2014.09.007; Emami S, 2006, MINI-REV MED CHEM, V6, P375, DOI 10.2174/138955706776361493; Endimiani A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-106; Fan J, 2014, ANTIMICROB AGENTS CH, V58, P7264, DOI 10.1128/AAC.03475-14; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HOSHINO K, 1989, ANTIMICROB AGENTS CH, V33, P1816, DOI 10.1128/AAC.33.10.1816; Huband MD, 2015, ANTIMICROB AGENTS CH, V59, P467, DOI 10.1128/AAC.04124-14; Jacobsson S, 2014, ANTIMICROB AGENTS CH, V58, P5585, DOI 10.1128/AAC.03090-14; Janion C, 2008, INT J BIOL SCI, V4, P338; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Lowndes C., 2014, UPDATE HLTH PROTECTI; MARTELL AE, 2001, NIST CRITICAL STABIL; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Maxwell A, 1999, BIOCHEM SOC T, V27, P48, DOI 10.1042/bst0270048; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; MIZUUCHI K, 1984, COLD SPRING HARB SYM, V49, P835, DOI 10.1101/SQB.1984.049.01.094; PALU G, 1992, P NATL ACAD SCI USA, V89, P9671, DOI 10.1073/pnas.89.20.9671; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Schlacher K, 2006, CHEM REV, V106, P406, DOI 10.1021/cr0404951; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Schwarzenbach G., 1969, COMPLEXOMETRIC TITRA; Segev S, 1999, CLIN INFECT DIS, V28, P299, DOI 10.1086/515132; Shapiro A, 2010, J BIOMOL SCREEN, V15, P1088, DOI 10.1177/1087057110378624; Shapiro AB, 2014, ANAL BIOCHEM, V448, P23, DOI 10.1016/j.ab.2013.11.029; Shapiro AB, 2013, BIOCHEM PHARMACOL, V85, P1269, DOI 10.1016/j.bcp.2013.02.006; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Wiener JJM, 2007, BIOORG MED CHEM LETT, V17, P2718, DOI 10.1016/j.bmcl.2007.03.004; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892	51	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20984	20994		10.1074/jbc.M115.663534	http://dx.doi.org/10.1074/jbc.M115.663534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26149691	Green Published, hybrid			2022-12-28	WOS:000360011800032
J	Tsalikis, J; Tattoli, I; Ling, A; Sorbara, MT; Croitoru, DO; Philpott, DJ; Girardin, SE				Tsalikis, Jessica; Tattoli, Ivan; Ling, Arthur; Sorbara, Matthew T.; Croitoru, David O.; Philpott, Dana J.; Girardin, Stephen E.			Intracellular Bacterial Pathogens Trigger the Formation of U Small Nuclear RNA Bodies (U Bodies) through Metabolic Stress Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SMN COMPLEX; INNATE IMMUNITY; CAJAL BODY; PROTEIN; SURVIVAL; TRANSLATION; KINASE; SNRNAS; MTOR	Invasive bacterial pathogens induce an amino acid starvation (AAS) response in infected host cells that controls host defense in part by promoting autophagy. However, whether AAS has additional significant effects on the host response to intracellular bacteria remains poorly characterized. Here we showed that Shigella, Salmonella, and Listeria interfere with spliceosomal U snRNA maturation in the cytosol. Bacterial infection resulted in the rerouting of U snRNAs and their cytoplasmic escort, the survival motor neuron (SMN) complex, to processing bodies, thus forming U snRNA bodies (U bodies). This process likely contributes to the decline in the cytosolic levels of U snRNAs and of the SMN complex proteins SMN and DDX20 that we observed in infected cells. U body formation was triggered by membrane damage in infected cells and was associated with the induction of metabolic stresses, such as AAS or endoplasmic reticulum stress. Mechanistically, targeting of U snRNAs to U bodies was regulated by translation initiation inhibition and the ATF4/ATF3 pathway, and U bodies rapidly disappeared upon removal of the stress, suggesting that their accumulation represented an adaptive response to metabolic stress. Importantly, this process likely contributed to shape the host response to invasive bacteria because down-regulation of DDX20 expression using short hairpin RNA (shRNA) amplified ATF3- and NF-kappa B-dependent signaling. Together, these results identify a critical role for metabolic stress and invasive bacterial pathogens in U body formation and suggest that this process contributes to host defense.	[Tsalikis, Jessica; Tattoli, Ivan; Ling, Arthur; Croitoru, David O.; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M6G 2T6, Canada; [Tattoli, Ivan; Sorbara, Matthew T.; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M6G 2T6, Canada	University of Toronto; University of Toronto	Girardin, SE (corresponding author), Univ Toronto, Med Sci Bldg,Rm 6336, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca	Tattoli, Ivan/H-2600-2017	Tattoli, Ivan/0000-0001-7925-4609	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to D. J. P and S. E. G). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Nour M, 2014, IMMUNOL CELL BIOL, V92, P346, DOI 10.1038/icb.2014.3; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Buckingham M, 2011, EXP CELL RES, V317, P2835, DOI 10.1016/j.yexcr.2011.09.001; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Chang TH, 2013, BBA-GENE REGUL MECH, V1829, P764, DOI 10.1016/j.bbagrm.2013.02.006; Custer SK, 2014, MOL CELL NEUROSCI, V61, P133, DOI 10.1016/j.mcn.2014.06.006; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Eulalio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017296; Garcera A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.209; Ghezala HA, 2012, NUCLEIC ACIDS RES, V40, P9557, DOI 10.1093/nar/gks762; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; Kye MJ, 2014, HUM MOL GENET, V23, P6318, DOI 10.1093/hmg/ddu350; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Sahashi K, 2012, GENE DEV, V26, P1874, DOI 10.1101/gad.197418.112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shukla S, 2014, P NATL ACAD SCI USA, V111, pE3277, DOI 10.1073/pnas.1412614111; Suzuki T, 2010, J CELL BIOL, V190, P603, DOI 10.1083/jcb.201004109; Takata A, 2012, BIOCHEM BIOPH RES CO, V420, P564, DOI 10.1016/j.bbrc.2012.03.034; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; Tattoli I, 2012, BIOL OPEN, V1, P1215, DOI 10.1242/bio.20122840; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Tsalikis J, 2013, CELL MICROBIOL, V15, P1632, DOI 10.1111/cmi.12165; Valadkhan S, 2010, PROTEOMICS, V10, P4128, DOI 10.1002/pmic.201000354; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	45	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20904	20918		10.1074/jbc.M115.659466	http://dx.doi.org/10.1074/jbc.M115.659466			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134566	Green Published, hybrid			2022-12-28	WOS:000360011800026
J	Hernandez-Rocamora, VM; Alfonso, C; Margolin, W; Zorrilla, S; Rivas, G				Hernandez-Rocamora, Vctor M.; Alfonso, Carlos; Margolin, William; Zorrilla, Silvia; Rivas, German			Evidence That Bacteriophage lambda Kil Peptide Inhibits Bacterial Cell Division by Disrupting FtsZ Protofilaments and Sequestering Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETON PROTEINS; QUANTITATIVE-ANALYSIS; FILAMENT DYNAMICS; SIZE-DISTRIBUTION; MINCDE SYSTEM; POLYMERIZATION; CYTOKINESIS; BINDING; ASSAY; RING	The effects of Kil peptide from bacteriophage lambda on the assembly of Escherichia coli FtsZ into one subunit thick protofilaments were studied using combined biophysical and biochemical methods. Kil peptide has recently been identified as the factor from bacteriophage lambda responsible for the inhibition of bacterial cell division during lytic cycle, targeting FtsZ polymerization. Here, we show that this antagonist blocks FtsZ assembly into GTP-dependent protofilaments, producing a wide distribution of smaller oligomers compared with the average size of the intact protofilaments. The shortening of FtsZ protofilaments by Kil is detectable at concentrations of the peptide in the low micromolar range, the midpoint of the inhibition being close to its apparent affinity for GDP-bound FtsZ. This antagonist not only interferes with FtsZ assembly but also reverses the polymerization reaction. The negative regulation by Kil significantly reduces the GTPase activity of FtsZ protofilaments, and FtsZ polymers assembled in guanosine-5'-[(alpha,beta)-methyleno] triphosphate are considerably less sensitive to Kil. Our results suggest that, at high concentrations, Kil may use an inhibition mechanism involving the sequestration of FtsZ subunits, similar to that described for other inhibitors like the SOS response protein SulA or the moonlighting enzyme OpgH. This mechanism is different from those employed by the division site selection antagonists MinC and SlmA. This work provides new insight into the inhibition of FtsZ assembly by phages, considered potential tools against bacterial infection.	[Hernandez-Rocamora, Vctor M.; Alfonso, Carlos; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Margolin, William] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Texas System; University of Texas Health Science Center Houston	Hernandez-Rocamora, VM (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	silvia@cib.csic.es; grivas@cib.csic.es	Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Regan, Clinton/E-6250-2012; Rivas, German/AAG-7458-2022; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; Zorrilla, Silvia/0000-0002-6309-9058; Hernandez-Rocamora, Victor M./0000-0003-2517-5707	National Institutes of Health [GM61074]; Human Frontier Science Program [RGP0050/2010]; Spanish Government [BIO2011-28941-C03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Spanish Government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61074 (to W. M.). This work was also supported by Human Frontier Science Program Grant RGP0050/2010 (to G. R. and W. M.) and Spanish Government Grant BIO2011-28941-C03 (to G. R. and S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Haeusser DP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004217; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Masuda H, 2012, FEMS MICROBIOL LETT, V328, P174, DOI 10.1111/j.1574-6968.2012.02496.x; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rivas German, 2013, Biophys Rev, V5, P63, DOI 10.1007/s12551-013-0115-1; Rosales T, 2008, ANAL BIOCHEM, V381, P270, DOI 10.1016/j.ab.2008.05.056; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROYER CA, 1990, ANAL BIOCHEM, V191, P287, DOI 10.1016/0003-2697(90)90221-T; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; Trusca D, 1998, J BACTERIOL, V180, P3946, DOI 10.1128/JB.180.15.3946-3953.1998; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yu XC, 1998, J BIOL CHEM, V273, P10216, DOI 10.1074/jbc.273.17.10216; Zorrilla S, 2008, BIOPHYS J, V95, P4403, DOI 10.1529/biophysj.108.135863	55	11	12	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20325	20335		10.1074/jbc.M115.653329	http://dx.doi.org/10.1074/jbc.M115.653329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124275	Green Published, hybrid			2022-12-28	WOS:000359608900031
J	Kazmin, R; Rose, A; Szczepek, M; Elgeti, M; Ritter, E; Piechnick, R; Hofmann, KP; Scheerer, P; Hildebrand, PW; Bartl, FJ				Kazmin, Roman; Rose, Alexander; Szczepek, Michal; Elgeti, Matthias; Ritter, Eglof; Piechnick, Ronny; Hofmann, Klaus Peter; Scheerer, Patrick; Hildebrand, Peter W.; Bartl, Franz J.			The Activation Pathway of Human Rhodopsin in Comparison to Bovine Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; METARHODOPSIN-II; FTIR SPECTROSCOPY; PHOTOACTIVATED RHODOPSIN; INFRARED-SPECTROSCOPY; CRYSTAL-STRUCTURE; NIGHT BLINDNESS; TRANSDUCIN; TEMPERATURE; MECHANISM	Rhodopsin, the photoreceptor of rod cells, absorbs light to mediate the first step of vision by activating the G protein transducin (G(t)). Several human diseases, such as retinitis pigmentosa or congenital night blindness, are linked to rhodopsin malfunctions. Most of the corresponding in vivo studies and structure-function analyses (e.g. based on protein x-ray crystallography or spectroscopy) have been carried out on murine or bovine rhodopsin. Because these rhodopsins differ at several amino acid positions from human rhodopsin, we conducted a comprehensive spectroscopic characterization ofhumanrhodopsin in combination with molecular dynamics simulations. We show by FTIR and UV-visible difference spectroscopy that the light-induced transformations of the early photointermediates are very similar. Significant differences between the pigments appear with formation of the still inactive Meta I state and the transition to active Meta II. However, the conformation of Meta II and its activity toward the G protein are essentially the same, presumably reflecting the evolutionary pressure under which the active state has developed. Altogether, our results show that although the basic activation pathways of human and bovine rhodopsin are similar, structural deviations exist in the inactive conformation and during receptor activation, even between closely related rhodopsins. These differences between the well studied bovine or murine rhodopsins and human rhodopsin have to be taken into account when the influence of point mutations on the activation pathway of human rhodopsin are investigated using the bovine or murine rhodopsin template sequences.	[Kazmin, Roman; Rose, Alexander; Szczepek, Michal; Elgeti, Matthias; Piechnick, Ronny; Hofmann, Klaus Peter; Scheerer, Patrick; Hildebrand, Peter W.; Bartl, Franz J.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Szczepek, Michal; Scheerer, Patrick] AG Prot Xray Crystallog & Signal Transduct, D-10117 Berlin, Germany; [Rose, Alexander; Hildebrand, Peter W.] AG ProteInformat, D-10117 Berlin, Germany; [Kazmin, Roman; Ritter, Eglof] Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat BPI, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Ritter, E (corresponding author), Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany.	eglof.ritter@hu-berlin.de; patrick.scheerer@charite.de; franz.bartl@charite.de	Rose, Alexander/I-4371-2019	Rose, Alexander/0000-0002-0893-5551; Scheerer, Patrick/0000-0001-5028-2075	"Norddeutscher Verbund fur Hoch-und Hochstleistungsrechner" (HLRN) project [bec00085]	"Norddeutscher Verbund fur Hoch-und Hochstleistungsrechner" (HLRN) project	We thank Martha E. Sommer for critical reading of the manuscript, Anja Koch, Jana Engelmann, and Brian Bauer for technical assistance and Rho purification, and Martin Heck for fruitful discussions. The computer time necessary was provided by the "Norddeutscher Verbund fur Hoch-und Hochstleistungsrechner" (HLRN) project bec00085.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Beck M, 1998, FEBS LETT, V436, P304, DOI 10.1016/S0014-5793(98)01156-9; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bosch L, 2003, J BIOL CHEM, V278, P20203, DOI 10.1074/jbc.M301319200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; GANTER UM, 1988, BIOCHEMISTRY-US, V27, P7480, DOI 10.1021/bi00419a046; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoersch D, 2008, BIOCHEMISTRY-US, V47, P11518, DOI 10.1021/bi801397e; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Ismer J, 2013, NUCLEIC ACIDS RES, V41, pD280, DOI 10.1093/nar/gks1061; Kandt C, 2004, BIOPHYS J, V86, P705, DOI 10.1016/S0006-3495(04)74149-1; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; LEWIS JW, 1991, BIOCHEMISTRY-US, V30, P11372, DOI 10.1021/bi00112a003; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Mertz B, 2011, BIOPHYS J, V101, pL17, DOI 10.1016/j.bpj.2011.06.020; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; Nishimura S, 1998, BIOCHEMISTRY-US, V37, P15816, DOI 10.1021/bi981451n; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Sandberg M.N., 2014, SOJ BIOCH, V1, P12; Sekharan S, 2013, J AM CHEM SOC, V135, P19064, DOI 10.1021/ja409896y; Siebert F, 1995, ISRAEL J CHEM, V35, P309; SIEBERT F, 1983, EUR J BIOCHEM, V136, P119, DOI 10.1111/j.1432-1033.1983.tb07714.x; Singhal A, 2013, EMBO REP, V14, P520, DOI 10.1038/embor.2013.44; Sullivan JM, 1999, BIOPHYS J, V77, P1333, DOI 10.1016/S0006-3495(99)76983-3; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; THORGEIRSSON TE, 1993, BIOCHEMISTRY-US, V32, P13861, DOI 10.1021/bi00213a015; THORGEIRSSON TE, 1992, PHOTOCHEM PHOTOBIOL, V56, P1135, DOI 10.1111/j.1751-1097.1992.tb09738.x; Vogel R, 2007, J MOL BIOL, V366, P1580, DOI 10.1016/j.jmb.2006.12.019; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wifling D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117185; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Zaitseva E, 2010, J AM CHEM SOC, V132, P4815, DOI 10.1021/ja910317a	58	8	8	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20117	20127		10.1074/jbc.M115.652172	http://dx.doi.org/10.1074/jbc.M115.652172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26105054	hybrid, Green Published			2022-12-28	WOS:000359608900015
J	Gentry, PR; Sexton, PM; Christopoulos, A				Gentry, Patrick R.; Sexton, Patrick M.; Christopoulos, Arthur			Novel Allosteric Modulators of G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MUSCARINIC ACETYLCHOLINE-RECEPTORS; METABOTROPIC GLUTAMATE RECEPTORS; IMPROVES GLYCEMIC CONTROL; DRUG DISCOVERY; BINDING-SITE; STRUCTURAL BASIS; IN-VIVO; FUNCTIONAL SELECTIVITY; MONOCLONAL-ANTIBODY; SIGNALING PATHWAYS	G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topographically distinct, yet conformationally linked, domains. Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chemical probes due to the potential for novel therapeutics. It is now apparent that some GPCRs possess more than one targetable allosteric site, in addition to a growing list of putative endogenous modulators. Advances in structural biology are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biological characterization.	[Gentry, Patrick R.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia	Monash University	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, 399 Royal Parade, Parkville, Vic 3052, Australia.	arthur.christopoulos@monash.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473	National Health and Medical Research Council (NHMRC) of Australia [APP1055134]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant APP1055134 of the National Health and Medical Research Council (NHMRC) of Australia. This is the second article in the Thematic Minireview series "New Directions in G Protein-coupled Receptor Pharmacology." The authors declare that they have no conflicts of interest with the contents of this article.	Acher FC, 2011, NEUROPHARMACOLOGY, V60, P102, DOI 10.1016/j.neuropharm.2010.07.002; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; Bhaskar V, 2013, DIABETES OBES METAB, V15, P272, DOI 10.1111/dom.12019; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; Bortolato A, 2014, BRIT J PHARMACOL, V171, P3132, DOI 10.1111/bph.12689; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Chen Y, 2008, MOL PHARMACOL, V73, P909, DOI 10.1124/mol.107.040097; Chen YL, 2007, MOL PHARMACOL, V71, P1389, DOI 10.1124/mol.106.032425; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 1998, CLIN EXP PHARMACOL P, V25, P185, DOI 10.1111/j.1440-1681.1998.t01-4-.x; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Christopoulos A, 2014, PHARMACOL REV, V66, P918, DOI 10.1124/pr.114.008862; CLARK AL, 1976, BRIT J PHARMACOL, V58, P323, DOI 10.1111/j.1476-5381.1976.tb07708.x; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Davie BJ, 2014, J MED CHEM, V57, P5405, DOI 10.1021/jm500556a; Didenko T, 2013, CURR OPIN STRUC BIOL, V23, P740, DOI 10.1016/j.sbi.2013.07.011; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Ellis J, 2000, MOL PHARMACOL, V58, P1451, DOI 10.1124/mol.58.6.1451; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Generoso SF, 2015, NAT CHEM BIOL, V11, P280, DOI [10.1038/NCHEMBIO.1770, 10.1038/nchembio.1770]; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2015, MOL PHARMACOL, V88, P188, DOI 10.1124/mol.114.097220; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Hammond AS, 2010, ACS CHEM NEUROSCI, V1, P702, DOI 10.1021/cn100051m; Heitman LH, 2008, MOL PHARMACOL, V73, P1808, DOI 10.1124/mol.107.043521; Hollenberg MD, 2004, BRIT J PHARMACOL, V143, P443, DOI 10.1038/sj.bjp.0705946; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Issafras H, 2014, J PHARMACOL EXP THER, V348, P202, DOI 10.1124/jpet.113.205443; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kirkegaard HS, 2014, DRUG DISCOV TODAY, V19, P1699, DOI 10.1016/j.drudis.2014.06.011; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lamb JP, 2011, BIOORG MED CHEM LETT, V21, P2711, DOI 10.1016/j.bmcl.2010.11.119; Lanzafame AA, 2006, MOL PHARMACOL, V70, P736, DOI 10.1124/mol.106.024711; Lazareno S, 2000, MOL PHARMACOL, V58, P194, DOI 10.1124/mol.58.1.194; Lazareno S, 2004, MOL PHARMACOL, V65, P257, DOI 10.1124/mol.65.1.257; Lazareno S, 2002, MOL PHARMACOL, V62, P1492, DOI 10.1124/mol.62.6.1492; Lazareno S, 1998, MOL PHARMACOL, V53, P573, DOI 10.1124/mol.53.3.573; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; LULLMANN H, 1969, EUR J PHARMACOL, V6, P241, DOI 10.1016/0014-2999(69)90181-2; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mohr K, 2010, BRIT J PHARMACOL, V159, P997, DOI 10.1111/j.1476-5381.2009.00601.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Nicolaou KC, 2014, ANGEW CHEM INT EDIT, V53, P9128, DOI 10.1002/anie.201404761; Noetzel MJ, 2013, MOL PHARMACOL, V83, P835, DOI 10.1124/mol.112.082891; Noetzel MJ, 2012, MOL PHARMACOL, V81, P120, DOI 10.1124/mol.111.075184; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; O'Brien JA, 2004, J PHARMACOL EXP THER, V309, P568, DOI 10.1124/jpet.103.061747; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pittolo I, 2014, NAT CHEM BIOL, V10, P813, DOI [10.1038/NCHEMBIO.1612, 10.1038/nchembio.1612]; PROSKA J, 1994, MOL PHARMACOL, V45, P709; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rodriguez AL, 2010, MOL PHARMACOL, V78, P1105, DOI 10.1124/mol.110.067207; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Selvam C, 2010, J MED CHEM, V53, P2797, DOI 10.1021/jm901523t; Steinfeld T, 2007, MOL PHARMACOL, V72, P291, DOI 10.1124/mol.106.033746; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; Sullivan SK, 2006, BIOCHEMISTRY-US, V45, P15327, DOI 10.1021/bi0617097; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tang W, 2014, J BIOL CHEM, V289, P28271, DOI 10.1074/jbc.M114.585067; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2014, P NATL ACAD SCI USA, V111, P4614, DOI 10.1073/pnas.1320962111; Valant C, 2012, ANNU REV PHARMACOL, V52, P153, DOI 10.1146/annurev-pharmtox-010611-134514; van der Westhuizen ET, 2015, J PHARMACOL EXP THER, V353, P246, DOI 10.1124/jpet.114.221606; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wood MR, 2011, BIOCHEMISTRY-US, V50, P2403, DOI 10.1021/bi200129s; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Zhang YQ, 2005, J PHARMACOL EXP THER, V315, P1212, DOI 10.1124/jpet.105.090308; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200; Zhao ZJ, 2007, BIOORG MED CHEM LETT, V17, P1386, DOI 10.1016/j.bmcl.2006.11.081	98	142	145	4	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19478	19488		10.1074/jbc.R115.662759	http://dx.doi.org/10.1074/jbc.R115.662759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100627	Green Published, hybrid			2022-12-28	WOS:000359364600009
J	Liao, XH; Wang, N; Zhao, DW; Zheng, DL; Zheng, L; Xing, WJ; Ma, WJ; Bao, LY; Dong, J; Zhang, TC				Liao, Xing-Hua; Wang, Nan; Zhao, Dong-Wei; Zheng, De-Liang; Zheng, Li; Xing, Wen-Jing; Ma, Wen-Jian; Bao, Le-Yuan; Dong, Jian; Zhang, Tong-Cun			STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; SERUM RESPONSE FACTOR; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; NEOINTIMA FORMATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; TUBE FORMATION; VEGF-A; DIFFERENTIATION	The JAK-STAT3 signaling pathway is one of the critical pathways regulating cell proliferation, differentiation, and apoptosis. Myocardin is regarded as a key mediator for the change of smooth muscle phenotypes. However, the relationship between STAT3 and myocardin in the vascular smooth muscle cell (VSMC) phenotypic switch has not been investigated. The goal of this study was to investigate the molecular mechanism by which STAT3 affects the myocardin-regulated VSMC phenotypic switch. Data presented in this study demonstrated that STAT3 was rapidly up-regulated after stimulation with VEGF. Inhibition of the STAT3 activation process impaired VSMC proliferation and enhanced the expression of VSMC contractile genes by increasing serum-response factor binding to the CArG-containing regions of VSMC-specific contractile genes. In contrast, the interaction between serum-response factor and its co-activator myocardin was reduced by overexpression of STAT3. In addition, treated VEGF inhibited the transcription activity of myocardin, and overexpression of STAT3 inhibited myocardin-induced up-regulation of VSMC contractile phenotype-specific genes. Although myocardin and STAT3 are negatively correlated, interestingly, both of them can enhance the expression of VEGF, suggesting a feedback loop to regulate the VSMC phenotypic switch. Taken together, these results indicate that the JAK-STAT3 signaling pathway plays a key role in controlling the phenotypic switch of VSMCs through the interactions between STAT3 and myocardin by various coordinated gene regulation pathways and feedback loops.	[Liao, Xing-Hua; Bao, Le-Yuan; Dong, Jian; Zhang, Tong-Cun] Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 43000, Peoples R China; [Liao, Xing-Hua; Wang, Nan; Zhao, Dong-Wei; Zheng, De-Liang; Zheng, Li; Xing, Wen-Jing; Ma, Wen-Jian; Zhang, Tong-Cun] Tianjin Univ Sci & Technol, Coll Biotechnol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin 300457, Peoples R China	Wuhan University of Science & Technology; Tianjin University Science & Technology	Zhang, TC (corresponding author), Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 43000, Peoples R China.	zhangtongcun@wust.edu.cn	Zhang, Tong/HGC-1090-2022; Wang, Nan/GRY-3150-2022		National Natural Science Foundation of China [30970615, 31071126, 31000343, 31171303, 31171297, 31200955]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT1166]; Research Fund for the Doctoral Program of Higher Education of China [20111208110001]; Chinese Ministry of Education [212010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 30970615, 31071126, 31000343, 31171303, 31171297, and 31200955, Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China Grant IRT1166, Research Fund for the Doctoral Program of Higher Education of China Grant 20111208110001, and Key Project of Chinese Ministry of Education Grant 212010. The authors declare that they have no conflicts of interest with the contents of this article.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Belgore F, 2004, J CLIN PATHOL, V57, P266, DOI 10.1136/jcp.2003.012419; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chai JY, 2004, FASEB J, V18, P1264, DOI 10.1096/fj.03-1232fje; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen SH, 2008, CANCER BIOL THER, V7, P1994, DOI 10.4161/cbt.7.12.6967; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Daniel JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0261-9; Demyanets S, 2011, BASIC RES CARDIOL, V106, P217, DOI 10.1007/s00395-010-0141-0; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Grote K, 2005, VASC PHARMACOL, V43, P357, DOI 10.1016/j.vph.2005.08.021; Haridas V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005578; Jin J, 2013, MOL CELL BIOCHEM, V381, P267, DOI 10.1007/s11010-013-1710-y; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Liao XH, 2014, CELL SIGNAL, V26, P2370, DOI 10.1016/j.cellsig.2014.07.023; Liao XH, 2014, CELL SIGNAL, V26, P1335, DOI 10.1016/j.cellsig.2014.03.001; Liao XH, 2011, IUBMB LIFE, V63, P54, DOI 10.1002/iub.415; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Shi X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.282; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tallquist MD, 1999, ONCOGENE, V18, P7917, DOI 10.1038/sj.onc.1203216; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HB, 2012, AM J PATHOL, V180, P1243, DOI 10.1016/j.ajpath.2011.11.031; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watanabe Y, 1997, EXP CELL RES, V233, P340, DOI 10.1006/excr.1997.3583; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; Xie CQ, 2012, J BIOL CHEM, V287, P14598, DOI 10.1074/jbc.M111.329268; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang MX, 2010, J CANCER RES CLIN, V136, P981, DOI 10.1007/s00432-009-0743-9	56	52	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19641	19652		10.1074/jbc.M114.630111	http://dx.doi.org/10.1074/jbc.M114.630111			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100622	hybrid, Green Published			2022-12-28	WOS:000359364600025
J	Yan, F; Shen, N; Pang, JX; Molina, JR; Yang, P; Liu, SJ				Yan, Fei; Shen, Na; Pang, Jiuxia; Molina, Julian R.; Yang, Ping; Liu, Shujun			The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2 '-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; IN-VITRO; PHASE-I; C-KIT; MYELODYSPLASTIC SYNDROME; POOR-PROGNOSIS; MAST-CELLS; EXPRESSION; INHIBITOR; MECHANISMS	Lung cancer cells are sensitive to 5-aza-2'-deoxycytidine (decitabine) or midostaurin (PKC412), because decitabine restores the expression of methylation-silenced tumor suppressor genes, whereas PKC412 inhibits hyperactive kinase signaling, which is essential for cancer cell growth. Here, we demonstrated that resistance to decitabine (decitabine(R)) or PKC412 (PKC412(R)) eventually results from simultaneously remethylated DNA and reactivated kinase cascades. Indeed, both decitabine(R) and PKC412(R) displayed the up-regulation of DNA methyltransferase DNMT1 and tyrosine-protein kinase KIT, the enhanced phosphorylation of KIT and its downstream effectors, and the increased global and gene-specific DNA methylation with the down-regulation of tumor suppressor gene epithelial cadherin CDH1. Interestingly, decitabine(R) and PKC412(R) had higher capability of colony formation and wound healing than parental cells in vitro, which were attributed to the hyperactive DNMT1 or KIT, because inactivation of KIT or DNMT1 reciprocally blocked decitabine(R) or PKC412(R) cell proliferation. Further, DNMT1 knockdown sensitized PKC412(R) cells to PKC412; conversely, KIT depletion synergized with decitabine in eliminating decitabine(R). Importantly, when engrafted into nude mice, decitabine(R) and PKC412(R) had faster proliferation with stronger tumorigenicity that was caused by the reactivated KIT kinase signaling and further CDH1 silencing. These findings identify functional cross-talk between KIT and DNMT1 in the development of drug resistance, implying the reciprocal targeting of protein kinases and DNA methyltransferases as an essential strategy for durable responses in lung cancer.	[Yan, Fei; Shen, Na; Pang, Jiuxia; Liu, Shujun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Molina, Julian R.] Mayo Clin, Dept Med Oncol, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA	University of Minnesota System; Mayo Clinic; Mayo Clinic	Liu, SJ (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	sliu@hi.umn.edu	Regan, Clinton/E-6250-2012; Yan, Fei/G-4941-2016	Yan, Fei/0000-0003-4750-1200	National Institutes of Health [R01CA149623, R21CA155915]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R21CA155915, R01CA149623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA149623 and R21CA155915 (to S. L.). This work was also supported in part by funds from the Hormel Foundation (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Ansari J, 2009, ANTI-CANCER AGENT ME, V9, P569, DOI 10.2174/187152009788451879; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Boldrini L, 2004, CLIN CANCER RES, V10, P4101, DOI 10.1158/1078-0432.CCR-03-0664; Brognard J, 2001, CANCER RES, V61, P3986; Carlomagno F, 2005, CURR MED CHEM, V12, P1773, DOI 10.2174/0929867054367266; COURAGE C, 1995, BRIT J CANCER, V71, P697, DOI 10.1038/bjc.1995.137; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17; Fabbro D, 1999, PHARMACOL THERAPEUT, V82, P293, DOI 10.1016/S0163-7258(99)00005-4; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Garcia-Manero G, 2011, J CLIN ONCOL, V29, P2521, DOI 10.1200/JCO.2010.34.4226; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Girault I, 2003, CLIN CANCER RES, V9, P4415; Gleixner KV, 2006, BLOOD, V107, P752, DOI 10.1182/blood-2005-07-3022; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Hopfer O, 2007, EXP HEMATOL, V35, P712, DOI 10.1016/j.exphem.2007.01.054; Ikegami Y, 1996, ARZNEIMITTEL-FORSCH, V46, P201; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Jafri Nazia F., 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P147, DOI 10.1615/JEnvPathToxOncol.v22.i3.10; Jelinek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022110; Jiang L, 2012, BIOCHEM BIOPH RES CO, V422, P739, DOI 10.1016/j.bbrc.2012.05.072; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kandasamy K, 2002, CANCER RES, V62, P4929; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Kurakawa E, 2001, INT J ONCOL, V19, P277; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu ZF, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1156; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Momparler RL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00188; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Muller CI, 2006, CURR PHARM BIOTECHNO, V7, P315, DOI 10.2174/138920106778521523; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Propper DJ, 2001, J CLIN ONCOL, V19, P1485, DOI 10.1200/JCO.2001.19.5.1485; Rossi Antonio, 2009, Curr Drug Discov Technol, V6, P91; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Tenzer A, 2001, CANCER RES, V61, P8203; TSUURA Y, 1994, VIRCHOWS ARCH, V424, P135; Wang Q, 2012, INT J ONCOL, V40, P418, DOI 10.3892/ijo.2011.1233; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Weisberg E, 2008, BLOOD, V112, P5161, DOI 10.1182/blood-2008-02-138065; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; Wu JJ, 2005, FEBS LETT, V579, P1940, DOI 10.1016/j.febslet.2005.02.041; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.380	64	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18480	18494		10.1074/jbc.M114.633693	http://dx.doi.org/10.1074/jbc.M114.633693			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085088	Green Published, hybrid			2022-12-28	WOS:000358512100021
J	Lin, HP; Oksuz, I; Hurley, E; Wrabetz, L; Awatramani, R				Lin, Hsin-Pin; Oksuz, Idil; Hurley, Edward; Wrabetz, Lawrence; Awatramani, Rajeshwar			Microprocessor Complex Subunit DiGeorge Syndrome Critical Region Gene 8 (Dgcr8) Is Required for Schwann Cell Myelination and Myelin Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; INHERITED DEMYELINATING NEUROPATHIES; NF-KAPPA-B; SCIATIC-NERVE; IN-VIVO; C-JUN; OLIGODENDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; MICRORNA BIOGENESIS; SIGNALING PATHWAY	We investigated the role of a key component of the Microprocessor complex, DGCR8, in the regulation of myelin formation and maintenance. We found that conditionally ablating Dgcr8 in Schwann cells (SCs) during development results in an arrest of SC differentiation. Dgcr8 conditional knock-out (cKO) SCs fail to form 1: 1 relationships with axons or, having achieved this, fail to form myelin sheaths. The expression of genes normally found in immature SCs, such as sex-determining region Y-box 2 (Sox2), is increased in Dgcr8 cKO SCs, whereas the expression of myelin-related genes, including the master regulatory transcription factor early growth response 2 (Egr2), is decreased. Additionally, expression of a novel gene expression program involving sonic hedgehog (Shh), activated de novo in injured nerves, is elevated in Dgcr8 cKOs but not in Egr2 null mice, a model of SC differentiation arrest, suggesting that the injury-related gene expression program in Dgcr8 cKOs cannot be attributed to differentiation arrest. Inducible ablation of Dgcr8 in adult SCs results in gene expression changes similar to those found in cKOs, including an increase in the expression of Sox2 and Shh. Analyses of these nerves mainly reveal normal myelin thickness and axon size distribution but some dedifferentiated SCs and increased macrophage infiltration. Together our data suggest that Dgcr8 is responsible for modulation of gene expression programs underlying myelin formation and maintenance as well as suppression of an injury-related gene expression program.	[Lin, Hsin-Pin; Oksuz, Idil; Awatramani, Rajeshwar] Northwestern Univ, Dept Neurol, Feinberg Sch Med, 7-113 Lurie,303 E Super St, Chicago, IL 60611 USA; [Lin, Hsin-Pin; Oksuz, Idil; Awatramani, Rajeshwar] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Hurley, Edward; Wrabetz, Lawrence] SUNY Buffalo, Hunter James Kelly Res Inst, Buffalo, NY 14203 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Awatramani, R (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, 7-113 Lurie,303 E Super St, Chicago, IL 60611 USA.	r-awatramani@northwestern.edu			National Cancer Institute, National Institutes of Health Cancer Center Support Grant [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071081] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Part of this work was performed at the Center for Advanced Microscopy and the Mouse Histology and Phenotyping Laboratory of Northwestern University generously supported by National Cancer Institute, National Institutes of Health Cancer Center Support Grant P30 CA060553 (to the Robert H. Lurie Comprehensive Cancer Center). We thank Courtney Williamson, Dr. Lin Li, Mr. Lennell Reynolds Jr., and Dr. Wensheng Liu for technical assistance. We also thank statistical analyst Amy Yang from Northwestern Bio-statistics Collaboration Center and Yannick Poitelon for help with our statistical analyses.	Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Baloh RH, 2009, J NEUROSCI, V29, P2312, DOI 10.1523/JNEUROSCI.2168-08.2009; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; BROWN MJ, 1981, EXP NEUROL, V74, P170, DOI 10.1016/0014-4886(81)90157-6; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang LW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-84; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emde A, 2014, EMBO J, V33, P1428, DOI 10.15252/embj.201488142; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Gokey NG, 2012, MOL CELL BIOL, V32, P558, DOI 10.1128/MCB.06270-11; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He XL, 2012, NEUROSCIENTIST, V18, P45, DOI 10.1177/1073858410392382; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hung HA, 2015, J BIOL CHEM, V290, P6937, DOI 10.1074/jbc.M114.622878; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jang SW, 2010, J NEUROCHEM, V115, P1409, DOI 10.1111/j.1471-4159.2010.07045.x; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jessen Kristjan R, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-19; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Li SY, 2011, SCI CHINA LIFE SCI, V54, P806, DOI 10.1007/s11427-011-4213-7; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mager GM, 2008, J BIOL CHEM, V283, P18187, DOI 10.1074/jbc.M803330200; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2015, GLIA, V63, P1376, DOI 10.1002/glia.22852; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Morton PD, 2013, J NEUROSCI, V33, P9932, DOI 10.1523/JNEUROSCI.2483-12.2013; Morton PD, 2012, GLIA, V60, P639, DOI 10.1002/glia.22297; Musso M, 2001, NEUROBIOL DIS, V8, P700, DOI 10.1006/nbdi.2001.0397; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2003, MOL CELL NEUROSCI, V23, P13, DOI 10.1016/S1044-7431(03)00024-1; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Scherer SS, 2008, GLIA, V56, P1578, DOI 10.1002/glia.20751; Sekiguchi H, 2012, LAB INVEST, V92, P532, DOI 10.1038/labinvest.2012.6; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Shin YK, 2013, GLIA, V61, P892, DOI 10.1002/glia.22482; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Taveggia C, 2004, J NEUROCHEM, V91, P813, DOI 10.1111/j.1471-4159.2004.02745.x; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Verrier JD, 2010, J NEUROSCI RES, V88, P2558, DOI 10.1002/jnr.22418; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Xu QG, 2008, NEUROSCIENCE, V152, P877, DOI 10.1016/j.neuroscience.2008.01.060; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	92	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24294	24307		10.1074/jbc.M115.636407	http://dx.doi.org/10.1074/jbc.M115.636407			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26272614	hybrid, Green Published			2022-12-28	WOS:000362218900020
J	Yang, YD; Ye, QL; Jia, ZC; Cote, GP				Yang, Yidai; Ye, Qilu; Jia, Zongchao; Cote, Graham P.			Characterization of the Catalytic and Nucleotide Binding Properties of the alpha-Kinase Domain of Dictyostelium Myosin-II Heavy Chain Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PHOSPHORYLATION REACTION; CRYSTAL-STRUCTURE; TRPM7; LOCALIZATION; THREONINE	The alpha-kinases are a widely expressed family of serine/threonine protein kinases that exhibit no sequence identity with conventional eukaryotic protein kinases. In this report, we provide new information on the catalytic properties of the alpha-kinase domain of Dictyostelium myosin-II heavy chain kinase-A (termed A- CAT). Crystallization of A- CAT in the presence of MgATP yielded structures with AMP or adenosine in the catalytic cleft together with a phosphorylated Asp-766 residue. The results show that the beta- and alpha-phosphoryl groups are transferred either directly or indirectly to the catalytically essential Asp-766. Biochemical assays confirmed that A- CAT hydrolyzed ATP, ADP, and AMP with k(cat) values of 1.9, 0.6, and 0.32 min(-1), respectively, and showed that A-CAT can use ADP to phosphorylate peptides and proteins. Binding assays using fluorescent 2'/3'-O-(N-methylanthraniloyl) analogs of ATP and ADP yielded K-d values for ATP, ADP, AMP, and adenosine of 20 +/- 3, 60 +/- 20, 160 +/- 60, and 45 +/- 15 +/- mu M, respectively. Site-directed mutagenesis showed that Glu-713, Leu-716, and Lys-645, all of which interact with the adenine base, were critical for nucleotide binding. Mutation of the highly conserved Gln-758, which chelates a nucleotide-associated Mg2+ ion, eliminated catalytic activity, whereas loss of the highly conserved Lys-722 and Arg-592 decreased k(cat) values for kinase and ATPase activities by 3-6-fold. Mutation of Asp-663 impaired kinase activity to a much greater extent than ATPase, indicating a specific role in peptide substrate binding, whereas mutation of Gln-768 doubled ATPase activity, suggesting that it may act to exclude water from the active site.	[Yang, Yidai; Ye, Qilu; Jia, Zongchao; Cote, Graham P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca; coteg@queensu.ca			New York Structural Biology Consortium	New York Structural Biology Consortium	We thank Kim Munro of the Queen's University Protein Function Discovery Laboratory for help with the fluorescence measurements and Dr. Jiaxi Wang of the Queen's University Department of Chemistry Mass Spectrometry Facility for peptide analysis. Structural data were collected using Beamline X4A at the National Synchrotron Light Source, Brookhaven National Laboratory, a United States Department of Energy facility, supported by the New York Structural Biology Consortium.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BHATNAGAR D, 1983, BIOCHEMISTRY-US, V22, P6310, DOI 10.1021/bi00295a042; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Chen C, 2014, MOL CELL, V53, P140, DOI 10.1016/j.molcel.2013.11.013; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; COTE GP, 1987, J BIOL CHEM, V262, P1065; Crawley SW, 2008, BBA-PROTEINS PROTEOM, V1784, P908, DOI 10.1016/j.bbapap.2008.03.001; Crawley SW, 2011, J BIOL CHEM, V286, P2607, DOI 10.1074/jbc.M110.177014; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Ferreira-Cerca S, 2014, NUCLEIC ACIDS RES, V42, P8635, DOI 10.1093/nar/gku542; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; FUTEY LM, 1995, J BIOL CHEM, V270, P523, DOI 10.1074/jbc.270.2.523; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kenney Justin W., 2014, Advances in Biological Regulation, V55, P15, DOI 10.1016/j.jbior.2014.04.003; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Krapivinsky G, 2014, CELL, V157, P1061, DOI 10.1016/j.cell.2014.03.046; LaRonde NA, 2014, J BIOL CHEM, V289, P9488, DOI 10.1074/jbc.R113.538090; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luo X, 2001, J BIOL CHEM, V276, P17836, DOI 10.1074/jbc.M009366200; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; Moore CE, 2014, MOL CELL BIOL, V34, P2294, DOI 10.1128/MCB.00388-14; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ni DQ, 2000, PROTEIN SCI, V9, P1818, DOI 10.1110/ps.9.9.1818; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219	47	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23935	23946		10.1074/jbc.M115.672410	http://dx.doi.org/10.1074/jbc.M115.672410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26260792	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000361816500038
J	Maltseva, EA; Rechkunova, NI; Sukhanova, MV; Lavrik, OI				Maltseva, Ekaterina A.; Rechkunova, Nadejda I.; Sukhanova, Maria V.; Lavrik, Olga I.			Poly(ADP-ribose) Polymerase 1 Modulates Interaction of the Nucleotide Excision Repair Factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOME-WIDE IDENTIFICATION; RIBOSE ACCEPTOR SITES; BINDING-PROTEINS; DAMAGE; BETA; MECHANISM; NUCLEASE; PARP1; MICE; CONFORMATION	Poly(ADP-ribosyl)ation is a reversible post-translational modification that plays an essential role in many cellular processes, including regulation of DNA repair. Cellular DNA damage response by the synthesis of poly(ADP-ribose) (PAR) is mediated mainly by poly(ADP-ribose) polymerase 1 (PARP1). The XPC-RAD23B complex is one of the key factors of nucleotide excision repair participating in the primary DNA damage recognition. By using several biochemical approaches, we have analyzed the influence of PARP1 and PAR synthesis on the interaction of XPC-RAD23B with damaged DNA. Free PAR binds to XPC-RAD23B with an affinity that depends on the length of the poly(ADP-ribose) strand and competes with DNA for protein binding. Using P-32-labeled NAD(+) and immuno-blotting, we also demonstrate that both subunits of the XPC-RAD23B are poly(ADP-ribosyl)ated by PARP1. The efficiency of XPC-RAD23B PARylation depends on DNA structure and increases after UV irradiation of DNA. Therefore, our study clearly shows that XPC-RAD23B is a target of poly(ADP-ribosyl)ation catalyzed by PARP1, which can be regarded as a universal regulator of DNA repair processes.	[Maltseva, Ekaterina A.; Rechkunova, Nadejda I.; Sukhanova, Maria V.; Lavrik, Olga I.] Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia; [Rechkunova, Nadejda I.; Sukhanova, Maria V.; Lavrik, Olga I.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University	Lavrik, OI (corresponding author), Inst Chem Biol & Fundamental Med, 8 Lavrentiev Ave, Novosibirsk 630090, Russia.	lavrik@niboch.nsc.ru	Rechkunova, Nadezda I/G-5093-2013; Maltseva, Ekaterina/ABE-2612-2021; Lavrik, Olga I/G-4641-2013	Maltseva, Ekaterina/0000-0002-6800-5989; 	Russian Scientific Foundation [14-24-00038]; Russian Foundation for Basic Research [14-04-31363]	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Scientific Foundation Project 14-24-00038 and Russian Foundation for Basic Research Project 14-04-31363. The authors declare that they have no conflicts of interest with the contents of this article.	Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CLEAVER JE, 1983, J BIOL CHEM, V258, P9059; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Evdokimov AN, 2011, BIOCHEMISTRY-MOSCOW+, V76, P157, DOI 10.1134/S0006297911010159; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Illuzzi G, 2014, NUCLEIC ACIDS RES, V42, P7776, DOI 10.1093/nar/gku505; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; KANAI Y, 1978, IMMUNOLOGY, V34, P501; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; KIEHLBAUCH CC, 1993, ANAL BIOCHEM, V208, P26, DOI 10.1006/abio.1993.1004; King BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393504; Luijsterburg MS, 2012, J CELL BIOL, V197, P267, DOI 10.1083/jcb.201106074; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; MINAGA T, 1983, J BIOL CHEM, V258, P725; MINAGA T, 1983, J BIOL CHEM, V258, P5726; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005; OGATA N, 1981, J BIOL CHEM, V256, P4135; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Rosenthal F, 2014, FRONT BIOSCI-LANDMRK, V19, P1041, DOI 10.2741/4266; Sambrook J., 1989, MOL CLONING LAB MANU; SIBLEY JT, 1988, J IMMUNOL, V140, P3502; SIBLEY JT, 1986, CLIN EXP IMMUNOL, V64, P563; Sukhanova M, 2010, MUTAT RES-FUND MOL M, V685, P80, DOI 10.1016/j.mrfmmm.2009.08.009; Sukhanova MV, 2005, NUCLEIC ACIDS RES, V33, P1222, DOI 10.1093/nar/gki266; Sukhanova MV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P558, DOI 10.1023/B:BIRY.0000029855.68502.fa; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	40	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21811	21820		10.1074/jbc.M115.646638	http://dx.doi.org/10.1074/jbc.M115.646638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26170451	hybrid, Green Published			2022-12-28	WOS:000360968500004
J	Santha, S; Viswakarma, N; Das, S; Rana, A; Rana, B				Santha, Sreevidya; Viswakarma, Navin; Das, Subhasis; Rana, Ajay; Rana, Basabi			Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; CYCLIN D1 TRANSCRIPTION; BETA-CATENIN; PPAR-GAMMA; GENE-EXPRESSION; DOWN-REGULATION; IN-VIVO; GROWTH; PATHWAYS; CLEAVAGE	Prostate cancer (PCa) is one of the most frequently diagnosed cancers in men with limited treatment options for the hormone-resistant forms. Development of novel therapeutic options is critically needed to target advanced forms. Here we demonstrate that combinatorial treatment with the thiazolidinedione troglitazone (TZD) and TNF-related apoptosis-inducing ligand (TRAIL) can induce significant apoptosis in various PCa cells independent of androgen receptor status. Because TZD is known to activate AMP-activated protein kinase (AMPK), we determined whether AMPK is a molecular target mediating this apoptotic cascade by utilizing PCa cell lines stably overexpressing AMPK alpha 1 dominant negative (C4-2-DN) or empty vector (C4-2-EV). Our results indicated a significantly higher degree of apoptosis with TRAIL-TZD combination in C4-2-EV cells compared with C4-2-DN cells. Similarly, results from a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed a larger reduction of viability of C4-2-EV cells compared with C4-2-DN cells when treated with TRAIL-TZD, thus suggesting that C4-2-DN cells were more apoptosisresistant. Additionally, siRNA-mediated knockdown of endogenousAMPK alpha 1 expression showed a reduction of TRAIL-TZD-induced apoptosis, further confirming the participation of AMPK in mediating this apoptosis. Apoptosis induction by this combinatorial treatment was also associated with a cleavage of beta-catenin that was inhibited in both C4-2-DN cells and those cells in which AMPK alpha 1 was knocked down. In addition, time course studies showed an increase in pACC(S79) (AMPK target) levels coinciding with the time of apoptosis. These studies indicate the involvement of AMPK in TRAIL-TZD-mediated apoptosis and beta-catenin cleavage and suggest the possibility of utilizing AMPK as a therapeutic target in apoptosis-resistant prostate cancer.	[Santha, Sreevidya; Rana, Basabi] Loyola Univ Chicago, Dept Med, Div Gastroenterol & Nutr, Maywood, IL 60153 USA; [Viswakarma, Navin; Das, Subhasis; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Rana, Ajay; Rana, Basabi] Edward Hines Vet Adm Med Ctr, Hines, IL 60141 USA	Loyola University Chicago; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Rana, B (corresponding author), Loyola Univ Chicago, Bldg 101,Rm 2729,2160 S First Ave, Maywood, IL 60153 USA.	arnavr_299@hotmail.com	DAS, SUBHASIS/O-8421-2017; Regan, Clinton/E-6250-2012; Rana, Ajay/ABE-3739-2020	DAS, SUBHASIS/0000-0003-1032-4407; Rana, Ajay/0000-0003-0951-2566	Department of Defense [W81XWH-10-1-0195]; VA Merit Awards [BX000571, BX002703]; National Institutes of Health [CA178063, CA176846]; NATIONAL CANCER INSTITUTE [R01CA178063, R01CA176846] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000571, I01BX002703] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); VA Merit Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Defense Award W81XWH-10-1-0195 (to B. R.), VA Merit Awards BX000571 (to B. R.) and BX002703 (to A. R.) and National Institutes of Health Grants CA178063 (to B. R.) and CA176846 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Akinyeke TO, 2011, CANCER BIOL THER, V11, P1046, DOI 10.4161/cbt.11.12.15709; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bracarda S, 2011, BJU INT, V107, P13, DOI 10.1111/j.1464-410X.2010.10036.x; Christian PA, 2009, CANCER BIOL THER, V8, P73, DOI 10.4161/cbt.8.1.7132; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Goke R, 2000, CELL IMMUNOL, V201, P77, DOI 10.1006/cimm.2000.1650; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Nimmanapalli R, 2001, CANCER RES, V61, P759; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tencer L, 2008, ANTICANCER RES, V28, P895; THALMANN GN, 1994, CANCER RES, V54, P2577; van Ophoven A, 1999, PROSTATE CANCER P D, V2, P227, DOI 10.1038/sj.pcan.4500373; Voelkel-Johnson C, 2002, CANCER GENE THER, V9, P164, DOI 10.1038/sj.cgt.7700420; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu XX, 2002, INT J ONCOL, V20, P949; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Zadra G, 2014, EMBO MOL MED, V6, P519, DOI 10.1002/emmm.201302734; Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zhang XY, 2009, TRANSL ONCOL, V2, P21, DOI 10.1593/tlo.08190; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zisman A, 2001, J IMMUNOTHER, V24, P459, DOI 10.1097/00002371-200111000-00003; Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555	55	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21865	21875		10.1074/jbc.M115.663526	http://dx.doi.org/10.1074/jbc.M115.663526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198640	Green Published, hybrid			2022-12-28	WOS:000360968500009
J	Reardon-Robinson, ME; Osipiuk, J; Chang, CY; Wu, CG; Jooya, N; Joachimiak, A; Das, A; Ton-That, H				Reardon-Robinson, Melissa E.; Osipiuk, Jerzy; Chang, Chungyu; Wu, Chenggang; Jooya, Neda; Joachimiak, Andrzej; Das, Asis; Ton-That, Hung			A Disulfide Bond-forming Machine Is Linked to the Sortase-mediated Pilus Assembly Pathway in the Gram-positive Bacterium Actinomyces oris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actinobacteria; crystal structure; crystallography; disulfide; secretion; Actinomyces; coaggregation; oxidative protein folding; pili; sortase	FORMATION IN-VIVO; ORAL BIOFILM DEVELOPMENT; CORYNEBACTERIUM-DIPHTHERIAE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; PROTEIN; DSBA; IDENTIFICATION; ENZYME; COAGGREGATION	Background: Gram-positive bacteria secrete pilins through the Sec translocon in unfolded states. Results: Disruption of pilus disulfide bonds or genetic disruption of oxidoreductase-encoding genes mdbA and vkor abrogates pilus assembly in Actinomyces oris. Conclusion: MdbA and VKOR constitute a disulfide bond-forming machine in A. oris. Significance: Oxidative protein folding may be common in Actinobacteria and an attractive target for antimicrobials. Export of cell surface pilins in Gram-positive bacteria likely occurs by the translocation of unfolded precursor polypeptides; however, how the unfolded pilins gain their native conformation is presently unknown. Here, we present physiological studies to demonstrate that the FimA pilin of Actinomyces oris contains two disulfide bonds. Alanine substitution of cysteine residues forming the C-terminal disulfide bridge abrogates pilus assembly, in turn eliminating biofilm formation and polymicrobial interaction. Transposon mutagenesis of A. oris yielded a mutant defective in adherence to Streptococcus oralis, and revealed the essential role of a vitamin K epoxide reductase (VKOR) gene in pilus assembly. Targeted deletion of vkor results in the same defects, which are rescued by ectopic expression of VKOR, but not a mutant containing an alanine substitution in its conserved CXXC motif. Depletion of mdbA, which encodes a membrane-bound thiol-disulfide oxidoreductase, abrogates pilus assembly and alters cell morphology. Remarkably, overexpression of MdbA or a counterpart from Corynebacterium diphtheriae, rescues the vkor mutant. By alkylation assays, we demonstrate that VKOR is required for MdbA reoxidation. Furthermore, crystallographic studies reveal that A. oris MdbA harbors a thioredoxin-like fold with the conserved CXXC active site. Consistently, each MdbA enzyme catalyzes proper disulfide bond formation within FimA in vitro that requires the catalytic CXXC motif. Because the majority of signal peptide-containing proteins encoded by A. oris possess multiple Cys residues, we propose that MdbA and VKOR constitute a major folding machine for the secretome of this organism. This oxidative protein folding pathway may be a common feature in Actinobacteria.	[Reardon-Robinson, Melissa E.; Chang, Chungyu; Wu, Chenggang; Jooya, Neda; Ton-That, Hung] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Dept Biosci, Argonne, IL 60439 USA; [Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Dept Biosci, Argonne, IL 60439 USA; [Das, Asis] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA	University of Texas System; University of Texas Health Science Center Houston; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Connecticut	Ton-That, H (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6431 Fannin St,R224 MSE, Houston, TX 77030 USA.	ton-that.hung@uth.tmc.edu	Ton-That, Hung/AAB-6155-2020	Wu, chenggang/0000-0002-5700-7188; Joachimiak, Andrzej/0000-0003-2535-6209; Ton-That, Hung/0000-0003-1611-0469	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017382, R01DE025015, F31DE024004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Structural Biology Center at Argonne National Laboratory for their help in conducting x-ray diffraction data collection and our lab members for critical review and discussion of the manuscript. Argonne is operated by the University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bayan N, 2003, J BIOTECHNOL, V104, P55, DOI 10.1016/S0168-1656(03)00163-9; Burkovski A, 2013, ISRN MICROBIOL, V2013, P935736, DOI 10.1155/2013/935736; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Chim N, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-23; Crow A, 2009, J BIOL CHEM, V284, P23719, DOI 10.1074/jbc.M109.005785; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIRARD AE, 1974, ARCH ORAL BIOL, V19, P71, DOI 10.1016/0003-9969(74)90228-3; GOLDBERGER RF, 1964, J BIOL CHEM, V239, P1406; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; Gorrec F, 2011, ACTA CRYSTALLOGR D, V67, P463, DOI 10.1107/S0907444911008754; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung TT, 2011, ORAL MICROBIAL COMMUNITIES: GENOMIC INQUIRY AND INTERSPECIES COMMUNICATION, P63; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mishra A, 2011, MOL MICROBIOL, V81, P1205, DOI 10.1111/j.1365-2958.2011.07745.x; Mishra A, 2010, MOL MICROBIOL, V77, P841, DOI 10.1111/j.1365-2958.2010.07252.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pedone E, 2008, ANTIOXID REDOX SIGN, V10, P157, DOI 10.1089/ars.2007.1855; Persson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048364; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Reardon-Robinson ME, 2014, P NATL ACAD SCI USA, V111, P3835, DOI 10.1073/pnas.1321417111; Ren G, 2014, MOL MICROBIOL, V94, P926, DOI 10.1111/mmi.12808; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; Wang L, 2013, PROTEIN CELL, V4, P628, DOI 10.1007/s13238-013-3033-x; Wang XY, 2011, ANTIOXID REDOX SIGN, V14, P1413, DOI 10.1089/ars.2010.3558; Wu CG, 2014, MOL MICROBIOL, V94, P1227, DOI 10.1111/mmi.12780; Wu C, 2011, J BACTERIOL, V193, P3197, DOI 10.1128/JB.00173-11	59	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21393	21405		10.1074/jbc.M115.672253	http://dx.doi.org/10.1074/jbc.M115.672253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170452	Green Published, hybrid			2022-12-28	WOS:000360637600016
J	Neal, SE; Dabir, DV; Tienson, HL; Horn, DM; Glaeser, K; Loo, RRO; Barrientos, A; Koehler, CM				Neal, Sonya E.; Dabir, Deepa V.; Tienson, Heather L.; Horn, Darryl M.; Glaeser, Kathrin; Loo, Rachel R. Ogozalek; Barrientos, Antoni; Koehler, Carla M.			Mia40 Protein Serves as an Electron Sink in the Mia40-Erv1 Import Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL INTERMEMBRANE SPACE; DISULFIDE RELAY SYSTEM; SMALL-MOLECULE INHIBITOR; C-OXIDASE BIOGENESIS; CYTOCHROME-C; SULFHYDRYL OXIDASE; RESPIRATORY-CHAIN; MEMBRANE-PROTEINS; SUBSTRATE; ERV1	A redox-regulated import pathway consisting of Mia40 and Erv1 mediates the import of cysteine-rich proteins into the mitochondrial intermembrane space. Mia40 is the oxidoreductase that inserts two disulfide bonds into the substrate simultaneously. However, Mia40 has one redox-active cysteine pair, resulting in ambiguity about how Mia40 accepts numerous electrons during substrate oxidation. In this study, we have addressed the oxidation of Tim13 in vitro and in organello. Reductants such as glutathione and ascorbate inhibited both the oxidation of the substrate Tim13 in vitro and the import of Tim13 and Cmc1 into isolated mitochondria. In addition, a ternary complex consisting of Erv1, Mia40, and substrate, linked by disulfide bonds, was not detected in vitro. Instead, Mia40 accepted six electrons from substrates, and this fully reduced Mia40 was sensitive to protease, indicative of conformational changes in the structure. Mia40 in mitochondria from the erv1-101 mutant was also trapped in a completely reduced state, demonstrating that Mia40 can accept up to six electrons as substrates are imported. Therefore, these studies support that Mia40 functions as an electron sink to facilitate the insertion of two disulfide bonds into substrates.	[Neal, Sonya E.; Tienson, Heather L.; Glaeser, Kathrin; Loo, Rachel R. Ogozalek; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Neal, Sonya E.; Tienson, Heather L.; Glaeser, Kathrin; Loo, Rachel R. Ogozalek; Koehler, Carla M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Dabir, Deepa V.] Loyola Marymount Univ, Dept Biol, Los Angeles, CA 90045 USA; [Horn, Darryl M.; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol & Biochem & Mol Biol, Miami, FL 33136 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Loyola Marymount University; University of Miami	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 951569, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health Ruth L. Kirschstein National Research Service Awards [GM871082, GM007185]; National Institutes of Health [R01 GM061721, R01 GM071775]; UCLA Cota-Robles Fellowship; American Heart Association [0640076N]; Muscular Dystrophy Association [022398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM105781, R01GM071775, R01GM061721] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Cota-Robles Fellowship; American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Awards GM871082 (to S. E. N.) and GM007185 (to H. L. T.) and National Institutes of Health Grants R01 GM061721 and R01 GM071775 (to A. B.). This work was also supported by the UCLA Cota-Robles Fellowship, American Heart Association Grant 0640076N (to C. M. K.), and Muscular Dystrophy Association Grant 022398. The authors declare that they have no conflicts of interest with the contents of this article.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Beverly KN, 2008, J MOL BIOL, V382, P1144, DOI 10.1016/j.jmb.2008.07.069; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Bottinger L, 2012, MOL BIOL CELL, V23, P3957, DOI 10.1091/mbc.E12-05-0358; Bourens M, 2012, J BIOL CHEM, V287, P31258, DOI 10.1074/jbc.M112.383562; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gross DP, 2011, MOL BIOL CELL, V22, P3758, DOI 10.1091/mbc.E11-04-0296; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Lionaki E, 2010, ANTIOXID REDOX SIGN, V13, P1327, DOI 10.1089/ars.2010.3200; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Spiller MP, 2013, BIOCHEM J, V455, P27, DOI 10.1042/BJ20130442; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20804	20814		10.1074/jbc.M115.669440	http://dx.doi.org/10.1074/jbc.M115.669440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26085103	Green Published, hybrid			2022-12-28	WOS:000360011800018
J	Gupta, K; Martin, R; Sharp, R; Sarachan, KL; Ninan, NS; Van Duyne, GD				Gupta, Kushol; Martin, Renee; Sharp, Robert; Sarachan, Kathryn L.; Ninan, Nisha S.; Van Duyne, Gregory D.			Oligomeric Properties of Survival Motor Neuron.Gemin2 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; X-RAY-SCATTERING; NEURON SMN PROTEIN; SELF-ASSOCIATION; SINGLE NUCLEOTIDE; GENE-PRODUCT; POMBE; MACROMOLECULES; IDENTIFICATION; INTERMEDIATE	The survival motor neuron(SMN) protein forms the oligomeric core of a multiprotein complex required for the assembly of spliceosomal small nuclear ribonucleoproteins. Deletions and mutations in the SMN1 gene are associated with spinal muscular atrophy (SMA), a devastating neurodegenerative disease that is the leading heritable cause of infant mortality. Oligomerization of SMN is required for its function, and some SMA patient mutations disrupt the ability of SMN to self-associate. Here, we investigate the oligomeric nature of the SMN.Gemin2 complexes from humans and fission yeast (hSMN.Gemin2 and ySMN.Gemin2). We find that hSMN.Gemin2 forms oligomers spanning the dimer to octamer range. The YG box oligomerization domain of SMN is both necessary and sufficient to form these oligomers. ySMN.Gemin2 exists as a dimer-tetramer equilibrium with K-d = 1.0 +/- 0.9 mu M. A 1.9 angstrom crystal structure of the ySMN YG box confirms a high level of structural conservation with the human ortholog in this important region of SMN. Disulfide cross-linking experiments indicate that SMN tetramers are formed by self-association of stable, non-dissociating dimers. Thus, SMN tetramers do not form symmetric helical bundles such as those found in glycine zipper transmembrane oligomers. The dimer-tetramer nature of SMN complexes and the dimer of dimers organization of the SMN tetramer provide an important foundation for ongoing studies to understand the mechanism of SMN-assisted small nuclear ribonucleoprotein assembly and the underlying causes of SMA.	[Gupta, Kushol; Martin, Renee; Sharp, Robert; Sarachan, Kathryn L.; Ninan, Nisha S.; Van Duyne, Gregory D.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Martin, Renee; Sarachan, Kathryn L.; Ninan, Nisha S.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Van Duyne, GD (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 242 Anat Chem Bldg, Philadelphia, PA 19104 USA.	vanduyne@mail.med.upenn.edu	Gupta, Kushol/GOE-5620-2022; Regan, Clinton/E-6250-2012	Gupta, Kushol/0000-0002-7006-2667; Sarachan, Kathryn/0000-0003-2511-1404	National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; Office of Biological and Environmental Research of the United States Department of Energy; Office of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) [DE-AC02-05CH11231]; United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Richard Gillilan (Cornell University High Energy Synchrotron Source (CHESS)), Gregory Hura, Jane Tanamachi, Kevin Dyer, and Michal Hammel (Advanced Light Source (ALS)), and Lin Yang and Marc Allaire (National Synchrotron Light Source (NSLS)) for technical expertise and support and G. V. laboratory members for helpful discussions. CHESS is supported by National Science Foundation Grant DMR 0225180, and the Mac-CHESS facility is supported by National Institutes of Health Grant RR-01646. Financial support for the NSLS comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources of the National Institutes of Health. X-ray scattering and diffraction technologies and their applications to the determination of macromolecular shapes and conformations at the SIBYLS beamline at ALS, Lawrence Berkeley National Laboratory, are supported in part by the Department of Energy programs Integrated Diffraction Analysis Technologies (IDAT) and Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under Contract DE-AC02-05CH11231 with the United States Department of Energy.	Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Anderton RS, 2013, MOL NEUROBIOL, V47, P821, DOI 10.1007/s12035-013-8399-5; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Campion Y, 2010, EMBO J, V29, P1817, DOI 10.1038/emboj.2010.70; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Green MR, 2012, MOL CLONING LAB MANU, V1; Grimm C, 2013, MOL CELL, V49, P692, DOI 10.1016/j.molcel.2012.12.009; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hannus S, 2000, HUM MOL GENET, V9, P663, DOI 10.1093/hmg/9.5.663; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; KEGELES G, 1967, P NATL ACAD SCI USA, V58, P45, DOI 10.1073/pnas.58.1.45; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Laue TM, 1992, BIOCH POLYM SCI, P90; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li DK, 2014, SEMIN CELL DEV BIOL, V32, P22, DOI 10.1016/j.semcdb.2014.04.026; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Martin R, 2012, STRUCTURE, V20, P1929, DOI 10.1016/j.str.2012.08.024; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Nielsen SS, 2012, J APPL CRYSTALLOGR, V45, P213, DOI 10.1107/S0021889812000957; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Owen N, 2000, HUM MOL GENET, V9, P1142; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Praveen K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004489; Sanchez G, 2013, HUM MOL GENET, V22, P668, DOI 10.1093/hmg/dds474; Sarachan KL, 2012, BIOCHEM J, V445, P361, DOI 10.1042/BJ20120241; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott DJ, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P1, DOI 10.1039/9781847552617-00001; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Tiziano FD, 2013, AM J MED GENET A, V161, P2836, DOI 10.1002/ajmg.a.36251; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043	61	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20185	20199		10.1074/jbc.M115.667279	http://dx.doi.org/10.1074/jbc.M115.667279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26092730	Green Published, hybrid			2022-12-28	WOS:000359608900020
J	Martinez-Rodriguez, L; Erdogan, O; Jimenez-Rodriguez, M; Gonzalez-Rivera, K; Williams, T; Li, L; Weinreb, V; Collier, M; Chandrasekaran, SN; Ambroggio, X; Kuhlman, B; Carter, CW				Martinez-Rodriguez, Luis; Erdogan, Ozguen; Jimenez-Rodriguez, Mariel; Gonzalez-Rivera, Katiria; Williams, Tishan; Li, Li; Weinreb, Violetta; Collier, Martha; Chandrasekaran, Srinivas Niranj; Ambroggio, Xavier; Kuhlman, Brian; Carter, Charles W., Jr.			Functional Class I and II Amino Acid-activating Enzymes Can Be Coded by Opposite Strands of the Same Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; RODIN-OHNO HYPOTHESIS; ATP-BINDING PEPTIDE; CIRCULAR-DICHROISM; SUBSTRATE-BINDING; ADENYLATE KINASE; DOMAIN MOTION; ATOMIC-LEVEL; EVOLUTION; SEQUENCE	Aminoacyl-tRNA synthetases (aaRS) catalyze both chemical steps that translate the universal genetic code. Rodin and Ohno offered an explanation for the existence of two aaRS classes, observing that codons for the most highly conserved Class I active-site residues are anticodons for corresponding Class II active-site residues. They proposed that the two classes arose simultaneously, by translation of opposite strands from the same gene. We have characterized wild-type 46-residue peptides containing ATP-binding sites of Class I and II synthetases and those coded by a gene designed by Rosetta to encode the corresponding peptides on opposite strands. Catalysis by WT and designed peptides is saturable, and the designed peptides are sensitive to active-site residue mutation. All have comparable apparent second-order rate constants 2.9-7.0E-3 M-1 s(-1) or similar to 750,000-1,300,000 times the uncatalyzed rate. The activities of the two complementary peptides demonstrate that the unique information in a gene can have two functional interpretations, one from each complementary strand. The peptides contain phylogenetic signatures of longer, more sophisticated catalysts we call Urzymes and are short enough to bridge the gap between them and simpler uncoded peptides. Thus, they directly substantiate the sense/antisense coding ancestry of Class I and II aaRS. Furthermore, designed 46-mers achieve similar catalytic proficiency to wild-type 46-mers by significant increases in both k(cat) and K-m values, supporting suggestions that the earliest peptide catalysts activated ATP for biosynthetic purposes.	[Martinez-Rodriguez, Luis; Erdogan, Ozguen; Jimenez-Rodriguez, Mariel; Gonzalez-Rivera, Katiria; Williams, Tishan; Li, Li; Weinreb, Violetta; Collier, Martha; Chandrasekaran, Srinivas Niranj; Ambroggio, Xavier; Kuhlman, Brian; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	carter@med.unc.edu	Chandrasekaran, Srinivas Niranj/J-8262-2019	Chandrasekaran, Srinivas Niranj/0000-0001-8874-9988; Gonzalez Rivera, Alba Katiria/0000-0001-7029-0240; Le Roux, Ozgun/0000-0002-9885-6872	American Biophysical Society Summer Course; University of North Carolina at Chapel Hill Post-baccalaureate Research Education and Summer Undergraduate Research Experience programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM089569, R01GM078227, R01GM073960] Funding Source: NIH RePORTER	American Biophysical Society Summer Course; University of North Carolina at Chapel Hill Post-baccalaureate Research Education and Summer Undergraduate Research Experience programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hermans for advice on the fluorescence experiments and R. Wolfenden, T. Traut, and C. Lewis for assistance with the manuscript. Completion of this work would not have been possible without the encouragement and support of L. Parise, the American Biophysical Society Summer Course, and the University of North Carolina at Chapel Hill Post-baccalaureate Research Education and Summer Undergraduate Research Experience programs.	Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; BELRHALI H, 1995, STRUCTURE, V3, P341, DOI 10.1016/S0969-2126(01)00166-6; Belrhali H, 1996, THESIS EUROPEAN SYNC; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; Carter Charles W. Jr., 2015, Life-Basel, V5, P294, DOI 10.3390/life5010294; Carter CW, 2014, J BIOL CHEM, V289, P30213, DOI 10.1074/jbc.R114.567495; Carter CW, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-11; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; CHAN KW, 1994, BBA-PROTEIN STRUCT M, V1205, P223, DOI 10.1016/0167-4838(94)90237-2; Chandrasekaran SN, 2013, MOL BIOL EVOL, V30, P1588, DOI 10.1093/molbev/mst070; CHUANG WJ, 1992, BIOCHEMISTRY-US, V31, P7915, DOI 10.1021/bi00149a024; CHUANG WJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P110, DOI 10.1006/abbi.1995.1272; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fersht A. R., 1999, STRUCTURE MECH PROTE, P89; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; FRY DC, 1988, BIOCHEMISTRY-US, V27, P3588, DOI 10.1021/bi00410a009; HARDIN RH, 1993, J STAT PLAN INFER, V37, P339, DOI 10.1016/0378-3758(93)90112-J; HARTLEIN M, 1995, J MOL EVOL, V40, P519; Hu H, 2014, SCI CHINA CHEM, V57, P156, DOI 10.1007/s11426-013-5021-7; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020937; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li L, 2013, J BIOL CHEM, V288, P34736, DOI 10.1074/jbc.M113.510958; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; MULLEN GP, 1993, ARCH BIOCHEM BIOPHYS, V301, P174, DOI 10.1006/abbi.1993.1130; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Rodin AS, 2009, J MOL EVOL, V69, P555, DOI 10.1007/s00239-009-9288-4; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; SAS Institute, 2007, JMP STAT GRAPH GUID; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Weinreb V, 2014, J BIOL CHEM, V289, P4367, DOI 10.1074/jbc.M113.538660; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051	58	35	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19710	19725		10.1074/jbc.M115.642876	http://dx.doi.org/10.1074/jbc.M115.642876			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088142	Green Published, hybrid			2022-12-28	WOS:000359364600030
J	Mongan, M; Meng, QH; Wang, JJ; Kao, WWY; Puga, A; Xia, Y				Mongan, Maureen; Meng, Qinghang; Wang, Jingjing; Kao, Winston W. -Y.; Puga, Alvaro; Xia, Ying			Gene-Environment Interactions Target Mitogen- activated Protein 3 Kinase 1 (MAP3K1) Signaling in Eyelid Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; DIOXIN-LIKE COMPOUNDS; C-JUN; DEVELOPMENTAL TOXICITY; PALATE DEVELOPMENT; CELL-MIGRATION; RETINOIC ACID; BIRTH-DEFECTS; C57BL/6N MICE; EGF RECEPTOR	Gene-environment interactions determine the biological outcomes through mechanisms that are poorly understood. Mouse embryonic eyelid closure is a well defined model to study the genetic control of developmental programs. Using this model, we investigated how exposure to dioxin-like environmental pollutants modifies the genetic risk of developmental abnormalities. Our studies reveal that mitogen-activated protein 3 kinase 1 (MAP3K1) signaling is a focal point of gene-environment crosstalk. Dioxin exposure, acting through the aryl hydrocarbon receptor (AHR), blocked eyelid closure in genetic mutants in which MAP3K1 signaling was attenuated but did not disturb this developmental program in either wild type or mutant mice with attenuated epidermal growth factor receptor or WNT signaling. Exposure also markedly inhibited c-Jun phosphorylation in Map3k1(+/-) embryonic eyelid epithelium, suggesting that dioxin-induced AHR pathways can synergize with gene mutations to inhibit MAP3K1 signaling. Our studies uncover a novel mechanism through which the dioxin-AHR axis interacts with the MAP3K1 signaling pathways during fetal development and provide strong empirical evidence that specific gene alterations can increase the risk of developmental abnormalities driven by environmental pollutant exposure.	[Mongan, Maureen; Meng, Qinghang; Wang, Jingjing; Puga, Alvaro; Xia, Ying] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Kao, Winston W. -Y.; Xia, Ying] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Xia, Y (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	ying.xia@uc.edu	Wang, Jingjing/GLS-7536-2022; Regan, Clinton/E-6250-2012	Wang, Jingjing/0000-0003-2347-7824; Xia, Ying/0000-0001-9532-9527	National Institutes of Health [RO1 EY15227, R21 ES023507, RO1 ES006273, RO1 ES024744, P30 ES006096]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023507, R01ES024744, P30ES006096, R01ES006273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY15227, R21 ES023507, RO1 ES006273, RO1 ES024744, and P30 ES006096. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott BD, 2003, TOXICOL SCI, V76, P427, DOI 10.1093/toxsci/kfg238; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; BIRNBAUM LS, 1989, TOXICOL APPL PHARM, V98, P487, DOI 10.1016/0041-008X(89)90177-4; Birnbaum LS, 1995, TOXICOL LETT, V82-3, P743, DOI 10.1016/0378-4274(95)03592-3; Brent RL, 2004, PEDIATRICS, V113, P957; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chevallier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053520; Choudhary M, 2015, J PATHOL, V235, P101, DOI 10.1002/path.4433; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Curran CP, 2011, TOXICOL SCI, V119, P189, DOI 10.1093/toxsci/kfq314; Das Dhanjit Kumar, 2013, Indian J Hum Genet, V19, P437, DOI 10.4103/0971-6866.124372; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; Dragin N, 2006, J BIOL CHEM, V281, P18591, DOI 10.1074/jbc.M601159200; FINDLATER GS, 1993, J ANAT, V183, P121; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Geh E, 2011, P NATL ACAD SCI USA, V108, P17349, DOI 10.1073/pnas.1102297108; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hakk H, 2009, TOXICOL APPL PHARM, V241, P119, DOI 10.1016/j.taap.2009.08.009; Heller E, 2014, DEV CELL, V28, P617, DOI 10.1016/j.devcel.2014.02.011; Hope WC, 2015, J AAPOS, V19, P277, DOI 10.1016/j.jaapos.2015.01.018; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Jacobs H, 2011, ENVIRON HEALTH PERSP, V119, P1590, DOI 10.1289/ehp.1003075; Jaillard S, 2011, AM J MED GENET A, V155A, P725, DOI 10.1002/ajmg.a.33758; Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; Loke J, 2014, HUM MOL GENET, V23, P1073, DOI 10.1093/hmg/ddt502; Maklad A, 2009, J INVEST DERMATOL, V129, P690, DOI 10.1038/jid.2008.281; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Meng QH, 2014, INVEST OPHTH VIS SCI, V55, P7652, DOI 10.1167/iovs.14-15155; Meng QH, 2014, DEV BIOL, V395, P29, DOI 10.1016/j.ydbio.2014.09.001; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Ngo AD, 2006, INT J EPIDEMIOL, V35, P1220, DOI 10.1093/ije/dyl038; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; PRESLAN M W, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P166; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; SEVEL D, 1988, EYE, V2, P123, DOI 10.1038/eye.1988.25; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Warr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019572; WEBER H, 1985, ARCH TOXICOL, V57, P159, DOI 10.1007/BF00290880; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; YAMASHITA F, 1985, ENVIRON HEALTH PERSP, V59, P41, DOI 10.2307/3429872; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	58	7	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19770	19779		10.1074/jbc.M115.665729	http://dx.doi.org/10.1074/jbc.M115.665729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109068	hybrid, Green Published			2022-12-28	WOS:000359364600034
J	He, T; Gershenson, A; Eyles, SJ; Lee, YJ; Liu, WSR; Wang, JY; Gao, JM; Roberts, MF				He, Tao; Gershenson, Anne; Eyles, Stephen J.; Lee, Yan-Jiun; Liu, Wenshe R.; Wang, Jiangyun; Gao, Jianmin; Roberts, Mary F.			Fluorinated Aromatic Amino Acids Distinguish Cation-pi Interactions from Membrane Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; PHOSPHOLIPASE-C; BINDING-SITES	Cation-pi interactions, where protein aromatic residues supply pi systems while a positive-charged portion of phospholipid head groups are the cations, have been suggested as important binding modes for peripheral membrane proteins. However, aromatic amino acids can also insert into membranes and hydrophobically interact with lipid tails. Heretofore there has been no facile way to differentiate these two types of interactions. We show that specific incorporation of fluorinated amino acids into proteins can experimentally distinguish cation-pi interactions from membrane insertion of the aromatic side chains. Fluorinated aromatic amino acids destabilize the cation-pi interactions by altering electrostatics of the aromatic ring, whereas their increased hydrophobicity enhances membrane insertion. Incorporation of pentafluorophenylalanine or difluorotyrosine into a Staphylococcus aureus phosphatidylinositol-specific phospholipase C variant engineered to contain a specific PC-binding site demonstrates the effectiveness of this methodology. Applying this methodology to the plethora of tyrosine residues in Bacillus thuringiensis phosphatidylinositol-specific phospholipase C definitively identifies those involved in cation-pi interactions with phosphatidylcholine. This powerful method can easily be used to determine the roles of aromatic residues in other peripheral membrane proteins and in integral membrane proteins.	[He, Tao; Gao, Jianmin; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Gershenson, Anne; Eyles, Stephen J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Lee, Yan-Jiun; Liu, Wenshe R.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Wang, Jiangyun] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Boston College; University of Massachusetts System; University of Massachusetts Amherst; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Institute of Biophysics, CAS	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Regan, Clinton/E-6250-2012; Liu, wenshe/O-4425-2014	Liu, wenshe/0000-0002-7078-6534; Eyles, Stephen/0000-0003-0451-2903; Gao, Jianmin/0000-0001-9341-1287; Gershenson, Anne/0000-0003-3124-9610; wang, jiang yun/0000-0002-5974-1562	National Institutes of Health [60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 60418 (to M. F. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Cheng JJ, 2013, BIOPHYS J, V104, P185, DOI 10.1016/j.bpj.2012.11.015; Cheng JJ, 2012, J BIOL CHEM, V287, P40317, DOI 10.1074/jbc.M112.395277; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Goldstein R, 2012, BIOCHEMISTRY-US, V51, P2579, DOI 10.1021/bi300057q; Grauffel C, 2013, J AM CHEM SOC, V135, P5740, DOI 10.1021/ja312656v; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li FH, 2013, ANGEW CHEM INT EDIT, V52, P3958, DOI 10.1002/anie.201300463; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIlwain BC, 2015, J BIOL CHEM, V290, P9780, DOI 10.1074/jbc.M114.630590; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Pace CJ, 2013, ACCOUNTS CHEM RES, V46, P907, DOI 10.1021/ar300086n; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Ravichandran KR, 2013, BIOCHEMISTRY-US, V52, P8907, DOI 10.1021/bi401494f; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Seyedsayamdost MR, 2007, NAT PROTOC, V2, P1225, DOI 10.1038/nprot.2007.159; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; Yang BQ, 2015, J AM CHEM SOC, V137, P14, DOI 10.1021/ja508631n; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	30	19	19	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19334	19342		10.1074/jbc.M115.668343	http://dx.doi.org/10.1074/jbc.M115.668343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26092728	Green Published, hybrid			2022-12-28	WOS:000358781100044
J	Singh, S; Michalska, K; Bigelow, L; Endres, M; Kharel, MK; Babnigg, G; Yennamalli, RM; Bingman, CA; Joachimiak, A; Thorson, JS; Phillips, GN				Singh, Shanteri; Michalska, Karolina; Bigelow, Lance; Endres, Michael; Kharel, Madan K.; Babnigg, Gyorgy; Yennamalli, Ragothaman M.; Bingman, Craig A.; Joachimiak, Andrzej; Thorson, Jon S.; Phillips, George N., Jr.			Structural Characterization of CalS8, a TDP-alpha-D-Glucose Dehydrogenase Involved in Calicheamicin Aminodideoxypentose Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES VIRIDOCHROMOGENES TU57; UDP-GLUCURONIC ACID; ESCHERICHIA-COLI; GENE-CLUSTER; MOLECULAR-REPLACEMENT; POLYMYXIN RESISTANCE; PURIFICATION; CLONING; INHIBITION; PROTEINS	Classical UDP-glucose 6-dehydrogenases (UGDHs; EC 1.1.1.22) catalyze the conversion of UDP-alpha-D-glucose (UDPGlc) to the key metabolic precursor UDP-alpha-D-glucuronic acid (UDP-GlcA) and display specificity for UDP-Glc. The fundamental biochemical and structural study of the UGDH homolog CalS8 encoded by the calicheamicin biosynthetic gene is reported and represents one of the first studies of a UGDH homolog involved in secondary metabolism. The corresponding biochemical characterization of CalS8 reveals CalS8 as one of the first characterized base-permissive UGDH homologs with a > 15-fold preference for TDP-Glc over UDP-Glc. The corresponding structure elucidations of apo-CalS8 and the CalS8.substrate .cofactor ternary complex (at 2.47 and 1.95 angstrom resolution, respectively) highlight a notably high degree of conservation between CalS8 and classical UGDHs where structural divergence within the intersubunit loop structure likely contributes to the CalS8 base permissivity. As such, this study begins to provide a putative blueprint for base specificity among sugar nucleotide-dependent dehydrogenases and, in conjunction with prior studies on the base specificity of the calicheamicin aminopentosyltransferase CalG4, provides growing support for the calicheamicin aminopentose pathway as a TDP-sugar-dependent process.	[Singh, Shanteri; Thorson, Jon S.] Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY 40536 USA; [Michalska, Karolina; Bigelow, Lance; Endres, Michael; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Michalska, Karolina; Bigelow, Lance; Endres, Michael; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Kharel, Madan K.] Univ Maryland Eastern Shore, Sch Pharm, Princess Anne, MD 21853 USA; [Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Yennamalli, Ragothaman M.; Phillips, George N., Jr.] Rice Univ, Dept Chem, Dept Biosci, Houston, TX 77005 USA	University of Kentucky; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland Eastern Shore; University of Wisconsin System; University of Wisconsin Madison; Rice University	Thorson, JS (corresponding author), Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY 40536 USA.	jsthorson@uky.edu; georgep@rice.edu	Yennamalli, Ragothaman/M-7870-2017; Thorson, Jon S/L-3696-2013	Yennamalli, Ragothaman/0000-0002-3327-1582; Thorson, Jon S/0000-0002-7148-0721; Joachimiak, Andrzej/0000-0003-2535-6209; Singh, Shanteri/0000-0003-0960-4794	U. S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CANCER INSTITUTE [R01CA084374] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098248, U54GM094585] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Structural Biology Center beamlines was supported by the U. S. Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. The Life Sciences Collaborative Access Team (LS-CAT) has been supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Alvarez D, 2000, INFECT IMMUN, V68, P953, DOI 10.1128/IAI.68.2.953-955.2000; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Bililign T, 2002, CHEMBIOCHEM, V3, P1143, DOI 10.1002/1439-7633(20021104)3:11<1143::AID-CBIC1143>3.0.CO;2-W; Bricogne G., 2011, BUSTER VERSION 2 10; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chang A, 2011, P NATL ACAD SCI USA, V108, P17649, DOI 10.1073/pnas.1108484108; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2011, J STRUCT BIOL, V175, P300, DOI 10.1016/j.jsb.2011.04.010; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DiMaio F, 2013, ACTA CRYSTALLOGR D, V69, P2202, DOI 10.1107/S0907444913023305; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2012, J BIOL CHEM, V287, P2119, DOI 10.1074/jbc.M111.313015; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Elshahawi SI, 2015, CHEM SOC REV, V44, P7591, DOI 10.1039/c4cs00426d; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fontaine T, 2009, CARBOHYD RES, V344, P1960, DOI 10.1016/j.carres.2009.07.012; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gaisser S, 1997, J BACTERIOL, V179, P6271, DOI 10.1128/jb.179.20.6271-6278.1997; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Granja AT, 2007, APPL MICROBIOL BIOT, V76, P1319, DOI 10.1007/s00253-007-1112-8; Guillemette C, 2003, PHARMACOGENOMICS J, V3, P136, DOI 10.1038/sj.tpj.6500171; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; Hung RJ, 2007, J BIOL CHEM, V282, P17738, DOI 10.1074/jbc.M701824200; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Kadirvelraj R, 2014, BIOCHEMISTRY-US, V53, P8043, DOI 10.1021/bi500594x; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; Mainprize IL, 2013, J BIOL CHEM, V288, P23064, DOI 10.1074/jbc.M113.486613; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Peltier-Pain P, 2015, CHEMBIOCHEM, V16, P2141, DOI 10.1002/cbic.201500365; PEROZICH J, 1995, ADV EXP MED BIOL, V372, P79; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rajakannan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025226; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rocha J, 2011, J BACTERIOL, V193, P3978, DOI 10.1128/JB.01076-10; Rocha J, 2010, ACTA CRYSTALLOGR F, V66, P69, DOI 10.1107/S174430910904929X; Sakuraba H, 2012, ACTA CRYSTALLOGR F, V68, P1003, DOI 10.1107/S1744309112030667; SCHILLER JG, 1973, BIOCHIM BIOPHYS ACTA, V293, P1, DOI 10.1016/0005-2744(73)90369-0; Simkhada D, 2009, APPL MICROBIOL BIOT, V83, P885, DOI 10.1007/s00253-009-1941-8; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Turner W, 2002, ARCH BIOCHEM BIOPHYS, V407, P209, DOI 10.1016/S0003-9861(02)00500-3; US PATENT, 2003, Patent No. 20030143666; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang CS, 2008, CHEM BIOL, V15, P842, DOI 10.1016/j.chembiol.2008.06.011; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	63	1	1	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26249	26258		10.1074/jbc.M115.673459	http://dx.doi.org/10.1074/jbc.M115.673459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26240141	hybrid, Green Published			2022-12-28	WOS:000363527300041
J	Vasilev, VV; Noe, R; Dragon-Durey, MA; Chauvet, S; Lazarov, VJ; Deliyska, BP; Fremeaux-Bacchi, V; Dimitrov, JD; Roumenina, LT				Vasilev, Vasil V.; Noe, Remi; Dragon-Durey, Marie-Agnes; Chauvet, Sophie; Lazarov, Valentin J.; Deliyska, Boriana P.; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.			Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; LINKED-IMMUNOSORBENT-ASSAY; FACTOR-H; ANTI-C1Q ANTIBODIES; DISEASE-ACTIVITY; FACTOR-B; NEPHROTIC SYNDROME; RECEPTORS CR-1; ERYTHEMATOSUS; SLE	Lupus nephritis (LN) is a complication of the autoimmune disease systemic lupus erythematosus. Because the complement system plays a critical role in orchestrating inflammatory and immune responses as well as in the clearance of immune complexes, autoreactivity to complement components may have considerable pathological consequences. Autoantibodies against the central complement component C3 have been reported in systemic lupus erythematosus, but their molecular mechanism and functional relevance are not well understood. The objective of this study was to evaluate the frequency and the functional properties of the anti-C3 autoantibodies. Anti-C3 autoantibodies were measured in plasma of 39 LN patients, and identification of their epitopes on the C3 molecule was performed. By using surface plasmon resonance, we analyzed the influence of patient-derived IgG antibodies on the interaction of C3b with Factor B, Factor H, and complement receptor 1. The capacity of these antibodies to dysregulate the C3 convertase on the surface of endothelial cell was measured by flow cytometry. Here we report that the frequency of anti-C3 autoantibodies in LNis similar to 30%. They inhibited interactions of the negative complement regulators Factor H and complement receptor 1 with C3b. An enhanced C3 deposition was also observed on human endothelial cells in the presence of C3 autoantibodies. In addition, anti-C3 autoantibody levels correlated with disease activity. In conclusion, the anti-C3 autoantibodies in LN may contribute to the autoimmune pathology by their capacity to overactivate the complement system.	[Vasilev, Vasil V.; Lazarov, Valentin J.; Deliyska, Boriana P.] Med Univ, Univ Hosp Tsaritsa Yoanna ISUL, Nephrol Clin, Sofia 1527, Bulgaria; [Noe, Remi; Dragon-Durey, Marie-Agnes; Chauvet, Sophie; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.] Cordeliers Res Ctr, INSERM UMRS 1138, F-75006 Paris, France; [Noe, Remi] Ecole Prat Hautes Etud, F-75014 Paris, France; [Dragon-Durey, Marie-Agnes; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.] Univ Paris 05, Cordeliers Res Ctr, UMR S 1138, Sorbonne Paris Cite, F-75006 Paris, France; [Dragon-Durey, Marie-Agnes; Chauvet, Sophie; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.] Univ Paris 06, Univ Paris 04, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Dragon-Durey, Marie-Agnes; Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Biol, F-75015 Paris, France; [Chauvet, Sophie] Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, F-75015 Paris, France	Medical University Sofia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Roumenina, LT (corresponding author), Cordeliers Res Ctr, INSERM UMRS 1138, 15 Rue Ecole Med,Entrance E,Floor 3, F-75006 Paris, France.	lubka.roumenina@crc.jussieu.fr	, Dragon-Durey/AGM-3653-2022; Vasilev, Vasil/D-5995-2016; Roumenina, Lubka/P-5906-2019; Roumenina, Lubka/L-2638-2017; Dimitrov, Jordan/N-2141-2014	Vasilev, Vasil/0000-0001-7588-2165; Roumenina, Lubka/0000-0002-9940-0324; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122; Dimitrov, Jordan/0000-0001-8536-8995; Noe, Remi/0000-0003-3474-4035	INSERM; Agence Nationale de la Recherche Grant [ANR-13-JCV1-006-01]; EMBO Long Term Fellowship [ALTF 444-2007]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche Grant(French National Research Agency (ANR)); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO))	This work was supported by INSERM and by Agence Nationale de la Recherche Grant ANR-13-JCV1-006-01. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of EMBO Long Term Fellowship ALTF 444-2007.	Arora M, 2000, LUPUS, V9, P127, DOI 10.1191/096120300678828154; Bao LH, 2011, J AM SOC NEPHROL, V22, P285, DOI 10.1681/ASN.2010060647; Ben Ghorbel I, 2010, REV MED INTERNE, V31, P372, DOI 10.1016/j.revmed.2009.10.434; Birmingham DJ, 2006, CLIN EXP IMMUNOL, V143, P274, DOI 10.1111/j.1365-2249.2005.02983.x; Chen Q, 2011, NEW ENGL J MED, V365, P2340, DOI 10.1056/NEJMc1107484; Churg J., 1995, RENAL DIS CLASSIFICA, P152; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; CORVETTA A, 1991, J RHEUMATOL, V18, P1021; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2013, MOL IMMUNOL, V56, P213, DOI 10.1016/j.molimm.2013.05.009; DURAND CG, 1984, J IMMUNOL METHODS, V73, P57, DOI 10.1016/0022-1759(84)90031-0; Frimat M, 2013, BLOOD, V122, P282, DOI 10.1182/blood-2013-03-489245; FYFE A, 1987, CLIN EXP IMMUNOL, V67, P300; HAUTANEN A, 1984, CLIN EXP RHEUMATOL, V2, P125; HAY EM, 1993, Q J MED, V86, P447; JASIN HE, 1979, J RHEUMATOL, V6, P43; Jozsi M, 2014, IMMUNOL LETT, V160, P163, DOI 10.1016/j.imlet.2014.01.014; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kavai M, 2008, AUTOIMMUN REV, V8, P160, DOI 10.1016/j.autrev.2008.06.002; Kenyon KD, 2011, J IMMUNOL, V187, P2101, DOI 10.4049/jimmunol.1003468; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kitahara M, 1999, CLIN NEPHROL, V51, P314; Lachmann P J, 1967, Adv Immunol, V6, P479, DOI 10.1016/S0065-2776(08)60527-1; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; LACHMANN PJ, 1966, IMMUNOLOGY, V11, P255; Lambris JD, 1996, J IMMUNOL, V156, P4821; Leffler J, 2014, ANN RHEUM DIS, V73, P1601, DOI 10.1136/annrheumdis-2014-205287; Marinozzi MC, 2014, J AM SOC NEPHROL, V25, P2053, DOI 10.1681/ASN.2013070796; Marto N, 2005, ANN RHEUM DIS, V64, P444, DOI 10.1136/ard.2004.024943; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; NGU JL, 1969, CLIN EXP IMMUNOL, V5, P557; NGU JL, 1970, J TROP MED HYG, V73, P250; NGU JL, 1970, CLIN EXP IMMUNOL, V6, P109; NILSSON B, 1992, CLIN EXP IMMUNOL, V90, P251; NILSSON B, 1990, CLIN EXP IMMUNOL, V82, P262; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Paixao-Cavalcante D, 2012, KIDNEY INT, V82, P1084, DOI 10.1038/ki.2012.250; Pickering MC, 2010, NAT REV RHEUMATOL, V6, P490, DOI 10.1038/nrrheum.2010.56; POTTER BJ, 1980, GUT, V21, P1030, DOI 10.1136/gut.21.12.1030; Radanova M, 2012, IMMUNOBIOLOGY, V217, P684, DOI 10.1016/j.imbio.2011.11.007; Raju KR, 2001, ASIAN PAC J ALLERGY, V19, P23; Rekvig OP, 2012, AUTOIMMUN REV, V11, P596, DOI 10.1016/j.autrev.2011.10.021; ROSS GD, 1985, J IMMUNOL, V135, P2005; Roumenina LT, 2012, BLOOD, V119, P4182, DOI 10.1182/blood-2011-10-383281; Roumenina LT, 2011, J IMMUNOL, V187, P4369, DOI 10.4049/jimmunol.1101749; Roumenina LT, 2009, BLOOD, V114, P2837, DOI 10.1182/blood-2009-01-197640; Schramm EC, 2015, BLOOD, V125, P2359, DOI 10.1182/blood-2014-10-609073; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Vanhecke D, 2012, ARTHRITIS RHEUM-US, V64, P3706, DOI 10.1002/art.34605; WALPORT MJ, 1994, Q J MED, V87, P609; Wang FM, 2012, RHEUMATOLOGY, V51, P2269, DOI 10.1093/rheumatology/kes218; WILSON JG, 1986, ARTHRITIS RHEUM, V29, P739, DOI 10.1002/art.1780290606; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Yaniv G, 2015, AUTOIMMUN REV, V14, P75, DOI 10.1016/j.autrev.2014.10.003	58	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25343	25355		10.1074/jbc.M115.647008	http://dx.doi.org/10.1074/jbc.M115.647008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26245903	hybrid, Green Published			2022-12-28	WOS:000362962800013
J	Dong, DJ; Jing, YP; Liu, W; Wang, JX; Zhao, XF				Dong, Du-Juan; Jing, Yu-Pu; Liu, Wen; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone Up-regulates Ste-20 Family Serine/Threonine Kinase Hippo to Induce Programmed Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; SIGNALING PATHWAY; PROMOTES APOPTOSIS; DROSOPHILA; PROLIFERATION; METAMORPHOSIS; TRANSCRIPTION; SALVADOR; PHOSPHORYLATION; EXPRESSION	The steroid hormone 20-hydroxyecdysone (20E) and the serine/threonine Ste20-like kinase Hippo signal promote programmed cell death (PCD) during development, although the interaction between them remains unclear. Here, we present evidence that 20E up-regulates Hippo to induce PCD during the metamorphic development of insects. We found that Hippo is involved in 20E-induced metamorphosis via promoting the phosphorylation and cytoplasmic retention of Yorkie (Yki), causing suppressed expression of the inhibitor of apoptosis (IAP), thereby releasing its inhibitory effect on caspase. Furthermore, we show that 20E induced the expression of Hippo at the transcriptional level through the ecdysone receptor (EcR), ultraspiracle protein (USP), and hormone receptor 3 (HR3). We also found that Hippo suppresses the binding of Yki complex to the HR3 promoter. In summary, 20E up-regulates the transcription of Hippo via EcRB1, USP1, and HR3 to induce PCD, and Hippo has negative feedback effects on HR3 expression. These two signaling pathways coordinate PCD during insect metamorphosis.	[Dong, Du-Juan; Jing, Yu-Pu; Liu, Wen; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Liu, Wen/S-8027-2019; Jing, Yu-Pu/AAE-3531-2022; Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Liu, Wen/0000-0002-4985-0618; Zhao, Xiao-Fan/0000-0003-1809-4730; Dong, Dujuan/0000-0003-3416-5017; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31372261, 31230067]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2012SW009]; Ph.D. Program Foundation of Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province; Ph.D. Program Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 31372261 and 31230067, Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province Grant BS2012SW009, and the Ph.D. Program Foundation of Ministry of Education of China Grant 20120131110025. The authors declare that they have no conflicts of interest with the contents of this article.	Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103; Andersen S.O., 1985, COMPREHENSIVE INSECT, V3, P59, DOI 10.1016/0020-711X(85)90033-3; Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Genevet A, 2009, J CELL SCI, V122, P2360, DOI 10.1242/jcs.041806; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jiang CG, 1997, DEVELOPMENT, V124, P4673; KARIM FD, 1993, DEVELOPMENT, V118, P977; KOELLE MR, 1992, P NATL ACAD SCI USA, V89, P6167, DOI 10.1073/pnas.89.13.6167; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Strassburger K., 2012, DEV BIOL, V367, P187; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Yin VP, 2004, P NATL ACAD SCI USA, V101, P8022, DOI 10.1073/pnas.0402647101; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang L, 2009, FLY, V3, P68, DOI 10.4161/fly.3.1.7788; Zhao XF, 2005, ARCH INSECT BIOCHEM, V58, P39, DOI 10.1002/arch.20030	30	12	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24738	24746		10.1074/jbc.M115.643783	http://dx.doi.org/10.1074/jbc.M115.643783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26272745	Green Published, hybrid			2022-12-28	WOS:000362598300010
J	Galiullina, RA; Kasperkiewicz, P; Chichkova, NV; Szalek, A; Serebryakova, MV; Poreba, M; Drag, M; Vartapetian, AB				Galiullina, Raisa A.; Kasperkiewicz, Paulina; Chichkova, Nina V.; Szalek, Aleksandra; Serebryakova, Marina V.; Poreba, Marcin; Drag, Marcin; Vartapetian, Andrey B.			Substrate Specificity and Possible Heterologous Targets of Phytaspase, a Plant Cell Death Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE FAMILY; GRANZYME-B; CHOLECYSTOKININ; GASTRIN; ARABIDOPSIS; METACASPASES; MEDIATORS; DISEASES; DEFENSE; DESIGN	Plants lack aspartate-specific cell death proteases homologous to animal caspases. Instead, a subtilisin-like serine-dependent plant protease named phytaspase shown to be involved in the accomplishment of programmed death of plant cells is able to hydrolyze a number of peptide-based caspase substrates. Here, we determined the substrate specificity of rice (Oryza sativa) phytaspase by using the positional scanning substrate combinatorial library approach. Phytaspase was shown to display an absolute specificity of hydrolysis after an aspartic acid residue. The preceding amino acid residues, however, significantly influence the efficiency of hydrolysis. Efficient phytaspase substrates demonstrated a remarkable preference for an aromatic amino acid residue in the P3 position. The deduced optimum phytaspase recognition motif has the sequence IWLD and is strikingly hydrophobic. The established pattern was confirmed through synthesis and kinetic analysis of cleavage of a set of optimized peptide substrates. An amino acid motif similar to the phytaspase cleavage site is shared by the human gastrointestinal peptide hormones gastrin and cholecystokinin. In agreement with the established enzyme specificity, phytaspase was shown to hydrolyze gastrin-1 and cholecystokinin at the predicted sites in vitro, thus destroying the active moieties of the hormones.	[Galiullina, Raisa A.; Chichkova, Nina V.; Serebryakova, Marina V.; Vartapetian, Andrey B.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Kasperkiewicz, Paulina; Szalek, Aleksandra; Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Dept Chem, Div Bioorgan Chem, PL-50370 Wroclaw, Poland	Lomonosov Moscow State University; Wroclaw University of Science & Technology	Drag, M (corresponding author), Wroclaw Univ Technol, Dept Chem, Div Bioorgan Chem, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.	marcin.drag@pwr.edu.pl; varta@genebee.msu.ru	Vartapetian, Andrey/B-8536-2012; Serebryakova, Marina/E-2986-2012; Chichkova, Nina/C-9994-2012	Serebryakova, Marina/0000-0002-5402-8215; 	Russian Foundation for Basic Research [14-04-00232, 14-04-00256, 14-04-91330]; National Science Centre in Poland [2011/03/B/ST5/01048]; Foundation for Polish Science; Polish Ministry of Science and Higher Education	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Science Centre in Poland(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Russian Foundation for Basic Research Grants 14-04-00232 (to N. V. C.) and 14-04-00256 and 14-04-91330 (to A. B. V.) and National Science Centre Grant 2011/03/B/ST5/01048 in Poland (to M. D.) and the Foundation for Polish Science. The work was also supported by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Cai YM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00041; Calatayud S, 2010, MINI-REV MED CHEM, V10, P8, DOI 10.2174/138955710791112532; Chichkova NV, 2014, RUSS J BIOORG CHEM+, V40, P606, DOI 10.1134/S1068162014060065; Chichkova NV, 2012, PHYSIOL PLANTARUM, V145, P77, DOI 10.1111/j.1399-3054.2011.01560.x; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Chichkova NV, 2004, PLANT CELL, V16, P157, DOI 10.1105/tpc.017889; CHICHKOVA NV, 2008, PLANT STRESS, V2, P89; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; Danon A, 2000, PLANT PHYSIOL BIOCH, V38, P647, DOI 10.1016/S0981-9428(00)01178-5; Fomicheva AS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1452, DOI 10.1134/S0006297912130044; Fourmy D, 2011, GASTROENTEROLOGY, V141, P814, DOI 10.1053/j.gastro.2011.07.006; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; GREGORY H, 1964, NATURE, V204, P931, DOI 10.1038/204931a0; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hatsugai N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00234; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Minina EA, 2014, AUTOPHAGY, V10, P926, DOI 10.4161/auto.28236; MORLEY JS, 1965, NATURE, V207, P1356, DOI 10.1038/2071356a0; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Poreba M, 2014, METHODS MOL BIOL, V1133, P41, DOI 10.1007/978-1-4939-0357-3_2; Rantong G, 2015, BOTANY, V93, P193, DOI 10.1139/cjb-2014-0152; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Reape TJ, 2010, APOPTOSIS, V15, P249, DOI 10.1007/s10495-009-0447-2; Reavy B, 2007, PLANT CELL REP, V26, P1215, DOI 10.1007/s00299-007-0335-6; Rehfeld JF, 2012, REGUL PEPTIDES, V173, P1, DOI 10.1016/j.regpep.2011.09.009; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; SPANARKEL M, 1983, J BIOL CHEM, V258, P6746; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Vartapetian AB, 2011, CELL DEATH DIFFER, V18, P1289, DOI 10.1038/cdd.2011.49; Walters J, 2009, BIOCHEM J, V424, P335, DOI 10.1042/BJ20090825; Watanabe N, 2011, PLANT J, V66, P969, DOI 10.1111/j.1365-313X.2011.04554.x; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]	44	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24806	24815		10.1074/jbc.M115.675819	http://dx.doi.org/10.1074/jbc.M115.675819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26283788	Green Published, hybrid			2022-12-28	WOS:000362598300016
J	Chen, YZ; Sun, YR; Song, HG; Guo, ZH				Chen, Yaozong; Sun, Yueru; Song, Haigang; Guo, Zhihong			Structural Basis for the ATP-dependent Configuration of Adenylation Active Site in Bacillus subtilis o-Succinylbenzoyl-CoA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; FORMING ENZYME SUPERFAMILY; PROTEIN LIGASE DLTA; CRYSTAL-STRUCTURE; MENAQUINONE BIOSYNTHESIS; MUTATIONAL ANALYSIS; FIREFLY LUCIFERASE; REACTION-MECHANISM; ESCHERICHIA-COLI; IDENTIFICATION	o-Succinylbenzoyl-CoA synthetase, or MenE, is an essential adenylate-forming enzyme targeted for development of novel antibiotics in the menaquinone biosynthesis. Using its crystal structures in a ligand-free form or in complex with nucleotides, a conserved pattern is identified in the interaction between ATP and adenylating enzymes, including acyl/aryl-CoA synthetases, adenylation domains of nonribosomal peptide synthetases, and luciferases. It involves tight gripping interactions of the phosphate-binding loop (P-loop) with the ATP triphosphate moiety and an open-closed conformational change to form a compact adenylation active site. In MenE catalysis, this ATP-enzyme interaction creates a new binding site for the carboxylate substrate, allowing revelation of the determinants of substrate specificities and in-line alignment of the two substrates for backside nucleophilic substitution reaction by molecular modeling. In addition, the ATP-enzyme interaction is suggested to play a crucial catalytic role by mutation of the P-loop residues hydrogen-bonded to ATP. Moreover, the ATP-enzyme interaction has also clarified the positioning and catalytic role of a conserved lysine residue in stabilization of the transition state. These findings provide new insights into the adenylation half-reaction in the domain alteration catalytic mechanism of the adenylate-forming enzymes.	[Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk		Guo, Zhihong/0000-0003-0374-8412; Chen, Yaozong/0000-0001-5380-2339; Sun, Yueru/0000-0002-8203-3740	Research Grants Council [GRF601413, N_HKUST621/13]; University Grants Council of Government of Hong Kong Special Administrative Region [SBI14SC05]	Research Grants Council(Hong Kong Research Grants Council); University Grants Council of Government of Hong Kong Special Administrative Region	This work was supported by Grants GRF601413 and N_HKUST621/13 from the Research Grants Council and Grant SBI14SC05 from the University Grants Council of the Government of the Hong Kong Special Administrative Region. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; BERG P, 1956, J BIOL CHEM, V222, P991; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Chen MJ, 2011, BIOCHEMISTRY-US, V50, P5893, DOI 10.1021/bi200376x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DeLano W.L, PYMOL MOL GRAPHICS S; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Du Liqin, 2014, F1000Res, V3, P106, DOI 10.12688/f1000research.4097.1; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; GOCHT M, 1994, J BACTERIOL, V176, P2654, DOI 10.1128/JB.176.9.2654-2662.1994; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gross J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-117; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2010, J BIOL CHEM, V285, P30159, DOI 10.1074/jbc.M110.147702; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; KIM YS, 1994, BIOCHEM J, V297, P327, DOI 10.1042/bj2970327; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2007, BBA-MOL CELL BIOL L, V1771, P1246, DOI 10.1016/j.bbalip.2007.05.009; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHLER EL, 1991, PROTEIN ENG, V4, P903, DOI 10.1093/protein/4.8.903; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SAITO M, 1995, J BIOCHEM-TOKYO, V117, P276, DOI 10.1093/jb/117.2.276; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Stuible HP, 2000, FEBS LETT, V467, P117, DOI 10.1016/S0014-5793(00)01133-9; Sun YR, 2014, J BIOL CHEM, V289, P15867, DOI 10.1074/jbc.M113.535641; Sun YR, 2012, BIOCHEMISTRY-US, V51, P4580, DOI 10.1021/bi300486j; Sundlov JA, 2012, BIOCHEMISTRY-US, V51, P6493, DOI 10.1021/bi300934s; Tian Y., 2008, THESIS U ILLINOIS CH; Tian Y, 2008, BIOCHEMISTRY-US, V47, P12434, DOI 10.1021/bi801311d; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vessey DA, 2001, BIOCHEM J, V357, P283, DOI 10.1042/0264-6021:3570283; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu R, 2008, BIOCHEMISTRY-US, V47, P8026, DOI 10.1021/bi800698m; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	68	10	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23971	23983		10.1074/jbc.M115.676304	http://dx.doi.org/10.1074/jbc.M115.676304			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26276389	Green Published, hybrid			2022-12-28	WOS:000361816500041
J	Yamauchi, Y; Iwamoto, N; Rogers, MA; Abe-Dohmae, S; Fujimoto, T; Chang, CCY; Ishigami, M; Kishimoto, T; Kobayashi, T; Ueda, K; Furukawa, K; Chang, TY; Yokoyama, S				Yamauchi, Yoshio; Iwamoto, Noriyuki; Rogers, Maximillian A.; Abe-Dohmae, Sumiko; Fujimoto, Toyoshi; Chang, Catherine C. Y.; Ishigami, Masato; Kishimoto, Takuma; Kobayashi, Toshihide; Ueda, Kazumitsu; Furukawa, Koichi; Chang, Ta-Yuan; Yokoyama, Shinji			Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER A1; HMG COA REDUCTASE; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; HELICAL APOLIPOPROTEINS; MEDIATED ENDOCYTOSIS; HDL CHOLESTEROL; TANGIER DISEASE; CELLS	Cellular cholesterol homeostasis involves sterol sensing at the endoplasmic reticulum (ER) and sterol export from the plasma membrane (PM). Sterol sensing at the ER requires efficient sterol delivery from the PM; however, the macromolecules that facilitate retrograde sterol transport at the PM have not been identified. ATP-binding cassette transporter A1 (ABCA1) mediates cholesterol and phospholipid export to apolipoprotein A-I for the assembly of high density lipoprotein (HDL). Mutations in ABCA1 cause Tangier disease, a familial HDL deficiency. Several lines of clinical and experimental evidence suggest a second function of ABCA1 in cellular cholesterol homeostasis in addition to mediating cholesterol efflux. Here, we report the unexpected finding that ABCA1 also plays a key role in facilitating retrograde sterol transport from the PM to the ER for sterol sensing. Deficiency in ABCA1 delays sterol esterification at the ER and activates the SREBP-2 cleavage pathway. The intrinsic ATPase activity in ABCA1 is required to facilitate retrograde sterol transport. ABCA1 deficiency causes alternation of PM composition and hampers a clathrin-independent endocytic activity that is required for ER sterol sensing. Our finding identifies ABCA1 as a key macromolecule facilitating bidirectional sterol movement at the PM and shows that ABCA1 controls retrograde sterol transport by modulating a certain clathrin-independent endocytic process.	[Yamauchi, Yoshio; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4668550, Japan; [Rogers, Maximillian A.; Chang, Catherine C. Y.; Chang, Ta-Yuan] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Iwamoto, Noriyuki; Abe-Dohmae, Sumiko] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan; [Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4668550, Japan; [Ishigami, Masato; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Inst Integrated Cell Mat Sci, Kyoto 6068502, Japan; [Ishigami, Masato; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Kishimoto, Takuma; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [Yokoyama, Shinji] Chubu Univ, Dept Food & Nutr Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Dartmouth College; Nagoya City University; Nagoya University; Kyoto University; Kyoto University; RIKEN; Chubu University; Chubu University	Yamauchi, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	yyoshio@med.nagoya-u.ac.jp; Ta.Yuan.Chang@Dartmouth.edu	KOBAYASHI, TOSHIHIDE/S-8313-2019; Yamauchi, Yoshio/I-7539-2014; Kishimoto, Takuma/AAP-1813-2021; Regan, Clinton/E-6250-2012; Fujimoto, Toyoshi/ABH-9058-2020	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Yamauchi, Yoshio/0000-0001-5559-4596; Fujimoto, Toyoshi/0000-0002-3601-7977; Ueda, Kazumitsu/0000-0003-2980-6078; Rogers, Maximillian/0000-0001-9277-3200	National Institutes of Health [AG037609, HL060306]; Japan Society for Promotion of Sciences; Ministry of Education, Sciences, Technology, Culture, and Sports of Japan; MEXT-supported program for Strategic Research Foundation at Private Universities; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037609] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05897, 25460385] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Sciences, Technology, Culture, and Sports of Japan; MEXT-supported program for Strategic Research Foundation at Private Universities; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants AG037609 and HL060306 (to T. Y. C. and C. C. Y. C.). This work was also supported by a grant-in-aid for young scientists from the Japan Society for the Promotion of Sciences (to Y. Y.), grants-in-aid for scientific research from the Ministry of Education, Sciences, Technology, Culture, and Sports of Japan (to Y. Y., to S. A.- D., to T. F., to K. U, and to S. Y.), and a MEXT-supported program for the Strategic Research Foundation at Private Universities (to S. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Assmann G, 2001, METABOLIC MOL BASES, P2937; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Brandis KA, 2013, J BIOL CHEM, V288, P35703, DOI 10.1074/jbc.M113.488577; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Chang CCY, 2010, BIOCHEMISTRY-US, V49, P9957, DOI 10.1021/bi1013936; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hu W, 2008, J LIPID RES, V49, P386, DOI 10.1194/jlr.M700402-JLR200; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ito J, 2000, J LIPID RES, V41, P894; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Metherall JE, 1996, J BIOL CHEM, V271, P2634, DOI 10.1074/jbc.271.5.2634; MOLLER ML, 1961, J LIPID RES, V2, P342; NISHIKAWA O, 1986, J BIOCHEM, V99, P295, DOI 10.1093/oxfordjournals.jbchem.a135473; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Shvets E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7867; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; Suzuki S, 2004, ARTERIOSCL THROM VAS, V24, P519, DOI 10.1161/01.ATV.0000117178.94087.ba; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Yamauchi Y, 2004, J LIPID RES, V45, P1943, DOI 10.1194/jlr.M400264-JLR200; Yamauchi Y, 2007, J BIOL CHEM, V282, P34994, DOI 10.1074/jbc.M703653200; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	70	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23464	23477		10.1074/jbc.M115.662668	http://dx.doi.org/10.1074/jbc.M115.662668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26198636	Green Published, hybrid			2022-12-28	WOS:000361816500001
J	Kleven, MD; Dlakic, M; Lawrence, CM				Kleven, Mark D.; Dlakic, Mensur; Lawrence, C. Martin			Characterization of a Single b-type Heme, FAD, and Metal Binding Sites in the Transmembrane Domain of Six-transmembrane Epithelial Antigen of the Prostate (STEAP) Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IDENTIFICATION; FERRIREDUCTASE; OXIDOREDUCTASE	Six-transmembrane epithelial antigen of the prostate 3 (Steap3) is the major ferric reductase in developing erythrocytes. Steap family proteins are defined by a shared transmembrane domain that in Steap3 has been shown to function as a transmembrane electron shuttle, moving cytoplasmic electrons derived from NADPH across the lipid bilayer to the extracellular face where they are used to reduce Fe3+ to Fe2+ and potentially Cu2+ to Cu1+. Although the cytoplasmic N-terminal oxidoreductase domain of Steap3 and Steap4 are relatively well characterized, little work has been done to characterize the transmembrane domain of any member of the Steap family. Here we identify high affinity FAD and iron biding sites and characterize a single b-type heme binding site in the Steap3 transmembrane domain. Furthermore, we show that Steap3 is functional as a homodimer and that it utilizes an intrasubunit electron transfer pathway through the single heme moiety rather than an intersubunit electron pathway through a potential domain-swapped dimer. Importantly, the sequence motifs in the transmembrane domain that are associated with the FAD and metal binding sites are not only present in Steap2 and Steap4 but also in Steap1, which lacks the N-terminal oxidoreductase domain. This strongly suggests that Steap1 harbors latent oxidoreductase activity.	[Kleven, Mark D.; Lawrence, C. Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Dlakic, Mensur] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Lawrence, CM (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	lawrence@chemistry.montana.edu	Lawrence, C. Martin/AAH-3420-2020; Dlakic, Mensur/S-2702-2019	Lawrence, C. Martin/0000-0002-5398-466X; Dlakic, Mensur/0000-0003-4315-1514; Kleven, Mark/0000-0003-1204-6658	National Science Foundation Major Research Instrumentation Program; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084326] Funding Source: NIH RePORTER	National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are deeply grateful to Mark D. Fleming for valuable insight and careful reading of the manuscript. We thank Chang-Deng Hu (Purdue University) for providing Venus plasmids that were used for making Gateway vectors. The Montana State University confocal microscope was purchased with funding from the National Science Foundation Major Research Instrumentation Program and the M. J. Murdock Charitable Trust. We also thank Jan Phillipp Kreysing for gracious help in producing Fig. 6.	Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Gauss GH, 2013, J BIOL CHEM, V288, P20668, DOI 10.1074/jbc.M113.479154; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lu PL, 2014, P NATL ACAD SCI USA, V111, P1813, DOI 10.1073/pnas.1323931111; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Ohgami RS, 2005, BLOOD, V106, P3625, DOI 10.1182/blood-2005-01-0379; Porkka KP, 2003, INT J CANCER, V106, P729, DOI 10.1002/ijc.11278; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Spratt DE, 2014, INT J RADIAT ONCOL, V90, pS791, DOI 10.1016/j.ijrobp.2014.05.2286; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126	30	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22558	22569		10.1074/jbc.M115.664565	http://dx.doi.org/10.1074/jbc.M115.664565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26205815	Green Published, hybrid			2022-12-28	WOS:000361171500022
J	Munoz-Escobar, J; Matta-Camacho, E; Kozlov, G; Gehring, K				Munoz-Escobar, Juliana; Matta-Camacho, Edna; Kozlov, Guennadi; Gehring, Kalle			The MLLE Domain of the Ubiquitin Ligase UBR5 Binds to Its Catalytic Domain to Regulate Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A)-BINDING PROTEIN; HYPERPLASTIC-DISCS; STRUCTURAL BASIS; INHIBITS TELOMERASE; EDD; RECOGNITION; PABC; GENE; IDENTIFICATION; AUTOINHIBITION	E3 ubiquitin ligases catalyze the transfer of ubiquitin from an E2-conjugating enzyme to a substrate. UBR5, homologous to the E6APC terminus (HECT)-type E3 ligase, mediates the ubiquitination of proteins involved in translation regulation, DNA damage response, and gluconeogenesis. In addition, UBR5 functions in a ligase-independent manner by prompting protein/protein interactions without ubiquitination of the binding partner. Despite recent functional studies, the mechanisms involved in substrate recognition and selective ubiquitination of its binding partners remain elusive. The C terminus of UBR5 harbors the HECT catalytic domain and an adjacent MLLE domain. MLLE domains mediate protein/protein interactions through the binding of a conserved peptide motif, termed PAM2. Here, we characterize the binding properties of the UBR5 MLLE domain to PAM2 peptides from Paip1 and GW182. The crystal structure with a Paip1 PAM2 peptide reveals the network of hydrophobic and ionic interactions that drive binding. In addition, we identify a novel interaction of the MLLE domain with the adjacent HECT domain mediated by a PAM2-like sequence. Our results confirm the role of the MLLE domain of UBR5 in substrate recruitment and suggest a potential role in regulating UBR5 ligase activity.	[Munoz-Escobar, Juliana; Matta-Camacho, Edna; Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS) was supported by the National Science Foundation Award DMR 0225180 and the National Institutes of Health Award RR-01646.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bethard JR, 2011, J PROTEOMICS, V75, P603, DOI 10.1016/j.jprot.2011.08.023; Bradley A, 2014, CARCINOGENESIS, V35, P1100, DOI 10.1093/carcin/bgt489; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cojocaru M, 2011, J BIOL CHEM, V286, P5012, DOI 10.1074/jbc.M110.176628; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Matta-Camacho E, 2012, ACTA CRYSTALLOGR F, V68, P1158, DOI 10.1107/S1744309112036937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie JW, 2014, BBA-GENE REGUL MECH, V1839, P1062, DOI 10.1016/j.bbagrm.2014.08.001; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	50	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22841	22850		10.1074/jbc.M115.672246	http://dx.doi.org/10.1074/jbc.M115.672246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224628	Green Published, hybrid			2022-12-28	WOS:000361171500046
J	Wang, GZ; Goff, SP				Wang, Gary Z.; Goff, Stephen P.			Regulation of Yin Yang 1 by Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; GROWTH-FACTOR RECEPTOR; MURINE LEUKEMIA-VIRUS; GENE-EXPRESSION; C-SRC; PROTEIN; KINASES; LYN; ASSOCIATION; REPRESSION	Yin Yang 1 (YY1) is a member of the GLI-Kruppel class of DNA and RNA binding transcription factors that can either activate or repress gene expression during cell growth, differentiation, and embryogenesis. Although much is known about YY1 interacting proteins and the target promoters regulated by YY1, much less is known about YY1 regulation through post-translational modifications. In this study we show that YY1 is tyrosine-phosphorylated in multiple cell types. Using a combination of pharmacological inhibition, kinase overexpression, and kinase knock-out studies, we demonstrate that YY1 is a target of multiple Src family kinases in vitro and in vivo. Moreover, we have identified multiple sites of YY1 phosphorylation and analyzed the effect of phosphorylation on the activity of YY1-responsive retroviral and cellular promoters. Phosphorylation of tyrosine 383 interferes with DNA and RNA binding, leading to the down-regulation of YY1 activity. Finally, we provide the first evidence that YY1 is a downstream target of epidermal growth factor receptor signaling in vivo. Taken together, the identification of YY1 as a target of Src family kinases provide key insights into the inhibitory role of tyrosine kinases in modulating YY1 activity.	Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Wang, Gary Z.] Columbia Univ Coll Phys & Surg, Med Scientist Training Program, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Goff, SP (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014; Regan, Clinton/E-6250-2012	Goff, Stephen P/0000-0003-0693-5547; 	National Institutes of Health [R01 CA30488]; NATIONAL CANCER INSTITUTE [R01CA030488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA30488 (NCI). The authors declare that they have no conflicts of interest with the contents of this article.	Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Belak ZR, 2008, BIOCHEM CELL BIOL, V86, P31, DOI [10.1139/O07-155, 10.1139/o07-155]; Bernhard W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077052; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; FLANAGAN JR, 1992, MOL CELL BIOL, V12, P38, DOI 10.1128/MCB.12.1.38; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; GUALBERTO A, 1992, MOL CELL BIOL, V12, P4209, DOI 10.1128/MCB.12.9.4209; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kassardjian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050645; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE TC, 1994, ONCOGENE, V9, P1047; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; Radha V, 1996, EUR J BIOCHEM, V236, P352, DOI 10.1111/j.1432-1033.1996.00352.x; Rizkallah R, 2011, CELL CYCLE, V10, P3327, DOI 10.4161/cc.10.19.17619; Rizkallah R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015928; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wang GZ, 2014, J VIROL, V88, P1825, DOI 10.1128/JVI.02578-13; WEERNINK PAO, 1995, J BIOL CHEM, V270, P2264, DOI 10.1074/jbc.270.5.2264; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632	46	15	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21890	21900		10.1074/jbc.M115.660621	http://dx.doi.org/10.1074/jbc.M115.660621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198631	Green Published, hybrid			2022-12-28	WOS:000360968500011
J	Caserta, E; Liu, LC; Grundy, FJ; Henkin, TM				Caserta, Enrico; Liu, Liang-Chun; Grundy, Frank J.; Henkin, Tina M.			Codon-Anticodon Recognition in the Bacillus subtilis glyQS T Box Riboswitch RNA-DEPENDENT CODON SELECTION OUTSIDE THE RIBOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITERMINATION IN-VITRO; AMINOACYL-TRANSFER-RNA; COGNATE TRANSFER-RNA; MESSENGER-RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; E-SITE; CRYSTAL-STRUCTURE; READING FRAME; P-SITE	Many amino acid-related genes in Gram-positive bacteria are regulated by the T box riboswitch. The leader RNA of genes in the T box family controls the expression of downstream genes by monitoring the aminoacylation status of the cognate tRNA. Previous studies identified a three-nucleotide codon, termed the "Specifier Sequence," in the riboswitch that corresponds to the amino acid identity of the downstream genes. Pairing of the Specifier Sequence with the anticodon of the cognate tRNA is the primary determinant of specific tRNA recognition. This interaction mimics codon-anticodon pairing in translation but occurs in the absence of the ribosome. The goal of the current study was to determine the effect of a full range of mismatches for comparison with codon recognition in translation. Mutations were individually introduced into the Specifier Sequence of the glyQS leader RNA and tRNA(Gly) anticodon to test the effect of all possible pairing combinations on tRNA binding affinity and antitermination efficiency. The functional role of the conserved purine 3' of the Specifier Sequence was also verified in this study. We found that substitutions at the Specifier Sequence resulted in reduced binding, the magnitude of which correlates well with the predicted stability of the RNA-RNA pairing. However, the tolerance for specific mismatches in antitermination was generally different from that during decoding, which reveals a unique tRNA recognition pattern in the T box antitermination system.	[Henkin, Tina M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Henkin, TM (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.	henkin.3@osu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM047823]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM047823. The authors declare that they have no conflict of interest with the contents of this article.	Ashraf SS, 1999, RNA, V5, P1191, DOI 10.1017/S1355838299990933; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; BOREN T, 1993, J MOL BIOL, V230, P739, DOI 10.1006/jmbi.1993.1196; Bucklin DJ, 2005, J MOL BIOL, V345, P39, DOI 10.1016/j.jmb.2004.10.037; Chang AT, 2013, FEBS LETT, V587, P3495, DOI 10.1016/j.febslet.2013.09.003; CURRAN JF, 1987, SCIENCE, V238, P1545, DOI 10.1126/science.3685992; CURRAN JF, 1993, NUCLEIC ACIDS RES, V21, P1837, DOI 10.1093/nar/21.8.1837; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Daviter T, 2006, BIOCHIMIE, V88, P1001, DOI 10.1016/j.biochi.2006.04.013; ELLIOTT MS, 1984, J BIOL CHEM, V259, P2407; Gallant J, 2004, J MOL BIOL, V342, P713, DOI 10.1016/j.jmb.2004.07.030; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Grigg JC, 2013, P NATL ACAD SCI USA, V110, P7240, DOI 10.1073/pnas.1222214110; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; GROSJEAN HJ, 1978, P NATL ACAD SCI USA, V75, P610, DOI 10.1073/pnas.75.2.610; GRUNDY FJ, 1994, J BACTERIOL, V176, P4518, DOI 10.1128/JB.176.15.4518-4526.1994; Grundy FJ, 2005, J MOL BIOL, V346, P73, DOI 10.1016/j.jmb.2004.11.051; Grundy FJ, 1997, J BACTERIOL, V179, P2587, DOI 10.1128/jb.179.8.2587-2594.1997; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Hansen TM, 2003, EMBO REP, V4, P499, DOI 10.1038/sj.embor.embor825; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; Lim VI, 2005, J MOL BIOL, V351, P470, DOI 10.1016/j.jmb.2005.06.019; Lim VI, 2001, RNA, V7, P942, DOI 10.1017/S135583820100214X; LIM VI, 1995, J MOL BIOL, V252, P277, DOI 10.1006/jmbi.1995.0494; LUSTIG F, 1989, P NATL ACAD SCI USA, V86, P6873, DOI 10.1073/pnas.86.18.6873; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; MIZUNO H, 1978, NUCLEIC ACIDS RES, V5, P4451, DOI 10.1093/nar/5.11.4451; Nasvall SJ, 2007, RNA, V13, P2151, DOI 10.1261/rna.731007; NEGRE D, 1986, BIOCHEMISTRY-US, V25, P6391, DOI 10.1021/bi00369a008; Nelson AR, 2006, RNA, V12, P1254, DOI 10.1261/rna.29906; Ninio J, 2006, BIOCHIMIE, V88, P963, DOI 10.1016/j.biochi.2006.06.002; O'Connor M, 2001, RNA, V7, P969, DOI 10.1017/S1355838201010184; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PARKER J, 1978, P NATL ACAD SCI USA, V75, P1091, DOI 10.1073/pnas.75.3.1091; Putzer H, 2002, NUCLEIC ACIDS RES, V30, P3026, DOI 10.1093/nar/gkf415; Qin D, 2007, RNA, V13, P2348, DOI 10.1261/rna.715307; RAFTERY LA, 1987, EMBO J, V6, P1499, DOI 10.1002/j.1460-2075.1987.tb02392.x; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rollins SM, 1997, MOL MICROBIOL, V25, P411, DOI 10.1046/j.1365-2958.1997.4851839.x; Sanbonmatsu KY, 2003, J MOL BIOL, V328, P33, DOI 10.1016/S0022-2836(03)00236-5; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Sponer J, 2004, J AM CHEM SOC, V126, P10142, DOI 10.1021/ja048436s; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Takai K, 1999, BIOCHEM BIOPH RES CO, V257, P662, DOI 10.1006/bbrc.1999.0538; Takai K, 2006, J THEOR BIOL, V242, P564, DOI 10.1016/j.jtbi.2006.04.009; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Wang JC, 2011, J MOL BIOL, V408, P99, DOI 10.1016/j.jmb.2011.02.014; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yousef MR, 2005, J MOL BIOL, V349, P273, DOI 10.1016/j.jmb.2005.03.061; Yousef MR, 2003, RNA, V9, P1148, DOI 10.1261/rna.5540203; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang JW, 2013, NATURE, V500, P363, DOI 10.1038/nature12440	75	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23336	23347		10.1074/jbc.M115.673236	http://dx.doi.org/10.1074/jbc.M115.673236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229106	Green Published, hybrid			2022-12-28	WOS:000361685500040
J	Kalnins, G; Kuka, J; Grinberga, S; Makrecka-Kuka, M; Liepinsh, E; Dambrova, M; Tars, K				Kalnins, Gints; Kuka, Janis; Grinberga, Solveiga; Makrecka-Kuka, Marina; Liepinsh, Edgars; Dambrova, Maija; Tars, Kaspars			Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						choline; conformational change; enzyme catalysis; enzyme structure; radical	TRIMETHYLAMINE-N-OXIDE; PYRUVATE FORMATE-LYASE; FISH ODOR SYNDROME; GUT MICROBIOTA; L-CARNITINE; METABOLISM; MECHANISM; PHOSPHATIDYLCHOLINE; DEGRADATION; CHEMISTRY	Background: The bacterial glycyl radical enzyme CutC converts choline to trimethylamine, a metabolite involved in pathogenesis of several diseases. Results: The structures of substrate-bound and substrate-free CutC revealed significant differences. Conclusion: Choline binding to the active site triggers a conformational change from the open to closed form. Significance: A novel substrate-driven conformational mechanism and a potential target for drug design have been identified. CutC choline trimethylamine-lyase is an anaerobic bacterial glycyl radical enzyme (GRE) that cleaves choline to produce trimethylamine (TMA) and acetaldehyde. In humans, TMA is produced exclusively by the intestinal microbiota, and its metabolite, trimethylamine oxide, has been associated with a higher risk of cardiovascular diseases. Therefore, information about the three-dimensional structures of TMA-producing enzymes is important for microbiota-targeted drug discovery. We have cloned, expressed, and purified the CutC GRE and the activating enzyme CutD from Klebsiella pneumoniae, a representative of the human microbiota. We have determined the first crystal structures of both the choline-bound and choline-free forms of CutC and have discovered that binding of choline at the ligand-binding site triggers conformational changes in the enzyme structure, a feature that has not been observed for any other characterized GRE.	[Kalnins, Gints; Tars, Kaspars] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia; [Kuka, Janis; Grinberga, Solveiga; Makrecka-Kuka, Marina; Liepinsh, Edgars; Dambrova, Maija] Latvian Inst Organ Synth, LV-1006 Riga, Latvia; [Tars, Kaspars] Univ Latvia, LV-1586 Riga, Latvia	Latvian Biomedical Research & Study Centre; Latvian Institute of Organic Synthesis; University of Latvia	Kalnins, G (corresponding author), Latvian Biomed Res & Study Ctr, Ratsupites 1, LV-1067 Riga, Latvia.	gints@biomed.lu.lv	Dambrova, Maija/V-6303-2019	Dambrova, Maija/0000-0002-1739-0928; Kuka, Janis/0000-0002-0411-0229; Tars, Kaspars/0000-0001-8421-9023; Liepinsh, Edgars/0000-0003-2213-8337	State Research Program BIOMEDICINE; Bio-Struct-X Grant [7869]	State Research Program BIOMEDICINE; Bio-Struct-X Grant	This work was supported by State Research Program BIOMEDICINE and Bio-Struct-X Grant Proposal ID 7869. The authors declare that they have no conflicts of interest with the contents of this article.	Becker A, 1999, NAT STRUCT BIOL, V6, P969; Brown JM, 2014, CURR OPIN LIPIDOL, V25, P48, DOI 10.1097/MOL.0000000000000036; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Dambrova M, 2002, TRENDS CARDIOVAS MED, V12, P275, DOI 10.1016/S1050-1738(02)00175-5; Dambrova M, 2013, J CLIN PHARMACOL, V53, P1095, DOI 10.1002/jcph.135; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1997, JOINT CCP4 ESF EAMCB; Fraser-Andrews EA, 2003, CLIN EXP DERMATOL, V28, P203, DOI 10.1046/j.1365-2230.2003.01230.x; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001; HAYWARD HR, 1960, J BIOL CHEM, V235, P538; He CX, 2015, NUTR RES, V35, P361, DOI 10.1016/j.nutres.2015.03.002; Howitt MR, 2012, NAT MED, V18, P1188, DOI 10.1038/nm.2895; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kuka J, 2014, LIFE SCI, V117, P84, DOI 10.1016/j.lfs.2014.09.028; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; SANDHU SS, 1986, CAN J MICROBIOL, V32, P743, DOI 10.1139/m86-135; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thibodeaux CJ, 2012, P NATL ACAD SCI USA, V109, P21184, DOI 10.1073/pnas.1219534110; TREACY E, 1995, J INHERIT METAB DIS, V18, P306, DOI 10.1007/BF00710420; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	40	55	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21732	21740		10.1074/jbc.M115.670471	http://dx.doi.org/10.1074/jbc.M115.670471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26187464	hybrid, Green Published			2022-12-28	WOS:000360637600044
J	Kim, YB; Shin, YJ; Roy, A; Kim, JH				Kim, Yong-Bae; Shin, Yong Jae; Roy, Adhiraj; Kim, Jeong-Ho			The Role of the Pleckstrin Homology Domain-containing Protein CKIP-1 in Activation of p21-activated Kinase 1 (PAK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-CAPPING PROTEIN; KINASE CK2; ADAPTER PROTEIN; CYTOSKELETAL REORGANIZATION; CELL MORPHOLOGY; PROSTATE-CANCER; ARP2/3 COMPLEX; VCA DOMAIN; PHOSPHORYLATION; INHIBITION	Upon growth factor stimulation, PAK1 is recruited to the plasma membrane and activated by a mechanism that requires its phosphorylation at Ser-223 by the protein kinase CK2. However, the upstream signaling molecules that regulate this phosphorylation event are not clearly defined. Here, we demonstrate a major role of the CK2 alpha-interacting protein CKIP-1 in activation of PAK1. CK2 alpha, CKIP-1, and PAK1 are translocated to membrane ruffles in response to the epidermal growth factor (EGF), where CKIP-1 mediates the interaction between CK2 alpha and PAK1 in a PI3K-dependent manner. Consistently, PAK1 mediates phosphorylation and modulation of the activity of p41-Arc, one of its plasma membrane substrate, in a fashion that requires PI3K and CKIP-1. Moreover, CKIP-1 knockdown or PI3K inhibition suppresses PAK1-mediated cell migration and invasion, demonstrating the physiological significance of the PI3K-CKIP-1-CK2-PAK1 signaling pathway. Taken together, these findings identify a novel mechanism for the activation of PAK1 at the plasma membrane, which is critical for cell migration and invasion.	[Kim, Yong-Bae; Roy, Adhiraj; Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Shin, Yong Jae] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Shin, Yong Jae] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea	George Washington University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, 2300 Eye St, Washington, DC 20037 USA.	jh_kim@gwu.edu	Roy, Adhiraj/AAR-7311-2021; Regan, Clinton/E-6250-2012	Roy, Adhiraj/0000-0001-7584-8872	National Institutes of Health [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM087470 (to J. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; Baas D, 2012, J CELL SCI, V125, P3790, DOI 10.1242/jcs.101048; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; King CC, 2000, J BIOL CHEM, V275, P18108, DOI 10.1074/jbc.M909663199; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Nie J, 2013, AGEING RES REV, V12, P276, DOI 10.1016/j.arr.2012.07.002; Olsten MEK, 2004, J BIOL CHEM, V279, P42114, DOI 10.1074/jbc.M407628200; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Parrini Maria Carla, 2012, Cell Logist, V2, P78; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pocha SM, 2009, CELL MOTIL CYTOSKEL, V66, P36, DOI 10.1002/cm.20323; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shin YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071495; Shin YJ, 2013, MOL BIOL CELL, V24, P2990, DOI 10.1091/mbc.E13-04-0204; Shin YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030393; Strochlic TI, 2010, MOL CELL, V40, P493, DOI 10.1016/j.molcel.2010.10.015; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Xavier CP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00241; Ye Diana Zi, 2012, Cell Logist, V2, P105; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhang L, 2013, BIOCHEM BIOPH RES CO, V436, P382, DOI 10.1016/j.bbrc.2013.05.109	50	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21076	21085		10.1074/jbc.M115.675124	http://dx.doi.org/10.1074/jbc.M115.675124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160174	hybrid, Green Published			2022-12-28	WOS:000360011800040
J	Liu, WJ; Shen, TT; Chen, RH; Wu, HL; Wang, YJ; Deng, JK; Chen, QH; Pan, QJ; Fu, CMH; Tao, JL; Liang, D; Liu, HF				Liu, Wei Jing; Shen, Ting Ting; Chen, Rui Hong; Wu, Hong-Luan; Wang, Yan Jin; Deng, Jian Kun; Chen, Qiu Hua; Pan, Qingjun; Fu, Chang-mei Huang; Tao, Jing-li; Liang, Dong; Liu, Hua-feng			Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; KIDNEY INJURY; HIGH GLUCOSE; DEATH; NEURODEGENERATION; APOPTOSIS; MEMBRANE; DISEASE; ALBUMIN; RAGE	It has been suggested that autophagy protects renal tubular epithelial cells (TECs) from injury in diabetic nephropathy (DN). However, the manner in which the autophagy-lysosome pathway is changed in this state remains unclear. In this study of DN, we investigated the autophagic activity and lysosomal alterations in vivo and in vitro. We found that autophagic vacuoles and SQSTM1-positive proteins accumulated in TECs from patients with DN and in human renal tubular epithelial cell line (HK-2 cells) treated with advanced glycation end products (AGEs), the important factors that involved in the pathogenesis of DN. In HK-2 cells, exposure to AGEs caused a significant increase in autophagosomes but a marked decrease in autolysosomes, and the lysosomal turnover of LC3-II was not observed, although LC3-II puncta were co-localized with the irregular lysosomal-associated membrane protein1 granules after AGEs treatment. Furthermore, lysosomal membrane permeabilization was triggered by AGEs, which likely resulted in a decrease in the enzymatic activities of cathepsin B and cathepsin L, the defective acidification of lysosomes, and suppression of the lysosomal degradation of DQ-ovalbumin. Oxidative stress evoked by AGEs-receptor for AGE interaction likely played an important role in the lysosomal dysfunction. Additionally, ubiquitinated proteins were co-localized with SQSTM1-positive puncta and accumulated in HK-2 cells after exposure to AGEs, indicating blocked degradation of SQSTM1-positive and ubiquitinated aggregates. Taken together, the results show that lysosomal membrane permeabilization and lysosomal dysfunction are triggered by AGEs, which induce autophagic inactivation in TECs from patients with DN. Disruption of the autophagy-lysosome pathway should be focused when studying the mechanisms underlying DN.	[Liu, Wei Jing; Shen, Ting Ting; Chen, Rui Hong; Wu, Hong-Luan; Wang, Yan Jin; Deng, Jian Kun; Chen, Qiu Hua; Pan, Qingjun; Fu, Chang-mei Huang; Tao, Jing-li; Liang, Dong; Liu, Hua-feng] Guangdong Med Coll, Inst Nephrol, Zhanjiang 524001, Guangdong, Peoples R China	Guangdong Medical University	Liu, HF (corresponding author), Guangdong Med Coll, Inst Nephrol, 57 Renmin Rd, Zhanjiang 524001, Guangdong, Peoples R China.	hf-liu@263.net			National Natural Science Foundation of China [81270798]; Guangdong Natural Science Foundation [2014A030313540, S2012040006276]; Zhanjiang Science and Technology Planning Project [2013B01056]; Scientific Research Foundation for the Returned Overseas Doctors in Guangdong Medical College [B2012080, BK201201]; Affiliated Hospital of Guangdong Medical College [B2012080, BK201201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Zhanjiang Science and Technology Planning Project; Scientific Research Foundation for the Returned Overseas Doctors in Guangdong Medical College(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Affiliated Hospital of Guangdong Medical College	This work was supported by National Natural Science Foundation of China Grant 81270798, Guangdong Natural Science Foundation Grants 2014A030313540 and S2012040006276, Zhanjiang Science and Technology Planning Project 2013B01056, and Grants B2012080 and BK201201 from the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Doctors in Guangdong Medical College and the Affiliated Hospital of Guangdong Medical College. The authors declare that they have no conflicts of interest with the contents of this article.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Daroux M, 2010, DIABETES METAB, V36, P1, DOI 10.1016/j.diabet.2009.06.005; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Furukawa M, 2013, SCI WORLD J, DOI 10.1155/2013/928197; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kume S, 2013, ARCH PHARM RES, V36, P230, DOI 10.1007/s12272-013-0019-4; Lee AS, 2011, CANCER RES, V71, P4506, DOI 10.1158/0008-5472.CAN-10-3787; Lim CH, 2007, CELL PHYSIOL BIOCHEM, V20, P473, DOI 10.1159/000107531; Liu WJ, 2014, AUTOPHAGY, V10, P243, DOI 10.4161/auto.27004; Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866; Ma TA, 2013, EXP CELL RES, V319, P779, DOI 10.1016/j.yexcr.2013.01.018; Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Osicka TM, 2001, DIABETOLOGIA, V44, P230, DOI 10.1007/s001250051604; Osicka TM, 2000, DIABETES, V49, P1579, DOI 10.2337/diabetes.49.9.1579; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pangare Meenal, 2012, Journal of Smooth Muscle Research, V48, P1; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sakurai S, 2003, J AM SOC NEPHROL, V14, pS259, DOI 10.1097/01.ASN.0000077414.59717.74; Sevillano N, 2009, J BIOCHEM, V145, P21, DOI 10.1093/jb/mvn137; SHECHTER P, 1994, J AM SOC NEPHROL, V4, P1582; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066781; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tanaka Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/628978; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Yu CY, 2013, ANAT REC, V296, P31, DOI 10.1002/ar.22612; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457; Zhao X, 2015, INT J MOL MED, V35, P684, DOI 10.3892/ijmm.2014.2052	39	82	91	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20499	20510		10.1074/jbc.M115.666354	http://dx.doi.org/10.1074/jbc.M115.666354			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26100632	Green Published, hybrid			2022-12-28	WOS:000359608900047
J	Miyata, S; Inoue, J; Shimizu, M; Sato, R				Miyata, Shingo; Inoue, Jun; Shimizu, Makoto; Sato, Ryuichiro			Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMULUS-LUPULUS L.; ENDOPLASMIC-RETICULUM; HEPATIC STEATOSIS; IN-VITRO; PROTEASOME PATHWAY; COPII PROTEINS; SMALL-MOLECULE; X-RECEPTOR; ER; TRANSPORT	Sterol regulatory element-binding proteins (SREBPs) are key transcription factors that stimulate the expression of genes involved in fatty acid and cholesterol biosynthesis. Here, we demonstrate that a prenylated flavonoid in hops, xanthohumol (XN), is a novel SREBP inactivator that reduces the de novo synthesis of fatty acid and cholesterol. XN independently suppressed the maturation of SREBPs of insulin-induced genes in a manner different from sterols. Our results suggest that XN impairs the endoplasmic reticulum-to-Golgi translocation of the SREBP cleavage-activating protein (SCAP)-SREBP complex by binding to Sec23/24 and blocking SCAP/SREBP incorporation into common coated protein II vesicles. Furthermore, in diet-induced obese mice, dietary XN suppressed SREBP-1 target gene expression in the liver accompanied by a reduction of the mature form of hepatic SREBP-1, and it inhibited the development of obesity and hepatic steatosis. Altogether, our data suggest that XN attenuates the function of SREBP-1 by repressing its maturation and that it has the potential of becoming a nutraceutical food or pharmacological agent for improving metabolic syndrome.	[Miyata, Shingo; Inoue, Jun; Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	University of Tokyo	Inoue, J (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ajinoue@mail.ecc.u-tokyo.ac.jp; aroysato@mail.ecc.u-tokyo.ac.jp	INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Japan Science and Technology Agency; Tojuro Iijima Foundation for Food Science and Technology; Japanese Council for Science, Technology and Innovation; Cross-ministerial Strategic Innovation Promotion Program SIP [14533567]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Tojuro Iijima Foundation for Food Science and Technology; Japanese Council for Science, Technology and Innovation; Cross-ministerial Strategic Innovation Promotion Program SIP	This work was supported by research grants from Japan Science and Technology Agency (Research for Promoting Technological Seeds) (to J. I.), The Tojuro Iijima Foundation for Food Science and Technology (to J. I.), the Japanese Council for Science, Technology and Innovation, and Cross-ministerial Strategic Innovation Promotion Program SIP Project ID 14533567. The authors declare that they have no conflicts of interest with the contents of this article.	Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Casaschi A, 2004, J NUTR, V134, P1340, DOI 10.1093/jn/134.6.1340; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Doddapattar P, 2013, MOL NUTR FOOD RES, V57, P1718, DOI 10.1002/mnfr.201200794; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Guo J, 2006, DRUG METAB DISPOS, V34, P1152, DOI 10.1124/dmd.105.008250; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kirkwood JS, 2013, J BIOL CHEM, V288, P19000, DOI 10.1074/jbc.M112.445452; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Legette LL, 2013, PHYTOCHEMISTRY, V91, P236, DOI 10.1016/j.phytochem.2012.04.018; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lupinacci E, 2009, J AGR FOOD CHEM, V57, P7274, DOI 10.1021/jf901244k; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miranda CL, 2000, J AGR FOOD CHEM, V48, P3876, DOI 10.1021/jf0002995; Miyata S, 2012, FEBS LETT, V586, P1778, DOI 10.1016/j.febslet.2012.04.060; Mukai R, 2013, J NUTR, V143, P1558, DOI 10.3945/jn.113.176818; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nozawa H, 2005, BIOCHEM BIOPH RES CO, V336, P754, DOI 10.1016/j.bbrc.2005.08.159; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Possemiers S, 2005, J AGR FOOD CHEM, V53, P6281, DOI 10.1021/jf0509714; Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Stevens JF, 2000, PHYTOCHEMISTRY, V53, P759, DOI 10.1016/S0031-9422(00)00005-4; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Wunderlich S, 2005, MOL NUTR FOOD RES, V49, P874, DOI 10.1002/mnfr.200500051; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yui K, 2014, J OLEO SCI, V63, P159, DOI 10.5650/jos.ess13136; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	48	56	59	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20565	20579		10.1074/jbc.M115.656975	http://dx.doi.org/10.1074/jbc.M115.656975			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26140926	Green Published, hybrid			2022-12-28	WOS:000359608900052
J	Yu, HN; Park, WK; Nam, KH; Song, DY; Kim, HS; Baik, TK; Woo, RS				Yu, Ha-Nul; Park, Woo-Kyu; Nam, Ki-Hoan; Song, Dae-Yong; Kim, Hye-Sun; Baik, Tai-Kyoung; Woo, Ran-Sook			Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PREFRONTAL CORTEX; POSITIVE INTERNEURONS; NEURAL DEVELOPMENT; TRANSPORTER EAAC1; PYRAMIDAL CELLS; CEREBRAL-CORTEX; NMDA RECEPTORS; ERBB4 RECEPTOR; GABA SYNTHESIS	Neuregulin 1 (NRG1) is a trophic factor that is thought to have important roles in the regulating brain circuitry. Recent studies suggest that NRG1 regulates synaptic transmission, although the precise mechanisms remain unknown. Here we report that NRG1 influences glutamate uptake by increasing the protein level of excitatory amino acid carrier (EAAC1). Our data indicate that NRG1 induced the up-regulation of EAAC1 in primary cortical neurons with an increase in glutamate uptake. These in vitro results were corroborated in the prefrontal cortex (PFC) of mice given NRG1. The stimulatory effect of NRG1 was blocked by inhibition of the NRG1 receptor ErbB4. The suppressed expression of ErbB4 by siRNA led to a decrease in the expression of EAAC1. In addition, the ablation of ErbB4 in parvalbumin (PV)-positive neurons in PV-ErbB4(-/-) mice suppressed EAAC1 expression. Taken together, our results show that NRG1 signaling through ErbB4 modulates EAAC1. These findings link proposed effectors in schizophrenia: NRG1/ErbB4 signaling perturbation, EAAC1 deficit, and neurotransmission dysfunction.	[Yu, Ha-Nul; Song, Dae-Yong; Baik, Tai-Kyoung; Woo, Ran-Sook] Eulji Univ, Dept Anat & Neurosci, Coll Med, Taejon 301746, South Korea; [Park, Woo-Kyu] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Taejon 305343, South Korea; [Nam, Ki-Hoan] Korea Res Inst Biosci & Biotechnol, Biomed Mouse Resource Ctr, Cheongju 363883, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Dept Pharmacol, Coll Med, Seoul 110799, South Korea	Eulji University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Baik, TK (corresponding author), Eulji Univ, Dept Anat & Neurosci, Coll Med, 143-5 Yongdu Dong, Taejon 301746, South Korea.	tkbaik@eulji.ac.kr; rswoo@eulji.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A4A01012426]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Grant Number NRF-2013R1A1A4A01012426. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott C, 2006, CURR OPIN PSYCHIATR, V19, P135, DOI 10.1097/01.yco.0000214337.29378.cd; Bauer D, 2008, SCHIZOPHR RES, V104, P108, DOI 10.1016/j.schres.2008.06.012; Bianchi MG, 2008, NEUROSCIENCE, V151, P1042, DOI 10.1016/j.neuroscience.2007.11.055; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bin Kwon O, 2008, P NATL ACAD SCI USA, V105, P15587, DOI 10.1073/pnas.0805722105; Bressan RA, 2000, EUR J NUCL MED, V27, P1723, DOI 10.1007/s002590000372; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hashimoto T, 2003, J NEUROSCI, V23, P6315; He Y, 2000, J COMP NEUROL, V418, P255; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lortet S, 2008, NEUROCHEM INT, V52, P1373, DOI 10.1016/j.neuint.2008.02.007; Mathews GC, 2003, J NEUROSCI, V23, P2040; McCullumsmith RE, 2002, NEUROPSYCHOPHARMACOL, V26, P368, DOI 10.1016/S0893-133X(01)00370-0; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Nudrnamud-Thanoi S, 2007, J NEURAL TRANSM-SUPP, P281; Ohnuma T, 1999, NEUROSCIENCE, V93, P441, DOI 10.1016/S0306-4522(99)00189-X; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pietraszek M, 2003, POL J PHARMACOL, V55, P133; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Ryu J, 2012, J PHARMACOL SCI, V119, P73, DOI 10.1254/jphs.12057FP; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2012, NEUROSCIENCE, V202, P413, DOI 10.1016/j.neuroscience.2011.11.026; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Yin DM, 2013, J NEUROSCI, V33, P19295, DOI 10.1523/JNEUROSCI.2090-13.2013	47	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20233	20244		10.1074/jbc.M114.591867	http://dx.doi.org/10.1074/jbc.M114.591867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26092725	Green Published, hybrid			2022-12-28	WOS:000359608900024
J	Bociek, K; Ferluga, S; Mardirossian, M; Benincasa, M; Tossi, A; Gennaro, R; Scocchi, M				Bociek, Karol; Ferluga, Sara; Mardirossian, Mario; Benincasa, Monica; Tossi, Alessandro; Gennaro, Renato; Scocchi, Marco			Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-RESISTANCE; HUMAN CATHELICIDIN; MOLECULAR-BASIS; PRIMATE CATHELICIDIN; GENE; SALMONELLA; POLYMYXIN; DIVERSITY; ROLES; CORE	The human cathelicidin LL-37 is a multifunctional host defense peptide with immunomodulatory and antimicrobial roles. It kills bacteria primarily by altering membrane barrier properties, although the exact sequence of events leading to cell lysis has not yet been completely elucidated. Random insertion mutagenesis allowed isolation of Escherichia coli mutants with altered susceptibility to LL-37, pointing to factors potentially relevant to its activity. Among these, inactivation of the waaY gene, encoding a kinase responsible for heptose II phosphorylation in the LPS inner core, leads to a phenotype with decreased susceptibility to LL-37, stemming from a reduced amount of peptide binding to the surface of the cells, and a diminished capacity to lyse membranes. This points to a specific role of the LPS inner core in guiding LL-37 to the surface of Gram-negative bacteria. Although electrostatic interactions are clearly relevant, the susceptibility of the waaY mutant to other cationic helical cathelicidins was unaffected, indicating that particular structural features or LL-37 play a role in this interaction.	[Bociek, Karol; Ferluga, Sara; Mardirossian, Mario; Benincasa, Monica; Tossi, Alessandro; Gennaro, Renato; Scocchi, Marco] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy	University of Trieste	Scocchi, M (corresponding author), Univ Trieste, Dept Life Sci, Via Giorgieri 5, I-34127 Trieste, Italy.	mscocchi@units.it	Benincasa, Monica/R-6457-2016; Tossi, Alessandro/ABC-9061-2020; Gennaro, Renato/AAJ-2511-2021	Benincasa, Monica/0000-0001-6087-4461; Gennaro, Renato/0000-0003-1331-3885; Ferluga, Sara/0000-0002-6151-5492	Italian Ministry for University and Research (PRIN); Regione Friuli Venezia Giulia [LR 26/2005]	Italian Ministry for University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)); Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia)	This work was supported by grants from the Italian Ministry for University and Research (PRIN) and from the Regione Friuli Venezia Giulia (grant under the LR 26/2005, art. 23 for the R<SUP>3</SUP>A<SUP>2</SUP> network). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benincasa M, 2004, PEPTIDES, V25, P2055, DOI 10.1016/j.peptides.2004.08.004; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; CLEMENTZ T, 1992, J BACTERIOL, V174, P7750, DOI 10.1128/JB.174.23.7750-7756.1992; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Ishiwa A, 2000, MOL GEN GENET, V263, P159, DOI 10.1007/s004380050043; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; KLENA JD, 1992, J BACTERIOL, V174, P7297, DOI 10.1128/jb.174.22.7297-7307.1992; Kraus D, 2006, CURR TOP MICROBIOL, V306, P231; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lee JH, 2009, J BACTERIOL, V191, P4441, DOI 10.1128/JB.01474-08; Lofton H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068875; Mattiuzzo M, 2007, MOL MICROBIOL, V66, P151, DOI 10.1111/j.1365-2958.2007.05903.x; Morgera F, 2009, BIOCHEM J, V417, P727, DOI 10.1042/BJ20081726; Moser S, 2014, CHEMBIOCHEM, V15, P2684, DOI 10.1002/cbic.201402354; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Xhindoli D, 2014, BIOCHEM J, V457, P263, DOI 10.1042/BJ20131048; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yethon JA, 2000, INFECT IMMUN, V68, P4485, DOI 10.1128/IAI.68.8.4485-4491.2000; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	56	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19933	19941		10.1074/jbc.M114.634758	http://dx.doi.org/10.1074/jbc.M114.634758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100635	Green Published, hybrid			2022-12-28	WOS:000359364600048
J	Zhang, Z; Wang, YY; Li, CC; Shi, ZB; Hao, Q; Wang, WJ; Song, XM; Zhao, Y; Jiao, S; Zhou, ZC				Zhang, Zhao; Wang, Yanyan; Li, Chuanchuan; Shi, Zhubing; Hao, Qian; Wang, Wenjia; Song, Xiaomin; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai			The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-kappa B Signaling via Partial Degradation of the NF-kappa B Subunit p100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING PROTEIN P97; INCLUSION-BODY MYOPATHY; FRONTOTEMPORAL DEMENTIA; EXPRESSION LEVEL; NF-KAPPA-B2 P100; GENE-EXPRESSION; UBIQUITIN; LYMPHOMA; PATHWAY; KINASE	Partial degradation of the p100 subunit to generate p52 subunit is a hallmark of the alternative NF-kappa B pathway, which has been implicated in cancer. Here, we uncovered a role of the p97-Npl4-Ufd1 complex in mediating p100-to-p52 processing and therefore positively regulating the alternative NF-kappa B pathway. We observed an elevation of p97 mRNA levels in lymphoma patients, which positively correlates with NFKB2 expression, a downstream target gene of the alternative NF-kappa B pathway. Moreover, NFKB2 mRNA levels were aberrantly down-regulated in patients with inclusion body myopathy associated with Paget's disease of the bone and frontotemporal dementia (IBMPFD), a disease caused by mutation of p97. Inactivation of p97 or depletion of the p97-Npl4-Ufd1 complex inhibits the processing of p100 into p52, decreasing transcription of the downstream target genes. Further analyses reveal that the p97-Npl4-Ufd1 complex interacts with F-box and WD repeats protein SCF beta TrCP complex to regulate the partial degradation of p100, a process involving K48- and K11-linked ubiquitination. In line with this, in LPS-induced lung damage mice model, generation of p52 is significantly decreased in p97-KD mice compared with mock mice. Finally, abrogation of p97 ATPase activity by its specific inhibitor DBeQ, efficiently decreased proliferation of lymphoma cells. Collectively, our study revealed a regulatory role of the p97-Npl4-Ufd1 complex in regulating p100 partial degradation, highlighting the potential of p97 as a drug target for cancers with aberrant activation of the alternative NF-kappa B pathway.	[Zhang, Zhao; Wang, Yanyan; Li, Chuanchuan; Shi, Zhubing; Hao, Qian; Wang, Wenjia; Song, Xiaomin; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai 200031, Peoples R China; [Shi, Zhubing] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhou, Zhaocai] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; ShanghaiTech University	Jiao, S (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010; Zhang, Zhao/S-2072-2016	Shi, Zhubing/0000-0002-9624-4960; Zhang, Zhao/0000-0001-9345-3663	Ministry of Science and Technology of China [2012CB910204]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868, 91442125]; Science and Technology Commission of Shanghai Municipality [13ZR1446400]; "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences; Youth Innovation Promotion Association of Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2014KIP202]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences; Youth Innovation Promotion Association of Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by the 973 program of the Ministry of Science and Technology of China (2012CB910204), the National Natural Science Foundation of China (31270808, 31300734, 31470736, 31470868, 91442125), the Science and Technology Commission of Shanghai Municipality (13ZR1446400), the "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences, the Youth Innovation Promotion Association of Chinese Academy of Sciences, and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2014KIP202). The authors declare that they have no conflicts of interest with the contents of this article.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Asaka SI, 2006, SURG TODAY, V36, P793, DOI 10.1007/s00595-006-3261-2; Chen CC, 2014, J BIOL CHEM, V289, P9651, DOI 10.1074/jbc.M113.529297; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Erzurumlu Y, 2013, INT J BIOCHEM CELL B, V45, P773, DOI 10.1016/j.biocel.2013.01.006; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Fukushima H, 2012, CELL REP, V1, P434, DOI 10.1016/j.celrep.2012.04.002; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; KAHN M, 1991, J IMMUNOL, V146, P3235; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Li JM, 2014, MOL CELL BIOL, V34, P335, DOI 10.1128/MCB.01190-13; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Qu ZX, 2004, J BIOL CHEM, V279, P44563, DOI 10.1074/jbc.M403689200; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; THAKUR S, 1994, ONCOGENE, V9, P2335; Torchia MLG, 2013, J IMMUNOL, V190, P549, DOI 10.4049/jimmunol.1201697; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yilmaz ZB, 2014, CELL REP, V9, P1756, DOI 10.1016/j.celrep.2014.11.014; ZHANG JD, 1994, ONCOGENE, V9, P1931; Zhang Z, 2013, DEV CELL, V25, P636, DOI 10.1016/j.devcel.2013.05.006; Zhao CH, 2005, WORLD J GASTROENTERO, V11, P4628, DOI 10.3748/wjg.v11.i30.4628	49	19	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19558	19568		10.1074/jbc.M114.630061	http://dx.doi.org/10.1074/jbc.M114.630061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26112410	hybrid, Green Published			2022-12-28	WOS:000359364600019
J	Agarwal, V; Talens, S; Grandits, AM; Blom, AM				Agarwal, Vaibhav; Talens, Simone; Grandits, Alexander M.; Blom, Anna M.			A Novel Interaction between Complement Inhibitor C4b-binding Protein and Plasminogen That Enhances Plasminogen Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEPTIDASE O PEPO; STREPTOCOCCUS-PNEUMONIAE; INNATE IMMUNITY; BINDING-PROTEIN; THROMBIN GENERATION; C4-BINDING PROTEIN; SYSTEM; COAGULATION; EVASION; FIBRIN	The complement, coagulation, and fibrinolytic systems are crucial for the maintenance of tissue homeostasis. To date numerous interactions and cross-talks have been identified between these cascades. In line with this, here we propose a novel, hitherto unknown interaction between the complement inhibitor C4b-binding protein (C4BP) and plasminogen of the fibrinolytic pathway. Binding of C4BP to Streptococcus pneumoniae is a known virulence mechanism of this pathogen and it was increased in the presence of plasminogen. Interestingly, the acute phase variant of C4BP lacking the beta-chain and protein S binds plasminogen much stronger than the main isoform containing the beta-chain and protein S. Indeed, the complement control protein (CCP) 8 domain of C4BP, which would otherwise be sterically hindered by the beta-chain, primarily mediates this interaction. Moreover, the lysine-binding sites in plasminogen kringle domains facilitate the C4BP-plasminogen interaction. Furthermore, C4BP readily forms complexes with plasminogen in fluid phase and such complexes are present in human serum and plasma. Importantly, whereas the presence of plasminogen did not affect the factor I cofactor activity of C4BP, the activation of plasminogen by urokinase-type plasminogen activator to active plasmin was significantly augmented in the presence of C4BP. Taken together, our data demonstrate a novel interaction between two proteins of the complement and fibrinolytic system. Most complexes might be formed during the acute phase of inflammation and have an effect on the homeostasis at the site of injury or acute inflammation.	[Agarwal, Vaibhav; Talens, Simone; Grandits, Alexander M.; Blom, Anna M.] Lund Univ, Med Prot Chem, Translat Med, S-20502 Malmo, Sweden	Lund University	Blom, AM (corresponding author), Wallenberg Inst & Labs, Floor 4,Inga Marie Nilssons St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Grandits, Alexander Michael/0000-0001-9929-1861	Swedish Research Council [K2012-66X-14928-09-5]; Foundation of Torsten Soderberg; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; Foundation of Ake Wiberg; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Torsten Soderberg; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; Foundation of Ake Wiberg; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported in part by Swedish Research Council Grant K2012-66X-14928-09-5, Foundations of Torsten Soderberg, Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, Ake Wiberg, Royal Physiographic Society in Lund, and the Skane University Hospital. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral stipend from Swedish Society for Medical Research.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P353, DOI 10.1016/0009-3084(94)90157-0; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chavakis T, 2005, BLOOD, V105, P1036, DOI 10.1182/blood-2004-01-0166; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; Duboscq C, 1997, THROMB RES, V86, P505, DOI 10.1016/S0049-3848(97)00099-6; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; HILLARP A, 1989, FEBS LETT, V259, P53, DOI 10.1016/0014-5793(89)81492-9; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Koenigs A, 2013, J BIOL CHEM, V288, P25229, DOI 10.1074/jbc.M112.413872; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; MIYASHITA C, 1988, Haemostasis, V18, P7; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; ROSENBERG RD, 1984, J CLIN INVEST, V74, P1, DOI 10.1172/JCI111389; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Souza NM, 2012, MICROB PATHOGENESIS, V53, P125, DOI 10.1016/j.micpath.2012.06.001; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	46	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18333	18342		10.1074/jbc.M114.619494	http://dx.doi.org/10.1074/jbc.M114.619494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26067271	Green Published, hybrid			2022-12-28	WOS:000358512100007
J	Huang, Y; Sun, LP; Liu, NN; Wei, Q; Jiang, LZ; Tong, XM; Ye, X				Huang, Yan; Sun, Liping; Liu, Ningning; Wei, Qian; Jiang, Liangzhen; Tong, Xiaomei; Ye, Xin			Polo-like Kinase 1 (Plk1) Up-regulates Telomerase Activity by Affecting Human Telomerase Reverse Transcriptase (hTERT) Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; E3 LIGASE; PHOSPHORYLATION; PROTEIN; MITOSIS; TRF1; CYTOKINESIS; DEGRADATION; PHOSPHATASE; PROTEOLYSIS	Maintenance of telomere is regulated by active telomerase complex, including telomerase holoenzyme and its associated proteins. The activity of telomerase is precisely controlled in cells, and its dysregulation is one of the hallmarks of cancer. The telomerase catalytic subunit human telomerase reverse transcriptase (hTERT) plays a central role for telomerase activity. In this study, we indentified that Polo-like kinase 1 (Plk1) is a novel telomerase-associated protein. Plk1 can interact with hTERT independently of its kinase activity. More importantly, we found that Plk1 is associated with active telomerase complex. In addition, we demonstrated that knockdown of Plk1 caused the reduction of telomerase activity, whereas overexpression of Plk1 increased telomerase activity. Further analysis showed that overexpression of Plk1 led to a significant increase of hTERT protein by prolonging its half-life but did not affect the level of hTERT mRNA. Furthermore, we found that Plk1 enhanced the chromatin loading of hTERT and inhibited its ubiquitination. This implied that Plk1 affected hTERT stability by inhibiting its ubiquitin-mediated degradation. Collectively, these observations suggested that Plk1 is a positive modulator of telomerase by enhancing the stability of hTERT.	[Huang, Yan; Sun, Liping; Liu, Ningning; Wei, Qian; Jiang, Liangzhen; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Huang, Yan; Sun, Liping; Liu, Ningning; Wei, Qian; Jiang, Liangzhen] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn		Liu, Ningning/0000-0002-3868-8395	National Natural Science Foundation of China [81272272, 31471278]; Ministry of Science and Technology of China [2013ZX10004611, 2012CB519003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by National Natural Science Foundation of China Grants 81272272 and 31471278 and Ministry of Science and Technology of China Grants 2013ZX10004611 and 2012CB519003. The authors declare that they have no conflicts of interest with the contents of this article.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chai WH, 2002, J BIOL CHEM, V277, P47242, DOI 10.1074/jbc.M208542200; Chang JT, 2006, BRIT J CANCER, V94, P870, DOI 10.1038/sj.bjc.6603008; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Ha GH, 2012, CELL DEATH DIFFER, V19, P321, DOI 10.1038/cdd.2011.101; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; Kim J, 2014, BIOCHEM BIOPH RES CO, V443, P1124, DOI 10.1016/j.bbrc.2013.12.118; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Liao ZL, 2013, INT IMMUNOPHARMACOL, V16, P444, DOI 10.1016/j.intimp.2013.05.006; Lobjois V, 2011, BIOCHEM BIOPH RES CO, V410, P87, DOI 10.1016/j.bbrc.2011.05.110; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Munoz P, 2009, MOL CELL BIOL, V29, P1608, DOI 10.1128/MCB.01339-08; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; O'Donovan DS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.208; Oh W, 2010, ONCOGENE, V29, P4101, DOI 10.1038/onc.2010.160; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Soohoo CY, 2011, J BIOL CHEM, V286, P3894, DOI 10.1074/jbc.M110.180174; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wang C, 2010, EUR J CELL BIOL, V89, P748, DOI 10.1016/j.ejcb.2010.05.005; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	41	9	9	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18865	18873		10.1074/jbc.M114.635375	http://dx.doi.org/10.1074/jbc.M114.635375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070557	Green Published, hybrid			2022-12-28	WOS:000358512100052
J	Borek, A; Kuleta, P; Ekiert, R; Pietras, R; Sarewicz, M; Osyczka, A				Borek, Arkadiusz; Kuleta, Patryk; Ekiert, Robert; Pietras, Rafal; Sarewicz, Marcin; Osyczka, Artur			Mitochondrial Disease-related Mutation G167P in Cytochrome b of Rhodobacter capsulatus Cytochrome bc(1) (S151P in Human) Affects the Equilibrium Distribution of [2Fe-2S] Cluster and Generation of Superoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE BYPASS REACTIONS; IRON-SULFUR SUBUNIT; Q(O) SITE; COMPLEX-III; ELECTRON-TRANSFER; UBIHYDROQUINONE OXIDATION; DOMAIN MOVEMENT; BC1 COMPLEX; HEAD DOMAIN; PROTEIN	Cytochrome bc(1) is one of the key enzymes of many bioenergetic systems. Its operation involves a large scale movement of a head domain of iron-sulfur protein (ISP-HD), which functionally connects the catalytic quinol oxidation Q(o) site in cytochrome b with cytochrome c(1). The Q(o) site under certain conditions can generate reactive oxygen species in the reaction scheme depending on the actual position of ISP-HD in respect to the Q(o) site. Here, using a bacterial system, we show that mutation G167P in cytochrome b shifts the equilibrium distribution of ISP-HD toward positions remote from the Q(o) site. This renders cytochrome bc(1) non-functional in vivo. This effect is remediated by addition of alanine insertions (1Ala and 2Ala) in the neck region of the ISP subunit. These insertions, which on their own shift the equilibrium distribution of ISP-HD in the opposite direction (i.e. toward the Q(o) site), also act in this manner in the presence of G167P. Changes in the equilibrium distribution of ISP-HD in G167P lead to an increased propensity of cytochrome bc(1) to generate superoxide, which becomes evident when the concentration of quinone increases. This result corroborates the recently proposed model in which "semireverse" electron transfer back to the Q(o) site, occurring when ISP-HD is remote from the site, favors reactive oxygen species production. G167P suggests possible molecular effects of S151P (corresponding in sequence to G167P) identified as a mitochondrial disease-related mutation in human cytochrome b. These effects may be valid for other human mutations that change the equilibrium distribution of ISP-HD in a manner similar to G167P.	[Borek, Arkadiusz; Kuleta, Patryk; Ekiert, Robert; Pietras, Rafal; Sarewicz, Marcin; Osyczka, Artur] Jagiellonian Univ, Dept Mol Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University	Osyczka, A (corresponding author), Jagiellonian Univ, Dept Mol Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland.	artur.osyczka@uj.edu.pl		Osyczka, Artur/0000-0002-1637-2365; Borek, Arkadiusz/0000-0003-3195-3579; Pietras, Rafal/0000-0001-8424-6590; Ekiert, Robert/0000-0002-8879-0646; Kuleta, Patryk/0000-0002-5533-1400; Sarewicz, Marcin/0000-0001-6813-5997	Ministry of Science and Higher Education	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. We thank Dr. Monika Czapla for generating the G167P single mutant.	ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Benit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry Edward A., 2009, V28, P425; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Borek A, 2008, BIOCHEMISTRY-US, V47, P12365, DOI 10.1021/bi801207f; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Brandt U, 1998, BBA-BIOENERGETICS, V1365, P261, DOI 10.1016/S0005-2728(98)00078-4; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Cieluch E, 2010, BBA-BIOENERGETICS, V1797, P296, DOI 10.1016/j.bbabio.2009.11.003; Cooley JW, 2004, BIOCHEMISTRY-US, V43, P2217, DOI 10.1021/bi035938u; Crofts AR, 2013, BBA-BIOENERGETICS, V1827, P1362, DOI 10.1016/j.bbabio.2013.01.009; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Czapla M, 2012, PROTEIN ENG DES SEL, V25, P15, DOI 10.1093/protein/gzr055; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3464, DOI 10.1074/jbc.M107973200; Darrouzet E, 2002, J BIOL CHEM, V277, P3471, DOI 10.1074/jbc.M107974200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011; Dutton P L, 1978, Methods Enzymol, V54, P411; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kramer D, 2004, METHOD ENZYMOL, V382, P21; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Lanciano P, 2011, BIOCHEMISTRY-US, V50, P1651, DOI 10.1021/bi101736v; Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678; Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2006, BIOCHEMISTRY-US, V45, P10492, DOI 10.1021/bi060013a; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; ROBERTSON DE, 1990, BIOCHEMISTRY-US, V29, P11249, DOI 10.1021/bi00503a014; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Sarewicz M, 2013, BIOCHEMISTRY-US, V52, P6388, DOI 10.1021/bi400624m; Sarewicz M, 2010, BBA-BIOENERGETICS, V1797, P1820, DOI 10.1016/j.bbabio.2010.07.005; Sarewicz M, 2009, BIOCHEMISTRY-US, V48, P5708, DOI 10.1021/bi900511b; Shinkarev VP, 2002, BIOCHEMISTRY-US, V41, P14372, DOI 10.1021/bi026198c; SIEDOW JN, 1978, J BIOL CHEM, V253, P2392; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2007, PHOTOSYNTH RES, V92, P17, DOI 10.1007/s11120-007-9155-3; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	59	12	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23781	23792		10.1074/jbc.M115.661314	http://dx.doi.org/10.1074/jbc.M115.661314			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245902	Green Published, hybrid			2022-12-28	WOS:000361816500025
J	Title, AC; Denzler, R; Stoffel, M				Title, Alexandra C.; Denzler, Remy; Stoffel, Markus			Uptake and Function Studies of Maternal Milk-derived MicroRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOMES; MIRNAS; CANCER; DIET; RNA; EXPRESSION; BIOMARKERS; XENOMIRS; MIR-375; DISEASE	MicroRNAs (miRNAs) are important regulators of cell-autonomous gene expression that influence many biological processes. They are also released from cells and are present in virtually all body fluids, including blood, urine, saliva, sweat, and milk. The functional role of nutritionally obtained extracellular miRNAs is controversial, and irrefutable demonstration of exogenous miRNA uptake by cells and canonical miRNA function is still lacking. Here we show that miRNAs are present at high levels in the milk of lactating mice. To investigate intestinal uptake of miRNAs in newborn mice, we employed genetic models in which newborn miR-375 and miR-200c/141 knockout mice received milk from wild-type foster mothers. Analysis of the intestinal epithelium, blood, liver, and spleen revealed no evidence for miRNA uptake. miR-375 levels in hepatocytes were at the limit of detection and remained orders of magnitude below the threshold for target gene regulation (between 1000 and 10,000 copies/cell). Furthermore, our study revealed rapid degradation of milk miRNAs in intestinal fluid. Together, our results indicate a nutritional rather than gene-regulatory role of miRNAs in the milk of newborn mice.	[Title, Alexandra C.; Denzler, Remy; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Stoffel, Markus] Univ Zurich, Fac Med, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Stoffel, M (corresponding author), Eidgenoss Tech Hsch Zurich, Swiss Fed Inst Technol, Inst Mol Hlth Sci, Otto Stern Weg 7,HPL H36, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817	Excellence and Opportunity Scholarship of Eidgenossische Technische Hochschule Zurich; European Research Council Grant "Metabolomirs"; Swiss National Science Foundation National Center of Competence in Research on RNA Biology and Disease; Starr Foundation International	Excellence and Opportunity Scholarship of Eidgenossische Technische Hochschule Zurich; European Research Council Grant "Metabolomirs"; Swiss National Science Foundation National Center of Competence in Research on RNA Biology and Disease; Starr Foundation International	This work was supported by an Excellence and Opportunity Scholarship of the Eidgenossische Technische Hochschule Zurich (to A. C. T), European Research Council Grant "Metabolomirs," the Starr Foundation International, and the Swiss National Science Foundation National Center of Competence in Research on RNA Biology and Disease (to M. S.). M. S. is a member of the scientific advisory board of Regulus Therapeutics and Alnylam Pharmaceuticals.	Arner P, 2015, NAT REV ENDOCRINOL, V11, P276, DOI 10.1038/nrendo.2015.25; Aslam MF, 2014, FASEB J, V28, P3671, DOI 10.1096/fj.14-251520; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Fujita M, 2007, MED MOL MORPHOL, V40, P1, DOI 10.1007/s00795-006-0346-3; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hassiotou F, 2015, ADV NUTR, V6, P267, DOI 10.3945/an.114.007377; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Laubier J, 2015, RNA BIOL, V12, P26, DOI 10.1080/15476286.2015.1017212; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2014, J NUTR, V144, P1880, DOI 10.3945/jn.114.202523; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Witwer KW, 2012, RNA BIOL, V9, P1147, DOI 10.4161/rna.21619; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	42	99	104	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23680	23691		10.1074/jbc.M115.676734	http://dx.doi.org/10.1074/jbc.M115.676734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240150	Green Published, hybrid			2022-12-28	WOS:000361816500018
J	Benlhabib, H; Guo, W; Pierce, BM; Mendelson, CR				Benlhabib, Houda; Guo, Wei; Pierce, Brianne M.; Mendelson, Carole R.			The miR-200 Family and Its Targets Regulate Type II Cell Differentiation in Human Fetal Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-A GENE; TRANSCRIPTION FACTOR-I; SURFACTANT PROTEINS; TUMOR PROGRESSION; REPRESSORS ZEB1; CANCER-CELLS; CYCLIC-AMP; MOUSE LUNG; TGF-BETA	Type II cell differentiation and expression of the major surfactant protein, SP-A, in mid-gestation human fetal lung (HFL) are induced by cAMP and inhibited by TGF-beta. cAMP induction of SP-A promoter activity is mediated by increased phosphorylation and DNA binding of thyroid transcription factor-1 (TTF1/Nkx2.1), a master regulator of lung development. To further define mechanisms for developmental induction of surfactant synthesis in HFL, herein, we investigated the potential roles of microRNAs (miRNAs, miRs). To identify and characterize differentially regulated miRNAs in mid-gestation HFL explants during type II pneumocyte differentiation in culture, we performed miRNA microarray of RNA from epithelial cells isolated from mid-gestation HFL explants before and after culture with or without Bt2cAMP. Interestingly, the miR-200 family was significantly up-regulated during type II cell differentiation; miR-200 induction was inversely correlated with expression of known targets, transcription factors ZEB1/2 and TGF-beta 2. miR-200 antagonists inhibited TTF-1 and surfactant proteins and up-regulated TGF-beta 2 and ZEB1 expression in type II cells. Overexpression of ZEB1 in type II cells decreased DNA binding of endogenous TTF-1, blocked cAMP stimulation of surfactant proteins, and inhibited miR-200 expression, whereas cAMP markedly inhibited ZEB1/2 and TGF-beta. Importantly, overexpression of ZEB1 or miR-200 antagonists in HFL type II cells also inhibited LPCAT1 and ABCA3, enzymes involved in surfactant phospholipid synthesis and trafficking, and blocked lamellar body biogenesis. Our findings suggest that the miR-200 family and ZEB1, which exist in a double-negative feedback loop regulated by TGF-beta, serve important roles in the developmental regulation of type II cell differentiation and function in HFL.	Univ Texas SW Med Ctr Dallas, North Texas March Dimes Birth Defects Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, North Texas March Dimes Birth Defects Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carole.mendelson@utsouthwestern.edu	Regan, Clinton/E-6250-2012	Dentel, Brianne/0000-0003-4384-3529; Benlhabib, Houda/0000-0002-7776-1508; Mendelson, Carole Ruth/0000-0003-1696-9791	National Institutes of Health [R01 HL050022]; March of Dimes Foundation Prematurity Research Initiative Grant [21-FY14-146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation Prematurity Research Initiative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL050022 (to C. R. M.). This work was also supported by March of Dimes Foundation Prematurity Research Initiative Grant 21-FY14-146 (to C. R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ACARREGUI MJ, 1993, AM J PHYSIOL, V264, pL465, DOI 10.1152/ajplung.1993.264.5.L465; ALCORN JL, 1993, MOL ENDOCRINOL, V7, P1072, DOI 10.1210/me.7.8.1072; Alcorn JL, 2004, AM J PHYSIOL-LUNG C, V286, pL767, DOI 10.1152/ajplung.00280.2003; Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Ambalavanan N, 2008, AM J PHYSIOL-LUNG C, V295, pL86, DOI 10.1152/ajplung.00534.2007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beers MF, 1998, AM J PHYSIOL-LUNG C, V275, pL950, DOI 10.1152/ajplung.1998.275.5.L950; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Gao L, 2015, J CLIN INVEST, V125, P2808, DOI 10.1172/JCI78544; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Islam KN, 2002, MOL ENDOCRINOL, V16, P1428, DOI 10.1210/me.16.6.1428; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; McDevitt TM, 2007, AM J PHYSIOL-LUNG C, V292, pL249, DOI 10.1152/ajplung.00088.2006; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; ODOM MJ, 1988, ENDOCRINOLOGY, V123, P1712; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Scavo LM, 1998, AM J PHYSIOL-LUNG C, V275, pL653, DOI 10.1152/ajplung.1998.275.4.L653; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SMITH BT, 1977, AM REV RESPIR DIS, V115, P285; SNYDER JM, 1981, CELL TISSUE RES, V220, P17; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WHITSETT JA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P257, DOI 10.1016/0005-2760(92)90004-F; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yang HB, 2008, AM J PHYSIOL-GASTR L, V295, pG170, DOI 10.1152/ajpgi.00492.2007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang Y, 2012, INT J MOL MED, V29, P393, DOI 10.3892/ijmm.2011.855; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103	72	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22409	22422		10.1074/jbc.M114.636068	http://dx.doi.org/10.1074/jbc.M114.636068			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26203191	Green Published, hybrid			2022-12-28	WOS:000361171500008
J	Ishihara, Y; Takemoto, T; Itoh, K; Ishida, A; Yamazaki, T				Ishihara, Yasuhiro; Takemoto, Takuya; Itoh, Kouichi; Ishida, Atsuhiko; Yamazaki, Takeshi			Dual Role of Superoxide Dismutase 2 Induced in Activated Microglia OXIDATIVE STRESS TOLERANCE AND CONVERGENCE OF INFLAMMATORY RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; NADPH OXIDASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL ROS; INTERFERON-GAMMA; REDOX REGULATION; NEURONAL INJURY; GENE-EXPRESSION	Microglia are activated quickly in response to external pathogens or cell debris and clear these substances via the inflammatory response. However, excessive activation of microglia can be harmful to host cells due to the increased production of reactive oxygen species and proinflammatory cytokines. Superoxide dismutase 2 (SOD2) is reportedly induced under various inflammatory conditions in the central nervous system. We herein demonstrated that activated microglia strongly express SOD2 and examined the role of SOD2, focusing on regulation of the microglial activity and the susceptibility of microglia to oxidative stress. When rat primary microglia were treated with LPS, poly(I:C), peptidoglycan, or CpG oligodeoxynucleotide, respectively, the mRNA and protein levels of SOD2 largely increased. However, an increased expression of SOD2 was not detected in the primary neurons or astrocytes, indicating that SOD2 is specifically induced in microglia under inflammatory conditions. The activated microglia showed high tolerance to oxidative stress, whereas SOD2 knockdown conferred vulnerability to oxidative stress. Interestingly, the production of proinflammatory cytokines was increased in the activated microglia treated with SOD2 siRNA compared with that observed in the control siRNA-treated cells. Pretreatment with NADPH oxidase inhibitors, diphenylene iodonium and apocynin, decreased in not only reactive oxygen species generation but also the proinflammatory cytokine expression. Notably, SOD2 knockdown largely potentiated the nuclear factor kappa B activity in the activated microglia. Taken together, increased SOD2 conferred tolerance to oxidative stress in the microglia and decreased proinflammatory cytokine production by attenuating the nuclear factor kappa B activity. Therefore, SOD2 might regulate neuroinflammation by controlling the microglial activities.	[Ishihara, Yasuhiro] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Lab Mol Brain Sci, Higashihiroshima 7398521, Japan; [Itoh, Kouichi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Brain Sci, Sanuki, Kagawa 7692193, Japan	Hiroshima University; Tokushima Bunri University	Ishihara, Y (corresponding author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, Lab Mol Brain Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.	ishiyasu@hiroshima-u.ac.jp	Ishihara, Yasuhiro/U-6511-2017	Ishihara, Yasuhiro/0000-0001-9751-7660	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26740024, 30291149, 22310041]; Fujii Foundation; Hiroshima University Education and Research Support Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fujii Foundation; Hiroshima University Education and Research Support Foundation	This work was supported in part by KAKENHI Grants 26740024, 30291149, and 22310041 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. I., K. I., and T. Y.); a grant from the Fujii Foundation (to Y. I.); and a grant from the Hiroshima University Education and Research Support Foundation (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Akyol O, 2005, PROG NEURO-PSYCHOPH, V29, P123, DOI 10.1016/j.pnpbp.2004.10.014; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Borrello S, 1997, ARCH BIOCHEM BIOPHYS, V348, P289, DOI 10.1006/abbi.1997.0355; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chen X, 2009, FREE RADICAL BIO MED, V46, P1204, DOI 10.1016/j.freeradbiomed.2009.01.027; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; DECHATELET LR, 1975, J CLIN INVEST, V55, P714, DOI 10.1172/JCI107981; Egger T, 2003, BIOCHEM J, V370, P459, DOI 10.1042/BJ20021358; Fullerton JM, 2010, BIPOLAR DISORD, V12, P550, DOI 10.1111/j.1399-5618.2010.00834.x; Galecki P, 2010, PSYCHIAT RES, V179, P43, DOI 10.1016/j.psychres.2009.06.016; Godbout JP, 2004, J NEUROIMMUNOL, V149, P101, DOI 10.1016/j.jneuroim.2003.12.017; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Hu ZQ, 2014, TOXICOL APPL PHARM, V276, P95, DOI 10.1016/j.taap.2014.01.020; Ishihara Y, 2006, TOXICOL APPL PHARM, V214, P109, DOI 10.1016/j.taap.2005.12.003; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Ishihara Y, 2014, LIFE SCI, V99, P24, DOI 10.1016/j.lfs.2014.01.061; Ishihara Y, 2012, NEUROCHEM INT, V60, P782, DOI 10.1016/j.neuint.2012.03.004; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; ITOH K, 1992, BRAIN RES, V580, P233, DOI 10.1016/0006-8993(92)90949-A; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Kairisalo M, 2007, BIOCHEM BIOPH RES CO, V364, P138, DOI 10.1016/j.bbrc.2007.09.115; Kaneko M, 2004, BIOL PHARM BULL, V27, P1202, DOI 10.1248/bpb.27.1202; Kaneko YS, 2012, CLIN EXP PHARMACOL P, V39, P599, DOI 10.1111/j.1440-1681.2012.05716.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiningham KK, 2008, FREE RADICAL BIO MED, V44, P1610, DOI 10.1016/j.freeradbiomed.2008.01.015; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Kramer BC, 2002, NEUROSCIENCE, V114, P361, DOI 10.1016/S0306-4522(02)00310-X; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Li YK, 2001, J NEUROSCI RES, V66, P163, DOI 10.1002/jnr.1208; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Sugaya K, 1998, MOL BRAIN RES, V58, P1, DOI 10.1016/S0169-328X(97)00365-3; Sugaya K, 1997, NEUROREPORT, V8, P3547, DOI 10.1097/00001756-199711100-00026; Takemoto T, 2015, ENVIRON TOXICOL PHAR, V40, P199, DOI 10.1016/j.etap.2015.06.010; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Wang VC, 2010, CLIN BIOCHEM, V43, P979, DOI 10.1016/j.clinbiochem.2010.05.009; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Warner BB, 1996, AM J PHYSIOL-LUNG C, V271, pL150, DOI 10.1152/ajplung.1996.271.1.L150; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wiener HW, 2007, GENES BRAIN BEHAV, V6, P770, DOI 10.1111/j.1601-183X.2007.00308.x; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	56	60	63	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22805	22817		10.1074/jbc.M115.659151	http://dx.doi.org/10.1074/jbc.M115.659151			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26231211	Green Published, hybrid			2022-12-28	WOS:000361171500043
J	Hu, CY; Yu, CF; Liu, YH; Hou, XH; Liu, XY; Hu, YF; Jin, CW				Hu, Cuiyun; Yu, Caifang; Liu, Yanhua; Hou, Xianhui; Liu, Xiaoyun; Hu, Yunfei; Jin, Changwen			A Hybrid Mechanism for the Synechocystis Arsenate Reductase Revealed by Structural Snapshots during Arsenate Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; AUREUS PLASMID PI258; BACILLUS-SUBTILIS; PCC 6803; NOE ASSIGNMENT; PROTEIN; CYANOBACTERIUM; DETOXIFICATION; PHOSPHATASES; RESISTANCE	Evolution of enzymes plays a crucial role in obtaining new biological functions for all life forms. Arsenate reductases (ArsC) are several families of arsenic detoxification enzymes that reduce arsenate to arsenite, which can subsequently be extruded from cells by specific transporters. Among these, the Synechocystis ArsC (SynArsC) is structurally homologous to the well characterized thioredoxin (Trx)-coupled ArsC family but requires the glutaredoxin (Grx) system for its reactivation, therefore classified as a unique Trx/Grx-hybrid family. The detailed catalytic mechanism of SynArsC is unclear and how the "hybrid" mechanism evolved remains enigmatic. Herein, we report the molecular mechanism of SynArsC by biochemical and structural studies. Our work demonstrates that arsenate reduction is carried out via an intramolecular thiol-disulfide cascade similar to the Trx-coupled family, whereas the enzyme reactivation step is diverted to the coupling of the glutathione-Grx pathway due to the local structural difference. The current results support the hypothesis that SynArsC is likely a molecular fossil representing an intermediate stage during the evolution of the Trx-coupled ArsC family from the low molecular weight protein phosphotyrosine phosphatase (LMW-PT Pase) family.	[Hu, Cuiyun; Yu, Caifang; Liu, Yanhua; Hou, Xianhui; Liu, Xiaoyun; Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Cuiyun; Yu, Caifang; Hou, Xianhui; Hu, Yunfei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Hu, YF (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei@pku.edu.cn; changwen@pku.edu.cn	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022		National Natural Science Foundation of China [31170681]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 31170681 from the National Natural Science Foundation of China (to C. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett MS, 2001, P NATL ACAD SCI USA, V98, P13577, DOI 10.1073/pnas.241397198; Bohari Y, 2002, J ENVIRON MONITOR, V4, P596, DOI 10.1039/b203988p; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Demel S, 2004, PROTEIN SCI, V13, P2330, DOI 10.1110/ps.04787204; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo XR, 2005, J BIOL CHEM, V280, P39601, DOI 10.1074/jbc.M508132200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu M, 2014, J PROTEOMICS, V109, P16, DOI 10.1016/j.jprot.2014.06.017; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; JI GY, 1994, BIOCHEMISTRY-US, V33, P7294, DOI 10.1021/bi00189a034; Kim SG, 2012, BBA-PROTEINS PROTEOM, V1824, P392, DOI [10.1016/j.bbapap.2011.10.012, 10.1016/j.bbapap.2011.11.012]; Li RH, 2003, J BACTERIOL, V185, P6780, DOI 10.1128/JB.185.23.6780-6789.2003; Li Y, 2007, J BIOL CHEM, V282, P11078, DOI 10.1074/jbc.M700970200; Lopez-Maury L, 2009, J BACTERIOL, V191, P3534, DOI 10.1128/JB.01798-08; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Messens J, 2002, P NATL ACAD SCI USA, V99, P8506, DOI 10.1073/pnas.132142799; Messens J, 2002, J BIOL INORG CHEM, V7, P146, DOI 10.1007/s007750100282; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; Mukhopadhyay R, 2009, J MOL BIOL, V386, P1229, DOI 10.1016/j.jmb.2008.07.056; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Slejkovec Z, 1999, TALANTA, V49, P619, DOI 10.1016/S0039-9140(99)00048-X; Suginaka K, 1999, BIOSCI BIOTECH BIOCH, V63, P1112, DOI 10.1271/bbb.63.1112; Yu CF, 2011, BIOMOL NMR ASSIGN, V5, P85, DOI 10.1007/s12104-010-9273-2; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843	38	5	6	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22262	22273		10.1074/jbc.M115.659896	http://dx.doi.org/10.1074/jbc.M115.659896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26224634	Green Published, hybrid			2022-12-28	WOS:000360968500042
J	Zeitler, M; Steringer, JP; Muller, HM; Mayer, MP; Nickel, W				Zeitler, Marcel; Steringer, Julia P.; Mueller, Hans-Michael; Mayer, Matthias P.; Nickel, Walter			HIV-Tat Protein Forms Phosphoinositide-dependent Membrane Pores Implicated in Unconventional Protein Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 2; HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMA-MEMBRANE; CELL-SURFACE; MAMMALIAN-CELLS; TRANSLOCATION; MACHINERY; EXPORT; FGF-2	HIV-Tat has been demonstrated to be secreted from cells in a phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2)-dependent manner. Here we show that HIV-Tat forms membrane-inserted oligomers, a process that is accompanied by changes in secondary structure with a strong increase in antiparallel beta sheet content. Intriguingly, oligomerization of HIV-Tat on membrane surfaces leads to the formation of membrane pores, as demonstrated by physical membrane passage of small fluorescent tracer molecules. Although membrane binding of HIV-Tat did not strictly depend on PI(4,5) P2 but, rather, was mediated by a range of acidic membrane lipids, a functional interaction between PI(4,5) P2 and HIV-Tat was critically required for efficient membrane pore formation by HIV-Tat oligomers. These properties are strikingly similar to what has been reported previously for fibroblast growth factor 2 (FGF2), providing strong evidence of a common core mechanism of unconventional secretion shared by HIV-Tat and fibroblast growth factor 2.	[Zeitler, Marcel; Steringer, Julia P.; Mueller, Hans-Michael; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Mayer, Matthias P.] Heidelberg Univ, Zentrum Mol Biol, Deutsch Krebsforschungszentrum, Univ Heidelberg Allianz, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Muller, Hans-Michael/0000-0002-2384-7285	German Research Council [DFG-SFB 638, DFG-SFB/TRR 83, DFG-GRK1188]; AID-NET program of the Federal Ministry for Education and Research of Germany; cluster of excellence CellNetworks	German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; cluster of excellence CellNetworks	This work was supported by German Research Council Grants DFG-SFB 638, DFG-SFB/TRR 83, and DFG-GRK1188; the AID-NET program of the Federal Ministry for Education and Research of Germany, and the cluster of excellence CellNetworks. The authors declare that they have no conflicts of interest with the contents of this article.	Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Bellino S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-49; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli F, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0151-y; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Muller HM, 2015, J BIOL CHEM, V290, P8925, DOI 10.1074/jbc.M114.622456; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; RUBEN S, 1989, J VIROL, V63, P1; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Shojania S, 2010, J VIROL METHODS, V164, P35, DOI 10.1016/j.jviromet.2009.11.021; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	42	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21976	21984		10.1074/jbc.M115.667097	http://dx.doi.org/10.1074/jbc.M115.667097			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183781	Green Published, hybrid			2022-12-28	WOS:000360968500018
J	Beam, J; Botta, A; Ye, JY; Soliman, H; Matier, BJ; Forrest, M; MacLeod, KM; Ghosh, S				Beam, Julianne; Botta, Amy; Ye, Jiayu; Soliman, Hesham; Matier, Brieanne J.; Forrest, Mary; MacLeod, Kathleen M.; Ghosh, Sanjoy			Excess Linoleic Acid Increases Collagen I/III Ratio and "Stiffens" the Heart Muscle Following High Fat Diets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; OXIDATIVE STRESS; I COLLAGEN; EJECTION FRACTION; ENZYME-ACTIVITY; SATURATED FAT; N-6 PUFA; TGF-BETA; DISEASE; MICE	Controversy exists on the benefits versus harms of n-6 polyunsaturated fatty acids (n-6 PUFA). Although n-6 PUFA demonstrates anti-atherosclerotic properties, survival following cardiac remodeling may be compromised. We hypothesized that n-6 PUFA like linoleic acid (LA) or other downstream PUFAs like gamma-linolenic acid or arachidonic acid alter the transforming growth factor-beta (TGF beta)-collagen axis in the heart. Excess dietary LA increased the collagen I/III ratio in the mouse myocardium, leading to cardiac "stiffening" characterized by impaired transmitral flow indicative of early diastolic dysfunction within 5 weeks. In vitro, LA under TGF beta 1 stimulation increased collagen I and lysyl oxidase (LOX), the enzyme that cross-links soluble collagen resulting in deposited collagen. Overexpression of fatty acid desaturase 2 (fads2), which metabolizes LA to downstream PUFAs, reduced collagen deposits, LOX maturation, and activity with LA, whereas overexpressing fads1, unrelated to LA desaturation, did not. Furthermore, fads2 knockdown by RNAi elevated LOX activity and collagen deposits in fibroblasts with LA but not oleic acid, implying a buildup of LA for aggravating such pro-fibrotic effects. As direct incubation with gamma-linolenic acid or arachidonic acid also attenuated collagen deposits and LOX activity, we concluded that LA itself, independent of other downstream PUFAs, promotes the pro-fibrotic effects of n-6 PUFA. Overall, these results attempt to reconcile opposing views of n-6 PUFA on the cardiovascular system and present evidence supporting a cardiac muscle-specific effect of n-6 PUFAs. Therefore, aggravation of the collagen I/III ratio and cardiac stiffening by excess n-6 PUFA represent a novel pathway of cardiac lipotoxicity caused by high n-6 PUFA diets.	[Beam, Julianne; Botta, Amy; Ye, Jiayu; Matier, Brieanne J.; Forrest, Mary; Ghosh, Sanjoy] Univ British Columbia Okanagan, Dept Biol, IK Barber Sch Arts & Sci, Kelowna, BC V1V 1V7, Canada; [Soliman, Hesham; MacLeod, Kathleen M.; Ghosh, Sanjoy] Univ British Columbia Okanagan, Mol & Cellular Pharmacol Res Grp, Fac Pharmaceut Sci, Kelowna, BC V1V 1V7, Canada; [Soliman, Hesham] Menia Univ, Fac Pharm, Dept Pharmacol & Toxicol, Al Minya 11432, Egypt	University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia Okanagan; Egyptian Knowledge Bank (EKB); Minia University	Ghosh, S (corresponding author), Univ British Columbia Okanagan, ASC 369, Dept Biol, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	sanjoy.ghosh@ubc.ca		MacLeod, Kathleen/0000-0002-4280-6083; ye, jiayu/0000-0002-1704-6780	Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada Masters award; Canadian Institutes of Health Research doctoral award; China Scholarship Council	Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada Masters award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research doctoral award(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council)	This work was supported by operating grants from Canadian Diabetes Association (to S. G. and K. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Natural Sciences and Engineering Research Council of Canada Masters award.; Supported by a Canadian Institutes of Health Research doctoral award.; Supported by the China Scholarship Council.	Balogun KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082399; Baylin A, 2007, AM J CLIN NUTR, V85, P554, DOI 10.1093/ajcn/85.2.554; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Botta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070248; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Briest W, 2004, HYPERTENSION, V44, P410, DOI 10.1161/01.HYP.0000141414.87026.4d; Buskohl PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042527; Cardoso CR, 2011, IMMUNOBIOLOGY, V216, P409, DOI 10.1016/j.imbio.2010.06.007; Chen C, 2013, ADV EXP MED BIOL, V765, P47, DOI 10.1007/978-1-4614-4989-8_7; Collier P, 2012, J MOL CELL CARDIOL, V52, P148, DOI 10.1016/j.yjmcc.2011.10.002; COLLINS FD, 1971, NUTR METAB, V13, P150; Das UN, 2007, PROSTAG LEUKOTR ESS, V76, P251, DOI 10.1016/j.plefa.2007.03.001; Galvao TF, 2012, CARDIOVASC RES, V93, P24, DOI 10.1093/cvr/cvr258; Ge L, 2003, J INVEST DERMATOL, V120, P707, DOI 10.1046/j.1523-1747.2003.12123.x; Ghosh S, 2004, AM J PHYSIOL-HEART C, V287, pH2518, DOI 10.1152/ajpheart.00480.2004; Ghosh S, 2007, AM J PHYSIOL-HEART C, V293, pH2919, DOI 10.1152/ajpheart.00324.2007; Ghosh S, 2006, FREE RADICAL BIO MED, V41, P1413, DOI 10.1016/j.freeradbiomed.2006.07.021; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Guillou H, 2003, J LIPID RES, V44, P450, DOI 10.1194/jlr.C200019-JLR200; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; HICKS M, 1989, ARCH BIOCHEM BIOPHYS, V268, P249, DOI 10.1016/0003-9861(89)90586-9; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; Hosokawa R, 2003, J DENT RES, V82, P558, DOI 10.1177/154405910308200714; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Knott L, 2011, OSTEOARTHR CARTILAGE, V19, P1150, DOI 10.1016/j.joca.2011.06.005; Laher I, 2013, FREE RADICAL RES, V47, P44, DOI 10.3109/10715762.2012.737463; LAST JA, 1983, THORAX, V38, P364, DOI 10.1136/thx.38.5.364; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Ling TY, 2003, FASEB J, V17, P1559, DOI 10.1096/fj.02-1063fje; LITTLE WC, 1995, CIRCULATION, V92, P1933, DOI 10.1161/01.CIR.92.7.1933; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lopez B, 2009, HYPERTENSION, V53, P236, DOI 10.1161/HYPERTENSIONAHA.108.125278; LOSTY TA, 1985, P SOC EXP BIOL MED, V179, P155; MARIJIANOWSKI MMH, 1994, J AM COLL CARDIOL, V23, P1204, DOI 10.1016/0735-1097(94)90612-2; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; MURATA K, 1984, HEPATO-GASTROENTEROL, V31, P158; Norton GR, 1997, CIRCULATION, V96, P1991, DOI 10.1161/01.CIR.96.6.1991; Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970; Omori Y, 2012, J HYPERTENS, V30, P1834, DOI 10.1097/HJH.0b013e3283569c5a; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Roy R, 1996, J CELL BIOCHEM, V62, P411, DOI 10.1002/(SICI)1097-4644(199609)62:3<411::AID-JCB11>3.0.CO;2-L; Saraswathi V, 2004, J LIPID RES, V45, P794, DOI 10.1194/jlr.M300497-JLR200; Schmidt AG, 2002, J AM SOC ECHOCARDIOG, V15, P1065, DOI 10.1067/mje.2002.121863; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Schwingshackl L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004487; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SUDA K, 1992, ARCH PATHOL LAB MED, V116, P934; Tanaka N, 2009, J GASTROENTEROL, V44, P983, DOI 10.1007/s00535-009-0088-9; Toborek M, 1996, J LIPID RES, V37, P123; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Zibadi S, 2010, CARDIOVASC TOXICOL, V10, P190, DOI 10.1007/s12012-010-9078-7; Zouein FA, 2013, J CARDIOVASC PHARM, V62, P13, DOI 10.1097/FJC.0b013e31829a4e61	65	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23371	23384		10.1074/jbc.M115.682195	http://dx.doi.org/10.1074/jbc.M115.682195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240151	Green Published, hybrid			2022-12-28	WOS:000361685500043
J	Torres-Salazar, D; Jiang, J; Divito, CB; Garcia-Olivares, J; Amara, SG				Torres-Salazar, Delany; Jiang, Jie; Divito, Christopher B.; Garcia-Olivares, Jennie; Amara, Susan G.			A Mutation in Transmembrane Domain 7 (TM7) of Excitatory Amino Acid Transporters Disrupts the Substrate-dependent Gating of the Intrinsic Anion Conductance and Drives the Channel into a Constitutively Open State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; CHLORIDE CHANNEL; FUNCTIONAL-PROPERTIES; VOLTAGE-DEPENDENCE; EXTRACELLULAR GATE; NOISE-ANALYSIS; ION-CHANNEL; BINDING; HOMOLOG; TRANSLOCATION	In the mammalian central nervous system, excitatory amino acid transporters (EAATs) are responsible for the clearance of glutamate after synaptic release. This energetically demanding activity is crucial for precise neuronal communication and for maintaining extracellular glutamate concentrations below neurotoxic levels. In addition to their ability to recapture glutamate from the extracellular space, EAATs exhibit a sodium-and glutamate-gated anion conductance. Here we show that substitution of a conserved positively charged residue (Arg-388, hEAAT1) in transmembrane domain 7 with a negatively charged amino acid eliminates the ability of glutamate to further activate the anion conductance. When expressed in oocytes, R388D or R388E mutants show large anion currents that display no further increase in amplitude after application of saturating concentrations of Na+ and glutamate. They also show a substantially reduced transport activity. The mutant transporters appear to exist preferentially in a sodium-and glutamate-independent constitutive open channel state that rarely transitions to complete the transport cycle. In addition, the accessibility of cytoplasmic residues to membrane-permeant modifying reagents supports the idea that this substrate-independent open state correlates with an intermediate outward facing conformation of the transporter. Our data provide additional insights into the mechanism by which substrates gate the anion conductance in EAATs and suggest that in EAAT1, Arg-388 is a critical element for the structural coupling between the substrate translocation and the gating mechanisms of the EAAT-associated anion channel.	[Torres-Salazar, Delany; Garcia-Olivares, Jennie; Amara, Susan G.] NIMH, Bethesda, MD 20892 USA; [Jiang, Jie; Divito, Christopher B.; Amara, Susan G.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Torres-Salazar, D (corresponding author), NIMH, Lab Mol & Cellular Neurobiol, NIH, 35 Convent Dr,Rm 3A-207, Bethesda, MD 20892 USA.	delany.torressalazar@nih.gov; susan.amara@nih.gov	Regan, Clinton/E-6250-2012	Torres-Salazar, Delany/0000-0002-6789-9810; Amara, Susan/0000-0001-8914-1106	National Institutes of Health [MH080726]; National Institute of Mental Health [MH002946]; American Heart Association [09POST2010115]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946, R01MH080726, T32MH016804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH080726 (to S. G. A.) and National Institute of Mental Health intramural research program Grant MH002946. This work was also supported by American Heart Association postdoctoral fellowship 09POST2010115 (to D. T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Focke PJ, 2011, J NEUROSCI, V31, P6255, DOI 10.1523/JNEUROSCI.6096-10.2011; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hotzy J, 2012, J BIOL CHEM, V287, P20016, DOI 10.1074/jbc.M112.344077; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Jiang J, 2011, NEUROPHARMACOLOGY, V60, P172, DOI 10.1016/j.neuropharm.2010.07.019; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Machtens JP, 2011, CHANNELS, V5, P468, DOI 10.4161/chan.5.6.17453; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2005, CLIN EXP PHARMACOL P, V32, P1, DOI 10.1111/j.1440-1681.2005.04164.x; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Schneider N, 2014, J BIOL CHEM, V289, P1815, DOI 10.1074/jbc.M113.517177; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; Seal RP, 1998, METHOD ENZYMOL, V296, P318; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shlaifer I, 2007, MOL PHARMACOL, V71, P1341, DOI 10.1124/mol.106.032607; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	57	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22977	22990		10.1074/jbc.M115.660860	http://dx.doi.org/10.1074/jbc.M115.660860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26203187	Green Published, hybrid			2022-12-28	WOS:000361685500011
J	Yan, LL; Lee, S; Lazzaro, DR; Aranda, J; Grant, MB; Chaqour, B				Yan, Lulu; Lee, Sangmi; Lazzaro, Douglas R.; Aranda, Jacob; Grant, Maria B.; Chaqour, Brahim			Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRICELLULAR PROTEIN CCN1; OXYGEN-INDUCED RETINOPATHY; IMMEDIATE-EARLY GENE; PATHOLOGICAL ANGIOGENESIS; REGULATES HEMATOPOIESIS; DEPENDENT MANNER; CYR61 CCN1; STEM-CELL; IN-VIVO; TISSUE	The response of the retina to ischemic insult typically leads to aberrant retinal neovascularization, a major cause of blindness. The epigenetic regulation of angiogenic gene expression by miRNAs provides new prospects for their therapeutic utility in retinal neovascularization. Here, we focus on miR-155, a microRNA functionally important in inflammation, which is of paramount importance in the pathogenesis of retinal neovascularization. Whereas constitutive miR-155-deficiency in mice results in mild vascular defects, forced expression of miR-155 causes endothelial hyperplasia and increases microglia count and activation. The mouse model of oxygen-induced retinopathy, which recapitulates ischemia-induced aberrant neovessel growth, is characterized by increased expression of miR-155 and localized areas of microglia activation. Interestingly, miR-155 deficiency in mice reduces microglial activation, curtails abnormal vessel growth, and allows for rapid normalization of the retinal vasculature following ischemic insult. miR-155 binds to the 3'-UTR and represses the expression of the CCN1 gene, which encodes an extracellular matrix-associated integrin-binding protein that both promotes physiological angiogenesis and harnesses growth factor-induced abnormal angiogenic responses. Single CCN1 deficiency or double CCN1 and miR-155 knock-out in mice causes retinal vascular malformations typical of faulty maturation, mimicking the vascular alterations of miR-155 gain of function. During development, the miR-155/ CCN1 regulatory axis balances the proangiogenic and proinflammatory activities of microglia to allow for their function as guideposts for sprout fusion and anastomosis. Under ischemic conditions, dysregulated miR-155 and CCN1 expression increases the inflammatory load and microglial activation, prompting aberrant angiogenic responses. Thus, miR-155 functions in tandem with CCN1 to modulate inflammation-induced vascular homeostasis and repair.	[Yan, Lulu; Lee, Sangmi; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Lazzaro, Douglas R.; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Aranda, Jacob] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Chaqour, Brahim] Suny Downstate Med Ctr, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Grant, Maria B.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Grant, Maria B.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Chaqour, B (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,MSC 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324; Lee, Sangmi/0000-0002-2362-7733	National Institutes of Health, NEI [EY022091, EY019387, EY007739]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY019387, R29EY007739, R01EY022091, R01EY007739] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants EY022091 and EY019387 (to B. C.) and EY007739 (to M. B. G.). This work was also supported by a grant from Research to Prevent Blindness (to D. R. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal Saloni, 2014, World J Biol Chem, V5, P1, DOI 10.4331/wjbc.v5.i1.1; Apte RS, 2010, ADV EXP MED BIOL, V664, P15, DOI 10.1007/978-1-4419-1399-9_2; Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bodeutsch N, 2000, GLIA, V32, P91, DOI 10.1002/1098-1136(200010)32:1<91::AID-GLIA90>3.0.CO;2-X; Cai M, 2015, BRIT J OPHTHALMOL, V99, P125, DOI 10.1136/bjophthalmol-2014-305690; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chaqour Brahim, 2013, Trends Dev Biol, V7, P59; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chintala H, 2015, DEVELOPMENT, V142, P2364, DOI 10.1242/dev.121913; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; Choi J, 2013, J BIOL CHEM, V288, P23075, DOI 10.1074/jbc.M113.475418; Couturier A, 2014, MOL VIS, V20, P908; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Rodriguez AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048485; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Feng YX, 2007, THROMB HAEMOSTASIS, V97, P99, DOI 10.1160/TH06-05-0277; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Marshall B, 2014, INVEST OPHTH VIS SCI, V55, P4151, DOI 10.1167/iovs.14-14375; Mizushina Y, 2015, J BIOL CHEM, V290, P5065, DOI 10.1074/jbc.M114.603217; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Nakagawa Y, 2013, J CELL COMMUN SIGNAL, V7, P207, DOI 10.1007/s12079-013-0202-x; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Robertson ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113050; Roitbak T, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-25; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Roy S, 2012, MICROCIRCULATION, V19, P224, DOI 10.1111/j.1549-8719.2011.00156.x; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Rymo SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015846; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tien T, 2014, MOL VIS, V20, P732; Tolentino MJ, 2009, CURR MOL MED, V9, P973, DOI 10.2174/156652409789712783; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Yan LL, 2013, J CELL COMMUN SIGNAL, V7, P253, DOI 10.1007/s12079-013-0206-6; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhao RB, 2015, INT J MOL SCI, V16, P840, DOI 10.3390/ijms16010840; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	73	48	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23264	23281		10.1074/jbc.M115.646950	http://dx.doi.org/10.1074/jbc.M115.646950			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26242736	Green Published, hybrid			2022-12-28	WOS:000361685500035
J	AbuSamra, DB; Al-Kilani, A; Hamdan, SM; Sakashita, K; Gadhoum, SZ; Merzaban, JS				AbuSamra, Dina B.; Al-Kilani, Alia; Hamdan, Samir M.; Sakashita, Kosuke; Gadhoum, Samah Z.; Merzaban, Jasmeen S.			Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; cell adhesion; cell migration; glycobiology; glycoprotein; surface plasmon resonance (SPR); PSGL-1; selectin; selectin ligand; sialyl Lewis x	MAJOR E-SELECTIN; LEUKOCYTE RECRUITMENT; CELL-ADHESION; ENDOTHELIAL-CELLS; KINETIC-ANALYSIS; LECTIN DOMAIN; AFFINITY; GLYCOSYLATION; DIMERIZATION; MOLECULE-1	Background: E-selectin interactions with glycoprotein ligands mediate the initial capturing of cells out of flow. Results: Adopting a Biacore-based immunoprecipitation binding assay unraveled differential binding kinetics of monomeric (m) versus dimeric (d) E-selectin to endogenous ligands. Conclusion: Although mE-selectin binds transiently, dE-selectin binds with remarkably slow on- and off-rates. Significance: Transitioning from monomeric to dimeric E-selectin could enable fast but firm capturing of cells out of flow. Selectins (E-, P-, and L-selectins) interact with glycoprotein ligands to mediate the essential tethering/rolling step in cell transport and delivery that captures migrating cells from the circulating flow. In this work, we developed a real time immunoprecipitation assay on a surface plasmon resonance chip that captures native glycoforms of two well known E-selectin ligands (CD44/hematopoietic cell E-/L-selectin ligand and P-selectin glycoprotein ligand-1) from hematopoietic cell extracts. Here we present a comprehensive characterization of their binding to E-selectin. We show that both ligands bind recombinant monomeric E-selectin transiently with fast on- and fast off-rates, whereas they bind dimeric E-selectin with remarkably slow on- and off-rates. This binding requires the sialyl Lewis x sugar moiety to be placed on both O- and N-glycans, and its association, but not dissociation, is sensitive to the salt concentration. Our results suggest a mechanism through which monomeric selectins mediate initial fast on and fast off kinetics to help capture cells out of the circulating shear flow; subsequently, tight binding by dimeric/oligomeric selectins is enabled to significantly slow rolling.	[AbuSamra, Dina B.; Al-Kilani, Alia; Hamdan, Samir M.; Sakashita, Kosuke; Gadhoum, Samah Z.; Merzaban, Jasmeen S.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia	King Abdullah University of Science & Technology	Merzaban, JS (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia.	jasmeen.merzaban@kaust.edu.sa	Merzaban, Jasmeen/V-3147-2018	Merzaban, Jasmeen/0000-0002-7276-2907; Al-Kilani, Alia/0000-0002-6428-1185; Hamdan, Samir/0000-0001-5192-1852	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This work was supported by King Abdullah University of Science and Technology faculty baseline research funding and a university competitive research grant (to J.S.M. and S.M.H.). The authors declare no conflict of interest.	ALON R, 1995, J IMMUNOL, V154, P5356; ASA D, 1995, J BIOL CHEM, V270, P11662, DOI 10.1074/jbc.270.19.11662; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Barkalow FJ, 2000, BLOOD, V96, P3070; Barthel SR, 2013, CANCER RES, V73, P942, DOI 10.1158/0008-5472.CAN-12-3264; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fuhlbrigge RC, 2002, J IMMUNOL, V168, P5645, DOI 10.4049/jimmunol.168.11.5645; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Klopocki AG, 2008, J BIOL CHEM, V283, P11493, DOI 10.1074/jbc.M709785200; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Lesley Jayne, 1998, Frontiers in Bioscience, V3, pD616; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Merzaban JS, 2015, GLYCOBIOLOGY, V25, P1392, DOI 10.1093/glycob/cwv046; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Mir GH, 2009, BLOOD, V114, P733, DOI 10.1182/blood-2009-03-210237; Molenaar TJM, 2002, BLOOD, V100, P3570, DOI 10.1182/blood-2002-02-0641; MOORE KL, 1994, J BIOL CHEM, V269, P23318; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Poeter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4738; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Sackstein R, 2009, METHODS MOL BIOL, V536, P343, DOI 10.1007/978-1-59745-542-8_36; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Torgersen D, 1998, J BIOL CHEM, V273, P6254, DOI 10.1074/jbc.273.11.6254; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Wild MK, 2001, J BIOL CHEM, V276, P31602, DOI 10.1074/jbc.M104844200; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	53	19	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21213	21230		10.1074/jbc.M114.629451	http://dx.doi.org/10.1074/jbc.M114.629451			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26124272	Green Published, hybrid			2022-12-28	WOS:000360637600003
J	Kelly, B; Tannahill, GM; Murphy, MP; O'Neill, LAJ				Kelly, Beth; Tannahill, Gillian M.; Murphy, Michael P.; O'Neill, Luke A. J.			Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1 beta (IL-1 beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIA-TARGETED ANTIOXIDANT; ELECTRON TRANSFER REACTIONS; NLRP3 INFLAMMASOME; HEPATIC GLUCONEOGENESIS; RESPIRATORY-CHAIN; MULTIPLE-SCLEROSIS; INSULIN-RESISTANCE; COMPLEX-I; MECHANISM	Metformin, a frontline treatment for type II diabetes mellitus, decreases production of the pro-form of the inflammatory cytokine IL-1 beta in response to LPS in macrophages. We found that it specifically inhibited pro-IL-1 beta production, having no effect on TNF-alpha. Furthermore, metformin boosted induction of the anti-inflammatory cytokine IL-10 in response to LPS. We ruled out a role for AMP-activated protein kinase (AMPK) in the effect of metformin because activation of AMPK with A769662 did not mimic metformin here. Furthermore, metformin was still inhibitory in AMKP alpha 1- or AMPK beta 1-deficient cells. The activity of NADH: ubiquinone oxidoreductase (complex I) was inhibited by metformin. Another complex I inhibitor, rotenone, mimicked the effect of metformin on pro-IL-1 beta and IL-10. LPS induced reactive oxygen species production, an effect inhibited by metformin or rotenone pretreatment. MitoQ, a mitochondrially targeted antioxidant, decreased LPS-induced IL-1 beta without affecting TNF-alpha. These results, therefore, implicate complex I in LPS action in macrophages.	[Kelly, Beth; Tannahill, Gillian M.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	kellyb3@tcd.ie	Murphy, Michael/C-2120-2009	Murphy, Michael/0000-0003-1115-9618; Kelly, Beth/0000-0002-3195-6860; O'Neill, Luke/0000-0002-4333-2748	European Research Council; Science Foundation Ireland; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council and Science Foundation Ireland. The authors declare that they have no conflicts of interest with the contents of this article.	Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Carroll KC, 2013, J LEUKOCYTE BIOL, V94, P1113, DOI 10.1189/jlb.0313157; CHANCE B, 1961, J BIOL CHEM, V236, P1534; CHANCE B, 1961, J BIOL CHEM, V236, P1562; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Guo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086881; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Kim J, 2014, J BIOL CHEM, V289, P23246, DOI 10.1074/jbc.M114.577908; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Mao PZ, 2013, BBA-MOL BASIS DIS, V1832, P2322, DOI 10.1016/j.bbadis.2013.09.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111; Zarrouk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106710; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	41	186	189	5	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20348	20359		10.1074/jbc.M115.662114	http://dx.doi.org/10.1074/jbc.M115.662114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26152715	Green Published, hybrid			2022-12-28	WOS:000359608900033
J	Wang, BL; Wei, H; Prabhu, L; Zhao, W; Martin, M; Hartley, AV; Lu, T				Wang, Benlian; Wei, Han; Prabhu, Lakshmi; Zhao, Wei; Martin, Matthew; Hartley, Antja-Voy; Lu, Tao			Role of Novel Serine 316 Phosphorylation of the p65 Subunit of NF-kappa B in Differential Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; PROTEIN-PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVATION; LYSINE METHYLATION; IKK-EPSILON; RELA/P65; KINASES; CANCER; INFLAMMATION	Nuclear factor kappa B (NF-kappa B) is a central coordinator in immune and inflammatory responses. Constitutive NF-kappa B is often found in some types of cancers, contributing to oncogenesis and tumor progression. Therefore, knowing how NF-kappa B is regulated is important for its therapeutic control. Post-translational modification of the p65 subunit of NF-kappa B is a well known approach for its regulation. Here, we reported that in response to interleukin 1 beta, the p65 subunit of NF-kappa B is phosphorylated on the novel serine 316. Overexpression of S316A (serine 316 -> alanine) mutant exhibited significantly reduced ability to activate NF-kappa B and decreased cell growth as compared with wtp65 (wild type p65). Moreover, conditioned media from cells expressing the S316A-p65 mutant had a considerably lower ability to induce NF-kappa B than that of wtp65. Our data suggested that phosphorylation of p65 on Ser-316 controls the activity and function of NF-kappa B. Importantly, we found that phosphorylation at the novel Ser-316 site and other two known phosphorylation sites, Ser-529 and Ser-536, either individually or cooperatively, regulated distinct groups of NF-kappa B-dependent genes, suggesting the unique role of each individual phosphorylation site on NF-kappa B-dependent gene regulation. Our novel findings provide an important piece of evidence regarding differential regulation of NF-kappa B-dependent genes through phosphorylation of different p65 serine residues, thus shedding light on novel mechanisms for the pathway-specific control of NF-kappa B. This knowledge is key to develop strategies for prevention and treatment of constitutive NF-kappa B-driven inflammatory diseases and cancers.	[Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wei, Han; Prabhu, Lakshmi; Martin, Matthew; Hartley, Antja-Voy; Lu, Tao] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhao, Wei; Lu, Tao] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lu, Tao] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Case Western Reserve University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lu, T (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	lut@iupui.edu	Prabhu, Lakshmi/AAK-8659-2020	Prabhu, Lakshmi/0000-0002-2093-1115				Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Casey SC, 2015, SEMIN CANCER BIOL, V35, pS199, DOI 10.1016/j.semcancer.2015.02.007; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Lu T, 2013, P NATL ACAD SCI USA, V110, P13510, DOI 10.1073/pnas.1311770110; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Sabatel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038246; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	35	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20336	20347		10.1074/jbc.M115.639849	http://dx.doi.org/10.1074/jbc.M115.639849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26082493	Green Published, hybrid			2022-12-28	WOS:000359608900032
J	Kodali, S; Vinogradov, E; Lin, F; Khoury, N; Hao, L; Pavliak, V; Jones, CH; Laverde, D; Huebner, J; Jansen, KU; Anderson, AS; Donald, RGK				Kodali, Srinivas; Vinogradov, Evgeny; Lin, Fiona; Khoury, Nancy; Hao, Li; Pavliak, Vilo; Jones, C. Hal; Laverde, Diana; Huebner, Johannes; Jansen, Kathrin U.; Anderson, Annaliesa S.; Donald, Robert G. K.			A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANCOMYCIN-RESISTANT; CAPSULAR POLYSACCHARIDE; LEGIONAMINIC ACID; PNEUMOCOCCAL CONJUGATE; STAPHYLOCOCCUS-AUREUS; NOSOCOMIAL PATHOGEN; LIPOTEICHOIC ACID; GENOME ANALYSIS; GENE-CLUSTER; CELL-WALL	The incidence of multidrug-resistant Enterococcus faecium hospital infections has been steadily increasing. With the goal of discovering new vaccine antigens, we systematically fractionated and purified four distinct surface carbohydrates from E. faecium endocarditis isolate Tx16, shown previously to be resistant to phagocytosis in the presence of human serum. The two most abundant polysaccharides consist of novel branched heteroglycan repeating units that include signature sugars altruronic acid and legionaminic acid, respectively. A minor high molecular weight polysaccharide component was recognized as the fructose homopolymer levan, and a glucosylated lipoteichoic acid (LTA) was identified in a micellar fraction. The polysaccharides were conjugated to the CRM197 carrier protein, and the resulting glycoconjugates were used to immunize rabbits. Rabbit immune sera were evaluated for their ability to kill Tx16 in opsonophagocytic assays and in a mouse passive protection infection model. Although antibodies raised against levan failed to mediate opsonophagocytic killing, the other glycoconjugates induced effective opsonic antibodies, with the altruronic acid-containing polysaccharide antisera showing the greatest opsonophagocytic assay activity. Antibodies directed against either novel heteroglycan or the LTA reduced bacterial load in mouse liver or kidney tissue. To assess antigen prevalence, we screened a diverse collection of blood isolates (n = 101) with antibodies to the polysaccharides. LTA was detected on the surface of 80% of the strains, and antigens recognized by antibodies to the two major heteroglycans were co-expressed on 63% of these clinical isolates. Collectively, these results represent the first steps toward identifying components of a glycoconjugate vaccine to prevent E. faecium infection.	[Kodali, Srinivas; Lin, Fiona; Khoury, Nancy; Hao, Li; Pavliak, Vilo; Jones, C. Hal; Jansen, Kathrin U.; Anderson, Annaliesa S.; Donald, Robert G. K.] Pfizer Vaccine Res & Early Dev, Pearl River, NY 10654 USA; [Vinogradov, Evgeny] CNR, Ottawa, ON K1A 0R6, Canada; [Laverde, Diana; Huebner, Johannes] Univ Hosp, Div Infect Dis, Dept Med, D-79106 Freiburg, Germany; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, D-80338 Munich, Germany	Pfizer; National Research Council Canada; University of Freiburg; University of Munich	Donald, RGK (corresponding author), Pfizer Vaccine Res, 401 N Middletown Rd, Pearl River, NY 10965 USA.	robert.donald@pfizer.com	Donald, Robert George Konrad/GNP-4958-2022	Huebner, Johannes/0000-0003-1232-4646	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Baseclear (Leiden, Netherlands) generated MLST data for the E. faecium blood isolates. We acknowledge the use of the E. faecium MLST database, which is located at Imperial College London and funded by The Wellcome Trust. We thank Michael Gilmore, Barbara Murray, and Rob Willems for strains and Philip Lee (Pfizer) and Lorna Nunez (Pfizer) for help with genome sequencing. We thank Ellen Murphy for help with bioinformatic analysis of putative biosynthetic genes. Dominique Wobser contributed expert technical support for the mouse model. We also thank Dee Illenburger, Jennifer Obregon, and Kathryn Mason for generating rabbit antibodies.	Allen GP, 2009, INT J ANTIMICROB AG, V34, P21, DOI 10.1016/j.ijantimicag.2008.12.011; Anderson AS, 2012, HUM VACC IMMUNOTHER, V8, P1585, DOI 10.4161/hv.21872; ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; Arias CA, 2007, CLIN INFECT DIS, V45, P1343, DOI 10.1086/522656; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bychowska A, 2011, CARBOHYD RES, V346, P2816, DOI 10.1016/j.carres.2011.09.026; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Cescutti P, 2003, CARBOHYD RES, V338, P2687, DOI 10.1016/S0008-6215(03)00384-7; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLEWELL DB, 1982, J BACTERIOL, V152, P1220; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; DISCHE Z, 1948, J BIOL CHEM, V175, P595; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Harding SE, 2012, CARBOHYD POLYM, V90, P237, DOI 10.1016/j.carbpol.2012.05.030; HERMANSSON K, 1990, CARBOHYD RES, V208, P145, DOI 10.1016/0008-6215(90)80094-J; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsu CT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-62; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Joels CS, 2003, AM SURGEON, V69, P514; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KNIREL YA, 1994, EUR J BIOCHEM, V221, P239, DOI 10.1111/j.1432-1033.1994.tb18734.x; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLean LL, 2011, CARBOHYD RES, V346, P2589, DOI 10.1016/j.carres.2011.09.003; Matulova M, 2011, CARBOHYD RES, V346, P501, DOI 10.1016/j.carres.2010.12.012; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Palmer KL, 2010, J BACTERIOL, V192, P2469, DOI 10.1128/JB.00153-10; Palusinska-Szysz Marta, 2009, Recent Pat Antiinfect Drug Discov, V4, P96; Paoletti Lawrence C, 2002, Semin Neonatol, V7, P315, DOI 10.1053/siny.2002.0114; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rakita RM, 2000, FEMS IMMUNOL MED MIC, V28, P291, DOI 10.1111/j.1574-695X.2000.tb01489.x; SAWARDEKAR JS, 1967, ANAL CHEM, V37, P1602; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Swierzko AS, 1996, FEBS LETT, V398, P297; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2009, INFECTION, V37, P540, DOI 10.1007/s15010-009-9023-5; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; Toniolo C, 2015, J BIOL CHEM, V290, P9521, DOI 10.1074/jbc.M114.631499; Toth A, 2000, BIOORG MED CHEM LETT, V10, P19, DOI 10.1016/S0960-894X(99)00585-5; Tran TT, 2013, ANTIMICROB AGENTS CH, V57, P261, DOI 10.1128/AAC.01454-12; TREVELYAN WE, 1952, NATURE, V170, P626, DOI 10.1038/170626a0; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Zunk M, 2014, RSC ADV, V4, P3413, DOI 10.1039/c3ra44924f	64	21	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19512	19526		10.1074/jbc.M115.655852	http://dx.doi.org/10.1074/jbc.M115.655852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109072	Green Published, hybrid			2022-12-28	WOS:000359364600012
J	Sani, MA; Henriques, ST; Weber, D; Separovic, F				Sani, Marc-Antoine; Henriques, Sonia Troeira; Weber, Daniel; Separovic, Frances			Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER MEMBRANES; LIPID-COMPOSITION; STAPHYLOCOCCUS-AUREUS; LITORIA-GENIMACULATA; CELLS; MECHANISM; INSERTION	Maculatin 1.1 (Mac1) is an antimicrobial peptide from the skin of Australian tree frogs and is known to possess selectivity toward Gram-positive bacteria. Although Mac1 has membrane disrupting activity, it is not known how Mac1 selectively targets Gram-positive over Gram-negative bacteria. The interaction of Mac1 with Escherichia coli, Staphylococcus aureus, and human red blood cells (hRBC) and with their mimetic model membranes is here reported. The peptide showed a 16-fold greater growth inhibition activity against S. aureus (4 mu M) than against E. coli (64 mu M) and an intermediate cytotoxicity against hRBC (30 mu M). Surprisingly, Sytox Green uptake monitored by flow cytometry showed that Mac1 compromised both bacterial membranes with similar efficiency at similar to 20-fold lower concentration than the reported minimum inhibition concentration against S. aureus. Mac1 also reduced the negative potential of S. aureus and E. coli membrane with similar efficacy. Furthermore, liposomes mimicking the cell membrane of S. aureus (POPG/TOCL) and E. coli (POPE/POPG) were lysed at similar concentrations, whereas hRBC-like vesicles (POPC/SM/Chol) remained mostly intact in the presence of Mac1. Remarkably, when POPG/TOCL and POPE/POPG liposomes were co-incubated, Mac1 did not induce leakage from POPE/POPG liposomes, suggesting a preference toward POPG/TOCL membranes that was supported by surface plasma resonance assays. Interestingly, circular dichroism spectroscopy showed a similar helical conformation in the presence of the anionic liposomes but not the hRBC mimics. Overall, the study showed that Mac1 disrupts bacterial membranes in a similar fashion before cell death events and would preferentially target S. aureus over E. coli or hRBC membranes.	[Sani, Marc-Antoine; Weber, Daniel; Separovic, Frances] Univ Melbourne, Sch Chem, Inst Bio21, Parkville, Vic 3010, Australia; [Henriques, Sonia Troeira] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Melbourne; University of Queensland	Sani, MA (corresponding author), Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia.	msani@unimelb.edu.au	Weber, Daniel/AAA-2329-2019; Henriques, Sonia Troeira/J-3500-2016; Separovic, Frances/D-9698-2011	Weber, Daniel/0000-0001-8400-767X; Henriques, Sonia Troeira/0000-0001-9564-9651; Separovic, Frances/0000-0002-6484-2763; Sani, Marc-antoine/0000-0003-3284-2176	Australian Research Council [DP140102127, DE120103152]	Australian Research Council(Australian Research Council)	This work was supported in part by Australian Research Council Grant DP140102127 (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Discovery Early Career Researcher Award DE120103152 from the Australian Research Council.	Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; BEINING PR, 1975, J BACTERIOL, V121, P137, DOI 10.1128/JB.121.1.137-143.1975; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chia BCS, 2000, EUR J BIOCHEM, V267, P1894, DOI 10.1046/j.1432-1327.2000.01089.x; Chia CSB, 2011, BIOPOLYMERS, V96, P147, DOI 10.1002/bip.21438; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Filippov A, 2004, BIOPHYS J, V86, P891, DOI 10.1016/S0006-3495(04)74164-8; Gehman JD, 2008, BIOCHEMISTRY-US, V47, P8557, DOI 10.1021/bi800320v; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; HURST A, 1977, CAN J MICROBIOL, V23, P935, DOI 10.1139/m77-139; Jamasbi E, 2014, AMINO ACIDS, V46, P2759, DOI 10.1007/s00726-014-1833-9; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Prenner EJ, 2001, BBA-BIOMEMBRANES, V1510, P83, DOI 10.1016/S0005-2736(00)00337-0; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rozek T, 1998, J PEPT SCI, V4, P111, DOI 10.1002/(SICI)1099-1387(199804)4:2<111::AID-PSC134>3.0.CO;2-8; SALVIOLI G, 1978, GUT, V19, P844, DOI 10.1136/gut.19.9.844; Sando L, 2011, CHEMBIOCHEM, V12, P2456, DOI 10.1002/cbic.201100450; Sani MA, 2013, ANTIMICROB AGENTS CH, V57, P3593, DOI 10.1128/AAC.00195-13; Sani MA, 2014, EUR BIOPHYS J BIOPHY, V43, P445, DOI 10.1007/s00249-014-0970-0; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Sudheendra US, 2015, EUR J MED CHEM, V91, P91, DOI 10.1016/j.ejmech.2014.08.021; Thennarasu S, 2010, BIOPHYS J, V98, P248, DOI 10.1016/j.bpj.2009.09.060; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	34	38	38	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19853	19862		10.1074/jbc.M115.643262	http://dx.doi.org/10.1074/jbc.M115.643262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100634	Green Published, hybrid			2022-12-28	WOS:000359364600041
J	Kim, B; Figueroa-Romero, C; Pacut, C; Backus, C; Feldman, EL				Kim, Bhumsoo; Figueroa-Romero, Claudia; Pacut, Crystal; Backus, Carey; Feldman, Eva L.			Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPK(Ser-485) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; ALZHEIMERS-DISEASE; COGNITIVE PERFORMANCE; DIABETES-MELLITUS; INCREASED RISK; FOOD-INTAKE; NEURONS; HYPERGLYCEMIA; BRAIN	Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors including obesity, diabetes, and dyslipidemia, and insulin resistance (IR) is the central feature of MetS. Recent studies suggest that MetS is a risk factor for Alzheimer disease (AD). AMP-activated kinase (AMPK) is an evolutionarily conserved fuel-sensing enzyme and a key player in regulating energy metabolism. In this report, we examined the role of IR on the regulation of AMPK phosphorylation and AMPK-mediated Tau phosphorylation. We found that AMPK(Ser-485), but not AMPK(Thr-172), phosphorylation is increased in the cortex of db/db and high fat diet-fed obese mice, two mouse models of IR. In vitro, treatment of human cortical stem cell line (HK-5320) and primary mouse embryonic cortical neurons with the AMPK activator, 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR), induced AMPK phosphorylation at both Thr-172 and Ser-485. AMPK activation also triggered Tau dephosphorylation. When IR was mimicked in vitro by chronically treating the cells with insulin, AICAR specifically induced AMPK(Ser-485), but not AMPK(Thr-172), hyperphosphorylation whereas AICAR-induced Tau dephosphorylation was inhibited. IR also resulted in the overactivation of Akt by AICAR treatment; however, preventing Akt overactivation during IR prevented AMPKSer-485 hyperphosphorylation and restored AMPK-mediated Tau dephosphorylation. Transfection of AMPK(S485A) mutant caused similar results. Therefore, our results suggest the following mechanism for the adverse effect of IR on AD pathology: IR -> 3 chronic overactivation of Akt3 -> AMPK(Ser-485) hyperphosphorylation -> inhibition of AMPK-mediated Tau dephosphorylation. Together, our results show for the first time a possible contribution of IR-induced AMPK(Ser-485) phosphorylation to the increased risk of AD in obesity and diabetes.	[Kim, Bhumsoo; Figueroa-Romero, Claudia; Pacut, Crystal; Backus, Carey; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kim, B (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,5371 AAT BSRB, Ann Arbor, MI 48109 USA.	bhumsoo@umich.edu	Regan, Clinton/E-6250-2012	Figueroa-Romero, Claudia/0000-0001-7546-4190; Feldman, Eva/0000-0002-9162-2694	National Institutes of Health [1DP3DK094292, 1R24082841]; Program for Neurology Research and Discovery; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, DP3DK094292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Neurology Research and Discovery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1DP3DK094292 and 1R24082841 (to E. L. F.). This work was also supported by the Program for Neurology Research and Discovery. The authors declare that they have no conflicts of interest with the contents of this article.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Carlsson CM, 2010, J ALZHEIMERS DIS, V20, P711, DOI 10.3233/JAD-2010-100012; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cox DJ, 2005, DIABETES CARE, V28, P71, DOI 10.2337/diacare.28.1.71; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Du LL, 2015, J ALZHEIMERS DIS, V43, P775, DOI 10.3233/JAD-140564; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x; Greco SJ, 2011, BIOCHEM BIOPH RES CO, V414, P170, DOI 10.1016/j.bbrc.2011.09.050; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; HA J, 1994, J BIOL CHEM, V269, P22162; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kim B, 2013, J ALZHEIMERS DIS, V34, P727, DOI 10.3233/JAD-121669; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Kim B, 2011, ENDOCRINOLOGY, V152, P3638, DOI 10.1210/en.2011-0029; Kim B, 2011, ANTIOXID REDOX SIGN, V14, P1829, DOI 10.1089/ars.2010.3816; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Watcho P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/268547; Won JS, 2010, BIOCHEM BIOPH RES CO, V399, P487, DOI 10.1016/j.bbrc.2010.07.081; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217	52	38	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19146	19157		10.1074/jbc.M115.636852	http://dx.doi.org/10.1074/jbc.M115.636852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26100639	hybrid, Green Published			2022-12-28	WOS:000358781100030
J	Kuznetsova, E; Nocek, B; Brown, G; Makarova, KS; Flick, R; Wolf, YI; Khusnutdinova, A; Evdokimova, E; Jin, K; Tan, K; Hanson, AD; Hasnain, G; Zallot, R; de Crecy-Lagard, V; Babu, M; Savchenko, A; Joachimiak, A; Edwards, AM; Koonin, EV; Yakunin, AF				Kuznetsova, Ekaterina; Nocek, Boguslaw; Brown, Greg; Makarova, Kira S.; Flick, Robert; Wolf, Yuri I.; Khusnutdinova, Anna; Evdokimova, Elena; Jin, Ke; Tan, Kemin; Hanson, Andrew D.; Hasnain, Ghulam; Zallot, Remi; de Crecy-Lagard, Valerie; Babu, Mohan; Savchenko, Alexei; Joachimiak, Andrzej; Edwards, Aled M.; Koonin, Eugene V.; Yakunin, Alexander F.			Functional Diversity of Haloacid Dehalogenase Superfamily Phosphatases from Saccharomyces cerevisiae BIOCHEMICAL, STRUCTURAL, AND EVOLUTIONARY INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; ESCHERICHIA-COLI; GENE ENCODES; MITOCHONDRIAL PHOSPHATASE; ENZYME PROMISCUITY; ETHANOL-PRODUCTION; PROVIDE INSIGHT; BUDDING YEAST; ABASIC SITES; EYES ABSENT	The haloacid dehalogenase (HAD)-like enzymes comprise a large superfamily of phosphohydrolases present in all organisms. The Saccharomyces cerevisiae genome encodes at least 19 soluble HADs, including 10 uncharacterized proteins. Here, we biochemically characterized 13 yeast phosphatases from the HAD superfamily, which includes both specific and promiscuous enzymes active against various phosphorylated metabolites and peptides with several HADs implicated in detoxification of phosphorylated compounds and pseudouridine. The crystal structures of four yeast HADs provided insight into their active sites, whereas the structure of the YKR070W dimer in complex with substrate revealed a composite substrate-binding site. Although the S. cerevisiae and Escherichia coli HADs share low sequence similarities, the comparison of their substrate profiles revealed seven phosphatases with common preferred substrates. The cluster of secondary substrates supporting significant activity of both S. cerevisiae and E. coli HADs includes 28 common metabolites that appear to represent the pool of potential activities for the evolution of novel HAD phosphatases. Evolution of novel substrate specificities of HAD phosphatases shows no strict correlation with sequence divergence. Thus, evolution of the HAD superfamily combines the conservation of the overall substrate pool and the substrate profiles of some enzymes with remarkable biochemical and structural flexibility of other superfamily members.	[Edwards, Aled M.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Nocek, Boguslaw; Tan, Kemin; Joachimiak, Andrzej; Edwards, Aled M.] Argonne Natl Lab, Midwest Ctr Struct Genom & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Brown, Greg; Flick, Robert; Khusnutdinova, Anna; Evdokimova, Elena; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Makarova, Kira S.; Wolf, Yuri I.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Jin, Ke; Babu, Mohan] Univ Regina, Dept Biochem, Res & Innovat Ctr, Regina, SK S4S 0A2, Canada; [Hanson, Andrew D.; Hasnain, Ghulam; Zallot, Remi; de Crecy-Lagard, Valerie; Babu, Mohan] Univ Florida, Dept Hort Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	University of Toronto; Structural Genomics Consortium; United States Department of Energy (DOE); Argonne National Laboratory; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Regina; State University System of Florida; University of Florida	Yakunin, AF (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	a.iakounine@utoronto.ca	Khusnutdinova, Anna/AAU-8164-2020; Mohan, Babu P./I-7362-2019; Regan, Clinton/E-6250-2012; Zallot, Rémi/J-9645-2019; de Crecy-Lagard, Valerie/AAN-8995-2020; ZALLOT, Rémi/D-3933-2014	Zallot, Rémi/0000-0002-7317-1578; ZALLOT, Rémi/0000-0002-7317-1578; Joachimiak, Andrzej/0000-0003-2535-6209; Yakunin, Alexander/0000-0003-0813-6490; Edwards, Aled/0000-0002-4782-6016; Wolf, Yuri/0000-0002-0247-8708	National Institutes of Health [GM094585]; Government of Canada through Genome Canada; Ontario Genomics Institute; Ontario Research Fund [2009-OGI-ABC-1405, ORF-GL2-01-004]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; U. S. National Science Foundation [IOS-1025398]; Direct For Biological Sciences [1025398, 1153413] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fund; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U. S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094585 (to A. J.). This work was also supported by the Government of Canada through Genome Canada, the Ontario Genomics Institute, and the Ontario Research Fund (Grants 2009-OGI-ABC-1405 and ORF-GL2-01-004 to A. F. Y.), by the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357 (to A. J.), and by U. S. National Science Foundation Grant IOS-1025398 (to A. D. H.). The authors declare that they have no conflict of interest with the content of this article.	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Archambault J, 1998, J BIOL CHEM, V273, P27593, DOI 10.1074/jbc.273.42.27593; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Blaby-Haas CE, 2011, TRENDS BIOTECHNOL, V29, P174, DOI 10.1016/j.tibtech.2011.01.001; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; BUCALA R, 1985, P NATL ACAD SCI USA, V82, P8439, DOI 10.1073/pnas.82.24.8439; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Charette M, 2000, IUBMB LIFE, V49, P341; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; Costanzo MC, 2014, NUCLEIC ACIDS RES, V42, pD717, DOI 10.1093/nar/gkt1158; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Daiyasu H, 2002, PROTEIN ENG, V15, P987, DOI 10.1093/protein/15.12.987; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FONDA ML, 1992, J BIOL CHEM, V267, P15978; Fortpied J, 2006, J BIOL CHEM, V281, P18378, DOI 10.1074/jbc.M513208200; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Fujitomi K, 2012, BIORESOURCE TECHNOL, V111, P161, DOI 10.1016/j.biortech.2012.01.161; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GOLDBERG IH, 1963, J BIOL CHEM, V238, P1793; Goyer A, 2013, BIOCHEM J, V454, P533, DOI 10.1042/BJ20130516; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; IRANI MH, 1977, J BACTERIOL, V132, P398, DOI 10.1128/JB.132.2.398-410.1977; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; KAHAN FM, 1962, J BIOL CHEM, V237, P3778; KANEKO Y, 1989, MOL GEN GENET, V220, P133, DOI 10.1007/BF00260867; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; KEPES F, 1988, J BIOL CHEM, V263, P9155; Kestler C, 2014, J BIOL CHEM, V289, P3094, DOI 10.1074/jbc.M113.536482; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Kim YC, 2004, J BIOL CHEM, V279, P517, DOI 10.1074/jbc.M306054200; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Kuznetsova E, 2010, J BIOL CHEM, V285, P21049, DOI 10.1074/jbc.M110.118315; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; LEE AT, 1987, P NATL ACAD SCI USA, V84, P8311, DOI 10.1073/pnas.84.23.8311; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; LUMENG L, 1975, J BIOL CHEM, V250, P8126; Lynch M, 2000, GENETICS, V154, P459; MELCHER K, 1992, CURR GENET, V21, P295, DOI 10.1007/BF00351686; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nobeli I, 2003, J MOL BIOL, V334, P697, DOI 10.1016/j.jmb.2003.10.008; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Norin M, 2002, TRENDS BIOTECHNOL, V20, P79, DOI 10.1016/S0167-7799(01)01884-4; Nosaka K, 2006, APPL MICROBIOL BIOT, V72, P30, DOI 10.1007/s00253-006-0464-9; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Otterlei M, 2000, EMBO J, V19, P5542, DOI 10.1093/emboj/19.20.5542; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Pellicer MT, 2003, J BACTERIOL, V185, P5815, DOI 10.1128/JB.185.19.5815-5821.2003; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Preumont A, 2008, J BIOL CHEM, V283, P25238, DOI 10.1074/jbc.M804122200; Preumont A, 2010, BIOCHEM J, V431, P237, DOI 10.1042/BJ20100174; Rachel WA, 2004, THEOR POPUL BIOL, V66, P93, DOI 10.1016/j.tpb.2004.03.004; RANDEZGIL F, 1995, YEAST, V11, P1233, DOI 10.1002/yea.320111303; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; Seifried A, 2014, J BIOL CHEM, V289, P3416, DOI 10.1074/jbc.M113.503359; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Shi N, 2011, PROTEINS, V79, P1358, DOI 10.1002/prot.22969; Sorokina M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-10; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tchigvintsev A, 2013, CHEM BIOL, V20, P1386, DOI 10.1016/j.chembiol.2013.09.011; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Tuleva B, 1998, FEMS MICROBIOL LETT, V161, P139; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Vance JR, 2001, J BIOL CHEM, V276, P15073, DOI 10.1074/jbc.M011075200; VANDERCAMMEN A, 1989, EUR J BIOCHEM, V182, P613, DOI 10.1111/j.1432-1033.1989.tb14870.x; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	133	53	57	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18678	18698		10.1074/jbc.M115.657916	http://dx.doi.org/10.1074/jbc.M115.657916			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26071590	Green Published, hybrid			2022-12-28	WOS:000358512100037
J	Rodriguez, AC; Yu, SH; Li, B; Zegzouti, H; Kohler, JJ				Rodriguez, Andrea C.; Yu, Seok-Ho; Li, Bin; Zegzouti, Hicham; Kohler, Jennifer J.			Enhanced Transfer of a Photocross-linking N-Acetylglucosamine (GlcNAc) Analog by an O-GlcNAc Transferase Mutant with Converted Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED PROTEINS; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; CHEMICAL REPORTERS; LINKED GLCNAC; GLYCOSYLATION; NUCLEAR; GLCNACYLATION; PHOSPHORYLATION; COACTIVATOR	O-Linked beta-N-acetylglucosamine (O-GlcNAc) is a post-translational modification of proteins in multicellular organisms. O-GlcNAc modification is catalyzed by the O-GlcNAc transferase (OGT), which transfers N-acetylglucosamine (GlcNAc) from the nucleotide sugar donor UDP-GlcNAc to serine or threonine residues of protein substrates. Recently, we reported a novel metabolic labeling method to introduce the diazirine photocross-linking functional group onto O-GlcNAc residues in mammalian cells. In this method, cells are engineered to produce diazirine-modified UDP-GlcNAc (UDP-GlcNDAz), and the diazirine-modified GlcNAc analog (GlcNDAz) is transferred to substrate proteins by endogenous OGT, producing O-GlcNDAz. O-GlcNDAz-modified proteins can be covalently cross-linked to their binding partners, providing information about O-GlcNAc-dependent interactions. The utility of the method was demonstrated by cross-linking highly O-GlcNAc-modified nucleoporins to proteins involved in nuclear transport. For practical application of this method to a broader range of O-GlcNAc-modified proteins, efficient O-GlcNDAz production is critical. Here we examined the ability of OGT to transfer GlcNDAz and found that the wild-type enzyme (wtOGT) prefers the natural substrate, UDP-GlcNAc, over the unnatural UDP-GlcNDAz. This competition limits O-GlcNDAz production in cells and the extent of O-GlcNDAz-dependent cross-linking. Here we identified an OGT mutant, OGT(C917A), that efficiently transfers GlcNDAz and, surprisingly, has altered substrate specificity, preferring to transfer GlcNDAz rather than GlcNAc to protein substrates. We confirmed the reversed substrate preference by determining the Michaelis-Menten parameters describing the activity of wtOGT and OGT(C917A) with both UDP-GlcNAc and UDP-GlcNDAz. Use of OGT(C917A) enhances O-GlcNDAz production, yielding improved cross-linking of O-GlcNDAz-modified molecules both in vitro and in cells.	[Rodriguez, Andrea C.; Yu, Seok-Ho; Li, Bin; Kohler, Jennifer J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Zegzouti, Hicham] Promega Corp, Madison, WI 53711 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Promega Corporation	Kohler, JJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jennifer.kohler@utsouthwestern.edu	Kohler, Jennifer J./B-6589-2009; rodriguez, andrea/GRO-4054-2022; Regan, Clinton/E-6250-2012	Kohler, Jennifer J./0000-0001-5373-3329; Yu, Seok-Ho/0000-0002-8372-1094; Zegzouti, Hicham/0000-0002-0989-6195	National Institutes of Health [R01GM090271, T32GM007062]; Welch Foundation [I-1686]; Graduate Programs Initiative from University of Texas System; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090271, T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Graduate Programs Initiative from University of Texas System; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM090271. This work was also supported by Welch Foundation Grant I-1686. H. Z. is an employee of Promega Corp., which sells the UDP-Glo (TM) glycosyltransferase assay. The remaining authors declare that they have no conflicts of interest with the contents of this article.; Supported by training grants from the National Institutes of Health (Grant T32GM007062) and the Graduate Programs Initiative from the University of Texas System.	Bateman LA, 2013, CHEM COMMUN, V49, P4328, DOI 10.1039/c2cc37963e; Bauer C, 2015, J BIOL CHEM, V290, P4801, DOI 10.1074/jbc.M114.605881; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HART GW, 1995, ADV EXP MED BIOL, V376, P115; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Leavy TM, 2007, BIOORG MED CHEM LETT, V17, P3851, DOI 10.1016/j.bmcl.2007.05.008; Lim K, 2010, BIOCHEM BIOPH RES CO, V393, P314, DOI 10.1016/j.bbrc.2010.01.128; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Mizuguchi-Hata C, 2013, BBA-MOL CELL RES, V1833, P2682, DOI 10.1016/j.bbamcr.2013.06.008; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Rodriguez AC, 2014, MEDCHEMCOMM, V5, P1227, DOI 10.1039/c4md00164h; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yu SH, 2012, P NATL ACAD SCI USA, V109, P4834, DOI 10.1073/pnas.1114356109; Zaro BW, 2011, P NATL ACAD SCI USA, V108, P8146, DOI 10.1073/pnas.1102458108; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]	34	23	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22638	22648		10.1074/jbc.M115.667006	http://dx.doi.org/10.1074/jbc.M115.667006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26240142	Green Published, hybrid			2022-12-28	WOS:000361171500029
J	Le, QT; Blanchet, M; Seidah, NG; Labonte, P				Le, Quoc-Tuan; Blanchet, Matthieu; Seidah, Nabil G.; Labonte, Patrick			Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; PROXIMITY LIGATION; LIVER-REGENERATION; IN-SITU; DEGRADATION; MUTATIONS; CHOLESTEROL; MUTANTS	Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important factor in plasma cholesterol regulation through modulation of low density lipoprotein receptor (LDLR) levels. Naturally occurring mutations can lead to hyper-or hypocholesterolemia in human. Recently, we reported that PCSK9 was also able to modulate CD81 in Huh7 cells. In the present study, several gain-of-function and loss-of-function mutants as well as engineered mutants of PCSK9 were compared for their ability to modulate the cell surface expression of LDLR and CD81. Although PCSK9 gain-of-function D374Y enhanced the degradation both receptors, D374H and D129N seemed to only reduce LDLR levels. In contrast, mutations in the C-terminal hinge-cysteine-histidine-rich domain segment primarily affected the PCSK9-induced CD81 degradation. Furthermore, when C-terminally fused to an ACE2 transmembrane anchor, the secretory N-terminal catalytic or hinge-cysteine-histidine-rich domain domains of PCSK9 were able to reduce CD81 and LDLR levels. These data confirm that PCSK9 reduces CD81 levels via an intracellular pathway as reported for LDLR. Using immunocytochemistry, a proximity ligation assay, and co-immunoprecipitation, we found that the cell surface level of PCSK9 was enhanced upon overexpression of CD81 and that both PCSK9 and LDLR interact with this tetraspanin protein. Interestingly, using CHO-A7 cells lacking LDLR expression, we revealed that LDLR was not required for the degradation of CD81 by PCSK9, but its presence strengthened the PCSK9 effect.	[Le, Quoc-Tuan; Blanchet, Matthieu; Labonte, Patrick] Inst Natl Rech Sci, Inst Armand Frappier, Laval, PQ H7V 1B7, Canada; [Le, Quoc-Tuan] Vietnam Mil Med Univ, Dept Malaria Parasitol & Entomol, Hanoi 151000, Vietnam; [Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Labonte, P (corresponding author), Inst Natl Rech Sci, Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.	patrick.labonte@iaf.inrs.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research Operating [93792]; Leducq Foundation [13 CVD-03]	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Operating Grant 93792 (to P. L.) and by Leducq Foundation Grant 13 CVD-03 (to N. G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Blokzijl A, 2014, BBA-PROTEINS PROTEOM, V1844, P933, DOI 10.1016/j.bbapap.2013.07.016; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Bourbon M, 2008, ATHEROSCLEROSIS, V196, P633, DOI 10.1016/j.atherosclerosis.2007.07.019; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fasano T, 2007, ARTERIOSCL THROM VAS, V27, P677, DOI 10.1161/01.ATV.0000255311.26383.2f; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Feneant L, 2014, VIRUSES-BASEL, V6, P535, DOI 10.3390/v6020535; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Homer VM, 2008, ATHEROSCLEROSIS, V196, P659, DOI 10.1016/j.atherosclerosis.2007.07.022; Horvath G, 1998, J BIOL CHEM, V273, P30537, DOI 10.1074/jbc.273.46.30537; Huang WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029092; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Noguchi T, 2010, ATHEROSCLEROSIS, V210, P166, DOI 10.1016/j.atherosclerosis.2009.11.018; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Urban D, 2013, J AM COLL CARDIOL, V62, P1401, DOI 10.1016/j.jacc.2013.07.056; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	59	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23385	23400		10.1074/jbc.M115.642991	http://dx.doi.org/10.1074/jbc.M115.642991			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26195630	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000361685500044
J	Das, S; Sondarva, G; Viswakarma, N; Nair, RS; Osipo, C; Tzivion, G; Rana, B; Rana, A				Das, Subhasis; Sondarva, Gautam; Viswakarma, Navin; Nair, Rakesh Sathish; Osipo, Clodia; Tzivion, Guri; Rana, Basabi; Rana, Ajay			Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; c-Jun N-terminal kinase (JNK); epidermal growth factor receptor (EGFR); mitogen-activated protein kinase (MAPK); signal transduction	INHIBITOR; PHOSPHORYLATES; TRASTUZUMAB; HERCEPTIN; GDC-0941; FAMILY; ERBB3	Background: Amplification of HER2 suppresses downstream pro-apoptotic pathways for breast cancer cell survival. Results: The pro-apoptotic MLK3 kinase activity is suppressed by HER2. Conclusion: MLK3 mediates HER2-induced breast cancer cell viability. Significance: Understanding the mechanisms of MLK3 suppression by HER2 provides a basis to target MLK3 in HER2 positive breast cancer. Human epidermal growth factor receptor 2 (HER2) is amplified in approximate to 15-20% of human breast cancer and is important for tumor etiology and therapeutic options of breast cancer. Up-regulation of HER2 oncogene initiates cascades of events cumulating to the stimulation of transforming PI3K/AKT signaling, which also plays a dominant role in supporting cell survival and efficacy of HER2-directed therapies. Although investigating the underlying mechanisms by which HER2 promotes cell survival, we noticed a profound reduction in the kinase activity of a pro-apoptotic mixed lineage kinase 3 (MLK3) in HER2-positive (HER2+) but not in HER2-negative (HER2-) breast cancer tissues, whereas both HER2+ and HER2- tumors expressed a comparable level of MLK3 protein. Furthermore, the kinase activity of MLK3 was inversely correlated with HER2+ tumor grades. Moreover, HER2-directed drugs such as trastuzumab and lapatinib as well as depletion of HER2 or HER3 stimulated MLK3 kinase activity in HER2+ breast cancer cell lines. In addition, the noted inhibitory effect of HER2 on MLK3 kinase activity was mediated via its phosphorylation on Ser(674) by AKT and that pharmacological inhibitors of PI3K/AKT prevented trastuzumab- and lapatinib-induced stimulation of MLK3 activity. Consistent with the pro-apoptotic function of MLK3, stable knockdown of MLK3 in the HER2+ cell line blunted the pro-apoptotic effects of trastuzumab and lapatinib. These findings suggest that HER2 activation inhibits the pro-apoptotic function of MLK3, which plays a mechanistic role in mediating anti-tumor activities of HER2-directed therapies. In brief, MLK3 represents a newly recognized integral component of HER2 biology in HER2+ breast tumors.	[Das, Subhasis; Sondarva, Gautam; Viswakarma, Navin; Nair, Rakesh Sathish; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Osipo, Clodia] Loyola Univ Chicago, Dept Pathol, Maywood, IL 60153 USA; [Tzivion, Guri] Univ Mississippi, Inst Canc, Med Ctr, Jackson, MS 39216 USA; [Tzivion, Guri] Univ Mississippi, Dept Biochem, Med Ctr, Jackson, MS 39216 USA; [Rana, Basabi] Loyola Univ Chicago, Dept Med, Div Gastroenterol & Nutr, Maywood, IL 60153 USA; [Rana, Basabi; Rana, Ajay] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Loyola University Chicago; Loyola University Chicago; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Rana, A (corresponding author), Loyola Univ, Med Ctr, Dept Pharmacol, Bldg 102,2160 S First Ave, Maywood, IL 60153 USA.	arana@luc.edu	Rana, Ajay/ABE-3739-2020; DAS, SUBHASIS/O-8421-2017; Regan, Clinton/E-6250-2012	Rana, Ajay/0000-0003-0951-2566; DAS, SUBHASIS/0000-0003-1032-4407; 	National Institutes of Health [CA176846, CA178063]; Veterans Affairs Merit Award [BX000571]; NATIONAL CANCER INSTITUTE [R01CA178063, R01CA176846] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant CA176846 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported through National Institutes of Health Grant CA178063 and Veterans Affairs Merit Award BX000571.	Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Choi BK, 2012, PROTEIN CELL, V3, P781, DOI 10.1007/s13238-012-2065-y; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Hynes Nancy E, 2005, Discov Med, V5, P483; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; KIM HH, 1994, J BIOL CHEM, V269, P24747; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Rangasamy V, 2010, CANCER RES, V70, P1731, DOI 10.1158/0008-5472.CAN-09-3492; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Yakes FM, 2002, CANCER RES, V62, P4132; Zhang MH, 2014, BIOMED REP, V2, P41, DOI 10.3892/br.2013.187	22	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21705	21712		10.1074/jbc.M115.655563	http://dx.doi.org/10.1074/jbc.M115.655563			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152725	Green Published, hybrid			2022-12-28	WOS:000360637600041
J	Glas, M; van Saparoea, HBV; McLaughlin, SH; Roseboom, W; Liu, F; Koningstein, GM; Fish, A; den Blaauwen, T; Heck, AJR; de Jong, L; Bitter, W; de Esch, IJP; Luirink, J				Glas, Marjolein; van Saparoea, H. Bart van den Berg; McLaughlin, Stephen H.; Roseboom, Winfried; Liu, Fan; Koningstein, Gregory M.; Fish, Alexander; den Blaauwen, Tanneke; Heck, Albert J. R.; de Jong, Luitzen; Bitter, Wilbert; de Esch, Iwan J. P.; Luirink, Joen			The Soluble Periplasmic Domains of Escherichia coli Cell Division Proteins FtsQ/FtsB/FtsL Form a Trimeric Complex with Submicromolar Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; cell division; Escherichia coli (E; coli); mass spectrometry (MS); protein cross-linking; protein-protein interaction; surface plasmon resonance (SPR)	SIGNAL RECOGNITION PARTICLE; OF-FLIGHT INSTRUMENT; MASS-SPECTROMETRY; BACILLUS-SUBTILIS; SEPTAL LOCALIZATION; SEQUENCE DATABASES; MEMBRANE-PROTEINS; FTSQ PROTEIN; DIVISOME; DIVIB	Background: The FtsQBL complex plays a key role in bacterial cell division. Results: Periplasmic domains of FtsQ, FtsB, and FtsL form a trimeric complex with submicromolar affinity. Interactions are focused at the C termini of the subunits. Conclusion: FtsQ, FtsB, and FtsL form a complex with 1:1:1 stoichiometry. Significance: Insight into FtsQBL complex formation will facilitate drug design. Cell division in Escherichia coli involves a set of essential proteins that assembles at midcell to form the so-called divisome. The divisome regulates the invagination of the inner membrane, cell wall synthesis, and inward growth of the outer membrane. One of the divisome proteins, FtsQ, plays a central but enigmatic role in cell division. This protein associates with FtsB and FtsL, which, like FtsQ, are bitopic inner membrane proteins with a large periplasmic domain (denoted FtsQ(p), FtsB(p), and FtsL(p)) that is indispensable for the function of each protein. Considering the vital nature and accessible location of the FtsQBL complex, it is an attractive target for protein-protein interaction inhibitors intended to block bacterial cell division. In this study, we expressed FtsQ(p), FtsB(p), and FtsL(p) individually and in combination. Upon co-expression, FtsQ(p) was co-purified with FtsB(p) and FtsL(p) from E. coli extracts as a stable trimeric complex. FtsB(p) was also shown to interact with FtsQ(p) in the absence of FtsL(p) albeit with lower affinity. Interactions were mapped at the C terminus of the respective domains by site-specific cross-linking. The binding affinity and 1:1:1 stoichiometry of the FtsQ(p)B(p)L(p) complex and the FtsQ(p)B(p) subcomplex were determined in complementary surface plasmon resonance, analytical ultracentrifugation, and native mass spectrometry experiments.	[Glas, Marjolein; van Saparoea, H. Bart van den Berg; Koningstein, Gregory M.; Bitter, Wilbert; de Esch, Iwan J. P.; Luirink, Joen] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, NL-1081 HV Amsterdam, Netherlands; [McLaughlin, Stephen H.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Roseboom, Winfried; de Jong, Luitzen] Univ Amsterdam, Dept Mass Spectrometry Biomacromol, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Dept Bacterial Cell Biol, NL-1098 XH Amsterdam, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Fish, Alexander] NKI Prot Facil, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; MRC Laboratory Molecular Biology; University of Amsterdam; University of Amsterdam; Utrecht University; Utrecht University; Netherlands Cancer Institute	Luirink, J (corresponding author), Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.luirink@vu.nl	Luirink, Joen/AAB-8658-2021; Heck, Albert/D-7098-2011; Liu, Fan/O-1138-2015; de Esch, Iwan/K-4909-2017; Bitter, Wilbert/AAA-6872-2019; Bitter, Wilbert/ABG-3726-2020; Bitter, W/CAJ-5778-2022	Heck, Albert/0000-0002-2405-4404; Bitter, Wilbert/0000-0001-8347-6511; Liu, Fan/0000-0002-2358-549X; McLaughlin, Stephen/0000-0001-9135-6253; de Esch, I.J.P./0000-0002-1969-0238; Luirink, J./0000-0001-8431-0804; van den Berg van Saparoea, Bart/0000-0003-3337-5506; den Blaauwen, Tanneke/0000-0002-5403-5597				Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bottomley AL, 2014, MOL MICROBIOL, V94, P1041, DOI 10.1111/mmi.12813; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Buncherd H, 2014, J CHROMATOGR A, V1348, P34, DOI 10.1016/j.chroma.2014.04.083; Chen JC, 1999, J BACTERIOL, V181, P521, DOI 10.1128/JB.181.2.521-530.1999; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; DeLano W.L., PYMOL MOL GRAPHICS S; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Grenga L, 2010, NEW BIOTECHNOL, V27, P870, DOI 10.1016/j.nbt.2010.05.002; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Kasper PT, 2007, CHEMBIOCHEM, V8, P1281, DOI 10.1002/cbic.200700150; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; OSHANNESSY DJ, 1992, ANAL BIOCHEM, V205, P132, DOI 10.1016/0003-2697(92)90589-Y; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Robichon C, 2011, J BACTERIOL, V193, P4988, DOI 10.1128/JB.00324-11; Robson SA, 2002, MOL MICROBIOL, V44, P663, DOI 10.1046/j.1365-2958.2002.02920.x; Scheffers DJ, 2007, J BACTERIOL, V189, P7273, DOI 10.1128/JB.00723-07; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; van Saparoea HBV, 2013, J BIOL CHEM, V288, P24340, DOI 10.1074/jbc.M113.485888; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	50	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21498	21509		10.1074/jbc.M115.654756	http://dx.doi.org/10.1074/jbc.M115.654756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160297	hybrid, Green Published			2022-12-28	WOS:000360637600025
J	Geng, SH; White, SN; Paine, ML; Snead, ML				Geng, Shuhui; White, Shane N.; Paine, Michael L.; Snead, Malcolm L.			Protein Interaction between Ameloblastin and Proteasome Subunit alpha Type 3 Can Facilitate Redistribution of Ameloblastin Domains within Forming Enamel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; AMELOGENIN NANOSPHERES; MATRIX; STAGE; BINDING; BIOMINERALIZATION; IDENTIFICATION; 20S; LOCALIZATION; DEGRADATION	Enamel is a bioceramic tissue composed of thousands of hydroxyapatite crystallites aligned in parallel within boundaries fabricated by a single ameloblast cell. Enamel is the hardest tissue in the vertebrate body; however, it starts development as a self-organizing assembly of matrix proteins that control crystallite habit. Here, we examine ameloblastin, a protein that is initially distributed uniformly across the cell boundary but redistributes to the lateral margins of the extracellular matrix following secretion thus producing cell-defined boundaries within the matrix and the mineral phase. The yeast two-hybrid assay identified that proteasome subunit alpha type 3 (Psma3) interacts with ameloblastin. Confocal microscopy confirmed Psma3 co-distribution with ameloblastin at the ameloblast secretory end piece. Co-immunoprecipitation assay of mouse ameloblast cell lysates with either ameloblastin or Psma3 antibody identified each reciprocal protein partner. Protein engineering demonstrated that only the ameloblastin C terminus interacts with Psma3. We show that 20S proteasome digestion of ameloblastin in vitro generates an N-terminal cleavage fragment consistent with the in vivo pattern of ameloblastin distribution. These findings suggest a novel pathway participating in control of protein distribution within the extracellular space that serves to regulate the protein-mineral interactions essential to biomineralization.	[Geng, Shuhui; Paine, Michael L.; Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [White, Shane N.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles	Snead, ML (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 142, Los Angeles, CA 90033 USA.	mlsnead@usc.edu	Snead, Malcolm L/A-1372-2015	Snead, Malcolm L/0000-0002-4496-6478; Geng, Shuhui/0000-0003-4787-2458	National Institutes of Health from USPHS [DE13045, DE06988]; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013045, R01DE006988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13045 (to M. L. S.) and DE06988 (to M. L. S.) from USPHS and NIDCR. The authors declare that they have no conflicts of interest with the contents of this article.	Ausubel F. M., 2008, CURRENT PROTOCOLS MO; Bae MH, 2002, BBA-MOL CELL RES, V1592, P163, DOI 10.1016/S0167-4889(02)00310-5; Baldassarri M, 2008, J DENT RES, V87, P645, DOI 10.1177/154405910808700711; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; BOYDE A, 1979, J DENT RES, V58, P981, DOI 10.1177/00220345790580025101; Boyde A, 1987, Adv Dent Res, V1, P135; Boyde A, 1997, CIBA F SYMP, V205, P18; Chun YHP, 2010, J DENT RES, V89, P1414, DOI 10.1177/0022034510379223; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; Elenich LA, 1999, IMMUNOGENETICS, V49, P835, DOI 10.1007/s002510050562; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fong CD, 1996, J BONE MINER RES, V11, P892; Fong H, 2003, J BONE MINER RES, V18, P2052, DOI 10.1359/jbmr.2003.18.11.2052; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu JCC, 2003, CRIT REV ORAL BIOL M, V14, P387, DOI 10.1177/154411130301400602; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Lacruz RS, 2011, EUR J ORAL SCI, V119, P149, DOI 10.1111/j.1600-0722.2011.00881.x; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Mueller O, 2012, J MOL NEUROSCI, V46, P509, DOI 10.1007/s12031-011-9631-2; Murakami C, 1997, HISTOCHEM CELL BIOL, V107, P485, DOI 10.1007/s004180050136; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Paine CT, 1998, CONNECT TISSUE RES, V38, P257, DOI 10.3109/03008209809017046; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 1997, J BONE MINER RES, V12, P221, DOI 10.1359/jbmr.1997.12.2.221; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; PETERS JM, 1994, J BIOL CHEM, V269, P7709; ROBINSON C, 1981, CALCIFIED TISSUE INT, V33, P513, DOI 10.1007/BF02409483; Shi Z, 2015, ONCOGENE, V34, P2538, DOI 10.1038/onc.2014.171; Shu FJ, 2003, MOL CELL BIOCHEM, V254, P157, DOI 10.1023/A:1027317014159; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Sixt SU, 2007, AM J PHYSIOL-LUNG C, V292, pL1280, DOI 10.1152/ajplung.00140.2006; Sixt Stephan Urs, 2010, Proc Am Thorac Soc, V7, P91, DOI 10.1513/pats.200906-035JS; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; SMITH CE, 1995, INT J DEV BIOL, V39, P153; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SMITH CE, 1995, CALCIFIED TISSUE INT, V57, P133, DOI 10.1007/BF00298434; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Snead ML, 1996, J BONE MINER RES, V11, P899; TERMINE JD, 1979, J DENT RES, V58, P773, DOI 10.1177/00220345790580022901; Tomes J., 1849, PHIL T, V140, P529; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wald T, 2013, J BIOL CHEM, V288, P22333, DOI 10.1074/jbc.M113.456012; Wald T, 2011, EUR J ORAL SCI, V119, P261, DOI 10.1111/j.1600-0722.2011.00913.x; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; WARSHAWSKY H, 1971, ANAT RECORD, V169, P585, DOI 10.1002/ar.1091690308; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; White SN, 2005, J PROSTHET DENT, V94, P330, DOI 10.1016/j.prosdent.2005.08.013; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Zhou YL, 2000, J BIOL CHEM, V275, P29066, DOI 10.1074/jbc.M002031200; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273; Zhu DH, 2006, J BIOL CHEM, V281, P21173, DOI 10.1074/jbc.M510757200	77	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20661	20673		10.1074/jbc.M115.640185	http://dx.doi.org/10.1074/jbc.M115.640185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26070558	hybrid, Green Published			2022-12-28	WOS:000360011800003
J	Ruiz, CA; Rossi, SG; Rotundo, RL				Ruiz, Carlos A.; Rossi, Susana G.; Rotundo, Richard L.			Rescue and Stabilization of Acetylcholinesterase in Skeletal Muscle by N-terminal Peptides Derived from the Noncatalytic Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH MEMBRANE ANCHOR; ENDOPLASMIC-RETICULUM; T-PEPTIDE; INTRACELLULAR-TRANSPORT; QUATERNARY ASSOCIATIONS; MOLECULAR-CLONING; GOLGI-APPARATUS; CHICKEN BRAIN; COLLAGEN TAIL; DEGRADATION	The vast majority of newly synthesized acetylcholinesterase (AChE) molecules do not assemble into catalytically active oligomeric forms and are rapidly degraded intracellularly by the endoplasmic reticulum-associated protein degradation pathway. We have previously shown that AChE in skeletal muscle is regulated in part post-translationally by the availability of the noncatalytic subunit collagen Q, and others have shown that expression of a 17-amino acid N-terminal proline-rich attachment domain of collagen Q is sufficient to promote AChE tetramerization in cells producing AChE. In this study we show that muscle cells, or cell lines expressing AChE catalytic subunits, incubated with synthetic proline-rich attachment domain peptides containing the endoplasmic reticulum retrieval sequence KDEL take up and retrogradely transport them to the endoplasmic reticulum network where they induce assembly of AChE tetramers. The peptides act to enhance AChE folding thereby rescuing them from reticulum degradation. This enhanced folding efficiency occurs in the presence of inhibitors of protein synthesis and in turn increases total cell-associated AChE activity and active tetramer secretion. Pulse-chase studies of isotopically labeled AChE molecules show that the enzyme is rescued from intracellular degradation. These studies provide a mechanistic explanation for the large scale intracellular degradation of AChE previously observed and indicate that simple peptides alone can increase the production and secretion of this critical synaptic enzyme in muscle tissue.	[Ruiz, Carlos A.; Rossi, Susana G.; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Rotundo, Richard L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	University of Miami; University of Miami	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol, R-124,1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu			National Institutes of Health CounterACT Program from NINDS [NS057994]; National Institutes of Health CounterACT Program from NIA [AG05917]; U.S. Army Research Office Training Grant [ARO 49497-LS-HIS]; Ruth Kirschstein National Research Service Award for Individual Predoctoral Fellows; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health CounterACT Program from NINDS; National Institutes of Health CounterACT Program from NIA; U.S. Army Research Office Training Grant; Ruth Kirschstein National Research Service Award for Individual Predoctoral Fellows(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health CounterACT Program, Grant NS057994 from NINDS, and Grant AG05917 from NIA (to R. L. R.). A patent has been awarded to R. L. R. covering the synthesis and use of this PRAD peptide, which is being developed for therapeutic applications. R. L. R. has not received any monetary remuneration for this peptide.; Supported by U.S. Army Research Office Training Grant ARO 49497-LS-HIS (to R. L. R.) and a Ruth Kirschstein National Research Service Award for Individual Predoctoral Fellows.	Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Campanari ML, 2014, J MOL NEUROSCI, V53, P446, DOI 10.1007/s12031-013-0183-5; CHATEL JM, 1993, FEBS LETT, V319, P12, DOI 10.1016/0014-5793(93)80027-R; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Chen VP, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00036; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Chitlaru T, 2001, BIOCHEM J, V354, P613, DOI 10.1042/0264-6021:3540613; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Lord JM, 1998, J CELL BIOL, V140, P733; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MIESENBOCK G, 1995, J CELL BIOL, V129, P309, DOI 10.1083/jcb.129.2.309; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; Ruiz CA, 2009, J BIOL CHEM, V284, P21488, DOI 10.1074/jbc.M109.030049; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SIMPSON JC, 1995, J BIOL CHEM, V270, P20078, DOI 10.1074/jbc.270.34.20078; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; WALES R, 1993, J BIOL CHEM, V268, P23986; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	41	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20774	20781		10.1074/jbc.M115.653741	http://dx.doi.org/10.1074/jbc.M115.653741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139603	Green Published, hybrid			2022-12-28	WOS:000360011800015
J	Ruiz-Medina, BE; Ross, JA; Kirken, RA				Ruiz-Medina, Blanca E.; Ross, Jeremy A.; Kirken, Robert A.			Interleukin-2 Receptor beta Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; HUMAN T-CELLS; IL-2 RECEPTOR; SERINE/THREONINE PHOSPHORYLATION; QUANTITATIVE PHOSPHOPROTEOMICS; GAMMA-CHAIN; PROTEIN; PATHWAY; IDENTIFICATION; PROLIFERATION	T, B, and natural killer cells are required for normal immune response and are regulated by cytokines such as IL-2. These cell signals are propagated following receptor-ligand engagement, controlling recruitment and activation of effector proteins. The IL-2 receptor beta subunit (IL-2R beta) serves in this capacity and is known to be phosphorylated. Tyrosine phosphorylation of the beta chain has been studied extensively. However, the identification and putative regulatory roles for serine and threonine phosphorylation sites have yet to be fully characterized. Using LC-MS/MS and phosphospecific antibodies, a novel IL-2/IL-15 inducible IL-2R beta phosphorylation site (Thr-450) was identified. IL-2 phosphokinetic analysis revealed that phosphorylation of IL-2R beta Thr-450 is rapid (2.5 min), transient (peaks at 15 min), and protracted compared with receptor tyrosine phosphorylation and occurs in multiple cell types, including primary human lymphocytes. Pharmacological and siRNA-mediated inhibition of various serine/threonine kinases revealed ERK1/2 as a positive regulator, whereas purified protein phosphatase 1 (PP1), dephosphorylated Thr-450 in vitro. Reconstitution assays demonstrated that Thr-450 is important for regulating IL-2R complex formation, recruitment of JAK3, and activation of AKT and ERK1/2 and a transcriptionally active STAT5. These results provide the first evidence of the identification and functional characterization for threonine phosphorylation of an interleukin receptor.	[Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu		Ruiz-Medina, Blanca E./0000-0003-1947-4014	National Institute on Minority Health and Health Disparities/National Institutes of Health [2G12MD007592]; Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; Woman's Auxiliary Fellowship; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities/National Institutes of Health; Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; Woman's Auxiliary Fellowship; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institute on Minority Health and Health Disparities/National Institutes of Health Grant 2G12MD007592. This work was also supported by grants from the Lizanell and Colbert Coldwell Foundation (to R. A. K.), the Edward N. and Margaret G. Marsh Foundation, and the Woman's Auxiliary Fellowship (to B. E. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amu S, 2007, SCAND J IMMUNOL, V65, P182, DOI 10.1111/j.1365-3083.2006.01889.x; ASAO H, 1990, J EXP MED, V171, P637, DOI 10.1084/jem.171.3.637; Atkinson TP, 2012, CURR OPIN RHEUMATOL, V24, P515, DOI 10.1097/BOR.0b013e32835680c6; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Brockdorff J, 1997, TISSUE ANTIGENS, V49, P228, DOI 10.1111/j.1399-0039.1997.tb02743.x; Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Bunn PA, 1996, J CELL BIOCHEM, P12; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Conlon KC, 2015, J CLIN ONCOL, V33, P74, DOI 10.1200/JCO.2014.57.3329; Delespine-Carmagnat M, 1999, FEBS LETT, V447, P241, DOI 10.1016/S0014-5793(99)00301-4; Depontieu FR, 2009, P NATL ACAD SCI USA, V106, P12073, DOI 10.1073/pnas.0903852106; DUPREZ V, 1992, J BIOL CHEM, V267, P18639; Espino-Paisan L, 2011, AUTOIMMUNITY, V44, P624, DOI 10.3109/08916934.2011.592515; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Fujii H, 1998, EMBO J, V17, P6551, DOI 10.1093/emboj/17.22.6551; Fung MM, 2003, CELL SIGNAL, V15, P625, DOI 10.1016/S0898-6568(03)00003-2; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gilmour KC, 2001, BLOOD, V98, P877, DOI 10.1182/blood.V98.3.877; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; McCubrey JA, 2000, LEUKEMIA, V14, P9, DOI 10.1038/sj.leu.2401657; Mitra A, 2012, J BIOL CHEM, V287, P16596, DOI 10.1074/jbc.M111.319756; MIYOSHI I, 1981, GANN, V72, P978; Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004; Morales JK, 2010, GENES IMMUN, V11, P599, DOI 10.1038/gene.2010.35; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nifoussi SK, 2014, J BIOL CHEM, V289, P21950, DOI 10.1074/jbc.M114.587873; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Olejniczak K, 2008, MED SCI MONITOR, V14, pRA179; Osinalde N, 2015, PROTEOMICS, V15, P520, DOI 10.1002/pmic.201400194; Osinalde N, 2011, J PROTEOMICS, V75, P177, DOI 10.1016/j.jprot.2011.06.007; Pal Z, 2010, J NEUROIMMUNOL, V229, P107, DOI 10.1016/j.jneuroim.2010.07.015; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sliva D, 2000, BIOCHEM J, V345, P741, DOI 10.1042/0264-6021:3450741; STARKEBAUM G, 1991, INT J CANCER, V49, P246, DOI 10.1002/ijc.2910490218; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANAKA N, 1994, P NATL ACAD SCI USA, V91, P7271, DOI 10.1073/pnas.91.15.7271; TRINCHIERI G, 1984, J EXP MED, V160, P1147, DOI 10.1084/jem.160.4.1147; VOSS SD, 1992, J EXP MED, V176, P531, DOI 10.1084/jem.176.2.531; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	68	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20972	20983		10.1074/jbc.M115.660654	http://dx.doi.org/10.1074/jbc.M115.660654			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152718	Green Published, hybrid			2022-12-28	WOS:000360011800031
J	Allen, SJ; Parthasarathy, G; Darke, PL; Diehl, RE; Ford, RE; Hall, DL; Johnson, SA; Reid, JC; Rickert, KW; Shipman, JM; Soisson, SM; Zuck, P; Munshi, SK; Lumb, KJ				Allen, Samantha J.; Parthasarathy, Gopal; Darke, Paul L.; Diehl, Ronald E.; Ford, Rachael E.; Hall, Dawn L.; Johnson, Scott A.; Reid, John C.; Rickert, Keith W.; Shipman, Jennifer M.; Soisson, Stephen M.; Zuck, Paul; Munshi, Sanjeev K.; Lumb, Kevin J.			Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSIN KINASE; GABA(B) RECEPTOR; BINDING-SITE; GRK4; POLYMORPHISMS; ACTIVATION; DOPAMINE; PHOSPHORYLATION; LOCALIZATION; COMPLEX	G-protein-coupled receptor (GPCR) kinases (GRKs) bind to and phosphorylate GPCRs, initiating the process of GPCR desensitization and internalization. GRK4 is implicated in the regulation of blood pressure, and three GRK4 polymorphisms (R65L, A142V, and A486V) are associated with hypertension. Here, we describe the 2.6 angstrom structure of human GRK4 alpha.A486V crystallized in the presence of 5'-adenylyl beta,gamma-imidodiphosphate. The structure of GRK4 alpha is similar to other GRKs, although slight differences exist within the RGS homology (RH) bundle subdomain, substrate-binding site, and kinase C-tail. The RH bundle subdomain and kinase C-terminal lobe form a strikingly acidic surface, whereas the kinase N-terminal lobe and RH terminal subdomain surfaces are much more basic. In this respect, GRK4 alpha is more similar to GRK2 than GRK6. A fully ordered kinase C-tail reveals interactions linking the C-tail with important determinants of kinase activity, including the alpha B helix, alpha D helix, and the P-loop. Autophosphorylation of wild-type GRK4 alpha is required for full kinase activity, as indicated by a lag in phosphorylation of a peptide from the dopamine D-1 receptor without ATP preincubation. In contrast, this lag is not observed in GRK4 alpha A486V. Phosphopeptide mapping by mass spectrometry indicates an increased rate of autophosphorylation of a number of residues in GRK4 alpha A486V relative to wild-type GRK4 alpha, including Ser-485 in the kinase C-tail.	[Allen, Samantha J.; Darke, Paul L.; Diehl, Ronald E.; Ford, Rachael E.; Hall, Dawn L.; Rickert, Keith W.; Shipman, Jennifer M.; Zuck, Paul; Munshi, Sanjeev K.; Lumb, Kevin J.] Merck Res Labs, Screening & Prot Sci, N Wales, PA 19454 USA; [Parthasarathy, Gopal; Johnson, Scott A.; Reid, John C.; Soisson, Stephen M.] Merck Res Labs, Struct Chem, West Point, PA 19486 USA	Merck & Company; Merck & Company	Allen, SJ (corresponding author), Merck Res Labs, NW1-105,502 Louise Ln, N Wales, PA 19454 USA.	samantha_allen@merck.com	Johnson, Scott A/A-6022-2009	Johnson, Scott A/0000-0002-0244-5201; Lumb, Kevin/0000-0003-2778-9956				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Beautrait A, 2014, J BIOL CHEM, V289, P25262, DOI 10.1074/jbc.M114.593178; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Felder RA, 2006, NAT CLIN PRACT NEPHR, V2, P637, DOI 10.1038/ncpneph0301; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; Freeman JLR, 1998, J BIOL CHEM, V273, P20653, DOI 10.1074/jbc.273.32.20653; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; Homan KT, 2013, CURR MED CHEM, V20, P39; Homan KT, 2015, J BIOL CHEM, V290, P20649, DOI 10.1074/jbc.M115.647370; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kanaide M, 2007, J CELL PHYSIOL, V210, P237, DOI 10.1002/jcp.20863; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Keever LB, 2008, BIOCHEM BIOPH RES CO, V367, P649, DOI 10.1016/j.bbrc.2007.12.181; Komolov KE, 2015, J BIOL CHEM, V290, P20629, DOI 10.1074/jbc.M115.647297; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; Li LY, 2015, J BIOL CHEM, V290, P10775, DOI 10.1074/jbc.M115.644773; Liu CB, 2012, INT J MED SCI, V9, P274, DOI 10.7150/ijms.4171; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rayner B, 2015, INT J MOL SCI, V16, P5741, DOI 10.3390/ijms16035741; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sallese M, 1997, J BIOL CHEM, V272, P10188; Sanada H, 2006, CLIN CHEM, V52, P352, DOI 10.1373/clinchem.2005.059139; Sanada H, 1999, HYPERTENSION, V33, P1036, DOI 10.1161/01.HYP.33.4.1036; Sanada H, 2016, PHARMACOGENOMICS J, V16, P3, DOI 10.1038/tpj.2015.6; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Speirs HJL, 2004, J HYPERTENS, V22, P931, DOI 10.1097/00004872-200405000-00014; Sterne-Marr R, 2009, BIOCHEMISTRY-US, V48, P4285, DOI 10.1021/bi900151g; Tesmer JJG, 2012, ACTA CRYSTALLOGR F, V68, P622, DOI 10.1107/S1744309112017435; Tesmer JJG, 2010, J MED CHEM, V53, P1867, DOI 10.1021/jm9017515; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vandell AG, 2012, HYPERTENSION, V60, P957, DOI 10.1161/HYPERTENSIONAHA.112.198721; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Xu H, 2014, MOL BIOL CELL, V25, P2105, DOI 10.1091/mbc.E13-09-0547; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870	50	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20360	20373		10.1074/jbc.M115.648907	http://dx.doi.org/10.1074/jbc.M115.648907			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134571	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000359608900034
J	Reed, BJ; Locke, MN; Gardner, RG				Reed, Benjamin J.; Locke, Melissa N.; Gardner, Richard G.			A Conserved Deubiquitinating Enzyme Uses Intrinsically Disordered Regions to Scaffold Multiple Protein Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY CONTROL DEGRADATION; RNA-POLYMERASE I; SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURE; UBIQUITIN LIGASE; CELL-GROWTH; HISTONE H2B; WEB SERVER; SEQUENCE; ROLES	In the canonical view of protein function, it is generally accepted that the three-dimensional structure of a protein determines its function. However, the past decade has seen a dramatic growth in the identification of proteins with extensive intrinsically disordered regions (IDRs), which are conformationally plastic and do not appear to adopt single three-dimensional structures. One current paradigm for IDR function is that disorder enables IDRs to adopt multiple conformations, expanding the ability of a protein to interact with a wide variety of disparate proteins. The capacity for many interactions is an important feature of proteins that occupy the hubs of protein networks, in particular protein-modifying enzymes that usually have a broad spectrum of substrates. One such protein modification is ubiquitination, where ubiquitin is attached to proteins through ubiquitin ligases (E3s) and removed through deubiquitinating enzymes. Numerous proteomic studies have found that thousands of proteins are dynamically regulated by cycles of ubiquitination and deubiquitination. Thus, how these enzymes target their wide array of substrates is of considerable importance for understanding the function of the cell's diverse ubiquitination networks. Here, we characterize a yeast deubiquitinating enzyme, Ubp10, that possesses IDRs flanking its catalytic protease domain. We show that Ubp10 possesses multiple, distinct binding modules within its IDRs that are necessary and sufficient for directing protein interactions important for Ubp10's known roles in gene silencing and ribosome biogenesis. The human homolog of Ubp10, USP36, also has IDRs flanking its catalytic domain, and these IDRs similarly contain binding modules important for protein interactions. This work highlights the significant protein interaction scaffolding abilities of IDRs in the regulation of dynamic protein ubiquitination.	[Reed, Benjamin J.; Locke, Melissa N.; Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gardner, RG (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 NE Pacific St, Seattle, WA 98195 USA.	gardnerr@uw.edu		Gardner, Richard/0000-0003-2162-6275; Locke, Melissa/0000-0001-8162-1471	National Institutes of Health/NIGMS Training Grant [5T32GM007750]; Sidney Kimmel Scholar Award; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS Training Grant; Sidney Kimmel Scholar Award; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This worked was supported by National Institutes of Health/NIGMS Training Grant 5T32GM007750 (to B. J. R.), a Sidney Kimmel Scholar Award (to R. G. G.), an Ellison Medical Foundation New Scholar Award in Aging (to R. G. G.), and a Marian E. Smith Junior Faculty Award (to R. G. G.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1991, Methods Enzymol, V194, P1; Bhowmick P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065443; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; James P, 1996, GENETICS, V144, P1425; Kahana A, 1999, MOL CELL BIOL, V19, P6608; Kahana A, 2001, BIOCHEM BIOPH RES CO, V282, P916, DOI 10.1006/bbrc.2001.4669; Li Jianduan, 2008, Int J Med Sci, V5, P133; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Singer MS, 1998, GENETICS, V150, P613; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2015, FEBS J, V282, P1182, DOI 10.1111/febs.13202; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	48	18	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20601	20612		10.1074/jbc.M115.650952	http://dx.doi.org/10.1074/jbc.M115.650952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149687	hybrid, Green Published			2022-12-28	WOS:000359608900055
J	Cailliau, K; Lescuyer, A; Burnol, AF; Cuesta-Marban, A; Widmann, C; Browaeys-Poly, E				Cailliau, Katia; Lescuyer, Arlette; Burnol, Anne-Francoise; Cuesta-Marban, Alvaro; Widmann, Christian; Browaeys-Poly, Edith			RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC TYROSINE KINASE; PROTEIN-KINASE; HUMAN BREAST; MESSENGER-RNAS; XENOPUS OOCYTE; SH3 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; FRAGMENT N2; CELL-CYCLE; AURORA-A	Fibroblast growth factor receptors (FGFRs) are involved in proliferative and differentiation physiological responses. Deregulation of FGFR-mediated signaling involving the Ras/PI3K/Akt and the Ras/Raf/ERK MAPK pathways is causally involved in the development of several cancers. The caspase-3/p120 RasGAP module is a stress sensor switch. Under mild stress conditions, RasGAP is cleaved by caspase-3 at position 455. The resulting N-terminal fragment, called fragment N, stimulates anti-death signaling. When caspase-3 activity further increases, fragment N is cleaved at position 157. This generates a fragment, called N2, that no longer protects cells. Here, we investigated in Xenopus oocytes the impact of RasGAP and its fragments on FGF1-mediated signaling during G(2)/M cell cycle transition. RasGAP used its N-terminal Src homology 2 domain to bind FGFR once stimulated by FGF1, and this was necessary for the recruitment of Akt to the FGFR complex. Fragment N, which did not associate with the FGFR complex, favored FGF1-induced ERK stimulation, leading to accelerated G(2)/M transition. In contrast, fragment N2 bound the FGFR, and this inhibited mTORC2-dependent Akt Ser-473 phosphorylation and ERK2 phosphorylation but not phosphorylation of Akt on Thr-308. This also blocked cell cycle progression. Inhibition of Akt Ser-473 phosphorylation and entry into G(2)/M was relieved by PHLPP phosphatase inhibition. Hence, full-length RasGAP favors Akt activity by shielding it from deactivating phosphatases. This shielding was abrogated by fragment N2. These results highlight the role played by RasGAP in FGFR signaling and how graded stress intensities, by generating different RasGAP fragments, can positively or negatively impact this signaling.	[Cailliau, Katia; Lescuyer, Arlette; Browaeys-Poly, Edith] Univ Lille 1, Sci & Technol, Team Signal Div Regulat, CNRS,UMR 8576,SN3, F-59655 Villeneuve Dascq, France; [Burnol, Anne-Francoise] INSERM, Inst Cochin, U1016, Paris, France; [Burnol, Anne-Francoise] CNRS, Inst Cochin, UMR8104, F-75014 Paris, France; [Burnol, Anne-Francoise] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Cuesta-Marban, Alvaro; Widmann, Christian] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne	Cailliau, K (corresponding author), Univ Lille 1, Equipe Regulat Signaux Div, CNRS, UMR 8576,SN3,Sci & Technol, F-59655 Villeneuve Dascq, France.	katia.maggio@univ-lille1.fr	Burnol, Anne-Francoise/P-2181-2017; Widmann, Christian/N-9851-2013	cailliau, katia/0000-0003-1772-1034; Cailliau, Katia/0000-0001-7993-8437; Widmann, Christian/0000-0002-6881-0363; Cuesta Marban, Alvaro/0000-0002-7144-0500	Ligue Nationale Contre le Cancer, Comite du Nord; Swiss National Science Foundation [31003A_141242/1]	Ligue Nationale Contre le Cancer, Comite du Nord(Ligue nationale contre le cancer); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the "Ligue Nationale Contre le Cancer, Comite du Nord" and by Swiss National Science Foundation Grant 31003A_141242/1 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ANANDAPPA SY, 1994, BRIT J CANCER, V69, P772, DOI 10.1038/bjc.1994.146; Annibaldi A, 2014, APOPTOSIS, V19, P719, DOI 10.1007/s10495-013-0958-8; Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024; Annibaldi A, 2009, EXP CELL RES, V315, P2081, DOI 10.1016/j.yexcr.2009.03.015; Barras D, 2014, ONCOGENE, V33, P5163, DOI 10.1038/onc.2013.465; Barras D, 2014, INT J CANCER, V135, P242, DOI 10.1002/ijc.28674; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Browaeys-Poly E, 2000, EUR J BIOCHEM, V267, P6256, DOI 10.1046/j.1432-1327.2000.01710.x; Browaeys-Poly E, 2005, BBA-MOL CELL RES, V1743, P1, DOI 10.1016/j.bbamcr.2004.07.003; Browaeys-Poly E, 2001, CELL SIGNAL, V13, P363, DOI 10.1016/S0898-6568(01)00149-8; Browaeys-Poly E, 2009, ANTICANCER RES, V29, P4965; Bulat N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022609; Cailliau K, 2001, FEBS LETT, V496, P161, DOI 10.1016/S0014-5793(01)02410-3; Cailliau Katia, 2009, V518, P43, DOI 10.1007/978-1-59745-202-1_4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Dillon C, 2004, J MAMMARY GLAND BIOL, V9, P207, DOI 10.1023/B:JOMG.0000037163.56461.1e; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fernig DG, 2000, BIOCHEM BIOPH RES CO, V267, P770, DOI 10.1006/bbrc.1999.2028; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; JACQUEMIER J, 1994, INT J CANCER, V59, P373, DOI 10.1002/ijc.2910590314; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Kumar A, 2013, SCI WORLD J, DOI 10.1155/2013/756134; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; LUQMANI YA, 1992, BRIT J CANCER, V66, P273, DOI 10.1038/bjc.1992.256; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2007, MOL CANCER RES, V5, P497, DOI 10.1158/1541-7786.MCR-06-0257; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Ornitz DM, 2001, GENOME BIOL, V2; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pascreau G, 2008, DEV BIOL, V317, P523, DOI 10.1016/j.ydbio.2008.02.053; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Pittet O, 2007, J PHOTOCH PHOTOBIO B, V88, P29, DOI 10.1016/j.jphotobiol.2007.04.009; Pomerance M, 1996, MOL CELL BIOL, V16, P3179; Renaud F, 1996, BIOCHEM BIOPH RES CO, V219, P679, DOI 10.1006/bbrc.1996.0294; Rong SB, 2001, J MED CHEM, V44, P898, DOI 10.1021/jm000493i; Ryan PJ, 1998, BIOCHEM BIOPH RES CO, V244, P763, DOI 10.1006/bbrc.1998.8326; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Woodcock SA, 2004, BIOCHEM J, V380, P767, DOI 10.1042/BJ20031848; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x; Yoshimura N, 1998, CLIN IMMUNOL IMMUNOP, V89, P28, DOI 10.1006/clin.1998.4551; Yue YZ, 2004, J BIOL CHEM, V279, P12883, DOI 10.1074/jbc.M312308200	69	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19653	19665		10.1074/jbc.M115.644633	http://dx.doi.org/10.1074/jbc.M115.644633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109071	hybrid, Green Published			2022-12-28	WOS:000359364600026
J	Takeishi, Y; Iwaya-Omi, R; Ohashi, E; Tsurimoto, T				Takeishi, Yukimasa; Iwaya-Omi, Rie; Ohashi, Eiji; Tsurimoto, Toshiki			Intramolecular Binding of the Rad9 C Terminus in the Checkpoint Clamp Rad9-Hus1-Rad1 Is Closely Linked with Its DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; HOMOLOGOUS RECOMBINATIONAL REPAIR; ATAXIA-TELANGIECTASIA; DAMAGE CHECKPOINT; IONIZING-RADIATION; EXCISION-REPAIR; HUMAN PCNA; ATR-ATRIP; COMPLEX; TOPBP1	The human checkpoint clamp Rad9-Hus1-Rad1 (9-1-1) is loaded onto chromatin by its loader complex, Rad17-RFC, following DNA damage. The 120-amino acid (aa) stretch of the Rad9 C terminus (C-tail) is unstructured and projects from the core ring structure (CRS). Recent studies showed that 9-1-1 and CRS bind DNA independently of Rad17-RFC. The DNA-binding affinity of mutant 9(Delta C)-1-1, which lacked the Rad9 C-tail, was much higher than that of wild-type 9-1-1, suggesting that 9-1-1 has intrinsic DNA binding activity that manifests in the absence of the C-tail. C-tail added in trans interacted with CRS and prevented it from binding to DNA. We narrowed down the amino acid sequence in the C-tail necessary for CRS binding to a 15-aa stretch harboring two conserved consecutive phenylalanine residues. We prepared 9-1-1 mutants containing the variant C-tail deficient for CRS binding, and we demonstrated that the mutant form restored DNA binding as efficiently as 9(Delta C)-1-1. Furthermore, we mapped the sequence necessary for TopBP1 binding within the same 15-aa stretch, demonstrating that TopBP1 and CRS share the same binding region in the C-tail. Indeed, we observed their competitive binding to the C-tail with purified proteins. The importance of interaction between 9-1-1 and TopBP1 for DNA damage signaling suggests that the competitive interactions of TopBP1 and CRS with the C-tail will be crucial for the activation mechanism.	[Takeishi, Yukimasa; Iwaya-Omi, Rie; Ohashi, Eiji; Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Tsurimoto, T (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ttsurimoto@kyudai.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; Tsurimoto, Toshiki/0000-0001-7597-2216; Takeishi, Yukimasa/0000-0001-9049-3117	KAKENHI [25131714, 22770172]; Uehara Memorial Foundation [103-2012];  [11J04189]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); 	This work was supported by Grant-in-aid for Scientific Research (KAKENHI) 25131714 (to T. T.) and 22770172 (to E. O.), Uehara Memorial Foundation Grant 103-2012 (to E. O.), and Grant-in-aid for Research Fellows of the Japan Society for the Promotion of Science 11J04189 (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Brandt PD, 2006, BIOCHEM BIOPH RES CO, V347, P232, DOI 10.1016/j.bbrc.2006.06.064; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Canfield C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-110; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu QH, 2000, GENE DEV, V14, P1448; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Mayanagia K, 2009, P NATL ACAD SCI USA, V106, P4647, DOI 10.1073/pnas.0811196106; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Park MJ, 2009, DNA REPAIR, V8, P1190, DOI 10.1016/j.dnarep.2009.06.004; PATERSON MC, 1976, NATURE, V260, P444, DOI 10.1038/260444a0; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Ueda S, 2012, GENES CELLS, V17, P807, DOI 10.1111/j.1365-2443.2012.01630.x; Wang X, 2006, ONCOGENE, V25, P1980, DOI 10.1038/sj.onc.1209212; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yang YT, 2012, J BIOCHEM, V151, P317, DOI 10.1093/jb/mvr145; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	57	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19923	19932		10.1074/jbc.M115.669002	http://dx.doi.org/10.1074/jbc.M115.669002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088138	hybrid, Green Published			2022-12-28	WOS:000359364600047
J	Cook, JD; Soto-Montoya, H; Korpela, MK; Lee, JE				Cook, Jonathan D.; Soto-Montoya, Hazel; Korpela, Markus K.; Lee, Jeffrey E.			Electrostatic Architecture of the Infectious Salmon Anemia Virus (ISAV) Core Fusion Protein Illustrates a Carboxyl-Carboxylate pH Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; INFLUENZA HEMAGGLUTININ; MEMBRANE-FUSION; STRUCTURAL-CHARACTERIZATION; STRUCTURE REFINEMENT; GLYCOPROTEIN GP2; VIRAL FUSION; COILED-COIL; MECHANISM; ENTRY	Segment 5, ORF 1 of the infectious salmon anemia virus (ISAV) genome, encodes for the ISAV F protein, which is responsible for viral-host endosomal membrane fusion during a productive ISAV infection. The entry machinery of ISAV is composed of a complex of the ISAV F and ISAV hemagglutinin esterase (HE) proteins in an unknown stoichiometry prior to receptor engagement by ISAV HE. Following binding of the receptor to ISAV HE, dissociation of the ISAV F protein from HE, and subsequent endocytosis, the ISAV F protein resolves into a fusion-competent oligomeric state. Here, we present a 2.1 angstrom crystal structure of the fusion core of the ISAV F protein determined at low pH. This structure has allowed us to unambiguously demonstrate that the ISAV entry machinery exhibits typical class I viral fusion protein architecture. Furthermore, we have determined stabilizing factors that accommodate the pH-dependent mode of ISAV transmission, and our structure has allowed the identification of a central coil that is conserved across numerous and varied post-fusion viral glycoprotein structures. We then discuss a mechanistic model of ISAV fusion that parallels the paramyxoviral class I fusion strategy wherein attachment and fusion are relegated to separate proteins in a similar fashion to ISAV fusion.	[Cook, Jonathan D.; Soto-Montoya, Hazel; Korpela, Markus K.; Lee, Jeffrey E.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Lee, JE (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.	jeff.lee@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council of Canada; Canadian Institutes of Health Research (CIHR); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work is based upon data collected by Canadian Light Source (CLS) staff under the instruction of J. D. C. at beamline 08ID-1 at the CLS. The CLS is supported by Natural Sciences and Engineering Research Council of Canada (NSERC), National Research Council of Canada, Canadian Institutes of Health Research (CIHR), the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. In addition, we thank Dr. Azmiri Sultana for extensive discussion and tutelage with regards to the XDS software program and Aiping Dong, Dr. Cheryl Arrowsmith, and Dr. Aled Edwards for access to the Structural Genomics Consortium x-ray diffraction facility. Finally, the authors would like to acknowledge the comments and suggestions made by the reviewers to improve this manuscript.	Aamelfot M, 2015, J FISH DIS, V38, P687, DOI 10.1111/jfd.12284; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; Aydin H, 2014, J VIROL, V88, P143, DOI 10.1128/JVI.02023-13; Aydin H, 2013, FASEB J, V27, P5059, DOI 10.1096/fj.13-232371; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; BULLOUGH PA, 1994, J MOL BIOL, V236, P1262, DOI 10.1016/0022-2836(94)90027-2; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Clouthier SC, 2002, J GEN VIROL, V83, P421, DOI 10.1099/0022-1317-83-2-421; Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 2014, FISH VACCINATION, P313; Fourrier M, 2014, J GEN VIROL, V95, P1015, DOI 10.1099/vir.0.061648-0; Harrison JS, 2013, STRUCTURE, V21, P1085, DOI 10.1016/j.str.2013.05.009; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Igonet S, 2012, CELL, V151, P1634, DOI 10.1016/j.cell.2012.11.041; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalani MR, 2013, BIOPHYS J, V105, P993, DOI 10.1016/j.bpj.2013.06.047; Koellhoffer JF, 2014, J MOL BIOL, V426, P1452, DOI 10.1016/j.jmb.2013.12.009; Langkilde A, 2008, ACTA CRYSTALLOGR D, V64, P851, DOI 10.1107/S0907444908017083; Lu B, 1996, VIROLOGY, V225, P11, DOI 10.1006/viro.1996.0570; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ni FY, 2014, BIOCHEMISTRY-US, V53, P846, DOI 10.1021/bi401525h; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stampfer SD, 2010, J VIROL, V84, P12924, DOI 10.1128/JVI.01750-10; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wohlfahrt G, 2005, PROTEINS, V58, P396, DOI 10.1002/prot.20328; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877	48	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18495	18504		10.1074/jbc.M115.644781	http://dx.doi.org/10.1074/jbc.M115.644781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26082488	Green Published, hybrid			2022-12-28	WOS:000358512100022
J	Zhou, XX; Cooper, KL; Sun, X; Liu, KJ; Hudson, LG				Zhou, Xixi; Cooper, Karen L.; Sun, Xi; Liu, Ke J.; Hudson, Laurie G.			Selective Sensitization of Zinc Finger Protein Oxidation by Reactive Oxygen Species through Arsenic Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARP-1 ACTIVITY; ULTRAVIOLET-RADIATION; REDOX REGULATION; STRAND BREAKS; DNA-REPAIR; STRESS; POLY(ADP-RIBOSYL)ATION; INHIBITION; CHEMISTRY; INTERACTS	Cysteine oxidation induced by reactive oxygen species (ROS) on redox-sensitive targets such as zinc finger proteins plays a critical role in redox signaling and subsequent biological outcomes. We found that arsenic exposure led to oxidation of certain zinc finger proteins based on arsenic interaction with zinc finger motifs. Analysis of zinc finger proteins isolated from arsenic-exposed cells and zinc finger peptides by mass spectrometry demonstrated preferential oxidation of C3H1 and C4 zinc finger configurations. C2H2 zinc finger proteins that do not bind arsenic were not oxidized by arsenic-generated ROS in the cellular environment. The findings suggest that selectivity in arsenic binding to zinc fingers with three or more cysteines defines the target proteins for oxidation by ROS. This represents a novel mechanism of selective protein oxidation and demonstrates how an environmental factor may sensitize certain target proteins for oxidation, thus altering the oxidation profile and redox regulation.	[Zhou, Xixi; Cooper, Karen L.; Sun, Xi; Liu, Ke J.; Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Liu, KJ (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	kliu@salud.unm.edu; lhudson@salud.unm.edu	Zhou, Xixi/F-1760-2011; Regan, Clinton/E-6250-2012	Zhou, Xixi/0000-0003-4202-8821; 	National Institutes of Health [R01ES15826, R01ES021100, R01CA182969, P30CA118100]; University of New Mexico Environmental Health Signature Program; NATIONAL CANCER INSTITUTE [P30CA118100, R01CA182969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021100, R01ES015826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Environmental Health Signature Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01ES15826, R01ES021100, and R01CA182969. This work was also supported by National Institutes of Health Grant P30CA118100 (to the University of New Mexico Cancer Center) through a postdoctoral matching grant and a pilot award and by a pilot project from the University of New Mexico Environmental Health Signature Program. The authors declare that they have no conflicts of interest with the contents of this article.	Bossak K, 2015, CHEM RES TOXICOL, V28, P191, DOI 10.1021/tx500320f; Chen K, 2012, CURR ATHEROSCLER REP, V14, P476, DOI 10.1007/s11883-012-0266-8; Cooper KL, 2014, TOXICOL LETT, V224, P407, DOI 10.1016/j.toxlet.2013.11.010; Cooper KL, 2007, TOXICOL APPL PHARM, V218, P119, DOI 10.1016/j.taap.2006.09.020; Cooper KL, 2013, TOXICOL APPL PHARM, V269, P81, DOI 10.1016/j.taap.2013.03.008; Cooper KL, 2009, FREE RADICAL BIO MED, V47, P381, DOI 10.1016/j.freeradbiomed.2009.04.034; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Hartwig A, 2003, INT J CANCER, V104, P1, DOI 10.1002/ijc.10911; Hartwig A, 2013, FREE RADICAL BIO MED, V55, P63, DOI 10.1016/j.freeradbiomed.2012.11.009; Huang B, 2010, FREE RADICAL BIO MED, V49, P447, DOI 10.1016/j.freeradbiomed.2010.05.001; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Kopera E, 2004, CHEM RES TOXICOL, V17, P1452, DOI 10.1021/tx049842s; Kroncke KD, 2009, ANTIOXID REDOX SIGN, V11, P1015, DOI [10.1089/ars.2008.2269, 10.1089/ARS.2008.2269]; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Maret W, 2013, METAL IONS LIFE SCI, V12, P479, DOI 10.1007/978-94-007-5561-1_14; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Payne JC, 2003, BIOCHEMISTRY-US, V42, P14214, DOI 10.1021/bi035002l; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; RAGO R, 1990, ANAL BIOCHEM, V191, P31; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Sun X, 2014, TOXICOL APPL PHARM, V274, P313, DOI 10.1016/j.taap.2013.11.010; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Wang F, 2013, FREE RADICAL BIO MED, V61, P249, DOI 10.1016/j.freeradbiomed.2013.04.019; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313; Yager JW, 1997, MUTAT RES-REV MUTAT, V386, P345, DOI 10.1016/S1383-5742(97)00011-2; You JS, 2000, BIOCHEMISTRY-US, V39, P12953, DOI 10.1021/bi001206f; Zhou XX, 2014, CHEM RES TOXICOL, V27, P690, DOI 10.1021/tx500022j; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926	43	38	38	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18361	18369		10.1074/jbc.M115.663906	http://dx.doi.org/10.1074/jbc.M115.663906			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063799	Green Published, hybrid			2022-12-28	WOS:000358512100009
J	Thakur, RS; Basavaraju, S; Khanduja, JS; Muniyappa, K; Nagaraju, G				Thakur, Roshan Singh; Basavaraju, Shivakumar; Khanduja, Jasbeer Singh; Muniyappa, K.; Nagaraju, Ganesh			Mycobacterium tuberculosis RecG Protein but Not RuvAB or RecA Protein Is Efficient at Remodeling the Stalled Replication Forks IMPLICATIONS FOR MULTIPLE MECHANISMS OF REPLICATION RESTART IN MYCOBACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; DNA-BINDING PROTEIN; HOMOLOGOUS RECOMBINATION; HOLLIDAY-JUNCTIONS; BRANCH MIGRATION; GENOME STABILITY; ATPASE ACTIVITY; LAGGING-STRAND; FANCONI-ANEMIA; SMEGMATIS RECA	Aberrant DNA replication, defects in the protection, and restart of stalled replication forks are major causes of genome instability in all organisms. Replication fork reversal is emerging as an evolutionarily conserved physiological response for restart of stalled forks. Escherichia coli RecG, RuvAB, and RecA proteins have been shown to reverse the model replication fork structures in vitro. However, the pathways and the mechanisms by which Mycobacterium tuberculosis, a slow growing human pathogen, responds to different types of replication stress and DNA damage are unclear. Here, we show that M. tuberculosis RecG rescues E. coli Delta recG cells from replicative stress. The purified M. tuberculosis RecG (MtRecG) and RuvAB(MtRuvAB) proteins catalyze fork reversal of model replication fork structures with and without a leading strand single-stranded DNA gap. Interestingly, single-stranded DNA-binding protein suppresses the MtRecG- and MtRuvAB-mediated fork reversal with substrates that contain lagging strand gap. Notably, our comparative studies with fork structures containing template damage and template switching mechanism of lesion bypass reveal that MtRecG but not MtRuvAB or MtRecA is proficient in driving the fork reversal. Finally, unlike MtRuvAB, we find that MtRecG drives efficient reversal of forks when fork structures are tightly bound by protein. These results provide direct evidence and valuable insights into the underlying mechanism of MtRecG-catalyzed replication fork remodeling and restart pathways in vivo.	[Thakur, Roshan Singh; Basavaraju, Shivakumar; Khanduja, Jasbeer Singh; Muniyappa, K.; Nagaraju, Ganesh] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nagaraju, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nganesh@biochem.iisc.ernet.in		Thakur, Roshan/0000-0001-5284-4975	Department of Atomic Energy [2010/37B/40/BRNS/1437, 37(1)/14/52/2014-BRNS/1620]; DBT-IISc Partnership Program [DBT/BF/PR/INS/IISc/2011-12]; Center of Excellence and Innovation program of the Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research fellowship	Department of Atomic Energy(Department of Atomic Energy (DAE)); DBT-IISc Partnership Program; Center of Excellence and Innovation program of the Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by in part Department of Atomic Energy Grants 2010/37B/40/BRNS/1437 and 37(1)/14/52/2014-BRNS/1620 and DBT-IISc Partnership Program Grant DBT/BF/PR/INS/IISc/2011-12 and by the Center of Excellence and Innovation program of the Department of Biotechnology, New Delhi (to the K. M. laboratory). The authors declare that they have no conflicts of interest with the contents of this article.r Supported through a Council of Scientific and Industrial Research fellowship.	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Bianco PR, 2015, PROG BIOPHYS MOL BIO, V117, P166, DOI 10.1016/j.pbiomolbio.2015.01.001; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Ganesh N, 2003, PROTEINS, V53, P6, DOI 10.1002/prot.10433; Ganesh N, 2003, BIOCHEMISTRY-US, V42, P7216, DOI 10.1021/bi0340548; Gorna AE, 2010, CLIN SCI, V119, P187, DOI 10.1042/CS20100041; Gupta S, 2014, J BIOL CHEM, V289, P28376, DOI 10.1074/jbc.M114.587881; Gupta S, 2014, J BIOL CHEM, V289, P28388, DOI 10.1074/jbc.M114.587907; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Khanduja JS, 2009, BIOCHEMISTRY-US, V48, P27, DOI 10.1021/bi8016526; Khanduja JS, 2012, J BIOL CHEM, V287, P1345, DOI 10.1074/jbc.M111.304741; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Kumar RA, 1996, BIOCHEMISTRY-US, V35, P1793, DOI 10.1021/bi9517751; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Kurthkoti K, 2011, TUBERCULOSIS, V91, P533, DOI 10.1016/j.tube.2011.06.005; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Le Masson M, 2008, MOL MICROBIOL, V70, P537, DOI 10.1111/j.1365-2958.2008.06431.x; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; LLOYD RG, 1991, J BACTERIOL, V173, P6837, DOI 10.1128/jb.173.21.6837-6843.1991; LLOYD RG, 1991, J BACTERIOL, V173, P1004, DOI 10.1128/jb.173.3.1004-1011.1991; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; Manosas M, 2012, SCIENCE, V338, P1217, DOI 10.1126/science.1225437; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2004, CURR OPIN GENET DEV, V14, P107, DOI 10.1016/j.gde.2004.01.001; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Muniyappa K, 2000, MICROBIOL-UK, V146, P2093, DOI 10.1099/00221287-146-9-2093; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Saravanan M, 2004, NUCLEIC ACIDS RES, V32, P6129, DOI 10.1093/nar/gkh951; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; SHURVINTON CE, 1982, MOL GEN GENET, V185, P352, DOI 10.1007/BF00330811; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Slocum SL, 2007, J MOL BIOL, V367, P647, DOI 10.1016/j.jmb.2007.01.007; Sommers JA, 2014, J BIOL CHEM, V289, P19928, DOI 10.1074/jbc.M113.542456; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Sun ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09625; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Syeda AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016550; Thakur RS, 2013, FEBS J, V280, P1841, DOI 10.1111/febs.12208; Thakur RS, 2014, J BIOL CHEM, V289, P25112, DOI 10.1074/jbc.M114.563569; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	90	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24119	24139		10.1074/jbc.M115.671164	http://dx.doi.org/10.1074/jbc.M115.671164			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276393	hybrid, Green Published			2022-12-28	WOS:000362218900007
J	Cao, D; Su, ZQ; Wang, WW; Wu, HH; Liu, X; Akram, S; Qin, B; Zhou, JJ; Zhuang, XX; Adams, G; Jin, CJ; Wang, XW; Liu, LF; Hill, DL; Wang, DM; Ding, X; Yao, XB				Cao, Dan; Su, Zeqi; Wang, Wenwen; Wu, Huihui; Liu, Xing; Akram, Saima; Qin, Bo; Zhou, Jiajia; Zhuang, Xiaoxuan; Adams, Gregory; Jin, Changjiang; Wang, Xiwei; Liu, Lifang; Hill, Donald L.; Wang, Dongmei; Ding, Xia; Yao, Xuebiao			Signaling Scaffold Protein IQGAP1 Interacts with Microtubule Plus-end Tracking Protein SKAP and Links Dynamic Microtubule Plus-end to Steer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHECKPOINT; BINDING-PROTEINS; CHROMOSOME STABILITY; SPINDLE MICROTUBULES; ACTIN-FILAMENTS; EB1; KINETOCHORES; MITOSIS; CLASP2; PLASTICITY	Cell migration is orchestrated by dynamic interaction of microtubules with the plasma membrane cortex. However, the regulatory mechanisms underlying the cortical actin cytoskeleton and microtubule dynamics are less characterized. Our earlier study showed that small GTPase-activating proteins, IQGAPs, regulate polarized secretion in epithelial cells (1). Here, we show that IQGAP1 links dynamic microtubules to steer cell migration via interacting with the plus-end tracking protein, SKAP. Biochemical characterizations revealed that IQGAP1 and SKAP form a cognate complex and that their binding interfaces map to the WWIQ motif and the C-terminal of SKAP, respectively. The WWIQ peptide disrupts the biochemical interaction between IQGAP1 and SKAP in vitro, and perturbation of the IQGAP1-SKAP interaction in vivo using a membrane-permeable TAT-WWIQ peptide results in inhibition of directional cell migration elicited by EGF. Mechanistically, the N-terminal of SKAP binds to EB1, and its C terminus binds to IQGAP1 in migrating cells. Thus, we reason that a novel IQGAP1 complex orchestrates directional cell migration via coupling dynamic microtubule plus-ends to the cell cortex.	[Cao, Dan; Su, Zeqi; Wang, Wenwen; Wu, Huihui; Liu, Xing; Akram, Saima; Qin, Bo; Zhou, Jiajia; Zhuang, Xiaoxuan; Adams, Gregory; Jin, Changjiang; Wang, Xiwei; Wang, Dongmei; Ding, Xia; Yao, Xuebiao] Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam & Chem Bio, Hefei 230027, Peoples R China; [Cao, Dan; Su, Zeqi; Wang, Wenwen; Liu, Xing; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Cao, Dan; Wang, Wenwen; Wu, Huihui; Liu, Xing; Qin, Bo; Adams, Gregory; Wang, Xiwei] Morehouse Sch Med, Atlanta, GA 30310 USA; [Wu, Huihui; Qin, Bo; Zhou, Jiajia; Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China; [Hill, Donald L.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine; Morehouse School of Medicine; University of Alabama System; University of Alabama Birmingham	Liu, X (corresponding author), Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam & Chem Bio, Hefei 230027, Peoples R China.	xing1017@ustc.edu.cn; wangdm@ustc.edu.cn; ding-bucm@hotmail.com	WANG, WENWEN/AAF-1080-2020; Regan, Clinton/E-6250-2012; Liu, Xing/H-2989-2018; liu, li/HGC-0900-2022; Zhuang, Xiaoxuan/R-7836-2019; Yao, Xuebiao/P-5771-2014	WANG, WENWEN/0000-0002-1545-4369; Liu, Xing/0000-0002-7480-5085; Zhuang, Xiaoxuan/0000-0003-4004-5329; 	National Institutes of Health [DK56292, CA164133, G12RR03034]; Chinese 973 Project [2012CB917204, 2013CB911203, 2014CB964803]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project [08040102005]; Chinese Natural Science Foundation [31320103904, 91313303, 31430054, 90913016, 31171300, 31100992, 31471275, 31301121, 20113402130010]; Fundamental Research Funds for Central Universities [WK2060190018, WK2340000021]; MOE Innovative Team [IRT13038];  [MOST2009DFA31010]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); MOE Innovative Team; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, and G12RR03034, Chinese 973 Project Grants 2012CB917204, 2013CB911203, and 2014CB964803, Chinese Academy of Science Grant KSCX2-YW-H-10, Anhui Province Key Project Grant 08040102005, International Collaboration Grant MOST2009DFA31010, Chinese Natural Science Foundation Grants 31320103904, 91313303, 31430054, 90913016, 31171300, and 31100992, 31471275, 31301121, MOE20113402130010, Fundamental Research Funds for Central Universities Grants WK2060190018 and WK2340000021, and MOE Innovative Team IRT13038. The authors declare no competing financial interests.	Adachi M, 2014, GENES CELLS, V19, P803, DOI 10.1111/gtc.12179; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gireesh KK, 2014, BIOCHEMISTRY-US, V53, P5551, DOI 10.1021/bi5007942; Hertzer KM, 2006, MOL BIOL CELL, V17, P700, DOI 10.1091/mbc.E05-08-0821; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Ward T, 2013, J BIOL CHEM, V288, P15771, DOI 10.1074/jbc.M112.448886; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zhao LL, 2010, J BIOL CHEM, V285, P2488, DOI 10.1074/jbc.M109.042614; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	45	19	20	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23766	23780		10.1074/jbc.M115.673517	http://dx.doi.org/10.1074/jbc.M115.673517			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242911	Green Published, hybrid			2022-12-28	WOS:000361816500024
J	Li, DY; Zhang, P; Li, F; Chi, LQ; Zhu, DY; Zhang, QY; Chi, LL				Li, Daoyuan; Zhang, Ping; Li, Fei; Chi, Lequan; Zhu, Deyu; Zhang, Qunye; Chi, Lianli			Recognition of N-Glycoforms in Human Chorionic Gonadotropin by Monoclonal Antibodies and Their Interaction Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERGLYCOSYLATED HCG; BIOLOGICAL FUNCTIONS; GLYCOSYLATION; BETA; PREGNANCY; DIAGNOSIS; PROTEINS; EPITOPES; CORE	The glycosylation of human chorionic gonadotropin (hCG) plays an important role in reproductive tumors. Detecting hCG N-glycosylation alteration may significantly improve the diagnostic accuracy and sensitivity of related cancers. However, developing an immunoassay directly against the N-linked oligosaccharides is unlikely because of the heterogeneity and low immunogenicity of carbohydrates. Here, we report a hydrogen/deuterium exchange and MS approach to investigate the effect of N-glycosylation on the binding of antibodies against different hCG glycoforms. Hyperglycosylated hCG was purified from the urine of invasive mole patients, and the structure of its N-linked oligosaccharides was confirmed to be more branched by MS. The binding kinetics of the anti-hCG antibodies MCA329 and MCA1024 against hCG and hyperglycosylated hCG were compared using biolayer interferometry. The binding affinity of MCA1024 changed significantly in response to the alteration of hCG N-linked oligosaccharides. Hydrogen/deuterium exchange-MS reveals that the peptide beta 65-83 of the hCG beta subunit is the epitope for MCA1024. Site-specific N-glycosylation analysis suggests that N-linked oligosaccharides at Asn-13 and Asn-30 on the beta subunit affect the binding affinity of MCA1024. These results prove that some antibodies are sensitive to the structural change of N-linked oligosaccharides, whereas others are not affected by N-glycosylation. It is promising to improve glycoprotein biomarker-based cancer diagnostics by developing combined immunoassays that can determine the level of protein and measure the degree of N-glycosylation simultaneously.	[Li, Daoyuan; Li, Fei; Chi, Lianli] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Li, Daoyuan; Zhu, Deyu; Chi, Lianli] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Ping] Shandong Univ, Hosp 2, Dept Obstet & Gynecol, Jinan 250033, Peoples R China; [Chi, Lequan] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Zhang, Qunye] Shandong Univ, Cent Res Lab, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res,Hosp 2, Jinan 250100, Peoples R China; [Zhang, Qunye] Shandong Univ, Qilu Hosp, Minist Publ Hlth, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Shandong University; Shandong University	Zhang, QY (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Peoples R China.	wz.zhangqy@sdu.edu.cn; lianlichi@sdu.edu.cn	Chi, Lianli/B-9149-2015	Chi, Lianli/0000-0003-1126-1022	National Basic Research Program of China [2012CB822102]; National High Technology Research and Development Program of China [2012AA021504]; National Natural Science Foundation of China [21472115, 31000367, 91439111]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China Grant 2012CB822102, the National High Technology Research and Development Program of China Grant 2012AA021504, and the National Natural Science Foundation of China Grants 21472115, 31000367, and 91439111. The authors declare that they have no conflicts of interest with the contents of this article.	AJDUKIEWICZ AB, 1993, CANCER LETT, V74, P43, DOI 10.1016/0304-3835(93)90042-8; Bai X, 2015, ANAL BIOANAL CHEM, V407, P1857, DOI 10.1007/s00216-014-8439-7; Barh D, 2014, CANCER BIOMARKERS: MINIMAL AND NONINVASIVE EARLY DIAGNOSIS AND PROGNOSIS, P1, DOI 10.1201/b16389; BERGER P, 1993, J CLIN ENDOCR METAB, V77, P347, DOI 10.1210/jc.77.2.347; Berger P, 2002, TUMOR BIOL, V23, P1, DOI 10.1159/000048686; Birken S, 1999, ENDOCRINE, V10, P137, DOI 10.1385/ENDO:10:2:137; Birken S, 2005, TUMOR BIOL, V26, P131, DOI 10.1159/000086484; Birken S, 2003, MOL CELL ENDOCRINOL, V204, P21, DOI 10.1016/S0303-7207(03)00153-9; Cole LA, 2007, MOL CELL ENDOCRINOL, V260, P228, DOI 10.1016/j.mce.2006.03.047; Cole LA, 2012, MOL CELL ENDOCRINOL, V349, P232, DOI 10.1016/j.mce.2011.10.029; Cole LA, 2012, CLIN CHIM ACTA, V413, P48, DOI 10.1016/j.cca.2011.09.037; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; de Medeiros SF, 2009, HUM REPROD UPDATE, V15, P69, DOI 10.1093/humupd/dmn036; Durand G, 2000, CLIN CHEM, V46, P795; Elliott MM, 1997, ENDOCRINE, V7, P15, DOI 10.1007/BF02778058; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Ford PJ, 2013, J Cancer Policy, V1, pE2, DOI 10.1016/j.jcpo.2013.04.002; Gam LH, 2005, INT J BIOL SCI, V1, P103; Gilgunn S, 2013, NAT REV UROL, V10, P99, DOI 10.1038/nrurol.2012.258; Heuvers ME, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-77; Jackson AM, 1996, J REPROD IMMUNOL, V31, P21, DOI 10.1016/0165-0378(96)00978-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; LUSTBADER JW, 1989, BIOCHEMISTRY-US, V28, P9239, DOI 10.1021/bi00450a001; Pan S., 2011, MOL CELL PROTEOMICS, V10; Stenman UH, 2004, CLIN BIOCHEM, V37, P549, DOI 10.1016/j.clinbiochem.2004.05.008; Toll H, 2006, ELECTROPHORESIS, V27, P2734, DOI 10.1002/elps.200600022; Tuccillo FM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/742831; Valmu L, 2006, GLYCOBIOLOGY, V16, P1207, DOI 10.1093/glycob/cwl034; Vashist SK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04407; Weinans MJN, 2000, PRENATAL DIAG, V20, P976, DOI 10.1002/1097-0223(200012)20:12<976::AID-PD962>3.0.CO;2-2; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922	34	7	7	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22715	22723		10.1074/jbc.M115.657072	http://dx.doi.org/10.1074/jbc.M115.657072			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26240146	Green Published, hybrid			2022-12-28	WOS:000361171500035
J	Zhu, GY; Fei, T; Li, ZW; Yan, XH; Chen, YG				Zhu, Gaoyang; Fei, Teng; Li, Zhongwei; Yan, Xiaohua; Chen, Ye-Guang			Activin Regulates Self-renewal and Differentiation of Trophoblast Stem Cells by Down-regulating the X Chromosome Gene Bcor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; TRANSCRIPTION FACTORS; POLYCOMB GROUP; MOUSE EMBRYO; EXPRESSION; FAMILY; SMADS; PROLIFERATION; COMPLICATIONS	The development of a functional placenta is largely dependent upon proper proliferation and differentiation of trophoblast stem cells (TSCs). Activin signaling has long been regarded to play important roles during this process, but the exact mechanism is largely unknown. Here, we demonstrate that the X chromosome gene BCL-6 corepressor (Bcor) is a critical downstream effector of activin to fine-tune mouse TSC fate decision. Bcor was specifically down-regulated by activinAin TSCs in a dose-dependent manner, and immediately up-regulated upon TSC differentiation. Knockdown of Bcor partially compensated for the absence of activin A in maintaining the self-renewal of TSCs together with FGF4, while promoting syncytiotrophoblast differentiation in the absence of FGF4. Moreover, the impaired trophoblast giant cell and spongiotrophoblast differentiation upon Bcor knockdown also resembled the function of activin. Reporter analysis showed that BCOR inhibited the expression of the key trophoblast regulator genes Eomes and Cebpa by binding to their promoter regions. Our findings provide us with a better understanding of placental development and placenta-related diseases.	[Zhu, Gaoyang; Fei, Teng; Li, Zhongwei; Yan, Xiaohua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771	973 Program [2011CB943803, 2013CB933700]; National Natural Science Foundation of China [31221064, 31330049]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the 973 Program (2011CB943803 and 2013CB933700) and the National Natural Science Foundation of China (31221064 and 31330049) (to Y. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Bergsmedh A, 2011, GENES-BASEL, V2, P420, DOI 10.3390/genes2030420; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bouillot S, 2006, PLACENTA, V27, P882, DOI 10.1016/j.placenta.2005.09.009; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Datto M, 2000, CYTOKINE GROWTH F R, V11, P37, DOI 10.1016/S1359-6101(99)00027-1; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Guzman-Ayala M, 2004, P NATL ACAD SCI USA, V101, P15656, DOI 10.1073/pnas.0405429101; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horn D, 2005, EUR J HUM GENET, V13, P563, DOI 10.1038/sj.ejhg.5201391; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Huynh KD, 2000, GENE DEV, V14, P1810; Jackman SM, 2012, MOL REPROD DEV, V79, P564, DOI 10.1002/mrd.22062; Jauniaux E, 2010, CURR OPIN OBSTET GYN, V22, P452, DOI 10.1097/GCO.0b013e3283404e44; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kondo Y, 2012, J HUM GENET, V57, P197, DOI 10.1038/jhg.2012.4; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Natale D. R., 2009, ACTIVIN PROMOTES DIF; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Norwitz ER, 2006, REPROD BIOMED ONLINE, V13, P591, DOI 10.1016/S1472-6483(10)60649-9; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Zhang JP, 2013, J BIOL CHEM, V288, P8053, DOI 10.1074/jbc.M112.433995	47	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22019	22029		10.1074/jbc.M115.674127	http://dx.doi.org/10.1074/jbc.M115.674127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26221038	hybrid, Green Published			2022-12-28	WOS:000360968500022
J	Dupre, E; Lesne, E; Guerin, J; Lensink, MF; Verger, A; de Ruyck, J; Brysbaert, G; Vezin, H; Locht, C; Antoine, R; Jacob-Dubuisson, F				Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Lensink, Marc F.; Verger, Alexis; de Ruyck, Jerome; Brysbaert, Guillaume; Vezin, Herve; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise			Signal Transduction by BvgS Sensor Kinase BINDING OF MODULATOR NICOTINATE AFFECTS THE CONFORMATION AND DYNAMICS OF THE ENTIRE PERIPLASMIC MOIETY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDETELLA-PERTUSSIS; MICROSCALE THERMOPHORESIS; GLUTAMATE-RECEPTOR; HISTIDINE KINASE; PAS DOMAIN; PROTEIN; VIRULENCE; MECHANISM; SYSTEM; TRANSPORT	The two-component sensory transduction system BvgAS controls the virulence regulon of the whooping-cough agent Bordetella pertussis. The periplasmic moiety of the homodimeric sensor kinase BvgS is composed of four bilobed Venus flytrap (VFT) perception domains followed by alpha helices that extend into the cytoplasmic membrane. In the virulent phase, the default state of B. pertussis, the cytoplasmic enzymatic moiety of BvgS acts as kinase by autophosphorylating and transferring the phosphoryl group to the response regulator BvgA. Under laboratory conditions, BvgS shifts to phosphatase activity in response to modulators, notably nicotinate ions. Here we characterized the effects of nicotinate and related modulators on the BvgS periplasmic moiety by using site-directed mutagenesis and in silico and biophysical approaches. Modulators bind with low affinity to BvgS in the VFT2 cavity. Electron paramagnetic resonance shows that their binding globally affects the conformation and dynamics of the periplasmic moiety. Specific amino acid substitutions designed to slacken interactions within and between the VFT lobes prevent BvgS from responding to nicotinate, showing that BvgS shifts from kinase to phosphatase activity in response to this modulator via a tense transition state that involves a large periplasmic structural block. We propose that this transition enables the transmembrane helices to adopt a distinct conformation that sets the cytoplasmic enzymatic moiety in the phosphatase mode. The bona fide, in vivo VFT ligands that remain to be identified are likely to trigger similar effects on the transmembrane and cytoplasmic moieties. This mechanism may be relevant to the other VFT-containing sensor kinases homologous to BvgS.	[Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Lensink, Marc F.; Verger, Alexis; de Ruyck, Jerome; Brysbaert, Guillaume; Vezin, Herve; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Univ Lille Nord France, F-59000 Lille, France; [Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] CNRS, UMR 8204, F-59046 Lille, France; [Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] INSERM, U1019, F-59045 Lille, France; [Lensink, Marc F.; Verger, Alexis; de Ruyck, Jerome; Brysbaert, Guillaume] CNRS, Unite Glycobiol Struct & Fonct, UMR 8576, F-59658 Villeneuve Dascq, France; [Vezin, Herve] CNRS, Lab Spectrochim Infrarouge & Raman LASIR, UMR 8516, F-59658 Villeneuve Dascq, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lille - ISITE; Universite de Lille	Antoine, R (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, 1 Rue Calmette, F-59019 Lille, France.	rudy.antoine@pasteur-lille.fr; francoise.jacob@ibl.cnrs.fr	Lensink, Marc F/A-1678-2008; Vezin, Hervé/I-8004-2015; Jacob-Dubuisson, Françoise/F-1610-2018; Antoine, Rudy/L-1630-2018; Locht, Camille/L-3516-2018; Antoine, Rudy/CAH-6653-2022	Lensink, Marc F/0000-0003-3957-9470; Vezin, Hervé/0000-0002-7282-2703; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; Antoine, Rudy/0000-0002-7369-0626; Antoine, Rudy/0000-0002-7369-0626; Brysbaert, Guillaume/0000-0002-6807-6621; Locht, Camille/0000-0001-7295-7336; Dupre, Elian/0000-0001-5281-0337; verger, alexis/0000-0002-0299-2344; de Ruyck, Jerome/0000-0003-4397-1870	Agence Nationale de la Recherche [ANR-13-BSV8-0002-01]; Fonds de la Recherche Scientifique (F. R. S.)-FNRS [2.4520.11]; French Research Ministry; Fonds de la Recherche Medicale	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fonds de la Recherche Scientifique (F. R. S.)-FNRS(Fonds de la Recherche Scientifique - FNRS); French Research Ministry(Ministry of Research, France); Fonds de la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Grant ANR-13-BSV8-0002-01 from the Agence Nationale de la Recherche (to F. J. D.). This research used resources from the Plateforme Technologique de Calcul Intensif at the University of Namur, Belgium, which is supported by the Fonds de la Recherche Scientifique (F. R. S.)-FNRS under convention 2.4520.11. The authors declare that they have no conflict of interest with the contents of this manuscript.; Recipient of predoctoral fellowships from the French Research Ministry and the Fonds de la Recherche Medicale.	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; Ayers RA, 2008, BIOCHEMISTRY-US, V47, P12078, DOI 10.1021/bi801254c; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Dupre E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004700; Dupre E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-172; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jacobdubuisson F, 2012, 2 COMPONENT SYSTEM B, P57; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; King HA, 2011, J MOL BIOL, V413, P561, DOI 10.1016/j.jmb.2011.08.048; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kristensen AS, 2006, TRENDS PHARMACOL SCI, V27, P65, DOI 10.1016/j.tips.2005.12.005; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Little R, 2011, MOL MICROBIOL, V82, P222, DOI 10.1111/j.1365-2958.2011.07812.x; Martinez de Tejada G. M., 1996, MOL MICROBIOL, V22, P895; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Molnar KS, 2014, STRUCTURE, V22, P1239, DOI 10.1016/j.str.2014.04.019; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; SCHNEIDER DR, 1982, INFECT IMMUN, V38, P548, DOI 10.1128/IAI.38.2.548-553.1982; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508	48	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23307	23319		10.1074/jbc.M115.655720	http://dx.doi.org/10.1074/jbc.M115.655720			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26203186	Green Published, hybrid			2022-12-28	WOS:000361685500038
J	Senechal, F; L'Enfant, M; Domon, JM; Rosiau, E; Crepeau, MJ; Surcouf, O; Esquivel-Rodriguez, J; Marcelo, P; Mareck, A; Guerineau, F; Kim, HR; Mravec, J; Bonnin, E; Jamet, E; Kihara, D; Lerouge, P; Ralet, MC; Pelloux, J; Rayon, C				Senechal, Fabien; L'Enfant, Melanie; Domon, Jean-Marc; Rosiau, Emeline; Crepeau, Marie-Jeanne; Surcouf, Ogier; Esquivel-Rodriguez, Juan; Marcelo, Paulo; Mareck, Alain; Guerineau, Francois; Kim, Hyung-Rae; Mravec, Jozef; Bonnin, Estelle; Jamet, Elisabeth; Kihara, Daisuke; Lerouge, Patrice; Ralet, Marie-Christine; Pelloux, Jerome; Rayon, Catherine			Tuning of Pectin Methylesterification PECTIN METHYLESTERASE INHIBITOR 7 MODULATES THE PROCESSIVE ACTIVITY OF CO-EXPRESSED PECTIN METHYLESTERASE 3 IN A pH-DEPENDENT MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL PECTINS; METHYL ESTERASE; METHYLESTERASE INHIBITORS; STRUCTURAL INSIGHTS; ALCOHOL OXIDASE; ARABIDOPSIS; EXPRESSION; PH; GENES; IDENTIFICATION	Pectin methylesterases (PMEs) catalyze the demethylesterification of homogalacturonan domains of pectin in plant cell walls and are regulated by endogenous pectin methylesterase inhibitors (PMEIs). In Arabidopsis dark-grown hypocotyls, one PME (AtPME3) and one PMEI (AtPMEI7) were identified as potential interacting proteins. Using RT-quantitative PCR analysis and gene promoter:: GUS fusions, we first showed that AtPME3 and AtPMEI7 genes had overlapping patterns of expression in etiolated hypocotyls. The two proteins were identified in hypocotyl cell wall extracts by proteomics. To investigate the potential interaction between AtPME3 and AtPMEI7, both proteins were expressed in a heterologous system and purified by affinity chromatography. The activity of recombinant AtPME3 was characterized on homogalacturonans (HGs) with distinct degrees/patterns of methylesterification. AtPME3 showed the highest activity at pH 7.5 on HG substrates with a degree of methylesterification between 60 and 80% and a random distribution of methyl esters. On the best HG substrate, AtPME3 generates long non-methylesterified stretches and leaves short highly methylesterified zones, indicating that it acts as a processive enzyme. The recombinant AtPMEI7 and AtPME3 interaction reduces the level of demethylesterification of the HG substrate but does not inhibit the processivity of the enzyme. These data suggest that the AtPME3.AtPMEI7 complex is not covalently linked and could, depending on the pH, be alternately formed and dissociated. Docking analysis indicated that the inhibition of AtPME3 could occur via the interaction of AtPMEI7 with aPMEligand-binding cleft structure. All of these data indicate that AtPME3 and AtPMEI7 could be partners involved in the fine tuning of HG methylesterification during plant development.	[Senechal, Fabien; L'Enfant, Melanie; Domon, Jean-Marc; Rosiau, Emeline; Guerineau, Francois; Pelloux, Jerome; Rayon, Catherine] Univ Picardie Jules Verne, Biol Plantes & Innovat, BIOPI EA3900, F-80039 Amiens, France; [Marcelo, Paulo] Univ Picardie Jules Verne, Plateforme Ingn Cellulaire & Anal Prot ICAP, F-80039 Amiens, France; [Crepeau, Marie-Jeanne; Bonnin, Estelle; Ralet, Marie-Christine] INRA, UMR 1268, Biopolymeres Interact Assemblages, F-44316 Nantes, France; [Surcouf, Ogier; Mareck, Alain; Lerouge, Patrice] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire Vegetale, UPRES EA 4358,Inst Rech & Innovat Biomed,Normandi, Grand Reseau Rech Vegetal,Agron,Sol,Innovat,UFR S, F-76821 Mont St Aignan 1, France; [Esquivel-Rodriguez, Juan; Kihara, Daisuke] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Kim, Hyung-Rae; Kihara, Daisuke] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Mravec, Jozef] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Jamet, Elisabeth] Univ Toulouse 3, LRSV, UMR 5546, CNRS, F-31326 Castanet Tolosan, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); INRAE; Universite de Rouen Normandie; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rayon, C (corresponding author), Univ Picardie Jules Verne, Biol Plantes & Innovat, BIOPI EA3900, F-80039 Amiens, France.	catherine.rayon@u-picardie.fr	Sénéchal, Fabien/AAR-8411-2021; Sénéchal, Fabien/K-4551-2016; Jamet, Elisabeth/Z-2476-2019; Regan, Clinton/E-6250-2012; Mravec, Jozef/J-7370-2016	Sénéchal, Fabien/0000-0002-4145-7205; Mravec, Jozef/0000-0003-0331-3304; Marcelo, Paulo/0000-0002-2586-8119; Bonnin, Estelle/0000-0002-8268-9408; Esquivel-Rodriguez, Juan/0000-0003-0638-1687; Ralet, Marie-Christine/0000-0002-0292-5272; Pelloux, Jerome/0000-0002-9371-1711; Guerineau, Francois/0000-0003-1383-0348	Agence Nationale de la Recherche [ANR-09-BLANC-0007-01 GROWPEC, ANR-12-BSV5-0001 GALAPAGOS]; Conseil Regional de Picardie; "Trans Channel Wallnet" project; National Institutes of Health [R01GM097528]; National Science Foundation [IIS1319551, DBI1262189, IOS1127027]; National Research Foundation of Korea [NRF-2011-220-C00004]; Institut Universitaire de France; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097528] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional de Picardie(Region Hauts-de-France); "Trans Channel Wallnet" project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Institut Universitaire de France; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Agence Nationale de la Recherche Grants ANR-09-BLANC-0007-01 GROWPEC and ANR-12-BSV5-0001 GALAPAGOS and by the Conseil Regional de Picardie through a Ph.D. studentship (to F. S.). Work was also supported in part by the "Trans Channel Wallnet" project, which was selected by the INTERREG IVA program France (Channel)-England European cross-border cooperation program and National Institutes of Health Grant R01GM097528 (to D. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by National Science Foundation Grants IIS1319551, DBI1262189, and IOS1127027 and National Research Foundation of Korea Grant NRF-2011-220-C00004.; Supported by the Institut Universitaire de France.	Agoda-Tandjawa G, 2012, CARBOHYD POLYM, V90, P1081, DOI 10.1016/j.carbpol.2012.06.047; Al-Qsous S, 2004, PLANTA, V219, P369, DOI 10.1007/s00425-004-1246-1; Anthon GE, 2004, J AGR FOOD CHEM, V52, P3749, DOI 10.1021/jf035284w; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; BALESTRIERI C, 1990, EUR J BIOCHEM, V193, P183, DOI 10.1111/j.1432-1033.1990.tb19321.x; Benhamed M, 2008, PLANT J, V56, P493, DOI 10.1111/j.1365-313X.2008.03606.x; Bourgault R, 2002, ANAL BIOCHEM, V300, P87, DOI 10.1006/abio.2001.5450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cameron RG, 2008, CARBOHYD POLYM, V71, P287, DOI 10.1016/j.carbpol.2007.07.007; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Castro SM, 2004, J AGR FOOD CHEM, V52, P5724, DOI 10.1021/jf0352071; Christgau S, 1996, BIOCHEM J, V319, P705, DOI 10.1042/bj3190705; Ciardiello MA, 2008, PROTEINS, V71, P195, DOI 10.1002/prot.21681; Ciardiello MA, 2004, J AGR FOOD CHEM, V52, P7700, DOI 10.1021/jf0491963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Avino R, 2003, PROTEINS, V53, P830, DOI 10.1002/prot.10487; Daas PJH, 2001, BIOPOLYMERS, V58, P195, DOI 10.1002/1097-0282(200102)58:2<195::AID-BIP80>3.0.CO;2-C; Denes JM, 2000, CARBOHYD RES, V327, P385, DOI 10.1016/S0008-6215(00)00070-7; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; Duvetter T, 2006, J AGR FOOD CHEM, V54, P7825, DOI 10.1021/jf060013h; Esquivel-Rodriguez J, 2014, METHODS MOL BIOL, V1137, P209, DOI 10.1007/978-1-4939-0366-5_15; Futamura N, 2000, PLANT CELL PHYSIOL, V41, P16, DOI 10.1093/pcp/41.1.16; Gonzalez SL, 2011, CIENCIA TECNOL ALIME, V31, P412, DOI 10.1590/S0101-20612011000200020; Grsic-Rausch S, 2004, ANAL BIOCHEM, V333, P14, DOI 10.1016/j.ab.2004.04.042; Guenin S, 2011, NEW PHYTOL, V192, P114, DOI 10.1111/j.1469-8137.2011.03797.x; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Jolie RP, 2009, INNOV FOOD SCI EMERG, V10, P601, DOI 10.1016/j.ifset.2009.02.003; KLAVONS JA, 1986, J AGR FOOD CHEM, V34, P597, DOI 10.1021/jf00070a004; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; Muller K, 2013, PLANT PHYSIOL, V161, P305, DOI 10.1104/pp.112.205724; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nguyen BL, 2002, BIOTECHNOL BIOENG, V78, P683, DOI 10.1002/bit.10249; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pilling J, 2000, PLANTA, V210, P391, DOI 10.1007/PL00008147; Raiola A, 2004, FEBS LETT, V557, P199, DOI 10.1016/S0014-5793(03)01491-1; Ralet MC, 2012, BIOMACROMOLECULES, V13, P1615, DOI 10.1021/bm300329r; Ralet MC, 2001, CARBOHYD RES, V336, P117, DOI 10.1016/S0008-6215(01)00248-8; Ralet MC, 2005, PHYTOCHEMISTRY, V66, P1832, DOI 10.1016/j.phytochem.2005.06.003; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; RESTREPO MA, 1990, PLANT CELL, V2, P987, DOI 10.1105/tpc.2.10.987; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Saez-Aguayo S, 2013, PLANT CELL, V25, P308, DOI 10.1105/tpc.112.106575; Senechal F, 2014, ANN BOT-LONDON, V114, P1161, DOI 10.1093/aob/mcu035; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Tanhatan-Nasseri A, 2011, CARBOHYD POLYM, V86, P1236, DOI 10.1016/j.carbpol.2011.06.019; Thonar C, 2006, J EXP BOT, V57, P81, DOI 10.1093/jxb/erj006; van Alebeek GJWM, 2003, BIOCHEM J, V372, P211, DOI 10.1042/BJ20021471; Venkatraman V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-407; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Weber M, 2013, PLANT J, V76, P151, DOI 10.1111/tpj.12279; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wolf S, 2003, FEBS LETT, V555, P551, DOI 10.1016/S0014-5793(03)01344-9; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yoo SH, 2006, FOOD HYDROCOLLOID, V20, P62, DOI 10.1016/j.foodhyd.2005.03.003	67	33	36	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23320	23335		10.1074/jbc.M115.639534	http://dx.doi.org/10.1074/jbc.M115.639534			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26183897	hybrid, Green Published			2022-12-28	WOS:000361685500039
J	Kang, I; Barth, JL; Sproul, EP; Yoon, DW; Workman, GA; Braun, KR; Argraves, WS; Wight, TN				Kang, Inkyung; Barth, Jeremy L.; Sproul, Erin P.; Yoon, Dong Won; Workman, Gail A.; Braun, Kathleen R.; Argraves, W. Scott; Wight, Thomas N.			Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; extracellular matrix; inflammation; inflammatory bowel disease (IBD); microarray; proteoglycan; proteoglycan structure; versican (VCAN)	FOCAL ADHESION KINASE; NF-KAPPA-B; RETROVIRALLY MEDIATED OVEREXPRESSION; CHONDROITIN SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; MOLECULAR REGULATION; SIGNALING PATHWAYS; ISOFORM EXPRESSION; ENDOTHELIAL-CELLS; MONOCYTE ADHESION	Background: Arterial smooth muscle cells (ASMCs) undergo phenotypic changes during pathophysiological processes. Results: V3 expression increases contractile SMC markers while decreasing a broad range of proinflammatory chemokines and transcription factors. Conclusion: V3 expression reprograms rat ASMCs promoting differentiated and anti-inflammatory phenotypes. Significance: Modifying ECM components via V3 expression could provide a potential therapeutic intervention against vascular and other diseases. Arterial smooth muscle cells (ASMCs) undergo phenotypic changes during development and pathological processes in vivo and during cell culture in vitro. Our previous studies demonstrated that retrovirally mediated expression of the versican V3 splice variant (V3) by ASMCs retards cell proliferation and migration in vitro and reduces neointimal thickening and macrophage and lipid accumulation in animal models of vascular injury and atherosclerosis. However, the molecular pathways induced by V3 expression that are responsible for these changes are not yet clear. In this study, we employed a microarray approach to examine how expression of V3 induced changes in gene expression and the molecular pathways in rat ASMCs. We found that forced expression of V3 by ASMCs affected expression of 521 genes by more than 1.5-fold. Gene ontology analysis showed that components of the extracellular matrix were the most significantly affected by V3 expression. In addition, genes regulating the formation of the cytoskeleton, which also serve as markers of contractile smooth muscle cells (SMCs), were significantly up-regulated. In contrast, components of the complement system, chemokines, chemokine receptors, and transcription factors crucial for regulating inflammatory processes were among the genes most down-regulated. Consistently, we found that the level of myocardin, a key transcription factor promoting contractile SMC phenotype, was greatly increased, and the proinflammatory transcription factors NFB1 and CCAAT/enhancer-binding protein were significantly attenuated in V3-expressing SMCs. Overall, these findings demonstrate that V3 expression reprograms ASMCs promoting differentiated and anti-inflammatory phenotypes.	[Kang, Inkyung; Yoon, Dong Won; Workman, Gail A.; Braun, Kathleen R.; Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Matrix Biol Program, Seattle, WA 98101 USA; [Barth, Jeremy L.; Sproul, Erin P.; Argraves, W. Scott] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA	Benaroya Research Institute; Virginia Mason Medical Center; Medical University of South Carolina	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Regan, Clinton/E-6250-2012		National Institutes of Health [EB012558, HL098067, HL106967, AI101990, GM103342, GM103499]; Medical University of South Carolina through the University Research Resource Facility program; MUSC Proteogenomics Facility; Ann Ramsay-Jenkins and William M. Jenkins Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL106967, P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499, P30GM103342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina through the University Research Resource Facility program; MUSC Proteogenomics Facility; Ann Ramsay-Jenkins and William M. Jenkins Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EB012558, HL098067, and HL106967 and a Pilot Project under Grant AI101990 (to T. N. W.) and Grants GM103342 and GM103499 (to W. S. A. and J. L. B.). This work was also supported by Medical University of South Carolina through the University Research Resource Facility program to (to W. S. A. and J. L. B. and MUSC Proteogenomics Facility). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Ann Ramsay-Jenkins and William M. Jenkins Fellowship for Matrix Biology.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Barth JL, 2010, DEV DYNAM, V239, P2024, DOI 10.1002/dvdy.22341; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Campbell Julie H., 1994, Current Opinion in Lipidology, V5, P323, DOI 10.1097/00041433-199410000-00003; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Gacchina CE, 2011, TISSUE ENG PT A, V17, P1699, DOI 10.1089/ten.tea.2010.0526; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Gupta N, 2015, CLIN CHIM ACTA, V442, P119, DOI 10.1016/j.cca.2015.01.012; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Henderson DJ, 1997, MECH DEVELOP, V69, P39, DOI 10.1016/S0925-4773(97)00151-2; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521; Kamiya N, 2006, J BIOL CHEM, V281, P2390, DOI 10.1074/jbc.M509341200; Kang I, 2014, J BIOL CHEM, V289, P15393, DOI 10.1074/jbc.M113.544338; Keire PA, 2014, J BIOL CHEM, V289, P34089, DOI 10.1074/jbc.M114.607168; Keire PA, 2010, TISSUE ENG PT A, V16, P501, DOI [10.1089/ten.tea.2009.0129, 10.1089/ten.TEA.2009.0129]; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koga T, 2005, CURR EYE RES, V30, P455, DOI 10.1080/02713680590959376; Koshman YE, 2011, ARTERIOSCL THROM VAS, V31, P2432, DOI 10.1161/ATVBAHA.111.235549; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; LIU RG, 1993, AM J PHYSIOL, V265, pL430, DOI 10.1152/ajplung.1993.265.5.L430; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; McGowan S, 2000, AM J RESP CELL MOL, V23, P162, DOI 10.1165/ajrcmb.23.2.3904; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Morla AO, 2000, BIOCHEM BIOPH RES CO, V272, P298, DOI 10.1006/bbrc.2000.2769; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Sayers RL, 2008, ARTERIOSCL THROM VAS, V28, P2115, DOI 10.1161/ATVBAHA.108.175455; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Shimizu-Hirota R, 2001, J AM SOC NEPHROL, V12, P2609, DOI 10.1681/ASN.V12122609; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Wang W, 2009, ARCH MED RES, V40, P321, DOI 10.1016/j.arcmed.2009.04.005; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914	68	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21629	21641		10.1074/jbc.M115.657486	http://dx.doi.org/10.1074/jbc.M115.657486			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152723	hybrid, Green Published			2022-12-28	WOS:000360637600035
J	Samejima, K; Platani, M; Wolny, M; Ogawa, H; Vargiu, G; Knight, PJ; Peckham, M; Earnshaw, WC				Samejima, Kumiko; Platani, Melpomeni; Wolny, Marcin; Ogawa, Hiromi; Vargiu, Giulia; Knight, Peter J.; Peckham, Michelle; Earnshaw, William C.			The Inner Centromere Protein (INCENP) Coil Is a Single -Helix (SAH) Domain That Binds Directly to Microtubules and Is Important for Chromosome Passenger Complex (CPC) Localization and Function in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; microtubule; mitosis; mutant; protein structure; CPC; INCENP; chromosome passenger complex; coiled coil; single -helix	AURORA-B-KINASE; PHOSPHORYLATED HISTONE H3; CENTRAL SPINDLE; ALPHA-HELIX; FORCE; PHOSPHOSITEPLUS; ARCHITECTURE; ORIENTATION; ACTIVATION; MUTATIONS	Background: INCENP is predicted to have a coiled coil domain. Results: The coil is actually a stable single -helix (SAH) domain that is highly extendable and directly binds microtubules. Conclusion: This flexible dog leash may allow Aurora B to associate with dynamic targets in the outer kinetochore. Significance: The SAH domain allows CPC flexibility without requiring complex dimerization. The chromosome passenger complex (CPC) is a master regulator of mitosis. Inner centromere protein (INCENP) acts as a scaffold regulating CPC localization and activity. During early mitosis, the N-terminal region of INCENP forms a three-helix bundle with Survivin and Borealin, directing the CPC to the inner centromere where it plays essential roles in chromosome alignment and the spindle assembly checkpoint. The C-terminal IN box region of INCENP is responsible for binding and activating Aurora B kinase. The central region of INCENP has been proposed to comprise a coiled coil domain acting as a spacer between the N- and C-terminal domains that is involved in microtubule binding and regulation of the spindle checkpoint. Here we show that the central region (213 residues) of chicken INCENP is not a coiled coil but a approximate to 32-nm-long single -helix (SAH) domain. The N-terminal half of this domain directly binds to microtubules in vitro. By analogy with previous studies of myosin 10, our data suggest that the INCENP SAH might stretch up to approximate to 80 nm under physiological forces. Thus, the INCENP SAH could act as a flexible dog leash, allowing Aurora B to phosphorylate dynamic substrates localized in the outer kinetochore while at the same time being stably anchored to the heterochromatin of the inner centromere. Furthermore, by achieving this flexibility via an SAH domain, the CPC avoids a need for dimerization (required for coiled coil formation), which would greatly complicate regulation of the proximity-induced trans-phosphorylation that is critical for Aurora B activation.	[Samejima, Kumiko; Platani, Melpomeni; Ogawa, Hiromi; Vargiu, Giulia; Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Wolny, Marcin; Knight, Peter J.; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Edinburgh; University of Leeds	Samejima, K (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	kumiko.samejima@ed.ac.uk; bill.earnshaw@ed.ac.uk	Peckham, Michelle/J-4991-2015; Earnshaw, William/AAY-7438-2020	Peckham, Michelle/0000-0002-3754-2028; Wolny, Marcin/0000-0003-1030-7607; Platani, Melpomeni/0000-0001-6408-4774; Earnshaw, William/0000-0002-7191-0621	Wellcome Trust Centre for Cell Biology [077707, 092076]; BBSRC [BB/I007423/1, BB/M009114/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007423/1, BB/M009114/1] Funding Source: researchfish	Wellcome Trust Centre for Cell Biology(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Drs. Alba Abad and Jeyaprakash Arulanandam for advice on the microtubule binding assays. We also thank Drs. Julie P. I. Welburn and Iain M. Cheeseman for anti-phospho-DSN1 antibody and Professor Hiroshi Kimura for anti-phospho-H3Ser<SUP>28</SUP> antibody. The Wellcome Trust Centre for Cell Biology is supported by Core Grants 077707 and 092076.	Abad MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3964; Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Batchelor M, 2015, BIOCHEM SOC T, V43, P58, DOI 10.1042/BST20140302; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Cormier A, 2013, J BIOL CHEM, V288, P23203, DOI 10.1074/jbc.M113.491480; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; EARNSHAW WC, 1991, J CELL SCI, V98, P443; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Hayashi-Takanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106271; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Jeyaprakash AA, 2012, MOL CELL, V46, P274, DOI 10.1016/j.molcel.2012.03.005; Jeyaprakash AA, 2011, STRUCTURE, V19, P1625, DOI 10.1016/j.str.2011.09.002; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACKAY AM, 1993, J CELL BIOL, V123, P373, DOI 10.1083/jcb.123.2.373; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Noujaim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086786; Peckham M, 2011, BIOCHEM SOC T, V39, P1142, DOI 10.1042/BST0391142; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Platani M, 2009, MOL BIOL CELL, V20, P5260, DOI 10.1091/mbc.E09-05-0377; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Swedlow JR, 2009, ANNU REV BIOPHYS, V38, P327, DOI 10.1146/annurev.biophys.050708.133641; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Vader G, 2007, MOL BIOL CELL, V18, P4553, DOI 10.1091/mbc.E07-04-0328; van der Horst A, 2014, CHROMOSOMA, V123, P25, DOI 10.1007/s00412-013-0437-6; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Wolny M, 2013, J BIOL CHEM, V288, P31952, DOI 10.1074/jbc.M113.513291; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yusko EC, 2014, MOL BIOL CELL, V25, P3717, DOI 10.1091/mbc.E13-12-0707	63	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21460	21472		10.1074/jbc.M115.645317	http://dx.doi.org/10.1074/jbc.M115.645317			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175154	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000360637600022
J	Skerrett, R; Pellegrino, MP; Casali, BT; Taraboanta, L; Landreth, GE				Skerrett, Rebecca; Pellegrino, Mateus P.; Casali, Brad T.; Taraboanta, Laura; Landreth, Gary E.			Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor Agonist Treatment Reduces Amyloid Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid (A); apolipoprotein E (apoE); microglia; peroxisome proliferator-activated receptor (PPAR); liver X receptor (LXR)	ALZHEIMERS-DISEASE; PPAR-GAMMA; A-BETA; TRANSGENIC MICE; NUCLEAR RECEPTORS; APOLIPOPROTEIN-E; MOUSE MODEL; MEMORY DEFICITS; LXR AGONIST; COGNITIVE DEFICITS	Background: In the brain, the type II nuclear receptors LXR and PPAR control cholesterol efflux and inflammation, key processes in Alzheimer disease pathology. Results: Combining the LXR and PPAR agonists decreases the levels of A and inflammation, resulting in improved cognition. Conclusion: The LXR and PPAR agonists complement each other, possibly by modulating microglial function. Significance: Targeting multiple nuclear receptors expands the therapeutic opportunities for AD treatment. Alzheimer disease (AD) is characterized by the extracellular accumulation of amyloid (A), which is accompanied by a robust inflammatory response in the brain. Both of these pathogenic processes are regulated by nuclear receptors, including the liver X receptors (LXRs) and peroxisome-proliferator receptor (PPAR). Agonists of LXRs have been demonstrated previously to reduce A levels and improve cognitive deficits in AD mouse models by inducing the transcription and lipidation of apolipoprotein E (apoE). Agonists targeting PPAR reduce the microglial expression of proinflammatory genes and have also been shown to modulate apoE expression. Here we investigate whether a combination therapy with both LXR and PPAR agonists results in increased benefits in an AD mouse model. We found that the LXR agonist GW3965 and the PPAR agonist pioglitazone were individually able to increase the levels of apoE and related genes, decrease the expression of proinflammatory genes, and facilitate A decreases in the hippocampus. Combined treatment with both agonists provoked a further increase in the expression of apoE and a decrease in the soluble and deposited forms of A. The decrease in plaques was associated with increased colocalization between microglia and plaques. In addition, the PPAR agonist in the combined treatment paradigm was able to counteract the elevation in plasma triglycerides that is a side effect of LXR agonist treatment. These results suggest that combined LXR/PPAR agonist treatment merits further investigation for the treatment of AD.	[Skerrett, Rebecca; Casali, Brad T.; Taraboanta, Laura; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Pellegrino, Mateus P.] Univ Estadual Campinas, Sch Med, BR-13083887 Campinas, SP, Brazil	Case Western Reserve University; Universidade Estadual de Campinas	Landreth, GE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	gel2@case.edu	Regan, Clinton/E-6250-2012	Paquesse Pellegrino, Mateus/0000-0001-5629-435X	National Institutes of Health [R01 AG030482, 5T32NS067431-13]; Gail and Elliott Schlang Philanthropic Fund; CAPES Foundation [5758/12-2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS067431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gail and Elliott Schlang Philanthropic Fund; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG030482 (to G. E. L.) and 5T32NS067431-13 (to R. R. S.). This work was also supported by the Gail and Elliott Schlang Philanthropic Fund and CAPES Foundation Grant 5758/12-2 (to M. P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Beyer TP, 2004, J PHARMACOL EXP THER, V309, P861, DOI 10.1124/jpet.103.064535; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cui W, 2012, NEUROSCIENCE, V210, P200, DOI 10.1016/j.neuroscience.2012.02.047; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fitz NF, 2014, J ALZHEIMERS DIS, V41, P535, DOI 10.3233/JAD-132789; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gosselin D, 2014, IMMUNOL REV, V262, P96, DOI 10.1111/imr.12213; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Hu Y, 2013, J MED CHEM, V56, P6033, DOI 10.1021/jm301913k; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Lacombe P, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-11; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Masciopinto F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.189; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; O'Reilly JA, 2012, J NEUROIMMUNE PHARM, V7, P140, DOI 10.1007/s11481-011-9282-7; Papadopoulos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068612; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Quinet EM, 2006, MOL PHARMACOL, V70, P1340, DOI 10.1124/mol.106.022608; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rodriguez-Rivera J, 2011, BEHAV BRAIN RES, V216, P255, DOI 10.1016/j.bbr.2010.08.002; Saijo K, 2013, GLIA, V61, P104, DOI 10.1002/glia.22423; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Skerrett R, 2014, NEUROBIOL DIS, V72, P104, DOI 10.1016/j.nbd.2014.05.019; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; van der Hoorn JWA, 2011, BRIT J PHARMACOL, V162, P1553, DOI 10.1111/j.1476-5381.2010.01168.x; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; Yan Q, 2003, J NEUROSCI, V23, P7504; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yue L, 2009, J BIOL CHEM, V284, P10453, DOI 10.1074/jbc.M808482200; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	70	62	63	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21591	21602		10.1074/jbc.M115.652008	http://dx.doi.org/10.1074/jbc.M115.652008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26163517	Green Published, hybrid			2022-12-28	WOS:000360637600032
J	Markolovic, S; Wilkins, SE; Schofield, CJ				Markolovic, Suzana; Wilkins, Sarah E.; Schofield, Christopher J.			Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HYPOXIA-INDUCIBLE-FACTOR; DOMAIN-CONTAINING PROTEINS; ANKYRIN REPEAT DOMAIN; VON-HIPPEL-LINDAU; PROLYL-HYDROXYLATION; HISTONE DEMETHYLATION; 6 JMJD6; ASPARAGINYL HYDROXYLATION; SUBSTRATE-SPECIFICITY; LYSYL-HYDROXYLATION	The post-translational hydroxylation of prolyl and lysyl residues, as catalyzed by 2-oxoglutarate (2OG)-dependent oxygenases, was first identified in collagen biosynthesis. 2OG oxygenases also catalyze prolyl and asparaginyl hydroxylation of the hypoxia-inducible factors that play important roles in the adaptive response to hypoxia. Subsequently, they have been shown to catalyze N-demethylation (via hydroxylation) of N-epsilon-methylated histone lysyl residues, as well as hydroxylation of multiple other residues. Recent work has identified roles for 2OG oxygenases in the modification of translation-associated proteins, which in some cases appears to be conserved from microorganisms through to humans. Here we give an overview of protein hydroxylation catalyzed by 2OG oxygenases, focusing on recent discoveries.	[Markolovic, Suzana; Wilkins, Sarah E.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford	Wilkins, SE (corresponding author), Univ Oxford, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	sarah.wilkins@chem.ox.ac.uk; christopher.schofield@chem.ox.ac.uk		Wilkins, Sarah/0000-0003-1347-3328; Schofield, Christopher/0000-0002-0290-6565; Markolovic, Suzana/0000-0001-9482-1851	Wellcome Trust; Cancer Research UK; British Heart Foundation; Biotechnology and Biological Sciences Research Council; University of Oxford Clarendon Fund; BBSRC [BB/L004275/1, BB/J003018/1, BB/L009846/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L009846/1, BB/J003018/1, BB/L004275/1] Funding Source: researchfish; Cancer Research UK [18245] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Oxford Clarendon Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by the Wellcome Trust, Cancer Research UK, the British Heart Foundation, and the Biotechnology and Biological Sciences Research Council, and by the University of Oxford Clarendon Fund (to S. M.). This is the second article in the Thematic Minireview series "Metals in Biology: alpha-Ketoglutarate/Iron-dependent Dioxygenases." The authors declare that they have no conflicts of interest with the contents of this article.	Aik WS, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P59; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Dinchuk JE, 2002, J BIOL CHEM, V277, P12970, DOI 10.1074/jbc.M110389200; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; GRONKE RS, 1990, J BIOL CHEM, V265, P8558; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hopkinson RJ, 2013, ANGEW CHEM INT EDIT, V52, P7709, DOI 10.1002/anie.201303282; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; HUTTON JJ, 1967, ARCH BIOCHEM BIOPHYS, V118, P231, DOI 10.1016/0003-9861(67)90302-5; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Katz MJ, 2014, P NATL ACAD SCI USA, V111, P4025, DOI 10.1073/pnas.1314485111; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mantri M, 2012, MEDCHEMCOMM, V3, P80, DOI 10.1039/c1md00225b; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Patel N, 2014, AM J HUM GENET, V94, P755, DOI 10.1016/j.ajhg.2014.04.002; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; PUISTOLA U, 1980, BIOCHIM BIOPHYS ACTA, V611, P40, DOI 10.1016/0005-2744(80)90040-6; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Scotti JS, 2014, P NATL ACAD SCI USA, V111, P13331, DOI 10.1073/pnas.1409916111; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SIEGEL RC, 1976, J BIOL CHEM, V251, P5779; Singleton RS, 2014, P NATL ACAD SCI USA, V111, P4031, DOI 10.1073/pnas.1314482111; Singleton RS, 2011, J BIOL CHEM, V286, P33784, DOI 10.1074/jbc.M111.262808; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; SUNNERHAGEN MS, 1993, J BIOL CHEM, V268, P23339; TATE WP, 1987, EUR J BIOCHEM, V165, P403, DOI 10.1111/j.1432-1033.1987.tb11453.x; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; van Staalduinen LM, 2014, J MOL BIOL, V426, P1898, DOI 10.1016/j.jmb.2014.02.008; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yang H, 2015, FRONT BIOSCI-LANDMRK, V20, P902, DOI 10.2741/4344; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	98	103	106	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20712	20722		10.1074/jbc.R115.662627	http://dx.doi.org/10.1074/jbc.R115.662627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152730	Green Published, hybrid			2022-12-28	WOS:000360011800008
J	Xu, KW; Harrison, RE				Xu, Kewei; Harrison, Rene E.			Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; RECEPTOR-MEDIATED PHAGOCYTOSIS; CATASTROPHE-PROMOTING ACTIVITY; CELL-CYCLE; POSTTRANSLATIONAL MODIFICATIONS; INTERPHASE MICROTUBULES; NERVOUS-SYSTEM; PROTEIN-KINASE; PHORBOL ESTER	Macrophages are important cells of innate immunity with specialized capacity for recognition and elimination of pathogens and presentation of antigens to lymphocytes for adaptive immunity. Macrophages become activated upon exposure to pro-inflammatory cytokines and pathogenic stimuli. Classical activation of macrophages with interferon-gamma (IFN gamma) and lipopolysaccharide (LPS) triggers a wide range of signaling events and morphological changes to induce the immune response. Our previous microtubule (MT) proteomic work revealed that the stathmin association with MTs is considerably reduced in activated macrophages, which contain significantly more stabilized MTs. Here, we show that there is a global decrease in stathmin levels, an MT catastrophe protein, in activated macrophages using both immunoblotting and immunofluorescent microscopy. This is an LPS-specific response that induces proteasome-mediated degradation of stathmin. We explored the functions of stathmin down-regulation in activated macrophages by generating a stable cell line overexpressing stathmin-GFP. We show that stathmin-GFP overexpression impacts MT stability, impairs cell spreading, and reduces activation-associated phenotypes. Furthermore, overexpressing stathmin reduces complement receptor 3-mediated phagocytosis and cellular activation, implicating a pivotal inhibitory role for stathmin in classically activated macrophages.	Univ Toronto Scarborough, Dept Cell & Syst Biol, Toronto, ON M1C 1A4, Canada; [Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada.	harrison@utsc.utoronto.ca			Canadian Institutes of Health Research [MOP-68992]; Natural Science and Engineering Research Council [RGPIN 298538-09]; Alfred and Florence Aiken and Dorothy Woods Memorial Graduate Scholarship; Canadian Institutes of Health Research New Investigator Award; Ontario Early Researcher Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alfred and Florence Aiken and Dorothy Woods Memorial Graduate Scholarship; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was supported by Canadian Institutes of Health Research Grant MOP-68992 and Natural Science and Engineering Research Council Grant RGPIN 298538-09 (to R. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Alfred and Florence Aiken and Dorothy Woods Memorial Graduate Scholarship.; Recipient of a Canadian Institutes of Health Research New Investigator Award and an Ontario Early Researcher Award.	Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belmont L, 1996, TRENDS BIOCHEM SCI, V21, P197, DOI 10.1016/S0968-0004(96)80013-2; Beningo KA, 2002, J CELL SCI, V115, P849; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bergqvist S, 2008, PROTEIN SCI, V17, P2051, DOI 10.1110/ps.037481.108; Bieche I, 1998, BRIT J CANCER, V78, P701, DOI 10.1038/bjc.1998.565; Binker MG, 2007, J IMMUNOL, V179, P3780, DOI 10.4049/jimmunol.179.6.3780; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CANNON GJ, 1992, J CELL SCI, V101, P907; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; DOWNEY GP, 1992, J CELL BIOL, V116, P695, DOI 10.1083/jcb.116.3.695; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Ghazanfari T, 2010, IMMUNOPHARM IMMUNOT, V32, P47, DOI [10.3109/08923970903117357, 10.1080/08923970903117357]; Gomes NE, 2010, BRAZ J MED BIOL RES, V43, P853, DOI 10.1590/S0100-879X2010000900007; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta KK, 2013, P NATL ACAD SCI USA, V110, P20449, DOI 10.1073/pnas.1309958110; HAMEROFF SR, 1982, J THEOR BIOL, V98, P549, DOI 10.1016/0022-5193(82)90137-0; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; HANASH SM, 1988, J BIOL CHEM, V263, P12813; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Howell B, 1999, J CELL SCI, V112, P3713; Iancu-Rubin C, 2005, TRENDS CELL BIOL, V15, P346, DOI 10.1016/j.tcb.2005.05.008; Iancu-Rubin C, 2011, BLOOD, V117, P4580, DOI 10.1182/blood-2010-09-305540; JOHNSON HM, 1985, P NATL ACAD SCI USA, V82, P5959, DOI 10.1073/pnas.82.17.5959; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kalis C, 2003, EUR J IMMUNOL, V33, P798, DOI 10.1002/eji.200323431; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kasas S, 2004, BIOL CELL, V96, P697, DOI 10.1016/j.biolcel.2004.09.002; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; LANE TE, 1994, INFECT IMMUN, V62, P1478, DOI 10.1128/IAI.62.4.1478-1479.1994; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lin XC, 2012, CANCER SCI, V103, P993, DOI 10.1111/j.1349-7006.2012.02271.x; Liu P, 2013, ONCOL REP, V29, P419, DOI 10.3892/or.2012.2157; Liu XW, 2004, WORLD J GASTROENTERO, V10, P2701, DOI 10.3748/wjg.v10.i18.2701; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Morimura S., 2011, INT J CELL BIOL, V2011; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Pace J, 1988, J LEUKOCYTE BIOL, V520, P514; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pixley Fiona J, 2012, Int J Cell Biol, V2012, P501962, DOI 10.1155/2012/501962; Pustylnik S, 2013, J BIOL CHEM, V288, P22096, DOI 10.1074/jbc.M113.481515; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Rubin CI, 2003, EXP HEMATOL, V31, P389, DOI 10.1016/S0301-472X(03)00043-2; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Sherbet G., 2005, CANCER GENOM PROTEOM, V238, P227; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Spencer W, 1999, ONCOGENE, V18, P495, DOI 10.1038/sj.onc.1202335; SWALLOW CJ, 1992, J LEUKOCYTE BIOL, V52, P395, DOI 10.1002/jlb.52.4.395; SWANSON JA, 1989, J CELL SCI, V94, P135; Takahashi K, 2010, CELL SIGNAL, V22, P510, DOI 10.1016/j.cellsig.2009.11.005; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Tsukamoto H, 2013, J IMMUNOL, V190, P195, DOI 10.4049/jimmunol.1201047; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; Welliver TP, 2011, J CELL SCI, V124, P4106, DOI 10.1242/jcs.091538; Wenzel RP, 1996, CLIN INFECT DIS, V22, P407, DOI 10.1093/clinids/22.3.407; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764; Zhang DW, 2010, MOL CANCER THER, V9, P3090, DOI 10.1158/1535-7163.MCT-10-0362	91	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19245	19260		10.1074/jbc.M115.639625	http://dx.doi.org/10.1074/jbc.M115.639625			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082487	Green Published, hybrid			2022-12-28	WOS:000358781100038
J	Yu, J; Pian, YY; Ge, JP; Guo, J; Zheng, YL; Jiang, H; Hao, HJ; Yuan, Y; Jiang, YQ; Yang, MJ				Yu, Jie; Pian, Yaya; Ge, Jingpeng; Guo, Jie; Zheng, Yuling; Jiang, Hua; Hao, Huaijie; Yuan, Yuan; Jiang, Yongqiang; Yang, Maojun			Functional and Structural Characterization of the Antiphagocytic Properties of a Novel Transglutaminase from Streptococcus suis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING ENZYMES; CRYSTAL-STRUCTURE; IDENTIFICATION; VIRULENCE; PROTEINS; SUILYSIN; PURIFICATION; SEROTYPE-2; VECTORS; GENE	Streptococcus suis serotype 2 (Ss2) is an important swine and human zoonotic pathogen. In the present study, we identified a novel secreted immunogenic protein, SsTGase, containing a highly conserved eukaryotic-like transglutaminase (TGase) domain at the N terminus. We found that inactivation of SsTGase significantly reduced the virulence of Ss2 in a pig infection model and impaired its antiphagocytosis in human blood. We further solved the crystal structure of the N-terminal portion of the protein in homodimer form at 2.1 angstrom Structure-based mutagenesis and biochemical studies suggested that disruption of the homodimer directly resulted in the loss of its TGase activity and antiphagocytic ability. Characterization of SsTGase as a novel virulence factor of Ss2 by acting as a TGase would be beneficial for developing new therapeutic agents against Ss2 infections.	[Yu, Jie; Pian, Yaya; Zheng, Yuling; Jiang, Hua; Yuan, Yuan; Jiang, Yongqiang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Yu, Jie; Pian, Yaya; Ge, Jingpeng; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Key Lab Prot Sci,Minist Educ, Beijing 100084, Peoples R China; [Guo, Jie; Hao, Huaijie] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Tsinghua University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Yuan, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	miniminiyuan@163.com; jiangyq@nic.bmi.ac.cn; maojunyang@tsinghua.edu.cn	Ge, Jingpeng/AGG-3471-2022; Hao, Huaijie/D-3861-2017; Gai, Jingpeng/AAT-9369-2021	Hao, Huaijie/0000-0002-1928-4205; Gai, Jingpeng/0000-0001-6164-1221; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology [2011CB910502, 2012CB911101]; National Natural Science Foundation [31030020, 31170679, 31101824, 81171528, 81441062, 81371766, 81401642]; State Key Laboratory of Pathogen and Biosecurity (Academy of Military Medical Science) [SKLPBS1414]; National Basic Research Program (973) of China [2012CB518804, 2012YQ18011706]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pathogen and Biosecurity (Academy of Military Medical Science); National Basic Research Program (973) of China(National Basic Research Program of China)	This work was supported by Ministry of Science and Technology Grants 2011CB910502 and 2012CB911101 (to M. Y.); National Natural Science Foundation Grants 31030020 and 31170679 (to M. Y.), 31101824 (to H. X.), 81171528, 81441062, and 81371766 (to Y. J.), and 81401642 (to Y. P.)); State Key Laboratory of Pathogen and Biosecurity (Academy of Military Medical Science) Grant SKLPBS1414 (to Y. Y.); and National Basic Research Program (973) of China Grants 2012CB518804 and 2012YQ18011706 (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beninati S, 2004, AMINO ACIDS, V26, P367, DOI 10.1007/s00726-004-0091-7; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; Geng HR, 2008, J PROTEOME RES, V7, P4132, DOI 10.1021/pr800196v; GOOD L, 1992, NUCLEIC ACIDS RES, V20, P4934, DOI 10.1093/nar/20.18.4934; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kobayashi K., 1998, European Patent Application EP, Patent No. [0851029A1, 0851029]; Kuraishi C, 2001, FOOD REV INT, V17, P221, DOI 10.1081/FRI-100001258; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Martins IM, 2014, APPL MICROBIOL BIOT, V98, P6957, DOI 10.1007/s00253-014-5894-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Reiss K, 2011, J BIOL CHEM, V286, P42585, DOI 10.1074/jbc.M111.290544; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Shleikin A G, 2011, Zh Evol Biokhim Fiziol, V47, P3; Smith HE, 1999, INFECT IMMUN, V67, P1750; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takeuchi D, 2014, J INFECT DIS, V209, P1509, DOI 10.1093/infdis/jit661; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Yang MT, 2011, J BIOL CHEM, V286, P7301, DOI 10.1074/jbc.M110.203315; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5	48	18	24	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19081	19092		10.1074/jbc.M115.643338	http://dx.doi.org/10.1074/jbc.M115.643338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085092	hybrid, Green Published			2022-12-28	WOS:000358781100025
J	Guo, A; Hall, D; Zhang, CM; Peng, TQ; Miller, JD; Kutschke, W; Grueter, CE; Johnson, FL; Lin, RZ; Song, LS				Guo, Ang; Hall, Duane; Zhang, Caimei; Peng, Tianqing; Miller, Jordan D.; Kutschke, William; Grueter, Chad E.; Johnson, Frances L.; Lin, Richard Z.; Song, Long-Sheng			Molecular Determinants of Calpain-dependent Cleavage of Junctophilin-2 Protein in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-TUBULE; RYANODINE RECEPTORS; HEART-FAILURE; CONTRACTILE DYSFUNCTION; SARCOPLASMIC-RETICULUM; MYOCARDIAL-INFARCTION; CA2+ CHANNEL; RAT-HEART; HYPERTROPHY; CALPASTATIN	Junctophilin-2 (JP2), a membrane-binding protein that provides a structural bridge between the plasmalemma and sarcoplasmic reticulum, is essential for precise Ca2+-induced Ca2+ release during excitation-contraction coupling in cardiomyocytes. In animal and human failing hearts, expression of JP2 is decreased markedly, but the molecular mechanisms underlying JP2 down-regulation remain incompletely defined. In mouse hearts, ischemia/reperfusion injury resulted in acute JP2 down-regulation, which was attenuated by pretreatment with the calpain inhibitor MDL-28170 or by transgenic overexpression of calpastatin, an endogenous calpain inhibitor. Using a combination of computational analysis to predict calpain cleavage sites and in vitro calpain proteolysis reactions, we identified four putative calpain cleavage sites within JP2 with three N-terminal and one C-terminal cleavage sites. Mutagenesis defined the C-terminal region of JP2 as the predominant calpain cleavage site. Exogenous expression of putative JP2 cleavage fragments was not sufficient to rescue Ca2+ handling in JP2-deficient cardiomyocytes, indicating that cleaved JP2 is non-functional for normal Ca2+-induced Ca2+ release. These data provide new molecular insights into the posttranslational regulatory mechanisms of JP2 in cardiac diseases.	[Guo, Ang; Hall, Duane; Zhang, Caimei; Kutschke, William; Grueter, Chad E.; Johnson, Frances L.; Song, Long-Sheng] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Guo, Ang; Hall, Duane; Zhang, Caimei; Kutschke, William; Grueter, Chad E.; Johnson, Frances L.; Song, Long-Sheng] Univ Iowa, Carver Coll Med, Francois M Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Peng, Tianqing] Univ Western Ontario, Dept Med, London, ON N6A 4G5, Canada; [Peng, Tianqing] Univ Western Ontario, Dept Pathol, London, ON N6A 4G5, Canada; [Miller, Jordan D.] Mayo Clin, Div Cardiovasc Surg, Rochester, MN 55905 USA; [Lin, Richard Z.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	University of Iowa; University of Iowa; Western University (University of Western Ontario); Western University (University of Western Ontario); Mayo Clinic; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Song, LS (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.	long-sheng-song@uiowa.edu	Hall, Duane/ACD-6815-2022; Regan, Clinton/E-6250-2012; Peng, Tianqing/G-3340-2011; Guo, Ang/M-3549-2013	Hall, Duane/0000-0003-2228-0966; Miller, Jordan/0000-0002-9868-4097; Guo, Ang/0000-0002-5551-2279; Song, Long-Sheng/0000-0002-6035-8106; Grueter, Chad/0000-0001-8950-742X; Lin, Richard/0000-0002-3967-0859	National Institutes of Health [R01 HL090905]; American Heart Association [13POST14630077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905, R01HL111121] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL090905 (to L. S. S.). This work was also supported by American Heart Association Postdoctoral Fellowship 13POST14630077 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Arthur GD, 1997, MOL CELL BIOCHEM, V176, P241, DOI 10.1023/A:1006857213829; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen BY, 2013, CARDIOVASC RES, V100, P54, DOI 10.1093/cvr/cvt180; Chen BY, 2012, FASEB J, V26, P2531, DOI 10.1096/fj.11-199505; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Golini L, 2011, J BIOL CHEM, V286, P43717, DOI 10.1074/jbc.M111.292755; Gomez AM, 2001, CIRCULATION, V104, P688, DOI 10.1161/hc3201.092285; Greyson CR, 2008, J MOL CELL CARDIOL, V44, P59, DOI 10.1016/j.yjmcc.2007.10.010; Guo A, 2014, P NATL ACAD SCI USA, V111, P12240, DOI 10.1073/pnas.1412729111; Guo A, 2013, CARDIOVASC RES, V98, P204, DOI 10.1093/cvr/cvt020; Guo A, 2012, J BIOL CHEM, V287, P16670, DOI 10.1074/jbc.M112.340927; Hall SRR, 2005, J HEART LUNG TRANSPL, V24, P1639, DOI 10.1016/j.healun.2004.11.004; Heidrich FM, 2009, CIRC RES, V104, pE19, DOI 10.1161/CIRCRESAHA.108.191072; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Jayasinghe ID, 2012, BIOPHYS J, V102, pL9, DOI 10.1016/j.bpj.2012.01.034; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Litwin SE, 2000, CIRC RES, V87, P1040, DOI 10.1161/01.RES.87.11.1040; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Singh RB, 2004, J MOL CELL CARDIOL, V37, P101, DOI 10.1016/j.yjmcc.2004.04.009; Song LS, 2012, CIRC RES, V111, P816, DOI 10.1161/CIRCRESAHA.112.278390; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H., 2015, CELL CALCIUM, DOI 10.1016/j.ceca.2015.01.007; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wu CYC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000527; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Xu M, 2012, CIRC RES, V111, P837, DOI 10.1161/CIRCRESAHA.112.277418; YOSHIDA K, 1995, CIRC RES, V77, P603, DOI 10.1161/01.RES.77.3.603; Zhang HB, 2013, CARDIOVASC RES, V98, P269, DOI 10.1093/cvr/cvt030	47	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17946	17955		10.1074/jbc.M115.652396	http://dx.doi.org/10.1074/jbc.M115.652396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26063807	Green Published, hybrid			2022-12-28	WOS:000358511700028
J	Robertson, CL; Srivastava, J; Siddiq, A; Gredler, R; Emdad, L; Rajasekaran, D; Akiel, M; Shen, XN; Corwin, F; Sundaresan, G; Zweit, J; Croniger, C; Gao, XL; Ghosh, S; Hylemon, PB; Subler, MA; Windle, JJ; Fisher, PB; Sarkar, D				Robertson, Chadia L.; Srivastava, Jyoti; Siddiq, Ayesha; Gredler, Rachel; Emdad, Luni; Rajasekaran, Devaraja; Akiel, Maaged; Shen, Xue-Ning; Corwin, Frank; Sundaresan, Gobalakrishnan; Zweit, Jamal; Croniger, Colleen; Gao, Xiaoli; Ghosh, Shobha; Hylemon, Philip B.; Subler, Mark A.; Windle, Jolene J.; Fisher, Paul B.; Sarkar, Devanand			Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; RECEPTOR LXR-ALPHA; NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR; PPAR-ALPHA; X-RECEPTOR; CHOLESTEROL; EXPRESSION; IDENTIFICATION; ABSORPTION	Astrocyte elevated gene-1 (AEG-1), also known as MTDH (metadherin) or LYRIC, is an established oncogene. However, the physiological function of AEG-1 is not known. To address this question, we generated an AEG-1 knock-out mouse (AEG-1KO) and characterized it. Although AEG-1KO mice were viable and fertile, they were significantly leaner with prominently less body fat and lived significantly longer compared with wild type (WT). When fed a high fat and cholesterol diet (HFD), WT mice rapidly gained weight, whereas AEG-1KO mice did not gain weight at all. This phenotype of AEG-1KO mice is due to decreased fat absorption from the intestines, not because of decreased fat synthesis or increased fat consumption. AEG-1 interacts with retinoid X receptor (RXR) and inhibits RXR function. In enterocytes of AEG-1KO mice, we observed increased activity of RXR heterodimer partners, liver X receptor and peroxisome proliferator-activated receptor-alpha, key inhibitors of intestinal fat absorption. Inhibition of fat absorption in AEG-1KO mice was further augmented when fed an HFD providing ligands to liver X receptor and peroxisome proliferator-activated receptor-alpha. Our studies reveal a novel role of AEG-1 in regulating nuclear receptors controlling lipid metabolism. AEG-1 may significantly modulate the effects of HFD and thereby function as a unique determinant of obesity.	[Robertson, Chadia L.; Srivastava, Jyoti; Siddiq, Ayesha; Gredler, Rachel; Emdad, Luni; Rajasekaran, Devaraja; Akiel, Maaged; Shen, Xue-Ning; Subler, Mark A.; Windle, Jolene J.; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Robertson, Chadia L.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; [Corwin, Frank; Sundaresan, Gobalakrishnan; Zweit, Jamal] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA 23298 USA; [Ghosh, Shobha] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Hylemon, Philip B.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Windle, Jolene J.; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA 23298 USA; [Croniger, Colleen] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Gao, Xiaoli] Univ Texas Hlth Sci Ctr San Antonio, Inst Mass Spectrometry Lab, San Antonio, TX 78229 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Case Western Reserve University; University of Texas System; University of Texas Health San Antonio	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Srivastava, Jyoti/AAD-7610-2022; Regan, Clinton/E-6250-2012; Akiel, Maaged/B-5109-2014	Akiel, Maaged/0000-0002-0211-2837; Windle, Jolene/0000-0001-6690-385X; Gobalakrishnan, Sundaresan/0000-0002-9620-5611	National Institutes of Health, NCI [R01 CA138540, R21 CA183954]; National Institutes of Health [R01 CA134721]; James S. McDonnell Foundation; National Institutes of Health, NIDDK [T32DK007150]; NATIONAL CANCER INSTITUTE [R21CA183954, R01CA138540, R01CA134721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants R01 CA138540 and R21 CA183954 (to D. S.) and National Institutes of Health Grant R01 CA134721 (to P. B. F.). This work was also supported in part by grants from The James S. McDonnell Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health, NIDDK, Grant T32DK007150.	Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Bonamassa B, 2013, TRENDS ENDOCRIN MET, V24, P120, DOI 10.1016/j.tem.2012.10.004; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; CLARK SB, 1973, J LIPID RES, V14, P581; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jeon HY, 2010, GENE EXPR PATTERNS, V10, P361, DOI 10.1016/j.gep.2010.08.004; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kimura R, 2013, OBES RES CLIN PRACT, V7, pE353, DOI 10.1016/j.orcp.2013.05.005; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2013, ADV CANCER RES, V120, P1, DOI 10.1016/B978-0-12-401676-7.00001-2; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Masson CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010380; Meng XB, 2015, J BIOL CHEM, V290, P11853, DOI 10.1074/jbc.M114.627653; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; TURLEY SD, 1994, J LIPID RES, V35, P328; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	40	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18227	18236		10.1074/jbc.M115.661801	http://dx.doi.org/10.1074/jbc.M115.661801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26070567	Green Published, hybrid			2022-12-28	WOS:000358511700051
J	Kegulian, NC; Sankhagowit, S; Apostolidou, M; Jayasinghe, SA; Malmstadt, N; Butler, PC; Langen, R				Kegulian, Natalie C.; Sankhagowit, Shalene; Apostolidou, Melania; Jayasinghe, Sajith A.; Malmstadt, Noah; Butler, Peter C.; Langen, Ralf			Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-BAR DOMAIN; ALPHA-SYNUCLEIN OLIGOMERS; AMPHIPATHIC HELICES; LIPID-BILAYERS; ANTIMICROBIAL PEPTIDE; HUMAN AMYLIN; MECHANISM; ENDOPHILIN; TOXICITY; PROTEINS	Islet amyloid polypeptide (IAPP) is a 37-amino acid amyloid protein intimately associated with pancreatic islet beta-cell dysfunction and death in type II diabetes. In this study, we combine spectroscopic methods and microscopy to investigate alpha-helical IAPP-membrane interactions. Using light scattering and fluorescence microscopy, we observe that larger vesicles become smaller upon treatment with human or rat IAPP. Electron microscopy shows the formation of various highly curved structures such as tubules or smaller vesicles in a membrane-remodeling process, and spectrofluorometric detection of vesicle leakage shows disruption of membrane integrity. This effect is stronger for human IAPP than for the less toxic rat IAPP. From CD spectra in the presence of different-sized vesicles, we also uncover the membrane curvature-sensing ability of IAPP and find that it transitions from inducing to sensing membrane curvature when lipid negative charge is decreased. Our in vivo EM images of immunogold-labeled rat IAPP and human IAPP show both forms to localize to mitochondrial cristae, which contain not only locally curved membranes but also phosphatidylethanolamine and cardiolipin, lipids with high spontaneous negative curvature. Disruption of membrane integrity by induction of membrane curvature could apply more broadly to other amyloid proteins and be responsible for membrane damage observed in other amyloid diseases as well.	[Kegulian, Natalie C.; Apostolidou, Melania; Jayasinghe, Sajith A.; Langen, Ralf] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Sankhagowit, Shalene; Malmstadt, Noah] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Butler, Peter C.] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Langen, R (corresponding author), Zilkha Neurogenet Inst, Dept Biochem & Mol Biol, 1501 San Pablo St,ZNI 119, Los Angeles, CA 90089 USA.	langen@usc.edu	Regan, Clinton/E-6250-2012; Malmstadt, Noah/GQA-6198-2022; Kegulian, Natalie/AAF-1086-2022; Kegulian, Natalie/AFF-8981-2022	Kegulian, Natalie/0000-0002-8574-1099; butler, peter/0000-0002-2981-8979	National Institutes of Health [G027936, GM063915, 1R01GM093279, 5T32GM067587-10]; NIDDK [DK-059579]; National Science Foundation [CMMI-1068212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587, R01GM093279, R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants G027936 and GM063915 (to R. L.) and 1R01GM093279 (to N. M.) and Grant DK-059579 from the NIDDK (to P. C. B.). This work was also supported by National Science Foundation Award CMMI-1068212 (to N. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Predoctoral Training Grant 5T32GM067587-10.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Ambroso MR, 2014, P NATL ACAD SCI USA, V111, P6982, DOI 10.1073/pnas.1402233111; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bertelsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047745; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Bram Yaron, 2014, Sci Rep, V4, P4267, DOI 10.1038/srep04267; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2013, PHYS CHEM CHEM PHYS, V15, P8908, DOI 10.1039/c3cp44696d; Brender JR, 2011, BIOPHYS J, V100, P685, DOI 10.1016/j.bpj.2010.09.070; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Burke KA, 2013, BBA-BIOMEMBRANES, V1828, P1953, DOI 10.1016/j.bbamem.2013.04.025; BUTLER PC, 1990, DIABETES, V39, P752, DOI 10.2337/diabetes.39.6.752; Caillon L, 2013, BBA-BIOMEMBRANES, V1828, P2091, DOI 10.1016/j.bbamem.2013.05.014; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Cao P, 2013, P NATL ACAD SCI USA, V110, P19279, DOI 10.1073/pnas.1305517110; Chang WK, 2008, BBA-BIOMEMBRANES, V1778, P2430, DOI 10.1016/j.bbamem.2008.06.016; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Cui HS, 2013, BIOPHYS J, V104, P404, DOI 10.1016/j.bpj.2012.12.006; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293; Gennis R. B., 1989, BIOMEMBRANE, P80; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Heyl DL, 2010, INT J PEPT RES THER, V16, P43, DOI 10.1007/s10989-010-9202-3; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Kumar S, 2015, CHEM BIOL, V22, P369, DOI 10.1016/j.chembiol.2015.01.006; Langham AA, 2008, J AM CHEM SOC, V130, P4338, DOI 10.1021/ja0780380; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; OBRIEN TD, 1994, DIABETES, V43, P329, DOI 10.2337/diabetes.43.2.329; Oren Z, 1998, BIOPOLYMERS, V47, P451; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Pannuzzo M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02781; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Relini A, 2014, ADV COLLOID INTERFAC, V207, P81, DOI 10.1016/j.cis.2013.10.015; RUSTENBECK I, 1994, LIPIDS, V29, P685, DOI 10.1007/BF02538912; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stefanovic AND, 2014, FEBS J, V281, P2838, DOI 10.1111/febs.12824; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Thapa A, 2013, LANGMUIR, V29, P11713, DOI 10.1021/la4020459; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Xu WX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051922; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; Zhang SP, 2014, FASEB J, V28, P5083, DOI 10.1096/fj.14-251744; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	83	28	28	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25782	25793		10.1074/jbc.M115.659797	http://dx.doi.org/10.1074/jbc.M115.659797			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26283787	Green Published, hybrid			2022-12-28	WOS:000363527300001
J	Xiao, JX; Sun, XX; Madhan, B; Brodsky, B; Baum, J				Xiao, Jianxi; Sun, Xiuxia; Madhan, Balaraman; Brodsky, Barbara; Baum, Jean			NMR Studies Demonstrate a Unique AAB Composition and Chain Register for a Heterotrimeric Type IV Collagen Model Peptide Containing a Natural Interruption Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL PEPTIDE; BASEMENT-MEMBRANE; MATRIX METALLOPROTEINASES; MOLECULAR-STRUCTURE; BACKBONE DYNAMICS; NEGATIVE DESIGN; RATIONAL DESIGN; CLEAVAGE SITE; SPECTROSCOPY; STABILITY	All non-fibrillar collagens contain interruptions in the (Gly-X-Y)(n) repeating sequence, such as the more than 20 interruptions found in chains of basement membrane type IV collagen. Two selectively doubly labeled peptides are designed to model a site in type IV collagen with a GVG interruption in the alpha 1(IV) and a corresponding GISLK sequence within the alpha 2(IV) chain. CD and NMR studies on a 2:1 mixture of these two peptides support the formation of a single-component heterotrimer that maintains the one-residue staggering in the triple-helix, has a unique chain register, and contains hydrogen bonds at the interruption site. Formation of hydrogen bonds at interruption sites may provide a driving force for self-assembly and chain register in type IV and other non-fibrillar collagens. This study illustrates the potential role of interruptions in the structure, dynamics, and folding of natural collagen heterotrimers and forms a basis for understanding their biological role.	[Xiao, Jianxi; Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Xiao, Jianxi; Sun, Xiuxia] Lanzhou Univ, Coll Chem & Chem Engn, State Key Lab Appl Organ Chem, Key Lab Nonferrous Met Chem & Resources Utilizat, Lanzhou 730000, Peoples R China; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02446 USA; [Madhan, Balaraman] Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India	Rutgers State University New Brunswick; Lanzhou University; Tufts University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI)	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02446 USA.	barbara.brodsky@tufts.edu; jean.baum@rutgers.edu	Balaraman, Madhan/B-3136-2009; Regan, Clinton/E-6250-2012; Xiao, Jianxi/Q-8692-2017	Balaraman, Madhan/0000-0002-4198-8452; Xiao, Jianxi/0000-0002-9863-572X	National Institutes of Health [GM45302, GM60048]; National Science Foundation [DBI-0403062, DBI-0320746]; National Natural Science Foundation of China [21305056]; Fundamental Research Funds for the Central Universities [lzujbky-2014-73]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM045302, R01GM060048, R01GM045302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM45302 (to J. B.) and GM60048 (to B. B.); National Science Foundation Grants DBI-0403062 and DBI-0320746 (to J. B.); and National Natural Science Foundation of China Grant 21305056 and Fundamental Research Funds for the Central Universities Grant lzujbky-2014-73) (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Bella J, 2014, J STRUCT BIOL, V186, P438, DOI 10.1016/j.jsb.2014.03.022; Boudko SP, 2012, J BIOL CHEM, V287, P44536, DOI 10.1074/jbc.M112.417543; BRAZEL D, 1987, EUR J BIOCHEM, V168, P529, DOI 10.1111/j.1432-1033.1987.tb13450.x; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Fallas JA, 2012, J AM CHEM SOC, V134, P1430, DOI 10.1021/ja209669u; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FURCHT LT, 1994, LAB INVEST, V70, P781; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jalan AA, 2014, J AM CHEM SOC, V136, P7535, DOI 10.1021/ja5001246; Jalan AA, 2013, CURR OPIN CHEM BIOL, V17, P960, DOI 10.1016/j.cbpa.2013.10.019; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; MILES AJ, 1994, J BIOL CHEM, V269, P30939; MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; O'Leary LER, 2011, J AM CHEM SOC, V133, P5432, DOI 10.1021/ja111239r; Palmer Arthur G. Iii, 1993, Current Opinion in Biotechnology, V4, P385, DOI 10.1016/0958-1669(93)90002-E; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; Xiao JX, 2011, BIOCHEMISTRY-US, V50, P10771, DOI 10.1021/bi201476a; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu F, 2012, J AM CHEM SOC, V134, P47, DOI 10.1021/ja2077894; Xu F, 2011, J AM CHEM SOC, V133, P15260, DOI 10.1021/ja205597g; Xu F, 2010, BIOCHEMISTRY-US, V49, P2307, DOI 10.1021/bi902077d; Xu YJ, 2003, BIOCHEMISTRY-US, V42, P8696, DOI 10.1021/bi034006n	49	15	15	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24201	24209		10.1074/jbc.M115.654871	http://dx.doi.org/10.1074/jbc.M115.654871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26209635	Green Published, hybrid			2022-12-28	WOS:000362218900013
J	Libiad, M; Sriraman, A; Banerjee, R				Libiad, Marouane; Sriraman, Anusha; Banerjee, Ruma			Polymorphic Variants of Human Rhodanese Exhibit Differences in Thermal Stability and Sulfur Transfer Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE METABOLISM; HUMAN LIVER RHODANESE; MITOCHONDRIAL RHODANESE; H2S BIOGENESIS; SULFURTRANSFERASE; THIOSULFATE; OXIDATION; SEQUENCE; CYANIDE; DETOXIFICATION	Rhodanese is a component of the mitochondrial H2S oxidation pathway. Rhodanese catalyzes the transfer of sulfane sulfur from glutathione persulfide (GSSH) to sulfite generating thiosulfate and from thiosulfate to cyanide generating thiocyanate. Two polymorphic variations have been identified in the rhodanese coding sequence in the French Caucasian population. The first, 306A -> C, has an allelic frequency of 1% and results in an E102D substitution in the encoded protein. The second polymorphism, 853C -> G, has an allelic frequency of 5% and leads to a P285A substitution. In this study, we have examined differences in the stability between wild-type rhodanese and the E102D and P285A variants and in the kinetics of the sulfur transfer reactions. The Asp-102 and Ala-285 variants are more stable than wild-type rhodanese and exhibit k(cat)/K-m,(CN) values that are 17- and 1.6-fold higher, respectively. All three rhodanese forms preferentially catalyze sulfur transfer from GSSH to sulfite, generating thiosulfate and glutathione. The k(cat)/K-m, sulfite values for the variants in the sulfur transfer reaction from GSSH to sulfite were 1.6- (Asp-102) and 4-fold (Ala-285) lower than for wild-type rhodanese, whereas the k(cat)/K-m, GSSH values were similar for all three enzymes. Thiosulfate-dependent H2S production in murine liver lysate is low, consistent with a role for rhodanese in sulfide oxidation. Our studies show that polymorphic variations that are distant from the active site differentially modulate the sulfurtransferase activity of human rhodanese to cyanide versus sulfite and might be important in differences in susceptibility to diseases where rhodanese dysfunction has been implicated, e.g. inflammatory bowel diseases.	[Libiad, Marouane; Sriraman, Anusha; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Sriraman, Anusha/ABA-6645-2020; Regan, Clinton/E-6250-2012	Sriraman, Anusha/0000-0003-1171-5717; Libiad, Marouane/0000-0003-1717-9206	National Institutes of Health [GM112455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM112455 (to R.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aita N, 1997, BIOCHEM BIOPH RES CO, V231, P56, DOI 10.1006/bbrc.1996.6046; ALEXANDER K, 1987, J BIOL CHEM, V262, P6595; AMINLARI M, 1991, COMP BIOCHEM PHYS B, V99, P673, DOI 10.1016/0305-0491(91)90353-F; Banerjee R, 2015, METHOD ENZYMOL, V554, P189, DOI 10.1016/bs.mie.2014.11.016; Bhattacharyya AM, 2002, BIOCHEMISTRY-US, V41, P2421, DOI 10.1021/bi0115378; Bhattacharyya AM, 2002, BIOCHEMISTRY-US, V41, P422, DOI 10.1021/bi011726q; Billaut-Laden I, 2006, TOXICOLOGY, V225, P1, DOI 10.1016/j.tox.2006.04.054; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JARABAK R, 1974, BIOCHEMISTRY-US, V13, P3233, DOI 10.1021/bi00713a006; Johnson-Winters K, 2010, BIOCHEMISTRY-US, V49, P1290, DOI 10.1021/bi9020296; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; KATO T, 1985, ACTA NEUROL SCAND, V72, P151; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Luebke JL, 2014, MOL MICROBIOL, V94, P1343, DOI 10.1111/mmi.12835; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; OGATA K, 1990, J BIOL CHEM, V265, P8087; OGATA K, 1989, J BIOL CHEM, V264, P2718; Picton R, 2002, GUT, V50, P201, DOI 10.1136/gut.50.2.201; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; Shen JC, 2015, BIOCHEMISTRY-US, V54, P4542, DOI 10.1021/acs.biochem.5b00584; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; SORBO BH, 1955, METHOD ENZYMOL, V2, P334, DOI 10.1016/S0076-6879(55)02207-6; Suarez F, 1998, AM J PHYSIOL-GASTR L, V274, pG727, DOI 10.1152/ajpgi.1998.274.4.G727; Taniguchi E, 2009, TOXICOLOGY, V264, P96, DOI 10.1016/j.tox.2009.07.018; Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938; Tsuge K, 2000, J HEALTH SCI, V46, P343; Vitvitsky V, 2015, METHOD ENZYMOL, V554, P111, DOI 10.1016/bs.mie.2014.11.013; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6	41	33	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23579	23588		10.1074/jbc.M115.675694	http://dx.doi.org/10.1074/jbc.M115.675694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269602	hybrid, Green Published			2022-12-28	WOS:000361816500010
J	Maitra, D; Elenbaas, JS; Whitesall, SE; Basrur, V; D'Alecy, LG; Omary, MB				Maitra, Dhiman; Elenbaas, Jared S.; Whitesall, Steven E.; Basrur, Venkatesha; D'Alecy, Louis G.; Omary, M. Bishr			Ambient Light Promotes Selective Subcellular Proteotoxicity after Endogenous and Exogenous Porphyrinogenic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-ELECTRON REDUCTION; PHOTODYNAMIC THERAPY; PROTOPORPHYRIN-IX; LIVER; HEME; PORPHYRIAS; AGGREGATION; METABOLISM; DISEASE; PROTEIN	Hepatic accumulation of protoporphyrin-IX (PP-IX) in erythropoietic protoporphyria (EPP) or X-linked-dominant protoporphyria (XLP) cause liver damage. Hepatocyte nuclear lamin aggregation is a sensitive marker for PP-IX-mediated liver injury. We tested the hypothesis that extracellular or intracellular protoporphyria cause damage to different subcellular compartments, in a light-triggered manner. Three hepatoma cell lines (HepG2, Hepa-1, and Huh-7) were treated with exogenous PP-IX (mimicking XLP extrahepatic protoporphyria) or with the iron chelator deferoxamine and the porphyrin precursor 5-aminolevulinic acid (ALA) (mimicking intracellular protoporphyrin accumulation in EPP). Exogenous PP-IX accumulated predominantly in the nuclear fraction and caused nuclear shape deformation and cytoplasmic vacuoles containing electron-dense particles, whereas ALA + deferoxamine treatment resulted in higher PP-IX in the cytoplasmic fraction. Protein aggregation in the nuclear and cytoplasmic fractions paralleled PP-IX levels and, in cell culture, the effects were exclusively ambient light-mediated. PP-IX and ALA caused proteasomal inhibition, whereas endoplasmic reticulum protein aggregation was more prominent in ALA-treated cells. The enhanced ALA-related toxicity is likely due to generation of additional porphyrin intermediates including uroporphyrin and coproporphyrin, based on HPLC analysis of cell lysates and the culture medium, as well as cell-free experiments with uroporphyrin/coproporphyrin. Mouse livers from drug-induced porphyria phenocopied the in vitro findings, and mass spectrometry of liver proteins isolated in light/dark conditions showed diminished (as compared with light-harvested) but detectable aggregation under dark-harvested conditions. Therefore, PP-IX leads to endoplasmic reticulum stress and proteasome inhibition in a manner that depends on the source of porphyrin buildup and light exposure. Porphyrin-mediated selective protein aggregation provides a potential mechanism for porphyria-associated tissue injury.	[Maitra, Dhiman; Elenbaas, Jared S.; Whitesall, Steven E.; D'Alecy, Louis G.; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Maitra, D (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci Bldg 2,1137 Catherine St, Ann Arbor, MI 48109 USA.	dhimanm@med.umich.edu	Regan, Clinton/E-6250-2012	, dhiman/0000-0002-8775-2963; Elenbaas, Jared/0000-0002-9612-7764; Omary, Bishr/0000-0002-8624-2347	NIH [DK034933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, P30DK034933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by an institutional grant to the University of Michigan (NIH Grant DK034933).	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Andrzejak M, 2011, AUTOPHAGY, V7, P979, DOI 10.4161/auto.7.9.15865; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Balwani M, 2012, BLOOD, V120, P4496, DOI 10.1182/blood-2012-05-423186; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Barr H, 1996, LANCET, V348, P584, DOI 10.1016/S0140-6736(96)03054-1; Bloomer JR, 1998, J GASTROEN HEPATOL, V13, P324, DOI 10.1111/j.1440-1746.1998.01548.x; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Donohue E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114964; GRANT WE, 1993, LANCET, V342, P147, DOI 10.1016/0140-6736(93)91347-O; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Casanova-Gonzalez MJ, 2010, WORLD J GASTROENTERO, V16, P4526, DOI 10.3748/wjg.v16.i36.4526; KNOBLER E, 1989, HEPATOLOGY, V10, P995, DOI 10.1002/hep.1840100617; KONINGSBERGER JC, 1995, J HEPATOL, V22, P57, DOI 10.1016/0168-8278(95)80260-6; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MOREHOUSE KM, 1990, ARCH BIOCHEM BIOPHYS, V283, P306, DOI 10.1016/0003-9861(90)90647-H; MOREHOUSE KM, 1987, ARCH BIOCHEM BIOPHYS, V257, P276, DOI 10.1016/0003-9861(87)90567-4; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Schaffer M, 2003, CURR PHARM DESIGN, V9, P2024, DOI 10.2174/1381612033454153; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4; To-Figueras J, 2011, BLOOD, V118, P1443, DOI 10.1182/blood-2011-03-342873; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Woods J S, 2001, Curr Protoc Toxicol, VChapter 8, DOI 10.1002/0471140856.tx0809s07	32	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23711	23724		10.1074/jbc.M114.636001	http://dx.doi.org/10.1074/jbc.M114.636001			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26205816	Green Published, hybrid			2022-12-28	WOS:000361816500020
J	Strobel, KL; Pfeiffer, KA; Blanch, HW; Clark, DS				Strobel, Kathryn L.; Pfeiffer, Katherine A.; Blanch, Harvey W.; Clark, Douglas S.			Structural Insights into the Affinity of Cel7A Carbohydrate-binding Module for Lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAM PRETREATED SOFTWOOD; ENZYMATIC-HYDROLYSIS; TRICHODERMA-REESEI; CELLULASE CEL7A; AMINO-ACIDS; SURFACE; INHIBITION; ADSORPTION; CELLOBIOHYDROLASES; LIGNOCELLULOSE	The high cost of hydrolytic enzymes impedes the commercial production of lignocellulosic biofuels. High enzyme loadings are required in part due to their non-productive adsorption to lignin, a major component of biomass. Despite numerous studies documenting cellulase adsorption to lignin, few attempts have been made to engineer enzymes to reduce lignin binding. In this work, we used alanine-scanning mutagenesis to elucidate the structural basis for the lignin affinity of Trichoderma reesei Cel7A carbohydrate binding module (CBM). T. reesei Cel7A CBM mutants were produced with a Talaromyces emersonii Cel7A catalytic domain and screened for their binding to cellulose and lignin. Mutation of aromatic and polar residues on the planar face of the CBM greatly decreased binding to both cellulose and lignin, supporting the hypothesis that the cellulose-binding face is also responsible for lignin affinity. Cellulose and lignin affinity of the 31 mutants were highly correlated, although several mutants displayed selective reductions in lignin or cellulose affinity. Four mutants with increased cellulose selectivity (Q2A, H4A, V18A, and P30A) did not exhibit improved hydrolysis of cellulose in the presence of lignin. Further reduction in lignin affinity while maintaining a high level of cellulose affinity is thus necessary to generate an enzyme with improved hydrolysis capability. This work provides insights into the structural underpinnings of lignin affinity, identifies residues amenable to mutation without compromising cellulose affinity, and informs engineering strategies for family one CBMs.	[Strobel, Kathryn L.; Pfeiffer, Katherine A.; Blanch, Harvey W.; Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Clark, DS (corresponding author), Univ Calif Berkeley, 201 Gilman Hall, Berkeley, CA 94720 USA.	clark@berkeley.edu			Energy Biosciences Institute	Energy Biosciences Institute	This work was supported by the Energy Biosciences Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Alekozai EM, 2014, CELLULOSE, V21, P951, DOI 10.1007/s10570-013-0026-0; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Berlin A, 2005, 26 S BIOT FUELS CHEM, P163, DOI DOI 10.1007/978-1-59259-991-2_14; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borjesson J, 2007, ENZYME MICROB TECH, V41, P186, DOI 10.1016/j.enzmictec.2007.01.003; Dana CM, 2012, BIOTECHNOL BIOENG, V109, P2710, DOI 10.1002/bit.24708; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Ju XH, 2013, BIORESOURCE TECHNOL, V132, P137, DOI 10.1016/j.biortech.2013.01.049; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Kumar R, 2009, BIOTECHNOL PROGR, V25, P807, DOI 10.1002/btpr.153; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Lai CH, 2014, BIORESOURCE TECHNOL, V163, P320, DOI 10.1016/j.biortech.2014.04.065; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Machado DL, 2015, BIOTECHNOL APPL BIOC, V62, P681, DOI 10.1002/bab.1307; Mooney CA, 1998, BIORESOURCE TECHNOL, V64, P113, DOI 10.1016/S0960-8524(97)00181-8; Nakagame S, 2011, BIORESOURCE TECHNOL, V102, P4507, DOI 10.1016/j.biortech.2010.12.082; Nakagame S, 2011, BIOTECHNOL BIOENG, V108, P538, DOI 10.1002/bit.22981; Nakagame S, 2010, BIOTECHNOL BIOENG, V105, P871, DOI 10.1002/bit.22626; NIDETZKY B, 1994, BIOCHEM J, V303, P817, DOI 10.1042/bj3030817; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nordwald EM, 2014, BIOTECHNOL BIOENG, V111, P1541, DOI 10.1002/bit.25216; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Pfeiffer K. A., 2015, BIOTECHNOL BIOENG, DOI 10.1002./bit.25657; Rahikainen J, 2011, BIOTECHNOL BIOENG, V108, P2823, DOI 10.1002/bit.23242; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V133, P270, DOI 10.1016/j.biortech.2013.01.075; Rahikainen JL, 2013, ENZYME MICROB TECH, V53, P315, DOI 10.1016/j.enzmictec.2013.07.003; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V146, P118, DOI 10.1016/j.biortech.2013.07.069; Sammond DW, 2014, J BIOL CHEM, V289, P20960, DOI 10.1074/jbc.M114.573642; Scott BR, 2010, Novel lignin-resistant cellulase enzymes., Patent No. [US-2010/0221778-A1, 20100221778]; Shill K, 2011, BIOTECHNOL BIOENG, V108, P511, DOI 10.1002/bit.23014; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	38	45	47	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22818	22826		10.1074/jbc.M115.673467	http://dx.doi.org/10.1074/jbc.M115.673467			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209638	hybrid, Green Published			2022-12-28	WOS:000361171500044
J	Vogt, AD; Chakraborty, P; Di Cera, E				Vogt, Austin D.; Chakraborty, Pradipta; Di Cera, Enrico			Kinetic Dissection of the Pre-existing Conformational Equilibrium in the Trypsin Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-THROMBOMODULIN COMPLEX; CRYSTAL-STRUCTURE ANALYSIS; COLI ALKALINE-PHOSPHATASE; PROTEIN-C ACTIVATION; LIGAND-BINDING; ACTIVE-SITE; NA+ BINDING; BOVINE TRYPSINOGEN; SERINE PROTEASES; ENZYME SPECIFICITY	Structural biology has recently documented the conformational plasticity of the trypsin fold for both the protease and zymogen in terms of a pre-existing equilibrium between closed (E*) and open (E) forms of the active site region. How such plasticity is manifested in solution and affects ligand recognition by the protease and zymogen is poorly understood in quantitative terms. Here we dissect the E*-E equilibrium with stopped-flow kinetics in the presence of excess ligand or macromolecule. Using the clotting protease thrombin and its zymogen precursor prethrombin-2 as relevant models we resolve the relative distribution of the E* and E forms and the underlying kinetic rates for their interconversion. In the case of thrombin, the E* and E forms are distributed in a 1:4 ratio and interconvert on a time scale of 45 ms. In the case of prethrombin-2, the equilibrium is shifted strongly (10:1 ratio) in favor of the closed E* form and unfolds over a faster time scale of 4.5 ms. The distribution of E* and E forms observed for thrombin and prethrombin-2 indicates that zymogen activation is linked to a significant shift in the pre-existing equilibrium between closed and open conformations that facilitates ligand binding to the active site. These findings broaden our mechanistic understanding of how conformational transitions control ligand recognition by thrombin and its zymogen precursor prethrombin-2 and have direct relevance to other members of the trypsin fold.	[Vogt, Austin D.; Chakraborty, Pradipta; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R29HL049413, U54HL112303, R01HL049413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL73813, and HL112303. The authors declare that they have no conflicts of interest with the contents of this article.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; AYALA YH, 1994, J MOL BIOL, V235, P733, DOI 10.1006/jmbi.1994.1024; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Barranco-Medina S, 2013, J BIOL CHEM, V288, P35749, DOI 10.1074/jbc.M113.509786; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1992, PROTEIN SCI, V1, P426; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2008, NAT CHEM BIOL, V4, P270, DOI 10.1038/nchembio0508-270; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Eigen M, 1968, Q Rev Biophys, V1, P3; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FEHLHAMMER H, 1975, J MOL BIOL, V98, P683, DOI 10.1016/S0022-2836(75)80004-0; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Feixas F, 2014, BIOPHYS CHEM, V186, P31, DOI 10.1016/j.bpc.2013.10.007; Fersht A.R., 1999, ENZYME STRUCTURE MEC; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Fuglestad B, 2013, J PHYS CHEM B, V117, P12857, DOI 10.1021/jp402107u; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Galletto R, 2005, CELL BIOCHEM BIOPHYS, V42, P121, DOI 10.1385/CBB:42:2:121; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; HALFORD SE, 1971, BIOCHEM J, V125, P319, DOI 10.1042/bj1250319; HALFORD SE, 1972, BIOCHEM J, V126, P727, DOI 10.1042/bj1260727; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henry BL, 2014, THROMB RES, V134, P1123, DOI 10.1016/j.thromres.2014.08.024; Hill T.L., 1977, FREE ENERGY TRANSDUC; HORTIN GL, 1991, J BIOL CHEM, V266, P6866; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Lai MT, 1997, J BIOL CHEM, V272, P30275, DOI 10.1074/jbc.272.48.30275; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; LIU LW, 1991, J BIOL CHEM, V266, P16977; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mengwasser KE, 2005, J BIOL CHEM, V280, P26997, DOI 10.1074/jbc.M502678200; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; NEURATH H, 1957, FED PROC, V16, P791; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; OLSON ST, 1981, J BIOL CHEM, V256, P1073; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; Pelc LA, 2015, BIOCHEMISTRY-US, V54, P1457, DOI 10.1021/acs.biochem.5b00014; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Plattner N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8653; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Pozzi N, 2011, BIOPHYS CHEM, V159, P6, DOI 10.1016/j.bpc.2011.04.003; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Rezaie AR, 2003, P NATL ACAD SCI USA, V100, P12051, DOI 10.1073/pnas.2135346100; ROSING J, 1980, J BIOL CHEM, V255, P274; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wyman J., 1990, BINDING AND LINKAGE; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515; Yang LK, 2006, P NATL ACAD SCI USA, V103, P879, DOI 10.1073/pnas.0507700103; Yang LK, 2004, J BIOL CHEM, V279, P38519, DOI 10.1074/jbc.M407304200; YE J, 1991, J BIOL CHEM, V266, P23016	88	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22435	22445		10.1074/jbc.M115.675538	http://dx.doi.org/10.1074/jbc.M115.675538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216877	Green Published, hybrid			2022-12-28	WOS:000361171500010
J	Wang, RS; Chen, SY; Liu, YC; Diao, SY; Xue, YQ; You, XQ; Park, EA; Liao, FF				Wang, Ruishan; Chen, Shaoya; Liu, Yingchun; Diao, Shiyong; Xue, Yueqiang; You, Xiaoqing; Park, Edwards A.; Liao, Francesca-Fang			All-trans-retinoic Acid Reduces BACE1 Expression under Inflammatory Conditions via Modulation of Nuclear Factor kappa B (NF kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELATIONAL MEMORY DEFICIT; TUMOR-NECROSIS-FACTOR; VITAMIN-A-DEFICIENCY; ALZHEIMERS-DISEASE; AMYLOID-BETA; DIFFERENTIAL REGULATION; THERAPEUTIC STRATEGY; PROMOTER ACTIVITY; RECEPTORS; INHIBITION	Insulin resistance and neuroinflammation have emerged as two likely key contributors in the pathogenesis of Alzheimer disease (AD), especially in those sporadic AD cases compromised by diabetes or cardiovascular disease. Amyloid-beta (A beta) deposition and its associated inflammatory response are hallmarks in sporadic AD brains. Elevated expression and activity of beta-secretase 1 (BACE1), the rate-limiting enzyme responsible for the beta-cleavage of amyloid precursor proteins to A beta peptides, are also observed in sporadic AD brains. Previous studies have suggested that there is therapeutic potential for retinoic acid in treating neurodegeneration based on decreased A beta. Here we discovered that BACE1 expression is elevated in the brains of both Tg2576 transgenic mice and mice on high fat diets. These conditions are associated with a neuroinflammatory response. We found that administration of all-trans-retinoic acid (atRA) down-regulated the expression of BACE1 in the brains of Tg2576 mice and in mice fed a high fat diet. Moreover, in LPS-treated mice and cultured neurons, BACE1 expression was repressed by the addition of atRA, correlating with the anti-inflammatory efficacy of atRA. Mutations of the NF kappa B binding site in BACE1 promoter abolished the suppressive effect of atRA. Furthermore, atRA disrupted LPS-induced nuclear translocation of NF kappa B and its binding to BACE1 promoter as well as promoting the recruitment of the corepressor NCoR. Our findings indicate that atRA represses BACE1 gene expression under inflammatory conditions via the modulation of NF kappa B signaling.	[Wang, Ruishan; Chen, Shaoya; Liu, Yingchun; Diao, Shiyong; Xue, Yueqiang; Park, Edwards A.; Liao, Francesca-Fang] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Park, Edwards A.] Dept Vet Affairs Med Ctr, Memphis, TN 38163 USA; [You, Xiaoqing] Fujian Med Univ, Div Cell Biol & Genet, Fuzhou 350004, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Fujian Medical University	Wang, RS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	rwang11@uthsc.edu; fliao@uthsc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 AG031893, R21 AG041934, R21NS083908]; Alzheimer Association [IIRG-11-204030]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031893, R01AG049772, R21AG041934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AG031893 and R21 AG041934 (to F. -F. L.) and R21NS083908 (to F. -F. L. and E. A. P.), and by Alzheimer Association Grant IIRG-11-204030 (to F. -F. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Austenaa LM, 2009, J NUTR BIOCHEM, V20, P726, DOI 10.1016/j.jnutbio.2008.07.002; Austenaa LMI, 2004, FASEB J, V18, P1255, DOI 10.1096/fj.03-1098fje; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Benkoussa M, 2002, MOL CELL BIOL, V22, P4522, DOI 10.1128/MCB.22.13.4522-4534.2002; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Culpan D, 2009, NEUROBIOL AGING, V30, P1052, DOI 10.1016/j.neurobiolaging.2007.10.014; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Dutta A, 2010, CELL ADHES MIGR, V4, P409, DOI 10.4161/cam.4.3.11682; Enderlin V, 1997, NEUROSCI LETT, V229, P125, DOI 10.1016/S0304-3940(97)00424-2; Espinosa-Oliva Ana M, 2013, Methods Mol Biol, V1041, P295, DOI 10.1007/978-1-62703-520-0_26; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Guglielmotto M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.026; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hong K, 2014, IMMUNOL LETT, V162, P34, DOI 10.1016/j.imlet.2014.06.011; Janardhan KS, 2006, HISTOL HISTOPATHOL, V21, P687, DOI 10.14670/HH-21.687; Jimenez-Jimenez FJ, 1999, EUR J NEUROL, V6, P495, DOI 10.1046/j.1468-1331.1999.640495.x; Kampmann E, 2008, J NEUROCHEM, V106, P320, DOI 10.1111/j.1471-4159.2008.05395.x; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kirchmeyer M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2569; Koryakina A, 2009, FEBS J, V276, P2645, DOI 10.1111/j.1742-4658.2009.06992.x; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; Lee HP, 2009, EXPERT REV NEUROTHER, V9, P1615, DOI 10.1586/ERN.09.86; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lerner AJ, 2012, BIOFACTORS, V38, P84, DOI 10.1002/biof.196; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Malaspina A, 2008, J NEUROCHEM, V104, P584, DOI 10.1111/j.1471-4159.2007.05071.x; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marwarha G, 2014, BBA-MOL BASIS DIS, V1842, P1587, DOI 10.1016/j.bbadis.2014.05.015; MEHTA K, 1994, J LEUKOCYTE BIOL, V55, P336, DOI 10.1002/jlb.55.3.336; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; Ono K, 2012, GERIATR GERONTOL INT, V12, P180, DOI 10.1111/j.1447-0594.2011.00786.x; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schmidt CK, 2003, ANAL BIOCHEM, V315, P36, DOI 10.1016/S0003-2697(02)00662-0; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302, DOI 10.2174/156720509788486581; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Valero J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00083; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; ZAMAN Z, 1992, AGE AGEING, V21, P91, DOI 10.1093/ageing/21.2.91; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x; ZITNIK RJ, 1994, J IMMUNOL, V152, P1419	63	54	60	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22532	22542		10.1074/jbc.M115.662908	http://dx.doi.org/10.1074/jbc.M115.662908			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26240147	hybrid, Green Published			2022-12-28	WOS:000361171500020
J	Sophocleous, A; Marino, S; Logan, JG; Mollat, P; Ralston, SH; Idris, AI				Sophocleous, Antonia; Marino, Silvia; Logan, John G.; Mollat, Patrick; Ralston, Stuart H.; Idris, Aymen I.			Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; OSTEOCLAST FUNCTION; CB2; MASS; DIFFERENTIATION; INVOLVEMENT; OSTEOBLAST; STIMULATION; ACTIVATION; LIGANDS	The cannabinoid type 2 receptor (CB2) has previously been implicated as a regulator of tumor growth, bone remodeling, and bone pain. However, very little is known about the role of the skeletal CB2 receptor in the regulation of osteoblasts and osteoclasts changes associated with breast cancer. Here we found that the CB2-selective agonists HU308 and JWH133 reduced the viability of a variety of parental and bone-tropic human and mouse breast cancer cells at high micromolar concentrations. Under conditions in which these ligands are used at the nanomolar range, HU308 and JWH133 enhanced human and mouse breast cancer cell-induced osteoclastogenesis and exacerbated osteolysis, and these effects were attenuated in cultures obtained from CB2-deficient mice or in the presence of a CB2 receptor blocker. HU308 and JWH133 had no effects on osteoblast growth or differentiation in the presence of conditioned medium from breast cancer cells, but under these circumstances both agents enhanced parathyroid hormone-induced osteoblast differentiation and the ability to support osteoclast formation. Mechanistic studies in osteoclast precursors and osteoblasts showed that JWH133 and HU308 induced PI3K/AKT activity in a CB2-dependent manner, and these effects were enhanced in the presence of osteolytic and osteoblastic factors such as RANKL (receptor activator of NF kappa B ligand) and parathyroid hormone. When combined with published work, these findings suggest that breast cancer and bone cells exhibit differential responses to treatment with CB2 ligands depending upon cell type and concentration used. We, therefore, conclude that both CB2-selective activation and antagonism have potential efficacy in cancer-associated bone disease, but further studies are warranted and ongoing.	[Marino, Silvia; Idris, Aymen I.] Mellanby Ctr Bone Res, Dept Human Metab, Acad Unit Bone Biol, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Sophocleous, Antonia; Marino, Silvia; Logan, John G.; Idris, Aymen I.] Univ Edinburgh, Western Gen Hosp, Edinburgh Canc Res Ctr, Bone & Canc Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Sophocleous, Antonia; Logan, John G.; Ralston, Stuart H.] Univ Edinburgh, MRC Inst Genet & Mol Med, Ctr Genom & Expt Med, Rheumatol & Bone Dis Unit,Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Mollat, Patrick] Galapagos SASU, F-93230 Romainville, France	University of Edinburgh; University of Edinburgh; Galapagos NV	Idris, AI (corresponding author), Mellanby Ctr Bone Res, Dept Human Metab, Acad Unit Bone Biol, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	aymen.idris@sheffield.ac.uk	Idris, Aymen I/AAX-1138-2020	Idris, Aymen I/0000-0003-4327-5306; Sophocleous, Antonia/0000-0003-0854-1429; Logan, John/0000-0003-2801-700X	European Calcified Tissue International Society/AMGEN (ECTS/AMGEN) fellowship; Arthritis Research UK [17713]; Versus Arthritis [17713] Funding Source: researchfish	European Calcified Tissue International Society/AMGEN (ECTS/AMGEN) fellowship; Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This work was supported in part by an European Calcified Tissue International Society/AMGEN (ECTS/AMGEN) fellowship grant (to A. I.) and a grant from the Arthritis Research UK (17713). Dr. A. I. Idris and Prof. S. H. Ralston are co-inventors on a patent claiming the use of cannabinoid receptor ligands as treatments for bone disease. Patrick Mollat is an employee of Galapagos SASU.	Aitken SJ, 2009, ARCH BIOCHEM BIOPHYS, V482, P96, DOI 10.1016/j.abb.2008.11.012; Bakker A., 2003, BONE RES PROTOCOLS, P183; Bhattacharjee R, 2009, BIOCHEM BIOPH RES CO, V382, P440, DOI 10.1016/j.bbrc.2009.03.044; Bifulco M, 2008, ENDOCR-RELAT CANCER, V15, P391, DOI 10.1677/ERC-07-0258; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Caffarel MM, 2008, ONCOGENE, V27, P5033, DOI 10.1038/onc.2008.145; Caffarel MM, 2012, CANCER TREAT REV, V38, P911, DOI 10.1016/j.ctrv.2012.06.005; Curto-Reyes V, 2010, BRIT J PHARMACOL, V160, P561, DOI 10.1111/j.1476-5381.2009.00629.x; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Garret R., 2012, BONE RES PROTOCOLS, V816, P545; Grimaldi C, 2006, EXP CELL RES, V312, P363, DOI 10.1016/j.yexcr.2005.10.024; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Idris AI, 2008, ENDOCRINOLOGY, V149, P5619, DOI 10.1210/en.2008-0150; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Idris AI, 2009, CELL METAB, V10, P139, DOI 10.1016/j.cmet.2009.07.006; Lozano-Ondoua AN, 2013, J BONE MINER RES, V28, P92, DOI 10.1002/jbmr.1732; Lozano-Ondoua AN, 2010, LIFE SCI, V86, P646, DOI 10.1016/j.lfs.2010.02.014; Lutz B, 2002, PROSTAG LEUKOTR ESS, V66, P123, DOI 10.1054/plef.2001.0342; Manera C, 2012, EUR J MED CHEM, V52, P284, DOI 10.1016/j.ejmech.2012.03.031; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; MUNSON AE, 1975, J NATL CANCER I, V55, P597, DOI 10.1093/jnci/55.3.597; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Rhee MH, 1998, J NEUROCHEM, V71, P1525; Ross FP, 2006, ANN NY ACAD SCI, V1068, P110, DOI 10.1196/annals.1346.014; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Sophocleous A, 2014, CALCIFIED TISSUE INT, V94, P259, DOI 10.1007/s00223-013-9793-8; Sophocleous A, 2011, ENDOCRINOLOGY, V152, P2141, DOI 10.1210/en.2010-0930; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Whyte LS, 2012, BRIT J PHARMACOL, V165, P2584, DOI 10.1111/j.1476-5381.2011.01519.x; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Xian XS, 2010, J CELL BIOCHEM, V110, P321, DOI 10.1002/jcb.22540; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	43	26	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22049	22060		10.1074/jbc.M115.649608	http://dx.doi.org/10.1074/jbc.M115.649608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195631	Green Published, hybrid			2022-12-28	WOS:000360968500024
J	Zheng, LJ; Farrell, DM; Fulton, RM; Bagg, EE; Salcedo, E; Manino, M; Britt, SG				Zheng, Lijun; Farrell, David M.; Fulton, Ruth M.; Bagg, Eve E.; Salcedo, Ernesto; Manino, Meridee; Britt, Steven G.			Analysis of Conserved Glutamate and Aspartate Residues in Drosophila Rhodopsin 1 and Their Influence on Spectral Tuning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINYLIDENE SCHIFF-BASE; DOMINANT RETINITIS-PIGMENTOSA; SITE-DIRECTED MUTAGENESIS; VISUAL PIGMENTS; BOVINE RHODOPSIN; MOLECULAR-DYNAMICS; COUNTERION SWITCH; SQUID RHODOPSIN; INVERTEBRATE PHOTORECEPTORS; RETINAL CHROMOPHORE	The molecular mechanisms that regulate invertebrate visual pigment absorption are poorly understood. Studies of amphioxus G(o)-opsin have demonstrated that Glu-181 functions as the counterion in this pigment. This finding has led to the proposal that Glu-181 may function as the counterion in other invertebrate visual pigments as well. Here we describe a series of mutagenesis experiments to test this hypothesis and to also test whether other conserved acidic amino acids in Drosophila Rhodopsin 1 (Rh1) may serve as the counterion of this visual pigment. Of the 5 Glu and Asp residues replaced by Gln or Asn in our experiments, none of the mutant pigments shift the absorption of Rh1 by more than 6 nm. In combination with prior studies, these results suggest that the counterion in Drosophila Rh1 may not be located at Glu-181 as in amphioxus, or at Glu-113 as in bovine rhodopsin. Conversely, the extremely low steady state levels of the E194Q mutant pigment (bovine opsin site Glu-181), and the rhabdomere degeneration observed in flies expressing this mutant demonstrate that a negatively charged residue at this position is essential for normal rhodopsin function in vivo. This work also raises the possibility that another residue or physiologic anion may compensate for the missing counterion in the E194Q mutant.	[Zheng, Lijun; Fulton, Ruth M.; Bagg, Eve E.; Salcedo, Ernesto; Manino, Meridee; Britt, Steven G.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Farrell, David M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado, Sch Med, Dept Ophthalmol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado, Sch Med, Rocky Mt Lions Eye Inst, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Britt, SG (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	steve.britt@ucdenver.edu	Britt, Steven/GVT-1340-2022	Britt, Steven/0000-0001-7656-7984	National Science Foundation [IOB-0449367]; National Eye Institute [R01-EY10759]; NATIONAL EYE INSTITUTE [R01EY010759] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Science Foundation Grant IOB-0449367 and National Eye Institute Grant R01-EY10759 (to S. G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Baudry J, 1997, J CHEM INF COMP SCI, V37, P1018, DOI 10.1021/ci9702398; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BUNGE S, 1993, GENOMICS, V17, P230, DOI 10.1006/geno.1993.1309; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chou WH, 1999, DEVELOPMENT, V126, P607; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DECALUWE GLJ, 1995, BIOPHYS CHEM, V56, P79, DOI 10.1016/0301-4622(95)00018-S; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; GOMEZ MD, 1994, J GEN PHYSIOL, V103, P939, DOI 10.1085/jgp.103.6.939; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JANSSEN JJM, 1990, FEBS LETT, V260, P113, DOI 10.1016/0014-5793(90)80080-3; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KIRSCHFELD K, 1977, BIOPHYS STRUCT MECH, V3, P191, DOI 10.1007/BF00535818; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; KOUTALOS Y, 1989, BIOCHEMISTRY-US, V28, P2732, DOI 10.1021/bi00432a055; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Kusnetzow AK, 2004, P NATL ACAD SCI USA, V101, P941, DOI 10.1073/pnas.0305206101; Lewis JW, 2004, BIOCHEMISTRY-US, V43, P12614, DOI 10.1021/bi049581l; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Nagata T, 1998, BIOCHEMISTRY-US, V37, P17216, DOI 10.1021/bi9810149; Nagata T, 2002, J PHYS CHEM A, V106, P1969, DOI 10.1021/jp0124488; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; NINA M, 1995, BIOPHYS J, V68, P25, DOI 10.1016/S0006-3495(95)80184-0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OSTROY SE, 1978, J GEN PHYSIOL, V72, P717, DOI 10.1085/jgp.72.5.717; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Ramos LS, 2007, BIOCHEMISTRY-US, V46, P5330, DOI 10.1021/bi700138g; SAGA M, 1994, OPHTHALMIC GENET, V15, P61, DOI 10.3109/13816819409098865; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salcedo E, 2003, J NEUROSCI, V23, P10873; Salcedo E, 2009, J BIOL CHEM, V284, P5717, DOI 10.1074/jbc.M807368200; Sekharan S, 2010, CHEM-EUR J, V16, P1744, DOI 10.1002/chem.200903194; Sekharan S, 2009, PHOTOCHEM PHOTOBIOL, V85, P517, DOI 10.1111/j.1751-1097.2008.00499.x; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; To K, 2000, AM J OPHTHALMOL, V130, P790, DOI 10.1016/S0002-9394(00)00559-6; VANDERMEER JM, 1983, DEV BIOL, V95, P249, DOI 10.1016/0012-1606(83)90025-8; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yamashita T, 2013, BIOCHEMISTRY-US, V52, P1192, DOI 10.1021/bi3016058; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Yan ECY, 2002, BIOCHEMISTRY-US, V41, P3620, DOI 10.1021/bi0160011; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	79	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21951	21961		10.1074/jbc.M115.677765	http://dx.doi.org/10.1074/jbc.M115.677765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195627	Green Published, hybrid			2022-12-28	WOS:000360968500016
J	Martinez, J; Truffault, V; Hothorn, M				Martinez, Jacobo; Truffault, Vincent; Hothorn, Michael			Structural Determinants for Substrate Binding and Catalysis in Triphosphate Tunnel Metalloenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA CAPPING ENZYME; 25-KDA THIAMINE TRIPHOSPHATASE; IV ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; POLYPHOSPHATE KINASE; 2-METAL MECHANISM; ESCHERICHIA-COLI; SUPERFAMILY; PROTEINS	Triphosphate tunnel metalloenzymes (TTMs) are present in all kingdoms of life and catalyze diverse enzymatic reactions such as mRNA capping, the cyclization of adenosine triphosphate, the hydrolysis of thiamine triphosphate, and the synthesis and breakdown of inorganic polyphosphates. TTMs have an unusual tunnel domain fold that harbors substrate-and metal co-factor binding sites. It is presently poorly understood how TTMs specifically sense different triphosphate-containing substrates and how catalysis occurs in the tunnel center. Here we describe substrate-bound structures of inorganic polyphosphatases from Arabidopsis and Escherichia coli, which reveal an unorthodox yet conserved mode of triphosphate and metal cofactor binding. We identify two metal binding sites in these enzymes, with one co-factor involved in substrate coordination and the other in catalysis. Structural comparisons with a substrate- and product-bound mammalian thiamine triphosphatase and with previously reported structures of mRNA capping enzymes, adenylate cyclases, and polyphosphate polymerases suggest that directionality of substrate binding defines TTM catalytic activity. Our work provides insight into the evolution and functional diversification of an ancient enzyme family.	[Martinez, Jacobo; Hothorn, Michael] Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, CH-1211 Geneva, Switzerland; [Truffault, Vincent] Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany	University of Geneva; Max Planck Society	Hothorn, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, Sci 3, 30 Quai E Ansermet, CH-1211 Geneva, Switzerland.	michael.hothorn@unige.ch		Hothorn, Michael/0000-0002-3597-5698	European Research Council under the European Union's Seventh Framework Programme/ERC [310856]; Max Planck Society; European Molecular Biology Organisation (EMBO) Young Investigator Programme	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Max Planck Society(Max Planck Society); European Molecular Biology Organisation (EMBO) Young Investigator Programme	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement 310856, the Max Planck Society, and the European Molecular Biology Organisation (EMBO) Young Investigator Programme (to MH). The authors declare that they have no conflicts of interest with the contents of this article.	AHN KH, 1990, J BIOL CHEM, V265, P11734; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Benarroch D, 2008, STRUCTURE, V16, P501, DOI 10.1016/j.str.2008.01.009; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Bettendorff L, 2013, FEBS J, V280, P6443, DOI 10.1111/febs.12498; Bisaillon M, 2001, J BIOL CHEM, V276, P17261, DOI 10.1074/jbc.M100980200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delvaux D, 2013, BBA-GEN SUBJECTS, V1830, P4513, DOI 10.1016/j.bbagen.2013.05.014; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gerasimaite R, 2014, J CELL SCI, V127, P5093, DOI 10.1242/jcs.159772; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Gong CL, 2003, VIROLOGY, V309, P125, DOI 10.1016/S0042-6822(03)00002-3; Gong CL, 2002, J BIOL CHEM, V277, P15317, DOI 10.1074/jbc.M200532200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Kohn G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043879; KORNBERG SR, 1957, BIOCHIM BIOPHYS ACTA, V26, P294, DOI 10.1016/0006-3002(57)90008-2; Kyrieleis OJP, 2014, STRUCTURE, V22, P452, DOI 10.1016/j.str.2013.12.014; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Martins A, 2003, NUCLEIC ACIDS RES, V31, P1455, DOI 10.1093/nar/gkg244; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeder W, 2013, PLANT J, V76, P615, DOI 10.1111/tpj.12325; Pei Y, 2001, NUCLEIC ACIDS RES, V29, P387, DOI 10.1093/nar/29.2.387; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	46	18	19	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23348	23360		10.1074/jbc.M115.674473	http://dx.doi.org/10.1074/jbc.M115.674473			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26221030	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000361685500041
J	Zhu, ST; Vik, SB				Zhu, Shaotong; Vik, Steven B.			Constraining the Lateral Helix of Respiratory Complex I by Cross-linking Does Not Impair Enzyme Activity or Proton Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI NDH-1; NADH-QUINONE OXIDOREDUCTASE; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; 3-DIMENSIONAL STRUCTURE; MEMBRANE DOMAIN; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ATP SYNTHASE; SUBUNIT NUOL	Complex I (NADH: ubiquinone oxidoreductase) is a multisubunit, membrane-bound enzyme of the respiratory chain. The energy from NADH oxidation in the peripheral region of the enzyme is used to drive proton translocation across the membrane. One of the integral membrane subunits, nuoL in Escherichia coli, has an unusual lateral helix of similar to 75 residues that lies parallel to the membrane surface and has been proposed to play a mechanical role as a piston during proton translocation (Efremov, R. G., Baradaran, R., and Sazanov, L. A. (2010) Nature 465, 441-445). To test this hypothesis we have introduced 11 pairs of cysteine residues into Complex I; in each pair one is in the lateral helix, and the other is in a nearby region of subunit N, M, or L. The double mutants were treated with Cu2+ ions or with bi-functional methanethiosulfonate reagents to catalyze cross-link formation in membrane vesicles. The yields of cross-linked products were typically 50-90%, as judged by immunoblotting, but in no case did the activity of Complex I decrease by >10-20%, as indicated by deamino-NADH oxidase activity or rates of proton translocation. In contrast, several pairs of cysteine residues introduced at other interfaces of N:M and M: L subunits led to significant loss of activity, in particular, in the region of residue Glu-144 of subunit M. The results do not support the hypothesis that the lateral helix of subunit L functions like a piston, but rather, they suggest that conformational changes might be transmitted more directly through the functional residues of the proton translocation apparatus.	[Zhu, Shaotong; Vik, Steven B.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	Southern Methodist University	Vik, SB (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	svik@smu.edu	Regan, Clinton/E-6250-2012; zhu, shaotong/ABE-6352-2020	ZHU, SHAOTONG/0000-0002-5066-3166; Vik, Steven/0000-0002-5285-015X	National Institutes of Health [R15GM099014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM099014. The authors declare that they have no conflicts of interest with the contents of this article.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Belevich G, 2011, MOL MICROBIOL, V82, P1086, DOI 10.1111/j.1365-2958.2011.07883.x; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LEONARD K, 1987, J MOL BIOL, V194, P277, DOI 10.1016/0022-2836(87)90375-5; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2010, NATURE, V465, P428, DOI 10.1038/465428a; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Sato M, 2013, J BIOL CHEM, V288, P24705, DOI 10.1074/jbc.M113.482968; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steimle S, 2012, FEBS LETT, V586, P699, DOI 10.1016/j.febslet.2012.01.056; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2012, J BIOL CHEM, V287, P42763, DOI 10.1074/jbc.M112.422824; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	40	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20761	20773		10.1074/jbc.M115.660381	http://dx.doi.org/10.1074/jbc.M115.660381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134569	Green Published, hybrid			2022-12-28	WOS:000360011800014
J	Alam, MS; Choudhary, V; Zeeshan, M; Tyagi, RK; Rathore, S; Sharma, YD				Alam, Mohd Shoeb; Choudhary, Vandana; Zeeshan, Mohammad; Tyagi, Rupesh K.; Rathore, Sumit; Sharma, Yagya D.			Interaction of Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; SIALIC-ACID; INVASION; FALCIPARUM; MALARIA; MEMBRANE; RECEPTOR; BINDING; PROTEIN; MEROZOITES	Plasmodium tryptophan-rich proteins are involved in host-parasite interaction and thus potential drug/vaccine targets. Recently, we have described several P. vivax tryptophan-rich antigens (PvTRAgs), including merozoite expressed PvTRAg38, from this noncultivable human malaria parasite. PvTRAg38 is highly immunogenic in humans and binds to host erythrocytes, and this binding is inhibited by the patient sera. This binding is also affected if host erythrocytes were pretreated with chymotrypsin. Here, Band 3 has been identified as the chymotrypsinsensitive erythrocyte receptor for this parasite protein. Interaction of PvTRAg38 with Band 3 has been mapped to its three different ectodomains (loops 1, 3, and 6) exposed at the surface of the erythrocyte. The binding region of PvTRAg38 to Band 3 has been mapped to its sequence, KWVQWKNDKIR-SWLSSEW, present at amino acid positions 197-214. The recombinant PvTRAg38 was able to inhibit the parasite growth in in vitro Plasmodium falciparum culture probably by competing with the ligand(s) of this heterologous parasite for the erythrocyte Band 3 receptor. In conclusion, the host-parasite interaction at the molecular level is much more complicated than known so far and should be considered during the development of anti-malarial therapeutics.	[Alam, Mohd Shoeb; Choudhary, Vandana; Zeeshan, Mohammad; Tyagi, Rupesh K.; Rathore, Sumit; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma@hotmail.com		Tyagi, Rupesh/0000-0002-5095-8976	Department of Biotechnology [BT/PR9800/MED/29/44/2007]; Indian Council for Medical Research [61/4/2012-BMS]; DST-INSA INSPIRE faculty fellowship from the Department of Science and Technology; Council of Scientific and Industrial Research; Department of Biotechnology	Department of Biotechnology; Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); DST-INSA INSPIRE faculty fellowship from the Department of Science and Technology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by Department of Biotechnology Grant BT/PR9800/MED/29/44/2007, by Indian Council for Medical Research Grant 61/4/2012-BMS; by a DST-INSA INSPIRE faculty fellowship (to S. R.) from the Department of Science and Technology; by senior research fellowships from the Council of Scientific and Industrial Research (to M. S. A. and V. C.), and by funds from the Department of Biotechnology (to M. Z. and R. K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin M, 2014, BBA-MOL CELL RES, V1843, P2855, DOI 10.1016/j.bbamcr.2014.08.008; BENNETT V, 1980, J BIOL CHEM, V255, P2540; Bhalla K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7049; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Burns JM, 1997, INFECT IMMUN, V65, P3138, DOI 10.1128/IAI.65.8.3138-3145.1997; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; CASEY JR, 1989, METHOD ENZYMOL, V173, P494; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; CLOUGH B, 1995, MOL BIOCHEM PARASIT, V69, P19, DOI 10.1016/0166-6851(94)00185-P; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Ipsaro JJ, 2008, BIOCHEMISTRY-US, V47, P7452, DOI 10.1021/bi702525z; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Koganei A, 2007, J IMMUNOTOXICOL, V4, P77, DOI 10.1080/15476910601161691; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; Kushwaha A, 2002, MOL BIOCHEM PARASIT, V122, P45, DOI 10.1016/S0166-6851(02)00077-4; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1983, J CLIN INVEST, V72, P1357, DOI 10.1172/JCI111092; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Naing C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003071; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; OKOYE VCN, 1985, SCIENCE, V227, P169, DOI 10.1126/science.3880920; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Roggwiller E, 1996, MOL BIOCHEM PARASIT, V82, P13, DOI 10.1016/0166-6851(96)02714-4; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; SORETTE MP, 1991, BLOOD, V77, P628; Tran TM, 2005, CYTOM PART A, V63A, P59, DOI 10.1002/cyto.a.20098; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650	40	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20257	20272		10.1074/jbc.M115.644906	http://dx.doi.org/10.1074/jbc.M115.644906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149684	hybrid, Green Published			2022-12-28	WOS:000359608900026
J	Cui, XB; Luan, JN; Chen, SY				Cui, Xiao-Bing; Luan, Jun-Na; Chen, Shi-You			RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHESIS; SMOOTH-MUSCLE DIFFERENTIATION; ALCOHOLIC LIVER-DISEASE; NEURAL CREST CELLS; INSULIN-RESISTANCE; RESPONSE GENE; TRANSCRIPTION FACTOR; COMPLEMENT 32; SREBP-1C TRANSCRIPTION	Hepatic steatosis is associated with insulin resistance and metabolic syndrome because of increased hepatic triglyceride content. We have reported previously that deficiency of response gene to complement 32 (RGC-32) prevents high-fat diet (HFD)-induced obesity and insulin resistance in mice. This study was conducted to determine the role of RGC-32 in the regulation of hepatic steatosis. We observed that hepatic RGC-32 was induced dramatically by both HFD challenge and ethanol administration. RGC-32 knockout (RGC32(-/-)) mice were resistant to HFD- and ethanol-induced hepatic steatosis. The hepatic triglyceride content of RGC32(-/-) mice was decreased significantly compared with WT controls even under normal chow conditions. Moreover, RGC-32 deficiency decreased the expression of lipogenesis-related genes, sterol regulatory element binding protein 1c (SREBP-1c), fatty acid synthase, and stearoyl-CoA desaturase 1 (SCD1). RGC-32 deficiency also decreased SCD1 activity, as indicated by decreased desaturase indices of the liver and serum. Mechanistically, insulin and ethanol induced RGC-32 expression through the NF-kappa B signaling pathway, which, in turn, increased SCD1 expression in a SREBP-1c-dependent manner. RGC-32 also promoted SREBP-1c expression through activating liver X receptor. These results demonstrate that RGC-32 contributes to the development of hepatic steatosis by facilitating de novo lipogenesis through activating liver X receptor, leading to the induction of SREBP-1c and its target genes. Therefore, RGC-32 may be a potential novel drug target for the treatment of hepatic steatosis and its related diseases.	[Cui, Xiao-Bing; Luan, Jun-Na; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Chen, Shi-You] Hubei Med Univ, Inst Clin Med, Renmin Hosp, Shiyan 442000, Hubei, Peoples R China; [Chen, Shi-You] Hubei Med Univ, Dept Cardiol, Renmin Hosp, Shiyan 442000, Hubei, Peoples R China	University System of Georgia; University of Georgia	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	sc229@uga.edu	Regan, Clinton/E-6250-2012; Cui, Xiaobing/B-1583-2017	Cui, Xiaobing/0000-0003-1272-9563	National Institutes of Health [HL119053, HL123302]; National Natural Science Foundation of China [81328002]; American Heart Association [14POST20480015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107526, R01HL119053, R01HL123302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL119053 and HL123302. This work was also supported by National Natural Science Foundation of China Grant 81328002. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by American Heart Association Postdoctoral Fellowship 14POST20480015.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Badea TC, 1998, J BIOL CHEM, V273, P26977, DOI 10.1074/jbc.273.41.26977; Boileau P, 2002, DIABETES, V51, pS343, DOI 10.2337/diabetes.51.2007.S343; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Cui XB, 2015, J ENDOCRINOL, V224, P127, DOI 10.1530/JOE-14-0548; Cui XB, 2013, CARDIOVASC RES, V99, P632, DOI 10.1093/cvr/cvt121; Cui XB, 2012, CARDIOVASC RES, V93, P69, DOI 10.1093/cvr/cvr273; Dobrzyn A, 2005, OBES REV, V6, P169, DOI 10.1111/j.1467-789X.2005.00177.x; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; Ge XD, 2014, J BIOL CHEM, V289, P22672, DOI 10.1074/jbc.M114.552141; Guo SZ, 2014, INT J CLIN EXP MED, V7, P2541; Hofacer R, 2012, PROSTAG LEUKOTR ESS, V86, P71, DOI 10.1016/j.plefa.2011.10.003; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Kim DS, 2011, CANCER-AM CANCER SOC, V117, P590, DOI 10.1002/cncr.25451; Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Li ZG, 2011, J BIOL CHEM, V286, P41323, DOI 10.1074/jbc.M111.259184; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Tateya S, 2013, DIABETES, V62, P1913, DOI 10.2337/db12-0325; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Vlaicu SI, 2010, EXP MOL PATHOL, V88, P67, DOI 10.1016/j.yexmp.2009.10.010; Wada S, 2008, J HEPATOL, V49, P441, DOI 10.1016/j.jhep.2008.04.026; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921; Yin HQ, 2007, TOXICOL APPL PHARM, V223, P225, DOI 10.1016/j.taap.2007.06.018; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	49	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20387	20395		10.1074/jbc.M114.630186	http://dx.doi.org/10.1074/jbc.M114.630186			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134570	hybrid, Green Published			2022-12-28	WOS:000359608900036
J	Tarhonskaya, H; Hardy, AP; Howe, EA; Loik, ND; Kramer, HB; McCullagh, JSO; Schofield, CJ; Flashman, E				Tarhonskaya, Hanna; Hardy, Adam P.; Howe, Emily A.; Loik, Nikita D.; Kramer, Holger B.; McCullagh, James S. O.; Schofield, Christopher J.; Flashman, Emily			Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOGLUTARATE DIOXYGENASE TAUD; ANKYRIN REPEAT DOMAIN; RENAL-CELL CARCINOMA; PROLYL HYDROXYLASE 2; SPIN FE(IV) COMPLEX; ASPARAGINYL HYDROXYLASE; ESCHERICHIA-COLI; 2-OXOGLUTARATE OXYGENASES; TRANSACTIVATION DOMAIN; SUBSTRATE SELECTIVITY	The hypoxia-inducible factor (HIF) hydroxylases regulate hypoxia sensing in animals. In humans, they comprise three prolyl hydroxylases (PHD1-3 or EGLN1-3) and factor inhibiting HIF (FIH). FIH is an asparaginyl hydroxylase catalyzing post-translational modification of HIF-alpha, resulting in reduction of HIF-mediated transcription. Like the PHDs, FIH is proposed to have a hypoxia-sensing role in cells, enabling responses to changes in cellular O-2 availability. PHD2, the most important human PHD isoform, is proposed to be biochemically/kinetically suited as a hypoxia sensor due to its relatively high sensitivity to changes in O-2 concentration and slow reaction with O-2. To ascertain whether these parameters are conserved among the HIF hydroxylases, we compared the reactions of FIH and PHD2 with O-2. Consistent with previous reports, we found lower K-m(app)(O-2) values for FIH than for PHD2 with all HIF-derived substrates. Under pre-steady-state conditions, the O-2-initiated FIH reaction is significantly faster than that of PHD2. We then investigated the kinetics with respect to O-2 of the FIH reaction with ankyrin repeat domain (ARD) substrates. FIH has lower K-m(app)(O-2) values for the tested ARDs than HIF-alpha substrates, and pre-steady-state O-2-initiated reactions were faster with ARDs than with HIF-alpha substrates. The results correlate with cellular studies showing that FIH is active at lower O-2 concentrations than the PHDs and suggest that competition between HIF-alpha and ARDs for FIH is likely to be biologically relevant, particularly in hypoxic conditions. The overall results are consistent with the proposal that the kinetic properties of individual oxygenases reflect their biological capacity to act as hypoxia sensors.	[Tarhonskaya, Hanna; Hardy, Adam P.; Howe, Emily A.; Loik, Nikita D.; McCullagh, James S. O.; Schofield, Christopher J.; Flashman, Emily] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Kramer, Holger B.] Univ Oxford, OXION Prote Facil, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Oxford; University of Oxford	Flashman, E (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	emily.flashman@chem.ox.ac.uk	Kramer, Holger/AAL-4433-2020; McCullagh, James/AAD-2669-2022	Kramer, Holger/0000-0002-6400-0945; McCullagh, James/0000-0003-4733-1205; Schofield, Christopher/0000-0002-0290-6565; Flashman, Emily/0000-0002-4169-4278	Cancer Research UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Clarendon-St Hugh's College-W. Louey Scholarship; Royal Society Dorothy Hodgkin Fellowship; L'Oreal-UNESCO For Women in Science Fellowship; Biotechnology and Biological Sciences Research Council [BB/J003018/1] Funding Source: researchfish; British Heart Foundation [PG/12/33/29546] Funding Source: researchfish; Cancer Research UK [18245, 16466] Funding Source: researchfish; BBSRC [BB/J003018/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Clarendon-St Hugh's College-W. Louey Scholarship; Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); L'Oreal-UNESCO For Women in Science Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Research UK, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the British Heart Foundation, the Clarendon-St Hugh's College-W. Louey Scholarship (to H. T.), and a Royal Society Dorothy Hodgkin Fellowship and L'Oreal-UNESCO For Women in Science Fellowship (to E. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Brocato J, 2014, MOL PHARMACOL, V85, P651, DOI 10.1124/mol.113.089623; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Flagg SC, 2012, BIOCHEMISTRY-US, V51, P6654, DOI 10.1021/bi300229y; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Hangasky JA, 2013, BIOCHEMISTRY-US, V52, P1594, DOI 10.1021/bi3015482; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Liu Y, 2013, BIOCHEM BIOPH RES CO, V432, P22, DOI 10.1016/j.bbrc.2013.01.093; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Loenarz C, 2009, ANGEW CHEM INT EDIT, V48, P1784, DOI 10.1002/anie.200805427; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Palmer BF, 2014, MOL CELL ENDOCRINOL, V397, P51, DOI 10.1016/j.mce.2014.08.001; Pavel EG, 1998, J AM CHEM SOC, V120, P743, DOI 10.1021/ja972408a; Pektas S, 2013, J INORG BIOCHEM, V126, P55, DOI 10.1016/j.jinorgbio.2013.05.006; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Sang NL, 2002, MOL CELL BIOL, V22, P2984, DOI 10.1128/MCB.22.9.2984-2992.2002; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scotti JS, 2014, P NATL ACAD SCI USA, V111, P13331, DOI 10.1073/pnas.1409916111; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Tarhonskaya H, 2014, BIOCHEM J, V463, P363, DOI 10.1042/BJ20140779; Tarhonskaya H, 2014, BIOCHEMISTRY-US, V53, P2483, DOI 10.1021/bi500086p; Tarhonskaya H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4423; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Wilkins SE, 2012, J BIOL CHEM, V287, P8769, DOI 10.1074/jbc.M111.294678; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x	62	55	57	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19726	19742		10.1074/jbc.M115.653014	http://dx.doi.org/10.1074/jbc.M115.653014			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26112411	Green Published, hybrid			2022-12-28	WOS:000359364600031
J	Tong, ZW; Li, M; Wang, W; Mo, PL; Yu, L; Liu, K; Ren, WJ; Li, WG; Zhang, H; Xu, JM; Yu, CD				Tong, Zhangwei; Li, Ming; Wang, Wei; Mo, Pingli; Yu, Li; Liu, Kun; Ren, Wenjing; Li, Wengang; Zhang, Hao; Xu, Jianming; Yu, Chundong			Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B-VIRUS; BETA-CATENIN; TRANSCRIPTIONAL COACTIVATOR; ANDROGEN RECEPTOR; CELL-GROWTH; C-MYC; EXPRESSION; PROTEINS; SRC-1; AIB1	Steroid receptor coactivator 1 (SRC-1) is a transcriptional coactivator not only for steroid receptors, such as androgen receptor and estrogen receptor, but also for other transcription factors. SRC-1 has been shown to play an important role in the progression of breast cancer and prostate cancer. However, its role in liver cancer progression remains unknown. In this study, we report that SRC-1 was overexpressed in 25 (62.5%) of 40 human hepatocellular carcinoma (HCC) specimens. Down-regulation of SRC-1 decreased HCC cell proliferation and impaired tumor maintenance in HCC xenografts. Knockdown of SRC-1 reduced protein levels of the proliferation marker proliferating cell nuclear antigen (PCNA) and the oncogene c-Myc. Knockout of SRC-1 in mice reduced diethylnitrosamine/CCl4-induced tumor formation in the liver and the expression of c-Myc and PCNA in liver tumors. SRC-1 promoted c-Myc expression, at least in part, by directly interacting with beta-catenin to enhance Wnt/beta-catenin signaling. Consistent with these results, the expression of SRC-1 was positively correlated with PCNA expression in human HCC specimens, and the expression levels of c-Myc in SRC-1-positive HCC specimens were higher than in SRC-1-negative HCC specimens. In addition, SRC-1 and SRC-3 were co-overexpressed in 47.5% of HCC specimens, and they cooperated to promote HCC cell proliferation. Simultaneous down-regulation of SRC-1 and SRC-3 dramatically inhibited HCC cell proliferation. Our results demonstrate that SRC-1 promotes HCC progression by enhancing Wnt/beta-catenin signaling and suggest that SRC-1 is a potential therapeutic molecular target for HCC.	[Tong, Zhangwei; Li, Ming; Wang, Wei; Mo, Pingli; Yu, Li; Liu, Kun; Ren, Wenjing; Yu, Chundong] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China; [Tong, Zhangwei; Yu, Chundong] Xiamen Univ, Engn Res Ctr Mol Diagnost, Minist Educ, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China; [Li, Ming; Li, Wengang] Xiamen Univ, Chenggong Hosp, Dept Hepatobiliary Pancreas & Vessel Surg, Xiamen 361003, Fujian, Peoples R China; [Liu, Kun] Xiamen Univ, Chenggong Hosp, Dept Pathol, Xiamen, Peoples R China; [Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou 515041, Guangdong, Peoples R China; [Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Xiamen University; Xiamen University; Xiamen University; Xiamen University; Shantou University; Baylor College of Medicine	Yu, CD (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China.	cdyu@xmu.edu.cn	Regan, Clinton/E-6250-2012; Tong, Zhangwei/V-2475-2019		National Basic Research Program of China (973 Program) [2015CB553800]; Natural Science Foundation of China [81372176, 31301128]; Fundamental Research Funds for the Central Universities [2012121038]; Xiamen Science and Technology Plan [3502Z20124049]; National Institutes of Health [R01 CA112403]; NATIONAL CANCER INSTITUTE [R01CA193455, R01CA112403] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen Science and Technology Plan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China (973 Program) Grant 2015CB553800 (to C. Y.); Natural Science Foundation of China Grants 81372176 (to C. Y.) and 31301128 (to P. M.); Fundamental Research Funds for the Central Universities Grant 2012121038 (to C. Y.); and Xiamen Science and Technology Plan Grant 3502Z20124049 (to W. L.). This work was also supported in part by National Institutes of Health Grant R01 CA112403 (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams BD, 2009, MOL ENDOCRINOL, V23, P1215, DOI 10.1210/me.2009-0062; Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fleming FJ, 2004, J CLIN ENDOCR METAB, V89, P375, DOI 10.1210/jc.2003-031048; Fonte C, 2005, P NATL ACAD SCI USA, V102, P14260, DOI 10.1073/pnas.0506930102; Gregory CW, 2001, CANCER RES, V61, P4315; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hudelist G, 2003, BREAST CANCER RES TR, V78, P193, DOI 10.1023/A:1022930710850; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong JW, 2006, MOL ENDOCRINOL, V20, P1138, DOI 10.1210/me.2005-0407; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Lin CP, 2010, WORLD J HEPATOL, V2, P16, DOI 10.4254/wjh.v2.i1.16; Liu YH, 2012, HEPATOLOGY, V56, P1015, DOI 10.1002/hep.25751; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; O'Donnell KA, 2012, P NATL ACAD SCI USA, V109, pE1377, DOI 10.1073/pnas.1115433109; ONATE SA, 1995, SCIENCE, V270, P1354; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Qin L, 2011, CANCER RES, V71, P1742, DOI 10.1158/0008-5472.CAN-10-3453; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tai H, 2000, BIOCHEM BIOPH RES CO, V267, P311, DOI 10.1006/bbrc.1999.1954; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Uriarte I, 2015, INT J CANCER, V136, P2469, DOI 10.1002/ijc.29287; Walsh CA, 2012, INT J BIOL SCI, V8, P470, DOI 10.7150/ijbs.4125; Wang Y, 2014, CANCER RES, V74, P1506, DOI 10.1158/0008-5472.CAN-13-2939; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu Y, 2010, ONCOGENE, V29, P3386, DOI 10.1038/onc.2010.90	35	21	23	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18596	18608		10.1074/jbc.M115.640490	http://dx.doi.org/10.1074/jbc.M115.640490			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26082485	Green Published, hybrid			2022-12-28	WOS:000358512100030
J	Gwiazda, K; Bonifacio, G; Vullo, S; Kellenberger, S				Gwiazda, Karolina; Bonifacio, Gaetano; Vullo, Sabrina; Kellenberger, Stephan			Extracellular Subunit Interactions Control Transitions between Functional States of Acid-sensing Ion Channel 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATION; MEMBRANE; NEURONS; COMPLEX; PROTONS; SITES; BRAIN	Acid-sensingion channels(ASICs) are neuronal, voltage-independent Na+ channels that are transiently activated by extracellular acidification. They are involved in pain sensation, the expression of fear, and in neurodegeneration after ischemic stroke. Our study investigates the role of extracellular subunit interactions in ASIC1a function. We identified two regions involved in critical intersubunit interactions. First, formation of an engineered disulfide bond between the palm and thumb domains leads to partial channel closure. Second, linking Glu-235 of a finger loop to either one of two different residues of the knuckle of a neighboring subunit opens the channel at physiological pH or disrupts its activity. This suggests that one finger-knuckle disulfide bond (E235C/K393C) sets the channel in an open state, whereas the other (E235C/Y389C) switches the channel to a non-conducting state. Voltage-clamp fluorometry experiments indicate that both the finger loop and the knuckle move away from the beta-ball residue Trp-233 during acidification and subsequent desensitization. Together, these observations reveal that ASIC1a opening is accompanied by a distance increase between adjacent thumb and palm domains as well as a movement of Glu-235 relative to the knuckle helix. Our study identifies subunit interactions in the extracellular loop and shows that dynamic changes of these interactions are critical for normal ASIC function.	[Gwiazda, Karolina; Bonifacio, Gaetano; Vullo, Sabrina; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch		Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [13003A_153419]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 13003A_153419 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Bonifacio G, 2014, J GEN PHYSIOL, V143, P105, DOI 10.1085/jgp.201311053; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hill, 2001, ION CHANNELS EXCITAB, P441; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Pantazis A, 2012, J GEN PHYSIOL, V140, P207, DOI 10.1085/jgp.201210807; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	32	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17956	17966		10.1074/jbc.M115.641688	http://dx.doi.org/10.1074/jbc.M115.641688			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26070563	Green Published, hybrid			2022-12-28	WOS:000358511700029
J	Jinadasa, T; Josephson, CB; Boucher, A; Orlowski, J				Jinadasa, Tushare; Josephson, Colin B.; Boucher, Annie; Orlowski, John			Determinants of Cation Permeation and Drug Sensitivity in Predicted Transmembrane Helix 9 and Adjoining Exofacial Re-entrant Loop 5 of Na+/H+ Exchanger NHE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-HYDROGEN EXCHANGE; CELL-VOLUME REGULATION; NA-H EXCHANGE; FUNCTIONAL-CHARACTERIZATION; TARGETED DISRUPTION; PH REGULATION; STEADY-STATE; PDGFR-ALPHA; SEGMENT-IV; INHIBITION	Mammalian Na+/H+ exchangers (NHEs) regulate numerous physiological processes and are involved in the pathogenesis of several diseases, including tissue ischemia and reperfusion injuries, cardiac hypertrophy and failure, and cancer progression. Hence, NHEs are being targeted for pharmaceutical-based clinical therapies, but pertinent information regarding the structural elements involved in cation translocation and drug binding remains incomplete. Molecular manipulations of the prototypical NHE1 isoform have implicated several predicted membrane-spanning (M) helices, most notably M4, M9, and M11, as important determinants of cation permeation and drug sensitivity. Here, we have used substituted-cysteine accessibility mutagenesis and thiol-modifying methanethiosulfonate (MTS) reagents to further probe the involvement of evolutionarily conserved sites withinM9(residues 342-363) and the adjacent exofacial re-entrant loop 5 between M9 and M10 (EL5; residues 364-415) of a cysteine-less variant of rat NHE1 on its kinetic and pharmacological properties. MTS treatment significantly reduced the activity of mutants containing substitutions within M9 (H353C, S355C, and G356C) and EL5 (G403C and S405C). In the absence of MTS, mutants S355C, G403C, and S405C showed modest to significant decreases in their apparent affinities for Na-o(+) and/or H-i(+). In addition, mutations Y370C and E395C within EL5, whereas failing to confer sensitivity to MTS, nevertheless, reduced the affinity for Na-o(+), but not for H-i(+). The Y370C mutant also exhibited higher affinity for ethylisopropylamiloride, a competitive antagonist of Na-o(+) transport. Collectively, these results further implicate helix M9 and EL5 of NHE1 as important elements involved in cation transport and inhibitor sensitivity, which may inform rational drug design.	[Jinadasa, Tushare; Josephson, Colin B.; Boucher, Annie; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Josephson, Colin B.] Univ Calgary, Foothills Med Ctr, Div Clin Neurosci, Calgary, AB T2N 2T9, Canada	McGill University; University of Calgary	Orlowski, J (corresponding author), Bellini Life Sci Bldg,Rm 166,3649 Promenade Sir W, Montreal, PQ H3G 0B1, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X	Canadian Institutes for Health Research [MOP-11221, MOP-111191]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grants MOP-11221 and MOP-111191 (to J. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Amith SR, 2013, CANCER RES, V73, P1259, DOI 10.1158/0008-5472.CAN-12-4031; Ayoub IM, 2003, CIRCULATION, V107, P1804, DOI 10.1161/01.CIR.0000058704.45646.0D; BELIVEAU R, 1988, BIOCHEM BIOPH RES CO, V152, P484, DOI 10.1016/S0006-291X(88)80739-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cengiz P, 2011, ANTIOXID REDOX SIGN, V14, P1803, DOI 10.1089/ars.2010.3468; Chahine M, 2005, J MOL CELL CARDIOL, V38, P571, DOI 10.1016/j.yjmcc.2005.01.003; Chaitman BR, 2003, J CARDIAC SURG, V18, P13, DOI 10.1046/j.1540-8191.18.s1.3.x; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Deisl C, 2013, P NATL ACAD SCI USA, V110, P10004, DOI 10.1073/pnas.1220009110; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; DOKTOR HS, 1991, J HUM HYPERTENS, V5, P161; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; FRANCHI A, 1986, P NATL ACAD SCI USA, V83, P9388, DOI 10.1073/pnas.83.24.9388; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Gawenis LR, 2005, J BIOL CHEM, V280, P12781, DOI 10.1074/jbc.M414118200; Gekle M, 2001, J PHYSIOL-LONDON, V531, P619, DOI 10.1111/j.1469-7793.2001.0619h.x; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Hisamitsu T, 2004, BIOCHEMISTRY-US, V43, P11135, DOI 10.1021/bi049367x; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horikawa N, 2001, PHARMACOLOGY, V63, P76, DOI 10.1159/000056116; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IVES HE, 1983, J BIOL CHEM, V258, P9710; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Karmazyn M, 2001, BASIC RES CARDIOL, V96, P325, DOI 10.1007/s003950170040; Karmazyn M, 1996, CAN J CARDIOL, V12, P1074; Karmazyn M, 2008, J MOL CELL CARDIOL, V44, P647, DOI 10.1016/j.yjmcc.2008.01.005; Karmazyn M, 2013, J MOL CELL CARDIOL, V61, P77, DOI 10.1016/j.yjmcc.2013.02.006; Kevelaitis E, 2005, EUR J CARDIO-THORAC, V27, P111, DOI 10.1016/j.ejcts.2004.08.032; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KINSELLA JL, 1981, AM J PHYSIOL, V241, pF374, DOI 10.1152/ajprenal.1981.241.4.F374; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee BL, 2009, J BIOL CHEM, V284, P11546, DOI 10.1074/jbc.M809201200; Loo SY, 2012, CURR PHARM DESIGN, V18, P1372; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Nygaard EB, 2011, J BIOL CHEM, V286, P634, DOI 10.1074/jbc.M110.159202; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; OTSU K, 1992, J BIOL CHEM, V267, P8089; OTSU K, 1993, J BIOL CHEM, V268, P3184; OTSU K, 1989, P NATL ACAD SCI USA, V86, P4818, DOI 10.1073/pnas.86.13.4818; Park JW, 2005, J PHARMACOL SCI, V98, P439, DOI 10.1254/jphs.FP0050078; Park K, 2001, J BIOL CHEM, V276, P27042, DOI 10.1074/jbc.M102901200; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Reddy T, 2008, J BIOL CHEM, V283, P22018, DOI 10.1074/jbc.M803447200; Reshkin SJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0100; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Schneider H, 1997, J BIOL CHEM, V272, P16158, DOI 10.1074/jbc.272.26.16158; Schneider L, 2009, J CELL BIOL, V185, P163, DOI 10.1083/jcb.200806019; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Schushan M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.L110.159202; SEMPLICINI A, 1989, J MEMBRANE BIOL, V107, P219, DOI 10.1007/BF01871937; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Tsushima RG, 1997, J GEN PHYSIOL, V110, P59, DOI 10.1085/jgp.110.1.59; Tzeng J, 2010, J BIOL CHEM, V285, P36656, DOI 10.1074/jbc.M110.161471; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Wu D, 2013, J SURG RES, V181, pE75, DOI 10.1016/j.jss.2012.07.026; Wu ML, 1997, J MOL CELL CARDIOL, V29, P1131, DOI 10.1006/jmcc.1996.0338; XU M, 1993, J BIOL CHEM, V268, P21505; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	86	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18173	18186		10.1074/jbc.M115.642199	http://dx.doi.org/10.1074/jbc.M115.642199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26063808	Green Published, hybrid			2022-12-28	WOS:000358511700047
J	Byun, S; Lim, S; Mun, JY; Kim, KH; Ramadhar, TR; Farrand, L; Shin, SH; Thimmegowda, NR; Lee, HJ; Frank, DA; Clardy, J; Lee, SW; Lee, KW				Byun, Sanguine; Lim, Semi; Mun, Ji Young; Kim, Ki Hyun; Ramadhar, Timothy R.; Farrand, Lee; Shin, Seung Ho; Thimmegowda, N. R.; Lee, Hyong Joo; Frank, David A.; Clardy, Jon; Lee, Sam W.; Lee, Ki Won			Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-PRODUCTS; GROWTH-FACTOR; CANCER-CELLS; EXPRESSION; APOPTOSIS; ACTIVATION; DRUG; BIM; 6-SHOGAOL; EXTRACT	Bioactive phytochemicals can suppress the growth of malignant cells, and investigation of the mechanisms responsible can assist in the identification of novel therapeutic strategies for cancer therapy. Ginger has been reported to exhibit potent anticancer effects, although previous reports have often focused on a narrow range of specific compounds. Through a direct comparison of various ginger compounds, we determined that gingerenone A selectively kills cancer cells while exhibiting minimal toxicity toward normal cells. Kinase array screening revealed JAK2 and S6K1 as the molecular targets primarily responsible for gingerenone A-induced cancer cell death. The effect of gingerenone A was strongly associated with relative phosphorylation levels of JAK2 and S6K1, and administration of gingerenone A significantly suppressed tumor growth in vivo. More importantly, the combined inhibition of JAK2 and S6K1 by commercial inhibitors selectively induced apoptosis in cancer cells, whereas treatment with either agent alone did not. These findings provide rationale for dual targeting of JAK2 and S6K1 in cancer for a combinatorial therapeutic approach.	[Byun, Sanguine; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Byun, Sanguine; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Byun, Sanguine; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea; [Lim, Semi; Lee, Hyong Joo; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul 151742, South Korea; [Mun, Ji Young] Eulji Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Songnam 461463, South Korea; [Kim, Ki Hyun; Ramadhar, Timothy R.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Ki Hyun] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Farrand, Lee] Yuhan Corp, Yuhan Res Inst, Yongin 446902, South Korea; [Shin, Seung Ho] Univ Minnesota, Program Biomed Informat & Computat Biol, Minneapolis, MN 55455 USA; [Thimmegowda, N. R.] Govt Sri Krishnarajendra Silver Jubilee Technol I, Dept Chem, Bangalore 560001, Karnataka, India; [Frank, David A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Thimmegowda, N. R.] Korea Res Inst Biosci & Biotechnol, World Class Inst, Ochang 363883, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Seoul National University (SNU); Seoul National University (SNU); Eulji University; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Dana-Farber Cancer Institute; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; swlee@mgh.harvard.edu; kiwon@snu.ac.kr	Ramadhar, Timothy R./AAF-5820-2019; Regan, Clinton/E-6250-2012; Byun, Sanguine/AAR-5451-2021; Lee, Ki Won/M-4114-2018	Ramadhar, Timothy R./0000-0002-7063-5445; Byun, Sanguine/0000-0003-3903-5887; Shin, Seung Ho/0000-0002-2694-3889	National Institutes of Health [1RO1CA142805, 1RO1CA149477]; National Leap Research Program through National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning (MSIP) of Korea, Republic of Korea [2010-0029233]; F32 postdoctoral fellowship from the National Institutes of Health [GM108415]; NATIONAL CANCER INSTITUTE [R01CA142805, R01CA149477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Leap Research Program through National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning (MSIP) of Korea, Republic of Korea; F32 postdoctoral fellowship from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1CA142805 and 1RO1CA149477 (NCI). This work was also supported by the National Leap Research Program (2010-0029233) through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (MSIP) of Korea, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an F32 postdoctoral fellowship from the National Institutes of Health (GM108415).	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Bode AM, 2011, HERBAL MED BIOMOLECU, V2nd, P129; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Byun S, 2013, CARCINOGENESIS, V34, P397, DOI 10.1093/carcin/bgs358; Chakraborty D, 2012, EUR J PHARMACOL, V694, P20, DOI 10.1016/j.ejphar.2012.08.001; Chen BJ, 2014, CANCER LETT, V354, P378, DOI 10.1016/j.canlet.2014.08.045; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Filonenko VV, 2004, EXP ONCOL, V26, P294; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; GOVINDARAJAN VS, 1982, CRC CR REV FOOD SCI, V17, P1; Gundala SR, 2014, CARCINOGENESIS, V35, P1320, DOI 10.1093/carcin/bgu011; Hart S, 2011, LEUKEMIA, V25, P1751, DOI 10.1038/leu.2011.148; Ip CKM, 2012, EXPERT OPIN THER TAR, V16, P619, DOI 10.1517/14728222.2012.684680; Karna P, 2012, BRIT J NUTR, V107, P473, DOI 10.1017/S0007114511003308; Katiyar SK, 1996, CANCER RES, V56, P1023; Kingston DGI, 2011, J NAT PROD, V74, P496, DOI 10.1021/np100550t; Koh EM, 2009, PLANTA MED, V75, P148, DOI 10.1055/s-0028-1088347; Kundu JK, 2009, FORUM NUTR, V61, P182, DOI 10.1159/000212750; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li FF, 2014, INT J CANCER, V134, P1257, DOI 10.1002/ijc.28261; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Liu Q, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-135; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Peng F, 2012, FITOTERAPIA, V83, P568, DOI 10.1016/j.fitote.2011.12.028; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Saha A, 2014, CANCER PREV RES, V7, P627, DOI 10.1158/1940-6207.CAPR-13-0420; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Sakamoto K, 2009, CANCER RES, V69, P6642, DOI 10.1158/0008-5472.CAN-09-0746; Sawyers CL, 2009, NAT MED, V15, P1158, DOI 10.1038/nm1009-1158; Seavey MM, 2012, BIOCHEM PHARMACOL, V83, P1136, DOI 10.1016/j.bcp.2011.12.024; Sehrawat A, 2014, BREAST CANCER RES TR, V146, P543, DOI 10.1007/s10549-014-3059-7; Sung BK, 2012, NUTR CANCER, V64, P173, DOI 10.1080/01635581.2012.630551; Tao Y, 2009, J AGR FOOD CHEM, V57, P10014, DOI 10.1021/jf9020224; Taylor IW, 2012, PROTEOMICS, V12, P1706, DOI 10.1002/pmic.201100594; Venkateswarlu S, 2001, INDIAN J CHEM B, V40, P495; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhou HY, 2006, ENDOCRINOLOGY, V147, P2557, DOI 10.1210/en.2005-1404; Zick SM, 2011, CANCER PREV RES, V4, P1929, DOI 10.1158/1940-6207.CAPR-11-0224	60	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23553	23562		10.1074/jbc.M115.662445	http://dx.doi.org/10.1074/jbc.M115.662445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242912	Green Published, hybrid			2022-12-28	WOS:000361816500008
J	Chen, YM; Chernyavsky, A; Webber, RJ; Grando, SA; Wang, PH				Chen, Yumay; Chernyavsky, Alex; Webber, Robert J.; Grando, Sergei A.; Wang, Ping H.			Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL SHRINKAGE; EPITHELIAL-CELLS; ACETYLCHOLINE-RECEPTORS; ENDOTHELIAL-CELLS; IMMUNOGLOBULIN-G; IGG; APOPTOSIS; DISEASE; KERATINOCYTES; MITOCHONDRIA	Pemphigus vulgaris (PV) is a life-long, potentially fatal IgG autoantibody-mediated blistering disease targeting mucocutaneous keratinocytes (KCs). PV patients develop pathogenic anti-desmoglein (Dsg) 3 +/- 1 and antimitochondrial antibodies (AMA), but it remained unknown whether and how AMA enter KCs and why other cell types are not affected in PV. Therefore, we sought to elucidate mechanisms of cell entry, trafficking, and pathogenic action of AMA in PV. We found that PVIgGs associated with neonatal Fc receptor (FcRn) on the cell membrane, and the PVIgG-FcRn complexes entered KCs and reached mitochondria where they dissociated. The liberated AMA altered mitochondrial membrane potential, respiration, and ATP production and induced cytochrome c release, although the lack or inactivation of FcRn abolished the ability of PVIgG to reach and damage mitochondria and to cause detachment of KCs. The assays of mitochondrial functions and keratinocyte adhesion demonstrated that although the pathobiological effects of AMA on KCs are reversible, they become irreversible, leading to epidermal blistering (acantholysis), when AMA synergize with anti-Dsg antibodies. Thus, it appears that AMA enter a keratinocyte in a complex with FcRn, become liberated from the endosome in the cytosol, and are trafficked to the mitochondria, wherein they trigger pro-apoptotic events leading to shrinkage of basal KCs uniquely expressing FcRn in epidermis. During recovery, KCs extend their cytoplasmic aprons toward neighboring cells, but anti-Dsg antibodies prevent assembly of nascent desmosomes due to steric hindrance, thus rendering acantholysis irreversible. In conclusion, FcRn is a common acceptor protein for internalization of AMA and, perhaps, for PV autoantibodies to other intracellular antigens, and PV is a novel disease paradigm for investigating and elucidating the role of FcRn in this autoimmune disease and possibly other autoimmune diseases.	[Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, Irvine Diabet Ctr, Dept Med, Irvine, CA 92697 USA; [Chernyavsky, Alex; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Grando, Sergei A.; Wang, Ping H.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Webber, Robert J.] Res & Diagnost Antibodies, Las Vegas, NV 89032 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu; phwang@uci.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 HL096987]; Oxnard Foundation; Department of Dermatology, University of California at Irvine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxnard Foundation; Department of Dermatology, University of California at Irvine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL096987. This work was also supported by a grant from the Oxnard Foundation (to P. H. W.) and internal funds from the Department of Dermatology, University of California at Irvine. The authors declare that they have no conflicts of interest with the contents of this article.	Amagai M, 2006, EXP DERMATOL, V15, P815, DOI 10.1111/j.1600-0625.2006.00499.x; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Antohe F, 2001, HUM IMMUNOL, V62, P93, DOI 10.1016/S0198-8859(00)00244-5; Aoyama Y, 2010, J DERMATOL, V37, P239, DOI 10.1111/j.1346-8138.2009.00796.x; Armitage CW, 2014, IMMUNOL CELL BIOL, V92, P417, DOI 10.1038/icb.2013.110; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Bai Y, 2011, P NATL ACAD SCI USA, V108, P18406, DOI 10.1073/pnas.1115348108; BHOGAL B, 1986, CLIN EXP DERMATOL, V11, P49, DOI 10.1111/j.1365-2230.1986.tb00423.x; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Cauza K, 2005, J INVEST DERMATOL, V124, P132, DOI 10.1111/j.0022-202X.2004.23542.x; Chen Y, 2010, BIOCHEM BIOPH RES CO, V394, P798, DOI 10.1016/j.bbrc.2010.03.077; Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551; Chernyavsky A, 2015, INT IMMUNOPHARMACOL, V29, P76, DOI 10.1016/j.intimp.2015.04.046; Cirillo N, 2012, ORAL DIS, V18, P442, DOI 10.1111/j.1601-0825.2011.01899.x; Gergalova G, 2014, INT J BIOCHEM CELL B, V49, P26, DOI 10.1016/j.biocel.2014.01.001; Gil MP, 2012, EXP DERMATOL, V21, P254, DOI 10.1111/j.1600-0625.2012.01441.x; Goebl NA, 2008, MOL BIOL CELL, V19, P5490, DOI 10.1091/mbc.E07-02-0101; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Huang WB, 2013, HUM PATHOL, V44, P1989, DOI 10.1016/j.humpath.2013.04.005; JORDON RE, 1974, J INVEST DERMATOL, V63, P256, DOI 10.1111/1523-1747.ep12680098; Kalantari-Dehaghi M, 2013, J BIOL CHEM, V288, P16916, DOI 10.1074/jbc.M113.472100; Kalantari-Dehaghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057587; Kobayashi N, 2002, AM J PHYSIOL-RENAL, V282, pF358, DOI 10.1152/ajprenal.0164.2001; Kurzen H, 2006, AUTOIMMUNITY, V39, P549, DOI 10.1080/08916930600971554; Lanza A, 2006, J CUTAN PATHOL, V33, P401, DOI 10.1111/j.0303-6987.2006.00523.x; Li N, 2005, J CLIN INVEST, V115, P3440, DOI 10.1172/JCI24394; Lykhmus O, 2014, INT J BIOCHEM CELL B, V53, P246, DOI 10.1016/j.biocel.2014.05.030; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; MILNER Y, 1989, J CELL PHYSIOL, V139, P441, DOI 10.1002/jcp.1041390229; Nagai J, 2011, DRUG METAB PHARMACOK, V26, P474, DOI 10.2133/dmpk.DMPK-11-RG-022; Nguyen VT, 2004, EXP CELL RES, V294, P534, DOI 10.1016/j.yexcr.2003.12.010; Ortolan DG, 2011, CLINICS, V66, P2019, DOI 10.1590/S1807-59322011001200004; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Saleh MA, 2015, J DERMATOL, V42, P685, DOI 10.1111/1346-8138.12888; Schilling R, 2003, J VIROL, V77, P8882, DOI 10.1128/JVI.77.16.8882-8892.2003; Sesarman A, 2010, CELL MOL LIFE SCI, V67, P2533, DOI 10.1007/s00018-010-0318-6; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Tang HL, 2009, BRIT J CANCER, V100, P118, DOI 10.1038/sj.bjc.6604802; Wan XL, 2001, ANTICANCER RES, V21, P2657; Ward ES, 2014, IMMUNOL LETT, V160, P158, DOI 10.1016/j.imlet.2014.02.008; Yamagami J, 2010, J CLIN INVEST, V120, P4111, DOI 10.1172/JCI44425	49	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23826	23837		10.1074/jbc.M115.668061	http://dx.doi.org/10.1074/jbc.M115.668061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26260795	Green Published, hybrid			2022-12-28	WOS:000361816500029
J	Cannon, B; Kachroo, AH; Jarmoskaite, I; Jayaram, M; Russell, R				Cannon, Brian; Kachroo, Aashiq H.; Jarmoskaite, Inga; Jayaram, Makkuni; Russell, Rick			Hexapeptides That Inhibit Processing of Branched DNA Structures Induce a Dynamic Ensemble of Holliday Junction Conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; SINGLE-MOLECULE FRET; ENERGY-TRANSFER ANALYSIS; STRAND EXCHANGE; CRYSTAL-STRUCTURE; PEPTIDE INHIBITORS; ESCHERICHIA-COLI; GENOME STABILITY; FLUORESCENCE; RESOLUTION	Holliday junctions are critical intermediates in DNA recombination, repair, and restart of blocked replication. Hexapeptides have been identified that bind to junctions and inhibit various junction-processing enzymes, and these peptides confer anti-microbial and anti-tumor properties. Earlier studies suggested that inhibition results from stabilization of peptide-bound Holliday junctions in the square planar conformation. Here, we use single molecule fluorescence resonance energy transfer (smFRET) and two model junctions, which are AT-or GC-rich at the branch points, to show that binding of the peptide KWWCRW induces a dynamic ensemble of junction conformations that differs from both the square planar and stacked X conformations. The specific features of the conformational distributions differ for the two peptide-bound junctions, but both junctions display greatly decreased Mg2+ dependence and increased conformational fluctuations. The smFRET results, complemented by gel mobility shift and small angle x-ray scattering analyses, reveal structural effects of peptides and highlight the sensitivity of smFRET for analyzing complex mixtures of DNA structures. The peptide-induced conformational dynamics suggest multiple stacking arrangements of aromatic amino acids with the nucleobases at the junction core. This conformational heterogeneity may inhibit DNA processing by increasing the population of inactive junction conformations, thereby preventing the binding of processing enzymes and/or resulting in their premature dissociation.	[Jayaram, Makkuni] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Jayaram, M (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	jayaram@austin.utexas.edu; rick_russell@cm.utexas.edu	Regan, Clinton/E-6250-2012; Kachroo, Aashiq/Z-2505-2019	Kachroo, Aashiq/0000-0001-9770-778X; Jarmoskaite, Inga/0000-0001-5847-5867	National Institutes of Health [GM070456]; Robert F. Welch Foundation [F-1563, F-1274]; National Science Foundation [MCB1049925]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert F. Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070456 (to R.R.), Robert F. Welch Foundation Grants F-1563 (to R.R.) and F-1274 (to M.J.), and National Science Foundation Grant MCB1049925 (to M.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; Cannon B, 2013, P NATL ACAD SCI USA, V110, P18868, DOI 10.1073/pnas.1309816110; Cannon B, 2013, MOL BIOTECHNOL, V53, P19, DOI 10.1007/s12033-012-9505-z; Cannon B, 2012, ANAL BIOCHEM, V431, P40, DOI 10.1016/j.ab.2012.08.017; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Cassell GD, 2003, J MOL BIOL, V327, P413, DOI 10.1016/S0022-2836(03)00058-5; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; CHURCHILL MEA, 1988, P NATL ACAD SCI USA, V85, P4653, DOI 10.1073/pnas.85.13.4653; CLEGG RM, 1994, BIOPHYS J, V66, P99, DOI 10.1016/S0006-3495(94)80765-9; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Craig NL, 2015, MOBILE DNA 3, P43; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Duyne G.D.V., 2015, MICROBIOL SPECTR, V3, P119; Fogg JM, 2001, J MOL BIOL, V313, P751, DOI 10.1006/jmbi.2001.5081; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grainger RJ, 1998, BIOCHEMISTRY-US, V37, P23, DOI 10.1021/bi9721492; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Gunderson CW, 2009, J BACTERIOL, V191, P2169, DOI 10.1128/JB.01559-08; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hyeon C, 2012, NAT CHEM, V4, P907, DOI [10.1038/nchem.1463, 10.1038/NCHEM.1463]; Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024; Karymov MA, 2008, BIOPHYS J, V95, P4372, DOI 10.1529/biophysj.108.135103; Kepple KV, 2008, NUCLEIC ACIDS RES, V36, P5319, DOI 10.1093/nar/gkn512; Kepple KV, 2005, P NATL ACAD SCI USA, V102, P6867, DOI 10.1073/pnas.0409496102; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lee J, 1998, MOL CELL, V1, P483, DOI 10.1016/S1097-2765(00)80049-0; Lilley DMJ, 2008, Q REV BIOPHYS, V41, P1, DOI 10.1017/S0033583508004678; Liu J, 2005, CHEM BIOL, V12, P217, DOI 10.1016/j.chembiol.2004.12.006; Ma CH, 2014, J MOL BIOL, V426, P793, DOI 10.1016/j.jmb.2013.11.017; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Miick SM, 1997, P NATL ACAD SCI USA, V94, P9080, DOI 10.1073/pnas.94.17.9080; MURCHIE AIH, 1991, EMBO J, V10, P713, DOI 10.1002/j.1460-2075.1991.tb08001.x; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Nollmann M, 2004, BIOPHYS J, V86, P3060, DOI 10.1016/S0006-3495(04)74355-6; Rajeev L, 2007, J BIOL CHEM, V282, P31228, DOI 10.1074/jbc.M705370200; Rideout MC, 2013, PEPTIDES, V40, P112, DOI 10.1016/j.peptides.2012.12.025; Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Su LY, 2010, ANTIMICROB AGENTS CH, V54, P1888, DOI 10.1128/AAC.01610-09; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Yu J, 2004, NUCLEIC ACIDS RES, V32, P6683, DOI 10.1093/nar/gkh1006	51	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22734	22746		10.1074/jbc.M115.663930	http://dx.doi.org/10.1074/jbc.M115.663930			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209636	Green Published, hybrid			2022-12-28	WOS:000361171500037
J	Funk, MA; Marsh, ENG; Drennan, CL				Funk, Michael A.; Marsh, E. Neil G.; Drennan, Catherine L.			Substrate-bound Structures of Benzylsuccinate Synthase Reveal How Toluene Is Activated in Anaerobic Hydrocarbon Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; THAUERA-AROMATICA; DENITRIFYING BACTERIUM; P-CYMENE; MECHANISM; OXIDATION; ENZYME; FUMARATE; METABOLISM; ALKANES	Various bacteria perform anaerobic degradation of small hydrocarbons as a source of energy and cellular carbon. To activate non-reactive hydrocarbons such as toluene, enzymes conjugate these molecules to fumarate in a radical-catalyzed, C-C bond-forming reaction. We have determined x-ray crystal structures of the glycyl radical enzyme that catalyzes the addition of toluene to fumarate, benzylsuccinate synthase (BSS), in two oligomeric states with fumarate alone or with both substrates. We find that fumarate is secured at the bottom of a long active site cavity with toluene bound directly above it. The two substrates adopt orientations that appear ideal for radical-mediated C-C bond formation; the methyl group of toluene is positioned between fumarate and a cysteine that forms a thiyl radical during catalysis, which is in turn adjacent to the glycine that serves as a radical storage residue. Toluene is held in place by fumarate on one face and tight packing by hydrophobic residues on the other face and sides. These hydrophobic residues appear to become ordered, thus encapsulating toluene, only in the presence of BSS beta, a small protein subunit that forms a tight complex with BSS beta, the catalytic subunit. Enzymes related to BSS are able to metabolize a wide range of hydrocarbons through attachment to fumarate. Using our structures as a guide, we have constructed homology models of several of these "X-succinate synthases" and determined conservation patterns that will be useful in understanding the basis for catalysis and specificity in this family of enzymes.	[Funk, Michael A.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Chem & Biol Chem, Ann Arbor, MI 48109 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Drennan, CL (corresponding author), MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.	cdrennan@mit.edu	Marsh, Neil/G-7553-2016	Marsh, Neil/0000-0003-1713-1683	Department of Energy Geosciences [DE-FG02-92ER14244]; Department of Energy Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093088] Funding Source: NIH RePORTER	Department of Energy Geosciences(United States Department of Energy (DOE)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at Beamline X26A, National Synchrotron Light Source, Brookhaven National Laboratory. Beamline X26A is supported by the Department of Energy Geosciences (DE-FG02-92ER14244 to the University of Chicago Center for Advanced Radiation Sources). The National Synchrotron Light Source is supported by the Department of Energy Office of Basic Energy Sciences under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annweiler E, 2000, APPL ENVIRON MICROB, V66, P5329, DOI 10.1128/AEM.66.12.5329-5333.2000; ATLAS RM, 1992, ADV MICROB ECOL, V12, P287; Beasley KK, 2012, ENVIRON SCI TECHNOL, V46, P8244, DOI 10.1021/es3009503; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Bhandare R, 2006, BIOCHEM BIOPH RES CO, V346, P992, DOI 10.1016/j.bbrc.2006.05.199; Bharadwaj VS, 2015, PHYS CHEM CHEM PHYS, V17, P4054, DOI 10.1039/c4cp04317k; Biegert T, 1996, EUR J BIOCHEM, V238, P661, DOI 10.1111/j.1432-1033.1996.0661w.x; Callaghan AV, 2008, BIOCHEM BIOPH RES CO, V366, P142, DOI 10.1016/j.bbrc.2007.11.094; Coschigano PW, 2002, FEMS MICROBIOL LETT, V217, P37, DOI 10.1016/S0378-1097(02)01051-0; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Duncan KE, 2009, ENVIRON SCI TECHNOL, V43, P7977, DOI 10.1021/es9013932; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Grundmann O, 2008, ENVIRON MICROBIOL, V10, P376, DOI 10.1111/j.1462-2920.2007.01458.x; Harms G, 1999, ARCH MICROBIOL, V172, P303, DOI 10.1007/s002030050784; Hilberg M., 2012, THESIS PHILIPPS U MA; Himo F, 2005, BBA-BIOENERGETICS, V1707, P24, DOI 10.1016/j.bbabio.2004.04.006; Kniemeyer O, 2007, NATURE, V449, P898, DOI 10.1038/nature06200; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lehtio L, 2004, PROTEIN ENG DES SEL, V17, P545, DOI 10.1093/protein/gzh059; Leuthner B, 1998, MOL MICROBIOL, V28, P615, DOI 10.1046/j.1365-2958.1998.00826.x; Leuthner B, 2000, J BACTERIOL, V182, P272, DOI 10.1128/JB.182.2.272-277.2000; Li L, 2006, BIOCHEMISTRY-US, V45, P13932, DOI 10.1021/bi061117o; Li L, 2006, J AM CHEM SOC, V128, P16056, DOI 10.1021/ja067329q; Li L, 2009, BIOCHEMISTRY-US, V48, P1284, DOI 10.1021/bi801766g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller JA, 2001, J BACTERIOL, V183, P752, DOI 10.1128/JB.183.2.752-757.2001; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Ocean Studies and Marine Board, 2003, OIL SEA, P89; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiao CH, 2005, J AM CHEM SOC, V127, P8608, DOI 10.1021/ja051972f; Selesi D, 2010, J BACTERIOL, V192, P295, DOI 10.1128/JB.00874-09; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Spormann AM, 2000, BIODEGRADATION, V11, P85, DOI 10.1023/A:1011122631799; Strijkstra A, 2014, APPL ENVIRON MICROB, V80, P7592, DOI 10.1128/AEM.02385-14; Verfurth K, 2004, ARCH MICROBIOL, V181, P155, DOI 10.1007/s00203-003-0642-4; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wohlbrand L, 2013, ENVIRON MICROBIOL, V15, P1334, DOI 10.1111/j.1462-2920.2012.02885.x	43	21	21	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22398	22408		10.1074/jbc.M115.670737	http://dx.doi.org/10.1074/jbc.M115.670737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224635	Green Published, hybrid			2022-12-28	WOS:000361171500007
J	Herrmann, D; Straubinger, M; Hashemolhosseini, S				Herrmann, Dustin; Straubinger, Marion; Hashemolhosseini, Said			Protein Kinase CK2 Interacts at the Neuromuscular Synapse with Rapsyn, Rac1, 14-3-3 gamma, and Dok-7 Proteins and Phosphorylates the Latter Two	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; HEPATOCELLULAR-CARCINOMA; JUNCTION; SYNAPTOGENESIS; IDENTIFICATION; SITES; AGRIN; MUSK	Previously, we demonstrated that the protein kinase CK2 associates with and phosphorylates the receptor tyrosine kinase MuSK (muscle specific receptor tyrosine kinase) at the neuromuscular junction (NMJ), thereby preventing fragmentation of the NMJs (Cheusova, T., Khan, M. A., Schubert, S. W., Gavin, A. C., Buchou, T., Jacob, G., Sticht, H., Allende, J., Boldyreff, B., Brenner, H. R., and Hashemolhosseini, S. (2006) Genes Dev. 20, 1800-1816). Here, we asked whether CK2 interacts with other proteins involved in processes at the NMJ, which would be consistent with the previous observation that CK2 appears enriched at the NMJ. We identified the following proteins to interact with protein kinase CK2: (a) the alpha and beta subunits of the nicotinic acetylcholine receptors with weak interaction, (b) dishevelled (Dsh), and (c) another four proteins, Rapsyn, Rac1, 14-3-3 gamma, and Dok-7, with strong interaction. CK2 phosphorylated 14-3-3 gamma at serine residue 235 and Dok-7 at several serine residues but does not phosphorylate Rapsyn or Rac1. Furthermore, phosphomimetic Dok-7 mutants aggregated nicotinic acetylcholine receptors in C2C12 myotubes with significantly higher frequency than wild type Dok-7. Additionally, we mapped the interacting epitopes of all four binding partners to CK2 and thereby gained insights into the potential role of the CK2/Rapsyn interaction.	[Herrmann, Dustin; Straubinger, Marion; Hashemolhosseini, Said] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Hashemolhosseini, S (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	said.hashemolhosseini@fau.de	Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649; Herrmann, Dustin/0000-0002-1555-540X	Deutsche Forschungsgemeinschaft [HA 3309/1-1, HA 3309/1-2, HA 3309/1-3]; Interdisciplinary Centre for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg [E2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	This work was supported by Deutsche Forschungsgemeinschaft Grants HA 3309/1-1 to 1-3) and by the Interdisciplinary Centre for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg (Grant E2) (both to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7184; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Feng GP, 1998, J NEUROSCI, V18, P4166; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Hamuro J, 2008, J BIOL CHEM, V283, P5518, DOI 10.1074/jbc.M708607200; Leshinsky-Silver E, 2012, J NEUROL SCI, V316, P112, DOI 10.1016/j.jns.2012.01.012; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sass G, 2008, J HEPATOL, V48, pS135, DOI 10.1016/S0168-8278(08)60347-5; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044358; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	30	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22370	22384		10.1074/jbc.M115.647610	http://dx.doi.org/10.1074/jbc.M115.647610			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198629	hybrid, Green Published			2022-12-28	WOS:000361171500005
J	Torihashi, S; Ho, M; Kawakubo, Y; Komatsu, K; Nagai, M; Hirayama, Y; Kawabata, Y; Takenaka-Ninagawa, N; Wanachewin, O; Zhuo, L; Kimata, K				Torihashi, Shigeko; Ho, Mioko; Kawakubo, Yuji; Komatsu, Kazumi; Nagai, Masataka; Hirayama, Yuri; Kawabata, Yuka; Takenaka-Ninagawa, Nana; Wanachewin, Orawan; Zhuo, Lisheng; Kimata, Koji			Acute and Temporal Expression of Tumor Necrosis Factor (TNF)-alpha-stimulated Gene 6 Product, TSG6, in Mesenchymal Stem Cells Creates Microenvironments Required for Their Successful Transplantation into Muscle Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; HEAVY-CHAINS; CONSTITUTIVE EXPRESSION; HYALURONAN-SYNTHESIS; CHONDROITIN SULFATE; TRYPSIN INHIBITOR; PROTEIN; DOMAIN; BINDING; PTX3	Previously, we demonstrated that when mesenchymal stem cells (MSCs) from mouse ES cells were transplanted into skeletal muscle, more than 60% of them differentiated into muscles in the crush-injured tibialis anterior muscle in vivo, although MSCs neither differentiated nor settled in the intact muscle. Microenvironments, including the extracellular matrix between the injured and intact muscle, were quite different. In the injured muscle, hyaluronan (HA), heavy chains of inter-alpha-inhibitor (I alpha I), CD44, and TNF-alpha-stimulated gene 6 product (TSG-6) increased 24-48 h after injury, although basement membrane components of differentiated muscle such as perlecan, laminin, and type IV collagen increased gradually 4 days after the crush. We then investigated the microenvironments crucial for cell transplantation, using the lysate of C2C12 myotubules for mimicking injured circumstances in vivo. MSCs settled in the intact muscle when they were transplanted together with the C2C12 lysate or TSG6. MSCs produced and released TSG6 when they were cultured with C2C12 lysates in vitro. MSCs pretreated with the lysate also settled in the intact muscle. Furthermore, MSCs whose TSG6 was knocked down by shRNA, even if transplanted or pretreated with the lysate, could not settle in the muscle. Immunofluorescent staining showed that HA and I alpha I always co-localized or were distributed closely, suggesting formation of covalent complexes, i.e. the SHAP-HA complex in the presence of TSG6. Thus, TSG6, HA, and I alpha I were crucial factors for the settlement and probably the subsequent differentiation of MSCs.	[Torihashi, Shigeko; Kawabata, Yuka; Takenaka-Ninagawa, Nana] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4619673, Japan; [Ho, Mioko; Kawakubo, Yuji; Komatsu, Kazumi; Nagai, Masataka; Hirayama, Yuri] Nagoya Univ, Sch Hlth Sci, Dept Phys Therapy, Nagoya, Aichi 4618673, Japan; [Wanachewin, Orawan; Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 4801195, Japan; [Wanachewin, Orawan; Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 4801195, Japan; [Takenaka-Ninagawa, Nana] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Wanachewin, Orawan] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand	Nagoya University; Nagoya University; Aichi Medical University; Aichi Medical University; Kyoto University; Chiang Mai University	Kimata, K (corresponding author), Aichi Med Univ, Adv Med Res Ctr, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	kimata@aichi-med-u.ac.jp			Japanese Government [22300185, 24650313, 23570148]	Japanese Government	This work was supported in part by Japanese Government Grants-in-aid for Scientific Research (B) 22300185, Challenging Exploratory Research Grant 24650313 (to S.T.), and Scientific Research (C) Grant 23570148 (to K.K.).	Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Di Battista AP, 2013, CELL STRESS CHAPERON, V18, P675, DOI 10.1007/s12192-013-0418-y; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Hunt LC, 2013, J BIOL CHEM, V288, P13006, DOI 10.1074/jbc.M113.453209; Hwang YS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072023, 10.1371/annotation/b02313dc-840f-4f03-91a2-77cb55a3a4c9]; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Kvezereli M, 2008, J MOL HISTOL, V39, P585, DOI 10.1007/s10735-008-9199-5; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; McDonald B, 2013, AM J PHYSIOL-GASTR L, V305, pG797, DOI 10.1152/ajpgi.00058.2013; Mikami T, 2012, J BIOL CHEM, V287, P38531, DOI 10.1074/jbc.M111.336925; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Ninagawa N, 2011, DIFFERENTIATION, V82, P153, DOI 10.1016/j.diff.2011.07.001; Ninagawa NT, 2013, BIORESEARCH OPEN ACC, V2, P295, DOI 10.1089/biores.2013.0012; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tan KT, 2011, AESTHET SURG J, V31, P47, DOI 10.1177/1090820X10391778; Tran T, 2013, INT REV CEL MOL BIO, V300, P51, DOI 10.1016/B978-0-12-405210-9.00002-3; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Trzeciak P, 2012, POSTEP HIG MED DOSW, V66, P543, DOI 10.5604/17322693.1006408; Tsukahara S, 2006, BIOCHEM J, V398, P595, DOI 10.1042/BJ20060027; UJITA M, 1994, J BIOL CHEM, V269, P27603; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang SZ, 2014, J BIOL CHEM, V289, P13531, DOI 10.1074/jbc.M113.525287; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	50	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22771	22781		10.1074/jbc.M114.629774	http://dx.doi.org/10.1074/jbc.M114.629774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26178374	Green Published, hybrid			2022-12-28	WOS:000361171500040
J	Sorensen, TH; Cruys-Bagger, N; Windahl, MS; Badino, SF; Borch, K; Westh, P				Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Windahl, Michael Skovbo; Badino, Silke Flindt; Borch, Kim; Westh, Peter			Temperature Effects on Kinetic Parameters and Substrate Affinity of Cel7A Cellobiohydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI; CELLULOSE HYDROLYSIS; ENZYMATIC-HYDROLYSIS; SACCHAROMYCES-CEREVISIAE; TALAROMYCES-EMERSONII; PROCESSIVE CELLULASES; INSOLUBLE CELLULOSE; PRODUCT INHIBITION; ETHANOL-PRODUCTION	We measured hydrolytic rates of four purified cellulases in small increments of temperature (10-50 degrees C) and substrate loads (0-100 g/liter) and analyzed the data by a steady state kinetic model that accounts for the processive mechanism. We used wild type cellobiohydrolases (Cel7A) from mesophilic Hypocrea jecorina and thermophilic Rasamsonia emersonii and two variants of these enzymes designed to elucidate the role of the carbohydrate binding module (CBM). We consistently found that the maximal rate increased strongly with temperature, whereas the affinity for the insoluble substrate decreased, and as a result, the effect of temperature depended strongly on the substrate load. Thus, temperature had little or no effect on the hydrolytic rate in dilute substrate suspensions, whereas strong temperature activation (Q(10) values up to 2.6) was observed at saturating substrate loads. The CBM had a dual effect on the activity. On one hand, it diminished the tendency of heat-induced desorption, but on the other hand, it had a pronounced negative effect on the maximal rate, which was 2-fold larger in variants without CBM throughout the investigated temperature range. We conclude that although the CBM is beneficial for affinity it slows down the catalytic process. Cel7A from the thermophilic organism was moderately more activated by temperature than the mesophilic analog. This is in accord with general theories on enzyme temperature adaptation and possibly relevant information for the selection of technical cellulases.	[Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Windahl, Michael Skovbo; Badino, Silke Flindt; Westh, Peter] Roskilde Univ, Nat Syst & Models, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Windahl, Michael Skovbo; Badino, Silke Flindt; Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, Nat Syst & Models, Res Unit Funct Biomat, 1 Univ Svej,Bldg 28, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Windahl, Michael Skovbo/0000-0002-0572-3115; Sorensen, Trine Holst/0000-0002-2045-7580; Westh, Peter/0000-0002-6185-0637	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment [2104-07-0028, 11-116772]; Carlsberg Foundation [2013-01-0208]	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment Grants 2104-07-0028 and 11-116772 (to P. W.) and by Carlsberg Foundation Grant 2013-01-0208 (to P. W.). Novozymes is a major enzyme-producing company.	Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Borch K., 2014, WIPO patent, Patent No. 2014138672; Brown RF, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-6; Cherry J, 2009, Variants of glycoside hydrolases, Patent No. [WO2005030926 A3, 2005030926]; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Day AG, 2004, Novel variant Hypocrea jecorina VBH1 cellulases, Patent No. [WO2004/016760, 2004016760]; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P1347, DOI 10.1016/0038-0717(94)90216-X; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Drissen RET, 2007, BIOCATAL BIOTRANSFOR, V25, P419, DOI 10.1080/10242420701510668; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fersht A., 1999, STRUCTURE MECH PROTE; Garsoux G, 2004, BIOCHEM J, V384, P247, DOI 10.1042/BJ20040325; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Hu G, 2009, J PHYS CHEM B, V113, P14761, DOI 10.1021/jp907155v; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Laidler K J, 1979, Methods Enzymol, V63, P234; Larsen J, 2008, CHEM ENG TECHNOL, V31, P765, DOI 10.1002/ceat.200800048; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002; NG TK, 1981, APPL ENVIRON MICROB, V42, P231, DOI 10.1128/AEM.42.2.231-240.1981; OOSHIMA H, 1983, BIOTECHNOL BIOENG, V25, P3103, DOI 10.1002/bit.260251223; Pakarinen A, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-27; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Sorensen TH, 2015, J BIOL CHEM, V290, P22203, DOI 10.1074/jbc.M115.659656; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Subhedar PB, 2014, J MOL CATAL B-ENZYM, V101, P108, DOI 10.1016/j.molcatb.2014.01.002; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Vasquez MP, 2007, APPL BIOCHEM BIOTECH, V137, P141, DOI 10.1007/s12010-007-9046-2; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Voutilainen SP, 2014, APPL MICROBIOL BIOT, V98, P2991, DOI 10.1007/s00253-013-5177-2; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Watanabe A, 2006, APPL SPECTROSC, V60, P611, DOI 10.1366/000370206777670549; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Wolfenden R, 1998, J AM CHEM SOC, V120, P6814, DOI 10.1021/ja9813055; Wu I, 2013, BIOTECHNOL BIOENG, V110, P1874, DOI 10.1002/bit.24864; Ye ZL, 2014, BIORESOURCE TECHNOL, V167, P582, DOI 10.1016/j.biortech.2014.06.070; Zhang S, 1999, BIOTECHNOL BIOENG, V66, P35, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;35::AID-BIT3&gt;3.0.CO;2-G; Zhang Y, 2012, APPL BIOCHEM BIOTECH, V168, P144, DOI 10.1007/s12010-011-9362-4; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	62	44	44	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22193	22202		10.1074/jbc.M115.658930	http://dx.doi.org/10.1074/jbc.M115.658930			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183777	hybrid, Green Published			2022-12-28	WOS:000360968500036
J	Hinz, JM; Mao, P; McNeill, DR; Wilson, DM				Hinz, John M.; Mao, Peng; McNeill, Daniel R.; Wilson, David M., III			Reduced Nuclease Activity of Apurinic/Apyrimidinic Endonuclease ( APE1)Variants on Nucleosomes IDENTIFICATION OF ACCESS RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; URACIL-DNA GLYCOSYLASE; GLUCOCORTICOID RESPONSE ELEMENT; CORE PARTICLES; MAJOR HUMAN; BINDING; APE1; ACCESSIBILITY; COORDINATION; PROTEIN	Non-coding apurinic/apyrimidinic (AP) sites are generated at high frequency in genomic DNA via spontaneous hydrolytic, damage-induced or enzyme-mediated base release. AP endonuclease 1 (APE1) is the predominant mammalian enzyme responsible for initiating removal of mutagenic and cytotoxic abasic lesions as part of the base excision repair (BER) pathway. We have examined here the ability of wild-type (WT) and a collection of variant/mutant APE1 proteins to cleave at an AP site within a nucleosome core particle. Our studies indicate that, in comparison to the WT protein and other variant/mutant enzymes, the incision activity of the tumor-associated variant R237C and the rare population variant G241R are uniquely hypersensitive to nucleosome complexes in the vicinity of the AP site. This defect appears to stem from an abnormal interaction of R237C and G241R with abasic DNA substrates, but is not simply due to a DNA binding defect, as the site-specific APE1 mutant Y128A, which displays markedly reduced AP-DNA complex stability, did not exhibit a similar hypersensitivity to nucleosome structures. Notably, this incision defect of R237C and G241R was observed on a pre-assembled DNA glycosylase.AP-DNA complex as well. Our results suggest that the BER enzyme, APE1, has acquired distinct surface residues that permit efficient processing of AP sites within the context of protein-DNA complexes independent of classic chromatin remodeling mechanisms.	[Hinz, John M.; Mao, Peng] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [McNeill, Daniel R.; Wilson, David M., III] NIA, Lab Mol Gerontol, IRP, NIH, Baltimore, MD 21224 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hinz, JM (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jmhinz@wsu.edu	Regan, Clinton/E-6250-2012; Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395	National Institutes of Health [ES020955, ES004106, ES002614]; National Institute of Environmental Health Sciences; Intramural Research Program at the National Institutes of Health, NIA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002614, R01ES004106, R21ES020955, R37ES002614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000750, ZIAAG000743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program at the National Institutes of Health, NIA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants ES020955 (to J. M. H.) and ES004106 and ES002614 (to M. Smerdon, Washington State University)), from the National Institute of Environmental Health Sciences, and the Intramural Research Program at the National Institutes of Health, NIA. The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin MR, 2010, BIOCHEMISTRY-US, V49, P7879, DOI 10.1021/bi100889r; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Brenerman BM, 2014, CARCINOGENESIS, V35, P2643, DOI 10.1093/carcin/bgu225; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Cabelof DC, 2012, CELL MOL LIFE SCI, V69, P727, DOI 10.1007/s00018-011-0839-7; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Chohan M, 2015, J MOL BIOL, V427, P298, DOI 10.1016/j.jmb.2014.12.001; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Illuzzi JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065922; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Kim WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090837; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI Q, 1995, MOL CELL BIOL, V15, P4375; LIBERTINI LJ, 1980, NUCLEIC ACIDS RES, V8, P3517, DOI 10.1093/nar/8.16.3517; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meira LB, 2001, CANCER RES, V61, P5552; Menoni H, 2012, NUCLEIC ACIDS RES, V40, P692, DOI 10.1093/nar/gkr761; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Odell ID, 2013, J CELL PHYSIOL, V228, P258, DOI 10.1002/jcp.24134; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	43	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21067	21075		10.1074/jbc.M115.665547	http://dx.doi.org/10.1074/jbc.M115.665547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134573	Green Published, hybrid			2022-12-28	WOS:000360011800039
J	Hsu, WL; Chung, HW; Wu, CY; Wu, HI; Lee, YT; Chen, EC; Fang, WL; Chang, YC				Hsu, Wei-Lun; Chung, Hui-Wen; Wu, Chih-Yueh; Wu, Huei-Ing; Lee, Yu-Tao; Chen, En-Chan; Fang, Weilun; Chang, Yen-Chung			Glutamate Stimulates Local Protein Synthesis in the Axons of Rat Cortical Neurons by Activating alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors and Metabotropic Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; TRPC CHANNELS; GROWTH CONES; EXCITATORY SYNAPSES; NEUROTROPHIC FACTOR; SIGNALING PATHWAY; HIPPOCAMPAL SLICE; RAPAMYCIN MTOR; P70S6 KINASE	Glutamate is the principal excitatory neurotransmitter in the mammalian CNS. By analyzing the metabolic incorporation of azidohomoalanine, a methionine analogue, in newly synthesized proteins, we find that glutamate treatments up-regulate protein translation not only in intact rat cortical neurons in culture but also in the axons emitting from cortical neurons before making synapses with target cells. The process by which glutamate stimulates local translation in axons begins with the binding of glutamate to the ionotropic AMPA receptors and metabotropic glutamate receptor 1 and members of group 2 metabotropic glutamate receptors on the plasma membrane. Subsequently, the activated mammalian target of rapamycin (mTOR) signaling pathway and the rise in Ca2+, resulting from Ca2+ influxes through calcium-permeable AMPA receptors, voltage-gated Ca2+ channels, and transient receptor potential canonical channels, in axons stimulate the local translation machinery. For comparison, the enhancement effects of brain-derived neurotrophic factor (BDNF) on the local protein synthesis in cortical axons were also studied. The results indicate that Ca2+ influxes via transient receptor potential canonical channels and activated the mTOR pathway in axons also mediate BDNF stimulation to local protein synthesis. However, glutamate-and BDNF-induced enhancements of translation in axons exhibit different kinetics. Moreover, Ca2+ and mTOR signaling appear to play roles carrying different weights, respectively, in transducing glutamate-and BDNF-induced enhancements of axonal translation. Thus, our results indicate that exposure to transient increases of glutamate and more lasting increases of BDNF would stimulate local protein synthesis in migrating axons en route to their targets in the developing brain.	[Hsu, Wei-Lun; Chung, Hui-Wen; Wu, Huei-Ing; Chang, Yen-Chung] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan; [Lee, Yu-Tao; Chen, En-Chan; Fang, Weilun] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu 300, Taiwan; [Wu, Chih-Yueh; Chang, Yen-Chung] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu 300, Taiwan; [Chang, Yen-Chung] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu 300, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Chang, YC (corresponding author), Natl Tsing Hua Univ, Coll Life Sci, 101 Sect 2 Kuang Fu Rd, Hsinchu 300, Taiwan.	ycchang@life.nthu.edu.tw		Hsu, Wei-Lun/0000-0002-3998-9181	National Science Council, Taiwan, Republic of China [NSC 99-2311-B-007-009-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by National Science Council Grant NSC 99-2311-B-007-009-MY3, Taiwan, Republic of China. The authors declare that they have no conflicts of interest with the contents of this article.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Cheng HH, 2006, J NEUROSCI RES, V84, P244, DOI 10.1002/jnr.20898; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; CHOI DW, 1987, J NEUROSCI, V7, P357; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; DJURICIC B, 1994, METAB BRAIN DIS, V9, P235, DOI 10.1007/BF01991197; Eng H, 1999, J NEUROSCI, V19, P1; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Gordon-Weeks P. R., 2005, DEV CELL BIOL SERIES, V37; Gracias NG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4506; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Herkert M, 1998, EUR J NEUROSCI, V10, P1553, DOI 10.1046/j.1460-9568.1998.00164.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hsu YH, 2012, ANAL BIOCHEM, V427, P1, DOI 10.1016/j.ab.2012.04.017; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Inamura N, 2005, J NEUROCHEM, V95, P1438, DOI 10.1111/j.1471-4159.2005.03466.x; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kaplan BB, 2004, ANN NY ACAD SCI, V1018, P244, DOI 10.1196/annals.1296.029; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Kerschensteiner D, 2014, NEUROSCIENTIST, V20, P272, DOI 10.1177/1073858413510044; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kopach O, 2013, BRAIN RES BULL, V93, P47, DOI 10.1016/j.brainresbull.2012.11.004; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; KUMAR RV, 1991, EUR J BIOCHEM, V195, P313, DOI 10.1111/j.1432-1033.1991.tb15708.x; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lushnikova I, 2009, HIPPOCAMPUS, V19, P753, DOI 10.1002/hipo.20551; Marin P, 1997, J NEUROSCI, V17, P3445; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Moccia R, 2003, J NEUROSCI, V23, P9409; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Rajan I, 1998, J NEUROSCI, V18, P7836; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Schenk U, 2003, EMBO J, V22, P558, DOI 10.1093/emboj/cdg059; Schmitz Y, 2009, J NEUROSCI, V29, P11973, DOI 10.1523/JNEUROSCI.2927-09.2009; Seeburg P., 1994, NMDA RECEPTOR, P147; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Takei N, 2009, J BIOL CHEM, V284, P26340, DOI 10.1074/jbc.M109.023010; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; VORNOV JJ, 1991, J NEUROCHEM, V56, P996, DOI 10.1111/j.1471-4159.1991.tb02020.x; Vuppalanchi D, 2012, MOL CELL NEUROSCI, V50, P136, DOI 10.1016/j.mcn.2012.04.001; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang PY, 2011, J NEUROSCI, V31, P9289, DOI 10.1523/JNEUROSCI.5639-10.2011; Wang YY, 2014, MOL CELL NEUROSCI, V61, P141, DOI 10.1016/j.mcn.2014.06.011; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu HI, 2010, LAB CHIP, V10, P647, DOI 10.1039/b918217a; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zheng JQ, 1996, J NEUROSCI, V16, P1140	83	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20748	20760		10.1074/jbc.M115.638023	http://dx.doi.org/10.1074/jbc.M115.638023			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134564	Green Published, hybrid			2022-12-28	WOS:000360011800013
J	Yu, C; Cui, S; Zong, C; Gao, WN; Xu, TF; Gao, P; Chen, JC; Qin, DD; Guan, QB; Liu, YT; Fu, YC; Li, X; Wang, XD				Yu, Cong; Cui, Shang; Zong, Chen; Gao, Weina; Xu, Tongfu; Gao, Peng; Chen, Jicui; Qin, Dandan; Guan, Qingbo; Liu, Yuantao; Fu, Yuchang; Li, Xia; Wang, Xiangdong			The Orphan Nuclear Receptor NR4A1 Protects Pancreatic beta-Cells from Endoplasmic Reticulum (ER) Stress-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; GROWTH ARREST; CANCER CELL; NUR77; PALMITATE; SURVIVIN; BCL-2; IRE1; TRANSLOCATION; TRANSLATION	The role of NR4A1 in apoptosis is controversial. Pancreatic beta-cells often face endoplasmic reticulum (ER) stress under adverse conditions such as high free fatty acid (FFA) concentrations and sustained hyperglycemia. Severe ER stress results in beta-cell apoptosis. The aim of this study was to analyze the role of NR4A1 in ER stress-mediated beta-cell apoptosis and to characterize the related mechanisms. We confirmed that upon treatment with the ER stress inducers thapsigargin (TG) or palmitic acid (PA), the mRNA and protein levels of NR4A1 rapidly increased in both MIN6 cells and mouse islets. NR4A1 overexpression in MIN6 cells conferred resistance to cell loss induced by TG or PA, as assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and TUNEL assays indicated that NR4A1 overexpression also protected against ER stress-induced apoptosis. This conclusion was further confirmed by experiments exploiting siRNA to knockdown NR4A1 expression in MIN6 cells or exploiting NR4A1 knock-out mice. NR4A1 overexpression in MIN6 cells reduced C/EBP homologous protein (CHOP) expression and Caspase3 activation induced by TG or PA. NR4A1 overexpression in MIN6 cells or mouse islets resulted in Survivin up-regulation. A critical regulatory element was identified in Survivin promoter (-1872 bp to -1866 bp) with a putative NR4A1 binding site; ChIP assays demonstrated that NR4A1 physically associates with the Survivin promoter. In conclusion, NR4A1 protects pancreatic beta-cells against ER stress-mediated apoptosis by up-regulating Survivin expression and down-regulating CHOP expression, which we termed as "positive and negative regulation."	[Yu, Cong; Cui, Shang; Zong, Chen; Gao, Weina; Xu, Tongfu; Gao, Peng; Chen, Jicui; Qin, Dandan; Li, Xia; Wang, Xiangdong] Shandong Univ, Sch Med, Dept Cell Biol, Jinan 250012, Peoples R China; [Guan, Qingbo] Shandong Univ, Prov Hosp, Dept Endocrinol, Jinan 250021, Peoples R China; [Liu, Yuantao] Qingdao Municipal Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China; [Fu, Yuchang] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Wang, Xiangdong] Shandong Univ, Key Lab Prot Sci Chron Degenerat Dis, Jinan 250012, Peoples R China	Shandong University; Shandong University; Qingdao Municipal Hospital; University of Alabama System; University of Alabama Birmingham; Shandong University	Li, X (corresponding author), Shandong Univ, Sch Med, Dept Cell Biol, 44 Wenhua Rd West, Jinan 250012, Peoples R China.	lixia1666@sdu.edu.cn; xdongw@sdu.edu.cn	, 鹏鹏/AGR-5462-2022		National Natural Science Foundation of China [81170814, 81370881]; Education Department of China [20100131110037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of China	This work was supported by the National Natural Science Foundation of China (81170814 and 81370881) and the Education Department of China for Ph.D. programs (20100131110037). The authors declare that there are no conflicts of interests with the contents of the article.	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen HZ, 2013, INT J BIOCHEM CELL B, V45, P1600, DOI 10.1016/j.biocel.2013.04.026; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; Gao WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091462; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jonas JC, 1998, DIABETES, V47, P1266, DOI 10.2337/diabetes.47.8.1266; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kuang AA, 1999, EUR J IMMUNOL, V29, P3722, DOI 10.1002/(SICI)1521-4141(199911)29:11<3722::AID-IMMU3722>3.0.CO;2-N; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin J. H., 2007, MOL CELL, V318, P944; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu CL, 2014, INT J MOL MED, V33, P499, DOI 10.3892/ijmm.2013.1603; Liu S, 2002, WORLD J GASTROENTERO, V8, P446, DOI 10.3748/wjg.v8.i3.446; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Sohn J, 2003, CANCER LETT, V191, P83, DOI 10.1016/S0304-3835(02)00624-9; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Strom BO, 2012, BIOCHEM BIOPH RES CO, V417, P1292, DOI 10.1016/j.bbrc.2011.12.132; Suzuki S, 2003, P NATL ACAD SCI USA, V100, P8276, DOI 10.1073/pnas.0932598100; Tamm I, 1998, CANCER RES, V58, P5315; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Yang L, 2010, FASEB J, V24, P3720, DOI 10.1096/fj.09-152363; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	45	25	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20687	20699		10.1074/jbc.M115.654863	http://dx.doi.org/10.1074/jbc.M115.654863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157144	Green Published, hybrid			2022-12-28	WOS:000360011800005
J	Sabirzhanova, I; Pacheco, ML; Rapino, D; Grover, R; Handa, JT; Guggino, WB; Cebotaru, L				Sabirzhanova, Inna; Pacheco, Miqueias Lopes; Rapino, Daniele; Grover, Rahul; Handa, James T.; Guggino, William B.; Cebotaru, Liudmila			Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HEAT-SHOCK PROTEINS; CYSTIC-FIBROSIS; MACULAR DEGENERATION; DELTA-F508 CFTR; RIM PROTEIN; WILD-TYPE; DEGRADATION; GENE; CHAPERONES	Stargardt disease is the most common form of early onset macular degeneration. Mutations in ABCA4, a member of the ATP-binding cassette (ABC) family, are associated with Stargardt disease. Here, we have examined two disease-causing mutations in the NBD1 region of ABCA4, R1108C, and R1129C, which occur within regions of high similarity with CFTR, another ABC transporter gene, which is associated with cystic fibrosis. We show that R1108C and R1129C are both temperature-sensitive processing mutants that engage the cellular quality control mechanism and show a strong interaction with the chaperone Hsp 27. Both mutant proteins also interact with HDCAC6 and are degraded in the aggresome. We also demonstrate that novel corrector compounds that are being tested as treatment for cystic fibrosis, such as VX-809, can rescue the processing of the ABCA4 mutants, particularly their expression at the cell surface, and can reduce their binding to HDAC6. Thus, our data suggest that VX-809 can potentially be developed as a new therapy for Stargardt disease, for which there is currently no treatment.	[Sabirzhanova, Inna; Pacheco, Miqueias Lopes; Rapino, Daniele; Grover, Rahul; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Sabirzhanova, Inna; Pacheco, Miqueias Lopes; Rapino, Daniele; Grover, Rahul; Cebotaru, Liudmila] Johns Hopkins Univ, Physiol Ctr Retinal Biol, Baltimore, MD 21231 USA; [Handa, James T.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Lopes-Pacheco, Miquéias/AAM-7432-2020; Lopes-Pacheco, Miquéias/I-1290-2017	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Grover, Rahul/0000-0002-3143-0228	National Council for Scientific and Technological Development (CNPq) Brazil;  [DK072084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Council for Scientific and Technological Development (CNPq) Brazil (Lopes Pacheco) and DK072084 (to W. B. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Boinot C, 2014, J PHARMACOL EXP THER, V350, P624, DOI 10.1124/jpet.114.214890; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P8181, DOI 10.1167/iovs.13-12104; Gusev NB, 2005, BIOCHEMISTRY-MOSCOW+, V70, P629, DOI 10.1007/s10541-005-0162-8; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Holleran JP, 2013, J CELL SCI, V126, P2692, DOI 10.1242/jcs.120196; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Okiyoneda T, 2012, J CELL BIOL, V199, P199, DOI 10.1083/jcb.201208083; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sudnitsyna MV, 2012, CURR PROTEIN PEPT SC, V13, P76; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Wei XF, 1996, J CELL PHYSIOL, V168, P373, DOI 10.1002/(SICI)1097-4652(199608)168:2<373::AID-JCP16>3.0.CO;2-4; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yan J, 2014, DNA CELL BIOL, V33, P567, DOI 10.1089/dna.2013.2300; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	40	37	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19743	19755		10.1074/jbc.M115.647685	http://dx.doi.org/10.1074/jbc.M115.647685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26092729	Green Published, hybrid			2022-12-28	WOS:000359364600032
J	Schneider, D; Kaiser, W; Stutz, C; Holinski, A; Mayans, O; Babinger, P				Schneider, Daniel; Kaiser, Wolfgang; Stutz, Cian; Holinski, Alexandra; Mayans, Olga; Babinger, Patrick			YbiB from Escherichia coli, the Defining Member of the Novel TrpD2 Family of Prokaryotic DNA-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SULFOLOBUS-SOLFATARICUS; METABOLIC ENZYME; HELICASE; GLYCOSYLASE; DENSITY; SYSTEM	We present the crystal structure and biochemical characterization of Escherichia coli YbiB, a member of the hitherto uncharacterized TrpD2 protein family. Our results demonstrate that the functional diversity of proteins with a common fold can be far greater than predictable by computational annotation. The TrpD2 proteins show high structural homology to anthranilate phosphoribosyltransferase (TrpD) and nucleoside phosphorylase class II enzymes but bind with high affinity (K-D = 10-100 nM) to nucleic acids without detectable sequence specificity. The difference in affinity between single-and double-stranded DNA is minor. Results suggest that multiple YbiB molecules bind to one longer DNA molecule in a cooperative manner. The YbiB protein is a homodimer that, therefore, has two electropositive DNA binding grooves. But due to negative cooperativity within the dimer, only one groove binds DNA in in vitro experiments. A monomerized variant remains able to bind DNA with similar affinity, but the negative cooperative effect is eliminated. The ybiB gene forms an operon with the DNA helicase gene dinG and is under LexA control, being induced by DNA-damaging agents. Thus, speculatively, the TrpD2 proteins may be part of the LexA-controlled SOS response in bacteria.	[Schneider, Daniel; Kaiser, Wolfgang; Holinski, Alexandra; Babinger, Patrick] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; [Stutz, Cian; Mayans, Olga] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland; [Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Regensburg; University of Basel; University of Liverpool	Babinger, P (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.	patrick.babinger@ur.de		Mayans, Olga/0000-0001-6876-8532; Holinski, Alexandra/0000-0003-2321-5568; Babinger, Patrick/0000-0002-7490-6732				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castell A, 2013, BIOCHEMISTRY-US, V52, P1776, DOI 10.1021/bi301387m; Cheng ZS, 2012, FEBS LETT, V586, P3825, DOI 10.1016/j.febslet.2012.09.032; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao XF, 2006, J STRUCT BIOL, V154, P20, DOI 10.1016/j.jsb.2005.11.014; Grippon S, 2011, NUCLEIC ACIDS RES, V39, P2593, DOI 10.1093/nar/gkq913; Hwang J, 2012, J MOL MICROB BIOTECH, V22, P135, DOI 10.1159/000339832; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim C, 2002, FEBS LETT, V523, P239, DOI 10.1016/S0014-5793(02)02905-8; Koroleva O, 2007, EMBO J, V26, P867, DOI 10.1038/sj.emboj.7601537; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee CE, 2006, J MOL BIOL, V355, P784, DOI 10.1016/j.jmb.2005.11.016; Marino M, 2006, J BIOL CHEM, V281, P21410, DOI 10.1074/jbc.M601403200; Mayans O, 2002, EMBO J, V21, P3245, DOI 10.1093/emboj/cdf298; McRobbie AM, 2012, BIOCHEM J, V442, P77, DOI 10.1042/BJ20111903; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Pugmire MJ, 1998, STRUCTURE, V6, P1467, DOI 10.1016/S0969-2126(98)00145-2; Pugmire WJ, 1998, J MOL BIOL, V281, P285, DOI 10.1006/jmbi.1998.1941; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P2212, DOI 10.1093/nar/30.10.2212; Schlee S, 2009, BIOCHEMISTRY-US, V48, P5199, DOI 10.1021/bi802335s; Schwab T, 2008, J MOL BIOL, V376, P506, DOI 10.1016/j.jmb.2007.11.078; Schwab T, 2011, CHEMBIOCHEM, V12, P1581, DOI 10.1002/cbic.201000770; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	42	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19527	19539		10.1074/jbc.M114.620575	http://dx.doi.org/10.1074/jbc.M114.620575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26063803	hybrid, Green Published			2022-12-28	WOS:000359364600013
J	Seto, DN; Kandarian, SC; Jackman, RW				Seto, Danielle N.; Kandarian, Susan C.; Jackman, Robert W.			A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; COLON-26 ADENOCARCINOMA; STAT3; INTERLEUKIN-6; CELLS; DIFFERENTIATION; PATHWAY; MICE; TRANSCRIPTION; ACTIVATION	Cachexia is an exacerbating event in many types of cancer that is strongly associated with a poor prognosis. We have identified cytokine, signaling, and transcription factors that are required for cachexia in the mouse C26 colon carcinoma model of cancer. C2C12 myotubes treated with conditioned medium from C26 cancer cells induced atrophy and activated a STAT-dependent reporter gene but not reporter genes dependent on SMAD, FOXO, C/EBP, NF-kappa B, or AP-1. Of the gp130 family members IL-11, IL-6, oncostatinM(OSM), and leukemia inhibitory factor (LIF), only OSM and LIF were sufficient to activate the STAT reporter in myotubes. LIF was elevated in C26 conditioned medium (CM), but IL-6, OSM, TNF alpha, and myostatin were not. A LIF-blocking antibody abolished C26 CM-induced STAT reporter activation, STAT3 phosphorylation, and myotube atrophy but blocking antibodies to IL-6 or OSM did not. JAK2 inhibitors also blocked C26 CM-induced STAT reporter activation, STAT3 phosphorylation, and atrophy in myotubes. LIF at levels found in the C26 CM was sufficient for STAT reporter activation and atrophy in myotubes. In vivo, an increase in serum LIF preceded the increase in IL-6 in mice with C26 tumors. Overexpression of a dominant negative Stat3C beta-EGFP gene in myotubes and in mouse muscle blocked the atrophy caused by C26 CM or C26 tumors, respectively. Taken together, these data support an important role of LIF-JAK2-STAT3 in C26 cachexia and point to a therapeutic approach for at least some types of cancer cachexia.	[Seto, Danielle N.; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Jackman, RW (corresponding author), Boston Univ, Dept Hlth Sci, 635 Commonwealth Ave, Boston, MA 02215 USA.	rjackman@bu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 AR060217]; CTSA Grant [UL1-TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR060217 (to S. C. K. and R. W. J.). The microarray analysis was supported by CTSA Grant UL1-TR000157 (to the CTSI at the Boston University Microarray Resource Core Facility). The authors declare that they have no conflicts of interest with the contents of this article.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007; Aulino P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-363; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; BERG M, 1994, CYTOKINE, V6, P425, DOI 10.1016/1043-4666(94)90067-1; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cornwell EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087776; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fujiki F, 1997, CANCER RES, V57, P94; GASCAN H, 1990, J IMMUNOL, V144, P2592; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Lazarus DD, 1999, AM J PHYSIOL-ENDOC M, V277, pE332, DOI 10.1152/ajpendo.1999.277.2.E332; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Lokireddy S, 2012, BIOCHEM J, V446, P23, DOI 10.1042/BJ20112024; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; MORI M, 1991, CANCER RES, V51, P6656; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Silva KAS, 2015, J BIOL CHEM, V290, P11177, DOI 10.1074/jbc.M115.641514; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; SODA K, 1994, JPN J CANCER RES, V85, P1124, DOI 10.1111/j.1349-7006.1994.tb02917.x; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANAKA Y, 1990, CANCER RES, V50, P2290; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; TOMIDA M, 1984, FEBS LETT, V178, P291, DOI 10.1016/0014-5793(84)80619-5; YASUMOTO K, 1995, CANCER RES, V55, P921; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	40	71	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19976	19986		10.1074/jbc.M115.638411	http://dx.doi.org/10.1074/jbc.M115.638411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26092726	Green Published, hybrid			2022-12-28	WOS:000359364600052
J	Sha, XJ; Meng, S; Li, XY; Xi, H; Maddaloni, M; Pascual, DW; Shan, HM; Jiang, XH; Wang, H; Yang, XF				Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Maddaloni, Massimo; Pascual, David W.; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng			Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; INDUCED ARTHRITIS; IL-35; EXPRESSION; ATHEROSCLEROSIS; CYTOKINE; RECEPTOR; FAMILY; AUTOIMMUNE; PROTECTION	Vascular response is an essential pathological mechanism underlying various inflammatory diseases. This study determines whether IL-35, a novel responsive anti-inflammatory cytokine, inhibits vascular response in acute inflammation. Using a mouse model of LPS-induced acute inflammation and plasma samples from sepsis patients, we found that IL-35 was induced in the plasma of mice after LPS injection as well as in the plasma of sepsis patients. In addition, IL-35 decreased LPS-induced proinflammatory cytokines and chemokines in the plasma of mice. Furthermore, IL-35inhibited leukocyte adhesion to the endothelium in the vessels of lung and cremaster muscle and decreased the numbers of inflammatory cells in bronchoalveolar lavage fluid. Mechanistically, IL-35 inhibited the LPS-induced up-regulation of endothelial cell (EC) adhesion molecule VCAM-1 through IL-35 receptors gp130 and IL-12R beta 2 via inhibition of the MAPK-activator protein-1 (AP-1) signaling pathway. We also found that IL-27, which shares the EBI3 subunit with IL-35, promoted LPS-induced VCAM-1 in human aortic ECs and that EBI3-deficient mice had similar vascular response to LPS when compared with that of WT mice. These results demonstrated for the first time that inflammation-induced IL-35 inhibits LPS-induced EC activation by suppressing MAPK-AP1-mediated VCAM-1 expression and attenuates LPS-induced secretion of proinflammatory cytokines/chemokines. Our results provide insight into the control of vascular inflammation by IL-35 and suggest that IL-35 is an attractive novel therapeutic reagent for sepsis and cardiovascular	[Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng] Temple Univ, Sch Med, Ctr Metab Dis Res, Dept Pharmacol, Philadelphia, PA 19140 USA; [Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng] Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Pharmacol, Philadelphia, PA 19140 USA; [Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng] Temple Univ, Sch Med, Thrombosis Res Ctr, Dept Pharmacol, Philadelphia, PA 19140 USA; [Maddaloni, Massimo; Pascual, David W.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32608 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida	Yang, XF (corresponding author), Temple Univ, Sch Med, Ctr Metab Dis Res, 3500 North Broad St,MERB 1059, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Pascual, David/AAC-2248-2022; Li, Xinyuan/Z-6299-2019; Regan, Clinton/E-6250-2012; Li, Xinyuan/B-1139-2015	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367	National Institutes of Health [5R01HL108910-05, 5R01HL116917-03, 5R01HL077288-11, 5R01HL110764-05, 5R01HL117654-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077288, R01HL117654, R01HL116917, R01HL110764, R01HL108910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by National Institutes of Health Grants 5R01HL108910-05; 5R01HL116917-03; 5R01HL077288-11; 5R01HL110764-05; and 5R01HL117654-03 (to X.F.Y and H.W). The authors declare that they have no conflicts of interest with the contents of this article.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Choi JJ, 2015, CLIN REV ALLERG IMMU, V49, P327, DOI 10.1007/s12016-015-8468-9; CHOWIENCZYK PJ, 1992, LANCET, V340, P1430, DOI 10.1016/0140-6736(92)92621-L; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dixon KO, 2015, EUR J IMMUNOL, V45, P1736, DOI 10.1002/eji.201445217; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; He SL, 2010, ARTERIOSCL THROM VAS, V30, P2621, DOI 10.1161/ATVBAHA.110.210492; Henke PK, 2000, J IMMUNOL, V164, P2131, DOI 10.4049/jimmunol.164.4.2131; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jersmann HPA, 2001, INFECT IMMUN, V69, P1273, DOI 10.1128/IAI.69.3.1273-1279.2001; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Koltsova EK, 2012, CIRC RES, V111, P1274, DOI 10.1161/CIRCRESAHA.112.277525; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Mannam P, 2013, J IMMUNOL, V190, P1264, DOI 10.4049/jimmunol.1202012; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tsoyi K, 2009, ATHEROSCLEROSIS, V207, P412, DOI 10.1016/j.atherosclerosis.2009.05.012; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yang WY, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0001-0; Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003	38	75	85	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19307	19318		10.1074/jbc.M115.663286	http://dx.doi.org/10.1074/jbc.M115.663286			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085094	Green Published, hybrid			2022-12-28	WOS:000358781100042
J	Mooren, OL; Kim, J; Li, JM; Cooper, JA				Mooren, Olivia L.; Kim, Joanna; Li, Jinmei; Cooper, John A.			Role of N-WASP in Endothelial Monolayer Formation and Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VE-CADHERIN; VASCULAR-PERMEABILITY; FOCAL ADHESION; ACTIN; JUNCTIONS; MAINTAIN; COMPLEX; GTPASES	Endothelial cells (ECs) form a monolayer that serves as a barrier between the blood and the underlying tissue. ECs tightly regulate their cell-cell junctions, controlling the passage of soluble materials and immune cells across the monolayer barrier. Westudied the role of N-WASP, a key regulator of Arp2/3 complex and actin assembly, in EC monolayers. We report that N-WASP regulates endothelial monolayer integrity by affecting the organization of cell junctions. Depletion of N-WASP resulted in an increase in transendothelial electrical resistance, a measure of monolayer integrity. N-WASP depletion increased the width of cell-cell junctions and altered the organization of F-actin and VE-cadherin at junctions. N-WASP was not present at cell-cell junctions in monolayers under resting conditions, but it was recruited following treatment with sphingosine-1-phosphate. Taken together, our results reveal a novel role for N-WASP in remodeling EC junctions, which is critical for monolayer integrity and function.	[Mooren, Olivia L.; Kim, Joanna; Li, Jinmei; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, JA (corresponding author), Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	jacooper@wustl.edu	Regan, Clinton/E-6250-2012; Kim, Joanna/U-5556-2018; Cooper, John/D-4448-2014	Kim, Joanna/0000-0001-7877-9446; Cooper, John/0000-0002-0933-4571	National Institutes of Health [R01 GM 38542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 38542. The authors declare that they have no conflicts of interest with the contents of this article.	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Blum MS, 1997, AM J PHYSIOL-HEART C, V273, pH286, DOI 10.1152/ajpheart.1997.273.1.H286; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Clark PR, 2007, J INVEST DERMATOL, V127, P762, DOI 10.1038/sj.jid.5700670; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Citalan-Madrid AF, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26938; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; STOLPEN AH, 1986, AM J PATHOL, V123, P16; Sun XG, 2009, MICROVASC RES, V77, P304, DOI 10.1016/j.mvr.2008.12.004; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	36	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18796	18805		10.1074/jbc.M115.668285	http://dx.doi.org/10.1074/jbc.M115.668285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070569	Green Published, hybrid			2022-12-28	WOS:000358512100046
J	Pinnola, A; Ghin, L; Gecchele, E; Merlin, M; Alboresi, A; Avesani, L; Pezzotti, M; Capaldi, S; Cazzaniga, S; Bassi, R				Pinnola, Alberta; Ghin, Leonardo; Gecchele, Elisa; Merlin, Matilde; Alboresi, Alessandro; Avesani, Linda; Pezzotti, Mario; Capaldi, Stefano; Cazzaniga, Stefano; Bassi, Roberto			Heterologous Expression of Moss Light-harvesting Complex Stress-related 1 (LHCSR1), the Chlorophyll a-Xanthophyll Pigment-protein Complex Catalyzing Non-photochemical Quenching, in Nicotiana sp.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-PATHOGEN INTERACTIONS; PHOTOSYSTEM-II; ANTENNA PROTEIN; SUPRAMOLECULAR ORGANIZATION; PHYSCOMITRELLA-PATENS; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; BINDING PROTEIN; INTACT LEAVES	Oxygenic photosynthetic organisms evolved mechanisms for thermal dissipation of energy absorbed in excess to prevent formation of reactive oxygen species. The major and fastest component, called non-photochemical quenching, occurs within the photosystem II antenna system by the action of two essential light-harvesting complex (LHC)-like proteins, photosystem II subunit S (PSBS) in plants and light-harvesting complex stress-related (LHCSR) in green algae and diatoms. In the evolutionary intermediate Physcomitrella patens, a moss, both gene products are active. These proteins, which are present in low amounts, are difficult to purify, preventing structural and functional analysis. Here, we report on the overexpression of the I,HCSR1 protein from P. patens in the heterologous systems Nicotiana bentharniana and Nicotiana tabacum using transient and stable nuclear transformation. We show that the protein accumulated in both heterologous systems is in its mature form, localizes in the chloroplast thylakoid membranes, and is correctly folded with chlorophyll a and xanthophylls but without chlorophyll b, an essential chrornophore for plants and algal LHC proteins. Finally, we show that recombinant I,HCSR1 is active in quenching in vivo, implying that the recombinant protein obtained is a good material for future structural and functional studies.	[Pinnola, Alberta; Ghin, Leonardo; Gecchele, Elisa; Merlin, Matilde; Alboresi, Alessandro; Avesani, Linda; Pezzotti, Mario; Capaldi, Stefano; Cazzaniga, Stefano; Bassi, Roberto] Univ Verona, Dept Biotechnol, Str Le Grazie 75, I-37134 Verona, Italy	University of Verona	Bassi, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 75, I-37134 Verona, Italy.	roberto.bassi@univr.it	Alboresi, Alessandro/Z-1220-2019; Cazzaniga, Stefano/ABG-3898-2021	Alboresi, Alessandro/0000-0003-4818-7778; Cazzaniga, Stefano/0000-0002-2824-7916; capaldi, stefano/0000-0003-4632-8100; Pinnola, Alberta/0000-0001-8373-7638; bassi, roberto/0000-0002-4140-8446	European Union [316427]; Italian Ministry of Agriculture, Food and Forestry	European Union(European Commission); Italian Ministry of Agriculture, Food and Forestry	This work was supported in part through the European Union Seventh Framework Program for Research Project 316427, Environmental Acclimation of Photosynthesis and the Italian Ministry of Agriculture, Food and Forestry Project HYDROBIO. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BASSI R, 1987, EUR J BIOCHEM, V163, P221, DOI 10.1111/j.1432-1033.1987.tb10791.x; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bruce D, 1997, BIOCHEMISTRY-US, V36, P749, DOI 10.1021/bi962216c; Cazzaniga S, 2013, PLANT J, V76, P568, DOI 10.1111/tpj.12314; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2508, DOI 10.1016/S0006-3495(03)75056-5; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2012, J BIOL CHEM, V287, P41820, DOI 10.1074/jbc.M112.405498; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Duysens L. N. M., 1963, STUDIES MICROALGAE P, P352; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Flachmann R, 1996, P NATL ACAD SCI USA, V93, P14966, DOI 10.1073/pnas.93.25.14966; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Hoober JK, 1999, PHOTOSYNTH RES, V61, P197; HORSCH RB, 1986, P NATL ACAD SCI USA, V83, P2571, DOI 10.1073/pnas.83.8.2571; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Krysan Patrick J., 2002, OMICS A Journal of Integrative Biology, V6, P163, DOI 10.1089/153623102760092760; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu J, 2014, PLANT PHYSIOL BIOCH, V79, P19, DOI 10.1016/j.plaphy.2014.02.026; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Morosinotto T, 2010, J BIOENERG BIOMEMBR, V42, P37, DOI 10.1007/s10863-009-9261-3; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; PETER G F, 1991, Methods (Orlando), V3, P115, DOI 10.1016/S1046-2023(05)80203-8; Pinnola A., 2014, THESIS; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; POWLES SB, 1982, PLANTA, V156, P97, DOI 10.1007/BF00395424; Rosgaard L, 2012, J BIOTECHNOL, V162, P134, DOI 10.1016/j.jbiotec.2012.05.006; SIMPSON DJ, 1983, EUR J CELL BIOL, V31, P305; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; STROTMANN H, 1987, FEBS LETT, V221, P265, DOI 10.1016/0014-5793(87)80938-9; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; TAL M, 1985, J BIOL CHEM, V260, P9976; Wientjes E, 2009, J BIOL CHEM, V284, P7803, DOI 10.1074/jbc.M808395200	62	18	18	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24340	24354		10.1074/jbc.M115.668798	http://dx.doi.org/10.1074/jbc.M115.668798			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26260788	Green Published, hybrid			2022-12-28	WOS:000362218900023
J	Chaman, N; Iqbal, MA; Siddiqui, FA; Gopinath, P; Bamezai, RNK				Chaman, Noor; Iqbal, Mohammad Askandar; Siddiqui, Farid Ahmad; Gopinath, Prakasam; Bamezai, Rameshwar N. K.			ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE; NUCLEAR TRANSLOCATION; ERYTHROID-DIFFERENTIATION; GENE-TRANSCRIPTION; ENERGY-METABOLISM; E7 ONCOPROTEIN; PROTEIN-KINASE; TUMOR-GROWTH; M2; PKM2	Metabolic changes that contribute to differentiation are not well understood. Overwhelming evidence shows the critical role of glycolytic enzyme pyruvate kinase (PK) in directing metabolism of proliferating cells. However, its role in metabolism of differentiating cells is unclear. Here we studied the role of PK in phorbol 12-myristate 13-acetate (PMA)-induced megakaryocytic differentiation in human leukemia K562 cells. We observed that PMA treatment decreased cancer-type anabolic metabolism but increased ATP production, along with up-regulated expression of two PK isoforms (PKM2 and PKR) in an ERK2-dependent manner. Interestingly, silencing of PK (PKM2 and PKR) inhibited PMA-induced megakaryocytic differentiation, as revealed by decreased expression of megakaryocytic differentiation marker CD61 and cell cycle behavior. Further, PMA-induced ATP production reduced greatly upon PK silencing, suggesting that PK is required for ATP synthesis. In addition to metabolic effects, PMA treatment also translocated PKM2, but not PKR, into nucleus. ERK1/2 knockdowns independently and together suggested the role of ERK2 in the up-regulation of both the isoforms of PK, proposing a role of ERK2-PK isoform axis in differentiation. Collectively, our findings unravel ERK2 guided PK-dependent metabolic changes during PMA induction, which are important in megakaryocytic differentiation.	[Chaman, Noor; Iqbal, Mohammad Askandar; Siddiqui, Farid Ahmad; Gopinath, Prakasam; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com	Siddiqui, Farid/AAI-2408-2021; prakasam, Gopinath/S-8438-2017	Siddiqui, Farid/0000-0002-3292-2363; prakasam, Gopinath/0000-0003-1839-7969; Bamezai, R.N.K/0000-0002-5128-2859; Iqbal, Mohammad Askandar/0000-0003-3485-3530	National Centre of Applied Human Genetics; University Grants Commission of Government of India; University Grants Commission	National Centre of Applied Human Genetics; University Grants Commission of Government of India(University Grants Commission, India); University Grants Commission(University Grants Commission, India)	This work was supported by funds from the National Centre of Applied Human Genetics and from the University Grants Commission of the Government of India (to the National Centre of Applied Human Genetics) and by a research fellowship from the University Grants Commission (to N. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Belhacene N, 1998, FASEB J, V12, P531; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Iqbal MA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-72; KANNO H, 1992, BIOCHEM BIOPH RES CO, V188, P516, DOI 10.1016/0006-291X(92)91086-6; Kim KW, 2001, J BIOL CHEM, V276, P13186, DOI 10.1074/jbc.M008092200; LAD PM, 1974, BIOCHEMISTRY-US, V13, P4530, DOI 10.1021/bi00719a009; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MAXAUDIT I, 1988, BLOOD, V72, P1039; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Mazurek S, 2000, ANTICANCER RES, V20, P5151; Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247; Mazurek S, 2007, ANTICANCER RES, V27, P3963; McGraw TE, 2010, NAT CHEM BIOL, V6, P176, DOI 10.1038/nchembio.324; Miyazaki R, 2001, ANN HEMATOL, V80, P284, DOI 10.1007/s002770000285; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; NIJHOF W, 1984, BLOOD, V64, P607; NOGUCHI T, 1991, BIOCHEM BIOPH RES CO, V181, P259, DOI 10.1016/S0006-291X(05)81411-1; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Shelly C, 1998, LEUKEMIA, V12, P1951, DOI 10.1038/sj.leu.2401221; Shimada N, 2008, GENES CELLS, V13, P245, DOI 10.1111/j.1365-2443.2008.01165.x; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Takenaka M, 1996, EUR J BIOCHEM, V235, P366, DOI 10.1111/j.1432-1033.1996.00366.x; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; VANVEELEN CWM, 1977, LANCET, V2, P384; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Wirt SE, 2010, J CELL BIOL, V191, P809, DOI 10.1083/jcb.201003048; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; YAMADA K, 1990, J BIOL CHEM, V265, P19885; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	51	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23803	23815		10.1074/jbc.M115.657411	http://dx.doi.org/10.1074/jbc.M115.657411			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269597	hybrid, Green Published			2022-12-28	WOS:000361816500027
J	Chiba, Y; Kamikawa, R; Nakada-Tsukui, K; Saito-Nakano, Y; Nozaki, T				Chiba, Yoko; Kamikawa, Ryoma; Nakada-Tsukui, Kumiko; Saito-Nakano, Yumiko; Nozaki, Tomoyoshi			Discovery of PPi-type Phosphoenolpyruvate Carboxykinase Genes in Eukaryotes and Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROPHOSPHATE-DEPENDENT PHOSPHOFRUCTOKINASE; ESCHERICHIA-COLI K-12; ENTAMOEBA-HISTOLYTICA; INORGANIC PYROPHOSPHATE; GLYCOLYTIC FUNCTION; TRYPANOSOMA-BRUCEI; ENZYME; CARBOXYTRANSPHOSPHORYLASE; EVOLUTION; SEQUENCE	Phosphoenolpyruvate carboxykinase (PEPCK) is one of the pivotal enzymes that regulates the carbon flow of the central metabolism by fixing CO2 to phosphoenolpyruvate (PEP) to produce oxaloacetate or vice versa. Whereas ATP- and GTP-type PEPCKs have been well studied, and their protein identities are established, inorganic pyrophosphate (PPi)-type PEPCK (PPi-PEPCK) is poorly characterized. Despite extensive enzymological studies, its protein identity and encoding gene remain unknown. In this study, PPi-PEPCK has been identified for the first time from a eukaryotic human parasite, Entamoeba histolytica, by conventional purification and mass spectrometric identification of the native enzyme, followed by demonstration of its enzymatic activity. A homolog of the amebic PPi-PEPCK from an anaerobic bacterium Propionibacterium freudenreichii subsp. shermanii also exhibited PPi-PEPCK activity. The primary structure of PPi-PEPCK has no similarity to the functional homologs ATP/GTP-PEPCKs and PEP carboxylase, strongly suggesting that PPi-PEPCK arose independently from the other functional homologues and very likely has unique catalytic sites. PPi-PEPCK homologs were found in a variety of bacteria and some eukaryotes but not in archaea. The molecular identification of this long forgotten enzyme shows us the diversity and functional redundancy of enzymes involved in the central metabolism and can help us to understand the central metabolism more deeply.	[Chiba, Yoko; Nozaki, Tomoyoshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Chiba, Yoko; Nakada-Tsukui, Kumiko; Saito-Nakano, Yumiko; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Kamikawa, Ryoma] Kyoto Univ, Grad Sch Human & Environm Studies, Grad Sch Environm Studies, Kyoto, Kyoto 6068501, Japan	University of Tsukuba; National Institute of Infectious Diseases (NIID); Kyoto University	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	nozaki@nih.go.jp		Chiba, Yoko/0000-0002-2734-0836	Ministry of Education, Culture, Sports, Science, and Technology [26293093, 23117001, 23117005]; Research Program on Emerging and Re-emerging Infectious Diseases of Japan Agency for Medical Research and Development (AMED); Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS) [26860275, 23117006, 15H05606, 15K14591]; Institute for Fermentation (Osaka, Japan); AMED	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Emerging and Re-emerging Infectious Diseases of Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation (Osaka, Japan)(Institute for Fermentation (IFO)); AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas 23117001 and 23117005 and Grants-in-Aid for Scientific Research (B) 26293093 from the Ministry of Education, Culture, Sports, Science, and Technology, the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED), the Science and Technology Research Partnership for Sustainable Development (SATREPS), and the Japan International Cooperation Agency (JICA) and AMED (to T. N.); Grant-in-Aid for Young Scientists (B) 26860275 from the Japan Society for the Promotion of Science (JSPS) (to Y. C.); and Grant-in-Aid for Scientific Research on Innovative Areas 23117006, for Young Scientists (A) 15H05606, and for Challenging Exploratory Research 15K14591 from JSPS (to R. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Institute for Fermentation (Osaka, Japan).	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Aich S, 2007, EVOL BIOINFORM, V3, P333; Alves AMCR, 1996, J BACTERIOL, V178, P149, DOI 10.1128/jb.178.1.149-155.1996; BANDURSKI RS, 1953, J BIOL CHEM, V204, P781; Bapteste E, 2003, GENE, V318, P185, DOI 10.1016/S0378-1119(03)00797-2; Baykov AA, 2013, MICROBIOL MOL BIOL R, V77, P267, DOI 10.1128/MMBR.00003-13; Chi A, 2000, J BIOL CHEM, V275, P35677, DOI 10.1074/jbc.C000581200; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Croniger CM, 2002, BIOCHEM MOL BIOL EDU, V30, P14, DOI 10.1002/bmb.2002.494030010018; DAVIES DD, 1979, ANNU REV PLANT PHYS, V30, P131, DOI 10.1146/annurev.pp.30.060179.001023; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Fukuda W, 2004, J BACTERIOL, V186, P4620, DOI 10.1128/JB.186.14.4620-4627.2004; GEST H, 1972, ADV MICROB PHYSIOL, V7, P243; HABERLAND ME, 1972, BIOCHEMISTRY-US, V11, P712, DOI 10.1021/bi00755a007; Jeelani G, 2014, CURR OPIN MICROBIOL, V20, P118, DOI 10.1016/j.mib.2014.05.016; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; KULAEV IS, 1983, ADV MICROB PHYSIOL, V24, P83, DOI 10.1016/S0065-2911(08)60385-9; LIU CL, 1982, SCIENCE, V217, P363, DOI 10.1126/science.217.4557.363; LOCHMULLER H, 1966, J BIOL CHEM, V241, P5678; Marumo K, 2014, INT J PARASITOL, V44, P625, DOI 10.1016/j.ijpara.2014.04.008; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; MEDINA V, 1990, J BACTERIOL, V172, P7151, DOI 10.1128/jb.172.12.7151-7156.1990; MERTENS E, 1991, FEBS LETT, V285, P1, DOI 10.1016/0014-5793(91)80711-B; Mertens E, 1998, J MOL EVOL, V47, P739, DOI 10.1007/PL00006433; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Michels PAM, 1997, EUR J BIOCHEM, V250, P698, DOI 10.1111/j.1432-1033.1997.00698.x; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Muller M, 2001, J BACTERIOL, V183, P6714, DOI 10.1128/JB.183.22.6714-6716.2001; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; NIERSBACH M, 1992, MOL GEN GENET, V231, P332, DOI 10.1007/BF00279808; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; OBRIEN WE, 1975, J BIOL CHEM, V250, P8690; Pineda E., 2015, AMEBIASIS, P351, DOI [10.1007/978-4-431-55200-0_20, DOI 10.1007/978-4-431-55200-0_20]; POCALYKO DJ, 1990, BIOCHEMISTRY-US, V29, P10757, DOI 10.1021/bi00500a006; REEVES RE, 1974, J BIOL CHEM, V249, P7737; REEVES RE, 1968, J BIOL CHEM, V243, P3202; REEVES RE, 1970, BIOCHIM BIOPHYS ACTA, V220, P346, DOI 10.1016/0005-2744(70)90021-5; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Siebers B, 1998, J BACTERIOL, V180, P2137, DOI 10.1128/JB.180.8.2137-2143.1998; SIU PML, 1962, J BIOL CHEM, V237, P3044; SIU PML, 1961, J BIOL CHEM, V236, pPC21; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanaka R, 2014, PHOTOSYNTH RES, V121, P251, DOI 10.1007/s11120-014-9968-9; van der Merwe MJ, 2010, PLANTA, V231, P595, DOI 10.1007/s00425-009-1069-1; ZUO X, 1995, FEMS MICROBIOL LETT, V130, P253	47	22	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23960	23970		10.1074/jbc.M115.672907	http://dx.doi.org/10.1074/jbc.M115.672907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269598	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000361816500040
J	Akagi, T; Kuure, S; Uranishi, K; Koide, H; Costantini, F; Yokota, T				Akagi, Tadayuki; Kuure, Satu; Uranishi, Kousuke; Koide, Hiroshi; Costantini, Frank; Yokota, Takashi			ETS-related Transcription Factors ETV4 and ETV5 Are Involved in Proliferation and Induction of Differentiation-associated Genes in Embryonic Stem (ES) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION NETWORK; SELF-RENEWAL; SIGNALING PATHWAYS; KIDNEY DEVELOPMENT; PLURIPOTENT CELLS; GROUND-STATE; MOUSE; NANOG; EXPRESSION; TARGET	The pluripotency and self-renewal capacity of embryonic stem (ES) cells is regulated by several transcription factors. Here, we show that the ETS-related transcription factors Etv4 and Etv5 (Etv4/5) are specifically expressed in undifferentiated ES cells, and suppression of Oct3/4 results in down-regulation of Etv4/5. Simultaneous deletion of Etv4 and Etv5( Etv4/5doubleknock-out(dKO)) in ES cells resulted in a flat, epithelial cell-like appearance, whereas the morphology changed into compact colonies in a 2i medium (containing two inhibitors for GSK3 and MEK/ERK). Expression levels of self-renewal marker genes, including Oct3/4 and Nanog, were similar between wild-type and dKO ES cells, whereas proliferation of Etv4/5 dKO ES cells was decreased with overexpression of cyclin-dependent kinase inhibitors (p16/p19, p15, and p57). A differentiation assay revealed that the embryoid bodies derived from Etv4/5 dKO ES cells were smaller than the control, and expression of ectoderm marker genes, including Fgf5, Sox1, and Pax3, was not induced in dKO-derived embryoid bodies. Microarray analysis demonstrated that stem cell-related genes, including Tcf15, Gbx2, Lrh1, Zic3, and Baf60c, were significantly repressed in Etv4/5 dKO ES cells. The artificial expression of Etv4 and/or Etv5 in Etv4/5 dKO ES cells induced re-expression of Tcf15 and Gbx2. These results indicate that Etv4 and Etv5, potentially through regulation of Gbx2 and Tcf15, are involved in the ES cell proliferation and induction of differentiation-associated genes in ES cells.	[Akagi, Tadayuki; Uranishi, Kousuke; Koide, Hiroshi; Yokota, Takashi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Kuure, Satu] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland; [Costantini, Frank] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Kanazawa University; University of Helsinki; Columbia University	Akagi, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	tadayuki@staff.kanazawa-u.ac.jp; tyokota@med.kanazawa-u.ac.jp	Yokota, Takashi/J-8483-2015; , shkuure/AAE-2751-2019; Akagi, Tadayuki/E-1078-2011	, shkuure/0000-0002-9076-0622; Akagi, Tadayuki/0000-0002-1733-9452; Koide, Hiroshi/0000-0001-5916-3179	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22370050, 21790268]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid for Scientific Research (B) 22370050 (to T. Y.) and for Young Scientists (B) 21790268 (to T. A.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Takeda Science Foundation (to T. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BLANAR MA, 1995, P NATL ACAD SCI USA, V92, P5870, DOI 10.1073/pnas.92.13.5870; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Davies OR, 2013, CELL REP, V3, P472, DOI 10.1016/j.celrep.2013.01.017; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Eo J, 2011, MOL HUM REPROD, V17, P568, DOI 10.1093/molehr/gar021; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Fujii S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09146; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Jiang JH, 2007, BIOCHEM BIOPH RES CO, V358, P53, DOI 10.1016/j.bbrc.2007.04.043; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Keld R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-313; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kuure S, 2010, DEVELOPMENT, V137, P1975, DOI 10.1242/dev.051656; Laing MA, 2000, MOL CELL BIOL, V20, P9337, DOI 10.1128/MCB.20.24.9337-9345.2000; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun C, 2008, BIOCHEM BIOPH RES CO, V372, P91, DOI 10.1016/j.bbrc.2008.04.154; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Uranishi K, 2013, MOL CELL BIOL, V33, P2056, DOI 10.1128/MCB.01520-12; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	66	31	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22460	22473		10.1074/jbc.M115.675595	http://dx.doi.org/10.1074/jbc.M115.675595			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224636	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000361171500014
J	Montoro, AG; Ramirez, SC; Taubas, JV				Gonzalez Montoro, Ayelen; Chumpen Ramirez, Sabrina; Valdez Taubas, Javier			The Canonical DHHC Motif Is Not Absolutely Required for the Activity of the Yeast S-acyltransferases Swf1 and Pfa4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; SUBSTRATE-SPECIFICITY; IDENTIFICATION; MECHANISM; PALMITOYLTRANSFERASES; ALIGNMENT; FAMILY; ERF2	Protein S-acyltransferases, also known as palmitoyltransferases (PATs), are characterized by the presence of a 50-amino acid domain called the DHHC domain. Within this domain, these four amino acids constitute a highly conserved motif. It has been proposed that the palmitoylation reaction occurs through a palmitoyl-PAT covalent intermediate that involves the conserved cysteine in the DHHC motif. Mutation of this cysteine results in lack of function for several PATs, and DHHA or DHHS mutants are used regularly as catalytically inactive controls. In a genetic screen to isolate loss-of-function mutations in the yeast PAT Swf1, we isolated an allele encoding a Swf1 DHHR mutant. Overexpression of this mutant is able to partially complement a swf1 Delta strain and to acylate the Swf1 substrates Tlg1, Syn8, and Snc1. Overexpression of the palmitoyltransferase Pfa4 DHHA or DHHR mutants also results in palmitoylation of its substrate Chs3. We also investigated the role of the first histidine of the DHHC motif. A Swf1 DQHC mutant is also partially active but a DQHR is not. Finally, we show that Swf1 substrates are differentially modified by both DHHR and DQHC Swf1 mutants. We propose that, in the absence of the canonical mechanism, alternative suboptimal mechanisms take place that are more dependent on the reactivity of the acceptor protein. These results also imply that caution must be exercised when proposing non-canonical roles for PATs on the basis of considering DHHC mutants as catalytically inactive and, more generally, contribute to an understanding of the mechanism of protein palmitoylation	Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC, RA-5000 Cordoba, Argentina; Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Taubas, JV (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, CIQUIBIC, Ciudad Univ,X5000HUA Cordoba, RA-5000 Cordoba, Argentina.	jvaldezt@dqb.fcq.unc.edu.ar		Valdez Taubas, Javier/0000-0002-2806-9419	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba; Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (ANPCyT) Prestamo BID PICT [0288]; Consejo Nacional de Ciencia y Tecnologia de Argentina (PIP); Consejo Nacional de Ciencia y Tecnologia de Argentina	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (ANPCyT) Prestamo BID PICT; Consejo Nacional de Ciencia y Tecnologia de Argentina (PIP); Consejo Nacional de Ciencia y Tecnologia de Argentina	This work was supported by the Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba; Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (ANPCyT) Prestamo BID PICT 0288 (to J. V. T.) and Consejo Nacional de Ciencia y Tecnologia de Argentina (PIP 2011). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the Consejo Nacional de Ciencia y Tecnologia de Argentina.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BHARADWAJ M, 1995, J NEUROCHEM, V65, P1805; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Montoro AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016969; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; Holthuis JCM, 1998, MOL BIOL CELL, V9, P3383, DOI 10.1091/mbc.9.12.3383; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yeste-Velasco M, 2014, J PATHOL, V232, P566, DOI 10.1002/path.4327	43	16	17	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22448	22459		10.1074/jbc.M115.651356	http://dx.doi.org/10.1074/jbc.M115.651356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224664	hybrid, Green Published			2022-12-28	WOS:000361171500013
J	Kudryavtsev, DS; Shelukhina, IV; Son, LV; Ojomoko, LO; Kryukova, EV; Lyukmanova, EN; Zhmak, MN; Dolgikh, DA; Ivanov, IA; Kasheverov, IE; Starkov, VG; Ramerstorfer, J; Sieghart, W; Tsetlin, VI; Utkin, YN				Kudryavtsev, Denis S.; Shelukhina, Irina V.; Son, Lina V.; Ojomoko, Lucy O.; Kryukova, Elena V.; Lyukmanova, Ekaterina N.; Zhmak, Maxim N.; Dolgikh, Dmitry A.; Ivanov, Igor A.; Kasheverov, Igor E.; Starkov, Vladislav G.; Ramerstorfer, Joachim; Sieghart, Werner; Tsetlin, Victor I.; Utkin, Yuri N.			Neurotoxins from Snake Venoms and alpha-Conotoxin ImI Inhibit Functionally Active Ionotropic gamma-Aminobutyric Acid (GABA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; POSITIVE ALLOSTERIC MODULATION; CRYSTAL-STRUCTURE; NAJA-KAOUTHIA; WEAK TOXIN; ANTAGONIST; BINDING; BUNGAROTOXIN; PROTEIN; DERIVATIVES	Ionotropic receptors of gamma-aminobutyric acid (GABA(A)R) regulate neuronal inhibition and are targeted by benzodiazepines and general anesthetics. We show that a fluorescent derivative of alpha-cobratoxin (alpha-Ctx), belonging to the family of three-finger toxins from snake venoms, specifically stained the alpha 1 beta 3 gamma 2 receptor; and at 10 mu M alpha-Ctx completely blocked GABA-induced currents in this receptor expressed in Xenopus oocytes (IC50 = 236 nM) and less potently inhibited alpha 1 beta 2 gamma 2 approximate to alpha 2 beta 2 gamma 2 > alpha 5 beta 2 gamma 2 > alpha 2 beta 3 gamma 2 and alpha 1 beta 3 delta GABA(A)Rs. The alpha 1 beta 3 gamma 2 receptor was also inhibited by some other three-finger toxins, long alpha-neurotoxin Ls III and nonconventional toxin WTX. alpha-Conotoxin ImI displayed inhibitory activity as well. Electrophysiology experiments showed mixed competitive and noncompetitive alpha-Ctx action. Fluorescent alpha-Ctx, however, could be displaced by muscimol indicating that most of the alpha-Ctx-binding sites overlap with the orthosteric sites at the beta/alpha subunit interface. Modeling and molecular dynamic studies indicated that alpha-Ctx or alpha-bungarotoxin seem to interact with GABA(A)R in a way similar to their interaction with the acetylcholine-binding protein or the ligand-binding domain of nicotinic receptors. This was supported by mutagenesis studies and experiments with alpha-conotoxin ImI and a chimeric Naja oxiana alpha-neurotoxin indicating that the major role in alpha-Ctx binding to GABA(A)R is played by the tip of its central loop II accommodating under loop C of the receptors.	[Kudryavtsev, Denis S.; Shelukhina, Irina V.; Ojomoko, Lucy O.; Kryukova, Elena V.; Lyukmanova, Ekaterina N.; Zhmak, Maxim N.; Dolgikh, Dmitry A.; Ivanov, Igor A.; Kasheverov, Igor E.; Starkov, Vladislav G.; Tsetlin, Victor I.; Utkin, Yuri N.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Son, Lina V.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Zhmak, Maxim N.] Syneuro OOO, Moscow 117997, Russia; [Lyukmanova, Ekaterina N.; Dolgikh, Dmitry A.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Ramerstorfer, Joachim; Sieghart, Werner] Med Univ Vienna, Ctr Brain Res, Dept Mol Neurosci, A-1090 Vienna, Austria	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Lomonosov Moscow State University; Medical University of Vienna	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	utkin@mx.ibch.ru	Lyukmanova, Ekaterina/F-2340-2014; Utkin, Yuri N./F-1958-2014; Ojomoko, Lucy/ABD-9910-2020; Shelukhina, Irina/AHE-5496-2022; Ivanov, Igor A/R-7543-2017; Kudryavtsev, Denis S/O-4811-2015; Dolgikh, Dmitry A/F-2369-2014; Sieghart, Werner/A-4877-2013; Tsetlin, Victor/X-2491-2018; Utkin, Yuri/L-2952-2019	Lyukmanova, Ekaterina/0000-0002-9728-9407; Utkin, Yuri N./0000-0002-4609-970X; Shelukhina, Irina/0000-0003-3476-1441; Kudryavtsev, Denis S/0000-0002-0313-9193; Sieghart, Werner/0000-0002-0443-0302; Utkin, Yuri/0000-0002-4609-970X; Dolgikh, Dmitry/0000-0002-9880-7202	Russian Science Foundation [14-24-00118, 14-14-00255]; Russian Foundation for Basic Research [14-04-00885]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Science Foundation Grant 14-24-00118. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Russian Foundation for Basic Research Grant 14-04-00885.; Supported by Russian Science Foundation Grant 14-14-00255 (NT II/I chimeric toxin was obtained with this grant).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfonso J, 2012, CELL STEM CELL, V10, P76, DOI 10.1016/j.stem.2011.11.011; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Ashton H, 2005, CURR OPIN PSYCHIATR, V18, P249, DOI 10.1097/01.yco.0000165594.60434.84; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERG DK, 1972, P NATL ACAD SCI USA, V69, P147, DOI 10.1073/pnas.69.1.147; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Christian CA, 2013, NEURON, V78, P1063, DOI 10.1016/j.neuron.2013.04.026; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dubovskii PV, 2014, CURR MED CHEM, V21, P270; Eastman P, 2010, COMPUT SCI ENG, V12, P34, DOI 10.1109/MCSE.2010.27; Gergalova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031361; GRISHIN EV, 1974, FEBS LETT, V45, P118, DOI 10.1016/0014-5793(74)80825-2; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hannan S, 2015, NEUROPHARMACOLOGY, V93, P28, DOI 10.1016/j.neuropharm.2015.01.001; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joshi S, 2013, MOL CELL NEUROSCI, V56, P201, DOI 10.1016/j.mcn.2013.05.003; Kasheverov IE, 2009, CURR PHARM DESIGN, V15, P2430, DOI 10.2174/138161209788682316; Krishek BJ, 1996, MOL PHARMACOL, V49, P494; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; McCann CM, 2006, P NATL ACAD SCI USA, V103, P5149, DOI 10.1073/pnas.0600847103; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mirheydari P., 2014, NEUROCHEM RES, V39, P1057; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Olsen RW, 2006, P NATL ACAD SCI USA, V103, P6081, DOI 10.1073/pnas.0601121103; Osipov AV, 2012, J BIOL CHEM, V287, P6725, DOI 10.1074/jbc.M111.322313; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Razet R, 2000, BIOORG MED CHEM LETT, V10, P2579, DOI 10.1016/S0960-894X(00)00514-X; Rosso JP, 2015, P NATL ACAD SCI USA, V112, pE891, DOI 10.1073/pnas.1415488112; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Starkov VG, 2009, RUSS J BIOORG CHEM+, V35, P10, DOI 10.1134/S1068162009010026; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; TSETLIN VI, 1979, FEBS LETT, V106, P47, DOI 10.1016/0014-5793(79)80692-4; Utkin YN, 1998, EUR J BIOCHEM, V253, P229, DOI 10.1046/j.1432-1327.1998.2530229.x; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Wyrembek P, 2012, EUR J PHARMACOL, V683, P35, DOI 10.1016/j.ejphar.2012.03.005; Zhang L, 2012, NEUROPHARMACOLOGY, V62, P1062, DOI 10.1016/j.neuropharm.2011.10.017; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	46	35	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22747	22758		10.1074/jbc.M115.648824	http://dx.doi.org/10.1074/jbc.M115.648824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221036	Green Published, hybrid			2022-12-28	WOS:000361171500038
J	Amazit, L; Le Billan, F; Kolkhof, P; Lamribet, K; Viengchareun, S; Fay, MR; Khan, JA; Hillisch, A; Lombes, M; Rafestin-Oblin, ME; Fagart, J				Amazit, Larbi; Le Billan, Florian; Kolkhof, Peter; Lamribet, Khadija; Viengchareun, Say; Fay, Michel R.; Khan, Junaid A.; Hillisch, Alexander; Lombes, Marc; Rafestin-Oblin, Marie-Edith; Fagart, Jerome			Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; HEART-FAILURE; LIVING CELLS; BAY 94-8862; BINDING; SPIROLACTONES; ANTAGONISTS; KIDNEY; HYPERTENSION; RAT	Aldosterone regulates sodium homeostasis by activating the mineralocorticoid receptor (MR), a member of the nuclear receptor superfamily. Hyperaldosteronism leads to deleterious effects on the kidney, blood vessels, and heart. Although steroidal antagonists such as spironolactone and eplerenone are clinically useful for the treatment of cardiovascular diseases, they are associated with several side effects. Finerenone, a novel nonsteroidal MR antagonist, is presently being evaluated in two clinical phase IIb trials. Here, we characterized the molecular mechanisms of action of finerenone and spironolactone at several key steps of the MR signaling pathway. Molecular modeling and mutagenesis approaches allowed identification of Ser-810 and Ala-773 as key residues for the high MR selectivity of finerenone. Moreover, we showed that, in contrast to spironolactone, which activates the S810L mutant MR responsible for a severe form of early onset hypertension, finerenone displaysstrict antagonistic properties. Aldosterone-dependent phosphorylation and degradation of MR are inhibited by both finerenone and spironolactone. However, automated quantification of MR subcellular distribution demonstrated that finerenone delays aldosterone-induced nuclear accumulation of MR more efficiently than spironolactone. Finally, chromatin immunoprecipitation assays revealed that, as opposed to spironolactone, finerenone inhibits MR, steroid receptor coactivator-1, and RNA polymerase II binding at the regulatory sequence of the SCNN1A gene and also remarkably reduces basal MR and steroid receptor coactivator-1 recruitment, unraveling a specific and unrecognized inactivating mechanism on MR signaling. Overall, our data demonstrate that the highly potent and selective MR antagonist finerenone specifically impairs several critical steps of the MR signaling pathway and therefore represents a promising new generation MR antagonist.	[Amazit, Larbi; Le Billan, Florian; Lamribet, Khadija; Viengchareun, Say; Khan, Junaid A.; Lombes, Marc; Fagart, Jerome] INSERM, UMR S 1185, F-94276 Le Kremlin Bicetre, France; [Amazit, Larbi; Le Billan, Florian; Lamribet, Khadija; Viengchareun, Say; Khan, Junaid A.; Lombes, Marc; Fagart, Jerome] Univ Paris 11, Fac Med Paris Sud, UMR S 1185, F-94276 Le Kremlin Bicetre, France; [Amazit, Larbi] Inst Biomed Bicetre, UMS 32, F-94276 Le Kremlin Bicetre, France; [Kolkhof, Peter] Bayer Pharma AG, Global Drug Discovery, Dept Cardiol Res, D-42113 Wuppertal, Germany; [Hillisch, Alexander] Bayer Pharma AG, Global Drug Discovery, Dept Med Chem, D-42113 Wuppertal, Germany; [Fay, Michel R.; Rafestin-Oblin, Marie-Edith; Fagart, Jerome] Ctr Rech Biomed Bichat Beaujon, INSERM U773, CRB3, F-75890 Paris, France; [Fay, Michel R.; Rafestin-Oblin, Marie-Edith; Fagart, Jerome] Univ Paris Denis Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fagart, J (corresponding author), INSERM, Fac Med Paris Sud, UMR S 1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	jerome.fagart@inserm.fr	Viengchareun, Say/GOV-6812-2022; Fagart, Jerome/S-4581-2018; Khan, Junaid/AAE-3522-2019; Khan, Junaid Ali/ABG-6129-2020; Hillisch, Alexander/AAN-5872-2021; Khan, Junaid Ali/ABG-2756-2020; Lombes, Marc/L-5933-2018; Viengchareun, Say/M-6612-2017	Fagart, Jerome/0000-0002-7965-0553; Hillisch, Alexander/0000-0002-4228-2347; Khan, Junaid Ali/0000-0003-2630-1744; Lombes, Marc/0000-0003-3189-023X; viengchareun, say/0000-0003-4280-3250; Le Billan, Florian/0000-0002-3400-9295	INSERM; Universite Paris Sud Agence Nationale de la Recherche [11-BSV1-028-01]; Bayer Pharma AG [05112/A11 3, SCCV2395]; Ministere de l'Enseignement Superieur et de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Sud Agence Nationale de la Recherche(French National Research Agency (ANR)); Bayer Pharma AG; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by grants from INSERM, by Universite Paris Sud Agence Nationale de la Recherche Grant 11-BSV1-028-01, and by Bayer Pharma AG Grants 05112/A11 and SCCV2395. P. K. and A. H. are employees of Bayer Pharma AG.; Recipient of a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Amazit L, 2011, MOL ENDOCRINOL, V25, P394, DOI 10.1210/me.2010-0458; Auzou G, 2000, MOL PHARMACOL, V58, P684, DOI 10.1124/mol.58.4.684; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BRASS EP, 1984, DRUGS, V27, P447, DOI 10.2165/00003495-198427050-00004; Cargnelli G, 2001, J CARDIOVASC PHARM, V37, P540, DOI 10.1097/00005344-200105000-00006; CASALSSTENZEL J, 1984, ARZNEIMITTEL-FORSCH, V34-1, P241; CHINN LJ, 1981, J MED CHEM, V24, P1103, DOI 10.1021/jm00141a020; CLAIRE M, 1978, FEBS LETT, V88, P295, DOI 10.1016/0014-5793(78)80197-5; Corvol P, 1977, Adv Nephrol Necker Hosp, V7, P199; CORVOL P, 1975, ENDOCRINOLOGY, V97, P52, DOI 10.1210/endo-97-1-52; COUSTAL S, 1995, TETRAHEDRON, V51, P3559, DOI 10.1016/0040-4020(95)00099-T; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Devin-Leclerc J, 1998, MOL ENDOCRINOL, V12, P842, DOI 10.1210/me.12.6.842; Epstein M, 2006, AM J MED, V119, P912, DOI 10.1016/j.amjmed.2006.03.038; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fagart J, 2005, MOL PHARMACOL, V67, P1714, DOI 10.1124/mol.104.010710; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Faresse N, 2012, FASEB J, V26, P4373, DOI 10.1096/fj.12-209924; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Funder JW, 2010, ENDOCRINOLOGY, V151, P5098, DOI 10.1210/en.2010-0465; Gekle M, 2014, STEROIDS, V81, P103, DOI 10.1016/j.steroids.2013.10.016; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; Grossmann C, 2012, CHEM BIOL, V19, P742, DOI 10.1016/j.chembiol.2012.04.014; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Khan JA, 2013, MOL ENDOCRINOL, V27, P909, DOI 10.1210/me.2012-1328; Kolkhof P, 2014, J CARDIOVASC PHARM, V64, P69, DOI 10.1097/FJC.0000000000000091; Kolkhof P, 2012, MOL CELL ENDOCRINOL, V350, P310, DOI 10.1016/j.mce.2011.06.025; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; LOMBES M, 1994, BIOCHEM J, V302, P191, DOI 10.1042/bj3020191; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; ROSSIER BC, 1983, AM J PHYSIOL, V244, pC24, DOI 10.1152/ajpcell.1983.244.1.C24; SCHANE HP, 1978, J CLIN ENDOCR METAB, V47, P691, DOI 10.1210/jcem-47-3-691; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Tirard M, 2007, MOL CELL ENDOCRINOL, V268, P20, DOI 10.1016/j.mce.2007.01.010; Tomaschitz A, 2010, NAT REV ENDOCRINOL, V6, P83, DOI 10.1038/nrendo.2009.263; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Yokota K, 2004, ENDOCR RES, V30, P611, DOI 10.1081/ERC-200043783; Zhang JH, 2008, J STEROID BIOCHEM, V109, P279, DOI 10.1016/j.jsbmb.2008.03.018	57	71	74	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21876	21889		10.1074/jbc.M115.657957	http://dx.doi.org/10.1074/jbc.M115.657957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203193	Green Published, hybrid			2022-12-28	WOS:000360968500010
J	Demelash, A; Pfannenstiel, LW; Tannenbaum, CS; Li, XX; Kalady, MF; DeVecchio, J; Gastman, BR				Demelash, Abeba; Pfannenstiel, Lukas W.; Tannenbaum, Charles S.; Li, Xiaoxia; Kalady, Matthew F.; DeVecchio, Jennifer; Gastman, Brian R.			Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; BH3 MIMETICS; LUNG-CANCER; BCL-XL; INHIBITORS; APOPTOSIS; THERAPY; P53; PHOSPHORYLATION; DEPENDENCY	Unlike other antiapoptotic Bcl-2 family members, Mcl-1 also mediates resistance to cancer therapy by uniquely inhibiting chemotherapy-induced senescence (CIS). In general, Bcl-2 family members regulate apoptosis at the level of the mitochondria through a common prosurvival binding groove. Through mutagenesis, we determined that Mcl-1 can inhibit CIS even in the absence of its apoptotically important mitochondrion-localizing domains. This finding prompted us to generate a series of Mcl-1 deletion mutants from both the N and C termini of the protein, including one that contained a deletion of all of the Bcl-2 homology domains, none of which impacted anti-CIS capabilities. Through subsequent structure-function analyses of Mcl-1, we identified a previously uncharacterized loop domain responsible for the anti-CIS activity of Mcl-1. The importance of the loop domain was confirmed in multiple tumor types, two in vivo models of senescence, and by demonstrating that a peptide mimetic of the loop domain can effectively inhibit the anti-CIS function of Mcl-1. The results from our studies appear to be highly translatable because we discerned an inverse relationship between the expression of Mcl-1 and of various senescence markers in cancerous human tissues. In summary, our findings regarding the unique structural properties of Mcl-1 provide new approaches for targeted cancer therapy.	[Demelash, Abeba; Pfannenstiel, Lukas W.; Tannenbaum, Charles S.; Li, Xiaoxia; Gastman, Brian R.] Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Kalady, Matthew F.; DeVecchio, Jennifer] Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Gastman, Brian R.] Taussig Canc Ctr, Inst Head & Neck Surg, Cleveland, OH 44195 USA; [Gastman, Brian R.] Taussig Canc Ctr, Inst Dermatol Surg, Cleveland, OH 44195 USA; [Gastman, Brian R.] Taussig Canc Ctr, Inst Plast Surg, Cleveland, OH 44195 USA; [Kalady, Matthew F.; DeVecchio, Jennifer] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Gastman, BR (corresponding author), Cleveland Clin, 9500 Euclid Ave NE60,NE6-303, Cleveland, OH 44195 USA.	gastmab@ccf.org						Baggstrom MQ, 2011, J THORAC ONCOL, V6, P1757, DOI 10.1097/JTO.0b013e31822e2941; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Bolesta E, 2012, MOL CELL BIOL, V32, P1879, DOI 10.1128/MCB.06214-11; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cairney CJ, 2012, DRUG DISCOV TODAY, V17, P269, DOI 10.1016/j.drudis.2012.01.019; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Demelash A, 2012, MOL BIOL CELL, V23, P2856, DOI 10.1091/mbc.E10-12-1010; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Elkholi Rana, 2011, Genes Cancer, V2, P523, DOI 10.1177/1947601911417177; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Giuliano S, 2011, PIGM CELL MELANOMA R, V24, P295, DOI 10.1111/j.1755-148X.2010.00820.x; Grabow S, 2014, BLOOD, V124, P3939, DOI 10.1182/blood-2014-09-601567; Haferkamp S, 2013, J INVEST DERMATOL, V133, P1601, DOI 10.1038/jid.2013.6; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Ng Samuel Y, 2014, Clin Adv Hematol Oncol, V12, P224; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2014, BIOORG MED CHEM LETT, V24, P1484, DOI 10.1016/j.bmcl.2014.02.010; Pfannenstiel LW, 2012, GENOME MED, V4, DOI 10.1186/gm352; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Placzek WJ, 2011, J BIOL CHEM, V286, P39829, DOI 10.1074/jbc.M111.305326; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Song JH, 2011, CANCER RES, V71, P506, DOI 10.1158/0008-5472.CAN-10-1977; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Varadarajan S, 2013, CELL DEATH DIFFER, V20, P1475, DOI 10.1038/cdd.2013.79; Warr MR, 2011, J BIOL CHEM, V286, P25098, DOI 10.1074/jbc.M111.218321; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	48	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21962	21975		10.1074/jbc.M115.663898	http://dx.doi.org/10.1074/jbc.M115.663898			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205817	Green Published, hybrid			2022-12-28	WOS:000360968500017
J	Orogo, AM; Gonzalez, ER; Kubli, DA; Baptista, IL; Ong, SB; Prolla, TA; Sussman, MA; Murphy, AN; Gustafsson, AB				Orogo, Amabel M.; Gonzalez, Eileen R.; Kubli, Dieter A.; Baptista, Igor L.; Ong, Sang-Bing; Prolla, Tomas A.; Sussman, Mark A.; Murphy, Anne N.; Gustafsson, Asa B.			Accumulation of Mitochondrial DNA Mutations Disrupts Cardiac Progenitor Cell Function and Reduces Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; ELECTRON-TRANSPORT; OXIDATIVE STRESS; RANDOMIZED-TRIAL; SKELETAL-MUSCLE; HEART-FAILURE; MUTATOR MICE; COMPLEX-III	Transfer of cardiac progenitor cells (CPCs) improves cardiac function in heart failure patients. However, CPC function is reduced with age, limiting their regenerative potential. Aging is associated with numerous changes in cells including accumulation of mitochondrial DNA (mtDNA) mutations, but it is unknown how this impacts CPC function. Here, we demonstrate that acquisition of mtDNA mutations disrupts mitochondrial function, enhances mitophagy, and reduces the replicative and regenerative capacities of the CPCs. We show that activation of differentiation in CPCs is associated with expansion of the mitochondrial network and increased mitochondrial oxidative phosphorylation. Interestingly, mutant CPCs are deficient in mitochondrial respiration and rely on glycolysis for energy. In response to differentiation, these cells fail to activate mitochondrial respiration. This inability to meet the increased energy demand leads to activation of cell death. These findings demonstrate the consequences of accumulating mtDNA mutations and the importance of mtDNA integrity in CPC homeostasis and regenerative potential.	[Orogo, Amabel M.; Gonzalez, Eileen R.; Kubli, Dieter A.; Baptista, Igor L.; Ong, Sang-Bing; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Murphy, Anne N.; Gustafsson, Asa B.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Sussman, Mark A.] San Diego State Univ, San Diego Heart Res Inst, San Diego, CA 92182 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr MC 0758, La Jolla, CA 92093 USA.	asag@ucsd.edu	ONG, SANG-BING/B-7786-2014; Baptista, Igor Luchini/N-6442-2016; Baptista, Igor/ABC-1551-2021; Regan, Clinton/E-6250-2012; Murphy, Anne N/H-3217-2016; Sussman, Mark/H-2284-2014	ONG, SANG-BING/0000-0001-7421-2610; Baptista, Igor Luchini/0000-0001-5185-0185; Baptista, Igor/0000-0001-5185-0185; Murphy, Anne N/0000-0002-5222-9902; Sussman, Mark/0000-0002-0104-4799	Fondation Leducq Transatlantic Network; National Institutes of Health [R01HL087023, R01HL101217, P01HL085577]; National Research Service Award Predoctoral Fellowship [F31HL123309, R01HL067245, R37HL091102, R01HL105759, R01HL113656, R01HL113647, R01HL122525];  [T32GM007752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113647, R01HL122525, R01HL113656, R01HL101217, P01HL085577, R37HL091102, R01HL067245, R01HL087023, F31HL123309, R01HL105759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	Fondation Leducq Transatlantic Network(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by an award from the Fondation Leducq Transatlantic Network.; This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087023, R01HL101217, and P01HL085577 (to A. B. G.), Institutional Training Grant T32GM007752 (NIGMS; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology) and National Research Service Award Predoctoral Fellowship F31HL123309 (to A. M. O.), and R01HL067245, R37HL091102, R01HL105759, R01HL113656, R01HL113647, and R01HL122525 (to M. A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Andres AM, 2015, J MOL CELL CARDIOL, V78, P62, DOI 10.1016/j.yjmcc.2014.10.003; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Frerichs FCP, 2002, NEW ENGL J MED, V347, P1895, DOI 10.1056/NEJM200212053472320; Gaspar JA, 2014, CIRC RES, V114, P1346, DOI 10.1161/CIRCRESAHA.113.302021; Goichberg P, 2013, CIRCULATION, V128, P2211, DOI 10.1161/CIRCULATIONAHA.113.004698; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Karantalis V, 2014, CIRC RES, V114, P1302, DOI 10.1161/CIRCRESAHA.114.303180; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mohsin S, 2013, CIRC RES, V113, P1169, DOI 10.1161/CIRCRESAHA.113.302302; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Wahlestedt M, 2014, STEM CELLS, V32, P1173, DOI 10.1002/stem.1630; Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483; Wang W, 2010, STEM CELLS, V28, P2195, DOI 10.1002/stem.542; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033407	62	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22061	22075		10.1074/jbc.M115.649657	http://dx.doi.org/10.1074/jbc.M115.649657			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183775	Green Published, hybrid			2022-12-28	WOS:000360968500025
J	Tikhanovich, I; Kuravi, S; Artigues, A; Villar, MT; Dorko, K; Nawabi, A; Roberts, B; Weinman, SA				Tikhanovich, Irina; Kuravi, Sudhakiranmayi; Artigues, Antonio; Villar, Maria T.; Dorko, Kenneth; Nawabi, Atta; Roberts, Benjamin; Weinman, Steven A.			Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; JMJD6; ACTIVATION; RESPONSES; SURVIVAL; CELLS; PRMT1; A20	Arginine methylation is a common post-translational modification, but its role in regulating protein function is poorly understood. This study demonstrates that, TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase involved in innate immune signaling, is regulated by reversible arginine methylation in a range of primary and cultured cells. Under basal conditions, TRAF6 is methylated by the methyltransferase PRMT1, and this inhibits its ubiquitin ligase activity, reducing activation of toll-like receptor signaling. In response to toll-like receptor ligands, TRAF6 is demethylated by the Jumonji domain protein JMJD6. Demethylation is required for maximal activation of NF-kappa B. Loss of JMJD6 leads to reduced response, and loss of PRMT1 leads to basal pathway activation with subsequent desensitization to ligands. In human primary cells, variations in the PRMT1/JMJD6ratiosignificantlycorrelatewithTRAF6methylation, basal activation of NF-kappa B, and magnitude of response to LPS. Reversible arginine methylation of TRAF6 by the opposing effects of PRMT1 and JMJD6 is, therefore, a novel mechanism for regulation of innate immune pathways.	[Tikhanovich, Irina; Kuravi, Sudhakiranmayi; Roberts, Benjamin; Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA; [Nawabi, Atta] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA; [Artigues, Antonio; Villar, Maria T.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Dorko, Kenneth] Univ Kansas, Med Ctr, Dept Pharmacol & Toxicol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Mailstop 1018, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Tikhanovich, Irina/GOK-0267-2022		National Institute on Alcohol Abuse and Alcoholism [AA012863]; National Institutes of Health COBRE Grant [P20 RR021940]; Biomedical Research Training Program from The University of Kansas Medical Center; Hans Popper Memorial Postdoctoral Research Fellowship from the American Liver Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health COBRE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Training Program from The University of Kansas Medical Center; Hans Popper Memorial Postdoctoral Research Fellowship from the American Liver Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institute on Alcohol Abuse and Alcoholism Grant AA012863 and National Institutes of Health COBRE Grant P20 RR021940 (Center for Research Resources). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Biomedical Research Training Program from The University of Kansas Medical Center and a Hans Popper Memorial Postdoctoral Research Fellowship from the American Liver Foundation.	Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Choi YW, 2005, ADV EXP MED BIOL, V560, P77; Davies John Q, 2005, Methods Mol Biol, V290, P91; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakamoto N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00221; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Skvorak KJ, 2009, MOL THER, V17, P1266, DOI 10.1038/mt.2009.99; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tikhanovich I, 2014, HEPATOLOGY, V59, P58, DOI 10.1002/hep.26618; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zakharova L, 2009, J CELL PHYSIOL, V221, P84, DOI 10.1002/jcp.21829	29	47	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22236	22249		10.1074/jbc.M115.653543	http://dx.doi.org/10.1074/jbc.M115.653543			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26221041	Green Published, hybrid			2022-12-28	WOS:000360968500040
J	Zhou, T; Frabutt, DA; Moremen, KW; Zheng, YH				Zhou, Tao; Frabutt, Dylan A.; Moremen, Kelley W.; Zheng, Yong-Hui			ERManI (Endoplasmic Reticulum Class I alpha-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; N-GLYCAN BIOSYNTHESIS; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; EDEM; ALPHA-1,2-MANNOSIDASES; IDENTIFICATION; MITOCHONDRIA; EXPRESSION	Previously, we reported that the mitochondrial translocator protein (TSPO) induces HIV-1 envelope (Env) degradation via the endoplasmic reticulum (ER)-associated protein degradation (ERAD) pathway, but the mechanism was not clear. Here we investigated how the four ER-associated glycoside hydrolase family 47 (GH47) alpha-mannosidases, ERManI, and ER-degradation enhancing alpha-mannosidase-like (EDEM) proteins 1, 2, and 3, are involved in the Env degradation process. Ectopic expression of these four alpha-mannosidases uncovers that only ERManI inhibits HIV-1 Env expression in a dose-dependent manner. In addition, genetic knock-out of the ERManI gene MAN1B1 using CRISPR/Cas9 technology disrupts the TSPO-mediated Env degradation. Biochemical studies show that HIV-1 Env interacts with ERManI, and between the ERManI cytoplasmic, transmembrane, lumenal stem, and lumenal catalytic domains, the catalytic domain plays a critical role in the Env-ERManI interaction. In addition, functional studies show that inactivation of the catalytic sites by site-directed mutagenesis disrupts the ERManI activity. These studies identify ERManI as a critical GH47 alpha-mannosidase in the ER-associated protein degradation pathway that initiates the Env degradation and suggests that its catalytic domain and enzymatic activity play an important role in this process.	[Zhou, Tao; Zheng, Yong-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, CAAS Michigan State Univ Joint Lab Innate Immun, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhou, Tao; Frabutt, Dylan A.; Zheng, Yong-Hui] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Zhou, Tao; Frabutt, Dylan A.; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University System of Georgia; University of Georgia; Michigan State University; Michigan State University	Zheng, YH (corresponding author), Rm 2215,567 Wilson Rd, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zhou, Tao/B-5757-2017; Regan, Clinton/E-6250-2012; Zheng, Yong-Hui/AAP-4492-2021; Moremen, Kelley/AAD-4661-2019	Zhou, Tao/0000-0002-3648-9923; Zheng, Yong-Hui/0000-0002-1098-7385; Frabutt, Dylan/0000-0002-8693-6656	National Institutes of Health [AI063944, P41GM103390, GM47533, DK075322]; "948" plan, Ministry of Agriculture, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120189, R56AI063944, R01AI063944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM047533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "948" plan, Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063944 (to Y.- H. Z) and P41GM103390, GM47533, and DK075322 (to K. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a grant from the "948" plan, Ministry of Agriculture, China. To whom correspondence should be addressed: Rm. 2215, 567 Wilson Rd., East Lansing, MI 48824. Tel.: 517-884-5314; Fax: 517-353-8957; E-mail: zhengyo@msu.edu.	Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Benyair R, 2015, MOL BIOL CELL, V26, P172, DOI 10.1091/mbc.E14-06-1152; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dellisanti C., 2015, NAT STRUCT MOL BIOL, V22, P184; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; FENNIE C, 1989, J VIROL, V63, P639, DOI 10.1128/JVI.63.2.639-646.1989; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; HALLENBERGER S, 1993, VIROLOGY, V193, P510, DOI 10.1006/viro.1993.1156; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Iannotti MJ, 2014, J BIOL CHEM, V289, P11844, DOI 10.1074/jbc.M114.552091; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Lipari F, 1996, J BIOL CHEM, V271, P27615, DOI 10.1074/jbc.271.44.27615; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang Y, 2007, P NATL ACAD SCI USA, V104, P10813, DOI 10.1073/pnas.0702027104; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13; Zhou T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-31	43	20	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22184	22192		10.1074/jbc.M115.675207	http://dx.doi.org/10.1074/jbc.M115.675207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205822	hybrid, Green Published			2022-12-28	WOS:000360968500035
J	Funk, KE; Mirbaha, H; Jiang, H; Holtzman, DM; Diamond, MI				Funk, Kristen E.; Mirbaha, Hilda; Jiang, Hong; Holtzman, David M.; Diamond, Marc I.			Distinct Therapeutic Mechanisms of Tau Antibodies PROMOTING MICROGLIAL CLEARANCE VERSUS BLOCKING NEURONAL UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; microglia; neuron; Tau protein (Tau); tauopathy; clearance	BETA-AMYLOID PEPTIDE; EXTRACELLULAR TAU; MOUSE MODEL; ALZHEIMERS-DISEASE; PASSIVE-IMMUNIZATION; PROTEIN; PATHOLOGY; BRAIN; IMMUNOTHERAPY; PROPAGATION	Background: Vaccination against Tau reduces pathology in vivo; however, the mechanism of action remains unclear. Results: Antibodies promote uptake of Tau fibrils in microglia or block uptake in neurons in a size- and epitope-dependent manner. Conclusion: Antibodies have multiple potential mechanisms. Significance: Establishing specific mechanisms of antibody activity may help in design and optimization of more effective agents. Tauopathies are neurodegenerative diseases characterized by accumulation of Tau amyloids, and include Alzheimer disease and certain frontotemporal dementias. Trans-neuronal propagation of amyloid mediated by extracellular Tau may underlie disease progression. Consistent with this, active and passive vaccination studies in mouse models reduce pathology, although by unknown mechanisms. We previously reported that intracerebroventricular administration of three anti-Tau monoclonal antibodies (HJ8.5, HJ9.3, and HJ9.4) reduces pathology in a model overexpressing full-length mutant (P301S) human Tau. We now study effects of these three antibodies and a negative control antibody (HJ3.4) on Tau aggregate uptake into BV2 microglial-like cells and primary neurons. Antibody-independent Tau uptake into BV2 cells was blocked by heparin, consistent with a previously described role for heparan sulfate proteoglycans. Two therapeutic antibodies (HJ8.5 and HJ9.4) promoted uptake of full-length Tau fibrils into microglia via Fc receptors. Surprisingly, HJ9.3 promoted uptake of fibrils composed of the Tau repeat domain or Alzheimer disease-derived Tau aggregates, but failed to influence full-length recombinant Tau fibrils. Size fractionation of aggregates showed that antibodies preferentially promote uptake of larger oligomers (n approximate to 20-mer) versus smaller oligomers (n approximate to 10-mer) or monomer. No antibody inhibited uptake of full-length recombinant fibrils into primary neurons, but HJ9.3 blocked neuronal uptake of Tau repeat domain fibrils and Alzheimer disease-derived Tau. Antibodies thus have multiple potential mechanisms, including clearance via microglia and blockade of neuronal uptake. However these effects are epitope- and aggregate size-dependent. Establishing specific mechanisms of antibody activity in vitro may help in design and optimization of agents that are more effective in vivo.	[Funk, Kristen E.; Jiang, Hong; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Mirbaha, Hilda; Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA	Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Diamond, MI (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	marc.diamond@utsouthwestern.edu	Funk, Kristen/AAC-6334-2020; Regan, Clinton/E-6250-2012	Funk, Kristen/0000-0002-1912-1430; 	National Institutes of Health [P50AG005681, P01AG003991]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Nigel Cairns, Erin Householder, the technical support of the Betty Martz Laboratory for Neurodegenerative Research, and the Knight Alzheimer's Disease Research Center at Washington University in St. Louis for brain tissue, supported by the following National Institutes of Health grants: P50AG005681 (Knight Alzheimer's Disease Research Center) and P01AG003991 (Healthy Aging and Senile Dementia).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Das P, 2003, J NEUROSCI, V23, P8532; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Majerova P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0161-z; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; METZGER H, 1988, FASEB J, V2, P3, DOI 10.1096/fasebj.2.1.3275562; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Sue W, 2006, AM J CLIN NUTR, V83, p470S; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wisniewski T, 2014, BIOCHEM PHARMACOL, V88, P499, DOI 10.1016/j.bcp.2013.12.020; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046	46	80	83	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21652	21662		10.1074/jbc.M115.657924	http://dx.doi.org/10.1074/jbc.M115.657924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26126828	hybrid, Green Published			2022-12-28	WOS:000360637600037
J	Miles, JA; Frost, MG; Carroll, E; Rowe, ML; Howard, MJ; Sidhu, A; Chaugule, VK; Alpi, AF; Walden, H				Miles, Jennifer A.; Frost, Mark G.; Carroll, Eilis; Rowe, Michelle L.; Howard, Mark J.; Sidhu, Ateesh; Chaugule, Viduth K.; Alpi, Arno F.; Walden, Helen			The Fanconi Anemia DNA Repair Pathway Is Regulated by an Interaction between Ubiquitin and the E2-like Fold Domain of FANCL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE COMPLEX; BINDING DOMAINS; MONOUBIQUITINATION; LIGASE; UBE2T; PCNA; REPLICATION; DEFICIENT; MECHANISM; ALDEHYDES	The Fanconi Anemia (FA) DNArepair pathway is essential for the recognition and repair of DNA interstrand crosslinks (ICL). Inefficient repair of these ICL can lead to leukemia and bone marrow failure. A critical step in the pathway is the monoubiquitination of FANCD2 by the RING E3 ligase FANCL. FANCL comprises 3 domains, a RING domain that interacts with E2 conjugating enzymes, a central domain required for substrate interaction, and an N-terminal E2-like fold (ELF) domain. The ELF domain is found in all FANCL homologues, yet the function of the domain remains unknown. We report here that the ELF domain of FANCL is required to mediate a non-covalent interaction between FANCL and ubiquitin. The interaction involves the canonical Ile44 patch on ubiquitin, and a functionally conserved patch on FANCL. We show that the interaction is not necessary for the recognition of the core complex, it does not enhance the interaction between FANCL and Ube2T, and is not required for FANCD2 monoubiquitination in vitro. However, we demonstrate that the ELF domain is required to promote efficient DNA damage-induced FANCD2 monoubiquitination in vertebrate cells, suggesting an important function of ubiquitin binding by FANCL in vivo.	[Miles, Jennifer A.; Sidhu, Ateesh; Walden, Helen] London Res Inst, Prot Struct & Funct Lab, Lincolns Inn Fields Labs, Canc Res, London WC2A 3LY, England; [Frost, Mark G.; Carroll, Eilis; Chaugule, Viduth K.; Alpi, Arno F.; Walden, Helen] Univ Dundee, Coll Life Sci, Med Res Council, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Carroll, Eilis; Alpi, Arno F.] Univ Dundee, Coll Life Sci, Scottish Inst Cell Signalling, Dundee DD1 5EH, Scotland; [Rowe, Michelle L.; Howard, Mark J.] Univ Kent, Sch Biosci, Prot Sci Grp, Canterbury CT2 7NZ, Kent, England	University of Dundee; University of Dundee; University of Kent	Alpi, AF (corresponding author), Univ Dundee, Coll Life Sci, Med Res Council, Prot Phosphorylat & Ubiquitylat Unit, Dow St, Dundee DD1 5EH, Scotland.	A.F.Alpi@dundee.ac.uk; h.walden@dundee.ac.uk	Chaugule, Viduth K./AAG-2753-2019	Chaugule, Viduth K./0000-0001-7814-5865; Miles, Jennifer/0000-0001-8839-9201; Alpi, Arno/0000-0002-9572-7266; Howard, Mark/0000-0002-0762-2887	Cancer Research UK; Medical Research Council; Scottish Government; EMBO Young Investigator Programme; MRC [MC_UU_12016/12] Funding Source: UKRI; Cancer Research UK [17739] Funding Source: researchfish; Medical Research Council [MC_UU_12016/12] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Government; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Cancer Research UK (to H. W., J. A. M., A. S., M. F.), the Medical Research Council, and a grant from the Scottish Government to The Scottish Institute for Cell Signaling (SCILLS) (to E. C. and A. F. A.), and the EMBO Young Investigator Programme (to H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Gurtan AM, 2006, J BIOL CHEM, V281, P10896, DOI 10.1074/jbc.M511411200; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Hodson C, 2011, J BIOL CHEM, V286, P32628, DOI 10.1074/jbc.M111.244632; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kupfer Gary M., 2013, Yale Journal of Biology and Medicine, V86, P491; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mcvey M, 2010, ENVIRON MOL MUTAGEN, V51, P646, DOI 10.1002/em.20551; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Park HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013313; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; St-Laurent Pedneault C., 2013, J GENET SYNDR GENE T, V4; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	43	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20995	21006		10.1074/jbc.M115.675835	http://dx.doi.org/10.1074/jbc.M115.675835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26149689	Green Published, hybrid			2022-12-28	WOS:000360011800033
J	Tarantino, ME; Bilotti, K; Huang, J; Delaney, S				Tarantino, Mary E.; Bilotti, Katharina; Huang, Ji; Delaney, Sarah			Rate-determining Step of Flap Endonuclease 1 (FEN1) Reflects a Kinetic Bias against Long Flaps and Trinucleotide Repeat Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CAG/CTG TRIPLET REPEATS; DNA-DAMAGE; SECONDARY STRUCTURE; STRUCTURAL BASIS; HUMAN-DISEASE; IN-VITRO; EXPANSION; SUBSTRATE; REPLICATION	Flap endonuclease 1 (FEN1) is a structure-specific nuclease responsible for removing 5'-flaps formed during Okazaki fragment maturation and long patch base excision repair. In this work, we use rapid quench flow techniques to examine the rates of 5'-flap removal on DNA substrates of varying length and sequence. Of particular interest are flaps containing trinucleotide repeats (TNR), which have been proposed to affect FEN1 activity and cause genetic instability. We report that FEN1 processes substrates containing flaps of 30 nucleotides or fewer at comparable single-turnover rates. However, for flaps longer than 30 nucleotides, FEN1 kinetically discriminates substrates based on flap length and flap sequence. In particular, FEN1 removes flaps containing TNR sequences at a rate slower than mixed sequence flaps of the same length. Furthermore, multiple-turnover kinetic analysis reveals that the rate-determining step of FEN1 switches as a function of flap length from product release to chemistry (or a step prior to chemistry). These results provide a kinetic perspective on the role of FEN1 in DNA replication and repair and contribute to our understanding of FEN1 in mediating genetic instability of TNR sequences.	[Tarantino, Mary E.; Bilotti, Katharina; Huang, Ji; Delaney, Sarah] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Delaney, S (corresponding author), Brown Univ, 324 Brook St, Providence, RI 02912 USA.	sarah_delaney@brown.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01ES019296]; Summer Research Assistantship in the Biomedical Sciences from the Program in Liberal Medical Education at Brown University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Research Assistantship in the Biomedical Sciences from the Program in Liberal Medical Education at Brown University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01ES019296. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Summer Research Assistantship in the Biomedical Sciences from the Program in Liberal Medical Education at Brown University.	Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Beddows A, 2012, CHEM COMMUN, V48, P8895, DOI 10.1039/c2cc33400c; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chan NLS, 2013, J BIOL CHEM, V288, P15015, DOI 10.1074/jbc.M113.464370; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Figueroa AA, 2011, BIOCHEMISTRY-US, V50, P4441, DOI 10.1021/bi200397b; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; GACY AM, 1995, CELL, V81, P533; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; Jarem DA, 2011, BIOCHEM BIOPH RES CO, V416, P146, DOI 10.1016/j.bbrc.2011.11.013; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JC, 2013, CURR OPIN GENET DEV, V23, P280, DOI 10.1016/j.gde.2013.04.009; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Paiva AM, 2004, BIOCHEMISTRY-US, V43, P14218, DOI 10.1021/bi0494368; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Ruggiero BL, 2004, J BIOL CHEM, V279, P23088, DOI 10.1074/jbc.M313170200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306	49	9	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21154	21162		10.1074/jbc.M115.666438	http://dx.doi.org/10.1074/jbc.M115.666438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160176	hybrid, Green Published			2022-12-28	WOS:000360011800046
J	Diderrich, R; Kock, M; Maestre-Reyna, M; Keller, P; Steuber, H; Rupp, S; Essen, LO; Mosch, HU				Diderrich, Rike; Kock, Michael; Maestre-Reyna, Manuel; Keller, Petra; Steuber, Holger; Rupp, Steffen; Essen, Lars-Oliver; Moesch, Hans-Ulrich			Structural Hot Spots Determine Functional Diversity of the Candida glabrata Epithelial Adhesin Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; PA14 DOMAIN; YEAST; SPECIFICITY; EXPRESSION; CONSURF; TOOLS; EPIDEMIOLOGY; ALBICANS; EPA1P	For host colonization, the human fungal pathogen Candida glabrata is known to utilize a large family of highly related surface-exposed cell wall proteins, the lectin-like epithelial adhesins (Epas). To reveal the structure-function relationships within the entire Epa family, we have performed a large scale functional analysis of the adhesion (A) domains of 17 Epa paralogs in combination with three-dimensional structural studies of selected members with cognate ligands. Our study shows that most EpaA domains exert lectin-like functions and together recognize a wide variety of glycans with terminal galactosides for conferring epithelial cell adhesion. We further identify several conserved and variable structural features within the diverse Epa ligand binding pockets, which affect affinity and specificity. These features rationalize why mere phylogenetic relationships within the Epa family are weak indicators for functional classification and explain how Epa-like adhesins have evolved in C. glabrata and related fungal species.	[Diderrich, Rike; Moesch, Hans-Ulrich] Univ Marburg, Dept Genet, D-35043 Marburg, Germany; [Kock, Michael; Maestre-Reyna, Manuel; Steuber, Holger; Essen, Lars-Oliver] Univ Marburg, Dept Biochem, D-35043 Marburg, Germany; [Keller, Petra; Rupp, Steffen] Fraunhofer Inst Grenzflachen & Bioverfahrenstech, D-70569 Stuttgart, Germany; [Rupp, Steffen] Univ Stuttgart, Inst Grenzflachenverfahrenstech & Plasmatech, D-70569 Stuttgart, Germany	Philipps University Marburg; Philipps University Marburg; Fraunhofer Gesellschaft; University of Stuttgart	Essen, LO (corresponding author), Univ Marburg, Dept Biochem, D-35043 Marburg, Germany.	essen@chemie.uni-marburg.de; moesch@staff.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	Deutsche Forschungsgemeinschaft [ES 152/7, MO 825/3, SFB 987, GRK 1216]; International Max-Planck Research School for Environmental, Cellular and Molecular Microbiology; Marburg Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max-Planck Research School for Environmental, Cellular and Molecular Microbiology; Marburg Center for Synthetic Microbiology	This work was supported by Deutsche Forschungsgemeinschaft Grants ES 152/7, MO 825/3, SFB 987, and GRK 1216, the International Max-Planck Research School for Environmental, Cellular and Molecular Microbiology, and the Marburg Center for Synthetic Microbiology. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1991, Methods Enzymol, V194, P1; Bolotin-Fukuhara M, 2014, YEAST, V31, P279, DOI 10.1002/yea.3019; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Castano I, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P163; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; de Groot PWJ, 2008, MOL MICROBIOL, V68, P535, DOI 10.1111/j.1365-2958.2008.06182.x; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Desai C, 2011, FEMS YEAST RES, V11, P595, DOI 10.1111/j.1567-1364.2011.00743.x; Dieterich C, 2002, MICROBIOL-SGM, V148, P497, DOI 10.1099/00221287-148-2-497; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Gallegos-Garcia V, 2012, GENETICS, V190, P1285, DOI 10.1534/genetics.111.138099; Geissner A, 2014, CURR OPIN CHEM BIOL, V18, P38, DOI 10.1016/j.cbpa.2013.11.013; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halliwell SC, 2012, EUKARYOT CELL, V11, P141, DOI 10.1128/EC.05232-11; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Ielasi FS, 2012, ACTA CRYSTALLOGR D, V68, P210, DOI 10.1107/S0907444911054898; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Maestre-Reyna M, 2012, P NATL ACAD SCI USA, V109, P16864, DOI 10.1073/pnas.1207653109; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sim L, 2013, FEBS J, V280, P1073, DOI 10.1111/febs.12102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wittmann V, 2013, CHEM SOC REV, V42, P4492, DOI 10.1039/c3cs60089k; Zepelin MBV, 2007, J ANTIMICROB CHEMOTH, V60, P424, DOI 10.1093/jac/dkm145; Zupancic ML, 2008, MOL MICROBIOL, V68, P547, DOI 10.1111/j.1365-2958.2008.06184.x	50	33	33	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19597	19613		10.1074/jbc.M115.655654	http://dx.doi.org/10.1074/jbc.M115.655654			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105055	Green Published, hybrid			2022-12-28	WOS:000359364600022
J	He, YN; Rangarajan, S; Kerzic, M; Luo, M; Chen, YH; Wang, Q; Yin, YY; Workman, CJ; Vignali, KM; Vignali, DAA; Mariuzza, RA; Orban, J				He, Yanan; Rangarajan, Sneha; Kerzic, Melissa; Luo, Ming; Chen, Yihong; Wang, Qian; Yin, Yiyuan; Workman, Creg J.; Vignali, Kate M.; Vignali, Dario A. A.; Mariuzza, Roy A.; Orban, John			Identification of the Docking Site for CD3 on the T Cell Receptor beta Chain by Solution NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CD3-EPSILON-GAMMA HETERODIMER; SECONDARY STRUCTURE; NEGATIVE SELECTION; ANTIGEN RECEPTOR; RETROGENIC MICE; COMPLEX; PROTEIN; TCR; RECOGNITION	The T cell receptor (TCR)-CD3 complex is composed of a genetically diverse alpha beta TCR heterodimer associated noncovalently with the invariant CD3 dimers CD3 epsilon gamma, CD3 epsilon delta, and CD3 zeta zeta. The TCR mediates peptide-MHC recognition, whereas the CD3 molecules transduce activation signals to the T cell. Although much is known about downstream T cell signaling pathways, the mechanism whereby TCR engagement by peptide-MHC initiates signaling is poorly understood. A key to solving this problem is defining the spatial organization of the TCR-CD3 complex and the interactions between its subunits. We have applied solution NMR methods to identify the docking site for CD3 on the beta chain of a human autoimmune TCR. We demonstrate a low affinity but highly specific interaction between the extracellular domains of CD3 and the TCR constant beta (C beta) domain that requires both CD3 epsilon gamma and CD3 epsilon delta subunits. The mainly hydrophilic docking site, comprising 9-11 solvent-accessible C beta residues, is relatively small (similar to 400 angstrom(2)), consistent with the weak interaction between TCR and CD3 extracellular domains, and devoid of glycosylation sites. The docking site is centered on the alpha A and alpha B helices of C beta, which are located at the base of the TCR. This positions CD3 epsilon gamma and CD3 epsilon delta between the TCR and the T cell membrane, permitting us to distinguish among several possible models of TCR-CD3 association. We further correlate structural results from NMR with mutational data on TCR-CD3 interactions from cell-based assays.	[Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [He, Yanan; Rangarajan, Sneha; Kerzic, Melissa; Luo, Ming; Chen, Yihong; Wang, Qian; Yin, Yiyuan; Mariuzza, Roy A.; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [He, Yanan; Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Rangarajan, Sneha; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Luo, Ming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Luo, Ming] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Workman, Creg J.; Vignali, Kate M.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Yin, Yiyuan/A-1384-2016; Yin, Yiyuan/AAP-3069-2020; Regan, Clinton/E-6250-2012	Yin, Yiyuan/0000-0003-1077-810X; Yin, Yiyuan/0000-0003-1077-810X; 	National Institutes of Health [AI101911, AI036900, AI52199]; W. M. Keck Foundation; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052199, R01AI036900, R56AI052199, R21AI101911, R37AI036900, R01AI052199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI101911 (to J. O. and R. A. M.), AI036900 (to R. A. M.), and AI52199 (to D. A. A. V.). The NMR facility is jointly supported by the University of Maryland, the National Institute of Standards and Technology, and a grant from the W. M. Keck Foundation. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the joint supervision Ph.D. Project of the China Scholarship Council.	Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Brazin KN, 2014, J BIOL CHEM, V289, P18880, DOI 10.1074/jbc.M114.574996; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fernandes RA, 2012, J BIOL CHEM, V287, P13324, DOI 10.1074/jbc.M111.332783; Goddard T.D., 2004, SPARKY 3; He YN, 2007, PROTEIN SCI, V16, P1490, DOI 10.1110/ps.072799507; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Li YL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00206; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Quandt JA, 2004, J EXP MED, V200, P223, DOI 10.1084/jem.20030994; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	48	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19796	19805		10.1074/jbc.M115.663799	http://dx.doi.org/10.1074/jbc.M115.663799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109064	Green Published, hybrid			2022-12-28	WOS:000359364600036
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Dimerization Domain of Retinal Membrane Guanylyl Cyclase 1 (RetGC1) Is an Essential Part of Guanylyl Cyclase-activating Protein (GCAP) Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; KNOCK-OUT MICE; PHOTORECEPTOR CELLS; CALCIUM SENSITIVITY; CATALYTIC-ACTIVITY; IDENTIFICATION; DEGENERATION; MUTATIONS; MECHANISM	The photoreceptor-specific proteins guanylyl cyclase-activating proteins (GCAPs) bind and regulate retinal membrane guanylyl cyclase 1 (RetGC1) but not natriuretic peptide receptor A (NPRA). Study of RetGC1 regulation in vitro and its association with fluorescently tagged GCAP in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photo-receptor-specific protein, retinal degeneration 3 (RD3). Likewise, the presence of the NPRA dimerization domain in RetGC1/NPRA chimera specifically disabled binding of GCAPs but not of RD3. In subsequent mapping using hybrid dimerization domains in RetGC1/NPRA chimera, multiple RetGC1-specific residues contributed to GCAP binding by the cyclase, but the region around Met(823) was the most crucial. Either positively or negatively charged residues in that position completely blocked GCAP1 and GCAP2 but not RD3 binding similarly to the disease-causing mutation in the neighboring Arg(822). The specificity of GCAP binding imparted by RetGC1 dimerization domain was not directly related to promoting dimerization of the cyclase. The probability of coiled coil dimer formation computed for RetGC1/NPRA chimeras, even those incapable of binding GCAP, remained high, and functional complementation tests showed that the RetGC1 active site, which requires dimerization of the cyclase, was formed even when Met(823) or Arg(822) was mutated. These results directly demonstrate that the interface for GCAP binding on RetGC1 requires not only the kinase homology region but also directly involves the dimerization domain and especially its portion containing Arg(822) and Met(823).	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Res, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Common-wealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Common-wealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11522 from the NEI. This work was also supported by a Common-wealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Duda T, 2015, J BIOL CHEM, V290, P11052, DOI 10.1074/jbc.M115.650408; Duda T, 2012, BIOCHEMISTRY-US, V51, P4650, DOI 10.1021/bi300572w; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; Zagel P, 2013, BIOCHEMISTRY-US, V52, P5065, DOI 10.1021/bi400288p; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	59	23	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19584	19596		10.1074/jbc.M115.661371	http://dx.doi.org/10.1074/jbc.M115.661371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100624	Green Published, hybrid			2022-12-28	WOS:000359364600021
J	Sattler, SA; Wang, X; Lewis, KM; Dehan, PJ; Park, CM; Xin, YF; Liu, HL; Xian, M; Xun, LY; Kang, C				Sattler, Steven A.; Wang, Xia; Lewis, Kevin M.; DeHan, Preston J.; Park, Chung-Min; Xin, Yufeng; Liu, Honglei; Xian, Ming; Xun, Luying; Kang, ChulHee			Characterizations of Two Bacterial Persulfide Dioxygenases of the Metallo-beta-lactamase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE METABOLISM; ETHYLMALONIC ENCEPHALOPATHY; CRYSTAL-STRUCTURE; SULFANE SULFUR; ETHE1; PROTEIN; MUTATIONS; H2S; ORGANIZATION; SUBSTRATE	Persulfide dioxygenases (PDOs), also known as sulfur dioxygenases (SDOs), oxidize glutathione persulfide (GSSH) to sulfite and GSH. PDOs belong to the metallo-beta-lactamase superfamily and play critical roles in animals, plants, and microorganisms, including sulfide detoxification. The structures of two PDOs from human and Arabidopsis thaliana have been reported; however, little is known about the substrate binding and catalytic mechanism. The crystal structures of two bacterial PDOs from Pseudomonas putida and Myxococcus xanthus were determined at 1.5- and 2.5-angstrom resolution, respectively. The structures of both PDOs were homodimers, and their metal centers and beta-lactamase folds were superimposable with those of related enzymes, especially the glyoxalases II. The PDOs share similar Fe(II) coordination and a secondary coordination sphere-based hydrogen bond network that is absent in glyoxalases II, in which the corresponding residues are involved instead in coordinating a second metal ion. The crystal structure of the complex between the Pseudomonas PDO and GSH also reveals the similarity of substrate binding between it and glyoxalases II. Further analysis implicates an identical mode of substrate binding by known PDOs. Thus, the data not only reveal the differences in metal binding and coordination between the dioxygenases and the hydrolytic enzymes in the metallo-beta-lactamase superfamily, but also provide detailed information on substrate binding by PDOs.	[Sattler, Steven A.; Wang, Xia; DeHan, Preston J.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Wang, Xia; Xin, Yufeng; Liu, Honglei; Xun, Luying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Lewis, Kevin M.; Park, Chung-Min; Xian, Ming; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Shandong University; Washington State University	Xun, LY (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	luying_xun@vetmed.wsu.edu; chkang@wsu.edu	xin, yufeng/GZB-1798-2022	Lewis, Kevin/0000-0003-3403-9520; Kang, ChulHee/0000-0002-0693-7860	National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust; China Scholarship Council [201208370133]	National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust; China Scholarship Council(China Scholarship Council)	This work was supported in part by National Science Foundation Grants MCB 1021148 and DBI 0959778 and the M. J. Murdock Charitable Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by China Scholarship Council Grant 201208370133 during a visit to Washington State University.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arisawa M, 2006, J ORGANOMET CHEM, V691, P1159, DOI 10.1016/j.jorganchem.2005.11.049; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bugg TDH, 2001, CURR OPIN CHEM BIOL, V5, P550, DOI 10.1016/S1367-5931(00)00236-2; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Choi LS, 2012, ANGEW CHEM INT EDIT, V51, P7972, DOI 10.1002/anie.201202365; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hayes RP, 2013, MOL MICROBIOL, V88, P523, DOI 10.1111/mmi.12204; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Liu HL, 2014, APPL ENVIRON MICROB, V80, P1799, DOI 10.1128/AEM.03281-13; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettinati I, 2015, HUM MOL GENET, V24, P2458, DOI 10.1093/hmg/ddv007; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135	32	20	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18914	18923		10.1074/jbc.M115.652537	http://dx.doi.org/10.1074/jbc.M115.652537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082492	Green Published, hybrid			2022-12-28	WOS:000358781100004
J	Tang, K; Knipp, M; Liu, BB; Cox, N; Stabel, R; He, Q; Zhou, M; Scheer, H; Zhao, KH; Gartner, W				Tang, Kun; Knipp, Markus; Liu, Bing-Bing; Cox, Nicholas; Stabel, Robert; He, Qi; Zhou, Ming; Scheer, Hugo; Zhao, Kai-Hong; Gaertner, Wolfgang			Redox-dependent Ligand Switching in a Sensory Heme-binding GAF Domain of the Cyanobacterium Nostoc sp PCC7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; MYCOBACTERIUM-TUBERCULOSIS DOSS; RESONANCE RAMAN-SPECTRA; SWISS-MODEL; PROTEIN INTERACTIONS; AXIAL LIGAND; FE(III) HEME; DNA-BINDING; CO; COMPLEXES	The genome of the cyanobacterium Nostoc sp. PCC7120 carries three genes (all4978, all7016, and alr7522) encoding putative heme/binding GAF (cGMP-specific phosphodiesterases, adenylyl cyclases, and FhlA) proteins that were annotated as transcriptional regulators. They are composed of an N-terminal cofactor domain and a C-terminal helix-turn-helix motif. All4978 showed the highest affinity for protoheme binding. The heme binding capability of All7016 was moderate, and Alr7522 did not bind heme at all. The "as isolated" form of All4978, identified by Soret band (lambda(max) = 427 nm), was assigned by electronic absorption, EPR, and resonance Raman spectroscopy as a hexa-coordinated low spin Fe-III heme with a distal cysteine ligand (absorption of delta-band around 360 nm). The protoheme cofactor is noncovalently incorporated. Reduction of the heme could be accomplished by chemically using sodium dithionite and electrospectrochemically; this latter method yielded remarkably low midpoint potentials of -445 and -453 mV(following Soret and alpha-band absorption changes, respectively). The reduced form of the heme (FeII state) binds both NO and CO. Cysteine coordination of the as isolated FeIII protein is unambiguous, but interestingly, the reduced heme instead displays spectral features indicative of histidine coordination. Cys-His ligand switches have been reported as putative signaling mechanisms in other heme-binding proteins; however, these novel cyanobacterial proteins are the first where such a ligand-switch mechanism has been observed in a GAF domain. DNA binding of the helix-turn-helix domain was investigated using a DNA sequence motif from its own promoter region. Formation of a protein-DNA complex preferentially formed in ferric state of the protein.	[Tang, Kun; Liu, Bing-Bing; He, Qi; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Tang, Kun; Knipp, Markus; Cox, Nicholas; Stabel, Robert; Gaertner, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Knipp, Markus] Ruhr Univ Bochum, Fac Chem & Biochem, Resolv, D-44780 Bochum, Germany; [Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Huazhong Agricultural University; Max Planck Society; Ruhr University Bochum; University of Munich	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com; wolfgang.gaertner@cec.mpg.de	liu, bb/GXA-2527-2022; Cox, Nicholas/J-8047-2014; Tang, Kun/GSD-3218-2022	Cox, Nicholas/0000-0002-7815-6115; 	Max-Planck-Society; Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft [EXC 1069]; China Scholar Council; National Natural Science Foundation of China [31370777, 31110103912, 31270893, 21472055]	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholar Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Max-Planck-Society and the Cluster of Excellence RESOLV (EXC 1069) funded by the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a grant from the China Scholar Council.; Recipient of Grant 31370777 from the National Natural Science Foundation of China.; Recipient of National Natural Science Foundation of China Grant 31110103912.; Recipient of National Natural Science Foundation of China Grants 31270893 and 21472055.	Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; ANDERSSON LA, 1989, J BIOL CHEM, V264, P19099; Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CHEEK J, 2000, PORPHYRIN HDB, V7, P339; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Chim N, 2014, J INORG BIOCHEM, V133, P118, DOI 10.1016/j.jinorgbio.2013.11.003; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; Dawson J. H., 1989, IRON PORPHYRINS 3, P1; DAWSON JH, 1978, BIOCHEMISTRY-US, V17, P33, DOI 10.1021/bi00594a006; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; Ding XD, 1999, J AM CHEM SOC, V121, P128, DOI 10.1021/ja982979i; DOLINGER PM, 1974, P NATL ACAD SCI USA, V71, P399, DOI 10.1073/pnas.71.2.399; EATON WA, 1967, J CHEM PHYS, V46, P2533, DOI 10.1063/1.1841081; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; He CM, 2013, J INORG BIOCHEM, V122, P38, DOI 10.1016/j.jinorgbio.2013.01.012; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ibrahim M, 2006, J AM CHEM SOC, V128, P16834, DOI 10.1021/ja064859d; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kincaid J. R., 2000, PORPHYRIN HDB, P225; KITAGAWA T, 1976, J AM CHEM SOC, V98, P5169, DOI 10.1021/ja00433a019; Knipp M, 2011, IUBMB LIFE, V63, P304, DOI 10.1002/iub.451; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Maes EM, 2001, J AM CHEM SOC, V123, P11664, DOI 10.1021/ja0031927; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Molitor B, 2013, J BIOL CHEM, V288, P18458, DOI 10.1074/jbc.M113.476267; Moran L. A., 1994, BIOCHEMISTRY-US, P1427; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohmori M, 2001, DNA RES, V8, P271, DOI 10.1093/dnares/8.6.271; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; SHIMIZU T, 1981, BIOCHIM BIOPHYS ACTA, V669, P46, DOI 10.1016/0005-2795(81)90222-1; Shimizu T, 2012, J INORG BIOCHEM, V108, P171, DOI 10.1016/j.jinorgbio.2011.08.018; Smith AT, 2012, J BIOL INORG CHEM, V17, P1071, DOI 10.1007/s00775-012-0920-1; SONO M, 1982, J BIOL CHEM, V257, P8308; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; SPIRO TG, 1979, J AM CHEM SOC, V101, P2648, DOI 10.1021/ja00504a027; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Spiro TG, 2013, COORDIN CHEM REV, V257, P511, DOI 10.1016/j.ccr.2012.05.008; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sun YH, 2013, BIOCHEMISTRY-US, V52, P5941, DOI 10.1021/bi400541v; SUTHERLAND JC, 1980, ANNU REV BIOPHYS BIO, V9, P293, DOI 10.1146/annurev.bb.09.060180.001453; Tang K, 2012, BBA-BIOENERGETICS, V1817, P1030, DOI 10.1016/j.bbabio.2012.03.018; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tomita T, 2002, BIOCHEMISTRY-US, V41, P4819, DOI 10.1021/bi0158831; Uchida T, 1998, J BIOL CHEM, V273, P19988, DOI 10.1074/jbc.273.32.19988; Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vogel KM, 1999, BIOCHEMISTRY-US, V38, P2679, DOI 10.1021/bi982375r; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; Yin L, 2012, J BIOL CHEM, V287, P13850, DOI 10.1074/jbc.M112.346494; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Zheng Z, 2009, PROTEINS, V75, P719, DOI 10.1002/prot.22282	76	10	10	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19067	19080		10.1074/jbc.M115.654087	http://dx.doi.org/10.1074/jbc.M115.654087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26063806	Green Published, hybrid			2022-12-28	WOS:000358781100024
J	Schorr, S; Klein, MC; Gamayun, I; Melnyk, A; Jung, M; Schauble, N; Wang, Q; Hemmis, B; Bochen, F; Greiner, M; Lampel, P; Urban, SK; Hassdenteufel, S; Dudek, J; Chen, XZ; Wagner, R; Cavalie, A; Zimmermann, R				Schorr, Stefan; Klein, Marie-Christine; Gamayun, Igor; Melnyk, Armin; Jung, Martin; Schaeuble, Nico; Wang, Qian; Hemmis, Birgit; Bochen, Florian; Greiner, Markus; Lampel, Pavel; Urban, Sabine Katharina; Hassdenteufel, Sarah; Dudek, Johanna; Chen, Xing-Zhen; Wagner, Richard; Cavalie, Adolfo; Zimmermann, Richard			Co-chaperone Specificity in Gating of the Polypeptide Conducting Channel in the Membrane of the Human Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CALCIUM LEAK; CA2+ LEAK; INTRACELLULAR CA2+; SECRETORY PROTEINS; DIABETES-MELLITUS; SEC61 TRANSLOCON; DNAJ HOMOLOG; BIP; STRESS	In mammalian cells, signal peptide-dependent protein transport into the endoplasmic reticulum (ER) is mediated by a dynamic polypeptide-conducting channel, the heterotrimeric Sec61 complex. Previous work has characterized the Sec61 complex as a potential ER Ca2+ leak channel in HeLa cells and identified ER lumenal molecular chaper one immunoglobulin heavy-chain-binding protein (BiP) as limiting Ca2+ leakage via the open Sec61 channel by facilitating channel closing. This BiP activity involves binding of BiP to the ER lumenal loop 7 of Sec61 alpha in the vicinity of tyrosine 344. Of note, the Y344H mutation destroys the BiP binding site and causes pancreatic alpha-cell apoptosis and diabetes in mice. Here, we systematically depleted HeLa cells of the BiP co-chaperones by siRNA-mediated gene silencing and used live cell Ca2+ imaging to monitor the effects on ER Ca2+ leakage. Depletion of either one of the ER lumenal BiP co-chaperones, ERj3 and ERj6, but not the ER membrane-resident co-chaperones (such as Sec63 protein, which assists BiP in Sec61 channel opening) led to increased Ca2+ leakage via Sec6 complex, thereby phenocopying the effect of BiP depletion. Thus, BiP facilitates Sec61 channel closure (i.e. limits ER Ca2+ leakage) via the Sec61 channel with the help of ERj3 and ERj6. Interestingly, deletion of ERj6 causes pancreatic beta-cell failure and diabetes in mice and humans. We suggest that co-chaperone-controlled gating of the Sec61 channel by BiP is particularly important for cells, which are highly active in protein secretion, and that breakdown of this regulatory mechanism can cause apoptosis and disease.	[Schorr, Stefan; Klein, Marie-Christine; Melnyk, Armin; Jung, Martin; Schaeuble, Nico; Bochen, Florian; Greiner, Markus; Lampel, Pavel; Urban, Sabine Katharina; Hassdenteufel, Sarah; Dudek, Johanna; Zimmermann, Richard] Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Gamayun, Igor; Cavalie, Adolfo] Univ Saarland, Dept Expt & Clin Pharmacol & Toxicol, D-66421 Homburg, Germany; [Wang, Qian; Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Hemmis, Birgit; Wagner, Richard] Univ Osnabruck, Div Biophys, FB Biol Chem, D-49076 Osnabruck, Germany	Saarland University; Saarland University; University of Alberta; University Osnabruck	Zimmermann, R (corresponding author), Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany.	richard.zimmermann@uks.eu	Jung, Martin/D-2207-2012; Jung, Martin/AAM-4547-2021; Hassdenteufel, Sarah/AAE-8915-2022	Jung, Martin/0000-0002-1482-7020; Jung, Martin/0000-0002-1482-7020; Hassdenteufel, Sarah/0000-0001-7243-6602; Bochen, Florian/0000-0002-1210-980X	Deutsche Forschungsgemeinschaft [FOR 967, IRTG 1830, SFB 894]; HOMFOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFOR	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR 967, IRTG 1830, and SFB 894 and by a HOMFOR grant (to M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Bies C, 1999, BIOL CHEM, V380, P1175, DOI 10.1515/BC.1999.149; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BRIGHTMAN SE, 1995, GENE, V153, P249, DOI 10.1016/0378-1119(94)00741-A; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Dudek J, 2002, EMBO J, V21, P2958, DOI 10.1093/emboj/cdf315; Dudek J, 2015, J MOL BIOL, V427, P1159, DOI 10.1016/j.jmb.2014.06.011; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Fritz JM, 2014, MOL BIOL CELL, V25, P431, DOI 10.1091/mbc.E13-06-0319; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Greiner M, 2011, INT J CANCER, V128, P2284, DOI 10.1002/ijc.25580; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hu QL, 2005, J BIOCHEM MOL BIOL, V38, P709; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lang S, 2011, JOVE-J VIS EXP, DOI 10.3791/2730; Lang S, 2011, CHANNELS, V5, P228, DOI 10.4161/chan.5.3.15314; Linxweiler M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-574; Linxweiler M, 2012, AM J PATHOL, V180, P473, DOI 10.1016/j.ajpath.2011.10.039; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Melnyk Armin, 2015, Subcell Biochem, V78, P179, DOI 10.1007/978-3-319-11731-7_9; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Ong HL, 2007, PFLUG ARCH EUR J PHY, V453, P797, DOI 10.1007/s00424-006-0163-5; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos A, 2014, ACTA NEUROPATHOL, V127, P761, DOI 10.1007/s00401-013-1224-4; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Suyama K, 2011, NEUROSCI LETT, V504, P271, DOI 10.1016/j.neulet.2011.09.045; Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Williams JM, 2013, MOL BIOL CELL, V24, P785, DOI 10.1091/mbc.E12-07-0522; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Zahedi RP, 2009, PROTEOMICS, V9, P3463, DOI 10.1002/pmic.200800722; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	72	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18621	18635		10.1074/jbc.M115.636639	http://dx.doi.org/10.1074/jbc.M115.636639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085089	Green Published, hybrid			2022-12-28	WOS:000358512100032
J	Tomasello, DL; Gancarz-Kausch, AM; Dietz, DM; Bhattacharjee, A				Tomasello, Danielle L.; Gancarz-Kausch, Amy M.; Dietz, David M.; Bhattacharjee, Arin			Transcriptional Regulation of the Sodium-activated Potassium Channel SLICK (KCNT2) Promoter by Nuclear Factor-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-NA CHANNELS; C-REL; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; MECHANISM; SURVIVAL; NEURONS; DIMERS	Although recent studies have shown the sodium-activated potassium channel SLACK (KCNT1) can contribute to neuronal excitability, there remains little information on the physiological role of the closely related SLICK (KCNT2) channel. Activation of SLICK channels may be important during pathological states such as ischemia, in which an increase in intracellular sodium and chloride can perturb membrane potential and ion homeostasis. Wehave identified two NF kappa B-binding sites within the promoter region of the human SLICK (KCNT2) and orthologous rat Slick (Kcnt2) genes, suggesting that conditions in which NF kappa B transcriptional activity is elevated promote expression of this channel. NF kappa B binding to the rat Slick promoter was confirmed in vivo by ChIP analyses, and NF kappa B was found differentially bound to the two sites. We verified NF kappa B transcriptional regulation of SLICK/Slick by mutational analyses and studying gene expression by luciferase assay in P19 cells, where NF kappa B is constitutively active. For the rat gene, activation of the Slick promoter was found to be additive in single NF kappa B mutations and synergistic in double mutations. Unexpectedly, for the human gene, NF kappa B exhibited cooperativity in activating the SLICK promoter. The human SLICK promoter constructs were then tested under hypoxic conditions in PC-12 cells, where NF kappa B is not active. Only under hypoxic conditions could luciferase activity be detected; the double NF kappa B mutant construct failed to exhibit activity. Transcriptional regulation of Slick by NF kappa B was verified in primary neurons. The Slick transcript decreased 24 h after NF kappa B inhibition. Our data show SLICK expression is predominantly under the control of NF kappa B. Because neuronal NF kappa B activation occurs during stressful stimuli such as hypoxia and injury, our findings suggest that SLICK is a neuroprotective gene.	[Tomasello, Danielle L.; Dietz, David M.; Bhattacharjee, Arin] SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA; [Gancarz-Kausch, Amy M.; Dietz, David M.; Bhattacharjee, Arin] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bhattacharjee, A (corresponding author), SUNY Buffalo, 102 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	ab68@buffalo.edu	Dietz, David/J-9458-2015; Regan, Clinton/E-6250-2012; Dietz, David/AAW-4574-2021	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Gancarz-Kausch, Amy/0000-0002-3231-9732	National Institutes of Health [NS078184]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS078184 (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Burke MA, 2003, J NEUROBIOL, V55, P191, DOI 10.1002/neu.10174; CHALAZONITIS A, 1987, P NATL ACAD SCI USA, V84, P289, DOI 10.1073/pnas.84.1.289; Chiechio S, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-20; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Deng P, 2011, J CEREBR BLOOD F MET, V31, P1823, DOI 10.1038/jcbfm.2011.88; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Garg P, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12118; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Kaltschmidt B., 2009, COLD SPRING HARB PER, V2, P1, DOI DOI 10.1101/CSHPERSPECT.A001271; KOONG AC, 1994, CANCER RES, V54, P1425; Kye MJ, 2007, MOL CELL BIOCHEM, V300, P9, DOI 10.1007/s11010-006-9320-6; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Panet H, 2001, J NEUROCHEM, V77, P391, DOI 10.1046/j.1471-4159.2001.00213.x; Paramar PN, 2006, BIOCHEM J, V394, P173, DOI 10.1042/BJ20051296; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Shah NH, 2014, J NEUROSCI, V34, P4326, DOI 10.1523/JNEUROSCI.5184-13.2014; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70	31	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18575	18583		10.1074/jbc.M115.643536	http://dx.doi.org/10.1074/jbc.M115.643536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26100633	Green Published, hybrid			2022-12-28	WOS:000358512100028
J	Camire, EJ; Grossman, JD; Thole, GJ; Fleischman, NM; Perlstein, DL				Camire, Eric J.; Grossman, John D.; Thole, Grace J.; Fleischman, Nicholas M.; Perlstein, Deborah L.			The Yeast Nbp35-Cfd1 Cytosolic Iron-Sulfur Cluster Scaffold Is an ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFD1-NBP35 COMPLEX; BACTERIAL APBC; PROTEIN; BINDING; MIND; MEMBRANE; REVEALS	Nbp35 and Cfd1 are prototypical members of the MRP/Nbp35 class of iron-sulfur (FeS) cluster scaffolds that function to assemble nascent FeS clusters for transfer to FeS-requiring enzymes. Both proteins contain a conserved NTPase domain that genetic studies have demonstrated is essential for their cluster assembly activity inside the cell. It was recently reported that these proteins possess no or very low nucleotide hydrolysis activity in vitro, and thus the role of the NTPase domain in cluster biogenesis has remained uncertain. We have reexamined the NTPase activity of Nbp35, Cfd1, and their complex. Using in vitro assays and site-directed mutagenesis, we demonstrate that the Nbp35 homodimer and the Nbp35-Cfd1 heterodimer are ATPases, whereas the Cfd1 homodimer exhibited no or very low ATPase activity. We ruled out the possibility that the observed ATP hydrolysis activity might result from a contaminating ATPase by showing that mutation of key active site residues reduced activity to background levels. Finally, we demonstrate that the fluorescent ATP analog 2'/3'-O-(N'-methylanthraniloyl)-ATP (mantATP) binds stoichiometrically to Nbp35 with a K-D = 15.6 mu M and that an Nbp35 mutant deficient in ATP hydrolysis activity also displays an increased K-D for mantATP. Together, our results demonstrate that the cytosolic iron-sulfur cluster assembly scaffold is an ATPase and pave the way for interrogating the role of nucleotide hydrolysis in cluster biogenesis by this large family of cluster scaffolding proteins found across all domains of life.	[Camire, Eric J.; Grossman, John D.; Thole, Grace J.; Fleischman, Nicholas M.; Perlstein, Deborah L.] Boston Univ, Dept Chem, Boston, MA 02114 USA	Boston University	Perlstein, DL (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave,Rm SCI299, Boston, MA 02114 USA.	dperl@bu.edu		Grossman, John/0000-0001-9586-0369; Perlstein, Deborah/0000-0002-7124-9896	Boston University; National Science Foundation [CHE1126545]	Boston University; National Science Foundation(National Science Foundation (NSF))	We thank Boston University for funding this work in the form of startup funds. We also thank Jin Gao, Mihayl Petkov, Tudor Gradinariu, Isaac Banda, and Harry Griffin for construction of clones and mutants and Xin Sun for development of the discontinuous ATPase assay and critical reading of the manuscript. The CD spectrometer was purchased under National Science Foundation Grant CHE1126545.	Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; Boyd JM, 2009, J BIOL CHEM, V284, P110, DOI 10.1074/jbc.M807003200; Fu HL, 2010, BIOCHEMISTRY-US, V49, P356, DOI 10.1021/bi901681v; Fuss JO, 2015, BBA-MOL CELL RES, V1853, P1253, DOI 10.1016/j.bbamcr.2015.01.018; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lutkenhaus J, 2012, TRENDS MICROBIOL, V20, P411, DOI 10.1016/j.tim.2012.05.002; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Pallesen LJ, 2013, J BIOL CHEM, V288, P23358, DOI 10.1074/jbc.M113.486878; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005; Zhou HJ, 2004, J BACTERIOL, V186, P1546, DOI 10.1128/JB.186.5.1546-1555.2004	28	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23793	23802		10.1074/jbc.M115.667022	http://dx.doi.org/10.1074/jbc.M115.667022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26195633	Green Published, hybrid			2022-12-28	WOS:000361816500026
J	Lyukmanova, EN; Shenkarev, ZO; Shulepko, MA; Paramonov, AS; Chugunov, AO; Janickova, H; Dolejsi, E; Dolezal, V; Utkin, YN; Tsetlin, VI; Arseniev, AS; Efremov, RG; Dolgikh, DA; Kirpichnikov, MP				Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Paramonov, Alexander S.; Chugunov, Anton O.; Janickova, Helena; Dolejsi, Eva; Dolezal, Vladimir; Utkin, Yuri N.; Tsetlin, Victor I.; Arseniev, Alexander S.; Efremov, Roman G.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.			Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BACTERIAL EXPRESSION; CONFORMATIONAL HETEROGENEITY; ALLOSTERIC MODULATION; MOLECULAR-DYNAMICS; ALPHA-NEUROTOXINS; BINDING; SNAKE; NEUROMODULATOR; RELAXATION	Weak toxin from Naja kaouthia (WTX) belongs to the group of nonconventional "three-finger" snake neurotoxins. It irreversibly inhibits nicotinic acetylcholine receptors and allosterically interacts with muscarinic acetylcholine receptors (mAChRs). Using site-directed mutagenesis, NMR spectroscopy, and computer modeling, we investigated the recombinant mutant WTX analogue (rWTX) which, compared with the native toxin, has an additional N-terminal methionine residue. In comparison with the wild-type toxin, rWTX demonstrated an altered pharmacological profile, decreased binding of orthosteric antagonist N-methylscopolamine to human M1- and M2-mAChRs, and increased antagonist binding to M3-mAChR. Positively charged arginine residues located in the flexible loop II were found to be crucial for rWTX interactions with all types of mAChR. Computer modeling suggested that the rWTX loop II protrudes to the M1-mAChR allosteric ligand-binding site blocking the entrance to the orthosteric site. In contrast, toxin interacts with M3-mAChR by loop II without penetration into the allosteric site. Data obtained provide new structural insight into the target-specific allosteric regulation of mAChRs by "three-finger" snake neurotoxins.	[Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Paramonov, Alexander S.; Chugunov, Anton O.; Utkin, Yuri N.; Tsetlin, Victor I.; Arseniev, Alexander S.; Efremov, Roman G.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Paramonov, Alexander S.; Chugunov, Anton O.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Janickova, Helena; Dolejsi, Eva; Dolezal, Vladimir] Acad Sci Czech Republ, Inst Physiol, Publ Res Inst, CR-14220 Prague, Czech Republic; [Shenkarev, Zakhar O.; Arseniev, Alexander S.; Efremov, Roman G.] Moscow Inst Phys & Technol, Inst Pereulok 9, Dolgoprudnyi 141700, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Moscow Institute of Physics & Technology	Lyukmanova, EN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya Str, Moscow 117997, Russia.	ekaterina-lyukmanova@yandex.ru	Chugunov, Anton O/D-1058-2009; Tsetlin, Victor/X-2491-2018; Dolezal, Vladimir/A-8732-2008; Janickova, Helena/Q-7211-2017; Dolejsi, Eva/G-1341-2016; Utkin, Yuri N./F-1958-2014; Utkin, Yuri/L-2952-2019; Dolejsi, Eva/AAM-9473-2020; Shenkarev, Zakhar O./P-1808-2015; Shulepko, Mikhail/N-9124-2016; Dolgikh, Dmitry A/F-2369-2014; Lyukmanova, Ekaterina/F-2340-2014; Roman, Efremov/A-7460-2014	Chugunov, Anton O/0000-0003-1331-3949; Dolezal, Vladimir/0000-0003-3412-256X; Janickova, Helena/0000-0003-0310-7893; Dolejsi, Eva/0000-0002-5845-182X; Utkin, Yuri N./0000-0002-4609-970X; Utkin, Yuri/0000-0002-4609-970X; Dolejsi, Eva/0000-0002-5845-182X; Shenkarev, Zakhar O./0000-0003-1383-3522; Lyukmanova, Ekaterina/0000-0002-9728-9407; Roman, Efremov/0000-0002-5474-4721; Shulepko, Mikhail/0000-0002-0436-2127; Kirpichnikov, Mikhail/0000-0001-8170-1607; Dolgikh, Dmitry/0000-0002-9880-7202	Russian Academy of Sciences (Program Molecular and Cellular Biology); Russian Federation [SS-1766.2014.4, YC-6310.2015.4]; Russian Foundation for Basic Research [13-04-00825, 14-04-31634]; Grant Agency of the Czech Republic [14-05696S]; Institute of Physiology of the Academy of Sciences of the Czech Republic [RVO:67985823]; Russian Scientific Foundation [14-14-00255]	Russian Academy of Sciences (Program Molecular and Cellular Biology)(Russian Academy of Sciences); Russian Federation(Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Physiology of the Academy of Sciences of the Czech Republic; Russian Scientific Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Academy of Sciences (Program Molecular and Cellular Biology), President of the Russian Federation Grants SS-1766.2014.4 and YC-6310.2015.4, Russian Foundation for Basic Research Grants 13-04-00825 and 14-04-31634, Grant Agency of the Czech Republic Grant 14-05696S (to V. D.), Institute of Physiology of the Academy of Sciences of the Czech Republic Project RVO:67985823 (to H. J., E. D., and V. D.), and Russian Scientific Foundation Project 14-14-00255 (to E. N. L., Z. O. S., M. A. S., A. S. P., A. O. C., and D. A. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P781, DOI 10.1016/B978-012164491-8/50012-9; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; Eletsky AV, 2001, RUSS J BIOORG CHEM+, V27, P72, DOI 10.1023/A:1011376918514; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He Y, 2014, PROTEIN CELL, V5, P658, DOI 10.1007/s13238-014-0086-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu JX, 2013, J BIOL CHEM, V288, P34777, DOI 10.1074/jbc.M113.503714; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Jakubik J, 2010, PHARMACEUTICALS, V3, P2838, DOI 10.3390/ph3092838; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kudryavtsev DS, 2015, J BIOL CHEM, V290, P22747, DOI 10.1074/jbc.M115.648824; Lazareno S, 1998, MOL PHARMACOL, V53, P573, DOI 10.1124/mol.53.3.573; Lyukmanova EN, 2014, ACTA NATURAE, V6, P60, DOI 10.32607/20758251-2014-6-4-60-66; Lyukmanova EN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1142, DOI 10.1134/S0006297909100101; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Mordvitsev DY, 2007, COMPUT BIOL CHEM, V31, P72, DOI 10.1016/j.compbiolchem.2007.02.011; Nirthanan S, 2003, TOXICON, V41, P397, DOI 10.1016/S0041-0101(02)00388-4; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; PILLET L, 1993, J BIOL CHEM, V268, P909; Pyrkov TV, 2007, PROTEINS, V66, P388, DOI 10.1002/prot.21122; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; RYCKAERT JP, 1975, CHEM PHYS LETT, V30, P123, DOI 10.1016/0009-2614(75)85513-8; Servent D, 2011, TOXICON, V58, P455, DOI 10.1016/j.toxicon.2011.08.004; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Utkin YN, 2001, TOXICON, V39, P921, DOI 10.1016/S0041-0101(00)00223-3; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379	47	29	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23616	23630		10.1074/jbc.M115.656595	http://dx.doi.org/10.1074/jbc.M115.656595			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242733	hybrid, Green Published			2022-12-28	WOS:000361816500013
J	Baker, SA; Lombardi, LM; Zoghbi, HY				Baker, Steven Andrew; Lombardi, Laura Marie; Zoghbi, Huda Yahya			Karyopherin alpha 3 and Karyopherin alpha 4 Proteins Mediate the Nuclear Import of Methyl-CpG Binding Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; MECP2; MUTATIONS; PHENOTYPE; LOCALIZATION; DOMAIN	Methyl-CpG binding protein 2 (MeCP2) is a nuclear protein with important roles in regulating chromatin structure and gene expression, and mutations in MECP2 cause Rett syndrome (RTT). Within the MeCP2 protein sequence, the nuclear localization signal (NLS) is reported to reside between amino acids 255-271, and certain RTT-causing mutations overlap with the MeCP2 NLS, suggesting that they may alter nuclear localization. One such mutation, R270X, is predicted to interfere with the localization of MeCP2, but recent in vivo studies have demonstrated that this mutant remains entirely nuclear. To clarify the mechanism of MeCP2 nuclear import, we isolated proteins that interact with the NLS and identified karyopherin alpha 3 (KPNA3 or Kap-alpha 3) and karyopherin alpha 4 (KPNA4 or Kap-alpha 4) as key binding partners of MeCP2. MeCP2-R270X did not interact with KPNA4, consistent with a requirement for an intact NLS in this interaction. However, this mutant retains binding to KPNA3, accounting for the normal localization of MeCP2-R270X to the nucleus. These data provide a mechanism for MeCP2 nuclear import and have implications for the design of therapeutics aimed at modulating the function of MeCP2 in RTT patients.	[Baker, Steven Andrew; Zoghbi, Huda Yahya] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Baker, Steven Andrew] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Lombardi, Laura Marie; Zoghbi, Huda Yahya] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lombardi, Laura Marie; Zoghbi, Huda Yahya] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Yahya] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Baker, Steven Andrew; Lombardi, Laura Marie; Zoghbi, Huda Yahya] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Lombardi, Laura/0000-0002-1793-7524; Zoghbi, Huda/0000-0002-0700-3349	NINDS/National Institutes of Health [NS057819, F30NS066527]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819, F30NS066527] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grants NS057819 (to H. Y. Z.) and F30NS066527 (to S. A. B.). This work was also supported by the Howard Hughes Medical Institute and services from the cores of the Baylor College of Medicine IDDRC (HD024064). The authors declare they have no conflicts of interest with the contents of this article.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Colvin L, 2004, J MED GENET, V41, P25, DOI 10.1136/jmg.2003.011130; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Heckman LD, 2014, ELIFE, V3, DOI 10.7554/eLife.02676; Huppke P, 2002, NEUROPEDIATRICS, V33, P63, DOI 10.1055/s-2002-32365; Jian L, 2005, EUR J HUM GENET, V13, P1235, DOI 10.1038/sj.ejhg.5201479; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kifayathullah LA, 2010, CYTOGENET GENOME RES, V129, P290, DOI 10.1159/000315906; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Miltenberger-Miltenyi G, 2003, HUM MUTAT, V22, P107, DOI 10.1002/humu.10243; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PAINE PL, 1972, EXP CELL RES, V74, P81, DOI 10.1016/0014-4827(72)90483-1; Pitcher MR, 2015, HUM MOL GENET, V24, P2662, DOI 10.1093/hmg/ddv030; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082	24	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22485	22493		10.1074/jbc.M115.658104	http://dx.doi.org/10.1074/jbc.M115.658104			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26245896	Green Published, hybrid			2022-12-28	WOS:000361171500016
J	Azevedo, EP; Rochael, NC; Guimaraes-Costa, AB; de Souza-Vieira, TS; Ganilho, J; Saraiva, EM; Palhano, FL; Foguel, D				Azevedo, Estefania P.; Rochael, Natalia C.; Guimaraes-Costa, Anderson B.; de Souza-Vieira, Thiago S.; Ganilho, Juliana; Saraiva, Elvira M.; Palhano, Fernando L.; Foguel, Debora			A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril-and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HYDROGEN-PEROXIDE; INNATE IMMUNITY; NITRIC-OXIDE; LUNG INJURY; COMPLEX III; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MYELOPEROXIDASE; MITOCHONDRIA; SUPEROXIDE	Neutrophils are the main defense cells of the innate immune system. Upon stimulation, neutrophils release their chromosomal DNA to trap and kill microorganisms and inhibit their dissemination. These chromatin traps are termed neutrophil extracellular traps (NETs) and are decorated with granular and cytoplasm proteins. NET release can be induced by several microorganism membrane components, phorbol 12-myristate 13-acetate as well as by amyloid fibrils, insoluble proteinaceous molecules associated with more than 40 different pathologies among other stimuli. The intracellular signaling involved in NET formation is complex and remains unclear for most tested stimuli. Herein we demonstrate that a metabolic shift toward the pentose phosphate pathway (PPP) is necessary for NET release because glucose-6-phosphate dehydrogenase (G6PD), an important enzyme from PPP, fuels NADPH oxidase with NADPH to produce superoxide and thus induce NETs. In addition, we observed that mitochondrial reactive oxygen species, which are NADPH-independent, are not effective in producing NETs. These data shed new light on how the PPP and glucose metabolism contributes to NET formation.	[Azevedo, Estefania P.; Ganilho, Juliana; Palhano, Fernando L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, BR-21941902 Rio De Janeiro, Brazil; [Rochael, Natalia C.; Guimaraes-Costa, Anderson B.; de Souza-Vieira, Thiago S.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941970 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Saraiva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941970 Rio De Janeiro, Brazil.	esaraiva@micro.ufrj.br; palhano@bioqmed.ufrj.br; foguel@bioqmed.ufrj.br	Saraiva, Elvira M/L-2864-2017; Vieira, Thiago/AAB-7097-2022; Palhano, Fernando/AAB-3144-2021; Costa, Anderson G. B./K-1059-2012; Palhano, Fernando/C-2586-2008	Saraiva, Elvira M/0000-0002-6388-5286; Palhano, Fernando/0000-0001-5336-632X; Costa, Anderson G. B./0000-0003-4582-1980; Palhano, Fernando/0000-0001-5336-632X; Foguel, Debora/0000-0001-7312-7115	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)The authors declare that they have no conflicts of interest with the contents of this article.	Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Cheng ML, 2013, FREE RADICAL RES, V47, P699, DOI 10.3109/10715762.2013.816420; Cooper PR, 2013, PERIODONTOL 2000, V63, P165, DOI 10.1111/prd.12025; Douda DN, 2014, BLOOD, V123, P597, DOI 10.1182/blood-2013-09-526707; GRAY GR, 1973, LANCET, V2, P530; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupte RS, 2011, ANTIOXID REDOX SIGN, V14, P543, DOI 10.1089/ars.2010.3207; Gyulkhandanyan AV, 2004, J NEUROCHEM, V90, P405, DOI 10.1111/j.1471-4159.2004.02489.x; HUANG FL, 1973, BIOCHIM BIOPHYS ACTA, V317, P394, DOI 10.1016/0005-2795(73)90233-X; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; LITCHFIELD WJ, 1977, INFECT IMMUN, V16, P189, DOI 10.1128/IAI.16.1.189-197.1977; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; MARTIN SP, 1955, ANN NY ACAD SCI, V59, P996, DOI 10.1111/j.1749-6632.1955.tb45997.x; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Perner A, 2003, INTENS CARE MED, V29, P642, DOI 10.1007/s00134-002-1628-4; Peyssonnaux C, 2004, CELL CYCLE, V3, P168; PLESNER L, 1974, J BIOL CHEM, V249, P1119; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; TOEWS ML, 1987, MOL PHARMACOL, V32, P737; Tsai KJ, 1998, FEBS LETT, V436, P411, DOI 10.1016/S0014-5793(98)01174-0; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Worthington K., 1988, WORTHINGTON MANUAL E, P159; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	40	107	109	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22174	22183		10.1074/jbc.M115.640094	http://dx.doi.org/10.1074/jbc.M115.640094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198639	hybrid, Green Published			2022-12-28	WOS:000360968500034
J	Jayakar, SS; Zhou, XJ; Savechenkov, PY; Chiara, DC; Desai, R; Bruzik, KS; Miller, KW; Cohen, JB				Jayakar, Selwyn S.; Zhou, Xiaojuan; Savechenkov, Pavel Y.; Chiara, David C.; Desai, Rooma; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			Positive and Negative Allosteric Modulation of an alpha 1 beta 3 gamma 2 gamma-Aminobutyric Acid Type A (GABA(A))Receptor by Binding to a Site in the Transmembrane Domain at the gamma(+)-beta(-) Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SUBUNIT INTERFACES; ETOMIDATE SITES; GABA RECEPTOR; CONVULSANT; IDENTIFICATION; BARBITURATE; AGONIST; DESENSITIZATION; PURIFICATION	In the process of developing safer general anesthetics, isomers of anesthetic ethers and barbiturates have been discovered that act as convulsants and inhibitors of gamma-aminobutyric acid type A receptors (GABA(A)Rs) rather than potentiators. It is unknown whether these convulsants act as negative allosteric modulators by binding to the intersubunit anesthetic-binding sites in the GABA(A)R transmembrane domain (Chiara, D. C., Jayakar, S. S., Zhou, X., Zhang, X., Savechenkov, P. Y., Bruzik, K. S., Miller, K. W., and Cohen, J. B. (2013) J. Biol. Chem. 288, 19343-19357) or to known convulsant sites in the ion channel or extracellular domains. Here, we show that S-1-methyl-5-propyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (S-mTFD-MPPB), a photoreactive analog of the convulsant barbiturate S-MPPB, inhibits alpha 1 beta 3 gamma 2 but potentiates alpha 1 beta 3 GABA(A)R responses. In the alpha 1 beta 3 gamma 2 GABA(A)R, S-mTFD-MPPB binds in the transmembrane domain with high affinity to the gamma(+)-beta(-) subunit interface site with negative energetic coupling to GABA binding in the extracellular domain at the beta(+)-alpha(-) subunit interfaces. GABA inhibits S-[H-3] mTFD-MPPB photolabeling of gamma 2Ser-280 (gamma M2-15') in this site. In contrast, within the same site GABA enhances photolabeling of beta 3Met-227 in beta M1 by an anesthetic barbiturate, R-[H-3] methyl-5-allyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (mTFD-MPAB), which differs from S-mTFD-MPPB in structure only by chirality and two hydrogens (propyl versus allyl). S-mTFD-MPPB and R-mTFD-MPAB are predicted to bind in different orientations at the gamma(+)-beta(-) site, based upon the distance in GABA(A)R homology models between gamma 2Ser-280 and beta 3Met-227. These results provide an explanation for S-mTFD-MPPB inhibition of alpha 1 beta 3 gamma 2 GABA(A)R function and provide a first demonstration that an intersubunit-binding site in the GABA(A)R transmembrane domain binds negative and positive allosteric modulators.	[Jayakar, Selwyn S.; Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Desai, Rooma; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408	National Institutes of Health from USPHS [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448 from USPHS. The authors declare that they have no conflicts of interest with the contents of the article.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Andreeva IE, 2006, BIOCHEMISTRY-US, V45, P195, DOI 10.1021/bi0516024; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BUCH HP, 1973, N-S ARCH PHARMACOL, V277, P191, DOI 10.1007/BF00501159; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; Desai R, 2013, FASEB J, V27; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; DOWNES H, 1970, J PHARMACOL EXP THER, V175, P692; Drexler B, 2011, CAN J ANESTH, V58, P178, DOI 10.1007/s12630-010-9414-1; Erkkila BE, 2008, BIOPHYS J, V94, P4299, DOI 10.1529/biophysj.107.118455; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HOLLAND KD, 1990, BRAIN RES, V516, P147, DOI 10.1016/0006-8993(90)90910-4; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kamiya Y, 1999, ANESTHESIOLOGY, V90, P1704, DOI 10.1097/00000542-199906000-00028; KOBLIN DD, 1981, ANESTH ANALG, V60, P464; KRANTZ JC, 1957, J PHARMACOL EXP THER, V121, P362; Krasowski MD, 2000, NEUROPHARMACOLOGY, V39, P1168, DOI 10.1016/S0028-3908(99)00221-X; LEEBLUNDBERG F, 1982, MOL PHARMACOL, V21, P320; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; LING ASC, 1959, J PHARMACOL EXP THER, V126, P366; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Nayak TK, 2013, P NATL ACAD SCI USA, V110, P13654, DOI 10.1073/pnas.1308247110; Patel P.M., 2011, GOODMAN GILMANS PHAR, P527; Prince RJ, 1999, J BIOL CHEM, V274, P19623, DOI 10.1074/jbc.274.28.19623; QUAST U, 1983, J NEUROCHEM, V41, P418, DOI 10.1111/j.1471-4159.1983.tb04758.x; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Sigel E, 2005, MED CHEM REV ONLINE, V2, P251, DOI [10.2174/1567203054065673, DOI 10.2174/1567203054065673]; TICKU MK, 1985, EUR J PHARMACOL, V112, P1, DOI 10.1016/0014-2999(85)90232-8; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	48	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23432	23446		10.1074/jbc.M115.672006	http://dx.doi.org/10.1074/jbc.M115.672006			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229099	Green Published, hybrid			2022-12-28	WOS:000361685500047
J	Remacle, AG; Kumar, S; Motamedchaboki, K; Cieplak, P; Hullugundi, S; Dolkas, J; Shubayev, VI; Strongin, AY				Remacle, Albert G.; Kumar, Sonu; Motamedchaboki, Khatereh; Cieplak, Piotr; Hullugundi, Swathi; Dolkas, Jennifer; Shubayev, Veronica I.; Strongin, Alex Y.			Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE LIBRARIES; CHANNELOPATHIES; INSENSITIVITY; MUTATIONS; TARGETS	Congenital insensitivity to pain (CIP) or congenital analgesia is a rare monogenic hereditary condition. This disorder is characterized by the inability to perceive any form of pain. Nonsense mutations in Nav. 1.7, the main pain signaling voltage-gated sodium channel, lead to its truncations and, consequently, to the inactivation of the channel functionality. However, a non-truncating homozygously inherited missense mutation in a Bedouin family with CIP (Nav1.7-R907Q) has also been reported. Based on our currently acquired in-depth knowledge of matrix metalloproteinase (MMP) cleavage preferences, we developed the specialized software that predicts the presence of the MMP cleavage sites in the peptide sequences. According to our in silico predictions, the peptide sequence of the exposed extracellular unstructured region linking the S5-S6 transmembrane segments in the DII domain of the human Nav1.7 sodium channel is highly sensitive to MMP-9 proteolysis. Intriguingly, the CIP R907Q mutation overlaps with the predicted MMP-9 cleavage site sequence. Using MMP-9 proteolysis of the wild-type, CIP, and control peptides followed by mass spectrometry of the digests, we demonstrated that the mutant sequence is several-fold more sensitive to MMP-9 proteolysis relative to the wild type. Because of the substantial level of sequence homology among sodium channels, our data also implicate MMP proteolysis in regulating the cell surface levels of the Nav1.7, Nav1.6, and Nav1.8 channels, but not Nav1.9. It is likely that the aberrantly accelerated MMP-9 proteolysis during neurogenesis is a biochemical rational for the functional inactivation in Nav1.7 and that the enhanced cleavage of the Nav1.7-R907Q mutant is a cause of CIP in the Bedouin family.	[Remacle, Albert G.; Kumar, Sonu; Motamedchaboki, Khatereh; Cieplak, Piotr; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Hullugundi, Swathi; Dolkas, Jennifer; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Hullugundi, Swathi; Dolkas, Jennifer; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Hullugundi, Swathi/I-6281-2019; Kumar, Sonu/GZA-9110-2022; Kumar, Sonu/AAH-2962-2019; Regan, Clinton/E-6250-2012; Kumar, Sonu/AAA-1746-2019	Strongin, Alex/0000-0003-3765-3016; Kumar, Sonu/0000-0003-0423-2880; hullugundi, swathi/0000-0003-0697-9988	National Institutes of Health [R01 DE022757, RO1 CA157328, R01 GM098835]; Department of Veterans Affairs [5I01BX000638]; NATIONAL CANCER INSTITUTE [R01CA157328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098835] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported, in whole or in part, by National Institutes of Health Grants R01 DE022757 (to V. I. S. and A. Y. S.), RO1 CA157328 (to A. Y. S.) and R01 GM098835 (to P. C.). The work was also supported by Department of Veterans Affairs Merit Review Award 5I01BX000638 (to V. I. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brouwer BA, 2014, J PERIPHER NERV SYST, V19, P53, DOI 10.1111/jns5.12071; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kukreja M, 2015, CHEM BIOL, V22, P1122, DOI 10.1016/j.chembiol.2015.07.008; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Tsai CJ, 2013, J MOL BIOL, V425, P4074, DOI 10.1016/j.jmb.2013.06.036; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Waxman SG, 2014, LANCET NEUROL, V13, P1152, DOI 10.1016/S1474-4422(14)70150-4	30	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22939	22944		10.1074/jbc.C115.671107	http://dx.doi.org/10.1074/jbc.C115.671107			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26283785	hybrid, Green Published			2022-12-28	WOS:000361685500007
J	Datta, D; Anbarasu, K; Rajabather, S; Priya, RS; Desai, P; Mahalingam, S				Datta, Debduti; Anbarasu, Kumaraswamy; Rajabather, Suryaraja; Priya, Rangasamy Sneha; Desai, Pavitra; Mahalingam, Sundarasamy			Nucleolar GTP-binding Protein-1 (NGP-1) Promotes G(1) to S Phase Transition by Activating Cyclin-dependent Kinase Inhibitor p21(Cip1/Waf1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; E2F transcription factor; mouse double minute 2 homolog (Mdm2); p53; tumor cell biology	HUMAN BREAST-CARCINOMA; HUMAN MYC PROMOTER; CELL-CYCLE; DNA-DAMAGE; TYROSINE PHOSPHORYLATION; STEM/PROGENITOR CELLS; ABERRANT EXPRESSION; HUMAN MALIGNANCIES; CDK INHIBITORS; GASTRIC-CANCER	Background: Breast cancer autoantigen nucleolar GTP-binding protein-1 (NGP-1) is overexpressed in cancers. Results: NGP-1 promotes G(1) to S phase transition by modulating the p53/p21 pathway. Conclusion: CDK inhibitor, p21, enhances cell proliferation in certain situations. Significance: This study provides evidence that p21 induces cell proliferation in addition to its traditional tumor suppressor function. Nucleolar GTP-binding protein (NGP-1) is overexpressed in various cancers and proliferating cells, but the functional significance remains unknown. In this study, we show that NGP-1 promotes G(1) to S phase transition of cells by enhancing CDK inhibitor p21(Cip-1/Waf1) expression through p53. In addition, our results suggest that activation of the cyclin D1-CDK4 complex by NGP-1 via maintaining the stoichiometry between cyclin D1-CDK4 complex and p21 resulted in hyperphosphorylation of retinoblastoma protein at serine 780 (p-RBSer-780) followed by the up-regulation of E2F1 target genes required to promote G(1) to S phase transition. Furthermore, our data suggest that ribosomal protein RPL23A interacts with NGP-1 and abolishes NGP-1-induced p53 activity by enhancing Mdm2-mediated p53 polyubiquitination. Finally, reduction of p-RBSer-780 levels and E2F1 target gene expression upon ectopic expression of RPL23a resulted in arrest at the G(1) phase of the cell cycle. Collectively, this investigation provides evidence that NGP-1 promotes cell cycle progression through the activation of the p53/p21(Cip-1/Waf1) pathway.	[Datta, Debduti; Anbarasu, Kumaraswamy; Rajabather, Suryaraja; Priya, Rangasamy Sneha; Desai, Pavitra; Mahalingam, Sundarasamy] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Lab Mol Virol & Cell Biol,Natl Canc Tissue Bioban, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mahalingam, S (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Lab Mol Virol & Cell Biol,Natl Canc Tissue Bioban, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in	Kumaraswamy, Anbarasu/Q-2208-2019	Kumaraswamy, Anbarasu/0000-0002-9997-7430; Mahalingam, Sundarasamy/0000-0003-4460-3949	Department of Science and Technology from the Government of India [VI-D&P/411/2012-2013/TDT(G)]; Council of Scientific and Industrial Research, Government of India	Department of Science and Technology from the Government of India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology Grant VI-D&P/411/2012-2013/TDT(G) from the Government of India (to S. M.) and a graduate fellowship from the Council of Scientific and Industrial Research, Government of India (to D. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aaltomaa S, 1999, PROSTATE, V39, P8; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adrover E, 1999, BRIT J CANCER, V81, P122, DOI 10.1038/sj.bjc.6690660; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Bahl R, 2000, ONCOGENE, V19, P323, DOI 10.1038/sj.onc.1203325; Balbin M, 1996, J BIOL CHEM, V271, P15782, DOI 10.1074/jbc.271.26.15782; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Biankin AV, 2001, CANCER RES, V61, P8830; Bockstaele L, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-25; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cazier JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4756; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chennupati V, 2011, BIOCHEMISTRY-US, V50, P4521, DOI 10.1021/bi200425b; Cheung TH, 2001, CANCER LETT, V172, P93, DOI 10.1016/S0304-3835(01)00624-3; COLES C, 1992, CANCER RES, V52, P5291; Dai M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3441; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge R. M., 1998, PROGNOSTIC VARIABLES, P169; Essers PB, 2014, DEV BIOL, V385, P304, DOI 10.1016/j.ydbio.2013.10.029; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ferrandina G, 2000, INT J ONCOL, V17, P1231; Geng Y, 1996, ONCOGENE, V12, P1173; GILLETT C, 1994, CANCER RES, V54, P1812; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JAKESZ R, 1984, CANCER RES, V44, P619; Jinno S, 1999, ONCOGENE, V18, P565, DOI 10.1038/sj.onc.1202347; JUNG JM, 1995, ONCOGENE, V11, P2021; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kumar PR, 2003, J MOL BIOL, V331, P1141, DOI 10.1016/s0022-2836(03)00853-3; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; Liu SJ, 2004, WORLD J GASTROENTERO, V10, P1246; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Meng L, 2011, ONCOGENE, V30, P1716, DOI 10.1038/onc.2010.550; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Paridaen JTML, 2011, DEV BIOL, V355, P286, DOI 10.1016/j.ydbio.2011.04.028; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Racevskis J, 1996, CELL GROWTH DIFFER, V7, P271; Ralhan R, 2000, CLIN CANCER RES, V6, P2440; Rey MJ, 1998, J PATHOL, V184, P265, DOI 10.1002/(SICI)1096-9896(199803)184:3<265::AID-PATH8>3.0.CO;2-8; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shiohara M, 1997, LEUKEMIA LYMPHOMA, V26, P35, DOI 10.3109/10428199709109155; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Takahashi Y, 2000, GENE DEV, V14, P804; TAMURA G, 1991, CANCER RES, V51, P3056; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TERADA Y, 1995, NATURE, V376, P358, DOI 10.1038/376358a0; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zhang Y., 2011, ONCOTARGET, V2, P234	83	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21536	21552		10.1074/jbc.M115.637280	http://dx.doi.org/10.1074/jbc.M115.637280			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26203195	hybrid, Green Published			2022-12-28	WOS:000360637600028
J	Kraus, A; Anson, KJ; Raymond, LD; Martens, C; Groveman, BR; Dorward, DW; Caughey, B				Kraus, Allison; Anson, Kelsie J.; Raymond, Lynne D.; Martens, Craig; Groveman, Bradley R.; Dorward, David W.; Caughey, Byron			Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; prion; prion disease; protein folding; protein structure; GSS; lysine; proline	IN-VITRO; TRANSGENIC MICE; HYDROGEN/DEUTERIUM EXCHANGE; ALZHEIMERS-DISEASE; PRP AMYLOIDS; MOUSE-BRAIN; SCRAPIE; MUTATION; CONFORMATION; MECHANISM	Background: We investigated how pathogenic prion protein mutations P102L and P105L lead to misfolding. Results: Mutations of these proline and adjacent lysine residues accelerated in vitro formation of amyloid with properties reminiscent of PrPSc. Conclusion: Specific proline and lysine residues might delay spontaneous prion disease by hindering PrP conversion into amyloid. Significance: These findings suggest mechanisms for genetic prion diseases. Human prion diseases can have acquired, sporadic, or genetic origins, each of which results in the conversion of prion protein (PrP) to transmissible, pathological forms. The genetic prion disease Gerstmann-Straussler-Scheinker syndrome can arise from point mutations of prolines 102 or 105. However, the structural effects of these two prolines, and mutations thereof, on PrP misfolding are not well understood. Here, we provide evidence that individual mutations of Pro-102 or Pro-105 to noncyclic aliphatic residues such as the Gerstmann-Straussler-Scheinker-linked leucines can promote the in vitro formation of PrP amyloid with extended protease-resistant cores reminiscent of infectious prions. This effect was enhanced by additional charge-neutralizing mutations of four nearby lysine residues comprising the so-called central lysine cluster. Substitution of these proline and lysine residues accelerated PrP conversion such that spontaneous amyloid formation was no longer slower than scrapie-seeded amyloid formation. Thus, Pro-102 and Pro-105, as well as the lysines in the central lysine cluster, impede amyloid formation by PrP, implicating these residues as key structural modulators in the conversion of PrP to disease-associated types of amyloid.	[Kraus, Allison; Anson, Kelsie J.; Raymond, Lynne D.; Groveman, Bradley R.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA; [Martens, Craig; Dorward, David W.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	bcaughey@nih.gov			National Institutes of Health Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIAID. The authors declare that they have no conflicts of interest with the contents of this article.	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Biljan I, 2011, J MOL BIOL, V412, P660, DOI 10.1016/j.jmb.2011.07.067; Cappai R, 1999, BIOCHEMISTRY-US, V38, P3280, DOI 10.1021/bi982328z; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY B, 1988, P NATL ACAD SCI USA, V85, P4657, DOI 10.1073/pnas.85.13.4657; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; GHETTI B, 2003, NEURODEGENERATION MO, P318; Groveman BR, 2015, J BIOL CHEM, V290, P1119, DOI 10.1074/jbc.M114.619627; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Inouye H, 2000, J MOL BIOL, V300, P1283, DOI 10.1006/jmbi.2000.3926; IRONSIDE JW, 2008, GREENFIELDS NEUROPAT, P1197; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Lu PJ, 1999, NATURE, V399, P784; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Noble GP, 2015, BIOCHEMISTRY-US, V54, P1180, DOI 10.1021/bi501495j; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rogaeva E, 2006, ARCH NEUROL-CHICAGO, V63, P1016, DOI 10.1001/archneur.63.7.1016; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tunnell E, 2008, NEUROLOGY, V71, P1431, DOI 10.1212/01.wnl.0000330237.94742.fa; Wan W, 2015, BIOPHYS J, V108, P1548, DOI 10.1016/j.bpj.2015.01.008; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	47	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21510	21522		10.1074/jbc.M115.665844	http://dx.doi.org/10.1074/jbc.M115.665844			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175152	Green Published, hybrid			2022-12-28	WOS:000360637600026
J	Weiss, SC; Skerra, A; Schiefner, A				Weiss, Simon C.; Skerra, Arne; Schiefner, Andre			Structural Basis for the Interconversion of Maltodextrins by MalQ, the Amylomaltase of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; enzyme mechanism; Escherichia coli (E; coli); protein crystallization; x-ray crystallography; acarbose; enzymatically derived inhibitor; maltose; maltodextrin metabolism	LARGE CYCLIC GLUCANS; ENZYME AMYLOMALTASE; MALTOSE UTILIZATION; THERMUS-AQUATICUS; METABOLISM; BINDING; SYSTEM; 4-ALPHA-GLUCANOTRANSFERASE; PHOSPHORYLASE; INTERMEDIATE	Background: Amylomaltase MalQ catalyzes the transglycosylation of maltose and maltodextrins in E. coli. Results: Three different x-ray structures and the product equilibrium concentrations for different substrates were determined. Conclusion: MalQ undergoes major conformational changes during catalysis, and its product spectrum depends on substrate chain length. Significance: Novel insights into the MalQ mechanism and its key role for maltose metabolism in E. coli were obtained. Amylomaltase MalQ is essential for the metabolism of maltose and maltodextrins in Escherichia coli. It catalyzes transglycosylation/disproportionation reactions in which glycosyl or dextrinyl units are transferred among linear maltodextrins of various lengths. To elucidate the molecular basis of transglycosylation by MalQ, we have determined three crystal structures of this enzyme, i.e. the apo-form, its complex with maltose, and an inhibitor complex with the transition state analog acarviosine-glucose-acarbose, at resolutions down to 2.1 angstrom. MalQ represents the first example of a mesophilic bacterial amylomaltase with known structure and exhibits an N-terminal extension of about 140 residues, in contrast with previously described thermophilic enzymes. This moiety seems unique to amylomaltases from Enterobacteriaceae and folds into two distinct subdomains that associate with different parts of the catalytic core. Intriguingly, the three MalQ crystal structures appear to correspond to distinct states of this enzyme, revealing considerable conformational changes during the catalytic cycle. In particular, the inhibitor complex highlights the requirement of both a 3-OH group and a 4-OH group (or 1-4-glycosidic bond) at the acceptor subsite +1 for the catalytically competent orientation of the acid/base catalyst Glu-496. Using an HPLC-based MalQ enzyme assay, we could demonstrate that the equilibrium concentration of maltodextrin products depends on the length of the initial substrate; with increasing numbers of glycosidic bonds, less glucose is formed. Thus, both structural and enzymatic data are consistent with the extremely low hydrolysis rates observed for amylomaltases and underline the importance of MalQ for the metabolism of maltodextrins in E. coli.	[Weiss, Simon C.; Skerra, Arne; Schiefner, Andre] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany	Technical University of Munich	Schiefner, A (corresponding author), Tech Univ Munich, Lehrstuhl Biol Chem, Emil Erlenmeyer Forum 5, D-85350 Freising Weihenstephan, Germany.	schiefner@wzw.tum.de	Skerra, Arne/A-2269-2013	Schiefner, Andre/0000-0001-5215-4122; Skerra, Arne/0000-0002-5717-498X	Deutsche Forschungsgemeinschaft [SCHI1 105/2-1]; Helmholtz-Zentrum Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Zentrum Berlin(Helmholtz Association)	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHI1 105/2-1 and Helmholtz-Zentrum Berlin. The authors declare that they have no conflict of interest with the contents of this article.	ALBER T, 1981, PHILOS T ROY SOC B, V293, P159, DOI 10.1098/rstb.1981.0069; AVIGAD G, 1977, J CHROMATOGR, V139, P343, DOI 10.1016/S0021-9673(00)89330-9; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BECKER S, 1994, J BIOL CHEM, V269, P2485; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Carvalho CC, 2015, BIOPOLYMERS, V103, P203, DOI 10.1002/bip.22584; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dippel R, 2005, J BACTERIOL, V187, P8332, DOI 10.1128/JB.187.24.8332-8339.2005; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Eckert K, 2009, J MOL BIOL, V394, P61, DOI 10.1016/j.jmb.2009.08.060; EHRMANN M, 1987, J BACTERIOL, V169, P3539, DOI 10.1128/jb.169.8.3539-3545.1987; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FREUNDLIEB S, 1988, J BIOL CHEM, V263, P314; GOLDBERG RN, 1991, BIOPHYS CHEM, V40, P69, DOI 10.1016/0301-4622(91)85030-T; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kartal O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.76; Lengsfeld C, 2009, J BACTERIOL, V191, P701, DOI 10.1128/JB.00767-08; LIEBL W, 1992, EUR J BIOCHEM, V207, P81, DOI 10.1111/j.1432-1033.1992.tb17023.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1950, Ann Inst Pasteur (Paris), V78, P65; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakatani H, 1999, BIOPOLYMERS, V50, P145, DOI 10.1002/(SICI)1097-0282(199908)50:2<145::AID-BIP3>3.3.CO;2-U; OReilly M, 1997, NAT STRUCT BIOL, V4, P405, DOI 10.1038/nsb0597-405; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PALMER TN, 1976, EUR J BIOCHEM, V69, P105, DOI 10.1111/j.1432-1033.1976.tb10863.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; PUGSLEY AP, 1988, MOL MICROBIOL, V2, P473, DOI 10.1111/j.1365-2958.1988.tb00053.x; Ruzanski C, 2013, J BIOL CHEM, V288, P28581, DOI 10.1074/jbc.M113.497867; Schwartz M, 1987, ESCHERICHIA COLI SAL, P1482; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; WIESMEYER H, 1960, BIOCHIM BIOPHYS ACTA, V39, P417, DOI 10.1016/0006-3002(60)90194-3; WIESMEYER H, 1960, BIOCHIM BIOPHYS ACTA, V39, P427, DOI 10.1016/0006-3002(60)90195-5; Xia T, 2015, APPL ENVIRON MICROB, V81, P3387, DOI 10.1128/AEM.04058-14	45	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21352	21364		10.1074/jbc.M115.667337	http://dx.doi.org/10.1074/jbc.M115.667337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26139606	hybrid, Green Published			2022-12-28	WOS:000360637600013
J	Durham, TB; Toth, JL; Klimkowski, VJ; Cao, JXC; Siesky, AM; Alexander-Chacko, J; Wu, GY; Dixon, JT; Mcgee, JE; Wang, Y; Guo, SY; Cavitt, RN; Schindler, J; Thibodeaux, SJ; Calvert, NA; Coghlan, MJ; Sindelar, DK; Christe, M; Kiselyov, VV; Michael, MD; Sloop, KW				Durham, Timothy B.; Toth, James L.; Klimkowski, Valentine J.; Cao, Julia X. C.; Siesky, Angela M.; Alexander-Chacko, Jesline; Wu, Ginger Y.; Dixon, Jeffrey T.; Mcgee, James E.; Wang, Yong; Guo, Sherry Y.; Cavitt, Rachel Nicole; Schindler, John; Thibodeaux, Stefan J.; Calvert, Nathan A.; Coghlan, Michael J.; Sindelar, Dana K.; Christe, Michael; Kiselyov, Vladislav V.; Michael, M. Dodson; Sloop, Kyle W.			Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE; IDE; PEPTIDE; SOMATOSTATIN; DEGRADATION; METABOLISM; SECRETION; RECOGNITION; PATHWAYS; PROTEIN	Insulin-degrading enzyme (IDE, insulysin) is the best characterized catabolic enzyme implicated in proteolysis of insulin. Recently, a peptide inhibitor of IDE has been shown to affect levels of insulin, amylin, and glucagon in vivo. However, IDE-/- mice display variable phenotypes relating to fasting plasma insulin levels, glucose tolerance, and insulin sensitivity depending on the cohort and age of animals. Here, we interrogated the importance of IDE-mediated catabolism on insulin clearance in vivo. Using a structure-based design, we linked two newly identified ligands binding at unique IDE exosites together to construct a potent series of novel inhibitors. These compounds do not interact with the catalytic zinc of the protease. Because one of these inhibitors (NTE-1) was determined to have pharmacokinetic properties sufficient to sustain plasma levels >50 times its IDE IC50 value, studies in rodents were conducted. In oral glucose tolerance tests with diet-induced obese mice, NTE-1 treatment improved the glucose excursion. Yet in insulin tolerance tests and euglycemic clamp experiments, NTE-1 did not enhance insulin action or increase plasma insulin levels. Importantly, IDE inhibition with NTE-1 did result in elevated plasma amylin levels, suggesting the in vivo role of IDE action on amylin may be more significant than an effect on insulin. Furthermore, using the inhibitors described in this report, we demonstrate that in HEK cells IDE has little impact on insulin clearance. In total, evidence from our studies supports a minimal role for IDE in insulin metabolism in vivo and suggests IDE may be more important in helping regulate amylin clearance.	[Durham, Timothy B.; Toth, James L.; Klimkowski, Valentine J.; Dixon, Jeffrey T.; Mcgee, James E.; Wang, Yong; Guo, Sherry Y.; Cavitt, Rachel Nicole; Schindler, John; Coghlan, Michael J.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA; [Cao, Julia X. C.; Siesky, Angela M.; Alexander-Chacko, Jesline; Wu, Ginger Y.; Sindelar, Dana K.; Christe, Michael; Kiselyov, Vladislav V.; Michael, M. Dodson; Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA; [Thibodeaux, Stefan J.] Eli Lilly & Co, Lilly Res Labs, Translat Sci & Technol, Indianapolis, IN 46285 USA; [Calvert, Nathan A.] Eli Lilly & Co, Lilly Res Labs, Drug Disposit, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Durham, TB (corresponding author), Lilly Res Labs, Discovery Chem Res & Technol, Drop Code 1920, Indianapolis, IN 46285 USA.	durham_timothy_barrett@lilly.com		Michael, Mervyn/0000-0002-0224-1065				Abdul-Hay SO, 2013, J MED CHEM, V56, P2246, DOI 10.1021/jm301280p; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; ALBERTI KGM, 1973, LANCET, V2, P1299; Amata O, 2009, J AM CHEM SOC, V131, P14804, DOI 10.1021/ja9037142; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Beck B., 2004, ASSAY GUIDANCE MANUA; Bennett RG, 1997, DIABETES, V46, P197, DOI 10.2337/diabetes.46.2.197; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Cakir B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031787; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Duckworth WC, 1997, BBA-MOL CELL RES, V1358, P163, DOI 10.1016/S0167-4889(97)00066-9; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; EFENDIC S, 1974, FEBS LETT, V42, P169, DOI 10.1016/0014-5793(74)80778-7; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fawcett J, 2010, BIOCHEM BIOPH RES CO, V402, P762, DOI 10.1016/j.bbrc.2010.10.104; GERICH JE, 1974, DIABETES, V23, P876, DOI 10.2337/diab.23.11.876; Godfrey A. G., 2011, 42 CENTR REG M AM CH; Grasso G, 2009, J MASS SPECTROM, V44, P735, DOI 10.1002/jms.1550; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; KUO WL, 1991, MOL ENDOCRINOL, V5, P1467, DOI 10.1210/mend-5-10-1467; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Liu ZH, 2012, J ALZHEIMERS DIS, V29, P329, DOI 10.3233/JAD-2011-111472; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; MCCLAIN DA, 1988, DIABETES, V37, P806, DOI 10.2337/diabetes.37.6.806; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Morita M, 2000, CELL STRUCT FUNCT, V25, P309, DOI 10.1247/csf.25.309; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; Noinaj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020864; OZAKI S, 1983, ENDOCRINOLOGY, V112, P381, DOI 10.1210/endo-112-1-381; Pak S. C., 1998, P 15 ESACT M TOURS F, P59; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Ralat LA, 2011, J BIOL CHEM, V286, P4670, DOI 10.1074/jbc.M110.173252; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046790; Song ES, 2006, BIOCHEMISTRY-US, V45, P15085, DOI 10.1021/bi061298u; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; YONEZAWA K, 1988, BIOCHEM BIOPH RES CO, V150, P605, DOI 10.1016/0006-291X(88)90436-6; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	49	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20044	20059		10.1074/jbc.M115.638205	http://dx.doi.org/10.1074/jbc.M115.638205			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26085101	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000359608900004
J	Matsumoto, S; Nakao, H; Kawabe, K; Nonaka, M; Toyoda, H; Takishima, Y; Kawabata, K; Yamaguchi, T; Furue, MK; Taki, T; Okumura, T; Yamazaki, Y; Nakaya, S; Kawasaki, N; Kawasaki, T				Matsumoto, Shogo; Nakao, Hiromi; Kawabe, Keiko; Nonaka, Motohiro; Toyoda, Hidenao; Takishima, Yuto; Kawabata, Kenji; Yamaguchi, Tomoko; Furue, Miho K.; Taki, Takao; Okumura, Takeshi; Yamazaki, Yuzo; Nakaya, Shuuichi; Kawasaki, Nobuko; Kawasaki, Toshisuke			A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TERATOCARCINOMA CELLS; EMBRYONAL CARCINOMA-CELLS; 3 MONOCLONAL-ANTIBODIES; LECTIN MICROARRAY; DIFFERENTIATION; GLYCOSPHINGOLIPIDS; APOPTOSIS; ANTIGENS; SERIES; BIOMARKERS	We have generated a mouse monoclonal antibody (R-17F, IgG1 subtype) specific to human induced pluripotent stem (hiPS)/embryonic stem (ES) cells by using a hiPS cell line as an antigen. Triple-color confocal immunostaining images of hiPS cells with R-17F indicated that the R-17F epitope was expressed exclusively and intensively on the cell membranes of hiPS cells and co-localized partially with those of SSEA-4 and SSEA-3. Lines of evidence suggested that the predominant part of the R-17F epitope was a glycolipid. Upon TLC blot of total lipid extracts from hiPS cells with R-17F, one major R-17F-positive band was observed at a slow migration position close to that of anti-blood group H1(O) antigen. MALDI-TOF-MS and MSn analyses of the purified antigen indicated that the presumptive structure of the R-17F antigen was Fuc-Hex-HexNAc-Hex-Hex-Cer. Glycan microarray analysis involving 13 different synthetic oligosaccharides indicated that R-17F bound selectively to LNFP I (Fuc alpha 1-2Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc). Acritical role of the terminal Fuc alpha 1-2 residue was confirmed by the selective disappearance of R-17F binding to the purified antigen upon alpha 1-2 fucosidase digestion. Most interestingly, R-17F, when added to hiPS/ES cell suspensions, exhibited potent dose-dependent cytotoxicity. The cytotoxic effect was augmented markedly upon the addition of the secondary antibody (goat anti-mouse IgG1 antibody). R-17F may be beneficial for safer regenerative medicine by eliminating residual undifferentiated hiPS cells in hiPS-derived regenerative tissues, which are considered to be a strong risk factor for carcinogenesis.	[Matsumoto, Shogo; Nakao, Hiromi; Kawabe, Keiko; Nonaka, Motohiro; Kawasaki, Nobuko; Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga 5258577, Japan; [Kawabe, Keiko; Furue, Miho K.] Natl Inst Biomed Innovat Hlth & Nutr, Lab Stem Cell Cultures, Osaka 5670085, Japan; [Kawabata, Kenji; Yamaguchi, Tomoko] Natl Inst Biomed Innovat Hlth & Nutr, Lab Stem Cell Regulat, Osaka 5670085, Japan; [Toyoda, Hidenao; Takishima, Yuto] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Bioanalyt Chem, Kusatsu, Shiga 5258577, Japan; [Taki, Takao] Niigata Univ Pharm & Appl Life Sci, Niigata 9560841, Japan; [Taki, Takao] AGT&T Co Ltd, Tokushima 7711151, Japan; [Okumura, Takeshi; Yamazaki, Yuzo; Nakaya, Shuuichi] Shimadzu Co Ltd, Analyt & Measuring Instruments Div, Kyoto 6048511, Japan	Ritsumeikan University; Ritsumeikan University; Niigata University; Shimadzu Corporation	Kawasaki, T (corresponding author), Ritsumeikan Univ, Res Ctr Glycobiotechnol, Noji Higashi 1-1-1, Kusatsu, Shiga 5258577, Japan.	tkawasak@fc.ritsumei.ac.jp		Furue, Miho/0000-0001-5032-9953	Japan Society for the Promotion of Science [24570171, 24110517]; Adaptable and Seamless Technology Transfer Program through target-driven R&D from the Japan Science and Technology Agency [AS242Z01520P, AS251Z01560P]; Ministry of Health, Labor, and Welfare; Ritsumeikan University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program through target-driven R&D from the Japan Science and Technology Agency; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ritsumeikan University	This work was supported by Grants-in-Aid for Scientific Research C 24570171 (to T. K.) and for Scientific Research on Innovative Areas 24110517 (to T. K.) from the Japan Society for the Promotion of Science. This work was also supported by the Adaptable and Seamless Technology Transfer Program through target-driven R&D AS242Z01520P (to T. K.) and AS251Z01560P (to H. T.) from the Japan Science and Technology Agency; Grants-in-Aid for Research on Regenerative Medicine for Clinical Application (to M. K. F. and T. K.) from the Ministry of Health, Labor, and Welfare; and Grants-in-Aid for the R-GIRO (Ritsumeikan Global Innovation Research Organization) Program (to H. T.) from Ritsumeikan University. The authors declare that they have no conflicts of interest with the contents of this article.	Andrews PW, 2011, NAT BIOTECHNOL, V29, P803, DOI 10.1038/nbt.1974; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; COOPER S, 1992, BIOCHEM J, V286, P959, DOI 10.1042/bj2860959; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Itskovitz-Eldor J, 2011, CELL STEM CELL, V9, P291, DOI 10.1016/j.stem.2011.09.005; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kawabe K, 2013, GLYCOBIOLOGY, V23, P322, DOI 10.1093/glycob/cws159; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; MAJNO G, 1995, AM J PATHOL, V146, P3; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Nakamura K, 2006, ANAL CHEM, V78, P5736, DOI 10.1021/ac0605501; Okuda S., 2014, GLYCOSCI BIOL MED, DOI [10.1007/978-4-431-54836-2_27-1, DOI 10.1007/978-4-431-54836-2_27-1]; PERA MF, 1988, DIFFERENTIATION, V39, P139, DOI 10.1111/j.1432-0436.1988.tb00089.x; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taki T, 1997, ANAL BIOCHEM, V251, P135, DOI 10.1006/abio.1997.2247; Taki T, 2009, METHODS MOL BIOL, V536, P545, DOI 10.1007/978-1-59745-542-8_55; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wright AJ, 2009, STEM CELL RES, V3, P3, DOI 10.1016/j.scr.2009.04.001; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yu Y, 2012, J BIOL CHEM, V287, P44784, DOI 10.1074/jbc.M112.425819	39	20	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20071	20085		10.1074/jbc.M115.657692	http://dx.doi.org/10.1074/jbc.M115.657692			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26100630	Green Published, hybrid			2022-12-28	WOS:000359608900006
J	Jazayeri, A; Dias, JM; Marshall, FH				Jazayeri, Ali; Dias, Joao M.; Marshall, Fiona H.			From G Protein-coupled Receptor Structure Resolution to Rational Drug Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ADENOSINE A(2A) RECEPTOR; CRYSTAL-STRUCTURE; DYNAMIC PROCESS; LIGAND-BINDING; DISCOVERY; INSIGHTS; AGONIST; COMPLEX; IDENTIFICATION; ANTAGONISTS	A number of recent technical solutions have led to significant advances in G protein-coupled receptor (GPCR) structural biology. Apart from a detailed mechanistic view of receptor activation, the new structures have revealed novel ligand binding sites. Together, these insights provide avenues for rational drug design to modulate the activities of these important drug targets. The application of structural data to GPCR drug discovery ushers in an exciting era with the potential to improve existing drugs and discover new ones. In this review, we focus on technical solutions that have accelerated GPCR crystallography as well as some of the salient findings from structures that are relevant to drug discovery. Finally, we outline some of the approaches used in GPCR structure based drug design.	[Jazayeri, Ali; Dias, Joao M.; Marshall, Fiona H.] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Jazayeri, A (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	ali.jazayeri@heptares.com	Marshall, Fiona/AAZ-9626-2020	Marshall, Fiona/0000-0002-8681-005X				Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bennett KA, 2013, MOL PHARMACOL, V83, P949, DOI 10.1124/mol.112.084509; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Erlanson DA, 2012, TOP CURR CHEM, V317, P1, DOI 10.1007/128_2011_180; Ghosh E, 2015, NAT REV MOL CELL BIO, V16, P69, DOI 10.1038/nrm3933; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Li J, 2013, INT J MOL SCI, V14, P22845, DOI 10.3390/ijms141122845; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Ramsey SJ, 2011, BRIT J PHARMACOL, V164, P992, DOI 10.1111/j.1476-5381.2011.01390.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Scott DJ, 2013, J MOL BIOL, V425, P662, DOI 10.1016/j.jmb.2012.11.015; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Yin J, 2015, NATURE, V519, P247, DOI 10.1038/nature14035; Yoshikawa Y, 2013, J MED CHEM, V56, P4236, DOI 10.1021/jm400307y; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	52	75	75	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19489	19495		10.1074/jbc.R115.668251	http://dx.doi.org/10.1074/jbc.R115.668251			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100628	Green Published, hybrid			2022-12-28	WOS:000359364600010
J	Linder, B; Weber, S; Dittmann, K; Adamski, J; Hahn, H; Uhmann, A				Linder, Benedikt; Weber, Susanne; Dittmann, Kai; Adamski, Jerzy; Hahn, Heidi; Uhmann, Anja			A Functional and Putative Physiological Role of Calcitriol in Patched1/Smoothened Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMA; STEROL-SENSING DOMAIN; SONIC HEDGEHOG; CHOLESTEROL HOMEOSTASIS; SIGNAL-TRANSDUCTION; VITAMIN-D; PROLIFERATION; PATHWAY; CYCLOPAMINE; MUTATIONS	The Patched1 (Ptch)-mediated inhibition of Smoothened (Smo) is still an open question. However, a direct Ptch/Smo interaction has been excluded, Smo modulators were identified, but the endogenous signal transmitting molecule remains undiscovered. Here, we demonstrate that calcitriol, the hormonally active form of vitamin D-3, is an excellent candidate for transmission of Ptch/Smo interaction. Our study reveals that Ptch expression is sufficient to release calcitriol from the cell and that calcitriol inhibits Smo action and ciliary translocation by acting on a site distinct from the 7-transmembrane domain or the cysteine-rich domain. Moreover calcitriol strongly synergizes with itraconazole (ITZ) in Smo inhibition, which did not result from elevated calcitriol bioavailability due to ITZ-mediated 24-hydroxylase inhibition but rather from a direct interaction of the compounds at the level of Smo. Together, we suggest that calcitriol represents a possible endogenous transmitter of Ptch/Smo interaction. Moreover calcitriol or calcitriol derivatives combined with ITZ might be a treatment option of Hedgehog-associated cancers.	[Linder, Benedikt; Hahn, Heidi; Uhmann, Anja] Univ Med Ctr, Inst Human Genet, Tumor Genet Grp, D-37073 Gottingen, Germany; [Weber, Susanne; Adamski, Jerzy] Univ Med Ctr, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Dittmann, Kai] Helmholtz Zentrum Muenchen, Inst Expt Genet, Dept Genome Anal Ctr, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany	University of Gottingen; University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Uhmann, A (corresponding author), Univ Med Ctr Goettingen, Inst Human Genet, Heinrich Dueker Weg 12, D-37073 Gottingen, Germany.	auhmann@gwdg.de	Linder, Benedikt/L-2516-2019	Linder, Benedikt/0000-0003-0908-571X; Adamski, Jerzy/0000-0001-9259-0199	Deutsche Forschungsgemeinschaft [UH 228/2-1, UH228/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants UH 228/2-1 and UH228/2-2 (to A. U.). The authors declare that they have no conflicts of interests with the contents of this article.	Bartik L, 2010, J NUTR BIOCHEM, V21, P1153, DOI 10.1016/j.jnutbio.2009.09.012; Bidet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023834; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen TC, 2012, ANTICANCER RES, V32, P291; Chou TC, 2005, COMPUSYN DRUG COMBIN; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Eaton S, 2008, NAT REV MOL CELL BIO, V9, P437, DOI 10.1038/nrm2414; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Ingham PW, 2000, CURR BIOL, V10, pR180, DOI 10.1016/S0960-9822(00)00346-8; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kota BP, 2011, BASIC CLIN PHARMACOL, V109, P97, DOI 10.1111/j.1742-7843.2011.00693.x; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marigo V, 1996, DEVELOPMENT, V122, P1225; Marklein D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052898; Muindi JR, 2010, ENDOCRINOLOGY, V151, P4301, DOI 10.1210/en.2009-1156; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tang JY, 2011, CANCER PREV RES, V4, P744, DOI 10.1158/1940-6207.CAPR-10-0285; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Uhmann Anja, 2012, Sarcoma, V2012, P357040, DOI 10.1155/2012/357040; Uhmann A, 2011, MOL CANCER THER, V10, P2179, DOI 10.1158/1535-7163.MCT-11-0422; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	49	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19614	19628		10.1074/jbc.M115.646141	http://dx.doi.org/10.1074/jbc.M115.646141			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26126827	Green Published, hybrid			2022-12-28	WOS:000359364600023
J	Roth, BL; Kroeze, WK				Roth, Bryan L.; Kroeze, Wesley K.			Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHARMACOLOGICAL CHARACTERIZATION; STRUCTURAL BASIS; OPIOID RECEPTOR; DRUG; DISCOVERY; AGONIST; SAFETY; FENFLURAMINE; TOLERABILITY; ANTAGONIST	G-protein-coupled receptors (GPCRs) are frequent and fruitful targets for drug discovery and development, as well as being off-targets for the side effects of a variety of medications. Much of the druggable non-olfactory human GPCR-ome remains under-interrogated, and we present here various approaches that we and others have used to shine light into these previously dark corners of the human genome.	[Roth, Bryan L.; Kroeze, Wesley K.] Univ N Carolina, Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Roth, BL (corresponding author), Univ N Carolina, Chapel Hill Sch Med, Dept Pharmacol, 4072 Genet Med Bldg,120 Mason Farms Rd, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520	National Institutes of Health [U01MH104974, U19MH82441, RO1MH61887]; NIMH Psychoactive Drug Screening Program Contract; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974, R01MH061887, U19MH082441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Psychoactive Drug Screening Program Contract; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants U01MH104974, U19MH82441, and RO1MH61887 and the NIMH Psychoactive Drug Screening Program Contract (to B. L. R.). This is the first article in the Thematic Minireview series "New Directions in G Protein-coupled Receptor Pharmacology." The authors declare that they have no conflicts of interest with the contents of this article.	Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Armbruster BN, 2005, J BIOL CHEM, V280, P5129, DOI 10.1074/jbc.R400030200; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; BARTHOLINI G, 1975, J PHARMACOL EXP THER, V193, P523; Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; Beets I, 2011, METHODS MOL BIOL, V789, P377, DOI 10.1007/978-1-61779-310-3_25; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bouyssou T, 2010, J PHARMACOL EXP THER, V334, P53, DOI 10.1124/jpet.110.167007; Bush MA, 2009, DIABETES OBES METAB, V11, P498, DOI 10.1111/j.1463-1326.2008.00992.x; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chey WD, 2014, NEW ENGL J MED, V370, P2387, DOI 10.1056/NEJMoa1310246; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Cox CD, 2010, J MED CHEM, V53, P5320, DOI 10.1021/jm100541c; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Gralla RJ, 2014, ANN ONCOL, V25, P1333, DOI 10.1093/annonc/mdu096; Gregori-Puigjane E, 2012, P NATL ACAD SCI USA, V109, P11178, DOI 10.1073/pnas.1204524109; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang XP, 2009, MOL PHARMACOL, V76, P710, DOI 10.1124/mol.109.058057; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Isserlin R, 2011, ARXIV11020448; Jenkins L, 2011, BRIT J PHARMACOL, V162, P733, DOI 10.1111/j.1476-5381.2010.01082.x; Jensen NH, 2008, COMB CHEM HIGH T SCR, V11, P420, DOI 10.2174/138620708784911483; Jin CY, 2014, ACS CHEM NEUROSCI, V5, P576, DOI 10.1021/cn500082p; Kaufmann H, 2014, NEUROLOGY, V83, P328, DOI 10.1212/WNL.0000000000000615; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kotsikorou E, 2013, BIOCHEMISTRY-US, V52, P9456, DOI 10.1021/bi4008885; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Laggner C, 2012, NAT CHEM BIOL, V8, P144, DOI 10.1038/nchembio.732; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lemieux GA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001712; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Lin XY, 2012, J MED CHEM, V55, P5749, DOI 10.1021/jm300338m; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Matthews JE, 2008, J CLIN ENDOCR METAB, V93, P4810, DOI 10.1210/jc.2008-1518; Meltzer HY, 2013, J CLIN INVEST, V123, P4986, DOI 10.1172/JCI70678; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rajaratnam SMW, 2009, LANCET, V373, P482, DOI 10.1016/S0140-6736(08)61812-7; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, CIRCULATION, V102, P2836; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Strachan RT, 2006, DRUG DISCOV TODAY, V11, P708, DOI 10.1016/j.drudis.2006.06.012; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; White KL, 2014, MOL PHARMACOL, V85, P83, DOI 10.1124/mol.113.089649; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746	72	56	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19471	19477		10.1074/jbc.R115.654764	http://dx.doi.org/10.1074/jbc.R115.654764			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100629	hybrid, Green Published			2022-12-28	WOS:000359364600008
J	Sasse, SK; Zuo, Z; Kadiyala, V; Zhang, LY; Pufall, MA; Jain, MK; Phang, TL; Stormo, GD; Gerber, AN				Sasse, Sarah K.; Zuo, Zheng; Kadiyala, Vineela; Zhang, Liyang; Pufall, Miles A.; Jain, Mukesh K.; Phang, Tzu L.; Stormo, Gary D.; Gerber, Anthony N.			Response Element Composition Governs Correlations between Binding Site Affinity and Transcription in Glucocorticoid Receptor Feed-forward Loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; DNA-BINDING; REGULATORY NETWORK; NUCLEAR RECEPTORS; CELL-TYPE; CHIP-SEQ; IN-VIVO; SEQUENCE; UNIT; SPECIFICITY	Combinatorial gene regulation through feed-forward loops (FFLs) can bestow specificity and temporal control to client gene expression; however, characteristics of binding sites that mediate these effects are not established. We previously showed that the glucocorticoid receptor (GR) and KLF15 form coherent FFLs that cooperatively induce targets such as the amino acid-metabolizing enzymes AASS and PRODH and incoherent FFLs exemplified by repression of MT2A by KLF15. Here, we demonstrate that GR and KLF15 physically interact and identify low affinity GR binding sites within glucocorticoid response elements (GREs) for PRODH and AASS that contribute to combinatorial regulation with KLF15. We used deep sequencing and electrophoretic mobility shift assays to derive in vitro GR binding affinities across sequence space. We applied these data to show that AASS GRE activity correlated (r(2) = 0.73) with predicted GR binding affinities across a 50-fold affinity range in transfection assays; however, the slope of the linear relationship more than doubled when KLF15 was expressed. Whereas activity of the MT2A GRE was even more strongly (r(2) = 0.89) correlated with GR binding site affinity, the slope of the linear relationship was sharply reduced by KLF15, consistent with incoherent FFL logic. Thus, GRE architecture and co-regulator expression together determine the functional parameters that relate GR binding site affinity to hormone-induced transcriptional responses. Utilization of specific affinity response functions and GR binding sites by FFLs may contribute to the diversity of gene expression patterns within GR-regulated transcriptomes.	[Sasse, Sarah K.; Kadiyala, Vineela; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Zuo, Zheng; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Zuo, Zheng; Stormo, Gary D.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Zhang, Liyang; Pufall, Miles A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Harrington Heart & Vasc Inst, Dept Med, Cleveland, OH 44106 USA; [Phang, Tzu L.; Gerber, Anthony N.] Univ Colorado, Dept Med, Denver, CO 80045 USA	National Jewish Health; Washington University (WUSTL); Washington University (WUSTL); University of Iowa; Case Western Reserve University; Case Western Reserve University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA.	gerbera@njhealth.org		Pufall, Miles/0000-0002-7022-6916	National Institutes of Health from the NCI [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ChIP-sequencing was performed at the University of Colorado Cancer Center, which is supported by National Institutes of Health Grant P30-CA046934 from the NCI. We thank David Granas for technical assistance. We thank Keith Yamamoto for the generous gift of the GR antibody and for critical review of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bain DL, 2012, J MOL BIOL, V422, P18, DOI 10.1016/j.jmb.2012.06.005; Chen SY, 2000, J BIOL CHEM, V275, P30106, DOI 10.1074/jbc.M005418200; Chinenov Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-656; Chinenov Y, 2013, MOL CELL ENDOCRINOL, V380, P55, DOI 10.1016/j.mce.2013.04.006; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; LABAER J, 1994, J MOL BIOL, V239, P664, DOI 10.1006/jmbi.1994.1405; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miranda TB, 2013, MOL CELL ENDOCRINOL, V380, P16, DOI 10.1016/j.mce.2013.03.002; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Noack C, 2012, EMBO MOL MED, V4, P992, DOI 10.1002/emmm.201101043; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Quax RA, 2013, NAT REV ENDOCRINOL, V9, P670, DOI 10.1038/nrendo.2013.183; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sasse SK, 2015, PHARMACOL THERAPEUT, V145, P85, DOI 10.1016/j.pharmthera.2014.08.004; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Scott DK, 1998, MOL ENDOCRINOL, V12, P482, DOI 10.1210/me.12.4.482; Smith CL, 2000, MOL ENDOCRINOL, V14, P956, DOI 10.1210/me.14.7.956; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Stormo GD, 2015, BRIEF FUNCT GENOMICS, V14, P30, DOI 10.1093/bfgp/elu043; Stormo Gary D, 2013, Quant Biol, V1, P115; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Tang BH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00875; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Waterman WR, 2006, MOL IMMUNOL, V43, P773, DOI 10.1016/j.molimm.2005.07.003; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Werner T, 2000, Methods Mol Biol, V132, P337; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zuo Z, 2014, GENETICS, V198, P1329, DOI 10.1534/genetics.114.170100	58	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19756	19769		10.1074/jbc.M115.668558	http://dx.doi.org/10.1074/jbc.M115.668558			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088140	Green Published, hybrid			2022-12-28	WOS:000359364600033
J	Xu, X; Xu, X; Liu, P; Zhu, ZY; Chen, J; Fu, HA; Chen, LL; Hu, LH; Shen, X				Xu, Xing; Xu, Xin; Liu, Peng; Zhu, Zhi-yuan; Chen, Jing; Fu, Hai-an; Chen, Li-li; Hu, Li-hong; Shen, Xu			Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor alpha (FXR alpha) in Stabilizing the Homodimerization of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; BILE-ACID RECEPTOR; NATURAL PRODUCT; IDENTIFICATION; LIGAND; AGONIST; OBESITY; CHOLESTEROL; HOMEOSTASIS; METABOLISM	Farnesoid X receptor alpha (FXR alpha) as a bile acid sensor plays potent roles in multiple metabolic processes, and its antagonist has recently revealed special interests in the treatment of metabolic disorders, although the underlying mechanisms still remain unclear. Here, we identified that the small molecule N-benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) benzamide (NDB) functioned as a selective antagonist of human FXR alpha (hFXR alpha), and the crystal structure of hFXR alpha ligand binding domain (hFXR alpha-LBD) in complex with NDB was analyzed. It was unexpectedly discovered that NDB induced rearrangements of helix 11 (H11) and helix 12 (H12, AF-2) by forming a homodimer of hFXR alpha-LBD, totally different from the active conformation in monomer state, and the binding details were further supported by the mutation analysis. Moreover, functional studies demonstrated that NDB effectively antagonized the GW4064-stimulated FXR/RXR interaction and FXR alpha target gene expression in primary mouse hepatocytes, including the small heterodimer partner (SHP) and bile-salt export pump (BSEP); meanwhile, administration of NDBto db/db mice efficiently decreased the gene expressions of phosphoenolpyruvate carboxykinase (PEPCK), glucose 6-phosphatase (G6-pase), small heterodimer partner, and BSEP. It is expected that our first analyzed crystal structure of hFXR alpha-LBD.NDB will help expound the antagonistic mechanism of the receptor, and NDB may find its potential as a lead compound in anti-diabetes research.	[Xu, Xing; Xu, Xin; Liu, Peng; Zhu, Zhi-yuan; Chen, Jing; Chen, Li-li; Hu, Li-hong; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Xu, Xing] Shanghai Jiao Tong Univ, Shanghai Key Lab Bone & Joint Dis, Shanghai Inst Traumatol & Orthopaed, Shanghai Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China; [Fu, Hai-an] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Emory University	Chen, LL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	lilichen@simm.ac.cn; lhhu@simm.ac.cn; xshen@mail.shcnc.ac.cn			National Natural Science Foundation of China [91413102, 81373462, 81173105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 91413102, 81373462, and 81173105.	Claudel T, 2002, J CLIN INVEST, V109, P961; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Evans MJ, 2009, AM J PHYSIOL-GASTR L, V296, pG543, DOI 10.1152/ajpgi.90585.2008; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Huang H, 2012, J MED CHEM, V55, P7037, DOI 10.1021/jm3002718; Jin LH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2924; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Koszewski NJ, 2001, BIOCHEM BIOPH RES CO, V283, P188, DOI 10.1006/bbrc.2001.4734; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lien F, 2014, J CLIN INVEST, V124, P1037, DOI 10.1172/JCI68815; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Mi LZ, 2003, MOL CELL, V11, P1093, DOI 10.1016/S1097-2765(03)00112-6; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Prawitt J, 2009, DRUG DISCOV TODAY DI, V6, pe55; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Puckett MC, 2013, MOL CELL BIOL, V33, P2252, DOI 10.1128/MCB.00047-13; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Sepe V, 2011, J MED CHEM, V54, P1314, DOI 10.1021/jm101336m; Soisson SM, 2008, P NATL ACAD SCI USA, V105, P5337, DOI 10.1073/pnas.0710981105; Song YY, 2012, J HEPATOL, V56, P248, DOI 10.1016/j.jhep.2011.07.014; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590; Xu X, 2013, STEROIDS, V78, P813, DOI 10.1016/j.steroids.2013.04.018; Zhang HT, 2011, J BIOL CHEM, V286, P24593, DOI 10.1074/jbc.M111.245498; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157	32	39	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19888	19899		10.1074/jbc.M114.630475	http://dx.doi.org/10.1074/jbc.M114.630475			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100621	Green Published, hybrid			2022-12-28	WOS:000359364600044
J	Zhao, M; Li, XJ; Tang, ZM; Yang, F; Wang, SL; Cai, W; Zhang, K; Xia, NS; Zheng, ZZ				Zhao, Min; Li, Xiao-Jing; Tang, Zi-Min; Yang, Fan; Wang, Si-Ling; Cai, Wei; Zhang, Ke; Xia, Ning-Shao; Zheng, Zi-Zheng			A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMITTED NON-A; NON-B-HEPATITIS; MONOCLONAL-ANTIBODIES; ORF3 PROTEIN; CRYSTAL-STRUCTURE; PARTICLES; IDENTIFICATION; EPITOPES; RELEASE; EXPRESSION	The hepatitis E virus (HEV) ORF2 encodes a single structural capsid protein. The E2s domain (amino acids 459-606) of the capsid protein has been identified as the major immune target. All identified neutralizing epitopes are located on this domain; however, a comprehensive characterization of antigenic sites on the domain is lacking due to its high degree of conformation dependence. Here, we used the statistical software SPSS to analyze cELISA (competitive ELISA) data to classify monoclonal antibodies (mAbs), which recognized conformational epitopes on E2s domain. Using this novel analysis method, we identified various conformational mAbs that recognized the E2s domain. These mAbs were distributed into 6 independent groups, suggesting the presence of at least 6 epitopes. Twelve representative mAbs covering the six groups were selected as a tool box to further map functional antigenic sites on the E2s domain. By combining functional and location information of the 12 representative mAbs, this study provided a complete picture of potential neutralizing epitope regions and immune-dominant determinants on E2s domain. One epitope region is located on top of the E2s domain close to the monomerinterface; the other is located on the monomer side of the E2s dimer around the groove zone. Besides, two non-neutralizing epitopes were also identified on E2s domain that did not stimulate neutralizing antibodies. Our results help further the understanding of protective mechanisms induced by the HEV vaccine. Furthermore, the tool box with 12 representative mAbs will be useful for studying the HEV infection process.	[Zhao, Min; Li, Xiao-Jing; Cai, Wei; Xia, Ning-Shao] Xiamen Univ, State Key Lab Mol Vaccinol & Mol Diagnost, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Tang, Zi-Min; Yang, Fan; Wang, Si-Ling; Zhang, Ke; Xia, Ning-Shao; Zheng, Zi-Zheng] Xiamen Univ, Sch Publ Hlth, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University	Xia, NS (corresponding author), Xiamen Univ, State Key Lab Mol Vaccinol & Mol Diagnost, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	nsxia@xmu.edu.cn; zhengzizheng@xmu.edu.cn		Wang, Siling/0000-0001-5485-0818; Xia, Ningshao/0000-0003-0179-5266	Chinese National High-tech R&D Program (863 program) [2011AA02A101]; Xiamen Science and Technology Platform Project Grant [3502Z20131001]; Xiamen Science and Technology Plan Project Grant [3502Z201410045]	Chinese National High-tech R&D Program (863 program); Xiamen Science and Technology Platform Project Grant; Xiamen Science and Technology Plan Project Grant	This work was supported in part by Chinese National High-tech R&D Program (863 program) Grant 2011AA02A101, Xiamen Science and Technology Platform Project Grant 3502Z20131001, and Xiamen Science and Technology Plan Project Grant 3502Z201410045. The authors declare that they have no conflicts of interest with the contents of this article.	BRYAN JP, 1994, J INFECT DIS, V170, P517, DOI 10.1093/infdis/170.3.517; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Dong JH, 2011, P NATL ACAD SCI USA, V108, P12681, DOI 10.1073/pnas.1104834108; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; He JK, 2007, J BIOMED SCI, V14, P555, DOI 10.1007/s11373-007-9172-4; He SZ, 2008, J GEN VIROL, V89, P245, DOI 10.1099/vir.0.83308-0; Im SWK, 2001, VACCINE, V19, P3726, DOI 10.1016/S0264-410X(01)00100-1; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Li SW, 2005, J BIOL CHEM, V280, P3400, DOI 10.1074/jbc.M410361200; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Li TC, 2005, J VIROL, V79, P12999, DOI 10.1128/JVI.79.20.12999-13006.2005; Meng JH, 2001, VIROLOGY, V288, P203, DOI 10.1006/viro.2001.1093; Mushahwar IK, 1996, EUR J GASTROEN HEPAT, V8, P312, DOI 10.1097/00042737-199604000-00004; Nagashima S, 2011, J GEN VIROL, V92, P2838, DOI 10.1099/vir.0.035378-0; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PURDY MA, 1992, ARCH VIROL, V123, P335, DOI 10.1007/BF01317268; Reyes G R, 1993, Arch Virol Suppl, V7, P15; Reyes G R, 1993, Prog Liver Dis, V11, P203; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; REYES GR, 1991, GASTROENTEROL JPN, V26, P142; RH P., 2005, VIRAL HEPATITIS, V3rd, P635; Schofield DJ, 2000, J VIROL, V74, P5548, DOI 10.1128/JVI.74.12.5548-5555.2000; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Takahashi M, 2008, ARCH VIROL, V153, P1703, DOI 10.1007/s00705-008-0179-6; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Wei MX, 2014, VACCINE, V32, P2859, DOI 10.1016/j.vaccine.2014.02.025; World Health Organization South-East Asia Region, 2012, VIR HEP WHO S E AS R; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Xing L, 1999, VIROLOGY, V265, P35, DOI 10.1006/viro.1999.0005; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang J, 2005, VACCINE, V23, P2881, DOI 10.1016/j.vaccine.2004.11.065; Zhang J, 2012, REV MED VIROL, V22, P339, DOI 10.1002/rmv.1719; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	41	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19910	19922		10.1074/jbc.M115.649764	http://dx.doi.org/10.1074/jbc.M115.649764			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085097	Green Published, hybrid			2022-12-28	WOS:000359364600046
J	Sakin, V; Richter, SM; Hsiao, HH; Urlaub, H; Melchior, F				Sakin, Volkan; Richter, Sebastian M.; Hsiao, He-Hsuan; Urlaub, Henning; Melchior, Frauke			Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN IMPORT; TRANSPORT FACTOR-2 NTF2; PORE COMPLEX; STRUCTURAL BASIS; ACTIVATING PROTEIN; LYSINE ACETYLATION; BINDING-SITES; GDP-RAN; IN-VIVO; RANGAP1	The SUMO E3 ligase complex RanBP2/RanGAP1*SUMO1/Ubc9 localizes at cytoplasmic nuclear pore complex (NPC) filaments and is a docking site in nucleocytoplasmic transport. RanBP2 has four Ran binding domains (RBDs), two of which flank RanBP2's E3 ligase region. We thus wondered whether the small GTPase Ran is a target for RanBP2-dependent sumoylation. Indeed, Ran is sumoylated both by a reconstituted and the endogenous RanBP2 complex in semi-permeabilized cells. Generic inhibition of SUMO isopeptidases or depletion of the SUMO isopeptidase SENP1 enhances sumoylation of Ran in semi-permeabilized cells. As Ran is typically associated with transport receptors, we tested the influence of Crm1, Imp beta, Transportin, and NTF2 on Ran sumoylation. Surprisingly, all inhibited Ran sumoylation. Mapping Ran sumoylation sites revealed that transport receptors may simply block access of the E2-conjugating enzyme Ubc9, however the acceptor lysines are perfectly accessible in Ran/NTF2 complexes. Isothermal titration calorimetry revealed that NTF2 prevents sumoylation by reducing RanGDP's affinity to RanBP2's RBDs to undetectable levels. Taken together, our findings indicate that RanGDP and not RanGTP is the physiological target for the RanBP2 SUMO E3 ligase complex. Recognition requires interaction of Ran with RanBP2's RBDs, which is prevented by the transport factor NTF2.	[Sakin, Volkan; Richter, Sebastian M.; Melchior, Frauke] Heidelberg Univ, Zentrum Mol Biol ZMBH, DKFZ, ZMBH Alliance, D-69120 Heidelberg, Germany; [Hsiao, He-Hsuan; Urlaub, Henning] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr, Dept Clin Chem, D-37075 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; University of Gottingen	Melchior, F (corresponding author), Heidelberg Univ, Zentrum Mol Biol ZMBH, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	f.melchior@zmbh.uni-heidelberg.de	Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797	German Research Society [SFB 638, TPB8]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	German Research Society(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	This project received funding from the German Research Society (SFB 638, TPB8) and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) and the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS), respectively (to V. S. and S. M. R.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bibak N, 2004, ANAL BIOCHEM, V333, P57, DOI 10.1016/j.ab.2004.06.017; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chow KH, 2012, NUCLEUS-PHILA, V3, P349, DOI 10.4161/nucl.20822; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Goeres J, 2011, MOL BIOL CELL, V22, P4868, DOI 10.1091/mbc.E10-12-0953; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Kent HM, 1996, J STRUCT BIOL, V116, P326, DOI 10.1006/jsbi.1996.0049; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Lu M, 2014, CELL, V157, P1130, DOI 10.1016/j.cell.2014.05.006; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Melchior F, 1998, METH MOL B, V88, P265; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rothenbusch U, 2012, EMBO J, V31, P2461, DOI 10.1038/emboj.2012.102; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Schou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100692; Schulz S, 2012, EMBO REP, V13, P930, DOI 10.1038/embor.2012.125; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	75	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23589	23602		10.1074/jbc.M115.660118	http://dx.doi.org/10.1074/jbc.M115.660118			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26251516	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000361816500011
J	Gentry, LR; Nishimura, A; Cox, AD; Martin, TD; Tsygankov, D; Nishida, M; Elston, TC; Der, CJ				Gentry, Leanna R.; Nishimura, Akiyuki; Cox, Adrienne D.; Martin, Timothy D.; Tsygankov, Denis; Nishida, Motohiro; Elston, Timothy C.; Der, Channing J.			Divergent Roles of CAAX Motif-signaled Posttranslational Modifications in the Regulation and Subcellular Localization of Ral GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-RAS; CARBOXYL METHYLATION; ACTIVATING PROTEINS; ENDOPROTEASE RCE1; GAMMA-SUBUNIT; CELL-GROWTH; CANCER; DEFICIENCY; PHOSPHORYLATION; IDENTIFICATION	The Ras-like small GTPases RalA and RalB are well validated effectors of RAS oncogene-driven human cancer growth, and pharmacologic inhibitors of Ral function may provide an effective anti-Ras therapeutic strategy. Intriguingly, although RalA and RalB share strong overall amino acid sequence identity, exhibit essentially identical structural and biochemical properties, and can utilize the same downstream effectors, they also exhibit divergent and sometimes opposing roles in the tumorigenic and metastatic growth of different cancer types. These distinct biological functions have been attributed largely to sequence divergence in their carboxyl-terminal hypervariable regions. However, the role of posttranslational modifications signaled by the hypervariable region carboxyl-terminal tetrapeptide CAAX motif (C = cysteine, A = aliphatic amino acid, X = terminal residue) in Ral isoform-selective functions has not been addressed. We determined that these modifications have distinct roles and consequences. Both RalA and RalB require Ras converting CAAX endopeptidase 1 (RCE1) for association with the plasma membrane, albeit not with endomembranes, and loss of RCE1 caused mislocalization as well as sustained activation of both RalA and RalB. In contrast, isoprenylcysteine carboxylmethyltransferase (ICMT) deficiency disrupted plasma membrane localization only of RalB, whereas RalA depended on ICMT for efficient endosomal localization. Furthermore, the absence of ICMT increased stability of RalB but not RalA protein. Finally, palmitoylation was critical for subcellular localization of RalB but not RalA. In summary, we have identified striking isoform-specific consequences of distinct CAAX-signaled posttranslational modifications that contribute to the divergent subcellular localization and activity of RalA and RalB.	[Gentry, Leanna R.; Cox, Adrienne D.; Martin, Timothy D.; Tsygankov, Denis; Elston, Timothy C.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Nishimura, Akiyuki; Nishida, Motohiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cardiocirculatory Signaling, Okazaki, Aichi 4448787, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Tsygankov, Denis/L-4672-2019; Regan, Clinton/E-6250-2012	Nishida, Motohiro/0000-0002-2587-5458; Tsygankov, Denis/0000-0002-1180-3584; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [R01 CA042978, T32 GM007040]; NATIONAL CANCER INSTITUTE [R01CA042978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271, T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA042978 (to C. J. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health T32 GM007040.	Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; CHARDIN P, 1989, NUCLEIC ACIDS RES, V17, P4380, DOI 10.1093/nar/17.11.4380; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Kashatus DF, 2013, EXP CELL RES, V319, P2337, DOI 10.1016/j.yexcr.2013.06.020; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Maske CP, 2003, J CELL BIOL, V162, P1223, DOI 10.1083/jcb.200303113; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Mitin N, 2012, METHODS MOL BIOL, V827, P87, DOI 10.1007/978-1-61779-442-1_6; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Neyraud V, 2012, J BIOL CHEM, V287, P29397, DOI 10.1074/jbc.M112.357764; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; PARISH CA, 1995, BIOCHEMISTRY-US, V34, P7722, DOI 10.1021/bi00023a019; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tsygankov D, 2014, J CELL BIOL, V204, P443, DOI 10.1083/jcb.201306067; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wahlstrom AM, 2007, BLOOD, V109, P763, DOI 10.1182/blood-2006-05-024752; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Yu YH, 2003, ANN NY ACAD SCI, V983, P268, DOI 10.1111/j.1749-6632.2003.tb05981.x	53	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22851	22861		10.1074/jbc.M115.656710	http://dx.doi.org/10.1074/jbc.M115.656710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216878	Green Published, hybrid			2022-12-28	WOS:000361171500047
J	Nata, T; Basheer, A; Cocchi, F; van Besien, R; Massoud, R; Jacobson, S; Azimi, N; Tagaya, Y				Nata, Toshie; Basheer, Asjad; Cocchi, Fiorenza; van Besien, Richard; Massoud, Raya; Jacobson, Steven; Azimi, Nazli; Tagaya, Yutaka			Targeting the Binding Interface on a Shared Receptor Subunit of a Cytokine Family Enables the Inhibition of Multiple Member Cytokines with Selectable Target Spectrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED KILLER-CELLS; CELIAC-DISEASE; T-CELLS; RHEUMATOID-ARTHRITIS; NATURAL-KILLER; INTRAEPITHELIAL LYMPHOCYTES; LYMPHOID DEVELOPMENT; ULCERATIVE-COLITIS; TRANSGENIC MICE; BETA-CHAIN	The common gamma molecule (gamma c) is a shared signaling receptor subunit used by six gamma c-cytokines. These cytokines play crucial roles in the differentiation of the mature immune system and are involved in many human diseases. Moreover, recent studies suggest that multiple gamma c-cytokines are pathogenically involved in a single disease, thus making the shared gamma c-molecule a logical target for therapeutic intervention. However, the current therapeutic strategies seem to lack options to treat such cases, partly because of the lack of appropriate neutralizing antibodies recognizing the gamma c and, more importantly, because of the inherent and practical limitations in the use of monoclonal antibodies. By targeting the binding interface of the gamma c and cytokines, we successfully designed peptides that not only inhibit multiple gamma c-cytokines but with a selectable target spectrum. Notably, the lead peptide inhibited three gamma c-cytokines without affecting the other three or non-gamma c-cytokines. Biological and mutational analyses of our peptide provide new insights to our current understanding on the structural aspect of the binding of gamma c-cytokines the gamma c-molecule. Furthermore, we provide evidence that our peptide, when conjugated to polyethylene glycol to gain stability in vivo, efficiently blocks the action of one of the target cytokines in animal models. Collectively, our technology can be expanded to target various combinations of gamma c-cytokines and thereby will provide a novel strategy to the current anti-cytokine therapies against immune, inflammatory, and malignant diseases.	[Nata, Toshie; Cocchi, Fiorenza; van Besien, Richard; Tagaya, Yutaka] Univ Maryland, Sch Med, Inst Human Virol, Cell Biol Lab,Div Basic Sci, Baltimore, MD 21201 USA; [Basheer, Asjad; Azimi, Nazli] BIONIZ Inc, Irvine, CA 92618 USA; [Massoud, Raya; Jacobson, Steven] NINDS, Sect Neuroimmunol, NIH, Bethesda, MD 20890 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tagaya, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Cell Biol Lab,Div Basic Sci, Baltimore, MD 21201 USA.	ytagaya@ihv.umaryland.edu		Van Besien, Richard/0000-0002-6967-0657; Tagaya, Yutaka/0000-0002-1342-9282	BIONIZ; Institute of Human Virology, University of Maryland School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003040, ZIANS002817] Funding Source: NIH RePORTER	BIONIZ; Institute of Human Virology, University of Maryland School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by research funding from BIONIZ (to T.N., F.C., and Y.T.) and in part by internal research funding from the Institute of Human Virology, University of Maryland School of Medicine. This work was authored, in whole or in part, by National Institutes of Health staff. A. B. is an employee of BIONIZ, Inc. N. A. is the founder of BIONIZ. BIONIZ holds the United States patent for the technology behind this work and the concept and peptides used in this paper. We also declare that these financial involvements of BIONIZ did not undermine the scientific objectivity and integrity of the presented work.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Antal Z, 2012, J IMMUNOL, V188, P5766, DOI 10.4049/jimmunol.1102930; Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Azimi N, 1999, J IMMUNOL, V163, P4064; Azimi N, 2001, P NATL ACAD SCI USA, V98, P14559, DOI 10.1073/pnas.251540598; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen J, 2008, BLOOD, V111, P5163, DOI 10.1182/blood-2007-09-113654; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; CRAIG DA, 1993, TRENDS PHARMACOL SCI, V14, P89, DOI 10.1016/0165-6147(93)90070-Z; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jiang JK, 2008, J MED CHEM, V51, P8012, DOI 10.1021/jm801142b; Ju W, 2011, BLOOD, V117, P1938, DOI 10.1182/blood-2010-09-305425; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Marquez A, 2009, AM J GASTROENTEROL, V104, P1968, DOI 10.1038/ajg.2009.224; Matsuura E, 2010, J NEUROIMMUNE PHARM, V5, P310, DOI 10.1007/s11481-010-9216-9; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Oh Chad K., 2011, Inflammation & Allergy Drug Targets, V10, P180; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; Sarra M, 2013, BIOFACTORS, V39, P368, DOI 10.1002/biof.1105; Sato N, 2011, BLOOD, V117, P4032, DOI 10.1182/blood-2010-09-307504; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Steinke JW, 2010, RECENT PATENTS INFLA, V4, P222, DOI 10.2174/187221310793564281; Steinke JW, 2003, J ALLERGY CLIN IMMUN, V111, P342, DOI 10.1067/mai.2003.67; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Tagaya Y., 2013, U.S. Patent, Patent No. 08455449; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; TENDLER CL, 1990, P NATL ACAD SCI USA, V87, P5218, DOI 10.1073/pnas.87.13.5218; VANDERHOEK JY, 1982, J BIOL CHEM, V257, P2191; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; West K, 2009, CURR OPIN INVEST DR, V10, P491; Yokoyama S, 2013, J CLIN IMMUNOL, V33, P586, DOI 10.1007/s10875-012-9849-y; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zambello R, 1997, BLOOD, V89, P201, DOI 10.1182/blood.V89.1.201.201_201_211	68	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22338	22351		10.1074/jbc.M115.661074	http://dx.doi.org/10.1074/jbc.M115.661074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26183780	Green Published, hybrid			2022-12-28	WOS:000361171500003
J	Townsend, PD; Rodgers, TL; Glover, LC; Korhonen, HJ; Richards, SA; Colwell, LJ; Pohl, E; Wilson, MR; Hodgson, DRW; McLeish, TCB; Cann, MJ				Townsend, Philip D.; Rodgers, Thomas L.; Glover, Laura C.; Korhonen, Heidi J.; Richards, Shane A.; Colwell, Lucy J.; Pohl, Ehmke; Wilson, Mark R.; Hodgson, David R. W.; McLeish, Tom C. B.; Cann, Martin J.			The Role of Protein-Ligand Contacts in Allosteric Regulation of the Escherichia coli Catabolite Activator Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP RECEPTOR PROTEIN; NORMAL-MODE ANALYSIS; CAP-DNA COMPLEX; DYNAMIC ALLOSTERY; EVOLUTIONARY CONSERVATION; CONFORMATIONAL CHANGE; VIBRATIONAL DYNAMICS; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; PLAUSIBLE MODEL	Allostery is a fundamental process by which ligand binding to a protein alters its activity at a distant site. Both experimental and theoretical evidence demonstrate that allostery can be communicated through altered slow relaxation protein dynamics without conformational change. The catabolite activator protein (CAP) of Escherichia coli is an exemplar for the analysis of such entropically driven allostery. Negative allostery in CAP occurs between identical cAMP binding sites. Changes to the cAMP-binding pocket can therefore impact the allosteric properties of CAP. Here we demonstrate, through a combination of coarse-grained modeling, isothermal calorimetry, and structural analysis, that decreasing the affinity of CAP for cAMP enhances negative cooperativity through an entropic penalty for ligand binding. The use of variant cAMP ligands indicates the data are not explained by structural heterogeneity between protein mutants. We observe computationally that altered interaction strength between CAP and cAMP variously modifies the change in allosteric cooperativity due to second site CAP mutations. As the degree of correlated motion between the cAMP-contacting site and a second site on CAP increases, there is a tendency for computed double mutations at these sites to drive CAP toward noncooperativity. Naturally occurring pairs of covarying residues in CAP do not display this tendency, suggesting a selection pressure to fine tune allostery on changes to the CAP ligand-binding pocket without a drive to a noncooperative state. In general, we hypothesize an evolutionary selection pressure to retain slow relaxation dynamics-induced allostery in proteins in which evolution of the ligand-binding site is occurring.	[Townsend, Philip D.; Glover, Laura C.; Richards, Shane A.; Pohl, Ehmke; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Townsend, Philip D.; Glover, Laura C.; Korhonen, Heidi J.; Pohl, Ehmke; Wilson, Mark R.; Hodgson, David R. W.; McLeish, Tom C. B.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Glover, Laura C.; Korhonen, Heidi J.; Pohl, Ehmke; Wilson, Mark R.; Hodgson, David R. W.; McLeish, Tom C. B.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [McLeish, Tom C. B.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Rodgers, Thomas L.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M13 9PL, Lancs, England; [Korhonen, Heidi J.] Univ Turku, Dept Chem, Turku 20014, Finland; [Colwell, Lucy J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Durham University; Durham University; Durham University; Durham University; University of Manchester; University of Turku; University of Cambridge	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, S Rd, Durham DH1 3LE, England.	j.cann@durham.ac.uk	Rodgers, Thomas/K-5785-2019; Townsend, Phiip/J-3761-2018; Rodgers, Thomas L/G-9335-2013; Pohl, Ehmke/I-2408-2012; Cann, Martin/G-2864-2012; Wilson, Mark R/F-8670-2011; Hodgson, David/F-7174-2011	Rodgers, Thomas/0000-0002-4025-3753; Townsend, Phiip/0000-0001-9235-3492; Rodgers, Thomas L/0000-0002-4025-3753; Pohl, Ehmke/0000-0002-9949-4471; Cann, Martin/0000-0001-6305-8769; Wilson, Mark R/0000-0001-6413-2780; Hodgson, David/0000-0003-4517-9166; McLeish, Tom/0000-0002-2025-0299; Richards, Shane/0000-0002-9638-5827	EPSRC [EP/H051759/1]; BBSRC [BB/M007405/1] Funding Source: UKRI; EPSRC [EP/H028064/2, EP/H028064/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M007405/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H051759/1, EP/H028064/1, EP/H028064/2] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC grant EP/H051759/1 (to T. C. B. M., M. J. C., E. P., and M. R. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BELDUZ AO, 1993, NUCLEIC ACIDS RES, V21, P1827, DOI 10.1093/nar/21.8.1827; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; COOPER A, 1994, FEBS LETT, V348, P41, DOI 10.1016/0014-5793(94)00579-6; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hawkins RJ, 2006, BIOPHYS J, V91, P2055, DOI 10.1529/biophysj.106.082180; Hawkins RJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098104; Hawkins RJ, 2006, J R SOC INTERFACE, V3, P125, DOI 10.1098/rsif.2005.0068; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLeish TCB, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056004; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolay S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.078104; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Raimondi F, 2010, STRUCTURE, V18, P402, DOI 10.1016/j.str.2009.12.015; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Ringe D, 1986, Methods Enzymol, V131, P389; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Rodgers TL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-183; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Toncrova H, 2010, BIOPHYS J, V98, P2317, DOI 10.1016/j.bpj.2010.01.039; Townsend Philip D, 2015, Biophys Rev, V7, P175, DOI 10.1007/s12551-015-0163-9; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Valadie H, 2003, J MOL BIOL, V332, P657, DOI 10.1016/S0022-2836(03)00851-9; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111	57	22	22	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22225	22235		10.1074/jbc.M115.669267	http://dx.doi.org/10.1074/jbc.M115.669267			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26187469	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000360968500039
J	Chen, ST; Okada, M; Nakato, R; Izumi, K; Bando, M; Shirahige, K				Chen, Shu-Ting; Okada, Maiko; Nakato, Ryuichiro; Izumi, Kosuke; Bando, Masashige; Shirahige, Katsuhiko			The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; gene transcription; prostate cancer; transcriptional coactivator; ubiquitin-dependent protease	UBIQUITIN-SPECIFIC PROTEASE; RESISTANT PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; NUCLEAR RECEPTORS; AR COREGULATORS; HAUSP; NETWORK; ACTIVATION; EXPRESSION; DISEASE	Background: The androgen receptor (AR) plays a key role in prostate cancer progression. Results: USP7 is required for binding of the AR to chromatin. Conclusion: USP7 is a novel AR co-regulator that mediates AR activity. Significance: Pharmacological inhibition of USP7 represents a compelling therapeutic strategy for the treatment of prostate cancer. The androgen receptor (AR), a nuclear receptor superfamily transcription factor, plays a key role in prostate cancer. AR signaling is the principal target for prostate cancer treatment, but current androgen-deprivation therapies cannot completely abolish AR signaling because of the heterogeneity of prostate cancers. Therefore, unraveling the mechanism of AR reactivation in androgen-depleted conditions can identify effective prostate cancer therapeutic targets. Increasing evidence indicates that AR activity is mediated by the interplay of modifying/demodifying enzymatic co-regulators. To better understand the mechanism of AR transcriptional activity regulation, we used antibodies against AR for affinity purification and identified the deubiquitinating enzyme ubiquitin-specific protease 7, USP7 as a novel AR co-regulator in prostate cancer cells. We showed that USP7 associates with AR in an androgen-dependent manner and mediates AR deubiquitination. Sequential ChIP assays indicated that USP7 forms a complex with AR on androgen-responsive elements of target genes upon stimulation with the androgen 5-dihydrotestosterone. Further investigation indicated that USP7 is necessary to facilitate androgen-activated AR binding to chromatin. Transcriptome profile analysis of USP7-knockdown LNCaP cells also revealed the essential role of USP7 in the expression of a subset of androgen-responsive genes. Hence, inhibition of USP7 represents a compelling therapeutic strategy for the treatment of prostate cancer.	[Chen, Shu-Ting; Nakato, Ryuichiro; Izumi, Kosuke; Bando, Masashige; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Okada, Maiko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan	University of Tokyo; Saint Marianna University	Shirahige, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan.	kshirahi@iam.u-tokyo.ac.jp	Nakato, Ryuichiro/AAV-6405-2020	Nakato, Ryuichiro/0000-0003-3019-5817; Shirahige, Katsuhiko/0000-0002-7862-1144	Research Program of Innovative Cell Biology by Innovative Technology; Japan Society for the Promotion of Science KAKENHI Grant [24-5985]	Research Program of Innovative Cell Biology by Innovative Technology; Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Research Program of Innovative Cell Biology by Innovative Technology, Grant-in-Aid for Scientific Research (to K. S.) (category S), Grant-in-Aid for Scientific Research (to M. B.) (category B) and Japan Society for the Promotion of Science KAKENHI Grant Number 24-5985. The authors declare no competing financial interests.	Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Cheng CD, 2013, ONCOL REP, V29, P1730, DOI 10.3892/or.2013.2342; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Felten A, 2013, ONCOGENE, V32, P4981, DOI 10.1038/onc.2012.503; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heemers HV, 2009, CANCER CELL, V15, P245, DOI 10.1016/j.ccr.2009.03.009; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecona E, 2015, MOL CELL BIOL, V35, P1157, DOI 10.1128/MCB.01197-14; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; R Core Team, 2013, LANG ENV STAT COMP; Ramos-Montoya A, 2014, EMBO MOL MED, V6, P651, DOI 10.1002/emmm.201303581; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tepper CG, 2002, CANCER RES, V62, P6606; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Whitfield GK, 1999, J CELL BIOCHEM, P110; WILSON JD, 1983, AUST J BIOL SCI, V36, P101; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	50	43	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21713	21723		10.1074/jbc.M114.628255	http://dx.doi.org/10.1074/jbc.M114.628255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175158	Green Published, hybrid			2022-12-28	WOS:000360637600042
J	Guengerich, FP				Guengerich, F. Peter			Introduction: Metals in Biology: alpha-Ketoglutarate/Iron-Dependent Dioxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MINIREVIEW SERIES METALS; GENERATION; MECHANISMS; ENZYMES	Four minireviews deal with aspects of the alpha-ketoglutarate/iron-dependent dioxygenases in this eighth Thematic Series on Metals in Biology. The minireviews cover a general introduction and synopsis of the current understanding of mechanisms of catalysis, the roles of these dioxygenases in post-translational protein modification and de-modification, the roles of the teneleven translocation (Tet) dioxygenases in the modification of methylated bases (5mC,T) in DNA relevant to epigenetic mechanisms, and the roles of the AlkB-related dioxygenases in the repair of damaged DNA and RNA. The use of alpha-ketoglutarate (alternatively termed 2-oxoglutarate) as a co-substrate in so many oxidation reactions throughout much of nature is notable and has surprisingly emerged from biochemical and genomic analysis. About 60 of these enzymes are now recognized in humans, and a number have been identified as having critical functions.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R37 CA090426]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R37 CA090426 (to F. P. G.). The author declares that he has no conflicts of interest with the contents of this article.	Chang SC, 2015, NUCLEIC ACIDS RES, V43, P5489, DOI 10.1093/nar/gkv243; Fedeles BI, 2015, J BIOL CHEM, V290, P20734, DOI 10.1074/jbc.R115.656462; Guengerich FP, 2015, J BIOL CHEM, V290, P18943, DOI 10.1074/jbc.R115.670265; Guengerich FP, 2014, J BIOL CHEM, V289, P28094, DOI 10.1074/jbc.R114.607093; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Guengerich FP, 2013, J BIOL CHEM, V288, P13164, DOI 10.1074/jbc.R113.467712; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Hashimoto H, 2015, J BIOL CHEM, V290, P20723, DOI 10.1074/jbc.R115.656884; Kramlinger VM, 2015, J BIOL CHEM, V290, P20200, DOI 10.1074/jbc.M115.665331; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; Martinez S, 2015, J BIOL CHEM, V290, P20702, DOI 10.1074/jbc.R115.648691; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811	17	19	19	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20700	20701		10.1074/jbc.R115.675652	http://dx.doi.org/10.1074/jbc.R115.675652			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152720	Green Published, hybrid			2022-12-28	WOS:000360011800006
J	Faridounnia, M; Wienk, H; Kovacic, L; Folkers, GE; Jaspers, NGJ; Kaptein, R; Hoeijmakers, JHJ; Boelens, R				Faridounnia, Maryam; Wienk, Hans; Kovacic, Lidija; Folkers, Gert E.; Jaspers, Nicolaas G. J.; Kaptein, Robert; Hoeijmakers, Jan H. J.; Boelens, Rolf			The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; LATE-ONSET; ENDONUCLEASE ERCC1-XPF; MOLECULAR-MECHANISM; INTERACTION DOMAINS; HYDROGEN-EXCHANGE; MAMMALIAN-CELLS; CHEMICAL-SHIFTS; FANCONI-ANEMIA	The ERCC1-XPF heterodimer, a structure-specific DNA endonuclease, is best known for its function in the nucleotide excision repair (NER) pathway. The ERCC1 point mutation F231L, located at the hydrophobic interaction interface of ERCC1 (excision repair cross-complementation group 1) and XPF (xeroderma pigmentosum complementation group F), leads to severe NER pathway deficiencies. Here, we analyze biophysical properties and report the NMR structure of the complex of the C-terminal tandem helix-hairpin- helix domains of ERCC1-XPF that contains this mutation. The structures of wild type and the F231L mutant are very similar. The F231L mutation results in only a small disturbance of the ERCC1-XPF interface, where, in contrast to Phe(231), Leu(231) lacks interactions stabilizing the ERCC1-XPF complex. One of the two anchor points is severely distorted, and this results in a more dynamic complex, causing reduced stability and an increased dissociation rate of the mutant complex as compared with wild type. These data provide a biophysical explanation for the severe NER deficiencies caused by this mutation.	[Faridounnia, Maryam; Wienk, Hans; Folkers, Gert E.; Kaptein, Robert; Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Kovacic, Lidija] Jozef Stefan Inst, Dept Mol & Biomed Sci, SI-1000 Ljubljana, Slovenia; [Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.] Erasmus MC, Dept Genet, NL-3000 CA Rotterdam, Netherlands	Utrecht University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Erasmus University Rotterdam; Erasmus MC	Boelens, R (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	r.boelens@uu.nl	Folkers, Gert E/C-2863-2009; Hoeijmakers, Jan/AAX-6972-2021; Faridounnia, Maryam/X-7736-2018; Wienk, Hans/P-8929-2015; Boelens, Rolf/B-4702-2009	Folkers, Gert E/0000-0003-1070-0505; Faridounnia, Maryam/0000-0002-6260-7639; Wienk, Hans/0000-0001-9577-0064; Boelens, Rolf/0000-0002-6939-8913	Netherlands Foundation of Chemical Research (NWO-CW); European Union [261863]; Royal Academy of Arts and Sciences of the Netherlands; European Research Council [GA233424]; Slovenian Ministry of Higher Education, Science, and Technology [Z1-4071]; Infrastructural Centre for Analysis of Molecular Interactions, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Netherlands Foundation of Chemical Research (NWO-CW); European Union(European Commission); Royal Academy of Arts and Sciences of the Netherlands; European Research Council(European Research Council (ERC)European Commission); Slovenian Ministry of Higher Education, Science, and Technology; Infrastructural Centre for Analysis of Molecular Interactions, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Netherlands Foundation of Chemical Research (NWO-CW) and the European Union (Project BioNMR, No. 261863); the Royal Academy of Arts and Sciences of the Netherlands (academic professorship to J. H. J. H.); the European Research Council (Project DamAge No. GA233424; to J. H. J. H.); and the Slovenian Ministry of Higher Education, Science, and Technology (Z1-4071; to L. K.) and their support of the Infrastructural Centre for Analysis of Molecular Interactions, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Chelli R, 2002, J AM CHEM SOC, V124, P6133, DOI 10.1021/ja0121639; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Das D, 2008, PROTEINS, V70, P1551, DOI 10.1002/prot.21635; Das D, 2012, STRUCTURE, V20, P667, DOI 10.1016/j.str.2012.02.009; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; FARABAUGH PJ, 1978, NATURE, V274, P765, DOI 10.1038/274765a0; Finkelstein A. V., 2002, METHODS MOL BIOPHYSI, p[57, 117]; Friedberg E.C., 1995, DNA REPAIR MUTAGENES, P135; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Goddard TD, 2006, SPARKY 3 VERSION 3 1; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Imoto K, 2007, J INVEST DERMATOL, V127, pS92; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; KONDO S, 1989, PHOTODERMATOLOGY, V6, P89; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1; PURICH DL, 1980, METHOD ENZYMOL, V64, P3; Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Serdyuk I. N., 2007, METHODS MOL BIOPHYSI, P21; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANDUIN M, 1988, NUCLEIC ACIDS RES, V16, P5305, DOI 10.1093/nar/16.12.5305; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wu YL, 2008, MECH AGEING DEV, V129, P602, DOI 10.1016/j.mad.2008.08.004; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	66	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20541	20555		10.1074/jbc.M114.635169	http://dx.doi.org/10.1074/jbc.M114.635169			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26085086	Green Published, hybrid			2022-12-28	WOS:000359608900050
J	Wang, SB; Awad, KS; Elinoff, JM; Dougherty, EJ; Ferreyra, GA; Wang, JY; Cai, RM; Sun, JF; Ptasinska, A; Danner, RL				Wang, Shuibang; Awad, Keytam S.; Elinoff, Jason M.; Dougherty, Edward J.; Ferreyra, Gabriela A.; Wang, Jennifer Y.; Cai, Rongman; Sun, Junfeng; Ptasinska, Anetta; Danner, Robert L.			G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; P38 MAPK; COACTIVATOR PGC-1-ALPHA; GLUCOSE-METABOLISM; INSULIN-SECRETION; DIABETES-MELLITUS; ENDOTHELIAL-CELLS; DEPENDENT MANNER; RETINOIC ACID; KINASE	Peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands have been widely used to treat type 2 diabetes mellitus. However, knowledge of PPAR gamma signaling remains incomplete. In addition to PPAR gamma, these drugs also activate G protein-coupled receptor 40 (GPR40), a G alpha(q)-coupled free fatty acid receptor linked to MAPK networks and glucose homeostasis. Notably, p38 MAPK activation has been implicated in PPAR gamma signaling. Here, rosiglitazone (RGZ) activation of GPR40 and p38 MAPK was found to boost PPAR gamma-induced gene transcription in human endothelium. Inhibition or knockdown of p38 MAPK or expression of a dominant negative (DN) p38 MAPK mutant blunted RGZ-induced PPAR gamma DNA binding and reporter activity in EA.hy926 human endothelial cells. GPR40 inhibition or knockdown, or expression of a DN-G(alpha)q mutant likewise blocked activation of both p38 MAPK and PPAR gamma reporters. Importantly, RGZ induction of PPAR gamma target genes in primary human pulmonary artery endothelial cells (PAECs) was suppressed by knockdown of either p38 MAPK or GPR40. GPR40/PPAR gamma signal transduction was dependent on p38 MAPK activation and induction of PPAR gamma co-activator-1 (PGC1 alpha). Silencing of p38 MAPK or GPR40 abolished the ability of RGZ to induce phosphorylation and expression of PGC1 alpha in PAECs. Knockdown of PGC1 alpha, its essential activator SIRT1, or its binding partner/co-activator EP300 inhibited RGZ induction of PPAR gamma-regulated genes in PAECs. RGZ/GPR40/p38 MAPK signaling also led to EP300 phosphorylation, an event that enhances PPAR gamma target gene transcription. Thus, GPR40 and PPAR gamma can function as an integrated two-receptor signal transduction pathway, a finding with implications for rational drug development.	[Wang, Shuibang; Awad, Keytam S.; Elinoff, Jason M.; Dougherty, Edward J.; Ferreyra, Gabriela A.; Wang, Jennifer Y.; Cai, Rongman; Sun, Junfeng; Ptasinska, Anetta; Danner, Robert L.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Danner, RL (corresponding author), NIH, Dept Crit Care Med, 10 Ctr Dr,Rm 2C145, Bethesda, MD 20892 USA.	rdanner@nih.gov	Regan, Clinton/E-6250-2012		National Institutes of Health; CLINICAL CENTER [ZIACL000188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health intramural funds. The authors declare that they have no conflicts of interest with the contents of this article.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bratton MR, 2009, CARCINOGENESIS, V30, P106, DOI 10.1093/carcin/bgn213; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; Camp HS, 1997, J BIOL CHEM, V272, P10811; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chu KM, 2007, J PHARM PHARM SCI, V10, P411, DOI 10.18433/J3159D; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Fernandez-Pisonero I, 2012, J IMMUNOL, V189, P5402, DOI 10.4049/jimmunol.1201309; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gardner OS, 2005, J BIOL CHEM, V280, P10109, DOI 10.1074/jbc.M410445200; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn BB, 2010, NEW ENGL J MED, V363, P2667, DOI 10.1056/NEJMcibr1012075; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kim HS, 2008, BIOCHEM BIOPH RES CO, V367, P623, DOI 10.1016/j.bbrc.2007.12.192; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lennon AM, 2002, J BIOL CHEM, V277, P29681, DOI 10.1074/jbc.M201517200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Maciag AE, 2013, REDOX BIOL, V1, P115, DOI 10.1016/j.redox.2012.12.002; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Mieczkowska A, 2012, J BIOL CHEM, V287, P23517, DOI 10.1074/jbc.M111.324814; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; SOHDA T, 1982, CHEM PHARM BULL, V30, P3563; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Tanaka H, 2013, J PHARMACOL EXP THER, V346, P443, DOI 10.1124/jpet.113.206466; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang L, 2009, EUR J PHARMACOL, V609, P40, DOI 10.1016/j.ejphar.2009.03.033; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Yang C, 2001, DIABETES, V50, P2598, DOI 10.2337/diabetes.50.11.2598; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zhou CY, 2010, BIOORG MED CHEM LETT, V20, P1298, DOI 10.1016/j.bmcl.2009.10.052	66	32	33	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19544	19557		10.1074/jbc.M115.638924	http://dx.doi.org/10.1074/jbc.M115.638924			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105050	Green Published, hybrid			2022-12-28	WOS:000359364600018
J	Askenasy, I; Pennington, JM; Tao, YQ; Marshall, AG; Young, NL; Shang, WF; Stroupe, ME				Askenasy, Isabel; Pennington, Joseph M.; Tao, Yeqing; Marshall, Alan G.; Young, Nicolas L.; Shang, Weifeng; Stroupe, M. Elizabeth			The N-terminal Domain of Escherichia coli Assimilatory NADPH-Sulfite Reductase Hemoprotein Is an Oligomerization Domain That Mediates Holoenzyme Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CYCLOTRON RESONANCE; FLAVIN ADENINE-DINUCLEOTIDE; MOLTEN GLOBULE STATE; IRON-SULFUR; SALMONELLA-TYPHIMURIUM; FLAVOPROTEIN COMPONENT; MASS-SPECTROMETRY; CATALYTIC PARAMETERS; PROSTHETIC GROUPS; BINDING DOMAIN	Assimilatory NADPH-sulfite reductase (SiR) from Escherichia coli is a structurally complex oxidoreductase that catalyzes the six-electron reduction of sulfite to sulfide. Two subunits, one a flavin-binding flavoprotein (SiRFP, the alpha subunit) and the other an iron-containing hemoprotein (SiRHP, the beta subunit), assemble to make a holoenzyme of about 800 kDa. How the two subunits assemble is not known. The iron-rich cofactors in SiRHP are unique because they are a covalent arrangement of a Fe4S4 cluster attached through a cysteine ligand to an iron-containing porphyrinoid called siroheme. The link between cofactor biogenesis and SiR stability is also ill-defined. By use of hydrogen/deuterium exchange and biochemical analysis, we show that the alpha(8)beta(4) SiR holoenzyme assembles through the N terminus of SiRHP and the NADPH binding domain of SiRFP. By use of small angle x-ray scattering, we explore the structure of the SiRHP N-terminal oligomerization domain. We also report a novel form of the hemoprotein that occurs in the absence of its cofactors. Apo-SiRHP forms a homotetramer, also dependent on its N terminus, that is unable to assemble with SiRFP. From these results, we propose that homotetramerization of apo-SiRHP serves as a quality control mechanism to prevent formation of inactive holoenzyme in the case of limiting cellular siroheme.	[Askenasy, Isabel; Pennington, Joseph M.; Stroupe, M. Elizabeth] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Askenasy, Isabel; Pennington, Joseph M.; Stroupe, M. Elizabeth] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Tao, Yeqing; Marshall, Alan G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Marshall, Alan G.; Young, Nicolas L.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Shang, Weifeng] IIT, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Shang, Weifeng] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Illinois Institute of Technology; Illinois Institute of Technology	Stroupe, ME (corresponding author), Florida State Univ, Dept Biol Sci, 91 Chieftain Way, Tallahassee, FL 32306 USA.	mestroupe@bio.fsu.edu	Young, Nicolas/AAI-5242-2020	Young, Nicolas/0000-0002-3323-2815; Stroupe, M. Elizabeth/0000-0002-4393-1951	DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER; Direct For Biological Sciences [1149763] Funding Source: National Science Foundation	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. CD and DLS were performed in Florida State University Physical Biochemistry Facility, managed by Dr. Claudius Mundoma. HDX experiments were performed at the National High Magnetic Field Laboratory in Tallahassee, FL. We kindly thank Drs. Christopher Stroupe, Scott Stagg, and Kathryn Jones for helpful conversations.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Andersson D, 2001, BIOCHEMISTRY-US, V40, P2653, DOI 10.1021/bi000957e; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; BEU SC, 1992, ANAL CHEM, V64, P177, DOI 10.1021/ac00026a016; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Coves J, 1997, BIOCHEMISTRY-US, V36, P5921, DOI 10.1021/bi9623744; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12101, DOI 10.1021/bi971065q; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12120, DOI 10.1021/bi971066i; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; FAEDER EJ, 1974, J BIOL CHEM, V249, P1599; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Gruez A, 1998, ACTA CRYSTALLOGR D, V54, P135, DOI 10.1107/S090744499701069X; Hermann B, 2015, NATURE, V520, P706, DOI 10.1038/nature14109; Kaiser NK, 2011, ANAL CHEM, V83, P6907, DOI 10.1021/ac201546d; KRUEGER RJ, 1982, BIOCHEMISTRY-US, V21, P2892, DOI 10.1021/bi00541a014; Leal SS, 2007, PROTEINS, V68, P606, DOI 10.1002/prot.21448; LEDFORD EB, 1984, ANAL CHEM, V56, P2744, DOI 10.1021/ac00278a027; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Marshall AG, 1996, RAPID COMMUN MASS SP, V10, P1819, DOI 10.1002/(SICI)1097-0231(199611)10:14<1819::AID-RCM686>3.0.CO;2-Z; MURPHY MJ, 1973, J BIOL CHEM, V248, P2801; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; OSTROWSKI J, 1989, J BACTERIOL, V171, P130, DOI 10.1128/jb.171.1.130-140.1989; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15726; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; PEAKMAN T, 1990, EUR J BIOCHEM, V191, P325, DOI 10.1111/j.1432-1033.1990.tb19126.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PILON M, 1992, J BIOL CHEM, V267, P19907; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rollings J. E., 1992, LASER LIGHT SCATTERI, P275; ROSE WC, 1950, J BIOL CHEM, V182, P541; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Sambrook J., 1989, MOL CLONING LAB MANU; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Senko MW, 1997, J AM SOC MASS SPECTR, V8, P970, DOI 10.1016/S1044-0305(97)00126-8; Shi SDH, 2000, INT J MASS SPECTROM, V195, P591, DOI 10.1016/S1387-3806(99)00226-2; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Sibille N, 2005, BIOCHEMISTRY-US, V44, P9086, DOI 10.1021/bi050437p; SIEGEL LM, 1982, J BIOL CHEM, V257, P6343; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SIEGEL LM, 1974, J BIOL CHEM, V249, P1587; SIEGEL LM, 1973, J BIOL CHEM, V248, P251; SIEGEL LM, 1974, J BIOL CHEM, V249, P1572; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Smith KW, 2012, BIOCHEMISTRY-US, V51, P9857, DOI 10.1021/bi300947a; STEUBER J, 1994, ARCH MICROBIOL, V162, P255, DOI 10.1007/s002030050134; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Swamy U, 2005, BIOCHEMISTRY-US, V44, P16054, DOI 10.1021/bi050981y; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wilcox BE, 2002, J AM SOC MASS SPECTR, V13, P1304, DOI 10.1016/S1044-0305(02)00622-0; Wu HC, 1998, MOL MICROBIOL, V27, P493, DOI 10.1046/j.1365-2958.1998.00699.x; WU JY, 1991, J BACTERIOL, V173, P325, DOI 10.1128/jb.173.1.325-333.1991; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024; Zeghouf M, 2000, J BIOL CHEM, V275, P37651, DOI 10.1074/jbc.M005619200; Zeghouf M, 1998, BIOCHEMISTRY-US, V37, P6114, DOI 10.1021/bi9728699; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203	69	8	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19319	19333		10.1074/jbc.M115.662379	http://dx.doi.org/10.1074/jbc.M115.662379			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26088143	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000358781100043
J	Motozono, C; Pearson, JA; De Leenheer, E; Rizkallah, PJ; Beck, K; Trimby, A; Sewell, AK; Wong, FS; Cole, DK				Motozono, Chihiro; Pearson, James A.; De Leenheer, Evy; Rizkallah, Pierre J.; Beck, Konrad; Trimby, Andrew; Sewell, Andrew K.; Wong, F. Susan; Cole, David K.			Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; KILL BETA-CELLS; CD8 CORECEPTOR; NOD MICE; MOLECULAR MIMICRY; STRUCTURAL BASIS; SELF-PEPTIDE; TCR-BINDING; MHC; RECOGNITION	The non-obese diabetic mouse model of type 1 diabetes continues to be an important tool for delineating the role of T-cell mediated destruction of pancreatic beta-cells. However, little is known about the molecular mechanisms that enable this disease pathway. We show that insulin reactivity by a CD8(+) T-cell clone, known to induce type 1 diabetes, is characterized by weak T-cell antigen receptor binding to a relatively unstable peptide-MHC. The structure of the native 9- and 10-mer insulin epitopes demonstrated that peptide residues 7 and 8 form a prominent solvent-exposed bulge that could potentially be the main focus of T-cell receptor binding. The C terminus of the peptide governed peptide-MHC stability. Unexpectedly, we further demonstrate a novel mode of flexible peptide presentation in which the MHC peptide-binding groove is able to "open the back door" to accommodate extra C-terminal peptide residues.	[Motozono, Chihiro; Rizkallah, Pierre J.; Trimby, Andrew; Sewell, Andrew K.; Cole, David K.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Pearson, James A.; De Leenheer, Evy; Wong, F. Susan] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales; [Motozono, Chihiro] Kinki Univ, Sch Med, Dept Immunol, Osaka 5898511, Japan; [Beck, Konrad] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales	Cardiff University; Cardiff University; Kindai University (Kinki University); Cardiff University	Wong, FS (corresponding author), Cardiff Univ, Sch Med, Inst Mol & Expt Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	wongfs@cf.ac.uk	Sewell, Andrew/GPT-4220-2022; Rizkallah, Pierre J/A-5367-2012; Beck, Konrad/AAX-1351-2020	Sewell, Andrew/0000-0003-3194-3135; Rizkallah, Pierre J/0000-0002-9290-0369; Beck, Konrad/0000-0001-5098-9484; Pearson, James/0000-0002-2867-2269; Cole, David/0000-0003-0028-9396; Wong, F. Susan/0000-0002-2812-8845	Wellcome Trust ISSF grant; United Kingdom Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Medical Research Council [G0901155]; Diabetes UK PhD studentship; Research Councils United Kingdom fellowship; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI; MRC [G0901155] Funding Source: UKRI	Wellcome Trust ISSF grant(Wellcome Trust); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK PhD studentship(Diabetes UK); Research Councils United Kingdom fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust ISSF grant (to F. S. W., D. K. C., and A. K. S.), United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/H001085/1 (to A. K. S.), and Medical Research Council Grant G0901155 (to F. S. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Diabetes UK PhD studentship.; Supported by a Research Councils United Kingdom fellowship.	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Alleva DG, 2002, DIABETES, V51, P2126, DOI 10.2337/diabetes.51.7.2126; Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Babad J, 2010, IMMUNOLOGY, V131, P459, DOI 10.1111/j.1365-2567.2010.03362.x; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2014, J BIOL CHEM, V289, P628, DOI 10.1074/jbc.M113.522110; Cole DK, 2012, IMMUNOLOGY, V137, P139, DOI 10.1111/j.1365-2567.2012.03625.x; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; de Marquesini LGP, 2008, EUR J IMMUNOL, V38, P240, DOI 10.1002/eji.2007377621; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Ekeruche-Makinde J, 2012, J BIOL CHEM, V287, P37269, DOI 10.1074/jbc.M112.386409; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Martinez CR, 2012, CHEM SCI, V3, P2191, DOI 10.1039/c2sc20045g; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melenhorst JJ, 2008, J IMMUNOL METHODS, V338, P31, DOI 10.1016/j.jim.2008.07.008; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Sandalova T, 2005, J BIOL CHEM, V280, P27069, DOI 10.1074/jbc.M500927200; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Uchtenhagen H, 2013, EUR J IMMUNOL, V43, P3051, DOI 10.1002/eji.201343456; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vizler C, 1999, IMMUNOL REV, V169, P81; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299; Wong FS, 1998, J EXP MED, V187, P1985; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	68	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18924	18933		10.1074/jbc.M114.622522	http://dx.doi.org/10.1074/jbc.M114.622522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085090	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000358781100005
J	Myers, CL; Ireland, RG; Garrett, TA; Brown, ED				Myers, Cullen L.; Ireland, Ronald G.; Garrett, Teresa A.; Brown, Eric D.			Characterization of Wall Teichoic Acid Degradation by the Bacteriophage phi 29 Appendage Protein GP12 Using Synthetic Substrate Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO RECONSTITUTION; CELL-WALL; STAPHYLOCOCCUS-AUREUS; PHOSPHODIESTERASE ACTIVITIES; GLYCEROL PHOSPHATE; POLYMERASE TAGF; MECHANISM; GLYCEROPHOSPHODIESTERASE; PROCESSIVITY; CATALYZES	The genetics and enzymology of the biosynthesis of wall teichoic acid have been the extensively studied, however, comparatively little is known regarding the enzymatic degradation of this biological polymer. The GP12 protein from the Bacillus subtilis bacteriophage phi 29 has been implicated as a wall teichoic acid hydrolase. We have studied the wall teichoic acid hydrolase activity of pure, recombinant GP12 using chemically defined wall teichoic acid analogs. The GP12 protein had potent wall teichoic acid hydrolytic activity in vitro and demonstrated similar to 13-fold kinetic preference for glycosylated poly(glycerol phosphate) teichoic acid compared with non-glycosylated. Product distribution patterns suggested that the degradation of glycosylated polymers proceeded from the hydroxyl terminus of the polymer, whereas hydrolysis occurred at random sites in the non-glycosylated polymer. In addition, we present evidence that the GP12 protein possesses both phosphodiesterase and phosphomonoesterase activities.	[Myers, Cullen L.; Ireland, Ronald G.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	McMaster University; Vassar College	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca		Ireland, Ronald G/0000-0002-4464-5412; Myers, Cullen/0000-0002-5789-2260	Canada Research Chair award; Canadian Institutes for Health Research [MOP-15496]	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canada Research Chair award (to E.D.B.) and Canadian Institutes for Health Research Grant MOP-15496. The authors declare that they have no conflicts of interest with the contents of this article.	Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; Badurina DS, 2003, BBA-PROTEINS PROTEOM, V1646, P196, DOI 10.1016/S1570-9639(03)00019-0; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Bulat E, 2011, J BIOL CHEM, V286, P33819, DOI 10.1074/jbc.M111.269779; Cox RS, 2007, J AM CHEM SOC, V129, P9550, DOI 10.1021/ja072647q; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Ghodge SV, 2013, J AM CHEM SOC, V135, P16360, DOI 10.1021/ja409376k; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; GLASER L, 1977, J BACTERIOL, V130, P610, DOI 10.1128/JB.130.2.610-619.1977; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; Hadler KS, 2008, J AM CHEM SOC, V130, P14129, DOI 10.1021/ja803346w; Hadler KS, 2010, J INORG BIOCHEM, V104, P211, DOI 10.1016/j.jinorgbio.2009.10.012; Hadler KS, 2009, J AM CHEM SOC, V131, P11900, DOI 10.1021/ja903534f; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; KUSSER W, 1983, J BACTERIOL, V155, P302, DOI 10.1128/JB.155.1.302-310.1983; KUSSER W, 1984, FEBS LETT, V166, P301, DOI 10.1016/0014-5793(84)80100-3; KUSSER W, 1982, FEBS LETT, V149, P67, DOI 10.1016/0014-5793(82)81073-9; LANG WK, 1982, J BACTERIOL, V151, P367, DOI 10.1128/JB.151.1.367-375.1982; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; MAUCK J, 1971, J BIOL CHEM, V246, P1820; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pereira MP, 2008, CHEMBIOCHEM, V9, P1385, DOI 10.1002/cbic.200800026; Pereira MP, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P337; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Schenk G, 2012, ACCOUNTS CHEM RES, V45, P1593, DOI 10.1021/ar300067g; Schertzer JW, 2008, J BACTERIOL, V190, P6940, DOI 10.1128/JB.00851-08; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Schulz EC, 2011, CURR OPIN STRUC BIOL, V21, P232, DOI 10.1016/j.sbi.2011.01.009; Sewell EWC, 2014, J ANTIBIOT, V67, P43, DOI 10.1038/ja.2013.100; Sewell EWC, 2009, J BIOL CHEM, V284, P21132, DOI 10.1074/jbc.M109.010215; Sobhanifar S, 2015, P NATL ACAD SCI USA, V112, pE576, DOI 10.1073/pnas.1418084112; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wang H, 2013, CHEM BIOL, V20, P272, DOI 10.1016/j.chembiol.2012.11.013; Wiersma-Koch H, 2013, BIOCHEMISTRY-US, V52, P9167, DOI 10.1021/bi4010045; Winstel V, 2014, INT J MED MICROBIOL, V304, P215, DOI 10.1016/j.ijmm.2013.10.009; WISE EM, 1972, P NATL ACAD SCI USA, V69, P233, DOI 10.1073/pnas.69.1.233; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009	54	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19133	19145		10.1074/jbc.M115.662866	http://dx.doi.org/10.1074/jbc.M115.662866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085106	Green Published, hybrid			2022-12-28	WOS:000358781100029
J	Chang, HHY; Watanabe, G; Lieber, MR				Chang, Howard H. Y.; Watanabe, Go; Lieber, Michael R.			Unifying the DNA End-processing Roles of the Artemis Nuclease KU-DEPENDENT ARTEMIS RESECTION AT BLUNT DNA ENDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINED IMMUNE-DEFICIENCY; CODING JOINT FORMATION; V(D)J RECOMBINATION; PROTEIN-KINASE; ENDONUCLEASE ACTIVITY; BREAK REPAIR; PKCS; CELLS; MECHANISM; HAIRPINS	Artemis is a member of the metallo-beta-lactamase protein family of nucleases. It is essential in vertebrates because, during V(D)J recombination, the RAG complex generates hairpins when it creates the double strand breaks at V, D, and J segments, and Artemis is required to open the hairpins so that they can be joined. Artemis is a diverse endo-and exonuclease, and creating a unified model for its wide range of nuclease properties has been challenging. Here we show that Artemis resects iteratively into blunt DNA ends with an efficiency that reflects the AT-richness of the DNA end. GC-rich ends are not cut by Artemis alone because of a requirement for DNA end breathing (and confirmed using fixed pseudo-Y structures). All DNA ends are cut when both the DNA-dependent protein kinase catalytic subunit and Ku accompany Artemis but not when Ku is omitted. These are the first biochemical data demonstrating a Ku dependence of Artemis action on DNA ends of any configuration. The action of Artemis at blunt DNA ends is slower than at overhangs, consistent with a requirement for a slow DNA end breathing step preceding the cut. The AT sequence dependence, the order of strand cutting, the length of the cuts, and the Ku-dependence of Artemis action at blunt ends can be reconciled with the other nucleolytic properties of both Artemis and Artemis DNA-PKcs in a model incorporating DNA end breathing of blunt ends to form transient single to double strand boundaries that have structural similarities to hairpins and fixed 5' and 3' overhangs.	[Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Immunol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA.	lieber@usc.edu	Regan, Clinton/E-6250-2012	Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health (to M. R. L.). The authors declare that they have no conflicts of interest with the contents of this article.	BLOMMERS MJJ, 1989, BIOCHEMISTRY-US, V28, P7491, DOI 10.1021/bi00444a049; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Kulesza P, 1998, NUCLEIC ACIDS RES, V26, P3944, DOI 10.1093/nar/26.17.3944; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lu H, 2008, MOL CELL, V31, P485, DOI 10.1016/j.molcel.2008.05.029; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Povirk Lawrence F, 2012, ISRN Mol Biol, V2012, DOI 10.5402/2012/345805; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Touvrey C, 2008, MOL IMMUNOL, V45, P3383, DOI 10.1016/j.molimm.2008.04.004; Tsai AG, 2009, J BIOL CHEM, V284, P7157, DOI 10.1074/jbc.M806866200; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Yannone SM, 2008, NUCLEIC ACIDS RES, V36, P3354, DOI 10.1093/nar/gkn205	30	33	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24036	24050		10.1074/jbc.M115.680900	http://dx.doi.org/10.1074/jbc.M115.680900			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276388	Green Published, hybrid			2022-12-28	WOS:000362218900001
J	Fazakerley, DJ; Naghiloo, S; Chaudhuri, R; Koumanov, F; Burchfield, JG; Thomas, KC; Krycer, JR; Prior, MJ; Parker, BL; Murrow, BA; Stockli, J; Meoli, CC; Holman, GD; James, DE				Fazakerley, Daniel J.; Naghiloo, Sheyda; Chaudhuri, Rima; Koumanov, Francoise; Burchfield, James G.; Thomas, Kristen C.; Krycer, James R.; Prior, Matthew J.; Parker, Ben L.; Murrow, Beverley A.; Stoeckli, Jacqueline; Meoli, Christopher C.; Holman, Geoffrey D.; James, David E.			Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; CELL-SURFACE GLUT4; RAT ADIPOSE-CELLS; STIMULATED TRANSLOCATION; PROTEIN; TISSUE; BINDING; SUFFICIENT; METFORMIN; INCREASES	Insulin signaling augments glucose transport by regulating glucose transporter 4 (GLUT4) trafficking from specialized intracellular compartments, termed GLUT4 storage vesicles (GSVs), to the plasma membrane. Proteomic analysis of GSVs by mass spectrometry revealed enrichment of 59 proteins in these vesicles. We measured reduced abundance of 23 of these proteins following insulin stimulation and assigned these as high confidence GSV proteins. These included established GSV proteins such as GLUT4 and insulin-responsive aminopeptidase, as well as six proteins not previously reported to be localized to GSVs. Tumor suppressor candidate 5 (TUSC5) was shown to be a novel GSV protein that underwent a 3.7-fold increase in abundance at the plasma membrane in response to insulin. siRNA-mediated knockdown of TUSC5 decreased insulin-stimulated glucose uptake, although overexpression of TUSC5 had the opposite effect, implicating TUSC5 as a positive regulator of insulin-stimulated glucose transport in adipocytes. Incubation of adipocytes with TNF alpha caused insulin resistance and a concomitant reduction in TUSC5. Consistent with previous studies, peroxisome proliferator-activated receptor (PPAR) gamma agonism reversed TNF alpha-induced insulin resistance. TUSC5 expression was necessary but insufficient for PPAR gamma-mediated reversal of insulin resistance. These findings functionally link TUSC5 to GLUT4 trafficking, insulin action, insulin resistance, and PPAR gamma action in the adipocyte. Further studies are required to establish the exact role of TUSC5 in adipocytes.	[Fazakerley, Daniel J.; Naghiloo, Sheyda; Chaudhuri, Rima; Burchfield, James G.; Thomas, Kristen C.; Krycer, James R.; Parker, Ben L.; Stoeckli, Jacqueline; Meoli, Christopher C.; James, David E.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Fazakerley, Daniel J.; Naghiloo, Sheyda; Chaudhuri, Rima; Burchfield, James G.; Krycer, James R.; Prior, Matthew J.; Parker, Ben L.; Murrow, Beverley A.; Stoeckli, Jacqueline; Meoli, Christopher C.; James, David E.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Koumanov, Francoise; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of Bath	James, DE (corresponding author), Univ Sydney, Sch Med, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au	Stoeckli, Jacqueline/Z-4443-2019; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/D-7053-2016; Burchfield, James/C-1779-2019; Koumanov, Francoise/AAV-7654-2020	Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Burchfield, James/0000-0002-6609-6151; Koumanov, Francoise/0000-0002-9029-3390; James, David/0000-0001-5946-5257; Holman, Geoffrey/0000-0001-7045-1358; Krycer, James/0000-0003-1536-7270; Cooke, Kristen/0000-0002-3534-1660	National Health and Medical Research Council of Australia [1052782]; Medical Research Council UK; Diabetes UK; National Health and Medical Research Council of Australia Early Career Fellowships; British Heart Foundation [PG/11/52/28989] Funding Source: researchfish; Medical Research Council [G9225018, MR/J003417/1, G0300415] Funding Source: researchfish; MRC [MR/J003417/1, G0300415, G9225018] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); National Health and Medical Research Council of Australia Early Career Fellowships(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 1052782 (to D.J.F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Medical Research Council UK and Diabetes UK.; Supported by National Health and Medical Research Council of Australia Early Career Fellowships.	Ahuja HS, 2001, MOL PHARMACOL, V59, P765, DOI 10.1124/mol.59.4.765; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Chen Y., 2013, COMMUN INTEGRATIVE B, V6, P545; Ciaraldi TP, 2002, DIABETES, V51, P30, DOI 10.2337/diabetes.51.1.30; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HOFMANN C, 1991, ENDOCRINOLOGY, V129, P1915, DOI 10.1210/endo-129-4-1915; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; IWAMOTO Y, 1991, DIABETES CARE, V14, P1083, DOI 10.2337/diacare.14.11.1083; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2005, DIABETES, V54, P1459, DOI 10.2337/diabetes.54.5.1459; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; Kim KY, 2007, MOL PHARMACOL, V71, P1554, DOI 10.1124/mol.106.031948; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; Knotts T. A., 2010, PPAR RES; Konishi H, 2003, ONCOGENE, V22, P1892, DOI 10.1038/sj.onc.1206304; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; Malide D, 2001, MOL BIOL CELL, V12, P101, DOI 10.1091/mbc.12.1.101; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ohiro Y, 2002, FEBS LETT, V524, P163, DOI 10.1016/S0014-5793(02)03049-1; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; R Development Core Team, 2009, R LANG ENV STAT COMP; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shibata T, 2007, MOL CELL ENDOCRINOL, V263, P38, DOI 10.1016/j.mce.2006.08.007; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sommer C., 2011, IEEE 8 INT S BIOM IM; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; VOLCHUK A, 1995, J BIOL CHEM, V270, P8233, DOI 10.1074/jbc.270.14.8233; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Yamakuni T, 2002, FEBS LETT, V530, P94, DOI 10.1016/S0014-5793(02)03431-2; Yang P., 2015, DIRECT ANAL PATHWAYS; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YOUNG PW, 1995, DIABETES, V44, P1087, DOI 10.2337/diabetes.44.9.1087	72	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23528	23542		10.1074/jbc.M115.657361	http://dx.doi.org/10.1074/jbc.M115.657361			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240143	Green Published, hybrid			2022-12-28	WOS:000361816500006
J	Kakar, S; Fang, XY; Lubkowska, L; Zhou, YN; Shaw, GX; Wang, YX; Jin, DJ; Kashlev, M; Ji, XH				Kakar, Smita; Fang, Xianyang; Lubkowska, Lucyna; Zhou, Yan Ning; Shaw, Gary X.; Wang, Yun-Xing; Jin, Ding Jun; Kashlev, Mikhail; Ji, Xinhua			Allosteric Activation of Bacterial Swi2/Snf2 (Switch/Sucrose Non-fermentable) Protein RapA by RNA Polymerase BIOCHEMICAL AND STRUCTURAL STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; MOLECULAR-STRUCTURE DETERMINATION; REPAIR COUPLING FACTOR; BIOLOGICAL MACROMOLECULES; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; XPLOR-NIH; TRANSCRIPTION	Members of the Swi2/Snf2 (switch/sucrose non-fermentable) family depend on their ATPase activity to mobilize nucleic acid-protein complexes for gene expression. In bacteria, RapA is an RNA polymerase (RNAP)-associated Swi2/Snf2 protein that mediates RNAP recycling during transcription. It is known that the ATPase activity of RapA is stimulated by its interaction with RNAP. It is not known, however, how the RapA-RNAP interaction activates the enzyme. Previously, we determined the crystal structure of RapA. The structure revealed the dynamic nature of its N-terminal domain (Ntd), which prompted us to elucidate the solution structure and activity of both the full-length protein and its Ntd-truncated mutant (RapA Delta N). Here, we report the ATPase activity of RapA and RapA Delta N in the absence or presence of RNAP and the solution structures of RapA and RapA Delta N either ligand-free or in complex with RNAP. Determined by small-angle x-ray scattering, the solution structures reveal a new conformation of RapA, define the binding mode and binding site of RapA on RNAP, and show that the binding sites of RapA and sigma(70) on the surface of RNAP largely overlap. We conclude that the ATPase activity of RapA is inhibited by its Ntd but stimulated by RNAP in an allosteric fashion and that the conformational changes of RapA and its interaction with RNAP are essential for RNAP recycling. These and previous findings outline the functional cycle of RapA, which increases our understanding of the mechanism and regulation of Swi2/Snf2 proteins in general and of RapA in particular. The new structural information also leads to a hypothetical model of RapA in complex with RNAP immobilized during transcription.	[Ji, Xinhua] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Fang, Xianyang; Wang, Yun-Xing] NCI, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Lubkowska, Lucyna; Zhou, Yan Ning; Jin, Ding Jun; Kashlev, Mikhail] NCI, Gene Regulat & Chromosome Biol Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jin, DJ (corresponding author), NCI, Gene Regulat & Chromosome Biol Lab, NIH, Frederick, MD 21702 USA.	jind@mail.nih.gov; kashlevm@mail.nih.gov; jix@mail.nih.gov	Ji, Xinhua/C-9664-2012	Ji, Xinhua/0000-0001-6942-1514; Fang, Xianyang/0000-0001-9432-9736	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC010326] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Xiaobing Zuo and Randall Winans for assistance with the SAXS experiments, Dr. Charles D. Schwieters for helpful discussions of Xplor-NIH, and Dr. Genbin Shi for critical reading of the manuscript. SAXS was collected at the Advanced Photon Source (APS), Argonne National Laboratory. Use of the APS was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357 and under Partner User Proposal PUP 22978. In-gel digestion and mass spectrometry were performed at the Protein Chemistry Laboratory, Frederick National Laboratory for Cancer Research.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Jin DJ, 2011, BBA-GENE REGUL MECH, V1809, P470, DOI 10.1016/j.bbagrm.2011.03.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Liu B, 2015, P NATL ACAD SCI USA, V112, P2006, DOI 10.1073/pnas.1417152112; Miropolskaya N, 2009, P NATL ACAD SCI USA, V106, P18942, DOI 10.1073/pnas.0905402106; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Muzzin O, 1998, J BIOL CHEM, V273, P15157, DOI 10.1074/jbc.273.24.15157; Nechaev S, 2008, STRUCTURE, V16, P1294, DOI 10.1016/j.str.2008.08.001; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Sukhodolets MV, 1998, J BIOL CHEM, V273, P7018, DOI 10.1074/jbc.273.12.7018; Sukhodolets MV, 2003, METHOD ENZYMOL, V370, P283; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Sukhodolets MV, 2000, J BIOL CHEM, V275, P22090, DOI 10.1074/jbc.M000056200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P1714, DOI 10.1021/bi061905d; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; WNENDT S, 1990, EUR J BIOCHEM, V191, P467, DOI 10.1111/j.1432-1033.1990.tb19145.x; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104; Zuo XB, 2008, J AM CHEM SOC, V130, P3292, DOI 10.1021/ja7114508; Zuo XB, 2010, P NATL ACAD SCI USA, V107, P1385, DOI 10.1073/pnas.0908140107	47	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23656	23669		10.1074/jbc.M114.618801	http://dx.doi.org/10.1074/jbc.M114.618801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26272746	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000361816500016
J	Otsubo, C; Bharathi, S; Uppala, R; Ilkayeva, OR; Wang, D; McHugh, K; Zou, Y; Wang, J; Alcorn, JF; Zuo, YY; Hirschey, MD; Goetzman, ES				Otsubo, Chikara; Bharathi, Sivakama; Uppala, Radha; Ilkayeva, Olga R.; Wang, Dongning; McHugh, Kevin; Zou, Ye; Wang, Jieru; Alcorn, John F.; Zuo, Yi Y.; Hirschey, Matthew D.; Goetzman, Eric S.			Long-chain Acylcarnitines Reduce Lung Function by Inhibiting Pulmonary Surfactant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE-DEFICIENCY; BETA-OXIDATION; L-CARNITINE; MILDRONATE; PLASMA; DRUG; PALMITOYLCARNITINE; ENHANCEMENT; MEMBRANE; MUTATION	The role of mitochondrial energy metabolism in maintaining lung function is not understood. We previously observed reduced lung function in mice lacking the fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase (LCAD). Here, we demonstrate that long-chain acylcarnitines, a class of lipids secreted by mitochondria when metabolism is inhibited, accumulate at the air-fluid interface in LCAD(-/-) lungs. Acylcarnitine accumulation is exacerbated by stress such as influenza infection or by dietary supplementation with L-carnitine. Long-chain acylcarnitines co-localize with pulmonary surfactant, a unique film of phospholipids and proteins that reduces surface tension and prevents alveolar collapse during breathing. In vitro, the long-chain species palmitoylcarnitine directly inhibits the surface adsorption of pulmonary surfactant as well as its ability to reduce surface tension. Treatment of LCAD(-/-) mice with mildronate, a drug that inhibits carnitine synthesis, eliminates acylcarnitines and improves lung function. Finally, acylcarnitines are detectable in normal human lavage fluid. Thus, long-chain acylcarnitines may represent a risk factor for lung injury in humans with dysfunctional fatty acid oxidation.	[Otsubo, Chikara; Bharathi, Sivakama; Uppala, Radha; McHugh, Kevin; Wang, Jieru; Alcorn, John F.; Goetzman, Eric S.] Univ Pittsburgh, Dept Pediat, Sch Med, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15224 USA; [Ilkayeva, Olga R.; Wang, Dongning; Hirschey, Matthew D.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Durham, NC 27701 USA; [Zou, Ye; Zuo, Yi Y.] Univ Hawaii Manoa, Dept Mech Engn, Honolulu, HI 96822 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University of Hawaii System; University of Hawaii Manoa	Goetzman, ES (corresponding author), Univ Pittsburgh, Dept Pediat, Sch Med, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15224 USA.	Eric.goetzman@chp.edu	Zou, Ye/AAY-1073-2021; Zuo, Yi Y./B-3177-2013	Zuo, Yi Y./0000-0002-3992-3238; Hirschey, Matthew/0000-0003-4541-5376; Zou, Ye/0000-0002-3145-9661	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000371] Funding Source: Medline; NHLBI NIH HHS [R01 HL113655] Funding Source: Medline; NIMHD NIH HHS [U54 MD007584] Funding Source: Medline; Div Of Chem, Bioeng, Env, & Transp Sys [1254795] Funding Source: National Science Foundation	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bakermans AJ, 2013, J INHERIT METAB DIS, V36, P973, DOI 10.1007/s10545-013-9604-4; BRACIALE TJ, 1977, CELL IMMUNOL, V33, P423, DOI 10.1016/0008-8749(77)90170-8; DATORRE SD, 1991, J MOL CELL CARDIOL, V23, P11, DOI 10.1016/0022-2828(91)90019-I; Doi N, 2011, DRUG METAB PHARMACOK, V26, P162, DOI 10.2133/dmpk.DMPK-10-RG-071; Duan YL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-4; Duizer E, 1998, J PHARMACOL EXP THER, V287, P395; Dzerve V, 2011, MEDICINA-LITHUANIA, V47, P544; Gentili A, 2008, MINERVA ANESTESIOL, V74, P207; Goetzman ES, 2014, J BIOL CHEM, V289, P10668, DOI 10.1074/jbc.M113.540260; Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Hayashi M, 1999, J CONTROL RELEASE, V62, P141, DOI 10.1016/S0168-3659(99)00031-0; Icard P, 1999, AM J PHYSIOL-LUNG C, V277, pL1232, DOI 10.1152/ajplung.1999.277.6.L1232; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kao HJ, 2006, HUM MOL GENET, V15, P3569, DOI 10.1093/hmg/ddl433; KURTH L, 1994, BBA-GEN SUBJECTS, V1201, P321, DOI 10.1016/0304-4165(94)90057-4; Liepinsh E, 2011, J PHARM PHARMACOL, V63, P1195, DOI 10.1111/j.2042-7158.2011.01325.x; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lopez-Rodriguez E., 2014, BIOCH BIOPHYS ACTA; Lundy CT, 2003, J INHERIT METAB DIS, V26, P537, DOI 10.1023/A:1025995813914; Madala SK, 2011, PULM MED, V2011, DOI 10.1155/2011/653524; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Miller ML, 1995, TISSUE CELL, V27, P613, DOI 10.1016/S0040-8166(05)80017-5; Millington DS, 2011, METHODS MOL BIOL, V708, P55, DOI 10.1007/978-1-61737-985-7_3; Nasser M., 2012, COCHRANE DB SYST REV, V2, P1; Onofrj M, 2013, EXPERT REV NEUROTHER, V13, P925, DOI 10.1586/14737175.2013.814930; REQUERO MA, 1995, BIOCHEMISTRY-US, V34, P10400, DOI 10.1021/bi00033a011; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Sjakste N, 2005, CNS DRUG REV, V11, P151; Spiekerkoetter U, 2004, MUSCLE NERVE, V29, P66, DOI 10.1002/mus.10500; Tyni T, 1997, J PEDIATR-US, V130, P67, DOI 10.1016/S0022-3476(97)70312-3; Ussher JR, 2014, J PHARMACOL EXP THER, V349, P487, DOI 10.1124/jpet.114.214197; Valle R. P., 2014, ACS SUSTAIN CHEM ENG, V2, P6; Veiga MP, 1996, MOL MEMBR BIOL, V13, P165, DOI 10.3109/09687689609160593; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Zhu Y, 2013, CLIN DRUG INVEST, V33, P755, DOI 10.1007/s40261-013-0121-x; Zuo YY, 2004, BBA-GEN SUBJECTS, V1675, P12, DOI 10.1016/j.bbagen.2004.08.003	43	36	36	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23897	23904		10.1074/jbc.M115.655837	http://dx.doi.org/10.1074/jbc.M115.655837			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240137	hybrid, Green Published			2022-12-28	WOS:000361816500035
J	Dai, C; Miao, CX; Xu, XM; Liu, LJ; Gu, YF; Zhou, D; Chen, LS; Lin, G; Lu, GX				Dai, Can; Miao, Cong-Xiu; Xu, Xiao-Ming; Liu, Lv-Jun; Gu, Yi-Fan; Zhou, Di; Chen, Lian-Sheng; Lin, Ge; Lu, Guang-Xiu			Transcriptional Activation of Human CDCA8 Gene Regulated by Transcription Factor NF-Y in Embryonic Stem Cells and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-APOPTOSIS GENE; EXPRESSION; SURVIVIN; BOREALIN; PROGNOSIS; PROTEIN; CYCLE; IDENTIFICATION; ACCUMULATION; CARCINOMAS	The cell division cycle associated 8 (CDCA8) gene plays an important role in mitosis. Overexpression of CDCA8 was reported in some human cancers and is required for cancer growth and progression. We found CDCA8 expression was also high in human ES cells (hESCs) but dropped significantly upon hESC differentiation. However, the regulation of CDCA8 expression has not yet been studied. Here, we characterized the CDCA8 promoter and identified its cis-elements and transcription factors. Three transcription start sites were identified. Reporter gene assays revealed that the CDCA8 promoter was activated in hESCs and cancer cell lines. The promoter drove the reporter expression specifically to pluripotent cells during early mouse embryo development and to tumor tissues in tumor-bearing mice. These results indicate that CDCA8 is transcriptionally activated in hESCs and cancer cells. Mechanistically, two key activation elements, bound by transcription factor NF-Y and CREB1, respectively, were identified in the CDCA8 basic promoter by mutation analyses and electrophoretic motility shift assays. NF-Y binding is positively correlated with promoter activities in different cell types. Interestingly, the NF-YA subunit, binding to the promoter, is primarily a short isoform in hESCs and a long isoform in cancer cells, indicating a different activation mechanism of the CDCA8 transcription between hESCs and cancer cells. Finally, enhanced CDCA8 promoter activities by NF-Y overexpression and reduced CDCA8 transcription by NF-Y knockdown further verified that NF-Y is a positive regulator of CDCA8 transcription. Our study unearths the molecular mechanisms underlying the activation of CDCA8 expression in hESCs and cancer cells, which provides a better understanding of its biological functions.	[Dai, Can; Miao, Cong-Xiu; Xu, Xiao-Ming; Liu, Lv-Jun; Gu, Yi-Fan; Zhou, Di; Lin, Ge; Lu, Guang-Xiu] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China; [Dai, Can; Chen, Lian-Sheng; Lin, Ge; Lu, Guang-Xiu] Natl Engn & Res Ctr Human Stem Cell, Changsha 410205, Hunan, Peoples R China; [Dai, Can; Gu, Yi-Fan] Cent S Univ, Sch Basic Med Sci, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University	Lin, G (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China.	linge_csu@yahoo.com; lugxdirector@aliyun.com			National Basic Research Program of China 973 Program [2011CB964900, 2012CB944901]; Hunan Provincial Natural Science Foundation of China [13JJ4012]; Post-doctoral Foundation of Central South University [105378]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Post-doctoral Foundation of Central South University	This work was supported by National Basic Research Program of China 973 Program, Grants 2011CB964900 and 2012CB944901, the Hunan Provincial Natural Science Foundation of China Grant 13JJ4012, and the Post-doctoral Foundation of Central South University Grant 105378. The authors declare that they have no conflicts of interest with the contents of this article.	Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Araki K, 2004, J NEURO-ONCOL, V67, P53, DOI 10.1023/B:NEON.0000021784.33421.05; Chang JL, 2006, EXP CELL RES, V312, P962, DOI 10.1016/j.yexcr.2005.12.015; Chen JS, 2004, CANCER GENE THER, V11, P740, DOI 10.1038/sj.cgt.7700752; Date DA, 2007, CELL BIOL INT, V31, P1470, DOI 10.1016/j.cellbi.2007.06.013; Dolfini D, 2012, STEM CELLS, V30, P2450, DOI 10.1002/stem.1232; Du Juan, 2004, Acta Genetica Sinica, V31, P956; Du Lili, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P1157; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Gerlach U, 2006, J PATHOL, V208, P462, DOI 10.1002/path.1914; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Higuchi T, 2003, NATURE, V426, P780, DOI 10.1038/426780a; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; LI XY, 1992, J BIOL CHEM, V267, P8984; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; Lu CD, 1998, CANCER RES, V58, P1808; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xie PY, 2014, STEM CELLS, V32, P391, DOI 10.1002/stem.1558; Zhang QJ, 2009, MOL BIOL REP, V36, P603, DOI 10.1007/s11033-008-9220-9; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	32	48	50	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22423	22434		10.1074/jbc.M115.642710	http://dx.doi.org/10.1074/jbc.M115.642710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26170459	hybrid, Green Published			2022-12-28	WOS:000361171500009
J	Li, H; Liu, Q; Wang, Z; Fang, RP; Shen, Y; Cai, XL; Gao, Y; Li, YH; Zhang, XD; Ye, LH				Li, Hang; Liu, Qian; Wang, Zhen; Fang, Runping; Shen, Yu; Cai, Xiaoli; Gao, Yuen; Li, Yinghui; Zhang, Xiaodong; Ye, Lihong			The Oncoprotein HBXIP Modulates the Feedback Loop of MDM2/p53 to Enhance the Growth of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTE PROLIFERATION; CENTROSOME DYNAMICS; CELL-PROLIFERATION; PROTEIN PROMOTES; UP-REGULATION; P53 FUNCTION; TRANSCRIPTION; EXPRESSION; TARGET; P300	MDM2 and p53 form a negative feedback loop, in which p53 as a transcription factor positively regulates MDM2 and MDM2 negatively regulates tumor suppressor p53 through promoting its degradation. However, the mechanism of the feedback loop is poorly understood in cancers. We had reported previously that the oncoprotein hepatitis B X-interacting protein (HBXIP) is a key oncoprotein in the development of cancer. Thus, we supposed that HBXIP might be involved in the event. Here, we observed that the expression levels of HBXIP were positively correlated to those of MDM2 in clinical breast cancer tissues. Interestingly, HBXIP was able to up-regulate MDM2 at the levels of mRNA and protein in MCF-7 breast cancer cells. Mechanically, HBXIP increased the promoter activities of MDM2 through directly binding to p53 in the P2 promoter of MDM2. Strikingly, we identified that the acetyltransferase p300 was recruited by HBXIP to p53 in the promoter of MDM2. Moreover, we validated that HBXIP enhanced the p53 degradation mediated by MDM2. Functionally, the knockdown of HBXIP or/and p300 inhibited the proliferation of breast cancer cells in vitro, and the depletion of MDM2 or overexpression of p53 significantly blocked the HBXIP-promoted growth of breast cancer in vitro and in vivo. Thus, we concluded that highly expressed HBXIP accelerates the MDM2-mediated degradation of p53 in breast cancer through modulating the feedback loop of MDM2/p53, resulting in the fast growth of breast cancer cells. Our findings provide new insights into the mechanism of the acceleration of the MDM2/p53 feedback loop in the development of cancer.	[Li, Hang; Liu, Qian; Wang, Zhen; Fang, Runping; Shen, Yu; Cai, Xiaoli; Li, Yinghui; Ye, Lihong] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China; [Gao, Yuen; Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Fang, Runping/AAF-6835-2020; Gao, Yuen/AAM-7541-2021	Gao, Yuen/0000-0002-2807-2976	National Basic Research Program of China (973 Program) [2015CB553905]; National Natural Science Foundation of China [81372186, 81272217, 81272218]; Project for Prevention and Treatment of Key Infectious Diseases [2014ZX0002002-005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Prevention and Treatment of Key Infectious Diseases	This work was supported by Grant 2015CB553905 from the National Basic Research Program of China (973 Program), Grants 81372186, 81272217, and 81272218 from the National Natural Science Foundation of China, and Grant 2014ZX0002002-005 from the Project for Prevention and Treatment of Key Infectious Diseases. The authors declare that they have no conflicts of interest with the contents of this article.	Amaral JD, 2007, J BIOL CHEM, V282, P34250, DOI 10.1074/jbc.M704075200; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chen HL, 2012, BIOMED PHARMACOTHER, V66, P334, DOI 10.1016/j.biopha.2011.12.005; D'Arcy P, 2009, CANCER LETT, V275, P285, DOI 10.1016/j.canlet.2008.10.030; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Debes JD, 2002, CANCER RES, V62, P5632; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Jenkins LMM, 2015, BIOCHEMISTRY-US, V54, P2001, DOI 10.1021/acs.biochem.5b00044; JUVEN T, 1993, ONCOGENE, V8, P3411; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Li SD, 2008, MOL THER, V16, P942, DOI 10.1038/mt.2008.51; Li Song, 2003, FASEB Journal, V17, P97; Li YH, 2014, CANCER LETT, V355, P288, DOI 10.1016/j.canlet.2014.09.047; Liu FB, 2014, CARCINOGENESIS, V35, P1144, DOI 10.1093/carcin/bgu021; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Maglic D, 2013, ONCOGENE, V32, P4120, DOI 10.1038/onc.2012.423; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miyajima K, 2001, CANCER LETT, V164, P177, DOI 10.1016/S0304-3835(00)00607-8; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Okita N, 2014, BIOCHEM BIOPH RES CO, V446, P91, DOI 10.1016/j.bbrc.2014.02.059; Onel K, 2004, MOL CANCER RES, V2, P1; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phelps M, 2003, CANCER RES, V63, P2616; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Sebti S, 2014, P NATL ACAD SCI USA, V111, P4115, DOI 10.1073/pnas.1313618111; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Turbin DA, 2006, MODERN PATHOL, V19, P69, DOI 10.1038/modpathol.3800484; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wang FZ, 2008, ACTA PHARMACOL SIN, V29, P83, DOI 10.1111/j.1745-7254.2008.00729.x; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu FQ, 2014, INT J ONCOL, V45, P255, DOI 10.3892/ijo.2014.2411; Xu FQ, 2013, CANCER LETT, V333, P124, DOI 10.1016/j.canlet.2013.01.029; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang X, 2012, J BIOL CHEM, V287, P30468, DOI 10.1074/jbc.M112.373738; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhang YY, 2013, BIOCHEM BIOPH RES CO, V434, P305, DOI 10.1016/j.bbrc.2013.02.123; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	59	21	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22649	22661		10.1074/jbc.M115.658468	http://dx.doi.org/10.1074/jbc.M115.658468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26229107	Green Published, hybrid			2022-12-28	WOS:000361171500030
J	Pal, R; Ramdzan, ZM; Kaur, S; Duquette, PM; Marcotte, R; Leduy, L; Davoudi, S; Lamarche-Vane, N; Iulianella, A; Nepveu, A				Pal, Ranjana; Ramdzan, Zubaidah M.; Kaur, Simran; Duquette, Philippe M.; Marcotte, Richard; Leduy, Lam; Davoudi, Sayeh; Lamarche-Vane, Nathalie; Iulianella, Angelo; Nepveu, Alain			CUX2 Protein Functions as an Accessory Factor in the Repair of Oxidative DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; AP-ENDONUCLEASE; CUT REPEATS; TRANSCRIPTION FACTORS; GLYCOSYLASE ACTIVITY; MOUSE MODELS; STIMULATION; EXPRESSION; BRAIN; GENE	CUX1 and CUX2 proteins are characterized by the presence of three highly similar regions called Cut repeats 1, 2, and 3. Although CUX1 is ubiquitously expressed, CUX2 plays an important role in the specification of neuronal cells and continues to be expressed in postmitotic neurons. Cut repeats from the CUX1 protein were recently shown to stimulate 8-oxoguanine DNA glycosylase 1 (OGG1), an enzyme that removes oxidized purines from DNA and introduces a single strand break through its apurinic/apyrimidinic lyase activity to initiate base excision repair. Here, we investigated whether CUX2 plays a similar role in the repair of oxidative DNA damage. Cux2 knockdown in embryonic cortical neurons increased levels of oxidative DNA damage. In vitro, Cut repeats from CUX2 increased the binding of OGG1 to 7,8-dihydro-8-oxoguanine-containing DNA and stimulated both the glycosylase and apurinic/apyrimidinic lyase activities of OGG1. Genetic inactivation in mouse embryo fibroblasts or CUX2 knockdown in HCC38 cells delayed DNA repair and increased DNA damage. Conversely, ectopic expression of Cut repeats from CUX2 accelerated DNA repair and reduced levels of oxidative DNA damage. These results demonstrate that CUX2 functions as an accessory factor that stimulates the repair of oxidative DNA damage. Neurons produce a high level of reactive oxygen species because of their dependence on aerobic oxidation of glucose as their source of energy. Our results suggest that the persistent expression of CUX2 in postmitotic neurons contributes to the maintenance of genome integrity through its stimulation of oxidative DNA damage repair.	[Pal, Ranjana; Ramdzan, Zubaidah M.; Kaur, Simran; Leduy, Lam; Nepveu, Alain] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kaur, Simran; Davoudi, Sayeh; Nepveu, Alain] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Duquette, Philippe M.; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Marcotte, Richard] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Iulianella, Angelo] Dalhousie Univ, Life Sci Res Inst, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Dalhousie University	Nepveu, A (corresponding author), Goodman Canc Res Ctr, 1160 Pine Ave West,Rm 414, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020	Pal, Ranjana/0000-0002-9824-6337; Iulianella, Angelo/0000-0003-0712-4295; Kaur, Simran/0000-0003-1510-928X	Canadian Foundation for Innovation; Ministere du Developpement economique, innovation et exportation Quebec	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ministere du Developpement economique, innovation et exportation Quebec	We are grateful to Drs. N. Noren Hooten and M. K. Evans (GST-OGG1) and Dr. G. Sauvageau (His-HOXB3) for generously providing plasmids. We are indebted to Drs. T. Paz-Elizur and Z. Livneh for the protocol on cleavage assays. Infrastructure support and technical assistance were made possible with funds from the Canadian Foundation for Innovation and the Ministere du Developpement economique, innovation et exportation Quebec.	Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Bachy I, 2011, DEV BIOL, V360, P77, DOI 10.1016/j.ydbio.2011.09.007; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Bruckner BA, 1999, METABOLISM, V48, P422, DOI 10.1016/S0026-0495(99)90098-7; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; CARADONNA SJ, 1982, MOL CELL BIOCHEM, V46, P49; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Conforto TL, 2012, MOL CELL BIOL, V32, P4611, DOI 10.1128/MCB.00886-12; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Cubelos B, 2008, DEV NEUROBIOL, V68, P917, DOI 10.1002/dneu.20626; Cubelos B, 2015, DEV NEUROBIOL, V75, P163, DOI 10.1002/dneu.22215; Cubelos Beatriz, 2010, Commun Integr Biol, V3, P483, DOI 10.4161/cib.3.6.12755; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Englander EW, 2008, MECH AGEING DEV, V129, P475, DOI 10.1016/j.mad.2008.02.001; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P169; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; HARADA R, 1994, J BIOL CHEM, V269, P2062; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hirano T, 1996, J GERONTOL A-BIOL, V51, pB303, DOI 10.1093/gerona/51A.5.B303; Hulea L, 2012, GENE, V497, P18, DOI 10.1016/j.gene.2012.01.039; Iulianella A, 2003, GENE EXPR PATTERNS, V3, P571, DOI 10.1016/S1567-133X(03)00123-6; Iulianella A, 2008, DEVELOPMENT, V135, P729, DOI 10.1242/dev.013276; Iulianella A, 2009, DEVELOPMENT, V136, P2329, DOI 10.1242/dev.032128; Jacobs AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081667; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Li Z, 2015, NUCLEIC ACIDS RES, V43, P3986, DOI 10.1093/nar/gkv283; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Magistretti PJ, 1996, CEREB CORTEX, V6, P50, DOI 10.1093/cercor/6.1.50; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Moore AW, 2008, CELL ADHES MIGR, V2, P81, DOI 10.4161/cam.2.2.6395; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Nakae D, 2000, LAB INVEST, V80, P249, DOI 10.1038/labinvest.3780028; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noren Hooten N, 2012, AGING-US, V4, P674, DOI 10.18632/aging.100492; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Quaggin SE, 1996, J BIOL CHEM, V271, P22624, DOI 10.1074/jbc.271.37.22624; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramdzan ZM, 2015, ONCOTARGET, V6, P3613, DOI 10.18632/oncotarget.2919; Ramdzan ZM, 2014, NAT REV CANCER, V14, P673, DOI 10.1038/nrc3805; Ramdzan ZM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001807; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Shen S, 2001, MUTAT RES-FUND MOL M, V480, P153, DOI 10.1016/S0027-5107(01)00179-8; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Viswanathan A, 1999, SCIENCE, V284, P159, DOI 10.1126/science.284.5411.159; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson DM, 2007, NEUROSCIENCE, V145, P1187, DOI 10.1016/j.neuroscience.2006.07.011; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wittmann W, 2014, DEV BIOL, V388, P35, DOI 10.1016/j.ydbio.2014.01.026; Yamada M, 2015, HIPPOCAMPUS, V25, P253, DOI 10.1002/hipo.22370	88	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22520	22531		10.1074/jbc.M115.651042	http://dx.doi.org/10.1074/jbc.M115.651042			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221032	Green Published, hybrid			2022-12-28	WOS:000361171500019
J	Samorodnitsky, D; Szyjka, C; Koudelka, GB				Samorodnitsky, Daniel; Szyjka, Courtney; Koudelka, Gerald B.			A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; STROMELYSIN-1 PROMOTER; UNSTRUCTURED REGION; IN-VIVO; DOMAIN; FAMILY; SITES; PU.1; PROTEINS; ENHANCER	ETS1 is the archetype of the ETS transcription factor (TF) family. ETS TFs share a DNA-binding domain, the ETS domain. All ETS TFs recognize a core GGA(A/T) binding site, and thus ETS TFs are found to redundantly regulate the same genes. However, each ETS TF has unique targets as well. One prevailing hypotheses explaining this duality is that protein-protein interactions, including homodimerization, allow each ETS TF to display distinct behavior. The behavior of ETS1 is further regulated by autoinhibition. Autoinhibition apparently modulates ETS1 DNA binding affinity, but the mechanism of this inhibition is not completely understood. We sought to characterize the relationship between DNA binding and ETS1 homodimer formation. We find that ETS1 interrogates DNA and forms dimers even when the DNA does not contain an ETS recognition sequence. Mutational studies also link nonspecific DNA backbone contacts with dimer formation, in addition to providing a new role for the recognition helix of ETS1 in maintaining the autoinhibited state. Finally, in showing that residues in the DNA recognition helix affect autoinhibition, we define a new function of ETS1 autoinhibition: maintenance of a monomeric state in the absence of DNA. The conservation of relevant amino acid residues across all ETS TFs indicates that the mechanisms of nonspecific DNA interrogation and protein oligomer formation elucidated here may be common to all ETS proteins that autoinhibit.	[Samorodnitsky, Daniel; Szyjka, Courtney; Koudelka, Gerald B.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Koudelka, GB (corresponding author), SUNY Buffalo, Dept Biol Sci, 109 Cooke Hall,North Campus, Buffalo, NY 14260 USA.	koudelka@buffalo.edu	Koudelka, Gerald B./AAI-3738-2020	Koudelka, Gerald B./0000-0001-6280-0837; Szyjka, Courtney/0000-0001-9991-8038	College of Arts and Sciences, University at Buffalo	College of Arts and Sciences, University at Buffalo	This work was supported by funds from the College of Arts and Sciences, University at Buffalo (to G. B. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Del S, 2014, J MOL BIOL, V426, P1390, DOI 10.1016/j.jmb.2013.11.031; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Graves BJ, 1996, NATURE, V384, P322, DOI 10.1038/384322a0; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gross P, 1998, BIOCHEMISTRY-US, V37, P5129, DOI 10.1021/bi972591k; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Leprivier G, 2009, NUCLEIC ACIDS RES, V37, P4341, DOI 10.1093/nar/gkp307; Li RH, 1999, P NATL ACAD SCI USA, V96, P3876, DOI 10.1073/pnas.96.7.3876; Lionneton F, 2003, ONCOGENE, V22, P9156, DOI 10.1038/sj.onc.1207241; Maxam A M, 1980, Methods Enzymol, V65, P499; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Poon GMK, 2012, BIOCHEMISTRY-US, V51, P4096, DOI 10.1021/bi300331v; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; Sharma S, 2014, NUCLEIC ACIDS RES, V42, P5543, DOI 10.1093/nar/gku211; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	34	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22101	22110		10.1074/jbc.M115.671339	http://dx.doi.org/10.1074/jbc.M115.671339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195629	Green Published, hybrid			2022-12-28	WOS:000360968500028
J	Yin, H; Frontini, MJ; Arpino, JM; Nong, ZX; O'Neil, C; Xu, YW; Balint, B; Ward, AD; Chakrabarti, S; Ellis, CG; Gros, R; Pickering, JG				Yin, Hao; Frontini, Matthew J.; Arpino, John-Michael; Nong, Zengxuan; O'Neil, Caroline; Xu, Yiwen; Balint, Brittany; Ward, Aaron D.; Chakrabarti, Subrata; Ellis, Christopher G.; Gros, Robert; Pickering, J. Geoffrey			Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PREMALIGNANT PROSTATE TUMORS; ANTIANGIOGENIC THERAPY; BLOOD-FLOW; VASCULAR NORMALIZATION; IN-VIVO; ANGIOGENESIS; FGF9; CANCER; MICE	Tumor vessel normalization has been proposed as a therapeutic paradigm. However, normal microvessels are hierarchical and vasoreactive with single file transit of red blood cells through capillaries. Such a network has not been identified in malignant tumors. We tested whether the chaotic tumor microcirculation could be reconfigured by the mesenchyme-selective growth factor, FGF9. Delivery of FGF9 to renal tumors in mice yielded microvessels that were covered by pericytes, smooth muscle cells, and a collagen-fortified basement membrane. This was associated with reduced pulmonary metastases. Intravital microvascular imaging revealed a haphazard web of channels in control tumors but a network of arterioles, bona fide capillaries, and venules in FGF9-expressing tumors. Moreover, whereas vasoreactivity was absent in control tumors, arterioles in FGF9-expressing tumors could constrict and dilate in response to adrenergic and nitric oxide releasing agents, respectively. These changes were accompanied by reduced hypoxia in the tumor core and reduced expression of the angiogenic factor VEGF-A. FGF9 was found to selectively amplify a population of PDGFR beta-positive stromal cells in the tumor and blocking PDGFR beta prevented microvascular differentiation by FGF9 and also worsened metastases. We conclude that harnessing local mesenchymal stromal cells with FGF9 can differentiate the tumor microvasculature to an extent not observed previously.	[Yin, Hao; Frontini, Matthew J.; Arpino, John-Michael; Nong, Zengxuan; O'Neil, Caroline; Xu, Yiwen; Balint, Brittany; Gros, Robert; Pickering, J. Geoffrey] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5A5, Canada; [Frontini, Matthew J.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Biochem, London, ON N6A 5A5, Canada; [Arpino, John-Michael; Xu, Yiwen; Balint, Brittany; Ward, Aaron D.; Ellis, Christopher G.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5A5, Canada; [Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada; [Gros, Robert] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5A5, Canada; [Gros, Robert; Pickering, J. Geoffrey] Univ Western Ontario, Dept Med, London, ON N6A 5A5, Canada; [Pickering, J. Geoffrey] London Hlth Sci Ctr, London, ON N6A 5A5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre	Pickering, JG (corresponding author), London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.	gpickering@robarts.ca	Gros, Robert/A-3010-2009; Pickering, J. Geoffrey/G-3341-2011; Gros, Robert/AAV-2237-2020; Ellis, Christopher G/AAV-2325-2020; Ellis, Christopher G/G-8649-2013; Ward, Aaron/B-4950-2015	Gros, Robert/0000-0002-3667-8011; Pickering, J. Geoffrey/0000-0001-6474-3274; Gros, Robert/0000-0002-3667-8011; Ellis, Christopher G/0000-0002-7760-1846; Balint, Brittany/0000-0002-7520-9509; Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Cancer Society [701080]; Canadian Institutes of Health Research [FRN-11715, FRN-126148]; Heart and Stroke Foundation of Canada (HSFC) [T7081]; University of Western Ontario (POEM); Canadian Institutes of Health Research Fellowship; New Investigator Award HSFC	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); University of Western Ontario (POEM); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); New Investigator Award HSFC	This work was supported in part by Canadian Cancer Society Grant 701080, Canadian Institutes of Health Research Grants FRN-11715 and FRN-126148, Heart and Stroke Foundation of Canada (HSFC) Grant T7081, and the University of Western Ontario (POEM). J. G. P., M. J. F., and Z. N. hold a patent relating to FGF9 and vascular remodeling, assigned to the University of Western Ontario.; Supported by a Canadian Institutes of Health Research Fellowship.; Supported by a New Investigator Award HSFC.	Agrawal V, 2014, ONCOTARGET, V5, P2761, DOI 10.18632/oncotarget.1942; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baum O, 2013, AM J PHYSIOL-REG I, V304, pR1175, DOI 10.1152/ajpregu.00434.2012; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Clifford PS, 2011, ADV PHYSIOL EDUC, V35, P5, DOI 10.1152/advan.00074.2010; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Fera E, 2004, J BIOL CHEM, V279, P35573, DOI 10.1074/jbc.M400711200; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; Jin CL, 2004, CANCER RES, V64, P4555, DOI 10.1158/0008-5472.CAN-03-3752; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; LESS JR, 1991, CANCER RES, V51, P265; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pickering JG, 1997, ARTERIOSCL THROM VAS, V17, P475, DOI 10.1161/01.ATV.17.3.475; SALUP RR, 1985, J UROLOGY, V134, P1236, DOI 10.1016/S0022-5347(17)47702-0; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vafaie F, 2014, AGING CELL, V13, P121, DOI 10.1111/acel.12155; Wang Q, 2011, INVEST OPHTH VIS SCI, V52, P6292, DOI 10.1167/iovs.10-6424; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Wu XC, 2003, CANCER RES, V63, P4936; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; Yin H, 2012, J CELL SCI, V125, P5770, DOI 10.1242/jcs.110262; Yin YJ, 2013, CANCER RES, V73, P5730, DOI 10.1158/0008-5472.CAN-13-0495; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	49	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22127	22142		10.1074/jbc.M115.652222	http://dx.doi.org/10.1074/jbc.M115.652222			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183774	hybrid, Green Published			2022-12-28	WOS:000360968500030
J	Puente, TD; Gallego-Jara, J; Castano-Cerezo, S; Sanchez, VB; Espin, VF; de la Torre, JG; Rubio, AM; Diaz, MC				de Diego Puente, Teresa; Gallego-Jara, Julia; Castano-Cerezo, Sara; Bernal Sanchez, Vicente; Fernandez Espin, Vanesa; Garcia de la Torre, Jose; Manjon Rubio, Arturo; Canovas Diaz, Manuel			The Protein Acetyltransferase PatZ from Escherichia coli Is Regulated by Autoacetylation-induced Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN5-RELATED N-ACETYLTRANSFERASE; ACETYL-COA SYNTHETASE; GCN5 TRANSCRIPTIONAL COACTIVATOR; CHAIN CONFORMATIONAL ENTROPY; 1.8 ANGSTROM RESOLUTION; HISTONE-ACETYLTRANSFERASE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; GLOBULAR-PROTEINS; COENZYME-A	Lysine acetylation is an important post-translational modification in the metabolic regulation of both prokaryotes and eukaryotes. In Escherichia coli, PatZ (formerly YfiQ) is the only known acetyltransferase protein and is responsible for acetylCoA synthetase acetylation. In this study, we demonstrated PatZ-positive cooperativity in response to acetyl-CoA and the regulation of acetyl-CoA synthetase activity by the acetylation level. Furthermore, functional analysis of an E809A mutant showed that the conserved glutamate residue is not relevant for the PatZ catalytic mechanism. Biophysical studies demonstrated that PatZ is a stable tetramer in solution and is transformed to its octameric form by autoacetylation. Moreover, this modification is reversed by the sirtuin CobB. Finally, an in silico PatZ tetramerization model based on hydrophobic and electrostatic interactions is proposed and validated by three-dimensional hydrodynamic analysis. These data reveal, for the first time, the structural regulation of an acetyltransferase by autoacetylation in a prokaryotic organism.	[de Diego Puente, Teresa; Gallego-Jara, Julia; Castano-Cerezo, Sara; Bernal Sanchez, Vicente; Manjon Rubio, Arturo; Canovas Diaz, Manuel] Univ Murcia, Fac Chem, Dept Biochem, Dept Mol Biol, E-30100 Murcia, Spain; [de Diego Puente, Teresa; Gallego-Jara, Julia; Castano-Cerezo, Sara; Bernal Sanchez, Vicente; Manjon Rubio, Arturo; Canovas Diaz, Manuel] Univ Murcia, Fac Chem, Dept Immunol B, E-30100 Murcia, Spain; [Fernandez Espin, Vanesa; Garcia de la Torre, Jose] Univ Murcia, Phys Chem, E-30100 Murcia, Spain	University of Murcia; University of Murcia; University of Murcia	Puente, TD (corresponding author), Univ Murcia, Fac Chem, Dept Biochem, Dept Mol Biol, Campus Espinardo, E-30100 Murcia, Spain.	tdp@um.es	Gallego, Julia/H-2395-2017; de Diego, Teresa/ABH-4509-2020; , Julia/ABH-6754-2020; Aithani, Anchal/AGX-7498-2022; de Diego, Teresa/N-9215-2013; de la Torre, Jose Garcia/A-7923-2015; Cerezo, Sara Castaño/AAW-1967-2020; Canovas, Manuel/K-3860-2014; Bernal, Vicente/M-4119-2014	Gallego, Julia/0000-0002-6680-359X; de Diego, Teresa/0000-0003-3501-5483; , Julia/0000-0002-6680-359X; Aithani, Anchal/0000-0003-1260-2554; de Diego, Teresa/0000-0003-3501-5483; de la Torre, Jose Garcia/0000-0001-9116-8957; Canovas, Manuel/0000-0003-3254-1736; Bernal, Vicente/0000-0003-2482-3477; Castano Cerezo, Sara/0000-0002-1404-4085	Ministry of Economy and Competitiveness [BIO2014-54411-C2-1-R]; Seneca Foundation Autonomous Community of the Region of Murcia [19236/PI/14]	Ministry of Economy and Competitiveness; Seneca Foundation Autonomous Community of the Region of Murcia(Fundacion Seneca)	This work was supported by Ministry of Economy and Competitiveness Grant BIO2014-54411-C2-1-R and in part by Seneca Foundation Autonomous Community of the Region of Murcia Grant 19236/PI/14. The authors declare that they have no conflicts of interest with the contents of this article.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angus-Hill ML, 1999, J MOL BIOL, V294, P1311, DOI 10.1006/jmbi.1999.3338; Avbelj F, 1998, J MOL BIOL, V279, P665, DOI 10.1006/jmbi.1998.1792; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; Castano-Cerezo S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145227; Castano-Cerezo S, 2011, MOL MICROBIOL, V82, P1110, DOI 10.1111/j.1365-2958.2011.07873.x; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Creamer TP, 2000, PROTEINS, V40, P443, DOI 10.1002/1097-0134(20000815)40:3<443::AID-PROT100>3.3.CO;2-C; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; FUKADA H, 1983, J BIOL CHEM, V258, P3193; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Langer MR, 2001, J BIOL CHEM, V276, P31321, DOI 10.1074/jbc.M103839200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Ma Q, 2011, BIOCHEM BIOPH RES CO, V410, P846, DOI 10.1016/j.bbrc.2011.06.076; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Moulder R, 2005, PROTEOMICS, V5, P2748, DOI 10.1002/pmic.200401187; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pisithkul T, 2015, CURR OPIN MICROBIOL, V24, P29, DOI 10.1016/j.mib.2014.12.006; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P11291, DOI 10.1021/bi0003184; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Thao S, 2011, MBIO, V2, DOI 10.1128/mBio.00216-11; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Tucker AC, 2014, J BIOL CHEM, V289, P36249, DOI 10.1074/jbc.M114.613901; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Williamson J., 1969, ASSAYS INTERMEDIATES, VXIII, P494; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Wybenga-Groot LE, 1999, STRUCTURE, V7, P497, DOI 10.1016/S0969-2126(99)80066-5; Xu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008140; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382	71	14	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23077	23093		10.1074/jbc.M115.649806	http://dx.doi.org/10.1074/jbc.M115.649806			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26251518	Green Published, hybrid			2022-12-28	WOS:000361685500021
J	Di Lorenzo, F; Kubik, L; Oblak, A; Lore, NI; Cigana, C; Lanzetta, R; Parrilli, M; Hamad, MA; De Soyza, A; Silipo, A; Jerala, R; Bragonzi, A; Valvano, MA; Martin-Santamaria, S; Molinaro, A				Di Lorenzo, Flaviana; Kubik, Lukasz; Oblak, Alja; Lore, Nicola Ivan; Cigana, Cristina; Lanzetta, Rosa; Parrilli, Michelangelo; Hamad, Mohamad A.; De Soyza, Anthony; Silipo, Alba; Jerala, Roman; Bragonzi, Alessandra; Valvano, Miguel A.; Martin-Santamaria, Sonsoles; Molinaro, Antonio			Activation of Human Toll-like Receptor 4 (TLR4)center dot Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; Gram-negative bacteria; innate immunity; lipopolysaccharide (LPS); molecular modeling; Burkholderia; TLR4; MD-2	LIPID-A; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; RECOGNITION; LPS; BACTERIAL; COMPLEX; TLR4; AMINOARABINOSE; BIOSYNTHESIS	Background: The Burkholderia cenocepacia lipid A is hypoacylated. Results: Aminoarabinose residues in lipid A contribute to Burkholderia lipid A binding to the TLR4MD-2 complex. Conclusion: A novel mode of Burkholderia lipopolysaccharide-TLR4MD-2 interactions promotes inflammation. Significance: Modifications of the lipid A structure enhance proinflammatory responses of hypoacylated lipopolysaccharide. Lung infection by Burkholderia species, in particular Burkholderia cenocepacia, accelerates tissue damage and increases post-lung transplant mortality in cystic fibrosis patients. Host-microbe interplay largely depends on interactions between pathogen-specific molecules and innate immune receptors such as Toll-like receptor 4 (TLR4), which recognizes the lipid A moiety of the bacterial lipopolysaccharide (LPS). The human TLR4myeloid differentiation factor 2 (MD-2) LPS receptor complex is strongly activated by hexa-acylated lipid A and poorly activated by underacylated lipid A. Here, we report that B. cenocepacia LPS strongly activates human TLR4MD-2 despite its lipid A having only five acyl chains. Furthermore, we show that aminoarabinose residues in lipid A contribute to TLR4-lipid A interactions, and experiments in a mouse model of LPS-induced endotoxic shock confirmed the proinflammatory potential of B. cenocepacia penta-acylated lipid A. Molecular modeling combined with mutagenesis of TLR4-MD-2 interactive surfaces suggests that longer acyl chains and the aminoarabinose residues in the B. cenocepacia lipid A allow exposure of the fifth acyl chain on the surface of MD-2 enabling interactions with TLR4 and its dimerization. Our results provide a molecular model for activation of the human TLR4MD-2 complex by penta-acylated lipid A explaining the ability of hypoacylated B. cenocepacia LPS to promote proinflammatory responses associated with the severe pathogenicity of this opportunistic bacterium.	[Di Lorenzo, Flaviana; Lanzetta, Rosa; Silipo, Alba; Molinaro, Antonio] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Parrilli, Michelangelo] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy; [Kubik, Lukasz; Martin-Santamaria, Sonsoles] Univ CEU San Pablo, Dept Chem & Biochem, Madrid 28668, Spain; [Kubik, Lukasz] Med Univ Gdansk, Dept Biopharmaceut & Pharmacodynam, PL-80416 Gdansk, Poland; [Di Lorenzo, Flaviana; Oblak, Alja; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia; [Oblak, Alja; Jerala, Roman] Ctr Excellence NMR Future Innovat Sustainable Tec, Ljubljana 1000, Slovenia; [Lore, Nicola Ivan; Cigana, Cristina; Bragonzi, Alessandra] Ist Ricovero & Cura Carattere Sci, San Raffaele Sci Inst, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Hamad, Mohamad A.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [De Soyza, Anthony] Univ Newcastle, Inst Cellular Med, Appl Immunobiol & Transplantat Grp, Newcastle NE1 7RU, Tyne & Wear, England; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7AE, Antrim, North Ireland	University of Naples Federico II; University of Naples Federico II; San Pablo CEU University; Fahrenheit Universities; Medical University Gdansk; National Institute of Chemistry - Slovenia; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Western University (University of Western Ontario); Newcastle University - UK; Queens University Belfast	Martin-Santamaria, S (corresponding author), CIB CSIC, Biol Res Ctr, Dept Chem & Phys Biol, Madrid 28040, Spain.	smsantamaria@cib.csic.es; molinaro@unina.it	Valvano, Miguel A/G-8759-2012; Martin-Santamaria, Sonsoles/A-8035-2012; Bragonzi, Alessandra/AAC-6751-2022; Lorè, Nicola Ivan/K-9285-2016; Cigana, Cristina/D-2883-2016; Silipo, Alba/L-5929-2014	Valvano, Miguel A/0000-0001-8229-3641; Martin-Santamaria, Sonsoles/0000-0002-7679-0155; Lorè, Nicola Ivan/0000-0001-9159-1632; Cigana, Cristina/0000-0003-0436-9721; Bragonzi, Alessandra/0000-0002-5808-7669; Parrilli, Michelangelo/0000-0001-8858-3623; Di Lorenzo, Flaviana/0000-0003-4821-0114; silipo, alba/0000-0002-5394-6532; LANZETTA, Rosa/0000-0002-1472-5825; Molinaro, Antonio/0000-0002-3456-7369	Spanish Ministry of Economy and Competitiveness [CTQ2011-22724]; Universidad CEU San Pablo [PC14/2011, PC13/2012]; Slovenian Research Agency; Centre of Excellence NMR - Future Innovation for Sustainable Technologies; European structural funds; Cystic Fibrosis Canada; European Cooperation in Science and Technology Actions [BM1003, CM1102]; Marie Curie Initial Training Networks (ITN) GLYCOPHARM [PITN-GA-2012-317297, H2020-MSCA-ITN-2014-ETN TOLLerant]; Airbus Military research contract; Higher Education Funding Council of England; Financial and Fiscal Commission grant	Spanish Ministry of Economy and Competitiveness(Spanish Government); Universidad CEU San Pablo; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence NMR - Future Innovation for Sustainable Technologies; European structural funds; Cystic Fibrosis Canada; European Cooperation in Science and Technology Actions; Marie Curie Initial Training Networks (ITN) GLYCOPHARM; Airbus Military research contract; Higher Education Funding Council of England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Financial and Fiscal Commission grant	This work was supported in part by Spanish Ministry of Economy and Competitiveness Grant CTQ2011-22724, Universidad CEU San Pablo Grants PC14/2011 and PC13/2012, the Slovenian Research Agency, Centre of Excellence NMR - Future Innovation for Sustainable Technologies, European structural funds, Cystic Fibrosis Canada, European Cooperation in Science and Technology Actions BM1003 and CM1102, and Marie Curie Initial Training Networks (ITN) GLYCOPHARM PITN-GA-2012-317297 and H2020-MSCA-ITN-2014-ETN TOLLerant. The authors declare that they have no conflict of interest with the content of this article.; Supported by an Airbus Military research contract.; Supported by a Higher Education Funding Council of England senior lecturership and a Financial and Fiscal Commission grant.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bainbridge BW, 2006, CELL MICROBIOL, V8, P120, DOI 10.1111/j.1462-5822.2005.00605.x; Bamford S, 2007, CELL MICROBIOL, V9, P532, DOI 10.1111/j.1462-5822.2006.00808.x; Brandenburg K, 1996, J ENDOTOXIN RES, V3, P173, DOI 10.1177/096805199600300302; BRANDENBURG K, 1993, EUR J BIOCHEM, V218, P555, DOI 10.1111/j.1432-1033.1993.tb18409.x; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; De Soyza A, 2004, AM J RESP CRIT CARE, V170, P70, DOI 10.1164/rccm.200304-592OC; Di Lorenzo F, 2015, MOL IMMUNOL, V63, P166, DOI 10.1016/j.molimm.2014.04.004; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Frisch M.J., 2004, GAUSSIAN 03; Fukuoka S, 2001, BBA-BIOMEMBRANES, V1510, P185, DOI 10.1016/S0005-2736(00)00347-3; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hollaus R, 2015, CHEM-EUR J, V21, P4102, DOI 10.1002/chem.201406058; Holst O, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P29; Jeukens J., 2013, GENOME ANNOUNC, V1; KITTELBERGER R, 1993, J BIOCHEM BIOPH METH, V26, P81, DOI 10.1016/0165-022X(93)90024-I; Klett J, 2014, CURR TOP MED CHEM, V14, P2672; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Knirel YA, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P57; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lohmann KL, 2007, J ENDOTOXIN RES, V13, P235, DOI 10.1177/0968051907083193; Maeshima N, 2015, J BIOL CHEM, V290, P13440, DOI 10.1074/jbc.M115.653881; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Molinaro A, 2015, CHEM-EUR J, V21, P500, DOI 10.1002/chem.201403923; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Oikawa M, 2004, ORG BIOMOL CHEM, V2, P3557, DOI 10.1039/b410544c; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Schrodinger, 2012, SUIT 2012 PROT PREP; Schrodinger, 2012, SUIT 2012 IMP VERS 5; Schrodinger, 2012, SUIT 2012 MAESTR VER; Schrodinger, 2012, SUIT 2012 MACROMODEL; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Silipo A, 2007, CHEM-EUR J, V13, P3501, DOI 10.1002/chem.200601406; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Speert David Paul, 2002, Paediatr Respir Rev, V3, P230, DOI 10.1016/S1526-0542(02)00185-9; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zughaier SM, 1999, INFECT IMMUN, V67, P1505, DOI 10.1128/IAI.67.3.1505-1507.1999	59	36	38	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21305	21319		10.1074/jbc.M115.649087	http://dx.doi.org/10.1074/jbc.M115.649087			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160169	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000360637600010
J	King, JR; Nordman, JC; Bridges, SP; Lin, MK; Kabbani, N				King, Justin R.; Nordman, Jacob C.; Bridges, Samuel P.; Lin, Ming-Kuan; Kabbani, Nadine			Identification and Characterization of a G Protein-binding Cluster in alpha 7 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL SUBUNITS; CELLS; GROWTH; EXPRESSION; NEURONS; BRAIN; MODULATION; ACTIVATION; RELEASE; MICE	alpha 7 nicotinic acetylcholine receptors (nAChRs) play an important role in synaptic transmission and inflammation. In response to ligands, this receptor channel opens to conduct cations into the cell but desensitizes rapidly. In recent studies we show that alpha 7 nAChRs bind signaling proteins such as heterotrimeric GTP-binding proteins (G proteins). Here, we demonstrate that direct coupling of alpha 7 nAChRs to G proteins enables a downstream calcium signaling response that can persist beyond the expected time course of channel activation. This process depends on a G protein-binding cluster (GPBC) in the M3-M4 loop of the receptor. A mutation of the GPBC in the alpha 7 nAChR (alpha 7(345-348A)) abolishes interaction with G alpha(q) as well as G beta gamma while having no effect on receptor synthesis, cell-surface trafficking, or alpha-bungarotoxin binding. Expression of alpha 7(345-348A), however, did significantly attenuate the alpha 7 nAChR-induced G alpha(q) calcium signaling response as evidenced by a decrease in PLC-beta activation and IP3R-mediated calcium store release in the presence of the alpha 7 selective agonist choline. Taken together, the data provides new evidence for the existence of a GPBC in nAChRs serving to promote intracellular signaling.	George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA; George Mason Univ, Dept Comp Sci, Fairfax, VA 22030 USA; INOVA Neurosci Program, Annandale, VA 22003 USA	George Mason University; George Mason University	Kabbani, N (corresponding author), 4400 Univ Dr, Fairfax, VA 22030 USA.	nkabbani@gmu.edu		Nordman, Jacob/0000-0003-2513-7831; Bridges, Samuel/0000-0002-8560-9004	Wings for Life Spinal Cord Research	Wings for Life Spinal Cord Research	This work was supported by a grant from Wings for Life Spinal Cord Research (to N. K.). We declare that they have no conflicts of interest with the contents of this article.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bourinet E, 1996, J NEUROSCI, V16, P4983; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Castillo M, 2006, J MOL NEUROSCI, V30, P153, DOI 10.1385/JMN:30:1:153; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Dau A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-47; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gomez-Varela D, 2013, J NEUROSCI, V 33, P17062, DOI 10.1523/JNEUROSCI.1482-13.2013; Guerra-Alvarez M, 2015, J NEUROCHEM, V133, P309, DOI 10.1111/jnc.13049; Halff AW, 2014, J NEUROSCI, V34, P2051, DOI 10.1523/JNEUROSCI.2795-13.2014; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Jacovina AT, 2001, J BIOL CHEM, V276, P49350, DOI 10.1074/jbc.M106289200; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Kumar A, 2010, J NEUROPHYSIOL, V104, P607, DOI 10.1152/jn.00278.2010; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Liu QS, 1999, J NEUROSCI, V19, P10280; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; McClure-Begley Tristan D., 2013, Genomics Proteomics & Bioinformatics, V11, P207, DOI 10.1016/j.gpb.2013.05.005; Murray TA, 2009, ACTA PHARMACOL SIN, V30, P828, DOI 10.1038/aps.2009.78; Nordman JC, 2014, FASEB J, V28, P2995, DOI 10.1096/fj.14-251439; Nordman JC, 2014, J NEUROCHEM, V129, P649, DOI 10.1111/jnc.12641; Nordman JC, 2014, MOL PHARMACOL, V85, P50, DOI 10.1124/mol.113.088484; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Papke RL, 2014, J PHARMACOL EXP THER, V350, P665, DOI 10.1124/jpet.114.215236; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Paulo JA, 2009, J PROTEOME RES, V8, P1849, DOI 10.1021/pr800731z; Qi XL, 2007, NEUROCHEM INT, V51, P377, DOI 10.1016/j.neuint.2007.04.002; Quarta D, 2007, NEUROPSYCHOPHARMACOL, V32, P35, DOI 10.1038/sj.npp.1301103; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Saragoza PA, 2003, MOL BRAIN RES, V117, P15, DOI 10.1016/S0169-328X(03)00261-4; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Tso PH, 2009, NEUROCHEM RES, V34, P1101, DOI 10.1007/s11064-008-9880-9; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zhong CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082719	48	63	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20060	20070		10.1074/jbc.M115.647040	http://dx.doi.org/10.1074/jbc.M115.647040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26088141	Green Published, hybrid			2022-12-28	WOS:000359608900005
J	Wang, L; Di, LJ				Wang, Li; Di, Li-jun			Wnt/beta-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NUCLEAR BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; CO-REPRESSOR; COREPRESSOR CTBP2; BINDING-PROTEIN; RETINOIC ACID; TARGET GENES; AMPK	A better understanding of the mechanism and manipulation of the tightly regulated cellular differentiation process of adipogenesis may contribute to a reduction in obesity and diabetes. Multiple transcription factors and signaling pathways are involved in the regulation of adipogenesis. Here, we report that the AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) can activate AMPK in preadipocytes and thus increase the expression of GATA3, an anti-adipogenic factor. However, AICAR-increased GATA3 is mediated by the stimulation of Wnt/beta-catenin signaling in preadipocytes. Mechanistically, AICAR-activated AMPK inhibits GSK3 beta through a phosphorylation process that stabilizes beta-catenin. This stabilized beta-catenin then translocates into nucleus where it interacts with T-cell factors (TCF), leading to the increased beta-catenin/TCF transcriptional activity that induces GATA3 expression. In addition, AICAR also relieves the repressing effect of the C-terminal-binding protein (CtBP) co-repressor by diverting CtBP away from the beta-catenin center dot TCF complex at the GATA3 promoter. The anti-adipogenic effect of GATA3 and AICAR is consistently attenuated by the disruption of Wnt/beta-catenin signaling. Furthermore, GATA3 suppresses key adipogenic regulators by binding to the promoters of these regulators, such as the peroxisome proliferator-activated receptor-gamma (PPAR gamma) gene, and the disruption of Wnt/beta-catenin signaling reduces the GATA3 binding at the PPAR gamma promoter. In differentiated adipocytes, GATA3 expression inhibition is facilitated by the down-regulation of beta-catenin levels, the reduction in beta-catenin binding, and the increase in CtBP binding at the GATA3 promoter. Our findings shed light on the molecular mechanism of adipogenesis by suggesting that different regulation pathways and adipogenic regulators collectively modulate adipocyte differentiation through cross-talk.	[Wang, Li] Univ Macau, Fac Hlth Sci, Metab Core, Macau Sar, Peoples R China; [Di, Li-jun] Univ Macau, Fac Hlth Sci, Macau Sar, Peoples R China	University of Macau; University of Macau	Di, LJ (corresponding author), Univ Macau, Fac Hlth Sci, Macau Sar, Peoples R China.	lijundi@umac.mo	Di, Li-jun/B-3352-2011		Science and Technology Development Fund (FDCT) of Macao SAR [FDCT 025/2014/A1, FDCT 088/2014/A2]; University of Macau [MYRG2015-00037-FHS, MYRG2015-00167-FHS]	Science and Technology Development Fund (FDCT) of Macao SAR; University of Macau	This work was supported by Grants FDCT 025/2014/A1 and FDCT 088/2014/A2 from the Science and Technology Development Fund (FDCT) of Macao SAR (to L. J. D.) and by Multi-year Research Grants MYRG2015-00037-FHS and MYRG2015-00167-FHS from the University of Macau (to L. J. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Bajpe PK, 2013, MOL CELL BIOL, V33, P3343, DOI 10.1128/MCB.01213-12; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Di LJ, 2010, NAT STRUCT MOL BIOL, V17, P1406, DOI 10.1038/nsmb.1941; Ding YN, 2002, TRENDS BIOCHEM SCI, V27, P327, DOI 10.1016/S0968-0004(02)02137-0; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Primus A, 2004, BIOESSAYS, V26, P474, DOI 10.1002/bies.20031; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Vingtdeux V, 2011, MOL MED, V17, P1022, DOI 10.2119/molmed.2011.00163; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.587; Wang L, 2014, INT J BIOCHEM CELL B, V54, P1, DOI 10.1016/j.biocel.2014.06.008; Wang L, 2013, INT J BIOCHEM CELL B, V45, P1155, DOI 10.1016/j.biocel.2013.03.007; Wang L, 2012, J BIOL CHEM, V287, P30157, DOI 10.1074/jbc.M112.376640; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Zhao JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199372; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161; Zhao LJ, 2007, ONCOGENE, V26, P7544, DOI 10.1038/sj.onc.1210569; Zhao LJ, 2006, J BIOL CHEM, V281, P36613, DOI 10.1074/jbc.M603550200; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	52	30	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19458	19468		10.1074/jbc.M115.641332	http://dx.doi.org/10.1074/jbc.M115.641332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109067	Green Published, hybrid			2022-12-28	WOS:000359364600006
J	Wang, XC; Karamariti, E; Simpson, R; Wang, W; Xu, QB				Wang, Xiaocong; Karamariti, Eirini; Simpson, Russell; Wang, Wen; Xu, Qingbo			Dickkopf Homolog 3 Induces Stem Cell Differentiation into Smooth Muscle Lineage via ATF6 Signalling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SERUM RESPONSE FACTOR; BETA-CATENIN; GENE-EXPRESSION; DOWN-REGULATION; MELANOMA-CELLS; ER STRESS; IN-VITRO; MYOCARDIN; PATHWAY	Smooth muscle cells (SMCs) are a key component of healthy and tissue engineered vessels and play a crucial role in vascular development and the pathogenic events of vascular remodeling i.e. restenosis. However, the cell source from which they can be isolated is limited. Embryonic stem (ES) cells that have the remarkable capability to differentiate into vascular SMCs in response to specific stimuli provide a useful model for studying SMC differentiation. Previous studies suggested that dickkopf homolog 3 (DKK3) has a role in human partially induced pluripotent stem cell to SMC differentiation. Here, we demonstrate that the expression of DKK3 is essential for the expression of SMC markers and myocardin at both the mRNA and protein levels during mouse ES cell differentiation into SMCs (ESC-SMC differentiation). Overexpression of DKK3 leads to further up-regulation of the aforementioned markers. Further investigation indicates that DKK3 added as a cytokine activates activating transcription factor 6 (ATF6), leading to the increased binding of ATF6 on the myocardin promoter and increased its expression. In addition, inhibition of extracellular signal-regulated kinases 1/2 (ERK1/2) promotes the expression of ATF6 and leads to further increase of myocardin transcription. Our findings offer a novel mechanism by which DKK3 regulates ESC-SMC differentiation by activating ATF6 and promoting myocardin expression.	[Wang, Xiaocong; Karamariti, Eirini; Simpson, Russell; Xu, Qingbo] Kings Coll London BHF Ctr, Div Cardiovasc, London SE5 9NU, England; [Wang, Xiaocong; Wang, Wen] Queen Mary Univ London, Inst Bioengn, London E1 4NS, England	University of London; King's College London; University of London; Queen Mary University London	Xu, QB (corresponding author), Kings Coll London BHF Ctr, Div Cardiovasc, London SE5 9NU, England.			Wang, Xiaocong/0000-0001-7080-7502	British Heart Foundation [RG/14/6/31144]; Oak Foundation; Queen Mary University of London	British Heart Foundation(British Heart Foundation); Oak Foundation; Queen Mary University of London	This work was supported by grants from the British Heart Foundation (RG/14/6/31144), Oak Foundation, and Queen Mary University of London. The authors declare that they have no conflicts of interest with the contents of this article.	Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Croft A, 2014, J INVEST DERMATOL, V134, P488, DOI 10.1038/jid.2013.325; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gu YM, 2011, WORLD J GASTROENTERO, V17, P3810, DOI 10.3748/wjg.v17.i33.3810; Han XF, 2014, HISTOCHEM CELL BIOL, V142, P497, DOI 10.1007/s00418-014-1233-y; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Kim JW, 2014, J DENT RES, V93, P483, DOI 10.1177/0022034514525199; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Lowe CE, 2012, INT J OBESITY, V36, P1248, DOI 10.1038/ijo.2011.233; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Nozaki I, 2001, INT J ONCOL, V19, P117; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Romero D, 2013, J CELL SCI, V126, P1858, DOI 10.1242/jcs.119388; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Siegel R, 2004, MAGN RESON CHEM, V42, P1022, DOI 10.1002/mrc.1485; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Tay KH, 2014, CELL SIGNAL, V26, P287, DOI 10.1016/j.cellsig.2013.11.008; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Watanabe M, 2009, INT J ONCOL, V34, P657, DOI 10.3892/ijo_00000191; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2012, ARTERIOSCL THROM VAS, V32, P730, DOI 10.1161/ATVBAHA.111.243188; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x	41	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19844	19852		10.1074/jbc.M115.641415	http://dx.doi.org/10.1074/jbc.M115.641415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105053	Green Published, hybrid			2022-12-28	WOS:000359364600040
J	Murphy, M; Xiong, YB; Pattabiraman, G; Qiu, F; Medvedev, AE				Murphy, Michael; Xiong, Yanbao; Pattabiraman, Goutham; Qiu, Fu; Medvedev, Andrei E.			Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS63-LINKED POLYUBIQUITINATION; TYROSINE PHOSPHORYLATION; PHAGOSOME MATURATION; CYTOKINE PRODUCTION; ADAPTIVE IMMUNITY; CELL RESPONSES; KINASE PATHWAY; ACTIVATION; IL-1; LIPOPOLYSACCHARIDE	Endotoxin tolerance reprograms Toll-like receptor (TLR) 4-mediated macrophage responses by attenuating induction of proinflammatory cytokines while retaining expression of anti-inflammatory and antimicrobial mediators. We previously demonstrated deficient TLR4-induced activation of IL-1 receptor-associated kinase (IRAK) 4, IRAK1, and TANK-binding kinase (TBK) 1 as critical hallmarks of endotoxin tolerance, but mechanisms remain unclear. In this study, we examined the role of the E3 ubiquitin ligase Pellino-1 in endotoxin tolerance and TLR signaling. LPS stimulation increased Pellino-1 mRNA and protein expression in macrophages from mice injected with saline and in medium-pretreated human monocytes, THP-1, and MonoMac-6 cells, whereas endotoxin tolerization abrogated LPS inducibility of Pellino-1. Overexpression of Pellino-1 in 293/TLR2 and 293/TLR4/MD2 cells enhanced TLR2- and TLR4-induced nuclear factor kappa B (NF-kappa B) and expression of IL-8 mRNA, whereas Pellino-1 knockdown reduced these responses. Pellino-1 ablation in THP-1 cells impaired induction of myeloid differentiation primary response protein (MyD88), and Toll-IL-1R domain-containing adapter inducing IFN-beta (TRIF)-dependent cytokine genes in response to TLR4 and TLR2 agonists and heat-killed Escherichia coli and Staphylococcus aureus, whereas only weakly affecting phagocytosis of heat-killed bacteria. Co-expressed Pellino-1 potentiated NF-kappa B activation driven by transfected MyD88, TRIF, IRAK1, TBK1, TGF-beta-activated kinase (TAK) 1, and TNFR-associated factor 6, whereas not affecting p65-induced responses. Mechanistically, Pellino-1 increased LPS-driven K63-linked polyubiquitination of IRAK1, TBK1, TAK1, and phosphorylation of TBK1 and IFN regulatory factor 3. These results reveal a novel mechanism by which endotoxin tolerance re-programs TLR4 signaling via suppression of Pellino-1, a positive regulator of MyD88- and TRIF-dependent signaling that promotes K63-linked polyubiquitination of IRAK1, TBK1, and TAK1.	[Murphy, Michael; Pattabiraman, Goutham; Medvedev, Andrei E.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Xiong, Yanbao; Qiu, Fu] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore	Medvedev, AE (corresponding author), 263 Farmington Ave,L Bldg,Rm L3019, Farmington, CT 06030 USA.	medvedev@uchc.edu		Pattabiraman, Goutham/0000-0002-5196-8279	National Institutes of Health from the NIAID [RO1 AI059524]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059524] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI059524 from the NIAID (to A. E. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Bennett JA, 2012, J VIROL, V86, P6595, DOI 10.1128/JVI.06755-11; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Butler MP, 2005, J BIOL CHEM, V280, P27759, DOI 10.1074/jbc.M500756200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Enesa K, 2012, J BIOL CHEM, V287, P34825, DOI 10.1074/jbc.M112.367557; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jacinto R, 2002, J IMMUNOL, V168, P6136, DOI 10.4049/jimmunol.168.12.6136; Jensen LE, 2003, FEBS LETT, V545, P199, DOI 10.1016/S0014-5793(03)00533-7; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim TW, 2012, J BIOL CHEM, V287, P25686, DOI 10.1074/jbc.M112.352625; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Lee YS, 2015, EMBO MOL MED, V7, P577, DOI 10.15252/emmm.201404653; Lee YS, 2010, BIOCHEM BIOPH RES CO, V393, P836, DOI 10.1016/j.bbrc.2010.02.094; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Moynagh PN, 2014, NAT REV IMMUNOL, V14, P122, DOI 10.1038/nri3599; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Peck OM, 2006, SHOCK, V26, P31, DOI 10.1097/01.shk.0000223128.79759.3d; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Quevedo-Diaz MA, 2010, J LEUKOCYTE BIOL, V88, P675, DOI 10.1189/jlb.1009674; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wysocka M, 2001, J IMMUNOL, V166, P7504, DOI 10.4049/jimmunol.166.12.7504; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Xiong YB, 2013, J LEUKOCYTE BIOL, V94, P291, DOI 10.1189/jlb.0812401; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	65	27	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19218	19232		10.1074/jbc.M115.640128	http://dx.doi.org/10.1074/jbc.M115.640128			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082489	Green Published, hybrid			2022-12-28	WOS:000358781100036
J	Effelsberg, D; Cruz-Zaragoza, LD; Tonillo, J; Schliebs, W; Erdmann, R				Effelsberg, Daniel; Cruz-Zaragoza, Luis Daniel; Tonillo, Jason; Schliebs, Wolfgang; Erdmann, Ralf			Role of Pex21p for Piggyback Import of Gpd1p and Pnc1p into Peroxisomes of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTS1 RECEPTOR PEX5P; PROTEIN IMPORT; TARGETING SIGNAL; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; SUBCELLULAR-DISTRIBUTION; 3-OXOACYL-COA THIOLASE; YARROWIA-LIPOLYTICA; YEAST; PATHWAY; PEX7P	Proteins designated for peroxisomal protein import harbor one of two common peroxisomal targeting signals (PTS). In the yeast Saccharomyces cerevisiae, theoleate-induced PTS2-dependent import of the thiolase Fox3p into peroxisomes is conducted by the soluble import receptor Pex7p in cooperation with the auxiliary Pex18p, one of two supposedly redundant PTS2 co-receptors. Here, we report on a novel function for the co-receptor Pex21p, which cannot be fulfilled by Pex18p. The data establish Pex21p as a general co-receptor in PTS2-dependent protein import, whereas Pex18p is especially important for oleate-induced import of PTS2 proteins. The glycerol-producing PTS2 protein glycerol-3-phosphate dehydrogenase Gpd1p shows a tripartite localization in peroxisomes, in the cytosol, and in the nucleus under osmotic stress conditions. We show the following: (i) Pex21p is required for peroxisomal import of Gpd1p as well as a key enzyme of the NAD(+) salvage pathway, Pnc1p; (ii) Pnc1p, a nicotinamidase without functional PTS2, is co-imported into peroxisomes by piggyback transport via Gpd1p. Moreover, the specific transport of these two enzymes into peroxisomes suggests a novel regulatory role for peroxisomes under various stress conditions.	[Effelsberg, Daniel; Cruz-Zaragoza, Luis Daniel; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Abt Syst Biochem, D-44780 Bochum, Germany; [Tonillo, Jason] Ruhr Univ Bochum, Med Proteomctr, Abt Syst Biochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Abt Syst Biochem, D-44780 Bochum, Germany.	ralf.erdmann@rub.de		Cruz-Zaragoza, Luis Daniel/0000-0001-9568-0245; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft Grant [FOR1905]; Marie Curie Initial Training Networks (PerFuMe) [316723]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Marie Curie Initial Training Networks (PerFuMe)	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1905 (to R. E.). This work was also supported by a grant from the Marie Curie Initial Training Networks (316723, PerFuMe) (to L.D.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Cramer J., 2015, SUBCELLULAR FRACTION, P97; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Flynn CR, 1998, PLANT J, V16, P709, DOI 10.1046/j.1365-313x.1998.00344.x; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Harlow E., 1988, ANTIBODIES LAB MANUA, P469; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jung S, 2010, J BIOL CHEM, V285, P6739, DOI 10.1074/jbc.M109.058552; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kim PK, 2015, J MOL BIOL, V427, P1176, DOI 10.1016/j.jmb.2015.02.005; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Lee JR, 2006, PLANT J, V47, P457, DOI 10.1111/j.1365-313X.2006.02797.x; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Okumoto K, 2014, J BIOL CHEM, V289, P14089, DOI 10.1074/jbc.M113.527937; Otzen M, 2005, J CELL SCI, V118, P3409, DOI 10.1242/jcs.02463; Padden J, 2014, MOL CELL PROTEOMICS, V13, P2661, DOI 10.1074/mcp.M113.034942; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 1998, J CELL BIOL, V143, P1859; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schroetter A, 2012, MOL CELL PROTEOMICS, V11, P1274, DOI 10.1074/mcp.M112.019364; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Smith JJ, 2001, J BIOL CHEM, V276, P1618, DOI 10.1074/jbc.M005072200; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Vendrell A, 2011, EMBO REP, V12, P1062, DOI 10.1038/embor.2011.154; Yang XD, 2001, EUR J CELL BIOL, V80, P126, DOI 10.1078/0171-9335-00144	57	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25333	25342		10.1074/jbc.M115.653451	http://dx.doi.org/10.1074/jbc.M115.653451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26276932	hybrid, Green Published			2022-12-28	WOS:000362962800012
J	Law, J; Salla, M; Zare, A; Wong, Y; Luong, L; Volodko, N; Syystun, O; Flood, K; Lim, J; Sung, M; Dyck, JRB; Tan, CT; Su, YC; Yu, VC; Mackey, J; Baksh, S				Law, Jennifer; Salla, Mohamed; Zare, Alaa; Wong, Yoke; Luong, Le; Volodko, Natalia; Syystun, Orysya; Flood, Kayla; Lim, Jonathan; Sung, Miranda; Dyck, Jason R. B.; Tan, Chong Teik; Su, Yu-Chin; Yu, Victor C.; Mackey, John; Baksh, Shairaz			Modulator of Apoptosis 1 (MOAP-1) Is a Tumor Suppressor Protein Linked to the RASSF1A Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC INACTIVATION; CELL-DEATH; BAX; ASSOCIATION; GENE; NEUROBLASTOMA; MICROTUBULE; EXPRESSION; STABILITY; MAP-1	Modulator of apoptosis 1 (MOAP-1) is a BH3-like protein that plays key roles in cell death or apoptosis. It is an integral partner to the tumor suppressor protein, Ras association domain family 1A (RASSF1A), and functions to activate the Bcl-2 family pro-apoptotic protein Bax. Although RASSF1A is now considered a bona fide tumor suppressor protein, the role of MOAP-1 as a tumor suppressor protein has yet to be determined. In this study, we present several lines of evidence from cancer databases, immunoblotting of cancer cells, proliferation, and xenograft assays as well as DNA microarray analysis to demonstrate the role of MOAP-1 as a tumor suppressor protein. Frequent loss of MOAP-1 expression, in at least some cancers, appears to be attributed to mRNA down-regulation and the rapid proteasomal degradation of MOAP-1 that could be reversed utilizing the proteasome inhibitor MG132. Overexpression of MOAP-1 in several cancer cell lines resulted in reduced tumorigenesis and up-regulation of genes involved in cancer regulatory pathways that include apoptosis (p53, Fas, and MST1), DNA damage control (poly(ADP)-ribose polymerase and ataxia telangiectasia mutated), those within the cell metabolism (IR-alpha, IR-beta, and AMP-activated protein kinase), and a stabilizing effect on microtubules. The loss of RASSF1A (an upstream regulator of MOAP-1) is one of the earliest detectable epigenetically silenced tumor suppressor proteins in cancer, and we speculate that the additional loss of function of MOAP-1 may be a second hit to functionally compromise the RASSF1A/MOAP-1 death receptor-dependent pathway and drive tumorigenesis.	[Law, Jennifer; Salla, Mohamed; Wong, Yoke; Luong, Le; Volodko, Natalia; Syystun, Orysya; Flood, Kayla; Lim, Jonathan; Sung, Miranda; Baksh, Shairaz] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2E1, Canada; [Zare, Alaa; Sung, Miranda; Dyck, Jason R. B.; Baksh, Shairaz] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2E1, Canada; [Sung, Miranda; Dyck, Jason R. B.] Univ Alberta, Fac Med & Dent, Cardiovasc Res Grp, Edmonton, AB T6G 2E1, Canada; [Tan, Chong Teik; Su, Yu-Chin; Yu, Victor C.] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore; [Mackey, John; Baksh, Shairaz] Univ Alberta, Cross Canc Inst, Dept Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Baksh, Shairaz] Canc Res Inst Northern Alberta, Edmonton, AB T6G 1Z2, Canada; [Baksh, Shairaz] Alberta IBD Consortium, Edmonton, AB T6G 2X8, Canada; [Baksh, Shairaz] Women & Childrens Hlth Res Inst, Edmonton, AB T6G 1C9, Canada	University of Alberta; University of Alberta; University of Alberta; National University of Singapore; University of Alberta	Baksh, S (corresponding author), Univ Alberta, Dept Pediat, Ctr Pharm & Hlth Res, Katz Grp, Rm 3-020E, Edmonton, AB T6G 2N8, Canada.	sbaksh@ualberta.ca	Yu, Victor/A-7899-2015; Salla, Mohamed/ABA-5843-2021; Baksh, Shairaz/GRX-2106-2022	Yu, Victor/0000-0003-3270-4734; Dyck, Jason/0000-0002-7045-2884; Tan, Chong Teik/0000-0002-9503-8364	National University of Singapore [R148-000-121-133]; National Medical Research Council of Singapore [IRG11may076]; Canadian Breast Cancer Foundation; Alberta Heritage Foundation for Medical Research; Alberta Innovates-Health Solutions; Canadian Foundation for Innovation; Department of Pediatrics/The Stollery Children's Foundation Hair Massacure grant; Alberta Innovates [201201237] Funding Source: researchfish	National University of Singapore(National University of Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Innovates-Health Solutions; Canadian Foundation for Innovation(Canada Foundation for Innovation); Department of Pediatrics/The Stollery Children's Foundation Hair Massacure grant; Alberta Innovates	Supported by National University of Singapore Grant R148-000-121-133 and National Medical Research Council of Singapore Grant IRG11may076. Minjiang Scholar Chair Professor at School of Life Sciences, Xiamen University, China.r Supported by grants from Canadian Breast Cancer Foundation, Alberta Heritage Foundation for Medical Research, Alberta Innovates-Health Solutions, Canadian Foundation for Innovation, and Department of Pediatrics/The Stollery Children's Foundation Hair Massacure grant generously donated by the MacDonald family.	Amoedo ND, 2013, BIOSCIENCE REP, V15, P33; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bheda A, 2008, ONCOGENE, V27, P4315, DOI 10.1038/onc.2008.65; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chow C, 2012, ONCOGENE, V31, P1975, DOI 10.1038/onc.2011.372; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Donninger H, 2015, MOL CELL BIOL, V35, P277, DOI 10.1128/MCB.00202-14; Donninger H, 2014, J BIOL CHEM, V289, P31287, DOI 10.1074/jbc.M114.609537; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Kalla M, 2010, ONCOGENE, V29, P5729, DOI 10.1038/onc.2010.316; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Fu NY, 2007, P NATL ACAD SCI USA, V104, P10051, DOI 10.1073/pnas.0700007104; Gao P, 2012, CURR GENE THER, V12, P285, DOI 10.2174/156652312802083620; Germain DR, 2011, BREAST CANCER RES TR, V127, P53, DOI 10.1007/s10549-010-0943-7; Gordon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075483; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Harada K, 2002, ONCOGENE, V21, P4345, DOI 10.1038/sj.onc.1205446; Huang NJ, 2012, J CELL BIOL, V197, P361, DOI [10.1083/jcb.201111141, 10.1083/jcb.201108062]; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Ishola TA, 2007, SURG ONCOL, V16, P149, DOI 10.1016/j.suronc.2007.09.005; Lee SS, 2009, EXP CELL RES, V315, P1313, DOI 10.1016/j.yexcr.2008.11.021; Li F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021977; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Michalowski MB, 2008, PEDIATR BLOOD CANCER, V50, P29, DOI 10.1002/pbc.21279; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagendran J, 2013, MOL CELL ENDOCRINOL, V366, P180, DOI 10.1016/j.mce.2012.06.015; Nakajima EC, 2013, MOL CARCINOGEN, V52, P329, DOI 10.1002/mc.21863; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Ousset M, 2010, CELL CYCLE, V9, P2814, DOI 10.4161/cc.9.14.12253; Rastelli F, 2010, TUMORI J, V96, P875, DOI 10.1177/548.6505; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Scrace Simon F, 2012, Mol Biol Int, V2012, P141732, DOI 10.1155/2012/141732; Song SJ, 2009, CANCER RES, V69, P8540, DOI 10.1158/0008-5472.CAN-09-1554; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Tommasi S, 2011, ONCOGENE, V30, P690, DOI 10.1038/onc.2010.440; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Verma SK, 2011, PROTEIN CELL, V2, P237, DOI 10.1007/s13238-011-1028-z; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Whitehurst AW, 2008, MOL CELL BIOL, V28, P3190, DOI 10.1128/MCB.02291-07; Xu J, 1999, MOL CELL BIOL, V19, P12; Yang QW, 2004, CLIN CANCER RES, V10, P8493, DOI 10.1158/1078-0432.CCR-04-1331	55	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24100	24118		10.1074/jbc.M115.648345	http://dx.doi.org/10.1074/jbc.M115.648345			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269600	hybrid, Green Published			2022-12-28	WOS:000362218900006
J	Wu, ML; Puddifoot, CA; Taylor, P; Joiner, WJ				Wu, Meilin; Puddifoot, Clare A.; Taylor, Palmer; Joiner, William J.			Mechanisms of Inhibition and Potentiation of alpha 4132 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED UP-REGULATION; VENTRAL TEGMENTAL AREA; SMOKING-CESSATION; PHARMACOLOGICAL CHAPERONE; ENDOPLASMIC-RETICULUM; CHOLINERGIC-RECEPTOR; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; PROTOTOXIN LYNX1; PARTIAL AGONIST	alpha 4 beta 2 nicotinic acetylcholine receptors (nAChRs) are abundantly expressed throughout the central nervous system and are thought to be the primary target of nicotine, the main addictive substance in cigarette smoking. Understanding the mechanisms by which these receptors are regulated may assist in developing compounds to selectively interfere with nicotine addiction. Here we report previously unrecognized modulatory properties of members of the Ly6 protein family on a402 nAChRs. Using a FRET-based Ca2+ flux assay, we found that the maximum response of alpha 4 beta 2 receptors to agonist was strongly inhibited by Ly6h and Lynx2 but potentiated by Ly6g6e. The mechanisms underlying these opposing effects appear to be fundamentally distinct. Receptor inhibition by Lynx2 was accompanied by suppression of a4132 expression at the cell surface, even when assays were preceded by chronic exposure of cells to an established chaperone, nicotine. Receptor inhibition by I,ynx2 also was resistant to pretreatment with extracellular phospholipase C, which cleaves lipid moieties like those that attach Ly6 proteins to the plasma membrane. In contrast, potentiation of a4/32 activity by Ly6g6e was readily reversible by pretreatment with phospholipase C. Potentiation was also accompanied by slowing of receptor desensitization and an increase in peak currents. Collectively our data support roles for Lynx2 and Ly6g6e in intracellular trafficking and allosteric potentiation of alpha 4 beta 2 nAChRs, respectively.	[Wu, Meilin; Puddifoot, Clare A.; Taylor, Palmer; Joiner, William J.] Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Taylor, Palmer; Joiner, William J.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Taylor, Palmer; Joiner, William J.] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA; [Joiner, William J.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Joiner, WJ (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wjoiner@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 NS072431, RO1 GM18360]; Whitehall Foundation [WF20110560]; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS072431, Whitehall Foundation Grant WF20110560, and a PhRMA Foundation Research Starter Grant (to W. J. J.), and by National Institutes of Health Grant RO1 GM18360 (to P. T.). The authors declare that they have no conflict of interest with the contents of this article.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Biala G, 2010, N-S ARCH PHARMACOL, V381, P361, DOI 10.1007/s00210-010-0498-5; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Cohen C, 2003, J PHARMACOL EXP THER, V306, P407, DOI 10.1124/jpet.103.049262; Conroy WG, 1998, MOL PHARMACOL, V53, P392, DOI 10.1124/mol.53.3.392; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Darsow T, 2005, J BIOL CHEM, V280, P18311, DOI 10.1074/jbc.M501157200; Darvas M, 2009, EUR NEUROPSYCHOPHARM, V19, P670, DOI 10.1016/j.euroneuro.2009.03.007; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Liu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055886; Lorenz R, 2014, ACTA NEUROL SCAND, V130, P164, DOI 10.1111/ane.12259; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Perez X. A., MOL PHARM, V78, P971; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Picciotto MR, 2008, FRONT BIOSCI-LANDMRK, V13, P492, DOI 10.2741/2695; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Puddifoot CA, 2015, J NEUROSCI, V35, P3420, DOI 10.1523/JNEUROSCI.3630-14.2015; Quik M, 2007, TRENDS PHARMACOL SCI, V28, P229, DOI 10.1016/j.tips.2007.03.001; Quik M, 2013, NEUROPHARMACOLOGY, V71, P191, DOI 10.1016/j.neuropharm.2013.03.038; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Srinivasan R, 2012, MOL PHARMACOL, V81, P759, DOI 10.1124/mol.112.077792; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tsetlin VI, 2015, TRENDS PHARMACOL SCI, V36, P109, DOI 10.1016/j.tips.2014.11.003; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Whiteaker P, 2006, J COMP NEUROL, V499, P1016, DOI 10.1002/cne.21181; WHITING PJ, 1988, J NEUROSCI, V8, P3395; Wu ML, 2008, J CLIN INVEST, V118, P2076, DOI 10.1172/JCI33715; Wu ML, 2014, CURR BIOL, V24, P621, DOI 10.1016/j.cub.2014.02.026; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743; Zoli M, 1998, J NEUROSCI, V18, P4461	58	26	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24509	24518		10.1074/jbc.M115.647248	http://dx.doi.org/10.1074/jbc.M115.647248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276394	hybrid, Green Published			2022-12-28	WOS:000362218900036
J	Ansari, IUH; Longacre, MJ; Paulusma, CC; Stoker, SW; Kendrick, MA; MacDonald, MJ				Ansari, Israr-ul H.; Longacre, Melissa J.; Paulusma, Coen C.; Stoker, Scott W.; Kendrick, Mindy A.; MacDonald, Michael J.			Characterization of P4 ATPase Phospholipid Translocases (Flippases) in Human and Rat Pancreatic Beta Cells THEIR GENE SILENCING INHIBITS INSULIN SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; PYRUVATE-CARBOXYLASE; LIPID FLIPPASES; ISLETS; MEMBRANE; GLUCOSE; GRANULES; CALCIUM; PROTEIN	The negative charge of phosphatidylserine in lipid bilayers of secretory vesicles and plasma membranes couples the domains of positively charged amino acids of secretory vesicle SNARE proteins with similar domains of plasma membrane SNARE proteins enhancing fusion of the two membranes to promote exocytosis of the vesicle contents of secretory cells. Our recent study of insulin secretory granules (ISG) (MacDonald, M. J., Ade, L., Ntambi, J. M., Ansari, I. H., and Stoker, S. W. (2015) Characterization of phospholipids in insulin secretory granules in pancreatic beta cells and their changes with glucose stimulation. J. Biol. Chem. 290, 1107511092) suggested that phosphatidylserine and other phospholipids, such as phosphatidylethanolamine, in ISG could play important roles in docking and fusion of ISG to the plasma membrane in the pancreatic beta cell during insulin exocytosis. P4 ATPase flippases translocate primarily phosphatidylserine and, to a lesser extent, phosphatidylethanolamine across the lipid bilayers of intracellular vesicles and plasma membranes to the cytosolic leaflets of these membranes. CDC50A is a protein that forms a heterodimer with P4 ATPases to enhance their translocase catalytic activity. We found that the predominant P4 ATPases in pure pancreatic beta cells and human and rat pancreatic islets were ATP8B1, ATP8B2, and ATP9A. ATP8B1 and CDC50A were highly concentrated in ISG. ATP9A was concentrated in plasma membrane. Gene silencing of individual P4 ATPases and CDC50A inhibited glucose-stimulated insulin release in pure beta cells and in human pancreatic islets. This is the first characterization of P4 ATPases in beta cells. The results support roles for P4 ATPases in translocating phosphatidylserine to the cytosolic leaflets of ISG and the plasma membrane to facilitate the docking and fusion of ISG to the plasma membrane during insulin exocytosis.	[MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI 53706 USA; [Paulusma, Coen C.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands	University of Wisconsin System; University of Wisconsin Madison; University of Amsterdam; Academic Medical Center Amsterdam	MacDonald, MJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI 53706 USA.	mjmacdon@wisc.edu	Regan, Clinton/E-6250-2012; Paulusma, Coen/AAR-7943-2021	ANSARI, Israrul/0000-0003-0326-0329; Paulusma, Coen/0000-0001-7284-1974; MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Nowlin Family Trust of the InFaith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nowlin Family Trust of the InFaith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK28348. This work was also supported by the Nowlin Family Trust of the InFaith Community Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aronson N N Jr, 1974, Methods Enzymol, V31, P90; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Clark MR, 2011, NAT IMMUNOL, V12, P373, DOI 10.1038/ni.2024; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Domanska MK, 2010, BIOPHYS J, V99, P2936, DOI 10.1016/j.bpj.2010.09.011; Folmer DE, 2012, J HISTOCHEM CYTOCHEM, V60, P205, DOI 10.1369/0022155411435705; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jacquot A, 2012, J BIOL CHEM, V287, P44580, DOI 10.1074/jbc.A111.313916; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; KOWLURU A, 1985, ARCH BIOCHEM BIOPHYS, V242, P72, DOI 10.1016/0003-9861(85)90481-3; KOWLURU A, 1994, BBA-MOL CELL RES, V1222, P348, DOI 10.1016/0167-4889(94)90040-X; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2015, J BIOL CHEM, V290, P11075, DOI 10.1074/jbc.M114.628420; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Morton LA, 2013, ACS CHEM BIOL, V8, P218, DOI 10.1021/cb300429e; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; RANA RS, 1986, HORM METAB RES, V18, P659, DOI 10.1055/s-2007-1012400; RANA RS, 1986, J CELL BIOCHEM, V32, P143, DOI 10.1002/jcb.240320206; RANA RS, 1986, ARCH BIOCHEM BIOPHYS, V245, P411, DOI 10.1016/0003-9861(86)90232-8; RHODES CJ, 1989, J BIOL CHEM, V264, P14240; Rodrigues RB, 2014, BIOCHEMISTRY-US, V53, P566, DOI 10.1021/bi401096m; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	54	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23110	23123		10.1074/jbc.M115.655027	http://dx.doi.org/10.1074/jbc.M115.655027			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240149	hybrid, Green Published			2022-12-28	WOS:000361685500023
J	Ho, SR; Lee, YJ; Lin, WC				Ho, Shiuh-Rong; Lee, Yu-Ju; Lin, Weei-Chin			Regulation of RNF144A E3 Ubiquitin Ligase Activity by Self-association through Its Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-FINGER PROTEIN; JUVENILE PARKINSONISM; LINEAR UBIQUITINATION; MUTATIONAL LANDSCAPE; ANTIVIRAL RESPONSE; IMMUNE-SYSTEM; GXXXG MOTIF; ACTIVATION; APOPTOSIS; FAMILY	RNF144A, an E3 ubiquitin ligase for DNA-dependent protein kinase catalytic subunit (DNA-PKcs), can promote DNA damage-induced cell apoptosis. Here we characterize an important regulation of RNF144A through its transmembrane (TM) domain. The TM domain of RNF144A is highly conserved among species. Deletion of the TM domain abolishes its membrane localization and also significantly reduces its ubiquitin ligase activity. Further evidence shows that the TM domain is required for RNF144A self-association and that the self-association may be partially mediated through a classic GXXXG interaction motif. A mutant RNF144A-G252L/G256L (in the G252XXXG256 motif) preserves membrane localization but is defective in self-association and ubiquitin ligase activity. On the other hand, a membrane localization loss mutant of RNF144A still retains self-association and E3 ligase activity, which can be blocked by additional G252L/G256L mutations. Therefore, our data demonstrate that the TM domain of RNF144A has at least two independent roles, membrane localization and E3 ligase activation, to regulate its physiological function. This regulatory mechanism may be applicable to other RBR (RING1-IBRRING2) E3 ubiquitin ligases because, first, RNF144B also self-associates. Second, all five TM-containing RBR E3 ligases, including RNF144A and RNF144B, RNF19A/Dorfin, RNF19B, and RNF217, have the RBR-TM(GXXXG) superstructure. Mutations of the GXXXG motifs in RNF144A and RNF217 have also be found in human cancers, including a G252D mutation of RNF144A. Interestingly, RNF144A-G252D still preserves self-association and ubiquitin ligase activity but loses membrane localization and is turned over rapidly. In conclusion, both proper membrane localization and self-association are important for RNF144A function.	[Ho, Shiuh-Rong; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Lee, Yu-Ju; Lin, Weei-Chin] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), One Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	Regan, Clinton/E-6250-2012; HO, SHIUH-RONG/M-4728-2019	HO, SHIUH-RONG/0000-0002-9612-722X	National Institutes of Health [R01CA100857, R01CA138641]; Department of Defense [W81XWH-14-1-0339, W81XWH-14-1-0306]; Howard Hughes Medical Institute through the Med into Grad Initiative;  [T32DK60445]; NATIONAL CANCER INSTITUTE [T32CA174647, R01CA100857, R01CA138641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute through the Med into Grad Initiative(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA100857 and R01CA138641. This work was also supported by Department of Defense Grants W81XWH-14-1-0339 and W81XWH-14-1-0306. The authors declare that they have no conflicts of interest with the contents of this article.; S. R. H. was supported by T32 Fellowship T32DK60445.; Y. J. L. is in the Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, which was supported, in part, by a grant from the Howard Hughes Medical Institute through the Med into Grad Initiative.	Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chong IY, 2013, J PATHOL, V231, P301, DOI 10.1002/path.4247; Conforti F, 2013, ONCOGENE, V32, P4758, DOI 10.1038/onc.2012.497; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Du W, 2010, J BIOL CHEM, V285, P37436, DOI 10.1074/jbc.M110.113209; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho SR, 2014, P NATL ACAD SCI USA, V111, pE2646, DOI 10.1073/pnas.1323107111; Huang J, 2006, FEBS LETT, V580, P940, DOI 10.1016/j.febslet.2005.09.105; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Lin AE, 2013, NAT IMMUNOL, V14, P27, DOI 10.1038/ni.2478; Liu K, 2013, MOL CELL BIOL, V33, P4685, DOI 10.1128/MCB.00373-13; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Matsumine H, 1997, AM J HUM GENET, V60, P588; Nakamura N, 2011, MEMBRANES-BASEL, V1, P354, DOI 10.3390/membranes1040354; Ng CC, 2003, ONCOGENE, V22, P4449, DOI 10.1038/sj.onc.1206586; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Sparr E, 2005, J BIOL CHEM, V280, P39324, DOI 10.1074/jbc.M502810200; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Taebunpakul P, 2012, APOPTOSIS, V17, P762, DOI 10.1007/s10495-012-0720-7; Wang YY, 2012, CELL HOST MICROBE, V12, P129, DOI 10.1016/j.chom.2012.07.006	37	18	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23026	23038		10.1074/jbc.M115.645499	http://dx.doi.org/10.1074/jbc.M115.645499			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26216882	Green Published, hybrid			2022-12-28	WOS:000361685500017
J	Lu, W; Fang, WQ; Li, J; Zhang, B; Yang, Q; Yan, XY; Peng, L; Ai, H; Wang, JJ; Liu, X; Luo, JH; Yang, W				Lu, Wen; Fang, Weiqing; Li, Jian; Zhang, Bin; Yang, Qian; Yan, Xunyi; Peng, Lin; Ai, Heng; Wang, Jie-jie; Liu, Xiao; Luo, Jianhong; Yang, Wei			Phosphorylation of Tyrosine 1070 at the GluN2B Subunit Is Regulated by Synaptic Activity and Critical for Surface Expression of N-Methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTORS; NR2B SUBUNIT; PROTEIN; SRC; FYN; TRAFFICKING; CONTRIBUTES; KINASES; COMPLEX; ACTIVATION	The number and subunit composition of synaptic N-methyl-D-aspartate receptors (NMDARs) play critical roles in synaptic plasticity, learning, and memory and are implicated in neurological disorders. Tyrosine phosphorylation provides a powerful means of regulating NMDAR function, but the underling mechanism remains elusive. In this study we identified a tyrosine site on the GluN2B subunit, Tyr-1070, which was phosphorylated by a proto-oncogene tyrosine-protein (Fyn) kinase and critical for the surface expression of GluN2B-containing NMDARs. The phosphorylation of GluN2B at Tyr-1070 was required for binding of Fyn kinase to GluN2B, which up-regulated the phosphorylation of GluN2B at Tyr-1472. Moreover, our results revealed that the phosphorylation change of GluN2B at Tyr-1070 accompanied the Tyr-1472 phosphorylation and Fyn associated with GluN2B in synaptic plasticity induced by both chemical and contextual fear learning. Taken together, our findings provide a new mechanism for regulating the surface expression of NMDARs with implications for synaptic plasticity.	[Lu, Wen; Fang, Weiqing; Li, Jian; Zhang, Bin; Yang, Qian; Yan, Xunyi; Peng, Lin; Wang, Jie-jie; Liu, Xiao; Luo, Jianhong; Yang, Wei] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Collabora, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Jian] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Ai, Heng] Zhejiang Med Coll, Dept Physiol, Hangzhou 310053, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn; yangwei@zju.edu.cn	Luo, jian/HGE-7331-2022; Lu, Wen/AAL-8524-2020	Wang, Jiejie/0000-0001-7585-0585; Yang, Qian/0000-0001-9861-2790	National Basic Research Program of China [2010CB912002, 2014CB910300, 2013CB910204]; Natural Science Foundation of China [91232303, 81221003, 30900418, 81371302]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2010CB912002 and 2014CB910300 (to J. Luo) and 2013CB910204 (to W. Y.) and Natural Science Foundation of China Grants 91232303 and 81221003 (to J. Luo) and 30900418 and 81371302 (to W. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Ai H, 2011, NEUROSCI LETT, V497, P94, DOI 10.1016/j.neulet.2011.04.038; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Barki-Harrington L, 2009, J NEUROSCI, V29, P9219, DOI 10.1523/JNEUROSCI.5667-08.2009; Behnisch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017276; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Knox R, 2014, STROKE, V45, P3040, DOI 10.1161/STROKEAHA.114.006170; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lu W, 2015, EXP NEUROL, V271, P251, DOI 10.1016/j.expneurol.2015.06.016; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Qiu S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003778; Salter MW, 2012, FEBS J, V279, P2, DOI 10.1111/j.1742-4658.2011.08390.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YB, 2012, J NEUROSCI, V32, P11919, DOI 10.1523/JNEUROSCI.3852-11.2012; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253	45	29	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22945	22954		10.1074/jbc.M115.663450	http://dx.doi.org/10.1074/jbc.M115.663450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229100	hybrid, Green Published			2022-12-28	WOS:000361685500008
J	Panwar, P; Lamour, G; Mackenzie, NCW; Yang, H; Ko, F; Li, HB; Bromme, D				Panwar, Preety; Lamour, Guillaume; Mackenzie, Neil C. W.; Yang, Heejae; Ko, Frank; Li, Hongbin; Broemme, Dieter			Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; CATHEPSIN-K ACTIVITY; MATRIX METALLOPROTEINASES; VASCULAR CALCIFICATION; CROSS-LINKING; NANOMECHANICAL PROPERTIES; ARTICULAR-CARTILAGE; CYSTEINE PROTEASES; BONE; AGE	During aging, changes occur in the collagen network that contribute to various pathological phenotypes in the skeletal, vascular, and pulmonary systems. The aim of this study was to investigate the consequences of age-related modifications on the mechanical stability and in vitro proteolytic degradation of type I collagen. Analyzing mouse tail and bovine bone collagen, we found that collagen at both fibril and fiber levels varies in rigidity and Young's modulus due to different physiological changes, which correlate with changes in cathepsin K (CatK)-mediated degradation. A decreased susceptibility to CatK-mediated hydrolysis of fibrillar collagen was observed following mineralization and advanced glycation end product-associated modification. However, aging of bone increased CatK-mediated osteoclastic resorption by similar to 27%, and negligible resorption was observed when osteoclasts were cultured on mineral-deficient bone. We observed significant differences in the excavations generated by osteoclasts and C-terminal telopeptide release during bone resorption under distinct conditions. Our data indicate that modification of collagen compromises its bio-mechanical integrity and affects CatK-mediated degradation both in bone and tissue, thus contributing to our understanding of extracellular matrix aging.	[Panwar, Preety; Mackenzie, Neil C. W.; Broemme, Dieter] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC 6T 1Z3, Canada; [Panwar, Preety; Mackenzie, Neil C. W.; Broemme, Dieter] Univ British Columbia, Fac Med, Ctr Blood Res, Vancouver, BC 6T 1Z3, Canada; [Yang, Heejae; Ko, Frank] Univ British Columbia, Fac Med, Dept Mech Engn, Vancouver, BC 6T 1Z3, Canada; [Broemme, Dieter] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC 6T 1Z3, Canada; [Lamour, Guillaume; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Bromme, D (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC 6T 1Z3, Canada.	dbromme@dentistry.ubc.ca	Lamour, Guillaume/D-6758-2015; Li, Hongbin/G-2949-2012	Lamour, Guillaume/0000-0002-9331-5532; Li, Hongbin/0000-0001-7813-1332	Canadian Institutes of Health Research [MOP-8994, MOP-125866]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants MOP-8994 and MOP-125866. The authors declare that they have no conflicts of interest with the contents of this article.	Aguda AH, 2014, P NATL ACAD SCI USA, V111, P17474, DOI 10.1073/pnas.1414126111; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; Cheng XW, 2013, ATHEROSCLEROSIS, V228, P211, DOI 10.1016/j.atherosclerosis.2013.01.004; Connizzo BK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023234; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Duong L. T., 2013, IBMS BONEKEY, DOI [10.1038/bonekey.2013.130, DOI 10.1038/BONEKEY.2013.130]; Ebenstein DM, 2009, J BIOMED MATER RES A, V91A, P1028, DOI 10.1002/jbm.a.32321; Ebrahimi Ali P, 2009, J Vasc Interv Neurol, V2, P155; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Garnero Patrick, 2012, Bonekey Rep, V1, P182, DOI 10.1038/bonekey.2012.182; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Gineyts E, 2000, BIOCHEM J, V345, P481, DOI 10.1042/0264-6021:3450481; Goh KL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898732; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Hofbauer LC, 2007, OSTEOPOROSIS INT, V18, P251, DOI 10.1007/s00198-006-0282-z; Hu LN, 2014, HYPERTENSION, V63, P607, DOI 10.1161/HYPERTENSIONAHA.113.02141; Huebschmann AG, 2006, DIABETES CARE, V29, P1420, DOI 10.2337/dc05-2096; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Lamour G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-16; Lamour G, 2014, ACS NANO, V8, P3851, DOI 10.1021/nn5007013; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Martin KJ, 2007, J AM SOC NEPHROL, V18, P875, DOI 10.1681/ASN.2006070771; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; MONNIER VM, 1984, P NATL ACAD SCI-BIOL, V81, P583, DOI 10.1073/pnas.81.2.583; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Noordzij MJ, 2008, J REN CARE, V34, P207, DOI 10.1111/j.1755-6686.2008.00038.x; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olsson LF, 2001, AM J KIDNEY DIS, V38, P377, DOI 10.1053/ajkd.2001.26104; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002; Rodriguez KJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-29; Rolewska P, 2013, EXP GERONTOL, V48, P29, DOI 10.1016/j.exger.2012.04.012; SCHMID K, 1980, ATHEROSCLEROSIS, V37, P199, DOI 10.1016/0021-9150(80)90005-2; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; Paiva KBS, 2014, ARCH BIOCHEM BIOPHYS, V561, P74, DOI 10.1016/j.abb.2014.07.034; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tan EPS, 2005, BIOMATERIALS, V26, P1453, DOI 10.1016/j.biomaterials.2004.05.021; Tang SY, 2011, J BIOMECH, V44, P330, DOI 10.1016/j.jbiomech.2010.10.016; Thiam S, 2004, J ENVIRON SCI HEAL A, V39, P1497, DOI 10.1081/ESE-120037849; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	75	63	64	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23291	23306		10.1074/jbc.M115.644310	http://dx.doi.org/10.1074/jbc.M115.644310			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26224630	Green Published, hybrid			2022-12-28	WOS:000361685500037
J	Yashin, DV; Ivanova, OK; Soshnikova, NV; Sheludchenkov, AA; Romanova, EA; Dukhanina, EA; Tonevitsky, AG; Gnuchev, NV; Gabibov, AG; Georgiev, GP; Sashchenko, LP				Yashin, Denis V.; Ivanova, Olga K.; Soshnikova, Natalia V.; Sheludchenkov, Anton A.; Romanova, Elena A.; Dukhanina, Elena A.; Tonevitsky, Alexander G.; Gnuchev, Nikolai V.; Gabibov, Alexander G.; Georgiev, Georgii P.; Sashchenko, Lidia P.			Tag7 (PGLYRP1) in Complex with Hsp70 Induces Alternative Cytotoxic Processes in Tumor Cells via TNFR1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell death; heat shock protein (HSP); RNA interference (RNAi); tumor necrosis factor (TNF); TNFR1; Tag7; Tag7-Hsp70 complex; necroptosis; Hsp70; TNFR1; cytotoxicity	PEPTIDOGLYCAN RECOGNITION PROTEIN; PROGRAMMED NECROSIS; KINASE RIP; DEATH; LYMPHOCYTES; DROSOPHILA; APOPTOSIS; PHOSPHORYLATION; NECROPTOSIS; MOLECULE	Background: A complex containing an innate immunity protein Tag7, and Hsp70 kills various cancer cells. Results: Tag7 and its complex with Hsp70 bind to the TNFR1 receptor, but only the Tag7-Hsp70 complex induces a cytotoxic effect via apoptosis and necroptosis. Conclusion: A new ligand has been found for the TNFR1 death receptor. Significance: Tag7 may be used as an inhibitor of the TNF--induced cytotoxicity. Tag7 (also known as peptidoglycan recognition protein PGRP-S, PGLYRP1), an innate immunity protein, interacts with Hsp70 to form a stable Tag7-Hsp70 complex with cytotoxic activity against some tumor cell lines. In this study, we have analyzed the programmed cell death mechanisms that are induced when cells interact with the Tag7-Hsp70 complex, which was previously shown to be released by human lymphocytes and is cytotoxic to cancer cells. We show that this complex induces both apoptotic and necroptotic processes in the cells. Apoptosis follows the classic caspase-8 and caspase-3 activation pathway. Inhibition of apoptosis leads to a switch to the RIP1-dependent necroptosis. Both of these cytotoxic processes are initiated by the involvement of TNFR1, a receptor for TNF-. Our results suggest that the Tag7-Hsp70 complex is a novel ligand for this receptor. One of its components, the innate immunity protein Tag7, can bind to the TNFR1 receptor, thereby inhibiting the cytotoxic actions of the Tag7-Hsp70 complex and TNF-, an acquired immunity cytokine.	[Yashin, Denis V.; Ivanova, Olga K.; Soshnikova, Natalia V.; Sheludchenkov, Anton A.; Romanova, Elena A.; Dukhanina, Elena A.; Gnuchev, Nikolai V.; Gabibov, Alexander G.; Georgiev, Georgii P.; Sashchenko, Lidia P.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Dukhanina, Elena A.] RAS, Engelhardt Inst Mol Biol, Moscow 119334, Russia; [Tonevitsky, Alexander G.] PA Hertsen Moscow Res Oncol Inst, Moscow 125284, Russia; [Gabibov, Alexander G.] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Sashchenko, LP (corresponding author), Russian Acad Sci, Inst Gene Biol, Vavilova 34-5, Moscow 119334, Russia.	sashchenko@genebiology.ru	Tonevitsky, Alexander/R-5596-2019	Tonevitsky, Alexander/0000-0002-7079-7145; Sheludchenkov, Anton/0000-0001-8636-649X	Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, International Centre for Genetic Engineering and Biotechnology (ICGEB)	Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, International Centre for Genetic Engineering and Biotechnology (ICGEB)	This work was supported by the Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, International Centre for Genetic Engineering and Biotechnology (ICGEB). The authors declare that they have no conflicts of interest with the contents of this article.	Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Corcione A, 1997, BLOOD, V90, P4493; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dukhanina E A, 2007, Dokl Biol Sci, V414, P246, DOI 10.1134/S0012496607030222; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Guan YJ, 2011, J IMMUNOL, V187, P1289, DOI 10.4049/jimmunol.1003399; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kiselev SL, 1998, J BIOL CHEM, V273, P18633, DOI 10.1074/jbc.273.29.18633; Kohler M, 2008, ELECTROPHORESIS, V29, P4495, DOI 10.1002/elps.200800221; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Kustikova OS, 1996, GENETIKA+, V32, P621; Larin SS, 2004, J GENE MED, V6, P798, DOI 10.1002/jgm.560; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARSTERS SA, 1992, J BIOL CHEM, V267, P5747; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Sashchenko LP, 2007, BLOOD, V110, P1997, DOI 10.1182/blood-2006-12-064444; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; VANHAESEBROECK B, 1991, CANCER RES, V51, P2469; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138	35	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21724	21731		10.1074/jbc.M115.639732	http://dx.doi.org/10.1074/jbc.M115.639732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26183779	Green Published, hybrid			2022-12-28	WOS:000360637600043
J	Elguindy, MM; Nakamaru-Ogiso, E				Elguindy, Mahmoud M.; Nakamaru-Ogiso, Eiko			Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH: Ubiquinone Oxidoreductases (NDH-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL ALTERNATIVE NADH; AEROBIC RESPIRATORY-CHAIN; ESCHERICHIA-COLI; QUINONE OXIDOREDUCTASE; MITOCHONDRIAL NADH; COMPLEX-I; REGULATES APOPTOSIS; INTERMEMBRANE-SPACE; MEMBRANE DOMAIN; FACTOR LEADS	Apoptosis-inducing factor (AIF) and AMID (AIF-homologous mitochondrion-associated inducer of death) are flavoproteins. Although AIF was originally discovered as a caspase-independent cell death effector, bioenergetic roles of AIF, particularly relating to complex I functions, have since emerged. However, the role of AIF in mitochondrial respiration and redox metabolism has remained unknown. Here, we investigated the redox properties of human AIF and AMID by comparing them with yeast Ndi1, a type 2 NADH: ubiquinone oxidoreductase (NDH-2) regarded as alternative complex I. Isolated AIF and AMID containing naturally incorporated FAD displayed no NADH oxidase activities. However, after reconstituting isolated AIF or AMID into bacterial or mitochondrial membranes, N-terminally tagged AIF and AMID displayed substantial NADH:O-2 activities and supported NADH-linked proton pumping activities in the host membranes almost as efficiently as Ndi1. NADH: ubiquinone-1 activities in the reconstituted membranes were highly sensitive to 2-n-heptyl-4-hydroxyquinoline-N-oxide (IC50 = similar to 1 mu M), a quinone-binding inhibitor. Overexpressing N-terminally tagged AIF and AMID enhanced the growth of a double knock-out Escherichia coli strain lacking complex I and NDH-2. In contrast, C-terminally tagged AIF and NADH-binding site mutants of N-terminally tagged AIF and AMID failed to show both NADH:O-2 activity and the growth-enhancing effect. The disease mutant AIF Delta R201 showed decreased NADH:O-2 activity and growth-enhancing effect. Furthermore, we surprisingly found that the redox activities of N-terminally tagged AIF and AMID were sensitive to rotenone, a well known complex I inhibitor. We propose that AIF and AMID are previously unidentified mammalian NDH-2 enzymes, whose bioenergetic function could be supplemental NADH oxidation in cells.	[Elguindy, Mahmoud M.; Nakamaru-Ogiso, Eiko] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Nakamaru-Ogiso, E (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, 422 Curie Blvd, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu	Regan, Clinton/E-6250-2012	Elguindy, Mahmoud/0000-0001-9151-1751	National Institutes of Health [RO1GM097409]; American Heart Association [11SDG5560001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM097409 (to E. N.-O.). This work was also supported by American Heart Association Grant 11SDG5560001 (to E. N.-O.). The authors declare that they have no conflicts of interest with the contents of this article.	Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Bilyy R, 2008, APOPTOSIS, V13, P729, DOI 10.1007/s10495-008-0198-5; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Duarte M, 2003, BIOCHEM J, V371, P1005, DOI 10.1042/BJ20021374; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Garofano A, 2006, YEAST, V23, P1129, DOI 10.1002/yea.1426; Ghelli A, 1997, J BIOCHEM, V121, P746; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Heikal A, 2014, MOL MICROBIOL, V91, P950, DOI 10.1111/mmi.12507; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Iwata M, 2012, P NATL ACAD SCI USA, V109, P15247, DOI 10.1073/pnas.1210059109; Jeuken LJC, 2006, J AM CHEM SOC, V128, P1711, DOI 10.1021/ja056972u; Joza N, 2008, CELL DEATH DIFFER, V15, P1009, DOI 10.1038/cdd.2008.24; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kim MS, 2004, J BIOCHEM MOL BIOL, V37, P753; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Matsuno-Yagi A., 1985, BIOL CHEM, V260, P11424; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MAYHEW SG, 1974, EUR J BIOCHEM, V44, P579, DOI 10.1111/j.1432-1033.1974.tb03515.x; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mogi T, 2009, FEMS MICROBIOL LETT, V291, P157, DOI 10.1111/j.1574-6968.2008.01451.x; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; NEGRI A, 1987, J BIOL CHEM, V262, P10026; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061; Polster BM, 2013, NEUROCHEM INT, V62, P695, DOI 10.1016/j.neuint.2012.12.002; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TOKUDA H, 1984, J BIOL CHEM, V259, P7785; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Varecha M, 2007, APOPTOSIS, V12, P1155, DOI 10.1007/s10495-007-0061-0; Varecha M, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-59; Verner Z, 2013, PARASITOLOGY, V140, P328, DOI 10.1017/S003118201200162X; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836	54	64	67	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20815	20826		10.1074/jbc.M115.641498	http://dx.doi.org/10.1074/jbc.M115.641498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26063804	hybrid, Green Published			2022-12-28	WOS:000360011800019
J	Song, K; Herzog, BH; Fu, JX; Sheng, MJ; Bergstrom, K; McDaniel, JM; Kondo, Y; McGee, S; Cai, XF; Li, P; Chen, H; Xia, LJ				Song, Kai; Herzog, Brett H.; Fu, Jianxin; Sheng, Minjia; Bergstrom, Kirk; McDaniel, J. Michael; Kondo, Yuji; McGee, Samuel; Cai, Xiaofeng; Li, Ping; Chen, Hong; Xia, Lijun			Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY TUMORIGENESIS; MUCINS; GLYCOSYLATION; EXPRESSION; ANTIGENS; MUC1; INDUCTION; PROGNOSIS; ONCOGENE; SURVIVAL	Mucin-type core 1-derived O-glycans, one of the major types of O-glycans, are highly expressed in mammary gland epithelium. Abnormal O-glycans such as Tn antigen are found in over 90% of breast cancers; however, the in vivo role of these aberrant O-glycans in the etiology of breast cancer is unclear. We generated mice with mammary epithelial specific deletion of core 1-derived O-glycans. By crossing with two spontaneous mouse breast cancer models, we determined that loss of core 1-derived O-glycans delays the onset and progression of breast cancer development. Deficiency of core 1 O-glycosylation impaired the localization of Muc1, a major O-glycoprotein, on the apical surfaces of mammary epithelium. Signaling mediated by Muc1, which is critical for breast cancer development, was also defective in the absence of core 1 O-glycans. This study reveals an unexpected role of core 1-derived O-glycans in breast cancer development in mice.	[Song, Kai; Herzog, Brett H.; Fu, Jianxin; Sheng, Minjia; Bergstrom, Kirk; McDaniel, J. Michael; Kondo, Yuji; McGee, Samuel; Cai, Xiaofeng; Chen, Hong; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Herzog, Brett H.; Chen, Hong; Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Fu, Jianxin; Xia, Lijun] Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis,Minist Hlth, Jiangsu Inst Hematol,Collaborat Innovat Ctr Hemat, Suzhou 215006, Peoples R China; [Sheng, Minjia] Jilin Univ, China Japan Union Hosp, Changchun 130033, Peoples R China; [Li, Ping] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Soochow University - China; Jilin University; China Pharmaceutical University	Chen, H (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	hong-chen@omrf.org; lijun-xia@omrf.org	Regan, Clinton/E-6250-2012; Cai, Xiaofeng/ABI-4780-2020; Bergstrom, Kirk/AAZ-8856-2021	Cai, Xiaofeng/0000-0002-0646-5218	National Institutes of Health [GM103441, HL085607, HL093242, HL118676]; Department of Defense [W81XWH-11-1-0226]; Oklahoma Center for the Advancement of Science and Technology [HR13-160, HR13-020]; National Natural Science Foundation of China [81470825, 31400692]; Jiangsu Provincial Special Program of Medical Science [BL2012005]; Jiangsu Province's Key Medical Center [ZX201102]; Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMKF201401]; American Heart Association [SDG7410022, SDG0835544N, 15EIA22210014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118676, R01HL093242, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Oklahoma Center for the Advancement of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Jiangsu Province's Key Medical Center; Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM103441, HL085607, HL093242, HL118676), Department of Defense (W81XWH-11-1-0226), Oklahoma Center for the Advancement of Science and Technology (HR13-160, HR13-020), National Natural Science Foundation of China (81470825, 31400692), Jiangsu Provincial Special Program of Medical Science (BL2012005), Jiangsu Province's Key Medical Center (ZX201102), Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (SKLNMKF201401), and American Heart Association (SDG7410022, SDG0835544N, 15EIA22210014). The authors declare that they have no conflicts of interest with the contents of this article.	Al Masri A, 2005, ONCOGENE, V24, P5799, DOI 10.1038/sj.onc.1208738; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Cao R, 2012, J PROTEOME RES, V11, P4013, DOI 10.1021/pr300058z; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chou CH, 2015, ONCOTARGET, V6, P6123, DOI 10.18632/oncotarget.3045; Denkert C, 2013, J CLIN ONCOL, V31, P836, DOI 10.1200/JCO.2012.47.1698; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gouyer V, 2001, FRONT BIOSCI, V6, pD1235, DOI 10.2741/gouyer; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Loi S, 2014, J CLIN ONCOL, V32, P2935, DOI 10.1200/JCO.2014.56.7677; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Milde-Langosch K, 2015, BREAST CANCER RES TR, V151, P515, DOI 10.1007/s10549-015-3425-0; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SPRINGER GF, 1979, J SURG ONCOL, V11, P95, DOI 10.1002/jso.2930110204; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144	29	24	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20159	20166		10.1074/jbc.M115.654483	http://dx.doi.org/10.1074/jbc.M115.654483			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124270	hybrid, Green Published			2022-12-28	WOS:000359608900018
J	Knockenhauer, KE; Schwartz, TU				Knockenhauer, Kevin E.; Schwartz, Thomas U.			Structural Characterization of Bardet-Biedl Syndrome 9 Protein (BBS9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; CILIARY MEMBRANE; COMPARATIVE GENOMICS; PRIMARY CILIUM; BBSOME; CONSERVATION; SEQUENCE; SUBUNIT; COPII; GENE	The Bardet-Biedl syndrome protein complex (BBSome) is an octameric complex that transports membrane proteins into the primary cilium signaling organelle in eukaryotes and is implicated in human disease. Here we have analyzed the 99-kDa human BBS9 protein, one of the eight BBSome components. The protein is composed of four structured domains, including a beta-stranded N-terminal domain. The 1.8 angstrom crystal structure of the 46-kDa N-terminal domain reveals a seven-bladed beta-propeller. A structure-based homology search suggests that it functions in protein-protein interactions. We show that the Bardet-Biedl syndrome-causing G141R mutation in BBS9 likely results in misfolding of the beta-propeller. Although the C-terminal half of BBS9 dimerizes in solution, the N-terminal domain only does so in the crystal lattice. This C-terminal dimerization interface might be important for the assembly of the BBSome.	[Knockenhauer, Kevin E.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	NIGMS, National Institutes of Health [GM103403]; Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, T32GM007287] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Saxton for performing the HEK 293T transient transfection and subsequent Western blot, N. Leksa for experimental advice, S. Bilokapic for help with crystal fishing, and E. Spooner for performing the LC-MS/MS. The x-ray crystallography work was conducted at the Advanced Photon Source (APS) NE-CAT beamlines, which are supported by award GM103403 from the NIGMS, National Institutes of Health. Use of the APS is supported by the Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (NSF-007031) is gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Heenan EJ, 2009, BIOCHEMISTRY-US, V48, P6390, DOI 10.1021/bi900621w; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Mans BJ, 2004, CELL CYCLE, V3, P1612; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mourao A, 2014, NAT STRUCT MOL BIOL, V21, P1035, DOI 10.1038/nsmb.2920; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Veleri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034389; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Wilkins MR, 1999, METH MOL B, V112, P531; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1	44	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19569	19583		10.1074/jbc.M115.649202	http://dx.doi.org/10.1074/jbc.M115.649202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085087	Green Published, hybrid			2022-12-28	WOS:000359364600020
J	Suenaga, T; Matsumoto, M; Arisawa, F; Kohyama, M; Hirayasu, K; Mori, Y; Arase, H				Suenaga, Tadahiro; Matsumoto, Maki; Arisawa, Fuminori; Kohyama, Masako; Hirayasu, Kouyuki; Mori, Yasuko; Arase, Hisashi			Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; HERPES-SIMPLEX; CRYSTALLOGRAPHIC ANALYSIS; MEMBRANE-FUSION; RECEPTOR; GB; COMPLEX; SIALOADHESIN; SIGLEC-7; GLYCAN	Varicella-zoster virus (VZV) is a member of the human Herpesvirus family that causes varicella (chicken pox) and zoster (shingles). VZV latently infects sensory ganglia and is also responsible for encephalomyelitis. Myelin-associated glycoprotein (MAG), a member of the sialic acid (SA)-binding immunoglobulin-like lectin family, is mainly expressed in neural tissues. VZV glycoprotein B (gB) associates with MAG and mediates membrane fusion during VZV entry into host cells. The SA requirements of MAG when associating with its ligands vary depending on the specific ligand, but it is unclear whether the SAs on gB are involved in the association with MAG. In this study, we found that SAs on gB are essential for the association with MAG as well as for membrane fusion during VZV infection. MAG with a point mutation in the SA-binding site did not bind to gB and did not mediate cell-cell fusion or VZV entry. Cell-cell fusion and VZV entry mediated by the gB-MAG interaction were blocked by sialidase treatment. N-glycosylation or O-glycosylation inhibitors also inhibited the fusion and entry mediated by gB-MAG interaction. Furthermore, gB with mutations in N-glycosylation sites, i.e. asparagine residues 557 and 686, did not associate with MAG, and the cell-cell fusion efficiency was low. Fusion between the viral envelope and cellular membrane is essential for host cell entry by herpesviruses. Therefore, these results suggest that SAs on gB play important roles in MAG-mediated VZV infection.	[Suenaga, Tadahiro; Matsumoto, Maki; Arisawa, Fuminori; Kohyama, Masako; Hirayasu, Kouyuki; Arase, Hisashi] Osaka Univ, Dept Immunochem, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Suenaga, Tadahiro; Matsumoto, Maki; Kohyama, Masako; Hirayasu, Kouyuki; Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka 5650871, Japan; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Ctr Infect Dis, Kobe, Hyogo 6500017, Japan	Osaka University; Osaka University; Kobe University	Mori, Y (corresponding author), Osaka Univ, Dept Immunochem, Microbial Dis Res Inst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsue@biken.osaka-u.ac.jp; arase@biken.osaka-u.ac.jp	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166	JSPS KAKENHI Japan [15H02545, 24115005, 25460565]; Takeda Science Foundation; Terumo Life Science Foundation; Uehara Memorial Foundation; Tokyo Biochemical Research Foundation; Naito Foundation	JSPS KAKENHI Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Terumo Life Science Foundation(Terumo Life Science Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Tokyo Biochemical Research Foundation; Naito Foundation(Naito Memorial Foundation)	This research was supported by JSPS KAKENHI grants 15H02545, 24115005, and 25460565 Japan (to T. S. and H. A.) and partly by grants from the Takeda Science Foundation (to T. S.) and from the Terumo Life Science Foundation, the Uehara Memorial Foundation, the Tokyo Biochemical Research Foundation, and the Naito Foundation (to H. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Arvin AM, 2001, CURR OPIN MICROBIOL, V4, P442, DOI 10.1016/S1369-5274(00)00233-2; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Berarducci B, 2009, J VIROL, V83, P228, DOI 10.1128/JVI.00913-08; Bukrinsky JT, 2004, BBA-PROTEINS PROTEOM, V1702, P173, DOI 10.1016/j.bbapap.2004.08.015; Cohen J.I., 2006, FIELDS VIROL, V2, P2773; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dimasi N, 2003, ACTA CRYSTALLOGR D, V59, P1856, DOI 10.1107/S0907444903018146; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Gerken TA, 2012, METHODS MOL BIOL, V842, P81, DOI 10.1007/978-1-61779-513-8_5; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuroki K, 2014, P NATL ACAD SCI USA, V111, P8877, DOI 10.1073/pnas.1324105111; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; LITWIN V, 1992, J VIROL, V66, P3643, DOI 10.1128/JVI.66.6.3643-3651.1992; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MATSUI S, 1994, VIROLOGY, V198, P50, DOI 10.1006/viro.1994.1007; MONTALVO EA, 1985, J VIROL, V53, P761, DOI 10.1128/JVI.53.3.761-770.1985; MONTALVO EA, 1987, J VIROL, V61, P2877, DOI 10.1128/JVI.61.9.2877-2884.1987; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Oliver SL, 2009, J VIROL, V83, P7495, DOI 10.1128/JVI.00400-09; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Quarles RH, 2009, NEUROCHEM RES, V34, P79, DOI 10.1007/s11064-008-9668-y; Sareneva T, 1996, EUR J BIOCHEM, V242, P191, DOI 10.1111/j.1432-1033.1996.0191r.x; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Shiraki K, 1997, ARCH VIROL, V142, P2295, DOI 10.1007/s007050050243; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; Steven AC, 2006, SCIENCE, V313, P177, DOI 10.1126/science.1129761; Strenge K, 1999, FEBS LETT, V444, P59, DOI 10.1016/S0014-5793(99)00029-0; Strenge K, 1998, EUR J BIOCHEM, V258, P677, DOI 10.1046/j.1432-1327.1998.2580677.x; Strenge K, 2001, FEBS LETT, V499, P262, DOI 10.1016/S0014-5793(01)02566-2; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; SUTTON CW, 1994, ANAL BIOCHEM, V218, P34, DOI 10.1006/abio.1994.1138; Tanaka Y, 2013, J VIROL, V87, P10900, DOI 10.1128/JVI.01427-13; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Teuton JR, 2007, J VIROL, V81, P3731, DOI 10.1128/JVI.02250-06; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Worter V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005218; Zaccai NR, 2007, J MOL BIOL, V365, P1469, DOI 10.1016/j.jmb.2006.10.084; Zaccai NR, 2003, STRUCTURE, V11, P557, DOI 10.1016/S0969-2126(03)00073-X; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304; Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	64	19	22	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19833	19843		10.1074/jbc.M114.635508	http://dx.doi.org/10.1074/jbc.M114.635508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105052	Green Published, hybrid			2022-12-28	WOS:000359364600039
J	Butkinaree, C; Canuel, M; Essalmani, R; Poirier, S; Benjannet, S; Asselin, MC; Roubtsova, A; Hamelin, J; Marcinkiewicz, J; Chamberland, A; Guillemot, J; Mayer, G; Sisodia, SS; Jacob, Y; Prat, A; Seidah, NG				Butkinaree, Chutikarn; Canuel, Maryssa; Essalmani, Rachid; Poirier, Steve; Benjannet, Suzanne; Asselin, Marie-Claude; Roubtsova, Anna; Hamelin, Josee; Marcinkiewicz, Jadwiga; Chamberland, Ann; Guillemot, Johann; Mayer, Gaetan; Sisodia, Sangram S.; Jacob, Yves; Prat, Annik; Seidah, Nabil G.			Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; CHONDROITIN SULFATE GLYCOSAMINOGLYCAN; LDL RECEPTOR; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; COMPLEMENTATION ASSAY; LIVER-REGENERATION; ADAPTER PROTEIN; HEPG2 CELLS; MOUSE-LIVER	Amyloid precursor-like protein 2 (APLP2) and sortilin were reported to individually bind the proprotein convertase subtilisin/kexin type 9 (PCSK9) and regulate its activity on the low-density lipoprotein receptor (LDLR). The data presented herein demonstrate that mRNA knockdowns of APLP2, sortilin, or both in the human hepatocyte cell lines HepG2 and Huh7 do not affect the ability of extracellular PCSK9 to enhance the degradation of the LDLR. Furthermore, mice deficient in APLP2 or sortilin do not exhibit significant changes in liver LDLR or plasma total cholesterol levels. Moreover, cellular overexpression of one or both proteins does not alter PCSK9 secretion, or its activity on the LDLR. We conclude that PCSK9 enhances the degradation of the LDLR independently of either APLP2 or sortilin both ex vivo and in mice. Interestingly, when co-expressed with PCSK9, both APLP2 and sortilin were targeted for lysosomal degradation. Using chemiluminescence proximity and co-immunoprecipitation assays, as well as biosynthetic analysis, we discovered that sortilin binds and stabilizes APLP2, and hence could regulate its intracellular functions on other targets.	[Butkinaree, Chutikarn; Canuel, Maryssa; Essalmani, Rachid; Benjannet, Suzanne; Asselin, Marie-Claude; Roubtsova, Anna; Hamelin, Josee; Marcinkiewicz, Jadwiga; Chamberland, Ann; Guillemot, Johann; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Poirier, Steve; Mayer, Gaetan] Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H18 1C8, Canada; [Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Jacob, Yves] Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, F-75015 Paris, France; [Jacob, Yves] CNRS, URA3015, F-75015 Paris, France; [Jacob, Yves] Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, F-75015 Paris, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Chicago; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Seidah, NG (corresponding author), 110 Pine Ave, West Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018; Guillemot, Johann/O-1066-2013	Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Guillemot, Johann/0000-0002-5902-9188; Jacob, Yves/0000-0001-9125-2374	Canadian Institutes of Health Research [MOP-102741, CTP-82946]; Canada Chair Grant [216684]; Leducq Foundation [13CVD03]; University of Pennsylvania Orphan Disease Center; Canadian Heart and Stroke Research Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant; Leducq Foundation(Leducq Foundation); University of Pennsylvania Orphan Disease Center; Canadian Heart and Stroke Research Fellowship Award	This work was supported in part by Canadian Institutes of Health Research Grants MOP-102741 and CTP-82946, Canada Chair Grant 216684, and Leducq Foundation Grant 13CVD03. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a research fellowship from the University of Pennsylvania Orphan Disease Center.; Supported by a Canadian Heart and Stroke Research Fellowship Award.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cousins SL, 2015, J NEUROCHEM, V133, P879, DOI 10.1111/jnc.13063; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Devay RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125127; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Leren TP, 2014, ATHEROSCLEROSIS, V237, P76, DOI 10.1016/j.atherosclerosis.2014.08.038; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; MBIKAY M, 1989, INT J PEPT PROT RES, V33, P39; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, CURR PHARM DESIGN, V19, P3161; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; THINAKARAN G, 1995, J BIOL CHEM, V270, P16522, DOI 10.1074/jbc.270.28.16522; Tuli A, 2008, J IMMUNOL, V181, P1978, DOI 10.4049/jimmunol.181.3.1978; Tuli A, 2009, J BIOL CHEM, V284, P34296, DOI 10.1074/jbc.M109.039727; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Yang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063049; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	61	35	35	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18609	18620		10.1074/jbc.M115.647180	http://dx.doi.org/10.1074/jbc.M115.647180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085104	Green Published, hybrid			2022-12-28	WOS:000358512100031
J	Tchesnokov, EP; Fellner, M; Siakkou, E; Kleffmann, T; Martin, LW; Aloi, S; Lamont, IL; Wilbanks, SM; Jameson, GNL				Tchesnokov, Egor P.; Fellner, Matthias; Siakkou, Eleni; Kleffmann, Torsten; Martin, Lois W.; Aloi, Sekotilani; Lamont, Iain L.; Wilbanks, Sigurd M.; Jameson, Guy N. L.			The Cysteine Dioxygenase Homologue from Pseudomonas aeruginosa Is a 3-Mercaptopropionate Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING AMINO-ACIDS; COENZYME-A; CROSS-LINK; ADVENELLA-MIMIGARDEFORDENSIS; 3,3'-DITHIODIPROPIONIC ACID; VARIOVORAX-PARADOXUS; THIOL DIOXYGENASES; CHEMICAL-SYNTHESIS; STREP-TAG; SUBSTRATE	Thiol dioxygenation is the initial oxidation step that commits a thiol to important catabolic or biosynthetic pathways. The reaction is catalyzed by a family of specific non-heme mononuclear iron proteins each of which is reported to react efficiently with only one substrate. This family of enzymes includes cysteine dioxygenase, cysteamine dioxygenase, mercaptosuccinate dioxygenase, and 3-mercaptopropionate dioxygenase. Using sequence alignment to infer cysteine dioxygenase activity, a cysteine dioxygenase homologue from Pseudomonas aeruginosa (p3MDO) has been identified. Mass spectrometry of P. aeruginosa under standard growth conditions showed that p3MDO is expressed in low levels, suggesting that this metabolic pathway is available to the organism. Purified recombinant p3MDO is able to oxidize both cysteine and 3-mercaptopropionic acid in vitro, with a marked preference for 3-mercaptopropionic acid. We therefore describe this enzyme as a 3-mercaptopropionate dioxygenase. Mossbauer spectroscopy suggests that substrate binding to the ferrous iron is through the thiol but indicates that each substrate could adopt different coordination geometries. Crystallographic comparison with mammalian cysteine dioxygenase shows that the overall active site geometry is conserved but suggests that the different substrate specificity can be related to replacement of an arginine by a glutamine in the active site.	[Tchesnokov, Egor P.; Fellner, Matthias; Siakkou, Eleni; Aloi, Sekotilani; Jameson, Guy N. L.] Univ Otago, Dept Chem, POB 56, Dunedin 9054, New Zealand; [Kleffmann, Torsten; Martin, Lois W.; Lamont, Iain L.; Wilbanks, Sigurd M.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago; University of Otago	Jameson, GNL (corresponding author), Univ Otago, Dept Chem, POB 56, Dunedin 9054, New Zealand.	guy.jameson@otago.ac.nz	Fellner, Matthias/AAG-6443-2022; Jameson, Guy N. L./J-3258-2015; Fellner, Matthias/AFL-6357-2022	Fellner, Matthias/0000-0003-3192-6984; Jameson, Guy N. L./0000-0001-9416-699X; Fellner, Matthias/0000-0003-3192-6984; Kleffmann, Torsten/0000-0001-9305-5980; Wilbanks, Sigurd/0000-0001-7565-8913; Lamont, Iain/0000-0002-7601-6354	Canadian Institutes of Health Research; Royal Society of New Zealand	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Royal Society of New Zealand(Royal Society of New Zealand)	Recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research.r Supported by the Marsden Fund of the Royal Society of New Zealand.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bella DL, 1999, AM J PHYSIOL-ENDOC M, V276, pE326, DOI 10.1152/ajpendo.1999.276.2.E326; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8015, DOI 10.1021/ja00097a008; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Bruland N, 2009, J BIOL CHEM, V284, P660, DOI 10.1074/jbc.M806762200; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; Chai SC, 2006, J BIOL CHEM, V281, P15774, DOI 10.1074/jbc.M601269200; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P76; CUEBAS D, 1985, J BIOL CHEM, V260, P7330; Davies CG, 2014, BIOCHEMISTRY-US, V53, P7961, DOI 10.1021/bi501277a; DELORES-.GR, 1973, J NEUROCHEM, V21, P615, DOI 10.1111/j.1471-4159.1973.tb06006.x; Diebold AR, 2010, BIOCHEMISTRY-US, V49, P6945, DOI 10.1021/bi100892w; Ding R, 2004, NEUROTOXICOL TERATOL, V26, P587, DOI 10.1016/j.ntt.2004.04.002; Dominy JE, 2006, BIOCHEM J, V394, P267, DOI 10.1042/BJ20051510; Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Driggers CM, 2015, PROTEIN SCI, V24, P154, DOI 10.1002/pro.2587; Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellner M, 2014, ANAL BIOCHEM, V459, P56, DOI 10.1016/j.ab.2014.05.008; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goodrich J. A., 2007, BINDING KINETICS MOL, P19; Goto M, 1997, BIOL PHARM BULL, V20, P1136, DOI 10.1248/bpb.20.1136; Groce SL, 2004, BIOCHEMISTRY-US, V43, P15141, DOI 10.1021/bi048690x; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; Hu HY, 2006, LIMNOL OCEANOGR, V51, P2763, DOI 10.4319/lo.2006.51.6.2763; Jameson GNL, 2004, ORG BIOMOL CHEM, V2, P777, DOI 10.1039/b316294j; Jameson GNL, 2011, MONATSH CHEM, V142, P325, DOI 10.1007/s00706-011-0475-9; Janaky R, 2000, NEUROCHEM RES, V25, P1397, DOI 10.1023/A:1007616817499; JOLLESBE.B, 1974, EUR J BIOCHEM, V42, P349, DOI 10.1111/j.1432-1033.1974.tb03346.x; Kapatral V, 2000, J BACTERIOL, V182, P1333, DOI 10.1128/JB.182.5.1333-1339.2000; Kasperova A, 2011, MYCOSES, V54, pE456, DOI 10.1111/j.1439-0507.2010.01948.x; Katritzky AR, 2003, MAGN RESON CHEM, V41, P37, DOI 10.1002/mrc.1110; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P156, DOI 10.1128/AEM.56.1.156-161.1990; KIENE RP, 1988, NATURE, V332, P148, DOI 10.1038/332148a0; Kleffmann T, 2009, J BIOL INORG CHEM, V14, P913, DOI 10.1007/s00775-009-0504-x; Leitgeb S, 2009, BIOCHEM J, V418, P403, DOI 10.1042/BJ20081161; Li W, 2015, ARCH BIOCHEM BIOPHYS, V565, P49, DOI 10.1016/j.abb.2014.11.004; Li W, 2013, BIOCHEMISTRY-US, V52, P9104, DOI 10.1021/bi4010232; Lomans BP, 2002, CELL MOL LIFE SCI, V59, P575, DOI 10.1007/s00018-002-8450-6; LOSCHER W, 1979, BIOCHEM PHARMACOL, V28, P1397, DOI 10.1016/0006-2952(79)90443-X; Luchsinger JA, 2004, NEUROLOGY, V62, P1972, DOI 10.1212/01.WNL.0000129504.60409.88; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama H, 2004, CHEM LETT, V33, P712, DOI 10.1246/cl.2004.712; OLNEY JW, 1990, SCIENCE, V248, P596, DOI 10.1126/science.2185543; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PERRY TL, 1985, ANN NEUROL, V18, P482, DOI 10.1002/ana.410180411; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; SABBAGH E, 1985, J BIOL CHEM, V260, P7337; Schiff J A, 1979, Ciba Found Symp, P49; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schurmann M, 2011, J BACTERIOL, V193, P3078, DOI 10.1128/JB.00049-11; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Siakkou E, 2011, BBA-PROTEINS PROTEOM, V1814, P2003, DOI 10.1016/j.bbapap.2011.07.019; Siakkou E, 2010, ANAL BIOCHEM, V405, P127, DOI 10.1016/j.ab.2010.06.013; Siemann S, 2003, BIOCHEMISTRY-US, V42, P1673, DOI 10.1021/bi027072i; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Simmons CR, 2006, PROTEIN EXPRES PURIF, V47, P74, DOI 10.1016/j.pep.2005.10.025; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Souness RJ, 2013, BIOCHEMISTRY-US, V52, P7606, DOI 10.1021/bi400661a; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Tchesnokov EP, 2012, BIOCHEMISTRY-US, V51, P257, DOI 10.1021/bi201597w; Toups M, 2010, BIODEGRADATION, V21, P309, DOI 10.1007/s10532-009-9302-y; Townsend DM, 2004, BIOMED PHARMACOTHER, V58, P47, DOI 10.1016/j.biopha.2003.11.005; Vermeij P, 1999, J BACTERIOL, V181, P5833, DOI 10.1128/JB.181.18.5833-5837.1999; VISSCHER PT, 1994, APPL ENVIRON MICROB, V60, P4617, DOI 10.1128/AEM.60.12.4617-4619.1994; VONRIESEN VL, 1963, J BACTERIOL, V85, P248, DOI 10.1128/JB.85.1.248-249.1963; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Wubbeler JH, 2010, APPL ENVIRON MICROB, V76, P7023, DOI 10.1128/AEM.01706-10; Wubbeler JH, 2010, MICROBIOL-SGM, V156, P1221, DOI 10.1099/mic.0.036178-0; YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479, DOI 10.1093/oxfordjournals.jbchem.a131935; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zhang JZ, 2004, LIMNOL OCEANOGR, V49, P2276, DOI 10.4319/lo.2004.49.6.2276	84	37	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24424	24437		10.1074/jbc.M114.635672	http://dx.doi.org/10.1074/jbc.M114.635672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26272617	hybrid, Green Published			2022-12-28	WOS:000362218900030
J	Cantero, MD; Velazquez, IF; Streets, AJ; Ong, ACM; Cantiello, HF				del Rocio Cantero, Maria; Velazquez, Irina F.; Streets, Andrew J.; Ong, Albert C. M.; Cantiello, Horacio F.			The cAMP Signaling Pathway and Direct Protein Kinase A Phosphorylation Regulate Polycystin-2 (TRPP2) Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE PROTEINS; CYST EPITHELIAL-CELLS; PRIMARY CILIA; CYCLIC-AMP; CATION CHANNEL; CALCIUM; CA2+; IDENTIFICATION; LOCALIZATION; EXPRESSION	Polycystin-2 (PC2) is a TRP-type, Ca2+-permeable non-selective cation channel that plays an important role in Ca2+ signaling in renal and non-renal cells. The effect(s) of the cAMP pathway and kinase mediated phosphorylation of PC2 seem to be relevant to PC2 trafficking and its interaction with polycystin-1. However, the role of PC2 phosphorylation in channel function is still poorly defined. Here we reconstituted apical membranes of term human syncytiotrophoblast (hST), containing endogenous PC2 (PC2(hst)), and in vitro translated channel protein (PC2(iv)). Addition of the catalytic subunit of PKA increased by 566% the spontaneous PC2(hst) channel activity in the presence of ATP. Interestingly, 8-Br-cAMP also stimulated spontaneous PC2(hst) channel activity in the absence of the exogenous kinase. Either stimulation was inhibited by addition of alkaline phosphatase, which in turn, was reversed by the phosphatase inhibitor vanadate. Neither maneuver modified the single channel conductance but instead increased channel mean open time. PKA directly phosphorylated PC2, which increased the mean open time but not the single channel conductance of the channel. PKA phosphorylation did not modify either R742X truncated or S829A-mutant PC2(iv) channel function. The data indicate that the cAMP pathway regulates PC2-mediated cation transport in the hST. The relevantPKAsite for PC2 channel regulation centers on a single residue serine 829, in the carboxyl terminus.	[del Rocio Cantero, Maria; Velazquez, Irina F.; Cantiello, Horacio F.] Univ Buenos Aires, Catedra Biofis, Fac Odontol, RA-1053 Buenos Aires, DF, Argentina; [Streets, Andrew J.; Ong, Albert C. M.] Univ Sheffield, Henry Wellcome Labs Med Res, Acad Nephrol Unit, Kidney Genet Grp,Med Sch, Sheffield S10 2RX, S Yorkshire, England	University of Buenos Aires; University of Sheffield	Ong, ACM (corresponding author), Univ Sheffield, Henry Wellcome Labs Med Res, Acad Unit Nephrol, Kidney Genet Grp,Med Sch, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk; hcantiello@yahoo.com.ar	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400; Cantero, Maria del Rocio/0000-0002-9690-8413	Grant FonCyT-MinCyT, PICT [1559]; Research Councils UK (RCUK)	Grant FonCyT-MinCyT, PICT; Research Councils UK (RCUK)(UK Research & Innovation (UKRI))	The study was funded by Grant FonCyT-MinCyT, PICT 2012 No 1559 (to H. F. C.). None of the authors report any conflict of interest.; Supported by a Fellowship from Research Councils UK (RCUK).	Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Berridge M J, 1975, Adv Cyclic Nucleotide Res, V6, P1; Brown D., 2000, CELL BIOL VASOPRESSI, P575; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Cantero Maria Del Rocio, 2013, Biophys J, V105, P365, DOI 10.1016/j.bpj.2013.05.058; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Choi YH, 2011, P NATL ACAD SCI USA, V108, P10679, DOI 10.1073/pnas.1016214108; Cowley BD, 2008, KIDNEY INT, V73, P251, DOI 10.1038/sj.ki.5002695; Cantero MD, 2015, BIOPHYS J, V108, P2191, DOI 10.1016/j.bpj.2015.03.050; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Givens MH, 1933, J BIOL CHEM, V102, P7; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hoffmeister H, 2011, J CELL BIOL, V192, P631, DOI 10.1083/jcb.201007050; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Li HP, 1999, BIOCHEM BIOPH RES CO, V259, P356, DOI 10.1006/bbrc.1999.0780; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Masyuk AI, 2008, AM J PHYSIOL-GASTR L, V295, pG725, DOI 10.1152/ajpgi.90265.2008; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Narayanan D, 2013, J PHYSIOL-LONDON, V591, P5031, DOI 10.1113/jphysiol.2013.258319; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nilius B, 2003, PFLUG ARCH EUR J PHY, V445, P584, DOI 10.1007/s00424-002-0923-9; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Parry H, 2005, J CELL BIOL, V171, P47, DOI 10.1083/jcb.200503139; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P193, DOI 10.1007/s00232-002-1055-z; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Raychowdhury MK, 2009, AM J PHYSIOL-RENAL, V296, pF87, DOI 10.1152/ajprenal.90509.2008; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; SALLE BL, 1987, BIOL NEONATE, V52, P119; Snedecor GW, 1973, STAT METHODS; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Sohara E, 2008, J AM SOC NEPHROL, V19, P469, DOI 10.1681/ASN.2006090985; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; Streets AJ, 2010, MOL BIOL CELL, V21, P3853, DOI 10.1091/mbc.E10-04-0377; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Tomic M, 2011, AM J PHYSIOL-ENDOC M, V301, pE370, DOI 10.1152/ajpendo.00130.2011; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073424; Zhao R, 2015, MOL NUTR FOOD RES, V59, P365, DOI 10.1002/mnfr.201400465; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	71	17	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23888	23896		10.1074/jbc.M115.661082	http://dx.doi.org/10.1074/jbc.M115.661082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269590	Green Published, hybrid			2022-12-28	WOS:000361816500034
J	Cai, YT; Teo, BHD; Yeo, JG; Lu, JH				Cai, Yitian; Teo, Boon Heng Dennis; Yeo, Joo Guan; Lu, Jinhua			C1q Protein Binds to the Apoptotic Nucleolus and Causes C1 Protease Degradation of Nucleolar Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMACYTOID DENDRITIC CELLS; COMPLEMENT DEFICIENCY; ALPHA PRODUCTION; 1ST COMPONENT; IFN-ALPHA; ACTIN; INTERFERON; ANTIGENS; IMMUNOLOGY; HEREDITARY	In infection, complement C1q recognizes pathogen-congregated antibodies and elicits complement activation. Among endogenous ligands, C1q binds to DNA and apoptotic cells, but whether C1q binds to nuclear DNA in apoptotic cells remains to be investigated. With UV irradiation-induced apoptosis, C1q initially bound to peripheral cellular regions in early apoptotic cells. By 6 h, binding concentrated in the nuclei to the nucleolus but not the chromatins. When nucleoli were isolated from non-apoptotic cells, C1q also bound to these structures. In vivo, C1q exists as the C1 complex (C1qC1r(2)C1s(2)), and C1q binding to ligands activates the C1r/C1s proteases. Incubation of nucleoli with C1 caused degradation of the nucleolar proteins nucleolin and nucleophosmin 1. This was inhibited by the C1 inhibitor. The nucleoli are abundant with autoantigens. C1q binding and C1r/C1s degradation of nucleolar antigens during cell apoptosis potentially reduces autoimmunity. These findings help us to understand why genetic C1q and C1r/C1s deficiencies cause systemic lupus erythematosus.	[Lu, Jinhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Lu, Jinhua] Natl Univ Singapore, Program Immunol, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Lu, JH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore.	miclujh@nus.edu.sg	Yeo, Joo Guan/GRR-5310-2022	Teo, Boon Heng Dennis/0000-0003-4696-9813; Lu, Jinhua/0000-0002-3699-9894; Yeo, Joo Guan/0000-0001-8981-5000	Singapore National University Health System Seed Fund [R-182-000-229-750]; Singapore Ministry of Education [MOE2012-T2-2-122]; NGS scholarship	Singapore National University Health System Seed Fund; Singapore Ministry of Education(Ministry of Education, Singapore); NGS scholarship	This project was supported by Singapore National University Health System Seed Fund R-182-000-229-750 and Singapore Ministry of Education Tier 2 Grant MOE2012-T2-2-122). The authors declare that they have no conflict of interests with the contents of this article.; Supported by an NGS scholarship.	AGNELLO V, 1970, IMMUNOLOGY, V19, P909; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bordet J., 1906, ANN I PASTEUR PARIS, V20, P467; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Brown GD, 2012, NATURE, V485, P589, DOI 10.1038/485589a; Busby WH, 2000, J BIOL CHEM, V275, P37638, DOI 10.1074/jbc.M006107200; Caminschi I, 2012, TRENDS IMMUNOL, V33, P71, DOI 10.1016/j.it.2011.10.007; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Cicardi M, 2012, ACTA HAEMATOL-BASEL, V127, P208, DOI 10.1159/000336590; Clarke EV, 2015, J LEUKOCYTE BIOL, V97, P147, DOI 10.1189/jlb.3A0614-278R; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Elkon KB, 2012, CURR OPIN IMMUNOL, V24, P665, DOI 10.1016/j.coi.2012.08.004; ERIKSSON H, 1990, BIOCHIM BIOPHYS ACTA, V1037, P209, DOI 10.1016/0167-4838(90)90169-G; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Geijtenbeek TBH, 2012, IMMUNITY, V36, P557, DOI 10.1016/j.immuni.2012.04.004; JIANG HX, 1992, J BIOL CHEM, V267, P25597; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kerr FK, 2005, J BIOL CHEM, V280, P39510, DOI 10.1074/jbc.M506131200; Korb LC, 1997, J IMMUNOL, V158, P4525; LEPOW IH, 1963, J EXP MED, V117, P983, DOI 10.1084/jem.117.6.983; Lewis MJ, 2006, AUTOIMMUNITY, V39, P367, DOI 10.1080/08916930600739233; Lipsker D, 2010, LUPUS, V19, P1096, DOI 10.1177/0961203310373370; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; MAMRACK MD, 1977, BIOCHEM BIOPH RES CO, V76, P150, DOI 10.1016/0006-291X(77)91680-1; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; NISHIOKA M, 1982, BIOCHEM BIOPH RES CO, V108, P1307, DOI 10.1016/0006-291X(82)92142-8; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; Santer DM, 2010, J IMMUNOL, V185, P4738, DOI 10.4049/jimmunol.1001731; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Tan EM, 2012, J CLIN INVEST, V122, P3835, DOI 10.1172/JCI66510; Teh BK, 2011, MOL IMMUNOL, V48, P1128, DOI 10.1016/j.molimm.2011.02.006; Triggianese P, 2015, AUTOIMMUN REV, V14, P665, DOI 10.1016/j.autrev.2015.03.006; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Welting TJM, 2003, AUTOIMMUN REV, V2, P313, DOI 10.1016/S1568-9972(03)00029-6; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	47	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22570	22580		10.1074/jbc.M115.670661	http://dx.doi.org/10.1074/jbc.M115.670661			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26231209	Green Published, hybrid			2022-12-28	WOS:000361171500023
J	Corradi, V; Vergani, P; Tieleman, DP				Corradi, Valentina; Vergani, Paola; Tieleman, D. Peter			Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) CLOSED AND OPEN STATE CHANNEL MODELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; ABC TRANSPORTER MSBA; CHLORIDE CHANNEL; ATP-BINDING; CASSETTE TRANSPORTER; MOLECULAR-DYNAMICS; ANION SELECTIVITY; P-GLYCOPROTEIN; ION-CHANNEL; CONFORMATIONAL-CHANGES	The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP-binding cassette (ABC) transporter superfamily. CFTR controls the flow of anions through the apical membrane of epithelia. Dysfunctional CFTR causes the common lethal genetic disease cystic fibrosis. Transitions between open and closed states of CFTR are regulated by ATP binding and hydrolysis on the cytosolic nucleotide binding domains, which are coupled with the transmembrane (TM) domains forming the pathway for anion permeation. Lack of structural data hampers a global understanding of CFTR and thus the development of "rational" approaches directly targeting defective CFTR. In this work, we explored possible conformational states of the CFTR gating cycle by means of homology modeling. As templates, we used structures of homologous ABC transporters, namely TM(287-288), ABC-B10, McjD, and Sav1866. In the light of published experimental results, structural analysis of the transmembrane cavity suggests that the TM(287-288)-based CFTR model could correspond to a commonly occupied closed state, whereas the McjD-based model could represent an open state. The models capture the important role played by Phe-337 as a filter/gating residue and provide structural information on the conformational transition from closed to open channel.	[Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Vergani, Paola] UCL, Res Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of Calgary; University of Calgary; University of London; University College London	Vergani, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6B6, England.	p.vergani@ucl.ac.uk; tieleman@ucalgary.ca	Corradi, Valentina/G-3937-2017; Tieleman, D. Peter/A-4790-2011; Vergani, Paola/C-2019-2008	Tieleman, D. Peter/0000-0001-5507-0688; Vergani, Paola/0000-0002-5422-4662	Canadian Institutes for Health Research; Alberta Innovates Technology Futures; Medical Research Council [G0501200] Funding Source: researchfish; Cystic Fibrosis Trust [RS31] Funding Source: researchfish; MRC [G0501200] Funding Source: UKRI	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cystic Fibrosis Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Canadian Institutes for Health Research and Alberta Innovates Technology Futures. The authors declare that they have no conflicts of interest with the contents of this article.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Becker JP, 2010, J PHYS CHEM B, V114, P15948, DOI 10.1021/jp1038392; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Chaves LAP, 2015, J GEN PHYSIOL, V145, P261, DOI 10.1085/jgp.201411347; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Corradi V, 2012, J BIOL CHEM, V287, P28099, DOI 10.1074/jbc.M112.381251; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2014, J GEN PHYSIOL, V143, P269, DOI 10.1085/jgp.201311089; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Damas JM, 2011, PROTEIN SCI, V20, P1220, DOI 10.1002/pro.650; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2014, BIOCHEM CELL BIOL, V92, P481, DOI 10.1139/bcb-2014-0038; El Hiani Y, 2014, J BIOL CHEM, V289, P28149, DOI 10.1074/jbc.M114.593103; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; FEREC C, 1993, HUM MOL GENET, V2, P1557, DOI 10.1093/hmg/2.10.1557; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Guo ZY, 2013, J MOL MODEL, V19, P2901, DOI 10.1007/s00894-013-1819-7; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Hyde BB, 2012, CELL DEATH DIFFER, V19, P1117, DOI 10.1038/cdd.2011.195; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LaRusch J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004376; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Linsdell P, 2000, BIOPHYS J, V78, P2973, DOI 10.1016/S0006-3495(00)76836-6; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 1997, J GEN PHYSIOL, V110, P355, DOI 10.1085/jgp.110.4.355; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 2001, J PHYSIOL-LONDON, V531, P51, DOI 10.1111/j.1469-7793.2001.0051j.x; Linsdell P, 2014, MOL MEMBR BIOL, V31, P1, DOI 10.3109/09687688.2013.868055; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaedel C, 1998, CLIN GENET, V53, P383; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Solymosi EA, 2013, P NATL ACAD SCI USA, V110, pE2308, DOI 10.1073/pnas.1216382110; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang GY, 2015, BIOCHEMISTRY-US, V54, P2828, DOI 10.1021/acs.biochem.5b00219; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2014, J BIOL CHEM, V289, P30364, DOI 10.1074/jbc.M114.595710; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Wang XH, 2009, J GEN PHYSIOL, V133, P69, DOI 10.1085/jgp.200810049; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Xu J, 2015, ONCOL REP, V33, P2227, DOI 10.3892/or.2015.3829; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	112	41	41	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22891	22906		10.1074/jbc.M115.665125	http://dx.doi.org/10.1074/jbc.M115.665125			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229102	Green Published, hybrid			2022-12-28	WOS:000361685500003
J	Smith, CE; Bowen, N; Graham, WJ; Goellner, EM; Srivatsan, A; Kolodner, RD				Smith, Catherine E.; Bowen, Nikki; Graham, William J.; Goellner, Eva M.; Srivatsan, Anjana; Kolodner, Richard D.			Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA recombination; DNA repair; DNA replication; mutagenesis; proliferating cell nuclear antigen (PCNA); replication factor C (RFC); yeast genetics; exonuclease 1; genome instability; Msh2-Msh6	CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; HUMAN EXONUCLEASE-I; MUTL-ALPHA; MSH2-MSH6 COMPLEX; ESCHERICHIA-COLI; MISPAIR-BINDING; DOMINANT MUTATIONS; COLORECTAL-CANCER; DNA-REPLICATION	Background: Biochemical analysis of S. cerevisiae MMR mutants has been limited by a lack of reconstituted MMR reactions. Results: 3 nick-directed Mlh1-Pms1-dependent endonuclease and reconstituted MMR reactions were developed. Conclusion: 3 nick-directed MMR required the Mlh1-Pms1 endonuclease and was eliminated by mutations inactivating Exo1-independent MMR. Significance: The reconstituted MMR reactions facilitated analysis of uncharacterized MMR mutants and the mechanism of Exo1-independent MMR. Previous studies reported the reconstitution of an Mlh1-Pms1-independent 5 nick-directed mismatch repair (MMR) reaction using Saccharomyces cerevisiae proteins. Here we describe the reconstitution of a mispair-dependent Mlh1-Pms1 endonuclease activation reaction requiring Msh2-Msh6 (or Msh2-Msh3), proliferating cell nuclear antigen (PCNA), and replication factor C (RFC) and a reconstituted Mlh1-Pms1-dependent 3 nick-directed MMR reaction requiring Msh2-Msh6 (or Msh2-Msh3), exonuclease 1 (Exo1), replication protein A (RPA), RFC, PCNA, and DNA polymerase . Both reactions required Mg2+ and Mn2+ for optimal activity. The MMR reaction also required two reaction stages in which the first stage required incubation of Mlh1-Pms1 with substrate DNA, with or without Msh2-Msh6 (or Msh2-Msh3), PCNA, and RFC but did not require nicking of the substrate, followed by a second stage in which other proteins were added. Analysis of different mutant proteins demonstrated that both reactions required a functional Mlh1-Pms1 endonuclease active site, as well as mispair recognition and Mlh1-Pms1 recruitment by Msh2-Msh6 but not sliding clamp formation. Mutant Mlh1-Pms1 and PCNA proteins that were defective for Exo1-independent but not Exo1-dependent MMR in vivo were partially defective in the Mlh1-Pms1 endonuclease and MMR reactions, suggesting that both reactions reflect the activation of Mlh1-Pms1 seen in Exo1-independent MMR in vivo. The availability of this reconstituted MMR reaction should now make it possible to better study both Exo1-independent and Exo1-dependent MMR.	[Smith, Catherine E.; Bowen, Nikki; Graham, William J.; Goellner, Eva M.; Srivatsan, Anjana; Kolodner, Richard D.] Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Moores UCSD Canc Ctr, Sch Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Inst Genom Med, Sch Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Srivatsan, Anjana/S-1518-2017; Regan, Clinton/E-6250-2012; Srivatsan, Anjana/Q-6312-2017; Classen, Scott/AAY-8176-2020	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; 	National Institutes of Health [R01 GM50006, P01 CA92584, F32 GM106598]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006, F32GM106598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM50006 and P01 CA92584 (to R. D. K.) and F32 GM106598 (to E. M. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; ALANI E, 1994, GENETICS, V137, P19; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; AU KG, 1992, J BIOL CHEM, V267, P12142; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Ban C, 1998, EMBO J, V17, P1526, DOI 10.1093/emboj/17.5.1526; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowen N, 2013, P NATL ACAD SCI USA, V110, P18472, DOI 10.1073/pnas.1318971110; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Campbell CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004327; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Datta A, 1996, MOL CELL BIOL, V16, P1085; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goellner EM, 2014, MOL CELL, V55, P291, DOI 10.1016/j.molcel.2014.04.034; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jagmohan-Changur S, 2003, CANCER RES, V63, P154; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Lee SD, 2007, J MOL BIOL, V366, P53, DOI 10.1016/j.jmb.2006.10.099; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagawa T, 2001, J BIOL CHEM, V276, P31487, DOI 10.1074/jbc.M104003200; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Plys AJ, 2012, J MOL BIOL, V422, P192, DOI 10.1016/j.jmb.2012.05.030; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; REENAN RAG, 1992, GENETICS, V132, P975; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schmutte C, 1998, CANCER RES, V58, P4537; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith CE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003869; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; Tishkoff DX, 1998, CANCER RES, V58, P5027; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	84	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21580	21590		10.1074/jbc.M115.662189	http://dx.doi.org/10.1074/jbc.M115.662189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170454	Green Published, hybrid			2022-12-28	WOS:000360637600031
J	Ma, HW; Butler, MR; Thapa, A; Belcher, J; Yang, F; Baehr, W; Biel, M; Michalakis, S; Ding, XQ				Ma, Hongwei; Butler, Michael R.; Thapa, Arjun; Belcher, Josh; Yang, Fan; Baehr, Wolfgang; Biel, Martin; Michalakis, Stylianos; Ding, Xi-Qin			cGMP/Protein Kinase G Signaling Suppresses Inositol 1,4,5-Trisphosphate Receptor Phosphorylation and Promotes Endoplasmic Reticulum Stress in Photoreceptors of Cyclic Nucleotide-gated Channel-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RETINAL DEGENERATION; INDUCED APOPTOSIS; CALCIUM INFLUX; CONE FUNCTION; CA2+ RELEASE; MOUSE MODEL; CELL-DEATH; CROSS-TALK; LONG-TERM	Photoreceptor cyclic nucleotide-gated (CNG) channels play a pivotal role in phototransduction. Mutations in the cone CNG channel subunits CNGA3 and CNGB3 are associated with achromatopsia and cone dystrophies. We have shown endoplasmic reticulum (ER) stress-associated apoptotic cone death and increased phosphorylation of the ER Ca2+ channel inositol 1,4,5-trisphosphate receptor 1 (IP(3)R1) in CNG channel-deficient mice. We also presented a remarkable elevation of cGMP and an increased activity of the cGMP-dependent protein kinase (protein kinase G, PKG) in CNG channel deficiency. This work investigated whether cGMP/PKG signaling regulates ER stress and IP3R1 phosphorylation in CNG channel-deficient cones. Treatment with PKG inhibitor and deletion of guanylate cyclase-1 (GC1), the enzyme producing cGMP in cones, were used to suppress cGMP/PKG signaling in cone-dominant Cnga3(-/-)/Nrl(-/-) mice. We found that treatment with PKG inhibitor or deletion of GC1 effectively reduced apoptotic cone death, increased expression levels of cone proteins, and decreased activation of Muller glial cells. Furthermore, we observed significantly increased phosphorylation of IP3R1 and reduced ER stress. Our findings demonstrate a role of cGMP/PKG signaling in ER stress and ER Ca2+ channel regulation and provide insights into the mechanism of cone degeneration in CNG channel deficiency.	[Ma, Hongwei; Butler, Michael R.; Thapa, Arjun; Belcher, Josh; Yang, Fan; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Baehr, Wolfgang] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Biel, Martin; Michalakis, Stylianos] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Biel, Martin; Michalakis, Stylianos] Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany	University of Oklahoma System; University of Oklahoma Health Sciences Center; Utah System of Higher Education; University of Utah; University of Munich; University of Munich	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Regan, Clinton/E-6250-2012; Michalakis, Stylianos/M-4677-2019; Yang, Fan/I-5735-2019; Michalakis, Stylianos/W-2094-2018; Biel, Martin/G-1175-2014	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052	National Institutes of Health [P30EY021725, T32EY023202, R01EY019490, R01EY08123, R01EY019298]; Deutsche Forschungsgemeinschaft; NATIONAL EYE INSTITUTE [T32EY023202, R01EY019490, R01EY008123, R01EY019298, P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants P30EY021725, T32EY023202, R01EY019490, R01EY08123, and R01EY019298. This work was also supported by the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; Bai GR, 2006, BIOCHEM BIOPH RES CO, V348, P1319, DOI 10.1016/j.bbrc.2006.07.208; Baldridge WH, 1998, J NEUROPHYSIOL, V79, P3012, DOI 10.1152/jn.1998.79.6.3012; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; Chao CC, 2012, J CELL BIOCHEM, V113, P1377, DOI 10.1002/jcb.24010; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Fallahian F, 2011, FEBS J, V278, P3360, DOI 10.1111/j.1742-4658.2011.08260.x; Feng XD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5487; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Michel M, 2011, LEARN MEMORY, V18, P108, DOI 10.1101/lm.2063611; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tegeder I, 2004, P NATL ACAD SCI USA, V101, P3253, DOI 10.1073/pnas.0304076101; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Tosi J, 2011, J CELL MOL MED, V15, P1778, DOI 10.1111/j.1582-4934.2010.01201.x; Varsanyi B, 2007, INVEST OPHTH VIS SCI, V48, P2249, DOI 10.1167/iovs.06-1173; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Zhao TT, 2010, ADV EXP MED BIOL, V664, P575, DOI 10.1007/978-1-4419-1399-9_66	54	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20880	20892		10.1074/jbc.M115.641159	http://dx.doi.org/10.1074/jbc.M115.641159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26124274	Green Published, hybrid			2022-12-28	WOS:000360011800024
J	Mancini, AD; Bertrand, G; Vivot, K; Carpentier, E; Tremblay, C; Ghislain, J; Bouvier, M; Poitout, V				Mancini, Arturo D.; Bertrand, Gyslaine; Vivot, Kevin; Carpentier, Eric; Tremblay, Caroline; Ghislain, Julien; Bouvier, Michel; Poitout, Vincent			beta-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOAVAILABLE GPR40 AGONIST; PROTEIN-KINASE D1; SECRETION IN-VIVO; INSULIN-SECRETION; ACTIVATION; TAK-875; ISLETS; CELLS; INTERNALIZATION; IDENTIFICATION	FFAR1/GPR40 is a seven-transmembrane domain receptor (7TMR) expressed in pancreatic beta cells and activated by FFAs. Pharmacological activation of GPR40 is a strategy under consideration to increase insulin secretion in type 2 diabetes. GPR40 is known to signal predominantly via the heterotrimeric G proteins G(q/11). However, 7TMRs can also activate functionally distinct G protein-independent signaling via beta-arrestins. Further, G protein- and beta-arrestin-based signaling can be differentially modulated by different ligands, thus eliciting ligand-specific responses ("biased agonism"). Whether GPR40 engages beta-arrestin-dependent mechanisms and is subject to biased agonism is unknown. Using bioluminescence resonance energy transfer-based biosensors for real-time monitoring of cell signaling in living cells, we detected a ligand-induced GPR40-beta-arrestin interaction, with the synthetic GPR40 agonist TAK-875 being more effective than palmitate or oleate in recruiting beta-arrestins 1 and 2. Conversely, TAK-875 acted as a partial agonist of G(q/11)-dependent GPR40 signaling relative to both FFAs. Pharmacological blockade of G(q) activity decreased FFA-induced insulin secretion. In contrast, knockdown or genetic ablation of beta-arrestin 2 in an insulin-secreting cell line and mouse pancreatic islets, respectively, uniquely attenuated the insulinotropic activity of TAK-875, thus providing functional validation of the biosensor data. Collectively, these data reveal that in addition to coupling to G(q/11), GPR40 is functionally linked to a beta-arrestin 2-mediated insulinotropic signaling axis. These observations expose previously unrecognized complexity for GPR40 signal transduction and may guide the development of biased agonists showing improved clinical profile in type 2 diabetes.	[Mancini, Arturo D.; Vivot, Kevin; Tremblay, Caroline; Ghislain, Julien; Poitout, Vincent] Univ Montreal, Res Ctr, Montreal Diabet Res Ctr, Hosp Ctr,CRCHUM, Montreal, PQ H2X 0A9, Canada; [Mancini, Arturo D.; Vivot, Kevin; Tremblay, Caroline; Ghislain, Julien; Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H2X 0A9, Canada; [Bertrand, Gyslaine] Univ Montpellier I, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, F-34060 Montpellier, France; [Bertrand, Gyslaine] Univ Montpellier 2, F-34060 Montpellier, France; [Carpentier, Eric; Bouvier, Michel; Poitout, Vincent] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montreal	Poitout, V (corresponding author), CRCHUM, 900 St Denis, Montreal, PQ H2X 0A9, Canada.	vincent.poitout@umontreal.ca	Vivot, Kevin/P-8329-2016; bertrand, gyslaine/AAC-6716-2020; Bouvier, Michel/H-2758-2014	Vivot, Kevin/0000-0003-4617-0016; Bouvier, Michel/0000-0003-1128-0100; Poitout, Vincent/0000-0002-6555-5053	Canadian Institutes of Health Research (CIHR) [MOP86545, 11215]; Canadian Diabetes Association	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by the Canadian Institutes of Health Research (CIHR) Grants MOP86545 (to V. P.) and 11215 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a postdoctoral fellowship from the Canadian Diabetes Association.	Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; HAGENFEL.L, 1972, J CLIN INVEST, V51, P2324, DOI 10.1172/JCI107043; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Leifke E, 2012, CLIN PHARMACOL THER, V92, P29, DOI 10.1038/clpt.2012.43; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mancini AD, 2015, DIABETES OBES METAB, V17, P622, DOI 10.1111/dom.12442; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Qian J, 2014, CELL SIGNAL, V26, P2412, DOI 10.1016/j.cellsig.2014.07.019; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ravier MA, 2014, DIABETOLOGIA, V57, P532, DOI 10.1007/s00125-013-3130-7; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sunil V, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-19; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wagner R, 2013, DIABETES, V62, P2106, DOI 10.2337/db12-1249; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672	41	69	71	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21131	21140		10.1074/jbc.M115.644450	http://dx.doi.org/10.1074/jbc.M115.644450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157145	Green Published, hybrid			2022-12-28	WOS:000360011800044
J	Martinez, S; Hausinger, RP				Martinez, Salette; Hausinger, Robert P.			Catalytic Mechanisms of Fe(II)-and 2-Oxoglutarate-dependent Oxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; SPIN FE(IV) COMPLEX; NONHEME IRON ENZYME; ALPHA-KETOGLUTARATE; CRYSTAL-STRUCTURE; HYOSCYAMINE 6-BETA-HYDROXYLASE; CARBAPENEM BIOSYNTHESIS; SPECTROSCOPIC EVIDENCE; ALIPHATIC HALOGENASE; FACIAL TRIAD	Mononuclear non-hemeFe(II)-and 2-oxoglutarate (2OG)-dependent oxygenases comprise a large family of enzymes that utilize an Fe(IV)-oxo intermediate to initiate diverse oxidative transformations with important biological roles. Here, four of the major types of Fe(II)/2OG-dependent reactions are detailed: hydroxylation, halogenation, ring formation, and desaturation. In addition, an atypical epimerization reaction is described. Studies identifying several key intermediates in catalysis are concisely summarized, and the proposed mechanisms are explained. In addition, a variety of other transformations catalyzed by selected family members are briefly described to further highlight the chemical versatility of these enzymes.	[Martinez, Salette; Hausinger, Robert P.] Michigan State Univ, Dept Microbiol, E Lansing, MI 48824 USA; [Martinez, Salette; Hausinger, Robert P.] Michigan State Univ, Dept Mol Genet, E Lansing, MI 48824 USA; [Hausinger, Robert P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Hausinger, RP (corresponding author), Michigan State Univ, Dept Microbiol, E Lansing, MI 48824 USA.	hausinge@msu.edu		Hausinger, Robert/0000-0002-3643-2054	National Institutes of Health [GM063584]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM063584 (to R. P. H.). This is the first article in the Thematic Minireview series "Metals in Biology: alpha-Ketoglutarate/Iron-dependent Dioxygenases." The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Omar MM, 2005, CHEM REV, V105, P2227, DOI 10.1021/cr040653o; Aik WS, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P59; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; Bollinger JM, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P95; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Borowski T, 2004, CHEM-EUR J, V10, P1031, DOI 10.1002/chem.200305306; Borowski T, 2006, J COMPUT CHEM, V27, P740, DOI 10.1002/jcc.20384; Borowski T, 2007, BIOCHEMISTRY-US, V46, P3682, DOI 10.1021/bi602458m; Brisson L, 2012, J BIOL INORG CHEM, V17, P939, DOI 10.1007/s00775-012-0910-3; Butler A, 2009, NATURE, V460, P848, DOI 10.1038/nature08303; Chang WC, 2014, SCIENCE, V343, P1140, DOI 10.1126/science.1248000; Chang WC, 2013, NATURE, V496, P114, DOI 10.1038/nature11998; Cheng AX, 2014, INT J MOL SCI, V15, P1080, DOI 10.3390/ijms15011080; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Clifton IJ, 2003, J BIOL CHEM, V278, P20843, DOI 10.1074/jbc.M213054200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Decker A, 2005, CURR OPIN CHEM BIOL, V9, P152, DOI 10.1016/j.cbpa.2005.02.012; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Fang D, 2014, J CHEM THEORY COMPUT, V10, P5136, DOI 10.1021/ct500572t; Fujimori DG, 2007, J AM CHEM SOC, V129, P13408, DOI 10.1021/ja076454e; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HASHIMOTO T, 1987, EUR J BIOCHEM, V164, P277, DOI 10.1111/j.1432-1033.1987.tb11055.x; HASHIMOTO T, 1993, FEBS LETT, V329, P35, DOI 10.1016/0014-5793(93)80187-Y; Hausinger RP, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P1; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hillwig ML, 2014, NAT CHEM BIOL, V10, P921, DOI [10.1038/NCHEMBIO.1625, 10.1038/nchembio.1625]; Ho RYN, 2001, J AM CHEM SOC, V123, P5022, DOI 10.1021/ja0041775; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Iwata-Reuyl D, 1999, J AM CHEM SOC, V121, P11356, DOI 10.1021/ja992649d; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Kulik HJ, 2013, J BIOL CHEM, V288, P11233, DOI 10.1074/jbc.M112.415570; Li J, 2012, BIOORGAN MED CHEM, V20, P4356, DOI 10.1016/j.bmc.2012.05.042; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Matthews ML, 2014, NAT CHEM BIOL, V10, P209, DOI [10.1038/NCHEMBIO.1438, 10.1038/nchembio.1438]; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Moran GR, 2014, ARCH BIOCHEM BIOPHYS, V544, P58, DOI 10.1016/j.abb.2013.10.022; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nair SK, 2011, ARCH BIOCHEM BIOPHYS, V505, P13, DOI 10.1016/j.abb.2010.09.012; Neidig ML, 2007, J AM CHEM SOC, V129, P14224, DOI 10.1021/ja074557r; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pau MYM, 2007, P NATL ACAD SCI USA, V104, P18355, DOI 10.1073/pnas.0704191104; Pratter SM, 2014, J AM CHEM SOC, V136, P9385, DOI 10.1021/ja503179m; Pratter SM, 2014, CHEMBIOCHEM, V15, P567, DOI 10.1002/cbic.201300345; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; Proshlyakov DA, 2011, IRON-CONTAINING ENZYMES: VERSATILE CATALYSTS OF HYDROXYLATION REACTIONS IN NATURE, P67, DOI 10.1039/9781849732987-00067; Riggs-Gelasco PJ, 2004, J AM CHEM SOC, V126, P8108, DOI 10.1021/ja048255q; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Srnec M, 2014, DALTON T, V43, P17567, DOI 10.1039/c4dt01366b; Stapon A, 2003, J AM CHEM SOC, V125, P15746, DOI 10.1021/ja037665w; Stapon A, 2003, J AM CHEM SOC, V125, P8486, DOI 10.1021/ja034248a; Steffan N, 2009, ORG BIOMOL CHEM, V7, P4082, DOI 10.1039/b908392h; Taabazuing CY, 2014, J INORG BIOCHEM, V133, P63, DOI 10.1016/j.jinorgbio.2013.12.010; Tarhonskaya H, 2014, BIOCHEMISTRY-US, V53, P2483, DOI 10.1021/bi500086p; Topf M, 2004, J AM CHEM SOC, V126, P9932, DOI 10.1021/ja047899v; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Ueki M, 2006, CHEM BIOL, V13, P1183, DOI 10.1016/j.chembiol.2006.09.012; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Wanders RJA, 2011, BBA-MOL CELL BIOL L, V1811, P498, DOI 10.1016/j.bbalip.2011.06.006; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127; Zhou J, 2001, J AM CHEM SOC, V123, P7388, DOI 10.1021/ja004025+	85	229	236	16	153	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20702	20711		10.1074/jbc.R115.648691	http://dx.doi.org/10.1074/jbc.R115.648691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152721	Green Published, hybrid			2022-12-28	WOS:000360011800007
J	Mathiassen, SG; Larsen, IB; Poulsen, EG; Madsen, CT; Papaleo, E; Lindorff-Larsen, K; Kragelund, BB; Nielsen, ML; Kriegenburg, F; Hartmann-Petersen, R				Mathiassen, Sos G.; Larsen, Ida B.; Poulsen, Esben G.; Madsen, Christian T.; Papaleo, Elena; Lindorff-Larsen, Kresten; Kragelund, Birthe B.; Nielsen, Michael L.; Kriegenburg, Franziska; Hartmann-Petersen, Rasmus			A Two-step Protein Quality Control Pathway for a Misfolded DJ-1 Variant in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; PARKINSONS-DISEASE; COTRANSLATIONAL UBIQUITINATION; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DEGRADATION; RIBOSOME; HSP104; HSP70	A mutation, L166P, in the cytosolic protein, PARK7/DJ-1, causes protein misfolding and is linked to Parkinson disease. Here, we identify the fission yeast protein Sdj1 as the orthologue of DJ-1 and calculate by in silico saturation mutagenesis the effects of point mutants on its structural stability. We also map the degradation pathways for Sdj1-L169P, the fission yeast orthologue of the disease-causing DJ-1 L166P protein. Sdj1-L169P forms inclusions, which are enriched for the Hsp104 disaggregase. Hsp104 and Hsp70-type chaperones are required for efficient degradation of Sdj1-L169P. This also depends on the ribosome-associated E3 ligase Ltn1 and its co-factor Rqc1. Although Hsp104 is absolutely required for proteasomal degradation of Sdj1-L169P aggregates, the degradation of already aggregated Sdj1-L169P occurs independently of Ltn1 and Rqc1. Thus, our data point to soluble Sdj1-L169P being targeted early by Ltn1 and Rqc1. The fraction of Sdj1-L169P that escapes this first inspection then forms aggregates that are subsequently cleared via an Hsp104- and proteasome-dependent pathway.	[Mathiassen, Sos G.; Larsen, Ida B.; Poulsen, Esben G.; Papaleo, Elena; Lindorff-Larsen, Kresten; Kragelund, Birthe B.; Kriegenburg, Franziska; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Madsen, Christian T.; Nielsen, Michael L.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen	Kriegenburg, F (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	fkriegenburg@bio.ku.dk; rhpetersen@bio.ku.dk	Lindorff-Larsen, Kresten/K-6469-2014; Hartmann-Petersen, Rasmus/K-4434-2014; Papaleo, Elena/M-6629-2014; Kragelund, Birthe/M-3927-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Papaleo, Elena/0000-0002-7376-5894; Kragelund, Birthe/0000-0002-7454-1761; , Elena/0000-0003-2296-898X; Nielsen, Michael/0000-0002-0067-9039	Danish Council for Independent Research (Natural Sciences); Novo Nordisk Foundation; Danish Cancer Society; Lundbeck Foundation; Novo Nordisk student scholarship; Novo Nordisk Foundation [NNF14CC0001]; Danish Council for Independent Research, Sapere Aude Grant [4002-00051A]; Novo Nordisk Fonden [NNF11OC1014446] Funding Source: researchfish	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk student scholarship; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research, Sapere Aude Grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from the Danish Council for Independent Research (Natural Sciences), The Novo Nordisk Foundation, The Danish Cancer Society, and the Lundbeck Foundation (to R. H.-P., B. B. K., and K. L.-L.).; Supported by a Novo Nordisk student scholarship.; Supported in part by the Novo Nordisk Foundation Grant NNF14CC0001 and the Danish Council for Independent Research, Sapere Aude Grant 4002-00051A.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329; Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Coelho M, 2013, CURR BIOL, V23, P1844, DOI 10.1016/j.cub.2013.07.084; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guerriero CJ, 2013, J BIOL CHEM, V288, P18506, DOI 10.1074/jbc.M113.475905; Le HT, 2012, J BIOL CHEM, V287, P5861, DOI 10.1074/jbc.M111.299198; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kriegenburg F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004140; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Madzelan P, 2012, FEBS J, V279, P4111, DOI 10.1111/febs.12004; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moscovitz O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7609; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Penney M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050796; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poulsen EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050548; Poulsen JW, 2013, J PROTEOME RES, V12, P1020, DOI 10.1021/pr300883y; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang CY, 2012, RNA, V18, P694, DOI 10.1261/rna.030270.111; Wang F, 2015, BIOCHIMIE, V114, P127, DOI 10.1016/j.biochi.2015.02.006; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100	65	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21141	21153		10.1074/jbc.M115.662312	http://dx.doi.org/10.1074/jbc.M115.662312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152728	Green Published, hybrid			2022-12-28	WOS:000360011800045
J	Kassem, A; Henning, P; Lundberg, P; Souza, PPC; Lindholm, C; Lerner, UH				Kassem, Ali; Henning, Petra; Lundberg, Pernilla; Souza, Pedro P. C.; Lindholm, Catharina; Lerner, Ulf H.			Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-kappa B Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; OSTEOCLAST PROGENITOR; PATTERN-RECOGNITION; PERIODONTAL-DISEASE; IMMUNE-SYSTEM; IN-VIVO; TLR2; LIPOPOLYSACCHARIDE; EXPRESSION	Periodontitis has been associated with rheumatoid arthritis. In experimental arthritis, concomitant periodontitis caused by oral infection with Porphyromonas gingivalis enhances articular bone loss. The aim of this study was to investigate how lipopolysaccharide (LPS) from P. gingivalis stimulates bone resorption. The effects by LPS P. gingivalis and four other TLR2 ligands on bone resorption, osteoclast formation, and gene expression in wild type and Tlr2-deficient mice were assessed in ex vivo cultures of mouse parietal bones and in an in vivo model in which TLR2 agonists were injected subcutaneously over the skull bones. LPS P. gingivalis stimulated mineral release and matrix degradation in the parietal bone organ cultures by increasing differentiation and formation of mature osteoclasts, a response dependent on increased RANKL (receptor activator of NF-kappa B ligand). LPS P. gingivalis stimulated RANKL in parietal osteoblasts dependent on the presence of TLR2 and through a MyD88 and NF-kappa B-mediated mechanism. Similarly, the TLR2 agonists HKLM, FSL1, Pam2, and Pam3 stimulated RANKL in osteoblasts and parietal bone resorption. LPS P. gingivalis and Pam2 robustly enhanced osteoclast formation in periosteal/endosteal cell cultures by increasing RANKL. LPS P. gingivalis and Pam2 also up-regulated RANKL and osteoclastic genes in vivo, resulting in an increased number of periosteal osteoclasts and immense bone loss in wild type mice but not in Tlr2-deficient mice. These data demonstrate that LPS P. gingivalis stimulates periosteal osteoclast formation and bone resorption by stimulating RANKL in osteoblasts via TLR2. This effect might be important for periodontal bone loss and for the enhanced bone loss seen in rheumatoid arthritis patients with concomitant periodontal disease.	[Kassem, Ali; Lundberg, Pernilla; Souza, Pedro P. C.; Lerner, Ulf H.] Umea Univ, Dept Periodontol, S-90187 Umea, Sweden; [Henning, Petra; Lindholm, Catharina; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res,Dept Internal Med & Clin N, S-41345 Gothenburg, Sweden; [Souza, Pedro P. C.] Univ Estadual Paulista, UNESP, Araraquara Sch Dent, Dept Physiol & Pathol, BR-14801903 Araraquara, Brazil; [Lindholm, Catharina] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, S-40350 Gothenburg, Sweden	Umea University; University of Gothenburg; Universidade Estadual Paulista; University of Gothenburg	Lerner, UH (corresponding author), Umea Univ, Dept Periodontol, S-90187 Umea, Sweden.	ulf.lerner@umu.se	Souza, Pedro Paulo Chaves/G-3801-2011; Souza, Pedro/GZH-1275-2022	Souza, Pedro Paulo Chaves/0000-0001-7266-6061; Lerner, Ulf/0000-0002-3579-1960; Henning, Petra/0000-0002-9330-6265; Kassem, Ali/0000-0002-1820-8518	Swedish Research Council; Swedish National Graduate School in Odontological Science; Swedish Dental Association; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg; Lundberg Foundation; County Council of Vasterbotten	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Graduate School in Odontological Science; Swedish Dental Association; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg; Lundberg Foundation(European Commission); County Council of Vasterbotten	This work was supported by the Swedish Research Council, Swedish National Graduate School in Odontological Science, Swedish Dental Association, Swedish Rheumatism Association, Royal 80-Year Fund of King Gustav V, COMBINE, an ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg, the Lundberg Foundation, and County Council of Vasterbotten. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Al-Katma MK, 2007, JCR-J CLIN RHEUMATOL, V13, P134, DOI 10.1097/RHU.0b013e3180690616; Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Bartold PM, 2010, J CLIN PERIODONTOL, V37, P405, DOI 10.1111/j.1600-051X.2010.01552.x; Bartold PM, 2010, PERIODONTOL 2000, V53, P55, DOI 10.1111/j.1600-0757.2010.00347.x; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; de Aquino SG, 2014, J IMMUNOL, V192, P4103, DOI 10.4049/jimmunol.1301970; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; LERNER UH, 1987, J BONE MINER RES, V2, P375; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Mikuls TR, 2012, ARTHRITIS RHEUM-US, V64, P655, DOI 10.1002/art.33408; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; Nakamura H, 2008, ORAL MICROBIOL IMMUN, V23, P190, DOI 10.1111/j.1399-302X.2007.00410.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schwab AM, 2005, ENDOCRINOLOGY, V146, P4349, DOI 10.1210/en.2005-0601; Shi B, 2012, ANN RHEUM DIS, V71, P1411, DOI 10.1136/annrheumdis-2011-200899; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085	54	73	76	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20147	20158		10.1074/jbc.M115.655787	http://dx.doi.org/10.1074/jbc.M115.655787			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26085099	hybrid, Green Published			2022-12-28	WOS:000359608900017
J	AlSalmi, W; Mahalingam, M; Ananthaswamy, N; Hamlin, C; Flores, D; Gao, GF; Rao, VB				AlSalmi, Wadad; Mahalingam, Marthandan; Ananthaswamy, Neeti; Hamlin, Christopher; Flores, Dalia; Gao, Guofen; Rao, Venigalla B.			A New Approach to Produce HIV-1 Envelope Trimers BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; CD4 BINDING-SITE; GLYCOPROTEIN TRIMERS; DEPENDENT EPITOPE; IN-VITRO; ELECTRON-MICROSCOPY; ENV TRIMERS; T4 MOLECULE	The trimeric envelope spike of HIV-1 mediates virus entry into human cells. The exposed part of the trimer, gp140, consists of two noncovalently associated subunits, gp120 and gp41 ectodomain. A recombinant vaccine that mimics the native trimer might elicit entry-blocking antibodies and prevent virus infection. However, preparation of authentic HIV-1 trimers has been challenging. Recently, an affinity column containing the broadly neutralizing antibody 2G12 has been used to capture recombinant gp140 and prepare trimers from clade A BG505 that naturally produces stable trimers. However, this antibody-based approach may not be as effective for the diverse HIV-1 strains with different epitope signatures. Here, we report a new and simple approach to produce HIV-1 envelope trimers. The C terminus of gp140 was attached to Strep-tag II with a long linker separating the tag from the massive trimer base and glycan shield. This allowed capture of nearly homogeneous gp140 directly from the culture medium. Cleaved, uncleaved, and fully or partially glycosylated trimers from different clade viruses were produced. Extensive biochemical characterizations showed that cleavage of gp140 was not essential for trimerization, but it triggered a conformational change that channels trimers into correct glycosylation pathways, generating compact three-blade propeller-shaped trimers. Uncleaved trimers entered aberrant pathways, resulting in hyperglycosylation, nonspecific cross-linking, and conformational heterogeneity. Even the cleaved trimers showed microheterogeneity in gp41 glycosylation. These studies established a broadly applicable HIV-1 trimer production system as well as generating new insights into their assembly and maturation that collectively bear on the HIV-1 vaccine design.	[AlSalmi, Wadad; Mahalingam, Marthandan; Ananthaswamy, Neeti; Hamlin, Christopher; Flores, Dalia; Gao, Guofen; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Institutes of Health, NIAID [AI102725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI102725 (to V. B. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Benjelloun F, 2012, J VIROL, V86, P13152, DOI 10.1128/JVI.01110-12; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; CAVACINI LA, 1993, J ACQ IMMUN DEF SYND, V6, P1093; Cavacini LA, 1998, AIDS RES HUM RETROV, V14, P1271, DOI 10.1089/aid.1998.14.1271; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dey AK, 2007, VIROLOGY, V360, P199, DOI 10.1016/j.virol.2006.09.046; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gao GF, 2013, J BIOL CHEM, V288, P234, DOI 10.1074/jbc.M112.424432; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2001, CURR OPIN IMMUNOL, V13, P489, DOI 10.1016/S0952-7915(00)00246-6; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; POSNER MR, 1991, J IMMUNOL, V146, P4325; POSNER MR, 1987, HYBRIDOMA, V6, P611, DOI 10.1089/hyb.1987.6.611; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tao P, 2013, P NATL ACAD SCI USA, V110, P5846, DOI 10.1073/pnas.1300867110; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yu L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00250; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	80	17	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19780	19795		10.1074/jbc.M115.656611	http://dx.doi.org/10.1074/jbc.M115.656611			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088135	hybrid, Green Published			2022-12-28	WOS:000359364600035
J	Hanes, MS; Salanga, CL; Chowdry, AB; Comerford, I; McColl, SR; Kufareva, I; Handel, TM				Hanes, Melinda S.; Salanga, Catherina L.; Chowdry, Arnab B.; Comerford, Iain; McColl, Shaun R.; Kufareva, Irina; Handel, Tracy M.			Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-DERIVED FACTOR-1-ALPHA; CRYSTAL-STRUCTURE; SMALL-MOLECULE; HIGHLY POTENT; PHAGE DISPLAY; BETA-ARRESTIN; BINDING; CXCL12; ANTAGONIST	The chemokine CXCL12 and its G protein-coupled receptors CXCR4 and ACKR3 are implicated in cancer and inflammatory and autoimmune disorders and are targets of numerous antagonist discovery efforts. Here, we describe a series of novel, high affinity CXCL12-based modulators of CXCR4 and ACKR3 generated by selection of N-terminal CXCL12 phage libraries on live cells expressing the receptors. Twelve of 13 characterized CXCL12 variants are full CXCR4 antagonists, and four have K-d values <5 nM. The new variants also showed high affinity for ACKR3. The variant with the highest affinity for CXCR4, LGGG-CXCL12, showed efficacy in a murine model for multiple sclerosis, demonstrating translational potential. Molecular modeling was used to elucidate the structural basis of binding and antagonism of selected variants and to guide future designs. Together, this work represents an important step toward the development of therapeutics targeting CXCR4 and ACKR3.	[Hanes, Melinda S.; Salanga, Catherina L.; Chowdry, Arnab B.; Kufareva, Irina; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Comerford, Iain; McColl, Shaun R.] Univ Adelaide, Sch Mol & Biomed Sci, Chemokine Biol Grp, Adelaide, SA 5005, Australia	University of California System; University of California San Diego; University of Adelaide	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,MC 0684, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Regan, Clinton/E-6250-2012	Kufareva, Irina/0000-0001-9083-7039; Comerford, Iain/0000-0001-8753-4774	National Institutes of Health [R01 AI037113, U01 GM094612, R01 GM071872, U54 GM094618, R01 AI118985]; National Health and Medical Research Council [APP1066781]; Multiple Sclerosis Research Australia Grant [12-001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985, R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094612, R01GM071872, U54GM094618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI037113 and U01 GM094612 (to T. M. H.), R01 GM071872 and U54 GM094618 (to I. K.), and R01 AI118985 (to T. M. H. and I. K.). This work was also supported by National Health and Medical Research Council Grant APP1066781 and Multiple Sclerosis Research Australia Grant 12-001 (to S. R. M. and I. C.). The authors declare that they have no conflicts of interest with the contents of this article.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chevigne A, 2011, BIOCHEM PHARMACOL, V82, P1438, DOI 10.1016/j.bcp.2011.07.091; Chevigne A, 2011, FEBS J, V278, P2867, DOI 10.1111/j.1742-4658.2011.08208.x; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DUFFAUD G, 1988, J BIOL CHEM, V263, P10224; Eldridge B, 2009, PROTEIN ENG DES SEL, V22, P691, DOI 10.1093/protein/gzp052; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Heitner T, 2001, J IMMUNOL METHODS, V248, P17, DOI 10.1016/S0022-1759(00)00340-9; Hori T, 1998, J IMMUNOL, V160, P180; Houimel M, 2012, CYTOKINE, V57, P322, DOI 10.1016/j.cyto.2011.11.022; Houimel M, 2009, J LEUKOCYTE BIOL, V85, P728, DOI 10.1189/jlb.0608380; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081454; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051813; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy JW, 2010, PROTEINS, V78, P1331, DOI 10.1002/prot.22666; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Patrussi L, 2011, CURR MED CHEM, V18, P497, DOI 10.2174/092986711794480159; Puchert M, 2014, CELL TISSUE RES, V355, P239, DOI 10.1007/s00441-013-1747-y; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Sarchio SNE, 2014, J INVEST DERMATOL, V134, P1091, DOI 10.1038/jid.2013.424; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Smith EW, 2014, J MED CHEM, V57, P9693, DOI 10.1021/jm501194p; Steinberg M, 2010, CLIN THER, V32, P821, DOI 10.1016/j.clinthera.2010.05.007; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan Y, 2009, CARDIOVASC RES, V82, P513, DOI 10.1093/cvr/cvp044; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; Vabeno J, 2006, CHEM BIOL DRUG DES, V67, P346, DOI 10.1111/j.1747-0285.2006.00387.x; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Walters MJ, 2014, BRIT J CANCER, V110, P1179, DOI 10.1038/bjc.2013.830; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2873, DOI 10.3748/wjg.v16.i23.2873; Yang OO, 1999, J VIROL, V73, P4582, DOI 10.1128/JVI.73.6.4582-4589.1999; Zhao B, 2011, J BIOL CHEM, V286, P28370, DOI 10.1074/jbc.M111.234799; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200	74	31	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22385	22397		10.1074/jbc.M115.675108	http://dx.doi.org/10.1074/jbc.M115.675108			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216880	Green Published, hybrid			2022-12-28	WOS:000361171500006
J	Nie, MH; Boddy, MN				Nie, Minghua; Boddy, Michael N.			Pli1(PIAS1) SUMO Ligase Protected by the Nuclear Pore-associated SUMO Protease Ulp1(SENP1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-SELECTIVE SEGREGASE; E3 LIGASE; LOCALIZATION; SUMOYLATION; ISOPEPTIDASE; COMPLEX; ULP2; RNF4; ACCUMULATION; MAINTENANCE	Covalent modification of the proteome by SUMO is critical for genetic stability and cell growth. Equally crucial to these processes is the removal of SUMO from its targets by the Ulp1 (HuSENP1/2) family of SUMO proteases. Ulp1 activity is normally spatially restricted, because it is localized to the nuclear periphery via interactions with the nuclear pore. Delocalization of Ulp1 causes DNA damage and cell cycle defects, phenotypes thought to be caused by inappropriate desumoylation of nucleoplasmic targets that are normally spatially protected from Ulp1. Here, we define a novel consequence of Ulp1 deregulation, with a major impact onSUMOpathway function. In fission yeast lacking Nup132 (Sc/HuNUP133), Ulp1 is delocalized and can no longer antagonize sumoylation of the PIAS family SUMO E3 ligase, Pli1. Consequently, SUMO chain-modified Pli1 is targeted for proteasomal degradation by the concerted action of a SUMO-targeted ubiquitin ligase (STUbL) and Cdc48-Ufd1Npl4. Pli1 degradation causes the profound SUMO pathway defects and associated centromere dysfunction in cells lacking Nup132. Thus, perhaps counterintuitively, Ulp1-mediated desumoylation can promote SUMO modification by stabilizing a SUMO E3 ligase.	[Nie, Minghua; Boddy, Michael N.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Boddy, MN (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nboddy@scripps.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM068608, GM081840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068608, R01GM081840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068608 and GM081840 (to M.N.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Asakawa H, 2014, NUCLEUS-PHILA, V5, P149, DOI 10.4161/nucl.28487; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Bukata L, 2013, CURR OPIN CELL BIOL, V25, P378, DOI 10.1016/j.ceb.2013.03.002; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Felberbaum R, 2008, CELL CYCLE, V7, P52, DOI 10.4161/cc.7.1.5218; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Goeres J, 2011, MOL BIOL CELL, V22, P4868, DOI 10.1091/mbc.E10-12-0953; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jongjitwimol J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094182; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kohler JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080442; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Liu NN, 2010, CELL RES, V20, P963, DOI 10.1038/cr.2010.107; Maison C, 2012, NAT STRUCT MOL BIOL, V19, P458, DOI 10.1038/nsmb.2244; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Miyagawa K, 2014, P NATL ACAD SCI USA, V111, P5950, DOI 10.1073/pnas.1401359111; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Mullen JR, 2011, GENETICS, V187, P73, DOI 10.1534/genetics.110.124347; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Skilton A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006750; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Taylor DL, 2002, J CELL SCI, V115, P1113; Texari L, 2013, MOL CELL, V51, P807, DOI 10.1016/j.molcel.2013.08.047; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Watts FZ, 2007, BIOCHEM SOC T, V35, P1379, DOI 10.1042/BST0351379; Westerbeck JW, 2014, MOL BIOL CELL, V25, P1, DOI 10.1091/mbc.E13-05-0291; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	63	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22678	22685		10.1074/jbc.M115.673038	http://dx.doi.org/10.1074/jbc.M115.673038			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221037	hybrid, Green Published			2022-12-28	WOS:000361171500032
J	Badal, S; Her, YF; Maher, LJ				Badal, Sujan; Her, Yeng F.; Maher, L. James, III			Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL HYDROXYLASE REACTION; ACHILLES-TENDON RUPTURE; ACUTE-RENAL-FAILURE; CIPROFLOXACIN THERAPY; BACTERICIDAL ACTIVITY; COLLAGEN-SYNTHESIS; ANTIBACTERIAL USE; METAL-COMPLEXES; CANCER-CELLS; 4-HYDROXYLASES	Fluoroquinolones (FQ) are powerful broad-spectrum antibiotics whose side effects include renal damage and, strangely, tendinopathies. The pathological mechanisms underlying these toxicities are poorly understood. Here, we show that the FQ drugs norfloxacin, ciprofloxacin, and enrofloxacin are powerful iron chelators comparable with deferoxamine, a clinically useful iron-chelating agent. We show that iron chelation by FQ leads to epigenetic effects through inhibition of alpha-ketoglutarate-dependent dioxygenases that require iron as a co-factor. Three dioxygenases were examined in HEK293 cells treated with FQ. At sub-millimolar concentrations, these antibiotics inhibited jumonji domain histone demethylases, TET DNA demethylases, and collagen prolyl 4-hydroxylases, leading to accumulation of methylated histones and DNA and inhibition of proline hydroxylation in collagen, respectively. These effects may explain FQ-induced nephrotoxicity and tendinopathy. By the same reasoning, dioxygenase inhibition by FQ was predicted to stabilize transcription factor HIF-1 alpha by inhibition of the oxygen-dependent hypoxia-inducible transcription factor prolyl hydroxylation. In dramatic contrast to this prediction, HIF-1 alpha protein was eliminated by FQ treatment. We explored possible mechanisms for this unexpected effect and show that FQ inhibit HIF-1 alpha mRNA translation. Thus, FQ antibiotics induce global epigenetic changes, inhibit collagen maturation, and block HIF-1 alpha accumulation. We suggest that these mechanisms explain the classic renal toxicities and peculiar tendinopathies associated with FQ antibiotics.	[Badal, Sujan; Her, Yeng F.; Maher, L. James, III] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	Maher@mayo.edu	Badal, Sujan/ABF-8294-2020; Regan, Clinton/E-6250-2012	Badal, Sujan/0000-0003-2271-7814; 	National Institutes of Health [1F31CA180698, 5T32GM065841, R25 GM55252, R25 GM075148]; Mayo Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE [F31CA180698, R01CA166025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148, R25GM055252, T32GM065841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F31CA180698 (to Y. F. H.), 5T32GM065841 (to Mayo Clinic), R25 GM55252 (to Mayo Clinic), and R25 GM075148 (to Mayo Clinic). This work was also supported by the Mayo Graduate School and the Mayo Foundation. The authors declare that they have no conflict of interest with the contents of this article.	Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; BAILEY JR, 1992, AM J NEPHROL, V12, P271, DOI 10.1159/000168458; Bird ST, 2013, CAN MED ASSOC J, V185, pE475, DOI 10.1503/cmaj.121730; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; BURKHARDT JE, 1993, FUND APPL TOXICOL, V20, P257, DOI 10.1006/faat.1993.1034; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; Chohan ZH, 2005, J ENZYM INHIB MED CH, V20, P303, DOI 10.1080/14756360310001624948; Corps AN, 2005, RHEUMATOLOGY, V44, P1514, DOI 10.1093/rheumatology/kei087; Corps AN, 2002, ARTHRITIS RHEUM, V46, P3034, DOI 10.1002/art.10617; Corrao G, 2006, DRUG SAFETY, V29, P889, DOI 10.2165/00002018-200629100-00006; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dharnidharka VR, 1998, AM J KIDNEY DIS, V31, P710, DOI 10.1053/ajkd.1998.v31.pm9531191; Ferry T, 2005, INFECTION, V33, P151, DOI 10.1007/s15010-005-4057-9; Gong LY, 2012, BIOORG MED CHEM LETT, V22, P7381, DOI 10.1016/j.bmcl.2012.10.066; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010; HACKBARTH CJ, 1986, ANTIMICROB AGENTS CH, V29, P611, DOI 10.1128/AAC.29.4.611; Hadimeri H, 1997, SCAND J UROL NEPHROL, V31, P481, DOI 10.3109/00365599709030647; Hall MM, 2011, PM&R, V3, P132, DOI 10.1016/j.pmrj.2010.10.003; Harrell RM, 1999, SOUTHERN MED J, V92, P622, DOI 10.1097/00007611-199906000-00014; Herath SC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009764.pub2; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hobson-Webb LD, 2006, J CHILD NEUROL, V21, P429, DOI 10.1177/08830738060210051201; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; HOOTKINS R, 1989, CLIN NEPHROL, V32, P75; Johannes CB, 2007, DRUG SAFETY, V30, P705, DOI 10.2165/00002018-200730080-00007; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kennedy J. F., 2003, CHEM FUNCTIONAL PROP; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Kim Grace K, 2010, J Clin Aesthet Dermatol, V3, P49; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Lim S, 2003, RENAL FAILURE, V25, P647, DOI 10.1081/JDI-120022557; Lipsky BA, 1999, CLIN INFECT DIS, V28, P352, DOI 10.1086/515104; Ma HHM, 1997, PHARMACEUT RES, V14, P366, DOI 10.1023/A:1012014608733; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Marti HP, 1998, BRIT J RHEUMATOL, V37, P343; Martin SJ, 1998, ANN PHARMACOTHER, V32, P320, DOI 10.1345/aph.17178; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Melhus Asa, 2005, Expert Opin Drug Saf, V4, P299, DOI 10.1517/14740338.4.2.299; Montagnac Richard, 2005, Nephrol Ther, V1, P44, DOI 10.1016/j.nephro.2005.02.005; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Peters JP, 2013, NUCLEIC ACIDS RES, V41, P10593, DOI 10.1093/nar/gkt808; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierfitte C, 1996, THERAPIE, V51, P419; Psomas G, 2008, J INORG BIOCHEM, V102, P1798, DOI 10.1016/j.jinorgbio.2008.05.012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Reece RJ, 1996, NEPHROL DIAL TRANSPL, V11, P393, DOI 10.1093/oxfordjournals.ndt.a027281; Rosenblat G, 1998, CONNECT TISSUE RES, V37, P303, DOI 10.3109/03008209809002447; Sadarangani SP, 2015, MAYO CLIN PROC, V90, P109, DOI 10.1016/j.mayocp.2014.09.006; Sandhu J, 2009, J CHROMATOGR B, V877, P1957, DOI 10.1016/j.jchromb.2009.05.032; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Simonin MA, 1999, ANTIMICROB AGENTS CH, V43, P2915, DOI 10.1128/AAC.43.12.2915; Simonin MA, 2000, ANTIMICROB AGENTS CH, V44, P867, DOI 10.1128/AAC.44.4.867-872.2000; Sode J, 2007, EUR J CLIN PHARMACOL, V63, P499, DOI 10.1007/s00228-007-0265-9; Stahlmann R, 1999, DRUGS, V58, P37, DOI 10.2165/00003495-199958002-00007; Steel HC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/584262; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Stratta P, 2007, AM J KIDNEY DIS, V50, P330, DOI 10.1053/j.ajkd.2007.05.014; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; Uivarosi V, 2013, MOLECULES, V18, P11153, DOI 10.3390/molecules180911153; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; Wagenlehner FME, 2006, INT J ANTIMICROB AG, V28, P551, DOI 10.1016/j.ijantimicag.2006.07.026; Walker RC, 1999, MAYO CLIN PROC, V74, P1030; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Williams RJ, 2000, AM J SPORT MED, V28, P364, DOI 10.1177/03635465000280031401; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; YAMAMOTO I, 1992, J NUTR, V122, P871, DOI 10.1093/jn/122.4.871; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	79	52	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22287	22297		10.1074/jbc.M115.671222	http://dx.doi.org/10.1074/jbc.M115.671222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205818	Green Published, hybrid			2022-12-28	WOS:000360968500044
J	Lauer, ME; Majors, AK; Comhair, S; Ruple, LM; Matuska, B; Subramanian, A; Farver, C; Dworski, R; Grandon, D; Laskowski, D; Dweik, RA; Erzurum, SC; Hascall, VC; Aronica, MA				Lauer, Mark E.; Majors, Alana K.; Comhair, Suzy; Ruple, Lisa M.; Matuska, Brittany; Subramanian, Ahila; Farver, Carol; Dworski, Ryszard; Grandon, Deepa; Laskowski, Dan; Dweik, Raed A.; Erzurum, Serpil C.; Hascall, Vincent C.; Aronica, Mark A.			Hyaluronan and Its Heavy Chain Modification in Asthma Severity and Experimental Asthma Exacerbation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; STIMULATED GENE-6; TSG-6 ACTIVITY; MURINE MODEL; INFLAMMATION; ACID; EXPRESSION; DEPOSITION	Hyaluronan (HA) is a large (>1500 kDa) polysaccharide of the extracellular matrix that has been linked to severity and inflammation in asthma. During inflammation, HA becomes covalently modified with heavy chains (HC-HA) from inter-alpha-inhibitor (I alpha I), which functions to increase its avidity for leukocytes. Our murine model of allergic pulmonary inflammation suggested that HC-HA may contribute to inflammation, adversely effecting lower airway remodeling and asthma severity. Our objective was to characterize the levels of HA and HC-HA in asthmatic subjects and to correlate these levels with asthma severity. We determined the levels and distribution of HA and HC-HA (i) from asthmatic and control lung tissue, (ii) in bron-choalveolar lavage fluid obtained from non-severe and severe asthmatics and controls, and (iii) in serum and urine from atopic asthmatics after an experimental asthma exacerbation. HC-HA distribution was observed (i) in the thickened basement membrane of asthmatic lower airways, (ii) around smooth muscle cells of the asthmatic submucosa, and (iii) around reserve cells of the asthmatic epithelium. Patients with severe asthma had increased HA levels in bronchoalveolar lavage fluid that correlated with pulmonary function and nitric oxide levels, whereas HC-HA was only observed in a patient with non-severe asthma. After an experimental asthma exacerbation, serum HA was increased within 4 h after challenge and remained elevated through 5 days after challenge. Urine HA and HC-HA were not significantly different. These data implicate HA and HC-HA in the pathogenesis of asthma severity that may occur in part due to repetitive asthma exacerbations over the course of the disease.	[Lauer, Mark E.] Cleveland Clin, Lerner Res Inst, Inst Pediat, Cleveland, OH 44195 USA; [Lauer, Mark E.; Matuska, Brittany; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Majors, Alana K.; Comhair, Suzy; Ruple, Lisa M.; Grandon, Deepa; Laskowski, Dan; Dweik, Raed A.; Aronica, Mark A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Farver, Carol] Cleveland Clin, Lerner Res Inst, Dept Anat Pathol, Cleveland, OH 44195 USA; [Subramanian, Ahila; Laskowski, Dan; Dweik, Raed A.; Erzurum, Serpil C.; Aronica, Mark A.] Cleveland Clin, Lerner Res Inst, Resp Inst, Cleveland, OH 44195 USA; [Dworski, Ryszard] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Vanderbilt University	Aronica, MA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol NB2 85, Cleveland, OH 44195 USA.	ARONICM@ccf.org	Regan, Clinton/E-6250-2012		National Institutes of Health [HL081064, HL103453]; Case Western Reserve University/Cleveland Clinic CTSA [UL1TR000439]; National Center for Advancing Translational Sciences (NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123767, P01HL107147, P01HL081064, R01HL113325, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University/Cleveland Clinic CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081064 and HL103453 (NHLBI). This work was also supported in part by Case Western Reserve University/Cleveland Clinic CTSA Grant UL1TR000439 and the National Center for Advancing Translational Sciences (NCATS). The authors declare that they have no conflict of interest with the contents of this article.	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Ayars AG, 2013, INT ARCH ALLERGY IMM, V161, P65, DOI 10.1159/000343031; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Comhair SAA, 2000, LANCET, V355, P624, DOI 10.1016/S0140-6736(99)04736-4; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Forteza RM, 2012, J BIOL CHEM, V287, P42288, DOI 10.1074/jbc.M112.387795; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Ghosh Sudakshina, 2012, Drug Discov Today Dis Mech, V9, pe89; Haserodt S, 2011, GLYCOBIOLOGY, V21, P175, DOI 10.1093/glycob/cwq145; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; Khatri SB, 2003, J APPL PHYSIOL, V95, P436, DOI 10.1152/japplphysiol.01127.2002; Khatri SB, 2001, AM J RESP CRIT CARE, V164, P1844, DOI 10.1164/ajrccm.164.10.2106119; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2015, METHODS MOL BIOL, V1229, P543, DOI 10.1007/978-1-4939-1714-3_42; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; SODERBERG M, 1989, INT ARCH ALLER A IMM, V88, P373, DOI 10.1159/000234719; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Westergren-Thorsson G, 2002, INT J BIOCHEM CELL B, V34, P1256, DOI 10.1016/S1357-2725(02)00058-4; Wisniewski HG, 2014, OSTEOARTHR CARTILAGE, V22, P235, DOI 10.1016/j.joca.2013.12.004; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	40	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23124	23134		10.1074/jbc.M115.663823	http://dx.doi.org/10.1074/jbc.M115.663823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26209637	Green Published, hybrid			2022-12-28	WOS:000361685500024
J	Richard-Greenblat, M; Bach, H; Adamson, J; Pena-Diaz, S; Li, W; Steyn, AJC; Av-Gay, Y				Richard-Greenblat, Melissa; Bach, Horacio; Adamson, John; Pena-Diaz, Sandra; Li, Wu; Steyn, Adrie J. C.; Av-Gay, Yossef			Regulation of Ergothioneine Biosynthesis and Its Effect on Mycobacterium tuberculosis Growth and Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; SER/THR PROTEIN-KINASE; MYCOTHIOL BIOSYNTHESIS; SMEGMATIS MUTANTS; CONIDIAL SURVIVAL; NEUROSPORA-CRASSA; PHOSPHORYLATION; GENE; TRANSPORTER; STARVATION	Ergothioneine (EGT) is synthesized in mycobacteria, but limited knowledge exists regarding its synthesis, physiological role, and regulation. We have identified Rv3701c from Mycobacterium tuberculosis to encode for EgtD, a required histidine methyltransferase that catalyzes first biosynthesis step in EGT biosynthesis. EgtD was found to be phosphorylated by the serine/ threonine protein kinase PknD. PknD phosphorylates EgtD both in vitro and in a cell-based system on Thr(213). The phosphomimetic (T213E) but not the phosphoablative (T213A) mutant of EgtD failed to restore EGT synthesis in a Delta egtD mutant. The findings together with observed elevated levels ofEGTin a pknD transposon mutant during in vitro growth suggests that EgtD phosphorylation by PknD negatively regulates EGT biosynthesis. We further showed that EGT is required in a nutrient-starved model of persistence and is needed for long term infection of murine macrophages.	[Richard-Greenblat, Melissa; Bach, Horacio; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V6H 3Z6, Canada; [Pena-Diaz, Sandra] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6H 3Z6, Canada; [Adamson, John; Steyn, Adrie J. C.] Kwazulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa; [Li, Wu] Southwest Univ, Sch Life Sci, Inst Modern Biopharmaceut, Chongqing 400715, Peoples R China; [Steyn, Adrie J. C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA; [Steyn, Adrie J. C.] Univ Alabama Birmingham, Ctr AIDS Res & Free Radical Biol, Birmingham, AL 35233 USA	University of British Columbia; University of British Columbia; Southwest University - China; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Av-Gay, Y (corresponding author), Jack Bell Res Ctr, 350-2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	yossi@mail.ubc.ca	Av-Gay, Yossef/H-5128-2019; Li, Wu/K-3792-2019	Av-Gay, Yossef/0000-0002-9547-0237; Steyn, Adrie JC/0000-0001-9177-8827; Li, Wu/0000-0002-0336-1843; Richard-Greenblatt, Melissa/0000-0001-6717-8856	British Columbia Lung Association; University of British Columbia; Friedman Scholars Program	British Columbia Lung Association; University of British Columbia; Friedman Scholars Program	This work was supported by grants from the British Columbia Lung Association (to Y. A.-G.), University of British Columbia's four-year doctoral fellowship (to M. R.-G.), and the Friedman Scholars Program (to M. R.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Bello MH, 2014, FUNGAL GENET BIOL, V73, P120, DOI 10.1016/j.fgb.2014.10.007; Bello MH, 2012, FUNGAL GENET BIOL, V49, P160, DOI 10.1016/j.fgb.2011.12.007; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Calvin M., 1954, GLUTATHIONE, P3; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Emani CS, 2013, ANTIMICROB AGENTS CH, V57, P3202, DOI 10.1128/AAC.02572-12; Fu P, 2015, ORG LETT, V17, P3046, DOI 10.1021/acs.orglett.5b01328; GENGHOF DS, 1964, J BACTERIOL, V87, P852, DOI 10.1128/JB.87.4.852-862.1964; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; Gomez-Velasco A, 2013, MICROBIOL-SGM, V159, P726, DOI 10.1099/mic.0.062067-0; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Luo DY, 2005, J PHARM SCI-US, V94, P304, DOI 10.1002/jps.20253; MELVILLE DB, 1956, J BIOL CHEM, V223, P9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller CC, 2007, ANTIMICROB AGENTS CH, V51, P3364, DOI 10.1128/AAC.00347-07; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Newton GL, 1999, BIOCHEM BIOPH RES CO, V255, P239, DOI 10.1006/bbrc.1999.0156; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Pfeiffer C, 2011, FOOD CHEM, V129, P1766, DOI 10.1016/j.foodchem.2011.06.047; Pluskal T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097774; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rawat M, 2004, J BACTERIOL, V186, P6050, DOI 10.1128/jb.186.18.6050-6058.2004; Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Rawat M, 2007, BIOCHEM BIOPH RES CO, V363, P71, DOI 10.1016/j.bbrc.2007.08.142; Reinhold VN, 1970, J BACTERIOL, V101, P881, DOI 10.1128/JB.101.3.881-884.1970; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rodriguez JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058378; Sajiki K, 2013, METABOLITES, V3, P1118, DOI 10.3390/metabo3041118; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Ung KSE, 2006, FEBS LETT, V580, P2712, DOI 10.1016/j.febslet.2006.04.026; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Vit A, 2015, CHEMBIOCHEM, V16, P119, DOI 10.1002/cbic.201402522; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zhao QF, 2015, NATURE, V518, P115, DOI 10.1038/nature14137; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	58	35	38	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23064	23076		10.1074/jbc.M115.648642	http://dx.doi.org/10.1074/jbc.M115.648642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229105	Green Published, hybrid			2022-12-28	WOS:000361685500020
J	Liu, HT; Tang, J; Du, YP; Lee, CA; Golczak, M; Muthusamy, A; Antonetti, DA; Veenstra, AA; Amengual, J; von Lintig, J; Palczewski, K; Kern, TS				Liu, Haitao; Tang, Jie; Du, Yunpeng; Lee, Chieh Allen; Golczak, Marcin; Muthusamy, Arivalagan; Antonetti, David A.; Veenstra, Alexander A.; Amengual, Jaume; von Lintig, Johannes; Palczewski, Krzysztof; Kern, Timothy S.			Retinylamine Benefits Early Diabetic Retinopathy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; endothelium; inflammation; reactive oxygen species (ROS); retina; hyperglycemia; retinal pigment epithelium; retinylamine	RETINAL ENDOTHELIAL-CELLS; INSULIN-DEPENDENT DIABETICS; MOUSE MODEL; VISUAL FUNCTION; CAPILLARY DEGENERATION; MACULAR DEGENERATION; SUPEROXIDE-DISMUTASE; ADULT RATS; VITAMIN-A; P38 MAPK	Background: The development of diabetic retinopathy (DR) is incompletely understood. Administered retinylamine is stored in the retinal pigmented epithelium (RPE) where it affects the ocular visual cycle. Results: Retinylamine inhibited vascular and neural lesions of early DR. Conclusion: Both the RPE and visual cycle are novel targets for the inhibition of DR. Significance: Vision-related processes can contribute to DR. Recent evidence suggests an important role for outer retinal cells in the pathogenesis of diabetic retinopathy (DR). Here we investigated the effect of the visual cycle inhibitor retinylamine (Ret-NH2) on the development of early DR lesions. Wild-type (WT) C57BL/6J mice (male, 2 months old when diabetes was induced) were made diabetic with streptozotocin, and some were given Ret-NH2 once per week. Lecithin-retinol acyltransferase (LRAT)-deficient mice and P23H mutant mice were similarly studied. Mice were euthanized after 2 (WT and Lrat(-/-)) and 8 months (WT) of study to assess vascular histopathology, accumulation of albumin, visual function, and biochemical and physiological abnormalities in the retina. Non-retinal effects of Ret-NH2 were examined in leukocytes treated in vivo. Superoxide generation and expression of inflammatory proteins were significantly increased in retinas of mice diabetic for 2 or 8 months, and the number of degenerate retinal capillaries and accumulation of albumin in neural retina were significantly increased in mice diabetic for 8 months compared with nondiabetic controls. Administration of Ret-NH2 once per week inhibited capillary degeneration and accumulation of albumin in the neural retina, significantly reducing diabetes-induced retinal superoxide and expression of inflammatory proteins. Superoxide generation also was suppressed in Lrat(-/-) diabetic mice. Leukocytes isolated from diabetic mice treated with Ret-NH2 caused significantly less cytotoxicity to retinal endothelial cells ex vivo than did leukocytes from control diabetics. Administration of Ret-NH2 once per week significantly inhibited the pathogenesis of lesions characteristic of early DR in diabetic mice. The visual cycle constitutes a novel target for inhibition of DR.	[Liu, Haitao; Tang, Jie; Du, Yunpeng; Lee, Chieh Allen; Veenstra, Alexander A.; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Golczak, Marcin; Amengual, Jaume; von Lintig, Johannes; Palczewski, Krzysztof; Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Muthusamy, Arivalagan; Antonetti, David A.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Kern, Timothy S.] Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Kern, TS (corresponding author), Case Western Reserve Univ, 441 Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	tsk@case.edu	Regan, Clinton/E-6250-2012; Liu, Haitao/AAY-3944-2021	Liu, Haitao/0000-0002-3757-779X; von Lintig, Johannes/0000-0002-2079-2143; antonetti, david/0000-0003-1130-6577	National Institutes of Health [EY00300, EY022938, R24 EY024864, EY023948, R24 EY021126, P30 EY011373]; Department of Veteran Affairs; NATIONAL EYE INSTITUTE [P30EY011373, R01EY023948, R24EY024864, R01EY012021, R01EY000300, R01EY022938, R24EY021126, R56EY000300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants EY00300, EY022938, and R24 EY024864 (to T. S. K.); EY023948 (to M. G.); R24 EY021126 (to K. P.), and P30 EY011373 (a core grant). This work was also supported by the Department of Veteran Affairs. K. P. and M. G. are inventors of United States Patent Number 8722669, "Compounds and Methods of Treating Ocular Disorders," and United States Patent Number 20080275134, " Methods for Treatment of Retinal Degenerative Disease," issued to Case Western Reserve University (CWRU), whose values may be affected by this publication. CWRU may license this technology for commercial development. K. P. is a member of the scientific board of Vision Medicine, Inc., involved in developing visual cycle modulators, and their values may be affected by this publication. The other authors declare that they have no conflicts of interest with the contents of this article.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Arden GB, 2012, DOC OPHTHALMOL, V124, P15, DOI 10.1007/s10633-011-9305-y; BANFORD D, 1994, OPHTHAL PHYSL OPT, V14, P339, DOI 10.1111/j.1475-1313.1994.tb00122.x; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Berkowitz BA, 2015, FASEB J, V29, P554, DOI 10.1096/fj.14-254953; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P1880, DOI 10.1167/iovs.08-2958; BRINCHMANNHANSEN O, 1993, ACTA OPHTHALMOL, V71, P230; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5561, DOI 10.1167/iovs.06-0647; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du YP, 2015, FASEB J, V29, P2194, DOI 10.1096/fj.14-269431; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golden JB, 2013, CYTOKINE, V62, P195, DOI 10.1016/j.cyto.2013.03.013; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; HAMMES HP, 1994, DIABETOLOGIA, V37, P32; HAMMES HP, 1995, DIABETOLOGIA, V38, P656, DOI 10.1007/s001250050333; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jackson GR, 2012, BRIT J OPHTHALMOL, V96, P699, DOI 10.1136/bjophthalmol-2011-300467; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kaul K, 2010, CURR DIABETES REV, V6, P294, DOI 10.2174/157339910793360851; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; Kern TS, 2010, AM J PATHOL, V176, P2550, DOI 10.2353/ajpath.2010.091062; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kern TS, 2001, DIABETES, V50, P1636, DOI 10.2337/diabetes.50.7.1636; Kern TS, 2010, OCULAR DIS MECH MANA, P506; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kowluru RA, 2000, CURR EYE RES, V21, P814, DOI 10.1076/ceyr.21.4.814.5545; Lee CA, 2014, INVEST OPHTH VIS SCI, V55, P2904, DOI 10.1167/iovs.13-11659; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Liu HT, 2015, INVEST OPHTH VIS SCI, V56, P647, DOI 10.1167/iovs.14-15220; LOVASIK JV, 1988, AM J OPTOM PHYS OPT, V65, P236; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4540, DOI 10.1167/iovs.06-0215; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4917, DOI 10.1167/iovs.09-3581; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puntel A, 2015, BIOMATERIALS, V44, P103, DOI 10.1016/j.biomaterials.2014.12.019; Puro Donald G, 2002, Trans Am Ophthalmol Soc, V100, P339; RANDOLPH RK, 1991, J BIOL CHEM, V266, P16453; Reddy VP, 2006, DRUG DISCOV TODAY, V11, P646, DOI 10.1016/j.drudis.2006.05.016; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; SCHMITT MC, 1993, BIOL REPROD, V49, P972, DOI 10.1095/biolreprod49.5.972; Su XJ, 2003, MOL VIS, V9, P171; Talahalli R, 2013, J LEUKOCYTE BIOL, V93, P135, DOI 10.1189/jlb.0112025; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thornalley PJ, 2000, BIOCHEM PHARMACOL, V60, P55, DOI 10.1016/S0006-2952(00)00287-2; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Tian P, 2013, MOL VIS, V19, P2092; Veenstra AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078405; Viberti G, 1997, LANCET, V350, P214; Wang YM, 2012, J INVEST DERMATOL, V132, P2067, DOI 10.1038/jid.2012.112; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang JY, 2015, MOL PHARMACOL, V87, P477, DOI 10.1124/mol.114.096560; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI [10.2735/3505, 10.2741/3505]; Zolfaghari R, 2002, BIOCHEM J, V368, P621, DOI 10.1042/BJ20020918; Zolfaghari R, 2002, J NUTR, V132, P1160, DOI 10.1093/jn/132.6.1160	81	37	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21568	21579		10.1074/jbc.M115.655555	http://dx.doi.org/10.1074/jbc.M115.655555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26139608	hybrid, Green Published			2022-12-28	WOS:000360637600030
J	Garcia-Belincon, M; Sanchez-Osuna, M; Martinez-Escardo, L; Granados-Colomina, C; Pascual-Guiral, S; Iglesias-Guimarais, V; Casanelles, E; Ribas, J; Yuste, VJ				Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Martinez-Escardo, Laura; Granados-Colomina, Carla; Pascual-Guiral, Sonia; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Ribas, Judit; Yuste, Victor J.			An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-APOPTOSIS SWITCH; HUMAN PROMONOCYTIC CELLS; MOLECULAR-MECHANISMS; HYDROGEN-PEROXIDE; GLUTATHIONE DEPLETION; HIPPOCAMPAL-NEURONS; DNA FRAGMENTATION; CORTICAL-NEURONS; CANCER-CELLS; IN-VITRO	Apoptosis is triggered by the activation of caspases and characterized by chromatin condensation and nuclear fragmentation (type II nuclear morphology). Necrosis is depicted by a gain in cell volume (oncosis), swelling of organelles, plasma membrane leakage, and subsequent loss of intracellular contents. Although considered as different cell death entities, there is an overlap between apoptosis and necrosis. In this sense, mounting evidence suggests that both processes can be morphological expressions of a common biochemical network known as "apoptosis-necrosis continuum." To gain insight into the events driving the apoptosis-necrosis continuum, apoptotically proficient cells were screened facing several apoptotic inducers for the absence of type II apoptotic nuclear morphologies. Chelerythrine was selected for further studies based on its cytotoxicity and the lack of apoptotic nuclear alterations. Chelerythrine triggered an early plasma membrane leakage without condensed chromatin aggregates. Ultrastructural analysis revealed that chelerythrine-mediated cytotoxicity was compatible with a necrotic-like type of cell death. Biochemically, chelerythrine induced the activation of caspases. Moreover, the inhibition of caspases prevented chelerythrine-triggered necrotic-like cell death. Compared with staurosporine, chelerythrine induced stronger caspase activation detectable at earlier times. After using a battery of chemicals, we found that high concentrations of thiolic antioxidants fully prevented chelerythrine-driven caspase activation and necrotic-like cell death. Lower amounts of thiolic antioxidants partially prevented chelerythrine-mediated cytotoxicity and allowed cells to display type II apoptotic nuclear morphology correlating with a delay in caspase-3 activation. Altogether, these data support that an early and pronounced activation of caspases can drive cells to undergo a form of necrotic-like regulated cell death.	[Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Martinez-Escardo, Laura; Granados-Colomina, Carla; Pascual-Guiral, Sonia; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death,Senescence & Survival Grp,Unit Med, E-08193 Barcelona, Spain; [Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Martinez-Escardo, Laura; Granados-Colomina, Carla; Pascual-Guiral, Sonia; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, E-08193 Barcelona, Spain; [Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenrat, E-08193 Barcelona, Spain; [Ribas, Judit] Univ Lleida, Cell Death Regulat Noncoding RNA Grp, Dept Expt Med, Inst Recerca Biomed Lleida,Pharmacol Unit, Lleida 25198, Spain	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; CIBERNED; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Ribas, Judit/B-3362-2011; Yuste, Victor J./C-7071-2008; Martínez-Escardó, Laura/AAL-6999-2021	Ribas, Judit/0000-0003-0834-2577; Yuste, Victor J./0000-0001-5322-9261; Martínez-Escardó, Laura/0000-0003-2979-4804; Pascual Guiral, Sonia/0000-0001-5791-3095	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (MICINN/FEDER) [SAF2011-24081]; Ministerio de Economia y Competitividad/FEDER Grant [SAF2012-31485]; Generalitat de Catalunya [2009-SGR-346, 2014-SGR-1609]; MICINN [BES-2009-028572, BES-2011-044769]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (MICINN/FEDER); Ministerio de Economia y Competitividad/FEDER Grant; Generalitat de Catalunya(Generalitat de Catalunya); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This work was supported in part by Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (MICINN/FEDER) Grant SAF2011-24081, Ministerio de Economia y Competitividad/FEDER Grant SAF2012-31485, and Generalitat de Catalunya Grants 2009-SGR-346 and 2014-SGR-1609. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Formacion de Personal Investigador Fellowship BES-2009-028572 from MICINN.; Recipient of Formacion de Personal Investigador Fellowship BES-2011-044769 from MICINN.; Supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya).; Supported by the Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia).	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Beyer C, 2013, AUTOIMMUNITY, V46, P298, DOI 10.3109/08916934.2012.750297; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Casanelles E, 2013, BBA-MOL CELL RES, V1833, P1085, DOI 10.1016/j.bbamcr.2013.01.014; Debiton E, 2003, CANCER CHEMOTH PHARM, V51, P474, DOI 10.1007/s00280-003-0609-9; Dursun B, 2006, AM J PHYSIOL-RENAL, V291, pF578, DOI 10.1152/ajprenal.00455.2005; Edelstein CL, 1999, J AM SOC NEPHROL, V10, P1940; FERNANDES RS, 1994, BIOCHEM PHARMACOL, V48, P675, DOI 10.1016/0006-2952(94)90044-2; Fujita R, 2003, CELL DEATH DIFFER, V10, P782, DOI 10.1038/sj.cdd.4401239; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Iglesias-Guimarais V, 2012, J BIOL CHEM, V287, P7766, DOI 10.1074/jbc.M111.290718; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lopez-Meraz ML, 2010, EPILEPSIA, V51, P56, DOI 10.1111/j.1528-1167.2010.02611.x; Lopez-Meraz ML, 2010, NEUROBIOL DIS, V37, P394, DOI 10.1016/j.nbd.2009.10.019; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meurette O, 2007, CANCER RES, V67, P218, DOI 10.1158/0008-5472.CAN-06-1610; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Niquet J, 2006, NEUROSCIENCE, V141, P77, DOI 10.1016/j.neuroscience.2006.03.073; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pena FJ, 2003, THERIOGENOLOGY, V60, P677, DOI 10.1016/S0093-691X(03)00081-5; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Radakovic-Fijan S, 1999, J INVEST DERMATOL, V112, P264, DOI 10.1046/j.1523-1747.1999.00533.x; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sanchez-Osuna M, 2014, J BIOL CHEM, V289, P18752, DOI 10.1074/jbc.M114.550020; Sancho P, 2006, APOPTOSIS, V11, P673, DOI 10.1007/s10495-006-5879-3; Schild H., 2003, MOL IMAGING BIOL, V5, P2; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200; Tschopp J., 2003, NAT IMMUNOL, V4, P416; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wan KF, 2008, J BIOL CHEM, V283, P8423, DOI 10.1074/jbc.M707687200; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Yasuhara S, 2003, J HISTOCHEM CYTOCHEM, V51, P873, DOI 10.1177/002215540305100703; Yoon S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.450; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	60	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20841	20855		10.1074/jbc.M115.644179	http://dx.doi.org/10.1074/jbc.M115.644179			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26124276	Green Published, hybrid			2022-12-28	WOS:000360011800021
J	Swisa, A; Granot, Z; Tamarina, N; Sayers, S; Bardeesy, N; Philipson, L; Hodson, DJ; Wikstrom, JD; Rutter, GA; Leibowitz, G; Glaser, B; Dor, Y				Swisa, Avital; Granot, Zvi; Tamarina, Natalia; Sayers, Sophie; Bardeesy, Nabeel; Philipson, Louis; Hodson, David J.; Wikstrom, Jakob D.; Rutter, Guy A.; Leibowitz, Gil; Glaser, Benjamin; Dor, Yuval			Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT PHOSPHORYLATION; ENERGY-METABOLISM; PANCREATIC-ISLETS; GLUTAMATE ACTS; AMPK; MTOR; AUTOPHAGY; POLARITY; PATHWAY; HYPERINSULINISM	The tumor suppressor liver kinase B1 (LKB1) is an important regulator of pancreatic beta cell biology. LKB1-dependent phosphorylation of distinct AMPK(adenosine monophosphate-activated protein kinase) family members determines proper beta cell polarity and restricts beta cell size, total beta cell mass, and glucose-stimulated insulin secretion (GSIS). However, the full spectrum of LKB1 effects and the mechanisms involved in the secretory phenotype remain incompletely understood. We report here that in the absence of LKB1 in beta cells, GSIS is dramatically and persistently improved. The enhancement is seen both in vivo and in vitro and cannot be explained by altered cell polarity, increased beta cell number, or increased insulin content. Increased secretion does require membrane depolarization and calcium influx but appears to rely mostly on a distal step in the secretion pathway. Surprisingly, enhanced GSIS is seen despite profound defects in mitochondrial structure and function in LKB1-deficient beta cells, expected to greatly diminish insulin secretion via the classic triggering pathway. Thus LKB1 is essential for mitochondrial homeostasis in beta cells and in parallel is a powerful negative regulator of insulin secretion. This study shows that beta cells can be manipulated to enhance GSIS to supra-normal levels even in the face of defective mitochondria and without deterioration over months.	[Swisa, Avital; Granot, Zvi; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Tamarina, Natalia; Philipson, Louis] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sayers, Sophie; Hodson, David J.; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol & Funct Genom, Div Diabet Endocrinol & Metab, Dept Med, London SW7 2AZ, England; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Wikstrom, Jakob D.; Leibowitz, Gil; Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel; [Wikstrom, Jakob D.] Karolinska Univ Hosp, Karolinska Inst, Unit Dermatol & Venereol, Dept Med, S-17177 Stockholm, Sweden	Hebrew University of Jerusalem; University of Chicago; Imperial College London; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Karolinska Institutet; Karolinska University Hospital	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000; Hodson, David/0000-0002-8641-8568; Rutter, Guy/0000-0001-6360-0343	National Institutes of Health (NIDDK) [P60 DK20595]; Juvenile Diabetes Research Foundation; Beta Cell Biology Consortium; Helmsley Charitable Trust; European Research Commission (European Research Council consolidator grant); BIRAX; DON foundation; Israel Science Foundation; Israel Science Foundation [41.11]; USAID American Schools and Hospitals Abroad Program; Innovative Medicines Initiative Joint Undertaking [155005]; European Union's Seventh Framework Programme (FP7); Adams foundation; Ariane de Rothschild Women Doctoral Program; DiabetesUK [BDA 12/0004431]; Svenska Sallskapet for Medicinsk Forskning (SSMF); Royal Society Wolfson Research Merit Awards; MRC Programme [MR/J0003042/1]; Diabetes UK [11/0004210]; Biotechnology and Biological Sciences Research Council [BB/J015873/1];  [WT098424AIA]; Medical Research Council [MR/K001981/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [MR/K001981/1] Funding Source: UKRI	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Beta Cell Biology Consortium; Helmsley Charitable Trust; European Research Commission (European Research Council consolidator grant); BIRAX; DON foundation; Israel Science Foundation(Israel Science Foundation); Israel Science Foundation(Israel Science Foundation); USAID American Schools and Hospitals Abroad Program(United States Agency for International Development (USAID)); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); Adams foundation; Ariane de Rothschild Women Doctoral Program; DiabetesUK(Diabetes UK); Svenska Sallskapet for Medicinsk Forskning (SSMF); Royal Society Wolfson Research Merit Awards(Royal Society of London); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant P60 DK20595 (NIDDK; to P. I. Graeme Bell). This work was also supported by grants from the Juvenile Diabetes Research Foundation, Beta Cell Biology Consortium, The Helmsley Charitable Trust, the European Research Commission (European Research Council consolidator grant), BIRAX, the DON foundation, the Israel Science Foundation, and the I-CORE Program of The Israel Science Foundation #41.11 (to Y. D.). This work was also supported in part by a grant from USAID American Schools and Hospitals Abroad Program for the upgrading of the Hebrew University Medical School Flow Cytometry laboratory. The work leading to this publication received support from the Innovative Medicines Initiative Joint Undertaking under Grant 155005 (IMIDIA), resources of which are composed of a financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution (to G. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of fellowships from the Adams foundation and the Ariane de Rothschild Women Doctoral Program.; Recipient of an R. D. Lawrence Fellowship from DiabetesUK (BDA 12/0004431).; Funded by a post-doctoral fellowship from the Svenska Sallskapet for Medicinsk Forskning (SSMF).; Supported by Wellcome Trust Senior Investigator (WT098424AIA) and Royal Society Wolfson Research Merit Awards, an MRC Programme (MR/J0003042/1), Diabetes UK (11/0004210), and Biotechnology and Biological Sciences Research Council (BB/J015873/1) project grants.	Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Dalboge LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082813; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hodson DJ, 2014, MOL ENDOCRINOL, V28, P860, DOI 10.1210/me.2014-1038; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nie J, 2013, P NATL ACAD SCI USA, V110, P13857, DOI 10.1073/pnas.1307698110; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Storto M, 2006, MOL PHARMACOL, V69, P1234, DOI 10.1124/mol.105.018390; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Ui A, 2014, ONCOGENE, V33, P1640, DOI 10.1038/onc.2013.125; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Zhou YS, 2010, J BIOL CHEM, V285, P33718, DOI 10.1074/jbc.M110.136846	70	27	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20934	20946		10.1074/jbc.M115.639237	http://dx.doi.org/10.1074/jbc.M115.639237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139601	Green Published, hybrid			2022-12-28	WOS:000360011800028
J	Cooper, DE; Young, PA; Klett, EL; Coleman, RA				Cooper, Daniel E.; Young, Pamela A.; Klett, Eric L.; Coleman, Rosalind A.			Physiological Consequences of Compartmentalized Acyl-CoA Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FATTY-ACID-METABOLISM; BROWN ADIPOSE-TISSUE; SYNTHETASE MESSENGER-RNA; CARNITINE PALMITOYLTRANSFERASE; BINDING-PROTEIN; LIPID DROPLETS; PPAR-ALPHA; TRIACYLGLYCEROL SYNTHESIS; TRANSPORT PROTEIN-1; MUSCLE GLYCOGEN	Meeting the complex physiological demands of mammalian life requires strict control of the metabolism of long-chain fatty acyl-CoAs because of the multiplicity of their cellular functions. Acyl-CoAs are substrates for energy production; stored within lipid droplets as triacylglycerol, cholesterol esters, and retinol esters; esterified to form membrane phospholipids; or used to activate transcriptional and signaling pathways. Indirect evidence suggests that acyl-CoAs do not wander freely within cells, but instead, are channeled into specific pathways. In this review, we will discuss the evidence for acyl-CoA compartmentalization, highlight the key modes of acyl-CoA regulation, and diagram potential mechanisms for controlling acyl-CoA partitioning.	[Cooper, Daniel E.; Young, Pamela A.; Klett, Eric L.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Klett, Eric L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, 2301 Michael Hooker Res Ctr,Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu		Klett, Eric/0000-0002-8000-6810	National Institutes of Health [DK56598, DK59935, K08 DK090141]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090141, R01DK056598, R01DK059935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56598 and DK59935 (to R. A. C.) and K08 DK090141 (to E. L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chang YS, 2011, J CELL BIOCHEM, V112, P881, DOI 10.1002/jcb.22996; CHENG BL, 1994, J LIPID RES, V35, P1115; Cohen DE, 2013, ADIPOCYTE, V2, P3, DOI 10.4161/adip.21853; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Frahm Jennifer L, 2011, J Proteomics Bioinform, V4, P129; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Goetzman ES, 2011, PROG MOL BIOL TRANSL, V100, P389, DOI 10.1016/B978-0-12-384878-9.00010-8; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hornemann T, 2015, J INHERIT METAB DIS, V38, P179, DOI 10.1007/s10545-014-9753-0; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; Jacome-Sosa MM, 2014, CURR OPIN LIPIDOL, V25, P213, DOI 10.1097/MOL.0000000000000080; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; Johnsson N, 2014, BIOCHEM BIOPH RES CO, V445, P739, DOI 10.1016/j.bbrc.2014.02.023; Kan CFK, 2015, BBA-MOL CELL BIOL L, V1851, P577, DOI 10.1016/j.bbalip.2015.01.008; Kan CFK, 2014, J LIPID RES, V55, P1657, DOI 10.1194/jlr.M045971; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kanter JE, 2013, TRENDS ENDOCRIN MET, V24, P137, DOI 10.1016/j.tem.2012.10.002; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kawano Y, 2014, MOL CELL BIOL, V34, P2396, DOI 10.1128/MCB.01601-13; Khaibullina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048733; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Klett EL, 2013, J BIOL CHEM, V288, P21618, DOI 10.1074/jbc.M113.481077; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Kuch EM, 2014, BBA-MOL CELL BIOL L, V1841, P227, DOI 10.1016/j.bbalip.2013.10.018; Kuwata H, 2014, BBA-MOL CELL BIOL L, V1841, P44, DOI 10.1016/j.bbalip.2013.09.015; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Lee RG, 2000, J LIPID RES, V41, P1991; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Li X, 2013, ARTERIOSCL THROM VAS, V33, P232, DOI 10.1161/ATVBAHA.112.252239; Liu Y, 2008, BBA-MOL CELL BIOL L, V1781, P97, DOI 10.1016/j.bbalip.2008.01.001; Maheshwari S, 2015, BRIEF BIOINFORM, V16, P1025, DOI 10.1093/bib/bbv009; Marszalek JR, 2005, J BIOL CHEM, V280, P10817, DOI 10.1074/jbc.M411750200; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Neess D, 2013, CELL REP, V5, P1403, DOI 10.1016/j.celrep.2013.11.010; Ning J, 2011, AM J PHYSIOL-ENDOC M, V301, pE391, DOI 10.1152/ajpendo.00164.2011; Ong KT, 2014, J LIPID RES, V55, P808, DOI 10.1194/jlr.M039867; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Poppelreuther M, 2012, J LIPID RES, V53, P888, DOI 10.1194/jlr.M024562; Qi JS, 2012, J LIPID RES, V53, P1106, DOI 10.1194/jlr.M020156; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Rubinow KB, 2013, J BIOL CHEM, V288, P9957, DOI 10.1074/jbc.M113.458372; Rufer AC, 2009, CELL MOL LIFE SCI, V66, P2489, DOI 10.1007/s00018-009-0035-1; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Talukder MMU, 2015, MOL METAB, V4, P199, DOI 10.1016/j.molmet.2014.12.013; Tuohetahuntila M, 2015, BBA-MOL CELL BIOL L, V1851, P220, DOI 10.1016/j.bbalip.2014.12.003; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolkart G, 2012, BRIT J PHARMACOL, V165, P380, DOI 10.1111/j.1476-5381.2011.01490.x; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087; Zhao H, 2015, J BIOL CHEM, V290, P6705, DOI 10.1074/jbc.M114.628701	100	46	48	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20023	20031		10.1074/jbc.R115.663260	http://dx.doi.org/10.1074/jbc.R115.663260			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124277	hybrid, Green Published			2022-12-28	WOS:000359608900002
J	Lupton, CJ; Steer, DL; Wintrode, PL; Bottomley, SP; Hughes, VA; Ellisdon, AM				Lupton, Christopher J.; Steer, David L.; Wintrode, Patrick L.; Bottomley, Stephen P.; Hughes, Victoria A.; Ellisdon, Andrew M.			Enhanced Molecular Mobility of Ordinarily Structured Regions Drives Polyglutamine Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACHADO-JOSEPH-DISEASE; PROTEIN AGGREGATION; MASS-SPECTROMETRY; FUNCTIONAL INTERACTIONS; HYDROGEN-EXCHANGE; MUTANT HUNTINGTIN; ATAXIN-3; DOMAIN; PATHOGENESIS; DETERMINANTS	Polyglutamine expansion is a hallmark of nine neurodegenerative diseases, with protein aggregation intrinsically linked to disease progression. Although polyglutamine expansion accelerates protein aggregation, the misfolding process is frequently instigated by flanking domains. For example, polyglutamine expansion in ataxin-3 allosterically triggers the aggregation of the catalytic Josephin domain. The molecular mechanism that underpins this allosteric aggregation trigger remains to be determined. Here, we establish that polyglutamine expansion increases the molecular mobility of two juxtaposed helices critical to ataxin-3 deubiquitinase activity. Within one of these helices, we identified a highly amyloidogenic sequence motif that instigates aggregation and forms the core of the growing fibril. Critically, by mutating residues within this key region, we decrease local structural fluctuations to slow ataxin-3 aggregation. This provides significant insight, down to the molecular level, into how polyglutamine expansion drives aggregation and explains the positive correlation between polyglutamine tract length, protein aggregation, and disease severity.	[Lupton, Christopher J.; Steer, David L.; Bottomley, Stephen P.; Hughes, Victoria A.; Ellisdon, Andrew M.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Hughes, Victoria A.] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic 3800, Australia; [Wintrode, Patrick L.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Monash University; Monash University; University System of Maryland; University of Maryland Baltimore	Hughes, VA (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia.	victoria.hughes@monash.edu; andrew.ellisdon@monash.edu		Lupton, Christopher Joseph/0000-0002-4617-4853; Ellisdon, Andrew/0000-0002-2248-9914	National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council, Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Cushman-Nick M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003781; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; He XH, 2010, NEUROSCI BULL, V26, P247, DOI 10.1007/s12264-010-0113-2; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Masino L, 2011, BIOPHYS J, V100, P2033, DOI 10.1016/j.bpj.2011.02.056; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Matos CA, 2011, PROG NEUROBIOL, V95, P26, DOI 10.1016/j.pneurobio.2011.06.007; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Scarff CA, 2015, MOL CELL PROTEOMICS, V14, P1241, DOI 10.1074/mcp.M114.044610; Scarff CA, 2013, INT J MASS SPECTROM, V345, P63, DOI 10.1016/j.ijms.2012.08.032; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Todd TW, 2013, MOL CELLS, V36, P185, DOI 10.1007/s10059-013-0167-x; Tsutsui Y, 2006, BIOCHEMISTRY-US, V45, P6561, DOI 10.1021/bi060431f; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Weeks SD, 2011, J BIOL CHEM, V286, P4555, DOI 10.1074/jbc.M110.177360; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	45	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24190	24200		10.1074/jbc.M115.659532	http://dx.doi.org/10.1074/jbc.M115.659532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26260925	Green Published, hybrid			2022-12-28	WOS:000362218900012
J	Takata, K; Tomida, J; Reh, S; Swanhart, LM; Takata, M; Hukriede, NA; Wood, RD				Takata, Kei-ichi; Tomida, Junya; Reh, Shelley; Swanhart, Lisa M.; Takata, Minoru; Hukriede, Neil A.; Wood, Richard D.			Conserved Overlapping Gene Arrangement, Restricted Expression, and Biochemical Activities of DNA Polymerase nu (POLN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVITY PROTEIN MUS308; UNIQUE ERROR SIGNATURE; CROSS-LINK REPAIR; LOW FIDELITY; MASS-SPECTROMETRY; FANCONI-ANEMIA; DAMAGE; BYPASS; EFFICIENCY; COMPLEXES	DNA polymerase nu (POLN) is one of 16 DNA polymerases encoded in vertebrate genomes. It is important to determine its gene expression patterns, biological roles, and biochemical activities. By quantitative analysis of mRNA expression, we found that POLN from the zebrafish Danio rerio is expressed predominantly in testis. POLN is not detectably expressed in zebrafish embryos or in mouse embryonic stem cells. Consistent with this, injection of POLN-specific morpholino antisense oligonucleotides did not interfere with zebrafish embryonic development. Analysis of transcripts revealed that vertebrate POLN has an unusual gene expression arrangement, sharing a first exon with HAUS3, the gene encoding augmin-like complex subunit 3. HAUS3 is broadly expressed in embryonic and adult tissues, in contrast to POLN. Differential expression of POLN and HAUS3 appears to arise by alternate splicing of transcripts in mammalian cells and zebrafish. When POLN was ectopically overexpressed in human cells, it specifically coimmunoprecipitated with the homologous recombination factors BRCA1 and FANCJ, but not with previously suggested interaction partners (HELQ and members of the Fanconi anemia core complex). Purified zebrafish POLN protein is capable of thymine glycol bypass and strand displacement, with activity dependent on a basic amino acid residue known to stabilize the primer-template. These properties are conserved with the human enzyme. Although the physiological function of pol nu remains to be clarified, this study uncovers distinctive aspects of its expression control and evolutionarily conserved properties of this DNA polymerase.	[Takata, Kei-ichi; Tomida, Junya; Reh, Shelley; Wood, Richard D.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, POB 389, Smithville, TX 78957 USA; [Takata, Kei-ichi; Tomida, Junya; Reh, Shelley; Wood, Richard D.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Swanhart, Lisa M.; Hukriede, Neil A.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15213 USA; [Takata, Minoru] Kyoto Univ, Dept Late Effects Studies, Ctr Radiat Biol, Lab DNA Damage Signaling, Kyoto 6068501, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyoto University	Takata, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, POB 389, Smithville, TX 78957 USA.	ktakata@mdanderson.org	Takata, Minoru/K-3772-2019; Wood, Richard D/M-6319-2018; Regan, Clinton/E-6250-2012	Wood, Richard D/0000-0002-9495-6892; Takata, Minoru/0000-0002-4926-3675; Tomida, Junya/0000-0002-0813-5757; Takata, Kei-ichi/0000-0002-8272-3397	National Institutes of Health [P01 CA097175, P30 ES007784]; MD Anderson Research Trust; Grady F. Saunders Ph.D. Distinguished Research Professorship; CPRIT [RP110782]; University of Texas MD Anderson Cancer Center Institutional Research Grant (IRG); Center for Radiation Oncology Research; NATIONAL CANCER INSTITUTE [P01CA097175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Research Trust; Grady F. Saunders Ph.D. Distinguished Research Professorship; CPRIT; University of Texas MD Anderson Cancer Center Institutional Research Grant (IRG); Center for Radiation Oncology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA097175 and P30 ES007784. This work was also supported by the MD Anderson Research Trust and the Grady F. Saunders Ph.D. Distinguished Research Professorship (to R. D. W.), CPRIT Grant RP110782 (to Maria D. Person), The University of Texas MD Anderson Cancer Center Institutional Research Grant (IRG), and Center for Radiation Oncology Research (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adelman CA, 2013, NATURE, V502, P381, DOI 10.1038/nature12565; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Arana ME, 2011, BIOCHEMISTRY-US, V50, P10126, DOI 10.1021/bi201197p; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Broering TJ, 2014, J CELL BIOL, V205, P663, DOI 10.1083/jcb.201311050; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Ching YH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-106; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Gowda ASP, 2015, J BIOL CHEM, V290, P16292, DOI 10.1074/jbc.M115.653287; Guo R, 2009, METHODS, V48, P72, DOI 10.1016/j.ymeth.2009.02.011; Harris PV, 1996, MOL CELL BIOL, V16, P5764; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kawamura K, 2001, INT J ONCOL, V18, P97; Kohzaki M, 2010, J CELL BIOL, V189, P1117, DOI 10.1083/jcb.200912012; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee YS, 2015, NAT STRUCT MOL BIOL, V22, P298, DOI 10.1038/nsmb.2985; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Luebben SW, 2013, NUCLEIC ACIDS RES, V41, P10283, DOI 10.1093/nar/gkt676; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Roy B, 2013, CURR GENOMICS, V14, P182, DOI 10.2174/1389202911314030004; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shima N, 2004, MOL CELL BIOL, V24, P10381, DOI 10.1128/MCB.24.23.10381-10389.2004; Suzuki M, 1996, P NATL ACAD SCI USA, V93, P9670, DOI 10.1073/pnas.93.18.9670; Suzuki M, 1997, J BIOL CHEM, V272, P11228; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Wang B, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-6; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zietlow L, 2009, BIOCHEMISTRY-US, V48, P11817, DOI 10.1021/bi9015346	50	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24278	24293		10.1074/jbc.M115.677419	http://dx.doi.org/10.1074/jbc.M115.677419			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269593	hybrid, Green Published			2022-12-28	WOS:000362218900019
J	Van Dang, H; Sakai, T; Pham, TA; Tran, DH; Yorita, K; Shishido, Y; Fukui, K				Van Dang, Huy; Sakai, Takashi; Pham, Tuan Anh; Tran, Diem Hong; Yorita, Kazuko; Shishido, Yuji; Fukui, Kiyoshi			Nucling, a Novel Apoptosis-associated Protein, Controls Mammary Gland Involution by Regulating NF-kappa B and STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL DEATH; BREAST-CANCER; SIGNAL TRANSDUCER; EXPRESSION; MICE; PATHWAY; DIFFERENTIATION; SUPPRESSION; REGRESSION; KNOCKOUT	Postpartum mammary gland involution is the physiological process by which the lactating gland returns to its pre-pregnant state. In rodent models, the microenvironment of mammary gland involution is sufficient to induce enhanced tumor cell growth, local invasion, and metastasis. Therefore, a deeper understanding of the physiological regulation of involution may provide in-depth information on breast cancer therapy. We herein identified Nucling as an important regulator of involution of the mammary gland. Aknock-out mouse model was generated and revealed that postpartum involution were impaired in mice lacking Nucling. Involution is normally associated with an increase in the activation of NF-kappa B and STAT3, which is required for the organized regulation of involution, and was observed in WT glands, but not in the absence of Nucling. Furthermore, the loss of Nucling led to the suppression of Calpain-1, IL-6, and C/EBP delta factors, which are known to be essential for normal involution. The number of M2 macrophages, which are crucial for epithelial cell death and adipocyte repopulation after weaning, was also reduced in Nucling-KO glands. Taken together, the results of the present study demonstrated that Nucling played an important role in mammary gland involution by regulating NF-kappa B and STAT3 signaling pathways.	[Van Dang, Huy; Sakai, Takashi; Pham, Tuan Anh; Tran, Diem Hong; Yorita, Kazuko; Shishido, Yuji; Fukui, Kiyoshi] Univ Tokushima, Inst Enzyme Res, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan	Tokushima University	Fukui, K (corresponding author), Univ Tokushima, Inst Enzyme Res, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	kiyo.fukui@tokushirna-u.ac.jp	Tran, Diem/L-5508-2019; Tran, Diem/P-3103-2016	Tran, Diem/0000-0003-3612-1464; Tran, Diem/0000-0003-3612-1464	Japan Society for the Promotion of Science [25460388]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (25460388) from the Japan Society for the Promotion of Science. The authors declare no conflict of interest.	Ackler S, 2002, ONCOGENE, V21, P198, DOI 10.1038/sj.onc.1205052; Arnandis T, 2012, CELL DEATH DIFFER, V19, P1536, DOI 10.1038/cdd.2012.46; Atabai K, 2007, J MAMMARY GLAND BIOL, V12, P37, DOI 10.1007/s10911-007-9036-6; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Bertucci PY, 2010, ENDOCRINOLOGY, V151, P5730, DOI 10.1210/en.2010-0517; Brantley DM, 2000, MECH DEVELOP, V97, P149, DOI 10.1016/S0925-4773(00)00405-6; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Connelly L, 2010, J CELL PHYSIOL, V222, P73, DOI 10.1002/jcp.21922; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fornetti J, 2014, J MAMMARY GLAND BIOL, V19, P213, DOI 10.1007/s10911-014-9322-z; Hughes K, 2012, J PATHOL, V227, P106, DOI 10.1002/path.3961; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Kim SM, 2013, J BIOCHEM, V153, P93, DOI 10.1093/jb/mvs119; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Liu L, 2004, BIOCHEM J, V380, P31, DOI 10.1042/BJ20031300; Liu L, 2009, FEBS J, V276, P1459, DOI 10.1111/j.1742-4658.2009.06888.x; Lund LR, 1996, DEVELOPMENT, V122, P181; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Nam HT, 2010, J BIOCHEM, V148, P573, DOI 10.1093/jb/mvq089; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Oida K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04057; Radisky DC, 2009, J MAMMARY GLAND BIOL, V14, P181, DOI 10.1007/s10911-009-9123-y; Resemann HK, 2014, MOL CELL ENDOCRINOL, V382, P603, DOI 10.1016/j.mce.2013.06.029; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200; Sakai T, 2003, J BIOCHEM, V133, P429, DOI 10.1093/jb/mvg056; Sakai T, 2006, SEIKAGAKU, V78, P867; Sakai T, 2010, INT J CANCER, V126, P1079, DOI 10.1002/ijc.24789; Schedin P, 2000, J CELL SCI, V113, P795; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; Scribner KC, 2011, MOL ENDOCRINOL, V25, P635, DOI 10.1210/me.2010-0423; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Teng XC, 2006, J NEUROCHEM, V97, P1126, DOI 10.1111/j.1471-4159.2006.03833.x; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Zhao L, 2004, J BIOL CHEM, V279, P44093, DOI 10.1074/jbc.M313131200; Zhao L, 2002, MOL ENDOCRINOL, V16, P2902, DOI 10.1210/me.2001-0330	41	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24626	24635		10.1074/jbc.M115.673848	http://dx.doi.org/10.1074/jbc.M115.673848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269594	hybrid, Green Published			2022-12-28	WOS:000362218900045
J	Pizzolato, J; Mukherjee, S; Scharer, OD; Jiricny, J				Pizzolato, Julia; Mukherjee, Shivam; Schaerer, Orlando D.; Jiricny, Josef			FANCD2-associated Nuclease 1, but Not Exonuclease 1 or Flap Endonuclease 1, Is Able to Unhook DNA Interstrand Cross-links in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMIA-ASSOCIATED NUCLEASE; STALLED REPLICATION FORKS; FANCONI-ANEMIA; REPAIR; FAN1; KIAA1018/FAN1; MECHANISM; CELLS; IDENTIFICATION; MUTATIONS	Cisplatin and its derivatives, nitrogen mustards and mitomycin C, are used widely in cancer chemotherapy. Their efficacy is linked primarily to their ability to generate DNA interstrand cross-links (ICLs), which effectively block the progression of transcription and replication machineries. Release of this block, referred to as unhooking, has been postulated to require endonucleases that incise one strand of the duplex on either side of the ICL. Here we investigated how the 5' flap nucleases FANCD2-associated nuclease 1 (FAN1), exonuclease 1 (EXO1), and flap endonuclease 1 (FEN1) process a substrate reminiscent of a replication fork arrested at an ICL. We now show that EXO1 and FEN1 cleaved the substrate at the boundary between the single-stranded 5' flap and the duplex, whereas FAN1 incised it three to four nucleotides in the double-stranded region. This affected the outcome of processing of a substrate containing a nitrogen mustard-like ICL two nucleotides in the duplex region because FAN1, unlike EXO1 and FEN1, incised the substrate predominantly beyond the ICL and, therefore, failed to release the 5' flap. We also show that FAN1 was able to degrade a linear ICL substrate. This ability of FAN1 to traverse ICLs in DNA could help to elucidate its biological function, which is currently unknown.	[Pizzolato, Julia; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Jiricny, Josef] Swiss Inst Technol ETH Zurich, Dept Biol, CH-8057 Zurich, Switzerland; [Mukherjee, Shivam; Schaerer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch	Schärer, Orlando D./AAF-8613-2021; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715	Swiss National Science Foundation [310030B-133123, 31003A-149989]; Advanced ERC Grant MIRIAM; University of Zurich; NATIONAL CANCER INSTITUTE [R01CA165911] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced ERC Grant MIRIAM; University of Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Swiss National Science Foundation Grants 310030B-133123 and 31003A-149989 and by Advanced ERC Grant MIRIAM (to J. J.). Funding for open access charge was from the University of Zurich. The authors declare that they have no conflicts of interest with the contents of this article.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bregenhorn S, 2014, NUCLEIC ACIDS RES, V42, P7096, DOI 10.1093/nar/gku419; Chaudhury I, 2014, MOL CELL BIOL, V34, P3939, DOI 10.1128/MCB.00457-14; Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Fontebasso Y, 2013, DNA REPAIR, V12, P1011, DOI 10.1016/j.dnarep.2013.10.003; Guainazzi A, 2010, CHEM-EUR J, V16, P12100, DOI 10.1002/chem.201002041; Gwon GH, 2014, GENE DEV, V28, P2276, DOI 10.1101/gad.248492.114; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mukherjee S, 2014, NUCLEIC ACIDS RES, V42, P7429, DOI 10.1093/nar/gku328; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Nair N, 2014, DNA REPAIR, V24, P131, DOI 10.1016/j.dnarep.2014.08.004; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Pennell S, 2014, CELL REP, V8, P84, DOI 10.1016/j.celrep.2014.06.001; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018; Zhao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6726; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	37	29	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22602	22611		10.1074/jbc.M115.663666	http://dx.doi.org/10.1074/jbc.M115.663666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221031	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000361171500026
J	Radhakrishnan, R; Li, YX; Xiang, SY; Yuan, FH; Yuan, ZG; Telles, E; Fang, J; Coppola, D; Shibata, D; Lane, WS; Zhang, YB; Zhang, XH; Seto, E				Radhakrishnan, Rangasudhagar; Li, Yixuan; Xiang, Shengyan; Yuan, Fenghua; Yuan, Zhigang; Telles, Elphine; Fang, Jia; Coppola, Domenico; Shibata, David; Lane, William S.; Zhang, Yanbin; Zhang, Xiaohong; Seto, Edward			Histone Deacetylase 10 Regulates DNA Mismatch Repair and May Involve the Deacetylation of MutS Homolog 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; DAMAGE RESPONSE; PROTEIN; ALPHA; CELLS; CANCER; MSH2; INHIBITION; CHROMATIN; DEFECTS	MutS homolog 2 (MSH2) is an essential DNA mismatch repair (MMR) protein. It interacts with MSH6 or MSH3 to form the MutS alpha or MutS beta complex, respectively, which recognize base-base mispairs and insertions/deletions and initiate the repair process. Mutation or dysregulation of MSH2 causes genomic instability that can lead to cancer. MSH2 is acetylated at its C terminus, and histone deacetylase (HDAC6) deacetylates MSH2. However, whether other regions of MSH2 can be acetylated and whether other histone deacetylases (HDACs) and histone acetyltransferases (HATs) are involved in MSH2 deacetylation/acetylation is unknown. Here, we report that MSH2 can be acetylated at Lys-73 near the N terminus. Lys-73 is highly conserved across many species. Although several Class I and II HDACs interact with MSH2, HDAC10 is the major enzyme that deacetylates MSH2 at Lys-73. Histone acetyltransferase HBO1 might acetylate this residue. HDAC10 overexpression in HeLa cells stimulates cellular DNA MMR activity, whereas HDAC10 knockdown decreases DNA MMR activity. Thus, our study identifies an HDAC10-mediated regulatory mechanism controlling the DNA mismatch repair function of MSH2.	[Radhakrishnan, Rangasudhagar; Li, Yixuan; Yuan, Zhigang; Telles, Elphine; Fang, Jia; Zhang, Xiaohong; Seto, Edward] Dept Mol Oncol, Tampa, FL 33612 USA; [Coppola, Domenico; Shibata, David] Dept Gastroenterol, Tampa, FL 33612 USA; [Coppola, Domenico; Shibata, David] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Xiang, Shengyan; Zhang, Xiaohong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Yuan, Fenghua; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Lane, William S.] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Miami; Harvard University	Zhang, XH (corresponding author), USF Morsani Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	xzhang1@health.usf.edu; ed.seto@moffitt.org	li, yixuan/P-5376-2016; radhakrishnan, rangasudhagar/B-8557-2016; Regan, Clinton/E-6250-2012; XIANG, SHENGYAN/C-3176-2013; Zhang, Yanbin/F-2998-2011	radhakrishnan, rangasudhagar/0000-0001-6616-8525; XIANG, SHENGYAN/0000-0002-6940-3559; Zhang, Yanbin/0000-0002-7263-5510; Fang, Jia/0000-0001-8583-1652; Li, Yixuan/0000-0002-3550-8192	National Institutes of Health [R01CA169210, R01HL105631]; Bank-head Coley Biomedical Research Program; NATIONAL CANCER INSTITUTE [R01CA172774, R01CA169210] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bank-head Coley Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Health grants R01CA169210 (to E. S.) and R01HL105631 (to Y. Z.), an endowment from the Kaul Foundation (to E. S.), and a postdoctoral fellowship from the Bank-head Coley Biomedical Research Program (to R. R.) The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Hafiz HA, 2014, J STEROID BIOCHEM, V140, P80, DOI 10.1016/j.jsbmb.2013.12.008; Christmann M, 2002, NUCLEIC ACIDS RES, V30, P1959, DOI 10.1093/nar/30.9.1959; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Fink D, 1998, CLIN CANCER RES, V4, P1; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gu Liya, 2012, Methods Mol Biol, V920, P135, DOI 10.1007/978-1-61779-998-3_10; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Smith JA, 2007, MOL CELL BIOL, V27, P7816, DOI 10.1128/MCB.00455-07; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0044596, 10.1371/journal.pone.0045491]; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan Fenghua, 2012, Methods Mol Biol, V920, P149, DOI 10.1007/978-1-61779-998-3_11; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	29	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22795	22804		10.1074/jbc.M114.612945	http://dx.doi.org/10.1074/jbc.M114.612945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221039	Green Published, hybrid			2022-12-28	WOS:000361171500042
J	Thiemann, S; Man, JH; Chang, MH; Lee, B; Baum, LG				Thiemann, Sandra; Man, Jeanette H.; Chang, Margaret H.; Lee, Benhur; Baum, Linda G.			Galectin-1 Regulates Tissue Exit of Specific Dendritic Cell Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHATIC ENDOTHELIUM; O-GLYCANS; IN-VIVO; T-CELLS; DIFFERENTIAL GLYCOSYLATION; LEUKOCYTE TRAFFICKING; MEMBRANE TRAFFICKING; EXTRACELLULAR-MATRIX; LYMPHOMA-CELLS; EMERGING ROLE	During inflammation, dendritic cells emigrate from inflamed tissue across the lymphatic endothelium into the lymphatic vasculature and travel to regional lymph nodes to initiate immune responses. However, the processes that regulate dendritic cell tissue egress and migration across the lymphatic endothelium are not well defined. The mammalian lectin galectin-1 is highly expressed by vascular endothelial cells in inflamed tissue and has been shown to regulate immune cell tissue entry into inflamed tissue. Here, we show that galectin-1 is also highly expressed by human lymphatic endothelial cells, and deposition of galectin-1 in extracellular matrix selectively regulates migration of specific human dendritic cell subsets. The presence of galectin-1 inhibits migration of immunogenic dendritic cells through the extracellular matrix and across lymphatic endothelial cells, but it has no effect on migration of tolerogenic dendritic cells. The major galectin-1 counter-receptor on both dendritic cell populations is the cell surface mucin CD43; differential core 2 O-glycosylation of CD43 between immunogenic dendritic cells and tolerogenic dendritic cells appears to contribute to the differential effect of galectin-1 on migration. Binding of galectin-1 to immunogenic dendritic cells reduces phosphorylation and activity of the protein-tyrosine kinase Pyk2, an effect that may also contribute to reduced migration of this subset. In a murine lymphedema model, galectin-1(-/-) animals had increased numbers of migratory dendritic cells in draining lymph nodes, specifically dendritic cells with an immunogenic phenotype. These findings define a novel role for galectin-1 in inhibiting tissue emigration of immunogenic, but not tolerogenic, dendritic cells, providing an additional mechanism by which galectin-1 can dampen immune responses.	[Thiemann, Sandra; Man, Jeanette H.; Lee, Benhur; Baum, Linda G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Chang, Margaret H.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lee, Benhur] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai	Baum, LG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu	Lee, Benhur/A-8554-2016; Regan, Clinton/E-6250-2012	Lee, Benhur/0000-0003-0760-1709; 	National Institutes of Health [R21HL102989]; Ruth L. Kirschstein National Research Award [T32 CA 009120, AI-28697, CA-16042]; Mizutani Glycoscience Foundation [120083]; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096392, R21HL102989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Glycoscience Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21HL102989, Ruth L. Kirschstein National Research Award T32 CA 009120 (to S.T.), Grant AI-28697 (to the Center for AIDS Research Virology Core Laboratory), and Grants CA-16042 and AI-28697 (to the Jonsson Comprehensive Cancer Center and Center for AIDS Research Flow Cytometry Core Facility). This work was also supported by Mizutani Glycoscience Foundation Research Grant 120083 (to L.G.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed H, 1996, J BIOCHEM, V120, P1007; Akbari O, 1999, J EXP MED, V189, P169, DOI 10.1084/jem.189.1.169; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; Balatoni CE, 2009, AM J PATHOL, V175, P1653, DOI 10.2353/ajpath.2009.090091; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAUM LG, 1995, GLYCOCONJUGATE J, V12, P63, DOI 10.1007/BF00731870; Baum LG, 2003, CLIN IMMUNOL, V109, P295, DOI 10.1016/j.clim.2003.08.003; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; Breiteneder-Geleff S, 1999, Verh Dtsch Ges Pathol, V83, P270; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Card CM, 2014, J CLIN INVEST, V124, P943, DOI 10.1172/JCI73316; CARLSSON SR, 1986, J BIOL CHEM, V261, P2779; Cattaneo V, 2014, GLYCOBIOLOGY, V24, P966, DOI 10.1093/glycob/cwu060; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cheng DE, 2014, BBA-GEN SUBJECTS, V1840, P1965, DOI 10.1016/j.bbagen.2014.01.026; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Clement CC, 2013, J PROTEOMICS, V78, P172, DOI 10.1016/j.jprot.2012.11.013; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Delacour D, 2008, J CELL SCI, V121, P458, DOI 10.1242/jcs.020800; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Erbacher A, 2009, HUM IMMUNOL, V70, P308, DOI 10.1016/j.humimm.2009.02.005; Fautsch MP, 2003, EXP EYE RES, V77, P11, DOI 10.1016/S0014-4835(03)00107-6; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; Gandhi MK, 2007, BLOOD, V110, P1326, DOI 10.1182/blood-2007-01-066100; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Gil CD, 2006, INFLAMM RES, V55, P99, DOI 10.1007/s00011-005-0059-4; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Ilarregui JM, 2010, NEUROIMMUNOMODULAT, V17, P157, DOI 10.1159/000258712; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Iqbal AJ, 2013, J IMMUNOL, V191, P171, DOI 10.4049/jimmunol.1203291; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu Fu-Tong, 2002, Expert Opin Ther Targets, V6, P461, DOI 10.1517/14728222.6.4.461; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Luo YC, 2014, P NATL ACAD SCI USA, V111, P15178, DOI 10.1073/pnas.1416714111; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Maquoi E, 1997, PLACENTA, V18, P433, DOI 10.1016/S0143-4004(97)80044-6; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Moiseeva EP, 1999, J VASC RES, V36, P47, DOI 10.1159/000025625; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Moreau A, 2012, EUR J IMMUNOL, V42, P2881, DOI 10.1002/eji.201142325; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Mukasa R, 1999, INT IMMUNOL, V11, P259, DOI 10.1093/intimm/11.2.259; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Ohtsubo K, 2013, BIOCHEM BIOPH RES CO, V434, P346, DOI 10.1016/j.bbrc.2013.03.076; OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pace KE, 2002, GLYCOCONJUGATE J, V19, P607, DOI 10.1023/B:GLYC.0000014092.86763.2f; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Perone MJ, 2006, J IMMUNOL, V176, P7207, DOI 10.4049/jimmunol.176.12.7207; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; POIRIER F, 1993, DEVELOPMENT, V119, P1229; QUN Z, 1993, ARCH BIOCHEM BIOPHYS, V300, P6, DOI 10.1006/abbi.1993.1002; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2000, EUR J IMMUNOL, V30, P1331, DOI 10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.3.CO;2-8; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Randolph GJ, 2005, SPRINGER SEMIN IMMUN, V26, P273, DOI 10.1007/s00281-004-0168-0; Renkawitz J, 2010, EMBO REP, V11, P744, DOI 10.1038/embor.2010.147; Rhee I, 2014, MOL CELL BIOL, V34, P888, DOI 10.1128/MCB.01369-13; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Russo E, 2013, LYMPHAT RES BIOL, V11, P172, DOI 10.1089/lrb.2013.0008; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; SMITH JB, 1970, J ANAT, V107, P87; Sparwasser T, 2000, EUR J IMMUNOL, V30, P3591, DOI 10.1002/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J; Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; STROSS WP, 1989, J CLIN PATHOL, V42, P953, DOI 10.1136/jcp.42.9.953; Svajger U, 2010, INT REV IMMUNOL, V29, P574, DOI 10.3109/08830185.2010.522280; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Tanikawa R, 2008, J BONE MINER RES, V23, P278, DOI 10.1359/JBMR.071008; Teijeira A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00433; Thiemann S, 2015, METHODS MOL BIOL, V1207, P215, DOI 10.1007/978-1-4939-1396-1_14; Thiemann S, 2011, J CLIN IMMUNOL, V31, P2, DOI 10.1007/s10875-010-9460-z; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Walzel H, 2006, GLYCOBIOLOGY, V16, P1262, DOI 10.1093/glycob/cwl037; Wollina U, 1999, HISTOL HISTOPATHOL, V14, P779, DOI 10.14670/HH-14.779; Wright RD, 2014, GLYCOBIOLOGY, V24, P1242, DOI 10.1093/glycob/cwu101; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	147	32	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22662	22677		10.1074/jbc.M115.644799	http://dx.doi.org/10.1074/jbc.M115.644799			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216879	Green Published, hybrid			2022-12-28	WOS:000361171500031
J	Borisova, AS; Isaksen, T; Dimarogona, M; Kognole, AA; Mathiesen, G; Varnai, A; Rohr, AK; Payne, CM; Sorlie, M; Sandgren, M; Eijsink, VGH				Borisova, Anna S.; Isaksen, Trine; Dimarogona, Maria; Kognole, Abhishek A.; Mathiesen, Geir; Varnai, Aniko; Rohr, Asmund K.; Payne, Christina M.; Sorlie, Morten; Sandgren, Mats; Eijsink, Vincent G. H.			Structural and Functional Characterization of a Lytic Polysaccharide Monooxygenase with Broad Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLO-OLIGOSACCHARIDES; CELLULOSE DEGRADATION; TRICHODERMA-REESEI; NEUROSPORA-CRASSA; ENZYMATIC-HYDROLYSIS; PICHIA-PASTORIS; BINDING; ENZYMES; PROTEINS; FAMILY	The recently discovered lytic polysaccharide monooxygenases (LPMOs) carry out oxidative cleavage of polysaccharides and are of major importance for efficient processing of biomass. NcLPMO9C from Neurospora crassa acts both on cellulose and on non-cellulose beta-glucans, including cellodextrins and xyloglucan. The crystal structure of the catalytic domain of NcLPMO9C revealed an extended, highly polar substrate-binding surface well suited to interact with a variety of sugar substrates. The ability of NcLPMO9C to act on soluble substrates was exploited to study enzyme-substrate interactions. EPR studies demonstrated that the Cu2+-center environment is altered upon substrate binding, whereas isothermal titration calorimetry studies revealed binding affinities in the low micromolar range for polymeric substrates that are due in part to the presence of a carbohydrate-binding module (CBM1). Importantly, the novel structure of NcLPMO9Cenabled a comparative study, revealing that the oxidative regioselectivity of LPMO9s (C1, C4, or both) correlates with distinct structural features of the copper coordination sphere. In strictly C1-oxidizing LPMO9s, access to the solvent-facing axial coordination position is restricted by a conserved tyrosine residue, whereas access to this same position seems unrestricted in C4-oxidizing LPMO9s. LPMO9s known to produce a mixture of C1- and C4- oxidized products show an intermediate situation.	Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Isaksen, Trine; Mathiesen, Geir; Varnai, Aniko; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Rohr, Asmund K.] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA	Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Oslo; University of Kentucky	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden.	mats.sandgren@slu.se; vincent.eijsink@nmbu.no	Payne, Christina/ABE-8330-2020; Kjendseth, Åsmund Røhr/O-2543-2016; Várnai, Anikó/Z-3190-2019; Payne, Christina M/C-7338-2011; Kognole, Abhishek A./AAB-5491-2019	Payne, Christina/0000-0001-5264-0964; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Várnai, Anikó/0000-0002-2796-514X; Payne, Christina M/0000-0001-5264-0964; Kognole, Abhishek A./0000-0002-6033-2344; Sandgren, Mats/0000-0002-2358-4534; Dimarogona, Maria/0000-0002-5663-1421; Borisova, Anna/0000-0002-3414-9888	National Science Foundation [ACI-1053575, TG-MCB090159]	National Science Foundation(National Science Foundation (NSF))	C. M. P. and A. A. K. thank the August T. Larsson Guest Researcher Programme at the Swedish University of Agricultural Sciences for the opportunity to work alongside the Sandgren and Stahlberg research groups. Computational time for this research was provided in part by the National Science Foundation through Extreme Science and Engineering Discovery Environment, which is supported by National Science Foundation Grant number ACI-1053575 under allocation number TG-MCB090159.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holt BTO, 2007, BIOCHEMISTRY-US, V46, P8816, DOI 10.1021/bi7007195; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liu YN, 1997, ANAL BIOCHEM, V250, P196, DOI 10.1006/abio.1997.2222; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Mattinen ML, 1998, EUR J BIOCHEM, V256, P279, DOI 10.1046/j.1432-1327.1998.2560279.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgenstern I, 2014, BRIEF FUNCT GENOMICS, V13, P471, DOI 10.1093/bfgp/elu032; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Sorlie M, 2000, ANAL BIOCHEM, V287, P118, DOI 10.1006/abio.2000.4826; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Varnai A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-57; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j	57	123	130	3	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22955	22969		10.1074/jbc.M115.660183	http://dx.doi.org/10.1074/jbc.M115.660183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26178376	Green Published, hybrid			2022-12-28	WOS:000361685500009
J	Yao, PL; Chen, LP; Hess, RA; Muller, R; Gonzalez, FJ; Peters, JM				Yao, Pei-Li; Chen, LiPing; Hess, Rex A.; Mueller, Rolf; Gonzalez, Frank J.; Peters, Jeffrey M.			Peroxisome Proliferator-activated Receptor-D (PPARD) Coordinates Mouse Spermatogenesis by Modulating Extracellular Signal-regulated Kinase (ERK)-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERTOLI-CELL NUMBER; MONO-(2-ETHYLHEXYL) PHTHALATE; ABNORMAL SPERMATOGENESIS; SEMINIFEROUS EPITHELIUM; LIGAND ACTIVATION; IN-VITRO; BETA/DELTA; TESTOSTERONE; EXPRESSION; PROTEIN	Ppard(-/-) mice exhibit smaller litter size compared with Ppard(+/+) mice. To determine whether peroxisome proliferator- activated receptor-D (PPARD) could possibly influence this phenotype, the role of PPARD in testicular biology was examined. Atrophic testes and testicular degeneration were observed in Ppard(-/-) mice compared with Ppard(+/+) mice, indicating that PPARD modulates spermatogenesis. Higher expression of p27 and decreased expression of proliferating cellular nuclear antigen in Sertoli cells were observed in Ppard(+/+) mice as compared with Ppard(-/-) mice, and these were associated with decreased Sertoli cell number in Ppard(+/+) mice. Cyclin D1 and cyclin D2 expression was lower in Ppard(+/+) as compared with Ppard(-/-) mice. Ligand activation of PPARD inhibited proliferation of a mouse Sertoli cell line, TM4, and an inverse agonist of PPARD (DG172) rescued this effect. Temporal inhibition of extracellular signal-regulated kinase (ERK) activation by PPARD in the testis was observed in Ppard(+/+) mice and was associated with decreased serum follicle-stimulating hormone and higher claudin-11 expression along the blood-testis barrier. PPARD-dependent ERK activation also altered expression of claudin-11, p27, cyclin D1, and cyclin D2 in TM4 cells, causing inhibition of cell proliferation, maturation, and formation of tight junctions in Sertoli cells, thus confirming a requirement for PPARD in accurate Sertoli cell function. Combined, these results reveal for the first time that PPARD regulates spermatogenesis by modulating the function of Sertoli cells during early testis development.	[Yao, Pei-Li; Chen, LiPing; Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Yao, Pei-Li; Chen, LiPing; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Hess, Rex A.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Reprod Biol & Toxicol, Urbana, IL 61802 USA; [Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res, Ctr Tumor & Immunobiol, D-35043 Marburg, Germany; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; Philipps University Marburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA.	pxy11@psu.edu; jmp21@psu.edu	Regan, Clinton/E-6250-2012; Müller, Rolf/L-4997-2016	Müller, Rolf/0000-0003-3339-4248; Yao, Pei-Li/0000-0003-0832-3771; Peters, Jeffrey/0000-0003-2782-2998; Hess, Rex/0000-0003-2649-3563	National Institutes of Health [CA124533, CA141029]; NCI Intramural Research Program [ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [R01CA140369, ZIABC005708, ZIABC005562, R01CA124533, R01CA141029, ZIABC005561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124533 and CA141029 (to J. M. P.) and ZIABC005561, ZIABC005562, and ZIABC005708 from the NCI Intramural Research Program (to F. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Beumer TL, 1999, ENDOCRINOLOGY, V140, P1834, DOI 10.1210/en.140.4.1834; Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583; Burdick AD, 2007, CELL SIGNAL, V19, P1163, DOI 10.1016/j.cellsig.2006.12.007; Chiba K, 2012, J ANDROL, V33, P368, DOI 10.2164/jandrol.111.013664; Cipriano SC, 2001, MOL ENDOCRINOL, V15, P985, DOI 10.1210/me.15.6.985; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; Dwyer Jessica L, 2012, Spermatogenesis, V2, P104; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Hemendinger RA, 2002, CELL TRANSPLANT, V11, P499; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hogarth CA, 2013, ADV EXP MED BIOL, V786, P105, DOI 10.1007/978-94-007-6621-1_7; Hollingshead HE, 2008, CARCINOGENESIS, V29, P169, DOI 10.1093/carcin/bgm209; Holsberger DR, 2005, BIOL REPROD, V72, P1429, DOI 10.1095/biolreprod.105.040386; Huang JC, 2008, PPAR RES, V2008, DOI 10.1155/2008/732303; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; Johnson L, 2008, ANIM REPROD SCI, V105, P23, DOI 10.1016/j.anireprosci.2007.11.029; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kanatsu-Shinohara M, 2010, P NATL ACAD SCI USA, V107, P6210, DOI 10.1073/pnas.0914448107; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Khatchadourian K, 2007, MOL REPROD DEV, V74, P341, DOI 10.1002/mrd.20564; Khozoie C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-665; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kopera IA, 2010, PHILOS T R SOC B, V365, P1593, DOI 10.1098/rstb.2009.0251; Lieber S, 2012, J MED CHEM, V55, P2858, DOI 10.1021/jm2017122; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; MACHIDA T, 1981, HORM BEHAV, V15, P238, DOI 10.1016/0018-506X(81)90013-1; McCoard SA, 2001, BIOL REPROD, V64, P689, DOI 10.1095/biolreprod64.2.689; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Meyer-Ficca ML, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123661; MOGER WH, 1976, BIOL REPROD, V14, P665, DOI 10.1095/biolreprod14.5.665; Mok KW, 2013, ADV EXP MED BIOL, V763, P334; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mukai M, 2005, BIOL REPROD, V73, P951, DOI 10.1095/biolreprod.105.040980; Nozawa YI, 2014, DEV BIOL, V388, P170, DOI 10.1016/j.ydbio.2014.02.002; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Schultz R, 1999, ENDOCRINOLOGY, V140, P2968, DOI 10.1210/en.140.7.2968; Shimon I, 2006, J ANDROL, V27, P358, DOI 10.2164/jandrol.05140; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Sonne SB, 2008, INT J ANDROL, V31, P275, DOI 10.1111/j.1365-2605.2007.00855.x; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tarulli GA, 2006, BIOL REPROD, V74, P798, DOI 10.1095/biolreprod.105.050450; Thomas Kelwyn, 2011, Front Biosci (Elite Ed), V3, P1209; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Yao PL, 2014, TOXICOLOGY, V326, P62, DOI 10.1016/j.tox.2014.10.008; Yao PL, 2014, MOL CANCER THER, V13, P1008, DOI 10.1158/1535-7163.MCT-13-0836; Yao PL, 2010, BIOL REPROD, V82, P516, DOI 10.1095/biolreprod.109.080374; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477; Zhu BK, 2014, J BIOL CHEM, V289, P20102, DOI 10.1074/jbc.M114.551069	60	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23416	23431		10.1074/jbc.M115.664508	http://dx.doi.org/10.1074/jbc.M115.664508			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26242735	hybrid, Green Published			2022-12-28	WOS:000361685500046
J	Li, QL; Li, YW; Gu, BN; Fang, L; Zhou, PB; Bao, SL; Huang, L; Dai, X				Li, Qiuling; Li, Yuewei; Gu, Bingnan; Fang, Lei; Zhou, Pengbo; Bao, Shilai; Huang, Lan; Dai, Xing			Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; phosphorylation; ubiquitin ligase; ubiquitylation (ubiquitination); Wnt signaling; Akt; Cul4; DDB1; Pygo2	GLYCOGEN-SYNTHASE KINASE-3; DNA-DAMAGE RESPONSE; BETA-CATENIN; PROTEIN-KINASE; UBIQUITIN LIGASE; GENE-EXPRESSION; STEM-CELLS; SIGNALING PATHWAY; BINDING PROTEIN; ACTIVATION	Background: Pygo2 is a chromatin effector of the Wnt signaling pathway that regulates cell growth and differentiation. Results: Pygo2 is degraded through the ubiquitin/proteasome pathway and is stabilized by Akt phosphorylation at its serine 48. Conclusion: Stabilizing phosphorylation by Akt regulates Pygo2 protein expression. Significance: Pygo2 is a common nodule downstream of Wnt and Akt pathways. Pygopus 2 (Pygo2/PYGO2) is an evolutionarily conserved coactivator and chromatin effector in the Wnt/-catenin signaling pathway that regulates cell growth and differentiation in various normal and malignant tissues. Although PYGO2 is highly overexpressed in a number of human cancers, the molecular mechanism underlying its deregulation is largely unknown. Here we report that Pygo2 protein is degraded through the ubiquitin/proteasome pathway and is posttranslationally stabilized through phosphorylation by activated phosphatidylinositol 3-kinase/Akt signaling. Specifically, Pygo2 is stabilized upon inhibition of the proteasome, and its intracellular level is regulated by Cullin 4 (Cul4) and DNA damage-binding protein 1 (DDB1), components of the Cul4-DDB1 E3 ubiquitin ligase complex. Furthermore, Pygo2 is phosphorylated at multiple residues, and Akt-mediated phosphorylation at serine 48 leads to its decreased ubiquitylation and increased stability. Finally, we provide evidence that Akt and its upstream growth factors act in parallel with Wnt to stabilize Pygo2. Taken together, our findings highlight chromatin regulator Pygo2 as a common node downstream of oncogenic Wnt and Akt signaling pathways and underscore posttranslational modification, particularly phosphorylation and ubiquitylation, as a significant mode of regulation of Pygo2 protein expression.	[Li, Qiuling; Gu, Bingnan; Dai, Xing] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Fang, Lei; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Irvine, CA 92697 USA; [Li, Qiuling; Bao, Shilai] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Li, Yuewei; Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Cornell University	Huang, L (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, D233 Med Sci 1, Irvine, CA 92697 USA.	lanhuang@uci.edu; xdai@uci.edu	Regan, Clinton/E-6250-2012	Fang, Lei/0000-0002-2582-4845; Dai, Xing/0000-0001-8134-1365	National Institutes of Health [R01-GM083089, R21CA161807, R01GM074830]; Susan G. Komen Grant [KG110897]; California Breast Cancer Research Program Postdoctoral Fellowship [14FB-0129]; NATIONAL CANCER INSTITUTE [R21CA161807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830, R01GM083089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Grant(Susan G. Komen Breast Cancer Foundation); California Breast Cancer Research Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM083089 (to X. D.) and R21CA161807 and R01GM074830 (to L. H.). This work was also supported by Susan G. Komen Grant KG110897 (to X. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by California Breast Cancer Research Program Postdoctoral Fellowship 14FB-0129.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Andrews PGP, 2007, INT J ONCOL, V30, P357; Andrews PGP, 2009, BIOCHEM J, V422, P493, DOI 10.1042/BJ20090134; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Berlato C, 2009, ENDOCRINOLOGY, V150, P2924, DOI 10.1210/en.2008-0668; Brembeck FH, 2011, GASTROENTEROLOGY, V141, P1359, DOI 10.1053/j.gastro.2011.06.039; Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Chen YY, 2011, MED ONCOL, V28, P631, DOI 10.1007/s12032-010-9488-1; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang L, 2012, MOL CELL PROTEOMICS, V11, P138, DOI 10.1074/mcp.M111.016352; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gu BN, 2013, CELL STEM CELL, V13, P48, DOI 10.1016/j.stem.2013.04.012; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; JACKSON DA, 1988, J CELL SCI, V90, P365; Jessen S, 2008, BIOESSAYS, V30, P448, DOI 10.1002/bies.20757; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kessler R, 2009, MECH DEVELOP, V126, P752, DOI 10.1016/j.mod.2009.04.003; KIRSCHNER RH, 1977, J CELL BIOL, V72, P118, DOI 10.1083/jcb.72.1.118; Klebba JE, 2013, CURR BIOL, V23, P2255, DOI 10.1016/j.cub.2013.09.019; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Li B, 2007, GENESIS, V45, P318, DOI 10.1002/dvg.20299; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-346; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mesquita B, 2013, BREAST CANCER RES TR, V138, P37, DOI 10.1007/s10549-013-2408-2; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nair M, 2008, DEV BIOL, V320, P446, DOI 10.1016/j.ydbio.2008.05.553; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Parker DS, 2002, DEVELOPMENT, V129, P2565; Popadiuk CM, 2006, CLIN CANCER RES, V12, P2216, DOI 10.1158/1078-0432.CCR-05-2433; POWIS G, 1994, CANCER RES, V54, P2419; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Schwab KR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-15; Shadeo A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1370; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song N, 2007, DEVELOPMENT, V134, P1873, DOI 10.1242/dev.001495; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sun P, 2014, P NATL ACAD SCI USA, V111, P10215, DOI 10.1073/pnas.1311395111; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tobin AB, 2002, TRENDS PHARMACOL SCI, V23, P337, DOI 10.1016/S0165-6147(02)02043-6; Townsley FM, 2004, J BIOL CHEM, V279, P5177, DOI 10.1074/jbc.M309722200; Tripathi R, 2007, J BIOSCIENCES, V32, P1133, DOI 10.1007/s12038-007-0114-0; Tzenov YR, 2013, MOL CANCER RES, V11, P19, DOI 10.1158/1541-7786.MCR-12-0510; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang ZX, 2010, J NEURO-ONCOL, V100, P31, DOI 10.1007/s11060-010-0144-6; Watanabe K, 2014, ONCOGENE, V33, P632, DOI 10.1038/onc.2012.620; Watanabe K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002436; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577	97	6	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21553	21567		10.1074/jbc.M115.639419	http://dx.doi.org/10.1074/jbc.M115.639419			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170450	hybrid, Green Published			2022-12-28	WOS:000360637600029
J	Lee, EH; Kim, SS; Lee, S; Baek, KH; Seo, SR				Lee, Eun Hye; Kim, Seon Sook; Lee, Seul; Baek, Kwan-Hyuck; Seo, Su Ryeon			Pituitary Adenylate Cyclase-activating Polypeptide ( PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RESPONSE ELEMENT; DSCR1 ADAPT78; PC12 CELLS; INHIBITS CALCINEURIN; NEURITE OUTGROWTH; OXIDATIVE STRESS; NERVOUS-SYSTEM; UP-REGULATION; MAP KINASE; C-FOS	Pituitary adenylate cyclase-activating peptide (PACAP) is a neurotrophic peptide involved in a wide range of nervous functions, including development, differentiation, and survival, and various aspects of learning and memory. Here we report that PACAP induces the expression of regulator of calcineurin 1 (RCAN1, also known as DSCR1), which is abnormally expressed in the brains of Down syndrome patients. Increased RCAN1 expression is accompanied by activation of the PKA-cAMP response element-binding protein pathways. EMSA and ChIP analyses demonstrate the presence of a functional cAMP response element in the RCAN1 promoter. Moreover, we show that PACAP-dependent neuronal differentiation is significantly disturbed by improper RCAN1 expression. Our data provide the first evidence of RCAN1, a Down syndrome-related gene, as a novel target for control of the neurotrophic function of PACAP.	[Lee, Eun Hye; Kim, Seon Sook; Seo, Su Ryeon] Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Chunchon 200701, South Korea; [Lee, Eun Hye; Kim, Seon Sook; Seo, Su Ryeon] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Seul; Baek, Kwan-Hyuck] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol & Cellular Biol, Suwon 440746, Gyeonggi, South Korea	Kangwon National University; Kangwon National University; Sungkyunkwan University (SKKU)	Seo, SR (corresponding author), Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Chunchon 200701, South Korea.	suryeonseo@kangwon.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2009-0065231, 2010-0023815]; Ministry of Education	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by Ministry of Education, Science, and Technology Grants 2009-0065231 and 2010-0023815. This work was also a result of study on the Leaders Industry-University Cooperation Project supported by the Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Casas C, 2001, MECH DEVELOP, V101, P289, DOI 10.1016/S0925-4773(00)00583-9; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Cho A, 2014, NEURON, V82, P109, DOI 10.1016/j.neuron.2014.02.015; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2001, BIOFACTORS, V15, P91, DOI 10.1002/biof.5520150208; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ermak G, 2013, FREE RADICAL BIO MED, V62, P47, DOI 10.1016/j.freeradbiomed.2013.01.016; Ermak G, 2012, J BIOL CHEM, V287, P14088, DOI 10.1074/jbc.M111.305342; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Fahrenkrug J, 2006, CHRONOBIOL INT, V23, P53, DOI 10.1080/07420520500464569; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; Hammond DR, 2010, DEV DYNAM, V239, P2443, DOI 10.1002/dvdy.22367; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIM KS, 1993, J BIOL CHEM, V268, P15689; Kim SS, 2012, BIOCHEM BIOPH RES CO, V418, P657, DOI 10.1016/j.bbrc.2012.01.071; KING MM, 1984, J BIOL CHEM, V259, P8080; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lorenzi H, 2010, BIOTECHNIQUES, V48, P35, DOI 10.2144/000113342; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Moroo I, 1998, BRAIN RES, V795, P191, DOI 10.1016/S0006-8993(98)00291-1; Nagao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049926; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; Roper RJ, 2009, MECH DEVELOP, V126, P212, DOI 10.1016/j.mod.2008.11.002; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Sakai Y, 2004, MOL BRAIN RES, V123, P18, DOI 10.1016/j.molbrainres.2003.12.013; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TATSUNO I, 1994, BRAIN RES, V662, P1, DOI 10.1016/0006-8993(94)90790-0; U M, 2004, LEUKEMIA, V18, P1850, DOI 10.1038/sj.leu.2403516; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Wang W, 2012, EMBO J, V31, P3655, DOI 10.1038/emboj.2012.190; Yoshida T, 2005, J NEUROSCI, V25, P3067, DOI 10.1523/JNEUROSCI.3738-04.2005	55	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21019	21031		10.1074/jbc.M115.639476	http://dx.doi.org/10.1074/jbc.M115.639476			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157140	Green Published, hybrid			2022-12-28	WOS:000360011800035
J	Beckman, D; Santos, LE; Americo, TA; Ledo, JH; de Mello, FG; Linden, R				Beckman, Danielle; Santos, Luis E.; Americo, Tatiana A.; Ledo, Jose H.; de Mello, Fernando G.; Linden, Rafael			Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; AMYLOID-BETA OLIGOMERS; CELLULAR PRION; ANIMAL-MODELS; 5-HT5A RECEPTOR; TYROSINE-HYDROXYLASE; 5-HT(5A) RECEPTOR; ADENYLATE-CYCLASE; ALZHEIMER-DISEASE; NERVOUS-SYSTEM	We sought to examine interactions of the prion protein (PrPC) with monoaminergic systems due to: the role of PrPC in both Prion and Alzheimer diseases, which include clinical depression among their symptoms, the implication of monoamines in depression, and the hypothesis that PrPC serves as a scaffold for signaling systems. To that effect we compared both behavior and monoaminergic markers in wild type (WT) and PrPC-null (PrP-/(-)) mice. PrP-/(-) mice performed poorly when compared with WT in forced swimming, tail suspension, and novelty suppressed feeding tests, typical of depressive-like behavior, but not in the control open field nor rotarod motor tests; cyclic AMP responses to stimulation of D1 receptors by dopamine was selectively impaired in PrP-/(-) mice, and responses to serotonin, but not to norepinephrine, also differed between genotypes. Contents of dopamine, tyrosine hydroxylase, and the 5-HT5A serotonin receptor were increased in the cerebral cortex of PrP-/(-), as compared with WT mice. Microscopic colocalization, as well as binding in overlay assays were found of PrPC with both the 5HT5A and D1, but not D4 receptors. The data are consistent with the scaffolding of monoaminergic signaling modules by PrPC, and may help understand the pathogenesis of clinical depression and neurodegenerative disorders.	[Beckman, Danielle; Santos, Luis E.; Americo, Tatiana A.; de Mello, Fernando G.; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biofis, BR-21941902 Rio de Janeiro, Brazil; [Ledo, Jose H.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Linden, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis, BR-21941902 Rio de Janeiro, Brazil.	rlinden@biof.ufrj.br	Beckman, Danielle/B-4656-2015; Santos, Luís/B-4961-2015; Linden, Rafael/F-2275-2011	Beckman, Danielle/0000-0002-9584-4411; Santos, Luís/0000-0002-0694-733X; Linden, Rafael/0000-0003-3287-336X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute of Translational Neuroscience	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Translational Neuroscience	This work was supported by grants and fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to R. L.), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to R. L.), and National Institute of Translational Neuroscience (to F. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adjou KT, 2008, NEUROCHEM INT, V52, P1416, DOI 10.1016/j.neuint.2008.03.002; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arita DY, 2002, J CELL BIOCHEM, V87, P58, DOI 10.1002/jcb.10277; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; BASSANT MH, 1984, BRAIN RES, V308, P182, DOI 10.1016/0006-8993(84)90934-X; Baumgarten HG, 2004, NEUROTOX RES, V6, P589, DOI 10.1007/BF03033455; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Black SAG, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00045; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Can A, 2011, GENES BRAIN BEHAV, V10, P434, DOI 10.1111/j.1601-183X.2011.00682.x; Can A, 2012, JOVE-J VIS EXP, V59, P3638, DOI DOI 10.3791/3638; Carson MJ, 1996, GLIA, V17, P317, DOI 10.1002/(SICI)1098-1136(199608)17:4<317::AID-GLIA6>3.0.CO;2-W; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Coitinho AS, 2003, NEUROREPORT, V14, P1375, DOI 10.1097/01.wnr.0000078541.07662.90; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cowin RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028409; Croes EA, 2003, ANN NEUROL, V54, P275, DOI 10.1002/ana.10658; CROSS AJ, 1985, J NEUROL SCI, V70, P231, DOI 10.1016/0022-510X(85)90090-5; Cumbler Ethan, 2009, Cases J, V2, P122, DOI 10.1186/1757-1626-2-122; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Francken BJB, 1998, EUR J PHARMACOL, V361, P299, DOI 10.1016/S0014-2999(98)00744-4; Gadotti VM, 2012, BEHAV BRAIN RES, V227, P319, DOI 10.1016/j.bbr.2011.03.012; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gasperini L, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00044; Giese KP, 2013, LEARN MEMORY, V20, P540, DOI 10.1101/lm.028449.112; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gonzalez R, 2013, BEHAV BRAIN RES, V252, P246, DOI 10.1016/j.bbr.2013.05.051; Goodfellow NM, 2012, J NEUROSCI, V32, P5804, DOI 10.1523/JNEUROSCI.4849-11.2012; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hirao K, 2015, NEUROSCI BIOBEHAV R, V49, P157, DOI 10.1016/j.neubiorev.2014.11.010; Hurley PT, 1998, BRIT J PHARMACOL, V124, P1238, DOI 10.1038/sj.bjp.0701928; Kassai F, 2012, BEHAV PHARMACOL, V23, P397, DOI 10.1097/FBP.0b013e3283565248; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Ledoux JM, 2005, MED HYPOTHESES, V64, P910, DOI 10.1016/j.mehy.2004.11.020; Leggio GM, 2013, EUR J PHARMACOL, V719, P25, DOI 10.1016/j.ejphar.2013.07.022; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Lobao-Soares B, 2008, BEHAV BRAIN RES, V194, P129, DOI 10.1016/j.bbr.2008.06.006; Lopes MH, 2012, PRION, V6, P142, DOI 10.4161/pri.19035; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Magnin E, 2011, EUR NEUROL, V65, P368, DOI 10.1159/000328670; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mariante RM, 2012, J BIOL CHEM, V287, P35506, DOI 10.1074/jbc.M112.394924; Martin-Lanneree S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00055; Massimino ML, 2016, MUSCLE NERVE, V53, P269, DOI 10.1002/mus.24708; Meeks TW, 2006, CURR OPIN PSYCHIATR, V19, P581, DOI 10.1097/01.yco.0000245746.45384.0e; Mehrpour M, 2010, CANCER LETT, V290, P1, DOI 10.1016/j.canlet.2009.07.009; Miranda A, 2013, REPRODUCTION, V146, pR91, DOI 10.1530/REP-13-0100; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Niciu MJ, 2013, CNS SPECTRUMS, V18, P231, DOI 10.1017/S1092852913000059; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Noda M, 2003, J NEUROCHEM, V84, P222, DOI 10.1046/j.1471-4159.2003.01518.x; Onodera T, 2014, MICROBIOL IMMUNOL, V58, P361, DOI 10.1111/1348-0421.12162; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Perona MTG, 2008, BEHAV PHARMACOL, V19, P566, DOI 10.1097/FBP.0b013e32830cd80f; Petrakis S, 2008, EUR J NEUROSCI, V27, P612, DOI 10.1111/j.1460-9568.2008.06037.x; PLASSAT JL, 1992, EMBO J, V11, P4779, DOI 10.1002/j.1460-2075.1992.tb05583.x; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Posser T, 2009, EUR J PHARMACOL, V602, P85, DOI 10.1016/j.ejphar.2008.10.055; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ragno M, 2009, ACTA NEUROL SCAND, V119, P131, DOI 10.1111/j.1600-0404.2008.01075.x; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; RASENICK MM, 1986, FEBS LETT, V198, P164, DOI 10.1016/0014-5793(86)81205-4; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Roesler R, 1999, MOL BRAIN RES, V71, P349, DOI 10.1016/S0169-328X(99)00193-X; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strom A, 2011, PANCREAS, V40, P229, DOI 10.1097/MPA.0b013e3181f7e547; Thomas DR, 2006, NEUROPHARMACOLOGY, V51, P566, DOI 10.1016/j.neuropharm.2006.04.019; Thomas EA, 2000, J NEUROSCI RES, V61, P75, DOI 10.1002/1097-4547(20000701)61:1<75::AID-JNR9>3.0.CO;2-9; Thompson A, 2014, AM J PSYCHIAT, V171, P265, DOI 10.1176/appi.ajp.2013.12111460; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Vermeiren Y, 2014, NEUROBIOL AGING, V35, P2691, DOI 10.1016/j.neurobiolaging.2014.05.031; Vidal C, 2009, NEUROSCIENCE, V160, P731, DOI 10.1016/j.neuroscience.2009.02.072; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wall CA, 2005, J NEUROPSYCH CLIN N, V17, P489, DOI 10.1176/appi.neuropsych.17.4.489; Wanschitz J, 2000, ANN NEUROL, V48, P788, DOI 10.1002/1531-8249(200011)48:5<788::AID-ANA13>3.0.CO;2-5; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Yan HC, 2010, NEUROSCI BULL, V26, P327, DOI 10.1007/s12264-010-0323-7; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanetti F, 2014, CARDIOVASC RES, V104, P93, DOI 10.1093/cvr/cvu194; Zarate C, 2013, ANN NY ACAD SCI, V1292, P21, DOI 10.1111/nyas.12223	103	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20488	20498		10.1074/jbc.M115.666156	http://dx.doi.org/10.1074/jbc.M115.666156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26152722	Green Published, hybrid			2022-12-28	WOS:000359608900046
J	Huygens, C; Lienart, S; Dedobbeleer, O; Stockis, J; Gauthy, E; Coulie, PG; Lucas, S				Huygens, Caroline; Lienart, Stephanie; Dedobbeleer, Olivier; Stockis, Julie; Gauthy, Emilie; Coulie, Pierre G.; Lucas, Sophie			Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor beta 1 (TGF-beta 1) Production in Human Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROGNOSTIC MARKER; LATENT TGF-BETA; POOR-PROGNOSIS; FOXP3 GENE; OVEREXPRESSION; SURFACE; EXPRESSION; RECEPTOR; GARP; IDENTIFICATION	Production of active TGF-beta 1 is one mechanism by which human regulatory T cells (Tregs) suppress immune responses. This production is regulated by glycoprotein A repetitions predominant (GARP), a transmembrane protein present on stimulated Tregs but not on other T lymphocytes (Th and CTLs). GARP forms disulfide bonds with proTGF-beta 1, favors its cleavage into latent inactive TGF-beta 1, induces the secretion and surface presentation of GARP.latent TGF-beta 1 complexes, and is required for activation of the cytokine in Tregs. We explored whether additional Treg-specific protein(s) associated with GARP.TGF-beta 1 complexes regulate TGF-beta 1 production in Tregs. We searched for such proteins by yeast two-hybrid assay, using GARP as a bait to screen a human Treg cDNA library. We identified lysosomal-associated transmembrane protein 4B (LAPTM4B), which interacts with GARP in mammalian cells and is expressed at higher levels in Tregs than in Th cells. LAPTM4B decreases cleavage of proTGF-beta 1, secretion of soluble latent TGF-beta 1, and surface presentation of GARP.TGF-beta 1 complexes by Tregs but does not contribute to TGF-beta 1 activation. Therefore, LAPTM4B binds to GARP and is a negative regulator of TGF-beta 1 production in human Tregs. It may play a role in the control of immune responses by decreasing Treg immunosuppression.	[Lucas, Sophie] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Lucas, S (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 74,B1-74-04, B-1200 Brussels, Belgium.	sophie.lucas@uclouvain.be		Stockis, Julie/0000-0003-4911-6891; Lucas, Sophie/0000-0003-1287-7996	Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan [Action 29_024]; Fonds National pour la Recherche Scientifique (Belgium); Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees ARC (Belgium) [09/14-021]; Fonds J. Maisin (Belgium); Televie grant (Belgium)	Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan; Fonds National pour la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees ARC (Belgium); Fonds J. Maisin (Belgium); Televie grant (Belgium)	This work was supported by grants from the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming and by grants from the Belgian Cancer Plan (Action 29_024), the Fonds National pour la Recherche Scientifique (Belgium), the Fondation contre le Cancer (Belgium), the Fondation Salus Sanguinis (Belgium), and the Actions de Recherche Concertees ARC 09/14-021 (Belgium) and the Fonds J. Maisin (Belgium). The authors declare that they have no conflict of interest with the contents of the article.; Supported by a Televie grant (Belgium).	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bourne GL, 2011, J IMMUNOL METHODS, V364, P101, DOI 10.1016/j.jim.2010.11.008; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; de Vries IJM, 2011, CLIN CANCER RES, V17, P841, DOI 10.1158/1078-0432.CCR-10-2227; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fan HH, 2012, IMMUNOLOGY, V136, P218, DOI 10.1111/j.1365-2567.2012.03573.x; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kang Y, 2012, AM J SURG, V204, P677, DOI 10.1016/j.amjsurg.2012.02.003; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Milkereit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027478; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ocklenburg F, 2006, LAB INVEST, V86, P724, DOI 10.1038/labinvest.3700432; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003161; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Stockis J, 2009, EUR J IMMUNOL, V39, P869, DOI 10.1002/eji.200838807; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Tang H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0974-8; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Zhang G, 2012, J INT MED RES, V40, P1275, DOI 10.1177/147323001204000406; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091069; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025	52	16	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20105	20116		10.1074/jbc.M115.655340	http://dx.doi.org/10.1074/jbc.M115.655340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26126825	Green Published, hybrid			2022-12-28	WOS:000359608900014
J	Iwahori, S; Hakki, M; Chou, S; Kalejta, RF				Iwahori, Satoko; Hakki, Morgan; Chou, Sunwen; Kalejta, Robert F.			Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; CYTOMEGALOVIRUS PP71 PROTEIN; RB FAMILY; TRANSCRIPTION FACTOR; E2F TRANSACTIVATION; HISTONE DEACETYLASE; STRUCTURAL BASIS; GENE-EXPRESSION; POCKET PROTEINS; TERMINAL DOMAIN	The retinoblastoma (Rb) tumor suppressor restricts cell cycle progression by repressing E2F-responsive transcription. Cellular cyclin-dependent kinase (CDK)-mediated Rb inactivation through phosphorylation disrupts Rb-E2F complexes, stimulating transcription. The human cytomegalovirus (HCMV) UL97 protein is a viral CDK (v-CDK) that phosphorylates Rb. Here we show that UL97 phosphorylates 11 of the 16 consensus CDK sites in Rb. A cleft within Rb accommodates peptides with the amino acid sequence LXCXE. UL97 contains three such motifs. We determined that the first LXCXE motif (L1) of UL97 and the Rb cleft enhance UL97-mediated Rb phosphorylation. A UL97 mutant with a non-functional L1 motif (UL97-L1m) displayed significantly reduced Rb phosphorylation at multiple sites. Curiously, however, it efficiently disrupted Rb-E2F complexes but failed to relieve Rb-mediated repression of E2F reporter constructs. The HCMV immediate early 1 protein cooperated with UL97-L1m to inactivate Rb in transfection assays, likely indicating that cells infected with a UL97-L1m mutant virus show no defects in growth or E2F-responsive gene expression because of redundant viral mechanisms to inactivate Rb. Ourdata suggest that UL97 possesses a mechanism to elicit E2F-dependent gene expression distinct from disruption of Rb-E2F complexes and dependent upon both the L1 motif of UL97 and the cleft region of Rb.	[Iwahori, Satoko; Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Iwahori, Satoko; Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Hakki, Morgan; Chou, Sunwen] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97239 USA; [Chou, Sunwen] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA.	rfkalejta@wisc.edu	Iwahori, Satoko/L-1948-2019; Regan, Clinton/E-6250-2012		National Institutes of Health [AI080675]; Department of Veterans Affairs [BX000925]; Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080675] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AI080675 (to R. F. K.). This work was also supported by Department of Veterans Affairs Grant BX000925 (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research.	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Albright ER, 2013, J VIROL, V87, P9802, DOI 10.1128/JVI.01436-13; Baek MC, 2004, VIROLOGY, V324, P184, DOI 10.1016/j.virol.2004.03.015; Baker GL, 2005, CELL CYCLE, V4, P330; Bellacchio E, 2013, J CELL PHYSIOL, V228, P285, DOI 10.1002/jcp.24137; Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Chou S, 2008, J VIROL, V82, P246, DOI 10.1128/JVI.01787-07; Chou SW, 2013, ANTIMICROB AGENTS CH, V57, P3375, DOI 10.1128/AAC.00511-13; Chou SW, 2010, ANTIMICROB AGENTS CH, V54, P2371, DOI 10.1128/AAC.00186-10; Chou SW, 2009, ANTIMICROB AGENTS CH, V53, P81, DOI 10.1128/AAC.01177-08; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Fang F, 2010, J IMMUNOL, V184, P6084, DOI 10.4049/jimmunol.0902561; Fera D, 2012, CHEM BIOL, V19, P518, DOI 10.1016/j.chembiol.2012.03.007; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gill RB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-9; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; He ZW, 1997, J VIROL, V71, P405, DOI 10.1128/JVI.71.1.405-411.1997; Heilmann AMF, 2012, GENE DEV, V26, P1128, DOI 10.1101/gad.195552.112; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Iwahori S, 2007, J VIROL, V81, P9653, DOI 10.1128/JVI.00568-07; Jiang H, 2009, CURR GENE THER, V9, P422, DOI 10.2174/156652309789753356; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Juckem LK, 2008, J IMMUNOL, V180, P4965, DOI 10.4049/jimmunol.180.7.4965; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Kim M, 2010, ONCOGENE, V29, P3990, DOI 10.1038/onc.2010.137; KITAGAWA M, 1995, ONCOGENE, V10, P229; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng XH, 1997, CURR BIOL, V7, P709, DOI 10.1016/S0960-9822(06)00301-0; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nicolay BN, 2013, CURR OPIN CELL BIOL, V25, P735, DOI 10.1016/j.ceb.2013.07.012; NOWAK B, 1984, VIROLOGY, V132, P325, DOI 10.1016/0042-6822(84)90039-4; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; PEEPER DS, 1995, ONCOGENE, V10, P39; Penkert RR, 2012, FUTURE VIROL, V7, P855, DOI 10.2217/FVL.12.86; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Sun XP, 2013, J VIROL, V87, P10126, DOI 10.1128/JVI.01671-13; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; VanDeusen HR, 2015, J VIROL, V89, P5012, DOI 10.1128/JVI.00175-15; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995	91	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19666	19680		10.1074/jbc.M115.660043	http://dx.doi.org/10.1074/jbc.M115.660043			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100623	Green Published, hybrid			2022-12-28	WOS:000359364600027
J	Opel, A; Nobles, M; Montaigne, D; Finlay, M; Anderson, N; Breckenridge, R; Tinker, A				Opel, Aaisha; Nobles, Muriel; Montaigne, David; Finlay, Malcolm; Anderson, Naomi; Breckenridge, Ross; Tinker, Andrew			Absence of the Regulator of G-protein Signaling, RGS4, Predisposes to Atrial Fibrillation and Is Associated with Abnormal Calcium Handling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; HEART-FAILURE; IN-VITRO; MYOCYTES; EXPRESSION; KINETICS; GENERATION; ARRHYTHMIA; CONNEXIN43; RECEPTOR	The description of potential molecular substrates for predisposition to atrial fibrillation (AF) is incomplete, and it is unknown what role regulators of G/protein signaling might play. We address whether the attenuation of RGS4 function may promote AF and the mechanism through which this occurs. For this purpose, we studied a mouse with global genetic deletion of RGS4 (RGS4(-/-)) and the normal littermate controls (RGS4(-/-)). In vivo electrophysiology using atrial burst pacing revealed that mice with global RGS4 deletion developed AF more frequently than control littermates. Isolated atrial cells from RGS4(-/-) mice show an increase in Ca2+ spark frequency under basal conditions and after the addition of endothelin-1 and abnormal spontaneous Ca2+ release events after field stimulation. Isolated left atria studied on a multielectrode array revealed modest changes in path length for re-entry but abnormal electrical events after a pacing train in RGS4(-/-) mice. RGS4 deletion results in a predisposition to atrial fibrillation from enhanced activity in the G alpha(q/11)-IP3 pathway, resulting in abnormal Ca2+ release and corresponding electrical events.	[Opel, Aaisha; Breckenridge, Ross; Tinker, Andrew] UCL, Rayne Inst, Dept Med, British Heart Fdn Labs, London WC1E 6JJ, England; [Opel, Aaisha; Nobles, Muriel; Montaigne, David; Finlay, Malcolm; Anderson, Naomi; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, London EC1M 6BQ, England	University of London; King's College London; University College London; University of London; Queen Mary University London	Tinker, A (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, Charter House Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk	Montaigne, David/R-6066-2018; Finlay, Malcolm/Q-2363-2015	Montaigne, David/0000-0002-2346-863X; Finlay, Malcolm/0000-0001-6403-9340	British Heart Foundation [FS/09/042/27860]; Wellcome Trust [081475/Z/06/Z]; National Institute for Health Research Barts Cardiovascular Biomedical Research Unit; Fondation Coeur et Arteres; Institut Servier	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Barts Cardiovascular Biomedical Research Unit; Fondation Coeur et Arteres; Institut Servier	This work was supported by British Heart Foundation Grant FS/09/042/27860, Wellcome Trust Grant 081475/Z/06/Z, and funds from the National Institute for Health Research Barts Cardiovascular Biomedical Research Unit, the Fondation Coeur et Arteres, and Institut Servier. The authors declare that they have no conflicts of interest with the contents of this article.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Beaumont J, 1998, BIOPHYS J, V75, P1, DOI 10.1016/S0006-3495(98)77490-9; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bussek A, 2012, J PHARMACOL TOX MET, V66, P145, DOI 10.1016/j.vascn.2011.12.002; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; de Groot JR, 2004, CARDIOVASC RES, V62, P323, DOI 10.1016/j.cardiores.2004.01.033; Doupnik CA, 2001, BBA-GENE STRUCT EXPR, V1522, P97, DOI 10.1016/S0167-4781(01)00342-6; Guasch E, 2013, J AM COLL CARDIOL, V62, P68, DOI 10.1016/j.jacc.2013.01.091; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Janvier NC, 1997, J PHYSIOL-LONDON, V504, P301, DOI 10.1111/j.1469-7793.1997.301be.x; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Kockskamper J, 2002, J PHYSIOL-LONDON, V545, P65, DOI 10.1113/jphysiol.2002.025502; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Opel A., 2011, EUROPACE, V13, P17; Owen VJ, 2001, EUR HEART J, V22, P1015, DOI 10.1053/euhj.2000.2578; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sheehan KA, 2003, J PHYSIOL-LONDON, V546, P119, DOI 10.1113/jphysiol.2002.026963; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; Tinker A, 2006, SEMIN CELL DEV BIOL, V17, P377, DOI 10.1016/j.semcdb.2006.03.007; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wieland T, 2007, CURR OPIN PHARMACOL, V7, P201, DOI 10.1016/j.coph.2006.11.007; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zuberi Z, 2010, CIRC-ARRHYTHMIA ELEC, V3, P391, DOI 10.1161/CIRCEP.109.894329	39	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19233	19244		10.1074/jbc.M115.666719	http://dx.doi.org/10.1074/jbc.M115.666719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26088132	hybrid, Green Published			2022-12-28	WOS:000358781100037
J	Plotkin, LI; Gortazar, AR; Davis, HM; Condon, KW; Gabilondo, H; Maycas, M; Allen, MR; Bellido, T				Plotkin, Lilian I.; Gortazar, Arancha R.; Davis, Hannah M.; Condon, Keith W.; Gabilondo, Hugo; Maycas, Marta; Allen, Matthew R.; Bellido, Teresita			Inhibition of Osteocyte Apoptosis Prevents the Increase in Osteocytic Receptor Activator of Nuclear Factor kappa B Ligand (RANKL) but Does Not Stop Bone Resorption or the Loss of Bone Induced by Unloading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANICAL STIMULATION; OSTEOCLAST FORMATION; M-CSF; BISPHOSPHONATES; CONNEXIN-43; EXPRESSION; OSTEOBLAST; OPG; GLUCOCORTICOIDS; REQUIREMENT	Apoptosis of osteocytes and osteoblasts precedes bone resorption and bone loss with reduced mechanical stimulation, and receptor activator of NF-kappa B ligand (RANKL) expression is increased with unloading in mice. Because osteocytes are major RANKL producers, we hypothesized that apoptotic osteocytes signal to neighboring osteocytes to increase RANKL expression, which, in turn, increases osteoclastogenesis and bone resorption. The traditional bisphosphonate (BP) alendronate (Aln) or IG9402, a BP analog that does not inhibit resorption, prevented the increase in osteocyte apoptosis and osteocytic RANKL expression. The BPs also inhibited osteoblast apoptosis but did not prevent the increase in osteoblastic RANKL. Unloaded mice exhibited high serum levels of the bone resorption marker C-telopeptide fragments of type I collagen (CTX), elevated osteoclastogenesis, and increased osteoclasts in bone. Aln, but not IG9402, prevented all of these effects. In addition, Aln prevented the reduction in spinal and femoral bone mineral density, spinal bone volume/tissue volume, trabecular thickness, mechanical strength, and material strength induced by unloading. Although IG9402 did not prevent the loss of bone mass, it partially prevented the loss of strength, suggesting a contribution of osteocyte viability to strength independent of bone mass. These results demonstrate that osteocyte apoptosis leads to increased osteocytic RANKL. However, blockade of these events is not sufficient to restrain osteoclast formation, inhibit resorption, or stop bone loss induced by skeletal unloading.	[Plotkin, Lilian I.; Gortazar, Arancha R.; Davis, Hannah M.; Condon, Keith W.; Gabilondo, Hugo; Maycas, Marta; Allen, Matthew R.; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Div Endocrinol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Plotkin, Lilian I.; Bellido, Teresita] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Plotkin, LI (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 5035, Indianapolis, IN 46202 USA.	lplotkin@iupui.edu; tbellido@iupui.edu	Plotkin, Lilian/H-7188-2019; Gortazar, Arancha/G-5385-2017; Gabilondo, Hugo/B-7138-2016; Regan, Clinton/E-6250-2012; Maycas, Marta/L-8145-2014	Plotkin, Lilian/0000-0002-9537-4544; Gortazar, Arancha/0000-0001-5072-3141; Maycas, Marta/0000-0002-9178-743X	National Institutes of Health [R01DK076007]; ARRA [S10-RR023710, R01AR053643]; Veterans Affairs Merit Award [I01BX002104]; IUSM Biomedical Research grant; Conchita Rabago Foundation; European Molecular Biology Organization; Universidad Autonoma de Madrid; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053643, R01AR067210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA; Veterans Affairs Merit Award(US Department of Veterans Affairs); IUSM Biomedical Research grant; Conchita Rabago Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Universidad Autonoma de Madrid; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK076007 and ARRA supplement S10-RR023710 (to T.B.) and R01AR053643 (to L.I.P.). This work was also supported by Veterans Affairs Merit Award I01BX002104 (to T. B.) and an IUSM Biomedical Research grant (to L. I. P.) and by scholarships from the Conchita Rabago Foundation (to A. R. G. and M. M.), the European Molecular Biology Organization (to M. M.), and Universidad Autonoma de Madrid (to H. G). The authors declare that they have no conflicts of interest with the contents of this article.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Bakker A, 2004, BIOCHEM BIOPH RES CO, V320, P1163, DOI 10.1016/j.bbrc.2004.06.056; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bellido T, 2014, CALCIFIED TISSUE INT, V94, P25, DOI 10.1007/s00223-013-9774-y; Bellido T, 2010, J CELL BIOCHEM, V111, P1, DOI 10.1002/jcb.22660; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Cheung MS, 2009, J BONE MINER RES, V24, P669, DOI [10.1359/jbmr.081225, 10.1359/JBMR.081225]; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Eslami B, 2011, CALCIFIED TISSUE INT, V88, P272, DOI 10.1007/s00223-011-9473-5; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Martini G, 2007, BONE, V40, P457, DOI 10.1016/j.bone.2006.08.003; Martini G, 2006, HAEMATOLOGICA, V91, P1720; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Ohe JY, 2012, CLIN ORAL INVEST, V16, P1153, DOI 10.1007/s00784-011-0614-z; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]; Plotkin LI, 2006, BONE, V39, P443, DOI 10.1016/j.bone.2006.02.060; Plotkin LI, 2014, CURR OSTEOPOROS REP, V12, P121, DOI 10.1007/s11914-014-0194-3; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rogers MJ, 2011, BONE, V49, P34, DOI 10.1016/j.bone.2010.11.008; Sanders JM, 2004, J MED CHEM, V47, P375, DOI 10.1021/jm0303709; Szymczak J, 2013, HORM METAB RES, V45, P759, DOI 10.1055/s-0033-1349842; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tsubaki M, 2012, MOL CELL ENDOCRINOL, V361, P219, DOI 10.1016/j.mce.2012.05.002; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	41	63	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18934	18942		10.1074/jbc.M115.642090	http://dx.doi.org/10.1074/jbc.M115.642090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085098	Green Published, hybrid			2022-12-28	WOS:000358781100006
J	He, YN; Chen, YH; Mooney, SM; Rajagopalan, K; Bhargava, A; Sacho, E; Weninger, K; Bryan, PN; Kulkarni, P; Orban, J				He, Yanan; Chen, Yihong; Mooney, Steven M.; Rajagopalan, Krithika; Bhargava, Ajay; Sacho, Elizabeth; Weninger, Keith; Bryan, Philip N.; Kulkarni, Prakash; Orban, John			Phosphorylation-induced Conformational Ensemble Switching in an Intrinsically Disordered Cancer/Testis Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENIGN PROSTATIC HYPERPLASIA; C-JUN; ANDROGEN RECEPTOR; STRESS-RESPONSE; BACKBONE DYNAMICS; PROTEIN FOLDS; CANCER; TRANSACTIVATION; NMR; EXPRESSION	Prostate-associated gene 4 (PAGE4) is an intrinsically disordered cancer/testis antigen that is up-regulated in the fetal and diseased human prostate. Knocking down PAGE4 expression results in cell death, whereas its overexpression leads to a growth advantage of prostate cancer cells (Zeng, Y., He, Y., Yang, F., Mooney, S. M., Getzenberg, R. H., Orban, J., and Kulkarni, P. (2011) The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J. Biol. Chem. 286, 13985-13994). Phosphorylation of PAGE4 at Thr-51 is critical for potentiating c-Jun transactivation, an important factor in controlling cell growth, apoptosis, and stress response. Using NMR spectroscopy, we show that the PAGE4 polypeptide chain has local and long-range conformational preferences that are perturbed by site-specific phosphorylation at Thr-51. The population of transient turn-like structures increases upon phosphorylation in an similar to 20-residue acidic region centered on Thr-51. This central region therefore becomes more compact and more negatively charged, with increasing intramolecular contacts to basic sequence motifs near the N and C termini. Although flexibility is decreased in the central region of phospho-PAGE4, the polypeptide chain remains highly dynamic overall. PAGE4 utilizes a transient helical structure adjacent to the central acidic region to bind c-Jun with low affinity in vitro. The binding interaction is attenuated by phosphorylation at Thr-51, most likely because of masking the effects of the more compact phosphorylated state. Therefore, phosphorylation of PAGE4 leads to conformational shifts in the dynamic ensemble, with large functional consequences. The changes in the structural ensemble induced by posttranslational modifications are similar conceptually to the conformational switching events seen in some marginally stable ("metamorphic") folded proteins in response to mutation or environmental triggers.	[He, Yanan; Chen, Yihong; Bryan, Philip N.; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [He, Yanan; Chen, Yihong; Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Mooney, Steven M.; Rajagopalan, Krithika; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA; [Bhargava, Ajay] Shakti BioRes, Woodbridge, CT 06525 USA; [Sacho, Elizabeth; Weninger, Keith] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; University of North Carolina; North Carolina State University	Orban, J (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	pkulkar4@ibbr.umd.edu; jorban@umd.edu	Regan, Clinton/E-6250-2012; Rajagopalan, Krithika/AAZ-7034-2021	Rajagopalan, Krithika/0000-0002-9090-7022; , keith/0000-0001-9543-4992	National Institutes of Health [CA181730, GM62154]; University of Maryland; National Institute of Standards and Technology; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [R21CA181730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grants CA181730 (to J. O. and P. K.) and GM62154 (to J. O. and P. B.). The NMR facility is jointly supported by the University of Maryland, the National Institute of Standards and Technology, and a grant from the W. M. Keck Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Andresen C, 2012, NUCLEIC ACIDS RES, V40, P6353, DOI 10.1093/nar/gks263; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bista M, 2013, P NATL ACAD SCI USA, V110, P17814, DOI 10.1073/pnas.1317398110; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Bull JH, 2001, BRIT J CANCER, V84, P1512, DOI 10.1054/bjoc.2001.1816; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Cordek DG, 2014, J BIOL CHEM, V289, P24397, DOI 10.1074/jbc.M114.589911; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dobrynin P, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/105108; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goddard T.D., 2004, SPARKY 3; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; He YA, 2012, STRUCTURE, V20, P283, DOI 10.1016/j.str.2011.11.018; Hellman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026633; Huang KL, 2013, RNA, V19, P295, DOI 10.1261/rna.037317.112; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Kalejs M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-4; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li WH, 2007, AM J PATHOL, V171, P1189, DOI 10.2353/ajpath.2007.070285; Lin-Tsai O, 2014, PROSTATE, V74, P669, DOI 10.1002/pros.22785; Mooney SM, 2014, BIOCHEMISTRY-US, V53, P1670, DOI 10.1021/bi500013w; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; ORBAN J, 1995, BIOCHEMISTRY-US, V34, P15291, DOI 10.1021/bi00046a038; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Plaxco KW, 1997, J BIOMOL NMR, V10, P221, DOI 10.1023/A:1018340217891; Prakash K, 2002, P NATL ACAD SCI USA, V99, P7598, DOI 10.1073/pnas.112191399; Rajagopalan K, 2014, BBA-MOL BASIS DIS, V1842, P154, DOI 10.1016/j.bbadis.2013.11.014; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Ruan B, 2004, BIOCHEMISTRY-US, V43, P14539, DOI 10.1021/bi048177j; Saito H, 2010, PROG NUCL MAG RES SP, V57, P181, DOI 10.1016/j.pnmrs.2010.04.005; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sampson N, 2012, AM J PATHOL, V181, P1443, DOI 10.1016/j.ajpath.2012.06.040; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Stott K, 2014, J BIOL CHEM, V289, P29817, DOI 10.1074/jbc.M114.591115; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Trudeau T, 2013, STRUCTURE, V21, P332, DOI 10.1016/j.str.2012.12.013; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Zeng Y, 2013, AM J CLIN EXP UROL, V1, P39; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	64	40	40	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25090	25102		10.1074/jbc.M115.658583	http://dx.doi.org/10.1074/jbc.M115.658583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26242913	Green Published, hybrid			2022-12-28	WOS:000362598300037
J	Georgiou, DK; Dagnino-Acosta, A; Lee, CS; Griffin, DM; Wang, H; Lagor, WR; Pautler, RG; Dirksen, RT; Hamilton, SL				Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Lee, Chang Seok; Griffin, Deric M.; Wang, Hui; Lagor, William R.; Pautler, Robia G.; Dirksen, Robert T.; Hamilton, Susan L.			Ca2+ Binding/Permeation via Calcium Channel, Ca(v)1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; S-NITROSYLATION; MITOCHONDRIAL-MEMBRANE; INSULIN-RESISTANCE; BETA-OXIDATION; COA; FAT/CD36; PHOSPHORYLATION; EXPRESSION	Ca2+ permeation and/or binding to the skeletal muscle L-type Ca2+ channel (Ca(V)1.1) facilitates activation of Ca2+ /calmodulin kinase type II (CaMKII) and Ca2+ store refilling to reduce muscle fatigue and atrophy (Lee, C. S., Dagnino-Acosta, A., Yarotskyy, V., Hanna, A., Lyfenko, A., Knoblauch, M., Georgiou, D. K., Poche, R. A., Swank, M. W., Long, C., Ismailov, I. I., Lanner, J., Tran, T., Dong, K., Rodney, G. G., Dickinson, M. E., Beeton, C., Zhang, P., Dirksen, R. T., and Hamilton, S. L. (2015) Skelet. Muscle 5, 4). Mice with a mutation (E1014K) in the Cacna1s (alpha(1) subunit of Ca(V)1.1) gene that abolishes Ca2+ binding within the Ca(V)1.1 pore gain more body weight and fat on a chow diet than control mice, without changes in food intake or activity, suggesting that Ca(V)1.1-mediated CaMKII activation impacts muscle energy expenditure. We delineate a pathway (Ca(v)1.1 -> CaMKII -> NOS) in normal skeletal muscle that regulates the intracellular distribution of the fatty acid transport protein, CD36, altering fatty acid metabolism. The consequences of blocking this pathway are decreased mitochondrial beta-oxidation and decreased energy expenditure. This study delineates a previously uncharacterized Ca(V)1.1-mediated pathway that regulates energy utilization in skeletal muscle.	[Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Lee, Chang Seok; Griffin, Deric M.; Wang, Hui; Lagor, William R.; Pautler, Robia G.; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Baylor College of Medicine; University of Rochester	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, One Baylor Plaza, Houston, TX 77030 USA.	susanh@bcm.edu	Regan, Clinton/E-6250-2012; Dagnino-Acosta, Adan/K-6786-2012; Wang, Hui J./AAT-7096-2020	Wang, Hui J./0000-0003-2654-0243; Dagnino-Acosta, Adan/0000-0001-8903-807X; Lagor, William/0000-0002-1703-5125; Hamilton, Susan/0000-0003-0241-9369	National Institutes of Health [P30 DK079638]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R01AR053349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the staff of the BCM core facilities (supported by National Institutes of Health Grant P30 DK079638).	Agostino PV, 2004, NEUROCHEM INT, V44, P617, DOI 10.1016/j.neuint.2003.09.005; Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028981; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Balon TW, 1997, J APPL PHYSIOL, V82, P359, DOI 10.1152/jappl.1997.82.1.359; Bays HE, 2009, AM J MED, V122, pS26, DOI 10.1016/j.amjmed.2008.10.015; CHANDLER WK, 1976, J PHYSIOL-LONDON, V254, P245, DOI 10.1113/jphysiol.1976.sp011232; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Holloway GP, 2008, ACTA PHYSIOL, V194, P293, DOI 10.1111/j.1748-1716.2008.01878.x; Isaeva E.V., 2003, J PHYSIOL-LONDON, V547, P453; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jeppesen J, 2010, J LIPID RES, V51, P1504, DOI 10.1194/jlr.M003756; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwak YD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-49; Lee CS, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0027-1; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Smith BK, 2012, EXERC SPORT SCI REV, V40, P211, DOI 10.1097/JES.0b013e31825eb263; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Stefanyk LE, 2012, METABOLISM, V61, P1518, DOI 10.1016/j.metabol.2012.04.002; Steinbusch LKM, 2011, CELL MOL LIFE SCI, V68, P2525, DOI 10.1007/s00018-011-0690-x; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yoshida Y, 2013, J PHYSIOL-LONDON, V591, P4415, DOI 10.1113/jphysiol.2012.238451; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	23	23	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23751	23765		10.1074/jbc.M115.643544	http://dx.doi.org/10.1074/jbc.M115.643544			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245899	Green Published, hybrid			2022-12-28	WOS:000361816500023
J	Lin, L; Gopal, S; Sharda, A; Passam, F; Bowley, SR; Stopa, J; Xue, GP; Yuan, C; Furie, BC; Flaumenhaft, R; Huang, MD; Furie, B				Lin, Lin; Gopal, Srila; Sharda, Anish; Passam, Freda; Bowley, Sheryl R.; Stopa, Jack; Xue, Guangpu; Yuan, Cai; Furie, Barbara C.; Flaumenhaft, Robert; Huang, Mingdong; Furie, Bruce			Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b ' x Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; THROMBUS FORMATION; PLATELET; FIBRIN; HEMOSTASIS; MOUSE	Quercetin-3-rutinoside inhibits thrombus formation in a mouse model by inhibiting extracellular protein disulfide isomerase (PDI), an enzyme required for platelet thrombus formation and fibrin generation. Prior studies have identified PDI as a potential target for novel antithrombotic agents. Using a fluorescence enhancement-based assay and isothermal calorimetry, we show that quercetin-3-rutinoside directly binds to the b'domain of PDI with a 1: 1 stoichiometry. The binding of quercetin-3-rutinoside to PDI induces a more compact conformation and restricts the conformational flexibility of PDI, as revealed by small angle x-ray scattering. The binding sites of quercetin-3-rutinoside to PDI were determined by studying its interaction with isolated fragments of PDI. Quercetin-3-rutinoside binds to the b'x domain of PDI. The infusion of the b'x fragment of PDI rescued thrombus formation that was inhibited by quercetin-3-rutinoside in a mouse thrombosis model. This b'x fragment does not possess reductase activity and, in the absence of quercetin-3-rutinoside, does not affect thrombus formation in vivo. The isolated b'domain of PDI has potential as an antidote to reverse the antithrombotic effect of quercetin-3-rutinoside by binding and neutralizing quercetin-3-rutinoside.	[Lin, Lin; Gopal, Srila; Sharda, Anish; Passam, Freda; Bowley, Sheryl R.; Stopa, Jack; Furie, Barbara C.; Flaumenhaft, Robert; Huang, Mingdong; Furie, Bruce] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02115 USA; [Lin, Lin; Gopal, Srila; Sharda, Anish; Passam, Freda; Bowley, Sheryl R.; Stopa, Jack; Furie, Barbara C.; Flaumenhaft, Robert; Huang, Mingdong; Furie, Bruce] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Xue, Guangpu; Yuan, Cai] Chinese Acad Sci, Fujian Inst Res Struct Matter, Fuzhou 350002, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Furie, B (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Life Sci, Dept Med, Div Hemostasis Thrombosis, 3 Blackfan Circle, Boston, MA 02215 USA.	bfurie@bidmc.harvard.edu	Passam, Freda/AAC-2005-2019; Huang, Mingdong/J-4278-2017	Passam, Freda/0000-0003-4584-2044; Huang, Mingdong/0000-0003-0085-9141; Gopal, Srila/0000-0003-2732-3216	Department of Energy Office of Biological and Environmental Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007917, U54HL112302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SAXS experiments were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by the Department of Energy Office of Biological and Environmental Research.	Bellido-Martin L, 2011, THROMB HAEMOSTASIS, V105, P776, DOI 10.1160/TH10-12-0771; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; Cho J, 2013, J THROMB HAEMOST, V11, P2084, DOI 10.1111/jth.12413; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532; Dubois C, 2007, PLATELETS, 2ND EDITION, P611, DOI 10.1016/B978-012369367-9/50796-5; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Flaumenhaft R, 2015, ARTERIOSCL THROM VAS, V35, P16, DOI 10.1161/ATVBAHA.114.303410; Furie B, 2014, CIRC RES, V114, P1162, DOI 10.1161/CIRCRESAHA.114.301808; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Nakasako M, 2010, BIOCHEMISTRY-US, V49, P6953, DOI 10.1021/bi1006089; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Passam FH, 2015, BLOOD, V125, P2276, DOI 10.1182/blood-2013-12-547208; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Wu Y, 2012, BLOOD, V119, P1737, DOI 10.1182/blood-2011-06-360685	27	60	60	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23543	23552		10.1074/jbc.M115.666180	http://dx.doi.org/10.1074/jbc.M115.666180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240139	Green Published, hybrid			2022-12-28	WOS:000361816500007
J	Martin-Tumasz, S; Brow, DA				Martin-Tumasz, Stephen; Brow, David A.			Saccharomyces cerevisiae Sen1 Helicase Domain Exhibits 5 ' -to 3 '-Helicase Activity with a Preference for Translocation on DNA Rather than RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II; SPLICING ENDONUCLEASE; EARLY TERMINATION; BUDDING YEAST; GENE; PROTEIN; MUTATIONS; TRANSCRIPTION; SENATAXIN; BINDING	In the yeast Saccharomyces cerevisiae, the essential nuclear helicase Sen1 is required for efficient termination of transcription of short noncoding RNA genes by RNA polymerase II. However, the mechanism by which Sen1 promotes transcription termination is not known. Prior biochemical studies on the Sen1 homolog from Schizosaccharomyces pombe showed that it can bind and unwind both DNA and RNA, but the S. pombe protein is not essential and has not been demonstrated to function in transcription. Furthermore, Sen1 from either yeast has not previously been expressed as a recombinant protein, due to its large molecular mass (252 kDa in S. cerevisiae). Here, we report the purification and characterization of the 89-kDa S. cerevisiae Sen1 helicase domain (Sen1-HD) produced in Escherichia coli. Sen1-HD binds single-stranded RNA and DNA with similar affinity in the absence of ATP, but it binds RNA more stably than DNA in the presence of ATP, apparently due to a slower translocation rate on RNA. Translocation occurs in the 5' to 3'direction, as for the S. pombe protein. When purified from E. coli at a moderate salt concentration, Sen1-HD was associated with short RNAs that are enriched for the trinucleotide repeat (CAN) 4. We propose that Sen1 binds to RNA sand prevents their stable pairing with DNA, consistent with in vivo studies by others showing increased R-loop (RNA/DNA hybrid) formation when Sen1 activity is impaired by mutations. Our results are consistent with a model in which Sen1 promotes transcription termination by resolving R-loops.	[Martin-Tumasz, Stephen; Brow, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Brow, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dabrow@wisc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 GM082956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM082956 (to D. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Castelnuovo M, 2014, NUCLEIC ACIDS RES, V42, P4348, DOI 10.1093/nar/gku100; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chan YJA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004288; Chen X, 2014, GENETICS, V198, P577, DOI 10.1534/genetics.114.167585; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; CZAPLINSKI K, 1995, RNA, V1, P610; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Guenther UP, 2009, HUM MOL GENET, V18, P1288, DOI 10.1093/hmg/ddp028; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Lim SC, 2012, NUCLEIC ACIDS RES, V40, P11009, DOI 10.1093/nar/gks792; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; WINEY M, 1988, GENETICS, V118, P609	30	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22880	22889		10.1074/jbc.M115.674002	http://dx.doi.org/10.1074/jbc.M115.674002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26198638	Green Published, hybrid			2022-12-28	WOS:000361685500002
J	Meekins, DA; Raththagala, M; Auger, KD; Turner, BD; Santelia, D; Kotting, O; Gentry, MS; Kooi, CWV				Meekins, David A.; Raththagala, Madushi; Auger, Kyle D.; Turner, Benjamin D.; Santelia, Diana; Koetting, Oliver; Gentry, Matthew S.; Kooi, Craig W. Vander			Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; SPECIFICITY PROTEIN PHOSPHATASE; CARBOHYDRATE-BINDING DOMAIN; LAFORA-DISEASE; WATER DIKINASE; STARCH DEGRADATION; ARABIDOPSIS LEAVES; TYROSINE PHOSPHATASES; CORPORA-AMYLACEA; R1 PROTEIN	Glucan phosphatases are central to the regulation of starch and glycogen metabolism. Plants contain two known glucan phosphatases, Starch EXcess4 (SEX4) and Like Sex Four2 (LSF2), which dephosphorylate starch. Starch is water-insoluble and reversible phosphorylation solubilizes its outer surface allowing processive degradation. Vertebrates contain a single known glucan phosphatase, laforin, that dephosphorylates glycogen. In the absence of laforin, water-soluble glycogen becomes insoluble, leading to the neurodegenerative disorder Lafora Disease. Because of their essential role in starch and glycogen metabolism glucan phosphatases are of significant interest, yet a comparative analysis of their activities against diverse glucan substrates has not been established. We identify active site residues required for specific glucan dephosphorylation, defining a glucan phosphatase signature motif (C zeta AG Psi GR) in the active site loop. We further explore the basis for phosphate position-specific activity of these enzymes and determine that their diverse phosphate position-specific activity is governed by the phosphatase domain. In addition, we find key differences in glucan phosphatase activity toward soluble and insoluble polyglucan substrates, resulting from the participation of ancillary glucan-binding domains. Together, these data provide fundamental insights into the specific activity of glucan phosphatases against diverse polyglucan substrates.	[Meekins, David A.; Raththagala, Madushi; Auger, Kyle D.; Turner, Benjamin D.; Gentry, Matthew S.; Kooi, Craig W. Vander] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Meekins, David A.; Raththagala, Madushi; Auger, Kyle D.; Turner, Benjamin D.; Gentry, Matthew S.; Kooi, Craig W. Vander] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Santelia, Diana] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Koetting, Oliver] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland	University of Kentucky; University of Kentucky; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gentry, MS (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone Ave, Lexington, KY 40536 USA.	matthew.gentry@uky.edu; craig.vanderkooi@uky.edu	Santelia, Diana/AAQ-3967-2020; Regan, Clinton/E-6250-2012; Kötting, Oliver/L-5325-2013; Raththagala, Madushi/AAU-5254-2020	Kötting, Oliver/0000-0002-8977-5907; Raththagala, Madushi/0000-0001-6227-6203	National Institutes of Health [R01NS070899, P20GM103486]; KSEF [KSEF-2268RDE-014, KSEF-2971-RDE-017]; Mitzutani Foundation for Glycoscience Award; NSF [IIA-1355438, MCB-1252345]; ETH-Eurich; Swiss-South African Joint Research Program [IZ LS X3122916]; Swiss National Science Foundation SNSF [31003A_147074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSEF; Mitzutani Foundation for Glycoscience Award; NSF(National Science Foundation (NSF)); ETH-Eurich; Swiss-South African Joint Research Program; Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS070899 (to M. S. G), P20GM103486 (to M. S. G. and C. W. V. K.); KSEF grants KSEF-2268RDE-014 and KSEF-2971-RDE-017 (to M. S. G.); Mitzutani Foundation for Glycoscience Award (to M. S. G.); NSF Grants IIA-1355438 (to M. S. G.) and MCB-1252345 (to M. S. G.); the ETH-Eurich (to O. K.), and Swiss-South African Joint Research Program Grant IZ LS X3122916 (to O. K.); Swiss National Science Foundation SNSF-Grant 31003A_147074 (to D. S.). M. S. G. and C. W. V. K. are founders of Opti-Mol Enzymes LLC.	Alonso A, 2003, DUAL SPECIFIC PROTEI; Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Comparot-Moss S, 2010, PLANT PHYSIOL, V152, P685, DOI 10.1104/pp.109.148981; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Fordham-Skelton AP, 2002, PLANT J, V29, P705, DOI 10.1046/j.1365-313X.2002.01250.x; Gallant DJ, 1997, CARBOHYD POLYM, V32, P177, DOI 10.1016/S0144-8617(97)00008-8; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Ganesh S, 2002, HUM MOL GENET, V11, P1263, DOI 10.1093/hmg/11.11.1263; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Hejazi M, 2008, PLANT J, V55, P323, DOI [10.1111/j.1365-313X.2008.03513.x, 10.1111/j.0960-7412.2008.03513.x]; Hejazi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28892; Hejazi M, 2010, PLANT PHYSIOL, V152, P711, DOI 10.1104/pp.109.149914; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kerk D, 2006, PLANT J, V46, P400, DOI 10.1111/j.1365-313X.2006.02704.x; Kotting O, 2010, CURR OPIN PLANT BIOL, V13, P321, DOI 10.1016/j.pbi.2010.01.003; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lafora G. R., 1911, ARCH F, P205; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Mahlow S, 2014, NEW PHYTOL, V203, P495, DOI 10.1111/nph.12801; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Meekins DA, 2013, PLANT CELL, V25, P2302, DOI 10.1105/tpc.113.112706; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; MUHRBECK P, 1991, J SCI FOOD AGR, V55, P13, DOI 10.1002/jsfa.2740550103; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Raththagala M, 2015, MOL CELL, V57, P261, DOI 10.1016/j.molcel.2014.11.020; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; Skeffington AW, 2014, PLANT PHYSIOL, V165, P866, DOI 10.1104/pp.114.237016; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Takeda Y., 1981, CARBOHYD RES, V39, P151; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; YOKOI S, 1967, J NEUROPATH EXP NEUR, V26, P125; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	74	20	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23361	23370		10.1074/jbc.M115.658203	http://dx.doi.org/10.1074/jbc.M115.658203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26231210	Green Published, hybrid			2022-12-28	WOS:000361685500042
J	Napoli, E; Tassone, F; Wong, S; Angkustsiri, K; Simon, TJ; Song, G; Giulivi, C				Napoli, Eleonora; Tassone, Flora; Wong, Sarah; Angkustsiri, Kathleen; Simon, Tony J.; Song, Gyu; Giulivi, Cecilia			Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME; D-2-AND L-2-HYDROXYGLUTARIC ACIDURIA; CREATINE-KINASE ACTIVITY; RAT CEREBRAL-CORTEX; D-2-HYDROXYGLUTARIC ACID; GENE-EXPRESSION; ALPHA-KETOGLUTARATE; OXIDATIVE STRESS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; SPECTRUM DISORDERS	The congenital disorder 22q11.2 deletion syndrome (22qDS), characterized by a hemizygous deletion of 1.5-3 Mb on chromosome 22 at locus 11.2, is the most common microdeletion disorder (estimated prevalence of 1 in 4000) and the second risk factor for schizophrenia. Nine of similar to 30 genes involved in 22qDS have the potential of disrupting mitochondrial metabolism (COMT, UFD1L, DGCR8, MRPL40, PRODH, SLC25A1, TXNRD2, T10, and ZDHHC8). Deficits in bioenergetics during early postnatal brain development could set the basis for a disrupted neuronal metabolism or synaptic signaling, partly explaining the higher incidence in developmental and behavioral deficits in these individuals. Here, we investigated whether mitochondrial outcomes and metabolites from 22qDS children segregated with the altered dosage of one or several of these mitochondrial genes contributing to 22qDS etiology and/or morbidity. Plasma metabolomics, lymphocytic mitochondrial outcomes, and epigenetics (histone H3 Lys-4 trimethylation and 5-methylcytosine) were evaluated in samples from 11 22qDS children and 13 age-and sex-matched neurotypically developing controls. Metabolite differences between 22qDS children and controls reflected a shift from oxidative phosphorylation to glycolysis (higher lactate/pyruvate ratios) accompanied by an increase in reductive carboxylation of alpha-ketoglutarate (increased concentrations of 2-hydroxyglutaric acid, cholesterol, and fatty acids). Altered metabolism in 22qDS reflected a critical role for the haploinsufficiency of the mitochondrial citrate transporter SLC25A1, further enhanced by HIF-1 alpha, MYC, and metabolite controls. This comprehensive profiling served to clarify the biochemistry of this disease underlying its broad, complex phenotype.	[Napoli, Eleonora; Wong, Sarah; Song, Gyu; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Tassone, Flora; Angkustsiri, Kathleen; Simon, Tony J.; Giulivi, Cecilia] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA; [Angkustsiri, Kathleen] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; [Simon, Tony J.] Univ Calif Davis, Med Ctr, Dept Psychiat, Sacramento, CA 95817 USA; [Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Sch Vet Med, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Regan, Clinton/E-6250-2012; Giulivi, Cecilia/AAV-6774-2021; Napoli, Eleonora/AAQ-6079-2021	Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242	National Institutes of Health [NIEHS020392, HD036071]; Simons Foundation [271406]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants NIEHS020392 and HD036071. This work was also supported by Simons Foundation Grant 271406. The authors declare that they have no conflicts of interest with the contents of this article.	Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Baldini A, 2006, THESCIENTIFICWORLDJO, V6, P1881, DOI 10.1100/tsw.2006.317; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Brauburger K, 2011, J INHERIT METAB DIS, V34, P477, DOI 10.1007/s10545-010-9268-2; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Campbell AM, 2002, BBA-BIOMEMBRANES, V1567, P123, DOI 10.1016/S0005-2736(02)00607-7; CASAZZA JP, 1990, TRENDS BIOCHEM SCI, V15, P26, DOI 10.1016/0968-0004(90)90127-W; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Correa-Cerro LS, 2005, J MED GENET, V42, P350, DOI 10.1136/jmg.2004.022749; da Silva CG, 2004, NEUROCHEM INT, V44, P45, DOI 10.1016/S0197-0186(03)00098-6; da Silva CG, 2002, BBA-MOL BASIS DIS, V1586, P81, DOI 10.1016/S0925-4439(01)00088-6; da Silva CG, 2003, EUR J CLIN INVEST, V33, P840, DOI 10.1046/j.1365-2362.2003.01237.x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dean RT, 1997, BIOCHEM J, V324, P1; Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; Fine SE, 2005, J AUTISM DEV DISORD, V35, P461, DOI 10.1007/s10803-005-5036-9; Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hwang VJ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0106-5; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Jurata LW, 2006, SCHIZOPHR RES, V88, P251, DOI 10.1016/j.schres.2006.07.017; Jurevics HA, 1997, J LIPID RES, V38, P723; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; KOWALOFF EM, 1976, METABOLISM, V25, P1087, DOI 10.1016/0026-0495(76)90016-0; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Latini A, 2003, J NEUROSCI RES, V74, P103, DOI 10.1002/jnr.10735; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; McComsey GA, 2008, HIV CLIN TRIALS, V9, P126, DOI 10.1310/hct0902-126; McDonald-McGinn DM, 2006, AM J MED GENET A, V140A, P906, DOI 10.1002/ajmg.a.31199; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Meechan DW, 2011, INT J DEV NEUROSCI, V29, P283, DOI 10.1016/j.ijdevneu.2010.08.005; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; MROCHEK JE, 1972, CLIN CHEM, V18, P821; Muhlhausen C, 2014, J INHERIT METAB DIS, V37, P775, DOI 10.1007/s10545-014-9702-y; MUNEKATA M, 1981, AGR BIOL CHEM TOKYO, V45, P2149, DOI 10.1080/00021369.1981.10864851; Muntau AC, 2000, NEUROPEDIATRICS, V31, P137, DOI 10.1055/s-2000-7497; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545; Napoli E, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-2; Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503; Napoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042504; Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; PENG L, 1991, NEUROCHEM RES, V16, P29, DOI 10.1007/BF00965824; PHANG J M, 1975, Annals of Clinical and Laboratory Science, V5, P298; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Robertson M, 2004, DRUG DISCOV TODAY, V9, P684, DOI 10.1016/S1359-6446(04)03217-9; ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Rutter M., 2003, SOCIAL COMMUNICATION; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schwichtenberg AJ, 2013, AUTISM RES, V6, P169, DOI 10.1002/aur.1278; Sellier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103884; Strauss KA, 2010, BRAIN, V133, P76, DOI 10.1093/brain/awp297; Struys EA, 2005, J INHERIT METAB DIS, V28, P921, DOI 10.1007/s10545-005-0114-x; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Swanson JM., 1995, SNAP 4 SCALE; Tint GS, 2006, J LIPID RES, V47, P1535, DOI 10.1194/jlr.M600141-JLR200; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Turley SD, 1996, J LIPID RES, V37, P1953; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Wajner M, 2002, J INHERIT METAB DIS, V25, P28, DOI 10.1023/A:1015165212965; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang XJ, 2014, J PHARMACEUT BIOMED, V95, P85, DOI 10.1016/j.jpba.2014.02.014	98	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23240	23253		10.1074/jbc.M115.672360	http://dx.doi.org/10.1074/jbc.M115.672360			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26221035	Green Published, hybrid			2022-12-28	WOS:000361685500033
J	Bonnemaison, ML; Back, N; Duffy, ME; Ralle, M; Mains, RE; Eipper, BA				Bonnemaison, Mathilde L.; Back, Nils; Duffy, Megan E.; Ralle, Martina; Mains, Richard E.; Eipper, Betty A.			Adaptor Protein-1 Complex Affects the Endocytic Trafficking and Function of Peptidylglycine alpha-Amidating Monooxygenase, a Luminal Cuproenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; copper; peptide biosynthesis; pituitary gland; secretion; AtT-20; Atp7a; PAM; amidation	GRANULE-ASSOCIATED PROTEINS; AMYLOID PRECURSOR PROTEIN; SECRETORY GRANULE; MEMBRANE-PROTEIN; ATT-20 CELLS; ADRENOCORTICOTROPIN-ENDORPHIN; COPPER TRANSPORTER; JOINING PEPTIDE; MEDNIK SYNDROME; RECEPTOR SORLA	Background: Trafficking of Atp7a, a copper pump, and PAM-1, a cuproenzyme, depends on adaptor protein-1 complex (AP-1). Results: Disruption of AP-1-dependent late endosomal trafficking diminishes the ability of PAM to retain copper and produce amidated peptides. Conclusion: Impaired AP-1 function alters luminal copper delivery to PAM. Significance: Altered luminal cuproenzyme function may contribute to diseases associated with diminished AP-1 function. The adaptor protein-1 complex (AP-1), which transports cargo between the trans-Golgi network and endosomes, plays a role in the trafficking of Atp7a, a copper-transporting P-type ATPase, and peptidylglycine -amidating monooxygenase (PAM), a copper-dependent membrane enzyme. Lack of any of the four AP-1 subunits impairs function, and patients with MEDNIK syndrome, a rare genetic disorder caused by lack of expression of the sigma 1A subunit, exhibit clinical and biochemical signs of impaired copper homeostasis. To explore the role of AP-1 in copper homeostasis in neuroendocrine cells, we used corticotrope tumor cells in which AP-1 function was diminished by reducing expression of its 1A subunit. Copper levels were unchanged when AP-1 function was impaired, but cellular levels of Atp7a declined slightly. The ability of PAM to function was assessed by monitoring 18-kDa fragment-NH2 production from proopiomelanocortin. Reduced AP-1 function made 18-kDa fragment amidation more sensitive to inhibition by bathocuproine disulfonate, a cell-impermeant Cu(I) chelator. The endocytic trafficking of PAM was altered, and PAM-1 accumulated on the cell surface when AP-1 levels were reduced. Reduced AP-1 function increased the Atp7a presence in early/recycling endosomes but did not alter the ability of copper to stimulate its appearance on the plasma membrane. Co-immunoprecipitation of a small fraction of PAM and Atp7a supports the suggestion that copper can be transferred directly from Atp7a to PAM, a process that can occur only when both proteins are present in the same subcellular compartment. Altered luminal cuproenzyme function may contribute to deficits observed when the AP-1 function is compromised.	[Bonnemaison, Mathilde L.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Back, Nils] Univ Helsinki, Fac Med, Dept Anat, FIN-00014 Helsinki, Finland; [Duffy, Megan E.; Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	University of Connecticut; University of Connecticut; University of Helsinki; Oregon Health & Science University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu	Regan, Clinton/E-6250-2012; Ralle, Martina/H-2936-2019	Back, Nils/0000-0001-9992-3726	National Institutes of Health [DK-32949, GM-090016, S10-RR-025512]; Perklen and Liv och Halsa Foundations; Finska Lakaresallskapet; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032949, R37DK032949, R01DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perklen and Liv och Halsa Foundations; Finska Lakaresallskapet; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-32949 (to B. A. E.), GM-090016 (to M. R.), and S10-RR-025512 (to M. R.). This work was also supported by grants from the Perklen and Liv och Halsa Foundations and Finska Lakaresallskapet (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acevedo KM, 2014, J BIOL CHEM, V289, P11007, DOI 10.1074/jbc.M113.538710; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Bell J, 2003, BIOCHEMISTRY-US, V42, P7133, DOI 10.1021/bi034247v; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonnemaison M, 2014, TRAFFIC, V15, P1099, DOI 10.1111/tra.12194; Bousquet-Moore D, 2009, ENDOCRINOLOGY, V150, P1739, DOI 10.1210/en.2008-1202; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; CULLEN EI, 1987, MOL ENDOCRINOL, V1, P583, DOI 10.1210/mend-1-9-583; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; D'Souza RS, 2014, CURR BIOL, V24, P1187, DOI 10.1016/j.cub.2014.04.003; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; EIPPER BA, 1986, J BIOL CHEM, V261, P8686; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holloway ZG, 2013, MOL BIOL CELL, V24, P1735, DOI 10.1091/mbc.E12-08-0625; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Luck AN, 2012, CURR TOP MEMBR, V69, P3, DOI 10.1016/B978-0-12-394390-3.00001-X; MAINS RE, 1978, J BIOL CHEM, V253, P651; MALTESE JY, 1992, MOL ENDOCRINOL, V6, P1998, DOI 10.1210/me.6.12.1998; Martinelli D, 2014, ANN NY ACAD SCI, V1314, P55, DOI 10.1111/nyas.12426; Martinelli D, 2013, BRAIN, V136, P872, DOI 10.1093/brain/awt012; MAY V, 1986, ENDOCRINOLOGY, V118, P1284, DOI 10.1210/endo-118-4-1284; Meskini RE, 2000, ENDOCRINOLOGY, V141, P3020; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Milgram SL, 1996, J BIOL CHEM, V271, P17526, DOI 10.1074/jbc.271.29.17526; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Niciu MJ, 2006, NEUROSCIENCE, V139, P947, DOI 10.1016/j.neuroscience.2006.01.044; Niciu MJ, 2007, NEUROBIOL DIS, V27, P278, DOI 10.1016/j.nbd.2007.05.004; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Orzech E, 2001, J BIOL CHEM, V276, P31340, DOI 10.1074/jbc.M101054200; Otoikhian A, 2012, J AM CHEM SOC, V134, P10458, DOI 10.1021/ja301221s; Perrin L, 2013, J CELL SCI, V126, P4950, DOI 10.1242/jcs.130575; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rajagopal C, 2010, J BIOL CHEM, V285, P34632, DOI 10.1074/jbc.M110.145334; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Traikov S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109372; Willnow TE, 2013, J CELL SCI, V126, P2751, DOI 10.1242/jcs.125393; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	59	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21264	21279		10.1074/jbc.M115.641027	http://dx.doi.org/10.1074/jbc.M115.641027			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170456	hybrid, Green Published			2022-12-28	WOS:000360637600007
J	Ero-Tolliver, IA; Hudson, BG; Bhave, G				Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam			The Ancient Immunoglobulin Domains of Peroxidasin Are Required to Form Sulfilimine Cross-links in Collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basement membrane; extracellular matrix; myeloperoxidase; peroxidase; protein cross-linking; collagen IV; peroxidasin; sulfilimine bond	BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; MYELOPEROXIDASE; EVOLUTION; BINDING; PROTEIN; BONDS	Background: Because peroxidasin generates HOBr to form sulfilimine cross-links in collagen IV, any peroxidase producing HOBr may cross-link collagen IV. Results: Among animal peroxidases, only peroxidasin efficiently cross-linked collagen IV requiring its catalytic and immunoglobulin domains. Conclusion: Peroxidasin uniquely reacts HOBr with collagen IV to catalyze sulfilimine bond formation. Significance: Insight into how peroxidasin cross-links collagen IV is critical to understand basement membrane function. The collagen IV sulfilimine cross-link and its catalyzing enzyme, peroxidasin, represent a dyad critical for tissue development, which is conserved throughout the animal kingdom. Peroxidasin forms novel sulfilimine bonds between opposing methionine and hydroxylysine residues to structurally reinforce the collagen IV scaffold, a function critical for basement membrane and tissue integrity. However, the molecular mechanism underlying cross-link formation remains unclear. In this work, we demonstrate that the catalytic domain of peroxidasin and its immunoglobulin (Ig) domains are required for efficient sulfilimine bond formation. Thus, these molecular features underlie the evolutionarily conserved function of peroxidasin in tissue development and integrity and distinguish peroxidasin from other peroxidases, such as myeloperoxidase (MPO) and eosinophil peroxidase (EPO).	[Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Ero-Tolliver, Isi A.; Hudson, Billy G.; Bhave, Gautam] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bhave, G (corresponding author), S-3223 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	gautam.bhave@vanderbilt.edu	Ero-Tolliver, Isi/AAD-6038-2019; Regan, Clinton/E-6250-2012	Hudson, Billy/0000-0002-5420-4100	National Institutes of Health [R01 DK18381, R01 DK 18381-38S1, K08 DK 097306]; Burroughs-Wellcome Fund Career Award for Medical Scientists [13030995]; Vanderbilt University Division of Nephrology Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097306, R01DK018381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Vanderbilt University Division of Nephrology Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK18381 (to B. G. H.), R01 DK 18381-38S1 (to I. A. E-T.), and K08 DK 097306 (to G. B.) and a Burroughs-Wellcome Fund Career Award for Medical Scientists (13030995) and developmental funds from the Vanderbilt University Division of Nephrology & Hypertension (to G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldus S, 2001, J CLIN INVEST, V108, P1759; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Kubala L, 2013, BBA-GEN SUBJECTS, V1830, P4524, DOI 10.1016/j.bbagen.2013.05.024; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Obinger C, 2006, ARCH BIOCHEM BIOPHYS, V445, P197, DOI 10.1016/j.abb.2005.10.015; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Rees MD, 2010, MATRIX BIOL, V29, P63, DOI 10.1016/j.matbio.2009.09.005; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Soudi M, 2015, J BIOL CHEM, V290, P10876, DOI 10.1074/jbc.M114.632273; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950	27	24	25	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21741	21748		10.1074/jbc.M115.673996	http://dx.doi.org/10.1074/jbc.M115.673996			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178375	Green Published, hybrid			2022-12-28	WOS:000360637600045
J	Shashikanth, N; Petrova, YI; Park, S; Chekan, J; Maiden, S; Spano, M; Ha, T; Gumbiner, BM; Leckband, DE				Shashikanth, Nitesh; Petrova, Yuliya I.; Park, Seongjin; Chekan, Jillian; Maiden, Stephanie; Spano, Martha; Ha, Taekjip; Gumbiner, Barry M.; Leckband, Deborah E.			Allosteric Regulation of E-Cadherin Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cadherin-1 (CDH1) (epithelial cadherin) (E-cadherin); catenin; cell adhesion; kinetics	LIGAND BINDING-KINETICS; CELL-ADHESION; ALPHA-CATENIN; LATERAL DIMERIZATION; TISSUE MORPHOGENESIS; P120 CATENIN; MUTATIONS; DOMAIN; PHOSPHORYLATION; CONFORMATIONS	Background: Measured binding kinetics between Colo 205 cells tested the postulate that E-cadherin adhesion is allosterically regulated. Results: p120 catenin dephosphorylation or cell treatment with activating anti-E-cadherin antibody increased E-cadherin binding affinities by 2-3-fold. Conclusion: Perturbations that do not directly affect the binding site enhanced the adhesive function of E-cadherin. Significance: These biophysical measurements demonstrated that E-cadherin is allosterically regulated. Cadherins are transmembrane adhesion proteins that maintain intercellular cohesion in all tissues, and their rapid regulation is essential for organized tissue remodeling. Despite some evidence that cadherin adhesion might be allosterically regulated, testing of this has been hindered by the difficulty of quantifying altered E-cadherin binding affinity caused by perturbations outside the ectodomain binding site. Here, measured kinetics of cadherin-mediated intercellular adhesion demonstrated quantitatively that treatment with activating, anti-E-cadherin antibodies or the dephosphorylation of a cytoplasmic binding partner, p120(ctn), increased the homophilic binding affinity of E-cadherin. Results obtained with Colo 205 cells, which express inactive E-cadherin and do not aggregate, demonstrated that four treatments, which induced Colo 205 aggregation and p120(ctn) dephosphorylation, triggered quantitatively similar increases in E-cadherin affinity. Several processes can alter cell aggregation, but these results directly demonstrated the allosteric regulation of cell surface E-cadherin by p120(ctn) dephosphorylation.	[Shashikanth, Nitesh; Ha, Taekjip; Leckband, Deborah E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Park, Seongjin; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Chekan, Jillian; Leckband, Deborah E.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Petrova, Yuliya I.; Maiden, Stephanie; Spano, Martha; Gumbiner, Barry M.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; Howard Hughes Medical Institute	Leckband, DE (corresponding author), Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	leckband@illinois.edu	Regan, Clinton/E-6250-2012; Ha, Taekjip/B-9506-2009; Park, Seongjin/AAU-9963-2020	Ha, Taekjip/0000-0003-2195-6258; Shashikanth, Nitesh/0000-0003-4114-8178; Maiden, Stephanie/0000-0002-5144-386X	National Institutes of Health [RO1 GM097443, R01 GM106659]; National Science Foundation (NSF) [CMMI 10-29871, PHY-1147498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097443, R01GM106659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM097443 (to D.E.L.) and R01 GM106659 (to B.M.G.). This work was also supported by National Science Foundation (NSF) Grants CMMI 10-29871 (to D.E.L.) and PHY-1147498 (to T.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Chen XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008411; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Chien YH, 2008, J BIOL CHEM, V283, P1848, DOI 10.1074/jbc.M708044200; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Ciesiolka M, 2004, J CELL SCI, V117, P4325, DOI 10.1242/jcs.01298; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Daneshjou N, 2015, J CELL BIOL, V208, P23, DOI 10.1083/jcb.201409108; Daszykowski M, 2002, J CHEM INF COMP SCI, V42, P500, DOI 10.1021/ci010384s; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huber O, 1999, J CELL SCI, V112, P4415; Hunter R., 1989, FDN COLLOID SCI, P440; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Itoh K, 2010, P NATL ACAD SCI USA, V107, P7775, DOI 10.1073/pnas.0912978107; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; KOFLER R, 1977, J IMMUNOL METHODS, V16, P201, DOI 10.1016/0022-1759(77)90198-3; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Law SM, 2014, P NATL ACAD SCI USA, V111, P12067, DOI 10.1073/pnas.1405831111; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; OZAWA M, 1990, MECH DEVELOP, V33, P49, DOI 10.1016/0925-4773(90)90134-8; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Prakasam A, 2006, BIOCHEMISTRY-US, V45, P6930, DOI 10.1021/bi060213m; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tabdili H, 2012, J CELL SCI, V125, P4362, DOI 10.1242/jcs.105775; Tabdili H, 2012, J CELL SCI, V125, P3299, DOI 10.1242/jcs.087395; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Thoumine O, 2005, BIOPHYS J, V89, pL40, DOI 10.1529/biophysj.105.071688; Tsuiji H, 2007, J BIOL CHEM, V282, P12871, DOI 10.1074/jbc.M611725200; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Wu Y, 2015, DEV CELL, V32, P139, DOI 10.1016/j.devcel.2014.12.003; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Xia XB, 2004, HYBRIDOMA HYBRIDOM, V23, P343, DOI 10.1089/hyb.2004.23.343; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Xia XB, 2006, EXP CELL RES, V312, P3336, DOI 10.1016/j.yexcr.2006.07.007; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	78	31	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21749	21761		10.1074/jbc.M115.657098	http://dx.doi.org/10.1074/jbc.M115.657098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175155	hybrid, Green Published			2022-12-28	WOS:000360637600046
J	Vittal, V; Stewart, MD; Brzovic, PS; Klevit, RE				Vittal, Vinayak; Stewart, Mikaela D.; Brzovic, Peter S.; Klevit, Rachel E.			Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						E3 ubiquitin ligase; parkin; ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); RING; cullin; ubiquitin regulation; HECT	QUALITY-CONTROL COMPLEX; STRUCTURAL BASIS; H2A UBIQUITYLATION; CONGENITAL ABNORMALITIES; LIGATION MECHANISM; MULTIPLE-MYELOMA; MESSENGER-RNAS; WW DOMAINS; RING; THALIDOMIDE	Since its discovery as a post-translational signal for protein degradation, our understanding of ubiquitin (Ub) has vastly evolved. Today, we recognize that the role of Ub signaling is expansive and encompasses diverse processes including cell division, the DNA damage response, cellular immune signaling, and even organismal development. With such a wide range of functions comes a wide range of regulatory mechanisms that control the activity of the ubiquitylation machinery. Ub attachment to substrates occurs through the sequential action of three classes of enzymes, E1s, E2s, and E3s. In humans, there are 2 E1s, approximate to 35 E2s, and hundreds of E3s that work to attach Ub to thousands of cellular substrates. Regulation of ubiquitylation can occur at each stage of the stepwise Ub transfer process, and substrates can also impact their own modification. Recent studies have revealed elegant mechanisms that have evolved to control the activity of the enzymes involved. In this minireview, we highlight recent discoveries that define some of the various mechanisms by which the activities of E3-Ub ligases are regulated.	[Vittal, Vinayak; Stewart, Mikaela D.; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357742, Seattle, WA 98195 USA.	klevit@uw.edu	Klevit, Rachel/AAI-7038-2021; Stewart, Mikaela/GXN-3417-2022	Klevit, Rachel/0000-0002-3476-969X; Stewart, Mikaela/0000-0002-0809-9469	National Institutes of Health through NIGMS [RO1 GM088055, R01 GM098503]; National Institutes of Health through NCI [T32 CA080416]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098503, R01GM088055] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health through NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM088055 (to R. E. K.) and R01 GM098503 (to P. S. B.) through the NIGMS and T32 CA080416 (to M. D. S.) through the NCI. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dove KK, 2013, CURR BIOL, V23, pR691, DOI 10.1016/j.cub.2013.07.039; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jia LY, 2011, MOL CELL, V44, P681, DOI 10.1016/j.molcel.2011.11.012; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kathania M, 2015, J IMMUNOL, V194, P2160, DOI 10.4049/jimmunol.1402742; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; LENZ W, 1962, LANCET, V1, P45; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; MCBRIDE WG, 1961, LANCET, V2, P1358; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Mergner J, 2015, PLANT CELL, V27, P741, DOI 10.1105/tpc.114.135996; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Muller J, 2014, NATURE, V514, P572, DOI 10.1038/514572a; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Taherbhoy AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8621; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	81	58	61	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21244	21251		10.1074/jbc.R115.675165	http://dx.doi.org/10.1074/jbc.R115.675165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26187467	hybrid, Green Published			2022-12-28	WOS:000360637600005
J	Fedeles, BI; Singh, V; Delaney, JC; Li, DY; Essigmann, JM				Fedeles, Bogdan I.; Singh, Vipender; Delaney, James C.; Li, Deyu; Essigmann, John M.			The AlkB Family of Fe(II)/alpha-Ketoglutarate-dependent Dioxygenases: Repairing Nucleic Acid Alkylation Damage and Beyond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESPONSE PROTEIN ALKB; AP LYASE ACTIVITY; ESCHERICHIA-COLI; DNA-REPAIR; OXIDATIVE DEMETHYLATION; TRANSFER-RNA; CRYSTAL-STRUCTURES; ENZYME ALKB; IN-VIVO; 2-OXOGLUTARATE-DEPENDENT OXYGENASES	The AlkB family of Fe(II)- and alpha-ketoglutarate-dependent dioxygenases is a class of ubiquitous direct reversal DNA repair enzymes that remove alkyl adducts from nucleobases by oxidative dealkylation. The prototypical and homonymous family member is an Escherichia coli "adaptive response" protein that protects the bacterial genome against alkylation damage. AlkB has a wide variety of substrates, including monoalkyl and exocyclic bridged adducts. Nine mammalian AlkB homologs exist (ALKBH1-8, FTO), but only a subset functions as DNA/RNA repair enzymes. This minireview presents an overview of the AlkB proteins including recent data on homologs, structural features, substrate specificities, and experimental strategies for studying DNA repair by AlkB family proteins.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Li, DY (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	deyuli@uri.edu; jessig@mit.edu		Fedeles, Bogdan/0000-0001-5252-826X	National Institutes of Health [P01 CA26731, R37 CA080024, P30 ES002109]; NATIONAL CANCER INSTITUTE [P01CA026731, R01CA080024, R37CA080024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020, P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA26731, R37 CA080024, and P30 ES002109 (to J. M. E.). This is the fourth article in the Thematic Minireview series "Metals in Biology: alpha-Ketoglutarate/Iron-dependent Dioxygenases." The authors declare that they have no conflicts of interest with the contents of this article.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Bjornstad LG, 2011, BIOCHEM J, V434, P391, DOI 10.1042/BJ20101667; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Cetica V, 2009, J NEURO-ONCOL, V94, P195, DOI 10.1007/s11060-009-9837-0; Chandola U, 2015, BRIEF FUNCT GENOMICS, V14, P169, DOI 10.1093/bfgp/elu039; Chang SC, 2015, NUCLEIC ACIDS RES, V43, P5489, DOI 10.1093/nar/gkv243; Chen BE, 2010, MOL BIOSYST, V6, P2143, DOI 10.1039/c005148a; CHEN BRJ, 1994, J BACTERIOL, V176, P6255, DOI 10.1128/jb.176.20.6255-6261.1994; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cisneros GA, 2010, INTERDISCIP SCI, V2, P70, DOI 10.1007/s12539-010-0092-z; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; EHRLICH M, 1985, NUCLEIC ACIDS RES, V13, P1399, DOI 10.1093/nar/13.4.1399; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Fang D, 2014, J CHEM THEORY COMPUT, V10, P5136, DOI 10.1021/ct500572t; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu D, 2012, DNA REPAIR, V11, P46, DOI 10.1016/j.dnarep.2011.10.004; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gao W, 2011, J GASTROEN HEPATOL, V26, P577, DOI 10.1111/j.1440-1746.2010.06531.x; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hegg EL, 1999, BIOCHEMISTRY-US, V38, P16714, DOI 10.1021/bi991796l; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kalliri E, 2005, BIOCHEM BIOPH RES CO, V338, P191, DOI 10.1016/j.bbrc.2005.08.223; Koike K, 2012, CURR CANCER DRUG TAR, V12, P847, DOI 10.2174/156800912802429283; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Korvald H, 2012, DNA REPAIR, V11, P453, DOI 10.1016/j.dnarep.2012.01.014; Krebs C, 2005, INORG CHEM, V44, P742, DOI 10.1021/ic048523l; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Krylova SM, 2012, J MED CHEM, V55, P3546, DOI 10.1021/jm300243h; Li D., 2010, J NUCL ACIDS, V2010; Li DY, 2013, CHEM RES TOXICOL, V26, P1182, DOI 10.1021/tx400096m; Li DY, 2012, J AM CHEM SOC, V134, P8896, DOI 10.1021/ja3010094; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Li PS, 2013, CELL REP, V4, P817, DOI 10.1016/j.celrep.2013.07.027; Liu CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082133; Liu HN, 2009, J PHYS CHEM B, V113, P4887, DOI 10.1021/jp810715t; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Maciejewska AM, 2013, J BIOL CHEM, V288, P432, DOI 10.1074/jbc.M112.353342; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Muller TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067403; Muller TA, 2013, BIOCHEM J, V452, P509, DOI 10.1042/BJ20121908; Nay SL, 2012, DNA REPAIR, V11, P502, DOI 10.1016/j.dnarep.2012.02.005; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Robbens S, 2008, J MOL EVOL, V66, P80, DOI 10.1007/s00239-007-9059-z; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shen F, 2015, J CLIN ENDOCR METAB, V100, pE148, DOI 10.1210/jc.2014-1893; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Shim EH, 2014, CANCER DISCOV, V4, P1290, DOI 10.1158/2159-8290.CD-13-0696; Shrivastav N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094716; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Silvestrov P, 2014, J MOL GRAPH MODEL, V54, P123, DOI 10.1016/j.jmgm.2014.10.013; Singh V, 2014, CHEM RES TOXICOL, V27, P1619, DOI 10.1021/tx5002817; Solberg A, 2013, J MOL CELL BIOL, V5, P194, DOI 10.1093/jmcb/mjt012; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Wang BJ, 2014, J AM CHEM SOC, V136, P13895, DOI 10.1021/ja507934g; Wang GQ, 2014, J BIOL CHEM, V289, P27924, DOI 10.1074/jbc.M114.590505; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Woon ECY, 2012, J MED CHEM, V55, P2173, DOI 10.1021/jm201417e; Xu C, 2014, J BIOL CHEM, V289, P17299, DOI 10.1074/jbc.M114.550350; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yi CQ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012575; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106; Zdzalik D, 2015, DNA REPAIR, V30, P1, DOI 10.1016/j.dnarep.2015.02.021; Zdzalik D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098729; Zhao X, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0486-0; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhu CX, 2014, ANGEW CHEM INT EDIT, V53, P3659, DOI 10.1002/anie.201310050	95	214	216	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20734	20742		10.1074/jbc.R115.656462	http://dx.doi.org/10.1074/jbc.R115.656462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152727	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000360011800010
J	Lucato, CM; Halls, ML; Ooms, LM; Liu, HJ; Mitchell, CA; Whisstock, JC; Ellisdon, AM				Lucato, Christina M.; Halls, Michelle L.; Ooms, Lisa M.; Liu, Heng-Jia; Mitchell, Christina A.; Whisstock, James C.; Ellisdon, Andrew M.			The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1.Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1.Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; G-BETA-GAMMA; RHO-GTPASES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MACROMOLECULAR CRYSTALLOGRAPHY; SELECTIVE ACTIVATION; MEDIATED REGULATION; 3 DIMENSIONS; G-PROTEINS	The P-Rex (phosphatidylinositol (3,4,5)-trisphosphate (PIP3)-dependent Rac exchanger) family (P-Rex1 and P-Rex2) of the Rho guanine nucleotide exchange factors (Rho GEFs) activate Rac GTPases to regulate cell migration, invasion, and metastasis in several human cancers. The family is unique among Rho GEFs, as their activity is regulated by the synergistic binding of PIP3 andG beta gamma at the plasma membrane. However, the molecular mechanism of this family of multi-domain proteins remains unclear. We report the 1.95 angstrom crystal structure of the catalytic P-Rex1 DH-PH tandem domain in complex with its cognate GTPase, Rac1 (Ras-related C3 botulinum toxin substrate-1). Mutations in the P-Rex1.Rac1 interface revealed a critical role for this complex in signaling downstream of receptor tyrosine kinases and G protein-coupled receptors. The structural data indicated that the PIP3/G beta gamma binding sites are on the opposite surface and markedly removed from the Rac1 interface, supporting a model whereby P-Rex1 binding to PIP3 and/or G beta gamma releases inhibitory C-terminal domains to expose the Rac1 binding site.	[Lucato, Christina M.; Ooms, Lisa M.; Liu, Heng-Jia; Mitchell, Christina A.; Whisstock, James C.; Ellisdon, Andrew M.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Lucato, Christina M.; Whisstock, James C.; Ellisdon, Andrew M.] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Halls, Michelle L.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	Monash University; Monash University; Monash University	Mitchell, CA (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu; james.whisstock@monash.edu; andrew.ellisdon@monash.edu	Ooms, Lisa/AGZ-7420-2022	Whisstock, James/0000-0003-4200-5611; Halls, Michelle/0000-0001-8555-8959; Ooms, Lisa Michelle/0000-0002-8918-9932; Ellisdon, Andrew/0000-0002-2248-9914; Mitchell, Christina A/0000-0001-9372-3192	Faculty of Medicine, Nursing, and Health Sciences; National Health and Medical Research Council of Australia (NHMRC) [APP1062230, APP1044737]; Australian Postgraduate Award; Monash Golden Jubilee Postgraduate Research Award; NHMRC [1061687]	Faculty of Medicine, Nursing, and Health Sciences; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Monash Golden Jubilee Postgraduate Research Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a Strategic Grant from the Faculty of Medicine, Nursing, and Health Sciences (to A. M. E.) and Project Grants APP1062230 (to A. M. E. and J. C. W.) and APP1044737 (to C. A. M.) from the National Health and Medical Research Council of Australia (NHMRC). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Australian Postgraduate Award and a Monash Golden Jubilee Postgraduate Research Award.; Recipient of R. D. Wright Career Development Fellowship 1061687 from the NHMRC.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Chang XZ, 2008, BREAST CANCER RES TR, V111, P65, DOI 10.1007/s10549-007-9761-y; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Herter JM, 2013, BLOOD, V121, P2301, DOI 10.1182/blood-2012-09-457085; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; Stumpf E, 2000, GENE CHROMOSOME CANC, V29, P83, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1011>3.0.CO;2-Z; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tong YF, 2010, P NATL ACAD SCI USA, V107, P20346, DOI 10.1073/pnas.1009008107; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong CYA, 2011, J BIOL CHEM, V286, P25813, DOI 10.1074/jbc.M110.211292; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	64	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20827	20840		10.1074/jbc.M115.660456	http://dx.doi.org/10.1074/jbc.M115.660456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26112412	Green Published, hybrid			2022-12-28	WOS:000360011800020
J	Kim, N; Lee, JO; Lee, HJ; Kim, HI; Kim, JK; Lee, YW; Lee, SK; Kim, SJ; Park, SH; Kim, HS				Kim, Nami; Lee, Jung Ok; Lee, Hye Jeong; Kim, Hyung Ip; Kim, Joong Kwan; Lee, Yong Woo; Lee, Soo Kyung; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo			Endogenous Ligand for GPR120, Docosahexaenoic Acid, Exerts Benign Metabolic Effects on the Skeletal Muscles via AMP-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CHAIN FATTY-ACIDS; INSULIN-SECRETION; SIGNALING PATHWAYS; GLUCOSE-TRANSPORT; COUPLED RECEPTORS; UPSTREAM KINASE; CONTRACTION; GLUT4; MICE	Docosahexaenoic acid (DHA) is an endogenous ligand of G protein-coupled receptor 120 (GPR120). However, the mechanisms underlying DHA action are poorly understood. In this study, DHA stimulated glucose uptake in the skeletal muscles in an AMP-activated protein kinase (AMPK)-dependent manner. GPR120-mediated increase in intracellular Ca2+ was critical for DHA-mediated AMPK phosphorylation and glucose uptake. In addition, DHA stimulated GLUT4 translocation AMPK-dependently. Inhibition of AMPK and Ca2+/calmodulin-dependent protein kinase kinase blocked DHA-induced glucose uptake. DHA and GW9508, a GPR120 agonist, increased GPR120 expression. DHA-mediated glucose uptake was not observed in GPR120 knockdown conditions. DHA increased AMPK phosphorylation, glucose uptake, and intracellular Ca2+ concentration in primary cultured myoblasts. Taken together, these results indicated that the beneficial metabolic role of DHA was attributed to its ability to regulate glucose via the GPR120-mediated AMPK pathway in the skeletal muscles.	[Kim, Nami; Lee, Jung Ok; Lee, Hye Jeong; Kim, Hyung Ip; Kim, Joong Kwan; Lee, Yong Woo; Lee, Soo Kyung; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Dept Anat, Coll Med, Seoul 136701, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 136701, South Korea.	anatomykim@korea.ac.kr			National Research Foundation of Korea - Korean government [NRF-2013R1A2A2A05004796]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This study was supported by Grant NRF-2013R1A2A2A05004796 from the National Research Foundation of Korea, which is funded by the Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Attar-Bashi NM, 2007, PROSTAG LEUKOTR ESS, V76, P121, DOI 10.1016/j.plefa.2006.11.002; Cornall LM, 2011, CELL PHYSIOL BIOCHEM, V28, P949, DOI 10.1159/000335820; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2014, J BIOL CHEM, V289, P20345, DOI 10.1074/jbc.M114.561449; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kato T, 2002, CANCER LETT, V187, P169, DOI 10.1016/S0304-3835(02)00432-9; Kelley DS, 2009, J NUTR, V139, P495, DOI 10.3945/jn.108.100354; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Ning Y, 2008, BRIT J PHARMACOL, V155, P1056, DOI 10.1038/bjp.2008.337; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P552, DOI 10.1358/dnp.2008.21.10.1314058; Pawlosky RJ, 2009, J LIPID RES, V50, P154, DOI 10.1194/jlr.M800322-JLR200; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; Rossetti L, 1997, J CLIN INVEST, V100, P1831, DOI 10.1172/JCI119711; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schonberg SA, 2006, FEBS J, V273, P2749, DOI 10.1111/j.1742-4658.2006.05292.x; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; Tsao TS, 2001, FASEB J, V15, P958, DOI 10.1096/fj.00-0381; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	43	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20438	20447		10.1074/jbc.M115.657379	http://dx.doi.org/10.1074/jbc.M115.657379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134561	hybrid, Green Published			2022-12-28	WOS:000359608900041
J	Liu, ZY; Dai, XY; Zhu, HP; Zhang, M; Zou, MH				Liu, Zhaoyu; Dai, Xiaoyan; Zhu, Huaiping; Zhang, Miao; Zou, Ming-Hui			Lipopolysaccharides Promote S-Nitrosylation and Proteasomal Degradation of Liver Kinase B1 (LKB1) in Macrophages in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; EXPRESSION; PHOSPHORYLATION; INDUCTION; STABILITY	LKB1 (liver kinase B1) plays important roles in tumor suppression, energy metabolism, and, recently, in innate immune responses. However, how LKB1 is regulated under physiological or pathological conditions is still unclear. Here, we report that LKB1 protein (but not mRNA) was decreased in both LPS-treated RAW 264.7 cells and peritoneal macrophages isolated from LPS/challenged mice. Additional LPS treatment promoted protein ubiquitination and degradation of LKB1. Pharmacological inhibition or gene silencing of inducible NOS abrogated LPS-induced LKB1 degradation, whereas exposure of RAW 264.7 cells to S-nitroso-L-glutathione, a NO donor, triggered LKB1 S-nitrosylation. Consistently, mutation of one cysteine (C430S) in LKB1 prevented LPS-induced S-nitrosylation, ubiquitination, and degradation. Moreover, S-nitrosylation and ubiquitination of LKB1 were confirmed in macrophages from LPS-challenged mice in vivo. Co-administration of the inducible NOS inhibitor S-methylisothiourea or the proteasome inhibitor MG132 prevented LPS-induced LKB1 degradation and improved the survival rate. Finally, mice lacking LKB1 in macrophages had significantly lower survival rates in response to LPS challenge compared with wild-type mice. Thus, we concluded that LKB1 is degraded by LPS treatment via S-nitrosylation- dependent proteasome pathways, and this had a protective role in LPS-induced septic shock.	[Liu, Zhaoyu; Dai, Xiaoyan; Zhu, Huaiping; Zhang, Miao; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, BSEB 306A,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	liu, zhao/GXV-6141-2022; Regan, Clinton/E-6250-2012		National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776, HL128014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096032, R01HL110488, R01HL079584, R01HL105157, R01HL128014, R01HL074399, R01HL080499, R01HL089920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776 (to M.-H. Z.) and HL128014 (to Z. Xie). The authors declare that they have no conflicts of interest with the contents of this article.	Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Banan A, 2001, AM J PHYSIOL-GASTR L, V280, pG1234, DOI 10.1152/ajpgi.2001.280.6.G1234; Brown KA, 2011, J STEROID BIOCHEM, V127, P439, DOI 10.1016/j.jsbmb.2011.06.005; Calamaras TD, 2012, J BIOL CHEM, V287, P42400, DOI 10.1074/jbc.M112.385831; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Haywood GA, 1996, CIRCULATION, V93, P1087, DOI 10.1161/01.CIR.93.6.1087; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang H, 2014, ATHEROSCLEROSIS, V235, P213, DOI 10.1016/j.atherosclerosis.2014.04.020; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Liu ZY, 2015, J BIOL CHEM, V290, P2312, DOI 10.1074/jbc.M114.616441; McInnes KJ, 2012, INT J OBESITY, V36, P982, DOI 10.1038/ijo.2011.172; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shi ZQ, 2013, P NATL ACAD SCI USA, V110, P3137, DOI 10.1073/pnas.1215501110; Stachura J, 1996, J PHYSIOL PHARMACOL, V47, P131; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	34	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19011	19017		10.1074/jbc.M115.649210	http://dx.doi.org/10.1074/jbc.M115.649210			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070564	Green Published, hybrid			2022-12-28	WOS:000358781100019
J	Jin, ZC; Bian, F; Tomcik, K; Kelleher, JK; Zhang, GF; Brunengraber, H				Jin, Zhicheng; Bian, Fang; Tomcik, Kristyen; Kelleher, Joanne K.; Zhang, Guo-Fang; Brunengraber, Henri			Compartmentation of Metabolism of the C-12-, C-9-, and C-5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis ANAPLEROSIS FROM DODECANEDIOATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ACETYL-COA; DICARBOXYLIC-ACIDS; BETA-OXIDATION; FATTY-ACIDS; MALONYL-COA; ACETATE; HEPATOCYTES; CHAIN; PATHWAY; HEART	We investigated the compartmentation of the catabolism of dodecanedioate (DODA), azelate, and glutarate in perfused rat livers, using a combination of metabolomics and mass isotopomer analyses. Livers were perfused with recirculating or nonrecirculating buffer containing one fully C-13-labeled dicarboxylate. Information on the peroxisomal versus mitochondrial catabolism was gathered from the labeling patterns of acetyl-CoA proxies, i.e. total acetyl-CoA, the acetyl moiety of citrate, C-1+2 of beta-hydroxybutyrate, malonyl-CoA, and acetylcarnitine. Additional information was obtained from the labeling patterns of citric acid cycle intermediates and related compounds. Thedata characterize the partial oxidation of DODA and azelate in peroxisomes, with terminal oxidation in mitochondria. We did not find evidence of peroxisomal oxidation of glutarate. Unexpectedly, DODA contributes a substantial fraction to anaplerosis of the citric acid cycle. This opens the possibility to use water-soluble DODA in nutritional or pharmacological anaplerotic therapy whenother anaplerotic substrates are impractical or contraindicated, e.g. in propionic acidemia and methylmalonic acidemia.	[Jin, Zhicheng; Bian, Fang; Tomcik, Kristyen; Zhang, Guo-Fang; Brunengraber, Henri] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Kelleher, Joanne K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Case Western Reserve University; Massachusetts Institute of Technology (MIT)	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, 10900 Euclid Ave WG 48, Cleveland, OH 44106 USA.	hxb8@case.edu	Regan, Clinton/E-6250-2012	Jin, Zhicheng/0000-0003-2770-9549	National Institutes of Health [R33DK070291, 5T32DK0077319]; American Heart Association [12GRNT12050453]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 (to H. B.) and Fellowship Training Grant 5T32DK0077319 (to Z. J.), American Heart Association Grant 12GRNT12050453 (to G. F. Z.), and the Cleveland Mt. Sinai Health Care Foundation. The authors declare that they have no conflicts of interests of this article.	BERGSETH S, 1990, BIOCHIM BIOPHYS ACTA, V1042, P182, DOI 10.1016/0005-2760(90)90005-I; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Bian F, 2006, J MOL CELL CARDIOL, V41, P868, DOI 10.1016/j.yjmcc.2006.08.011; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; CHANG HC, 1966, J BIOL CHEM, V241, P2421; CRABTREE B, 1989, BIOCHEM J, V257, P673, DOI 10.1042/bj2570673; CRABTREE B, 1990, BIOCHEM J, V270, P219, DOI 10.1042/bj2700219; Dils R, 1975, Methods Enzymol, V35, P74, DOI 10.1016/0076-6879(75)35140-9; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Hunt MC, 2014, BIOCHIMIE, V98, P45, DOI 10.1016/j.biochi.2013.12.018; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; Kolker S, 2007, J INHERIT METAB DIS, V30, P5, DOI 10.1007/s10545-006-0451-4; Korman SH, 2000, J INHERIT METAB DIS, V23, P425, DOI 10.1023/A:1005624523611; Korman SH, 2005, MOL GENET METAB, V86, P337, DOI 10.1016/j.ymgme.2005.07.022; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Mingrone G, 1999, JPEN-PARENTER ENTER, V23, P80, DOI 10.1177/014860719902300280; Mingrone G, 2013, BRIT J CLIN PHARMACO, V75, P671, DOI 10.1111/j.1365-2125.2012.04177.x; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Reszko AE, 2003, J BIOL CHEM, V278, P34959, DOI 10.1074/jbc.M302013200; ROCCHICCIOLI F, 1986, PEDIATR RES, V20, P62, DOI 10.1203/00006450-198601000-00018; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; ROTHSTEIN M, 1952, J BIOL CHEM, V199, P199; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Thielitz A, 2015, J EUR ACAD DERMATOL, V29, P789, DOI 10.1111/jdv.12823; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; TSERNG KY, 1991, J BIOL CHEM, V266, P2924; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; VAMECQ J, 1989, AM J PHYSIOL, V256, pG680, DOI 10.1152/ajpgi.1989.256.4.G680; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665; ZHANG Y, 1994, J BIOL CHEM, V269, P11025	35	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18671	18677		10.1074/jbc.M115.651737	http://dx.doi.org/10.1074/jbc.M115.651737			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070565	hybrid, Green Published			2022-12-28	WOS:000358512100036
J	Thapa, N; Choi, SY; Tan, XJ; Wise, T; Anderson, RA				Thapa, Narendra; Choi, Suyong; Tan, Xiaojun; Wise, Thomas; Anderson, Richard A.			Phosphatidylinositol Phosphate 5-Kinase I gamma and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TYROSINE PHOSPHORYLATION; PTDINS(4,5)P-2 SYNTHESIS; FOCAL ADHESIONS; CELL REGULATION; TUMOR-CELLS; C-SRC; KINASE; ACTIVATION; BINDING	The assembly of signaling complexes at the plasma membrane is required for the initiation and propagation of cellular signaling upon cell activation. The class I PI3K and the serine/threonine-specific protein kinase Akt signaling pathways (PI3K/Akt) are often activated in tumors. These pathways are initiated by the generation of phosphatidylinositol 3,4,5-triphosphate (PIP3) by PI3K-mediated phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2), synthesized by phosphatidylinositol 4-phosphate 5-kinase (PIPKI) enzymes. The mechanism of how tumor cells recruit and organize the PIP2-synthesizing enzymes with PI3K in the plasma membrane for activation of PI3K/Akt signaling is not defined. Here, we demonstrated a role for the phosphatidylinositol 4-phosphate5-kinase I gamma (PIPKI gamma) inPI3K/Aktsignaling. PIPKI gamma is overexpressed in triple-negative breast cancers. Loss of PIPKI gamma or its focal adhesion-targeting variant, PIPKI gamma i2, impaired PI3K/Akt activation upon stimulation with growth factors or extracellular matrix proteins in different tumor cells. PIPKI gamma i2 assembles into a complex containing Src and PI3K; Src was required for the recruitment of PI3K enzyme into the complex. PIPKI gamma i2 interaction with Src and its lipid kinase activity were required for promoting PI3K/Akt signaling. These results define a mechanism by which PIPKI gamma i2 and PI3K are integrated into a complex regulated by Src, resulting in the spatial generation of PIP2, which is the substrate PI3K required for PIP3 generation and subsequent Akt activation. This study elucidates the mechanism by which PIP2-generating enzyme controls Akt activation upstream of a PI3K enzyme. This pathway may represent a signaling nexus required for the survival and growth of metastasizing and circulating tumor cells in vivo.	[Thapa, Narendra; Choi, Suyong; Tan, Xiaojun; Wise, Thomas; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, 3750 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	Regan, Clinton/E-6250-2012; Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240; Anderson, Richard/0000-0001-6265-8359; Wise, Thomas/0000-0001-7007-6279	National Institutes of Health [CA104708, GM057549]; American Heart Association [10POST4290052, 13PRE14690057]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104708 and GM057549 (to R. A. A). This work was also supported by American Heart Association Grants 10POST4290052 (to N. T.) and 13PRE14690057 (to S. C.) and a Howard Hughes Medical Institute International Student Research Fellowship (to X. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Divecha N, 2010, CURR BIOL, V20, pR154, DOI 10.1016/j.cub.2010.01.016; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jin W, 2007, CANCER RES, V67, P3192, DOI 10.1158/0008-5472.CAN-06-3526; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nozu F, 2000, EUR J CELL BIOL, V79, P803, DOI 10.1078/0171-9335-00108; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Thapa N, 2013, J BIOL CHEM, V288, P34707, DOI 10.1074/jbc.M113.512848; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	51	27	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18843	18854		10.1074/jbc.M114.596742	http://dx.doi.org/10.1074/jbc.M114.596742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26070568	Green Published, hybrid			2022-12-28	WOS:000358512100050
J	Wojciechowski, D; Fischer, M; Fahlke, C				Wojciechowski, Daniel; Fischer, Martin; Fahlke, Christoph			Tryptophan Scanning Mutagenesis Identifies the Molecular Determinants of Distinct Barttin Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLC-K CHANNELS; CHLORIDE CHANNEL; SENSORINEURAL DEAFNESS; SURFACE EXPRESSION; POTASSIUM CHANNEL; RAT-KIDNEY; DISEASE; DOMAIN; LOCALIZATION; PERTURBATION	CLC-K chloride channels are expressed in the kidney and in the inner ear and require the accessory subunit barttin for proper function and membrane insertion. Barttin exerts multiple functions on CLC-proteins: it modifies protein stability and intracellular trafficking as well as channel activity, ion conduction, and gating. So far, the molecular determinants of these distinct barttin functions have remained elusive. Here we performed serial perturbation mutagenesis to identify the sequence determinants of barttin function. Barttin consists of two transmembrane helices followed by a long intracellular carboxyl terminus, and earlier work demonstrated that the transmembrane core of barttin suffices for most effects on the alpha-subunit. We individually substituted every amino acid of the predicted transmembrane core (amino acids 9-26 and 35-55) with tryptophan, co-expressed mutant barttin with hClC-Ka or V166E rClC-K1, and characterized CLC-K/barttin channels by patch clamp techniques, biochemistry, and confocal microscopy. The majority of mutations left the chaperone function of barttin, i.e. the effects on endoplasmic reticulum exit and surface membrane insertion, unaffected. In contrast, tryptophan insertion at multiple positions resulted in impaired activity of hClC-Ka/barttin and changes in gating of V166E rClC-K1/barttin. These results demonstrate that mutations in a cluster of hydrophobic residues within transmembrane domain 1 affect barttin-CLC-K interaction and impair gating modification by the accessory subunit. Whereas tight interaction is necessary for functional modification, even impaired association of barttin and CLC-K suffices for normal intracellular trafficking. Our findings allow definition of a likely interaction surface and clarify the mechanisms underlying CLC-K channel modification by barttin.	[Wojciechowski, Daniel; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst Zellulare Biophys ICS 4, D-52428 Julich, Germany	Hannover Medical School; Helmholtz Association; Research Center Julich	Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst Zellulare Biophys ICS 4, D-52428 Julich, Germany.	c.fahlke@fzjuelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952	Deutsche Forschungsgemeinschaft [FA301/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/10; to Ch. F). The authors declare that they have no conflicts of interest with the contents of this article.	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; ADACHI S, 1994, J BIOL CHEM, V269, P17677; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Chen H, 2007, BIOPHYS J, V93, P2332, DOI 10.1529/biophysj.107.109702; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Gradogna A, 2010, J GEN PHYSIOL, V136, P311, DOI 10.1085/jgp.201010455; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; L'Hoste S, 2013, BBA-BIOMEMBRANES, V1828, P2399, DOI 10.1016/j.bbamem.2013.06.012; LANDAU D, 1995, AM J MED GENET, V59, P454, DOI 10.1002/ajmg.1320590411; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Ozlu F, 2006, PEDIATR NEPHROL, V21, P1056, DOI 10.1007/s00467-006-0108-4; Riazuddin S, 2009, AM J HUM GENET, V85, P273, DOI 10.1016/j.ajhg.2009.07.003; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shalev H, 2003, PEDIATRICS, V112, P628, DOI 10.1542/peds.112.3.628; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014; Stolting G, 2014, PFLUG ARCH EUR J PHY, V466, P2191, DOI 10.1007/s00424-014-1490-6; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Stolting G, 2013, PFLUG ARCH EUR J PHY, V465, P1423, DOI 10.1007/s00424-013-1286-0; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; TAUBER R, 1986, EMBO J, V5, P2109, DOI 10.1002/j.1460-2075.1986.tb04473.x; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Zuniga L, 2004, J PHYSIOL-LONDON, V555, P671, DOI 10.1113/jphysiol.2003.060046	45	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18732	18743		10.1074/jbc.M114.625376	http://dx.doi.org/10.1074/jbc.M114.625376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063802	Green Published, hybrid			2022-12-28	WOS:000358512100041
J	Capparelli, C; Rosenbaum, S; Berger, AC; Aplin, AE				Capparelli, Claudia; Rosenbaum, Sheera; Berger, Adam C.; Aplin, Andrew E.			Fibroblast-derived Neuregulin 1 Promotes Compensatory ErbB3 Receptor Signaling in Mutant BRAF Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-ASSOCIATED FIBROBLASTS; RAF INHIBITORS; FEEDBACK INHIBITION; MEK INHIBITION; UP-REGULATION; TUMOR-GROWTH; RESISTANCE; CELLS; PROLIFERATION; VEMURAFENIB	Rapidly accelerated fibrosarcoma (RAF) inhibitors are first-line treatments for patients harboring V600E/K mutant BRAF melanoma. Although RAF inhibitors produce high response rates, the degree of tumor regression is heterogeneous. Compensatory/adaptive responses to targeted inhibitors are frequently initiated by the activation of growth factor receptor tyrosine kinases, including ErbB3, and factors from the tumor microenvironment may play an important role. We have shown previously that mutant v-raf murine sarcoma viral oncogene homolog B1 (BRAF) melanoma cells have enhanced activation of ErbB3 following RAF inhibition. However, the source of neuregulin 1 (NRG1), the ligand for ErbB3, is unknown. In this study, we demonstrate that NRG1 is highly expressed by dermal fibroblasts and cancer-associated fibroblasts (CAFs) isolated from mutant BRAF melanomas. Conditioned medium from fibroblasts and CAFs enhanced ErbB3 pathway activation and limited RAF inhibitor cytotoxicity in V600 mutant BRAF-harboring melanomas. Targeting the ErbB3/ErbB2 pathway partially reversed the protective effects of fibroblast/CAF-derived NRG1 on cell growth properties of RAF inhibitor-treated melanoma cells. These findings support the idea that NRG1, acting in a paracrine manner, promotes resistance to RAF inhibitors and emphasize that targeting the ErbB3/ErbB2 pathway will likely improve the efficacy of RAF inhibitors for mutant BRAF melanoma patients.	[Capparelli, Claudia; Rosenbaum, Sheera; Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Berger, Adam C.] Thomas Jefferson Univ, Div Gen Surg, Dept Surg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Aplin, AE (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	aea004@jefferson.edu	Regan, Clinton/E-6250-2012	Rosenbaum, Sheera/0000-0002-7917-2969	National Institutes of Health [R01 CA160495]; NCI/National Institutes of Health Support Grant [P30CA56036]; OutRun the Sun; American-Italian Cancer Foundation postdoctoral research fellowship; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [R01CA160495, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/National Institutes of Health Support Grant; OutRun the Sun; American-Italian Cancer Foundation postdoctoral research fellowship; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA160495 (to A. E. A.). The Thomas Jefferson University, Sidney Kimmel Cancer Center core facilities are funded by NCI/National Institutes of Health Support Grant P30CA56036. This work was also supported by grants from OutRun the Sun (to C. C.), an American-Italian Cancer Foundation postdoctoral research fellowship (to C. C.), and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to A. E. A.). The authors declare that they have no conflicts of interest with the content of this article.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Basile KJ, 2014, PIGM CELL MELANOMA R, V27, P479, DOI 10.1111/pcmr.12218; Basile KJ, 2013, CANCER RES, V73, P7101, DOI 10.1158/0008-5472.CAN-13-1628; Buac K, 2009, PIGM CELL MELANOMA R, V22, P773, DOI 10.1111/j.1755-148X.2009.00616.x; Capparelli C., 2015, CANCER RES, DOI [10.1158/0008-5472, DOI 10.1158/0008-5472]; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Cirri P, 2011, AM J CANCER RES, V1, P482; Fedorenko IV, 2016, ONCOGENE, V35, P1225, DOI 10.1038/onc.2015.188; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Garrett JT, 2013, CANCER RES, V73, P6013, DOI 10.1158/0008-5472.CAN-13-1191; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hartsough E, 2014, J INVEST DERMATOL, V134, P319, DOI 10.1038/jid.2013.358; Hartsough EJ, 2014, MOL CANCER RES, V12, P795, DOI 10.1158/1541-7786.MCR-13-0581; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Kugel CH, 2014, PIGM CELL MELANOMA R, V27, P1032, DOI 10.1111/pcmr.12264; Kugel CH, 2014, CANCER RES, V74, P4122, DOI 10.1158/0008-5472.CAN-14-0464; Le K, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12092; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Liles JS, 2011, BRIT J CANCER, V105, P523, DOI 10.1038/bjc.2011.263; Lin MCJ, 2014, MOL CANCER RES, V12, P940, DOI 10.1158/1541-7786.MCR-13-0555; Lindzen M, 2012, ONCOGENE, V31, P3505, DOI 10.1038/onc.2011.518; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Liu F, 2013, J INVEST DERMATOL, V133, P2041, DOI 10.1038/jid.2013.32; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; RETTIG WJ, 1993, CANCER RES, V53, P3327; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Villanueva J, 2011, CANCER RES, V71, P7137, DOI 10.1158/0008-5472.CAN-11-1243; Wang T, 2015, CLIN CANCER RES, V21, P1652, DOI 10.1158/1078-0432.CCR-14-1554; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang K, 2012, ONCOGENE, V31, P4609, DOI 10.1038/onc.2011.606; Zhang KM, 2013, PIGM CELL MELANOMA R, V26, P408, DOI 10.1111/pcmr.12089	49	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24267	24277		10.1074/jbc.M115.657270	http://dx.doi.org/10.1074/jbc.M115.657270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269601	hybrid, Green Published			2022-12-28	WOS:000362218900018
J	Fairweather, SJ; Broer, A; Subramanian, N; Turner, E; Cheng, Q; Schmoll, D; O'Mara, ML; Broer, S				Fairweather, Stephen J.; Broeer, Angelika; Subramanian, Nandhitha; Turner, Ennrah; Cheng, Qi; Schmoll, Dieter; O'Mara, Megan L.; Broeer, Stefan			Molecular Basis for the Interaction of the Mammalian Amino Acid Transporters B(0)AT1 and B(0)AT3 with Their Ancillary Protein Collectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; BRAIN GABA TRANSPORTER; XENOPUS-LAEVIS OOCYTES; ENZYME 2 HOMOLOG; SYNTAXIN 1A; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; DYNAMICS SIMULATIONS; HARTNUP DISORDER; PLASMA-MEMBRANE	Many solute carrier 6 (SLC6) family transporters require ancillary subunits to modify their expression and activity. The main apical membrane neutral amino acid transporters in mouse intestine and kidney, B(0)AT1 and B(0)AT3, require the ancillary protein collectrin or ACE2 for plasma membrane expression. Expression and activity of SLC6 neurotransmitter transporters are modulated by interaction with syntaxin 1A. Utilizing monocarboxylate-B(0)AT1/3 fusion constructs, we discovered that collectrin is also necessary for B(0)AT1 and B(0)AT3 catalytic function. Syntaxin 1A and syntaxin 3 inhibit the membrane expression of B(0)AT1 by competing with collectrin for access. A mutagenesis screening approach identified residues on trans-membrane domains 1 alpha, 5, and 7 on one face of B(0)AT3 as a key region involved in interaction with collectrin. Mutant analysis established residues that were involved in collectrin-dependent functions as follows: plasma membrane expression of B(0)AT3, catalytic activation, or both. These results identify a potential binding site for collectrin and other SLC6 ancillary proteins.	[Fairweather, Stephen J.; Broeer, Angelika; Turner, Ennrah; Cheng, Qi; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Subramanian, Nandhitha; O'Mara, Megan L.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Ind Pk Hoechst, D-65926 Frankfurt, Germany	Australian National University; Australian National University; Sanofi-Aventis	Broer, S (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Bldg 134, Canberra, ACT 2601, Australia.	stefan.broeer@anu.edu.au	O'Mara, Megan L/A-4962-2011; O'Mara, Megan/AAY-5934-2021; Fairweather, Stephen James/AFK-2946-2022; Broer, Stefan/A-1286-2008; O'Mara, Megan/ABF-8913-2020	O'Mara, Megan L/0000-0002-8764-1585; O'Mara, Megan/0000-0002-8764-1585; Fairweather, Stephen James/0000-0003-1530-7876; Broer, Stefan/0000-0002-8040-1634; Cheng, Qi/0000-0003-0811-6369; Schmoll, Dieter/0000-0003-2578-3366; Subramanian, Nandhitha/0000-0003-2491-0474	Sanofi [525415]; National Health and Medical Research Council [525415]	Sanofi; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a sponsored research agreement with Sanofi and National Health and Medical Research Council Grant 525415 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binda F, 2006, NEUROPHARMACOLOGY, V50, P354, DOI 10.1016/j.neuropharm.2005.09.012; Blakely RD, 2000, NAT NEUROSCI, V3, P969, DOI 10.1038/79898; Bohmer C, 2005, BIOCHEM J, V389, P745; Bril A, 2014, M S-MED SCI, V30, P136, DOI 10.1051/medsci/20143002007; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer S, 2013, CURR OPIN NEPHROL HY, V22, P539, DOI 10.1097/MNH.0b013e328363fff6; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Broer Stefan, 2013, Curr Mol Pharmacol, V6, P74; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cechova S, 2013, CIRCULATION, V128, P1770, DOI 10.1161/CIRCULATIONAHA.113.003301; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; de Macedo SM, 2014, PEPTIDES, V62, P189, DOI 10.1016/j.peptides.2014.10.005; De Mello WC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00016; de Wit H, 2010, BIOCHEM SOC T, V38, P192, DOI 10.1042/BST0380192; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Delgrossi MH, 1997, J CELL SCI, V110, P2207; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Egan BM, 2013, CIRCULATION, V128, P1727, DOI 10.1161/CIRCULATIONAHA.113.005695; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Esterhazy D, 2012, BIOL CHEM, V393, P473, DOI 10.1515/hsz-2012-0104; Fairweather SJ, 2012, BIOCHEM J, V446, P135, DOI 10.1042/BJ20120307; Fan H, 2004, PROTEIN SCI, V13, P211, DOI 10.1110/ps.03381404; Fan HP, 2006, J BIOL CHEM, V281, P28174, DOI 10.1074/jbc.M601382200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Fraser R, 2014, MOL PHARMACOL, V86, P76, DOI 10.1124/mol.114.091926; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Ganeshan R, 2003, J BIOL CHEM, V278, P2876, DOI 10.1074/jbc.M211790200; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Horton N, 2001, MOL MEMBR BIOL, V18, P39; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang Y, 2015, MOL METAB, V4, P406, DOI 10.1016/j.molmet.2015.02.003; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lang Thorsten, 2008, V184, P107; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Lopez-Corcuera B, 2001, BIOCHEM SOC T, V29, P742, DOI 10.1042/0300-5127:0290742; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Patel SK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00227; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Quick MW, 2006, HANDB EXP PHARM, V175, P181; Quick MW, 2002, P NATL ACAD SCI USA, V99, P5686, DOI 10.1073/pnas.082712899; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Saisho K, 2009, BIOCHEM BIOPH RES CO, V389, P133, DOI 10.1016/j.bbrc.2009.08.111; Saxena S, 2000, CURR OPIN NEPHROL HY, V9, P523, DOI 10.1097/00041552-200009000-00011; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schwartz JH, 2007, KIDNEY INT, V72, P1310, DOI 10.1038/sj.ki.5002500; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Singer D, 2009, J BIOL CHEM, V284, P19953, DOI 10.1074/jbc.M109.011171; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Sung U, 2003, J NEUROSCI, V23, P1697; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Tumer E, 2013, J BIOL CHEM, V288, P33813, DOI 10.1074/jbc.M113.482760; Vanslambrouck JM, 2010, BIOCHEM J, V428, P397, DOI 10.1042/BJ20091667; Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6; Wang D, 2003, MOL PHARMACOL, V64, P905, DOI 10.1124/mol.64.4.905; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Yamagata K, 2007, DIABETES OBES METAB, V9, P40, DOI 10.1111/j.1463-1326.2007.00773.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yasuhara A, 2008, CIRCULATION, V118, P2146, DOI 10.1161/CIRCULATIONAHA.108.787259; Zhong HL, 2012, BIOCHEM PHARMACOL, V83, P435, DOI 10.1016/j.bcp.2011.09.020	85	32	33	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24308	24325		10.1074/jbc.M115.648519	http://dx.doi.org/10.1074/jbc.M115.648519			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26240152	Green Published, hybrid			2022-12-28	WOS:000362218900021
J	Jules, J; Wang, SQ; Shi, ZQ; Liu, JZ; Wei, S; Feng, X				Jules, Joel; Wang, Shunqing; Shi, Zhenqi; Liu, Jianzhong; Wei, Shi; Feng, Xu			The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor kappa B (RANK) Cooperate to Induce Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; OSTEOPROTEGERIN LIGAND; BONE-RESORPTION; FAMILY-MEMBERS; DIFFERENTIATION; INTERLEUKIN-1; IDENTIFICATION; SUPERFAMILY; MACROPHAGES; ARTHRITIS	Receptor activator of NF-kappa B (RANK) activation by RANK ligand (RANKL) mediates osteoclastogenesis by recruiting TNF receptor-associated factors (TRAFs) via three cytoplasmic motifs (motif 1, PFQEP(369-373); motif 2, PVQEET(559-564); and motif 3, PVQEQG(604-609)) to activate the NF-kappa B and MAPK signaling pathways. RANK also has a TRAF-independent motif (IVVY535-538), which is dispensable for the activation of TRAF-induced signaling pathways but essential for osteoclast lineage commitment by inducing the expression of nuclear factor of activated T-cells c1 (NFATc1) to regulate osteoclast gene expression. Notably, TNF/IL-1-mediated osteoclastogenesis requires RANK ligand assistance, and the IVVY motif is also critical for TNF/IL-1-mediated osteoclastogenesis by rendering osteoclast genes responsive to these two cytokines. Here we show that the two types of RANK cytoplasmic motifs have to be on the same RANK molecule to mediate osteoclastogenesis, suggesting a functional cooperation between them. Subsequent osteoclastogenesis assays with TNF or IL-1 revealed that, although all three TRAF motifs play roles in TNF/IL-1-mediated osteoclastogenesis, motifs 2 and 3 are more potent than motif 1. Accordingly, inactivation of motifs 2 and 3 blocks TNF/IL-1-mediated osteoclastogenesis. Mechanistically, double mutation of motifs 2 and 3, similar to inactivation of the IVVY motif, abrogates the expression of nuclear factor of activated T-cells c1 and osteoclast genes in assays reflecting RANK-initiated and TNF/IL-1-mediated osteoclastogenesis. In contrast, double inactivation of motifs 2 and 3 did not affect the ability of RANK to activate the NF-kappa B and MAPK signaling pathways. Collectively, these results indicate that the RANK IVVY motif cooperates with the TRAF-binding motifs to promote osteoclastogenesis, which provides novel insights into the molecular mechanism of RANK signaling in osteoclastogenesis.	[Jules, Joel; Wang, Shunqing; Shi, Zhenqi; Liu, Jianzhong; Wei, Shi; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wang, Shunqing] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Hematol, Guangzhou 510180, Guangdong, Peoples R China	University of Alabama System; University of Alabama Birmingham; Guangzhou Medical University	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1670 Univ Blvd,Volker Hall G019E, Birmingham, AL 35294 USA.	xufeng@uab.edu			NIAMS/National Institutes of Health [AR47830]; NIAMS [AR47830]; Research and Education Foundation of the American College of Rheumatology; National Natural Science Foundation of China [3087110, 80171939]; Guangzhou Science and Technology Program [11C33150710]; Guangzhou Medical Science and Technology Project [201102A212024]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311, R01AR047830] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Research and Education Foundation of the American College of Rheumatology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Program; Guangzhou Medical Science and Technology Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NIAMS/National Institutes of Health Grant AR47830 (to X. F.) and a NIAMS graduate research supplement to Grant AR47830 (to J. J.). This work was also supported by a Within Our Reach innovative basic research grant from the Research and Education Foundation of the American College of Rheumatology (to X. F.), Grants 3087110 and 80171939 from the National Natural Science Foundation of China (to S. Wang), Grant 11C33150710 from the Guangzhou Science and Technology Program (to S. Wang), and Grant 201102A212024 from the Guangzhou Medical Science and Technology Project (to S. Wang). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961	36	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23738	23750		10.1074/jbc.M115.667535	http://dx.doi.org/10.1074/jbc.M115.667535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26276390	Green Published, hybrid			2022-12-28	WOS:000361816500022
J	Momiuchi, Y; Kumada, K; Kuraishi, T; Takagaki, T; Aigaki, T; Oshima, Y; Kurata, S				Momiuchi, Yoshiki; Kumada, Kohei; Kuraishi, Takayuki; Takagaki, Takeshi; Aigaki, Toshiro; Oshima, Yoshiteru; Kurata, Shoichiro			The Role of the Phylogenetically Conserved Cochaperone Protein Droj2/DNAJA3 in NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN-RECOGNITION PROTEIN; ANTIMICROBIAL PEPTIDE GENES; INNATE IMMUNE RECOGNITION; TOLL-LIKE-RECEPTORS; DROSOPHILA-MELANOGASTER; FACTOR RELISH; ANTIBACTERIAL DEFENSE; FUNGAL-INFECTIONS; HUMAN HOMOLOG; HUMAN DNAJ	The NF-kappa B pathway is a phylogenetically conserved signaling pathway with a central role in inflammatory and immune responses. Here we demonstrate that a cochaperone protein, Droj2/DNAJA3, is involved in the activation of canonical NF-kappa B signaling in flies and in human cultured cells. Overexpression of Droj2 induced the expression of an antimicrobial peptide in Drosophila. Conversely, Droj2 knockdown resulted in reduced expression of antimicrobial peptides and higher susceptibility to Gram-negative bacterial infection in flies. Similarly, Toll-like receptor-stimulated I kappa B phosphorylation and NF-kappa B activation were suppressed by DNAJA3 knockdown in HEK293 cells. I kappa B kinase overexpression-induced NF-kappa B phosphorylation was also compromised in DNAJA3 knockdown cells. Our study reveals a novel conserved regulator of the NF-kappa B pathway acting at the level of I kappa B phosphorylation.	[Momiuchi, Yoshiki; Kumada, Kohei; Kuraishi, Takayuki; Takagaki, Takeshi; Oshima, Yoshiteru; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Kuraishi, Takayuki] Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, Tokyo 3320012, Japan; [Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tokyo Metropolitan University	Kurata, S (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	kurata@m.tohoku.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24390014, 21117005, 21310134, 14657577, 13143202]; Promotion of Basic Research Activities for Innovative Biosciences; Global COE (Centers of Excellence) research grant (Tohoku University Ecosystem Adaptability); Takeda Science Foundation; Kao Foundation for Arts and Sciences; Uehara Memorial Foundation; Futaba Electronics Memorial Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Basic Research Activities for Innovative Biosciences; Global COE (Centers of Excellence) research grant (Tohoku University Ecosystem Adaptability); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kao Foundation for Arts and Sciences; Uehara Memorial Foundation(Uehara Memorial Foundation); Futaba Electronics Memorial Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Japan Science and Technology Agency; by Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) Grants 24390014, 21117005, 21310134, 14657577, and 13143202; by the Program for the Promotion of Basic Research Activities for Innovative Biosciences; by a Global COE (Centers of Excellence) research grant (Tohoku University Ecosystem Adaptability); by the Takeda Science Foundation; by the Kao Foundation for Arts and Sciences; by the Uehara Memorial Foundation; and by the Futaba Electronics Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Elwi AN, 2012, INT J BIOCHEM CELL B, V44, P1366, DOI 10.1016/j.biocel.2012.05.004; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goto A, 2010, J BIOL CHEM, V285, P15731, DOI 10.1074/jbc.M109.082115; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hofius D, 2007, J VIROL, V81, P11870, DOI 10.1128/JVI.01525-07; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; REICHHART JM, 1992, EMBO J, V11, P1469, DOI 10.1002/j.1460-2075.1992.tb05191.x; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Toba G, 1999, GENETICS, V151, P725; Towb P, 1998, DEVELOPMENT, V125, P2443; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang YJ, 2003, DEV BIOL, V262, P350, DOI 10.1016/S0012-1606(03)00396-8; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	67	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23816	23825		10.1074/jbc.M115.664193	http://dx.doi.org/10.1074/jbc.M115.664193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245905	Green Published, hybrid			2022-12-28	WOS:000361816500028
J	Riling, C; Kamadurai, H; Kumar, S; O'Leary, CE; Wu, KP; Manion, EE; Ying, M; Schulman, BA; Oliver, PM				Riling, Christopher; Kamadurai, Hari; Kumar, Suresh; O'Leary, Claire E.; Wu, Kuen-Phon; Manion, Erica E.; Ying, Mingjie; Schulman, Brenda A.; Oliver, Paula M.			Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; HECT-DOMAIN; STRUCTURAL BASIS; C2 DOMAIN; PY MOTIFS; AUTOINHIBITION; PHOSPHORYLATION; ACTIVATION; NEDD4; INFLAMMATION	Nedd4-family E3 ubiquitin ligases regulate an array of biologic processes. Autoinhibition maintains these catalytic ligases in an inactive state through several mechanisms. However, although some Nedd4 family members are activated by binding to Nedd4 family-interacting proteins (Ndfips), how binding activates E3 function remains unclear. Our data reveal how these two regulatory processes are linked functionally. In the absence of Ndfip1, the Nedd4 family member Itch can bind an E2 but cannot accept ubiquitin onto its catalytic cysteine. This is because Itch is autoinhibited by an intramolecular interaction between its HECT (homologous to the E6-AP carboxy terminus domain) and two central WW domains. Ndfip1 binds these WW domains to release the HECT, allowing trans-thiolation and Itch catalytic activity. This molecular switch also regulates the closely related family member WWP2. Importantly, multiple PY motifs are required for Ndfip1 to activate Itch, functionally distinguishing Ndfips from single PY-containing substrates. These data establish a novel mechanism for control of the function of a subfamily of Nedd4 E3 ligases at the level of E2-E3 trans-thiolation.	[Riling, Christopher; O'Leary, Claire E.; Oliver, Paula M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kamadurai, Hari; Wu, Kuen-Phon; Schulman, Brenda A.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Kumar, Suresh; Manion, Erica E.] Progenra Inc, Malvern, PA 19355 USA; [Ying, Mingjie; Oliver, Paula M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Schulman, Brenda A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Oliver, Paula M.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; University of Pennsylvania	Oliver, PM (corresponding author), Childrens Hosp Philadelphia, Cell Pathol Div ARC 816F, Philadelphia, PA 19104 USA.	paulao@mail.med.upenn.edu	Wu, Kuen-Phon/B-7983-2009; Regan, Clinton/E-6250-2012; Wu, Kuen-Phon/I-1789-2019	Wu, Kuen-Phon/0000-0002-1525-6004; Wu, Kuen-Phon/0000-0002-1525-6004; O'Leary, Claire/0000-0001-9052-4593; Kumar, Suresh/0000-0001-5682-0938; Kamadurai, Hari/0000-0001-9021-0279	National Institutes of Health [R37GM065930]; American Asthma Foundation scholar award; Institute for Translational Medicine and Therapeutics award; American Lebanese Syrian Associated Charities; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI109256, R01AI114515, R01AI093566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM069530, T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation scholar award; Institute for Translational Medicine and Therapeutics award; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM065930 (to B. A. S.). This work was also supported by an American Asthma Foundation scholar award and an Institute for Translational Medicine and Therapeutics award (to P. M. O.), by American Lebanese Syrian Associated Charities, and by the Howard Hughes Medical Institute (to B. A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beal AM, 2012, NAT IMMUNOL, V13, P77, DOI 10.1038/ni.2154; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kathania M, 2015, J IMMUNOL, V194, P2160, DOI 10.4049/jimmunol.1402742; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Marblestone JG, 2012, BBA-MOL CELL RES, V1823, P2094, DOI 10.1016/j.bbamcr.2012.06.013; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Ramon HE, 2011, MUCOSAL IMMUNOL, V4, P314, DOI 10.1038/mi.2010.69; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	42	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23875	23887		10.1074/jbc.M115.649269	http://dx.doi.org/10.1074/jbc.M115.649269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245901	hybrid, Green Published			2022-12-28	WOS:000361816500033
J	Zaanan, A; Okamoto, K; Kawakami, H; Khazaie, K; Huang, SB; Sinicrope, FA				Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Khazaie, Khashayarsha; Huang, Shengbing; Sinicrope, Frank A.			The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; BH3 MIMETIC ABT-737; MEK INHIBITION; COLON-CANCER; MEDIATED APOPTOSIS; DRIVEN CANCERS; ACTIVATION; LUNG; PHOSPHORYLATION; COMBINATION	In colorectal cancers with oncogenic GTPase Kras (KRAS) mutations, inhibition of downstream MEK/ERK signaling has shown limited efficacy, in part because of failure to induce a robust apoptotic response. We studied the mechanism of apoptosis resistance in mutant KRAS cells and sought to enhance the efficacy of a KRAS-specific MEK/ERK inhibitor, GDC-0623. GDC-0623 was shown to potently up-regulate BIM expression to a greater extent versus other MEK inhibitors in isogenic KRAS HCT116 and mutant KRAS SW620 colon cancer cells. ERK silencing enhanced BIM up-regulation by GDC-0623 that was due to its loss of phosphorylation at Ser(69), confirmed by a BIM-EL phosphorylation-defective mutant (S69G) that increased protein stability and blocked BIM induction. Despite BIM and BIK induction, the isogenic KRAS mutant versus wildtype cells remained resistant to GDC-0623-induced apoptosis, in part because of up-regulation of BCL-XL. KRAS knockdown by a doxycycline-inducible shRNA attenuated BCL-XL expression. BCL-XL knockdown sensitized KRAS mutant cells to GDC-0623- mediated apoptosis, as did the BH3 mimetic ABT-263. GDC-0623 plus ABT-263 induced a synergistic apoptosis by a mechanism that includes release of BIM from its sequestration by BCL-XL. Furthermore, mutant KRAS activated p-STAT3 (Tyr(705)) in the absence of IL-6 secretion, and STAT3 knockdown reduced BCL-XL mRNA and protein expression. These data suggest that BCL-XL up-regulation by STAT3 contributes to mutant KRAS-mediated apoptosis resistance. Such resistance can be overcome by potent BIM induction and concurrent BCL-XL antagonism to enable a synergistic apoptotic response.	[Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Huang, Shengbing; Sinicrope, Frank A.] Mayo Clin, Dept Med, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Huang, Shengbing; Sinicrope, Frank A.] Mayo Clin, Dept Oncol, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Huang, Shengbing; Sinicrope, Frank A.] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA; [Khazaie, Khashayarsha] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Mayo Clin, Dept Med, Gastroenterol Res Unit, 200 First St,SW, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu	Kawakami, Hisato/L-6845-2019	Kawakami, Hisato/0000-0002-3280-4850; Zaanan, Aziz/0000-0001-8372-5653	NCI/National Institutes of Health [5 K05 CA142885, CA113681]; Mayo Cancer Center Core [CA15083]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; French Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA113681, R01CA160436, K05CA142885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Cancer Center Core; Mayo Clinic Center for Cell Signaling in Gastroenterology; French Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute(Institut National du Cancer (INCA) France); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grants 5 K05 CA142885 and CA113681 (to F. A. S.). This work was also supported by Mayo Cancer Center Core Grant CA15083 and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the French Multi-Organizational Thematic Institute for Cancer and the French National Cancer Institute.; Supported by the Uehara Memorial Foundation.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; [Anonymous], 2014, R LANG ENV STAT COMP; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bennouna J, 2011, INVEST NEW DRUG, V29, P1021, DOI 10.1007/s10637-010-9392-8; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Huang Y, 2013, INFLAMMATION, V36, P1064, DOI 10.1007/s10753-013-9638-7; INFANTE JR, 2010, J CLIN ONCOL S, V28, pS15; Kasper S, 2013, ONCOGENE, V32, P2873, DOI 10.1038/onc.2012.302; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013026; Milella M, 2002, BLOOD, V99, P3461, DOI 10.1182/blood.V99.9.3461; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Tan N, 2013, MOL CANCER THER, V12, P853, DOI 10.1158/1535-7163.MCT-12-0949; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Okamoto K, 2015, MOL CANCER RES, V13, P659, DOI 10.1158/1541-7786.MCR-14-0476; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Stintzing S, 2015, HEMATOL ONCOL CLIN N, V29, P43, DOI 10.1016/j.hoc.2014.09.009; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang J, 2005, CANCER RES, V65, P939; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Yoon HH, 2014, CLIN CANCER RES, V20, P3033, DOI 10.1158/1078-0432.CCR-13-3140; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	43	41	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23838	23849		10.1074/jbc.M115.657833	http://dx.doi.org/10.1074/jbc.M115.657833			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245900	Green Published, hybrid			2022-12-28	WOS:000361816500030
J	Brehove, M; Wang, T; North, J; Luo, Y; Dreher, SJ; Shimko, JC; Ottesen, JJ; Luger, K; Poirier, MG				Brehove, Matthew; Wang, Tao; North, Justin; Luo, Yi; Dreher, Sarah J.; Shimko, John C.; Ottesen, Jennifer J.; Luger, Karolin; Poirier, Michael G.			Histone Core Phosphorylation Regulates DNA Accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; EMBRYONIC STEM-CELLS; NUCLEOSOME DYNAMICS; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN-STRUCTURE; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; LYSINE 56; H3; ACETYLATION	Nucleosome unwrapping dynamics provide transient access to the complexes involved in DNA transcription, repair, and replication, whereas regulation of nucleosome unwrapping modulates occupancy of these complexes. Histone H3 is phosphorylated at tyrosine 41 (H3Y41ph) and threonine 45 (H3T45ph). H3Y41ph is implicated in regulating transcription, whereas H3T45ph is involved in DNA replication and apoptosis. These modifications are located in the DNA-histone interface near where the DNA exits the nucleosome, and are thus poised to disrupt DNA-histone interactions. However, the impact of histone phosphorylation on nucleosome unwrapping and accessibility is unknown. We find that the phosphorylation mimics H3Y41E and H3T45E, and the chemically correct modification, H3Y41ph, significantly increase nucleosome unwrapping. This enhances DNA accessibility to protein binding by 3-fold. H3K56 acetylation(H3K56ac) is also located in the same DNA-histone interface and increases DNA unwrapping. H3K56ac is implicated in transcription regulation, suggesting that H3Y41ph and H3K56ac could function together. We find that the combination of H3Y41ph with H3K56ac increases DNA accessibility by over an order of magnitude. These results suggest that phosphorylation within the nucleosome DNA entry-exit region increases access to DNA binding complexes and that the combination of phosphorylation with acetylation has the potential to significantly influence DNA accessibility to transcription regulatory complexes.	[Brehove, Matthew; Poirier, Michael G.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [North, Justin] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Luo, Yi; Ottesen, Jennifer J.; Poirier, Michael G.] Ohio State Univ, Biophys Grad Program, Columbus, OH 43210 USA; [Dreher, Sarah J.; Shimko, John C.; Ottesen, Jennifer J.; Poirier, Michael G.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Shimko, John C.; Ottesen, Jennifer J.; Poirier, Michael G.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; [Wang, Tao; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Colorado State University; Howard Hughes Medical Institute; Colorado State University	Poirier, MG (corresponding author), Ohio State Univ, Dept Phys, 191 W Woodruff Ave, Columbus, OH 43214 USA.	mpoirier@mps.ohio-state.edu	Poirier, Michael Guy/B-5378-2012	, Yi/0000-0001-9279-9726; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Wang, Tao/0000-0002-9641-6558; Ottesen, Jennifer/0000-0003-3323-6290	DOE Office of Biological and Environmental Research; National Institute of Health MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, R01GM096192, P01GM088409, R01GM083055] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Poirier, Ottesen, and Luger laboratories for helpful discussions. We are grateful to Cody Alsaker, Mark van der Woerd, and F. Jay Breidt for help with the statistical analysis of the SAXS data. SAXS data collection in this work was conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health project MINOS (R01GM105404).	Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dawson MA, 2012, CELL REP, V2, P470, DOI 10.1016/j.celrep.2012.08.016; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Griffiths DS, 2011, NAT CELL BIOL, V13, P13, DOI 10.1038/ncb2135; Guinier A., 1955, J POLYM SCI, V19, P594, DOI [10.1002/pol.1956.120199326, DOI 10.1002/POL.1956.120199326]; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Jang SM, 2014, EMBO REP, V15, P686, DOI 10.15252/embr.201338356; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; LITTLE JW, 1994, METHOD ENZYMOL, V244, P266; Lo KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019778; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahto SK, 2011, CHEMBIOCHEM, V12, P2488, DOI 10.1002/cbic.201100472; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; North JA, 2014, NUCLEIC ACIDS RES, V42, P4922, DOI 10.1093/nar/gku150; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; North JA, 2011, NUCLEIC ACIDS RES, V39, P6465, DOI 10.1093/nar/gkr304; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ranjith P, 2007, P NATL ACAD SCI USA, V104, P13649, DOI 10.1073/pnas.0701459104; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Shimko John C, 2013, Methods Mol Biol, V981, P177, DOI 10.1007/978-1-62703-305-3_14; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tan YL, 2013, P NATL ACAD SCI USA, V110, P11493, DOI 10.1073/pnas.1309914110; Tropberger P, 2013, NAT STRUCT MOL BIOL, V20, P657, DOI 10.1038/nsmb.2581; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yang CH, 2011, NUCLEIC ACIDS RES, V39, P4122, DOI 10.1093/nar/gkr005; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	61	61	63	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22612	22621		10.1074/jbc.M115.661363	http://dx.doi.org/10.1074/jbc.M115.661363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26175159	Green Published, hybrid			2022-12-28	WOS:000361171500027
J	Shaik, MM; Lombardi, C; Trindade, DM; Fenel, D; Schoehn, G; Di Guilmi, AM; Dessen, A				Shaik, Md Munan; Lombardi, Charlotte; Trindade, Daniel Maragno; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea			A Structural Snapshot of Type II Pilus Formation in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; PROTEIN SECRETION; CRYSTAL-STRUCTURE; ISOPEPTIDE BONDS; SORTING SIGNAL; PILIN PROTEIN; SORTASE-B; CELL-WALL; TRANSPEPTIDASE	Pili are fibrous appendages expressed on the surface of a vast number of bacterial species, and their role in surface adhesion is important for processes such as infection, colonization, and biofilm formation. The human pathogen Streptococcus pneumoniae expresses two different types of pili, PI-1 and PI-2, both of which require the concerted action of structural proteins and sortases for their polymerization. The type PI-1 streptococcal pilus is a complex, well studied structure, but the PI-2 type, present in a number of invasive pneumococcal serotypes, has to date remained less well understood. The PI-2 pilus consists of repeated units of a single protein, PitB, whose covalent association is catalyzed by cognate sortase SrtG-1 and partner protein SipA. Here we report the high resolution crystal structures of PitB and SrtG1 and use molecular modeling to visualize a "trapped" 1:1 complex between the two molecules. X-ray crystallography and electron microscopy reveal that the pneumococcal PI-2 backbone fiber is formed by PitB monomers associated in head-to-tail fashion and that short, flexible fibers can be formed even in the absence of coadjuvant proteins. These observations, obtained with a simple pilus biosynthetic system, are likely to be applicable to other fiber formation processes in a variety of Gram-positive organisms.	[Shaik, Md Munan; Lombardi, Charlotte; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea] Univ Grenoble Alpes, Inst Biol Struct, F-38044 Grenoble, France; [Shaik, Md Munan; Lombardi, Charlotte; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea] CNRS, IBS, F-38044 Grenoble, France; [Shaik, Md Munan; Lombardi, Charlotte; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea] CEA, IBS, Grenoble, France; [Trindade, Daniel Maragno; Dessen, Andrea] Brazilian Natl Lab Biosci LNBio, CNPEM, BR-13083 Campinas, SP, Brazil	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Dessen, A (corresponding author), Inst Biol Struct, Bacterial Pathogenesis Grp, 71 Ave Martyrs, Grenoble, France.	andrea.dessen@ibs.fr	Trindade, Daniel Maragno/J-6085-2012	Trindade, Daniel Maragno/0000-0002-8005-8784; Dessen, Andrea/0000-0001-6487-4020; Di Guilmi, Anne Marie/0000-0001-7335-3470; Schoehn, Guy/0000-0002-1459-3201	FRISBI [ANR-10-INSB-05-02]; GRAL within Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	FRISBI; GRAL within Grenoble Partnership for Structural Biology (PSB)	We thank J. Marquez and the HTX Laboratory team for access to and help with high throughput crystallization and the ESRF for access to beamlines. This project used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). The electron microscope facility is supported by the Rhone-Alpes Region, the Fondation pour la Recherche Medicale (FRM), and the FEDER funds.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cozzi R, 2013, FASEB J, V27, P3144, DOI 10.1096/fj.13-227793; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; El Mortaji L, 2012, BIOCHEMISTRY-US, V51, P342, DOI 10.1021/bi201591n; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Hament JM, 2003, EUR J CLIN INVEST, V33, P169, DOI 10.1046/j.1365-2362.2002.01109.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Khare B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022995; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nielsen HV, 2013, J BACTERIOL, V195, P4484, DOI 10.1128/JB.00451-13; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shaik MM, 2014, J BIOL CHEM, V289, P16988, DOI 10.1074/jbc.M114.555854; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Solovyova AS, 2010, EUR BIOPHYS J BIOPHY, V39, P469, DOI 10.1007/s00249-009-0432-2; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wu CG, 2012, J BACTERIOL, V194, P2531, DOI 10.1128/JB.00093-12; Young PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099135; Zahner D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025124; Zahner D, 2010, EMERG INFECT DIS, V16, P955, DOI 10.3201/eid1606.091820; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001	69	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22581	22592		10.1074/jbc.M115.647834	http://dx.doi.org/10.1074/jbc.M115.647834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198632	Green Published, hybrid			2022-12-28	WOS:000361171500024
J	Tam, MF; Tam, TCS; Simplaceanu, V; Ho, NT; Zou, M; Ho, C				Tam, Ming F.; Tam, Tsuey Chyi S.; Simplaceanu, Virgil; Ho, Nancy T.; Zou, Ming; Ho, Chien			Sickle Cell Hemoglobin with Mutation at His-50 Has Improved Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hemoglobin; mutant; nuclear magnetic resonance (NMR); oxygen binding; protein stability; Csat; autoxidation; sickle cell	NUCLEAR-MAGNETIC-RESONANCE; REFINED CRYSTAL-STRUCTURE; EXCHANGEABLE PROTON NMR; NORMAL HUMAN ADULT; DEOXYHEMOGLOBIN-S; AMINO-ACID; RECOMBINANT HEMOGLOBINS; ACCEPTOR POCKET; HYDROGEN-BOND; BETA 88	Background: Deoxy sickle cell hemoglobin (Hb S) tetramers polymerize in solution via lateral and axial contacts among neighbors. Results: His-50 Gln mutation can, whereas His-20 Gln mutation cannot, improve the solubility of Hb S. Conclusion: (2)His-50 interacts with the (S)(1) CD corner, whereas (2)His-20 has minimal interaction with (S)(1)Glu-22. Significance: (2)His-50 contributes significantly to the polymerization of the Hb S tetramers. The unliganded tetrameric Hb S has axial and lateral contacts with neighbors and can polymerize in solution. Novel recombinants of Hb S with single amino acid substitutions at the putative axial (recombinant Hb (rHb) (E6V/H20R) and rHb (E6V/H20Q)) or lateral (rHb (E6V/H50Q)) or double amino acid substitutions at both the putative axial and lateral (rHb (E6V/H20R/H50Q) and rHb (E6V/H20Q/H50Q)) contact sites were expressed in Escherichia coli and purified for structural and functional studies. The H-1 NMR spectra of the CO and deoxy forms of these mutants indicate that substitutions at either His-20 or His-50 do not change the subunit interfaces or the heme pockets of the proteins. The double mutants show only slight structural alteration in the -heme pockets. All mutants have similar cooperativity (n(50)), alkaline Bohr effect, and autoxidation rate as Hb S. The oxygen binding affinity (P-50) of the single mutants is comparable with that of Hb S. The double mutants bind oxygen with slightly higher affinity than Hb S under the acidic conditions. In high salt, rHb (E6V/H20R) is the only mutant that has a shorter delay time of polymerization and forms polymers more readily than Hb S with a dextran-Csat value of 1.86 +/- 0.20 g/dl. Hb S, rHb (E6V/H20Q), rHb (E6V/H50Q), rHb (E6V/H20R/H50Q), and rHb (E6V/H20Q/H50Q) have dextran-Csat values of 2.95 +/- 0.10, 3.04 +/- 0.17, 11.78 +/- 0.59, 7.11 +/- 0.66, and 10.89 +/- 0.83 g/dl, respectively. rHb (E6V/H20Q/H50Q) is even more stable than Hb S under elevated temperature (60 degrees C).	[Tam, Ming F.; Tam, Tsuey Chyi S.; Simplaceanu, Virgil; Ho, Nancy T.; Zou, Ming; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Ho, C (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 Fifth Ave, Pittsburgh, PA 15213 USA.	chienho@andrew.cmu.edu	Regan, Clinton/E-6250-2012; Ho, Chien/O-6112-2016	Ho, Chien/0000-0002-4094-9232	National Institutes of Health [R01GM084614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM084614. The authors declare that they have no conflicts of interest with the contents of this article.	ACHARYA AS, 1985, BIOCHEMISTRY-US, V24, P4885, DOI 10.1021/bi00339a024; ADACHI K, 1993, J BIOL CHEM, V268, P21650; ADACHI K, 1987, J BIOL CHEM, V262, P12920; ADACHI K, 1979, J BIOL CHEM, V254, P7765; Adachi K, 1996, J BIOL CHEM, V271, P24557, DOI 10.1074/jbc.271.40.24557; ADACHI K, 1994, J BIOL CHEM, V269, P9562; ADACHI K, 1994, J BIOL CHEM, V269, P31563; ADACHI K, 1994, J BIOL CHEM, V269, P17477; Adachi K, 2008, BIOCHEMISTRY-US, V47, P5441, DOI 10.1021/bi800149u; Adachi K, 2009, ARCH BIOCHEM BIOPHYS, V481, P137, DOI 10.1016/j.abb.2008.11.006; Banerjee S, 2007, PROTEIN J, V26, P445, DOI 10.1007/s10930-007-9084-1; BAUDINCHICH V, 1990, P NATL ACAD SCI USA, V87, P1845, DOI 10.1073/pnas.87.5.1845; BENSINGER TA, 1974, ARCH INTERN MED, V133, P624, DOI 10.1001/archinte.133.4.624; Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; Cao ZQ, 1997, J MOL BIOL, V265, P580, DOI 10.1006/jmbi.1996.0749; Chang CK, 2002, BIOCHEMISTRY-US, V41, P5644, DOI 10.1021/bi011919d; DALVIT C, 1985, BIOCHEMISTRY-US, V24, P3398, DOI 10.1021/bi00335a003; Dickerson R E., 1983, HEMOGLOBIN STRUCTURE, P19; DYKES GW, 1979, J MOL BIOL, V130, P451, DOI 10.1016/0022-2836(79)90434-0; EATON WA, 1987, BLOOD, V70, P1245; Fang TY, 2000, BIOCHEMISTRY-US, V39, P13708, DOI 10.1021/bi001115i; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P2526, DOI 10.1021/bi00682a036; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HIMANEN JP, 1995, J BIOL CHEM, V270, P13885, DOI 10.1074/jbc.270.23.13885; Himanen JP, 1997, BLOOD, V89, P4196, DOI 10.1182/blood.V89.11.4196; Ho C, 1996, J MOL BIOL, V263, P475, DOI 10.1006/jmbi.1996.0590; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; ISHIMORI K, 1992, BIOCHEMISTRY-US, V31, P3256, DOI 10.1021/bi00127a030; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; LAMAR GN, 1980, BIOCHEM BIOPH RES CO, V96, P1172, DOI 10.1016/0006-291X(80)90075-3; LINDSTROM TR, 1972, P NATL ACAD SCI USA, V69, P1707, DOI 10.1073/pnas.69.7.1707; LINDSTROM TR, 1972, BIOCHEMISTRY-US, V11, P1677, DOI 10.1021/bi00759a023; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; PADLAN EA, 1985, J BIOL CHEM, V260, P8272; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; Patskovska LN, 2005, ACTA CRYSTALLOGR D, V61, P566, DOI 10.1107/S0907444905004622; PERUTZ MF, 1950, NATURE, V166, P677, DOI 10.1038/166677a0; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Reddy LR, 1996, J BIOL CHEM, V271, P24564, DOI 10.1074/jbc.271.40.24564; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; RHODA MD, 1984, BIOCHIM BIOPHYS ACTA, V786, P62, DOI 10.1016/0167-4838(84)90154-7; RUSSU IM, 1987, BIOCHIM BIOPHYS ACTA, V914, P40, DOI 10.1016/0167-4838(87)90159-2; RUSSU IM, 1980, P NATL ACAD SCI-BIOL, V77, P6577, DOI 10.1073/pnas.77.11.6577; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Simplaceanu V, 2000, BIOPHYS J, V79, P1146, DOI 10.1016/S0006-3495(00)76368-5; Sivaram MVS, 2001, J BIOL CHEM, V276, P18209, DOI 10.1074/jbc.M101788200; Srinivasulu S, 2007, PROTEIN J, V26, P523, DOI 10.1007/s10930-007-9089-9; Srinivasulu S, 2006, PROTEIN J, V25, P503, DOI 10.1007/s10930-006-9034-3; TAKAHASHI S, 1980, BIOCHEMISTRY-US, V19, P5196, DOI 10.1021/bi00564a007; Tam MF, 2005, BIOCHEMISTRY-US, V44, P12188, DOI 10.1021/bi050300z; Tam MF, 2013, J BIOL CHEM, V288, P25512, DOI 10.1074/jbc.M113.474841; WATOWICH SJ, 1989, J MOL BIOL, V209, P821, DOI 10.1016/0022-2836(89)90610-4; WELLEMS TE, 1979, J MOL BIOL, V135, P651, DOI 10.1016/0022-2836(79)90170-0; WELLEMS TE, 1981, J MOL BIOL, V153, P1011, DOI 10.1016/0022-2836(81)90464-2; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Yuan Y, 2015, CHEM REV, V115, P1702, DOI 10.1021/cr500495x	63	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21762	21772		10.1074/jbc.M115.658054	http://dx.doi.org/10.1074/jbc.M115.658054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26187468	Green Published, hybrid			2022-12-28	WOS:000360637600047
J	Keeler, AB; Schreiner, D; Weiner, JA				Keeler, Austin B.; Schreiner, Dietmar; Weiner, Joshua A.			Protein Kinase C Phosphorylation of a gamma-Protocadherin C-terminal Lipid Binding Domain Regulates Focal Adhesion Kinase Inhibition and Dendrite Arborization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR SLICE CULTURES; PURKINJE-CELLS; HOMOPHILIC INTERACTION; CYTOPLASMIC DOMAIN; SEQUENCE-ANALYSIS; BIPOLAR DISORDER; SPINAL-CORD; GENE; ALPHA; MECHANISMS	The gamma-protocadherins (gamma-Pcdhs) are a family of 22 adhesion molecules with multiple critical developmental functions, including the proper formation of dendritic arbors by forebrain neurons. The gamma-Pcdhs bind to and inhibit focal adhesion kinase (FAK) via a constant C-terminal cytoplasmic domain shared by all 22 proteins. In cortical neurons lacking the gamma-Pcdhs, aberrantly high activity of FAK and of PKC disrupts dendrite arborization. Little is known, however, about how gamma-Pcdh function is regulated by other factors. Here we show that PKC phosphorylates a serine residue situated within a phospholipid binding motif at the shared gamma-Pcdh C terminus. Western blots using a novel phospho-specific antibody against this site suggest that a portion of gamma-Pcdh proteins is phosphorylated in the cortex in vivo. We find that PKC phosphorylation disrupts both phospholipid binding and the gamma-Pcdh inhibition of (but not binding to) FAK. Introduction of a non-phosphorylatable (S922A) gamma-Pcdh construct into wild-type cortical neurons significantly increases dendrite arborization. This same S922A construct can also rescue dendrite arborization defects in gamma-Pcdh null neurons cell autonomously. Consistent with these data, introduction of a phosphomimetic (S/D) gamma-Pcdh construct or treatment with a PKC activator reduces dendrite arborization in wild-type cortical neurons. Together, these data identify a novel mechanism through which gamma-Pcdh control of a signaling pathway important for dendrite arborization is regulated.	[Keeler, Austin B.; Schreiner, Dietmar; Weiner, Joshua A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Keeler, Austin B.; Weiner, Joshua A.] Univ Iowa, Neurosci Grad Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Weiner, JA (corresponding author), Univ Iowa, Dept Biol, 143 Biol Bldg, Iowa City, IA 52242 USA.	joshua-weiner@uiowa.edu	Weiner, Joshua/AAA-6532-2021; Regan, Clinton/E-6250-2012	Keeler, Austin/0000-0002-6148-0891; Weiner, Joshua/0000-0002-3352-2847	National Institutes of Health [R01NS055272]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS055272 (to J. A. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anitha A, 2013, J PSYCHIATR NEUROSCI, V38, P192, DOI 10.1503/jpn.120058; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Chen J, 2009, J BIOL CHEM, V284, P2880, DOI 10.1074/jbc.M807417200; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Fernandez-Monreal M, 2010, EUR J NEUROSCI, V32, P921, DOI 10.1111/j.1460-9568.2010.07386.x; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gundlfinger A, 2003, J NEUROBIOL, V57, P95, DOI 10.1002/neu.10259; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Lachman HM, 2008, PSYCHIAT GENET, V18, P110, DOI 10.1097/YPG.0b013e3282fa1838; Ledderose J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01514; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; O'Leary R, 2011, MOL BIOL CELL, V22, P4362, DOI 10.1091/mbc.E11-04-0283; Pedrosa E, 2008, SCHIZOPHR RES, V102, P210, DOI 10.1016/j.schres.2008.04.013; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Prasad T, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00054; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Schrenk K, 2002, NEUROSCIENCE, V110, P675, DOI 10.1016/S0306-4522(01)00559-0; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Suo L, 2012, J MOL CELL BIOL, V4, P362, DOI 10.1093/jmcb/mjs034; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00045; YU FX, 1992, J BIOL CHEM, V267, P14616; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	45	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20674	20686		10.1074/jbc.M115.642306	http://dx.doi.org/10.1074/jbc.M115.642306			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139604	Green Published, hybrid			2022-12-28	WOS:000360011800004
J	Tattikota, SG; Rathjen, T; Hausser, J; Khedkar, A; Kabra, UD; Pandey, V; Sury, M; Wessels, HH; Mollet, IG; Eliasson, L; Selbach, M; Zinzen, RP; Zavolan, M; Kadener, S; Tschop, MH; Jastroch, M; Friedlander, MR; Poy, MN				Tattikota, Sudhir G.; Rathjen, Thomas; Hausser, Jean; Khedkar, Aditya; Kabra, Uma D.; Pandey, Varun; Sury, Matthias; Wessels, Hans-Hermann; Mollet, Ines G.; Eliasson, Lena; Selbach, Matthias; Zinzen, Robert P.; Zavolan, Mihaela; Kadener, Sebastian; Tschoep, Matthias H.; Jastroch, Martin; Friedlaender, Marc R.; Poy, Matthew N.			miR-184 Regulates Pancreatic beta-Cell Function According to Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; IN-VIVO; DROSOPHILA; PROTEIN; STRESS; REPLICATION; MICRORNAS; REVEALS; DIFFERENTIATION; PROLIFERATION	In response to fasting or hyperglycemia, the pancreatic beta-cell alters its output of secreted insulin; however, the pathways governing this adaptive response are not entirely established. Although the precise role of microRNAs (miRNAs) is also unclear, a recurring theme emphasizes their function in cellular stress responses. We recently showed that miR-184, an abundant miRNA in the beta-cell, regulates compensatory proliferation and secretion during insulin resistance. Consistent with previous studies showing miR-184 suppresses insulin release, expression of this miRNA was increased in islets after fasting, demonstrating an active role in the beta-cell as glucose levels lower and the insulin demand ceases. Additionally, miR-184 was negatively regulated upon the administration of a sucrose-rich diet in Drosophila, demonstrating strong conservation of this pathway through evolution. Furthermore, miR-184 and its target Argonaute2 remained inversely correlated as concentrations of extracellular glucose increased, underlining a functional relationship between this miRNA and its targets. Lastly, restoration of Argonaute2 in the presence of miR-184 rescued suppression of miR-375-targeted genes, suggesting these genes act in a coordinated manner during changes in the metabolic context. Together, these results highlight the adaptive role of miR-184 according to glucose metabolism and suggest the regulatory role of this miRNA in energy homeostasis is highly conserved.	[Tattikota, Sudhir G.; Rathjen, Thomas; Khedkar, Aditya; Sury, Matthias; Wessels, Hans-Hermann; Selbach, Matthias; Zinzen, Robert P.; Poy, Matthew N.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, Computat & Syst Biol, CH-4056 Basel, Switzerland; [Kabra, Uma D.; Tschoep, Matthias H.; Jastroch, Martin] Tech Univ Munich, Inst Diabet & Obes, Helmholtz Ctr Hlth & Environm, D-85748 Munich, Germany; [Kabra, Uma D.; Tschoep, Matthias H.; Jastroch, Martin] Tech Univ Munich, Div Metab Dis, D-85748 Munich, Germany; [Pandey, Varun; Kadener, Sebastian] Hebrew Univ Jerusalem, Dept Biol Chem, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Mollet, Ines G.; Eliasson, Lena] Lund Univ, Ctr Diabet, Islet Cell Exocytosis, S-20502 Malmo, Sweden; [Friedlaender, Marc R.] Stockholm Univ, Wenner Gren Inst, Sci Life Lab, Dept Mol Biosci, S-17121 Stockholm, Sweden	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Basel; Technical University of Munich; Technical University of Munich; Hebrew University of Jerusalem; Lund University; Stockholm University	Poy, MN (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10,WFH C27,Rm 131, D-13125 Berlin, Germany.	matthew.poy@mdc-berlin.de	Tattikota, Sudhir Gopal/K-4830-2018; Mollet, Ines Guerra/H-8526-2019; Zavolan, Mihaela/S-3888-2016; Zinzen, Robert/AAG-2784-2020; Kabra, Uma/ABG-9421-2020; Poy, Matthew/F-6914-2017; Eliasson, Lena/E-9294-2012; Jastroch, Martin/I-7494-2017; PANDEY, VARUN/B-8844-2018; Zinzen, Robert/A-3130-2015	Tattikota, Sudhir Gopal/0000-0003-0318-5533; Mollet, Ines Guerra/0000-0002-1422-1336; Poy, Matthew/0000-0002-4904-2426; Eliasson, Lena/0000-0002-6467-5029; Tschoep, Matthias/0000-0002-4744-371X; Zinzen, Robert/0000-0002-8638-5102; Hausser, Jean/0000-0002-3321-7199; Friedlander, Marc/0000-0001-6577-4363; Zavolan, Mihaela/0000-0002-8832-2041	Helmholtz Gemeinschaft; ERC [IsletVasc 260744]; Fritz Thyssen Stiftung; Deutsches Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK); Israeli Science Foundation (ISF) [840/2014]; Swedish Research Council; Swedish Diabetes Association	Helmholtz Gemeinschaft(Helmholtz Association); ERC(European Research Council (ERC)European Commission); Fritz Thyssen Stiftung; Deutsches Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK); Israeli Science Foundation (ISF)(Israel Science Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association	This work was supported by the Helmholtz Gemeinschaft, an ERC starting grant (IsletVasc 260744), the Fritz Thyssen Stiftung, the Deutsches Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK), Israeli Science Foundation (ISF#840/2014 to S. K.), and the Swedish Research Council and Swedish Diabetes Association (to L. E.). The authors do not declare any competing financial interests.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; ASHCROFT SJ, 1968, P ROY SOC MED, V61, P814, DOI 10.1177/003591576806100831; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; CHICK WL, 1973, DIABETES, V22, P687, DOI 10.2337/diab.22.9.687; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; GREY NJ, 1970, J CLIN INVEST, V49, P881, DOI 10.1172/JCI106307; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Hija A, 2014, DIABETES, V63, P578, DOI 10.2337/db12-1035; Hong X, 2009, P NATL ACAD SCI USA, V106, P15085, DOI 10.1073/pnas.0908149106; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; La Rocca G, 2015, P NATL ACAD SCI USA, V112, P767, DOI 10.1073/pnas.1424217112; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Luciani DS, 2013, DIABETES, V62, P170, DOI 10.2337/db11-1464; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Padmanabha D, 2014, TRENDS ENDOCRIN MET, V25, P518, DOI 10.1016/j.tem.2014.03.011; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Tattikota SG, 2013, MOL CELL PROTEOMICS, V12, P1214, DOI 10.1074/mcp.M112.024786; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	39	44	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20284	20294		10.1074/jbc.M115.658625	http://dx.doi.org/10.1074/jbc.M115.658625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26152724	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000359608900028
J	Chang, HY; Liao, CY; Su, GC; Lin, SW; Wang, HW; Chi, P				Chang, Hao-Yen; Liao, Chia-Yu; Su, Guan-Chin; Lin, Sheng-Wei; Wang, Hong-Wei; Chi, Peter			Functional Relationship of ATP Hydrolysis, Presynaptic Filament Stability, and Homologous DNA Pairing Activity of the Human Meiotic Recombinase DMC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALKER-B MOTIF; HUMAN RAD51 PROTEIN; NUCLEOTIDE-BINDING; CHROMOSOME SYNAPSIS; PROMOTES; HOP2-MND1; HSDMC1	DMC1 and RAD51 are conserved recombinases that catalyze homologous recombination. DMC1 and RAD51 share similar properties in DNA binding, DNA-stimulated ATP hydrolysis, and catalysis of homologousDNAstrand exchange. Alarge body of evidence indicates that attenuation ofATPhydrolysis leads to stabilization of the RAD51-ssDNA presynaptic filament and enhancement ofDNAstrand exchange. However, the functional relationship of ATPase activity, presynaptic filament stability, and DMC1-mediated homologous DNA strand exchange has remained largely unexplored. To address this important question, we have constructed several mutant variants of human DMC1and characterized them biochemically to gain mechanistic insights. Two mutations, K132R and D223N, that change key residues in the WalkerAandBnucleotide-binding motifs ablate ATP binding and renderDMC1inactive. On the other hand, the nucleotide-binding cap D317K mutant binds ATP normally but shows significantly attenuated ATPase activity and, accordingly, forms a highly stable presynaptic filament. Surprisingly, unlike RAD51, presynaptic filament stabilization achieved via ATP hydrolysis attenuation does not lead to any enhancement of DMC1-catalyzed homologous DNA pairing and strand exchange. This conclusion is further supported by examining wild-type DMC1 with non-hydrolyzable ATP analogues. Thus, our results reveal an important mechanistic difference between RAD51 and DMC1.	[Chang, Hao-Yen; Liao, Chia-Yu; Su, Guan-Chin; Chi, Peter] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Lin, Sheng-Wei; Chi, Peter] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Wang, Hong-Wei] Tsinghua Univ, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Ctr Struct Bio, Beijing 100084, Peoples R China	National Taiwan University; Academia Sinica - Taiwan; Tsinghua University	Chi, P (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	peterhchi@ntu.edu.tw	Lin, Sheng-Wei/G-8142-2015; Chi, Peter/AAI-1580-2019; Huang, Wenchi/F-3981-2010	Lin, Sheng-Wei/0000-0001-7777-2090; Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; Chang, Hao-Yen/0000-0001-5677-816X	Academia Sinica; National Taiwan University [NTU-ICRP-103R7560-6, NTU-CDP-103R7848, NTU-ERP-104R8955-3]; Ministry of Science and Technology [MOST 102-2628-B-002-044-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Taiwan University(National Taiwan University); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Academia Sinica, National Taiwan University (Grants NTU-ICRP-103R7560-6, NTU-CDP-103R7848, and NTU-ERP-104R8955-3), and Ministry of Science and Technology (MOST 102-2628-B-002-044-MY3). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Amunugama R, 2012, J BIOL CHEM, V287, P8724, DOI 10.1074/jbc.M111.239426; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bugreev DV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5198; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chiraniya A, 2013, GENES-BASEL, V4, P134, DOI 10.3390/genes4020134; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Cole F, 2012, ANN NY ACAD SCI, V1267, P95, DOI 10.1111/j.1749-6632.2012.06595.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fung CW, 2006, MOL CELL BIOL, V26, P9544, DOI 10.1128/MCB.00599-06; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rai V, 2006, BIOCHEMISTRY-US, V45, P14726, DOI 10.1021/bi061535t; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; Sehorn MG, 2004, CELL CYCLE, V3, P1375, DOI 10.4161/cc.3.11.1364; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sharma D, 2013, DNA REPAIR, V12, P53, DOI 10.1016/j.dnarep.2012.10.005; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Su GC, 2014, NUCLEIC ACIDS RES, V42, P349, DOI 10.1093/nar/gkt879; Tombline G, 2002, J BIOL CHEM, V277, P14426, DOI 10.1074/jbc.M109916200; Tsai SP, 2012, NUCLEIC ACIDS RES, V40, P6558, DOI 10.1093/nar/gks305; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yu X, 2010, J MOL BIOL, V401, P544, DOI 10.1016/j.jmb.2010.06.049; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924	41	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19863	19873		10.1074/jbc.M115.666289	http://dx.doi.org/10.1074/jbc.M115.666289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088134	Green Published, hybrid			2022-12-28	WOS:000359364600042
J	Bartlett, PJ; Metzger, W; Gaspers, LD; Thomas, AP				Bartlett, Paula J.; Metzger, Walson; Gaspers, Lawrence D.; Thomas, Andrew P.			Differential Regulation of Multiple Steps in Inositol 1,4,5-Trisphosphate Signaling by Protein Kinase C Shapes Hormone-stimulated Ca2+ Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CALCIUM OSCILLATIONS; PHOSPHORYLATION; RECEPTOR; WAVES; FREQUENCY; MODEL; IP3; ACTIVATION; DIACYLGLYCEROL; PHENYLEPHRINE	How Ca2+ oscillations are generated and fine-tuned to yield versatile downstream responses remains to be elucidated. In hepatocytes, G protein-coupled receptor-linked Ca2+ oscillations report signal strength via frequency, whereas Ca2+ spike amplitude and wave velocity remain constant. IP3 uncaging also triggers oscillatory Ca2+ release, but, in contrast to hormones, Ca2+ spike amplitude, width, and wave velocity were dependent on [IP3] and were not perturbed by phospholipase C (PLC) inhibition. These data indicate that oscillations elicited by IP3 uncaging are driven by the biphasic regulation of the IP3 receptor by Ca2+, and, unlike hormone-dependent responses, do not require PLC. Removal of extracellular Ca2+ did not perturb Ca2+ oscillations elicited by IP3 uncaging, indicating that reloading of endoplasmic reticulum stores via plasma membrane Ca2+ influx does not entrain the signal. Activation and inhibition of PKC attenuated hormone-induced Ca2+ oscillations but had no effect on Ca2+ increases induced by uncaging IP3. Importantly, PKC activation and inhibition differentially affected Ca2+ spike frequencies and kinetics. PKC activation amplifies negative feedback loops at the level of G protein-coupled receptor PLC activity and/or IP3 metabolism to attenuate IP3 levels and suppress the generation of Ca2+ oscillations. Inhibition of PKC relieves negative feedback regulation of IP3 accumulation and, thereby, shifts Ca2+ oscillations toward sustained responses or dramatically prolonged spikes. PKC down-regulation attenuates phenylephrine-induced Ca2+ wave velocity, whereas responses to IP3 uncaging are enhanced. The ability to assess Ca2+ responses in the absence of PLC activity indicates that IP3 receptor modulation by PKC regulates Ca2+ release and wave velocity.	[Bartlett, Paula J.; Metzger, Walson; Gaspers, Lawrence D.; Thomas, Andrew P.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Thomas, AP (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA.	andrew.thomas@rutgers.edu	Gaspers, Lawrence/W-8766-2019; Regan, Clinton/E-6250-2012	Gaspers, Lawrence/0000-0002-5620-3283; Thomas, Andrew/0000-0002-9026-7467	National Institutes of Health [DK082954, AI099277]; Thomas P. Infusion Endowed Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas P. Infusion Endowed Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082954 and AI099277 (to A. P. T.). This work was also supported by the Thomas P. Infusion Endowed Chair (to A. P. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; BANNO Y, 1994, J BIOL CHEM, V269, P15846; Bartlett PJ, 2014, CELL CALCIUM, V55, P306, DOI 10.1016/j.ceca.2014.02.007; Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIE CP, 1995, CELL CALCIUM, V18, P232, DOI 10.1016/0143-4160(95)90068-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bootman MD, 1996, BIOCHEM J, V314, P347, DOI 10.1042/bj3140347; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; CONNOLLY TM, 1986, CELL, V46, P951, DOI 10.1016/0092-8674(86)90077-2; Dakin K, 2007, CELL CALCIUM, V42, P291, DOI 10.1016/j.ceca.2006.12.003; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dupont G, 1997, CELL CALCIUM, V22, P321, DOI 10.1016/S0143-4160(97)90017-8; Dupont G, 2011, COLD SPRING HARB PER, V3; Dupont G, 2011, BIOCHIMIE, V93, P2132, DOI 10.1016/j.biochi.2011.09.010; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fraiman D, 2004, CELL CALCIUM, V35, P403, DOI 10.1016/j.ceca.2003.10.004; Gaspers LD, 2014, CELL REP, V9, P1209, DOI 10.1016/j.celrep.2014.10.033; Gaspers LD, 2005, CELL CALCIUM, V38, P329, DOI 10.1016/j.ceca.2005.06.009; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P586, DOI 10.1038/nrm1152; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Kim JK, 2011, CELL SIGNAL, V23, P1022, DOI 10.1016/j.cellsig.2011.01.017; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; NATHANSON MH, 1995, AM J PHYSIOL-GASTR L, V269, pG167, DOI 10.1152/ajpgi.1995.269.1.G167; NATHANSON MH, 1994, AM J PHYSIOL, V267, pG338, DOI 10.1152/ajpgi.1994.267.3.G338; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Robb-Gaspers LD, 1998, BBA-BIOENERGETICS, V1366, P17, DOI 10.1016/S0005-2728(98)00118-2; ROBBGASPERS LD, 1995, J BIOL CHEM, V270, P8102, DOI 10.1074/jbc.270.14.8102; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROONEY TA, 1991, J BIOL CHEM, V266, P12272; ROONEY TA, 1991, PHARMACOL THERAPEUT, V49, P223, DOI 10.1016/0163-7258(91)90056-R; Salazar C, 2008, BIOPHYS J, V94, P1203, DOI 10.1529/biophysj.107.113084; SANCHEZBUENO A, 1990, BIOCHEM J, V268, P627, DOI 10.1042/bj2680627; Shin DM, 2001, J BIOL CHEM, V276, P44146, DOI 10.1074/jbc.M105203200; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Sneyd J, 2006, P NATL ACAD SCI USA, V103, P1675, DOI 10.1073/pnas.0506135103; Strassheim D, 2000, J BIOL CHEM, V275, P39767, DOI 10.1074/jbc.M007775200; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; THOMAS AP, 1991, CELL CALCIUM, V12, P111, DOI 10.1016/0143-4160(91)90013-5; Thurley K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005237; Thurley K, 2011, P NATL ACAD SCI USA, V108, P427, DOI 10.1073/pnas.1008435108; Tordjmann T, 1998, EMBO J, V17, P4695, DOI 10.1093/emboj/17.16.4695; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; Yamasaki-Mann M, 2011, CELL CALCIUM, V50, P36, DOI 10.1016/j.ceca.2011.04.008; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Zhu LP, 2011, J CELL SCI, V124, P2591, DOI 10.1242/jcs.082727	62	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18519	18533		10.1074/jbc.M115.657767	http://dx.doi.org/10.1074/jbc.M115.657767			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26078455	Green Published, hybrid			2022-12-28	WOS:000358512100024
J	Rojas-Benitez, D; Thiaville, PC; de Crecy-Lagard, V; Glavic, A				Rojas-Benitez, Diego; Thiaville, Patrick C.; de Crecy-Lagard, Valerie; Glavic, Alvaro			The Levels of a Universally Conserved tRNA Modification Regulate Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-RELATED PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; THREONYLCARBAMOYLADENOSINE T(6)A; BIOSYNTHESIS; ACTIVATION; SEQUENCE; TOR; PHOSPHORYLATION; PROLIFERATION; TRANSLATION	N-6-Threonylcarbamoyl-adenosine (t(6)A) is a universal modification occurring at position 37 in nearly all tRNAs that decode A-starting codons, including the eukaryotic initiator tRNA (tRNA(i)(Met)). Yeast lacking central components of the t(6)A synthesis machinery, such as Tcs3p (Kae1p) or Tcs5p (Bud32p), show slow-growth phenotypes. In the present work, we show that loss of the Drosophila tcs3 homolog also leads to a severe reduction in size and demonstrate, for the first time in a non-microbe, that Tcs3 is required for t(6)A synthesis. In Drosophila and in mammals, tRNA(i)(Met) is a limiting factor for cell and animal growth. We report that the t(6)A-modified form of tRNA(i)(Met) is the actual limiting factor. We show that changing the proportion of t(6)A-modified tRNA(i)(Met), by expression of an un-modifiable tRNA(i)(Met) or changing the levels of Tcs3, regulate target of rapamycin (TOR) kinase activity and influences cell and animal growth in vivo. These findings reveal an unprecedented relationship between the translation machinery and TOR, where translation efficiency, limited by the availability of t(6)A-modified tRNA, determines growth potential in eukaryotic cells.	[Rojas-Benitez, Diego; Glavic, Alvaro] Univ Chile, Fac Ciencias, Ctr Regul Genoma, Santiago 7800024, Chile; [Thiaville, Patrick C.; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	Universidad de Chile; State University System of Florida; University of Florida	Glavic, A (corresponding author), Univ Chile, Fac Ciencias, Ctr Regul Genoma, Palmeras 3425, Santiago 7800024, Chile.	alglavic@uchile.cl	de Crecy-Lagard, Valerie/AAN-8995-2020; Regan, Clinton/E-6250-2012; Glavic, Alvaro/F-5608-2013	de Crecy-Lagard, Valerie/0000-0002-9955-3785	Company of Biologists; International Union of Biochemistry and Molecular Biology; National Institutes of Health [P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Company of Biologists; International Union of Biochemistry and Molecular Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank The Company of Biologists and International Union of Biochemistry and Molecular Biology for travel funding (to D. R. B.). Stocks obtained from the Bloomington Drosophila Stock Center (National Institutes of Health Grant P40OD018537) were used in this study.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COOPER HL, 1980, EXP CELL RES, V127, P351, DOI 10.1016/0014-4827(80)90440-1; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Huynh LN, 2010, CELL CYCLE, V9, P3112, DOI 10.4161/cc.9.15.12525; Ibar C, 2013, DEVELOPMENT, V140, P1282, DOI 10.1242/dev.086918; Kanduc D, 1997, BIOCHEM MOL BIOL INT, V43, P1323; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Morin A, 1998, RNA, V4, P24; Mulder Nicola, 2007, V396, P59; NA JG, 1992, GENETICS, V131, P791; Naor A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043013; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P9484, DOI 10.1093/nar/gkt720; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P1953, DOI 10.1093/nar/gks1287; Phizicky EM, 2010, FEBS LETT, V584, P265, DOI 10.1016/j.febslet.2009.11.049; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Rideout EJ, 2012, P NATL ACAD SCI USA, V109, P1139, DOI 10.1073/pnas.1113311109; Rojas-Benitez D, 2013, FLY, V7, P168, DOI 10.4161/fly.25227; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheidt V, 2014, MICROB CELL, V1, P416, DOI 10.15698/mic2014.12.179; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; SHARP S, 1981, NUCLEIC ACIDS RES, V9, P5867, DOI 10.1093/nar/9.22.5867; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Thiaville PC, 2014, RNA BIOL, V11, P1529, DOI 10.4161/15476286.2014.992277; Thiaville PC, 2014, EUKARYOT CELL, V13, P1222, DOI 10.1128/EC.00147-14; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; van Sluijters DA, 2000, BIOCHEM J, V351, P545, DOI 10.1042/0264-6021:3510545; VOLD BS, 1986, CANCER RES, V46, P3164; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Willis IM, 2012, CELL CYCLE, V11, P2769, DOI 10.4161/cc.21257; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	65	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18699	18707		10.1074/jbc.M115.665406	http://dx.doi.org/10.1074/jbc.M115.665406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063805	Green Published, hybrid			2022-12-28	WOS:000358512100038
J	Yamano, K; Queliconi, BB; Koyano, F; Saeki, Y; Hirokawa, T; Tanaka, K; Matsuda, N				Yamano, Koji; Queliconi, Bruno B.; Koyano, Fumika; Saeki, Yasushi; Hirokawa, Takatsugu; Tanaka, Keiji; Matsuda, Noriyuki			Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK1-DEPENDENT PHOSPHORYLATION; PINK1; MUTATIONS; BINDING; TRANSLOCATION; MITOCHONDRIA; MECHANISM; MITOPHAGY; IMPORT; DOMAIN	Damaged mitochondria are eliminated through autophagy machinery. A cytosolic E3 ubiquitin ligase Parkin, a gene product mutated in familial Parkinsonism, is essential for this pathway. Recent progress has revealed that phosphorylation of both Parkin and ubiquitin at Ser(65) by PINK1 are crucial for activation and recruitment of Parkin to the damaged mitochondria. However, the mechanism by which phosphorylated ubiquitin associates with and activates phosphorylated Parkin E3 ligase activity remains largely unknown. Here, we analyze interactions between phosphorylated forms of both Parkin and ubiquitin at a spatial resolution of the amino acid residue by site-specific photo-crosslinking. We reveal that the in-between-RING (IBR)domain along with RING1 domain of Parkin preferentially binds to ubiquitin in a phosphorylation-dependent manner. Furthermore, another approach, the Fluoppi (fluorescent-based technology detecting protein-protein interaction) assay, also showed that pathogenic mutations in these domains blocked interactions with phosphomimetic ubiquitin in mammalian cells. Molecular modeling based on the site-specific photo-crosslinking interaction map combined with mass spectrometry strongly suggests that a novel binding mechanism between Parkin and ubiquitin leads to a Parkin conformational change with subsequent activation of Parkin E3 ligase activity.	[Yamano, Koji; Koyano, Fumika; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Setagaya Ku, Tokyo 1568506, Japan; [Queliconi, Bruno B.; Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; National Institute of Advanced Industrial Science & Technology (AIST)	Yamano, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	yamano-kj@igakuken.or.jp; matsuda-nr@igakuken.or.jp	Saeki, Yasushi/AAR-8198-2021; Matsuda, Noriyuki/AAI-3156-2020	Saeki, Yasushi/0000-0002-9202-5453; Matsuda, Noriyuki/0000-0001-8199-952X; Queliconi, Bruno Barros/0000-0001-7361-5573	Japan Society for the Promotion of Science (JSPS) PRESTO, KAKENHI [23687018]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) KAKENHI [24111557, 25112522]; Tomizawa Jun-ichi and Keiko Fund for Young Scientist by MEXT KAKENHI [15K19037]; MEXT KAKENHI [24112008]; JSPS KAKENHI [21000012]; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) PRESTO, KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tomizawa Jun-ichi and Keiko Fund for Young Scientist by MEXT KAKENHI; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) PRESTO, KAKENHI Grant 23687018, Ministry of Education, Culture, Sports, Science, and Technology (MEXT) KAKENHI Grants 24111557 and 25112522, and the Tomizawa Jun-ichi and Keiko Fund for Young Scientist (to N.M.); by MEXT KAKENHI Grant 15K19037 (to F.K.); by MEXT KAKENHI Grant 24112008 (to Y.S.); by JSPS KAKENHI Grant 21000012 (to K.T.); by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT (to T.H.); and by the Takeda Science Foundation (to K.T. and N.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	41	45	49	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25199	25211		10.1074/jbc.M115.671446	http://dx.doi.org/10.1074/jbc.M115.671446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26260794	Green Published, hybrid			2022-12-28	WOS:000362962800001
J	Trampari, E; Stevenson, CEM; Little, RH; Wilhelm, T; Lawson, DM; Malone, JG				Trampari, Eleftheria; Stevenson, Clare E. M.; Little, Richard H.; Wilhelm, Thomas; Lawson, David M.; Malone, Jacob G.			Bacterial Rotary Export ATPases Are Allosterically Regulated by the Nucleotide Second Messenger Cyclic-di-GMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLAR PROTEIN-EXPORT; PSEUDOMONAS-FLUORESCENS SBW25; BIOFILM FORMATION; BINDING PROTEIN; RHIZOSPHERE COLONIZATION; VI SECRETION; PILZ DOMAIN; AERUGINOSA; IDENTIFICATION; MOTILITY	The widespread second messenger molecule cyclic di-GMP (cdG) regulates the transition from motile and virulent lifestyles to sessile, biofilm-forming ones in a wide range of bacteria. Many pathogenic and commensal bacterial-host interactions are known to be controlled by cdG signaling. Although the biochemistry of cyclic dinucleotide metabolism is well understood, much remains to be discovered about the downstream signaling pathways that induce bacterial responses upon cdG binding. As part of our ongoing research into the role of cdG signaling in plant-associated Pseudomonas species, we carried out an affinity capture screen for cdG binding proteins in the model organism Pseudoinonas fluorescens SBW25. The flagella export AAA + ATPase Flit was identified as a result of this screen and subsequently shown to bind specifically to the cdG molecule, with a K14 in the low micromolar range. The interaction between Flit and crki appears to be very widespread. In addition to Flit homologs from diverse bacterial species, high affinity binding was also observed fir the type III secretion system homolog HrcN and the type VI ATPase CIpB2. The addition of cdG was shown to inhibit Flit and HrcN ATPase activity in vitro. Finally, a combination of site-specific mutagenesis, mass spectrometry, and in silk analysis was used to predict that cdG binds to Flit in a pocket of highly conserved residues at the interface between two Flit subunits. Our results suggest a novel, fundamental role for cdG in controlling the function of multiple important bacterial export pathways, through direct allosteric control of export ATPase proteins.	[Trampari, Eleftheria; Little, Richard H.; Malone, Jacob G.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Stevenson, Clare E. M.; Lawson, David M.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Wilhelm, Thomas] Norwich Res Pk, Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Malone, Jacob G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of East Anglia	Malone, JG (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.	jacob.malone@jic.ac.uk		Malone, Jacob/0000-0003-1959-6820; Trampari, Eleftheria/0000-0001-8886-8442	Institute Strategic Program Grants; Institute for Food Research; University of East Anglia; Biotechnology and Biological Sciences Research Council; BBSRC [BBS/E/J/000C0655] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0655] Funding Source: researchfish	Institute Strategic Program Grants; Institute for Food Research; University of East Anglia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Institute Strategic Program Grants awarded to the John Innes Centre (to J. G. M., R. L., C. E. M. S., and D. L.) and the Institute for Food Research (to T. W.) and by University of East Anglia start-up funding (to J. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Partnership Ph.D. studentship.	Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Aragon IM, 2015, MOL PLANT PATHOL, V16, P604, DOI 10.1111/mpp.12218; Barahona E, 2010, ENVIRON MICROBIOL, V12, P3185, DOI 10.1111/j.1462-2920.2010.02291.x; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Bell CE, 2005, MOL MICROBIOL, V58, P358, DOI 10.1111/j.1365-2958.2005.04876.x; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engl C, 2014, MBIO, V5, DOI 10.1128/mBio.01168-14; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Gal M, 2003, MOL ECOL, V12, P3109, DOI 10.1046/j.1365-294X.2003.01953.x; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Iino R, 2013, CURR OPIN STRUC BIOL, V23, P229, DOI 10.1016/j.sbi.2013.01.004; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuchma SL, 2015, J BACTERIOL, V197, P420, DOI 10.1128/JB.02130-14; Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; Little R, 2011, MOL MICROBIOL, V82, P222, DOI 10.1111/j.1365-2958.2011.07812.x; Lovering AL, 2011, MBIO, V2, DOI 10.1128/mBio.00163-11; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Martinez-Granero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087608; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller J. H, 1972, EXPT MOL GENETICS; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2006, ACTA CRYSTALLOGR F, V62, P973, DOI 10.1107/S1744309106033100; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Minamino T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07579; Minamino T, 2014, BBA-MOL CELL RES, V1843, P1642, DOI 10.1016/j.bbamcr.2013.09.005; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Moscoso JA, 2014, J BACTERIOL, V196, P4081, DOI 10.1128/JB.01850-14; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Naseby DC, 2001, J APPL MICROBIOL, V90, P421, DOI 10.1046/j.1365-2672.2001.01260.x; Navazo A, 2009, MICROB BIOTECHNOL, V2, P489, DOI 10.1111/j.1751-7915.2009.00103.x; Nesper J, 2012, J PROTEOMICS, V75, P4874, DOI 10.1016/j.jprot.2012.05.033; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Perez-Mendoza D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091645; Pfeilmeier S, 2016, MOL PLANT PATHOL, V17, P521, DOI 10.1111/mpp.12297; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Srivastava D, 2013, MOL MICROBIOL, V90, P1262, DOI 10.1111/mmi.12432; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Wilhelm T, 2014, J PROTEOME RES, V13, P4002, DOI 10.1021/pr500347e; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321	84	58	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24470	24483		10.1074/jbc.M115.661439	http://dx.doi.org/10.1074/jbc.M115.661439			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26265469	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000362218900033
J	Little, DJ; Milek, S; Bamford, NC; Ganguly, T; DiFrancesco, BR; Nitz, M; Deora, R; Howell, PL				Little, Dustin J.; Milek, Sonja; Bamford, Natalie C.; Ganguly, Tridib; DiFrancesco, Benjamin R.; Nitz, Mark; Deora, Rajendar; Howell, P. Lynne			The Protein BpsB Is a Poly-beta-1,6-N-acetyl-D-glucosamine Deacetylase Required for Biofilm Formation in Bordetella bronchiseptica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PGAB; DE-N-ACETYLATION; STAPHYLOCOCCUS-EPIDERMIDIS; CARBOHYDRATE ESTERASE; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; POLYSACCHARIDE; PERTUSSIS; COLONIZATION; SYSTEM	Bordetella pertussis and Bordetella bronchiseptica are the causative agents of whooping cough in humans and a variety of respiratory diseases in animals, respectively. Bordetella species produce an exopolysaccharide, known as the Bordetella polysaccharide (Bps), which is encoded by the bpsABCD operon. Bps is required for Bordetella biofilm formation, colonization of the respiratory tract, and confers protection from complement-mediated killing. In this report, we have investigated the role of BpsB in the biosynthesis of Bps and biofilm formation by B. bronchiseptica. BpsB is a two-domain protein that localizes to the periplasm and outer membrane. BpsB displays metal-and length-dependent deacetylation on poly-beta-1,6-N-acetyl-D-glucosamine (PNAG) oligomers, supporting previous immunogenic data that suggests Bps is a PNAG polymer. BpsB can use a variety of divalent metal cations for deacetylase activity and showed highest activity in the presence of Ni2+ and Co2+. The structure of the BpsB deacetylase domain is similar to the PNAG deacetylases PgaB and IcaB and contains the same circularly permuted family four carbohydrate esterase motifs. Unlike PgaB from Escherichia coli, BpsB is not required for polymer export and has unique structural differences that allow the N-terminal deacetylase domain to be active when purified in isolation from the C-terminal domain. Our enzymatic characterizations highlight the importance of conserved active site residues in PNAG deacetylation and demonstrate that the C-terminal domain is required for maximal deacetylation of longer PNAG oligomers. Furthermore, we show that BpsB is critical for the formation and complex architecture of B. bronchiseptica biofilms.	[Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Milek, Sonja; Ganguly, Tridib; Deora, Rajendar] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [DiFrancesco, Benjamin R.; Nitz, Mark] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wake Forest University; University of Toronto	Deora, R (corresponding author), Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.	rdeora@wakehealth.edu	ganguly, tridib/H-8767-2019	ganguly, tridib/0000-0002-5283-5689; Bamford, Natalie/0000-0003-1959-856X	Canadian Institutes of Health Research [43998, 89708]; University of Toronto; Ontario Graduate Scholarship Program; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Canadian Institutes of Health Research Grants 43998 and 89708 (to P. L. H. and M. N., respectively). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by graduate scholarships from the University of Toronto, the Ontario Graduate Scholarship Program, and Canadian Institutes of Health Research.; Supported in part by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada and Mary H. Beatty and Dr. James A. and Connie P. Dickson Scholarships from the University of Toronto.	Abu Khweek A, 2010, MICROBIOL-SGM, V156, P1424, DOI 10.1099/mic.0.036640-0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganguly T, 2014, CELL MICROBIOL, V16, P1105, DOI 10.1111/cmi.12264; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Irie Y, 2007, FEMS MICROBIOL LETT, V275, P191, DOI 10.1111/j.1574-6968.2007.00852.x; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jakinovich A, 2014, CURR OPIN PEDIATR, V26, P597, DOI 10.1097/MOP.0000000000000139; Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Laganowsky A, 2011, PROTEIN SCI, V20, P1876, DOI 10.1002/pro.727; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leung C, 2009, CARBOHYD RES, V344, P570, DOI 10.1016/j.carres.2008.12.021; Little D. J., 2014, ENCY INORGANIC BIOIN, P1; Little DJ, 2014, J BIOL CHEM, V289, P35907, DOI 10.1074/jbc.M114.611400; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Little DJ, 2012, ACTA CRYSTALLOGR F, V68, P842, DOI 10.1107/S1744309112022075; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nishiyama T, 2013, ACTA CRYSTALLOGR D, V69, P44, DOI 10.1107/S0907444912042059; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pokrovskaya V, 2013, BIOCHEMISTRY-US, V52, P5463, DOI 10.1021/bi400836g; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; Sisti F, 2013, MICROBIOL-SGM, V159, P869, DOI 10.1099/mic.0.064345-0; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Sukumar N, 2007, J BACTERIOL, V189, P3695, DOI 10.1128/JB.00009-07; Sukumar N, 2014, INFECT IMMUN, V82, P1627, DOI 10.1128/IAI.01453-13; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001	68	26	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22827	22840		10.1074/jbc.M115.672469	http://dx.doi.org/10.1074/jbc.M115.672469			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26203190	Green Published, hybrid			2022-12-28	WOS:000361171500045
J	Tsai, LCL; Xie, L; Dore, K; Xie, L; Del Rio, JC; King, CC; Martinez-Ariza, G; Hulme, C; Malinow, R; Bourne, PE; Newton, AC				Tsai, Li-Chun Lisa; Xie, Lei; Dore, Kim; Xie, Li; Del Rio, Jason C.; King, Charles C.; Martinez-Ariza, Guillermo; Hulme, Christopher; Malinow, Roberto; Bourne, Philip E.; Newton, Alexandra C.			Zeta Inhibitory Peptide Disrupts Electrostatic Interactions That Maintain Atypical Protein Kinase C in Its Active Conformation on the Scaffold p62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; PKC-ZETA; SPATIOTEMPORAL DYNAMICS; SYNAPTIC PLASTICITY; DOMAIN; TRANSLOCATION; DOCKING; BINDING; ALPHA; PHOSPHORYLATION	Atypical protein kinase C (aPKC) enzymes signal on protein scaffolds, yet how they are maintained in an active conformation on scaffolds is unclear. A myristoylated peptide based on the autoinhibitory pseudosubstrate fragment of the atypical PKC zeta, zeta inhibitory peptide (ZIP), has been extensively used to inhibit aPKC activity; however, we have previously shown that ZIP does not inhibit the catalytic activity of aPKC isozymes in cells (Wu-Zhang, A. X., Schramm, C. L., Nabavi, S., Malinow, R., and Newton, A. C. (2012) J. Biol. Chem. 287, 12879-12885). Here we sought to identify a bona fide target of ZIP and, in so doing, unveiled a novel mechanism by which aPKCs are maintained in an active conformation on a protein scaffold. Specifically, we used protein-protein interaction network analysis, structural modeling, and protein-protein docking to predict that ZIP binds an acidic surface on the Phox and Bem1 (PB1) domain of p62, an interaction validated by peptide array analysis. Using a genetically encoded reporter for PKC activity fused to the p62 scaffold, we show that ZIP inhibits the activity of wild-type aPKC, but not a construct lacking the pseudosubstrate. These data support a model in which the pseudosubstrate of aPKCs is tethered to the acidic surface on p62, locking aPKC in an open, signaling-competent conformation. ZIP competes for binding to the acidic surface, resulting in displacement of the pseudosubstrate of aPKC and re-engagement in the substrate-binding cavity. This study not only identifies a cellular target for ZIP, but also unveils a novel mechanism by which scaffolded aPKC is maintained in an active conformation.	[Tsai, Li-Chun Lisa; Del Rio, Jason C.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dore, Kim; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Xie, Li] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA; [King, Charles C.] Univ Calif San Diego, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Xie, Lei] CUNY, Hunter Coll, Dept Comp Sci, New York, NY 10065 USA; [Martinez-Ariza, Guillermo; Hulme, Christopher] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Bourne, Philip E.] NIH, Off Director, Bethesda, MD 20892 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; City University of New York (CUNY) System; Hunter College (CUNY); University of Arizona; National Institutes of Health (NIH) - USA	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Dore, Kim/AAN-1470-2021; Bourne, Philip/ABG-8967-2021; Regan, Clinton/E-6250-2012	Dore, Kim/0000-0001-6263-367X; Bourne, Philip/0000-0002-7618-7292; Del Rio, Jason/0000-0001-8540-2065; Martinez-Ariza, Guillermo/0000-0003-2002-3958	National Institutes of Health [P01 DK54441]; University of California San Diego through Training Program in Diabetes Research from the National Institute of Diabetes and Digestive and kidney Diseases [5T32DK007494]; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology from the National Institute of General Medical Sciences [T32GM007752]; NATIONAL LIBRARY OF MEDICINE [ZIALM000928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego through Training Program in Diabetes Research from the National Institute of Diabetes and Digestive and kidney Diseases; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology from the National Institute of General Medical Sciences; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health Grant P01 DK54441 (to A. C. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the University of California San Diego through Training Program in Diabetes Research 5T32DK007494 from the National Institute of Diabetes and Digestive and kidney Diseases.; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through Training Grant T32GM007752 from the National Institute of General Medical Sciences.	Antal CE, 2015, CELL REP, V12, P1252, DOI 10.1016/j.celrep.2015.07.039; Antal CE, 2013, MOL CELL PROTEOMICS, V12, P3498, DOI 10.1074/mcp.R113.029819; Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bandyopadhyay G, 2002, J CLIN ENDOCR METAB, V87, P716, DOI 10.1210/jc.87.2.716; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Cariou B, 2004, FRONT BIOSCI-LANDMRK, V9, P1626, DOI 10.2741/1228; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2011, METHODS MOL BIOL, V756, P295, DOI 10.1007/978-1-61779-160-4_17; GOODE NT, 1994, FEBS LETT, V340, P145, DOI 10.1016/0014-5793(94)80190-8; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jiang JX, 2009, HIPPOCAMPUS, V19, P392, DOI 10.1002/hipo.20528; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Lu RF, 2015, MOL BIOL CELL, V26, P1523, DOI 10.1091/mbc.E14-12-1613; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; ORR JW, 1992, J BIOL CHEM, V267, P15263; Parker PJ, 2014, BIOCHEM PHARMACOL, V88, P1, DOI 10.1016/j.bcp.2013.10.023; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Ren J, 2014, SCI CHINA LIFE SCI, V57, P69, DOI 10.1007/s11427-013-4592-z; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; SCOTT JD, 1986, P NATL ACAD SCI USA, V83, P1613, DOI 10.1073/pnas.83.6.1613; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Trujillo JI, 2009, BIOORG MED CHEM LETT, V19, P908, DOI 10.1016/j.bmcl.2008.11.105; Viger ML, 2014, ACS NANO, V8, P4815, DOI 10.1021/nn500702g; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065	56	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21845	21856		10.1074/jbc.M115.676221	http://dx.doi.org/10.1074/jbc.M115.676221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26187466	Green Published, hybrid			2022-12-28	WOS:000360968500007
J	Zhao, YG; Ma, CA; Wu, LM; Iwai, K; Ashwell, JD; Oltz, EM; Ballard, DW; Jain, A				Zhao, Yongge; Ma, Chi A.; Wu, Liming; Iwai, Kazuhiro; Ashwell, Jonathan D.; Oltz, Eugene M.; Ballard, Dean W.; Jain, Ashish			CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ECTODERMAL DYSPLASIA; POLYUBIQUITINATION; INFLAMMATION; ACTIVATION; APOPTOSIS; MICE	NF-kappa B essential modulator (NEMO) and cylindromatosis protein (CYLD) are intracellular proteins that regulate the NF-kappa B signaling pathway. Although mice with either CYLD deficiency or an alteration in the zinc finger domain of NEMO (K392R) are born healthy, we found that the combination of these two gene defects in double mutant (DM) mice is early embryonic lethal but can be rescued by the absence of TNF receptor 1 (TNFR1). Notably, NEMO was not recruited into the TNFR1 complex of DM cells, and consequently NF-kappa B induction by TNF was severely impaired and DM cells were sensitized to TNF-induced cell death. Interestingly, the TNF signaling defects can be fully rescued by reconstitution of DM cells with CYLD lacking ubiquitin hydrolase activity but not with CYLD mutated in TNF receptor-associated factor 2 (TRAF2) or NEMO binding sites. Therefore, our data demonstrate an unexpected non-catalytic function for CYLD as an adapter protein between TRAF2 and the NEMO zinc finger that is important for TNF-induced NF-kappa B signaling during embryogenesis.	[Zhao, Yongge; Ma, Chi A.; Wu, Liming; Jain, Ashish] NIAID, Lab Host Defenses, NIH, Bethesda, MD 20892 USA; [Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Kyoto 6068501, Japan; [Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; [Oltz, Eugene M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ballard, Dean W.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Vanderbilt University	Zhao, YG (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Clin Res Ctr, Rm 5-W-5832,9000 Rockville Pike, Bethesda, MD 20892 USA.	yongge.zhao@nih.gov; ashish.jain1@merck.com	Wu, liming/AAH-5415-2019; IWAI, KAZUHIRO/GSN-7385-2022; Regan, Clinton/E-6250-2012	Iwai, Kazuhiro/0000-0001-5620-5951	Intramural Research Program of the National Institutes of Health, NIAID; National Institutes of Health [CA082556, AI052379]; NATIONAL CANCER INSTITUTE [R01CA082556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052379] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIAID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIAID, and National Institutes of Health Grants CA082556 and AI052379 (to D. W. B). The authors declare that they have no conflicts of interest with the contents of this article.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cao Z, 1999, COLD SPRING HARB SYM, V64, P473, DOI 10.1101/sqb.1999.64.473; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Ma CA, 2011, HUM MUTAT, V32, P318, DOI 10.1002/humu.21439; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Ni CY, 2008, J IMMUNOL, V180, P7107, DOI 10.4049/jimmunol.180.11.7107; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Temmerman ST, 2006, BLOOD, V108, P2324, DOI 10.1182/blood-2006-04-017210; Temmerman ST, 2012, J CLIN INVEST, V122, P315, DOI 10.1172/JCI42534; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhao YG, 2011, J BIOL CHEM, V286, P40520, DOI 10.1074/jbc.M111.292961	24	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22076	22084		10.1074/jbc.M115.658096	http://dx.doi.org/10.1074/jbc.M115.658096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26224629	hybrid, Green Published			2022-12-28	WOS:000360968500026
J	Chong, PA; Farber, PJ; Vernon, RM; Hudson, RP; Mittermaier, AK; Forman-Kay, JD				Chong, P. Andrew; Farber, Patrick J.; Vernon, Robert M.; Hudson, Rhea P.; Mittermaier, Anthony K.; Forman-Kay, Julie D.			Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-F508 CFTR; NMR RELAXATION; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; SIDE-CHAIN; MUTATION; PROTEINS; MUTANT; STABILITY; PHOSPHORYLATION	Deletion of Phe-508 (F508del) in the first nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR) results in destabilization of the domain, intramolecular interactions involving the domain, and the entire channel. The destabilization caused by F508del manifests itself in defective channel processing and channel gating defects. Here, we present NMR studies of the effect of F508del and the I539T stabilizing mutation on NBD1 dynamics, with a view to understanding these changes in stability. Qualitatively, F508del NMR spectra exhibit significantly more peak broadening than WT spectra due to the enhanced intermediate time scale (millisecond to microsecond) motions in the mutant. Unexpectedly, studies of fast (nanosecond to picosecond) motions revealed that F508del NBD1 tumbles more rapidly in solution than WT NBD1. Whereas F508del tumbles at a rate nearly consistent with the monomeric state, the WT protein tumbles significantly more slowly. Paramagnetic relaxation enhancement experiments confirm that NBD1 homodimerizes in solution in the expected head-to-tail orientation. NMR spectra of WT NBD1 reveal significant concentration-dependent chemical shift perturbations consistent with NBD1 dimerization. Chemical shift analysis suggests that the more rapid tumbling of F508del is the result of an impaired ability to dimerize. Based on previously published crystal structures and NMR spectra of various NBD1 mutants, we propose that deletion of Phe-508 affects Q-loop conformational sampling in a manner that inhibits dimerization. These results provide a potential mechanism for inhibition of channel opening by F508del and support the dimer interface as a target for cystic fibrosis therapeutics.	[Chong, P. Andrew; Farber, Patrick J.; Vernon, Robert M.; Hudson, Rhea P.; Forman-Kay, Julie D.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Mittermaier, Anthony K.] McGill Univ, Dept Chem, Montreal, PQ H3A 0B8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University	Forman-Kay, JD (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada.	forman@sickkids.ca	Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225; Forman-Kay, Julie/0000-0001-8265-972X	Cystic Fibrosis Foundation [FORMAN05XX0]; Cystic Fibrosis Canada	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada	This work was supported by Cystic Fibrosis Foundation Therapeutics Grant FORMAN05XX0 (to J. D. F.-K.) and a Cystic Fibrosis Canada grant (to J. D. F.-K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Cavanagh John, 1996, P243; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dawson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074347; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Goddard T.D., 2008, SPARKY 3, P3; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Konrat R, 1999, J BIOMOL NMR, V15, P309, DOI 10.1023/A:1008310617047; Korzhnev DM, 2002, J AM CHEM SOC, V124, P10743, DOI 10.1021/ja0204776; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Molinski SV, 2014, GENET MED, V16, P625, DOI 10.1038/gim.2014.4; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Salzmann M, 1999, J BIOMOL NMR, V14, P85, DOI 10.1023/A:1008346931993; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wei SP, 2014, J BIOL CHEM, V289, P19942, DOI 10.1074/jbc.M114.562116; Wieczorek G, 2008, J CYST FIBROS, V7, P295, DOI 10.1016/j.jcf.2007.11.008; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975; Zhang OW, 1997, J BIOMOL NMR, V9, P181, DOI 10.1023/A:1018658305040; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	64	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22862	22878		10.1074/jbc.M115.641134	http://dx.doi.org/10.1074/jbc.M115.641134			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26149808	Green Published, hybrid			2022-12-28	WOS:000361685500001
J	Li, MY; Ko, TY; Li, SS				Li, Mingyang; Ko, Tengyu; Li, Shisheng			High-resolution Digital Mapping of N-Methylpurines in Human Cells Reveals Modulation of Their Induction and Repair by Nearest-neighbor Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; SEQUENCE CONTEXT; DNA GLYCOSYLASE; DAMAGE; TRANSCRIPTION; MITOCHONDRIA; 8-OXOGUANINE; MECHANISM; AGENTS; SITES	N-Methylpurines (NMPs), including N-7-methylguanine (7MeG) and N-3-methyladenine (3MeA), can be induced by environmental methylating agents, chemotherapeutics, and natural cellular methyl donors. In human cells, NMPs are repaired by the multi-step base excision repair pathway initiated by human alkyladenine glycosylase. Repair of NMPs has been shown to be affected by DNA sequence contexts. However, the nature of the sequence contexts has been poorly understood. We developed a sensitive method, LAF-Seq (Lesion-Adjoining Fragment Sequencing), which allows nucleotide-resolution digital mapping of DNA damage and repair in multiple genomic fragments of interest in human cells. We also developed a strategy that allows accurate measurement of the excision kinetics of NMP bases in vitro. We demonstrate that 3MeAs are induced to a much lower level by the SN2 methylating agent dimethyl sulfate and repaired much faster than 7MeGs in human fibroblasts. Induction of 7MeGs by dimethyl sulfate is affected by nearest-neighbor nucleotides, being enhanced at sites neighbored by aG orTon the 3' side, but impaired at sites neighbored by a Gon the 5' side. Repair of 7MeGs is also affected by nearest-neighbor nucleotides, being slow if the lesions are between purines, especially Gs, and fast if the lesions are between pyrimidines, especially Ts. Excision of 7MeG bases from the DNA backbone by human alkyladenine glycosylase in vitro is similarly affected by nearest-neighbor nucleotides, suggesting that the effect of nearest-neighbor nucleotides on repair of 7MeGs in the cells is primarily achieved by modulating the initial step of the base excision repair process.	[Li, Mingyang; Ko, Tengyu; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@lsu.edu	Li, Mingyang/GXG-9833-2022		National Institute of Health [R15CA164862]; National Science Foundation [MCB-1244019]; NATIONAL CANCER INSTITUTE [R15CA164862] Funding Source: NIH RePORTER; Direct For Biological Sciences [1244019] Funding Source: National Science Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of Health Grant R15CA164862 (to S. L.) and National Science Foundation Grant MCB-1244019 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620; Besaratinia Ahmad, 2012, Methods Mol Biol, V920, P189, DOI 10.1007/978-1-61779-998-3_14; Blondal T, 2005, NUCLEIC ACIDS RES, V33, P135, DOI 10.1093/nar/gki149; Cloutier JF, 1999, CHEM RES TOXICOL, V12, P840, DOI 10.1021/tx990025f; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Donigan KA, 2009, MOL CARCINOGEN, V48, P362, DOI 10.1002/mc.20497; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Henderson D. S., 2005, DNA REPAIR PROTOCOLS; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Li SS, 2011, DNA REPAIR, V10, P65, DOI 10.1016/j.dnarep.2010.09.020; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 1999, J BIOL CHEM, V274, P12201, DOI 10.1074/jbc.274.18.12201; Luke April M, 2012, Methods Mol Biol, V920, P307, DOI 10.1007/978-1-61779-998-3_21; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Prakash A, 2012, PROG MOL BIOL TRANSL, V110, P71, DOI 10.1016/B978-0-12-387665-2.00004-3; PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; ROSA S, 1991, NUCLEIC ACIDS RES, V19, P5569, DOI 10.1093/nar/19.20.5569; Ruszczynska K, 2003, BIOPHYS J, V85, P1450, DOI 10.1016/S0006-3495(03)74577-9; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; van Loon B, 2013, DNA REPAIR, V12, P177, DOI 10.1016/j.dnarep.2012.11.009; Vaughan P., 2000, DNA REPAIR PROTOCOLS; WEINER PK, 1982, P NATL ACAD SCI-BIOL, V79, P3754, DOI 10.1073/pnas.79.12.3754; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Ye N, 1998, J MOL BIOL, V284, P269, DOI 10.1006/jmbi.1998.2138	32	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23148	23161		10.1074/jbc.M115.676296	http://dx.doi.org/10.1074/jbc.M115.676296			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240148	hybrid, Green Published			2022-12-28	WOS:000361685500026
J	Altgarde, N; Eriksson, C; Peerboom, N; Phan-Xuan, T; Moeller, S; Schnabelrauch, M; Svedhem, S; Trybala, E; Bergstrom, T; Bally, M				Altgarde, Noomi; Eriksson, Charlotta; Peerboom, Nadia; Phan-Xuan, Tuan; Moeller, Stephanie; Schnabelrauch, Matthias; Svedhem, Sofia; Trybala, Edward; Bergstrom, Tomas; Bally, Marta			Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycoprotein; glycosaminoglycan; glycosylation; herpesvirus; surface plasmon resonance (SPR); mucin-like region	SULFATE-BINDING DOMAIN; HEPARAN-SULFATE; CHONDROITIN SULFATE; COMPLEMENT COMPONENT; CELLS; SURFACE; GLYCOSYLATION; HYALURONAN; RECEPTORS; IMMOBILIZATION	Background: Herpes simplex virus attachment protein gC comprises a glycosaminoglycan-binding site and a mucin-like region. Results: Removal of the mucin-like region modifies gC interaction with glycosaminoglycans. Conclusion: The mucin-like region balances the gC-glycosaminoglycan interaction during virus binding to and release from target cells. Significance: The finding might be of relevance for similar proteins on other GAG-binding viruses. Glycoprotein C (gC) mediates the attachment of HSV-1 to susceptible host cells by interacting with glycosaminoglycans (GAGs) on the cell surface. gC contains a mucin-like region located near the GAG-binding site, which may affect the binding activity. Here, we address this issue by studying a HSV-1 mutant lacking the mucin-like domain in gC and the corresponding purified mutant protein (gCmuc) in cell culture and GAG-binding assays, respectively. The mutant virus exhibited two functional alterations as compared with native HSV-1 (i.e. decreased sensitivity to GAG-based inhibitors of virus attachment to cells and reduced release of viral particles from the surface of infected cells). Kinetic and equilibrium binding characteristics of purified gC were assessed using surface plasmon resonance-based sensing together with a surface platform consisting of end-on immobilized GAGs. Both native gC and gCmuc bound via the expected binding region to chondroitin sulfate and sulfated hyaluronan but not to the non-sulfated hyaluronan, confirming binding specificity. In contrast to native gC, gCmuc exhibited a decreased affinity for GAGs and a slower dissociation, indicating that once formed, the gCmuc-GAG complex is more stable. It was also found that a larger number of gCmuc bound to a single GAG chain, compared with native gC. Taken together, our data suggest that the mucin-like region of HSV-1 gC is involved in the modulation of the GAG-binding activity, a feature of importance both for unrestricted virus entry into the cells and release of newly produced viral particles from infected cells.	[Altgarde, Noomi; Peerboom, Nadia; Phan-Xuan, Tuan; Svedhem, Sofia; Bally, Marta] Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Eriksson, Charlotta; Trybala, Edward; Bergstrom, Tomas] Univ Gothenburg, Dept Clin Virol, S-41346 Gothenburg, Sweden; [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Dept Biomat, D-07745 Jena, Germany; [Bally, Marta] Inst Curie, CNRS, Ctr Rech, UMR 168,Physicochim Curie, F-75248 Paris, France	Chalmers University of Technology; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Bally, M (corresponding author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.	bally@chalmers.se	Bally, Marta/G-8744-2011; Svedhem, Sofia/AAC-8727-2020	Peerboom, Nadia/0000-0002-5026-0586; Bergstrom, Tomas/0000-0002-9257-6757; Bally, Marta/0000-0002-5865-8302; Eriksson, Charlotta E/0000-0003-0743-0399; Trybala, Edward/0000-0003-2384-2123	European Union [NMP4-SL2009-229292]; Chalmers Area of Advance in Materials Science; Vetenskapsradet (through the Linneus program SUPRA); Deutsche Forschungsgemeinschaft [Transregio TR 67]; Vetenskapsradet [521-2011-3297, LUA-ALF-Gbg 145-841, 612-2012-5024]	European Union(European Commission); Chalmers Area of Advance in Materials Science; Vetenskapsradet (through the Linneus program SUPRA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vetenskapsradet(Swedish Research Council)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement NMP4-SL2009-229292 ("Find & Bind"), the Chalmers Area of Advance in Materials Science, and Vetenskapsradet (through the Linneus program SUPRA). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Deutsche Forschungsgemeinschaft (Transregio TR 67 (subproject A2)). Supported by Vetenskapsradet Grant 521-2011-3297 and by Grant LUA-ALF-Gbg 145-841.; Supported by Vetenskapsradet Grant 612-2012-5024. To whom correspondence should be addressed. E-mail: bally@chalmers.se.	Adamiak B, 2007, J VIROL, V81, P13424, DOI 10.1128/JVI.01528-07; Adamiak B, 2010, VIROLOGY, V400, P197, DOI 10.1016/j.virol.2010.01.032; Altgarde N, 2013, ACTA BIOMATER, V9, P8158, DOI 10.1016/j.actbio.2013.05.031; Arakawa T, 2001, ANAL BIOCHEM, V299, P158, DOI 10.1006/abio.2001.5432; Bally M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188103; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; CARLSTROM D, 1957, J BIOPHYS BIOCHEM CY, V3, P669, DOI 10.1083/jcb.3.5.669; DeAngelis PL, 2002, CARBOHYD RES, V337, P1547, DOI 10.1016/S0008-6215(02)00219-7; Ekbad M, 2007, VIROLOGY, V367, P244, DOI 10.1016/j.virol.2007.05.040; Ekblad M, 2010, ANTIVIR RES, V86, P196, DOI 10.1016/j.antiviral.2010.02.318; Feyzi E, 1997, J BIOL CHEM, V272, P24850, DOI 10.1074/jbc.272.40.24850; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; Gama CI, 2005, CURR OPIN CHEM BIOL, V9, P609, DOI 10.1016/j.cbpa.2005.10.003; GUNALP A, 1964, P SOC EXP BIOL MED, V118, P85; Hadigal SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7985; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; HOFFMAN J, 1983, CARBOHYD RES, V117, P328, DOI 10.1016/0008-6215(83)88103-8; Hokputsa S, 2003, CARBOHYD POLYM, V52, P111, DOI 10.1016/S0144-8617(02)00298-9; HOLLAND TC, 1983, J VIROL, V45, P672, DOI 10.1128/JVI.45.2.672-682.1983; Horkay F, 2012, MACROMOLECULES, V45, P2882, DOI 10.1021/ma202693s; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n; Lebedev K, 2006, J COLLOID INTERF SCI, V296, P527, DOI 10.1016/j.jcis.2005.09.032; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; Mardberg K, 2002, J GEN VIROL, V83, P291, DOI 10.1099/0022-1317-83-2-291; Mardberg K, 2001, J GEN VIROL, V82, P1941, DOI 10.1099/0022-1317-82-8-1941; Namvar L, 2005, J CLIN MICROBIOL, V43, P2058, DOI 10.1128/JCM.43.5.2058-2064.2005; Nileback E, 2011, BIOSENS BIOELECTRON, V28, P407, DOI 10.1016/j.bios.2011.07.060; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Rux AH, 2002, VIROLOGY, V294, P324, DOI 10.1006/viro.2001.1326; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Satoh A, 2000, FEBS LETT, V477, P249, DOI 10.1016/S0014-5793(00)01746-4; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; STANNARD LM, 1987, J GEN VIROL, V68, P715, DOI 10.1099/0022-1317-68-3-715; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Tao YY, 2011, J CHROMATOGR A, V1218, P1530, DOI 10.1016/j.chroma.2011.01.050; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Trybala E, 2000, J VIROL, V74, P9106, DOI 10.1128/JVI.74.19.9106-9114.2000; TRYBALA E, 1994, J GEN VIROL, V75, P743, DOI 10.1099/0022-1317-75-4-743; Vaheri A., 1964, ACTA PATHOL MICROB S, V171, P171; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WIDEHN S, 1990, ULTRASTRUCT PATHOL, V14, P81, DOI 10.3109/01913129009050876; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Yu GL, 2002, EUR J MED CHEM, V37, P783, DOI 10.1016/S0223-5234(02)01347-8	56	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21473	21485		10.1074/jbc.M115.637363	http://dx.doi.org/10.1074/jbc.M115.637363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160171	Green Published, hybrid			2022-12-28	WOS:000360637600023
J	Dueholm, MS; Larsen, P; Finster, K; Stenvang, MR; Christiansen, G; Vad, BS; Boggild, A; Otzen, DE; Nielsen, PH				Dueholm, Morten S.; Larsen, Poul; Finster, Kai; Stenvang, Marcel R.; Christiansen, Gunna; Vad, Brian S.; Boggild, Andreas; Otzen, Daniel E.; Nielsen, Per Halkjaer			The Tubular Sheaths Encasing Methanosaeta thermophila Filaments Are Functional Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOSPIRILLUM-HUNGATEI GP1; GAS VESICLES; STREPTOMYCES-COELICOLOR; SULFOLOBUS-SOLFATARICUS; SALMONELLA-ENTERITIDIS; AGGREGATIVE FIMBRIAE; RODLET LAYER; CELL-WALL; FIBRILS; PROTEIN	Archaea are renowned for their ability to thrive in extreme environments, although they can be found in virtually all habitats. Their adaptive success is linked to their unique cell envelopes that are extremely resistant to chemical and thermal denaturation and that resist proteolysis by common proteases. Here we employ amyloid-specific conformation antibodies and biophysical techniques to show that the extracellular cell wall sheaths encasing the methanogenic archaea Methanosaeta thermophila PT are functional amyloids. Depolymerization of sheaths and subsequent MS/MS analyses revealed that the sheaths are composed of a single major sheath protein (MspA). The amyloidogenic nature of MspA was confirmed by in vitro amyloid formation of recombinant MspA under a wide range of environmental conditions. This is the first report of a functional amyloid from the archaeal domain of life. The amyloid nature explains the extreme resistance of the sheath, the elastic properties that allow diffusible substrates to penetrate through expandable hoop boundaries, and how the sheaths are able to split and elongate outside the cell. The archaeal sheath amyloids do not share homology with any of the currently known functional amyloids and clearly represent a new function of the amyloid protein fold.	[Dueholm, Morten S.; Larsen, Poul; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, DK-9220 Aalborg, Denmark; [Finster, Kai] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark; [Stenvang, Marcel R.; Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Stenvang, Marcel R.; Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Stenvang, Marcel R.; Vad, Brian S.; Boggild, Andreas; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Aalborg University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredriks Bajers Vej 7H, DK-9220 Aalborg, Denmark.	phn@bio.aau.dk	Bøggild, Andreas/J-4763-2013; Nielsen, Per Halkjær/T-6796-2018; Dueholm, Morten Simonsen/T-6718-2018; Finster, Kai W/I-7475-2013	Bøggild, Andreas/0000-0003-2130-3521; Nielsen, Per Halkjær/0000-0002-6402-1877; Dueholm, Morten Simonsen/0000-0003-4135-2670; Finster, Kai W/0000-0002-9132-5542; Christiansen, Gunna/0000-0003-0540-1367	Villum Foundation; Innovation Fund Denmark; Sino-Danish Centre for Education and Research	Villum Foundation(Villum Fonden); Innovation Fund Denmark; Sino-Danish Centre for Education and Research	This work was supported in part by funds from the Villum Foundation and Innovation Fund Denmark (to M. S. D.) and is in part supported by the Sino-Danish Centre for Education and Research (to M. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Bayro MJ, 2012, J BIOL CHEM, V287, P3479, DOI 10.1074/jbc.M111.313049; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Bemporad F, 2009, FEBS LETT, V583, P2630, DOI 10.1016/j.febslet.2009.07.013; BEVERIDGE TJ, 1985, J BACTERIOL, V162, P728, DOI 10.1128/JB.162.2.728-737.1985; BEVERIDGE TJ, 1987, CAN J MICROBIOL, V33, P725, DOI 10.1139/m87-126; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chimileski S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0065-5; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Ezzeldin HM, 2012, J STRUCT BIOL, V179, P18, DOI 10.1016/j.jsb.2012.04.015; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; FIRTEL M, 1993, J BACTERIOL, V175, P7550, DOI 10.1128/JB.175.23.7550-7560.1993; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018; Hedderich R, 2013, PROKARYOTES, P635; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; KAMAGATA Y, 1992, INT J SYST BACTERIOL, V42, P463, DOI 10.1099/00207713-42-3-463; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Pagano K, 2010, J BIOL CHEM, V285, P14689, DOI 10.1074/jbc.M109.082156; PATEL GB, 1986, CAN J MICROBIOL, V32, P623, DOI 10.1139/m86-117; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sawyer EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018839; SHAW PJ, 1985, J BACTERIOL, V161, P750, DOI 10.1128/JB.161.2.750-757.1985; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shokri MM, 2013, AMYLOID, V20, P226, DOI 10.3109/13506129.2013.830246; Smith KS, 2007, TRENDS MICROBIOL, V15, P150, DOI 10.1016/j.tim.2007.02.002; SOUTHAM G, 1992, J BACTERIOL, V174, P935, DOI 10.1128/jb.174.3.935-946.1992; SPROTT GD, 1986, CAN J MICROBIOL, V32, P847, DOI 10.1139/m86-156; SPROTT GD, 1980, CAN J MICROBIOL, V26, P115, DOI 10.1139/m80-017; STEWART M, 1985, J MOL BIOL, V183, P509, DOI 10.1016/0022-2836(85)90019-1; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Tian PF, 2015, J AM CHEM SOC, V137, P22, DOI 10.1021/ja5093634; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Welte C, 2011, J BACTERIOL, V193, P2868, DOI 10.1128/JB.00162-11; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; Xu W, 1996, J BACTERIOL, V178, P3106, DOI 10.1128/jb.178.11.3106-3112.1996; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zykwinska A, 2014, BBA-PROTEINS PROTEOM, V1844, P1231, DOI 10.1016/j.bbapap.2014.04.003	73	25	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20590	20600		10.1074/jbc.M115.654780	http://dx.doi.org/10.1074/jbc.M115.654780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26109065	Green Published, hybrid			2022-12-28	WOS:000359608900054
J	Hiess, F; Vallmitjana, A; Wang, RW; Cheng, HQ; ter Keurs, HEDJ; Chen, J; Hove-Madsen, L; Benitez, R; Chen, SRW				Hiess, Florian; Vallmitjana, Alexander; Wang, Ruiwu; Cheng, Hongqiang; ter Keurs, Henk E. D. J.; Chen, Ju; Hove-Madsen, Leif; Benitez, Raul; Chen, S. R. Wayne			Distribution and Function of Cardiac Ryanodine Receptor Clusters in Live Ventricular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE SITES; CALCIUM TRANSIENTS; 3-DIMENSIONAL DISTRIBUTION; MITOCHONDRIAL CALCIUM; LOCAL-CONTROL; HEART; RAT; SPARKS; MODEL; ORGANIZATION	The cardiac Ca2+ release channel (ryanodine receptor, RyR2) plays an essential role in excitation-contraction coupling in cardiac muscle cells. Effective and stable excitation-contraction coupling critically depends not only on the expression of RyR2, but also on its distribution. Despite its importance, little is known about the distribution and organization of RyR2 in living cells. To study the distribution of RyR2 in living cardiomyocytes, we generated a knock-in mouse model expressing a GFP-tagged RyR2 (GFP-RyR2). Confocal imaging of live ventricular myocytes isolated from the GFP-RyR2 mouse heart revealed clusters of GFP-RyR2 organized in rows with a striated pattern. Similar organization of GFP-RyR2 clusters was observed in fixed ventricular myocytes. Immunofluorescence staining with the anti-alpha-actinin antibody (a z-line marker) showed that nearly all GFP-RyR2 clusters were localized in the z-line zone. There were small regions with dislocated GFP-RyR2 clusters. Interestingly, these same regions also displayed dislocated z-lines. Staining with di-8-ANEPPS revealed that nearly all GFP-RyR2 clusters were co-localized with transverse but not longitudinal tubules, whereas staining with MitoTracker Red showed that GFP-RyR2 clusters were not co-localized with mitochondria in live ventricular myocytes. We also found GFP-RyR2 clusters interspersed between z-lines only at the periphery of live ventricular myocytes. Simultaneous detection of GFP-RyR2 clusters and Ca2+ sparks showed that Ca2+ sparks originated exclusively from RyR2 clusters. Ca2+ sparks from RyR2 clusters induced no detectable changes in mitochondrial Ca2+ level. These results reveal, for the first time, the distribution of RyR2 clusters and its functional correlation in living ventricular myocytes.	[Hiess, Florian; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [ter Keurs, Henk E. D. J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Calgary, AB T2N 1N4, Canada; [Vallmitjana, Alexander; Benitez, Raul] Univ Politecn Cataluna, Dept Automat Control, ES-08034 Barcelona, Spain; [Cheng, Hongqiang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92161 USA; [Hove-Madsen, Leif] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona 08025, Spain	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Universitat Politecnica de Catalunya; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Chen, SRW (corresponding author), HRIC GAC58,3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	swchen@ucalgary.ca	Chen, Ju/E-5579-2011; Vallmitjana, Alexander/B-5058-2019; Benítez, Raúl/AGO-5018-2022	Vallmitjana, Alexander/0000-0002-7149-9385; Benítez, Raúl/0000-0002-8782-9406; Hove-Madsen, Leif/0000-0001-5493-3998	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Spanish Ministry of Science and Innovation [SAF2011-30312, CNIC-2009-08, DPI2013-44584-R]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research grants from the Natural Sciences and Engineering Research Council, Canadian Institutes of Health Research, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.), and Spanish Ministry of Science and Innovation Grants SAF2011-30312; CNIC-2009-08 (to L. H. M.) and DPI2013-44584-R (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Asghari P, 2009, BIOPHYS J, V96, P4651, DOI 10.1016/j.bpj.2009.02.058; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2001, EXCITATION CONTRACTI; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Cleemann L, 1998, P NATL ACAD SCI USA, V95, P10984, DOI 10.1073/pnas.95.18.10984; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Dan P, 2007, BIOPHYS J, V93, P2504, DOI 10.1529/biophysj.107.104943; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Griffiths EJ, 1999, BIOCHEM BIOPH RES CO, V263, P554, DOI 10.1006/bbrc.1999.1311; Griffiths EJ, 1997, AM J PHYSIOL-CELL PH, V273, pC37, DOI 10.1152/ajpcell.1997.273.1.C37; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Jayasinghe ID, 2010, J MOL CELL CARDIOL, V48, P964, DOI 10.1016/j.yjmcc.2009.12.012; Jayasinghe ID, 2009, BIOPHYS J, V97, P2664, DOI 10.1016/j.bpj.2009.08.036; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; LOPEZLOPEZ JR, 1994, J PHYSIOL-LONDON, V480, P21, DOI 10.1113/jphysiol.1994.sp020337; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lukyanenko V, 2007, J PHYSIOL-LONDON, V583, P251, DOI 10.1113/jphysiol.2007.136549; NIGGLI E, 1990, SCIENCE, V250, P565, DOI 10.1126/science.2173135; Parker I, 1996, J PHYSIOL-LONDON, V497, P31, DOI 10.1113/jphysiol.1996.sp021747; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Sedarat F, 2000, AM J PHYSIOL-HEART C, V279, pH202, DOI 10.1152/ajpheart.2000.279.1.H202; Smith GD, 1998, BIOPHYS J, V75, P15, DOI 10.1016/S0006-3495(98)77491-0; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; STERN MD, 1992, FASEB J, V6, P3092, DOI 10.1096/fasebj.6.12.1325933; Stern MD, 1997, J GEN PHYSIOL, V110, P415, DOI 10.1085/jgp.110.4.415; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; Subramanian S, 2001, BIOPHYS J, V80, P1, DOI 10.1016/S0006-3495(01)75991-7; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037	38	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20477	20487		10.1074/jbc.M115.650531	http://dx.doi.org/10.1074/jbc.M115.650531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26109063	hybrid, Green Published			2022-12-28	WOS:000359608900045
J	Kitanishi, K; Cracan, V; Banerjee, R				Kitanishi, Kenichi; Cracan, Valentin; Banerjee, Ruma			Engineered and Native Coenzyme B-12-dependent Isovaleryl-CoA/Pivalyl-CoA Mutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIVALIC ACID; FATTY-ACID; ENZYME; COBALAMIN; ADENOSYLCOBALAMIN; BIOSYNTHESIS; SUBSTRATE; CATALYSIS; INSIGHTS; PATHWAY	Adenosylcobalamin-dependent isomerases catalyze carbon skeleton rearrangements using radical chemistry. We have recently demonstrated that an isobutyryl-CoA mutase variant, IcmF, a member of this enzyme family that catalyzes the interconversion of isobutyryl-CoA and n-butyryl-CoA also catalyzes the interconversion between isovaleryl-CoA and pivalyl-CoA, albeit with low efficiency and high susceptibility to inactivation. Given the biotechnological potential of the isovaleryl-CoA/pivalyl-CoA mutase (PCM) reaction, we initially attempted to engineer IcmF to be a more proficient PCM by targeting two active site residues predicted based on sequence alignments and crystal structures, to be key to substrate selectivity. Of the eight mutants tested, the F598A mutation was the most robust, resulting in an similar to 17-fold increase in the catalytic efficiency of the PCM activity and a concomitant similar to 240-fold decrease in the isobutyryl-CoA mutase activity compared with wild-type IcmF. Hence, mutation of a single residue in IcmF tuned substrate specificity yielding an similar to 4000-fold increase in the specificity for an unnatural substrate. However, the F598A mutant was even more susceptible to inactivation than wild-type IcmF. To circumvent this limitation, we used bioinformatics analysis to identify an authentic PCM in genomic databases. Cloning and expression of the putative AdoCbl-dependent PCM with an alpha(2)beta(2) heterotetrameric organization similar to that of isobutyryl-CoA mutase and a recently characterized archaeal methylmalonyl-CoA mutase, allowed demonstration of its robust PCM activity. To simplify kinetic analysis and handling, a variant PCM-F was generated in which the alpha beta sub-units were fused into a single polypeptide via a short 11-amino acid linker. The fusion protein, PCM-F, retained high PCM activity and like PCM, was resistant to inactivation. Neither PCM nor PCM-F displayed detectable isobutyryl-CoA mutase activity, demonstrating that PCM represents a novel 5' -deoxyadenosylcobalamin-dependent acyl-CoA mutase. The newly discovered PCM and the derivative PCM-F, have potential applications in bioremediation of pivalic acid found in sludge, in stereospecific synthesis of C5 carboxylic acids and alcohols, and in the production of potential commodity and specialty chemicals.	[Kitanishi, Kenichi; Cracan, Valentin; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Regan, Clinton/E-6250-2012; Kitanishi, Kenichi/I-3323-2014	Kitanishi, Kenichi/0000-0002-2110-8104; Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [DK45776]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776 (to R. B.) and a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science (to K. K). The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee R., 1999, Chemistry and biochemistry of B12., P707; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2001, BIOCHEMISTRY-US, V40, P6191, DOI 10.1021/bi0104423; Bode HB, 2009, CHEMBIOCHEM, V10, P128, DOI 10.1002/cbic.200800219; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; Ensign SA, 1998, ARCH MICROBIOL, V169, P179, DOI 10.1007/s002030050558; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Frey PA, 2014, ACCOUNTS CHEM RES, V47, P540, DOI 10.1021/ar400194k; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; HAY BP, 1987, J AM CHEM SOC, V109, P8012, DOI 10.1021/ja00260a011; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Padmakumar R, 1995, BIOFACTORS, V5, P83; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Rezanka T, 2012, APPL MICROBIOL BIOT, V95, P1371, DOI 10.1007/s00253-012-4267-x; Rezanka T, 2011, ENVIRON MICROBIOL, V13, P1577, DOI 10.1111/j.1462-2920.2011.02465.x; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Toraya T, 1999, J BIOL CHEM, V274, P3372, DOI 10.1074/jbc.274.6.3372; Toraya T, 2014, ARCH BIOCHEM BIOPHYS, V544, P40, DOI 10.1016/j.abb.2013.11.002; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; Yaneva N, 2012, J BIOL CHEM, V287, P15502, DOI 10.1074/jbc.M111.314690	39	8	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20466	20476		10.1074/jbc.M115.646299	http://dx.doi.org/10.1074/jbc.M115.646299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134562	hybrid, Green Published			2022-12-28	WOS:000359608900044
J	Zhang, DD; Yan, HY; Li, H; Hao, SY; Zhuang, Z; Liu, M; Sun, Q; Yang, YQ; Zhou, ML; Li, KY; Hang, CH				Zhang, Dingding; Yan, Huiying; Li, Hua; Hao, Shuangying; Zhuang, Zong; Liu, Ming; Sun, Qing; Yang, Yiqing; Zhou, Mengliang; Li, Kuanyu; Hang, Chunhua			TGF beta-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; LEARNING-DEFICITS; GROWTH; PHOSPHORYLATION; INFLAMMATION; MECHANISMS; EXPRESSION; VASOSPASM; PROTECTS	Accumulating evidence suggests that activation of mitogen-activated protein kinases (MAPKs) and nuclear factor NF-kappa B exacerbates early brain injury (EBI) following subarachnoid hemorrhage (SAH) by provoking proapoptotic and proinflammatory cellular signaling. Here we evaluate the role of TGF beta-activated kinase 1 (TAK1), a critical regulator of the NF-kappa B and MAPK pathways, in early brain injury following SAH. Although the expression level of TAK1 did not present significant alternation in the basal temporal lobe after SAH, the expression of phosphorylated TAK1 (Thr-187, p-TAK1) showed a substantial increase 24 h post-SAH. Intracerebroventricular injection of a selective TAK1 inhibitor (10 min post-SAH), 5Z-7-oxozeaenol (OZ), significantly reduced the levels of TAK1 and p-TAK1 at 24 h post-SAH. Involvement of MAPKs and NF-kappa B signaling pathways was revealed that OZ inhibited SAH-induced phosphorylation of p38 and JNK, the nuclear translocation of NF-kappa B p65, and degradation of I kappa B alpha. Furthermore, OZ administration diminished the SAH-induced apoptosis and EBI. As a result, neurological deficits caused by SAH were reversed. Our findings suggest that TAK1 inhibition confers marked neuroprotection against EBI following SAH. Therefore, TAK1 might be a promising new molecular target for the treatment of SAH.	[Zhang, Dingding; Yan, Huiying; Li, Hua; Zhuang, Zong; Sun, Qing; Yang, Yiqing; Zhou, Mengliang; Hang, Chunhua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Hao, Shuangying; Li, Kuanyu] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210093, Jiangsu, Peoples R China; [Liu, Ming; Hang, Chunhua] Southern Med Univ Guangzhou, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Southern Medical University - China	Li, KY (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	likuanyu@nju.edu.cn; hang_neurosurgery@163.com	Li, Kuanyu/AAL-2051-2020	Zhou, Meng-liang/0000-0002-1165-5489; Li, Hua/0000-0001-5893-535X	National Natural Science Foundation [81371294, 31371060, 81400980]; Nature Science Foundation of the Jiangsu Province [BK2010459]; National Basic Research Program, China [2105CB856300]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of the Jiangsu Province; National Basic Research Program, China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation Grants 81371294, 31371060, and 81400980, Nature Science Foundation of the Jiangsu Province Grant BK2010459, and National Basic Research Program Grant 2105CB856300, China. The authors declare that they have no conflicts of interest with the contents of this article.	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Altay O, 2014, NEUROBIOL DIS, V62, P365, DOI 10.1016/j.nbd.2013.09.016; Cai PCH, 2014, ONCOTARGET, V5, P7549, DOI 10.18632/oncotarget.2273; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Carr KR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/506584; Chen G, 2013, NEUROSCIENCE, V231, P136, DOI 10.1016/j.neuroscience.2012.11.024; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Ireland DJ, 2015, MOL HUM REPROD, V21, P479, DOI 10.1093/molehr/gav005; Ivshina M, 2015, MOL CELL BIOL, V35, P610, DOI 10.1128/MCB.00800-14; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kooijman E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-2; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Neubert M, 2011, CELL DEATH DIFFER, V18, P1521, DOI 10.1038/cdd.2011.29; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Ridder DA, 2013, EXP NEUROL, V239, P68, DOI 10.1016/j.expneurol.2012.09.010; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Sabri M, 2013, J CEREBR BLOOD F MET, V33, P1008, DOI 10.1038/jcbfm.2013.49; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sun Q, 2013, BRAIN RES, V1520, P134, DOI 10.1016/j.brainres.2013.05.010; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; White BJ, 2012, EXP NEUROL, V237, P238, DOI 10.1016/j.expneurol.2012.05.019; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Xu H, 2015, BRIT J PHARMACOL, V172, P2892, DOI 10.1111/bph.13094; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022	45	36	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19900	19909		10.1074/jbc.M115.636795	http://dx.doi.org/10.1074/jbc.M115.636795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100626	hybrid, Green Published			2022-12-28	WOS:000359364600045
J	Dujardin, M; Madan, V; Montserret, R; Ahuja, P; Huvent, I; Launay, H; Leroy, A; Bartenschlager, R; Penin, F; Lippens, G; Hanoulle, X				Dujardin, Marie; Madan, Vanesa; Montserret, Roland; Ahuja, Puneet; Huvent, Isabelle; Launay, Helene; Leroy, Arnaud; Bartenschlager, Ralf; Penin, Franois; Lippens, Guy; Hanoulle, Xavier			A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMERASE ACTIVE-SITE; NONSTRUCTURAL PROTEIN; VIRAL-PROTEINS; MEMBRANOUS REPLICATION; PROLYL ISOMERIZATION; CRYSTAL-STRUCTURE; BINDING-SITE; CYCLOPHILIN; 5A; PROPENSITY	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) and its interaction with the human chaperone cyclophilin A are both targets for highly potent and promising antiviral drugs that are in the late stages of clinical development. Despite its high interest in regards to the development of drugs to counteract the worldwide HCV burden, NS5A is still an enigmatic multifunctional protein poorly characterized at the molecular level. NS5A is required for HCV RNA replication and is involved in viral particle formation and regulation of host pathways. Thus far, no enzymatic activity or precise molecular function has been ascribed to NS5A that is composed of a highly structured domain 1 (D1), as well as two intrinsically disordered domains 2 (D2) and 3 (D3), representing half of the protein. Here, we identify a short structural motif in the disordered NS5A-D2 and report its NMR structure. We show that this structural motif, a minimal Pro(314)-Trp(316) turn, is essential for HCV RNA replication, and its disruption alters the subcellular distribution of NS5A. We demonstrate that this Pro-Trpturn is required for proper interaction with the host cyclophilin A and influences its peptidyl-prolyl cis/trans isomerase activity on residue Pro(314) of NS5A-D2. This work provides a molecular basis for further understanding of the function of the intrinsically disordered domain 2 of HCV NS5A protein. In addition, our work highlights how very small structural motifs present in intrinsically disordered proteins can exert a specific function.	[Dujardin, Marie; Ahuja, Puneet; Huvent, Isabelle; Launay, Helene; Lippens, Guy; Hanoulle, Xavier] CNRS, Unit Glycobiol Structurale & Fonctionnelle, F-59655 Villeneuve Dascq, France; [Dujardin, Marie; Ahuja, Puneet; Huvent, Isabelle; Launay, Helene; Lippens, Guy; Hanoulle, Xavier] Univ Lille 1, F-59655 Villeneuve Dascq, France; [Montserret, Roland; Penin, Franois] CNRS, Bases Mol & Struct Syst Infectieux, IBCP, LabEx Ecofect,UMR 5086, F-69367 Lyon, France; [Montserret, Roland; Penin, Franois] Univ Lyon 1, F-69367 Lyon, France; [Madan, Vanesa; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany; [Leroy, Arnaud] Univ Paris Sud, EA4529 & InstruL2, UFR Pharm, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Universite Paris Saclay	Hanoulle, X (corresponding author), Univ Lille 1, CNRS, Unit Glycobiol Struct & Fonctionnelle, UMR 8576, F-59655 Villeneuve Dascq, France.	xavier.hanoulle@univ-lille1.fr	Hanoulle, Xavier/AAK-7236-2021; HANOULLE, Xavier/HHN-4815-2022; Bartenschlager, Ralf/L-2582-2015	Hanoulle, Xavier/0000-0002-3755-2680; Huvent, Isabelle/0000-0002-7241-0290; Lippens, Guy/0000-0002-8236-0901; Bartenschlager, Ralf/0000-0001-5601-9307; Launay, Helene/0000-0003-0639-2642	French National Agency for Research [ANR-11-JSV8-005]; French National Agency for Research on AIDS and Viral Hepatitis [A02007-2, A02011-2]; Mapping 128 Project [ANR-11-BINF-003]; Deutsche Forschungsgemeinschaft [TRR83, TP13]	French National Agency for Research(French National Research Agency (ANR)); French National Agency for Research on AIDS and Viral Hepatitis(ANRS); Mapping 128 Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by French National Agency for Research Grant ANR-11-JSV8-005 and French National Agency for Research on AIDS and Viral Hepatitis Grant A02007-2 and A02011-2. The NMR facility was supported by the European Community, the CNRS (TGIR RMN THC, FR-3050), the Universities of Lille1 and Lille2, the Region Nord-Pas-de-Calais (France), and the Institut Pasteur de Lille. This work was also supported by Mapping 128 Project ANR-11-BINF-003 (to F. P. and R. M.) and Deutsche Forschungsgemeinschaft Grants TRR83 and TP13 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Postdoctoral Fellowship ANR-11-JSV8-005 from the French National Agency for Research.	Alves C, 2012, FUTURE VIROL, V7, P1183, DOI 10.2217/FVL.12.114; Anderson LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-329; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Barua B, 2008, PROTEIN ENG DES SEL, V21, P171, DOI 10.1093/protein/gzm082; Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Brown JW, 2009, J MOL BIOL, V393, P608, DOI 10.1016/j.jmb.2009.08.018; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Casteleijn MG, 2006, BIOCHEMISTRY-US, V45, P15483, DOI 10.1021/bi061683j; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kursula I, 2004, PROTEIN ENG DES SEL, V17, P375, DOI 10.1093/protein/gzh048; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	71	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19104	19120		10.1074/jbc.M115.644419	http://dx.doi.org/10.1074/jbc.M115.644419			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085105	hybrid, Green Published			2022-12-28	WOS:000358781100027
J	Chakraborty, A; Wakamiya, M; Venkova-Canova, T; Pandita, RK; Aguilera-Aguirre, L; Sarker, AH; Singh, DK; Hosoki, K; Wood, TG; Sharma, G; Cardenas, V; Sarkar, PS; Sur, S; Pandita, TK; Boldogh, I; Hazra, TK				Chakraborty, Anirban; Wakamiya, Maki; Venkova-Canova, Tatiana; Pandita, Raj K.; Aguilera-Aguirre, Leopoldo; Sarker, Altaf H.; Singh, Dharniendra Kumar; Hosoki, Koa; Wood, Thomas G.; Sharma, Gulshan; Cardenas, Victor; Sarkar, Partha S.; Sur, Sanjiv; Pandita, Tej K.; Boldogh, Istvan; Hazra, Tapas K.			Neil2-null Mice Accumulate Oxidized DNA Bases in the Transcriptionally Active Sequences of the Genome and Are Susceptible to Innate Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GLYCOSYLASE NEIL1; ENDONUCLEASE-III; MAMMALIAN-CELLS; GENE-EXPRESSION; EXCISION-REPAIR; COUPLED REPAIR; MOUSE; IDENTIFICATION; 8-OXOGUANINE	Why mammalian cells possess multiple DNA glycosylases (DGs) with overlapping substrate ranges for repairing oxidatively damaged bases via the base excision repair (BER) pathway is a long-standing question. To determine the biological role of these DGs, null animal models have been generated. Here, we report the generation and characterization of mice lacking Neil2 (Nei-like 2). As in mice deficient in each of the other four oxidized base-specific DGs (OGG1, NTH1, NEIL1, and NEIL3), Neil2-null mice show no overt phenotype. However, middle-aged to old Neil2-null mice show the accumulation of oxidative genomic damage, mostly in the transcribed regions. Immunopulldown analysis from wild-type (WT) mouse tissue showed the association of NEIL2 with RNA polymerase II, along with Cockayne syndrome group B protein, TFIIH, and other BER proteins. Chromatin immunoprecipitation analysis from mouse tissue showed co-occupancy of NEIL2 and RNA polymerase II only on the transcribed genes, consistent with our earlier in vitro findings on NEIL2's role in transcription-coupled BER. This study provides the first in vivo evidence of genomic region-specific repair in mammals. Furthermore, telomere loss and genomic instability were observed at a higher frequency in embryonic fibroblasts from Neil2-null mice than from the WT. Moreover, Neil2-null mice are much more responsive to inflammatory agents than WT mice. Taken together, our results underscore the importance of NEIL2 in protecting mammals from the development of various pathologies that are linked to genomic instability and/or inflammation. NEIL2 is thus likely to play an important role in long term genomic maintenance, particularly in long- lived mammals such as humans.	[Chakraborty, Anirban; Venkova-Canova, Tatiana; Hosoki, Koa; Sharma, Gulshan; Cardenas, Victor; Sur, Sanjiv; Hazra, Tapas K.] Univ Texas Med Branch, Sealy Ctr Mol Med, Dept Internal Med, Galveston, TX 77555 USA; [Wakamiya, Maki; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci, Galveston, TX 77555 USA; [Wakamiya, Maki; Sarkar, Partha S.] Univ Texas Med Branch, Dept Cell Biol, Galveston, TX 77555 USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Wood, Thomas G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Wakamiya, Maki] Univ Texas Med Branch, Transgen Mouse Core Facil, Galveston, TX 77555 USA; [Pandita, Raj K.; Singh, Dharniendra Kumar; Pandita, Tej K.] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX 77030 USA; [Sarker, Altaf H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; The Methodist Hospital System; The Methodist Hospital - Houston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm & Crit Care Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	Pandita, Tej K/AAM-9188-2020; CHAKRABORTY, ANIRBAN/ABC-6552-2020; Sharma, Gulshan/AAC-5804-2019; Wood, Thomas/GWZ-2481-2022; Aguilera-Aguirre, Leopoldo/B-9864-2012	Wood, Thomas/0000-0001-8962-8571; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Hosoki, Koa/0000-0003-4228-2176	National Institutes of Health from USPHS [NS073976];  [RO1 CA129537];  [RO1 CA154320];  [P30 ES 06676]; NATIONAL CANCER INSTITUTE [R01CA154320, R01CA129537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007254, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073976] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS073976 from USPHS (to T. K. H.), RO1 CA129537 and RO1 CA154320 (to T. K. P.), and Grant P30 ES 06676 (to NIEHS Center Cell Biology Core and Molecular Geno<INF>m</INF>ics Core of UTMB's NIEHS Center for DNA sequencing). The authors declare that they have no conflicts of interest with the contents of this article.	Aamann MD, 2014, MECH AGEING DEV, V135, P1, DOI 10.1016/j.mad.2013.12.008; Aguilera-Aguirre L, 2014, J IMMUNOL, V193, P4643, DOI 10.4049/jimmunol.1401625; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bacsi A, 2007, MECH AGEING DEV, V128, P637, DOI 10.1016/j.mad.2007.09.005; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Bah A, 2012, INT J BIOCHEM CELL B, V44, P1055, DOI 10.1016/j.biocel.2012.03.021; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Chatterjee A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004749; Choudhary S, 2013, J BIOL CHEM, V288, P14612, DOI 10.1074/jbc.M113.464081; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Das A, 2005, J BIOL CHEM, V280, P35272, DOI 10.1074/jbc.M505526200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2013, P NATL ACAD SCI USA, V110, pE3090, DOI 10.1073/pnas.1304231110; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; KASAI H, 1991, OXIDATIVE STRESS OXI, P99; Kawakami H, 1996, BIOCHEM BIOPH RES CO, V221, P199, DOI 10.1006/bbrc.1996.0569; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026; KUDRYCKI K, 1993, MOL CELL BIOL, V13, P3002, DOI 10.1128/MCB.13.5.3002; Lee Choogon, 2007, Methods Mol Biol, V362, P385; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Maiti AK, 2008, DNA REPAIR, V7, P1213, DOI 10.1016/j.dnarep.2008.03.025; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nijland R, 2014, MAR DRUGS, V12, P4260, DOI 10.3390/md12074260; Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002; Osorio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004256; Pandita RK, 2015, CANCER RES, V75, P858, DOI 10.1158/0008-5472.CAN-14-2289; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Reis AMC, 2012, NUCLEIC ACIDS RES, V40, P206, DOI 10.1093/nar/gkr704; Sailaja BS, 2012, METHODS MOL BIOL, V809, P353, DOI 10.1007/978-1-61779-376-9_24; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Suganya R, 2015, DNA REPAIR, V27, P40, DOI 10.1016/j.dnarep.2015.01.003; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Torisu K, 2005, J BIOCHEM, V138, P763, DOI 10.1093/jb/mvi168; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zhai XD, 2008, CLIN CANCER RES, V14, P4345, DOI 10.1158/1078-0432.CCR-07-5282; Zhang JH, 1998, J BIOL CHEM, V273, P23454, DOI 10.1074/jbc.273.36.23454	80	57	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24636	24648		10.1074/jbc.M115.658146	http://dx.doi.org/10.1074/jbc.M115.658146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26245904	hybrid, Green Published			2022-12-28	WOS:000362598300001
J	Alfaidi, M; Wilson, H; Daigneault, M; Burnett, A; Ridger, V; Chamberlain, J; Francis, S				Alfaidi, Mabruka; Wilson, Heather; Daigneault, Marc; Burnett, Amanda; Ridger, Victoria; Chamberlain, Janet; Francis, Sheila			Neutrophil Elastase Promotes Interleukin-1 beta Secretion from Human Coronary Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEASES; IL-1-BETA SECRETION; HEART-DISEASE; CELLS; INFLAMMATION; ACTIVATION; PATHWAY; CASPASE-1; ATHEROSCLEROSIS; MACROPHAGES	The endothelium is critically involved in the pathogenesis of atherosclerosis by producing pro-inflammatory mediators, including IL-1 beta. Coronary arteries from patients with ischemic heart disease express large amounts of IL-1 beta in the endothelium. However, the mechanism by which endothelial cells (ECs) release IL-1 beta remains to be elucidated. We investigated neutrophil elastase (NE), a potent serine protease detected in vulnerable areas of human carotid plaques, as a potential "trigger" for IL-1 beta processing and release. This study tested the hypothesis that NE potentiates the processing and release of IL-1 beta from human coronary endothelium. We found that NE cleaves the pro-isoform of IL-1 beta in ECs and causes significant secretion of bioactive IL-1 beta via extracellular vesicles. This release was attenuated significantly by inhibition of neutrophil elastase but not caspase-1. Transient increases in intracellular Ca2+ levels were observed prior to secretion. Inside ECs, and after NE treatment only, IL-1 beta was detected within LAMP-1-positive multivesicular bodies. The released vesicles contained bioactive IL-1 beta. In vivo, in experimental atherosclerosis, NE was detected in mature atherosclerotic plaques, predominantly in the endothelium, alongside IL-1 beta. This study reveals a novel mechanistic link between NE expression in atherosclerotic plaques and concomitant pro-inflammatory bioactive IL-1 beta secretion from ECs. This could reveal additional potential anti-IL-1 beta therapeutic targets and provide further insights into the inflammatory process by which vascular disease develops.	[Alfaidi, Mabruka; Wilson, Heather; Daigneault, Marc; Burnett, Amanda; Ridger, Victoria; Chamberlain, Janet; Francis, Sheila] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Francis, S (corresponding author), Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	s.francis@sheffield.ac.uk	Wilson, Heather/O-5909-2019; Alfaidi, Mabruka/ABC-1062-2020; Ridger, Victoria/GLN-8158-2022	Wilson, Heather/0000-0002-7892-3425; Alfaidi, Mabruka/0000-0001-7970-0840; Ridger, Victoria/0000-0003-4163-669X; Francis, Sheila/0000-0001-6552-0339	Medical School, Omar Al-Mukhtar University, Al-Bayda, Libya; British Heart Foundation [PG/11/85/29147, PG/14/38/30862] Funding Source: researchfish	Medical School, Omar Al-Mukhtar University, Al-Bayda, Libya; British Heart Foundation(British Heart Foundation)	This work was supported by a Ph.D. studentship from The Medical School, Omar Al-Mukhtar University, Al-Bayda, Libya (to M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Aird WC, 2008, PHARMACOL REP, V60, P139; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Chamberlain J, 2006, AM J PATHOL, V168, P1396, DOI 10.2353/ajpath.2006.051054; Chamberlain J, 1999, CARDIOVASC RES, V44, P156, DOI 10.1016/S0008-6363(99)00175-3; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Coffman LG, 2008, AM J PHYSIOL-LUNG C, V294, pL505, DOI 10.1152/ajplung.00347.2007; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Drose S, 1997, J EXP BIOL, V200, P1; Ettelaie C, 2014, J EXTRACELL VESICLES, V13, P3, DOI [10.3402/jev.v3.23592, DOI 10.3402/JEV.V3.23592]; Evans I, 2006, CYTOKINE, V33, P274, DOI 10.1016/j.cyto.2006.02.003; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Galliher-Beckley Amy J, 2013, World J Biol Chem, V4, P30, DOI 10.4331/wjbc.v4.i2.30; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Gupta P, 2012, BLOOD, V119, P3767, DOI 10.1182/blood-2011-09-381988; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kiss-Toth E, 2000, J IMMUNOL METHODS, V239, P125, DOI 10.1016/S0022-1759(00)00151-4; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Lee KY, 2006, AM J RESP CELL MOL, V35, P407, DOI 10.1165/rcmb.2006-0012OC; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu H, 1999, AM J PHYSIOL-LUNG C, V276, pL28, DOI 10.1152/ajplung.1999.276.1.L28; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Lutz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115603; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Place DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107188; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rao SK, 1996, ANN NY ACAD SCI, V800, P131; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Van Tassell BW, 2013, CIRCULATION, V128, P1910, DOI 10.1161/CIRCULATIONAHA.113.003199; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Ward JR, 2009, IMMUNOLOGY, V128, P58, DOI 10.1111/j.1365-2567.2009.03071.x; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213	52	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24067	24078		10.1074/jbc.M115.659029	http://dx.doi.org/10.1074/jbc.M115.659029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269588	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000362218900003
J	Namgaladze, D; Snodgrass, RG; Angioni, C; Grossmann, N; Dehne, N; Geisslinger, G; Brune, B				Namgaladze, Dmitry; Snodgrass, Ryan G.; Angioni, Carlo; Grossmann, Nina; Dehne, Nathalie; Geisslinger, Gerd; Bruene, Bernhard			AMP-activated Protein Kinase Suppresses Arachidonate 15-Lipoxygenase Expression in Interleukin 4-polarized Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; KAPPA-B; INFLAMMATION; 12/15-LIPOXYGENASE; PPAR; DIFFERENTIATION; IL-4; POLARIZATION	Macrophages respond to the Th2 cytokine 11,-4 with elevated expression of arachidonate 15-lipoxygenase (ALOX15). Although IL-4 signaling elicits anti-inflammatory responses, 15-lipoxygenase may either support or inhibit inflammatory processes in a context-dependent manner. AMP-activated protein kinase (AMPK) is a metabolic sensor/regulator that supports an anti-inflammatory macrophage phenotype. How AMPK activation is linked to IL-4-elicited gene signatures remains unexplored. Using primary human macrophages stimulated with IL-4, we observed elevated ALOX15 mRNA and protein expression, which was attenuated by AMPK activation. AMPK activators, e.g. phenformin and aminoimidazole-4-carboxamide 1-0D-ribofuranoside inhibited IL-4-evoked activation of STAT3 while leaving activation of STAT6 and induction of typical IL-4responsive genes intact. In addition, phenformin prevented IL-4-induced association of STAT6 and Lys-9 acetylation of histone H3 at the AL0X15 promoter. Activating AMPK abolished cellular production of 15-lipoxygenase arachidonic acid metabolites in IL-4-stimulated macrophages, which was mimicked by AI,OX15 knockdown. Finally, pretreatment of macrophages with IL-4 for 48 h increased the mRNA expression of the proinflammatory cytokines IL-6, IL-12, CXCL9, and CXCI,10 induced by subsequent stimulation with lipopolysaccharide. This response was attenuated by inhibition of AI,OX15 or activation of AMPK during incubation with IL-4. In conclusion, limiting ALOX15 expression by AMPK may promote an anti-inflammatory phenotype of IL-4-stimulated human macrophages.	[Namgaladze, Dmitry; Snodgrass, Ryan G.; Grossmann, Nina; Dehne, Nathalie; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Angioni, Carlo; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Brune, B (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	b.bruene@biochem.uni-frankfurt.de	Snodgrass, Ryan G./AAH-5110-2021; Snodgrass, Ryan G/U-1031-2018	Snodgrass, Ryan G./0000-0001-9896-5297; Snodgrass, Ryan G/0000-0001-9896-5297	Deutsche Forschungsgemeinschaft [NA429/2-1, SFB 1039]; Else Kroner Fresenius Foundation (TRIP)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Fresenius Foundation (TRIP)	This study was supported by Deutsche Forschungsgemeinschaft Grants NA429/2-1 and SFB 1039 Teilprojekt A05, B04, and Z01 and by the Else Kroner Fresenius Foundation (TRIP). The authors declare that they have no conflicts of interest with the contents of this article.	Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cole BK, 2013, PROSTAG OTH LIPID M, V104, P84, DOI 10.1016/j.prostaglandins.2012.07.004; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P780, DOI 10.1016/j.imbio.2010.05.032; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jenkins Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081870; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P15830, DOI 10.1074/jbc.M113.453290; Li J, 2013, ARTERIOSCL THROM VAS, V33, P971, DOI 10.1161/ATVBAHA.113.301335; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Meares GP, 2013, J IMMUNOL, V190, P372, DOI 10.4049/jimmunol.1202390; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Namgaladze D, 2013, CARDIOVASC RES, V98, P479, DOI 10.1093/cvr/cvt073; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nerstedt A, 2010, DIABETOLOGIA, V53, P2406, DOI 10.1007/s00125-010-1856-z; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rydberg EK, 2004, ARTERIOSCL THROM VAS, V24, P2040, DOI 10.1161/01.ATV.0000144951.08072.0b; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453	46	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24484	24494		10.1074/jbc.M115.678243	http://dx.doi.org/10.1074/jbc.M115.678243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276392	Green Published, hybrid			2022-12-28	WOS:000362218900034
J	Mottershead, DG; Sugimura, S; Al-Musawi, SL; Li, JJ; Richani, D; White, MA; Martin, GA; Trotta, AP; Ritter, LJ; Shi, J; Mueller, TD; Harrison, CA; Gilchrist, RB				Mottershead, David G.; Sugimura, Satoshi; Al-Musawi, Sara L.; Li, Jing-Jie; Richani, Dulama; White, Melissa A.; Martin, Georgia A.; Trotta, Andrew P.; Ritter, Lesley J.; Shi, Junyan; Mueller, Thomas D.; Harrison, Craig A.; Gilchrist, Robert B.			Cumulin, an Oocyte-secreted Heterodimer of the Transforming Growth Factor-beta Family, Is a Potent Activator of Granulosa Cells and Improves Oocyte Quality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-15; DIFFERENTIATION FACTOR 9; IN-VITRO MATURATION; DEVELOPMENTAL COMPETENCE; GROWTH-DIFFERENTIATION-FACTOR-9 COOPERATE; BINDING-SPECIFICITY; SUBSEQUENT EMBRYO; MOLECULAR-BASIS; SINGLE RESIDUE; OVULATION RATE	Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are oocyte-specific growth factors with central roles in mammalian reproduction, regulating species-specific fecundity, ovarian follicular somatic cell differentiation, and oocyte quality. In the human, GDF9 is produced in a latent form, the mechanism of activation being an open question. Here, we produced a range of recombinant GDF9 and BMP15 variants, examined their in silico and physical interactions and their effects on ovarian granulosa cells (GC) and oocytes. We found that the potent synergistic actions of GDF9 and BMP15 on GC can be attributed to the formation of a heterodimer, which we have termed cumulin. Structural modeling of cumulin revealed a dimerization interface identical to homodimeric GDF9 and BMP15, indicating likely formation of a stable complex. This was confirmed by generation of recombinant heterodimeric complexes of pro/mature domains (pro-cumulin) and covalent mature domains (cumulin). Both pro-cumulin and cumulin exhibited highly potent bioactivity on GC, activating both SMAD2/3 and SMAD1/5/8 signaling pathways and promoting proliferation and expression of a set of genes associated with oocyte-regulated GC differentiation. Cumulin was more potent than pro-cumulin, pro-GDF9, pro-BMP15, or the two combined on GC. However, on cumulus-oocyte complexes, pro-cumulin was more effective than all other growth factors at notably improving oocyte quality as assessed by subsequent day 7 embryo development. Our results support a model of activation for human GDF9 dependent on cumulin formation through heterodimerization with BMP15. Oocyte-secreted cumulin is likely to be a central regulator of fertility in mono-ovular mammals.	[Mottershead, David G.; Sugimura, Satoshi; Li, Jing-Jie; White, Melissa A.; Martin, Georgia A.; Trotta, Andrew P.; Ritter, Lesley J.; Shi, Junyan; Gilchrist, Robert B.] Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Mottershead, David G.; Sugimura, Satoshi; Li, Jing-Jie; White, Melissa A.; Martin, Georgia A.; Trotta, Andrew P.; Ritter, Lesley J.; Shi, Junyan; Gilchrist, Robert B.] Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Ritter, Lesley J.] Univ Adelaide, Australian Res Council, Ctr Excellence Nanoscale BioPhoton, Adelaide, SA 5005, Australia; [Mottershead, David G.] Mottasis Oy Ltd, Helsinki 00430, Finland; [Sugimura, Satoshi] Tokyo Univ Agr & Technol, Dept Biol Prod, Inst Agr, Tokyo 1830057, Japan; [Al-Musawi, Sara L.; Harrison, Craig A.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Li, Jing-Jie] Sun Yat Sen Univ, Ctr Reprod Med, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Richani, Dulama; Gilchrist, Robert B.] Univ New S Wales, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW 2052, Australia; [Mueller, Thomas D.] Univ Wurzburg, Dept Plant Physiol & Biophys, Julius Von Sachs Inst, D-97082 Wurzburg, Germany	Robinson Research Institute; University of Adelaide; Tokyo University of Agriculture & Technology; Hudson Institute of Medical Research; Sun Yat Sen University; University of New South Wales Sydney; University of Wurzburg	Gilchrist, RB (corresponding author), Univ New S Wales, Royal Hosp Women, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW, Australia.	r.gilchrist@unsw.edu.au	Ritter, Lesley/R-5608-2016; Richani, Dulama/H-5807-2019; Sugimura, Satoshi/B-9877-2015	Ritter, Lesley/0000-0001-5942-851X; Richani, Dulama/0000-0003-1886-0423; Sugimura, Satoshi/0000-0002-6473-5941; Mottershead, David G./0000-0003-2593-0725; Mueller, Thomas/0000-0003-1862-7357; Harrison, Craig/0000-0003-1059-3682; Gilchrist, Robert/0000-0003-1611-7142	National Health and Medical Research Council of Australia [627151, 1024358, 1062762, 1017484, 1076004, 1023210, 1013533]; Cook Medical; Sun Yat-sen University International Program Fund 985 Project; Japanese Society for Promotion of Science Postdoctoral Fellowship for Research Abroad; Grants-in-Aid for Scientific Research [15K18768] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cook Medical; Sun Yat-sen University International Program Fund 985 Project; Japanese Society for Promotion of Science Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Health and Medical Research Council of Australia through Project Grants 627151, 1024358, and 1062762, Development Grants 1017484 and 1076004, and Fellowships 1023210 and 1013533. This work was also supported by research grants from Cook Medical, Sun Yat-sen University International Program Fund 985 Project (to J. J. L.) and from the Japanese Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (to S. S.). R. B. G. is listed as an inventor on Patent US20140073052A1 owned by the University of Adelaide. R. B. G. and D. G. M. are listed on a distribution of benefits agreement in connection with Patent US20140073052A1.	Al-Musawi SL, 2013, ENDOCRINOLOGY, V154, P888, DOI 10.1210/en.2012-2015; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Crawford JL, 2012, MOL CELL ENDOCRINOL, V348, P339, DOI 10.1016/j.mce.2011.09.033; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dragovic RA, 2007, BIOL REPROD, V76, P848, DOI 10.1095/biolreprod.106.057471; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gilchrist RB, 2004, BIOL REPROD, V71, P732, DOI 10.1095/biolreprod.104.028852; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Gilchrist RB, 2011, REPRODUCTION, V142, P647, DOI 10.1530/REP-11-0196; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; Harrison CA, 2011, GROWTH FACTORS, V29, P174, DOI 10.3109/08977194.2011.608666; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Kaivo-Oja N, 2005, J CLIN ENDOCR METAB, V90, P271, DOI 10.1210/jc.2004-1288; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Li JJ, 2015, MOL ENDOCRINOL, V29, P40, DOI 10.1210/me.2014-1173; Li QL, 2009, MOL HUM REPROD, V15, P779, DOI 10.1093/molehr/gap062; Li R, 2000, BIOL REPROD, V63, P839, DOI 10.1095/biolreprod63.3.839; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Marchal R, 2002, THERIOGENOLOGY, V57, P1523, DOI 10.1016/S0093-691X(02)00655-6; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; McIntosh CJ, 2008, BIOL REPROD, V79, P889, DOI 10.1095/biolreprod.108.068163; McMahon HE, 2008, ENDOCRINOLOGY, V149, P812, DOI 10.1210/en.2007-1439; McNatty KP, 2005, REPRODUCTION, V129, P481, DOI 10.1530/rep.1.00517; McNatty KP, 2005, REPRODUCTION, V129, P473, DOI 10.1530/rep.1.0511; McNatty KP, 2004, REPRODUCTION, V128, P379, DOI 10.1530/rep.1.00280; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Mottershead DG, 2013, P NATL ACAD SCI USA, V110, pE2257, DOI 10.1073/pnas.1303459110; Mottershead DG, 2012, MOL HUM REPROD, V18, P121, DOI 10.1093/molehr/gar056; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Peng J, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.123158; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Pulkki MM, 2012, ENDOCRINOLOGY, V153, P1509, DOI 10.1210/en.2010-1390; Pulkki MM, 2011, MOL CELL ENDOCRINOL, V332, P106, DOI 10.1016/j.mce.2010.10.002; Reader KL, 2016, REPROD FERT DEVELOP, V28, P491, DOI 10.1071/RD14099; Richani D, 2013, MOL HUM REPROD, V19, P500, DOI 10.1093/molehr/gat028; Ritter LJ, 2015, ENDOCRINOLOGY, V156, P2299, DOI 10.1210/en.2014-1884; Simpson CM, 2012, ENDOCRINOLOGY, V153, P1301, DOI 10.1210/en.2011-1632; Smitz JEJ, 2011, SEMIN REPROD MED, V29, P24, DOI 10.1055/s-0030-1268701; Sudiman J, 2014, J ASSIST REPROD GEN, V31, P295, DOI 10.1007/s10815-013-0152-5; Sudiman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103563; Sugimura S, 2015, DEV BIOL, V403, P139, DOI 10.1016/j.ydbio.2015.05.008; Sugimura S, 2014, MOL HUM REPROD, V20, P499, DOI 10.1093/molehr/gau013; Sutton-McDowall ML, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102061; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Watson LN, 2012, ENDOCRINOLOGY, V153, P4544, DOI 10.1210/en.2012-1181; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	63	94	104	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					24007	24020		10.1074/jbc.M115.671487	http://dx.doi.org/10.1074/jbc.M115.671487			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26254468	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000361816500044
J	de Araujo, ED; Alvarez, CP; Lopez-Alonso, JP; Sooklal, CR; Stagljar, M; Kanelis, V				de Araujo, Elvin D.; Alvarez, Claudia P.; Lopez-Alonso, Jorge P.; Sooklal, Clarissa R.; Stagljar, Marijana; Kanelis, Voula			Phosphorylation- dependent Changes in Nucleotide Binding, Conformation, and Dynamics of the First Nucleotide Binding Domain (NBD1) of the Sulfonylurea Receptor 2B (SUR2B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; SENSITIVE POTASSIUM CHANNEL; ABC TRANSPORTER; P-GLYCOPROTEIN; MEDIATED PHOSPHORYLATION; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; MOLECULAR-BASIS; DRUG-BINDING	The sulfonylurea receptor 2B (SUR2B) forms the regulatory subunit of ATP-sensitive potassium (K-ATP) channels in vascular smooth muscle. Phosphorylation of the SUR2B nucleotide binding domains (NBD1 and NBD2) by protein kinase A results in increased channel open probability. Here, we investigate the effects of phosphorylation on the structure and nucleotide binding properties of NBD1. Phosphorylation sites in SUR2B NBD1 are located in an N-terminal tail that is disordered. Nuclear magnetic resonance (NMR) data indicate that phosphorylation of the N-terminal tail affects multiple residues in NBD1, including residues in the NBD2-binding site, and results in altered conformation and dynamics of NBD1. NMR spectra of NBD1 lacking the N-terminal tail, NBD1-Delta N, suggest that phosphorylation disrupts interactions of the N-terminal tail with the core of NBD1, a model supported by dynamic light scattering. Increased nucleotide binding of phosphorylated NBD1 and NBD1-Delta N, compared with non-phosphorylated NBD1, suggests that by disrupting the interaction of theNBDcore with the N-terminal tail, phosphorylation also exposes the MgATP-binding site on NBD1. These data provide insights into the molecular basis by which phosphorylation of SUR2BNBD1activates K-ATP channels.	[de Araujo, Elvin D.; Alvarez, Claudia P.; Lopez-Alonso, Jorge P.; Sooklal, Clarissa R.; Stagljar, Marijana; Kanelis, Voula] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; [de Araujo, Elvin D.; Alvarez, Claudia P.; Lopez-Alonso, Jorge P.; Sooklal, Clarissa R.; Stagljar, Marijana; Kanelis, Voula] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Lopez-Alonso, Jorge P.; Stagljar, Marijana; Kanelis, Voula] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University of Toronto	Kanelis, V (corresponding author), Univ Toronto, DV Dept Chem & Phys Sci 4042, 3359 Mississauga Rd N, Mississauga, ON L5L 1C6, Canada.	voula.kanelis@utoronto.ca	López-Alonso, Jorge Pedro/U-5551-2018	López-Alonso, Jorge Pedro/0000-0003-2081-2607	Canadian Institutes of Health Research [MOP-106470]; Natural Sciences and Engineering Council of Canada [RGPIN 357118-09]; Ontario Postdoctoral Fellowship; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research New Investigator Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Postdoctoral Fellowship; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-106470 and the Natural Sciences and Engineering Council of Canada Grant RGPIN 357118-09 (to V.K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Postdoctoral Fellowship. Present address: CIC bio-GUNE, Edificio 800, Parque Tecnologico de Bizkaia, 48160 Derio (Bizkaia), Spain.; Supported by an Early Researcher Award from the Ontario Ministry of Economic Development and Innovation and a Canadian Institutes of Health Research New Investigator Award.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; [Anonymous], [No title captured]; Arakel EC, 2014, J CELL SCI, V127, P2106, DOI 10.1242/jcs.141440; Atreya HS, 2012, ADV EXP MED BIOL, V992, pV; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Chutkow WA, 1996, DIABETES, V45, P1439, DOI 10.2337/diabetes.45.10.1439; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Araujo ED, 2014, PROTEIN EXPRES PURIF, V103, P38, DOI 10.1016/j.pep.2014.08.006; de Araujo ED, 2011, BIOCHEMISTRY-US, V50, P6655, DOI 10.1021/bi200434d; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deber C. M., 2010, PROLINE RESIDUES PRO; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Fang K, 2006, J PHYSIOL-LONDON, V576, P379, DOI 10.1113/jphysiol.2006.112748; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Grifman M, 1997, MOL BRAIN RES, V51, P179, DOI 10.1016/S0169-328X(97)00246-5; Guarnieri MT, 2011, ASSAY DRUG DEV TECHN, V9, P174, DOI 10.1089/adt.2010.0289; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hu D, 2014, INT J CARDIOL, V171, P431, DOI 10.1016/j.ijcard.2013.12.084; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kanelis V, 2011, METHODS MOL BIOL, V741, P377, DOI 10.1007/978-1-61779-117-8_25; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Karger AB, 2008, J GEN PHYSIOL, V131, P185, DOI 10.1085/jgp.200709852; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krishnarjuna B, 2011, J BIOMOL NMR, V49, P39, DOI 10.1007/s10858-010-9459-z; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Lopez-Alonso JP, 2012, BIOCHEMISTRY-US, V51, P9211, DOI 10.1021/bi301019e; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Minoretti P, 2006, CLIN CHIM ACTA, V370, P124, DOI 10.1016/j.cca.2006.02.007; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Olson TM, 2007, NAT CLIN PRACT CARD, V4, P110, DOI 10.1038/ncpcardio0792; Ortiz D, 2013, J BIOL CHEM, V288, P18894, DOI 10.1074/jbc.M113.476887; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Ribalet B, 2000, J GEN PHYSIOL, V116, P391, DOI 10.1085/jgp.116.3.391; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Smith KJ, 2013, INT J CARDIOL, V168, P3506, DOI 10.1016/j.ijcard.2013.04.210; Smith SP, 1997, PROTEIN SCI, V6, P1110, DOI 10.1002/pro.5560060518; Stolarczyk EI, 2011, CURR PHARM BIOTECHNO, V12, P621; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yamada M, 2004, MOL PHARMACOL, V66, P807, DOI 10.1124/mol.104.002717; Yuan Y. R., 2001, J BIOL CHEM, V276, P32313; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	96	11	11	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22699	22714		10.1074/jbc.M114.636233	http://dx.doi.org/10.1074/jbc.M114.636233			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198630	hybrid, Green Published			2022-12-28	WOS:000361171500034
J	Gurel, PS; Mu, A; Guo, BQ; Shu, R; Mierke, DF; Higgs, HN				Gurel, Pinar S.; Mu, A.; Guo, Bingqian; Shu, Rui; Mierke, Dale F.; Higgs, Henry N.			Assembly and Turnover of Short Actin Filaments by the Formin INF2 and Profilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP HYDROLYSIS; ACANTHAMOEBA PROFILIN; ENDOPLASMIC-RETICULUM; NUCLEOTIDE EXCHANGE; BOUND NUCLEOTIDE; MOUSE FORMIN; ADP-ACTIN; POLYMERIZATION; NUCLEATION; MECHANISM	INF2 (inverted formin 2) is a formin protein with unique biochemical effects on actin. In addition to the common formin ability to accelerate actin nucleation and elongation, INF2 can also sever filaments and accelerate their depolymerization. Although we understand key attributes of INF2-mediated severing, we do not understand the mechanism by which INF2 accelerates depolymerization subsequent to severing. Here, we show that INF2 can create short filaments (<60 nm) that continuously turn over actin subunits through a combination of barbed end elongation, severing, and WH2 motif-mediated depolymerization. This pseudo-steady state condition occurs whether starting from actin filaments or monomers. The rate-limiting step of the cycle is nucleotide exchange of ADP for ATP on actin monomers after release from the INF2/actin complex. Profilin addition has two effects: 1) to accelerate filament turnover 6-fold by accelerating nucleotide exchange and 2) to shift the equilibrium toward polymerization, resulting in longer filaments. In sum, our findings show that the combination of multiple interactions of INF2 with actin can work in concert to increase the ATP turnover rate of actin. Depending on the ratio of INF2: actin, this increased flux can result in rapid filament depolymerization or maintenance of short filaments. We also show that high concentrations of cytochalasin D accelerate ATP turnover by actin but through a different mechanism from that of INF2.	[Gurel, Pinar S.; Mu, A.; Shu, Rui; Higgs, Henry N.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Guo, Bingqian; Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Higgs, HN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu	A, Mu/U-7936-2019; Regan, Clinton/E-6250-2012	Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [R01 GM069818, T32 GM008704]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818, T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM069818 (to H. N. H.) and T32 GM008704 (to P. S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; CARLIER MF, 1988, FEBS LETT, V235, P211, DOI 10.1016/0014-5793(88)81264-X; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Guo BQ, 2014, CHEM COMMUN, V50, P12037, DOI 10.1039/c4cc04399e; Gurel PS, 2014, CURR BIOL, V24, pR660, DOI 10.1016/j.cub.2014.05.033; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hatch AL, 2014, J CELL SCI, V127, P4549, DOI 10.1242/jcs.153791; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; McCullagh M, 2014, J AM CHEM SOC, V136, P13053, DOI 10.1021/ja507169f; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; OHM T, 1994, BBA-PROTEIN STRUCT M, V1208, P8, DOI 10.1016/0167-4838(94)90153-8; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Selden LA, 1999, BIOCHEMISTRY-US, V38, P2769, DOI 10.1021/bi981543c; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l	44	17	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22494	22506		10.1074/jbc.M115.670166	http://dx.doi.org/10.1074/jbc.M115.670166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26124273	hybrid, Green Published			2022-12-28	WOS:000361171500017
J	Burkhalter, RJ; Westfall, SD; Liu, YY; Stack, MS				Burkhalter, Rebecca J.; Westfall, Suzanne D.; Liu, Yueying; Stack, M. Sharon			Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces beta-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; SIGNALING PATHWAY; SEROUS CARCINOMA; GROWTH-FACTOR; CANCER CELLS; WNT PATHWAY; INTEGRIN; LPA; ACTIVATION; TARGET	During tumor progression, epithelial ovarian cancer (EOC) cells undergo epithelial-to-mesenchymal transition (EMT), which influences metastatic success. Mutation-dependent activation of Wnt/beta-catenin signaling has been implicated in gain of mesenchymal phenotype and loss of differentiation in several solid tumors; however, similar mutations are rare in most EOC histotypes. Nevertheless, evidence for activated Wnt/beta-catenin signaling in EOC has been reported, and immunohistochemical analysis of human EOC tumors demonstrates nuclear staining in all histotypes. This study addresses the hypothesis that the bioactive lipid lysophosphatidic acid (LPA), prevalent in the EOC microenvironment, functions to regulate EMT in EOC. Our results demonstrate that LPA induces loss of junctional beta-catenin, stimulates clustering of beta 1 integrins, and enhances the conformationally active population of surface beta 1 integrins. Furthermore, LPA treatment initiates nuclear translocation of beta-catenin and transcriptional activation of Wnt/beta-catenin target genes resulting in gain of mesenchymal marker expression. Together these data suggest that LPA initiates EMT in ovarian tumors through beta 1-integrin-dependent activation of Wnt/beta-catenin signaling, providing a novel mechanism for mutation-independent activation of this pathway in EOC progression.	[Burkhalter, Rebecca J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Westfall, Suzanne D.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Burkhalter, Rebecca J.; Liu, Yueying; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN 46617 USA; [Liu, Yueying; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46617 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Notre Dame; University of Notre Dame	Stack, MS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA.	sstack@nd.edu			National Institutes of Health from the NCI [RO1 CA109545, RO1 CA086984]; Leo and Ann Albert Charitable Trust;  [CA086984-11S1]; NATIONAL CANCER INSTITUTE [R01CA086984, R01CA109545] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leo and Ann Albert Charitable Trust; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109545 (to M. S. S.) and RO1 CA086984 (to M. S. S.) from the NCI and Research Supplement to Promote Diversity CA086984-11S1 (to R. J. B.). This work was also supported by the Leo and Ann Albert Charitable Trust (to M. S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; *AM CANC SOC, 2010, CANC FACTS FIG; Arend RC, 2014, GYNECOL ONCOL, V134, P112, DOI 10.1016/j.ygyno.2014.04.005; Auersperg N, 1998, SEMIN ONCOL, V25, P281; AUERSPERG N, 1995, OVARIAN CANC, V3, P157; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2013, J BIOL CHEM, V288, P141, DOI 10.1074/jbc.M112.431411; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Bian YS, 2000, AM J CLIN PATHOL, V114, P583, DOI 10.1309/3QLC-5MF1-JYXU-A5XX; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Do TV, 2007, MOL CANCER RES, V5, P121, DOI 10.1158/1541-7786.MCR-06-0319; FAGOTTO F, 1994, DEVELOPMENT, V120, P3667; Fishman DA, 2001, CANCER RES, V61, P3194; Ford CE, 2014, GYNECOL ONCOL, V134, P338, DOI 10.1016/j.ygyno.2014.06.004; Fukushima N, 2001, PROSTAG OTH LIPID M, V64, P21, DOI 10.1016/S0090-6980(01)00105-8; Gardi NL, 2014, CLIN CANCER RES, V20, P87, DOI 10.1158/1078-0432.CCR-13-2063; Gilcrease MZ, 2004, CANCER RES, V64, P7395, DOI 10.1158/0008-5472.CAN-04-1809; Guo LL, 2015, CELL SIGNAL, V27, P961, DOI 10.1016/j.cellsig.2015.02.005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jiang YH, 2011, CANCER RES, V71, P2959, DOI 10.1158/0008-5472.CAN-10-4077; Jin HY, 2010, INT J CANCER, V126, P2102, DOI 10.1002/ijc.24901; Jourquin J, 2006, J CELL PHYSIOL, V206, P337, DOI 10.1002/jcp.20470; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lili LN, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-49; Liu YY, 2012, J ONCOL, V2012, DOI 10.1155/2012/501492; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Marchini S, 2013, EUR J CANCER, V49, P520, DOI 10.1016/j.ejca.2012.06.026; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; ROZENGURT E, 1995, CANCER SURV, V24, P81; Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Smicun Y, 2007, GYNECOL ONCOL, V107, P298, DOI 10.1016/j.ygyno.2007.06.024; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; Surveillance Research Program NCI, 2014, SEER STAT FACT SHEET; Symowicz J, 2005, CANCER RES, V65, P2234, DOI 10.1158/0008.5472.CAN-04-2781; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuhkanen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-289; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063731; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107	81	41	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22143	22154		10.1074/jbc.M115.641092	http://dx.doi.org/10.1074/jbc.M115.641092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26175151	Green Published, hybrid			2022-12-28	WOS:000360968500031
J	Niizuma, K; Tahara-Hanaoka, S; Noguchi, E; Shibuya, A				Niizuma, Kouta; Tahara-Hanaoka, Satoko; Noguchi, Emiko; Shibuya, Akira			Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; MAST-CELL; ACTIVATING RECEPTOR; SOLUBLE FORM; CMRF-35-LIKE MOLECULE-1; FCR-GAMMA; MAIR-II; MONOCYTES; EXPRESSION; INFECTION	Recruitment of circulating monocytes and neutrophils to infection sites is essential for host defense against infections. Here, we identified a previously unannotated gene that encodes an immunoglobulin-like receptor, designated CD300H, which is located in the CD300 gene cluster. CD300H has a short cytoplasmic tail and associates with the signaling adaptor proteins, DAP12 and DAP10. CD300H is expressed on CD16(+) monocytes and myeloid dendritic cells. Ligation of CD300H on CD16(+) monocytes and myeloid dendritic cells with anti-CD300H monoclonal antibody induced the production of neutrophil chemoattractants. Interestingly, CD300H expression varied among healthy subjects, who could be classified into two groups according to "positive" and "negative" expression. Genomic sequence analysis revealed a single-nucleotide substitution (rs905709 (G -> A)) at a splice donor site on intron 1 on either one or both alleles. The International HapMap Project database has demonstrated that homozygosity for the A allele of single nucleotide polymorphism (SNP) rs905709 ("negative" expression) is highly frequent in Han Chinese in Beijing, Japanese in Tokyo, and Europeans (A/A genotype frequencies 0.349, 0.167, and 0.138, respectively) but extremely rare in Sub-Saharan African populations. Together, these results suggest that CD300H may play an important role in innate immunity, at least in populations that carry the G/G or G/A genotype of CD300H.	[Niizuma, Kouta; Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance TARA, Tsukuba, Ibaraki 3058575, Japan; [Tahara-Hanaoka, Satoko; Noguchi, Emiko; Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, CREST, Tsukuba, Ibaraki 3058575, Japan; [Niizuma, Kouta] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba	Tahara-Hanaoka, S (corresponding author), Univ Tsukuba, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tokothr@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15K15659, 15J08253] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Can I, 2008, J IMMUNOL, V180, P207, DOI 10.4049/jimmunol.180.1.207; Can I, 2008, HYBRIDOMA, V27, P59, DOI 10.1089/hyb.2007.0534; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Comas-Casellas E, 2012, J BIOL CHEM, V287, P9682, DOI 10.1074/jbc.M111.279224; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Frankenberger M, 2013, IMMUNOBIOLOGY, V218, P169, DOI 10.1016/j.imbio.2012.02.013; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Moshkovits I, 2014, MUCOSAL IMMUNOL, V7, P292, DOI 10.1038/mi.2013.47; Nakahashi C, 2007, J IMMUNOL, V178, P765, DOI 10.4049/jimmunol.178.2.765; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Nakano T, 2008, MOL IMMUNOL, V45, P289, DOI 10.1016/j.molimm.2007.04.011; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Phongsisay V, 2014, MOL IMMUNOL, V62, P169, DOI 10.1016/j.molimm.2014.06.012; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shibuya Akira, 2009, Immune Netw, V9, P41, DOI 10.4110/in.2009.9.2.41; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2012, J IMMUNOL, V189, P1773, DOI 10.4049/jimmunol.1201139; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhou YH, 1998, J IMMUNOL, V160, P4018; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22298	22308		10.1074/jbc.M115.643361	http://dx.doi.org/10.1074/jbc.M115.643361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26221034	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000360968500045
J	Sathe, L; Bolinger, C; Amin-ul Mannan, M; Dever, TE; Dey, M				Sathe, Leena; Bolinger, Cheryl; Amin-ul Mannan, M.; Dever, Thomas E.; Dey, Madhusudan			Evidence That Base-pairing Interaction between Intron and mRNA Leader Sequences Inhibits Initiation of HAC1 mRNA Translation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; SECONDARY STRUCTURE; MECHANISM; HELICASE; INDUCTION; RIBOSOMES; LIGASE; ROLES	The Hac1 transcription factor in yeast up-regulates a collection of genes that control protein homeostasis. Base-pairing interactions between sequences in the intron and the 5'-untranslated region (5' UTR) of the HAC1 mRNA represses Hac1 protein production under basal conditions, whereas cytoplasmic splicing of the intron by the Ire1 kinase-endonuclease, activated under endoplasmic reticulum stress conditions, relieves the inhibition and enables Hac1 synthesis. Using a random mutational screen as well as site-directed mutagenesis, we identify point mutations within the 5' UTR-intron interaction site that derepress translation of the unspliced HAC1 mRNA. We also show that insertion of an in-frame AUG start codon upstream of the interaction site releases the translational block, demonstrating that an elongating ribosome can disrupt the interaction. Moreover, overexpression of translation initiation factor eIF4A, a helicase, enhances production of Hac1 from an mRNA containing an upstream AUG start codon at the beginning of the base-paired region. These results suggest that the major block of translation occurs at the initiation stage. Supporting this interpretation, the point mutations that enhanced Hac1 production resulted in an increased percentage of the HAC1 mRNA associating with polysomes versus free ribosomal subunits. Thus, our results provide evidence that the 5' UTR-intron interaction represses translation initiation on the unspliced HAC1 mRNA.	[Sathe, Leena; Amin-ul Mannan, M.; Dey, Madhusudan] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA; [Bolinger, Cheryl; Dever, Thomas E.] Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD 20892 USA	University of Wisconsin System; University of Wisconsin Milwaukee; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dever, TE (corresponding author), NIH, Bldg 6,Rm 228,6 Ctr Dr, Bethesda, MD 20892 USA.	tdever@nih.gov; deym@uwm.edu	Dever, Thomas/GSE-0966-2022; Mannan, Mohammad Amin-ul/AAT-6203-2021; Regan, Clinton/E-6250-2012	Mannan, Mohammad Amin-ul/0000-0001-7484-6736; Dever, Thomas/0000-0001-7120-9678	National Institutes of Health (NIH) [1R15GM101575-01]; Intramural Research Program of the NIH (NICHD); Research Growth Initiative (UW-Milwaukee Graduate School); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research Growth Initiative (UW-Milwaukee Graduate School); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants 1R15GM101575-01 (to M. D.) and by the Intramural Research Program of the N<INF>I</INF>H (NICHD; to T. E. D.). This work was also supported by Research Growth Initiative (UW-Milwaukee Graduate School; to M. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Amin-ul Mannan M, 2013, J MOL BIOL, V425, P2083, DOI 10.1016/j.jmb.2013.02.036; Anshu A, 2015, MOL CELL BIOL, V35, P199, DOI 10.1128/MCB.00981-14; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Gebauer F, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012245; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hooks KB, 2011, RNA BIOL, V8, P552, DOI 10.4161/rna.8.4.15396; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1991, GENE EXPRESSION, V1, P111; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhou FJ, 2014, J BIOL CHEM, V289, P1704, DOI 10.1074/jbc.M113.529370	47	19	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21821	21832		10.1074/jbc.M115.649335	http://dx.doi.org/10.1074/jbc.M115.649335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26175153	hybrid, Green Published			2022-12-28	WOS:000360968500005
J	Sorensen, TH; Cruys-Bagger, N; Borch, K; Westh, P				Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Borch, Kim; Westh, Peter			Free Energy Diagram for the Heterogeneous Enzymatic Hydrolysis of Glycosidic Bonds in Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; TRICHODERMA-REESEI; CELLOBIOHYDROLASE-I; TRANSITION-STATE; MICROCRYSTALLINE CELLULOSE; PROCESSIVE CELLULASES; TRANSLATIONAL ENTROPY; INSOLUBLE CELLULOSE; SUBSTRATE AFFINITY; ENZYMES	Kinetic and thermodynamic data have been analyzed according to transition state theory and a simplified reaction scheme for the enzymatic hydrolysis of insoluble cellulose. For the cellobiohydrolase Cel7A from Hypocrea jecorina (Trichoderma reesei), we were able to measure or collect relevant values for all stable and activated complexes defined by the reaction scheme and hence propose a free energy diagram for the full heterogeneous process. For other Cel7A enzymes, including variants with and without carbohydrate binding module (CBM), we obtained activation parameters for the association and dissociation of the enzyme-substrate complex. The results showed that the kinetics of enzyme-substrate association (i.e. formation of the Michaelis complex) was almost entirely entropy-controlled and that the activation entropy corresponded approximately to the loss of translational and rotational degrees of freedom of the dissolved enzyme. This implied that the transition state occurred early in the path where the enzyme has lost these degrees of freedom but not yet established extensive contact interactions in the binding tunnel. For dissociation, a similar analysis suggested that the transition state was late in the path where most enzyme-substrate contacts were broken. Activation enthalpies revealed that the rate of dissociation was far more temperature-sensitive than the rates of both association and the inner catalytic cycle. Comparisons of one-and two-domain variants showed that the CBM had no influence on the transition state for association but increased the free energy barrier for dissociation. Hence, the CBM appeared to promote the stability of the complex by delaying dissociation rather than accelerating association.	[Sorensen, Trine Holst; Cruys-Bagger, Nicolaj; Westh, Peter] Roskilde Univ, NSM, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, NSM, Res Unit Funct Biomat, 1 Univ Svej,Bldg 28, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Westh, Peter/0000-0002-6185-0637; Sorensen, Trine Holst/0000-0002-2045-7580	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment [2104-07-0028, 11-116772]; Carlsberg Foundation [2013-01-0208]	Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment Grants 2104-07-0028 and 11-116772 (to P. W.) and by Carlsberg Foundation Grant 2013-01-0208 (to P. W.). Novozymes is a major enzyme-producing company.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Alsallaq R, 2007, BIOPHYS J, V92, P1486, DOI 10.1529/biophysj.106.096024; Amzel LM, 1997, PROTEINS, V28, P144; Anslyn E. V., 2004, MODERN PHYS ORGANIC; Barnett CB, 2011, J AM CHEM SOC, V133, P19474, DOI 10.1021/ja206842j; Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, BIOTECHNOL BIOENG, V109, P3199, DOI 10.1002/bit.24593; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Illanes A., 2013, PROBLEM SOLVING ENZY; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Laidler K J, 1979, Methods Enzymol, V63, P234; Li JH, 2010, J PHYS CHEM B, V114, P15261, DOI 10.1021/jp1064177; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Marx JC, 2007, MAR BIOTECHNOL, V9, P293, DOI 10.1007/s10126-006-6103-8; Maurer SA, 2012, IND ENG CHEM RES, V51, P11389, DOI 10.1021/ie3008538; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Medve J, 1997, APPL BIOCHEM BIOTECH, V66, P39, DOI 10.1007/BF02788806; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Murphy L, 2010, ENZYME MICROB TECH, V46, P141, DOI 10.1016/j.enzmictec.2009.09.009; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Pu JZ, 2006, CHEM REV, V106, P3140, DOI 10.1021/cr050308e; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Tewari YB, 2008, J CHEM THERMODYN, V40, P1517, DOI 10.1016/j.jct.2008.05.015; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; WEBER JP, 1980, J BIOL CHEM, V255, P9030; Wicki J, 2007, J AM CHEM SOC, V129, P4530, DOI 10.1021/ja0707254; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Withers SG, 2001, CARBOHYD POLYM, V44, P325, DOI 10.1016/S0144-8617(00)00249-6; YAMAMOTO K, 1974, J BIOCHEM-TOKYO, V76, P385, DOI 10.1093/oxfordjournals.jbchem.a130580; Yan SH, 2011, J PHYS CHEM B, V115, P4982, DOI 10.1021/jp200384m; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048	71	24	24	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22203	22211		10.1074/jbc.M115.659656	http://dx.doi.org/10.1074/jbc.M115.659656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26183776	hybrid, Green Published			2022-12-28	WOS:000360968500037
J	Xu, GF; Shang, D; Zhang, ZP; Shaw, TS; Ran, YL; Lopez, JA; Peng, YD				Xu, Guofeng; Shang, Dan; Zhang, Zuping; Shaw, Tanner S.; Ran, Yali; Lopez, Jose A.; Peng, Yuandong			The Transmembrane Domains of beta and IX Subunits Mediate the Localization of the Platelet Glycoprotein Ib-IX Complex to the Glycosphingolipid-enriched Membrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; BERNARD-SOULIER-SYNDROME; RECEPTOR GAMMA-CHAIN; LIPID RAFTS; V COMPLEX; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; ALPHA; ACTIVATION; BINDING	We have previously reported that the structural elements of the GP Ib-IX complex required for its localization to glycosphingolipid- enriched membranes (GEMs) reside in the Ib beta and IX subunits. To identify them, we generated a series of cell lines expressing mutant GP Ib beta and GP IX where 1) the cytoplasmic tails (CTs) of either or both GP Ib beta and IX are truncated, and 2) the transmembrane domains (TMDs) of GP Ib beta and GP IX were swapped with the TMD of a non-GEMs associating molecule, human transferrin receptor. Sucrose density fractionation analysis showed that the removal of either or both of the CTs from GP Ib beta and GP IX does not alter GP Ib beta-GEMs association when compared with the wild type. In contrast, swapping of the TMDs of either GP Ib beta or GP IX with that of transferrin receptor results in a significant loss (similar to 50%) of GP Ib beta from the low density GEMs fractions, with the largest effect seen in the dual TMD-replaced cells (>80% loss) when compared with the wild type cells (100% of GP Ib beta present in the GEMs fractions). Under high shear flow, the TMD-swapped cells adhere poorly to a von Willebrand factor-immobilized surface to a much lesser extent than the previously reported disulfide linkage dysfunctional GP Ib beta-expressing cells. Thus, our data demonstrate that the bundle of GP Ib beta and GP IX TMDs instead of their individual CTs is the structural element that mediates the beta/IX complex localization to the membrane GEMs, which through the alpha/beta disulfide linkage brings GP Ib beta into the GEMs.	[Xu, Guofeng] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Shanghai 200092, Peoples R China; [Shang, Dan] Huazhong Univ Sci & Technol, Dept Vasc Surg, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Zhang, Zuping] Cent S Univ, Sch Basic Med, Changsha 410013, Hunan, Peoples R China; [Lopez, Jose A.] Univ Washington, Dept Med, Puget Sound Blood Ctr, Div Hematol, Seattle, WA 98195 USA; [Xu, Guofeng; Shang, Dan; Zhang, Zuping; Shaw, Tanner S.; Ran, Yali; Peng, Yuandong] Baylor Coll Med, Dept Med, Cardiovasc Res Sect, Houston, TX 77030 USA	Shanghai Jiao Tong University; Huazhong University of Science & Technology; Central South University; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Baylor College of Medicine	Peng, YD (corresponding author), Baylor Coll Med, Dept Med, One Baylor Plaza,Alkek N1317-06, Houston, TX 77030 USA.	Yuandong@bcm.edu		Zhang, Zuping/0000-0002-3295-2861	American Heart Association [0635155N]; National Institute of Health [HL095676]; Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095676] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by American Heart Association Scientist Development Grant 0635155N (to Y. P.), National Institute of Health Grant HL095676 (to Y. P.), and funds from the Alkek Endowment Fund (to Y. P.) and the Fondren Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Andrews RK, 2001, BLOOD, V98, P681, DOI 10.1182/blood.V98.3.681; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen ZZ, 2008, BIOPHYS J, V95, P1303, DOI 10.1529/biophysj.108.132324; DU XP, 1994, J BIOL CHEM, V269, P18287; DU XP, 1987, BLOOD, V69, P1524; Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656; Fredrickson BJ, 1998, BLOOD, V92, P3684, DOI 10.1182/blood.V92.10.3684.422k39_3684_3693; Geng HQ, 2011, J BIOL CHEM, V286, P21315, DOI 10.1074/jbc.M110.202549; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Jin W, 2007, J THROMB HAEMOST, V5, P1034, DOI 10.1111/j.1538-7836.2007.02476.x; Kasirer-Friede A, 2002, J BIOL CHEM, V277, P11949, DOI 10.1074/jbc.M108727200; Li R, 2013, J THROMB HAEMOST, V11, P605, DOI 10.1111/jth.12144; LOPEZ JA, 1995, BLOOD, V85, P1254, DOI 10.1182/blood.V85.5.1254.bloodjournal8551254; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Lou JZ, 2008, P NATL ACAD SCI USA, V105, P13847, DOI 10.1073/pnas.0801965105; McEwan PA, 2011, BLOOD, V118, P5292, DOI 10.1182/blood-2011-05-356253; Mo X, 2009, J THROMB HAEMOST, V7, P1533, DOI 10.1111/j.1538-7836.2009.03536.x; Mo X, 2008, FEBS LETT, V582, P3270, DOI 10.1016/j.febslet.2008.08.036; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; Mo X, 2010, J BIOL CHEM, V285, P32096, DOI 10.1074/jbc.M110.111864; Mu FT, 2010, J THROMB HAEMOST, V8, P324, DOI 10.1111/j.1538-7836.2009.03672.x; Peng YD, 2005, BLOOD, V106, P1982, DOI 10.1182/blood-2005-02-0514; Peng YD, 2004, BLOOD, V104, P3971, DOI 10.1182/blood-2004-07-2544; PERSCHL A, 1995, J CELL SCI, V108, P1033; Pradhan S, 2013, J THROMB HAEMOST, V11, P1612, DOI 10.1111/jth.12329; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shen Y, 2006, J BIOL CHEM, V281, P26419, DOI 10.1074/jbc.M604296200; Shrimpton CN, 2002, J EXP MED, V196, P1057, DOI 10.1084/jem.20020143; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; van der Wal DE, 2010, THROMB HAEMOSTASIS, V103, P1033, DOI 10.1160/TH09-11-0751; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Wu Y, 2001, BLOOD, V97, P3836, DOI 10.1182/blood.V97.12.3836; Zhang W, 2015, BLOOD, V125, P562, DOI 10.1182/blood-2014-07-589507; Zhou L, 2014, J THROMB HAEMOST, V12, P82, DOI 10.1111/jth.12437	38	2	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22155	22162		10.1074/jbc.M115.668145	http://dx.doi.org/10.1074/jbc.M115.668145			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203189	Green Published, hybrid			2022-12-28	WOS:000360968500032
J	Cao, Y; Zhang, SP; Yuan, N; Wang, J; Li, X; Xu, F; Lin, WW; Song, L; Fang, YX; Wang, ZJ; Wang, Z; Zhang, H; Zhang, Y; Zhao, WL; Hu, SY; Zhang, XG; Wang, JR				Cao, Yan; Zhang, Suping; Yuan, Na; Wang, Jian; Li, Xin; Xu, Fei; Lin, Weiwei; Song, Lin; Fang, Yixuan; Wang, Zhijian; Wang, Zhen; Zhang, Han; Zhang, Yi; Zhao, Wenli; Hu, Shaoyan; Zhang, Xueguang; Wang, Jianrong			Hierarchal Autophagic Divergence of Hematopoietic System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES LIPID-METABOLISM; MESENCHYMAL STEM-CELLS; BASAL AUTOPHAGY; IN-VIVO; DIFFERENTIATION; MAINTENANCE; MICE; GENE; MITOCHONDRIA; EXPRESSION	Autophagy is integral to hematopoiesis and protects against leukemogenesis. However, the fundamentals of the required molecular machinery have yet to be fully explored. Using conditional mouse models to create strategic defects in the hematopoietic hierarchy, we have shown that recovery capacities in stem cells and somatic cells differ if autophagy is impaired or flawed. An in vivo Atg7 deletion in hematopoietic stem cells completely ablates the autophagic response, leading to irreversible and ultimately lethal hematopoiesis. However, while no adverse phenotype is manifested in vivo by Atg7-deficient myeloid cells, they maintain active autophagy that is sensitive to brefeldin A, an inhibitor targeting Golgi-derived membranes destined for autophagosome formation in alternative autophagy. Removing Rab9, a key regulatory protein, in alternative autophagy, disables autophagy altogether in Atg7-deficient macrophages. Functional analysis indicates that ATG7-dependent canonical autophagy is physiologically active in both hematopoietic stem cells and in terminally differentiated hematopoietic cells; however, only terminally differentiated cells such as macrophages are rescued by alternative autophagy if canonical autophagy is ineffective. Thus, it appears that hematopoietic stem cells rely solely on ATG7-dependent canonical autophagy, whereas terminally differentiated or somatic cells are capable of alternative autophagy in the event that ATG7-mediated autophagy is dysfunctional. These findings offer new insight into the transformational trajectory of hematopoietic stem cells, which in our view renders the autophagic machinery in stem cells more vulnerable to disruption.	[Cao, Yan; Zhang, Suping; Yuan, Na; Wang, Jian; Li, Xin; Xu, Fei; Lin, Weiwei; Song, Lin; Fang, Yixuan; Wang, Zhijian; Wang, Zhen; Zhang, Han; Zhang, Yi; Zhao, Wenli; Hu, Shaoyan; Zhang, Xueguang; Wang, Jianrong] Soochow Univ, Affiliated Childrens Hosp, Collaborat Innovat Ctr Hematol,Jiangsu Key Lab S, Sch Med,Jiangsu Inst Hematol,Hematol Ctr,Cyrus Ta, Suzhou 215123, Peoples R China	Soochow University - China	Wang, JR (corresponding author), Soochow Univ, Hematol Ctr, Sch Med, Cyrus Tang Med Inst, 199 Renai Rd, Suzhou 215123, Peoples R China.	jrwang@suda.edu.cn	wang, jie/GRS-0942-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [31071258, 81272336, 31271526, 31201073]; Ministry of Science and Technology of China [2011CB512101]; Department of Science and Technology of Jiangsu Province of China [BK20130333]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (No.31071258, No.81272336, No.31271526, and No.31201073), The Ministry of Science and Technology of China (No. 2011CB512101), The Department of Science and Technology of Jiangsu Province of China (No. BK20130333), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cao Y, 2015, STEM CELLS DEV, V24, P2660, DOI 10.1089/scd.2015.0176; Cao Y, 2015, EXP HEMATOL, V43, P488, DOI 10.1016/j.exphem.2015.01.001; Cao Y, 2015, EXP HEMATOL, V43, P229, DOI 10.1016/j.exphem.2014.11.002; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Lee Y, 2013, J CELL BIOCHEM, V114, P79, DOI 10.1002/jcb.24303; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124; Pan HZ, 2013, EMBO MOL MED, V5, P327, DOI 10.1002/emmm.201201999; Sanchez-Aguilera A, 2011, P NATL ACAD SCI USA, V108, P9607, DOI 10.1073/pnas.1102018108; Seino J, 2013, J BIOL CHEM, V288, P26898, DOI 10.1074/jbc.M113.464503; Shimizu S, 2010, AUTOPHAGY, V6, P290, DOI 10.4161/auto.6.2.11127; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tra T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027485; Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	43	21	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23050	23063		10.1074/jbc.M115.650028	http://dx.doi.org/10.1074/jbc.M115.650028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26245898	hybrid, Green Published			2022-12-28	WOS:000361685500019
J	Nijaguna, MB; Patil, V; Urbach, S; Shwetha, SD; Sravani, K; Hegde, AS; Chandramouli, BA; Arivazhagan, A; Marin, P; Santosh, V; Somasundaram, K				Nijaguna, Mamatha Bangalore; Patil, Vikas; Urbach, Serge; Shwetha, Shivayogi D.; Sravani, Kotha; Hegde, Alangar S.; Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan; Marin, Philippe; Santosh, Vani; Somasundaram, Kumaravel			Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; POSSIBLE INVOLVEMENT; FACTOR-I; CANCER; PROGRESSION; EXPRESSION; SURVIVAL; MICROENVIRONMENT; CYTOKINE; CELLS	Glioblastoma (grade IV glioma/GBM) is the most common primary adult malignant brain tumor with poor prognosis. To characterize molecular determinants of tumor-stroma interaction in GBM, we profiled 48 serum cytokines and identified macrophage colony-stimulating factor (MCSF) as one of the elevated cytokines in sera from GBM patients. Both MCSF transcript and protein were up-regulated in GBM tissue samples through a spleen tyrosine kinase (SYK)-dependent activation of the PI3K-NF kappa B pathway. Ectopic overexpression and silencing experiments revealed that glioma-secreted MCSF has no role in autocrine functions and M2 polarization of macrophages. In contrast, silencing expression of MCSF in glioma cells prevented tube formation of human umbilical vein endothelial cells elicited by the supernatant from monocytes/microglial cells treated with conditioned medium from glioma cells. Quantitative proteomics based on stable isotope labeling by amino acids in cell culture showed that glioma-derived MCSF induces changes in microglial secretome and identified insulin-like growth factor-binding protein 1 (IGFBP1) as one of the MCSF-regulated proteins secreted by microglia. Silencing IGFBP1 expression in microglial cells or its neutralization by an antibody reduced the ability of supernatants derived from microglial cells treated with glioma cell-conditioned medium to induce angiogenesis. In conclusion, this study shows up-regulation of MCSF in GBM via a SYK-PI3K-NF kappa B-dependent mechanism and identifies IGFBP1 released by microglial cells as a novel mediator of MCSF-induced angiogenesis, of potential interest for developing targeted therapy to prevent GBM progression.	[Nijaguna, Mamatha Bangalore; Patil, Vikas; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Urbach, Serge; Marin, Philippe] CNRS UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France; [Urbach, Serge; Marin, Philippe] INSERM U1191, F-34094 Montpellier, France; [Urbach, Serge; Marin, Philippe] Univ Montpellier, F-34094 Montpellier, France; [Shwetha, Shivayogi D.; Sravani, Kotha] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Hegde, Alangar S.] Sri Satya Sai Inst Higher Med Sci, Bangalore 560066, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Indian Institute of Science and the Department of Biotechnology; CNRS; INSERM; la Fondation pour la Recherche Medicale (Equipe FRM); la Region Languedoc-Roussillon; Department of Biotechnology, Government of India; J. C. Bose Fellow of the Department of Science and Technology	Indian Institute of Science and the Department of Biotechnology; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); la Region Languedoc-Roussillon(Region Occitanie); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); J. C. Bose Fellow of the Department of Science and Technology	Supported by a fellowship from the Indian Institute of Science and the Department of Biotechnology.; Supported by grants from CNRS, INSERM, la Fondation pour la Recherche Medicale (Equipe FRM 2009), and la Region Languedoc-Roussillon.; Supported by the Department of Biotechnology, Government of India; a J. C. Bose Fellow of the Department of Science and Technology.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; ALTERMAN RL, 1994, MOL CHEM NEUROPATHOL, V21, P177, DOI 10.1007/BF02815350; Arimappamagan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062042; Badie B, 2001, MICROSC RES TECHNIQ, V54, P106, DOI 10.1002/jemt.1125; Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; BRUGGER W, 1991, J LEUKOCYTE BIOL, V49, P483, DOI 10.1002/jlb.49.5.483; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen LF, 2013, CANCER CELL, V23, P826, DOI 10.1016/j.ccr.2013.05.002; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Chuang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095180; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; Fiedler LR, 2009, BIOCHEM SOC T, V37, P1243, DOI 10.1042/BST0371243; Gadducci A, 1998, GYNECOL ONCOL, V70, P111, DOI 10.1006/gyno.1998.4259; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gutmann DH, 2015, NEURO-ONCOLOGY, V17, P171, DOI 10.1093/neuonc/nou346; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Hao CH, 2002, ACTA NEUROPATHOL, V103, P171; Hatton O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042610; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Kogan M, 2012, DNA CELL BIOL, V31, P279, DOI 10.1089/dna.2011.1357; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Krisenko MO, 2015, BBA-MOL CELL RES, V1853, P254, DOI 10.1016/j.bbamcr.2014.10.022; Lee OH, 2000, BRIT J CANCER, V82, P385; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leu JIJ, 2007, GENE DEV, V21, P3095, DOI 10.1101/gad.1567107; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mattern Ralph-Heiko, 2005, Cancer Ther, V3A, P325; Menke J, 2012, CANCER RES, V72, P187, DOI 10.1158/0008-5472.CAN-11-1232; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nash GF, 2001, LANCET ONCOL, V2, P608, DOI 10.1016/S1470-2045(01)00518-6; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Steuerwald NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081974; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Thouvenot E, 2008, J PROTEOME RES, V7, P4409, DOI 10.1021/pr8003858; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006	65	54	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23401	23415		10.1074/jbc.M115.664037	http://dx.doi.org/10.1074/jbc.M115.664037			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26245897	Green Published, hybrid			2022-12-28	WOS:000361685500045
J	Arora, K; Cheng, J; Nichols, RA				Arora, Komal; Cheng, Justin; Nichols, Robert A.			Nicotinic Acetylcholine Receptors Sensitize a MAPK-linked Toxicity Pathway on Prolonged Exposure to beta-Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); c-Jun N-terminal kinase (JNK); extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); nicotinic acetylcholine receptors (nAChR)	N-TERMINAL KINASE; HIPPOCAMPAL SLICE CULTURES; ALZHEIMERS-DISEASE; PROTEIN-KINASE; FYN-KINASE; MOUSE MODEL; IN-VIVO; INDUCED PHOSPHORYLATION; INDUCED NEUROTOXICITY; SYNAPTIC DYSFUNCTION	Background: Signaling pathways involved in the sensitization by target receptors of -amyloid-triggered neurotoxicity have not been identified. Results: Exposure to -amyloid in the presence of nicotinic receptors led to ERK activation followed by JNK activation and increased PHF-tau. Conclusion: -amyloid neurotoxicity entails activation of discrete intracellular signaling pathways. Significance: Activation of select signaling pathways by -amyloid may be an early event in Alzheimer disease. Among putative downstream synaptic targets of -amyloid (A) are signaling molecules involved in synaptic function, memory formation and cognition, such as the MAP kinases, MKPs, CaMKII, CREB, Fyn, and Tau. Here, we assessed the activation and interaction of signaling pathways upon prolonged exposure to A in model nerve cells expressing nicotinic acetylcholine receptors (nAChRs). Our goal was to characterize the steps underlying sensitization of the nerve cells to neurotoxicity when A-target receptors are present. Of particular focus was the connection of the activated signaling molecules to oxidative stress. Differentiated neuroblastoma cells expressing mouse 42-nAChRs were exposed to A(1-42) for intervals from 30 min to 3 days. The cells and cell-derived protein extracts were then probed for activation of signaling pathway molecules (ERK, JNK, CaMKII, CREB, MARCKS, Fyn, tau). Our results show substantial, progressive activation of ERK in response to nanomolar A exposure, starting at the earliest time point. Increased ERK activation was followed by JNK activation as well as an increased expression of PHF-tau, paralleled by increased levels of reactive oxygen species (ROS). The impact of prolonged A on the levels of pERK, pJNK, and ROS was attenuated by MEK-selective and JNK-selective inhibitors. In addition, the MEK inhibitor as well as a JNK inhibitor attenuated A-induced nuclear fragmentation, which followed the changes in ROS levels. These results demonstrate that the presence of nAChRs sensitizes neurons to the neurotoxic action of A through the timed activation of discrete intracellular signaling molecules, suggesting pathways involved in the early stages of Alzheimer disease.	[Arora, Komal; Cheng, Justin; Nichols, Robert A.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa	Nichols, RA (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	robert.nichols@hawaii.edu			Hawaii Community Foundation [09ADVC-45413]; National Institute on Aging [AG21586]; National Institute for General Medical Sciences [P20 GM103466]; National Institute on Minority Health and Health Disparities [G12MD007601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER	Hawaii Community Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants (to R. A. N.) from the Hawaii Community Foundation (09ADVC-45413), the National Institute on Aging (AG21586) and the National Institute for General Medical Sciences (P20 GM103466). Additional support for the microscopy core at the University of Hawaii was provided by a Research Center for Minority Institutions grant from the National Institute on Minority Health and Health Disparities (G12MD007601). The authors declare that they have no conflicts of interest with the contents of this article.	Arora K, 2013, J BIOL CHEM, V288, P11175, DOI 10.1074/jbc.M113.453746; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Balleza-Tapia H, 2009, MINI-REV MED CHEM, V9, P724, DOI 10.2174/138955709788452784; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Blum S, 1999, J NEUROSCI, V19, P3535; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Ferrer I, 2001, BRAIN PATHOL, V11, P144; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Gubbins EJ, 2010, BRAIN RES, V1328, P1, DOI 10.1016/j.brainres.2010.02.083; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Liao DZ, 2014, EUR J NEUROSCI, V39, P1202, DOI 10.1111/ejn.12504; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; LU Q, 1993, J NEUROSCI RES, V35, P439, DOI 10.1002/jnr.490350411; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nakayama H, 2001, J NEUROCHEM, V79, P489, DOI 10.1046/j.1471-4159.2001.00602.x; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pei JJ, 2001, J ALZHEIMERS DIS, V3, P41, DOI 10.3233/JAD-2001-3107; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Rapoport M, 2000, J NEUROCHEM, V74, P125, DOI 10.1046/j.1471-4159.2000.0740125.x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Schafe GE, 1999, LEARN MEMORY, V6, P97; Sclip A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.559; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Sherrin T, 2010, J NEUROSCI, V30, P13348, DOI 10.1523/JNEUROSCI.3492-10.2010; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; Steiner RC, 2007, J NEUROCHEM, V103, P666, DOI 10.1111/j.1471-4159.2007.04799.x; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Yang K, 2011, J ALZHEIMERS DIS, V27, P243, DOI 10.3233/JAD-2011-110353; Yao MZ, 2005, J NEUROSCI, V25, P1149, DOI 10.1523/JNEUROSCI.4736-04.2005; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	53	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21409	21420		10.1074/jbc.M114.634162	http://dx.doi.org/10.1074/jbc.M114.634162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26139609	Green Published, hybrid			2022-12-28	WOS:000360637600018
J	Lee, JH; Lee, YK; Lim, JJ; Byun, HO; Park, I; Kim, GH; Xu, WG; Wang, HJ; Yoon, G				Lee, Jong-Hyuk; Lee, Young-Kyoung; Lim, Jin J.; Byun, Hae-Ok; Park, Imkyong; Kim, Gyeong-Hyeon; Xu, Wei Guang; Wang, Hee-Jung; Yoon, Gyesoon			Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; heat shock factor protein 1 (HSF1); hepatocellular carcinoma; mitochondrial respiratory chain complex; reactive oxygen species (ROS)	HUMAN GASTRIC-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR-1; OXIDATIVE STRESS; TUMOR-CELLS; MUTATIONS; METABOLISM; GENOME; HSF1	Background: Increased claudin-1 (Cln-1) expression in human hepatoma cells with mitochondrial defects leads to high tumor cell invasiveness. Results: Cln-1-mediated hepatoma cell invasiveness occurs via heat shock factor 1 (HSF1) activation. Conclusion: The mitochondrial defect-ROS-HSF1 axis controls hepatoma cell invasiveness. Significance: HSF1 is a key mitochondrial retrograde-responsive transcription factor controlling hepatoma cell invasiveness. Although mitochondrial dysfunction has been implicated in tumor metastasis, it is unclear how it regulates tumor cell aggressiveness. We have reported previously that human hepatoma cells harboring mitochondrial defects have high tumor cell invasion activity via increased claudin-1 (Cln-1) expression. In this study, we demonstrated that mitochondrial respiratory defects induced Cln-1 transcription via reactive oxygen species (ROS)-mediated heat shock factor 1 (HSF1) activation, which contributed to hepatoma invasiveness. We first confirmed the inverse relationship between mitochondrial defects and Cln-1 induction in SNU hepatoma cells and hepatocellular carcinoma tissues. We then examined five different respiratory complex inhibitors, and complex I inhibition by rotenone most effectively induced Cln-1 at the transcriptional level. Rotenone increased both mitochondrial and cytosolic ROS. In addition, rotenone-induced Cln-1 expression was attenuated by N-acetylcysteine, an antioxidant, and exogenous H2O2 treatment was enough to increase Cln-1 transcription, implying the involvement of ROS. Next we found that ROS-mediated HSF1 activation via hyperphosphorylation was the key event for Cln-1 transcription. Moreover, the Cln-1 promoter region (from -529 to +53) possesses several HSF1 binding elements, and this region showed increased promoter activity and HSF1 binding affinity in response to rotenone treatment. Finally, we demonstrated that the invasion activity of SNU449 cells, which harbor mitochondrial defects, was blocked by siRNA-mediated HSF1 knockdown. Taken together, these results indicate that mitochondrial respiratory defects enhance Cln-1-mediated hepatoma cell invasiveness via mitochondrial ROS-mediated HSF1 activation, presenting a potential role for HSF1 as a novel mitochondrial retrograde signal-responsive transcription factor to control hepatoma cell invasiveness.	[Lee, Jong-Hyuk; Lee, Young-Kyoung; Lim, Jin J.; Byun, Hae-Ok; Park, Imkyong; Kim, Gyeong-Hyeon; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 443380, South Korea; [Xu, Wei Guang; Wang, Hee-Jung] Ajou Univ, Sch Med, Dept Surg, Suwon 443380, South Korea; [Lee, Jong-Hyuk; Lee, Young-Kyoung; Lim, Jin J.; Byun, Hae-Ok; Park, Imkyong; Kim, Gyeong-Hyeon; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 443380, South Korea	Ajou University; Ajou University; Ajou University	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 443721, South Korea.	ypeace@ajou.ac.kr		LIM, Jin J./0000-0003-0616-5183	National Research Foundation of Korea - Korean government (MSIP) [NRF-2012R1A5A2048183, NRF-2012R1A2A2A01043185]	National Research Foundation of Korea - Korean government (MSIP)	This work was supported by National Research Foundation of Korea Grants NRF-2012R1A5A2048183 and NRF-2012R1A2A2A01043185 funded by the Korean government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Chang CJ, 2009, CELL MOL LIFE SCI, V66, P1755, DOI 10.1007/s00018-009-8767-5; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guaragnella N, 2014, BIOCHEM PHARMACOL, V92, P62, DOI 10.1016/j.bcp.2014.07.027; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061677; Hengstler JG, 2008, ARCH TOXICOL, V82, P271, DOI 10.1007/s00204-008-0305-y; Hoevel T, 2002, J CELL PHYSIOL, V191, P60, DOI 10.1002/jcp.10076; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Hung WY, 2010, BBA-GEN SUBJECTS, V1800, P264, DOI 10.1016/j.bbagen.2009.06.006; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; Lee HW, 2014, ANAL CHEM, V86, P10001, DOI 10.1021/ac5031013; Lee YK, 2013, MOL CELLS, V35, P489, DOI 10.1007/s10059-013-2343-4; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069485; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Michl P, 2003, CANCER RES, V63, P6265; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nishikawa M, 2001, CANCER RES, V61, P1843; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Singh AK, 2014, MITOCHONDR DNA, V25, P329, DOI 10.3109/19401736.2013.796520; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007538; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189; Yu JS, 2011, MOL CELLS, V31, P327, DOI 10.1007/s10059-011-0041-7	50	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21421	21431		10.1074/jbc.M115.654913	http://dx.doi.org/10.1074/jbc.M115.654913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26157141	hybrid, Green Published			2022-12-28	WOS:000360637600019
J	Parker, WH; Qu, ZC; May, JM				Parker, William H.; Qu, Zhi-chao; May, James M.			Intracellular Ascorbate Prevents Endothelial Barrier Permeabilization by Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cyclic AMP (cAMP); cyclic GMP (cGMP); nitric oxide; Ras-related C3 botulinum toxin substrate 1 (Rac1); Ras-related protein 1 (Rap1); thrombin; ascorbate; endothelial permeability; paracellular transport	NITRIC-OXIDE SYNTHESIS; KINASE RHO-KINASE; VE-CADHERIN; CYCLIC-AMP; MICROVASCULAR PERMEABILITY; TYROSINE PHOSPHORYLATION; VASCULAR ENDOTHELIUM; ADENYLYL-CYCLASE; EXCHANGE FACTOR; PROTEIN-KINASE	Background: Vitamin C (ascorbate) promotes endothelial barrier stability during inflammation. Results: Ascorbate prevents inflammatory decreases in cAMP. Conclusion: cAMP preserves the cortical actin cytoskeleton and prevents stress fiber formation. Significance: Dietary vitamin C may promote vascular integrity in patients with inflammatory diseases. Intracellular ascorbate (vitamin C) has previously been shown to tighten the endothelial barrier and maintain barrier integrity during acute inflammation in vitro. However, the downstream effectors of ascorbate in the regulation of endothelial permeability remain unclear. In this study, we evaluated ascorbate as a mediator of thrombin-induced barrier permeabilization in human umbilical vein endothelial cells and their immortalized hybridoma line, EA.hy926. We found that the vitamin fully prevented increased permeability to the polysaccharide inulin by thrombin in a dose-dependent manner, and it took effect both before and after subjection to thrombin. Thrombin exposure consumed intracellular ascorbate but not the endogenous antioxidant GSH. Likewise, the antioxidants dithiothreitol and tempol did not reverse permeabilization. We identified a novel role for ascorbate in preserving cAMP during thrombin stimulation, resulting in two downstream effects. First, ascorbate maintained the cortical actin cytoskeleton in a Rap1- and Rac1-dependent manner, thus preserving stable adherens junctions between adjacent cells. Second, ascorbate prevented actin polymerization and formation of stress fibers by reducing the activation of RhoA and phosphorylation of myosin light chain. Although ascorbate and thrombin both required calcium for their respective effects, ascorbate did not prevent thrombin permeabilization by obstructing calcium influx. However, preservation of cAMP by ascorbate was found to depend on both the production of nitric oxide by endothelial nitric-oxide synthase, which ascorbate is known to activate, and the subsequent generation cGMP by guanylate cyclase. Together, these data implicate ascorbate in the prevention of inflammatory endothelial barrier permeabilization and explain the underlying signaling mechanism.	[Parker, William H.; Qu, Zhi-chao; May, James M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University	May, JM (corresponding author), Vanderbilt Univ, Sch Med, 7465 Med Res Bldg 4, Nashville, TN 37232 USA.	james.may@vanderbilt.edu	Regan, Clinton/E-6250-2012	Parker, William/0000-0003-3426-3709	National Institutes of Health [CA68485, DK20593, DK58404, DK59637, EY08126]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK050435, U24DK059637, P30DK020593, P60DK020593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Fiona Harrison for reading and editing the manuscript. Microscope image acquisition was performed in part through the use of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Bordignon B, 2013, BIOCHEM BIOPH RES CO, V439, P137, DOI 10.1016/j.bbrc.2013.08.004; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Doise JM, 2008, FUND CLIN PHARMACOL, V22, P203, DOI 10.1111/j.1472-8206.2008.00573.x; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Esser S, 1998, J CELL SCI, V111, P1853; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Falk MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-34; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Heller R, 1999, J BIOL CHEM, V274, P8254, DOI 10.1074/jbc.274.12.8254; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HUANG WQ, 1993, ENDOCRINOLOGY, V132, P2271, DOI 10.1210/en.132.5.2271; Jones W, 2002, FREE RADICAL BIO MED, V33, P83, DOI 10.1016/S0891-5849(02)00862-6; Kaya F, 2008, FEBS LETT, V582, P3614, DOI 10.1016/j.febslet.2008.09.040; Kim JE, 2010, J ENDOCRINOL, V207, P35, DOI 10.1677/JOE-10-0093; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lopez-Lluch G, 1998, BIOCHEM J, V331, P21, DOI 10.1042/bj3310021; May JM, 2013, ANTIOXID REDOX SIGN, V19, P2068, DOI 10.1089/ars.2013.5205; May JM, 2011, BIOCHEM BIOPH RES CO, V404, P701, DOI 10.1016/j.bbrc.2010.12.046; May JM, 2011, BIOFACTORS, V37, P46, DOI 10.1002/biof.134; May JM, 2010, FREE RADICAL RES, V44, P1359, DOI 10.3109/10715762.2010.508496; May JM, 2009, AM J PHYSIOL-CELL PH, V297, pC169, DOI 10.1152/ajpcell.00674.2008; May JM, 1998, ARCH BIOCHEM BIOPHYS, V349, P281, DOI 10.1006/abbi.1997.0473; Meredith ME, 2014, BIOCHEM BIOPH RES CO, V445, P30, DOI 10.1016/j.bbrc.2014.01.078; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Parker WH, 2015, BIOCHEM BIOPH RES CO, V458, P262, DOI 10.1016/j.bbrc.2015.01.096; PechAmsellem MA, 1996, EXPERIENTIA, V52, P234, DOI 10.1007/BF01920713; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Price KD, 2001, ATHEROSCLEROSIS, V158, P1, DOI 10.1016/S0021-9150(01)00569-X; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; THURSTON G, 1994, MICROVASC RES, V47, P1, DOI 10.1006/mvre.1994.1001; UTOGUCHI N, 1995, J CELL PHYSIOL, V163, P393, DOI 10.1002/jcp.1041630219; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; vanHinsbergh VWM, 1997, ARTERIOSCL THROM VAS, V17, P1018, DOI 10.1161/01.ATV.17.6.1018; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Voigt K, 2002, FREE RADICAL RES, V36, P735, DOI 10.1080/10715760290032557; Werthmann RC, 2009, J PHYSIOL-LONDON, V587, P4091, DOI 10.1113/jphysiol.2009.172957; YAMADA Y, 1990, ARTERIOSCLEROSIS, V10, P410, DOI 10.1161/01.ATV.10.3.410; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	57	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21486	21497		10.1074/jbc.M115.662098	http://dx.doi.org/10.1074/jbc.M115.662098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152729	hybrid, Green Published			2022-12-28	WOS:000360637600024
J	Zuo, RJ; Gu, XW; Qi, QR; Wang, TS; Zhao, XY; Liu, JL; Yang, ZM				Zuo, Ru-Juan; Gu, Xiao-Wei; Qi, Qian-Rong; Wang, Tong-Song; Zhao, Xu-Yu; Liu, Ji-Long; Yang, Zeng-Ming			Warburg-like Glycolysis and Lactate Shuttle in Mouse Decidua during Early Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; glycolysis; pregnancy; reproduction; Warburg effect; Warburg-like glycolysis; lactate flux; decidualization; Hif1; progesterone	PYRUVATE-KINASE M2; GLUCOSE TRANSPORTERS; HUMAN ENDOMETRIUM; RECEPTOR-ALPHA; EXPRESSION; UTERUS; DECIDUALIZATION; PROGESTERONE; METABOLISM; ESTROGEN	Background: Carbohydrate metabolism during decidualization is unknown. Results: Decidual cells undergo glycolysis upon progesterone signals, and the undifferentiated stromal cells consume lactate for proliferation. Inhibition of glycolysis or lactate flux could compromise decidual development. Conclusion: Warburg-like glycolysis and lactate communication play critical roles during decidualization. Significance: Our study will be valuable for understanding the mechanism underlying decidualization. Decidualization is an essential process of maternal endometrial stromal cells to support pregnancy. Although it is known that enhanced glucose influx is critical for decidualization, the underlying mechanism in regulating glucose metabolism in decidua remains insufficiently understood. Here, we demonstrate that aerobic glycolysis-related genes and factors are all substantially induced during decidualization, indicating the existence of Warburg-like glycolysis in decidua. In vitro, progesterone activates hypoxia-inducible factor 1 (Hif1) and c-Myc through Pi3k-Akt signaling pathway to maintain aerobic glycolysis in decidualizing cells. Knocking down of pyruvate kinase M2 (Pkm2) attenuates the induction of decidual marker gene. Decidual formation in vivo is also impaired by glycolysis inhibitor 3-bromopyruvate. Besides, lactate exporter monocarboxylate transporter 4 (Mct4) is induced in newly formed decidual cells, whereas lactate importer Mct1 and proliferation marker Ki-67 are complementarily located in the surrounding undifferentiated cells, which are supposed to consume lactate for proliferation. Hif1 activation is required for lactate-dependent proliferation of the undifferentiated cells. Inhibition of lactate flux leads to compromised decidualization and decelerated lactate-dependent proliferation. In summary, we reveal that Warburg-like glycolysis and local lactate shuttle are activated in decidua and play important roles for supporting early pregnancy.	[Zuo, Ru-Juan; Liu, Ji-Long; Yang, Zeng-Ming] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Gu, Xiao-Wei; Qi, Qian-Rong; Wang, Tong-Song; Zhao, Xu-Yu] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China	South China Agricultural University; Shantou University	Yang, ZM (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	zmyang@scau.edu.cn	Qi, Qian-Rong/AAV-7553-2020	Qi, Qian-Rong/0000-0003-0276-7187; Yang, Zeng-Ming/0000-0001-6775-0082; Zuo, Rujuan/0000-0003-3060-2179; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402, 2013CB910803]; National Natural Science Foundation of China [31271602, 31471397, 31272263]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China Grants 2011CB944402 and 2013CB910803) and National Natural Science Foundation of China (Grants 31271602, 31471397 and 31272263). The authors declare that they have no conflicts of interest with the contents of this article.	Bombail V, 2010, J CLIN ENDOCR METAB, V95, pE224, DOI 10.1210/jc.2010-0154; Cardaci S, 2012, CANCER RES, V72, P4526, DOI 10.1158/0008-5472.CAN-12-1741; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Daikoku T, 2003, J BIOL CHEM, V278, P7683, DOI 10.1074/jbc.M211390200; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Del Prete E, 2004, PHYSIOL BEHAV, V80, P489, DOI 10.1016/j.physbeh.2003.10.007; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Frolova A, 2009, ENDOCRINOLOGY, V150, P1512, DOI 10.1210/en.2008-1081; Frolova AI, 2011, MOL ENDOCRINOL, V25, P1444, DOI 10.1210/me.2011-0026; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Frolova AI, 2011, ENDOCRINOLOGY, V152, P2123, DOI 10.1210/en.2010-1266; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; HACKL H, 1973, ACTA OBSTET GYN SCAN, V52, P135, DOI 10.3109/00016347309158301; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jansen S, 2008, BIOL REPROD, V79, P84, DOI 10.1095/biolreprod.107.066811; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kim JY, 2009, J CLIN ENDOCR METAB, V94, P1416, DOI 10.1210/jc.2008-1612; Kim ST, 2009, BIOL REPROD, V81, P188, DOI 10.1095/biolreprod.108.072629; Kommagani R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003900; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MURDOCH RN, 1987, TERATOLOGY, V35, P169, DOI 10.1002/tera.1420350202; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Salama SA, 2014, J CLIN ENDOCR METAB, V99, P3790, DOI 10.1210/jc.2013-2639; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SURAN MAH, 1971, ACTA ENDOCRINOL-COP, V68, P805, DOI 10.1530/acta.0.0680805; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; von Wolff M, 2003, J CLIN ENDOCR METAB, V88, P3885, DOI 10.1210/jc.2002-021890; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	41	67	69	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21280	21291		10.1074/jbc.M115.656629	http://dx.doi.org/10.1074/jbc.M115.656629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26178372	Green Published, hybrid			2022-12-28	WOS:000360637600008
J	Chen, J; Guo, J; Yang, TH; Li, WT; Lamothe, SM; Kang, YD; Szendrey, JA; Zhang, ST				Chen, Jeffery; Guo, Jun; Yang, Tonghua; Li, Wentao; Lamothe, Shawn M.; Kang, Yudi; Szendrey, John A.; Zhang, Shetuan			Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; CELL-SURFACE GLYCOPROTEINS; TRANS-GOLGI NETWORK; POTASSIUM CHANNELS; I-KR; CARDIAC-ARRHYTHMIA; ENDOCYTIC DEGRADATION; MEMBRANE-TRANSPORT; EXTRACELLULAR K+; RAB GTPASES	The human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel (I-Kr). Areduction in the hERG current causes long QT syndrome, which predisposes affected individuals to ventricular arrhythmias and sudden death. We reported previously that hERG channels in the plasma membrane undergo vigorous internalization under low K+ conditions. In the present study, we addressed whether hERG internalization occurs under normal K+ conditions and whether/ how internalized channels are recycled back to the plasma membrane. Using patch clamp, Western blot, and confocal imaging analyses, we demonstrated that internalized hERG channels can effectively recycle back to the plasma membrane. Low K+-enhanced hERG internalization is accompanied by an increased rate of hERG recovery in the plasma membrane upon reculture following proteinase K-mediated clearance of cell-surface proteins. The increased recovery rate is not due to enhanced protein synthesis, as hERG mRNA expression was not altered by low K+ exposure, and the increased recovery was observed in the presence of the protein biosynthesis inhibitor cycloheximide. GTPase Rab11, but not Rab4, is involved in the recycling of hERG channels. Interfering with Rab11 function not only delayed hERG recovery in cells after exposure to low K+ medium but also decreased hERG expression and function in cells under normal culture conditions. We concluded that the recycling pathway plays an important role in the homeostasis of plasma membrane-bound hERG channels.	[Chen, Jeffery; Guo, Jun; Yang, Tonghua; Li, Wentao; Lamothe, Shawn M.; Kang, Yudi; Szendrey, John A.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Canadian Institutes of Health Research [MOP 72911]; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Canadian Institutes of Health Research Grant MOP 72911 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Heart and Stroke Foundation of Ontario Career Investigator Award.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Cheng SB, 2012, J BIOL CHEM, V287, P14178, DOI 10.1074/jbc.M111.323782; Cui Z, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461715; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Delisle BP, 2009, J BIOL CHEM, V284, P2844, DOI 10.1074/jbc.M807289200; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2011, J BIOL CHEM, V286, P34664, DOI 10.1074/jbc.M111.253351; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kramer A, 2013, NAT CHEM BIOL, V9, P731, DOI [10.1038/NCHEMBIO.1356, 10.1038/nchembio.1356]; KREISEL W, 1988, J BIOL CHEM, V263, P11736; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lamothe SM, 2013, J BIOL CHEM, V288, P15075, DOI 10.1074/jbc.M113.453670; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Porwoll S, 1998, J BIOL CHEM, V273, P1075, DOI 10.1074/jbc.273.2.1075; Rajamani S, 2006, BRIT J PHARMACOL, V149, P481, DOI 10.1038/sj.bjp.0706892; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Reynders E, 2011, GLYCOBIOLOGY, V21, P853, DOI 10.1093/glycob/cwq179; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VOLZ B, 1995, J CELL BIOL, V130, P537, DOI 10.1083/jcb.130.3.537; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	48	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21101	21113		10.1074/jbc.M115.636324	http://dx.doi.org/10.1074/jbc.M115.636324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152716	Green Published, hybrid			2022-12-28	WOS:000360011800042
J	Fan, HT; Hahm, J; Diggs, S; Perry, JJP; Blaha, G				Fan, Haitian; Hahm, Joseph; Diggs, Stephen; Perry, J. Jefferson P.; Blaha, Gregor			Structural and Functional Analysis of BipA, a Regulator of Virulence in Enteropathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; PATHOGENICITY ISLAND; CRYSTAL-STRUCTURE; DIFFRACTION DATA; EF-G; BINDING; RIBOSOME; GTPASE; PPGPP; EXPRESSION	The translational GTPase BipA regulates the expression of virulence and pathogenicity factors in several eubacteria. BipA-dependent expression of virulence factors occurs under starvation conditions, such as encountered during infection of a host. Under these conditions, BipA associates with the small ribosomal subunit. BipA also has a second function to promote the efficiency of late steps in biogenesis of large ribosomal subunits at low temperatures, presumably while bound to the ribosome. During starvation, the cellular concentration of stress alarmone guanosine-3', 5'-bis pyrophosphate (ppGpp) is increased. This increase allows ppGpp to bind to BipA and switch its binding specificity from ribosomes to small ribosomal subunits. A conformational change of BipA upon ppGpp binding could explain the ppGpp regulation of the binding specificity of BipA. Here, we present the structures of the full-length BipA from Escherichia coli in apo, GDP-, and ppGpp-bound forms. The crystal structure and small-angle x-ray scattering data of the protein with bound nucleotides, together with a thermodynamic analysis of the binding of GDP and of ppGpp to BipA, indicate that the ppGpp-bound form of BipA adopts the structure of the GDP form. This suggests furthermore, that the switch in binding preference only occurs when both ppGpp and the small ribosomal subunit are present. This molecular mechanism would allow BipA to interact with both the ribosome and the small ribosomal subunit during stress response.	[Fan, Haitian; Hahm, Joseph; Diggs, Stephen; Perry, J. Jefferson P.; Blaha, Gregor] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Blaha, G (corresponding author), Univ Calif Riverside, Dept Biochem, 900 Univ Ave,Boyce Hall 5489, Riverside, CA 92521 USA.	gregor.blaha@ucr.edu	Regan, Clinton/E-6250-2012	Fan, Haitian/0000-0003-4337-665X	NIH [P41 GM103403]; DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kennedy Ngotran, Bryan Peguero, and Carlos Rodriguez for help with sample preparation, Dr. Zhimin Zhang for assistance during data collection, Tim Rowsell and Sarah Radi for critical reading of the manuscript, and Dr. Russ Hille for critical discussions. In addition, we thank the staff of beamlines 5.0.1 and 5.0.2 of the Berkeley Center of Structure Biology at the Advanced Light Source (ALS), of the SIBYLS beamline 12.3.1 at ALS, and of beamline 24-ID-C of the Northeastern Collaborative Access Team (funded by NIH, award P41 GM103403) at the Advanced Photon Source (APS; funded by DOE, award DE-AC02-06CH11357) for their expert support during data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Choudhury P, 2015, J BACTERIOL, V197, P1819, DOI 10.1128/JB.00023-15; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; deLivron MA, 2009, BIOCHEMISTRY-US, V48, P10533, DOI 10.1021/bi901026z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hauryliuk V, 2008, P NATL ACAD SCI USA, V105, P15678, DOI 10.1073/pnas.0807912105; Hauryliuk V, 2008, BIOPHYS J, V95, P1704, DOI 10.1529/biophysj.107.127290; Hauryliuk V, 2009, J MOL BIOL, V394, P621, DOI 10.1016/j.jmb.2009.10.015; Krishnan K, 2008, J BACTERIOL, V190, P7675, DOI 10.1128/JB.00835-08; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liljas A, 1995, BIOCHEM CELL BIOL, V73, P1209, DOI 10.1139/o95-130; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mitkevich VA, 2010, J MOL BIOL, V402, P838, DOI 10.1016/j.jmb.2010.08.016; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Perry JJP, 2013, METHODS, V59, P363, DOI 10.1016/j.ymeth.2013.01.005; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	39	21	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20856	20864		10.1074/jbc.M115.659136	http://dx.doi.org/10.1074/jbc.M115.659136			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26163516	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000360011800022
J	Maguire, SE; Rhoades, S; Chen, WF; Sengupta, A; Yue, ZF; Lim, JC; Mitchell, CH; Weljie, AM; Sehgal, A				Maguire, Sarah E.; Rhoades, Seth; Chen, Wen-Feng; Sengupta, Arjun; Yue, Zhifeng; Lim, Jason C.; Mitchell, Claire H.; Weljie, Aalim M.; Sehgal, Amita			Independent Effects of gamma-Aminobutyric Acid Transaminase (GABAT) on Metabolic and Sleep Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-AMINOBUTYRATE AMINOTRANSFERASE; GLUTAMINE; CELLS; CYCLE	Breakdown of the major sleep-promoting neurotransmitter, gamma-aminobutyric acid (GABA), in the GABA shunt generates catabolites that may enter the tricarboxylic acid cycle, but it is unknown whether catabolic by-products of the GABA shunt actually support metabolic homeostasis. In Drosophila, the loss of the specific enzyme that degrades GABA, GABA transaminase (GABAT), increases sleep, and we show here that it also affects metabolism such that flies lacking GABAT fail to survive on carbohydrate media. Expression of GABAT in neurons or glia rescues this phenotype, indicating a general metabolic function for this enzyme in the brain. As GABA degradation produces two catabolic products, glutamate and succinic semialdehyde, we sought to determine which was responsible for the metabolic phenotype. Through genetic and pharmacological experiments, we determined that glutamate, rather than succinic semialdehyde, accounts for the metabolic phenotype of gabat mutants. This is supported by biochemical measurements of catabolites in wild-type and mutant animals. Using in vitro labeling assays, we found that inhibition of GABAT affects energetic pathways. Interestingly, we also observed that gaba mutants display a general disruption in bioenergetics as measured by altered levels of tricarboxylic acid cycle intermediates, NAD(+)/NADH, and ATP levels. Finally, we report that the effects of GABAT on sleep do not depend upon glutamate, indicating that GABAT regulates metabolic and sleep homeostasis through independent mechanisms. These data indicate a role of the GABA shunt in the development of metabolic risk and suggest that neurological disorders caused by altered glutamate or GABA may be associated with metabolic disruption.	[Maguire, Sarah E.; Sehgal, Amita] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Lim, Jason C.; Mitchell, Claire H.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Rhoades, Seth; Sengupta, Arjun; Weljie, Aalim M.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Chen, Wen-Feng; Yue, Zhifeng; Sehgal, Amita] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Sehgal, Amita] Univ Penn, Perelman Sch Med, Dept Cell & Mol Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine	Sehgal, A (corresponding author), Dept Neurosci, 10-136 Smilow Ctr Translat Res,Bldg 421, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu	Regan, Clinton/E-6250-2012; Weljie, Aalim/V-6952-2019; Sengupta, Arjun/AAS-8787-2021; Sengupta, Arjun/R-5802-2019	Weljie, Aalim/0000-0002-7145-4494; Sengupta, Arjun/0000-0003-2210-1876; Rhoades, Seth/0000-0001-7864-447X	National Institutes of Health [HL07953]; Pharmacology T32 Training Grant [T32 GM008076, EY015537, 2P40OD010949-10A1]; NATIONAL EYE INSTITUTE [R01EY015537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacology T32 Training Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Training Grant HL07953 (to S. E. M.), Pharmacology T32 Training Grant T32 GM008076 (to S. R.), Grant EY015537 (to C. H. M.), and Grant 2P40OD010949-10A1 (to The Drosophila Genomics Resource Center). The authors declare that they have no conflicts of interest with the contents of this article.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; BALAZS R, 1970, BIOCHEM J, V116, P445; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Chen WF, 2015, MOL PSYCHIATR, V20, P240, DOI 10.1038/mp.2014.11; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; FOWLER LJ, 1972, BIOCHEM J, V130, P569, DOI 10.1042/bj1300569; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Qu H, 2001, J NEUROSCI RES, V66, P885, DOI 10.1002/jnr.10055; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Studart-Guimaraes C, 2007, PLANT PHYSIOL, V145, P626, DOI 10.1104/pp.107.103101; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	26	20	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20407	20416		10.1074/jbc.M114.602276	http://dx.doi.org/10.1074/jbc.M114.602276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124278	hybrid, Green Published			2022-12-28	WOS:000359608900038
J	Pedersen, JT; Falhof, J; Ekberg, K; Buch-Pedersen, MJ; Palmgren, M				Pedersen, Jesper Torbol; Falhof, Janus; Ekberg, Kira; Buch-Pedersen, Morten Jeppe; Palmgren, Michael			Metal Fluoride Inhibition of a P-type H+ Pump STABILIZATION OF THE PHOSPHOENZYME INTERMEDIATE CONTRIBUTES TO POST-TRANSLATIONAL PUMP ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PLASMA-MEMBRANE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; C-TERMINAL END; FLUOROALUMINATE COMPLEXES; SACCHAROMYCES-CEREVISIAE; INORGANIC-PHOSPHATE; REGULATORY DOMAIN; CRYSTAL-STRUCTURE; DELETION ANALYSIS; CALCIUM-ATPASE	The plasma membrane H+-ATPase is a P-type ATPase responsible for establishing electrochemical gradients across the plasma membrane in fungi and plants. This essential proton pump exists in two activity states: an autoinhibited basal state with a low turnover rate and a low H+/ATP coupling ratio and an activated state in which ATP hydrolysis is tightly coupled to proton transport. Here we characterize metal fluorides as inhibitors of the fungal enzyme in both states. In contrast to findings for other P-type ATPases, inhibition of the plasma membrane H+-ATPase by metal fluorides was partly reversible, and the stability of the inhibition varied with the activation state. Thus, the stability of the ATPase inhibitor complex decreased significantly when the pump transitioned from the activated to the basal state, particularly when using beryllium fluoride, which mimics the bound phosphate in the E2P conformational state. Taken together, our results indicate that the phosphate bond of the phosphoenzyme intermediate of H+-ATPases is labile in the basal state, which may provide an explanation for the low H+/ATP coupling ratio of these pumps in the basal state.	[Pedersen, Jesper Torbol; Falhof, Janus; Ekberg, Kira; Buch-Pedersen, Morten Jeppe; Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Ekberg, K (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg, Denmark.	kiek@plen@ku.dk; palmgren@plen.ku.dk	Pedersen, Jesper Torbøl/AAX-5500-2020; Palmgren, Michael/A-9808-2013	Pedersen, Jesper Torbøl/0000-0003-3094-1461; Palmgren, Michael/0000-0002-9982-6114	Danish Strategic Research Council ("FungalFight")	Danish Strategic Research Council ("FungalFight")	This work was supported by the Danish Strategic Research Council ("FungalFight"). The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; Abe K, 2010, J STRUCT BIOL, V170, P60, DOI 10.1016/j.jsb.2009.12.008; AMORY A, 1982, J BIOL CHEM, V257, P2509; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; COLL RJ, 1992, J BIOL CHEM, V267, P21584; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; ERASO P, 1994, J BIOL CHEM, V269, P10393; FACANHA AR, 1995, PLANT PHYSIOL, V108, P241, DOI 10.1104/pp.108.1.241; Fuglsang AT, 2014, PLANT J, V80, P951, DOI 10.1111/tpj.12680; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lefebvre B, 2003, PROG NUCLEIC ACID RE, V74, P203, DOI 10.1016/S0079-6603(03)01014-6; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; MARTIN DW, 1981, BIOCHEMISTRY-US, V20, P4597, DOI 10.1021/bi00519a013; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Miranda M, 2001, J BIOL CHEM, V276, P22485, DOI 10.1074/jbc.M102332200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; RAPINLEGROUX C, 1994, BBA-BIOENERGETICS, V1184, P127, DOI 10.1016/0005-2728(94)90162-7; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SETOYOUNG D, 1991, J BIOL CHEM, V266, P1383; SLAYMAN CL, 1987, J BIOENERG BIOMEMBR, V19, P1; Takahashi K, 2012, PLANT PHYSIOL, V159, P632, DOI 10.1104/pp.112.196428; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Tomasi N, 2009, PLANT CELL ENVIRON, V32, P465, DOI 10.1111/j.1365-3040.2009.01938.x; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Wielandt AG, 2015, J BIOL CHEM, V290, P16281, DOI 10.1074/jbc.M114.617746; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yang YQ, 2010, PLANT CELL, V22, P1313, DOI 10.1105/tpc.109.069609	56	11	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20396	20406		10.1074/jbc.M115.639385	http://dx.doi.org/10.1074/jbc.M115.639385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134563	hybrid, Green Published			2022-12-28	WOS:000359608900037
J	Torrent, J; Lange, R; Rezaei, H				Torrent, Joan; Lange, Reinhard; Rezaei, Human			The Volumetric Diversity of Misfolded Prion Protein Oligomers Revealed by Pressure Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE OLIGOMERS; SCRAPIE; HYDRATION; KINETICS; INSIGHTS; DISEASE; CONFORMATIONS; MOLECULES; PATHWAYS; STRAINS	Protein oligomerization has been associated with a wide range of diseases. High pressure approaches offer a powerful tool for deciphering the underlying molecular mechanisms by revealing volume changes associated with the misfolding and assembly reactions. We applied high pressure to induce conformational changes in three distinct beta-sheet-rich oligomers of the prion protein PrP, a protein characterized by a variety of infectious quaternary structures that can propagate stably and faithfully and cause diseases with specific phenotypic traits. We show that pressure induces dissociation of the oligomers and leads to a lower volume monomeric PrP state that refolds into the native conformation after pressure release. By measuring the different pressure and temperature sensitivity of the tested PrP oligomers, we demonstrate significantly different void volumes in their quaternary structure. In addition, by focusing on the kinetic and energetic behavior of the pressure-induced dissociation of one specific PrP oligomer, we reveal a large negative activation volume and an increase in both apparent activation enthalpy and entropy. This suggests a transition state ensemble that is less structured and significantly more hydrated than the oligomeric state. Finally, we found that site-specific fluorescent labeling allows monitoring of the transient population of a kinetic intermediate in the dissociation reaction. Our results indicate that defects in atomic packing may deserve consideration as a new factor that influences differences between PrP assemblies and that could be relevant also for explaining the origin of prion strains.	[Torrent, Joan; Rezaei, Human] INRA, UR892, Virol Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France; [Lange, Reinhard] Univ Montpellier, Inst Natl Rech Agron, UMR1208, Ingn Agropolymeres & Technol Emergentes, F-34095 Montpellier, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Montpellier	Torrent, J (corresponding author), INRA, UR892, Virol Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France.	joan.torrent@inserm.fr		TORRENT, Joan/0000-0002-6908-4084				Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Cavaliere P, 2013, BBA-MOL BASIS DIS, V1832, P20, DOI 10.1016/j.bbadis.2012.09.005; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Chich JF, 2010, J MOL BIOL, V397, P1017, DOI 10.1016/j.jmb.2010.02.013; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; El Moustaine D, 2011, J BIOL CHEM, V286, P13448, DOI 10.1074/jbc.M110.192872; Font J, 2006, BIOPHYS J, V91, P2264, DOI 10.1529/biophysj.106.082552; Forst P, 2000, RHEOL ACTA, V39, P566, DOI 10.1007/s003970000114; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Laferriere F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003702; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Torrent J, 2006, BBA-PROTEINS PROTEOM, V1764, P489, DOI 10.1016/j.bbapap.2006.01.002; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916; VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Woenckhaus J, 2001, BIOPHYS J, V80, P1518, DOI 10.1016/S0006-3495(01)76124-3	36	6	6	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20417	20426		10.1074/jbc.M115.661710	http://dx.doi.org/10.1074/jbc.M115.661710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26126829	hybrid, Green Published			2022-12-28	WOS:000359608900039
J	Tsuboi, K; Nishitani, M; Takakura, A; Imai, Y; Komatsu, M; Kawashima, H				Tsuboi, Koichiro; Nishitani, Mayo; Takakura, Atsushi; Imai, Yasuyuki; Komatsu, Masaaki; Kawashima, Hiroto			Autophagy Protects against Colitis by the Maintenance of Normal Gut Microflora and Secretion of Mucus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; INTESTINAL EPITHELIUM; SUSCEPTIBILITY LOCI; IMPAIRED AUTOPHAGY; ACTIVATING ENZYME; CROHN-DISEASE; UP-REGULATION; EXPRESSION; INNATE; ATG16L1	Genome-wide association studies of inflammatory bowel diseases identified susceptible loci containing an autophagy-related gene. However, the role of autophagy in the colon, a major affected area in inflammatory bowel diseases, is not clear. Here, we show that colonic epithelial cell-specific autophagy-related gene 7 (Atg7) conditional knock-out (cKO) mice showed exacerbation of experimental colitis with more abundant bacterial invasion into the colonic epithelium. Quantitative PCR analysis revealed that cKO mice had abnormal microflora with an increase of some genera. Consistently, expression of antimicrobial or antiparasitic peptides such as angiogenin-4, Relm beta, intelectin-1, and intelectin-2 as well as that of their inducer cytokines was significantly reduced in the cKO mice. Furthermore, secretion of colonic mucins that function as a mucosal barrier against bacterial invasion was also significantly diminished in cKO mice. Taken together, our results indicate that autophagy in colonic epithelial cells protects against colitis by the maintenance of normal gut microflora and secretion of mucus.	[Tsuboi, Koichiro; Kawashima, Hiroto] Hoshi Univ, Dept Biochem, Sch Pharm & Pharmaceut Sci, Tokyo 1428501, Japan; [Tsuboi, Koichiro; Nishitani, Mayo; Takakura, Atsushi; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Komatsu, Masaaki] Niigata Univ, Sch Med, Dept Biochem, Niigata 9518510, Japan	Hoshi University; University of Shizuoka; Niigata University	Kawashima, H (corresponding author), Hoshi Univ, Dept Biochem, Sch Pharm & Pharmaceut Sci, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	h-kawashima@hoshi.ac.jp	Imai, Yasuyuki/E-8701-2010; Komatsu, Masaaki/B-8321-2011	Imai, Yasuyuki/0000-0002-8937-0221; Komatsu, Masaaki/0000-0001-7672-7722	Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan [24390018]; Institute for Fermentation, Osaka; Honjo International Scholarship Foundation;  [26-7438]; Grants-in-Aid for Scientific Research [15K14955] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Precursory Research for Embryonic Science and Technology, the Japan Science and Technology Agency (to H. K.), Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant 24390018 (to H. K.), Grant-in-aid for JSPS Fellows 26-7438 (to K. T.), and in part by the Institute for Fermentation, Osaka (to H. K.), and the Honjo International Scholarship Foundation (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Forman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042248; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; French AT, 2007, VET IMMUNOL IMMUNOP, V120, P41, DOI 10.1016/j.vetimm.2007.07.014; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Greenbloom SL, 1998, CAN J GASTROENTEROL, V12, P53, DOI 10.1155/1998/349460; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Inoue J, 2012, ARCH BIOCHEM BIOPHYS, V521, P95, DOI 10.1016/j.abb.2012.03.019; Ishikawa T, 2011, MOL IMAGING BIOL, V13, P284, DOI 10.1007/s11307-010-0333-x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawashima H, 2009, J IMMUNOL, V182, P5461, DOI 10.4049/jimmunol.0802327; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Koutroubakis Ioannis E, 2010, World J Gastrointest Pharmacol Ther, V1, P43, DOI 10.4292/wjgpt.v1.i2.43; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Nishiumi S, 2012, BIOCHEM BIOPH RES CO, V421, P768, DOI 10.1016/j.bbrc.2012.04.081; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanders ME, 2011, J CLIN GASTROENTEROL, V45, pS115, DOI 10.1097/MCG.0b013e318227414a; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2012, AUTOPHAGY, V8, P88, DOI 10.4161/auto.8.1.18339; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Voehringer D, 2007, EXP PARASITOL, V116, P458, DOI 10.1016/j.exppara.2007.02.015; Wittkopf N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/278059; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	70	61	63	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20511	20526		10.1074/jbc.M114.632257	http://dx.doi.org/10.1074/jbc.M114.632257			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149685	Green Published, hybrid			2022-12-28	WOS:000359608900048
J	Nguyen, S; Leija, C; Kinch, L; Regmi, S; Li, Q; Grishin, NV; Phillips, MA				Suong Nguyen; Leija, Chrisopher; Kinch, Lisa; Regmi, Sandesh; Li, Qiong; Grishin, Nick V.; Phillips, Margaret A.			Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; BLOOD-STREAM FORMS; FACTOR EF-P; SACCHAROMYCES-CEREVISIAE; HYPUSINE MODIFICATION; POLYAMINE METABOLISM; ACTIN CYTOSKELETON; CELL-GROWTH; HOMOLOG; YEAST	The eukaryotic protozoan parasite Trypanosoma brucei is the causative agent of human African trypanosomiasis. Polyamine biosynthesis is essential in T. brucei, and the polyamine spermidine is required for synthesis of a novel cofactor called trypanothione and for deoxyhypusine modification of eukaryotic translation initiation factor 5A (eIF5A). eIF5A promotes translation of proteins containing polyprolyl tracts in mammals and yeast. To evaluate the function of eIF5A in T. brucei, we used RNA interference (RNAi) to knock down eIF5A levels and found that it is essential for T. brucei growth. The RNAi-induced growth defect was complemented by expression of wild-type human eIF5A but not by a Lys-50 mutant that blocks modification by deoxyhypusine. Bioinformatics analysis showed that 15% of the T. brucei proteome contains 3 or more consecutive prolines and that actin-related proteins and cysteine proteases were highly enriched in the group. Steady-state protein levels of representative proteins containing 9 consecutive prolines that are involved in actin assembly (formin and CAP/Srv2p) were significantly reduced by knockdown of eIF5A. Several T. brucei polyprolyl proteins are involved in flagellar assembly. Knockdown of TbeIF5A led to abnormal cell morphologies and detached flagella, suggesting that eIF5A is important for translation of proteins needed for these processes. Potential specialized functions for eIF5A in T. brucei in translation of variable surface glycoproteins were also uncovered. Inhibitors of deoxyhypusination would be expected to cause a pleomorphic effect on multiple cell processes, suggesting that deoxyhypusine/hypusine biosynthesis could be a promising drug target in not just T. brucei but in other eukaryotic pathogens.	[Suong Nguyen; Leija, Chrisopher; Regmi, Sandesh; Li, Qiong; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu	Regan, Clinton/E-6250-2012	Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [2R37 AI034432, GM007062, GM094575]; Welch Foundation [I-1257, I-1505]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R37 AI034432 (to M. A. P.), GM007062 (to C. L.), and GM094575 (to N. V. G.). This work was also supported by Welch Foundation Grants I-1257 (to M. A. P.) and I-1505 (to N. V. G.). The authors declare that they have no conflicts of interest with the content of this article.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chawla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033138; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hall JPJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003502; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobs RT, 2011, CURR TOP MED CHEM, V11, P1255; Kalidas S, 2011, MOL BIOCHEM PARASIT, V178, P51, DOI 10.1016/j.molbiopara.2011.03.002; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Li T, 2014, GENETICS, V197, P1191, DOI 10.1534/genetics.114.166926; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Mirey G, 2005, BIOCHEM SOC T, V33, P1247, DOI 10.1042/BST0331247; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pratt C, 2014, EUKARYOT CELL, V13, P614, DOI 10.1128/EC.00015-14; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Santos CC, 2007, MOL MICROBIOL, V66, P991, DOI 10.1111/j.1365-2958.2007.05970.x; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Nguyen S, 2013, J BIOL CHEM, V288, P15256, DOI 10.1074/jbc.M113.461137; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; WHO, 2014, TRYP HUM AFR SLEEP S; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	49	20	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19987	19998		10.1074/jbc.M115.656785	http://dx.doi.org/10.1074/jbc.M115.656785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26082486	Green Published, hybrid			2022-12-28	WOS:000359364600053
J	Li, WQ; Koutmou, KS; Leahy, DJ; Li, M				Li, Weiqiang; Koutmou, Kristin S.; Leahy, Daniel J.; Li, Min			Systemic RNA Interference Deficiency-1 (SID-1) Extracellular Domain Selectively Binds Long Double-stranded RNA and Is Required for RNA Transport by SID-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE PREDICTION; ECTOPIC EXPRESSION; PROTEIN; DSRNA; WEB; FILAMENTS; SEQUENCE; CELLS	During systemic RNA interference (RNAi) in Caenorhabditis elegans, RNA spreads across different cells and tissues in a process that requires the systemic RNA interference deficient-1 (sid-1) gene, which encodes an integral membrane protein. SID-1 acts cell-autonomously and is required for cellular import of interfering RNAs. Heterologous expression of SID-1 in Drosophila Schneider 2 cells enables passive uptake of dsRNA and subsequent soaking RNAi. Previous studies have suggested that SID-1 may serve as an RNA channel, but its precise molecular role remains unclear. To test the hypothesis that SID-1 mediates a direct biochemical recognition of RNA molecule and subsequent permeation, we expressed the extracellular domain (ECD) of SID-1 and purified it to near homogeneity. Recombinant purified SID-1ECD selectively binds dsRNA but not dsDNA in a length-dependent and sequence-independent manner. Genetic missense mutations in SID-1 ECD causal for deficient systemic RNAi resulted in significant reduction in its affinity for dsRNA. Furthermore, full-length proteins with these mutations decrease SID-1-mediated RNA transport efficiency, providing evidence that dsRNA binding to SID-1 ECD is related to RNA transport. To examine the functional similarity of mammalian homologs of SID-1 (SIDT1 and SIDT2), we expressed and purified mouse SIDT1 and SIDT2 ECDs. We show that they bind long dsRNA in vitro, supportive of dsRNA recognition. In summary, our study illustrates the functional importance of SID-1 ECD as a dsRNA binding domain that contributes to RNA transport.	[Li, Weiqiang; Li, Min] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Koutmou, Kristin S.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Li, Weiqiang; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Li, Min] GlaxoSmithKline, King Of Prussia, PA 19406 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; GlaxoSmithKline	Li, M (corresponding author), GlaxoSmithKline, 709 Swedeland Rd, King Of Prussia, PA 19406 USA.	min.x.li@gsk.com	Regan, Clinton/E-6250-2012		National Institutes of Health [GM078579, MH084691, R01GM099321, F32 GM100608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100608, R01GM099321, R01GM078579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078579 and MH084691 (to M.L.), R01GM099321 (to D.L.), and F32 GM100608 (to K.S.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DRAPER DE, 1978, J MOL BIOL, V122, P339; Elhassan MO, 2012, J BIOL CHEM, V287, P5267, DOI 10.1074/jbc.M111.318865; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi I, 2012, INSECT BIOCHEM MOLEC, V42, P148, DOI 10.1016/j.ibmb.2011.11.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Pratt AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033607; Ren RW, 2011, DEV COMP IMMUNOL, V35, P692, DOI 10.1016/j.dci.2011.02.003; Sarov-Blat L, 1998, J BIOL CHEM, V273, P5520, DOI 10.1074/jbc.273.10.5520; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Serna-Rico A, 2002, J BIOL CHEM, V277, P6733, DOI 10.1074/jbc.M109312200; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Shih JD, 2009, RNA, V15, P384, DOI 10.1261/rna.1286409; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xu J, 2013, APPL MICROBIOL BIOT, V97, P5921, DOI 10.1007/s00253-013-4785-1	32	28	30	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18904	18913		10.1074/jbc.M115.658864	http://dx.doi.org/10.1074/jbc.M115.658864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26067272	Green Published, hybrid			2022-12-28	WOS:000358781100003
J	Harte, NP; Klyubin, I; McCarthy, EK; Min, S; Garrahy, SA; Xie, YJ; Davey, GP; Boland, JJ; Rowan, MJ; Mok, KH				Harte, Nial P.; Klyubin, Igor; McCarthy, Eoin K.; Min, Soyoung; Garrahy, Sarah Ann; Xie, Yongjing; Davey, Gavin P.; Boland, John J.; Rowan, Michael J.; Mok, K. Hun			Amyloid Oligomers and Mature Fibrils Prepared from an Innocuous Protein Cause Diverging Cellular Death Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; A-BETA; MOLECULAR-BASIS; PRION PROTEIN; TOXICITY; CELLS; CYTOTOXICITY; NEURODEGENERATION; PATHOGENESIS	Despite significant advances, the molecular identity of the cytotoxic species populated during in vivo arnyloid formation crucial for the understanding of neurodegenerative disorders is yet to be revealed. In this study lysozyme prefibrillar oligomers and fibrils in both mature and sonicated states have been isolated through an optimized ultrafiltration/ultracentrifugation method and characterized with various optical spectroscopic techniques, atomic force microscopy, and transmission electron microscopy. We examined their level and mode of toxicity on rat pheochromocytoma (PC12) cells in both differentiated and undifferentiated states. We find that oligomers and fibrils display cytotoxic capabilities toward cultured cells in vitro, with oligomers producing elevated levels of cellular injury toward undifferentiated PC 12 cells (PC2(undiff)), Furthermore, dual flow cytometry staining experiments demonstrate that the oligomers and mature fibrils induce divergent cellular death pathways (apoptosis and secondary necrosis, respectively) in these PC12 cells. We have also shown that oligomers but not sonicated mature fibrils inhibit hippocampal long term potentiation, a form of synaptic plasticity implicated in learning and memory, in vivo. We conclude that our in vitro and in vivo findings confer a level of resistance toward amyloid fibrils, and that the PC 12-based comparative cytotoxicity assay can provide insights into toxicity differences between differently aggregated protein species.	[Harte, Nial P.; Min, Soyoung; Xie, Yongjing; Davey, Gavin P.; Mok, K. Hun] Univ Dublin Trinity Coll, Sch Biochem & Immunol, TBSI, Dublin 2, Ireland; [Klyubin, Igor; Rowan, Michael J.] Univ Dublin Trinity Coll, TCIN, Dept Pharmacol & Therapeut, Dublin 2, Ireland; [McCarthy, Eoin K.; Boland, John J.] Univ Dublin Trinity Coll, Sch Chem, Dublin 2, Ireland; [McCarthy, Eoin K.; Boland, John J.; Mok, K. Hun] Univ Dublin Trinity Coll, CRANN, Dublin 2, Ireland; [Garrahy, Sarah Ann; Davey, Gavin P.] Univ Dublin Trinity Coll, TCIN, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Mok, KH (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, TBSI, 152-160 Pearse St, Dublin 2, Ireland.	mok1@tcd.ie	Boland, John J/P-9740-2016; Davey, Gavin/HGB-4233-2022; Boland, John/AAB-8498-2022	Boland, John J/0000-0002-3229-8038; Boland, John/0000-0002-3229-8038; Mok, K Hun/0000-0003-3663-2002; Xie, Yongjing/0000-0001-5482-5743; Rowan, Michael Joseph/0000-0002-3867-9536; Min, Soyoung/0000-0001-7511-1520	Health Research Board of Ireland; Science Foundation Ireland	Health Research Board of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported in part by grants from the Health Research Board of Ireland (to I. K.) and Science Foundation Ireland (to M. J. R). The authors declare that they have no conflicts of interest with the contents of this article.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Bucciantini M, 2004, FASEB J, V18, P437, DOI 10.1096/fj.04-3086fje; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Cecchi C, 2008, NEUROCHEM RES, V33, P2516, DOI 10.1007/s11064-008-9627-7; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klyubin I., 2012, ALZHEIMERS DEMENT, V8, pP648; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; Min SY, 2012, BIOCHEM SOC T, V40, P746, DOI 10.1042/BST20120029; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oberdoerster J, 1999, LIFE SCI, V64, pPL267, DOI 10.1016/S0024-3205(99)00166-6; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Olesen OF, 1998, MOL BRAIN RES, V57, P266, DOI 10.1016/S0169-328X(98)00096-5; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SHIMADA K, 1989, MOL BIOL MED, V6, P333; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Wang XD, 2001, GENE DEV, V15, P2922; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	48	19	19	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28343	28352		10.1074/jbc.M115.676072	http://dx.doi.org/10.1074/jbc.M115.676072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26221033	hybrid, Green Published			2022-12-28	WOS:000365761900026
J	Mohamed, JS; Hajira, A; Lopez, MA; Boriek, AM				Mohamed, Junaith S.; Hajira, Ameena; Lopez, Michael A.; Boriek, Aladin M.			Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; MESSENGER-RNA EXPRESSION; SMAD SIGNAL-TRANSDUCTION; TGF-BETA; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; CAENORHABDITIS-ELEGANS; ENDOMYSIAL FIBROSIS; MECHANICAL STRETCH; FORCE TRANSMISSION	Muscular dystrophies (MDs) are a heterogeneous group of genetic and neuromuscular disorders, which result in severe loss of motor ability and skeletal muscle mass and function. Aberrant mechanotransduction and dysregulated-microRNA pathways are often associated with the progression of MD. Here, we hypothesized that dysregulation of mechanosensitive microRNAs (mechanomiRs) in dystrophic skeletal muscle plays a major role in the progression of MD. To test our hypothesis, we performed a genome-wide expression profile of anisotropically regulated mechanomiRs and bioinformatically analyzed their target gene networks. We assessed their functional roles in the advancement of MD using diaphragm muscles from mdm (MD with myositis) mice, an animal model of human tibial MD (titinopathy), and their wild-type littermates. We were able to show that ex vivo anisotropic mechanical stretch significantly alters the miRNA expression profile in diaphragm muscles from WT and mdm mice; as a result, some of the genes associated with MDs are dysregulated in mdm mice due to differential regulation of a distinct set of mechanomiRs. Interestingly, we found a contrasting expression pattern of the highly expressed let-7 family mechanomiRs, let-7e-5p and miR-98-5p, and their target genes associated with the extracellular matrix and TGF-beta pathways, respectively, between WT and mdm mice. Gain-and loss-of-function analysis of let-7e-5p in myocytes isolated from the diaphragms of WT and mdm mice confirmed Col1a1, Col1a2, Col3a1, Col24a1, Col27a1, Itga1, Itga4, Scd1, and Thbs1 as target genes of let-7e-5p. Furthermore, we found that miR-98 negatively regulates myoblast differentiation. Our study therefore introduces additional biological players in the regulation of skeletal muscle structure and myogenesis that may contribute to unexplained disorders of MD.	[Mohamed, Junaith S.; Hajira, Ameena; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Pulm & Crit Care Sect, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Pulm & Crit Care Sect, Houston, TX 77030 USA.	boriek@bcm.edu	Lopez, Michael A./AAT-2145-2021; Mohamed, Junaith/AAC-4050-2020	Lopez, Michael A./0000-0002-3029-0761; 	National Institutes of Health from the NHLBI [HL-63134]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063134] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL-63134 from the NHLBI. This work was also supported by the National Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Alexander MS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-27; Andreetta F, 2006, J NEUROIMMUNOL, V175, P77, DOI 10.1016/j.jneuroim.2006.03.005; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; BORIEK AM, 1994, J APPL PHYSIOL, V77, P2065, DOI 10.1152/jappl.1994.77.5.2065; Boriek AM, 2001, AM J PHYSIOL-REG I, V280, pR156, DOI 10.1152/ajpregu.2001.280.1.R156; Boriek AM, 2001, AM J PHYSIOL-CELL PH, V280, pC46, DOI 10.1152/ajpcell.2001.280.1.C46; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Claflin DR, 2008, AM J PHYSIOL-CELL PH, V294, pC651, DOI 10.1152/ajpcell.00244.2007; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Davies KE, 2007, CELL STEM CELL, V1, P595, DOI 10.1016/j.stem.2007.11.003; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Goldstein JA, 2014, HUM MOL GENET, V23, P6722, DOI 10.1093/hmg/ddu390; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Huang Y, 2012, FASEB J, V26, P3351, DOI 10.1096/fj.11-199240; Hurschler BA, 2011, NUCLEIC ACIDS RES, V39, P5647, DOI 10.1093/nar/gkr145; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kobus K, 2012, LIVER INT, V32, P1222, DOI 10.1111/j.1478-3231.2012.02791.x; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kropp J, 2015, BIOCHEM J, V466, P85, DOI 10.1042/BJ20141175; Kumar A, 2004, FASEB J, V18, P1524, DOI 10.1096/fj.04-2414com; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lopez MA, 2005, AM J PHYSIOL-CELL PH, V288, pC282, DOI 10.1152/ajpcell.00362.2003; Lopez MA, 2008, AM J PHYSIOL-CELL PH, V295, pC1092, DOI 10.1152/ajpcell.16.2008; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Marin T, 2013, FREE RADICAL BIO MED, V64, P61, DOI 10.1016/j.freeradbiomed.2013.05.034; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364; Mohamed JS, 2013, J BIOL CHEM, V288, P24560, DOI 10.1074/jbc.M112.434423; Mohamed JS, 2011, J BIOL CHEM, V286, P43394, DOI 10.1074/jbc.M111.235127; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Patel ND, 2003, AM J PHYSIOL-CELL PH, V284, pC962, DOI 10.1152/ajpcell.00326.2002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sharma M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00239; Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35; Wei FL, 2015, STEM CELLS DEV, V24, P312, DOI 10.1089/scd.2014.0191; Winbanks CE, 2014, CLIN EXP PHARMACOL P, V41, P727, DOI 10.1111/1440-1681.12281; YAMAZAKI M, 1994, AM J PATHOL, V144, P221; Zacharewicz E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00266; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009	73	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24986	25011		10.1074/jbc.M115.659375	http://dx.doi.org/10.1074/jbc.M115.659375			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26272747	Green Published, hybrid			2022-12-28	WOS:000362598300029
J	Fox, AM; Moonschi, FH; Richards, CI				Fox, Ashley M.; Moonschi, Faruk H.; Richards, Christopher I.			The Nicotine Metabolite, Cotinine, Alters the Assembly and Trafficking of a Subset of Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED UP-REGULATION; PHARMACOLOGICAL CHAPERONE; SUBUNIT STOICHIOMETRY; RAT-BRAIN; ALPHA-4-BETA-2; BINDING; SENSITIVITY; EXPRESSION; TOLERANCE; SMOKERS	Exposure to nicotine alters the trafficking and assembly of nicotinic receptors (nAChRs), leading to their up-regulation on the plasma membrane. Although the mechanism is not fully understood, nicotine-induced up-regulation is believed to contribute to nicotine addiction. The effect of cotinine, the primary metabolite of nicotine, on nAChR trafficking and assembly has not been extensively investigated. We utilize a pH-sensitive variant of GFP, super ecliptic pHluorin, to differentiate between intracellular nAChRs and those expressed on the plasma membrane to quantify changes resulting from cotinine and nicotine exposure, Similar to nicotine, exposure to cotinine increases the number of a4 beta 2 receptors on the plasma membrane and causes a redistribution of intracellular receptors. In contrast to this, cotinine exposure down-regulates alpha 6 beta 2 beta 3 receptors. We also used single molecule fluorescence studies to show that cotinine and nicotine both alter the assembly of alpha 4 beta 2 receptors to favor the high sensitivity (alpha 4)(2)(beta 2)(3) stoichiometry.	[Fox, Ashley M.; Moonschi, Faruk H.; Richards, Christopher I.] Univ Kentucky, Dept Chem, 505 Rose St, Lexington, KY 40506 USA	University of Kentucky	Richards, CI (corresponding author), Univ Kentucky, Dept Chem, 505 Rose St, Lexington, KY 40506 USA.	chris.richards@uky.edu			National Institute on Drug Abuse (NIDA) [DA016176]; NIDA [DA038817]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R21DA038817] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institute on Drug Abuse (NIDA) Training Grant DA016176 (to A. M. F) and NIDA Grant DA038817 (C. I. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ANAND R, 1991, J BIOL CHEM, V266, P11192; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Buccafusco JJ, 2003, LIFE SCI, V72, P2931, DOI 10.1016/S0024-3205(03)00226-1; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Colombo SF, 2013, BIOCHEM PHARMACOL, V86, P1063, DOI 10.1016/j.bcp.2013.06.023; Das SK, 2014, NANO LETT, V14, P620, DOI 10.1021/nl403820m; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Ghosheh O, 1999, DRUG METAB DISPOS, V27, P1448; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grizzell JA, 2015, NEUROCHEM RES, V40, P2032, DOI 10.1007/s11064-014-1359-2; Henderson BJ, 2015, NEUROPHARMACOLOGY, V96, P178, DOI 10.1016/j.neuropharm.2015.01.022; Henderson BJ, 2014, J GEN PHYSIOL, V143, P51, DOI 10.1085/jgp.201311102; John PAS, 2001, J NEUROBIOL, V49, P212, DOI 10.1002/neu.1076; Khiroug SS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-141; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Lomazzo E, 2011, J NEUROCHEM, V119, P153, DOI 10.1111/j.1471-4159.2011.07408.x; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Marks MJ, 2014, J NEUROCHEM, V130, P185, DOI 10.1111/jnc.12721; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Marotta CB, 2014, ACS CHEM BIOL, V9, P1153, DOI 10.1021/cb400937d; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mazzo F, 2013, J NEUROSCI, V33, P12316, DOI 10.1523/JNEUROSCI.2393-13.2013; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Moonschi FH, 2015, ANGEW CHEM INT EDIT, V54, P481, DOI 10.1002/anie.201408707; Moran VE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00173; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; O'Leary K, 2008, J PHARMACOL EXP THER, V325, P646, DOI 10.1124/jpet.108.136838; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pauly JR, 1996, J PHARMACOL EXP THER, V278, P361; Perez XA, 2008, MOL PHARMACOL, V74, P844, DOI 10.1124/mol.108.048843; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; Riah O, 1998, CELL MOL NEUROBIOL, V18, P311, DOI 10.1023/A:1022501131709; Richards CI, 2012, NANO LETT, V12, P3690, DOI 10.1021/nl301480h; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Srinivasan R, 2012, INT J MOL SCI, V13, P10022, DOI 10.3390/ijms130810022; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Terry AV, 2015, J PHARMACOL EXP THER, V352, P405, DOI 10.1124/jpet.114.219881; Terry AV, 2005, CNS DRUG REV, V11, P229; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vainio P J, 2001, Nicotine Tob Res, V3, P177; VINE MF, 1993, AM J PUBLIC HEALTH, V83, P1335, DOI 10.2105/AJPH.83.9.1335; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	57	20	21	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24403	24412		10.1074/jbc.M115.661827	http://dx.doi.org/10.1074/jbc.M115.661827			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26269589	Green Published, hybrid			2022-12-28	WOS:000362218900028
J	Kadyrova, LY; Dahal, BK; Kadyrov, FA				Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.			Evidence That the DNA Mismatch Repair System Removes 1-Nucleotide Okazaki Fragment Flaps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; SIMPLE REPETITIVE DNA; SACCHAROMYCES-CEREVISIAE; MUTL-ALPHA; MUTATION AVOIDANCE; REPLICATION FORK; POLYMERASES DELTA; PROTEIN MUTS; TUMOR-CELLS; IN-VITRO	The DNA mismatch repair (MMR) system plays a major role in promoting genome stability and suppressing carcinogenesis. In this work, we investigated whether the MMR system is involved in Okazaki fragment maturation. We found that in the yeast Saccharomyces cerevisiae, the MMR system and the flap endonuclease Rad27 act in overlapping pathways that protect the nuclear genome from 1-bp insertions. In addition, we determined that purified yeast and human MutS alpha proteins recognize 1-nucleotide DNA and RNA flaps. In reconstituted human systems, MutS alpha, proliferating cell nuclear antigen, and replication factor C activate MutL alpha endonuclease to remove the flaps. ATPase and endonuclease mutants of MutL alpha are defective in the flap removal. These results suggest that the MMR system contributes to the removal of 1-nucleotide Okazaki fragment flaps.	[Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Kadyrov, FA (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	fkadyrov@siumed.edu			National Institutes of Health from NIGMS [R01GM095758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095758] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM095758 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Formosa T, 1999, GENETICS, V151, P1459; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Greene CN, 2001, GENETICS, V159, P65; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kadyrova LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003899; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kuhn H, 2002, ELECTROPHORESIS, V23, P2384, DOI 10.1002/1522-2683(200208)23:15<2384::AID-ELPS2384>3.0.CO;2-O; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; MODRICH P, 1995, PHILOS T ROY SOC B, V347, P89, DOI 10.1098/rstb.1995.0014; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pena-Diaz J, 2012, TRENDS BIOCHEM SCI, V37, P206, DOI 10.1016/j.tibs.2012.03.001; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200	74	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24051	24065		10.1074/jbc.M115.660357	http://dx.doi.org/10.1074/jbc.M115.660357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26224637	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000362218900002
J	Foryst-Ludwig, A; Kreissl, MC; Benz, V; Brix, S; Smeir, E; Ban, Z; Januszewicz, E; Salatzki, J; Grune, J; Schwanstecher, AK; Blumrich, A; Schirbel, A; Klopfleisch, R; Rothe, M; Blume, K; Halle, M; Wolfarth, B; Kershaw, EE; Kintscher, U				Foryst-Ludwig, Anna; Kreissl, Michael C.; Benz, Verena; Brix, Sarah; Smeir, Elia; Ban, Zsofia; Januszewicz, Elzbieta; Salatzki, Janek; Grune, Jana; Schwanstecher, Anne-Kathrin; Blumrich, Annelie; Schirbel, Andreas; Klopfleisch, Robert; Rothe, Michael; Blume, Katharina; Halle, Martin; Wolfarth, Bernd; Kershaw, Erin E.; Kintscher, Ulrich			Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; LEFT-VENTRICULAR HYPERTROPHY; TRIGLYCERIDE LIPASE; PRESSURE-OVERLOAD; PPAR-ALPHA; CARDIOMYOCYTE; MUSCLE; MICE; SEX; METABOLISM	Endurance exercise training induces substantial adaptive cardiac modifications such as left ventricular hypertrophy (LVH). Simultaneously to the development of LVH, adipose tissue (AT) lipolysis becomes elevated upon endurance training to cope with enhanced energy demands. In this study, we investigated the impact of adipose tissue lipolysis on the development of exercise-induced cardiac hypertrophy. Mice deficient for adipose triglyceride lipase (Atgl) in AT (atATGL-KO) were challenged with chronic treadmill running. Exercise-induced AT lipolytic activity was significantly reduced in atATGL-KO mice accompanied by the absence of a plasma fatty acid (FA) increase. These processes were directly associated with a prominent attenuation of myocardial FA uptake in atATGL-KO and a significant reduction of the cardiac hypertrophic response to exercise. FA serum profiling revealed palmitoleic acid (C16:1n7) as a new molecular co-mediator of exercise-induced cardiac hypertrophy by inducing nonproliferative cardiomyocyte growth. In parallel, serum FA analysis and echocardiography were performed in 25 endurance athletes. In consonance, the serum C16:1n7 palmitoleate level exhibited a significantly positive correlation with diastolic interventricular septum thickness in those athletes. No correlation existed between linoleic acid (18:2n6) and diastolic interventricular septum thickness. Collectively, our data provide the first evidence that adipose tissue lipolysis directly promotes the development of exercise-induced cardiac hypertrophy involving the lipokine C16:1n7 palmitoleate as a molecular co-mediator. The identification of a lipokine involved in physiological cardiac growth may help to develop future lipid-based therapies for pathological LVH or heart failure.	[Foryst-Ludwig, Anna; Benz, Verena; Brix, Sarah; Smeir, Elia; Ban, Zsofia; Januszewicz, Elzbieta; Salatzki, Janek; Grune, Jana; Schwanstecher, Anne-Kathrin; Blumrich, Annelie; Kintscher, Ulrich] Charite, Inst Pharmacol, Ctr Cardiovasc Res, D-10115 Berlin, Germany; [Kreissl, Michael C.; Schirbel, Andreas] Univ Hosp Wuerzburg, Dept Nucl Med, D-97080 Wurzburg, Germany; [Klopfleisch, Robert] Free Univ Berlin, Coll Vet Med, Dept Vet Pathol, D-14163 Berlin, Germany; [Rothe, Michael] Lipidomix GmbH, D-13088 Berlin, Germany; [Blume, Katharina; Halle, Martin] Tech Univ Munich, Dept Prevent Rehabil & Sports Med, D-80809 Munich, Germany; [Halle, Martin] Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, D-80809 Munich, Germany; [Wolfarth, Bernd] Charite, Humboldt Univ, Dept Sports Med, D-10115 Berlin, Germany; [Kershaw, Erin E.] Univ Pittsburgh, Div Endocrinol & Metab, Pittsburgh, PA 15261 USA; [Kintscher, Ulrich] DZHK German Ctr Cardiovasc Res, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Free University of Berlin; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; German Centre for Cardiovascular Research	Kintscher, U (corresponding author), Charite, Inst Pharmacol, Ctr Cardiovasc Res, Hess Str 3-4, D-10115 Berlin, Germany.	ulrich.kintscher@charite.de	Regan, Clinton/E-6250-2012; Kershaw, Erin E/G-9587-2013; Kreissl, Michael/AAB-7270-2021	Kershaw, Erin E/0000-0002-3887-4868; Kreissl, Michael/0000-0001-5905-6015; Kintscher, Ulrich/0000-0001-7386-0990; Blumrich, Annelie/0000-0003-4720-8717; Wolfarth, Bernd/0000-0001-6501-3003; Klopfleisch, Robert/0000-0002-6308-0568	Deutsche Forschungsgemeinschaft [FG 1054/2 (Ki712/5-2), FG 1054/2, KFO 218/2, KFO 192/2]; National Institutes of Health [R01DK090166]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; Else Kroner-Fresenius Stiftung [2014_A100, 2012_A82]; Deutsche Stiftung fur Herzforschung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090166] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Else Kroner-Fresenius Stiftung; Deutsche Stiftung fur Herzforschung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Deutsche Forschungsgemeinschaft Grant FG 1054/2 (Ki712/5-2). This work was also supported in part by National Institutes of Health Grant R01DK090166 (to E. E. K.). M. R. is an employee of Lipidomix GmbH, Berlin, Germany.; Supported by Deutsche Forschungsgemeinschaft Grant FG 1054/2, KFO 218/2.; Supported by Deutsche Forschungsgemeinschaft Grant KFO 218/2.; Supported by the Deutsche Stiftung fur Herzforschung.; Supported by Else Kroner-Fresenius Stiftung Grant 2012_A82.; Supported by National Institutes of Health Grant R01 DK090166 and Howard Hughes Medical Institute Physician-Scientist Early Career Award.; Supported by the Deutsche Forschungsgemeinschaft Grant FG 1054/2, KFO 192/2, KFO 218/2, and the Else Kroner-Fresenius Stiftung Grant 2014_A100. To whom correspondence should be addressed: Charite-Universitaetsmedizin Berlin, Institute of Pharmacology, Center for Cardiovascular Research; Hessische Str. 3-4, 10115 Berlin, Germany.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bolsoni-Lopes A, 2013, AM J PHYSIOL-ENDOC M, V305, pE1093, DOI 10.1152/ajpendo.00082.2013; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; DeGrado TR, 2006, J NUCL MED, V47, P173; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Foryst-Ludwig A, 2011, AM J PHYSIOL-HEART C, V301, pH115, DOI 10.1152/ajpheart.01222.2010; Gao H, 2015, ARCH BIOCHEM BIOPHYS, V565, P76, DOI 10.1016/j.abb.2014.11.009; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kienesberger PC, 2013, CARDIOVASC RES, V99, P442, DOI 10.1093/cvr/cvt124; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Konhilas JP, 2004, AM J PHYSIOL-HEART C, V287, pH2768, DOI 10.1152/ajpheart.00292.2004; Kromhout D, 2014, CURR OPIN LIPIDOL, V25, P85, DOI 10.1097/MOL.0000000000000041; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Mittendorfer B, 2002, AM J PHYSIOL-ENDOC M, V283, pE58, DOI 10.1152/ajpendo.00504.2001; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Rawlins J, 2009, EUR J ECHOCARDIOGR, V10, P350, DOI 10.1093/ejechocard/jep017; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Sitnick MT, 2013, DIABETES, V62, P3350, DOI 10.2337/db13-0500; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620	37	31	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23603	23615		10.1074/jbc.M115.645341	http://dx.doi.org/10.1074/jbc.M115.645341			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26260790	Green Published, hybrid			2022-12-28	WOS:000361816500012
J	Torres, M; Medinas, DB; Matamala, JM; Woehlbier, U; Cornejo, VH; Solda, T; Andreu, C; Rozas, P; Matus, S; Munoz, N; Vergara, C; Cartier, L; Soto, C; Molinari, M; Hetz, C				Torres, Mauricio; Medinas, Danilo B.; Matamala, Jose Manuel; Woehlbier, Ute; Cornejo, Victor Hugo; Solda, Tatiana; Andreu, Catherine; Rozas, Pablo; Matus, Soledad; Munoz, Natalia; Vergara, Carmen; Cartier, Luis; Soto, Claudio; Molinari, Maurizio; Hetz, Claudio			The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE FORM; PEPTIDE; DISEASE; RETROTRANSLOCATION; ACCUMULATION; TRAFFICKING; MODULATION; TRANSPORT; APOPTOSIS	Although the accumulation of a misfolded and protease-resistant form of the prion protein (PrP) is a key event in prion pathogenesis, the cellular factors involved in its folding and quality control are poorly understood. PrP is a glycosylated and disulfide-bonded protein synthesized at the endoplasmic reticulum (ER). The ER foldase ERp57 (also known as Grp58) is highly expressed in the brain of sporadic and infectious forms of prion-related disorders. ERp57 is a disulfide isomerase involved in the folding of a subset of glycoproteins in the ER as part of the calnexin/calreticulin cycle. Here, we show that levels of ERp57 increase mainly in neurons of Creutzfeldt-Jacob patients. Using gain- and loss-of-function approaches in cell culture, we demonstrate that ERp57 expression controls the maturation and total levels of wild-type PrP and mutant forms associated with human disease. In addition, we found that PrP physically interacts with ERp57, and also with the closest family member PDIA1, but not ERp72. Furthermore, we generated a conditional knock-out mouse for ERp57 in the nervous system and detected a reduction in the steady-state levels of the mono- and nonglycosylated forms of PrP in the brain. In contrast, ERp57 transgenic mice showed increased levels of endogenous PrP. Unexpectedly, ERp57 expression did not affect the susceptibility of cells to ER stress in vitro and in vivo. This study identifies ERp57 as a new modulator of PrP levels and may help with understanding the consequences of ERp57 up-regulation observed in human disease.	[Torres, Mauricio; Medinas, Danilo B.; Matamala, Jose Manuel; Woehlbier, Ute; Cornejo, Victor Hugo; Andreu, Catherine; Rozas, Pablo; Matus, Soledad; Munoz, Natalia; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 8380453, Chile; [Torres, Mauricio; Medinas, Danilo B.; Woehlbier, Ute; Cornejo, Victor Hugo; Andreu, Catherine; Rozas, Pablo; Molinari, Maurizio; Hetz, Claudio] Univ Chile, Ctr Mol Studie Cell, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago 8380453, Chile; [Matamala, Jose Manuel; Vergara, Carmen; Cartier, Luis] Univ Chile, Fac Med, Dept Neurol Sci, Santiago 7500691, Chile; [Solda, Tatiana; Molinari, Maurizio] Inst Biomed Res, CH-6500 Bellinzona, Switzerland; [Matus, Soledad; Munoz, Natalia] CENPAR, Neurounion Biomed Fdn, Santiago 7630614, Chile; [Molinari, Maurizio] Univ Svizzera Italiana, CH-6900 Lugano, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Soto, Claudio] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX 77030 USA; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universita della Svizzera Italiana; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard T.H. Chan School of Public Health	Hetz, C (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Independencia 1027,POB 70086, Santiago 8380453, Chile.	chetz@med.uchile.cl	Medinas, Danilo/ABA-1182-2021; Cornejo, Victor Hugo/ABD-8410-2021; Matus, Soledad/AAA-3857-2020; Molinari, Maurizio/N-2587-2019; Hetz, Claudio/ABD-7514-2021; Andreu, Catherine/AAV-6825-2021	Molinari, Maurizio/0000-0002-7636-5829; Andreu, Catherine/0000-0003-2402-0252; Bilches Medinas, Danilo/0000-0002-1822-1974; Matamala, Jose Manuel/0000-0001-9062-5642; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044; Woehlbier, Ute/0000-0003-3114-9708	FONDECYT [1140549, 1100176, 11121524]; Millennium Institute [P09-015-F]; Ring Initiative [ACT1109]; FONDEF [D11I1007]; CONICYT [USA2013-0003, ECOS-CONICYTC13S02]; Michael J. Fox Foundation for Parkinson Research; Frick Foundation; Amyotrophic Lateral Sclerosis Therapy Alliance; Muscular Dystrophy Association, Foundation Grant COPEC-UC; FONDECYT Postdoctoral Fellowship [3110067, 3130351]; CONICYT; Foundation for Research on Neurodegenerative Diseases; Swiss National Science Foundation; Comel Foundation; Gabriele Foundation; Gelu Foundation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute(Takeda Pharmaceutical Company Ltd); Ring Initiative; FONDEF; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Michael J. Fox Foundation for Parkinson Research; Frick Foundation; Amyotrophic Lateral Sclerosis Therapy Alliance; Muscular Dystrophy Association, Foundation Grant COPEC-UC(Muscular Dystrophy Association); FONDECYT Postdoctoral Fellowship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Foundation for Research on Neurodegenerative Diseases; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Comel Foundation; Gabriele Foundation; Gelu Foundation	This work was supported in part by FONDECYT Grants 1140549 and 1100176, Millennium Institute Grant P09-015-F, Ring Initiative Grant ACT1109, FONDEF Grant D11I1007, CONICYT Grant USA2013-0003, ECOS-CONICYTC13S02, The Michael J. Fox Foundation for Parkinson Research, The Frick Foundation, Amyotrophic Lateral Sclerosis Therapy Alliance, Muscular Dystrophy Association, Foundation Grant COPEC-UC (to C. H.), FONDECYT Grant 11121524 (to S. M.), FONDECYT Postdoctoral Fellowships 3110067 (to U. W.) and 3130351 (to D. B. M.), CONICYT Ph.D. fellowship (to M. T. and V. H. C.), and Master fellowship (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Signora Alessandra, by the Foundation for Research on Neurodegenerative Diseases, the Swiss National Science Foundation, and the Comel, Gabriele, and Gelu Foundations.	Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Capellari S, 1999, J BIOL CHEM, V274, P34846, DOI 10.1074/jbc.274.49.34846; Castillo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136620; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moreno J. A., 2013, TRANSL MED, V5; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Moya KL, 2005, J NEUROCHEM, V92, P1044, DOI 10.1111/j.1471-4159.2004.02940.x; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B., 2014, PRION, V8, P1; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Tompa P, 2002, BIOPHYS J, V82, P1711, DOI 10.1016/S0006-3495(02)75523-9; Torres M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036159; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Wang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014602; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Welker E, 2001, P NATL ACAD SCI USA, V98, P4334, DOI 10.1073/pnas.071066598; Xu K, 2012, REV NEUROSCIENCE, V23, P79, DOI [10.1515/RNS.2011.062, 10.1515/rns.2011.062]; Yanai A, 1999, FEBS LETT, V460, P11, DOI 10.1016/S0014-5793(99)01316-2; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6	70	41	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23631	23645		10.1074/jbc.M114.635565	http://dx.doi.org/10.1074/jbc.M114.635565			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26170458	Green Published, hybrid			2022-12-28	WOS:000361816500014
J	Feng, X; Coulombe, PA				Feng, Xia; Coulombe, Pierre A.			Complementary Roles of Specific Cysteines in Keratin 14 toward the Assembly, Organization, and Dynamics of Intermediate Filaments in Skin Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; SULFHYDRYL OXIDASE; POINT MUTATIONS; DISULFIDE BONDS; DISEASE; EPITHELIA; DIFFERENTIATION; CYTOSKELETON; MECHANISMS; DISORDERS	We recently showed that inter-keratin disulfide bonding plays an important role in the assembly, organization, and dynamics of keratin intermediate filaments in skin keratinocytes. In particular, cysteine 367 located in the central alpha-helical rod domain of keratin 14 is necessary for the formation of a stable perinuclear network of keratin filaments (with type II partner keratin 5) in skin keratinocytes analyzed by static and live cell imaging. Here, we show that two additional cysteine residues located in the non-helical head domain of K14, Cys-4 and Cys-40, also participate in inter-keratin disulfide bonding and tandemly play a key role complementary to that of Cys-367 in the assembly, organization, and dynamics of keratin filaments in skin keratinocytes in primary culture. Analysis of K14 variants with single or multiple substitutions of cysteine residues points to a spatial and temporal hierarchy in how Cys-4/Cys-40 and Cys-367 regulate keratin assembly in vitro and filament dynamics in live keratinocytes in culture. Our findings substantiate the importance and complexity of a novel determinant, namely inter-keratin disulfide bonding, for the regulation of several aspects of keratin filaments in surface epithelia.	[Feng, Xia; Coulombe, Pierre A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	coulombe@jhu.edu	Regan, Clinton/E-6250-2012	Feng, Xia/0000-0003-2460-192X	National Institutes of Health [S10 OD016374]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to members of the Coulombe laboratory for support; to Jill Hakim and Janet Folmer for technical assistance; to the School of Medicine Microscope Facility for live cell imaging experiments (National Institutes of Health Grant S10 OD016374); and to Valeria Culotta, Michael Matunis, Andrew Ewald, and Ryan Hobbs for advice.	AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131; AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341; Clarke SJ, 2006, NAT MATER, V5, P409, DOI 10.1038/nmat1631; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Darby N, 1995, Methods Mol Biol, V40, P219; Feng X, 2015, J CELL BIOL, V209, P59, DOI 10.1083/jcb.201408079; Feng X, 2013, J INVEST DERMATOL, V133, P850, DOI 10.1038/jid.2012.397; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hashimoto Y, 2000, ARCH DERMATOL RES, V292, P570, DOI 10.1007/s004030000171; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Saaranen MJ, 2013, ANTIOXID REDOX SIGN, V19, P36, DOI 10.1089/ars.2012.4868; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STRICKLAND JE, 1988, CANCER RES, V48, P165; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; TAKAMORI K, 1980, BIOCHIM BIOPHYS ACTA, V615, P309, DOI 10.1016/0005-2744(80)90499-4; Thiele JJ, 2001, CURR PROBL DERMATOL, V29, P26; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; Windoffer R, 2004, METHOD CELL BIOL, V78, P321; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095	39	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22507	22519		10.1074/jbc.M115.654749	http://dx.doi.org/10.1074/jbc.M115.654749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216883	Green Published, hybrid			2022-12-28	WOS:000361171500018
J	Irimia, JM; Tagliabracci, VS; Meyer, CM; Segvich, DM; DePaoli-Roach, AA; Roach, PJ				Irimia, Jose M.; Tagliabracci, Vincent S.; Meyer, Catalina M.; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.			Muscle Glycogen Remodeling and Glycogen Phosphate Metabolism following Exhaustive Exercise of Wild Type and Laforin Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; SKELETAL-MUSCLE; INSULIN SENSITIVITY; POMPE DISEASE; AUTOPHAGY; GLUCOSE; SYNTHASE; ACCUMULATION; GRANULE; BODIES	Glycogen, the repository of glucose in many cell types, contains small amounts of covalent phosphate, of uncertain function and poorly understood metabolism. Loss-of-function mutations in the laforin gene cause the fatal neurodegenerative disorder, Lafora disease, characterized by increased glycogen phosphorylation and the formation of abnormal deposits of glycogen- like material called Lafora bodies. It is generally accepted that the phosphate is removed by the laforin phosphatase. To study the dynamics of skeletal muscle glycogen phosphorylation in vivo under physiological conditions, mice were subjected to glycogen-depleting exercise and then monitored while they resynthesized glycogen. Depletion of glycogen by exercise was associated with a substantial reduction in total glycogen phosphate and the newly resynthesized glycogen was less branched and less phosphorylated. Branching returned to normal on a time frame of days, whereas phosphorylation remained suppressed over a longer period of time. We observed no change in markers of autophagy. Exercise of 3-month-old laforin knockout mice caused a similar depletion of glycogen but no loss of glycogen phosphate. Furthermore, remodeling of glycogen to restore the basal branching pattern was delayed in the knockout animals. From these results, we infer that 1) laforin is responsible for glycogen dephosphorylation during exercise and acts during the cytosolic degradation of glycogen, 2) excess glycogen phosphorylation in the absence of laforin delays the normal remodeling of the branching structure, and 3) the accumulation of glycogen phosphate is a relatively slow process involving multiple cycles of glycogen synthesis-degradation, consistent with the slow onset of the symptoms of Lafora disease.	[Irimia, Jose M.; Tagliabracci, Vincent S.; Meyer, Catalina M.; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK27221, NS56454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R01DK027221, R56DK027221, P30DK097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 and NS56454. The authors disclose no actual or perceived conflicts of interest.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andrade D M, 2007, Acta Myol, V26, P83; Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2014, J BIOL CHEM, V289, P20606, DOI 10.1074/jbc.M114.580167; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hirschhorn R., 2000, METABOLIC MOL BASES, P3389; Irimia JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042453; Jensen TE, 2012, J PHYSIOL-LONDON, V590, P1069, DOI 10.1113/jphysiol.2011.224972; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; KIRKMAN B R, 1990, Biofactors, V2, P193; Knecht E, 2010, AUTOPHAGY, V6, P991, DOI [10.4161/auto.6.7.13308, 10.4161/auto6.7.13308]; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; Marchand I, 2007, J PHYSIOL-LONDON, V580, P617, DOI 10.1113/jphysiol.2006.122457; Marchand I, 2002, J APPL PHYSIOL, V93, P1598, DOI 10.1152/japplphysiol.00585.2001; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Nielsen J, 2011, J PHYSIOL-LONDON, V589, P2871, DOI 10.1113/jphysiol.2010.204487; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2003, BIOCHEM BIOPH RES CO, V305, P826, DOI 10.1016/S0006-291X(03)00862-3; Pederson BA, 2013, ANN NEUROL, V74, P297, DOI 10.1002/ana.23899; Puri R, 2012, AUTOPHAGY, V8, P289, DOI 10.4161/auto.8.2.19010; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Roach P. J., 2013, ROTEIN TYROSINE PHOS, P239; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	55	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22686	22698		10.1074/jbc.M115.673897	http://dx.doi.org/10.1074/jbc.M115.673897			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216881	Green Published, hybrid			2022-12-28	WOS:000361171500033
J	Patel, VA; Massenburg, D; Vujicic, S; Feng, LF; Tang, MY; Litbarg, N; Antoni, A; Rauch, J; Lieberthal, W; Levine, JS				Patel, Vimal A.; Massenburg, Donald; Vujicic, Snezana; Feng, Lanfei; Tang, Meiyi; Litbarg, Natalia; Antoni, Angelika; Rauch, Joyce; Lieberthal, Wilfred; Levine, Jerrold S.			Apoptotic Cells Activate AMP-activated Protein Kinase (AMPK) and Inhibit Epithelial Cell Growth without Change in Intracellular Energy Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING EVENTS; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNE-RESPONSE; NECROTIC CELLS; AKT; PATHWAY; PHOSPHORYLATION; RECOGNITION; BETA; MECHANISMS	Apoptosis plays an indispensable role in the maintenance and development of tissues. We have shown that receptor-mediated recognition of apoptotic target cells by viable kidney proximal tubular epithelial cells (PTECs) inhibits the proliferation and survival of PTECs. Here, we examined the effect of apoptotic targets on PTEC cell growth (cell size during G1 phase of the cell cycle). Using a cell culture model, we show that apoptotic cells potently activate AMP-activated protein kinase (AMPK), a highly sensitive sensor of intracellular energy stores. AMPK activation leads to decreased activity of its downstream target, ribosomal protein p70 S6 kinase (p70S6K), and concomitant inhibition of cell growth. Importantly, these events occur without detectable change in intracellular levels of AMP, ADP, or ATP. Inhibition of AMPK, either pharmacologically by compound C or molecularly by shRNA, diminishes the effects of apoptotic targets and largely restores p70S6K activity and cell size to normal levels. Apoptotic targets also inhibit Akt, a second signaling pathway regulating cell growth. Expression of a constitutively active Akt construct partially relieved cell growth inhibition but was less effective than inhibition of AMPK. Inhibition of cell growth by apoptotic targets is dependent on physical interaction between apoptotic targets and PTECs but independent of phagocytosis. We conclude that receptor-mediated recognition of apoptotic targets mimics the effects of intracellular energy depletion, activating AMPK and inhibiting cell growth. By acting as sentinels of environmental change, apoptotic death may enable nearby viable cells, especially nonmigratory epithelial cells, to monitor and adapt to local stresses.	Univ Illinois, Nephrol Sect, Chicago, IL 60612 USA; [Patel, Vimal A.; Massenburg, Donald; Vujicic, Snezana; Feng, Lanfei; Litbarg, Natalia; Levine, Jerrold S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Levine, Jerrold S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Patel, Vimal A.; Massenburg, Donald; Vujicic, Snezana; Feng, Lanfei; Litbarg, Natalia; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Tang, Meiyi; Lieberthal, Wilfred] SUNY Stony Brook, Med Ctr, Dept Med, Nephrol Sect, Stony Brook, NY 11794 USA; [Tang, Meiyi; Lieberthal, Wilfred] Northport Vet Affairs Hosp, Northport, NY 11768 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Div Rheumatol,Dept Med, Montreal, PQ H4A 3J1, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Nephrol Sect, 840 South Wood St,MC-793, Chicago, IL 60612 USA.	jslevine@uic.edu			National Institutes of Health from NCRR [S10RR024516]; Section of Nephrology, University of Illinois at Chicago; Canadian Institutes of Health Research [MOP-67101, MOP-97916]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024516] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; Section of Nephrology, University of Illinois at Chicago; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant S10RR024516 from NCRR (for purchase of the 5500 QTRAP LC/MS/MS system). This work was also supported by institutional funds from Dr. Jose A. Arruda and the Section of Nephrology, University of Illinois at Chicago (to J. S. L. and N. L.), and Operating Grants MOP-67101 and MOP-97916 from the Canadian Institutes of Health Research (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chen P, 2009, PHARM RES-DORDR, V26, P1504, DOI 10.1007/s11095-009-9863-9; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hess KL, 1997, EXP CELL RES, V236, P404, DOI 10.1006/excr.1997.3745; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2012, J BIOL CHEM, V287, P13761, DOI 10.1074/jbc.M112.350843; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Patel VA, 2009, AUTOIMMUNITY, V42, P317, DOI 10.1080/08916930902832124; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	56	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22352	22369		10.1074/jbc.M115.667345	http://dx.doi.org/10.1074/jbc.M115.667345			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26183782	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000361171500004
J	Lemonidis, K; Sanchez-Perez, MC; Chamberlain, LH				Lemonidis, Kimon; Sanchez-Perez, Maria C.; Chamberlain, Luke H.			Identification of a Novel Sequence Motif Recognized by the Ankyrin Repeat Domain of zDHHC17/13 S-Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-STRING PROTEIN; HUNTINGTIN-INTERACTING PROTEIN-14; DHHC-PALMITOYL-TRANSFERASES; LEUCINE ZIPPER PROTEIN; SHORT LINEAR MOTIFS; CAENORHABDITIS-ELEGANS; SUBSTRATE RECOGNITION; MEMBRANE INTERACTIONS; REGION PREDICTIONS; STRUCTURAL BASIS	S-Acylation is a major post-translational modification affecting several cellular processes. It is particularly important for neuronal functions. This modification is catalyzed by a family of transmembrane S-acyltransferases that contain a conserved zinc finger DHHC (zDHHC) domain. Typically, eukaryote genomes encode for 7-24 distinct zDHHC enzymes, with two members also harboring an ankyrin repeat (AR) domain at their cytosolic N termini. The AR domain of zDHHC enzymes is predicted to engage in numerous interactions and facilitates both substrate recruitment and S-acylation-independent functions; however, the sequence/structural features recognized by this module remain unknown. The two mammalian AR-containing S-acyltransferases are the Golgi-localized zDHHC17 and zDHHC13, also known as Huntingtin-interacting proteins 14 and 14-like, respectively; they are highly expressed in brain, and their loss in mice leads to neuropathological deficits that are reminiscent of Huntington's disease. Here, we report that zDHHC17 and zDHHC13 recognize, via their AR domain, evolutionary conserved and closely related sequences of a [VIAP][VIT] XXQP consensus in SNAP25, SNAP23, cysteine string protein, Huntingtin, cytoplasmic linker protein 3, and microtubule-associated protein 6. This novel AR-binding sequence motif is found in regions predicted to be unstructured and is present in a number of zDHHC17 substrates and zDHHC17/13-interacting S-acylated proteins. This is the first study to identify a motif recognized by AR-containing zDHHCs.	[Lemonidis, Kimon; Sanchez-Perez, Maria C.; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland	University of Strathclyde	Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	luke.chamberlain@strath.ac.uk		Lemonidis, Kimon/0000-0003-1332-6002	Wellcome Trust [WT094184MA]; Medical Research Council [0601597/2]; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust Grant WT094184MA and Medical Research Council Grant 0601597/2. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold C, 2004, J EXP BIOL, V207, P1323, DOI 10.1242/jeb.00898; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bannan Barbra A, 2008, Fly (Austin), V2, P198; Bennett V, 2013, CURR TOP MEMBR, V72, P1, DOI 10.1016/B978-0-12-417027-8.00001-5; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Butland SL, 2014, HUM MOL GENET, V23, P4142, DOI 10.1093/hmg/ddu137; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Edmonds MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-841; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao TY, 2009, PROTEINS, V76, P772, DOI 10.1002/prot.22452; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Gory-Faure S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114905; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Harada T, 2003, GENES CELLS, V8, P493, DOI 10.1046/j.1365-2443.2003.00650.x; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Lemonidis K, 2014, MOL BIOL CELL, V25, P3870, DOI 10.1091/mbc.E14-06-1169; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Milde S, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582338; Milnerwood AJ, 2013, P NATL ACAD SCI USA, V110, P20296, DOI 10.1073/pnas.1222384110; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sanders SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090669; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Song IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092194; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tom CTMB, 2013, ACS CHEM BIOL, V8, P46, DOI 10.1021/cb300607e; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Xu C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002979; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang G, 2012, CELL DEATH DIFFER, V19, P553, DOI 10.1038/cdd.2011.124; Yang G, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003727; Yang G, 2011, J NEUROSCI, V31, P11980, DOI 10.1523/JNEUROSCI.2510-11.2011; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	72	45	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21939	21950		10.1074/jbc.M115.657668	http://dx.doi.org/10.1074/jbc.M115.657668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198635	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000360968500015
J	Yang, XX; Yao, H; Chen, YL; Sun, L; Li, Y; Ma, XZ; Duan, SZ; Li, XJ; Xiang, R; Han, JH; Duan, YJ				Yang, Xiaoxiao; Yao, Hui; Chen, Yuanli; Sun, Lei; Li, Yan; Ma, Xingzhe; Duan, Shengzhong; Li, Xiaoju; Xiang, Rong; Han, Jihong; Duan, Yajun			Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; MONOCYTE-DERIVED MACROPHAGES; B SCAVENGER RECEPTOR; VITAMIN-E; PPAR-GAMMA; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; MODIFIER SUBUNIT; OXIDATIVE STRESS; GENE-EXPRESSION	The glutathione (GSH)-dependent antioxidant system has been demonstrated to inhibit atherosclerosis. Macrophage CD36 uptakes oxidized low density lipoprotein (oxLDL) thereby facilitating foam cell formation and development of atherosclerosis. It remains unknown if GSH can influence macrophage CD36 expression and cellular oxLDL uptake directly. Herein we report that treatment of macrophages with L-buthionine-S, R-sulfoximine (BSO) decreased cellular GSH production and ratios of GSH to glutathione disulfide (GSH/GSSG) while increasing production of reactive oxygen species. Associated with decreased GSH levels, macrophage CD36 expression was increased, which resulted in enhanced cellular oxLDL uptake. In contrast, N-acetyl cysteine and antioxidant enzyme (catalase or superoxide dismutase) blocked BSO-induced CD36 expression as well as oxLDL uptake. In vivo, administration of mice with BSO increased CD36 expression in peritoneal macrophages and kidneys. BSO had no effect on CD36 mRNA expression and promoter activity but still induced CD36 protein expression in macrophages lacking peroxisome proliferator-activated receptor gamma expression, suggesting it induced CD36 expression at the translational level. Indeed, we determined that BSO enhanced CD36 translational efficiency. Taken together, our study demonstrates that cellular GSH levels and GSH/GSSG status can regulate macrophage CD36 expression and cellular oxLDL uptake and demonstrate an important anti-atherogenic function of the GSH-dependent antioxidant system by providing a novel molecular mechanism.	[Yang, Xiaoxiao; Yao, Hui; Chen, Yuanli; Xiang, Rong; Han, Jihong; Duan, Yajun] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yang, Xiaoxiao; Yao, Hui; Sun, Lei; Li, Yan; Ma, Xingzhe; Li, Xiaoju; Duan, Yajun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Yuanli; Xiang, Rong] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Chen, Yuanli; Han, Jihong] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China; [Duan, Shengzhong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Han, JH (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	jihonghan2008@nankai.edu.cn; yajunduan@nankai.edu.cn			National Science Foundation of China (NSFC) [81272460, 81473204, 31400694]; Tianjin Municipal Science and Technology Commission of China [14JCY-BJC25100, 13JCYBJC24600]; Nankai University	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China; Nankai University	This work was supported by National Science Foundation of China (NSFC) Grants 81272460 and 81473204 (to J. H.) and 31400694 (to Y. C.), Tianjin Municipal Science and Technology Commission of China Grants 14JCY-BJC25100 (to Y. D.) and 13JCYBJC24600 (to X. L.), respectively, and the Ph.D. Candidate Research Innovation Fund of Nankai University (to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Aviram M, 1999, ANTIOXID REDOX SIGN, V1, P585, DOI 10.1089/ars.1999.1.4-585; Babaev VR, 2011, FREE RADICAL BIO MED, V50, P27, DOI 10.1016/j.freeradbiomed.2010.10.702; Babaev VR, 2010, ARTERIOSCL THROM VAS, V30, P1751, DOI 10.1161/ATVBAHA.110.209502; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Callegari A, 2011, ARTERIOSCL THROM VAS, V31, P2473, DOI 10.1161/ATVBAHA.111.229765; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Devaraj S, 2001, J LIPID RES, V42, P521; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Koide S, 2003, J AM COLL CARDIOL, V41, P539, DOI 10.1016/S0735-1097(02)02866-8; Kotla S, 2014, FREE RADICAL BIO MED, V76, P147, DOI 10.1016/j.freeradbiomed.2014.08.007; Lee JG, 2008, CELL SIGNAL, V20, P2266, DOI 10.1016/j.cellsig.2008.08.022; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; MACH M, 1986, J BIOL CHEM, V261, P1697; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakamura S, 2002, CIRCULATION, V105, P2968, DOI 10.1161/01.CIR.0000019739.66514.1E; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nikulina MA, 2000, CYTOKINE, V12, P1391, DOI 10.1006/cyto.2000.0712; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Qiao M, 2007, ARTERIOSCL THROM VAS, V27, P1375, DOI 10.1161/ATVBAHA.107.142109; Qiao M, 2009, ARTERIOSCL THROM VAS, V29, P1779, DOI 10.1161/ATVBAHA.109.191759; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Rosenblat M, 1998, FREE RADICAL BIO MED, V24, P305, DOI 10.1016/S0891-5849(97)00231-1; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schwenke DC, 1998, CIRC RES, V83, P366, DOI 10.1161/01.RES.83.4.366; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Thomas SR, 2001, ARTERIOSCL THROM VAS, V21, P585, DOI 10.1161/01.ATV.21.4.585; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang C, 2014, BIOCHEM BIOPH RES CO, V447, P57, DOI 10.1016/j.bbrc.2014.03.103; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025	50	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21788	21799		10.1074/jbc.M115.654582	http://dx.doi.org/10.1074/jbc.M115.654582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26187465	Green Published, hybrid			2022-12-28	WOS:000360968500002
J	Chung, C; Wu, WH; Chen, BS				Chung, Connie; Wu, Wei-Hua; Chen, Bo-Shiun			Identification of Novel 14-3-3 Residues That Are Critical for Isoform-specific Interaction with GluN2C to Regulate N-Methyl-D-aspartate (NMDA) Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT-SPECIFIC REGULATION; NR2C SUBUNIT; STRUCTURAL BASIS; RAT-BRAIN; MEMBRANE-PROTEINS; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; SURFACE EXPRESSION; SPLICE VARIANTS	The 14-3-3 family of proteins is widely distributed in the CNS where they are major regulators of essential neuronal functions. There are seven known mammalian 14-3-3 isoforms (zeta,gamma, tau, epsilon, eta, beta, and sigma), which generally function as adaptor proteins. Previously, we have demonstrated that 14-3-3 epsilon isoform dynamically regulates forward trafficking of GluN2C-containing NMDA receptors (NMDARs) in cerebellar granule neurons, that when expressed on the surface, promotes neuronal survival following NMDA-induced excitotoxicity. Here, we report 14-3-3 isoform-specific binding and functional regulation of GluN2C. In particular, we show that GluN2C C-terminal domain (CTD) binds to all 14-3-3 isoforms except 14-3-3 sigma, and binding is dependent on GluN2C serine 1096 phosphorylation. Co-expression of 14-3-3 (zeta and epsilon) and GluN1/ GluN2C promotes the forward delivery of receptors to the cell surface. We further identify novel residues serine 145, tyrosine 178, and cysteine 189 on alpha-helices 6, 7, and 8, respectively, within zeta-isoform as part of the GluN2C binding motif and independent of the canonical peptide binding groove. Mutation of these conserved residues abolishes GluN2C binding and has no functional effect on GluN2C trafficking. Reciprocal mutation of alanine 145, histidine 180, and isoleucine 191 on 14-3-3 sigma isoform promotes GluN2C binding and surface expression. Moreover, inhibiting endogenous 14-3-3 using a high-affinity peptide inhibitor, difopein, greatly diminishes GluN2C surface expression. Together, these findings highlight the isoform-specific structural and functional differences within the 14-3-3 family of proteins, which determine GluN2C binding and its essential role in targeting the receptor to the cell surface to facilitate glutamatergic neurotransmission.	[Chen, Bo-Shiun] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, BS (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, CA 3008,1120 15th St, Augusta, GA 30912 USA.	bochen@gru.edu		Chung, Connie/0000-0002-3065-7498	National Institutes of Health NINDS [R00NS057266]; NCI [1K22CA122453]; NATIONAL CANCER INSTITUTE [K22CA122453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS057266] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS Career Transition Award R00NS057266 (to B.-S. C.) and an NCI Career Transition Award 1K22CA122453 (to W.-H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Binshtok AM, 2006, J NEUROSCI, V26, P708, DOI 10.1523/JNEUROSCI.4409-05.2006; Brennan GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054491; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dalal SN, 2004, CELL CYCLE, V3, P672; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Kaniakova M, 2012, J BIOL CHEM, V287, P26423, DOI 10.1074/jbc.M112.339085; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001; Kumar SS, 2003, J NEUROSCI, V23, P10074; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lichnerova K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00375; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; PEREZVELAZQUEZ JL, 1994, J NEUROCHEM, V63, P1171; POLLARD H, 1993, NEUROREPORT, V4, P411, DOI 10.1097/00001756-199304000-00018; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roque PJ, 2011, METHODS MOL BIOL, V758, P361, DOI 10.1007/978-1-61779-170-3_25; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Small DL, 1997, NEUROSCI LETT, V232, P87, DOI 10.1016/S0304-3940(97)00592-2; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Umahara T, 2009, BRAIN RES, V1253, P15, DOI 10.1016/j.brainres.2008.11.065; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; Wei Z, 2015, J BIOL CHEM, V290, P5105, DOI 10.1074/jbc.M114.599969; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2	49	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23188	23200		10.1074/jbc.M115.648436	http://dx.doi.org/10.1074/jbc.M115.648436			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229101	hybrid, Green Published			2022-12-28	WOS:000361685500029
J	Weston, C; Lu, J; Li, NC; Barkan, K; Richards, GO; Roberts, DJ; Skerry, TM; Poyner, D; Pardamwar, M; Reynolds, CA; Dowell, SJ; Willars, GB; Ladds, G				Weston, Cathryn; Lu, Jing; Li, Naichang; Barkan, Kerry; Richards, Gareth O.; Roberts, David J.; Skerry, Timothy M.; Poyner, David; Pardamwar, Meenakshi; Reynolds, Christopher A.; Dowell, Simon J.; Willars, Gary B.; Ladds, Graham			Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; CALCITONIN-RECEPTOR; COUPLED RECEPTORS; DIFFERENTIALLY MODULATE; ADENYLYL-CYCLASE; AMYLIN RECEPTORS; YEAST; OXYNTOMODULIN; AGONIST; ADRENOMEDULLIN	The glucagon and glucagon-like peptide-1 (GLP-1) receptors play important, opposing roles in regulating blood glucose levels. Consequently, these receptors have been identified as targets for novel diabetes treatments. However, drugs acting at the GLP-1 receptor, although having clinical efficacy, have been associated with severe adverse side-effects, and targeting of the glucagon receptor has yet to be successful. Here we use a combination of yeast reporter assays and mammalian systems to provide a more complete understanding of glucagon receptor signaling, considering the effect of multiple ligands, association with the receptor-interacting protein receptor activity-modifying protein-2 (RAMP2), and the role of individual G protein alpha-subunits. We demonstrate that RAMP2 alters both ligand selectivity and G protein preference of the glucagon receptor. Importantly, we also uncover novel cross-reactivity of therapeutically used GLP-1 receptor ligands at the glucagon receptor that is abolished by RAMP2 interaction. This study reveals the glucagon receptor as a previously unidentified target for GLP-1 receptor agonists and highlights a role for RAMP2 in regulating its pharmacology. Such previously unrecognized functions of RAMPs highlight the need to consider all receptor-interacting proteins in future drug development.	[Weston, Cathryn; Barkan, Kerry; Ladds, Graham] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Lu, Jing; Li, Naichang; Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Richards, Gareth O.; Roberts, David J.; Skerry, Timothy M.] Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield S10 2RX, S Yorkshire, England; [Poyner, David] Aston Univ, Sch Life Sci, Birmingham B4 7ET, W Midlands, England; [Pardamwar, Meenakshi; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Dowell, Simon J.] GlaxoSmithKline, Dept Biol Sci, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Ladds, Graham] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Warwick; University of Leicester; University of Sheffield; Aston University; University of Essex; GlaxoSmithKline; University of Cambridge	Weston, C (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England.	caw38@leicester.ac.uk; grl30@cam.ac.uk	; Reynolds, Christopher/G-1036-2010	Dowell, Simon/0000-0001-6499-7573; Richards, Gareth Owain/0000-0001-7984-6882; Skerry, Timothy/0000-0003-1319-5575; Poyner, David R/0000-0003-1590-112X; Ladds, Graham/0000-0001-7320-9612; Reynolds, Christopher/0000-0001-9267-5141	Warwick Impact Fund; Biotechnology and Biological Sciences Research Council [BB/G01227X/1, BB/F008392/1, BB/M007529/1, BB/M000176/1]; Warwick Research Development Fund [RD13301]; Birmingham Science City Research Alliance; BBSRC [BB/G01227X/1, BB/M00015X/1, BB/M006883/1, BB/F008392/1, BB/M00015X/2, BB/M007529/1, BB/M000176/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M00015X/2, BB/M00015X/1, BB/M006883/1] Funding Source: researchfish; Prostate Cancer UK [PA12-12] Funding Source: researchfish	Warwick Impact Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Warwick Research Development Fund; Birmingham Science City Research Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prostate Cancer UK	This work was supported by the Warwick Impact Fund (to C. W. and G. L.), Biotechnology and Biological Sciences Research Council Grants BB/G01227X/1 (to G. L.), BB/F008392/1 (to T. S., G. R., and D. R.), and BB/M007529/1 and BB/M000176/1 (to D. P.); Warwick Research Development Fund Grant RD13301 (to C. W. and G. L.); and the Birmingham Science City Research Alliance (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Ali S, 2015, MOL METAB, V4, P132, DOI 10.1016/j.molmet.2014.11.005; Bagger JI, 2011, DIABETES OBES METAB, V13, P965, DOI 10.1111/j.1463-1326.2011.01427.x; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bertheleme N, 2013, BRIT J PHARMACOL, V169, P988, DOI 10.1111/bph.12165; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bond M, 2013, YEAST, V30, P145, DOI 10.1002/yea.2949; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown AJ, 2011, J PHARMACOL EXP THER, V337, P236, DOI 10.1124/jpet.110.172650; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Croft W, 2013, J BIOL CHEM, V288, P27327, DOI 10.1074/jbc.M113.497826; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GRADY T, 1987, J BIOL CHEM, V262, P15514; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hay DL, 2006, MOL PHARMACOL, V70, P1984, DOI 10.1124/mol.106.027953; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Husmann K, 2000, MOL CELL ENDOCRINOL, V162, P35, DOI 10.1016/S0303-7207(00)00212-4; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Marks J, 2003, CLIN SCI, V104, P253, DOI 10.1042/CS20020336; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Rudling JE, 1999, BRIT J PHARMACOL, V127, P877, DOI 10.1038/sj.bjp.0702614; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Schepp W, 1996, DIGESTION, V57, P398, DOI 10.1159/000201367; Scott DA, 2013, DIABETES OBES METAB, V15, P213, DOI 10.1111/dom.12007; Shen DM, 2011, EXPERT OPIN THER PAT, V21, P1211, DOI 10.1517/13543776.2011.587001; Shyu JF, 1999, EUR J BIOCHEM, V262, P95, DOI 10.1046/j.1432-1327.1999.00346.x; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Stewart GD, 2009, J PHARMACOL EXP THER, V331, P277, DOI 10.1124/jpet.109.158667; Totsune K, 2000, CLIN SCI, V99, P541, DOI 10.1042/CS20000108; Udawela M, 2006, MOL PHARMACOL, V69, P1984, DOI 10.1124/mol.105.021915; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Usdin TB, 1999, NAT NEUROSCI, V2, P941, DOI 10.1038/14724; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390; Xu YZ, 2009, J RECEPT SIG TRANSD, V29, P318, DOI 10.3109/10799890903295150	50	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23009	23022		10.1074/jbc.M114.624601	http://dx.doi.org/10.1074/jbc.M114.624601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26198634	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000361685500013
J	Carbone, V; Schofield, LR; Zhang, YL; Sang, C; Dey, D; Hannus, IM; Martin, WF; Sutherland-Smith, AJ; Ronimus, RS				Carbone, Vincenzo; Schofield, Linley R.; Zhang, Yanli; Sang, Carrie; Dey, Debjit; Hannus, Ingegerd M.; Martin, William F.; Sutherland-Smith, Andrew J.; Ronimus, Ron S.			Structure and Evolution of the Archaeal Lipid Synthesis Enzyme sn-Glycerol-1-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; dehydrogenase; evolution; lipid synthesis; phylogenetics; structural biology; thermophile; cell membrane; sn-glycerol-1-phosphate dehydrogenase; stereospecific	ENANTIOMERIC GLYCEROPHOSPHATE BACKBONE; DEHYDROQUINATE SYNTHASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; HYPERTHERMOPHILIC ARCHAEON; 3 DOMAINS; BIOSYNTHESIS; ORIGIN; CELLS; IDENTIFICATION; MEMBRANES	Background: Archaea synthesize glycerol-based membrane lipids of unique stereochemistry, utilizing distinct enzymology. Results: The structure of sn-glycerol-1-phosphate dehydrogenase (G1PDH), the first step in archaeal lipid synthesis, was determined. Conclusion: G1PDH is a member of the iron-dependent alcohol dehydrogenase and dehydroquinate synthase superfamily. Significance: The data contribute to our understanding of the origins of cellular lipids at the divergence of the Archaea and Bacteria. One of the most critical events in the origins of cellular life was the development of lipid membranes. Archaea use isoprenoid chains linked via ether bonds to sn-glycerol 1-phosphate (G1P), whereas bacteria and eukaryotes use fatty acids attached via ester bonds to enantiomeric sn-glycerol 3-phosphate. NAD(P)H-dependent G1P dehydrogenase (G1PDH) forms G1P and has been proposed to have played a crucial role in the speciation of the Archaea. We present here, to our knowledge, the first structures of archaeal G1PDH from the hyperthermophilic methanogen Methanocaldococcus jannaschii with bound substrate dihydroxyacetone phosphate, product G1P, NADPH, and Zn2+ cofactor. We also biochemically characterized the enzyme with respect to pH optimum, cation specificity, and kinetic parameters for dihydroxyacetone phosphate and NAD(P)H. The structures provide key evidence for the reaction mechanism in the stereospecific addition for the NAD(P)H-based pro-R hydrogen transfer and the coordination of the Zn2+ cofactor during catalysis. Structure-based phylogenetic analyses also provide insight into the origins of G1PDH.	[Carbone, Vincenzo; Schofield, Linley R.; Zhang, Yanli; Sang, Carrie; Dey, Debjit; Hannus, Ingegerd M.; Ronimus, Ron S.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North 4442, New Zealand; [Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Sutherland-Smith, Andrew J.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand	AgResearch - New Zealand; Heinrich Heine University Dusseldorf; Massey University	Ronimus, RS (corresponding author), AgResearch Ltd, Anim Nutr & Hlth, Grasslands Res Ctr, Tennent Dr,Private Bag 11008, Palmerston North 4442, New Zealand.	ron.ronimus@agresearch.co.nz	Martin, William F./O-5446-2015; Sutherland-Smith, Andrew/F-1813-2011	Martin, William F./0000-0003-1478-6449; Sutherland-Smith, Andrew/0000-0001-9485-1428; Sang, Carrie/0000-0003-4368-1558; carbone, vincenzo/0000-0003-4231-2785; Ronimus, Ron/0000-0001-8669-5840; /0000-0001-7288-2792	Pastoral Greenhouse Gas Research Consortium; Royal Society of New Zealand; New Zealand Synchrotron Group; Australian Synchrotron Foundation investor access program	Pastoral Greenhouse Gas Research Consortium; Royal Society of New Zealand(Royal Society of New Zealand); New Zealand Synchrotron Group; Australian Synchrotron Foundation investor access program	This work was supported by the Pastoral Greenhouse Gas Research Consortium, the Royal Society of New Zealand, the New Zealand Synchrotron Group, and the Australian Synchrotron Foundation investor access program. The authors declare no conflicts of interest.	Alarcon DA, 2012, ACTA CRYSTALLOGR F, V68, P1279, DOI 10.1107/S1744309112037736; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Boucher Y, 2004, MOL MICROBIOL, V52, P515, DOI 10.1111/j.1365-2958.2004.03992.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter EP, 1998, NATURE, V394, P299, DOI 10.1038/28431; Daiyasu H, 2002, PROTEIN ENG, V15, P987, DOI 10.1093/protein/15.12.987; Dibrova DV, 2014, ENVIRON MICROBIOL, V16, P907, DOI 10.1111/1462-2920.12359; Doolittle WF, 2000, SCI AM, V282, P90, DOI 10.1038/scientificamerican0200-90; Elleuche S, 2013, APPL MICROBIOL BIOT, V97, P8963, DOI 10.1007/s00253-013-4725-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Grochowski LL, 2008, ANN NY ACAD SCI, V1125, P190, DOI 10.1196/annals.1419.001; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Guldan H, 2011, ANGEW CHEM INT EDIT, V50, P8188, DOI 10.1002/anie.201101832; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Han Jin-Suk, 2005, Archaea, V1, P311, DOI 10.1155/2005/257264; Han JS, 2002, EUR J BIOCHEM, V269, P969, DOI 10.1046/j.0014-2956.2001.02731.x; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Jain S, 2014, CHEM BIOL, V21, P1392, DOI 10.1016/j.chembiol.2014.07.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandler Otto, 1998, P19; Koga Y, 2006, BIOSCI BIOTECH BIOCH, V70, P282, DOI 10.1271/bbb.70.282; Koga Y, 2003, BIOSCI BIOTECH BIOCH, V67, P1605, DOI 10.1271/bbb.67.1605; Koga Y, 1998, J MOL EVOL, V46, P54, DOI 10.1007/PL00006283; Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652; Koga Y, 2014, J MOL EVOL, V78, P234, DOI 10.1007/s00239-014-9613-4; Koga Y, 2011, J MOL EVOL, V72, P274, DOI 10.1007/s00239-011-9428-5; Koonin EV, 2009, ANN NY ACAD SCI, V1178, P47, DOI 10.1111/j.1749-6632.2009.04992.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lane N, 2010, BIOESSAYS, V32, P271, DOI 10.1002/bies.200900131; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Lombard J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/630910; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin WF, 2014, SCIENCE, V344, P1092, DOI 10.1126/science.1251653; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mittelstadt G, 2013, ARCH BIOCHEM BIOPHYS, V537, P185, DOI 10.1016/j.abb.2013.07.022; Moon JH, 2011, J MOL BIOL, V407, P413, DOI 10.1016/j.jmb.2011.01.045; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakatani Y, 2014, ORIGINS LIFE EVOL B, V44, P197, DOI 10.1007/s11084-014-9365-6; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; NISHIHARA M, 1995, J BIOCHEM-TOKYO, V117, P933, DOI 10.1093/oxfordjournals.jbchem.a124822; Nishihara M, 1997, J BIOCHEM-TOKYO, V122, P572; Nogly P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5169; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Sciara G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5068; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; Sojo V, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001926; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sugahara M, 2005, PROTEINS, V58, P249, DOI 10.1002/prot.20281; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wachtershauser G, 2003, MOL MICROBIOL, V47, P13, DOI 10.1046/j.1365-2958.2003.03267.x; Wedlock DN, 2010, NEW ZEAL VET J, V58, P29, DOI 10.1080/00480169.2010.65058; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	71	13	14	1	44	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21690	21704		10.1074/jbc.M115.647461	http://dx.doi.org/10.1074/jbc.M115.647461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175150	Green Published, hybrid			2022-12-28	WOS:000360637600040
J	Huang, YL; Pai, FS; Tsou, YT; Mon, HC; Hsu, TL; Wu, CY; Chou, TY; Yang, WB; Chen, CH; Wong, CH; Hsieh, SL				Huang, Ya-Lang; Pai, Feng-Shuo; Tsou, Yun-Ting; Mon, Hsien-Chen; Hsu, Tsui-Ling; Wu, Chung-Yi; Chou, Teh-Ying; Yang, Wen-Bin; Chen, Chung-Hsuan; Wong, Chi-Huey; Hsieh, Shie-Liang			Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycobiology; glycoconjugate; glycolipid; glycoprotein; lectin	CAP SUPERFAMILY; RECOGNITION; MODULATION; PROTEINS	Background: CLEC18 is a novel C-type lectin not being characterized. Results: The amino acid residue in the C-type lectin-like domain of CLEC18 contribute to the differential glycan-binding ability. Conclusion: CLEC18 members are expressed in immune and non-immune cells, and preferentially bind to fucoidan, -glucan, and galactan. Significance: The biochemical features, tissue distribution, and the glycan-binding specificity suggest that CLEC18 may contribute to host immunity against pathogens. The human C-type lectin 18 (clec18) gene cluster, which contains three clec18a, clec18b, and clec18c loci, is located in human chromosome 16q22. Although the amino acid sequences of CLEC18A, CLEC18B, and CLEC18C are almost identical, several amino acid residues located in the C-type lectin-like domain (CTLD) and the sperm-coating protein/Tpx-1/Ag5/PR-1/Sc7 (SCP/TAPS) domain, also known as the cysteine-rich secretory proteins/antigen 5/pathogenesis-related 1 proteins (CAP) domain, are distinct from each other. Genotyping by real-time PCR and sequencing further shows the presence of multiple alleles in clec18a/b/c loci. Flow cytometry analysis demonstrates that CLEC18 (CLEC18A, -B, and -C) are expressed abundantly in human peripheral blood cells. Moreover, CLEC18 expression is further up-regulated when monocytes differentiate into macrophages and dendritic cells. Immunofluorescence staining reveals that CLEC18 are localized in the endoplasmic reticulum, Golgi apparatus, and endosome. Interestingly, CLEC18 are also detectable in human sera and culture supernatants from primary cells and 293T cells overexpressing CLEC18. Moreover, CLEC18 bind polysaccharide in Ca2+-independent manner, and amino acid residues Ser/Arg(339) and Asp/Asn(421) in CTLD domain contribute to their differential binding abilities to polysaccharides isolated from Ganoderma lucidum (GLPS-F3). The Ser(339) (CLEC18A) Arg(339) (CLEC18A-1) mutation completely abolishes CLEC18A-1 binding to GLPS-F3, and a sugar competition assay shows that CLEC18 preferentially binds to fucoidan, -glucans, and galactans. Because proteins with the SCP/TAPS/CAP domain are able to bind sterol and acidic glycolipid, and are involved in sterol transport and -amyloid aggregation, it would be interesting to investigate whether CLEC18 modulates host immunity via binding to glycolipids, and are also involved in glycolipid transportation and protein aggregation in the future.	[Huang, Ya-Lang; Tsou, Yun-Ting; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Pai, Feng-Shuo; Chou, Teh-Ying; Hsieh, Shie-Liang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Mon, Hsien-Chen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hsu, Tsui-Ling; Wu, Chung-Yi; Yang, Wen-Bin; Chen, Chung-Hsuan; Wong, Chi-Huey; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Hsieh, Shie-Liang] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Taipei Medical University	Hsieh, SL (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	slhsieh@gate.sinica.edu.tw	Wu, Chung-Yi/K-8334-2018; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Hsu, Tsui-Ling/AAE-8821-2019; Hsu, Tsui-Ling/H-6704-2015	Hsu, Tsui-Ling/0000-0002-2912-3261; Hsieh, Shie-Liang/0000-0001-9415-346X	National Institutes of Health NIGMS [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the BioLegend (R) for their technique support and related antibody preparation. The glycan arrays were provided by the Consortium for the Functional Glycomics funded by National Institutes of Health NIGMS Grant GM62116.	Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Chang YC, 2004, J LEUKOCYTE BIOL, V75, P486, DOI 10.1189/jlb.0903448; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Hsu TL, 2002, J IMMUNOL, V168, P4846, DOI 10.4049/jimmunol.168.10.4846; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Olrichs NK, 2014, AMYLOID, V21, P88, DOI 10.3109/13506129.2014.882304; Poget SF, 2001, BIOCHEMISTRY-US, V40, P10966, DOI 10.1021/bi002698z; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; Stanley P., 2009, ESSENTIALS GLYCOBIOL, P425; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	20	16	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21252	21263		10.1074/jbc.M115.649814	http://dx.doi.org/10.1074/jbc.M115.649814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170455	Green Published, hybrid			2022-12-28	WOS:000360637600006
J	Sakanaka, A; Kuboniwa, M; Takeuchi, H; Hashino, E; Amano, A				Sakanaka, Akito; Kuboniwa, Masae; Takeuchi, Hiroki; Hashino, Ei; Amano, Atsuo			Arginine-Ornithine Antiporter ArcD Controls Arginine Metabolism and Interspecies Biofilm Development of Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofilm; cell metabolism; metabolic regulation; metabolomics; Streptococcus; symbiosis; Fusobacterium; arginine metabolism; cross-feeding; ornithine export	ORAL MICROBIAL COMMUNITY; HUMAN DENTAL PLAQUE; FUSOBACTERIUM-NUCLEATUM; PORPHYROMONAS-GINGIVALIS; PSEUDOMONAS-AERUGINOSA; ACTINOMYCES-NAESLUNDII; MULTISPECIES BIOFILM; BIOLOGICAL FITNESS; DEIMINASE OPERON; MEMBRANE-PROTEIN	Background: Arginine and its derivatives are key factors for inter-bacterial communication in periodontal microflora. Results: ArcD-mediated export of ornithine by oral commensal Streptococcus gordonii facilitates biofilm development of Fusobacterium nucleatum. Conclusion: Ornithine cross-feeding from S. gordonii to F. nucleatum mediates dental biofilm maturation. Significance: This is the first report of metabolic cross-feeding between S. gordonii and F. nucleatum. Arginine is utilized by the oral inhabitant Streptococcus gordonii as a substrate of the arginine deiminase system (ADS), eventually producing ATP and NH3, the latter of which is responsible for microbial resistance to pH stress. S. gordonii expresses a putative arginine-ornithine antiporter (ArcD) whose function has not been investigated despite relevance to the ADS and potential influence on inter-bacterial communication with periodontal pathogens that utilize amino acids as a main energy source. Here, we generated an S. gordonii arcD mutant to explore the role of ArcD in physiological homeostasis and bacterial cross-feeding. First, we confirmed that S. gordonii ArcD plays crucial roles for mediating arginine uptake and promoting bacterial growth, particularly under arginine-limited conditions. Next, metabolomic profiling and transcriptional analysis of the arcD mutant revealed that deletion of this gene caused intracellular accumulation of ornithine leading to malfunction of the ADS and suppression of de novo arginine biosynthesis. The mutant strain also showed increased susceptibility to low pH stress due to reduced production of ammonia. Finally, accumulation of Fusobacterium nucleatum was found to be significantly decreased in biofilm formed by the arcD mutant as compared with the wild-type strain, although ornithine supplementation restored fusobacterium biovolume in dual-species biofilms with the arcD mutant and also enhanced single species biofilm development by F. nucleatum. Our results are the first direct evidence showing that S. gordonii ArcD modulates not only alkali and energy production but also interspecies interaction with F. nucleatum, thus initiating a middle stage of periodontopathic biofilm formation, by metabolic cross-feeding.	[Sakanaka, Akito; Kuboniwa, Masae; Takeuchi, Hiroki; Hashino, Ei; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan; [Kuboniwa, Masae] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Kuboniwa, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan.	kuboniwa@dent.osaka-u.ac.jp		Kuboniwa, Masae/0000-0002-3332-2431; Sakanaka, Akito/0000-0001-9733-6886	CREST from Japan Science and Technology Agency; Japan Society for the Promotion of Science [262530940, 245931500]; Osaka University Graduate School of Dentistry; Grants-in-Aid for Scientific Research [15K20642] Funding Source: KAKEN	CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University Graduate School of Dentistry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST from the Japan Science and Technology Agency, Grants-in-aid (A) 262530940 and (C) 245931500 from the Japan Society for the Promotion of Science, and the "Challenge to Intractable Oral Diseases" Project of Osaka University Graduate School of Dentistry. The authors declare that they have no conflicts of interest with the contents of this article.	Biyikoglu B, 2012, ANAEROBE, V18, P459, DOI 10.1016/j.anaerobe.2012.06.003; BOURDINEAUD JP, 1993, J BIOL CHEM, V268, P5417; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Catenazzi MCE, 2014, MOL MICROBIOL, V93, P346, DOI 10.1111/mmi.12664; Christopher AB, 2010, MICROBIOL-SGM, V156, P3469, DOI 10.1099/mic.0.042671-0; CLARK WB, 1989, INFECT IMMUN, V57, P3003, DOI 10.1128/IAI.57.10.3003-3008.1989; Cugini C, 2013, MICROBIOL-SGM, V159, P275, DOI 10.1099/mic.0.062695-0; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Dong YQ, 2004, J BACTERIOL, V186, P2511, DOI 10.1128/JB.186.8.2511-2514.2004; Dong YQ, 2002, APPL ENVIRON MICROB, V68, P5549, DOI 10.1128/AEM.68.11.5549-5553.2002; DRIESSEN AJM, 1987, P NATL ACAD SCI USA, V84, P6093, DOI 10.1073/pnas.84.17.6093; Fukui K, 2011, J BIOTECHNOL, V154, P25, DOI 10.1016/j.jbiotec.2011.03.010; Fulde M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00107; Fulde M, 2011, MICROBIOL-SGM, V157, P572, DOI 10.1099/mic.0.043067-0; GHARBIA SE, 1991, ORAL MICROBIOL IMMUN, V6, P264, DOI 10.1111/j.1399-302X.1991.tb00489.x; Griswold A, 2004, APPL ENVIRON MICROB, V70, P1321, DOI 10.1128/AEM.70.3.1321-1327.2004; Gupta R, 2013, INFECT IMMUN, V81, P3903, DOI 10.1128/IAI.00778-13; Hashino E, 2013, MOL ORAL MICROBIOL, V28, P435, DOI 10.1111/omi.12037; Hendrickson EL, 2014, MICROBIOLOGYOPEN, V3, P729, DOI 10.1002/mbo3.204; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; HIGHAM SM, 1989, ARCH ORAL BIOL, V34, P329, DOI 10.1016/0003-9969(89)90105-2; Jakubovics NS, 2008, J BACTERIOL, V190, P3646, DOI 10.1128/JB.00088-08; Jakubovics NS, 2015, MOL MICROBIOL, V97, P281, DOI 10.1111/mmi.13023; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Kloosterman TG, 2011, J BIOL CHEM, V286, P44594, DOI 10.1074/jbc.M111.295832; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-98; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; Liu YL, 2012, INT J ORAL SCI, V4, P135, DOI 10.1038/ijos.2012.54; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Liu YL, 2009, J BACTERIOL, V191, P7353, DOI 10.1128/JB.01053-09; LUTHI E, 1990, GENE, V87, P37, DOI 10.1016/0378-1119(90)90493-B; Mouz N, 1996, P NATL ACAD SCI USA, V93, P9414, DOI 10.1073/pnas.93.18.9414; Nascimento MM, 2014, MOL ORAL MICROBIOL, V29, P45, DOI 10.1111/omi.12044; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rogers AH, 1998, ANAEROBE, V4, P111, DOI 10.1006/anae.1997.0140; Rosen G, 2006, FEMS MICROBIOL LETT, V256, P304, DOI 10.1111/j.1574-6968.2006.00131.x; Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; VANWUYCKHUYSE BC, 1995, J DENT RES, V74, P686, DOI 10.1177/00220345950740021001; VERHOOGT HJC, 1992, J BACTERIOL, V174, P1568, DOI 10.1128/jb.174.5.1568-1573.1992; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056131; Whitmore SE, 2011, MOL MICROBIOL, V81, P305, DOI 10.1111/j.1365-2958.2011.07707.x; Wimmer F, 2008, FEBS LETT, V582, P3771, DOI 10.1016/j.febslet.2008.10.004; Yamamoto H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-51; Yoneda S, 2013, MOL ORAL MICROBIOL, V28, P354, DOI 10.1111/omi.12029; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60	62	38	40	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21185	21198		10.1074/jbc.M115.644401	http://dx.doi.org/10.1074/jbc.M115.644401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26085091	Green Published, hybrid			2022-12-28	WOS:000360637600001
J	Hegde, PM; Dutta, A; Sengupta, S; Mitra, J; Adhikari, S; Tomkinson, AE; Li, GM; Boldogh, I; Hazra, TK; Mitra, S; Hegde, ML				Hegde, Pavana M.; Dutta, Arijit; Sengupta, Shiladitya; Mitra, Joy; Adhikari, Sanjay; Tomkinson, Alan E.; Li, Guo-Min; Boldogh, Istvan; Hazra, Tapas K.; Mitra, Sankar; Hegde, Muralidhar L.			The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome DOMINANT NEGATIVE FUNCTION OF THE CTD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; STRAND BREAK REPAIR; AP-ENDONUCLEASE; OXIDIZED BASES; MULTIPROTEIN COMPLEX; OXIDATIVE DAMAGE; MAMMALIAN-CELLS; IDENTIFICATION; MITOCHONDRIA	The human DNA glycosylase NEIL1 was recently demonstrated to initiate prereplicative base excision repair (BER) of oxidized bases in the replicating genome, thus preventing mutagenic replication. A significant fraction of NEIL1 in cells is present in large cellular complexes containing DNA replication and other repair proteins, as shown by gel filtration. However, how the interaction of NEIL1 affects its recruitment to the replication site for prereplicative repair was not investigated. Here, we show that NEIL1 binarily interacts with the proliferating cell nuclear antigen clamp loader replication factor C, DNA polymerase delta, and DNA ligase I in the absence of DNA via its non-conserved C-terminal domain (CTD); replication factor C interaction results in similar to 8-fold stimulation of NEIL1 activity. Disruption of NEIL1 interactions within the BERosome complex, as observed for a NEIL1 deletion mutant (N311) lacking the CTD, not only inhibits complete BER in vitro but also prevents its chromatin association and reduced recruitment at replication foci in S phase cells. This suggests that the interaction of NEIL1 with replication and other BER proteins is required for efficient repair of the replicating genome. Consistently, the CTD polypeptide acts as a dominant negative inhibitor during in vitro repair, and its ectopic expression sensitizes human cells to reactive oxygen species. We conclude that multiple interactions among BER proteins lead to large complexes, which are critical for efficient BER in mammalian cells, and the CTD interaction could be targeted for enhancing drug/radiation sensitivity of tumor cells.	[Hegde, Pavana M.; Dutta, Arijit; Sengupta, Shiladitya; Mitra, Joy; Adhikari, Sanjay; Mitra, Sankar; Hegde, Muralidhar L.] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX 77030 USA; [Dutta, Arijit; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Mitra, Sankar; Hegde, Muralidhar L.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Hegde, Muralidhar L.] Houston Methodist Neurol Inst, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico; University of New Mexico; University of Kentucky; University of Kentucky; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Mitra, S (corresponding author), Houston Methodist Res Inst, Dept Radiat Oncol, 6550 Fannin St,Smith 8-04, Houston, TX 77030 USA.	smitra2@houstonmethodist.org; mlhegde@houstonmethodist.org	Mitra, Joy/AAH-5977-2020; Classen, Scott/AAY-8176-2020; Dutta, Arijit/I-1604-2019; Regan, Clinton/E-6250-2012; Sengupta, Shiladitya/L-5951-2015	Mitra, Joy/0000-0002-5985-0582; Dutta, Arijit/0000-0002-5675-0092; Li, Guo-Min/0000-0002-9842-4578; Hegde, Muralidhar/0000-0001-7333-8123; Sengupta, Shiladitya/0000-0001-9558-2741; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health [R01 NS088645, R01 CA158910, R01 GM105090, P01 CA092584, R01 NS073976, R01 ES018948, R01 GM57479, R01 CA167181]; Muscular Dystrophy Association [MDA 294842]; ALS Association [15-IIP-204]; Alzheimer's Association [NIRG-12-242135]; NATIONAL CANCER INSTITUTE [R01CA167181, R01CA158910, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105090, R01GM057479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073976, R01NS088645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); ALS Association; Alzheimer's Association(Alzheimer's Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS088645 (to M. L. H.), R01 CA158910, R01 GM105090, and P01 CA092584 (to S. M.), R01 NS073976 (to T. K. H.), R01 ES018948 (to I. B.), R01 GM57479 (to A. E. T), and R01 CA167181 (to G. M. L). This work was also supported by Muscular Dystrophy Association Grant MDA 294842, ALS Association Grant 15-IIP-204), and Alzheimer's Association Grant NIRG-12-242135) (to M. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Bartels M, 2007, J IMMUNOL, V179, P7605, DOI 10.4049/jimmunol.179.11.7605; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bulgar AD, 2010, LEUKEMIA, V24, P1795, DOI 10.1038/leu.2010.166; Chatterjee M, 2012, J BIOL CHEM, V287, DOI [10.1074/jbc.M112.415067, 10.1074/jbc.M111.272179]; CHIU RW, 1975, J BIOL CHEM, V250, P7951; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Dutta A, 2015, CELL MOL LIFE SCI, V72, P1679, DOI 10.1007/s00018-014-1820-z; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Furqan M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-90; Geertsema HJ, 2013, CURR OPIN STRUC BIOL, V23, P788, DOI 10.1016/j.sbi.2013.06.018; Hashiguchi K, 2007, NUCLEIC ACIDS RES, V35, P2913, DOI 10.1093/nar/gkm115; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; He ZG, 1997, NUCLEIC ACIDS RES, V25, P1136, DOI 10.1093/nar/25.6.1136; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2013, P NATL ACAD SCI USA, V110, pE3090, DOI 10.1073/pnas.1304231110; Hegde ML, 2012, BIOMOLECULES, V2, P564, DOI 10.3390/biom2040564; Hegde ML, 2013, J MOL BIOL, V425, P2359, DOI 10.1016/j.jmb.2013.03.030; Hegde ML, 2012, J BIOL CHEM, V287, P34202, DOI 10.1074/jbc.M112.384032; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Koczor CA, 2009, METHODS MOL BIOL, V554, P233, DOI 10.1007/978-1-59745-521-3_15; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; MILLS AD, 1989, J CELL SCI, V94, P471; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; Nischan N, 2015, ANGEW CHEM INT EDIT, V54, P1950, DOI 10.1002/anie.201410006; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rodriguez K, 1998, J BIOL CHEM, V273, P34180, DOI 10.1074/jbc.273.51.34180; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shokolenko IN, 2005, DNA REPAIR, V4, P511, DOI 10.1016/j.dnarep.2004.11.009; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Theriot CA, 2010, DNA REPAIR, V9, P643, DOI 10.1016/j.dnarep.2010.02.014; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003	47	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20919	20933		10.1074/jbc.M115.642918	http://dx.doi.org/10.1074/jbc.M115.642918			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134572	hybrid, Green Published			2022-12-28	WOS:000360011800027
J	Kim, JK; Son, DW; Kim, CH; Cho, JH; Marchetti, R; Silipo, A; Sturiale, L; Park, HY; Huh, YR; Nakayama, H; Fukatsu, T; Molinaro, A; Lee, BL				Kim, Jiyeun Kate; Son, Dae Woo; Kim, Chan-Hee; Cho, Jae Hyun; Marchetti, Roberta; Silipo, Alba; Sturiale, Luisa; Park, Ha Young; Huh, Ye Rang; Nakayama, Hiroshi; Fukatsu, Takema; Molinaro, Antonio; Lee, Bok Luel			Insect Gut Symbiont Susceptibility to Host Antimicrobial Peptides Caused by Alteration of the Bacterial Cell Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; FACULTATIVE SYMBIONTS; PURINE BIOSYNTHESIS; WOLBACHIA; BUCHNERA; APHID; LIPOPOLYSACCHARIDES; POPULATION; STINKBUG; COLONIZATION	The molecular characterization of symbionts is pivotal for understanding the cross-talk between symbionts and hosts. In addition to valuable knowledge obtained from symbiont genomic studies, the biochemical characterization of symbionts is important to fully understand symbiotic interactions. The bean bug (Riptortus pedestris) has been recognized as a useful experimental insect gut symbiosis model system because of its cultivatable Burkholderia symbionts. This system is greatly advantageous because it allows the acquisition of a large quantity of homogeneous symbionts from the host midgut. Using these naive gut symbionts, it is possible to directly compare in vivo symbiotic cells with in vitro cultured cells using biochemical approaches. With the goal of understanding molecular changes that occur in Burkholderia cells as they adapt to the Riptortus gut environment, we first elucidated that symbiotic Burkholderia cells are highly susceptible to purified Riptortus antimicrobial peptides. In search of the mechanisms of the increased immunosusceptibility of symbionts, we found striking differences in cell envelope structures between cultured and symbiotic Burkholderia cells. The bacterial lipopolysaccharide O antigen was absent from symbiotic cells examined by gel electrophoretic and mass spectrometric analyses, and their membranes were more sensitive to detergent lysis. These changes in the cell envelope were responsible for the increased susceptibility of the Burkholderia symbionts to host innate immunity. Our results suggest that the symbiotic interactions between the Riptortus host and Burkholderia gut symbionts induce bacterial cell envelope changes to achieve successful gut symbiosis.	[Kim, Jiyeun Kate; Son, Dae Woo; Kim, Chan-Hee; Cho, Jae Hyun; Park, Ha Young; Huh, Ye Rang; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab, Busan 609735, South Korea; [Marchetti, Roberta; Silipo, Alba; Molinaro, Antonio] Univ Naples Federico II, Dipartimento Sci Chim, I-80126 Naples, Italy; [Sturiale, Luisa] CNR, Ist Polimeri Compositi & Biomat IPCB, I-95126 Catania, Italy; [Nakayama, Hiroshi] RIKEN Adv Sci Inst, Biomol Characterizat Team, Saitama 3510198, Japan; [Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan	Pusan National University; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea.	brlee@pusan.ac.kr	Silipo, Alba/L-5929-2014; Kim, Chan-Hee/C-6849-2016; Marchetti, Roberta/G-2902-2018	Kim, Chan-Hee/0000-0002-5315-4981; Marchetti, Roberta/0000-0002-7173-7099; STURIALE, LUISELLA/0000-0002-3996-1138; Molinaro, Antonio/0000-0002-3456-7369; silipo, alba/0000-0002-5394-6532	Global Research Laboratory [2011-0021535]; National Research Foundation of Korea [2014R1A1A4A01007507]	Global Research Laboratory; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the Global Research Laboratory Program Grant 2011-0021535) and Basic Science Research Program Grant 2014R1A1A4A01007507 of the National Research Foundation of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Baumann P, 1997, ANTON LEEUW INT J G, V72, P39, DOI 10.1023/A:1000239108771; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; De Soyza A, 2008, INNATE IMMUN-LONDON, V14, P127, DOI 10.1177/1753425908093984; Grimaldi David, 2005, pi; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2013, APPL ENVIRON MICROB, V79, P2088, DOI 10.1128/AEM.03299-12; Kikuchi Y, 2011, APPL ENVIRON MICROB, V77, P4075, DOI 10.1128/AEM.00358-11; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kim JK, 2014, APPL ENVIRON MICROB, V80, P4374, DOI 10.1128/AEM.00739-14; Kim JK, 2014, ISME J, V8, P552, DOI 10.1038/ismej.2013.168; Kim JK, 2014, DEV COMP IMMUNOL, V43, P10, DOI 10.1016/j.dci.2013.10.010; Kim JK, 2013, APPL ENVIRON MICROB, V79, P7229, DOI 10.1128/AEM.02152-13; Kim JK, 2013, APPL ENVIRON MICROB, V79, P4879, DOI 10.1128/AEM.01269-13; Kim JK, 2013, P NATL ACAD SCI USA, V110, pE2381, DOI 10.1073/pnas.1303228110; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kragol G, 2002, EUR J BIOCHEM, V269, P4226, DOI 10.1046/j.1432-1033.2002.03119.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mouton L, 2004, GENETICS, V168, P181, DOI 10.1534/genetics.104.026716; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Silipo A, 2006, EUR J ORG CHEM, V2006, P4874, DOI 10.1002/ejoc.200600520; Silipo A, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P133, DOI 10.1007/978-3-642-05062-6_4; Sturiale L, 2005, RAPID COMMUN MASS SP, V19, P1829, DOI 10.1002/rcm.1994; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	46	33	34	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21042	21053		10.1074/jbc.M115.651158	http://dx.doi.org/10.1074/jbc.M115.651158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26116716	Green Published, hybrid			2022-12-28	WOS:000360011800037
J	Ogita, Y; Egami, S; Ebihara, A; Ueda, N; Katada, T; Kontani, K				Ogita, Yoshitaka; Egami, Sachiko; Ebihara, Arisa; Ueda, Nami; Katada, Toshiaki; Kontani, Kenji			Di-Ras2 Protein Forms a Complex with SmgGDS Protein in Brain Cytosol in Order to Be in a Low Affinity State for Guanine Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; RAS-FAMILY; SMALL GTPASES; AMINO-ACID; DI-RAS; EXCHANGE; MOTIF; LOCALIZATION; SUPERFAMILY; PRENYLATION	The Ras family of small GTPases function in a wide variety of biological processes as "molecular switches" by cycling between inactive GDP-bound and active GTP-bound forms. Di-Ras1 and Di-Ras2 were originally identified as small GTPases forming a distinct subgroup of the Ras family. Di-Ras1/Di-Ras2 mRNAs are detected predominantly in brain and heart tissues. Biochemical analysis of Di-Ras1/Di-Ras2 has revealed that they have little GTPase activity and that their intrinsic guanine-nucleotide exchange rates are much faster than that of H-Ras. Yet little is known about the biological role(s) of Di-Ras1/Di-Ras2 or of how their activities are regulated. In the present study we found that endogenous Di-Ras2 co-purifies with SmgGDS from rat brain cytosol. Size-exclusion chromatography of purified recombinant proteins showed that Di-Ras2 forms a high affinity complex with SmgGDS. SmgGDS is a guanine nucleotide exchange factor with multiple armadillo repeats and has recently been shown to specifically activate RhoA and RhoC. In contrast to the effect on RhoA, SmgGDS does not act as a guanine nucleotide exchange factor for Di-Ras2 but instead tightly associates with Di-Ras2 to reduce its binding affinity for guanine nucleotides. Finally, pulse-chase analysis revealed that Di-Ras2 binds, in a C-terminal CAAX motif-dependent manner, to SmgGDS immediately after its synthesis. This leads to increased Di-Ras2 stability. We thus propose that isoprenylated Di-Ras2 forms a tight complex with SmgGDS in cytosol immediately after its synthesis, which lowers its affinity for guanine nucleotides.	[Ogita, Yoshitaka; Egami, Sachiko; Ebihara, Arisa; Ueda, Nami; Katada, Toshiaki; Kontani, Kenji] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan	University of Tokyo	Kontani, K (corresponding author), Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan.	kontani@my-pharm.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to K. K. and T. K.) and the Japan Society for the Promotion of Science (JSPS) (to K. K. and T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; BONIFACINO JS, 2001, CURR PROTOC CELL BIO, pCH7; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; Gasper Raphael, 2010, Small GTPases, V1, P133, DOI 10.4161/sgtp.1.3.14742; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; Hansen M, 2003, BIOCHEM BIOPH RES CO, V311, P829, DOI 10.1016/j.bbrc.2003.10.074; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Kontani K, 2002, J BIOL CHEM, V277, P41070, DOI 10.1074/jbc.M202150200; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; QUILLIAM LA, 1995, P NATL ACAD SCI USA, V92, P1272, DOI 10.1073/pnas.92.5.1272; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; REPKO EM, 1989, J BIOL CHEM, V264, P9945; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Tada M, 2012, GENES CELLS, V17, P778, DOI 10.1111/j.1365-2443.2012.01627.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAMATANI T, 1990, INT IMMUNOL, V2, P165, DOI 10.1093/intimm/2.2.165; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626	27	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20245	20256		10.1074/jbc.M115.637769	http://dx.doi.org/10.1074/jbc.M115.637769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149690	Green Published, hybrid			2022-12-28	WOS:000359608900025
J	Rosch, TC; Graumann, PL				Roesch, Thomas C.; Graumann, Peter L.			Induction of Plasmid Conjugation in Bacillus subtilis Is Bistable and Driven by a Direct Interaction of a Rap/Phr Quorum-sensing System with a Master Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORIZONTAL GENE-TRANSFER; COMPETENCE DEVELOPMENT; HIGH-THROUGHPUT; PROTEIN; LOCALIZATION; SPORULATION; BACTERIA; TRANSCRIPTION; ARCHITECTURE; PHOSPHATASE	Conjugation of plasmid pLS20 from Bacillus subtilis is limited to a time window between early and late exponential growth. Genetic evidence has suggested that pLS20-encoded protein Rco(LS20) represses expression of a large conjugation operon, whereas Rap protein Rap(LS20) relieves repression. We show that Rap(LS20) is a true antirepressor protein that forms dimers in vivo and in vitro and that it directly binds to the repressor protein Rco(LS20) in a 1: 1 stoichiometry. We provide evidence that Rap(LS20) binds to the helix-turn-helix-containing domain of Rco(LS20) in vivo, probably obstructing DNA binding of Rco(LS20), as seen in competitive DNA binding experiments. The activity of Rap(LS20) in turn is counteracted by the addition of the cognate Phr(LS20) peptide, which directly binds to the Rap protein and presumably induces a conformational change of the antirepressor. Thus, a Rap protein acts directly as an antirepressor protein during regulation of plasmid conjugation, turning on conjugation, and is counteracted by the Phr(LS20) peptide, which, by analogy to known Rap/Phr systems, is secreted and taken back up into the cells, mediating cell density-driven regulation. Finally, we show that this switchlike process establishes a population heterogeneity, where up to 30% of the cells induce transcription of the conjugation operon.	[Roesch, Thomas C.; Graumann, Peter L.] LOEWE Zentrum Synthet Mikrobiol SYNMIKRO, D-35043 Marburg, Germany; [Roesch, Thomas C.] Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Roesch, Thomas C.; Graumann, Peter L.] Univ Marburg, Fachbereich Chem, D-35043 Marburg, Germany	Philipps University Marburg	Graumann, PL (corresponding author), LOEWE Zentrum Synthet Mikrobiol SYNMIKRO, D-35043 Marburg, Germany.	peter.graumann@synmikro.uni-marburg.de		Graumann, Peter/0000-0002-8033-5171	Deutsche Forschungsgemeinschaft (DFG); Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); LOEWE Centre for Synthetic Microbiology, SYNMIKRO, in Marburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); LOEWE Centre for Synthetic Microbiology, SYNMIKRO, in Marburg	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School), and by the LOEWE Centre for Synthetic Microbiology, SYNMIKRO, in Marburg. The authors declare that they have no conflicts of interest with the contents of this article.	Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Baker MD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001226; Bauer T, 2011, J BACTERIOL, V193, P6244, DOI 10.1128/JB.00175-11; Boguslawski KM, 2015, MOL MICROBIOL, V96, P325, DOI 10.1111/mmi.12939; Bongiorni C, 2006, J BACTERIOL, V188, P487, DOI 10.1128/JB.188.2.487-498.2006; Bongiorni C, 2005, J BACTERIOL, V187, P4353, DOI 10.1128/JB.187.13.4353-4361.2005; Bose B, 2011, J BACTERIOL, V193, P22, DOI 10.1128/JB.01143-10; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Core L, 2003, MOL MICROBIOL, V49, P1509, DOI 10.1046/j.1365-2958.2003.03659.x; Edwards AN, 2009, ANAL BIOCHEM, V395, P166, DOI 10.1016/j.ab.2009.08.015; Feucht A, 2001, GENE, V264, P289, DOI 10.1016/S0378-1119(01)00338-9; del Sol FG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001511; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Itaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P740, DOI 10.1271/bbb.70.740; Koetje EJ, 2003, MICROBIOL-SGM, V149, P19, DOI 10.1099/mic.0.25737-0; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Parashar V, 2013, J BACTERIOL, V195, P2437, DOI 10.1128/JB.02030-12; Parashar V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001512; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Perego M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001516; Ramachandran G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004733; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Rosch TC, 2014, APPL ENVIRON MICROB, V80, P1349, DOI 10.1128/AEM.03154-13; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Singh PK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003892; Singh PK, 2012, ENVIRON MICROBIOL, V14, P2812, DOI 10.1111/j.1462-2920.2012.02819.x; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Zellmeier S, 2006, MOL MICROBIOL, V61, P1569, DOI 10.1111/j.1365-2958.2006.05323.x	34	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20221	20232		10.1074/jbc.M115.664110	http://dx.doi.org/10.1074/jbc.M115.664110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26112413	hybrid, Green Published			2022-12-28	WOS:000359608900023
J	Wu, TF; Yao, YL; Lai, IL; Lai, CC; Lin, PL; Yang, WM				Wu, Tsu-Fang; Yao, Ya-Li; Lai, I-Lu; Lai, Chien-Chen; Lin, Pei-Lun; Yang, Wen-Ming			Loading of PAX3 to Mitotic Chromosomes Is Mediated by Arginine Methylation and Associated with Waardenburg Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION ACTIVITY; CELL MAINTENANCE; BINDING; GENES; HETEROCHROMATIN; BOOKMARKING; EXPRESSION; PROTEIN-1; TISSUE; PRMT5	PAX3 is a transcription factor critical to gene regulation in mammalian development. Mutations in PAX3 are associated with Waardenburg syndrome (WS), but the mechanism of how mutant PAX3 proteins cause WS remains unclear. Here, we found that PAX3 loads on mitotic chromosomes using its homeodomain. PAX3 WS mutants with mutations in homeodomain lose the ability to bind mitotic chromosomes. Moreover, loading of PAX3 on mitotic chromosomes requires arginine methylation, which is regulated by methyltransferase PRMT5 and demethylase JMJD6. Mutant PAX3 proteins that lose mitotic chromosome localization block cell proliferation and normal development of zebrafish. These results reveal the molecular mechanism of PAX3s loading on mitotic chromosomes and the importance of this localization pattern in normal development. Our findings suggest that PAX3 WS mutants interfere with the normal functions of PAX3 in a dominant negative manner, which is important to the understanding of the pathogenesis of Waardenburg syndrome.	[Wu, Tsu-Fang] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lai, I-Lu; Lai, Chien-Chen; Yang, Wen-Ming] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Lin, Pei-Lun] Natl Chung Hsing Univ, Bachelor Program Biotechnol, Taichung 40227, Taiwan; [Yao, Ya-Li] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Wu, Tsu-Fang] Hung Kuang Univ, Dept Biotechnol, Taichung 43302, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; Hungkuang University	Yao, YL (corresponding author), Asia Univ, Dept Biotechnol, 500 Liu Feng Rd, Taichung 41354, Taiwan.	yyao@asia.edu.tw; yangwm@nchu.edu.tw	/AGZ-4617-2022	/0000-0002-7133-8266; Yang, Wen-Ming/0000-0002-5871-5979	Ministry of Science and Technology [NSC 99-2311-B-005-005-MY3, NSC 102-2311-B-005-005, NSC 98-2311-B-468-001-MY3]; Asia University [103-asia-05]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Asia University	This work was supported by grants from the Ministry of Science and Technology (NSC 99-2311-B-005-005-MY3 and NSC 102-2311-B-005-005 (to W.-M. Y.); NSC 98-2311-B-468-001-MY3 (to Y.-L. Y.)) and Asia University (103-asia-05; to Y.-L. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Birrane G, 2009, BIOCHEMISTRY-US, V48, P1148, DOI 10.1021/bi802052y; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Corry GN, 2008, HUM MOL GENET, V17, P1825, DOI 10.1093/hmg/ddn076; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Hsieh FS, 2014, BBA-GENE REGUL MECH, V1839, P579, DOI 10.1016/j.bbagrm.2014.05.007; Hsieh MJ, 2006, BIOCHEM BIOPH RES CO, V349, P573, DOI 10.1016/j.bbrc.2006.08.064; Jeon HY, 2013, FEBS J, V280, P1518, DOI 10.1111/febs.12153; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; Vogan KJ, 1997, J BIOL CHEM, V272, P28289, DOI 10.1074/jbc.272.45.28289; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wu TF, 2014, ANTICANCER RES, V34, P4717; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827	29	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20556	20564		10.1074/jbc.M114.607713	http://dx.doi.org/10.1074/jbc.M114.607713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149688	hybrid, Green Published			2022-12-28	WOS:000359608900051
J	Sun, CC; Dong, WR; Zhao, J; Nie, L; Xiang, LX; Zhu, G; Shao, JZ				Sun, Cen-Cen; Dong, Wei-Ren; Zhao, Jing; Nie, Li; Xiang, Li-Xin; Zhu, Guan; Shao, Jian-Zhong			Cysteine-independent Catalase-like Activity of Vertebrate Peroxiredoxin 1 (Prx1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; MAMMALIAN PEROXIREDOXIN; 2-CYS PEROXIREDOXIN; CRYSTAL-STRUCTURE; SULFINIC ACID; ANTIOXIDANT; H2O2; PROTEIN; SULFIREDOXIN; DEFICIENCY	Peroxiredoxins (Prxs) are a ubiquitous family of antioxidant proteins that are known as thioredoxin peroxidases. Here we report that Prx1 proteins from Tetraodon nigroviridis and humans also possess a previously unknown catalase-like activity that is independent of Cys residues and reductants but dependent on iron. We identified that the GVL motif was essential to the catalase (CAT)-like activity of Prx1 but not to the Cys-dependent thioredoxin peroxidase (POX) activity, and we generated mutants lacking POX and/or CAT activities for individually delineating their functional features. Wediscovered that the TnPrx1 POX and CAT activities possessed different kinetic features in reducing H2O2. The overexpression of wild-type TnPrx1 and mutants differentially regulated the intracellular levels of reactive oxygen species and p38 phosphorylation in HEK-293T cells treated with H2O2. These observations suggest that the dual antioxidant activities of Prx1 may be crucial for organisms to mediate intracellular redox homeostasis.	[Sun, Cen-Cen; Dong, Wei-Ren; Zhao, Jing; Nie, Li; Xiang, Li-Xin; Zhu, Guan; Shao, Jian-Zhong] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Cen-Cen; Dong, Wei-Ren; Zhao, Jing; Nie, Li; Xiang, Li-Xin; Zhu, Guan; Shao, Jian-Zhong] Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310058, Zhejiang, Peoples R China; [Zhu, Guan] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Zhejiang University; Texas A&M University System; Texas A&M University College Station	Xiang, LX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xianglx@zju.edu.cn; gzhu@cvm.tamu.edu; shaojz@zju.edu.cn	Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/GQB-0299-2022	Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659	Hi-Tech Research and Development Program of China (863) [2012AA092202]; National Basic Research Program of China (973) [2012CB114402, 2012CB114404]; National Natural Science Foundation of China [31000366, 31172436, 31272691, 31372554, 31472298]; Program for Key Innovative Research Team of Zhejiang Province [2010R50026]; Zhejiang Provincial Science and Technology Department [2013C12907-9]; Recruitment Program of Global Experts, Zhejiang Province	Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Key Innovative Research Team of Zhejiang Province; Zhejiang Provincial Science and Technology Department; Recruitment Program of Global Experts, Zhejiang Province	This work was supported by Hi-Tech Research and Development Program of China (863) Grant 2012AA092202; National Basic Research Program of China (973) Grants 2012CB114402 and 2012CB114404; National Natural Science Foundation of China Grants 31000366, 31172436, 31272691, 31372554, and 31472298; Program for Key Innovative Research Team of Zhejiang Province Grant 2010R50026; Scientific Research Fund of Zhejiang Provincial Science and Technology Department Grant 2013C12907-9; and the Recruitment Program of Global Experts, Zhejiang Province (2013). The authors declare that they have no conflicts of interest with the contents of this article.	Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Alfonso-Prieto M, 2012, ARCH BIOCHEM BIOPHYS, V525, P121, DOI 10.1016/j.abb.2012.04.004; Andreini C, 2009, J MOL BIOL, V388, P356, DOI 10.1016/j.jmb.2009.02.052; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Avshalumov MV, 2007, ANTIOXID REDOX SIGN, V9, P219, DOI 10.1089/ars.2007.9.219; Baek JY, 2012, J BIOL CHEM, V287, P81, DOI 10.1074/jbc.M111.316711; BENDAYAN M, 1982, LAB INVEST, V47, P364; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brown JD, 2013, CELL REP, V5, P1425, DOI 10.1016/j.celrep.2013.10.036; Cai CY, 2015, EJSO-EUR J SURG ONC, V41, P228, DOI 10.1016/j.ejso.2014.11.037; Chae HZ, 2012, ANTIOXID REDOX SIGN, V16, P506, DOI 10.1089/ars.2011.4260; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Dong WR, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-29; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Han YH, 2012, BMB REP, V45, P560, DOI 10.5483/BMBRep.2012.45.10.082; Henkle-Duhrsen K, 2001, MOL BIOCHEM PARASIT, V114, P129, DOI 10.1016/S0166-6851(01)00252-3; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karplus P. Andrew, 2007, V44, P41; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; Knoops Bernard, 2007, V44, P27; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Lechardeur D, 2010, J BIOL CHEM, V285, P16032, DOI 10.1074/jbc.M109.024505; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; PANFILI E, 1991, FEBS LETT, V290, P35, DOI 10.1016/0014-5793(91)81219-X; Parejo I, 2000, J PHARMACOL TOXICOL, V43, P183, DOI 10.1016/S1056-8719(00)00085-X; Park J., 2014, INT J CELL BIOL, V2014, DOI DOI 10.1155/2014/715867; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rice ME, 2011, NEUROSCIENTIST, V17, P389, DOI 10.1177/1073858411404531; Robinson MW, 2010, PARASITE IMMUNOL, V32, P305, DOI 10.1111/j.1365-3024.2010.01201.x; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Wang DD, 2012, CELL STRESS CHAPERON, V17, P423, DOI 10.1007/s12192-011-0317-z; Wang XS, 2004, ATHEROSCLEROSIS, V177, P61, DOI 10.1016/j.atherosclerosis.2004.06.007; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	48	4	4	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19942	19954		10.1074/jbc.M115.659011	http://dx.doi.org/10.1074/jbc.M115.659011			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088136	Green Published, hybrid			2022-12-28	WOS:000359364600049
J	Steneberg, P; Sykaras, AG; Backlund, F; Straseviciene, J; Soderstrom, I; Edlund, H				Steneberg, Par; Sykaras, Alexandros G.; Backlund, Fredrik; Straseviciene, Jurate; Soderstrom, Ingegerd; Edlund, Helena			Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; BASAL-STATE HYPERINSULINEMIA; HEALTHY NORMOGLYCEMIC ADULTS; DIET-INDUCED OBESITY; PPAR-GAMMA; LIVER-DISEASE; MONOACYLGLYCEROL ACYLTRANSFERASE; UP-REGULATION; MOUSE MODEL; LIPID-ACCUMULATION	Hepatosteatosis is associated with the development of both hepatic insulin resistance and Type 2 diabetes. Hepatic expression of Cd36, a fatty acid transporter, is enhanced in obese and diabetic murine models and human nonalcoholic fatty liver disease, and thus it correlates with hyperinsulinemia, steatosis, and insulin resistance. Here, we have explored the effect of hyperinsulinemia on hepatic Cd36 expression, development of hepatosteatosis, insulin resistance, and dysglycemia. A 3-week sucrose-enriched diet was sufficient to provoke hyperinsulinemia, hepatosteatosis, hepatic insulin resistance, and dysglycemia in CBA/J mice. The development of hepatic steatosis and insulin resistance in CBA/J mice on a sucrose-enriched diet was paralleled by increased hepatic expression of the transcription factor Ppar gamma and its target gene Cd36 whereas that of genes implicated in lipogenesis, fatty acid oxidation, and VLDL secretion was unaltered. Additionally, we demonstrate that insulin, in a Ppar gamma-dependent manner, is sufficient to directly increase Cd36 expression in perfused livers and isolated hepatocytes. Mouse strains that display low insulin levels, i.e. C57BL6/J, and/or lack hepatic Ppar gamma, i.e. C3H/HeN, do not develop hepatic steatosis, insulin resistance, or dysglycemia on a sucrose-enriched diet, suggesting that elevated insulin levels, via enhanced CD36 expression, provoke fatty liver development that in turn leads to hepatic insulin resistance and dysglycemia. Thus, our data provide evidence for a direct role for hyperinsulinemia in stimulating hepatic Cd36 expression and thus the development of hepatosteatosis, hepatic insulin resistance, and dysglycemia.	[Steneberg, Par; Sykaras, Alexandros G.; Backlund, Fredrik; Straseviciene, Jurate; Edlund, Helena] Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden; [Soderstrom, Ingegerd] Umea Univ, Dept Publ Hlth & Clin Med, SE-90187 Umea, Sweden	Umea University; Umea University	Edlund, H (corresponding author), Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden.	helena.edlund@umu.se	Sykaras, Alexandros/AAO-1565-2020	Sykaras, Alexandros/0000-0002-2972-0138; Edlund, Helena/0000-0002-3553-7348	Strategic Research Program in Diabetes at Umea University; Swedish Research Council [521-2010-3618]; Knut and Alice Wallenberg Foundation [KAW 2010.0033, KAW 2012.0060]	Strategic Research Program in Diabetes at Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Strategic Research Program in Diabetes at Umea University, by Grants 521-2010-3618 from the Swedish Research Council, and by Grants KAW 2010.0033 and KAW 2012.0060 from The Knut and Alice Wallenberg Foundation. H. E. is a co-founder, shareholder, and consultant of the unlisted biotech company Betagenon AB. Par Steneberg, Alexandros Sykaras, Fredrik Backlund, Jurate Straseviciene, and Ingegerd Soderstrom have no conflicts of interest with the contents of this article.	Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Buque X, 2012, AM J PHYSIOL-ENDOC M, V303, pE504, DOI 10.1152/ajpendo.00653.2011; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Chabowski A, 2004, AM J PHYSIOL-ENDOC M, V287, pE781, DOI 10.1152/ajpendo.00573.2003; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen JL, 2014, J LIPID RES, V55, P32, DOI 10.1194/jlr.M039453; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Corpeleijn E, 2008, J PHYSIOL PHARMACOL, V59, P77; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Dankner R, 2012, DIABETES-METAB RES, V28, P618, DOI 10.1002/dmrr.2322; Dankner R, 2009, DIABETES CARE, V32, P1464, DOI 10.2337/dc09-0153; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; Edvardsson U, 2006, BIOCHEM BIOPH RES CO, V340, P111, DOI 10.1016/j.bbrc.2005.12.008; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hames KC, 2014, DIABETES, V63, P3606, DOI 10.2337/db14-0369; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Memon RA, 1999, DIABETES, V48, P121, DOI 10.2337/diabetes.48.1.121; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rhee EJ, 2011, AM J MED, V124, P69, DOI 10.1016/j.amjmed.2010.08.012; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	50	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19034	19043		10.1074/jbc.M115.640292	http://dx.doi.org/10.1074/jbc.M115.640292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085100	hybrid, Green Published			2022-12-28	WOS:000358781100021
J	Wong, SH; King, CY				Wong, Shenq-Huey; King, Chih-Yen			Amino Acid Proximities in Two Sup35 Prion Strains Revealed by Chemical Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRILS; STRUCTURAL BASIS; YEAST; PROTEIN; PROPAGATION; PEPTIDE; VARIANTS; PSI(+); STATE	Strains of the yeast prion [PSI] are different folding patterns of the same Sup35 protein, which stacks up periodically to form a prion fiber. Chemical cross-linking is employed here to probe different fiber structures assembled with a mutant Sup35 fragment. The photo-reactive cross-linker, p-benzoyl-L-phenylalanine (pBpa), was biosynthetically incorporated into bacterially prepared recombinant Sup(1-61)-GFP, containing the first 61 residues of Sup35, followed by the green fluorescent protein. Four methionine substitutions and two alanine substitutions were introduced at fixed positions in Sup(1-61) to allow cyanogen bromide cleavage to facilitate subsequent mass spectrometry analysis. Amyloid fibers of pBpa and Met/Ala-substituted Sup(1-61)-GFP were nucleated from purified yeast prion particles of two different strains, namely VK and VL, and shown to faithfully transmit specific strain characteristics to yeast expressing the wild type Sup35 protein. Intra-and intermolecular cross-linking were distinguished by tandem mass spectrometry analysis on fibers seeded from solutions containing equal amounts of N-14- and N-15-labeled protein. Fibers propagating the VL strain type exhibited intra-and intermolecular cross-linking between amino acid residues 3 and 28, as well as intra-and intermolecular linking between 32 and 55. Inter-and intramolecular cross-linking between residues 32 and 55 were detected in fibers propagating the VK strain type. Adjacencies of amino acid residues in space revealed by cross-linking were used to constrain possible chain folds of different [PSI] strains.	[Wong, Shenq-Huey] Acad Sinica, Taiwan Int Grad Program, Mol Cell Biol, Taipei 11529, Taiwan; [Wong, Shenq-Huey] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [King, Chih-Yen] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan	King, CY (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	cking@imb.sinica.edu.tw	King, Chih-Yen/ABG-2110-2021	Wong, Shenq Huey/0000-0002-2806-3607	Ministry of Science and Technology, Taiwan [103-2311-B-001-032]; Academia Sinica [99-CDA-L07]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Grant 103-2311-B-001-032 from Ministry of Science and Technology, Taiwan, and by Career Development Grant 99-CDA-L07 from Academia Sinica. The authors declare that they have no conflicts of interest with the contents of this article.	Chang HY, 2008, P NATL ACAD SCI USA, V105, P13345, DOI 10.1073/pnas.0802215105; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Egnaczyk GF, 2001, BIOCHEMISTRY-US, V40, P11706, DOI 10.1021/bi002852h; Gorkovskiy A, 2014, P NATL ACAD SCI USA, V111, pE4615, DOI 10.1073/pnas.1417974111; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Huang YW, 2015, PRION, V9, P207, DOI 10.1080/19336896.2015.1039217; INGLIS AS, 1970, ANAL BIOCHEM, V37, P73, DOI 10.1016/0003-2697(70)90259-9; Kaiser R, 1999, ANAL BIOCHEM, V266, P1, DOI 10.1006/abio.1998.2945; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; KAUER JC, 1986, J BIOL CHEM, V261, P695; King CY, 2006, METHODS, V39, P68, DOI 10.1016/j.ymeth.2006.04.003; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weerasekera R, 2007, PROTEOMICS, V7, P3835, DOI 10.1002/pmic.200700688; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133	33	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25062	25071		10.1074/jbc.M115.676379	http://dx.doi.org/10.1074/jbc.M115.676379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26265470	Green Published, hybrid			2022-12-28	WOS:000362598300034
J	Comps-Agrar, L; Dunshee, DR; Eaton, DL; Sonoda, J				Comps-Agrar, Laetitia; Dunshee, Diana Ronai; Eaton, Dan L.; Sonoda, Junichiro			Unliganded Fibroblast Growth Factor Receptor 1 Forms Density-independent Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KLOTHO; EGF RECEPTOR; STRUCTURAL BIOLOGY; METABOLIC-ACTIVITY; HUMAN PATHOLOGIES; TYROSINE KINASES; LIVING CELLS; FGF; ACTIVATION; DIMERIZATION	Fibroblast growth factors receptors (FGFRs) are thought to initiate intracellular signaling cascades upon ligand-induced dimerization of the extracellular domain. Although the existence of unliganded FGFR1 dimers on the surface of living cells has been proposed, this notion remains rather controversial. Here, we employed time-resolved Forster resonance energy transfer combined with SNAP-and ACP-tag labeling in COS7 cells to monitor dimerization of full-length FGFR1 at the cell-surface with or without the coreceptor Klotho. Using this approach we observed homodimerization of unliganded FGFR1 that is independent of its surface density. The homo-interaction signal observed for FGFR1 was indeed as robust as that obtained for epidermal growth factor receptor (EGFR) and was further increased by the addition of activating ligands or pathogenic mutations. Mutational analysis indicated that the kinase and the transmembrane domains, rather than the extracellular domain, mediate the ligand-independent FGFR1 dimerization. In addition, we observed a formation of a higher order ligand-independent complex by the c-spliced isoform of FGFR1 and beta Klotho. Collectively, our approach provides novel insights into the assembly and dynamics of the full-length FGFRs on the cell surface.	[Comps-Agrar, Laetitia] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Comps-Agrar, Laetitia; Eaton, Dan L.] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Dunshee, Diana Ronai; Sonoda, Junichiro] Genentech Inc, Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Comps-Agrar, L (corresponding author), 1 DNA Way, San Francisco, CA 94080 USA.	compsagrar.laetitia@gene.com; junichis@gene.com		Comps-Agrar, Laetitia/0000-0002-5260-6536	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was supported by Genentech, Inc. All the authors were employees of Genentech, Inc. The authors declare that they have no conflicts of interest with the contents of this article.	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Ballinger MD, 1999, NAT BIOTECHNOL, V17, P1199, DOI 10.1038/70746; Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Belov AA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003576; Bocharov EV, 2013, STRUCTURE, V21, P2087, DOI 10.1016/j.str.2013.08.026; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Comps-Agrar L, 2012, FASEB J, V26, P3430, DOI 10.1096/fj.12-203646; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Du XL, 2012, J CELL PHYSIOL, V227, P3731, DOI 10.1002/jcp.24083; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; Kelleher FC, 2013, CARCINOGENESIS, V34, P2198, DOI 10.1093/carcin/bgt254; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kiselyov VV, 2006, PROTEIN SCI, V15, P1512, DOI 10.1110/ps.062207906; Kolumam G, 2015, EBIOMEDICINE, V2, P730, DOI 10.1016/j.ebiom.2015.05.028; Kuro-o M, 2012, ADV EXP MED BIOL, V728, P25, DOI 10.1007/978-1-4614-0887-1_2; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; MATHIS G, 1995, CLIN CHEM, V41, P1391; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Ming AYK, 2012, J BIOL CHEM, V287, P19997, DOI 10.1074/jbc.M111.325670; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Placone J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046678; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; Sarabipour S, 2015, J MOL BIOL, V427, P1705, DOI 10.1016/j.jmb.2015.02.013; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang F, 1997, J BIOL CHEM, V272, P23887, DOI 10.1074/jbc.272.38.23887; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yie JM, 2012, CHEM BIOL DRUG DES, V79, P398, DOI 10.1111/j.1747-0285.2012.01325.x; Zhang J, 2014, DRUG DISCOV TODAY, V19, P579, DOI 10.1016/j.drudis.2013.10.021; Zwier JM, 2014, INORG CHEM, V53, P1854, DOI 10.1021/ic402234k	58	22	23	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24166	24177		10.1074/jbc.M115.681395	http://dx.doi.org/10.1074/jbc.M115.681395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26272615	hybrid, Green Published			2022-12-28	WOS:000362218900010
J	Saha, SS; Singh, D; Raymond, EL; Ganesan, R; Caviness, G; Grimaldi, C; Woska, JR; Mennerich, D; Brown, SE; Mbow, ML; Kao, CC				Saha, Siddhartha S.; Singh, Divyendu; Raymond, Ernest L.; Ganesan, Rajkumar; Caviness, Gary; Grimaldi, Christine; Woska, Joseph R., Jr.; Mennerich, Detlev; Brown, Su-Ellen; Mbow, M. Lamine; Kao, C. Cheng			Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; ENDOCYTOSIS; FAMILY; CLATHRIN; ENDOSOMES; PATHWAY; CELLS; IL-36; TLR3; ACTIVATION	Improper signaling of the IL-36 receptor (IL-36R), a member of the IL-1 receptor family, has been associated with various inflammation-associated diseases. However, the requirements for IL-36R signal transduction remain poorly characterized. This work seeks to define the requirements for IL-36R signaling and intracellular trafficking. In the absence of cognate agonists, IL-36R was endocytosed and recycled to the plasma membrane. In the presence of IL-36, IL-36R increased accumulation in LAMP1 + lysosomes. Endocytosis predominantly used a clathrin-mediated pathway, and the accumulation of the IL-36R in lysosomes did not result in increased receptor turnover. The ubiquitin-binding Tollip protein contributed to IL-36R signaling and increased the accumulation of both subunits of the IL-36R.	[Saha, Siddhartha S.; Singh, Divyendu; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA; [Raymond, Ernest L.; Ganesan, Rajkumar; Caviness, Gary; Grimaldi, Christine; Woska, Joseph R., Jr.; Mennerich, Detlev; Brown, Su-Ellen; Mbow, M. Lamine] Boehringer Ingelheim Pharmaceut, Ridgefield, CT 06877 USA	Indiana University System; Indiana University Bloomington; Boehringer Ingelheim	Mbow, ML (corresponding author), Boehringer Ingelheim Pharmaceut, Ridgefield, CT 06877 USA.	lamine.mbow@boehringer-ingelheim.com; ckao@indiana.edu	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664				Ahmed S, 2013, J IMMUNOL, V190, P2217, DOI 10.4049/jimmunol.1201630; Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Blanco AM, 2008, J NEUROCHEM, V106, P625, DOI 10.1111/j.1471-4159.2008.05425.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	38	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23997	24006		10.1074/jbc.M115.653378	http://dx.doi.org/10.1074/jbc.M115.653378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26269592	Green Published, hybrid			2022-12-28	WOS:000361816500043
J	Mar, AC; Chu, CH; Lee, HJ; Chien, CW; Cheng, JJ; Yang, SH; Jiang, JK; Lee, TC				Mar, Ai-Chung; Chu, Chun-Ho; Lee, Hui-Ju; Chien, Chia-Wen; Cheng, Jing-Jy; Yang, Shung-Haur; Jiang, Jeng-Kai; Lee, Te-Chang			Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECTOPIC EXPRESSION; GENE-EXPRESSION; IL-1 RECEPTOR; PROTEINS; KERATINOCYTES; INFLAMMATION; ARSENITE; ANTIBODY; MODEL; STAT3	Interleukin-1 receptor type 2 (IL1R2) acts as a decoy receptor of exogenous IL-1; however, its intracellular activity is poorly understood. We previously demonstrated that IL1R2 intracellularly activates the expression of several proinflammatory cytokines and affects cell migration. In this study, we found that intracellular IL1R2 expression was increased in human colorectal cancer cells (CRCs) compared with normal colon cells. We also observed that the mRNA levels of IL1R2 were highly correlated with IL-6 in tumor tissues of CRC patients. By modulating its expression in CRC cells, we verified that enhanced IL1R2 expression transcriptionally activated the expression of IL-6 and VEGF-A. Conditioned medium harvested from IL1R2-over-expressing CRC cells contained higher levels of IL-6 and VEGF-A than that from vector control cells and significantly enhanced the proliferation, migration, and tube formation of cultured endothelial cells. We further demonstrated a positive association of intracellular IL1R2 levels with tumor growth and microvessel density in xenograft mouse models. These results revealed that IL1R2 activates the expression of angiogenic factors. Mechanistically, we revealed that IL1R2 complexes with c-Fos and binds to the AP-1 site at the IL-6 and VEGF-A promoters. Together, these results reveal a novel function of intracellular IL1R2 that acts with c-Fos to enhance the transcription of IL-6 and VEGF-A, which promotes angiogenesis in CRC.	[Mar, Ai-Chung] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei 11529, Taiwan; [Mar, Ai-Chung] Acad Sinica, Taipei 11529, Taiwan; [Mar, Ai-Chung; Lee, Hui-Ju; Chien, Chia-Wen; Lee, Te-Chang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chu, Chun-Ho] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan; [Yang, Shung-Haur; Jiang, Jeng-Kai] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Chu, Chun-Ho] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Surg, Taipei 11221, Taiwan; [Cheng, Jing-Jy] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei 11221, Taiwan; [Yang, Shung-Haur; Jiang, Jeng-Kai] Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; Taipei Veterans General Hospital	Lee, TC (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	bmtcl@ibms.sinica.edu.tw			Academia Sinica; Taiwan National Science Council [NSC-97-2314-B-0010MY3, MOST-104-2320-B-001-008-MY3]	Academia Sinica(Academia Sinica - Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and by Taiwan National Science Council Grants NSC-97-2314-B-0010MY3 and MOST-104-2320-B-001-008-MY3 (to T.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aceto N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3329; ALLEY MC, 1988, CANCER RES, V48, P589; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Buys TPH, 2007, GENE CHROMOSOME CANC, V46, P1069, DOI 10.1002/gcc.20492; Chang SY, 2009, CYTOKINE, V45, P32, DOI 10.1016/j.cyto.2008.10.013; Chen YJ, 2011, PROTEOMICS, V11, P4331, DOI 10.1002/pmic.201100329; Chien CW, 2004, ENVIRON HEALTH PERSP, V112, P1704, DOI 10.1289/ehp.7224; Chung YC, 2006, ANTICANCER RES, V26, P3905; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Duda Dan G, 2012, ISRN Cell Biol, V2012; Eldesoky A, 2011, SAUDI J GASTROENTERO, V17, P170, DOI 10.4103/1319-3767.80378; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P90, DOI 10.1038/sj.jcbfm.9600509; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Goto H, 2004, CLIN CANCER RES, V10, P7671, DOI 10.1158/1078-0432.CCR-04-1171; GROVES RW, 1995, J IMMUNOL, V154, P4065; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; Kondera-Anasz Zdzislawa, 2003, Ginekol Pol, V74, P761; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-8; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lin KY, 2007, CANCER RES, V67, P1832, DOI 10.1158/0008-5472.CAN-06-3014; Lin SY, 2012, GENES IMMUN, V13, P214, DOI 10.1038/gene.2011.74; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martinetti A, 2014, CANCERS, V6, P1753, DOI 10.3390/cancers6031753; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Murukesh N, 2010, BRIT J CANCER, V102, P8, DOI 10.1038/sj.bjc.6605483; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Nakagawa K, 2007, J NUTR, V137, P1938, DOI 10.1093/jn/137.8.1938; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Nishida N, 2006, VASC HEALTH RISK MAN, V2, P213, DOI 10.2147/vhrm.2006.2.3.213; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Pou J, 2011, BBA-MOL CELL BIOL L, V1811, P556, DOI 10.1016/j.bbalip.2011.05.014; Ramadas RA, 2006, IMMUNOGENETICS, V58, P851, DOI 10.1007/s00251-006-0146-x; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Ruckert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012243; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; SIMS JE, 1989, P NATL ACAD SCI USA, V86, P8946, DOI 10.1073/pnas.86.22.8946; Su PS, 2006, ENVIRON HEALTH PERSP, V114, P394, DOI 10.1289/ehp.8174; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	55	59	65	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22212	22224		10.1074/jbc.M115.644823	http://dx.doi.org/10.1074/jbc.M115.644823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26209639	Green Published, hybrid			2022-12-28	WOS:000360968500038
J	Wang, CD; Kam, RKT; Shi, WL; Xia, Y; Chen, XF; Cao, Y; Sun, JM; Du, YZ; Lu, G; Chen, ZJ; Chan, WY; Chan, SO; Deng, Y; Zhao, H				Wang, Chengdong; Kam, Richard Kin Ting; Shi, Weili; Xia, Yin; Chen, Xiongfong; Cao, Ying; Sun, Jianmin; Du, Yanzhi; Lu, Gang; Chen, Zijiang; Chan, Wood Yee; Chan, Sun On; Deng, Yi; Zhao, Hui			The Proto-oncogene Transcription Factor Ets1 Regulates Neural Crest Development through Histone Deacetylase 1 to Mediate Output of Bone Morphogenetic Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; XENOPUS-EMBRYOS; PARAXIAL MESODERM; BINDING-PROTEIN; INDUCTION; EXPRESSION; SPECIFICATION; WNT; ACTIVATION; MIGRATION	The neural crest (NC) is a transient, migratory cell population that differentiates into a large variety of tissues including craniofacial cartilage, melanocytes, and peripheral nervous system. NC is initially induced at the border of neural plate and non-neural ectoderm by balanced regulation of multiple signaling pathways among which an intermediate bone morphogenetic protein (BMP) signaling is essential for NC formation. ets1, a proto-oncogene playing important roles in tumor invasion, has also been implicated in delamination of NC cells. In this study, we investigated Ets1 function in NC formation using Xenopus. Overexpression of ets1 repressed NC formation through down-regulation of BMP signaling. Moreover, ets1 repressed the BMP-responsive gene id3 that is essential for NC formation. Conversely, overexpression of id3 can partially rescue the phenotype of NC inhibition induced by ectopic ets1. Mechanistically, we found that Ets1 binds to id3 promoter as well as histone deacetylase 1, suggesting that Ets1 recruits histone deacetylase 1 to the promoter of id3, thereby inducing histone deacetylation of the id3 promoter. Thus, our studies indicate that Ets1 regulates NC formation through attenuating BMP signaling epigenetically.	[Wang, Chengdong; Kam, Richard Kin Ting; Xia, Yin; Lu, Gang; Chan, Wood Yee; Chan, Sun On; Zhao, Hui] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Shi, Weili] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Deng, Yi] South Univ Sci & Technol China, Dept Biol, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [Xia, Yin; Lu, Gang; Chan, Wood Yee; Chan, Sun On; Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Chen, Xiongfong] NCI, Adv Biomed Comp Ctr, NIH, Frederick, MD 21702 USA; [Cao, Ying] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Cao, Ying] Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Sun, Jianmin] Lund Univ, Dept Lab Med, Translat Canc Res & Stem Cell Ctr, S-22381 Lund, Sweden; [Du, Yanzhi; Chen, Zijiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Southern University of Science & Technology; Chinese University of Hong Kong, Shenzhen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nanjing University; Lund University; Shanghai Jiao Tong University	Zhao, H (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	zhaohui@cuhk.edu.hk	Chan, Sun-On/R-6547-2018; Chen, Zi-Jiang/GOE-6119-2022; Xia, Yin/M-5440-2018; Chan, Wood Yee/R-6692-2018; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Zhao, Hui/B-8429-2016; Sun, Jianmin/AAX-5094-2021	Chan, Sun-On/0000-0002-3221-3786; Xia, Yin/0000-0003-0315-7532; Chan, Wood Yee/0000-0002-7114-1463; Zhao, Hui/0000-0001-8160-6415; Sun, Jianmin/0000-0003-2327-4285; Deng, Yi/0000-0003-1378-015X; Chen, Zi-Jiang/0000-0001-6637-6631; Wang, Chengdong/0000-0001-9891-8765	Research Grants Council of Hong Kong [CUHK413/12, CUHK480709, CUHK432/12]; Lo Kwee-Seong Biomedical Research Fund; National Basic Research Program of China [81200566]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Lo Kwee-Seong Biomedical Research Fund; National Basic Research Program of China(National Basic Research Program of China)	This work is supported by Research Grants Council of Hong Kong Grants N_CUHK413/12 and CUHK480709 (to H. Z.) and N_CUHK432/12 (to Y. X.), the Lo Kwee-Seong Biomedical Research Fund (to H. Z.), and National Basic Research Program of China Grant 81200566 (to Y. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Akkers Robert C, 2012, Methods Mol Biol, V917, P279, DOI 10.1007/978-1-61779-992-1_17; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Barembaum M, 2013, DEV BIOL, V382, P567, DOI 10.1016/j.ydbio.2013.08.009; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; ESSEX LJ, 1993, DEV DYNAM, V198, P108, DOI 10.1002/aja.1001980205; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Kee Y, 2005, GENE DEV, V19, P744, DOI 10.1101/gad.1257405; Kiyota Tomomi, 2007, Organogenesis, V3, P93; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Kos R, 2001, DEVELOPMENT, V128, P1467; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Lee CG, 2012, J IMMUNOL, V188, P2244, DOI 10.4049/jimmunol.1101614; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lee PC, 2012, J CELL BIOL, V198, P799, DOI 10.1083/jcb.201204161; Light W, 2005, DEVELOPMENT, V132, P1831, DOI 10.1242/dev.01734; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; MAYOR R, 1993, DEVELOPMENT, V119, P661; MAYOR R, 1995, DEVELOPMENT, V121, P767; Meyer D, 1997, INT J DEV BIOL, V41, P607; Milet C, 2013, P NATL ACAD SCI USA, V110, P5528, DOI 10.1073/pnas.1219124110; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nichane M, 2008, DEV BIOL, V322, P355, DOI 10.1016/j.ydbio.2008.08.003; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Pohl BS, 2001, MECH DEVELOP, V103, P93, DOI 10.1016/S0925-4773(01)00334-3; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schumacher JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027403; Spokony RF, 2002, DEVELOPMENT, V129, P421; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Steventon B, 2009, DEVELOPMENT, V136, P771, DOI 10.1242/dev.029017; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Tropepe V, 2006, DEV BIOL, V289, P517, DOI 10.1016/j.ydbio.2005.10.004; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Wang CD, 2011, DEV DYNAM, V240, P2028, DOI 10.1002/dvdy.22693; Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255; Wu MY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000593; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Zhao H, 2001, INT J DEV BIOL, V45, P817; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	62	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21925	21938		10.1074/jbc.M115.644864	http://dx.doi.org/10.1074/jbc.M115.644864			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198637	Green Published, hybrid			2022-12-28	WOS:000360968500014
J	Cordeiro, TN; Garcia, J; Bernado, P; Millet, O; Pons, M				Cordeiro, Tiago N.; Garcia, Jesus; Bernado, Pau; Millet, Oscar; Pons, Miquel			A Three-protein Charge Zipper Stabilizes a Complex Modulating Bacterial Gene Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrostatics; gene silencing; nuclear magnetic resonance (NMR); protein dynamic; protein-protein interaction; horizontal gene transfer; charge zipper complexes; nucleoid-associated proteins	PARAMAGNETIC RELAXATION ENHANCEMENT; HORIZONTALLY ACQUIRED DNA; HHA-LIKE PROTEINS; H-NS; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; CHEMICAL-EXCHANGE; BIOFILM FORMATION; EXPRESSION; YMOA	Background: The complex between Hha and H-NS selective represses genes in Enterobacteria acquired by horizontal transfer. Results: A structural model for the regulatory complex is described. Conclusion: A charge zipper formed by interdigitation of residues from three proteins stabilizes the complex. Significance: Charge zippers provide selectivity to electrostatic protein complexes. Understanding selective gene silencing may help fighting antibiotic resistance. The Hha/YmoA nucleoid-associated proteins help selectively silence horizontally acquired genetic material, including pathogenicity and antibiotic resistance genes and their maintenance in the absence of selective pressure. Members of the Hha family contribute to gene silencing by binding to the N-terminal dimerization domain of H-NS and modifying its selectivity. Hha-like proteins and the H-NS N-terminal domain are unusually rich in charged residues, and their interaction is mostly electrostatic-driven but, nonetheless, highly selective. The NMR-based structural model of the complex between Hha/YmoA and the H-NS N-terminal dimerization domain reveals that the origin of the selectivity is the formation of a three-protein charge zipper with interdigitated complementary charged residues from Hha and the two units of the H-NS dimer. The free form of YmoA shows collective microsecond-millisecond dynamics that can by measured by NMR relaxation dispersion experiments and shows a linear dependence with the salt concentration. The number of residues sensing the collective dynamics and the population of the minor form increased in the presence of H-NS. Additionally, a single residue mutation in YmoA (D43N) abolished H-NS binding and the dynamics of the apo-form, suggesting the dynamics and binding are functionally related.	[Cordeiro, Tiago N.; Pons, Miquel] Univ Barcelona, Dept Organ Chem, Biomol NMR Lab, E-08028 Barcelona, Spain; [Cordeiro, Tiago N.; Bernado, Pau] Univ Montpellier 1 & 2, CNRS UMR 5048, INSERM, Ctr Biochim Struct,U1054, F-34092 Montpellier, France; [Garcia, Jesus] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Millet, Oscar] Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Elexalde Derio 48160, Spain	University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIC bioGUNE	Millet, O (corresponding author), Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Parque Cient Tecnol Bizkaia Bldg 801A, Elexalde Derio 48160, Spain.	omillet@cicbiogune.es; mpons@ub.edu	pons, miquel/C-8657-2011; Cordeiro, Tiago N/E-9842-2012; Millet, Oscar/F-9696-2011	pons, miquel/0000-0002-0586-8322; Cordeiro, Tiago N/0000-0003-2663-3220; Millet, Oscar/0000-0001-8748-4105; Bernado, Pau/0000-0001-7395-5922; Garcia, Jesus/0000-0003-2961-9790	Spanish Ministry of Economy and Competitivity [BIO2010-15683, BIO2013-45793R, CTQ2012-32183]; Generalitat de Catalunya [2009SGR1352]; European Commission (BioNMR) [261863]; Department of Industry, Tourism, and Trade of Government of the Autonomous Community of Basque Country	Spanish Ministry of Economy and Competitivity(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission (BioNMR)(European CommissionEuropean Commission Joint Research Centre); Department of Industry, Tourism, and Trade of Government of the Autonomous Community of Basque Country	This work was supported by the Spanish Ministry of Economy and Competitivity (BIO2010-15683, BIO2013-45793R, and CTQ2012-32183), the Generalitat de Catalunya (2009SGR1352), the European Commission (BioNMR, contract 261863), and by the Department of Industry, Tourism, and Trade of the Government of the Autonomous Community of the Basque Country. The authors declare that they have no conflicts of interest with the contents of this article.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Aznar S, 2013, MICROBIOL-SGM, V159, P545, DOI 10.1099/mic.0.062448-0; Balsalobre C, 1996, MICROBIOL-SGM, V142, P1841, DOI 10.1099/13500872-142-7-1841; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cordeiro TN, 2008, FEBS LETT, V582, P3139, DOI 10.1016/j.febslet.2008.07.037; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; CORNELIS GR, 1991, MOL MICROBIOL, V5, P1023, DOI 10.1111/j.1365-2958.1991.tb01875.x; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; de Alba CF, 2011, FEBS LETT, V585, P1765, DOI 10.1016/j.febslet.2011.05.024; Fernandez-de-Alba C, 2013, J MOL BIOL, V425, P2347, DOI 10.1016/j.jmb.2013.03.006; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Garcia J, 2005, BIOCHEM J, V388, P755, DOI 10.1042/BJ20050002; Garcia J, 2006, J MOL BIOL, V359, P679, DOI 10.1016/j.jmb.2006.03.059; Garcia J, 2009, FEBS LETT, V583, P2911, DOI 10.1016/j.febslet.2009.07.054; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kieslich CA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002840; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Madrid C, 2007, J BACTERIOL, V189, P265, DOI 10.1128/JB.01124-06; McFeeters RL, 2007, BIOCHEMISTRY-US, V46, P13975, DOI 10.1021/bi701210j; MIKULSKIS AV, 1994, MOL MICROBIOL, V11, P77, DOI 10.1111/j.1365-2958.1994.tb00291.x; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; NIETO JM, 1991, MOL MICROBIOL, V5, P1285, DOI 10.1111/j.1365-2958.1991.tb01902.x; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paytubi S, 2011, CENT EUR J BIOL, V6, P879, DOI 10.2478/s11535-011-0071-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renault M, 2013, FEBS J, V280, P2916, DOI 10.1111/febs.12297; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takeda Toshiharu, 2011, Int J Evol Biol, V2011, P685015, DOI 10.4061/2011/685015; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Walther TH, 2013, CELL, V152, P316, DOI 10.1016/j.cell.2012.12.017; World Health Organization, 2016, ANTIMICROBIAL RESIST; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhou HX, 2001, BIOPOLYMERS, V59, P427, DOI 10.1002/1097-0282(200111)59:6<427::AID-BIP1047>3.0.CO;2-7	53	13	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21200	21212		10.1074/jbc.M114.630400	http://dx.doi.org/10.1074/jbc.M114.630400			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26085102	hybrid, Green Published			2022-12-28	WOS:000360637600002
J	Courivaud, T; Ferrand, N; Elkhattouti, A; Kumar, S; Levy, L; Ferrigno, O; Atfi, A; Prunier, C				Courivaud, Thomas; Ferrand, Nathalie; Elkhattouti, Abdelouahid; Kumar, Santosh; Levy, Laurence; Ferrigno, Olivier; Atfi, Azeddine; Prunier, Celine			Functional Characterization of a WWP1/Tiul1 Tumor-derived Mutant Reveals a Paradigm of Its Constitutive Activation in Human Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN E3 LIGASE; BREAST-CANCER; PROTEASOMAL DEGRADATION; HECT FAMILY; WWP1; DOMAIN; TARGET; DIFFERENTIATION; TRANSCRIPTION; MIGRATION	Although E3 ubiquitin ligases are deemed to play key roles in normal cell function and homeostasis, whether their alterations contribute to cancer pathogenesis remains unclear. In this study, we sought to investigate potential mechanisms that govern WWP1/Tiul1 (WWP1) ubiquitin ligase activity, focusing on its ability to trigger degradation of TGF beta type I receptor (T beta RI) in conjunction with Smad7. Our data reveal that the WWP1 protein is very stable at steady states because its autopolyubiquitination activity is silenced due to an intra-interaction between the C2 and/or WW and Hect domains that favors WWP1 monoubiquitination at the expense of its polyubiquitination or polyubiquitination of T beta RI. Upon binding of WWP1 to Smad7, this functional interplay is disabled, switching its monoubiquitination activity toward a polyubiquitination activity, thereby driving its own degradation and that of T beta RI as well. Intriguingly, a WWP1 point mutation found in human prostate cancer disrupts this regulatory mechanism by relieving the inhibitory effects of C2 and WW on Hect and thereby causing WWP1 hyperactivation. That cancer-driven alteration of WWP1 culminates in excessive T beta RI degradation and attenuated TGF beta cytostatic signaling, a consequence that could conceivably confer tumorigenic properties to WWP1.	[Courivaud, Thomas; Ferrand, Nathalie; Levy, Laurence; Ferrigno, Olivier; Atfi, Azeddine; Prunier, Celine] Univ Paris 06, F-75005 Paris, France; [Courivaud, Thomas; Ferrand, Nathalie; Levy, Laurence; Ferrigno, Olivier; Atfi, Azeddine; Prunier, Celine] INSERM, UMR S 938, Lab Cell Signaling & Carcinogenesis, F-75012 Paris, France; [Elkhattouti, Abdelouahid; Kumar, Santosh; Atfi, Azeddine] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Elkhattouti, Abdelouahid; Kumar, Santosh; Atfi, Azeddine] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Prunier, C (corresponding author), Hop St Antoine, Lab Cell Signaling & Carcinogenesis, 34 Rue Crozatier, F-75012 Paris, France.	celine.prunier@inserm.fr	Frottier, Celine Prunier/G-8259-2017; ferrigno, olivier/GSN-8581-2022; LEVY, Laurence/AAF-5672-2021	Frottier, Celine Prunier/0000-0002-7784-0273; ferrigno, olivier/0000-0001-7544-4384; 	La Ligue contre le Cancer; "Association pour la Recherche contre le Cancer," France; La Ligue Nationale contre le Cancer	La Ligue contre le Cancer(Ligue nationale contre le cancer); "Association pour la Recherche contre le Cancer," France(Fondation ARC pour la Recherche sur le Cancer); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by grants from "La Ligue contre le Cancer" and "Association pour la Recherche contre le Cancer," France (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral fellowship from "La Ligue Nationale contre le Cancer" and "Association pour la Recherche contre le Cancer," France.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2009, INT J CANCER, V124, P2829, DOI 10.1002/ijc.24266; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Feng SM, 2009, MOL CELL BIOL, V29, P892, DOI 10.1128/MCB.00595-08; Huu NSN, 2008, J PATHOL, V216, P93, DOI 10.1002/path.2385; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Lin XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067633; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shu L, 2013, J BONE MINER RES, V28, P1925, DOI 10.1002/jbmr.1938; Subik K, 2012, BONE, V50, P813, DOI 10.1016/j.bone.2011.12.022; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yeung B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061027; Zaarour RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037490; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao L, 2011, STEM CELLS, V29, P1601, DOI 10.1002/stem.703; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7; Zhou ZM, 2012, INT J CANCER, V130, P1504, DOI 10.1002/ijc.26122	30	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21007	21018		10.1074/jbc.M115.642314	http://dx.doi.org/10.1074/jbc.M115.642314			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152726	Green Published, hybrid			2022-12-28	WOS:000360011800034
J	Luo, SK; Xin, XR; Du, LL; Ye, KQ; Wei, Y				Luo, Shukun; Xin, Xiaoran; Du, Li-Lin; Ye, Keqiong; Wei, Yi			Dimerization Mediated by a Divergent Forkhead-associated Domain Is Essential for the DNA Damage and Spindle Functions of Fission Yeast Mdb1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN; BRCT DOMAIN; DEPENDENT DIMERIZATION; MOLECULAR-BASIS; HISTONE H2AX; FHA DOMAIN; MDC1; PHOSPHORYLATION; BINDING; REPAIR	MDC1 is a key factor of DNA damage response in mammalian cells. It possesses two phospho-binding domains. In its C terminus, a tandem BRCA1 C-terminal domain binds phosphorylated histone H2AX, and in its N terminus, a forkhead-associated (FHA) domain mediates a phosphorylation-enhanced homodimerization. The FHA domain of the Drosophila homolog of MDC1, MU2, also forms a homodimer but utilizes a different dimer interface. The functional importance of the dimerization of MDC1 family proteins is uncertain. In the fission yeast Schizosaccharomyces pombe, a protein sharing homology with MDC1 in the tandem BRCA1 C-terminal domain, Mdb1, regulates DNA damage response and mitotic spindle functions. Here, we report the crystal structure of the N-terminal 91 amino acids of Mdb1. Despite a lack of obvious sequence conservation to the FHA domain of MDC1, this region of Mdb1 adopts an FHA-like fold and is therefore termed Mdb1-FHA. Unlike canonical FHA domains, Mdb1-FHA lacks all the conserved phospho-binding residues. It forms a stable homodimer through an interface distinct from those of MDC1 and MU2. Mdb1-FHA is important for the localization of Mdb1 to DNA damage sites and the spindle midzone, contributes to the roles of Mdb1 in cellular responses to genotoxins and an antimicrotubule drug, and promotes in vitro binding of Mdb1 to a phospho-H2A peptide. The defects caused by the loss of Mdb1-FHA can be rescued by fusion with either of two heterologous dimerization domains, suggesting that the main function of Mdb1-FHA is mediating dimerization. Our data support that FHA-mediated dimerization is conserved for MDC1 family proteins.	[Luo, Shukun; Xin, Xiaoran; Du, Li-Lin; Ye, Keqiong; Wei, Yi] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Ye, Keqiong] Chinese Acad Sci, Key Lab RNA Biol, Inst Biophys, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS	Du, LL (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	dulilin@nibs.ac.cn; yekeqiong@nibs.ac.cn	Luo, Shukun/AAT-8195-2021; Luo, Shukun/A-8371-2017	Luo, Shukun/0000-0002-2766-3125; Luo, Shukun/0000-0002-2766-3125; Du, Li-Lin/0000-0002-1028-7397	Chinese Ministry of Science and Technology 863 Project [2008AA022310]; 973 Project [2010CB835402]; 863 Project [2007AA02Z1A5]; National Natural Science Foundation of China [31325007]; Beijing Municipal Government	Chinese Ministry of Science and Technology 863 Project(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); 973 Project(National Basic Research Program of China); 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Government	This work was supported by Chinese Ministry of Science and Technology 863 Project 2008AA022310 and 973 Project 2010CB835402 (to K. Y.) and 863 Project 2007AA02Z1A5 (to L.-L. D.), by National Natural Science Foundation of China Grant 31325007 (to K. Y.), and by the Beijing Municipal Government. The authors declare that they have no conflicts of interest with the contents of this article.	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; DeLano WL, 2002, PYMOL USERS MANUAL; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Du LL, 2004, J BIOL CHEM, V279, P38409, DOI 10.1074/jbc.M403326200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Granata M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001047; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098291; Jungmichel S, 2012, NUCLEIC ACIDS RES, V40, P3913, DOI 10.1093/nar/gkr1300; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Liu JP, 2012, NUCLEIC ACIDS RES, V40, P3898, DOI 10.1093/nar/gkr1296; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luo KT, 2011, J BIOL CHEM, V286, P28192, DOI 10.1074/jbc.M111.258087; Luo SK, 2012, FEBS LETT, V586, P344, DOI 10.1016/j.febslet.2012.01.023; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matthews L. A., 2013, MECH DNA REPLICATION; Mermershtain I, 2013, MUTAT RES-FUND MOL M, V750, P15, DOI 10.1016/j.mrfmmm.2013.07.004; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qu M, 2013, MOL CELL, V51, P723, DOI 10.1016/j.molcel.2013.08.030; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Sofueva S, 2010, MOL CELL BIOL, V30, P4732, DOI 10.1128/MCB.00413-10; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wei Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092079; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Wu HH, 2012, BIOCHEMISTRY-US, V51, P575, DOI 10.1021/bi201709w; Xu QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107309; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	43	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21054	21066		10.1074/jbc.M115.642538	http://dx.doi.org/10.1074/jbc.M115.642538			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160178	Green Published, hybrid			2022-12-28	WOS:000360011800038
J	Haji-Ghassemi, O; Muller-Loennies, S; Rodriguez, T; Brade, L; Kosma, P; Brade, H; Evans, SV				Haji-Ghassemi, Omid; Mueller-Loennies, Sven; Rodriguez, Teresa; Brade, Lore; Kosma, Paul; Brade, Helmut; Evans, Stephen V.			Structural Basis for Antibody Recognition of Lipid A INSIGHTS TO POLYSPECIFICITY TOWARD SINGLE-STRANDED DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; FAB FRAGMENT; CRYSTAL-STRUCTURE; SEVERE SEPSIS; V-J; BINDING; SPECIFICITY; LPS; LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN	Septic shock is a leading cause of death, and it results from an inflammatory cascade triggered by the presence of microbial products in the blood. Certain LPS from Gram-negative bacteria are very potent inducers and are responsible for a high percentage of septic shock cases. Despite decades of research, mAbs specific for lipid A (the endotoxic principle of LPS) have not been successfully developed into a clinical treatment for sepsis. To understand the molecular basis for the observed inability to translate in vitro specificity for lipid A into clinical potential, the structures of antigen-binding fragments of mAbs S1-15 and A6 have been determined both in complex with lipid A carbohydrate backbone and in the unliganded form. The two antibodies have separate germ line origins that generate two markedly different combining-site pockets that are complementary both in shape and charge to the antigen. mAb A6 binds lipid A through both variable light and heavy chain residues, whereas S1-15 utilizes exclusively the variable heavy chain. Both antibodies bind lipid A such that the GlcN-O6 attachment point for the core oligosaccharide is buried in the combining site, which explains the lack of LPS recognition. Longstanding reports of polyspecificity of anti-lipid A antibodies toward single-stranded DNA combined with observed homology of S1-15 and A6 and the reports of several single-stranded DNA-specific mAbs prompted the determination of the structure of S1-15 in complex with single-stranded DNA fragments, which may provide clues about the genesis of autoimmune diseases such as systemic lupus erythematosus, thyroiditis, and rheumatic autoimmune diseases.	[Haji-Ghassemi, Omid; Rodriguez, Teresa; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3P6, Canada; [Mueller-Loennies, Sven; Brade, Lore; Brade, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Kosma, Paul] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria	University of Victoria; Forschungszentrum Borstel; University of Natural Resources & Life Sciences, Vienna	Muller-Loennies, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Parkallee 22, D-23845 Borstel, Germany.	sml@fz-borstel.de; svevans@uvic.ca	Kosma, Paul/Y-7443-2019; Martín, Teresa Rodríguez/GZL-1938-2022	Kosma, Paul/0000-0001-5342-7161; Haji-Ghassemi, Omid/0000-0003-0116-005X; Evans, Stephen/0000-0002-0366-4027	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We gratefully acknowledge the technical assistance of Ute Agge, Veronika Susott, and Christine Schneider at the Research Center Borstel, Germany. Research described in this paper was performed at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; APPELMELK BJ, 1988, J MED MICROBIOL, V26, P107, DOI 10.1099/00222615-26-2-107; Blackler R. J., 2012, ANTICARBOHYDRATE ANT, P75; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; BRADE L, 1985, INFECT IMMUN, V48, P776, DOI 10.1128/IAI.48.3.776-781.1985; BRADE L, 1993, INFECT IMMUN, V61, P4514, DOI 10.1128/IAI.61.10.4514-4517.1993; Brade L, 1997, INFECT IMMUN, V65, P3961, DOI 10.1128/IAI.65.9.3961-3965.1997; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Buttenschoen K, 2010, LANGENBECK ARCH SURG, V395, P597, DOI 10.1007/s00423-010-0658-6; Cross AS, 2014, VIRULENCE, V5, P219, DOI 10.4161/viru.25965; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; DENG SJ, 1994, J BIOL CHEM, V269, P9533; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; ElSamalouti VT, 1997, EUR J BIOCHEM, V250, P418, DOI 10.1111/j.1432-1033.1997.0418a.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; FUJIHARA Y, 1993, J INFECT DIS, V168, P1429, DOI 10.1093/infdis/168.6.1429; GALANOS C, 1971, EUR J BIOCHEM, V24, P116; Gomery K, 2012, P NATL ACAD SCI USA, V109, P20877, DOI 10.1073/pnas.1209253109; Helmerhorst EJ, 1998, INFECT IMMUN, V66, P870, DOI 10.1128/IAI.66.2.870-873.1998; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Hold GL, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P371, DOI 10.1007/978-3-7091-0733-1_12; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; Ianaro A, 2009, MINI-REV MED CHEM, V9, P306, DOI 10.2174/1389557510909030306; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; IZUI S, 1977, J IMMUNOL, V119, P2157; KABURAKI J, 1992, Keio Journal of Medicine, V41, P10; Kaminski MJ, 1999, J BIOL CHEM, V274, P5597, DOI 10.1074/jbc.274.9.5597; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Krishnan MR, 1996, J IMMUNOL, V157, P2430; KUHN HM, 1993, INFECTION, V21, P179, DOI 10.1007/BF01710544; KUHN HM, 1992, INFECT IMMUN, V60, P2201, DOI 10.1128/IAI.60.6.2201-2210.1992; Li Joan, 2011, Hosp Pract (1995), V39, P99, DOI 10.3810/hp.2011.08.585; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; MOL CD, 1994, J BIOL CHEM, V269, P3615; MOL CD, 1994, J BIOL CHEM, V269, P3605; MONESTIER M, 1987, J EXP MED, V166, P1109, DOI 10.1084/jem.166.4.1109; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Pedro ABP, 2006, EXP CLIN ENDOCR DIAB, V114, P35, DOI 10.1055/s-2005-873005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POKKULURI PR, 1994, J MOL BIOL, V243, P283, DOI 10.1006/jmbi.1994.1654; Pollack M, 1997, J IMMUNOL, V159, P3519; RATHBUN GA, 1988, J MOL BIOL, V202, P383, DOI 10.1016/0022-2836(88)90272-0; Ravirajan CT, 2001, RHEUMATOLOGY, V40, P1405, DOI 10.1093/rheumatology/40.12.1405; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; ROBERTSON CR, 1992, CLIN EXP RHEUMATOL, V10, P589; Rynkiewicz MJ, 2012, BIOCHEMISTRY-US, V51, P5684, DOI 10.1021/bi201711m; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; Spellerberg M, 1995, ANN NY ACAD SCI, V764, P427; SUMAZAKI R, 1986, CLIN EXP IMMUNOL, V66, P103; Tanner JJ, 2001, J MOL BIOL, V314, P807, DOI 10.1006/jmbi.2001.5178; TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761; TORMO J, 1992, PROTEIN SCI, V1, P1154, DOI 10.1002/pro.5560010909; Vranken W, 2002, BIOCHEMISTRY-US, V41, P8570, DOI 10.1021/bi012169a; Vulliez-Le Normand B, 2008, P NATL ACAD SCI USA, V105, P9976, DOI 10.1073/pnas.0801711105; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	65	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19629	19640		10.1074/jbc.M115.657874	http://dx.doi.org/10.1074/jbc.M115.657874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085093	Green Published, hybrid			2022-12-28	WOS:000359364600024
J	Mehrazarin, S; Chen, W; Oh, JE; Liu, ZX; Kang, KL; Yi, JK; Kim, RH; Shin, KH; Park, NH; Kang, MK				Mehrazarin, Shebli; Chen, Wei; Oh, Ju-Eun; Liu, Zi X.; Kang, Kyung L.; Yi, Jin K.; Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.			The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through Reciprocal Feedback and Determines the Epithelial Phenotype in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ORAL KERATINOCYTES; MESENCHYMAL TRANSITION; STEM-CELLS; DIFFERENTIATION; ZEB1; SUPPRESSION; ACTIVATION; SENESCENCE; REPRESSION; MIGRATION	In this study, we investigated the effects of p63 modulation in epithelial plasticity in human keratinocytes. The p63 isoforms Delta Np63 alpha, Delta Np63 beta, and Delta Np63 gamma were ectopically expressed in normal human epidermal keratinocytes (NHEKs). The epithelial or mesenchymal state was determined by morphological changes and altered expression of various markers, e.g. fibronectin, E-Cadherin, and keratin 14. Overexpression of Delta Np63 alpha and Delta Np63 beta but not Delta Np63 gamma isoforms led to morphological changes consistent with epithelial-mesenchymal transition (EMT). However, only Delta Np63 alpha overexpression was able to maintain the morphological changes and molecular phenotype consistent with EMT. Interestingly, knockdown of all p63 isoforms by transfection of p63 siRNA also led to the EMT phenotype, further confirming the role of p63 in regulating the epithelial phenotype in NHEKs. EMT in NHKs accompanied loss of Grainyhead-Like 2 (GHRL2) and miR-200 family gene expression, both of which play crucial roles in determining the epithelial phenotype. Modulation of GRHL2 in NHKs also led to congruent changes in p63 expression. ChIP revealed direct GRHL2 binding to the p63 promoter. GRHL2 knockdown in NHK led to impaired binding of GRHL2 and changes in the histone marks consistent with p63 gene silencing. These data indicate the presence of a reciprocal feedback regulation between p63 and GRHL2 in NHEKs to regulate epithelial plasticity.	[Mehrazarin, Shebli; Chen, Wei; Oh, Ju-Eun; Liu, Zi X.; Kang, Kyung L.; Yi, Jin K.; Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kang, Kyung L.; Yi, Jin K.; Park, No-Hee] Kyung Hee Univ, Sch Dent, Seoul 130701, South Korea	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kyung Hee University	Kang, MK (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Sch Dent, Rm 43-009,10833 Conte Ave, Los Angeles, CA 90024 USA.	mkang@dentistry.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01DE18295, K02DE18959, R56DE024593]; Jack Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959, R56DE024593, R03DE024259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jack Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE18295, K02DE18959, and R56DE024593. This work was also supported by the Jack Weichman Endowed Fund (to M. K. K.). The authors declare no conflict of interest with the content of this article.	Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Chen W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.190; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Grille SJ, 2003, CANCER RES, V63, P2172; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Kang MK, 2000, EXP CELL RES, V258, P288, DOI 10.1006/excr.2000.4943; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	28	25	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19999	20008		10.1074/jbc.M115.659144	http://dx.doi.org/10.1074/jbc.M115.659144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085095	Green Published, hybrid			2022-12-28	WOS:000359364600054
J	Huang, JW; Cardamone, MD; Johnson, HE; Neault, M; Chan, M; Floyd, ZE; Mallette, FA; Perissi, V				Huang, Jiawen; Cardamone, M. Dafne; Johnson, Holly E.; Neault, Mathieu; Chan, Michelle; Floyd, Z. Elizabeth; Mallette, Frederick A.; Perissi, Valentina			Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE GENES; TRANSCRIPTIONAL REPRESSION; BETA-CATENIN; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; SUBUNIT GPS2; PPAR-GAMMA; METHYLATION; SUMOYLATION; RECRUITMENT	G protein pathway suppressor 2 (GPS2) is a multifunctional protein involved in the regulation of a number of metabolic organs. First identified as part of the NCoR/SMRT corepressor complex, GPS2 is known to play an important role in the nucleus in the regulation of gene transcription and meiotic recombination. In addition, we recently reported a non-transcriptional role of GPS2 as an inhibitor of the proinflammatory TNF alpha pathway in the cytosol. Although this suggests that the control of GPS2 localization may be an important determinant of its molecular functions, a clear understanding of GPS2 differential targeting to specific cellular locations is still lacking. Here we show that a fine balance between protein stabilization and degradation tightly regulates GPS2 nuclear function. Our findings indicate that GPS2 is degraded upon polyubiquitination by the E3 ubiquitin ligase Siah2. Unexpectedly, interaction with the exchange factor TBL1 is required to protect GPS2 from degradation, with methylation of GPS2 by arginine methyltransferase PRMT6 regulating the interaction with TBL1 and inhibiting proteasome-dependent degradation. Overall, our findings indicate that regulation of GPS2 by posttranslational modifications provides an effective strategy for modulating its molecular function within the nuclear compartment.	[Huang, Jiawen; Cardamone, M. Dafne; Johnson, Holly E.; Chan, Michelle; Perissi, Valentina] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Neault, Mathieu; Mallette, Frederick A.] Hop Maison Neuve Rosemont, Ctr Rech, Chromatin Struct & Cellular Senescence Res Unit, Montreal, PQ H1T 2M4, Canada; [Floyd, Z. Elizabeth] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Mallette, Frederick A.] Univ Montreal, Dept Med, Montreal, PQ H1T 2M4, Canada	Boston University; Universite de Montreal; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universite de Montreal	Perissi, V (corresponding author), Boston Univ, Sch Med, Dept Biochem, Silvio Conte Bldg, Boston, MA 02118 USA.	vperissi@bu.edu	Regan, Clinton/E-6250-2012; Mallette, Frédérick A./J-6646-2019; Floyd, Elizabeth/W-2758-2019; Floyd, Elizabeth/N-1962-2017	Mallette, Frédérick A./0000-0001-7932-0338; Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186; Perissi, Valentina/0000-0002-3716-0003; Cardamone, Maria/0000-0003-4591-3447; Neault, Mathieu/0000-0002-0479-1001	National Institutes of Health [DK078756, DK100422]; Canadian Institutes of Health Research Operating Grant [MOP-133442]; Fonds de Recherche du Quebec-Sante; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK078756, R01DK099625, R01DK100422, K99DK078756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078756 and DK100422 (to V. P.). This work was also supported by Canadian Institutes of Health Research Operating Grant MOP-133442 (to F. A. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Holder of a Ph.D. studentship from the Fonds de Recherche du Quebec-Sante.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bi HL, 2014, MOL BIOL CELL, V25, P2499, DOI 10.1091/mbc.E13-12-0733; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cheng DH, 2012, METHOD ENZYMOL, V512, P71, DOI 10.1016/B978-0-12-391940-3.00004-4; Choi HK, 2013, J CELL PHYSIOL, V228, P1159, DOI 10.1002/jcp.24269; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; Di Lorenzo A, 2014, NUCLEIC ACIDS RES, V42, P8297, DOI 10.1093/nar/gku530; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Guo C, 2015, J BIOL CHEM, V290, P3666, DOI 10.1074/jbc.M114.598797; Harrison MJ, 2010, NUCLEIC ACIDS RES, V38, P2201, DOI 10.1093/nar/gkp1203; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jarmalavicius S, 2010, FASEB J, V24, P937, DOI 10.1096/fj.09-136283; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Sambrook J., 2001, MOL CLONING LAB MANU; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Stein C, 2012, NUCLEIC ACIDS RES, V40, P9522, DOI 10.1093/nar/gks767; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Zhang DF, 2008, GENOMICS, V92, P107, DOI 10.1016/j.ygeno.2008.04.008; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127	49	11	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19044	19054		10.1074/jbc.M115.637660	http://dx.doi.org/10.1074/jbc.M115.637660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26070566	Green Published, hybrid			2022-12-28	WOS:000358781100022
J	Zeng, JW; Mi, RJ; Wang, YC; Li, YJ; Lin, L; Yao, B; Song, LN; van Die, I; Chapman, AB; Cummings, RD; Jin, P; Ju, TZ				Zeng, Junwei; Mi, Rongjuan; Wang, Yingchun; Li, Yujing; Lin, Li; Yao, Bing; Song, Lina; van Die, Irma; Chapman, Arlene B.; Cummings, Richard D.; Jin, Peng; Ju, Tongzhong			Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-O-GLYCOSYLATION; MOLECULAR CHAPERONE COSMC; IGA NEPHROPATHY; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; EPITHELIAL-CELLS; BINDING-SITES; P-SELECTIN; I GENE; SP1	The T/synthase (core 1 beta 3-galactosyltransferase) and its molecular chaperone Cosmc regulate the biosynthesis of mucin type O-glycans on glycoproteins, and evidence suggests that both T-synthase and Cosmc are transcriptionally suppressed in several human diseases, although the transcriptional regulation of these two genes is not understood. Here, we characterized the promoters essential for human Cosmc and T-synthase transcription. The upstream regions of the genes lack a conventional TATA box but contain CpG islands, cCpG-I and cCpG-II for Cosmc and tCpG for T-synthase. Using luciferase reporter assays, site-directed mutagenesis, ChIP assays, and mithramycin A treatment, we identified the core promoters within cCpG-II and tCpG, which contain two binding sites for Kruppel-like transcription factors, including SP1/SP3, respectively. Methylome analysis of Tn4 B cells, which harbor a silenced Cosmc, confirmed the hypermethylation of the Cosmc core promoter but not for T-synthase. These results demonstrate that Cosmc and T-synthase are transcriptionally regulated at a basal level by the specificity protein/Krupple-like transcription factor family of members, which explains their ubiquitous and coordinated expression, and also indicate that they are differentially epigenetically regulated beyond X chromosome imprinting. These results are important in understanding the regulation of these genes that have roles in human diseases, such as IgA nephropathy and cancer.	[Zeng, Junwei; Mi, Rongjuan; Wang, Yingchun; Song, Lina; Cummings, Richard D.; Ju, Tongzhong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Li, Yujing; Lin, Li; Yao, Bing; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Emory University; Emory University; Emory University; Vrije Universiteit Amsterdam	Ju, TZ (corresponding author), Emory Univ, Sch Med, 1510 Clifton Rd NE,Rm 4029, Atlanta, GA 30322 USA.	tju@emory.edu	Regan, Clinton/E-6250-2012; Li, Yujing/AAJ-1411-2020; Li, yujing/GQA-4109-2022	Li, Yujing/0000-0002-4363-2484; Yao, Bing/0000-0002-3205-8130; Ju, Tongzhong/0000-0002-4429-1976	National Institutes of Health [RO1DK80876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK80876 (to T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Berger EG, 1999, BBA-MOL BASIS DIS, V1455, P255, DOI 10.1016/S0925-4439(99)00069-1; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Falkenberg VR, 2007, GLYCOCONJUGATE J, V24, P511, DOI 10.1007/s10719-007-9043-2; Falkenberg VR, 2003, GLYCOBIOLOGY, V13, P411, DOI 10.1093/glycob/cwg039; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Giannakakis K, 2007, J AM SOC NEPHROL, V18, P3139, DOI 10.1681/ASN.2007030259; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Higai K, 2006, BIOL PHARM BULL, V29, P2372, DOI 10.1248/bpb.29.2372; Hiki Y, 2009, CLIN EXP NEPHROL, V13, P415, DOI 10.1007/s10157-009-0173-7; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Inoue T, 2011, ADV OTO-RHINO-LARYNG, V72, P71, DOI 10.1159/000324610; Inoue T, 2010, CLIN IMMUNOL, V136, P447, DOI 10.1016/j.clim.2010.05.009; ITZKOWITZ S, 1992, APMIS, V100, P173; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Ju T., 2014, HDB GLYCOSYLTRANSFER, V1, P149; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Jung EM, 2011, BIOCHEM BIOPH RES CO, V404, P463, DOI 10.1016/j.bbrc.2010.12.003; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Kudo T, 2013, BLOOD, V122, P1649, DOI 10.1182/blood-2012-12-471102; Kwon HY, 2010, EXP MOL MED, V42, P849, DOI 10.3858/emm.2010.42.12.088; Lehoux S, 2014, MOL CELL PROTEOMICS, V13, P3097, DOI 10.1074/mcp.M114.039693; Lehoux S, 2010, GLYCOCONJUGATE J, V27, P99, DOI 10.1007/s10719-009-9260-y; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Mestecky J, 2008, KIDNEY BLOOD PRESS R, V31, P29, DOI 10.1159/000112922; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Muller B, 2009, J BIOL CHEM, V284, P30775, DOI 10.1074/jbc.M109.016592; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Qin W, 2005, J INTERN MED, V258, P467, DOI 10.1111/j.1365-2796.2005.01558.x; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCHMITT FC, 1995, VIRCHOWS ARCH, V427, P251; Sengupta PK, 2010, J BIOL CHEM, V285, P31164, DOI 10.1074/jbc.M110.149195; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki Yusuke, 2008, Nihon Jinzo Gakkai Shi, V50, P456; SVENSSON EC, 1990, J BIOL CHEM, V265, P20863; Takashima S, 2000, J BIOCHEM-TOKYO, V127, P399, DOI 10.1093/oxfordjournals.jbchem.a022621; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Terasawa K, 1996, CANCER RES, V56, P2229; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xie LS, 2010, CLIN INVEST MED, V33, pE5; Xu QS, 2011, J BIOL CHEM, V286, P4310, DOI 10.1074/jbc.M110.182576; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yao B, 2014, HUM MOL GENET, V23, P1095, DOI 10.1093/hmg/ddt504; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yu HH, 2011, CLIN REV ALLERG IMMU, V41, P198, DOI 10.1007/s12016-010-8232-0	78	16	18	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19018	19033		10.1074/jbc.M115.654244	http://dx.doi.org/10.1074/jbc.M115.654244			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26063800	Green Published, hybrid			2022-12-28	WOS:000358781100020
J	Cuevasanta, E; Lange, M; Bonanata, J; Coitino, EL; Ferrer-Sueta, G; Filipovic, MR; Alvarez, B				Cuevasanta, Ernesto; Lange, Mike; Bonanata, Jenner; Laura Coitino, E.; Ferrer-Sueta, Gerardo; Filipovic, Milos R.; Alvarez, Beatriz			Reaction of Hydrogen Sulfide with Disulfide and Sulfenic Acid to Form the Strongly Nucleophilic Persulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; PROTEIN S-SULFHYDRATION; INTERCHANGE REACTIONS; SULFANE SULFUR; OXIDIZED GLUTATHIONE; THIOL; CYSTEINE; OXIDATION; H2S; CHEMISTRY	Background: Hydrogen sulfide (H2S) modulates physiological processes in mammals. Results: The reactivity of H2S toward disulfides (RSSR) and albumin sulfenic acid (RSOH) to form persulfides (RSSH) was assessed. Conclusion: H2S is less reactive than thiols. Persulfides have enhanced nucleophilicity. Significance: This kinetic study helps rationalize the contribution of the reactions with oxidized thiol derivatives to H2S biology.	[Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Lab Enzimol, Montevideo 11400, Uruguay; [Bonanata, Jenner; Laura Coitino, E.] Univ Republica, Lab Quim Teor & Computac, Montevideo 11400, Uruguay; [Ferrer-Sueta, Gerardo] Univ Republica, Lab Fisicoquim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Cuevasanta, Ernesto; Ferrer-Sueta, Gerardo; Alvarez, Beatriz] Univ Republica, Ctr Free Radical & Biomed Res, Montevideo 11400, Uruguay; [Lange, Mike; Filipovic, Milos R.] Univ Erlangen Nurnberg, Dept Chem & Pharm, Div Bioinorgan Chem, D-91058 Erlangen, Germany	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Erlangen Nuremberg	Filipovic, MR (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Div Bioinorgan Chem, D-91058 Erlangen, Germany.	milos.filipovic@fau.de; beatriz.alvarez@fcien.edu.uy	Coitiño Izaguirre, Elena Laura/A-8101-2016; Ferrer-Sueta, Gerardo/C-3316-2011; Filipovic, Milos/D-5482-2014	Coitiño Izaguirre, Elena Laura/0000-0002-6214-2413; Ferrer-Sueta, Gerardo/0000-0002-8663-8480; Alvarez, Beatriz/0000-0001-6911-3132; Bonanata, Jenner/0000-0002-3413-8038; Filipovic, Milos/0000-0003-0060-0041	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica); L'Oreal-UNESCO, Uruguay; Friedrich-Alexander University of Erlangen-Nuremberg (MRIC); Agencia Nacional de Investigacion e Innovacion; PEDECIBA, Uruguay	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica); L'Oreal-UNESCO, Uruguay; Friedrich-Alexander University of Erlangen-Nuremberg (MRIC); Agencia Nacional de Investigacion e Innovacion; PEDECIBA, Uruguay	This work was supported in part by grants from Comision Sectorial de Investigacion Cientifica (Universidad de la Republica) and L'Oreal-UNESCO, Uruguay (to B.A.), and Emerging Field Initiative intramural grant from Friedrich-Alexander University of Erlangen-Nuremberg (MRIC) (to M. R. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from the Agencia Nacional de Investigacion e Innovacion and by PEDECIBA, Uruguay.	Abiko Y, 2015, CHEM RES TOXICOL, V28, P1301, DOI 10.1021/acs.chemrestox.5b00101; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Bailey TS, 2014, J AM CHEM SOC, V136, P10573, DOI 10.1021/ja505371z; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; BUNNETT JF, 1963, ANNU REV PHYS CHEM, V14, P271, DOI 10.1146/annurev.pc.14.100163.001415; Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Chatterji T, 2005, BIOORG MED CHEM LETT, V15, P3921, DOI 10.1016/j.bmcl.2005.05.110; Cotton F. A., 1988, ADV INORGANIC CHEM; CREIGHTON TE, 1975, J MOL BIOL, V96, P767, DOI 10.1016/0022-2836(75)90151-5; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; EDWARDS JO, 1962, J AM CHEM SOC, V84, P16, DOI 10.1021/ja00860a005; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Frey P. A., 2007, ENZYMATIC REACTION M, P16; Frisch M.J, 2016, GAUSSIAN16 REVISON A; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; Geerlings P, 2014, CHEM SOC REV, V43, P4989, DOI 10.1039/c3cs60456j; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Iversen R, 2010, BIOCHEMISTRY-US, V49, P810, DOI 10.1021/bi9015956; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JENCKS WP, 1960, J AM CHEM SOC, V82, P1778, DOI 10.1021/ja01492a058; Torres MJ, 2012, ARCH BIOCHEM BIOPHYS, V521, P102, DOI 10.1016/j.abb.2012.03.011; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KEIRE DA, 1992, J ORG CHEM, V57, P123, DOI 10.1021/jo00027a023; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Liu CR, 2014, FREE RADICAL BIO MED, V76, P200, DOI 10.1016/j.freeradbiomed.2014.08.003; LIU DK, 1987, CAN J CHEM, V65, P770, DOI 10.1139/v87-131; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagahara N, 2012, ANTIOXID REDOX SIGN, V16, P747, DOI 10.1089/ars.2011.4468; Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019; Ono K, 2014, FREE RADICAL BIO MED, V77, P82, DOI 10.1016/j.freeradbiomed.2014.09.007; Pan J, 2013, ACS CHEM BIOL, V8, P1110, DOI 10.1021/cb4001052; Park CM, 2015, METHOD ENZYMOL, V555, P39, DOI 10.1016/bs.mie.2014.11.033; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Portillo-Ledesma S, 2014, BIOCHEMISTRY-US, V53, P6113, DOI 10.1021/bi500389m; Saha A, 1998, FREE RADICAL BIO MED, V24, P653, DOI 10.1016/S0891-5849(97)00365-1; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Singh R., 1993, SULPHUR CONTAINING F, P633; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Ubuka T, 2002, J CHROMATOGR B, V781, P227, DOI 10.1016/S1570-0232(02)00623-2; Vasas A, 2015, NITRIC OXIDE-BIOL CH, V46, P93, DOI 10.1016/j.niox.2014.12.003; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; WHITESIDES GM, 1977, J ORG CHEM, V42, P332, DOI 10.1021/jo00422a034; WILSON JM, 1977, J AM CHEM SOC, V99, P7922, DOI 10.1021/ja00466a027; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Yu HZ, 2014, J PHYS CHEM A, V118, P606, DOI 10.1021/jp410274n; Zhang DH, 2014, ANGEW CHEM INT EDIT, V53, P575, DOI 10.1002/anie.201305876	64	168	171	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26866	26880		10.1074/jbc.M115.672816	http://dx.doi.org/10.1074/jbc.M115.672816			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26269587	Green Published, hybrid			2022-12-28	WOS:000364794000001
J	Barfoot, T; Herdendorf, TJ; Behning, BR; Stohr, BA; Gao, Y; Kreuzer, KN; Nelson, SW				Barfoot, Tasida; Herdendorf, Timothy J.; Behning, Bryanna R.; Stohr, Bradley A.; Gao, Yang; Kreuzer, Kenneth N.; Nelson, Scott W.			Functional Analysis of the Bacteriophage T4 Rad50 Homolog (gp46) Coiled-coil Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; MRE11 COMPLEX; DNA-REPAIR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; ZINC-HOOK; COORDINATION; ROLES; ENDS	Rad50 and Mre11 form a complex involved in the detection and processing of DNA double strand breaks. Rad50 contains an anti-parallel coiled-coil with two absolutely conserved cysteine residues at its apex. These cysteine residues serve as a dimerization domain and bind a Zn2+ cation in a tetrathiolate coordination complex known as the zinc-hook. Mutation of the zinc-hook in bacteriophage T4 is lethal, indicating the ability to bind Zn2+ is critical for the functioning of the MR complex. In vitro, we found that complex formation between Rad50 and a peptide corresponding to the C-terminal domain of Mre11 enhances the ATPase activity of Rad50, supporting the hypothesis that the coiled-coil is a major conduit for communication between Mre11 and Rad50. We constructed mutations to perturb this domain in the bacteriophage T4 Rad50 homolog. Deletion of the Rad50 coiled-coil and zinc-hook eliminates Mre11 binding and ATPase activation but does not affect its basal activity. Mutation of the zinc-hook or disruption of the coiled-coil does not affect Mre11 or DNA binding, but their activation of Rad50 ATPase activity is abolished. Although these mutants excise a single nucleotide at a normal rate, they lack processivity and have reduced repetitive exonuclease rates. Restricting the mobility of the coiled-coil eliminates ATPase activation and repetitive exonuclease activity, but the ability to support single nucleotide excision is retained. These results suggest that the coiled-coiled domain adopts at least two conformations throughout the ATPase/nuclease cycle, with one conformation supporting enhanced ATPase activity and processivity and the other supporting nucleotide excision.	[Barfoot, Tasida; Herdendorf, Timothy J.; Behning, Bryanna R.; Gao, Yang; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Stohr, Bradley A.; Kreuzer, Kenneth N.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Iowa State University; Duke University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu	Regan, Clinton/E-6250-2012; Gao, Yang/O-3445-2016		National Institutes of Health [RO1 GM066934]; Carver Trust Young Investigator [10-3603]; National Science Foundation [MCB-1121693]; Div Of Molecular and Cellular Bioscience [1121693] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Trust Young Investigator; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM066934 (to K. N. K). This work was also supported by Carver Trust Young Investigator Grant 10-3603 (to S. W. N.), Iowa State University institutional support (to S. W. N), and National Science Foundation Grant MCB-1121693 (to S. W. N). The authors declare that they have no conflicts of interest with the contents of this article.	ALANI E, 1989, GENETICS, V122, P47; Albrecht DW, 2012, J BIOL CHEM, V287, P31371, DOI 10.1074/jbc.M112.392316; Almond JR, 2013, GENETICS, V195, P739, DOI 10.1534/genetics.113.154872; Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Das D, 2010, J MOL BIOL, V397, P647, DOI 10.1016/j.jmb.2010.01.049; de Jager M, 2004, J MOL BIOL, V339, P937, DOI 10.1016/j.jmb.2004.04.014; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Deshpande RA, 2014, EMBO J, V33, P482, DOI 10.1002/embj.201386100; Gao Y, 2014, J BIOL CHEM, V289, P26505, DOI 10.1074/jbc.M114.583625; Gell DA, 2012, ADV EXP MED BIOL, V747, P19, DOI 10.1007/978-1-4614-3229-6_2; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Harvey SH, 2002, GENOME BIOL, V3; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Herdendorf T. J., 2011, BIOCHEMISTRY, P6030; Herdendorf TJ, 2014, BIOCHEMISTRY-US, V53, P5647, DOI 10.1021/bi500558d; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hohl M, 2015, MOL CELL, V57, P479, DOI 10.1016/j.molcel.2014.12.018; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafrance-Vanasse J, 2015, PROG BIOPHYS MOL BIO, V117, P182, DOI 10.1016/j.pbiomolbio.2014.12.004; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee JH, 2013, J BIOL CHEM, V288, P12840, DOI 10.1074/jbc.M113.460378; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Mosig G, 2001, P NATL ACAD SCI USA, V98, P8306, DOI 10.1073/pnas.131007398; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shcherbakov VP, 2006, DNA REPAIR, V5, P773, DOI 10.1016/j.dnarep.2006.03.007; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stohr BA, 2002, GENETICS, V162, P1019; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008	48	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23905	23915		10.1074/jbc.M115.675132	http://dx.doi.org/10.1074/jbc.M115.675132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242734	Green Published, hybrid			2022-12-28	WOS:000361816500036
J	Samuel, PP; Smith, LP; Phillips, GN; Olson, JS				Samuel, Premila P.; Smith, Lucian P.; Phillips, George N., Jr.; Olson, John S.			Apoglobin Stability Is the Major Factor Governing both Cell-free and in Vivo Expression of Holomyoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS SYSTEM; SITE-DIRECTED MUTAGENESIS; FOLDED APOMYOGLOBIN INTERMEDIATE; SPERM-WHALE MYOGLOBIN; ESCHERICHIA-COLI; MESSENGER-RNA; STRUCTURAL-CHARACTERIZATION; HEMIN DISSOCIATION; LIPID OXIDATION; AMYLOID FIBRILS	Expression levels in animal muscle tissues and in Escherichia coli vary widely for naturally occurring mammalian myoglobins (Mb). To explore this variation, we developed an in vitro transcription and wheat germ extract-based translation assay to examine quantitatively the factors that govern expression of holoMb. We constructed a library of naturally occurring Mbs from two terrestrial and four deep-diving aquatic mammals and three distal histidine mutants designed to enhance apoglobin stability but decrease hemin affinity. A strong linear correlation is observed between cell-free expression levels of holo-metMb variants and their corresponding apoglobin stabilities, which were measured independently by guanidine HCl-induced unfolding titrations using purified proteins. In contrast, there is little dependence of expression on hemin affinity. Our results confirm quantitatively that deep diving mammals have highly stable Mbs that express to higher levels in animal myocytes, E. coli, and the wheat germ cell-free system than Mbs from terrestrial mammals. Our theoretical analyses show that the rate of aggregation of unfolded apoMb is very large, and as a result, the key factor for high level expression of holoMb, and presumably other heme proteins, is an ultra high fraction of folded, native apoglobin that is capable of rapidly binding hemin. This fraction is determined by the overall equilibrium folding constant and not hemin affinity. These results also demonstrate that the cell-free transcription/translation system can be used as a high throughput platform to screen for apoglobin stability without the need to generate large amounts of protein for in vitro unfolding measurements.	[Samuel, Premila P.; Smith, Lucian P.; Phillips, George N., Jr.; Olson, John S.] Rice Univ, BioSci Rice, Houston, TX 77005 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University; Rice University	Olson, JS (corresponding author), Rice Univ, BioSci Rice, MS 140,6100 Main St, Houston, TX 77005 USA.	olson@rice.edu	Regan, Clinton/E-6250-2012	Olson, John/0000-0002-0760-5403; Samuel, Premila/0000-0001-6690-0886; Smith, Lucian/0000-0001-7002-6386	National Institutes of Health [P01 HL110900, U01 GM098248, HL47020, GM35649]; Robert A. Welch Foundation [C-0612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020, P01HL110900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, U01GM098248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL110900 (to J. S. O.). This work was also supported by Grant C-0612 from Robert A. Welch Foundation (to J. S. O.). The initial funds for setting up the cell-free technology at Rice University were supported by the National Institutes of Health Grant U01 GM098248 (Protein Structure Initiative) (to G. N. P., Jr.). The earlier work on holoMb expression in E. coli was supported by the National Institutes of Health Grants HL47020 and GM35649 (to J. S. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar M Kalim, 2014, Front Bioeng Biotechnol, V2, P30, DOI 10.3389/fbioe.2014.00030; Alayash AI, 2013, TRENDS BIOTECHNOL, V31, P2, DOI 10.1016/j.tibtech.2012.10.003; Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, V21; Ascoli F, 1981, Methods Enzymol, V76, P72; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Banci L., 2013, METALLOMICS CELL, P565; BARRICK D, 1994, J MOL BIOL, V237, P588, DOI 10.1006/jmbi.1994.1257; BARRICK D, 1993, BIOCHEMISTRY-US, V32, P3790, DOI 10.1021/bi00065a035; BASTOS RN, 1977, J MOL BIOL, V110, P205, DOI 10.1016/S0022-2836(77)80069-7; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Egan TJ, 2001, BIOCHEMISTRY-US, V40, P204, DOI 10.1021/bi0013501; Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; Elmer J, 2011, J CHROMATOGR B, V879, P131, DOI 10.1016/j.jchromb.2010.11.021; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; FLANAGAN MA, 1983, BIOCHEMISTRY-US, V22, P6027, DOI 10.1021/bi00294a051; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Grunwald EW, 2006, J AGR FOOD CHEM, V54, P4452, DOI 10.1021/jf0603228; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Harnastai IN, 2006, PROTEIN EXPRES PURIF, V46, P47, DOI 10.1016/j.pep.2005.07.006; HUGHSON FM, 1989, BIOCHEMISTRY-US, V28, P4415, DOI 10.1021/bi00436a044; HUGHSON FM, 1991, BIOCHEMISTRY-US, V30, P4113, DOI 10.1021/bi00231a001; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Imamura H, 2013, J SYNCHROTRON RADIAT, V20, P919, DOI 10.1107/S0909049513022772; INADA Y, 1962, BIOCHEM BIOPH RES CO, V9, P323, DOI 10.1016/0006-291X(62)90048-7; IRACE G, 1981, BIOCHEMISTRY-US, V20, P792, DOI 10.1021/bi00507a022; Itoh T, 2001, BIOCONJUGATE CHEM, V12, P3, DOI 10.1021/bc000055q; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kelley C., 2013, GNUPLOT VERSION 4 5; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; KIRBY EP, 1970, J BIOL CHEM, V245, P6300; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lee SK, 2015, FOOD CHEM, V167, P258, DOI 10.1016/j.foodchem.2014.06.098; Lepeshkevich SV, 2009, BBA-PROTEINS PROTEOM, V1794, P103, DOI 10.1016/j.bbapap.2008.09.024; Light W. R., 1987, THESIS RICE U HOUSTO; Lo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060704; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Madin K, 2004, FEBS LETT, V562, P155, DOI 10.1016/S0014-5793(04)00221-2; Makino S, 2010, METHODS MOL BIOL, V607, P127, DOI 10.1007/978-1-60327-331-2_12; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022; MOORE RE, 1980, CANCER RES, V40, P1449; Nishimura C, 2006, J MOL BIOL, V355, P139, DOI 10.1016/j.jmb.2005.10.047; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Scott EE, 2000, J BIOL CHEM, V275, P27129; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; SINGER RH, 1973, J MOL BIOL, V78, P321, DOI 10.1016/0022-2836(73)90119-8; SMERDON SJ, 1991, BIOCHEMISTRY-US, V30, P6252, DOI 10.1021/bi00239a025; Smith L., 2003, THESIS RICE U HOUSTO; Spirin AS, 2008, CELL FREE PROTEIN SY, P1; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SRINIVAS V, 1990, BIOCHEM INT, V21, P849; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Takai K, 2010, CURR PHARM BIOTECHNO, V11, P272, DOI 10.2174/138920110791111933; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tcherkasskaya O, 2000, BIOCHEMISTRY-US, V39, P1879, DOI 10.1021/bi992117+; Tcherkasskaya O, 2000, J BIOL CHEM, V275, P36285, DOI 10.1074/jbc.M003008200; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tyler RC, 2005, PROTEINS, V59, P633, DOI 10.1002/prot.20436; Varnado CL, 2013, ANTIOXID REDOX SIGN, V18, P2314, DOI 10.1089/ars.2012.4917; WEDZICHA BL, 1988, FOOD CHEM, V27, P47, DOI 10.1016/0308-8146(88)90035-0; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443	89	21	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23479	23495		10.1074/jbc.M115.672204	http://dx.doi.org/10.1074/jbc.M115.672204			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26205820	hybrid, Green Published			2022-12-28	WOS:000361816500002
J	Koenig, P; Lee, CV; Sanowar, S; Wu, P; Stinson, J; Harris, SF; Fuh, G				Koenig, Patrick; Lee, Chingwei V.; Sanowar, Sarah; Wu, Ping; Stinson, Jeremy; Harris, Seth F.; Fuh, Germaine			Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; 2-IN-ONE ANTIBODY; MATURATION; BINDING; CONFORMATIONS; LIBRARIES; STRATEGY; DISPLAY; DOMAIN; VEGF	The development of dual targeting antibodies promises therapies with improved efficacy over mono-specific antibodies. Here, we engineered a Two-in-One VEGF/angiopoietin 2 antibody with dual action Fab (DAF) as a potential therapeutic for neovascular age-related macular degeneration. Crystal structures of the VEGF/angiopoietin 2 DAF in complex with its two antigens showed highly overlapping binding sites. To achieve sufficient affinity of the DAF to block both angiogenic factors, we turned to deep mutational scanning in the complementarity determining regions (CDRs). By mutating all three CDRs of each antibody chain simultaneously, we were able not only to identify affinity improving single mutations but also mutation pairs from different CDRs that synergistically improve both binding functions. Furthermore, insights into the cooperativity between mutations allowed us to identify fold-stabilizing mutations in the CDRs. The data obtained from deep mutational scanning reveal that the majority of the 52 CDR residues are utilized differently for the two antigen binding function and permit, for the first time, the engineering of several DAF variants with subnanomolar affinity against two structurally unrelated antigens. The improved variants show similar blocking activity of receptor binding as the high affinity mono-specific antibodies against these two proteins, demonstrating the feasibility of generating a dual specificity binding surface with comparable properties to individual high affinity mono-specific antibodies.	[Koenig, Patrick; Lee, Chingwei V.; Sanowar, Sarah; Fuh, Germaine] Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA 94080 USA; [Stinson, Jeremy] Genentech Res & Early Dev, Dept Mol Biol, San Francisco, CA 94080 USA; [Wu, Ping; Harris, Seth F.] Genentech Res & Early Dev, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fuh, G (corresponding author), Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA 94080 USA.	gml@gene.com			Genentech, Inc., a member of the Roche Group	Genentech, Inc., a member of the Roche Group	All authors are paid employees of Genentech, Inc., a member of the Roche Group, and are inventors of a patent application based on the work described herein.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bostrom Jenny, 2009, V525, P353, DOI 10.1007/978-1-59745-554-1_19; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bricogne G., 2011, BUSTER; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Christinger HW, 1996, PROTEINS, V26, P353, DOI 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Forsyth CM, 2013, MABS-AUSTIN, V5, P523, DOI 10.4161/mabs.24979; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fujino Y, 2012, BIOCHEM BIOPH RES CO, V428, P395, DOI 10.1016/j.bbrc.2012.10.066; Hotzel I, 2012, MABS-AUSTIN, V4, P753, DOI 10.4161/mabs.22189; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee CV, 2006, BLOOD, V108, P3103, DOI 10.1182/blood-2006-03-011031; Lee CV, 2014, MABS-AUSTIN, V6, P622, DOI 10.4161/mabs.28483; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Li B, 2014, MABS-AUSTIN, V6, P437, DOI 10.4161/mabs.27875; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; R Development Core Team, 2009, R LANG ENV STAT COMP; Rajpal A, 2005, P NATL ACAD SCI USA, V102, P8466, DOI 10.1073/pnas.0503543102; Rennel ES, 2011, MICROCIRCULATION, V18, P598, DOI 10.1111/j.1549-8719.2011.00120.x; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Skinner MM, 1996, P NATL ACAD SCI USA, V93, P10753, DOI 10.1073/pnas.93.20.10753; Thurston G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006650; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037	50	28	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21773	21786		10.1074/jbc.M115.662783	http://dx.doi.org/10.1074/jbc.M115.662783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26088137	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000360968500001
J	Kubic, JD; Lui, JW; Little, EC; Ludvik, AE; Konda, S; Salgia, R; Aplin, AE; Lang, D				Kubic, Jennifer D.; Lui, Jason W.; Little, Elizabeth C.; Ludvik, Anton E.; Konda, Sasank; Salgia, Ravi; Aplin, Andrew E.; Lang, Deborah			PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; B16 TUMOR-CELLS; NEURAL CREST; GENOMIC ORGANIZATION; ENDOTHELIAL-CELLS; MET RECEPTOR; METASTASIS; ACTIVATION; FUSION; DOMAIN	Metastatic melanoma is an aggressive and deadly disease. The chemokine receptor CXCR4 is active in melanoma metastasis, although the mechanism for the promotion and maintenance of CXCR4 expression in these cells is mostly unknown. Here, we find melanoma cells express two CXCR4 isoforms, the common version and a variant that is normally restricted to cells during development or to mature blood cells. CXCR4 expression is driven through a highly conserved intronic enhancer element by the transcription factors PAX3 and FOXD3. Inhibition of these transcription factors slows melanoma cell growth, migration, and motility, as well as reduces CXCR4 expression. Overexpression of these transcription factors drives the production of increased CXCR4 levels. Loss of PAX3 and FOXD3 transcription factor activity results in a reduction in cell motility, migration, and chemotaxis, all of which are rescued by CXCR4 overexpression. Here, we discover a molecular pathway wherein PAX3 and FOXD3 promote CXCR4 gene expression in melanoma.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lang, Deborah] Univ Chicago, Dermatol Sect, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Surg, Philadelphia, PA 19107 USA	University of Chicago; University of Chicago; University of Chicago; Jefferson University; Jefferson University; Jefferson University	Lang, D (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 5067, Chicago, IL 60637 USA.	dlang@medicine.bsd.uchicago.edu	Regan, Clinton/E-6250-2012	Lang, Deborah/0000-0003-1057-0923	National Institutes of Health [T32 GM007183, T35 DK062719, R01 CA160495, R01 CA130202, R01-AR062547, R01CA184001]; American Cancer Society [RSG-CSM-121505]; Friends of Dermatology-University of Chicago; Wendy Will Case Foundation; University of Chicago Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA130202, R01CA160495, R01CA184001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Friends of Dermatology-University of Chicago; Wendy Will Case Foundation; University of Chicago Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007183 (to J. W. L.), T35 DK062719 (TO S. K.), R01 CA160495 (to A. E. A.), and R01 CA130202, R01-AR062547, and R01CA184001 (to D. L.), American Cancer Society Research Scholar Award RSG-CSM-121505 (to D. L.), Friends of Dermatology-University of Chicago, the Wendy Will Case Foundation, and the University of Chicago Comprehensive Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Basile KJ, 2012, ONCOGENE, V31, P2471, DOI 10.1038/onc.2011.424; Bonvin E, 2012, MOL CELL BIOL, V32, P4674, DOI 10.1128/MCB.01067-12; Cardones AR, 2003, CANCER RES, V63, P6751; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; CHALEPAKIS G, 1995, GENE, V162, P267, DOI 10.1016/0378-1119(95)00345-7; Duquenne C, 2014, J IMMUNOL, V193, P4188, DOI 10.4049/jimmunol.1303298; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gupta SK, 1999, J IMMUNOL, V163, P2368; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; He SJ, 2011, MELANOMA RES, V21, P24, DOI 10.1097/CMR.0b013e328341c7e0; Izraely S, 2010, IMMUNOL LETT, V130, P107, DOI 10.1016/j.imlet.2009.12.003; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jun S, 1996, DEVELOPMENT, V122, P2639; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Kubic JD, 2015, ONCOGENE, V34, P4964, DOI 10.1038/onc.2014.420; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Kubic JD, 2012, MOL CANCER RES, V10, P1065, DOI 10.1158/1541-7786.MCR-11-0387; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Li DJ, 2011, J VASC SURG, V53, P1668, DOI 10.1016/j.jvs.2011.01.044; Liedtke D, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12188; Liu F, 2013, PIGM CELL MELANOMA R, V26, P67, DOI 10.1111/pcmr.12029; Longo-Imedio MI, 2005, INT J CANCER, V117, P861, DOI 10.1002/ijc.21269; Mascarenhas JB, 2010, PIGM CELL MELANOMA R, V23, P225, DOI 10.1111/j.1755-148X.2010.00667.x; Murakami T, 2002, CANCER RES, V62, P7328; Nelms BL, 2011, GENESIS, V49, P10, DOI 10.1002/dvg.20686; O'Boyle G, 2013, BRIT J CANCER, V108, P1634, DOI 10.1038/bjc.2013.124; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Sasai N, 2001, DEVELOPMENT, V128, P2525; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Scholl FA, 2001, CANCER RES, V61, P823; Sloane AJ, 2005, IMMUNOL CELL BIOL, V83, P129, DOI 10.1111/j.1440-1711.2004.01304.x; Sutton J, 1996, J BIOL CHEM, V271, P23126, DOI 10.1074/jbc.271.38.23126; Takekoshi T, 2012, MOL CANCER THER, V11, P2516, DOI 10.1158/1535-7163.MCT-12-0494; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Thompson JA, 2012, J NATL COMPR CANC NE, V10, P932, DOI 10.6004/jnccn.2012.0096; Tomescu O, 2004, LAB INVEST, V84, P1060, DOI 10.1038/labinvest.3700125; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vianello F, 2006, J IMMUNOL, V176, P2902, DOI 10.4049/jimmunol.176.5.2902; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Zhu ZB, 2004, GENE THER, V11, P645, DOI 10.1038/sj.gt.3302089	56	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21901	21914		10.1074/jbc.M115.670976	http://dx.doi.org/10.1074/jbc.M115.670976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205821	Green Published, hybrid			2022-12-28	WOS:000360968500012
J	Marshall, J; Wong, KY; Rupasinghe, CN; Tiwari, R; Zhao, XW; Berberoglu, ED; Sinkler, C; Liu, J; Lee, I; Parang, K; Spaller, MR; Huttemann, M; Goebel, DJ				Marshall, John; Wong, Kwoon Y.; Rupasinghe, Chamila N.; Tiwari, Rakesh; Zhao, Xiwu; Berberoglu, Eren D.; Sinkler, Christopher; Liu, Jenney; Lee, Icksoo; Parang, Keykavous; Spaller, Mark R.; Huettemann, Maik; Goebel, Dennis J.			Inhibition of N-Methyl-D-aspartate-induced Retinal Neuronal Death by Polyarginine Peptides Is Linked to the Attenuation of Stress-induced Hyperpolarization of the Inner Mitochondrial Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR SUBUNITS; CELL-DEATH; OXIDATIVE STRESS; PERMEABILITY TRANSITION; SYNAPTIC-TRANSMISSION; INDUCED NEUROTOXICITY; SIGNALING PATHWAYS; DIFFERENT ROLES; CYTOCHROME-C; PDZ DOMAIN	It is widely accepted that overactivation of NMDA receptors, resulting in calcium overload and consequent mitochondrial dysfunction in retinal ganglion neurons, plays a significant role in promoting neurodegenerative disorders such as glaucoma. Calcium has been shown to initiate a transient hyperpolarization of the mitochondrial membrane potential triggering a burst of reactive oxygen species leading to apoptosis. Strategies that enhance cell survival signaling pathways aimed at preventing this adverse hyperpolarization of the mitochondrial membrane potential may provide a novel therapeutic intervention in retinal disease. In the retina, brain-derived neurotrophic factor has been shown to be neuroprotective, and our group previously reported a PSD-95/PDZ-binding cyclic peptide (CN2097) that augments brain-derived neurotrophic factor-induced pro-survival signaling. Here, we examined the neuroprotective properties of CN2097 using an established retinal in vivo NMDA toxicity model. CN2097 completely attenuated NMDA-induced caspase 3-dependent and -independent cell death and PARP-1 activation pathways, blocked necrosis, and fully prevented the loss of long term ganglion cell viability. Although neuroprotection was partially dependent upon CN2097 binding to the PDZ domain of PSD-95, our results show that the polyarginine-rich transport moiety C-R(7), linked to the PDZ-PSD-95-binding cyclic peptide, was sufficient to mediate short and long term protection via a mitochondrial targeting mechanism. C-R(7) localized to mitochondria and was found to reduce mitochondrial respiration, mitochondrial membrane hyperpolarization, and the generation of reactive oxygen species, promoting survival of retinal neurons.	[Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Wong, Kwoon Y.; Zhao, Xiwu] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Rupasinghe, Chamila N.; Spaller, Mark R.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; [Rupasinghe, Chamila N.; Spaller, Mark R.] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Tiwari, Rakesh; Parang, Keykavous] Chapman Univ, Sch Pharm, Irvine, CA 92618 USA; [Berberoglu, Eren D.; Goebel, Dennis J.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Sinkler, Christopher; Liu, Jenney; Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea	Brown University; University of Michigan System; University of Michigan; Dartmouth College; Norris Cotton Cancer Center; Chapman University System; Chapman University; Wayne State University; Wayne State University; Dankook University	Goebel, DJ (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48202 USA.	dgoebel@med.wayne.edu	Parang, Keykavous/ABC-1584-2021	Parang, Keykavous/0000-0001-8600-0893; Wong, Kwoon/0000-0001-9279-7827; Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health from NINDS [R21 NS061176]; NEI [R01 EY014430, GM63021, P30EY0468, P20-EY00700]; NHLBI [T32HL120822]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061176] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS061176 (to D. J. G., M. R. S., and J. M.) from NINDS, Grants R01 EY014430 (to D. J. G.) and GM63021 (to M. R. S.) from NEI, NEI Core Grants P30EY0468 (Wayne State University) and P20-EY00700 (University of Michigan), and NHLBI Training Grant T32HL120822 (to C. S.). J. M. owns shares in Angelus Therapeutics. No materials or support were received from this company. United States patent application entitled "Neuroprotective Composition and Method of Use" (United States Patent Application WO2013158739) has been filed by Brown University, with D. J. G. and J. M. listed as inventors.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Abeti R, 2015, PHARMACOL RES, V99, P377, DOI 10.1016/j.phrs.2015.05.007; Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-34; Bartlett TE, 2013, NEUROPHARMACOLOGY, V74, P59, DOI 10.1016/j.neuropharm.2013.01.012; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Eriksson O, 1998, J BIOL CHEM, V273, P12669, DOI 10.1074/jbc.273.20.12669; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; Goebel DJ, 1998, BRAIN RES, V808, P141, DOI 10.1016/S0006-8993(98)00749-5; Grover GJ, 2004, AM J PHYSIOL-HEART C, V287, pH1747, DOI 10.1152/ajpheart.01019.2003; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hernandez C, 2012, CURR DIABETES REP, V12, P329, DOI 10.1007/s11892-012-0284-5; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jonas EA, 2009, EXP NEUROL, V218, P203, DOI 10.1016/j.expneurol.2009.03.025; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LeBlanc BW, 2010, NEUROSCIENCE, V167, P490, DOI 10.1016/j.neuroscience.2010.02.031; Lee D, 2014, APOPTOSIS, V19, P603, DOI 10.1007/s10495-013-0956-x; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; LEVY DI, 1990, NEUROLOGY, V40, P852, DOI 10.1212/WNL.40.5.852; Li T, 2004, BIOORG MED CHEM LETT, V14, P1385, DOI 10.1016/j.bmcl.2003.09.103; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Patra CR, 2012, ACS CHEM BIOL, V7, P770, DOI 10.1021/cb200536r; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Pourcho RG, 2001, J COMP NEUROL, V433, P75, DOI 10.1002/cne.1126; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RIGOBELLO MP, 1995, BIOCHEM BIOPH RES CO, V217, P144, DOI 10.1006/bbrc.1995.2756; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Saro D, 2004, ORG LETT, V6, P3429, DOI 10.1021/ol049181q; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stafford BK, 2014, J NEUROSCI, V34, P1942, DOI 10.1523/JNEUROSCI.4461-13.2014; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Vaslin A, 2009, NEUROTOX RES, V15, P123, DOI 10.1007/s12640-009-9012-6; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82	68	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22030	22048		10.1074/jbc.M115.662791	http://dx.doi.org/10.1074/jbc.M115.662791			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26100636	Green Published, hybrid			2022-12-28	WOS:000360968500023
J	Calattini, S; Fusil, F; Mancip, J; Thi, VLD; Granier, C; Gadot, N; Scoazec, JY; Zeisel, MB; Baumert, TF; Lavillette, D; Dreux, M; Cosset, FL				Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Gadot, Nicolas; Scoazec, Jean-Yves; Zeisel, Mirjam B.; Baumert, Thomas F.; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic			Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR-BI; SURFACE HEPARAN-SULFATE; HUMAN HEPATOCYTES; SR-BI; NEUTRALIZING ANTIBODIES; CHOLESTERYL ESTER; CELL-CULTURE; ENTRY FACTOR	Lipoprotein components are crucial factors for hepatitis C virus (HCV) assembly and entry. As hepatoma cells producing cell culture-derived HCV (HCVcc) particles are impaired in some aspects of lipoprotein metabolism, it is of upmost interest to biochemically and functionally characterize the in vivo produced viral particles, particularly regarding how lipoprotein components modulate HCV entry by lipid transfer receptors such as scavenger receptor BI (SR-BI). Sera from HCVcc-infected liver humanized FRG mice were separated by density gradients. Viral subpopulations, termed HCVfrg particles, were characterized for their physical properties, apolipoprotein association, and infectivity. We demonstrate that, in contrast to the widely spread distribution of apolipoproteins across the different HCVcc subpopulations, the most infectious HCVfrg particles are highly enriched in apoE, suggesting that such apolipoprotein enrichment plays a role for entry of in vivo derived infectious particles likely via usage of apolipoprotein receptors. Consistent with this salient feature, we further reveal previously undefined functionalities of SR-BI in promoting entry of in vivo produced HCV. First, unlike HCVcc, SR-BI is a particularly limiting factor for entry of HCVfrg subpopulations of very low density. Second, HCVfrg entry involves SR-BI lipid transfer activity but not its capacity to bind to the viral glycoprotein E2. In conclusion, we demonstrate that composition and biophysical properties of the different subpopulations of in vivo produced HCVfrg particles modulate their levels of infectivity and receptor usage, hereby featuring divergences with in vitro produced HCVcc particles and highlighting the powerfulness of this in vivo model for the functional study of the interplay between HCV and liver components.	[Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon, CIRI Int Ctr Infectiol Res, Team EVIR Enveloped Viruses Vectors & Innate Resp, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] INSERM, U1111, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon 1, Ctr Int Rech Infectiol, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] CNRS, UMR5308, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon, LabEx Ecofect, F-69007 Lyon, France; [Gadot, Nicolas; Scoazec, Jean-Yves] CNRS, ANIPATH Ctr Histopathol Petit Anim Lab, SFR Lyon Est, UMS3453 INSERM US7, F-69372 Lyon, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] INSERM, Inst Malad Virales & Hepat, U1110, F-67000 Strasbourg, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] Univ Strasbourg, F-67000 Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, Inst Hosp Univ, Pole Hepatodigestif, F-67000 Strasbourg, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cosset, FL (corresponding author), Univ Lyon, CIRI Int Ctr Infectiol Res, Team EVIR, F-69007 Lyon, France.	flcosset@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019; Dreux, Marlene/M-7295-2014; Baumert, Thomas/ABF-4718-2020; Zeisel, Mirjam B/E-9205-2016	Cosset, François-Loïc/0000-0001-8842-3726; Dreux, Marlene/0000-0002-6607-4796; Baumert, Thomas/0000-0002-8864-2168; Zeisel, Mirjam B/0000-0003-1606-0131; Lavillette, Dimitri/0000-0002-4706-1519; Christelle, GRANIER/0000-0001-8987-0632; FUSIL, Floriane/0000-0002-1619-7333; Dao Thi, Viet Loan/0000-0003-2293-3592	French "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS); ANRS consortium on humanized mouse models for viral hepatitis; FINOVI foundation; European Research Council [ERC-2008-AdG-233130-HEPCENT]; LabEx Ecofect Grant [ANR-11-LABX-0048]; ANRS	French "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS)(French National Research Agency (ANR)); ANRS consortium on humanized mouse models for viral hepatitis(French National Research Agency (ANR)); FINOVI foundation; European Research Council(European Research Council (ERC)European Commission); LabEx Ecofect Grant; ANRS(ANRSFrench National Research Agency (ANR))	This work was supported in part by the French "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS), "ANRS consortium on humanized mouse models for viral hepatitis," the FINOVI foundation, European Research Council Grant ERC-2008-AdG-233130-HEPCENT, and LabEx Ecofect Grant ANR-11-LABX-0048. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the ANRS.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Ellis ECS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078550; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067982; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Lavillette D, 2005, J VIROL, V79, P6023, DOI 10.1128/JVI.79.10.6023-6034.2005; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; Lefevre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095550; Li GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035895; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loison C, 2002, BRIT J NUTR, V87, P199, DOI [10.1079/BJNBJN2002521, 10.1079/BJN2002521]; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Spady DK, 1999, J LIPID RES, V40, P1384; SPARKS DL, 1995, J BIOL CHEM, V270, P26910, DOI 10.1074/jbc.270.45.26910; Steenbergen RH, 2013, HEPATOLOGY, V58, P1907, DOI 10.1002/hep.26566; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Thi VLD, 2012, J BIOL CHEM, V287, P31242, DOI 10.1074/jbc.M112.365924; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Xu Y, 2015, J VIROL, V89, P3846, DOI 10.1128/JVI.03647-14; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097	64	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23173	23187		10.1074/jbc.M115.662999	http://dx.doi.org/10.1074/jbc.M115.662999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26224633	Green Published, hybrid			2022-12-28	WOS:000361685500028
J	Saez-Jimenez, V; Baratto, MC; Pogni, R; Rencoret, J; Gutierrez, A; Santos, JI; Martinez, AT; Ruiz-Duenas, FJ				Saez-Jimenez, Veronica; Baratto, Maria Camilla; Pogni, Rebecca; Rencoret, Jorge; Gutierrez, Ana; Ignacio Santos, Jose; Martinez, Angel T.; Javier Ruiz-Duenas, Francisco			Demonstration of Lignin-to-Peroxidase Direct Electron Transfer A TRANSIENT-STATE KINETICS, DIRECTED MUTAGENESIS, EPR, AND NMR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYNGII VERSATILE PEROXIDASE; PLEUROTUS-ERYNGII; MICROBIAL-DEGRADATION; VERATRYL ALCOHOL; OXIDATION SITES; LACCASE; IDENTIFICATION; EXPRESSION; RESONANCE; ENZYMES	Versatile peroxidase (VP) is a high redox-potential peroxidase of biotechnological interest that is able to oxidize phenolic and non-phenolic aromatics, Mn2+, and different dyes. The ability of VP from Pleurotus eryngii to oxidize water-soluble lignins (softwood and hardwood lignosulfonates) is demonstrated here by a combination of directed mutagenesis and spectroscopic techniques, among others. In addition, direct electron transfer between the peroxidase and the lignin macromolecule was kinetically characterized using stopped-flow spectrophotometry. VP variants were used to show that this reaction strongly depends on the presence of a solvent-exposed tryptophan residue (Trp-164). Moreover, the tryptophanyl radical detected by EPR spectroscopy of H2O2-activated VP (being absent from the W164S variant) was identified as catalytically active because it was reduced during lignosulfonate oxidation, resulting in the appearance of a lignin radical. The decrease of lignin fluorescence (excitation at 355 nm/emission at 400 nm) during VP treatment under steady-state conditions was accompanied by a decrease of the lignin (aromatic nuclei and side chains) signals in one-dimensional and two-dimensional NMR spectra, confirming the ligninolytic capabilities of the enzyme. Simultaneously, size-exclusion chromatography showed an increase of the molecular mass of the modified residual lignin, especially for the (low molecular mass) hardwood lignosulfonate, revealing that the oxidation products tend to recondense during the VP treatment. Finally, mutagenesis of selected residues neighboring Trp-164 resulted in improved apparent second-order rate constants for lignosulfonate reactions, revealing that changes in its protein environment (modifying the net negative charge and/or substrate accessibility/binding) can modulate the reactivity of the catalytic tryptophan.	[Martinez, Angel T.; Javier Ruiz-Duenas, Francisco] CSIC, CIB, E-28040 Madrid, Spain; [Baratto, Maria Camilla; Pogni, Rebecca] Univ Siena, Dept Biotechnol Chem & Pharm, I-53100 Siena, Italy; [Rencoret, Jorge; Gutierrez, Ana] CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain; [Ignacio Santos, Jose] Univ Basque Country, UPV EHU Donostia, SGIKER, NMR Facil, Leioa 48940, Leioa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Siena; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Basque Country	Martinez, AT (corresponding author), CSIC, CIB, Ramiro Maeztu 9, E-28040 Madrid, Spain.	ATMartinez@cib.csic.es; fjruiz@cib.csic.es	RENCORET, JORGE/E-1747-2013; Martínez, Angel T/G-7284-2017; Santos, Jose I/C-9546-2016; Ruiz-Dueñas, Francisco J/L-9837-2015; Gutiérrez, Ana/ABG-9861-2020; RENCORET, JORGE/ABE-4139-2020; Santos, José I./AAH-1969-2019	RENCORET, JORGE/0000-0003-2728-7331; Martínez, Angel T/0000-0002-1584-2863; Santos, Jose I/0000-0002-5199-2332; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Gutiérrez, Ana/0000-0002-8823-9029; RENCORET, JORGE/0000-0003-2728-7331; Santos, José I./0000-0002-5199-2332; Saez-Jimenez, Veronica/0000-0001-7043-5622	European Union [KBBE-2013-613549]; Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2011-26694, BIO2014-56388-R, AGL2014-53730-R]; FEDER funds; Italian Ministry of Education, Universities and Research (MIUR) [PRIN 2009-STNWX3]; Spanish MINECO; CSIC [201440E097]; Ramon y Cajal contract of the Spanish MINECO	European Union(European Commission); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); FEDER funds(European Commission); Italian Ministry of Education, Universities and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Spanish MINECO(Spanish Government); CSIC; Ramon y Cajal contract of the Spanish MINECO	This work was supported by the INDOX (KBBE-2013-613549) European Union project, the HIPOP (BIO2011-26694), NOESIS (BIO2014-56388-R), and BIORENZYMERY (AGL2014-53730-R) projects of the Spanish Ministry of Economy and Competitiveness (MINECO) co-financed by FEDER funds, and the PRIN 2009-STNWX3 project of the Italian Ministry of Education, Universities and Research (MIUR).; Supported by an FPI Fellowship of the Spanish MINECO.; Supported by a contract of the CSIC project 201440E097.; Supported by a Ramon y Cajal contract of the Spanish MINECO. To whom correspondence may be addressed: CIB, CSIC, Ramiro de Maeztu 9, E-28040 Madrid, Spain. Tel.: 34-918373112; Fax: 34-915360432; E-mail: fjruiz@cib.csic.es.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Albinsson B, 1999, J MOL STRUCT, V508, P19, DOI 10.1016/S0022-2860(98)00913-2; Areskogh D, 2011, THESIS KTH STOCKHOLM; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Felby C, 1997, APPL MICROBIOL BIOT, V48, P459, DOI 10.1007/s002530051080; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-2; Floudas D, 2015, FUNGAL GENET BIOL, V76, P78, DOI 10.1016/j.fgb.2015.02.002; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gelpke MDS, 2002, BIOCHEMISTRY-US, V41, P3498, DOI 10.1021/bi011930d; Glennie D.W., 1971, LIGNINS OCCURRENCE F, P597; Gronqvist S, 2005, APPL MICROBIOL BIOT, V67, P489, DOI 10.1007/s00253-004-1800-6; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Lebo SE, 2008, CHARACTERIZATION LIG, P189; Lu FC, 2011, J BIOBASED MATER BIO, V5, P169, DOI 10.1166/jbmb.2011.1131; Lutnaes BF, 2008, MAGN RESON CHEM, V46, P299, DOI 10.1002/mrc.2184; Magina S, 2015, HOLZFORSCHUNG, V69, P513, DOI 10.1515/hf-2014-0218; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2005, INT MICROBIOL, V8, P195; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Prasetyo EN, 2010, BIORESOURCE TECHNOL, V101, P5054, DOI 10.1016/j.biortech.2010.01.048; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ralph J., 1999, PROGR LIGNOCELLULOSI, P55; Rencoret J, 2009, HOLZFORSCHUNG, V63, P691, DOI 10.1515/HF.2009.070; Rico A, 2015, BIOENERG RES, V8, P211, DOI 10.1007/s12155-014-9505-x; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200; Schmidt JA., 2010, LIGNIN LIGNANS ADV C, P49, DOI 10.1201/EBK1574444865-c3; Shin Kwang-Soo, 1995, Mycoscience, V36, P31, DOI 10.1007/BF02268570; Smith AT, 2009, P NATL ACAD SCI USA, V106, P16084, DOI 10.1073/pnas.0904535106; Taboada-Puig R, 2013, APPL BIOCHEM BIOTECH, V169, P1262, DOI 10.1007/s12010-012-0023-z; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661	46	29	29	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23201	23213		10.1074/jbc.M115.665919	http://dx.doi.org/10.1074/jbc.M115.665919			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240145	Green Published, hybrid			2022-12-28	WOS:000361685500030
J	Williamson, DM; Elferich, J; Shinde, U				Williamson, Danielle M.; Elferich, Johannes; Shinde, Ujwal			Mechanism of Fine-tuning pH Sensors in Proprotein Convertases IDENTIFICATION OF A pH-SENSING HISTIDINE PAIR IN THE PROPEPTIDE OF PROPROTEIN CONVERTASE 1/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; INTRAMOLECULAR CHAPERONE; CIS/TRANS ISOMERIZATION; ENZYME ACTIVATION; PRO-DOMAIN; FURIN; OBESITY; CLEAVAGE; PC1/3; DEFICIENCY	The propeptides of proprotein convertases (PCs) regulate activation of cognate protease domains by sensing pH of their organellar compartments as they transit the secretory pathway. Earlier experimental work identified a conserved histidine-encoded pH sensor within the propeptide of the canonical PC, furin. To date, whether protonation of this conserved histidine is solely responsible for PC activation has remained unclear because of the observation that various PC paralogues are activated at different organellar pH values. To ascertain additional determinants of PC activation, we analyzed PC1/3, a paralogue of furin that is activated at a pH of similar to 5.4. Using biophysical, biochemical, and cell-based methods, we mimicked the protonation status of various histidines within the propeptide of PC1/3 and examined how such alterations can modulate pH-dependent protease activation. Our results indicate that whereas the conserved histidine plays a crucial role in pH sensing and activation of this protease an additional histidine acts as a "gatekeeper" that fine-tunes the sensitivity of the PC1/3 propeptide to facilitate the release inhibition at higher proton concentrations when compared with furin. Coupled with earlier analyses that highlighted the enrichment of the amino acid histidine within propeptides of secreted eukaryotic proteases, our work elucidates how secreted proteases have evolved to exploit the pH of the secretory pathway by altering the spatial juxtaposition of titratable groups to regulate their activity in a spatiotemporal fashion.	[Williamson, Danielle M.; Elferich, Johannes; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Shinde, U (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	shindeu@ohsu.edu		Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health Ruth L. Kirschstein National Research Service [5F30DK096752]; National Science Foundation [MCB0746589]; American Heart Association [12PRE11470005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award 5F30DK096752 (to D. M. W.). This work was also supported by National Science Foundation Grant MCB0746589 (to U. S.) and American Heart Association Predoctoral Training Grant 12PRE11470005 (to J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Arsenault D, 2012, J CELL PHYSIOL, V227, P789, DOI 10.1002/jcp.22792; Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; Bassi DE, 2010, NEOPLASIA, V12, P516, DOI 10.1593/neo.92030; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Blanco EH, 2014, ENDOCRINOLOGY, V155, P3434, DOI 10.1210/en.2013-2151; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; de Cicco RL, 2005, CANCER RES, V65, P4162, DOI 10.1158/0008-5472.CAN-04-2820; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; Elferich J., 2012, P 6 INT C BIOINF BIO; Elferich J, 2015, ANAL CHEM, V87, P7909, DOI 10.1021/acs.analchem.5b01721; Elferich J, 2013, FASEB J, V27, P2939, DOI 10.1096/fj.12-226886; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu J, 2012, NEOPLASIA, V14, P271, DOI 10.1593/neo.12166; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Martin MG, 2013, GASTROENTEROLOGY, V145, P138, DOI 10.1053/j.gastro.2013.03.048; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pasquato A, 2013, ANTIVIR RES, V99, P49, DOI 10.1016/j.antiviral.2013.04.013; Pickett LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055065; Prabhu Y, 2014, ENDOCRINOLOGY, V155, P2391, DOI 10.1210/en.2013-1985; Rashid S, 2014, CIRCULATION, V130, P431, DOI 10.1161/CIRCULATIONAHA.113.006720; Reimer U, 1997, BIOCHEMISTRY-US, V36, P13802, DOI 10.1021/bi9713916; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Scamuffa N, 2014, CARCINOGENESIS, V35, P528, DOI 10.1093/carcin/bgt345; Schonichen A, 2013, ANNU REV BIOPHYS, V42, P289, DOI 10.1146/annurev-biophys-050511-102349; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Stijnen P, 2014, AM J EPIDEMIOL, V180, P1051, DOI 10.1093/aje/kwu237; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Subbian E., 2015, ADV BIOSCI BIOTECHNO, V06, P73; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; TANFORD C, 1961, J BIOL CHEM, V236, P1711; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tangrea MA, 2001, BIOCHEMISTRY-US, V40, P5488, DOI 10.1021/bi0026472; TEXTER FL, 1992, BIOCHEMISTRY-US, V31, P5687, DOI 10.1021/bi00140a001; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Williamson DM, 2013, J BIOL CHEM, V288, P19154, DOI 10.1074/jbc.M112.442681; Yabuta Y, 2003, J BIOL CHEM, V278, P15246, DOI 10.1074/jbc.M212003200; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x; Zandberg WF, 2011, GLYCOBIOLOGY, V21, P1290, DOI 10.1093/glycob/cwr060; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	59	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23214	23225		10.1074/jbc.M115.665430	http://dx.doi.org/10.1074/jbc.M115.665430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229104	Green Published, hybrid			2022-12-28	WOS:000361685500031
J	McLean, R; Hobbs, JK; Suits, MD; Tuomivaara, ST; Jones, DR; Boraston, AB; Abbott, DW				McLean, Richard; Hobbs, Joanne K.; Suits, Michael D.; Tuomivaara, Sami T.; Jones, Darryl R.; Boraston, Alisdair B.; Abbott, D. Wade			Functional Analyses of Resurrected and Contemporary Enzymes Illuminate an Evolutionary Path for the Emergence of Exolysis in Polysaccharide Lyase Family 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme structure; magnesium; manganese; protein evolution; exolysis; polysaccharide lyase	GLYCOSIDE HYDROLASE; BETA-ELIMINATION; STRUCTURE VALIDATION; PROTEIN; MODELS; CLASSIFICATION; SEQUENCE; ORGANIZATION; PHYLOGENIES; ALIGNMENT	Background: The evolutionary history of family 2 polysaccharide lyases is unknown. Results: Functional analysis highlights a key lysine-tryptophan transition involved in exolysis. Conclusion: Subtle changes in amino acid structure can transform enzyme activity. Significance: Combinatorial use of ancestral sequence reconstruction, gene resurrection, and structure-function analysis is valuable for elucidating the function and evolutionary history of polysaccharide lyases. Family 2 polysaccharide lyases (PL2s) preferentially catalyze the -elimination of homogalacturonan using transition metals as catalytic cofactors. PL2 is divided into two subfamilies that have been generally associated with secretion, Mg2+ dependence, and endolysis (subfamily 1) and with intracellular localization, Mn2+ dependence, and exolysis (subfamily 2). When present within a genome, PL2 genes are typically found as tandem copies, which suggests that they provide complementary activities at different stages along a catabolic cascade. This relationship most likely evolved by gene duplication and functional divergence (i.e. neofunctionalization). Although the molecular basis of subfamily 1 endolytic activity is understood, the adaptations within the active site of subfamily 2 enzymes that contribute to exolysis have not been determined. In order to investigate this relationship, we have conducted a comparative enzymatic analysis of enzymes dispersed within the PL2 phylogenetic tree and elucidated the structure of VvPL2 from Vibrio vulnificus YJ016, which represents a transitional member between subfamiles 1 and 2. In addition, we have used ancestral sequence reconstruction to functionally investigate the segregated evolutionary history of PL2 progenitor enzymes and illuminate the molecular evolution of exolysis. This study highlights that ancestral sequence reconstruction in combination with the comparative analysis of contemporary and resurrected enzymes holds promise for elucidating the origins and activities of other carbohydrate active enzyme families and the biological significance of cryptic metabolic pathways, such as pectinolysis within the zoonotic marine pathogen V. vulnificus.	[McLean, Richard; Jones, Darryl R.; Abbott, D. Wade] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada; [Hobbs, Joanne K.; Suits, Michael D.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Suits, Michael D.] Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON N2L 3C5, Canada; [Tuomivaara, Sami T.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Agriculture & Agri Food Canada; University of Victoria; Wilfrid Laurier University; University System of Georgia; University of Georgia	Abbott, DW (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, 5403 1st Ave S, Lethbridge, AB T1J 4B1, Canada.	wade.abbott@agr.gc.ca		McLean, Richard/0000-0002-3237-3288; Hobbs, Joanne/0000-0001-5239-8039; Abbott, Wade/0000-0003-4893-5799; Boraston, Alisdair/0000-0001-6417-0592	Agriculture and Agri-Food Canada (Agri-Flex) [2668]; Beef and Cattle Research Council [FDE.15.13]; Natural Sciences and Engineering Research Council of Canada Discovery Grant [FRN 04355]	Agriculture and Agri-Food Canada (Agri-Flex)(Agriculture & Agri Food Canada); Beef and Cattle Research Council; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Agriculture and Agri-Food Canada (Agri-Flex #2668) and the Beef and Cattle Research Council (FDE.15.13) (to D.W.A.) and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (FRN 04355) (to A.B.B.).	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Abbott DW, 2013, APPL BIOCHEM BIOTECH, V171, P1911, DOI 10.1007/s12010-013-0483-9; Abbott DW, 2010, J BIOL CHEM, V285, P39029, DOI 10.1074/jbc.M110.153981; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Boraston AB, 2012, ACTA CRYSTALLOGR F, V68, P129, DOI 10.1107/S1744309111055400; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2010, SCI CHINA CHEM, V53, P52, DOI 10.1007/s11426-010-0011-5; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hutter CAJ, 2014, ACTA CRYSTALLOGR D, V70, P1770, DOI 10.1107/S1399004714007147; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zwickl DJ, 2006, THESIS	48	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21231	21243		10.1074/jbc.M115.664847	http://dx.doi.org/10.1074/jbc.M115.664847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160170	Green Published, hybrid			2022-12-28	WOS:000360637600004
J	Xhabija, B; Vacratsis, PO				Xhabija, Besa; Vacratsis, Panayiotis O.			Receptor-mediated Endocytosis 8 Utilizes an N-terminal Phosphoinositide-binding Motif to Regulate Endosomal Clathrin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); clathrin; endocytosis; protein motif; protein sorting; protein-protein interaction; PI(3)P; RME-8; SNX1; retrograde transport	DOMAIN PROTEIN RME-8; MANNOSE 6-PHOSPHATE RECEPTORS; FYVE DOMAIN; PX DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; INTEGRIN-BINDING; SORTING NEXIN-1; COATED VESICLES	Background: RME-8 is involved in clathrin removal at early endosomes. Results: RME-8 possesses a novel PI(3)P-binding motif within its N terminus. Conclusion: Association of RME-8 with PI(3)P is required for endosomal clathrin removal and alters the steady state localization of retrograde transport cargo CI-MPR. Significance: Regulation of PI(3)P association or PI(3)P levels is likely critical for controlling early endosomal organizational activities. Receptor-mediated endocytosis 8 (RME-8) is a DnaJ domain containing protein implicated in translocation of Hsc70 to early endosomes for clathrin removal during retrograde transport. Previously, we have demonstrated that RME-8 associates with early endosomes in a phosphatidylinositol 3-phosphate (PI(3)P)-dependent fashion. In this study, we have now identified amino acid determinants required for PI(3)P binding within a region predicted to adopt a pleckstrin homology-like fold in the N terminus of RME-8. The ability of RME-8 to associate with PI(3)P and early endosomes is largely abolished when residues Lys(17), Trp(20), Tyr(24), or Arg(26) are mutated resulting in diffuse cytoplasmic localization of RME-8 while maintaining the ability to interact with Hsc70. We also provide evidence that RME-8 PI(3)P binding regulates early endosomal clathrin dynamics and alters the steady state localization of the cation-independent mannose 6-phosphate receptor. Interestingly, RME-8 endosomal association is also regulated by the PI(3)P-binding protein SNX1, a member of the retromer complex. Wild type SNX1 restores endosomal localization of RME-8 W20A, whereas a SNX1 variant deficient in PI(3)P binding disrupts endosomal localization of wild type RME-8. These results further highlight the critical role for PI(3)P in the RME-8-mediated organizational control of various endosomal activities, including retrograde transport.	[Xhabija, Besa; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Vacratsis, PO (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	vacratsi@uwindsor.ca	Xhabija, Besa/GOP-2447-2022	Xhabija, Besa/0000-0002-4784-2454	Canadian Institutes of Health Research [123241]; University of Windsor Golden Jubilee Health Research Award; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Windsor Golden Jubilee Health Research Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by Operating Grant 123241 from Canadian Institutes of Health Research (to P. O. V.) and by a University of Windsor Golden Jubilee Health Research Award (to P. O. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Graduate Scholarship.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Busse RA, 2013, AUTOPHAGY, V9, P770, DOI 10.4161/auto.23978; CHANG FN, 1978, BIOCHIM BIOPHYS ACTA, V518, P89, DOI 10.1016/0005-2787(78)90118-1; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Ellson CD, 2002, J CELL SCI, V115, P1099; Fujibayashi A, 2008, CELL STRUCT FUNCT, V33, P35, DOI 10.1247/csf.07045; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; Koumandou VL, 2013, EUKARYOT CELL, V12, P330, DOI 10.1128/EC.00273-12; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon SK, 2001, CURR BIOL, V11, pR49, DOI 10.1016/S0960-9822(01)00010-0; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; McGough IJ, 2013, J CELL SCI, V126, P45, DOI 10.1242/jcs.112904; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Scheele U, 2003, J BIOL CHEM, V278, P25357, DOI 10.1074/jbc.M303738200; Seaman Matthew Nj, 2014, Commun Integr Biol, V7, pe29483, DOI 10.4161/cib.29483; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Silady RA, 2004, PLANT PHYSIOL, V136, P3095, DOI 10.1104/pp.104.050583; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Xhabija B, 2011, FEBS LETT, V585, P1722, DOI 10.1016/j.febslet.2011.04.016; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	53	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21676	21689		10.1074/jbc.M115.644757	http://dx.doi.org/10.1074/jbc.M115.644757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26134565	Green Published, hybrid			2022-12-28	WOS:000360637600039
J	Hashimoto, H; Zhang, X; Vertino, PM; Cheng, XD				Hashimoto, Hideharu; Zhang, Xing; Vertino, Paula M.; Cheng, Xiaodong			The Mechanisms of Generation, Recognition, and Erasure of DNA 5-Methylcytosine and Thymine Oxidations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EMBRYONIC STEM-CELLS; STRUCTURAL BASIS; GLYCOSYLASE DOMAIN; MAMMALIAN DNA; CXXC DOMAIN; POSTNATAL-DEVELOPMENT; METHYLATION PATTERNS; ESCHERICHIA-COLI; TERMINAL DOMAIN; PARTNER KAISO	One of the most fundamental questions in the control of gene expression in mammals is how the patterns of epigenetic modifications of DNA are generated, recognized, and erased. This includes covalent cytosine methylation of DNA and its associated oxidation states. An array of AdoMet-dependent methyltransferases, Fe(II)-and alpha-ketoglutarate-dependent dioxygenases, base excision glycosylases, and sequence-specific transcription factors is responsible for changing, maintaining, and interpreting the modification status of specific regions of chromatin. This review focuses on recent developments in characterizing the functional and structural links between the modification status of two DNA bases 5-methylcytosine and thymine (5-methyluracil).	[Hashimoto, Hideharu; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Vertino, Paula M.; Cheng, Xiaodong] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	xcheng@emory.edu	hashimoto, hal/C-2079-2012	hashimoto, hal/0000-0002-5674-5779	National Institutes of Health [GM049245-21, GM105132-02, DK094346-01, CA077337, CA132065]; Winship Cancer Institute of Emory University Cancer Center Support Grant [P30CA138292]; NATIONAL CANCER INSTITUTE [R01CA077337, R01CA132065, P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM105132, R01GM049245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winship Cancer Institute of Emory University Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM049245-21, GM105132-02 (subcontract via Yu Zheng), and DK094346-01 (to X. C.) and CA077337 and CA132065 (to P. M. V.), and in part by developmental funds from the Winship Cancer Institute of Emory University Cancer Center Support Grant (Grant P30CA138292). This is the third article in the Thematic Minireview series "Metals in Biology: alpha-Ketoglutarate/Iron-dependent Dioxygenases." The authors declare that they have no conflicts of interest with the contents of this article.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Arand J, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-1; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen-Karni D, 2011, P NATL ACAD SCI USA, V108, P11040, DOI 10.1073/pnas.1018448108; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dunwell TL, 2013, CELL CYCLE, V12, P3357, DOI 10.4161/cc.26540; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Golla JP, 2014, BIOCHEM BIOPH RES CO, V449, P248, DOI 10.1016/j.bbrc.2014.05.018; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P10203, DOI 10.1093/nar/gks845; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; HOLLIDAY R, 1996, EPIGENETIC MECH GENE, P5; Hong S, 2014, J MOL BIOL, V426, P3703, DOI 10.1016/j.jmb.2014.09.010; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ponferrada-Marin MI, 2011, NUCLEIC ACIDS RES, V39, P1473, DOI 10.1093/nar/gkq982; Ponferrada-Marin MI, 2009, NUCLEIC ACIDS RES, V37, P4264, DOI 10.1093/nar/gkp390; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Khund Sayeed S., 2015, BIOCHIM BIOPHYS ACTA, V1849, P583, DOI DOI 10.1016/j.bbagrm.2015.03.002; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Knaevelsrud I, 2009, INT J RADIAT BIOL, V85, P413, DOI 10.1080/09553000902818915; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kubosaki A, 2012, BIOCHEM BIOPH RES CO, V426, P141, DOI 10.1016/j.bbrc.2012.08.053; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Li Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004905; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YW, 2014, NUCLEIC ACIDS RES, V42, P4859, DOI 10.1093/nar/gku134; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morera S, 2012, NUCLEIC ACIDS RES, V40, P9917, DOI 10.1093/nar/gks714; Muller U, 2014, NUCLEIC ACIDS RES, V42, P8592, DOI 10.1093/nar/gku552; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Pais JE, 2015, P NATL ACAD SCI USA, V112, P4316, DOI 10.1073/pnas.1417939112; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Shi YG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017947; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Szulik MW, 2015, BIOCHEMISTRY-US, V54, P1294, DOI 10.1021/bi501534x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takai H, 2014, CELL REP, V9, P48, DOI 10.1016/j.celrep.2014.08.071; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Upadhyay AK, 2011, CURR OPIN STRUC BIOL, V21, P750, DOI 10.1016/j.sbi.2011.08.003; VAIRAPANDI M, 1993, NUCLEIC ACIDS RES, V21, P5323, DOI 10.1093/nar/21.23.5323; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wang YP, 2015, MOL CELL, V57, P662, DOI 10.1016/j.molcel.2014.12.023; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Wojciechowski M, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140110; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; WU JC, 1987, J BIOL CHEM, V262, P4778; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018; Zhang L, 2014, J AM CHEM SOC, V136, P4801, DOI 10.1021/ja500979k; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	99	30	30	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20723	20733		10.1074/jbc.R115.656884	http://dx.doi.org/10.1074/jbc.R115.656884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152719	hybrid, Green Published			2022-12-28	WOS:000360011800009
J	Zhang, XN; Gao, Y; Lu, L; Zhang, Z; Gan, SC; Xu, LY; Lei, AH; Cao, Y				Zhang, Xuena; Gao, Yan; Lu, Lei; Zhang, Zan; Gan, Shengchun; Xu, Liyang; Lei, Anhua; Cao, Ying			JmjC Domain-containing Protein 6 (Jmjd6) Derepresses the Transcriptional Repressor Transcription Factor 7-like 1 (Tcf7l1) and Is Required for Body Axis Patterning during Xenopus Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; PHOSPHATIDYLSERINE RECEPTOR; SPEMANNS ORGANIZER; APOPTOTIC CELLS; TARGET GENES; TCF3; SPECIFICATION; EXPRESSION; TCF/LEF	Tcf7l1 (also known as Tcf3) is a bimodal transcription factor that plays essential roles in embryogenesis and embryonic and adult stem cells. On one hand, Tcf7l1 works as transcriptional repressor via the recruitment of Groucho-related transcriptional corepressors to repress the transcription of Wnt target genes, and, on the other hand, it activates Wnt target genes when Wnt-activated beta-catenin interacts with it. However, how its activity is modulated is not well understood. Here we demonstrate that a JmjC-domain containing protein, Jmjd6, interacts with Tcf7l and derepresses Tcf7l. We show that Jmjd6 binds to a region of Tcf7l1 that is also responsible for Groucho interaction, therefore making it possible that Jmjd6 binding displaces the Groucho transcriptional corepressor from Tcf7l1. Moreover, we show that Jmjd6 antagonizes the repression effect of Tcf7l1 on target gene transcription and is able to enhance beta-catenin-induced gene activation and that, vice versa, inhibition of Jmjd6 activity compromises gene activation in both cells and Xenopus early embryos. We also show that jmjd6 is both maternally and zygotically transcribed during Xenopus embryogenesis. Loss of Jmjd6 function causes defects in anterioposterior body axis formation and down-regulation of genes that are involved in anterioposterior axis patterning. The results elucidate a novel mechanism underlying the regulation of Tcf7l1 activity and the regulation of embryonic body axis formation.	[Cao, Ying] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University	Cao, Y (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	caoying@nju.edu.cn			Ministry of Science and Technology [2011CB943804, 2014CB964701]; National Science Foundation of China [31271544, 31261160492]; Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences [KLRB201306]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences	This work was supported by Ministry of Science and Technology Grants 2011CB943804 and 2014CB964701, National Science Foundation of China Grants 31271544 and 31261160492, and Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences Grant KLRB201306 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Andoniadou CL, 2011, DEVELOPMENT, V138, P4931, DOI 10.1242/dev.066597; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cao Q, 2012, DEVELOPMENT, V139, P3950, DOI 10.1242/dev.082024; Cao Y, 2008, J BIOL CHEM, V283, P34168, DOI 10.1074/jbc.M803532200; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Houston DW, 2002, DEVELOPMENT, V129, P4015; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kuwahara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094408; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Molenaar M, 1998, MECH DEVELOP, V75, P151, DOI 10.1016/S0925-4773(98)00085-9; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	42	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20273	20283		10.1074/jbc.M115.646554	http://dx.doi.org/10.1074/jbc.M115.646554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26157142	hybrid, Green Published			2022-12-28	WOS:000359608900027
J	Osman, D; Piergentili, C; Chen, JJ; Chakrabarti, B; Foster, AW; Lurie-Luke, E; Huggins, TG; Robinson, NJ				Osman, Deenah; Piergentili, Cecilia; Chen, Junjun; Chakrabarti, Buddhapriya; Foster, Andrew W.; Lurie-Luke, Elena; Huggins, Thomas G.; Robinson, Nigel J.			Generating a Metal-responsive Transcriptional Regulator to Test What Confers Metal Sensing in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RCNR; BACILLUS-SUBTILIS; REPRESSOR CSOR; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; COPPER EFFLUX; BINDING SITES; HIGH-AFFINITY; TRANSFER-RNA; CODON USAGE	FrmR from Salmonella enterica serovar typhimurium (a CsoR/RcnR-like transcriptional de-repressor) is shown to repress the frmRA operator-promoter, and repression is alleviated by formaldehyde but not manganese, iron, cobalt, nickel, copper, or Zn(II) within cells. In contrast, repression by a mutant FrmRE64H (which gains an RcnR metal ligand) is alleviated by cobalt and Zn(II). Unexpectedly, FrmR was found to already bind Co(II), Zn(II), and Cu(I), and moreover metals, as well as formaldehyde, trigger an allosteric response that weakens DNA affinity. However, the sensory metal sites of the cells' endogenous metal sensors (RcnR, ZntR, Zur, and CueR) are all tighter than FrmR for their cognate metals. Furthermore, the endogenous metal sensors are shown to out-compete FrmR. The metal-sensing FrmRE64H mutant has tighter metal affinities than FrmR by approximately 1 order of magnitude. Gain of cobalt sensing by FrmRE64H remains enigmatic because the cobalt affinity of FrmRE64H is substantially weaker than that of the endogenous cobalt sensor. Cobalt sensing requires glutathione, which may assist cobalt access, conferring a kinetic advantage. For Zn(II), the metal affinity of FrmRE64H approaches the metal affinities of cognate Zn(II) sensors. Counter-intuitively, the allosteric coupling free energy for Zn(II) is smaller in metal-sensing FrmRE64H compared with nonsensing FrmR. By determining the copies of FrmR and FrmRE64H tetramers per cell, then estimating promoter occupancy as a function of intracellular Zn(II) concentration, we show how a modest tightening of Zn(II) affinity, plus weakened DNA affinity of the apoprotein, conspires to make the relative properties of FrmRE64H (compared with ZntR and Zur) sufficient to sense Zn(II) inside cells.	[Osman, Deenah; Piergentili, Cecilia; Chakrabarti, Buddhapriya; Foster, Andrew W.; Robinson, Nigel J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Osman, Deenah; Piergentili, Cecilia; Chakrabarti, Buddhapriya; Foster, Andrew W.; Robinson, Nigel J.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Chen, Junjun; Huggins, Thomas G.] Procter & Gamble Co, Mason Business Ctr, Cincinnati, OH 45040 USA; [Lurie-Luke, Elena] Procter & Gamble Tech Ctr Ltd, London Innovat Ctr, Life Sci Open Innovat, Egham TW20 9NW, Surrey, England	Durham University; Durham University; Procter & Gamble; Procter & Gamble	Robinson, NJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Chakrabarti, Buddhapriya/AAC-8351-2020; Osman, Deenah/AAB-4516-2020; Robinson, Nigel J/J-6363-2012	Chakrabarti, Buddhapriya/0000-0003-2699-4157; Osman, Deenah/0000-0002-0251-9231; Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council [BB/J017787/1]; Procter and Gamble; BBSRC [BB/J017787/1, BB/L013711/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L013711/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Procter and Gamble(Procter & Gamble); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council Industrial Partnership Award BB/J017787/1 in conjunction with a financial contribution from Procter and Gamble.	Ammendola S, 2014, BIOMETALS, V27, P703, DOI 10.1007/s10534-014-9763-2; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Chang FMJ, 2014, J BIOL CHEM, V289, P19204, DOI 10.1074/jbc.M114.556704; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denby KJ, 2015, ENVIRON MICROBIOL, V17, P2477, DOI 10.1111/1462-2920.12726; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Gilston BA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001987; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Grossoehme Nicholas E, 2012, Methods Mol Biol, V875, P165, DOI 10.1007/978-1-61779-806-1_8; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; GUTHEIL WG, 1992, BIOCHEMISTRY-US, V31, P475, DOI 10.1021/bi00117a025; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Higgins KA, 2014, CHEM LETT, V43, P20, DOI 10.1246/cl.130965; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; JEFFERSON JR, 1990, ANAL BIOCHEM, V187, P328, DOI 10.1016/0003-2697(90)90465-L; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; KWAN CY, 1990, J BIOL CHEM, V265, P678; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Luebke JL, 2014, MOL MICROBIOL, V94, P1343, DOI 10.1111/mmi.12835; Ma Z, 2014, MOL MICROBIOL, V94, P756, DOI 10.1111/mmi.12794; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; McGuire AM, 2013, BIOCHEMISTRY-US, V52, P701, DOI 10.1021/bi301550t; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Patterson CJ, 2013, METALLOMICS, V5, P352, DOI 10.1039/c3mt20241k; Pennella MA, 2006, J MOL BIOL, V356, P1124, DOI 10.1016/j.jmb.2005.12.019; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Rubio-Sanz L, 2013, APPL ENVIRON MICROB, V79, P6414, DOI 10.1128/AEM.01954-13; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Sambrook J., 2001, MOL CLONING LAB MANU; SCHELLER KH, 1980, EUR J BIOCHEM, V107, P455; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Teramoto H, 2015, APPL MICROBIOL BIOT, V99, P3505, DOI 10.1007/s00253-015-6373-z; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VanZile ML, 2002, BIOCHEMISTRY-US, V41, P9765, DOI 10.1021/bi0201771; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang D, 2012, J INORG BIOCHEM, V111, P173, DOI 10.1016/j.jinorgbio.2012.02.008; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	73	17	17	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19806	19822		10.1074/jbc.M115.663427	http://dx.doi.org/10.1074/jbc.M115.663427			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109070	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000359364600037
J	Teder, T; Lohelaid, H; Boeglin, WE; Calcutt, WM; Brash, AR; Samel, N				Teder, Tarvi; Lohelaid, Helike; Boeglin, William E.; Calcutt, Wade M.; Brash, Alan R.; Samel, Nigulas			A Catalase-related Hemoprotein in Coral Is Specialized for Synthesis of Short-chain Aldehydes DISCOVERY OF P450-TYPE HYDROPEROXIDE LYASE ACTIVITY IN A CATALASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; FATTY-ACID HYDROPEROXIDES; MAGNETIC CIRCULAR-DICHROISM; LIPOXYGENASE FUSION PROTEIN; SOYBEAN LIPOXYGENASE; ANAEROBIC REACTION; MOLECULAR-CLONING; LINOLEIC-ACID; ACTIVE-SITE; LYASE	In corals a catalase-lipoxygenase fusion protein transforms arachidonic acid to the allene oxide 8R,9-epoxy-5,9,11,14-eico-satetraenoic acid from which arise cyclopentenones such as the prostanoid-related clavulones. Recently we cloned two catalase-lipoxygenase fusion protein genes (a and b) from the coral Capnella imbricata, form a being an allene oxide synthase and form b giving uncharacterized polar products (Lohelaid, H., Teder, T., Toldsepp, K., Ekins, M., and Samel, N. (2014) PloS ONE 9, e89215). Here, using HPLC-UV, LC-MS, andNMRmethods, we identify a novel activity of fusion protein b, establishing its role in cleaving the lipoxygenase product 8R-hydroperoxy-eicosatetraenoic acid into the short-chain aldehydes (5Z)-8-oxo-octenoic acid and (3Z,6Z)-dodecadienal; these primary products readily isomerize in an aqueous medium to the corresponding 6E- and 2E, 6Z derivatives. This type of enzymatic cleavage, splitting the carbon chain within the conjugated diene of the hydroperoxide substrate, is known only in plant cytochrome P450 hydroperoxide lyases. In mechanistic studies using O-18-labeled substrate and incubations in (H2O)-O-18, we established synthesis of the C8-oxo acid and C12 aldehyde with the retention of the hydroperoxy oxygens, consistent with synthesis of a short-lived hemiacetal intermediate that breaks down spontaneously into the two aldehydes. Taken together with our initial studies indicating differing gene regulation of the allene oxide synthase and the newly identified catalase-related hydroperoxide lyase and given the role of aldehydes in plant defense, this work uncovers a potential pathway in coral stress signaling and a novel enzymatic activity in the animal kingdom.	[Teder, Tarvi; Lohelaid, Helike; Samel, Nigulas] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Teder, Tarvi; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Teder, Tarvi; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Calcutt, Wade M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Tallinn University of Technology; Vanderbilt University; Vanderbilt University; Vanderbilt University	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia.	nigulas.samel@ttu.ee	Teder, Tarvi/M-6893-2018; Samel, Nigulas/A-1420-2019; Regan, Clinton/E-6250-2012; Lõhelaid, Helike/G-5425-2013	Teder, Tarvi/0000-0002-8489-3955; Lõhelaid, Helike/0000-0002-6885-8666	National Institutes of Health [GM-074888]; Estonian Ministry of Education and Research [IUT19-9]; Estonian Science Foundation [9410]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888 (to A. R. B.). This work was also supported by the Institutional Research Funding IUT19-9 of the Estonian Ministry of Education and Research and the Estonian Science Foundation Grant 9410 (both to N. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham BD, 2001, BIOCHEMISTRY-US, V40, P2251, DOI 10.1021/bi002121h; Bandara DMI, 2011, J INORG BIOCHEM, V105, P1786, DOI 10.1016/j.jinorgbio.2011.09.026; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2014, J BIOL CHEM, V289, P13101, DOI 10.1074/jbc.M114.555904; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brash AR, 1996, J BIOL CHEM, V271, P20949, DOI 10.1074/jbc.271.34.20949; BRASH AR, 1991, J BIOL CHEM, V266, P22926; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; GARSSEN GJ, 1972, BIOCHEM J, V130, P435, DOI 10.1042/bj1300435; Gilbert NC, 2008, BIOCHEMISTRY-US, V47, P10665, DOI 10.1021/bi800751p; GLASGOW WC, 1986, J BIOL CHEM, V261, P200; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Gomi K, 2003, J PLANT PHYSIOL, V160, P1219, DOI 10.1078/0176-1617-01177; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; Grechkin AN, 2004, BBA-MOL CELL BIOL L, V1636, P47, DOI 10.1016/j.bbalip.2003.12.003; Grechkin AN, 2002, PROSTAG OTH LIPID M, V68-9, P457, DOI 10.1016/S0090-6980(02)00048-5; HAMBERG M, 1989, J AM OIL CHEM SOC, V66, P1445, DOI 10.1007/BF02661968; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hoffmann I, 2013, J BIOL CHEM, V288, P11459, DOI 10.1074/jbc.M113.458257; Hughes RK, 2008, PROTEINS, V72, P1199, DOI 10.1002/prot.22012; Jarving R, 2012, BIOCHEMISTRY-US, V51, P3310, DOI 10.1021/bi201690z; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; LABEQUE R, 1988, BIOCHEMISTRY-US, V27, P7060, DOI 10.1021/bi00418a059; LAM BK, 1987, BIOCHEM BIOPH RES CO, V149, P1111, DOI 10.1016/0006-291X(87)90523-7; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Li LO, 2008, P NATL ACAD SCI USA, V105, P13883, DOI 10.1073/pnas.0804099105; Lohelaid H, 2015, CORAL REEFS, V34, P143, DOI 10.1007/s00338-014-1238-y; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Lohelaid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089215; Matsui K, 2000, FEBS LETT, V481, P183, DOI 10.1016/S0014-5793(00)01997-9; Matsui K, 2000, BIOSCI BIOTECH BIOCH, V64, P1189, DOI 10.1271/bbb.64.1189; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Noordermeer MA, 2000, EUR J BIOCHEM, V267, P2473, DOI 10.1046/j.1432-1327.2000.01283.x; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; Noordermeer MA, 2002, J AGR FOOD CHEM, V50, P4270, DOI 10.1021/jf0202685; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Takamura H, 1996, BBA-LIPID LIPID MET, V1303, P83, DOI 10.1016/0005-2760(96)00076-8; TANABE T, 1995, J LIPID MEDIAT CELL, V12, P243, DOI 10.1016/0929-7855(95)00031-K; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Wichard T, 2005, ANGEW CHEM INT EDIT, V44, P158, DOI 10.1002/anie.200460686; ZIMMERMAN DC, 1979, PLANT PHYSIOL, V63, P536, DOI 10.1104/pp.63.3.536	56	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19823	19832		10.1074/jbc.M115.660282	http://dx.doi.org/10.1074/jbc.M115.660282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100625	Green Published, hybrid			2022-12-28	WOS:000359364600038
J	Kobayashi, Y; Takahashi, T; Shibata, T; Ikeda, S; Koshiba, T; Mizumura, H; Oda, T; Kawabata, S				Kobayashi, Yuki; Takahashi, Toshiaki; Shibata, Toshio; Ikeda, Shunsuke; Koshiba, Takumi; Mizumura, Hikaru; Oda, Toshio; Kawabata, Shun-ichiro			Factor B Is the Second Lipopolysaccharide-binding Protease Zymogen in the Horseshoe Crab Coagulation Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-C; SERINE PROTEASES; HEMOCYTES; RECOGNITION; ACTIVATION; EXPRESSION	Factor B is a serine-protease zymogen in the horseshoe crab coagulation cascade, and it is the primary substrate for activated factor C, the LPS-responsive initiator of the cascade. Factor C is autocatalytically activated to alpha-factor C on LPS and is artificially converted to beta-factor C, another activated form, by chymotrypsin. It is not known, however, whether LPS is required for the activation of factor B. Here we found that wild-type factor B expressed in HEK293S cells is activated by alpha-factor C, but not by beta-factor C, in an LPS-dependent manner and that beta-factor C loses the LPS binding activity of factor C through additional cleavage by chymotrypsin within the N-terminal LPS-binding region. Surface plasmon resonance and quartz crystal microbalance analyses revealed that wild-type factor B binds to LPS with high affinity comparable with that of factor C, demonstrating that factor B is the second LPS-binding zymogen in the cascade. An LPS-binding site of wild-type factor B was found in the N-terminal clip domain, and the activation rate of a clip domain deletion mutant was considerably slower than that of wild-type factor B. Moreover, in the presence of LPS, Triton X-100 inhibited the activation of wild-type factor B by alpha-factor C. We conclude that the clip domain of factor B has an important role in localizing factor B to the surface of Gram-negative bacteria or LPS released from bacteria to initiate effective proteolytic activation by alpha-factor C.	[Kobayashi, Yuki; Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; [Takahashi, Toshiaki; Ikeda, Shunsuke; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Mizumura, Hikaru; Oda, Toshio] Seikagaku Corp, LAL Res & Dev Grp, Higashiyamato, Tokyo 2070021, Japan	Kyushu University; Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	skawascb@kyudai.jp	Shibata, Toshio/AAE-1694-2020	Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Seikagaku Corporation	Seikagaku Corporation	This work was supported by the joint research fund of the Seikagaku Corporation. The authors declare that they have no conflicts of interest with the contents of this article.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Armstrong Peter B., 2003, P288; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Cao XL, 2015, INSECT BIOCHEM MOLEC, V62, P51, DOI 10.1016/j.ibmb.2014.10.006; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Jang IH, 2008, BMB REP, V41, P102, DOI 10.5483/BMBRep.2008.41.2.102; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Kawabata S, 2010, J BIOCHEM, V147, P611, DOI 10.1093/jb/mvq026; Kobayashi Y, 2014, J BIOL CHEM, V289, P25987, DOI 10.1074/jbc.M114.586933; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Levin Jack, 2003, P310; MIURA Y, 1992, J BIOCHEM-TOKYO, V112, P476, DOI 10.1093/oxfordjournals.jbchem.a123924; MUTA T, 1991, J BIOL CHEM, V266, P6554; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; NAKAMURA T, 1988, J BIOCHEM, V103, P370, DOI 10.1093/oxfordjournals.jbchem.a122276; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1986, J BIOCHEM, V99, P847, DOI 10.1093/oxfordjournals.jbchem.a135545; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; SATO T, 1994, BIOCHEM BIOPH RES CO, V204, P551, DOI 10.1006/bbrc.1994.2494; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337	29	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19379	19386		10.1074/jbc.M115.653196	http://dx.doi.org/10.1074/jbc.M115.653196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26109069	hybrid, Green Published			2022-12-28	WOS:000358781100048
J	Jie, J; Lohr, F; Barbar, E				Jie, Jing; Loehr, Frank; Barbar, Elisar			Interactions of Yeast Dynein with Dynein Light Chain and Dynactin GENERAL IMPLICATIONS FOR INTRINSICALLY DISORDERED DUPLEX SCAFFOLDS IN MULTIPROTEIN ASSEMBLIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; SACCHAROMYCES-CEREVISIAE; SELF-ASSOCIATION; PROTEIN; COMPLEX; DOMAIN; LC8; DYNAMICS; MOTOR	Intrinsically disordered protein (IDP) duplexes composed of two IDP chains cross-linked by bivalent partner proteins form scaffolds for assembly of multiprotein complexes. The N-terminal domain of dynein intermediate chain (N-IC) is one such IDP that forms a bivalent scaffold with multiple dynein light chains including LC8, a hub protein that promotes duplex formation of diverse IDP partners. N-IC also binds a subunit of the dynein regulator, dynactin. Here we characterize interactions of a yeast ortholog of N-IC (N-Pac11) with yeast LC8 (Dyn2) or with the intermediate chain-binding subunit of yeast dynactin (Nip100). Residue level changes in Pac11 structure are monitored by NMR spectroscopy, and binding energetics are monitored by isothermal titration calorimetry (ITC). N-Pac11 is monomeric and primarily disordered except for a single alpha-helix (SAH) at the N terminus and a short nascent helix, LH, flanked by the two Dyn2 recognition motifs. Upon binding Dyn2, the only Pac11 residues making direct protein-protein interactions are in and immediately flanking the recognition motifs. Dyn2 binding also orders LH residues of Pac11. Upon binding Nip100, only Pac11 SAH residues make direct protein-protein interactions, but LH residues at a distant sequence position and L1 residues in an adjacent linker are also ordered. The long distance, ligand-dependent ordering of residues reveals new elements of dynamic structure within IDP linker regions.	[Jie, Jing; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Loehr, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany	Oregon State University; Goethe University Frankfurt	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Regan, Clinton/E-6250-2012	Barbar, Elisar/0000-0003-4892-5259	National Institutes of Health [GM 084276, 00210]; Oregon State University Environmental Health Sciences Center through NIEHS; Bio-NMR (Frankfurt, Germany) [261863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon State University Environmental Health Sciences Center through NIEHS; Bio-NMR (Frankfurt, Germany); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084276 (to E. B.), the protein core facility in the Oregon State University Environmental Health Sciences Center through NIEHS, National Institutes of Health Grant 00210 and by Bio-NMR, Project Number 261863 (Frankfurt, Germany). The authors declare that they have no conflicts of interest with the contents of this article.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Barbar E, 2015, SEMIN CELL DEV BIOL, V37, P20, DOI 10.1016/j.semcdb.2014.09.016; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; DeLano W.L, PYMOL MOL GRAPHICS S; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Goddard T. D., SPARKY3; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kidane AI, 2013, BIOCHEMISTRY-US, V52, P6011, DOI 10.1021/bi400642u; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kini AR, 2001, CELL MOTIL CYTOSKEL, V48, P52, DOI 10.1002/1097-0169(200101)48:1<52::AID-CM5>3.0.CO;2-X; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Lohr F, 1999, J AM CHEM SOC, V121, P11821, DOI 10.1021/ja991356h; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; Nyarko A, 2013, J BIOL CHEM, V288, P2614, DOI 10.1074/jbc.M112.432831; Nyarko A, 2012, J BIOL CHEM, V287, P24884, DOI 10.1074/jbc.M112.376038; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Rao L, 2013, MOL BIOL CELL, V24, P2362, DOI 10.1091/mbc.E13-03-0166; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Slevin LK, 2014, J BIOL CHEM, V289, P20727, DOI 10.1074/jbc.M114.576041; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	48	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23863	23874		10.1074/jbc.M115.649715	http://dx.doi.org/10.1074/jbc.M115.649715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26253171	Green Published, hybrid			2022-12-28	WOS:000361816500032
J	Li, J; Ma, WX; Li, HZ; Hou, N; Wang, XJ; Kim, IM; Li, FQ; Su, HB				Li, Jie; Ma, Wenxia; Li, Huizhong; Hou, Ning; Wang, Xuejun; Kim, Il-man; Li, Faqian; Su, Huabo			NEDD8 Ultimate Buster 1 Long (NUB1L) Protein Suppresses Atypical Neddylation and Promotes the Proteasomal Degradation of Misfolded Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMIN-RELATED CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CARDIAC PROTEINOPATHY; UBIQUITIN; MICE; SYSTEM; ACTIVATION; AUTOPHAGY; PATHWAY; CANCER	Neddylation is a posttranslational modification that controls diverse biological processes by covalently conjugating the ubiquitin-like protein NEDD8 to specific targets. Neddylation is commonly mediated by NEDD8-specific enzymes (typical neddylation) and, sometimes, by ubiquitin enzymes (atypical neddylation). Although typical neddylation is known to regulate protein function in many ways, the regulatory mechanisms and biological consequence of atypical neddylation remain largely unexplored. Here we report that NEDD8 conjugates were accumulated in the diseased hearts from mouse models and human patients. Proteotoxic stresses induced typical and atypical neddylation in cardiomyocytes. Loss of NUB1L exaggerated atypical neddylation, whereas NUB1L overexpression repressed atypical neddylation through promoting the degradation of NEDD8. Activation of atypical neddylation accumulated a surrogate misfolded protein, GFPu. In contrast, suppression of atypical neddylation by NUB1L overexpression enhanced GFPu degradation. Moreover, NUB1L depletion accumulated a cardiomyopathy-linked misfolded protein, CryAB(R120G), whereas NUB1L overexpression promoted its degradation through suppressing neddylation of ubiquitinated proteins in cardiomyocytes. Consequently, NUB1L protected cells from proteotoxic stress-induced cell injury. In summary, these data indicate that NUB1L suppresses atypical neddylation and promotes the degradation of misfolded proteins by the proteasome. Our findings also suggest that induction of NUB1L could potentially become a novel therapeutic strategy for diseases with increased proteotoxic stress.	[Li, Jie; Ma, Wenxia; Li, Huizhong; Kim, Il-man; Su, Huabo] Georgia Regents Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA 30912 USA; [Su, Huabo] Georgia Regents Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA; [Hou, Ning; Li, Faqian] Univ Rochester, Dept Pathol & Lab Med, Med Ctr, Rochester, NY 14642 USA; [Wang, Xuejun] Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Rochester; University of South Dakota	Su, HB (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Med Coll Georgia, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	HSU@gru.edu	Wang, Xuejun/AAT-9490-2021; Regan, Clinton/E-6250-2012; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Su, Huabo/0000-0002-8475-2685; LI, JIE/0000-0003-3902-642X; Kim, Il-man/0000-0002-9268-8337	National Institutes of Health [R01HL124248, R01HL124251, R01HL085629, R01HL072166, R01HL111480]; American Heart Association [11SDG696001, 14SDG18970040]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085629, R01HL072166, R01HL111480, R01HL124248, R01HL124251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL124248 (to H.S.), R01HL124251 (to I.K.), R01HL085629 and R01HL072166 (to X.W.), and R01HL111480 (to F.L.). This work was also supported by American Heart Association Grants 11SDG6960011 (to H.S.) and 14SDG18970040 (to I.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Fahmi A, 2013, CELL SIGNAL, V25, P898, DOI 10.1016/j.cellsig.2012.12.008; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hosono T, 2010, BRIT J CANCER, V102, P873, DOI 10.1038/sj.bjc.6605574; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kandala S, 2014, AM J CARDIOVASC DIS, V4, P140; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Liu S, 2013, J BIOL CHEM, V288, P31339, DOI 10.1074/jbc.M113.484816; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Richet E, 2012, HUM MOL GENET, V21, P5254, DOI 10.1093/hmg/dds376; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sandri M, 2014, J MOL CELL CARDIOL, V71, P3, DOI 10.1016/j.yjmcc.2013.12.015; Singh RK, 2012, MOL CELL PROTEOMICS, V11, P1595, DOI 10.1074/mcp.M112.022467; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Su HB, 2013, CIRC-HEART FAIL, V6, P1049, DOI 10.1161/CIRCHEARTFAILURE.113.000338; Su HB, 2011, CIRC RES, V108, P40, DOI 10.1161/CIRCRESAHA.110.230607; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vogl AM, 2015, NAT NEUROSCI, V18, P239, DOI 10.1038/nn.3912; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zheng QW, 2011, CIRC RES, V109, P296, DOI 10.1161/CIRCRESAHA.111.244707; Zuo W, 2013, MOL CELL, V49, P499, DOI 10.1016/j.molcel.2012.12.002	43	17	17	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23850	23862		10.1074/jbc.M115.664375	http://dx.doi.org/10.1074/jbc.M115.664375			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26260793	hybrid, Green Published			2022-12-28	WOS:000361816500031
J	Markandeya, YS; Phelan, LJ; Woon, MT; Keefe, AM; Reynolds, CR; August, BK; Hacker, TA; Roth, DM; Patel, HH; Balijepalli, RC				Markandeya, Yogananda S.; Phelan, Laura J.; Woon, Marites T.; Keefe, Alexis M.; Reynolds, Courtney R.; August, Benjamin K.; Hacker, Timothy A.; Roth, David M.; Patel, Hemal H.; Balijepalli, Ravi C.			Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase C alpha in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-SIGNALING COMPONENTS; SOLUBLE GUANYLYL CYCLASE; PATHOLOGICAL HYPERTROPHY; FAILING HUMAN; HEART; CHANNEL; EXPRESSION; MYOCYTES; CALCINEURIN; CONTRACTILE	Pathological cardiac hypertrophy is characterized by subcellular remodeling of the ventricular myocyte with a reduction in the scaffolding protein caveolin-3 (Cav-3), altered Ca2+ cycling, increased protein kinase C expression, and hyperactivation of calcineurin/nuclear factor of activated T cell (NFAT) signaling. However, the precise role of Cav-3 in the regulation of local Ca2+ signaling in pathological cardiac hypertrophy is unclear. We used cardiac-specific Cav-3-overexpressing mice and in vivo and in vitro cardiac hypertrophy models to determine the essential requirement for Cav-3 expression in protection against pharmacologically and pressure overload-induced cardiac hypertrophy. Transverse aortic constriction and angiotensin-II (Ang-II) infusion in wild type (WT) mice resulted in cardiac hypertrophy characterized by significant reduction in fractional shortening, ejection fraction, and a reduced expression of Cav-3. In addition, association of PKC alpha and angiotensin-II receptor, type 1, with Cav-3 was disrupted in the hypertrophic ventricular myocytes. Whole cell patch clamp analysis demonstrated increased expression of T-type Ca2+ current (I-Ca,(T)) in hypertrophic ventricular myocytes. In contrast, the Cav-3-overexpressing mice demonstrated protection from transverse aortic constriction or Ang-II-induced pathological hypertrophy with inhibition of I-Ca,(T) and intact Cav-3-associated macromolecular signaling complexes. siRNA-mediated knockdown of Cav-3 in the neonatal cardiomyocytes resulted in enhanced Ang-II stimulation of I-Ca,(T) mediated by PKC alpha, which caused nuclear translocation of NFAT. Overexpression of Cav-3 in neonatal myocytes prevented a PKC alpha -mediated increase in I-Ca,(T) and nuclear translocation of NFAT. In conclusion, we show that stable Cav-3 expression is essential for protecting the signaling mechanisms in pharmacologically and pressure overload-induced cardiac hypertrophy.	[Markandeya, Yogananda S.; Phelan, Laura J.; Woon, Marites T.; Keefe, Alexis M.; Reynolds, Courtney R.; August, Benjamin K.; Hacker, Timothy A.; Balijepalli, Ravi C.] Univ Wisconsin, Cellular & Mol Arrhythmia Res Program, Dept Med, Madison, WI 53706 USA; [Roth, David M.; Patel, Hemal H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Roth, David M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92161 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Balijepalli, RC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, 1111 Highland Ave,Rm 8405 WIMR II, Madison, WI 53706 USA.	rcb@medicine.wisc.edu			National Institutes of Health from NHLBI [HL105713, HL091071, HL107200, HL066941, HL115933]; United States Department of Veterans Affairs (Washington D. C.) [BX001963, BX000783]; American Heart Association [11GRNT7610094]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105713, R01HL091071, P01HL066941, R01HL107200, R01HL115933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX001963] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs (Washington D. C.)(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL105713 (to R. C. B.), HL091071 (to H. H. P.), HL107200 (to H. H. P.), HL066941 (to D. M. R.), and HL115933 (to D. M. R.) from NHLBI. This work was also supported by the United States Department of Veterans Affairs (Washington D. C.) Grants BX001963 (to H. H. P.) and BX000783 (to D. M. R.) and American Heart Association Grant-in-aid 11GRNT7610094 (to R. C. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bkaily G, 2005, PEPTIDES, V26, P1410, DOI 10.1016/j.peptides.2005.03.021; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chen XW, 2011, J MOL CELL CARDIOL, V50, P460, DOI 10.1016/j.yjmcc.2010.11.012; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Goonasekera SA, 2012, J MOL CELL CARDIOL, V52, P317, DOI 10.1016/j.yjmcc.2011.05.001; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Houser SR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125pe31; Huang BY, 2000, CARDIOVASC RES, V46, P442, DOI 10.1016/S0008-6363(00)00017-1; Huang CH, 2013, FEBS LETT, V587, P1723, DOI 10.1016/j.febslet.2013.04.040; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; LEVY D, 1987, AM J CARDIOL, V60, P560, DOI 10.1016/0002-9149(87)90305-5; Liu YH, 2013, J MOL CELL CARDIOL, V60, P72, DOI 10.1016/j.yjmcc.2013.03.019; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Markandeya YS, 2011, J BIOL CHEM, V286, P2433, DOI 10.1074/jbc.M110.182550; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Mialet-Perez J, 2012, J MOL CELL CARDIOL, V52, P502, DOI 10.1016/j.yjmcc.2011.07.019; Morishima M, 2009, EUR J PHARMACOL, V609, P105, DOI 10.1016/j.ejphar.2009.03.024; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Pluteanu F, 2009, AM J PHYSIOL-HEART C, V297, pH1304, DOI 10.1152/ajpheart.00528.2009; Rinne A, 2010, AM J PHYSIOL-HEART C, V298, pH2001, DOI 10.1152/ajpheart.01072.2009; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; SEN L, 1994, CIRC RES, V75, P149, DOI 10.1161/01.RES.75.1.149; Tsai EJ, 2012, CIRC RES, V110, P295, DOI 10.1161/CIRCRESAHA.111.259242; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Wang F, 2013, J MOL CELL CARDIOL, V62, P122, DOI 10.1016/j.yjmcc.2013.05.016; Wang Y, 2008, J BIOL CHEM, V283, P25524, DOI 10.1074/jbc.M803043200; Wang YG, 2014, TRENDS CARDIOVAS MED, V24, P14, DOI 10.1016/j.tcm.2013.05.004; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yamamoto E, 2010, J HYPERTENS, V28, P1321, DOI 10.1097/HJH.0b013e3283388045; Yasui K, 2005, J PHARMACOL SCI, V99, P205, DOI 10.1254/jphs.FMJ05002X3; Zheng MQ, 2010, J MOL CELL CARDIOL, V48, P131, DOI 10.1016/j.yjmcc.2009.08.032	55	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22085	22100		10.1074/jbc.M115.674945	http://dx.doi.org/10.1074/jbc.M115.674945			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26170457	Green Published, hybrid			2022-12-28	WOS:000360968500027
J	Schermerhorn, KM; Gardner, AF				Schermerhorn, Kelly M.; Gardner, Andrew F.			Pre-steady-state Kinetic Analysis of a Family D DNA Polymerase from Thermococcus sp 9 degrees N Reveals Mechanisms for Archaeal Genomic Replication and Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROCOCCUS-HORIKOSHII; HYPERTHERMOPHILIC ARCHAEON; REVERSE-TRANSCRIPTASE; SUBUNIT INTERACTION; ESCHERICHIA-COLI; TERMINAL DOMAINS; B-SUBUNITS; I KLENOW; FIDELITY; RIBONUCLEOTIDES	Family D DNA polymerases (polDs) have been implicated as the major replicative polymerase in archaea, excluding the Crenarchaeota branch, and bear little sequence homology to other DNA polymerase families. Here we report a detailed kinetic analysis of nucleotide incorporation and exonuclease activity for a Family D DNA polymerase from Thermococcus sp. 9 degrees N. Pre-steady-state single-turnover nucleotide incorporation assays were performed to obtain the kinetic parameters, k(pol) and K-d, for correct nucleotide incorporation, incorrect nucleotide incorporation, and ribonucleotide incorporation by exonuclease-deficient polD. Correct nucleotide incorporation kinetics revealed a relatively slow maximal rate of polymerization (k(pol) similar to 2.5 s(-1)) and especially tight nucleotide binding (K-d(dNTP) similar to 1.7 mu M), compared with DNA polymerases from Families A, B, C, X, and Y. Furthermore, pre-steady-state nucleotide incorporation assays revealed that polD prevents the incorporation of incorrect nucleotides and ribonucleotides primarily through reduced nucleotide binding affinity. Pre-steady-state single-turnover assays on wild-type 9 degrees N polD were used to examine 3'-5' exonuclease hydrolysis activity in the presence of Mg2+ and Mn2+. Interestingly, substituting Mn2+ for Mg2+ accelerated hydrolysis rates > 40-fold (k(exo) >= 110 s(-1) versus >= 2.5 s(-1)). Preference for Mn2+ over Mg2+ in exonuclease hydrolysis activity is a property unique to the polD family. The kinetic assays performed in this work provide critical insight into the mechanisms that polD employs to accurately and efficiently replicate the archaeal genome. Furthermore, despite the unique properties of polD, this work suggests that a conserved polymerase kinetic pathway is present in all known DNA polymerase families.	[Schermerhorn, Kelly M.; Gardner, Andrew F.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Gardner, AF (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	gardner@neb.com			New England Biolabs, Inc.	New England Biolabs, Inc.	This work was supported by New England Biolabs, Inc. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Ali SF, 2011, J BIOSCI BIOENG, V112, P118, DOI 10.1016/j.jbiosc.2011.03.018; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brandis JW, 1996, BIOCHEMISTRY-US, V35, P2189, DOI 10.1021/bi951682j; Brown JA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/871939; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Cann IKO, 1998, P NATL ACAD SCI USA, V95, P14250, DOI 10.1073/pnas.95.24.14250; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Cubonova L, 2013, J BACTERIOL, V195, P2322, DOI 10.1128/JB.02037-12; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; Dieckman LM, 2010, BIOCHEMISTRY-US, V49, P7344, DOI 10.1021/bi100556m; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Furge LL, 1998, BIOCHEMISTRY-US, V37, P3567, DOI 10.1021/bi9722094; Greenough L, 2015, J BIOL CHEM, V290, P12514, DOI 10.1074/jbc.M115.638130; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Gueguen Y, 2001, EUR J BIOCHEM, V268, P5961, DOI 10.1046/j.0014-2956.2001.02550.x; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Ishino Y, 1998, J BACTERIOL, V180, P2232, DOI 10.1128/JB.180.8.2232-2236.1998; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Jokela M, 2005, PROTEIN EXPRES PURIF, V43, P73, DOI 10.1016/j.pep.2005.05.002; Jokela M, 2004, NUCLEIC ACIDS RES, V32, P2430, DOI 10.1093/nar/gkh558; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kuba Y, 2012, GENES CELLS, V17, P923, DOI 10.1111/gtc.12007; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Lahiri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063489; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; Miller H, 1996, BIOCHEMISTRY-US, V35, P12919, DOI 10.1021/bi960326d; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Shen Y, 2004, BIOCHEM SOC T, V32, P245, DOI 10.1042/BST0320245; Shen YL, 2004, NUCLEIC ACIDS RES, V32, P158, DOI 10.1093/nar/gkh153; Shen YL, 2003, J BIOL CHEM, V278, P21247, DOI 10.1074/jbc.M212286200; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uemori T, 1997, GENES CELLS, V2, P499, DOI 10.1046/j.1365-2443.1997.1380336.x; Wang WN, 2012, J BIOL CHEM, V287, P28215, DOI 10.1074/jbc.M112.366609; Wohrl BM, 1997, J BIOL CHEM, V272, P17581, DOI 10.1074/jbc.272.28.17581; Yang GW, 2005, BIOCHEMISTRY-US, V44, P3338, DOI 10.1021/bi047921x; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI 10.1021/bi400803v	55	18	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21800	21810		10.1074/jbc.M115.662841	http://dx.doi.org/10.1074/jbc.M115.662841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26160179	hybrid, Green Published			2022-12-28	WOS:000360968500003
J	Singha, UK; Hamilton, V; Chaudhuri, M				Singha, Ujjal K.; Hamilton, VaNae; Chaudhuri, Minu			Tim62, a Novel Mitochondrial Protein in Trypanosoma brucei, Is Essential for Assembly and Stability of the TbTim17 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PREPROTEIN TRANSLOCASE; PRESEQUENCE TRANSLOCASE; IMPORT; INSERTION; TIM23; KINETOPLAST; CRITHIDIA; CHANNEL; TIM50	Trypanosoma brucei, the causative agent of human African trypanosomiasis, possesses non-canonical mitochondrial protein import machinery. Previously, we characterized the essential translocase of the mitochondrial inner membrane (TIM) consisting of Tim17 in T. brucei. TbTim17 is associated with TbTim62. Here we show that TbTim62, a novel protein, is localized in the mitochondrial inner membrane, and its import into mitochondria depends on TbTim17. Knockdown (KD) of TbTim62 decreased the steady-state levels of TbTim17 post-transcriptionally. Further analysis showed that import of TbTim17 into mitochondria was not inhibited, but its half-life was reduced >4-fold due to TbTim62 KD. Blue-native gel electrophoresis revealed that TbTim62 is present primarily in similar to 150-kDa and also in similar to 1100-kDa protein complexes, whereas TbTim17 is present in multiple complexes within the range of similar to 300 to similar to 1100 kDa. TbTim62 KD reduced the levels of both TbTim62 as well as TbTim17 protein complexes. Interestingly, TbTim17 was accumulated as lower molecular mass complexes in TbTim62 KD mitochondria. Furthermore, depletion of TbTim62 hampered the assembly of the ectopically expressed TbTim17-2X-myc into TbTim17 protein complex. Co-immunoprecipitation analysis revealed that association of TbTim17 with mHSP70 was markedly reduced in Tb Tim62 KD mitochondria. All together our results demonstrate that TbTim62, a unique mitochondrial protein in T. brucei, is required for the formation of a stable TbTim17 protein complex. TbTim62 KD destabilizes this complex, and unassembled TbTim17 degrades. Therefore, TbTim62 acts as a novel regulatory factor to maintain the levels of TIM in T. brucei mitochondria.	[Singha, Ujjal K.; Hamilton, VaNae; Chaudhuri, Minu] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Meharry Medical College	Chaudhuri, M (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, West Basic Sci Bldg,Rm 4105, Nashville, TN 37208 USA.	mchaudhuri@mmc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [2SC1GM081146, T32HL007727, U54RR026140, U54MDO7593, G12RR003032]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, SC1GM081146] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 2SC1GM081146, T32HL007727, U54RR026140, U54MDO7593, and G12RR003032. The authors declare that they have no conflicts of interest with the contents of this article.	Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Bagos PG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-189; Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903; Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Beschin A, 2014, TRENDS PARASITOL, V30, P538, DOI 10.1016/j.pt.2014.08.006; Brennand Ana, 2012, Cells, V1, P346, DOI 10.3390/cells1030346; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; de Macedo JP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004875; Duncan MR, 2013, J BIOL CHEM, V288, P3184, DOI 10.1074/jbc.M112.436378; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; EFFRON PN, 1993, MOL BIOCHEM PARASIT, V59, P191, DOI 10.1016/0166-6851(93)90217-L; Esseiva AC, 2004, EMBO REP, V5, P268, DOI 10.1038/sj.embor.7400095; Ferramosca A, 2013, BBA-MOL CELL RES, V1833, P494, DOI 10.1016/j.bbamcr.2012.11.014; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Hamilton V, 2014, EUKARYOT CELL, V13, P539, DOI 10.1128/EC.00312-13; Hasne MP, 2000, MOL BIOCHEM PARASIT, V111, P299, DOI 10.1016/S0166-6851(00)00321-2; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Hewitt VL, 2014, BBA-GEN SUBJECTS, V1840, P1246, DOI 10.1016/j.bbagen.2013.08.013; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Melin J, 2014, MOL CELL BIOL, V34, P3473, DOI 10.1128/MCB.00433-14; Milisav I, 2001, J BIOL CHEM, V276, P25856, DOI 10.1074/jbc.M102132200; Mokranjac D, 2008, BBA-BIOENERGETICS, V1777, P758, DOI 10.1016/j.bbabio.2008.04.009; Motta MCM, 2008, CURR PHARM DESIGN, V14, P847, DOI 10.2174/138161208784041051; Murcha MW, 2014, BBA-GEN SUBJECTS, V1840, P1233, DOI 10.1016/j.bbagen.2013.09.026; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni XQ, 2013, BIOMED REP, V1, P674, DOI 10.3892/br.2013.120; Povelones ML, 2014, MOL BIOCHEM PARASIT, V196, P53, DOI 10.1016/j.molbiopara.2014.03.008; PRIEST JW, 1994, MOL BIOCHEM PARASIT, V65, P291, DOI 10.1016/0166-6851(94)90080-9; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Rezende AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1175; Rodrigues Juliany Cola Fernandes, 2014, Subcell Biochem, V74, P1, DOI 10.1007/978-94-007-7305-9_1; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Singha UK, 2012, J BIOL CHEM, V287, P14480, DOI 10.1074/jbc.M111.322925; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Volpato H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130652; Weems E, 2015, EUKARYOT CELL, V14, P286, DOI 10.1128/EC.00203-14; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618	64	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23226	23239		10.1074/jbc.M115.663492	http://dx.doi.org/10.1074/jbc.M115.663492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240144	Green Published, hybrid			2022-12-28	WOS:000361685500032
J	Cao, CZ; Zhao, JJ; Doughty, EK; Migliorini, M; Strickland, DK; Kann, MG; Zhang, L				Cao, Chunzhang; Zhao, Juanjuan; Doughty, Emily K.; Migliorini, Mary; Strickland, Dudley K.; Kann, Maricel G.; Zhang, Li			Mac-1 Regulates IL-13 Activity in Macrophages by Directly Interacting with IL-13R alpha 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioinformatics; cell signaling; cytokine; integrin; macrophage	FOAM-CELL-FORMATION; MULTIPLE SEQUENCE ALIGNMENT; ALPHA(M)BETA(2) INTEGRIN; PROTEIN INTERACTIONS; HUMAN MONOCYTES; ATHEROSCLEROSIS; RECEPTOR; MICE; ACTIVATION; BINDING	Background: Mac-1 strongly suppresses IL-13-induced JAK/STAT activation in macrophages, but the mechanism is unknown. Results: Our data demonstrate that Mac-1 interacts with the IL-13R1 subunit of IL-13R and thereby suppresses IL-13 signaling. Conclusion: Mac-1 regulates macrophage to foam cell transformation by binding to IL-13R1. Significance: This study identifies a novel interaction and provides a potential mechanism by which Mac-1 safeguards macrophages from foam cell differentiation. Mac-1 exhibits a unique inhibitory activity toward IL-13-induced JAK/STAT activation and thereby regulates macrophage to foam cell transformation. However, the underlying molecular mechanism is unknown. In this study, we report the identification of IL-13R1, a component of the IL-13 receptor (IL-13R), as a novel ligand of integrin Mac-1, using a co-evolution-based algorithm. Biochemical analyses demonstrated that recombinant IL-13R1 binds Mac-1 in a purified system and supports Mac-1-mediated cell adhesion. Co-immunoprecipitation experiments revealed that endogenous Mac-1 forms a complex with IL-13R1 in solution, and confocal fluorescence microscopy demonstrated that these two receptors co-localize with each other on the surface of macrophages. Moreover, we found that genetic inactivation of Mac-1 promotes IL-13-induced JAK/STAT activation in macrophages, resulting in enhanced polarization along the alternative activation pathway. Importantly, we observed that Mac-1(-/-) macrophages exhibit increased expression of foam cell differentiation markers including 15-lipoxygenase and lectin-type oxidized LDL receptor-1 both in vitro and in vivo. Indeed, we found that Mac-1(-/-)LDLR(-/-) mice develop significantly more foam cells than control LDLR-/- mice, using an in vivo model of foam cell formation. Together, our data establish for the first time a molecular mechanism by which Mac-1 regulates the signaling activity of IL-13 in macrophages. This newly identified IL-13R1/Mac-1-dependent pathway may offer novel targets for therapeutic intervention in the future.	[Cao, Chunzhang; Zhao, Juanjuan; Zhang, Li] Univ Maryland, Dept Physiol, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; [Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Dept Surg, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; [Doughty, Emily K.; Kann, Maricel G.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhang, L (corresponding author), Univ Maryland, Dept Physiol, Ctr Vasc & Inflammatory Dis, Sch Med, 800 W Baltimore St, Baltimore, MD 21201 USA.	lizhang@som.umaryland.edu	Regan, Clinton/E-6250-2012		National Institute of Health [NHLBI HL054710, NINDS NS082607]; National Institutes of Health [K22CA143148]; American Heart Association [14GRNT20510058]; NATIONAL CANCER INSTITUTE [K22CA143148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082607] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants NHLBI HL054710 and NINDS NS082607 (to L. Z.); National Institutes of Health K22CA143148 (to M. G. K.) and American Heart Association Grant 14GRNT20510058 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ehirchiou D, 2005, J BIOL CHEM, V280, P8324, DOI 10.1074/jbc.M413525200; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Folcik VA, 1997, ARTERIOSCL THROM VAS, V17, P1954, DOI 10.1161/01.ATV.17.10.1954; Gertz J, 2003, BIOINFORMATICS, V19, P2039, DOI 10.1093/bioinformatics/btg278; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Overbeek R, 1999, In Silico Biol, V1, P93; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Yakubenko VP, 2013, J BIOL CHEM, V288, P2778, DOI 10.1074/jbc.M112.381343; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211	50	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21642	21651		10.1074/jbc.M115.645796	http://dx.doi.org/10.1074/jbc.M115.645796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160172	Green Published, hybrid			2022-12-28	WOS:000360637600036
J	Kramlinger, VM; Rojas, MA; Kanamori, T; Guengerich, FP				Kramlinger, Valerie M.; Rojas, Monica Alvarado; Kanamori, Tatsuyuki; Guengerich, F. Peter			Cytochrome P450 3A Enzymes Catalyze the O-6-Demethylation of Thebaine, a Key Step in Endogenous Mammalian Morphine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA M10; IN-VITRO; OPIUM POPPY; KETOGLUTARATE DIOXYGENASE; O-DEMETHYLATION; DRUG OXIDATION; RAT-LIVER; CODEINE; BRAIN; REDUCTASE	Morphine, first characterized in opium from the poppy Papaver somniferum, is one of the strongest known analgesics. Endogenous morphine has been identified in several mammalian cells and tissues. The synthetic pathway of morphine in the opium poppy has been elucidated. The presence of common intermediates in plants and mammals suggests that biosynthesis occurs through similar pathways (beginning with the amino acid L-tyrosine), and the pathway has been completely delineated in plants. Some of the enzymes in the mammalian pathway have been identified and characterized. Two of the latter steps in the morphine biosynthesis pathway are demethylation of thebaine at the O-3- and the O-6-positions, the latter of which has been difficult to demonstrate. The plant enzymes responsible for both the O-3-demethylation and the O-6-demethylation are members of the Fe-II/alpha-ketoglutarate-dependent dioxygenase family. Previous studies showed that human cytochrome P450 (P450) 2D6 can catalyze thebaine O-3-demethylation. We report that demethylation of thebaine at the O-6-position is selectively catalyzed by human P450s 3A4 and 3A5, with the latter being more efficient, and rat P450 3A2. Our results do not support O-6-demethylation of thebaine by an Fe-II/alpha-ketoglutarate-dependent dioxygenase. In rat brain microsomes, O-6-demethylation was inhibited by ketoconazole, but not sulfaphenazole, suggesting that P450 3A enzymes are responsible for this activity in the brain. An alternate pathway to morphine, oripavine O-6-demethylation, was not detected. The major enzymatic steps in mammalian morphine synthesis have now been identified.	[Kramlinger, Valerie M.; Rojas, Monica Alvarado; Kanamori, Tatsuyuki; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institute of Health [R37 CA090426, T32 E5007028]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or part by National Institute of Health Grants R37 CA090426 (to F. P. G.) and T32 E5007028 (to V. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Bu HZ, 2001, EUR J PHARM SCI, V12, P447, DOI 10.1016/S0928-0987(00)00190-1; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; CARDINALE GJ, 1987, LIFE SCI, V40, P301, DOI 10.1016/0024-3205(87)90347-X; Charron G, 2011, BRAIN, V134, P2321, DOI 10.1093/brain/awr166; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Craig DH, 1998, BIOCHEMISTRY-US, V37, P7598, DOI 10.1021/bi980345i; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; Daly Ann K, 2006, Methods Mol Biol, V320, P193; DAYER P, 1988, BIOCHEM BIOPH RES CO, V152, P411, DOI 10.1016/S0006-291X(88)80729-0; DONNERER J, 1986, P NATL ACAD SCI USA, V83, P4566, DOI 10.1073/pnas.83.12.4566; DONNERER J, 1987, J PHARMACOL EXP THER, V242, P583; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; FINDLAY JWA, 1978, CLIN PHARMACOL THER, V24, P60; FOWLER CJ, 1994, NEUROCHEM INT, V24, P401, DOI 10.1016/0197-0186(94)90089-2; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; Fricchione G, 2008, MED SCI MONITOR, V14, pCS45; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; FUKUMORI F, 1993, J BACTERIOL, V175, P2083, DOI 10.1128/JB.175.7.2083-2086.1993; Glattard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008791; GOLDSTEIN A, 1985, P NATL ACAD SCI USA, V82, P5203, DOI 10.1073/pnas.82.15.5203; Goldstein S, 1999, ACCOUNTS CHEM RES, V32, P547, DOI 10.1021/ar9800789; Grobe N, 2011, ARCH BIOCHEM BIOPHYS, V506, P42, DOI 10.1016/j.abb.2010.11.010; Grobe N, 2010, P NATL ACAD SCI USA, V107, P8147, DOI 10.1073/pnas.1003423107; Grobe N, 2009, J BIOL CHEM, V284, P24425, DOI 10.1074/jbc.M109.011320; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; GUENGERICH FP, 1979, MOL PHARMACOL, V15, P154; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hausinger RP, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P1, DOI 10.1039/9781782621959; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hiroi T, 1998, BIOCHEM BIOPH RES CO, V249, P838, DOI 10.1006/bbrc.1998.9232; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KIRBY GW, 1967, SCIENCE, V155, P170, DOI 10.1126/science.155.3759.170; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Kobayashi K, 2003, DRUG METAB DISPOS, V31, P833, DOI 10.1124/dmd.31.7.833; KODAIRA H, 1989, P NATL ACAD SCI USA, V86, P716, DOI 10.1073/pnas.86.2.716; KODAIRA H, 1988, P NATL ACAD SCI USA, V85, P1267, DOI 10.1073/pnas.85.4.1267; Kok GB, 2011, ORG BIOMOL CHEM, V9, P1008, DOI 10.1039/c0ob01021a; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Laux-Biehlmann A, 2013, NEUROSCIENCE, V233, P95, DOI 10.1016/j.neuroscience.2012.12.013; Laux-Biehlmann A, 2012, BRIT J CLIN PHARMACO, V74, P381, DOI 10.1111/j.1365-2125.2012.04199.x; LEE CS, 1991, J PHARMACOL EXP THER, V257, P647; Li DY, 2013, CHEM RES TOXICOL, V26, P1182, DOI 10.1021/tx400096m; Lister DL, 1999, FEMS MICROBIOL LETT, V181, P137; MacFaul PA, 1998, ACCOUNTS CHEM RES, V31, P159, DOI 10.1021/ar970057z; Meijerink WJHJ, 1999, SHOCK, V12, P165, DOI 10.1097/00024382-199909000-00001; Messiha HL, 2005, J BIOL CHEM, V280, P10695, DOI 10.1074/jbc.M410595200; MIKUS G, 1994, J PHARMACOL EXP THER, V268, P546; Niwa T, 2008, CURR DRUG METAB, V9, P20; Onoyovwe A, 2013, PLANT CELL, V25, P4110, DOI 10.1105/tpc.113.115113; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Perea-Sasiaín José, 2008, rev.fac.med., V56, P161; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Richter T, 2004, J PHARMACOL EXP THER, V308, P189, DOI 10.1124/jpet.103.056127; Sohl CD, 2009, NAT PROTOC, V4, P1252, DOI 10.1038/nprot.2009.122; Stevens JC, 2006, DRUG DISCOV TODAY, V11, P440, DOI 10.1016/j.drudis.2006.03.002; Tseng E, 2014, DRUG METAB DISPOS, V42, P1163, DOI 10.1124/dmd.114.057000; Turpeinen M, 2005, EUR J PHARM SCI, V24, P123, DOI 10.1016/j.ejps.2004.10.006; Tyndale RF, 1999, DRUG METAB DISPOS, V27, P924; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1686, DOI 10.1124/dmd.112.045302; WEITZ CJ, 1986, P NATL ACAD SCI USA, V83, P9784, DOI 10.1073/pnas.83.24.9784; WEITZ CJ, 1987, NATURE, V330, P674, DOI 10.1038/330674a0; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Yin H, 2000, XENOBIOTICA, V30, P141, DOI 10.1080/004982500237749; Zhang WJ, 2001, DRUG METAB DISPOS, V29, P897; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357	75	23	24	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20200	20210		10.1074/jbc.M115.665331	http://dx.doi.org/10.1074/jbc.M115.665331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26157146	Green Published, hybrid			2022-12-28	WOS:000359608900021
J	Cai, ZQ; Cao, R; Zhang, K; Xue, YC; Zhang, C; Zhou, Y; Zhou, J; Sun, H; Fu, XD				Cai, Zhiqiang; Cao, Ran; Zhang, Kai; Xue, Yuanchao; Zhang, Chen; Zhou, Yu; Zhou, Jie; Sun, Hui; Fu, Xiang-Dong			Oncogenic miR-17/20a Forms a Positive Feed-forward Loop with the p53 Kinase DAPK3 to Promote Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; SERINE/THREONINE KINASE; ZIP KINASE; MICRORNAS; CANCER; IDENTIFICATION; FAMILY; DIFFERENTIATION; EXPRESSION; REPRESSION	MicroRNAs (miRs) are a class of small regulatory RNAs that have been implicated in diverse biological pathways, including cancer. miR-17/20a encoded by the c13orf25 locus is among the first miRs discovered to have oncogenic functions. The E2F family members have been established as the targets for these oncomiRs, which form a negative feedback loop to control cell cycle progression. However, this pathway does not seem to be sufficient to account for elevated expression of these oncomiRs in cancer cells to promote tumorigenesis. Here we report that miR-17/20a targets a p53 activating kinase DAPK3, leading to p53-dependent transcriptional de-repression of the oncomiRs. We demonstrate that DAPK3 plays a central role in preventing miR-17/20a depletion-induced genome instability and in miR17/20a overexpression-triggered tumor formation. This newly identified tumorigenic pathway may thus contribute to miR-17/20a amplification and tumor growth in diverse human cancers.	[Cai, Zhiqiang; Cao, Ran; Zhang, Kai; Zhang, Chen; Zhou, Jie; Sun, Hui; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Xue, Yuanchao; Zhou, Yu; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego	Fu, XD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	xdfu@ucsd.edu	Regan, Clinton/E-6250-2012	Zhou, Yu/0000-0002-2102-9377	National Institutes of Health [GM049369, GM052872]; China 973 program [2011CB811300, 2012CB910800]; Chinese 111 program [B06018]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369, R01GM052872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 973 program(National Basic Research Program of China); Chinese 111 program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049369 and GM052872. This work was also supported by the China 973 program (2011CB811300 and 2012CB910800) and Chinese 111 program Grant B06018. The authors declare that they have no conflicts of interest with the contents of this article.	Bi J, 2009, INT J CANCER, V124, P1587, DOI 10.1002/ijc.24164; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	25	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19967	19975		10.1074/jbc.M115.661504	http://dx.doi.org/10.1074/jbc.M115.661504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26117336	Green Published, hybrid			2022-12-28	WOS:000359364600051
J	Krasner, DS; Daley, JM; Sung, P; Niu, HY				Krasner, Danielle S.; Daley, James M.; Sung, Patrick; Niu, Hengyao			Interplay between Ku and Replication Protein A in the Restriction of Exo1-mediated DNA Break End Resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; REPAIR PATHWAY CHOICE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHECKPOINT ACTIVATION; JOINING REPAIR; COMPLEX; EXO1; DAMAGE	DNA double-strand breaks can be eliminated via non-homologous end joining or homologous recombination. Non-homologous end joining is initiated by the association of Ku with DNA ends. In contrast, homologous recombination entails nucleolytic resection of the 5'-strands, forming 3'-ssDNA tails that become coated with replication protein A (RPA). Ku restricts end access by the resection nuclease Exo1. It is unclear how partial resection might affect Ku engagement and Exo1 restriction. Here, we addressed these questions in a reconstituted system with yeast proteins. With blunt-ended DNA, Ku protected against Exo1 in a manner that required its DNA end-binding activity. Despite binding poorly to ssDNA, Ku could nonetheless engage a 5'-recessed DNA end with a 40-nucleotide (nt) ssDNA overhang, where it localized to the ssDNA-dsDNA junction and efficiently blocked resection by Exo1. Interestingly, RPA could exclude Ku from a partially resected structure with a 22-nt ssDNA tail and thus restored processing by Exo1. However, at a 40-nt tail, Ku remained stably associated at the ssDNA-dsDNA junction, and RPA simultaneously engaged the ssDNA region. We discuss a model in which the dynamic equilibrium between Ku and RPA binding to a partially resected DNA end influences the timing and efficiency of the resection process.	[Krasner, Danielle S.; Daley, James M.; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Niu, Hengyao] Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA	Yale University; Indiana University System; Indiana University Bloomington	Sung, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA.	patrick.sung@yale.edu; hniu@indiana.edu	Regan, Clinton/E-6250-2012; Niu, Hengyao/AAE-9269-2020		National Institutes of Health [R01 ES007016, R01 ES015632, R01 ES015252, R01 GM057814, K99/R00 ES021441]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021441, R01ES015632, K99ES021441, R01ES015252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES007016, R01 ES015632, R01 ES015252, R01 GM057814, and K99/R00 ES021441. The authors declare that they have no conflicts of interest with the contents of this article.	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bizard AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016477; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; FALZON M, 1993, J BIOL CHEM, V268, P10546; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Grob P, 2012, DNA REPAIR, V11, P74, DOI 10.1016/j.dnarep.2011.10.023; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2012, NAT CELL BIOL, V14, P448, DOI 10.1038/ncb2494; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Karathanasis E, 2002, GENETICS, V161, P1015; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; LeBel C, 2009, GENETICS, V182, P671, DOI 10.1534/genetics.109.102939; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wasko BM, 2009, DNA REPAIR, V8, P162, DOI 10.1016/j.dnarep.2008.09.010; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Wu TJ, 2009, J BIOL CHEM, V284, P12801, DOI 10.1074/jbc.M809131200; Wyatt HDM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a023192; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhou Y, 2013, J BIOL CHEM, V288, P37112, DOI 10.1074/jbc.M113.514398; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	56	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18806	18816		10.1074/jbc.M115.660191	http://dx.doi.org/10.1074/jbc.M115.660191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26067273	Green Published, hybrid			2022-12-28	WOS:000358512100047
J	Kloverpris, S; Mikkelsen, JH; Pedersen, JH; Jepsen, MR; Laursen, LS; Petersen, SV; Oxvig, C				Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Jepsen, Malene R.; Laursen, Lisbeth S.; Petersen, Steen V.; Oxvig, Claus			Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BASIC-PROTEIN; PAPP-A; MOLECULAR-CLONING; STC1 EXPRESSION; GROWTH; INSULIN; IGF; CALCIUM; IDENTIFICATION; REGULATOR	Stanniocalcin-1 (STC1) is a disulfide-bound homodimeric glycoprotein, first identified as a hypocalcemic hormone important for maintaining calcium homeostasis in teleost fish. STC1 was later found to be widely expressed in mammals, although it is not believed to function in systemic calcium regulation in these species. Several physiological functions of STC1 have been reported, although many molecular details are still lacking. We here demonstrate that STC1 is an inhibitor of the metzincin metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A), which modulates insulin-like growth factor (IGF) signaling through proteolytic cleavage of IGF-binding proteins (IGFBPs). STC1 potently (K-i = 68 pM) inhibits PAPP-A cleavage of IGFBP-4, and we show in a cell-based assay that STC1 effectively antagonizes PAPP-A-mediated type 1 IGF receptor (IGF1R) phosphorylation. It has recently been found that the homologous STC2 inhibits PAPP-A proteolytic activity, and that this depends on the formation of a covalent complex between the inhibitor and the proteinase, mediated by Cys-120 of STC2. We find that STC1 is unable to bind covalently to PAPP-A, in agreement with the absence of a corresponding cysteine residue. It rather binds to PAPP-A with high affinity(K-D = 75 pM). We further demonstrate that both STC1 and STC2 show inhibitory activity toward PAPP-A2, but not selected serine proteinases and metalloproteinases. We therefore conclude that the STCs are proteinase inhibitors, probably restricted in specificity to the pappalysin family of metzincin metalloproteinases. Ourdata are the first to identify STC1 as a proteinase inhibitor, suggesting a previously unrecognized function of STC1 in the IGF system.	[Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Jepsen, Malene R.; Laursen, Lisbeth S.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Petersen, Steen V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Oxvig, C (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.	co@mbg.au.dk		Mikkelsen, Jakob Hauge/0000-0002-2914-3297; Vang Petersen, Steen/0000-0002-9338-911X; Jepsen, Malene/0000-0003-1959-5019; Laursen, Lisbeth Schmidt/0000-0002-8676-5869; Oxvig, Claus/0000-0002-4715-9719	Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research; Novo Nordisk Fonden [NNF14OC0010497] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, and the Danish Council for Independent Research. The authors declare that they have no conflicts of interest with the contents of this article.	Becker MA, 2015, MOL CANCER THER, V14, P973, DOI 10.1158/1535-7163.MCT-14-0880; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 1998, MOL CELL ENDOCRINOL, V141, P95, DOI 10.1016/S0303-7207(98)00097-5; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chang ACM, 2008, ENDOCRINOLOGY, V149, P2403, DOI 10.1210/en.2007-1219; Chang ACM, 2015, CLIN EXP METASTAS, V32, P15, DOI 10.1007/s10585-014-9687-9; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; DiMattia GE, 1998, MOL CELL ENDOCRINOL, V146, P137, DOI 10.1016/S0303-7207(98)00163-4; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Gyrup C, 2007, CLIN CHEM, V53, P947, DOI 10.1373/clinchem.2006.080614; Gyrup C, 2007, BIOCHEMISTRY-US, V46, P1972, DOI 10.1021/bi062229i; Hulova I, 1999, BIOCHEM BIOPH RES CO, V257, P295, DOI 10.1006/bbrc.1999.0466; Hwang PP, 2013, PFLUG ARCH EUR J PHY, V465, P1233, DOI 10.1007/s00424-013-1269-1; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V250, P252, DOI 10.1006/bbrc.1998.9300; Jepsen MR, 2015, J BIOL CHEM, V290, P3430, DOI 10.1074/jbc.M114.611665; Kjaer-Sorensen K, 2013, J BIOL CHEM, V288, P9982, DOI 10.1074/jbc.M112.426304; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Lin CH, 2014, ENDOCRINOLOGY, V155, P56, DOI 10.1210/en.2013-1608; Loddo M, 2014, J PATHOL, V233, P344, DOI 10.1002/path.4393; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; Mikkelsen JH, 2014, ONCOTARGET, V5, P1014, DOI 10.18632/oncotarget.1629; Monget P, 2003, BIOL REPROD, V68, P77, DOI 10.1095/biolreprod.102.007609; Moore EE, 1999, HORM METAB RES, V31, P406, DOI 10.1055/s-2007-978764; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; Oxvig C, 2015, J CELL COMMUN SIGNAL, V9, P177, DOI 10.1007/s12079-015-0259-9; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qin QP, 1997, CLIN CHEM, V43, P2323; Roch GJ, 2011, GENOME BIOL EVOL, V3, P284, DOI 10.1093/gbe/evr020; Serlachius M, 2004, EXP CELL RES, V296, P256, DOI 10.1016/j.yexcr.2004.02.016; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; WAGNER GF, 1986, GEN COMP ENDOCR, V63, P481, DOI 10.1016/0016-6480(86)90149-8; Wagner GF, 1997, J BONE MINER RES, V12, P165, DOI 10.1359/jbmr.1997.12.2.165; Wagner GF, 2006, J EXP ZOOL PART A, V305A, P769, DOI 10.1002/jez.a.313; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Zhang JL, 1998, PROTEIN EXPRES PURIF, V12, P390, DOI 10.1006/prep.1997.0857	54	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21915	21924		10.1074/jbc.M115.650143	http://dx.doi.org/10.1074/jbc.M115.650143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195635	Green Published, hybrid			2022-12-28	WOS:000360968500013
J	Yamauchi, S; Takeuchi, K; Chihara, K; Sun, XD; Honjoh, C; Yoshiki, H; Hotta, H; Sada, K				Yamauchi, Shota; Takeuchi, Kenji; Chihara, Kazuyasu; Sun, Xuedong; Honjoh, Chisato; Yoshiki, Hatsumi; Hotta, Hak; Sada, Kiyonao			Hepatitis C Virus Particle Assembly Involves Phosphorylation of NS5A by the c-Abl Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; DIFFERENTIAL PHOSPHORYLATION; RNA REPLICATION; CORE PROTEIN; LIFE-CYCLE; SRC FAMILY; BINDING; CANCER; DOMAIN; ASSOCIATION	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is thought to regulate the replication of viral RNA and the assembly of virus particles in a serine/threonine phosphorylation-dependent manner. However, the host kinases that phosphorylate NS5A have not been fully identified. Here, we show that HCV particle assembly involves the phosphorylation of NS5A by the c-Abl tyrosine kinase. Pharmacological inhibition or knockdown of c-Abl reduces the production of infectious HCV (J6/JFH1) particles in Huh-7.5 cells without markedly affecting viral RNA translation and replication. NS5A is tyrosine-phosphorylated in HCV-infected cells, and this phosphorylation is also reduced by the knockdown of c-Abl. Mutational analysis reveals that NS5A tyrosine phosphorylation is dependent, at least in part, on Tyr(330) (Tyr(2306) in polyprotein numbering). Mutation of this residue to phenylalanine reduces the production of infectious HCV particles but does not affect the replication of the JFH1 subgenomic replicon. These findings suggest that c-Abl promotes HCV particle assembly by phosphorylating NS5A at Tyr(330).	[Yamauchi, Shota; Takeuchi, Kenji; Chihara, Kazuyasu; Sun, Xuedong; Honjoh, Chisato; Yoshiki, Hatsumi; Sada, Kiyonao] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, Fukui 9101193, Japan; [Honjoh, Chisato] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 9101193, Japan; [Yamauchi, Shota; Takeuchi, Kenji; Chihara, Kazuyasu; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Fukui 9101193, Japan; [Hotta, Hak] Kobe Univ, Grad Sch Med, Div Microbiol, Kobe, Hyogo 6500017, Japan	University of Fukui; University of Fukui; University of Fukui; Kobe University	Sada, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100	Japan Society for the Promotion of Science (JSPS) [15K19021, 25460383]; Research and Education Program for Life Science at the University of Fukui; Yakult Honsha Co., Ltd.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research and Education Program for Life Science at the University of Fukui; Yakult Honsha Co., Ltd.	This work was supported by KAKENHI Grants 15K19021 (to S. Y.) and 25460383 (to K. S.) from the Japan Society for the Promotion of Science (JSPS), a grant from the Research and Education Program for Life Science at the University of Fukui (to S. Y.), and a grant from Yakult Honsha Co., Ltd. (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Colpitts CC, 2015, BBA-PROTEINS PROTEOM, V1854, P1657, DOI 10.1016/j.bbapap.2015.04.011; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; deLemos AS, 2014, TRENDS MOL MED, V20, P315, DOI 10.1016/j.molmed.2014.02.002; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Inubushi S, 2008, J GEN VIROL, V89, P1231, DOI 10.1099/vir.0.83510-0; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nakashima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046634; Okuda K, 2001, BLOOD, V97, P2440, DOI 10.1182/blood.V97.8.2440; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Ross-Thriepland D, 2013, J GEN VIROL, V94, P1009, DOI 10.1099/vir.0.050633-0; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Yamauchi S, 2014, J CELL BIOL, V204, P1191, DOI 10.1083/jcb.201309107; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	57	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21857	21864		10.1074/jbc.M115.666859	http://dx.doi.org/10.1074/jbc.M115.666859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203192	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000360968500008
J	Yang, H; Liu, S; He, WT; Zhao, J; Jiang, LL; Hu, HY				Yang, Hui; Liu, Shuai; He, Wen-Tian; Zhao, Jian; Jiang, Lei-Lei; Hu, Hong-Yu			Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HISTONE ACETYLTRANSFERASE ACTIVITY; DOMINANT CEREBELLAR-ATAXIA; STEM-CELL MARKER; TRANSCRIPTIONAL ACTIVATION; SPINOCEREBELLAR ATAXIA-7; RETINAL DEGENERATION; MACULAR DYSTROPHY; 26S PROTEASOME; SCA7	Human ataxin 7 (Atx7) is a component of the deubiquitination module (DUBm) in the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex for transcriptional regulation, and expansion of its polyglutamine (polyQ) tract leads to spinocerebellar ataxia type 7. However, how polyQ expansion of Atx7 affects DUBm function remains elusive. We investigated the effects of polyQ-expanded Atx7 on ubiquitin-specific protease (USP22), an interacting partner of Atx7 functioning in deubiquitination of histone H2B. The results showed that the inclusions or aggregates formed by polyQ-expanded Atx7 specifically sequester USP22 through their interactions mediated by the N-terminal zinc finger domain of Atx7. The mutation of the zinc finger domain in Atx7 that disrupts its interaction with USP22 dramatically abolishes sequestration of USP22. Moreover, polyQ expansion of Atx7 decreases the deubiquitinating activity of USP22 and, consequently, increases the level of monoubiquitinated H2B. Therefore, we propose that polyQ-expanded Atx7 forms insoluble aggregates that sequester USP22 into a catalytically inactive state, and then the impaired DUBm loses the function to deubiquitinate monoubiquitinated histone H2B or H2A. This may result in dysfunction of the SAGA complex and transcriptional dysregulation in spinocerebellar ataxia type 7 disease.	[Yang, Hui; Liu, Shuai; He, Wen-Tian; Zhao, Jian; Jiang, Lei-Lei; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020	Liu, Shuai/0000-0002-6069-4900	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31270773, 31200570, 31470758]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB911003 and National Natural Science Foundation of China Grants 31270773, 31200570, and 31470758. The authors declare that they have no conflicts of interest with the contents of this article.	Ansorge O, 2004, ANN NEUROL, V56, P448, DOI 10.1002/ana.20230; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Blum ES, 2013, TRENDS CELL BIOL, V23, P168, DOI 10.1016/j.tcb.2012.11.003; Bonnet J, 2010, EMBO REP, V11, P612, DOI 10.1038/embor.2010.98; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Choi YJ, 2012, MOL CELL NEUROSCI, V49, P127, DOI 10.1016/j.mcn.2011.11.003; Chou AH, 2010, NEUROCHEM INT, V56, P329, DOI 10.1016/j.neuint.2009.11.003; Damrath E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002920; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Einum DD, 2001, NEUROGENETICS, V3, P83, DOI 10.1007/s100480000100; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Gao YG, 2014, STRUCTURE, V22, P378, DOI 10.1016/j.str.2013.12.005; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Holmes WM, 2014, CRIT REV BIOCHEM MOL, V49, P294, DOI 10.3109/10409238.2014.914151; Hsu TC, 2014, HUM MOL GENET, V23, P6878, DOI 10.1093/hmg/ddu410; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Jiang YJ, 2013, FEBS LETT, V587, P2905, DOI 10.1016/j.febslet.2013.07.021; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Johnsen SA, 2012, FEBS LETT, V586, P1592, DOI 10.1016/j.febslet.2012.04.002; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Lan XJ, 2015, MOL CELL BIOL, V35, P1777, DOI 10.1128/MCB.01454-14; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; Lebre AS, 2001, HUM MOL GENET, V10, P1201, DOI 10.1093/hmg/10.11.1201; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McCullough SD, 2012, P NATL ACAD SCI USA, V109, P21319, DOI 10.1073/pnas.1218331110; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Mohan RD, 2014, GENE DEV, V28, P259, DOI 10.1101/gad.225151.113; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rantanen K, 2013, J CELL SCI, V126, P1144, DOI 10.1242/jcs.115667; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101; Takahashi J, 2002, BRAIN, V125, P1534, DOI 10.1093/brain/awf154; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao XH, 2012, J BIOL CHEM, V287, P23346, DOI 10.1074/jbc.M111.287748; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	60	24	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21996	22004		10.1074/jbc.M114.631663	http://dx.doi.org/10.1074/jbc.M114.631663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26195632	Green Published, hybrid			2022-12-28	WOS:000360968500020
J	Chen, C; Shrestha, R; Jia, K; Gao, PF; Geisbrecht, BV; Bossmann, SH; Shi, JS; Li, P				Chen, Chao; Shrestha, Ruben; Jia, Kaimin; Gao, Philip F.; Geisbrecht, Brian V.; Bossmann, Stefan H.; Shi, Jishu; Li, Ping			Characterization of Dye-decolorizing Peroxidase (DyP) from Thermomonospora curvata Reveals Unique Catalytic Properties of A-type DyPs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; SUBSTRATE-INTERACTION-SITES; EXTRACELLULAR HEME ENZYME; RHODOCOCCUS-JOSTII RHA1; HORSERADISH-PEROXIDASE; MANGANESE PEROXIDASE; LIGNIN PEROXIDASE; SPECTRAL CHARACTERIZATION; HYDROGEN-PEROXIDE	Dye-decolorizing peroxidases (DyPs) comprise a new family of heme peroxidases, which has received much attention due to their potential applications in lignin degradation. A new DyP from Thermomonospora curvata (TcDyP) was identified and characterized. Unlike other A-type enzymes, TcDyP is highly active toward a wide range of substrates including model lignin compounds, in which the catalytic efficiency with ABTS (k(cat)(app)/K-m(app) = (1.7 x 10(7)) M-1 s(-1)) is close to that of fungal DyPs. Stopped-flow spectroscopy was employed to elucidate the transient intermediates as well as the catalytic cycle involving wildtype (wt) and mutant TcDyPs. Although residues Asp(220) and Arg(327) are found necessary for compound I formation, His(312) is proposed to play roles in compound II reduction. Transient kinetics of hydroquinone (HQ) oxidation by wt-TcDyP showed that conversion of the compound II to resting state is a rate-limiting step, which will explain the contradictory observation made with the aspartate mutants of A-type DyPs. Moreover, replacement of His(312) and Arg(327) has significant effects on the oligomerization and redox potential (E degrees') of the enzyme. Both mutants were found to promote the formation of dimeric state and to shift E degrees' to a more negative potential. Not only do these results reveal the unique catalytic property of the A-type DyPs, but they will also facilitate the development of these enzymes as lignin degraders.	[Chen, Chao; Shrestha, Ruben; Jia, Kaimin; Bossmann, Stefan H.; Li, Ping] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA; [Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Shi, Jishu] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Gao, Philip F.] Univ Kansas, Prot Prod Grp, Lawrence, KS 66045 USA	Kansas State University; Kansas State University; Kansas State University; University of Kansas	Li, P (corresponding author), Kansas State Univ, CB 213, Manhattan, KS 66506 USA.	pli@ksu.edu	Shi, Jishu/AAJ-3664-2021; Regan, Clinton/E-6250-2012; Bossmann, Stefan/AAG-9881-2020	Chen, Chao/0000-0003-1028-3182	National Institutes of Health [P30GM110761]; Johnson Cancer Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant P30GM110761 and the Johnson Cancer Research Center. The authors declare that they have no conflicts of interest with the contents of this article.	Adak S, 1996, BIOCHEM J, V314, P985, DOI 10.1042/bj3140985; Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Baciocchi E, 2002, TETRAHEDRON, V58, P8087, DOI 10.1016/S0040-4020(02)00997-3; Banci L, 2003, J BIOL INORG CHEM, V8, P751, DOI 10.1007/s00775-003-0476-1; Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y; Brown ME, 2011, J AM CHEM SOC, V133, P18006, DOI 10.1021/ja203972q; Chertkov O, 2011, STAND GENOMIC SCI, V4, P13, DOI 10.4056/sigs.1453580; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6; Dunford H. B., 2010, PEROXIDASES CATALASE; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; FENNINGTON G, 1984, APPL ENVIRON MICROB, V47, P201, DOI 10.1128/AEM.47.1.201-204.1984; Fernandez-Fueyo E, 2012, J BIOL CHEM, V287, P16903, DOI 10.1074/jbc.M112.356378; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Hiner ANP, 2001, EUR J BIOCHEM, V268, P3091, DOI 10.1046/j.1432-1327.2001.02208.x; Johjima T, 2003, APPL MICROBIOL BIOT, V61, P220, DOI 10.1007/s00253-003-1236-4; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; Koua D, 2009, NUCLEIC ACIDS RES, V37, pD261, DOI 10.1093/nar/gkn680; Kroppenstedt RM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P682, DOI 10.1007/0-387-30743-5_27; KUAN IC, 1993, J BIOL CHEM, V268, P20064; LAMAR GN, 1992, BIOCHEMISTRY-US, V31, P9158, DOI 10.1021/bi00153a007; Li J, 2012, APPL BIOCHEM BIOTECH, V166, P774, DOI 10.1007/s12010-011-9466-x; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Linde D, 2015, BIOCHEM J, V466, P253, DOI 10.1042/BJ20141211; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Mcllvaine T. C., 1921, J BIOL CHEM, V49, P183; Min K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08245; MINO Y, 1988, J BIOL CHEM, V263, P7029; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Paliwal R, 2012, APPL BIOCHEM BIOTECH, V167, P1865, DOI 10.1007/s12010-012-9735-3; Petruccioli M, 2009, J BIOL INORG CHEM, V14, P1153, DOI 10.1007/s00775-009-0559-8; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; RENGANATHAN V, 1986, BIOCHEMISTRY-US, V25, P1626, DOI 10.1021/bi00355a027; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Sambrook J., 2006, CONDENSED PROTOCOLS; Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4; Santucci R, 2000, BIOCHEM J, V349, P85, DOI 10.1042/0264-6021:3490085; SCHONBAUM GR, 1972, J BIOL CHEM, V247, P3353; Sezer M, 2013, BIOCHEMISTRY-US, V52, P3074, DOI 10.1021/bi301630a; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strittmatter E, 2015, ARCH BIOCHEM BIOPHYS, V574, P75, DOI 10.1016/j.abb.2014.12.016; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; STUTZENBERGER FJ, 1979, BIOTECHNOL BIOENG, V21, P909, DOI 10.1002/bit.260210514; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Sugano Y, 2009, BIODEGRADATION, V20, P433, DOI 10.1007/s10532-008-9234-y; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Tien M, 1997, J BIOL CHEM, V272, P8912; Torres E, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P1, DOI 10.1007/978-3-642-12627-7; van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; Wang WC, 1999, BIOCHEM J, V340, P329, DOI 10.1042/0264-6021:3400329; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; Wei K, 2004, J MOL STRUC-THEOCHEM, V712, P197, DOI 10.1016/j.theochem.2004.10.032; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; Zhang Z, 2002, ANAL CHEM, V74, P163, DOI 10.1021/ac010701u; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	70	72	72	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23447	23463		10.1074/jbc.M115.658807	http://dx.doi.org/10.1074/jbc.M115.658807			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26205819	Green Published, hybrid			2022-12-28	WOS:000361685500048
J	Li, RZ; Uttarwar, L; Gao, B; Charbonneau, M; Shi, YX; Chan, JSD; Dubois, CM; Krepinsky, JC				Li, Renzhong; Uttarwar, Lalita; Gao, Bo; Charbonneau, Martine; Shi, Yixuan; Chan, John S. D.; Dubois, Claire M.; Krepinsky, Joan C.			High Glucose Up-regulates ADAM17 through HIF-1 alpha in Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; diabetes; epidermal growth factor receptor (EGFR); extracellular matrix; hypoxia-inducible factor (HIF); kidney; diabetic nephropathy	GROWTH-FACTOR RECEPTOR; TUMOR-NECROSIS-FACTOR; HYPOXIA-INDUCIBLE FACTOR; ALPHA-CONVERTING ENZYME/ADAM17; PREVENTS DIABETIC-NEPHROPATHY; ELEMENT-BINDING PROTEIN; EGFR TRANSACTIVATION; FACTOR 1-ALPHA; EXPRESSION; ACTIVATION	Background: ADAM17 is an important promoter of fibrosis in diabetic kidney disease. Results: ADAM17 is transcriptionally up-regulated by glucose through HIF-1 in kidney mesangial cells, associated with enhanced enzymatic activity. Conclusion: ADAM17 induces its own up-regulation, thereby augmenting its activity, in response to glucose. Significance: These studies provide a strong foundation for further evaluation of the role of ADAM17 in the profibrotic response of kidney cells to high glucose. We previously showed that ADAM17 mediates high glucose-induced matrix production by kidney mesangial cells. ADAM17 expression is increased in diabetic kidneys, suggesting that its up-regulation may augment high glucose profibrotic responses. We thus studied the effects of high glucose on ADAM17 gene regulation. Primary rat mesangial cells were treated with high glucose (30 mm) or mannitol as osmotic control. High glucose dose-dependently increased ADAM17 promoter activity, transcript, and protein levels. This correlated with augmented ADAM17 activity after 24 h versus 1 h of high glucose. We tested involvement of transcription factors shown in other settings to regulate ADAM17 transcription. Promoter activation was not affected by NF-B or Sp1 inhibitors, but was blocked by hypoxia-inducible factor-1 (HIF-1) inhibition or down-regulation. This also prevented ADAM17 transcript and protein increases. HIF-1 activation by high glucose was shown by its increased nuclear translocation and activation of the HIF-responsive hypoxia-response element (HRE)-luciferase reporter construct. Assessment of ADAM17 promoter deletion constructs coupled with mutation analysis and ChIP studies identified HIF-1 binding to its consensus element at -607 as critical for the high glucose response. Finally, inhibitors of epidermal growth factor receptor (EGFR) and downstream PI3K/Akt, or ADAM17 itself, prevented high glucose-induced HIF-1 activation and ADAM17 up-regulation. Thus, high glucose induces ADAM17 transcriptional up-regulation in mesangial cells, which is associated with augmentation of its activity. This is mediated by HIF-1 and requires EGFR/ADAM17 signaling, demonstrating the potentiation by ADAM17 of its own up-regulation. ADAM17 inhibition thus provides a potential novel therapeutic strategy for the treatment of diabetic nephropathy.	[Li, Renzhong; Uttarwar, Lalita; Gao, Bo; Krepinsky, Joan C.] McMaster Univ, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Charbonneau, Martine; Dubois, Claire M.] Univ Sherbrooke, Div Immunol, Sherbrooke, PQ J1H 5N4, Canada; [Shi, Yixuan; Chan, John S. D.] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada	McMaster University; University of Sherbrooke; Universite de Montreal	Krepinsky, JC (corresponding author), St Josephs Hosp, 50 Charlton Ave East,Rm T3311, Hamilton, ON L8N 4A6, Canada.	krepinj@mcmaster.ca			Canadian Institutes of Health Research (CIHR) [MOP-258039, MOP-86634, MOP-84363]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (CIHR) Grants MOP-258039 (to J. C. K.), MOP-86634 (to C. M. D.), and MOP-84363 (to J. S. D. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; Chae YM, 2004, BIOCHEM BIOPH RES CO, V319, P550, DOI 10.1016/j.bbrc.2004.05.025; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Fischer Oliver M., 2006, V327, P85; Ford BM, 2013, AM J PHYSIOL-RENAL, V305, pF323, DOI 10.1152/ajprenal.00522.2012; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hurtado O, 2001, NEUROPHARMACOLOGY, V40, P1094, DOI 10.1016/S0028-3908(01)00035-1; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Krepinsky JC, 2003, J AM SOC NEPHROL, V14, P2790, DOI 10.1097/01.ASN.0000094085.04161.A7; Lauzier MC, 2007, ENDOCRINOLOGY, V148, P4023, DOI 10.1210/en.2007-0285; LEE YJ, 1995, BIOCHEM BIOPH RES CO, V207, P216, DOI 10.1006/bbrc.1995.1175; Majka S, 2002, INVEST OPHTH VIS SCI, V43, P260; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Matoba K, 2013, KIDNEY INT, V84, P545, DOI 10.1038/ki.2013.130; Melenhorst WB, 2009, AM J PHYSIOL-RENAL, V297, pF781, DOI 10.1152/ajprenal.90610.2008; Miyazawa T, 2013, KIDNEY INT, V84, P1176, DOI 10.1038/ki.2013.214; Mizui Y, 1999, GENE, V233, P67, DOI 10.1016/S0378-1119(99)00155-9; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Murumkar PR, 2010, EXPERT OPIN THER PAT, V20, P31, DOI 10.1517/13543770903465157; Navarro-Gonzalez JF, 2009, CYTOKINE GROWTH F R, V20, P165, DOI 10.1016/j.cytogfr.2009.02.005; Nordquist L, 2015, J AM SOC NEPHROL, V26, P328, DOI 10.1681/ASN.2013090990; Obama T, 2015, AM J HYPERTENS, V28, P10, DOI 10.1093/ajh/hpu094; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Portik-Dobos V, 2006, AM J PHYSIOL-REG I, V290, pR435, DOI 10.1152/ajpregu.00300.2005; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Salem ESB, 2014, AM J PHYSIOL-RENAL, V306, pF629, DOI 10.1152/ajprenal.00516.2013; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Shi YX, 2015, CLIN SCI, V128, P649, DOI 10.1042/CS20140329; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Taniguchi K, 2013, DIABETES, V62, P3874, DOI 10.2337/db12-1010; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; Wassef L, 2004, KIDNEY INT, V66, P1805, DOI 10.1111/j.1523-1755.2004.00955.x; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wu D, 2009, AM J PHYSIOL-RENAL, V297, pF822, DOI 10.1152/ajprenal.00054.2009; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Yu HM, 2012, J APPL TOXICOL, V32, P282, DOI 10.1002/jat.1679; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279	52	45	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21603	21614		10.1074/jbc.M115.651604	http://dx.doi.org/10.1074/jbc.M115.651604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175156	Green Published, hybrid			2022-12-28	WOS:000360637600033
J	Kaur, G; Pinggera, A; Ortner, NJ; Lieb, A; Sinnegger-Brauns, MJ; Yarov-Yarovoy, V; Obermair, GJ; Flucher, BE; Striessnig, J				Kaur, Gurjot; Pinggera, Alexandra; Ortner, Nadine J.; Lieb, Andreas; Sinnegger-Brauns, Martina J.; Yarov-Yarovoy, Vladimir; Obermair, Gerald J.; Flucher, Bernhard E.; Striessnig, Jorg			A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated Ca(V)1.2 Calcium Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; PHOSPHOLIPASE-C; CA2+ CHANNELS; BETA-SUBUNIT; STRUCTURAL DETERMINANTS; INTRACELLULAR LINKER; STRUCTURE PREDICTION; FLUORESCENT-PROTEIN; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE	L-type voltage-gated Ca2+ channels (LTCCs) regulate many physiological functions like muscle contraction, hormone secretion, gene expression, and neuronal excitability. Their activity is strictly controlled by various molecular mechanisms. The pore-forming alpha(1)-subunit comprises four repeated domains (I-IV), each connected via an intracellular linker. Here we identified a polybasic plasma membrane binding motif, consisting of four arginines, within the I-II linker of all LTCCs. The primary structure of this motif is similar to polybasic clusters known to interact with polyphosphoinositides identified in other ion channels. We used de novo molecular modeling to predict the conformation of this polybasic motif, immunofluorescence microscopy and live cell imaging to investigate the interaction with the plasma membrane, and electrophysiology to study its role for Ca(v)1.2 channel function. According to our models, this polybasic motif of the I-II linker forms a straight alpha-helix, with the positive charges facing the lipid phosphates of the inner leaflet of the plasma membrane. Membrane binding of the I-II linker could be reversed after phospholipase C activation, causing polyphosphoinositide breakdown, and was accelerated by elevated intracellular Ca2+ levels. This indicates the involvement of negatively charged phospholipids in the plasma membrane targeting of the linker. Neutralization of four arginine residues eliminated plasma membrane binding. Patch clamp recordings revealed facilitated opening of Cav1.2 channels containing these mutations, weaker inhibition by phospholipase C activation, and reduced expression of channels (as quantified by ON-gating charge) at the plasma membrane. Our data provide new evidence for a membrane binding motif within the I-II linker of LTCC alpha(1)-subunits essential for stabilizing normal Ca2+ channel function.	[Kaur, Gurjot; Pinggera, Alexandra; Ortner, Nadine J.; Lieb, Andreas; Sinnegger-Brauns, Martina J.; Striessnig, Jorg] Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, A-6020 Innsbruck, Austria; [Kaur, Gurjot; Pinggera, Alexandra; Ortner, Nadine J.; Lieb, Andreas; Sinnegger-Brauns, Martina J.; Striessnig, Jorg] Univ Innsbruck, Inst Pharm, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Obermair, Gerald J.; Flucher, Bernhard E.] Med Univ Innsbruck, Div Physiol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of California System; University of California Davis; Medical University of Innsbruck	Striessnig, J (corresponding author), Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, Ctr Chem & Biomed, Innrain 80-82-3, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Yarov-Yarovoy, Vladimir/ABE-5454-2020; , Gerald/AAD-3183-2020; Kaur, Gurjot/AAB-7988-2022; Striessnig, Joerg/S-9334-2017	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Striessnig, Joerg/0000-0002-9406-7120; Ortner, Nadine Jasmin/0000-0003-3882-3283; Lieb, Andreas/0000-0001-9567-649X; Kaur, Gurjot/0000-0002-2894-4009; Flucher, Bernhard/0000-0002-5255-4705; Brauns, Martina/0000-0002-0547-2731	Austrian Science Fund [F44020, F44060, W1101]; University of Innsbruck	Austrian Science Fund(Austrian Science Fund (FWF)); University of Innsbruck	This work was supported by Austrian Science Fund Grants F44020, F44060, and W1101 and the University of Innsbruck. The authors declare that they have no conflicts of interest with the contents of this article.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Campiglio M, 2013, J CELL SCI, V126, P2092, DOI 10.1242/jcs.jcs124537; Cao YM, 2015, P NATL ACAD SCI USA, V112, P2239, DOI 10.1073/pnas.1405748112; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Doering CJ, 2007, NEUROSCIENCE, V146, P1032, DOI 10.1016/j.neuroscience.2007.02.049; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Fu Y, 2014, P NATL ACAD SCI USA, V111, P16598, DOI 10.1073/pnas.1419129111; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; Gonzalez-Gutierrez G, 2010, CHANNELS, V4, P42, DOI 10.4161/chan.4.1.10562; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hermosilla T, 2011, CHANNELS, V5, P280, DOI 10.4161/chan.5.3.15833; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Lieb A, 2012, CHANNELS, V6, P197, DOI 10.4161/chan.21002; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Michailidis IE, 2007, PFLUG ARCH EUR J PHY, V455, P147, DOI 10.1007/s00424-007-0272-9; Miranda-Laferte E, 2014, J BIOL CHEM, V289, P10387, DOI 10.1074/jbc.M113.507244; Neely A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00209; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Obermair GJ, 2004, J MUSCLE RES CELL M, V25, P239, DOI 10.1023/B:JURE.0000038361.47060.fe; Ortner NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4897; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Rousset M, 2004, J BIOL CHEM, V279, P14619, DOI 10.1074/jbc.M313284200; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Striessnig Jorg, 2014, Wiley Interdiscip Rev Membr Transp Signal, V3, P15; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tedford HW, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-6; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605; Zhen XG, 2006, FEBS LETT, V580, P5733, DOI 10.1016/j.febslet.2006.09.027	80	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21086	21100		10.1074/jbc.M115.645671	http://dx.doi.org/10.1074/jbc.M115.645671			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26100638	Green Published, hybrid			2022-12-28	WOS:000360011800041
J	Mizuguchi, C; Ogata, F; Mikawa, S; Tsuji, K; Baba, T; Shigenaga, A; Shimanouchi, T; Okuhira, K; Otaka, A; Saito, H				Mizuguchi, Chiharu; Ogata, Fuka; Mikawa, Shiho; Tsuji, Kohei; Baba, Teruhiko; Shigenaga, Akira; Shimanouchi, Toshinori; Okuhira, Keiichiro; Otaka, Akira; Saito, Hiroyuki			Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN AGGREGATION; BIOLOGICAL-MEMBRANES; CHOLESTEROL EFFLUX; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; HELICAL SEGMENTS; DOMAIN-STRUCTURE; APOA-I; POLYPEPTIDE	The N-terminal amino acid 1-83 fragment of apolipoprotein A-I (apoA-I) has a strong propensity to form amyloid fibrils at physiological neutral pH. Because apoA-I has an ability to bind to lipid membranes, we examined the effects of the lipid environment on fibril-forming properties of the N-terminal fragment of apoA-I variants. Thioflavin T fluorescence assay as well as fluorescence and transmission microscopies revealed that upon lipid binding, fibril formation by apoA-I 1-83 is strongly inhibited, whereas the G26R mutant still retains the ability to form fibrils. Such distinct effects of lipid binding on fibril formation were also observed for the amyloidogenic prone region-containing peptides, apoA-I 8-33 and 8-33/G26R. This amyloidogenic region shifts from random coil to alpha-helical structure upon lipid binding. The G26R mutation appears to prevent this helix transition because lower helical propensity and more solvent-exposed conformation of the G26R variant upon lipid binding were observed in the apoA-I 1-83 fragment and 8-33 peptide. With a partially alpha-helical conformation induced by the presence of 2,2,2-trifluoroethanol, fibril formation by apoA-I 1-83 was strongly inhibited, whereas the G26R variant can form amyloid fibrils. These findings suggest a new possible pathway for amyloid fibril formation by the N-terminal fragment of apoA-I variants: the amyloidogenic mutations partially destabilize the alpha-helical structure formed upon association with lipid membranes, resulting in physiologically relevant conformations that allow fibril formation.	[Mizuguchi, Chiharu; Ogata, Fuka; Mikawa, Shiho; Tsuji, Kohei; Shigenaga, Akira; Okuhira, Keiichiro; Otaka, Akira; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Biomed Sci, Tokushima 7708505, Japan; [Baba, Teruhiko] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn SCRC, Tsukuba, Ibaraki 3058565, Japan; [Shimanouchi, Toshinori] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Tokushima University; National Institute of Advanced Industrial Science & Technology (AIST); Okayama University	Saito, H (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Biomed Sci, 1-78-1 Shomachi, Tokushima 7708505, Japan.	hsaito@tokushima-u.ac.jp	Baba, Teruhiko/J-3351-2018	Baba, Teruhiko/0000-0002-9075-2999; Shigenaga, Akira/0000-0002-6474-5517; Tsuji, Kohei/0000-0003-4773-8793	Japan Society for the Promotion of Science [25293006, 25670014]; Tokushima University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima University	This work was supported in part by Grant-in-Aid for Scientific Research 25293006 and 25670014 (to H. S.) from Japan Society for the Promotion of Science, and the research program for development of intelligent Tokushima artificial exosome (iTEX) from Tokushima University. The authors declare that they have no conflicts of interest with the contents of this article.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Adachi E, 2014, FEBS LETT, V588, P389, DOI 10.1016/j.febslet.2013.11.031; Adachi E, 2013, J BIOL CHEM, V288, P2848, DOI 10.1074/jbc.M112.428052; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Arciello A, 2011, J CELL MOL MED, V15, P2652, DOI 10.1111/j.1582-4934.2011.01271.x; Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Bucciantini M, 2014, J PHYS CHEM LETT, V5, P517, DOI 10.1021/jz4024354; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Bystrom R, 2008, CELL BIOCHEM BIOPHYS, V52, P175, DOI 10.1007/s12013-008-9033-4; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Chetty PS, 2012, BIOCHEMISTRY-US, V51, P8993, DOI 10.1021/bi300926j; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Das M, 2014, FEBS J, V281, P2525, DOI 10.1111/febs.12809; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Di Gaetano S, 2006, BIOCHEM BIOPH RES CO, V351, P223, DOI 10.1016/j.bbrc.2006.10.026; Frank PG, 2000, J LIPID RES, V41, P853; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Girych M, 2014, J STRUCT BIOL, V185, P116, DOI 10.1016/j.jsb.2013.10.017; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Griffin MDW, 2008, J MOL BIOL, V375, P240, DOI 10.1016/j.jmb.2007.10.038; Guo C, 2015, J PHYS CHEM B, V119, P3366, DOI 10.1021/jp5111357; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Joy T, 2003, CLIN BIOCHEM, V36, P641, DOI 10.1016/S0009-9120(03)00110-3; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047580; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Mendoza-Espinosa P, 2014, MOL CELL BIOCHEM, V393, P99, DOI 10.1007/s11010-014-2050-2; Mizuguchi C, 2012, BIOCHEMISTRY-US, V51, P5580, DOI 10.1021/bi300672s; Monti DM, 2010, EUR BIOPHYS J BIOPHY, V39, P1289, DOI 10.1007/s00249-010-0582-2; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; Petrlova J, 2014, PROTEIN SCI, V23, P1559, DOI 10.1002/pro.2534; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; RADER DJ, 1992, J LIPID RES, V33, P755; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Shen L, 2012, J AM CHEM SOC, V134, P14172, DOI 10.1021/ja305398f; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Tanaka M, 2009, J PEPT SCI, V15, P36, DOI 10.1002/psc.1092; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Terakawa MS, 2015, J BIOL CHEM, V290, P815, DOI 10.1074/jbc.M114.592527; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wong YQ, 2012, FEBS LETT, V586, P1754, DOI 10.1016/j.febslet.2012.05.007; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	72	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20947	20959		10.1074/jbc.M115.664227	http://dx.doi.org/10.1074/jbc.M115.664227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26175149	hybrid, Green Published			2022-12-28	WOS:000360011800029
J	Shah, NB; Duncan, TM				Shah, Naman B.; Duncan, Thomas M.			Aerobic Growth of Escherichia coli Is Reduced, and ATP Synthesis Is Selectively Inhibited when Five C-terminal Residues Are Deleted from the epsilon Subunit of ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; H+-ATPASE; BETA-SUBUNIT; OXIDATIVE-PHOSPHORYLATION; CONFORMATIONAL-CHANGES; F0F1-ATP SYNTHASE; F-1 MOTOR; F-1-ATPASE; F1F0; MUTATIONS	F-type ATP synthases are rotary nanomotor enzymes involved in cellular energy metabolism in eukaryotes and eubacteria. The ATP synthase from Gram-positive and -negative model bacteria can be autoinhibited by the C-terminal domain of its epsilon subunit (epsilon TD), but the importance of epsilon inhibition in vivo is unclear. Functional rotation is thought to be blocked by insertion of the latter half of the epsilon CTD into the central cavity of the catalytic complex (F1). In the inhibited state of the Escherichia coli enzyme, the final segment of epsilon CTD is deeply buried but has few specific interactions with other subunits. This region of the epsilon CTD is variable or absent in other bacteria that exhibit strong epsilon-inhibition in vitro. Here, genetically deleting the last five residues of the epsilon CTD (epsilon Delta 5) caused a greater defect in respiratory growth than did the complete absence of the epsilon CTD. Isolated membranes with epsilon Delta 5 generated proton-motive force by respiration as effectively as with wild-type epsilon but showed a nearly 3-fold decrease in ATP synthesis rate. In contrast, the epsilon Delta 5 truncation did not change the intrinsic rate of ATP hydrolysis with membranes. Further, the epsilon Delta 5 subunit retained high affinity for isolated F-1 but reduced the maximal inhibition of F-1-ATPase by epsilon from >90% to similar to 20%. The results suggest that the epsilon CTD has distinct regulatory interactions with F1 when rotary catalysis operates in opposite directions for the hydrolysis or synthesis of ATP.	[Shah, Naman B.; Duncan, Thomas M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Duncan, TM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	duncant@upstate.edu	Regan, Clinton/E-6250-2012	Duncan, Thomas/0000-0002-6432-4958	National Institutes of Health [R01GM083088]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM083088. The authors declare that they have no conflicts of interest with the contents of this article.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balemans W, 2012, ANTIMICROB AGENTS CH, V56, P4131, DOI 10.1128/AAC.00273-12; Bijlsma JJE, 2000, J INFECT DIS, V182, P1566, DOI 10.1086/315855; Biukovic G, 2013, ANTIMICROB AGENTS CH, V57, P168, DOI 10.1128/AAC.01039-12; Bockenhauer S. D., 2014, P SOC PHOTO-OPT INS, V8950; Borsch M, 2013, BIOCHEM SOC T, V41, P1219, DOI 10.1042/BST20130101; Boogerd FC, 1998, J BACTERIOL, V180, P5855, DOI 10.1128/JB.180.22.5855-5859.1998; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Braman J, 1996, Methods Mol Biol, V57, P31; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Cipriano DJ, 2002, J BIOL CHEM, V277, P16782, DOI 10.1074/jbc.M201349200; Cohen J, 2013, SCIENCE, V339, P130, DOI 10.1126/science.339.6116.130; COX GB, 1992, MOL MECHANISMS BIOEN, P283; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Duncan T. M., 2004, ENZYMES, VXXIII, P203; Duncan TM, 1995, BIOCHEM SOC T, V23, P736, DOI 10.1042/bst0230736; DUNCAN TM, 1985, J BIOL CHEM, V260, P4901; Dunn S. D., 2004, HDB ATPASES, P311; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; Etzold C, 1997, EUR J BIOCHEM, V243, P336, DOI 10.1111/j.1432-1033.1997.0336a.x; Feniouk BA, 2005, FEBS LETT, V579, P5114, DOI 10.1016/j.febslet.2005.08.030; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gibson F, 2000, TRENDS BIOCHEM SCI, V25, P342, DOI 10.1016/S0968-0004(00)01607-8; GIBSON F, 1977, BIOCHEM J, V162, P665, DOI 10.1042/bj1620665; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; HIGASHI T, 1975, J BIOL CHEM, V250, P6541; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Iserte J, 2015, NUCLEIC ACIDS RES, V43, pW320, DOI 10.1093/nar/gkv572; JENSEN PR, 1993, EMBO J, V12, P1277, DOI 10.1002/j.1460-2075.1993.tb05772.x; JOUNOUCHI M, 1992, ARCH BIOCHEM BIOPHYS, V292, P87, DOI 10.1016/0003-9861(92)90054-Z; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; KUKI M, 1988, J BIOL CHEM, V263, P17437; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Lu P, 2014, BBA-BIOENERGETICS, V1837, P1208, DOI 10.1016/j.bbabio.2014.01.022; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P10987, DOI 10.1021/bi00109a025; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Noda S, 2006, J BACTERIOL, V188, P6869, DOI 10.1128/JB.00452-06; Northen H, 2010, VACCINE, V28, P940, DOI 10.1016/j.vaccine.2009.10.146; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; SCHAEFER EM, 1989, J BACTERIOL, V171, P3901, DOI 10.1128/jb.171.7.3901-3908.1989; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tomashek JJ, 2004, J BIOL CHEM, V279, P4465, DOI 10.1074/jbc.M310826200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Unden Gottfried, 2014, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0005-2013; VIK SB, 1988, J BIOL CHEM, V263, P6599; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WilkeMounts S, 1995, ARCH BIOCHEM BIOPHYS, V324, P153, DOI 10.1006/abbi.1995.9915; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; WISE JG, 1990, J BIOL CHEM, V265, P10403; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	77	23	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21032	21041		10.1074/jbc.M115.665059	http://dx.doi.org/10.1074/jbc.M115.665059			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160173	hybrid, Green Published			2022-12-28	WOS:000360011800036
J	Whiting, JL; Nygren, PJ; Tunquist, BJ; Langeberg, LK; Seternes, OM; Scott, JD				Whiting, Jennifer L.; Nygren, Patrick J.; Tunquist, Brian J.; Langeberg, Lorene K.; Seternes, Ole-Morten; Scott, John D.			Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3 beta to A-kinase Anchoring Protein 220	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; SIGNALING COMPLEX; PKA; AKAP; SPECIFICITY; BINDING; INACTIVATION; MECHANISM; MOTIFS; RI	The proximity of an enzyme to its substrate can influence rate and magnitude of catalysis. A-kinase anchoring protein 220 (AKAP220) is a multivalent anchoring protein that can sequester a variety of signal transduction enzymes. These include protein kinase A (PKA) and glycogen synthase kinase 3 beta (GSK3 beta). Using a combination of molecular and cellular approaches we show that GSK3 beta phosphorylation of Thr-1132 on AKAP220 initiates recruitment of this kinase into the enzyme scaffold. We also find that AKAP220 anchors GSK3 beta and its substrate beta-catenin in membrane ruffles. Interestingly, GSK3 beta can be released from the multienzyme complex in response to PKA phosphorylation on serine 9, which suppresses GSK3 beta activity. The signaling scaffold may enhance this regulatory mechanism, as AKAP220 has the capacity to anchor two PKA holoenzymes. Site 1 on AKAP220 (residues 610-623) preferentially interacts with RII, whereas site 2 (residues 1633-1646) exhibits a dual specificity for RI and RII. In vitro affinity measurements revealed that site 2 on AKAP220 binds RII with similar to 10-fold higher affinity than site 1. Occupancy of both R subunit binding sites on AKAP220 could provide a mechanism to amplify local cAMP responses and enable cross-talk between PKA and GSK3 beta.	[Whiting, Jennifer L.; Nygren, Patrick J.; Langeberg, Lorene K.; Seternes, Ole-Morten; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Tunquist, Brian J.] Array BioPharma Inc, Translat Oncol, Boulder, CO 80301 USA; [Seternes, Ole-Morten] Univ Tromso, Arctic Univ Norway, Dept Pharm, N-9037 Tromso, Norway	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Pfizer; Array BioPharma; UiT The Arctic University of Tromso	Scott, JD (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA.	scottjdw@uw.edu	Regan, Clinton/E-6250-2012; Seternes, Ole Morten/M-9520-2019	Seternes, Ole Morten/0000-0001-8537-3612	National Institutes of Health [DK105542, DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105542, P30DK017047, P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK105542 and DK054441.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Asirvatham AL, 2004, J IMMUNOL, V173, P4806, DOI 10.4049/jimmunol.173.8.4806; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Burgers PP, 2015, BIOCHEMISTRY-US, V54, P11, DOI 10.1021/bi500721a; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; CARR DW, 1991, J BIOL CHEM, V266, P14188; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Day ME, 2011, J CELL BIOL, V193, P347, DOI 10.1083/jcb.201010034; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gold MG, 2013, J BIOL CHEM, V288, P17111, DOI 10.1074/jbc.M112.447326; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Hinke SA, 2012, EMBO J, V31, P3991, DOI 10.1038/emboj.2012.244; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Kritzer MD, 2014, CIRC-HEART FAIL, V7, P663, DOI 10.1161/CIRCHEARTFAILURE.114.001266; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Logue Jeremy S, 2011, Small GTPases, V2, P173; Logue JS, 2011, J BIOL CHEM, V286, P39269, DOI 10.1074/jbc.M111.277756; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Prince JT, 2010, MOL CELL, V37, P455, DOI 10.1016/j.molcel.2010.02.010; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Smith FD, 2011, BIOCHEM J, V438, P103, DOI 10.1042/BJ20110720; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026	59	15	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19445	19457		10.1074/jbc.M115.654822	http://dx.doi.org/10.1074/jbc.M115.654822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088133	Green Published, hybrid			2022-12-28	WOS:000359364600005
J	Caetano, SM; Menezes, R; Amaral, C; Rodrigues-Pousada, C; Pimentel, C				Caetano, Soraia M.; Menezes, Regina; Amaral, Catarina; Rodrigues-Pousada, Claudina; Pimentel, Catarina			Repression of the Low Affinity Iron Transporter Gene FET4 A NOVEL MECHANISM AGAINST CADMIUM TOXICITY ORCHESTRATED BY YAP1 VIA ROX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CADMIUM TOLERANCE; ABC TRANSPORTER; HYPOXIC GENES; YEAST; EXPRESSION; PROTEIN; TRANSCRIPTION; TOXICITY; ROX1	Cadmiumis a well known mutagenic metal that can enter cells via nonspecific metal transporters, causing several cellular damages and eventually leading to death. In the yeast Saccharomyces cerevisiae, the transcription factor Yap1 plays a key role in the regulation of several genes involved in metal stress response. We have previously shown that Yap1 represses the expression of FET4, a gene encoding a low affinity iron transporter able to transport metals other than iron. Here, we have studied the relevance of this repression in cell tolerance to cadmium. Our results indicate that genomic deletion of Yap1 increases FET4 transcript and protein levels. In addition, the cadmium toxicity exhibited by this strain is completely reversed by co-deletion of FET4 gene. These data correlate well with the increased intracellular levels of cadmium observed in the mutant yap1. Rox1, a well known aerobic repressor of hypoxic genes, conveys the Yap1-mediated repression of FET4. We further show that, in a scenario where the activity of Yap1 or Rox1 is compromised, cells activate post-transcriptional mechanisms, involving the exoribonuclease Xrn1, to compensate the derepression of FET4. Our data thus reveal a novel protection mechanism against cadmium toxicity mediated by Yap1 that relies on the aerobic repression of FET4 and results in the impairment of cadmium uptake.	[Caetano, Soraia M.; Menezes, Regina; Amaral, Catarina; Rodrigues-Pousada, Claudina; Pimentel, Catarina] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2781901 Oeiras, Portugal; [Menezes, Regina] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal	Universidade Nova de Lisboa	Rodrigues-Pousada, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Ave Republ,EAN, P-2781901 Oeiras, Portugal.	claudina@itqb.unl.pt; pimentel@itqb.unl.pt	Echaniz, Regina Menezes/AAE-8041-2020; Menezes Echaniz, Regina/L-3792-2014	Menezes Echaniz, Regina/0000-0003-0552-8480; Rodrigues-Pousada, Claudina/0000-0002-5075-3639; Caetano, Soraia/0000-0001-7427-5670; Pimentel, Catarina/0000-0002-5158-6414; Amaral, Catarina/0000-0002-9442-2225	Fundacao para Ciencia e Tecnologia [EXPL/BIA-MIC/2525/2013, Pest-OE/EQB/LA0004/2011, SFRH/BD/91077/2012, SFRH/BPD/74294/2010, SFRH/BPD/90823/2012]	Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para Ciencia e Tecnologia through Grants EXPL/BIA-MIC/2525/2013 (to C. P.) and Pest-OE/EQB/LA0004/2011 (to Instituto de Tecnologia Quimica e Biologica) and Fellowships SFRH/BD/91077/2012 (to S. M. C.), SFRH/BPD/74294/2010 (to C. A.), and SFRH/BPD/90823/2012 (to C. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Batista-Nascimento L, 2013, BBA-MOL CELL RES, V1833, P997, DOI 10.1016/j.bbamcr.2012.12.018; Chanfreau C, 2000, P NATL ACAD SCI USA, V97, P3142, DOI 10.1073/pnas.070043997; CHOLLET A, 1983, Toxicological European Research, V5, P71; Clemens S, 1998, P NATL ACAD SCI USA, V95, P12043, DOI 10.1073/pnas.95.20.12043; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; DECKERT J, 1995, GENETICS, V139, P1149; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; DIX DR, 1994, J BIOL CHEM, V269, P26092; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Heo DH, 2010, BIOCHEM J, V431, P257, DOI 10.1042/BJ20100638; Himeno S, 2002, TOHOKU J EXP MED, V196, P43, DOI 10.1620/tjem.196.43; Huang YH, 2006, J CELL BIOCHEM, V98, P577, DOI 10.1002/jcb.20772; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; JEYAPRAKASH A, 1991, MOL GEN GENET, V225, P363, DOI 10.1007/BF00261675; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KENG T, 1992, MOL CELL BIOL, V12, P2616, DOI 10.1128/MCB.12.6.2616; Kern AL, 2005, BIOMETALS, V18, P31, DOI 10.1007/s10534-004-5772-x; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Liu JJ, 2013, ANTIOXID REDOX SIGN, V19, P1916, DOI 10.1089/ars.2012.4589; Liu XF, 1997, J BIOL CHEM, V272, P11763, DOI 10.1074/jbc.272.18.11763; LOWRY CV, 1988, MOL CELL BIOL, V8, P4651, DOI 10.1128/MCB.8.11.4651; Mielniczki-Pereira AA, 2011, TOXICOL LETT, V207, P104, DOI 10.1016/j.toxlet.2011.08.023; Nagy Z, 2006, BIOCHIMIE, V88, P1665, DOI 10.1016/j.biochi.2006.05.014; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Pimentel C, 2014, BBA-GEN SUBJECTS, V1840, P1977, DOI 10.1016/j.bbagen.2014.01.032; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; RHODES ML, 1976, LAB INVEST, V35, P496; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Sharma KG, 2002, EUKARYOT CELL, V1, P391, DOI 10.1128/EC.1.3.391-400.2002; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; TELLMANN G, 2006, NAT METHODS, V3, P3; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wawrzycka D, 2010, FEMS YEAST RES, V10, P828, DOI 10.1111/j.1567-1364.2010.00673.x; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	53	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18584	18595		10.1074/jbc.M114.600742	http://dx.doi.org/10.1074/jbc.M114.600742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26063801	Green Published, hybrid			2022-12-28	WOS:000358512100029
J	Xue, JF; Zhou, AD; Tan, C; Wu, YM; Lee, HT; Li, WL; Xie, KP; Huang, SY				Xue, Jianfei; Zhou, Aidong; Tan, Christina; Wu, Yamei; Lee, Hsueh-Te; Li, Wenliang; Xie, Keping; Huang, Suyun			Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG PATHWAY; GENE-EXPRESSION; FOXM1; TARGET; GLI1; SUPPRESSOR	The transcription factors glioma-associated oncogene homolog 1 (GLI1), a primary marker of Hedgehog pathway activation, and Forkhead box M1 (FOXM1) are aberrantly activated in a wide range of malignancies, including glioma. However, the mechanism of nuclear localization of GLI1 and whether FOXM1 regulates the Hedgehog signaling pathway are poorly understood. Here we found that FOXM1 promotes nuclear import of GLI1 in glioblastoma multiforme cells and thus increases the expression of its target genes. Conversely, knockdown of FOXM1 expression with FOXM1 siRNA abrogated its nuclear import and inhibited the expression of its target genes. Also, genetic deletion of FOXM1 in mouse embryonic fibroblasts abolished nuclear localization of GLI1. We observed that FOXM1 directly binds to the importin-7 (IPO7) promoter and increases its promoter activity. IPO7 interacted with GLI1, leading to enhanced nuclear import of GLI1. Depletion of IPO7 by IPO7 siRNA reduced nuclear accumulation of GLI1. In addition, FOXM1 induced nuclear import of GLI1 by promoting IPO7 expression. Moreover, the FOXM1/IPO7/GLI1 axis promoted cell proliferation, migration, and invasion in vitro. Finally, expression of FOXM1 was markedly correlated with that of GLI1 in human glioblastoma specimens. These data suggest that FOXM1 and GLI1 form a positive feedback loop that contributes to glioblastoma development. Furthermore, our study revealed a mechanism that controls nuclear import of GLI1 in glioblastoma multiforme cells.	[Xue, Jianfei; Zhou, Aidong; Tan, Christina; Wu, Yamei; Lee, Hsueh-Te; Huang, Suyun] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Li, Wenliang] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Li, Wenliang] Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China; [Xie, Keping] Univ Texas Houston, Grad Sch Biomed Sci, Dept Gastroenterol Hepatol, Houston, TX 77030 USA; [Xie, Keping] Univ Texas Houston, Grad Sch Biomed Sci, Dept Nutr, Houston, TX 77030 USA; [Xie, Keping; Huang, Suyun] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Xue, JF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Unit 1004,1515 Holcombe Blvd, Houston, TX 77030 USA.	jfxue09@gmail.com		Zhou, Aidong/0000-0001-8389-9522	National Institutes of Health NCI [R01CA157933, R01CA182684, R01CA152309, P50CA127001, P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA182684, R01CA152309, P30CA016672, P50CA127001, R01CA157933] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health NCI Grants R01CA157933, R01CA182684, R01CA152309, P50CA127001, and P30CA016672 (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Fernandez M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00030; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Cai YQ, 2013, J BIOL CHEM, V288, P22527, DOI 10.1074/jbc.M113.455089; Carpenter RL, 2012, DISCOV MED, V13, P105; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chi SM, 2012, CELL SIGNAL, V24, P1222, DOI 10.1016/j.cellsig.2012.02.004; Dai BB, 2013, J BIOL CHEM, V288, P1634, DOI 10.1074/jbc.M112.379362; Deng WT, 2015, J CELL SCI, V128, P1123, DOI 10.1242/jcs.162164; Gai XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084551; Golomb L, 2012, MOL CELL, V45, P222, DOI 10.1016/j.molcel.2011.11.022; Infante P, 2015, EMBO J, V34, P200, DOI 10.15252/embj.201489213; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kim K, 2010, BIOCHEM J, V427, P413, DOI 10.1042/BJ20091445; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Li X, 2015, ONCOGENE, V34, P1619, DOI 10.1038/onc.2014.98; Li Y, 2012, FUTURE ONCOL, V8, P223, DOI [10.2217/FON.12.1, 10.2217/fon.12.1]; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; POWERS MA, 1994, CELL, V79, P931, DOI 10.1016/0092-8674(94)90024-8; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Szczepny A, 2014, BIOCHEM J, V461, P469, DOI 10.1042/BJ20130709; Teh MT, 2002, CANCER RES, V62, P4773; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Xue JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7156; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	33	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18662	18670		10.1074/jbc.M115.662882	http://dx.doi.org/10.1074/jbc.M115.662882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085085	hybrid, Green Published			2022-12-28	WOS:000358512100035
